data_2k7q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k7q _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 110.372 -0.232 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 23.6 ptm -149.39 159.29 44.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 13.3 m -148.53 151.66 35.5 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.377 1.871 . . . . 0.0 109.774 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -147.32 159.77 43.29 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.9 150.85 24.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.539 1.936 . . . . 0.0 109.796 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -134.07 144.08 48.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.546 1.138 . . . . 0.0 111.972 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 46.8 t -140.37 134.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.64 1.576 . . . . 0.0 109.658 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.89 139.51 21.43 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 124.013 0.816 . . . . 0.0 111.661 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 29.6 m -131.22 132.14 44.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.809 0.804 . . . . 0.0 112.764 -166.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.63 148.64 16.19 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -74.47 150.33 39.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.439 1.095 . . . . 0.0 111.323 170.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -93.28 122.81 36.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.422 1.089 . . . . 0.0 110.667 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.9 mm -112.46 108.73 54.2 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.588 1.155 . . . . 0.0 109.266 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.91 137.62 17.78 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.178 2.585 . . . . 0.0 111.17 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 65.1 mt -145.69 141.14 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.377 1.471 . . . . 0.0 110.21 -170.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.26 61.47 2.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.625 1.57 . . . . 0.0 112.0 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.26 104.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.666 1.186 . . . . 0.0 110.616 -169.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.8 t -172.61 178.74 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.274 1.83 . . . . 0.0 110.543 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.99 45.42 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.018 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.8 p -71.47 138.06 48.69 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.001 1.321 . . . . 0.0 111.364 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 15.0 t70 -85.09 141.13 30.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.436 1.094 . . . . 0.0 111.323 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 -16.95 46.53 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 60.4 m -82.16 -31.93 30.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.038 1.29 . . . . 0.0 114.055 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -99.39 -0.49 40.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.5 1.12 . . . . 0.0 113.845 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.83 146.81 24.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.601 1.161 . . . . 0.0 111.492 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 41.0 p -138.87 162.67 34.23 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.732 2.013 . . . . 0.0 109.448 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.1 145.25 24.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.689 0.795 . . . . 0.0 112.08 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.7 p -138.4 162.57 34.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.148 1.779 . . . . 0.0 109.9 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -120.12 137.59 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.21 1.404 . . . . 0.0 109.462 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.1 t -102.82 111.05 64.6 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.14 1.376 . . . . 0.0 107.832 165.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.28 168.65 22.68 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.042 3.161 . . . . 0.0 110.696 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.55 -18.1 61.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.923 2.415 . . . . 0.0 112.645 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 12.8 m -67.63 -17.18 64.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.84 1.256 . . . . 0.0 113.925 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.87 31.24 54.17 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.61 1.1 . . . . 0.0 114.239 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -125.84 97.57 5.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.318 1.447 . . . . 0.0 110.488 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.93 135.74 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.417 1.087 . . . . 0.0 112.155 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -137.49 151.06 70.39 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.515 1.526 . . . . 0.0 111.097 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.19 156.23 42.11 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.793 2.996 . . . . 0.0 112.664 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.0 m -112.48 154.49 25.8 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.354 1.462 . . . . 0.0 111.751 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 58.2 tp -85.85 120.34 27.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.287 1.035 . . . . 0.0 109.397 170.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 21.9 mt -84.03 141.7 30.99 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.597 1.159 . . . . 0.0 110.95 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.23 139.1 31.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.459 1.503 . . . . 0.0 111.75 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -92.82 109.45 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 160.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.57 164.3 23.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.862 1.265 . . . . 0.0 111.735 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.27 -34.52 68.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -167.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.12 -9.24 58.61 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.19 37.99 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 126.003 1.764 . . . . 0.0 114.435 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.07 156.57 33.78 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 113.351 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.6 t -104.08 143.01 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.137 1.375 . . . . 0.0 110.042 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.2 178.61 28.48 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.557 1.075 . . . . 0.0 115.039 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -116.59 165.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.948 1.699 . . . . 0.0 111.615 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 71.1 p -151.59 150.73 30.64 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 110.678 166.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.7 p90 -167.17 167.59 14.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.945 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 59.5 t -110.67 117.68 50.22 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.816 0.846 . . . . 0.0 109.676 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.45 147.65 28.96 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.944 3.096 . . . . 0.0 110.917 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -105.34 -7.67 18.7 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -145.72 174.93 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.403 2.281 . . . . 0.0 109.687 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 36.3 p -88.56 167.07 13.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.614 1.165 . . . . 0.0 111.21 166.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.05 -170.22 25.97 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.268 1.413 . . . . 0.0 113.79 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.84 117.88 12.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.186 0.994 . . . . 0.0 111.742 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.8 m80 -104.11 143.58 32.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.036 1.734 . . . . 0.0 108.968 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.44 125.31 50.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.993 0.917 . . . . 0.0 110.083 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.1 t -85.62 137.46 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -119.96 114.76 22.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.347 1.459 . . . . 0.0 109.693 169.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 94.1 t -106.48 136.52 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.054 1.341 . . . . 0.0 108.995 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -131.09 142.28 50.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.989 1.315 . . . . 0.0 112.435 -172.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -112.81 121.21 44.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.544 1.938 . . . . 0.0 109.169 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.19 26.27 10.12 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.668 1.187 . . . . 0.0 113.259 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.65 84.85 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.649 1.595 . . . . 0.0 115.452 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.43 134.87 46.07 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.167 1.484 . . . . 0.0 109.64 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 19.3 p80 -63.36 140.15 58.84 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.953 -1.092 . . . . 0.0 113.337 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 16.6 m -78.54 159.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.666 0.786 . . . . 0.0 110.983 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.42 62.76 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.4 m -75.35 -20.76 58.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 56.4 m -82.25 149.89 63.01 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.64 150.24 92.49 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 118.649 0.553 . . . . 0.0 111.949 -5.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -107.41 119.24 51.37 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.86 139.89 12.49 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.806 2.338 . . . . 0.0 111.385 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -134.1 124.35 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.384 1.474 . . . . 0.0 107.643 171.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.4 t -99.75 122.58 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.879 0.872 . . . . 0.0 109.97 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.45 128.14 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.886 1.274 . . . . 0.0 109.655 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.2 t -99.66 161.24 13.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.026 0.931 . . . . 0.0 111.457 170.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -59.54 -31.38 69.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.768 0.827 . . . . 0.0 112.87 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -68.0 -14.93 63.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 113.516 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -92.12 -9.5 42.29 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.564 1.146 . . . . 0.0 112.763 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 44.1 mm -76.49 -31.94 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 0.0 112.948 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.44 47.74 0.04 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -85.43 98.9 10.84 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.261 1.031 . . . . 0.0 110.78 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.44 73.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.482 1.113 . . . . 0.0 113.495 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.9 p -56.78 -23.4 42.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 113.91 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -84.84 -14.45 47.92 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.213 1.405 . . . . 0.0 113.913 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.5 t -75.12 135.42 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.641 1.11 . . . . 0.0 110.524 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -113.53 156.88 22.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.381 1.472 . . . . 0.0 111.329 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.55 159.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.697 1.599 . . . . 0.0 110.706 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -159.95 175.69 12.74 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.577 1.151 . . . . 0.0 112.419 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.84 161.73 30.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.239 1.399 . . . . 0.0 114.189 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -72.16 -28.24 63.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.582 1.153 . . . . 0.0 113.398 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.45 -4.29 37.21 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.703 1.144 . . . . 0.0 115.24 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.28 -4.39 58.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.323 1.449 . . . . 0.0 112.76 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -134.53 -40.12 0.8 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.812 1.245 . . . . 0.0 113.876 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.22 152.51 44.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 111.267 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.38 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 122.256 0.92 . . . . 0.0 114.748 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 66.0 m80 -135.43 160.06 39.63 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.543 1.937 . . . . 0.0 110.29 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 16.9 p -71.21 -68.55 0.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.37 0.668 . . . . 0.0 111.498 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -82.44 -14.59 54.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -166.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -104.89 136.71 19.13 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 0.0 109.349 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.49 152.34 54.3 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -105.2 136.77 44.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.018 1.327 . . . . 0.0 110.708 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.4 148.49 42.48 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.282 1.433 . . . . 0.0 113.123 -175.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.5 p90 -155.76 153.61 30.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.369 1.468 . . . . 0.0 111.456 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.87 142.36 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.013 1.725 . . . . 0.0 109.655 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.74 134.69 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.251 1.82 . . . . 0.0 108.621 171.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.84 101.87 7.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.662 1.585 . . . . 0.0 110.833 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.7 p -100.33 -1.64 35.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.515 1.926 . . . . 0.0 112.946 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -57.95 -40.49 80.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.282 1.033 . . . . 0.0 111.627 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.02 -5.62 56.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.477 1.511 . . . . 0.0 113.27 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -101.68 -3.96 27.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.871 1.668 . . . . 0.0 114.734 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.57 -118.86 4.83 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.03 0.824 . . . . 0.0 111.163 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -121.49 165.06 16.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.236 1.415 . . . . 0.0 112.752 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.35 -140.05 7.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.635 1.112 . . . . 0.0 113.188 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -158.87 137.99 5.47 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 124.169 0.89 . . . . 0.0 112.501 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.19 122.52 40.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.488 1.915 . . . . 0.0 109.477 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 12.3 m -110.5 139.86 45.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 110.014 165.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -136.51 134.49 37.63 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.348 1.059 . . . . 0.0 110.174 -168.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.8 m -135.48 125.3 25.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.573 0.749 . . . . 0.0 110.667 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.8 mt -104.07 130.72 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.614 1.166 . . . . 0.0 108.224 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -127.94 147.92 50.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.555 1.542 . . . . 0.0 109.781 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 169.72 -157.81 29.65 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.349 -0.845 . . . . 0.0 114.83 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.5 -20.18 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 113.885 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -151.47 169.84 21.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.567 1.076 . . . . 0.0 112.527 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.19 149.27 50.57 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 9.3 m -132.71 146.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.427 1.091 . . . . 0.0 111.442 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -85.48 111.67 20.2 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.216 0.606 . . . . 0.0 109.821 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.06 132.84 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.392 1.077 . . . . 0.0 109.555 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -128.85 158.58 38.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.158 1.783 . . . . 0.0 110.626 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 32.8 p -139.75 153.63 47.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.132 1.373 . . . . 0.0 111.658 -174.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.41 115.6 4.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.06 1.344 . . . . 0.0 110.461 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.58 129.22 34.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.548 1.139 . . . . 0.0 110.858 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 62.7 mt -101.47 153.84 19.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.546 1.138 . . . . 0.0 112.007 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.81 -18.61 64.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.312 1.045 . . . . 0.0 113.253 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.89 -9.05 58.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.984 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.23 -1.37 62.58 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.084 1.802 . . . . 0.0 114.783 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.0 p -88.87 166.3 14.06 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.117 1.767 . . . . 0.0 111.678 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.0 t -114.85 126.3 54.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 0.0 110.777 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -87.98 134.59 33.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.506 1.122 . . . . 0.0 109.466 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.1 t -117.01 141.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.234 1.814 . . . . 0.0 108.275 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.1 p -134.58 151.24 50.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 110.926 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.95 149.86 29.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.578 0.751 . . . . 0.0 112.955 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.2 t -120.84 99.47 47.06 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.932 1.293 . . . . 0.0 110.192 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.25 135.85 12.36 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.265 2.643 . . . . 0.0 111.829 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 98.2 m -78.3 -46.46 20.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.068 0.547 . . . . 0.0 111.734 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -99.84 148.17 34.43 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.795 1.238 . . . . 0.0 111.06 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 165.26 29.31 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.435 2.757 . . . . 0.0 111.26 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 138.2 -152.59 21.96 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 113.184 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.2 t30 -107.03 121.99 45.57 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.242 1.017 . . . . 0.0 110.663 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -104.45 144.5 31.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.898 1.279 . . . . 0.0 111.104 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.1 130.37 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.716 1.607 . . . . 0.0 107.943 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.1 mt -112.34 121.83 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.638 1.175 . . . . 0.0 109.265 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -100.51 124.85 46.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.582 1.553 . . . . 0.0 109.907 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 34.4 mm -116.56 111.17 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 108.882 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 132.56 53.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.919 1.288 . . . . 0.0 111.276 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 75.3 t80 -125.24 124.14 41.05 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 109.723 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.59 44.67 27.3 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.359 1.064 . . . . 0.0 112.982 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 70.7 m-20 66.39 19.91 10.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.345 2.258 . . . . 0.0 114.634 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -125.53 130.6 52.07 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.593 1.557 . . . . 0.0 110.113 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -71.54 125.65 27.62 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 120.892 -1.13 . . . . 0.0 111.237 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.2 m -78.8 157.44 76.66 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.159 -0.963 . . . . 0.0 111.905 -168.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.87 142.27 64.0 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.83 3.02 . . . . 0.0 113.69 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.34 5.72 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.018 1.294 . . . . 0.0 113.999 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -76.29 144.61 75.0 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-N 118.282 1.041 . . . . 0.0 110.585 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.58 144.52 79.28 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 120.567 1.238 . . . . 0.0 112.273 4.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.76 117.81 35.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.391 1.077 . . . . 0.0 110.427 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.8 p -86.41 136.78 32.99 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.078 0.951 . . . . 0.0 111.395 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.2 t -133.96 113.1 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.203 1.401 . . . . 0.0 109.446 -168.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -77.93 118.29 20.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.99 0.516 . . . . 0.0 110.722 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 81.7 t -110.88 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.879 1.672 . . . . 0.0 109.036 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 9.3 t -104.3 154.36 19.9 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.464 1.106 . . . . 0.0 111.301 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -176.76 173.82 46.58 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.716 1.151 . . . . 0.0 114.484 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 126.188 1.795 . . . . 0.0 111.027 178.225 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.8 ptm -144.69 156.93 44.34 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.175 0.99 . . . . 0.0 113.445 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 65.4 m -138.96 148.5 43.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -138.52 156.47 47.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.333 1.053 . . . . 0.0 113.705 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.9 tt -159.82 150.61 19.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.932 1.693 . . . . 0.0 110.431 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.33 148.23 52.13 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 0.0 112.724 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 53.0 t -139.11 134.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.073 1.749 . . . . 0.0 109.375 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.42 123.94 6.99 Favored Glycine 0 N--CA 1.471 0.987 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 70.9 m -97.19 123.3 40.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.272 1.029 . . . . 0.0 111.526 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -125.33 115.28 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.37 1.468 . . . . 0.0 110.013 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.04 142.72 47.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.145 0.578 . . . . 0.0 111.805 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.51 130.58 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.711 1.204 . . . . 0.0 111.586 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.6 mm -122.43 120.86 27.86 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.367 1.467 . . . . 0.0 108.461 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 145.05 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.451 2.101 . . . . 0.0 110.922 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.47 145.13 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.852 1.661 . . . . 0.0 108.51 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.2 t30 -42.46 114.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.093 1.357 . . . . 0.0 113.596 -166.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.35 135.97 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.869 0.868 . . . . 0.0 110.757 -160.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.4 t -159.84 175.7 12.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.729 1.611 . . . . 0.0 110.527 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.11 33.93 0.5 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 112.664 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -71.97 139.03 48.45 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.578 1.551 . . . . 0.0 111.412 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.19 131.06 36.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.098 0.959 . . . . 0.0 111.469 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.75 -14.98 59.43 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 50.8 m -85.7 -24.05 27.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.659 1.118 . . . . 0.0 113.383 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pp -107.26 3.98 26.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.171 1.388 . . . . 0.0 113.98 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.66 146.98 23.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.252 1.421 . . . . 0.0 111.166 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 58.1 p -140.51 152.99 46.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.435 1.494 . . . . 0.0 110.121 167.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.19 148.39 43.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.422 1.089 . . . . 0.0 112.582 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 2.5 p -147.01 132.37 18.54 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.966 2.106 . . . . 0.0 109.552 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -91.7 136.72 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.22 1.008 . . . . 0.0 109.937 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 90.1 t -109.98 113.76 56.8 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.078 1.351 . . . . 0.0 108.372 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.03 172.77 11.61 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.074 3.183 . . . . 0.0 111.232 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.48 -32.53 53.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.977 3.118 . . . . 0.0 113.875 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 16.4 m -74.14 -10.56 59.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.726 1.21 . . . . 0.0 114.238 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.28 74.87 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.523 1.535 . . . . 0.0 115.173 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -75.62 87.62 2.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.811 1.644 . . . . 0.0 111.297 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.65 135.31 57.31 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.261 1.025 . . . . 0.0 111.892 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -140.24 147.18 49.06 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.136 1.375 . . . . 0.0 111.474 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.2 152.49 45.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.934 3.089 . . . . 0.0 112.066 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.6 m -114.11 150.15 34.53 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.05 1.34 . . . . 0.0 112.052 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.86 115.5 28.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.476 1.11 . . . . 0.0 109.033 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.4 mt -78.78 131.15 36.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.106 1.362 . . . . 0.0 111.131 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 95.8 mttt -132.2 142.03 49.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.191 1.397 . . . . 0.0 112.545 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -93.17 122.04 35.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.57 1.148 . . . . 0.0 108.058 161.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.3 mt -100.8 172.71 6.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.841 1.656 . . . . 0.0 112.577 -165.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -57.55 -35.75 70.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.6 1.56 . . . . 0.0 115.038 -165.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 4.46 44.22 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.245 1.018 . . . . 0.0 113.13 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 90.67 -6.36 82.11 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.485 1.517 . . . . 0.0 113.896 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -71.95 162.71 29.06 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.603 1.561 . . . . 0.0 113.153 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 93.1 t -112.07 141.97 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.462 1.505 . . . . 0.0 109.634 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.0 -176.17 24.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.168 0.89 . . . . 0.0 115.164 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.19 165.91 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.475 1.91 . . . . 0.0 111.063 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 66.3 p -149.07 152.57 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.315 1.046 . . . . 0.0 111.278 167.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.4 p90 -169.32 -172.06 1.41 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.585 2.354 . . . . 0.0 109.522 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.8 t -133.77 118.71 14.56 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 0.0 110.085 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.76 147.82 22.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.615 3.544 . . . . 0.0 111.264 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.1 mptt -100.66 -13.25 18.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.045 0.938 . . . . 0.0 113.194 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -139.97 167.8 21.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.187 2.195 . . . . 0.0 110.104 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.0 p -85.24 167.8 15.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.685 1.194 . . . . 0.0 111.435 168.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.29 -174.04 22.69 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.523 1.535 . . . . 0.0 114.059 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.95 113.08 9.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.2 1.0 . . . . 0.0 111.467 -175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -96.97 144.18 27.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 109.169 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.8 mt -103.08 126.41 50.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.764 0.825 . . . . 0.0 110.043 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.5 t -89.71 112.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.903 1.281 . . . . 0.0 107.744 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -92.83 138.51 31.43 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.115 . . . . 0.0 109.665 169.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.3 p -151.55 135.93 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.4 -0.813 . . . . 0.0 111.363 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -137.78 145.71 42.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.451 1.1 . . . . 0.0 113.935 -162.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -114.2 127.08 55.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.737 2.415 . . . . 0.0 109.121 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.58 24.0 8.29 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.265 1.026 . . . . 0.0 113.636 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.83 4.41 65.29 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.442 1.496 . . . . 0.0 115.979 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -127.91 141.56 51.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.832 1.816 . . . . 0.0 111.706 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -61.29 138.27 58.24 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.255 -0.903 . . . . 0.0 113.182 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 19.1 m -74.09 163.02 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.388 0.675 . . . . 0.0 111.334 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.15 -24.85 65.05 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 64.4 m -86.67 -12.26 48.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 28.6 t -86.9 143.14 34.81 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 120.771 -1.205 . . . . 0.0 112.757 -172.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.99 156.85 88.04 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.495 0.855 . . . . 0.0 112.836 -3.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.02 126.99 28.09 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.781 1.632 . . . . 0.0 109.127 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.33 141.22 14.19 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.989 2.459 . . . . 0.0 111.594 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 24.7 t -134.25 122.08 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.863 1.665 . . . . 0.0 107.68 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.8 t -97.53 122.42 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.669 0.788 . . . . 0.0 110.179 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.29 117.76 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.804 1.242 . . . . 0.0 108.942 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 59.3 m -92.69 161.54 14.51 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.091 0.956 . . . . 0.0 111.479 172.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.73 -31.86 70.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.991 -1.068 . . . . 0.0 112.197 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.0 m -59.68 -14.31 13.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.323 1.449 . . . . 0.0 114.202 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -100.11 -9.8 22.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.75 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 38.0 mm -80.89 -27.77 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.747 -1.22 . . . . 0.0 112.856 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 169.1 38.7 0.03 OUTLIER Glycine 0 N--CA 1.469 0.844 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.46 96.93 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.197 0.998 . . . . 0.0 111.259 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.59 93.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.9 0.88 . . . . 0.0 112.356 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.3 m -61.44 -18.89 61.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.705 1.202 . . . . 0.0 113.87 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -89.06 -10.22 48.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.445 1.498 . . . . 0.0 114.36 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.8 t -74.66 137.56 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.18 1.355 . . . . 0.0 110.111 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.3 mmt-85 -121.14 161.19 22.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 110.675 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.4 m -147.94 160.97 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.292 1.437 . . . . 0.0 110.999 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -158.41 175.58 13.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.733 1.213 . . . . 0.0 112.285 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 94.99 161.49 34.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.263 1.411 . . . . 0.0 114.08 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -73.81 -26.77 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 113.611 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.19 -2.25 39.23 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.918 1.247 . . . . 0.0 115.364 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.93 -6.83 50.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.542 1.537 . . . . 0.0 112.674 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.36 -39.95 2.29 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.334 1.453 . . . . 0.0 113.163 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.24 155.68 32.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 0.0 113.233 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.08 -174.41 19.86 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.715 1.626 . . . . 0.0 113.382 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 60.5 m80 -138.57 147.48 43.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.467 1.107 . . . . 0.0 112.7 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.4 p -71.82 -19.79 61.93 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -116.23 -1.9 12.27 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -143.67 147.57 39.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.368 1.467 . . . . 0.0 110.492 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.35 142.43 45.32 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.865 2.377 . . . . 0.0 111.204 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 152.39 20.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.631 1.172 . . . . 0.0 110.246 168.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.58 148.07 51.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.887 0.875 . . . . 0.0 112.362 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.14 151.2 27.97 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.61 140.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.953 1.701 . . . . 0.0 109.508 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.92 136.45 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.638 1.575 . . . . 0.0 108.758 169.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.2 t0 -125.93 99.06 5.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.223 1.809 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.2 p -96.48 1.3 51.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.231 1.812 . . . . 0.0 113.085 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -58.65 -39.34 80.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.539 1.063 . . . . 0.0 112.697 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.65 -13.84 59.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.457 1.103 . . . . 0.0 113.249 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -93.52 -5.35 49.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.878 1.671 . . . . 0.0 113.618 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.14 -119.31 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.733 1.158 . . . . 0.0 112.172 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.55 161.54 16.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.377 1.871 . . . . 0.0 112.498 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 138.29 -176.8 20.53 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.065 0.84 . . . . 0.0 115.117 169.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -92.92 123.21 7.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.459 1.028 . . . . 0.0 111.985 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.33 123.0 42.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.119 1.768 . . . . 0.0 108.394 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -114.72 140.79 48.59 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.288 1.435 . . . . 0.0 110.829 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 2.9 tp -125.61 137.39 53.89 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.362 1.865 . . . . 0.0 109.656 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 68.2 m -138.59 126.66 22.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.254 0.622 . . . . 0.0 110.277 167.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 30.0 mt -111.3 135.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.541 1.136 . . . . 0.0 108.466 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -145.4 154.87 42.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.284 1.034 . . . . 0.0 112.246 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.48 -155.67 26.49 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.879 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.92 -10.21 27.19 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.124 3.216 . . . . 0.0 114.286 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.2 t -152.94 164.3 38.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.662 1.185 . . . . 0.0 111.1 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -69.98 144.23 52.38 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.135 -0.978 . . . . 0.0 111.171 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 17.8 m -125.02 151.93 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 0.0 110.962 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -97.26 131.25 44.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.776 0.83 . . . . 0.0 110.064 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.1 135.37 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.132 1.373 . . . . 0.0 109.737 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.57 164.89 24.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 111.069 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.0 p -136.36 160.22 39.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.482 1.513 . . . . 0.0 112.227 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -154.33 122.53 6.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.362 1.465 . . . . 0.0 110.041 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.25 128.56 33.68 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.419 1.088 . . . . 0.0 110.58 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -101.16 152.43 20.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 111.84 -173.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -66.42 -20.33 66.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.283 1.033 . . . . 0.0 113.423 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.2 t0 -80.25 -3.93 51.18 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.112 1.365 . . . . 0.0 113.256 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.37 0.65 67.27 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.606 1.574 . . . . 0.0 114.571 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 18.5 p -88.76 167.7 13.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.604 1.962 . . . . 0.0 111.558 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 45.6 t -121.42 124.88 45.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.096 0.958 . . . . 0.0 111.207 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -84.18 135.49 34.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.775 1.23 . . . . 0.0 109.642 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.71 141.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.901 1.681 . . . . 0.0 108.587 164.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 3.2 p -130.54 148.74 52.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 110.761 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -157.45 148.65 21.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.428 1.091 . . . . 0.0 111.818 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.9 t -118.33 102.65 50.2 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.862 0.865 . . . . 0.0 111.145 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.58 145.88 23.7 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.245 2.63 . . . . 0.0 110.221 173.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 96.6 m -104.87 -38.62 6.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.984 0.914 . . . . 0.0 112.74 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -103.08 147.53 34.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.929 1.292 . . . . 0.0 110.627 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.89 168.31 23.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.498 2.799 . . . . 0.0 111.902 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 131.98 -145.63 17.35 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 125.126 1.346 . . . . 0.0 112.129 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -123.85 129.72 51.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.565 0.746 . . . . 0.0 111.664 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -108.39 143.65 37.03 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.552 1.541 . . . . 0.0 110.373 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 135.99 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.959 1.304 . . . . 0.0 109.0 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 25.7 mt -117.76 122.97 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.095 1.358 . . . . 0.0 109.385 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -102.06 127.62 48.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.965 1.706 . . . . 0.0 110.269 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 18.9 mm -120.02 112.22 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.877 1.271 . . . . 0.0 109.345 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -122.83 134.42 54.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.316 1.446 . . . . 0.0 111.215 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.9 t80 -127.22 123.93 37.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.486 1.514 . . . . 0.0 110.249 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.02 31.09 12.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.423 1.489 . . . . 0.0 114.069 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.59 12.51 0.68 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.337 2.655 . . . . 0.0 114.679 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -116.76 133.88 55.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.673 1.189 . . . . 0.0 110.71 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -72.06 126.74 30.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 110.946 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.7 m -79.44 153.84 76.44 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.318 -0.864 . . . . 0.0 110.954 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.94 146.86 91.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.816 2.344 . . . . 0.0 112.113 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.49 -29.25 6.3 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.263 1.411 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 3.7 t -78.47 145.48 67.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.076 0.95 . . . . 0.0 110.682 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.54 140.5 67.64 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.507 1.217 . . . . 0.0 111.875 2.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.71 116.0 28.24 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.987 0.915 . . . . 0.0 109.936 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 10.3 p -87.53 124.22 33.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.662 1.185 . . . . 0.0 110.651 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.1 t -121.21 114.98 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 109.733 -167.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -76.99 119.64 21.01 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.368 0.667 . . . . 0.0 111.168 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.7 t -109.24 125.84 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.076 1.35 . . . . 0.0 109.342 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.9 t -125.16 168.83 12.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.032 1.333 . . . . 0.0 112.279 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 118.28 148.36 8.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.293 1.901 . . . . 0.0 112.701 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 126.419 1.888 . . . . 0.0 109.729 -173.143 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.0 ptm -161.77 151.25 16.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.495 1.518 . . . . 0.0 111.969 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.2 m -130.54 147.53 52.24 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.445 1.898 . . . . 0.0 108.509 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -149.81 160.58 43.45 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -170.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.04 134.2 15.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.004 2.122 . . . . 0.0 108.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -128.04 139.59 52.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.202 1.001 . . . . 0.0 110.896 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.4 p -156.84 139.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.952 0.901 . . . . 0.0 111.764 -175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -73.62 152.91 46.82 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.079 0.847 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 52.1 m -139.83 133.06 29.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.449 1.1 . . . . 0.0 111.174 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -164.54 150.77 10.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.767 0.827 . . . . 0.0 112.864 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -76.99 151.24 35.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 111.197 168.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 141.85 28.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.852 1.261 . . . . 0.0 112.358 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.3 mt -125.45 111.5 25.84 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.034 1.334 . . . . 0.0 108.38 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.82 139.79 17.9 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.988 2.459 . . . . 0.0 110.376 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 66.7 mt -139.34 136.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.306 1.042 . . . . 0.0 110.451 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 52.47 82.18 0.07 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.007 2.123 . . . . 0.0 112.56 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.7 mm -83.14 43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.705 1.202 . . . . 0.0 110.495 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 60.4 m -132.24 -57.42 0.96 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.277 1.431 . . . . 0.0 111.963 -173.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -162.9 107.29 1.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.873 0.869 . . . . 0.0 111.628 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.7 p -141.78 160.83 39.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.585 1.954 . . . . 0.0 110.139 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -151.56 126.77 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.608 1.163 . . . . 0.0 110.81 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.86 -15.25 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 56.5 m -80.65 -9.88 59.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.693 1.133 . . . . 0.0 113.415 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.93 7.42 2.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.53 145.9 24.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.613 1.165 . . . . 0.0 111.84 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 22.8 p -141.94 152.01 43.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.939 2.096 . . . . 0.0 108.829 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.63 149.2 27.33 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 73.1 p -141.68 162.45 35.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.126 2.17 . . . . 0.0 110.056 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -118.07 137.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.275 1.43 . . . . 0.0 109.976 169.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.2 t -105.77 114.12 63.2 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.172 1.389 . . . . 0.0 108.396 167.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.67 173.55 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.166 3.244 . . . . 0.0 111.272 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.22 -33.4 54.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.063 3.175 . . . . 0.0 114.097 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.6 m -75.78 -8.24 56.37 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.29 -1.62 75.12 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.459 1.505 . . . . 0.0 115.196 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -76.9 88.82 3.48 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.445 1.498 . . . . 0.0 111.299 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.47 129.6 41.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.278 1.031 . . . . 0.0 111.796 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -130.63 149.28 73.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.084 1.754 . . . . 0.0 110.6 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.39 153.76 35.59 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.795 2.996 . . . . 0.0 112.547 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 79.8 m -99.16 155.94 17.21 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 112.24 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.7 tt -93.91 113.03 24.96 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.305 1.442 . . . . 0.0 108.101 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mt -83.05 136.37 34.51 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.886 1.275 . . . . 0.0 111.246 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -137.95 143.8 40.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.74 1.216 . . . . 0.0 113.533 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -94.17 122.31 36.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 155.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.49 167.6 11.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.379 1.472 . . . . 0.0 112.303 -166.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.04 -29.9 67.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.34 1.25 53.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.21 1.004 . . . . 0.0 113.341 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.64 67.54 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.804 1.669 . . . . 0.0 114.772 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -77.12 168.97 19.18 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.383 1.473 . . . . 0.0 113.443 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 77.8 t -112.05 140.3 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.452 1.501 . . . . 0.0 110.486 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.12 -171.81 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.355 0.978 . . . . 0.0 115.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.1 162.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.502 1.521 . . . . 0.0 112.458 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 37.0 m -132.33 159.83 38.05 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.946 1.699 . . . . 0.0 110.438 161.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.29 -177.05 5.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.425 1.89 . . . . 0.0 109.998 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.8 t -130.27 121.05 19.33 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.795 0.838 . . . . 0.0 109.738 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.71 139.01 15.51 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.95 3.1 . . . . 0.0 110.799 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 55.6 tptt -88.95 -20.03 25.01 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -135.55 176.01 9.06 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.494 1.918 . . . . 0.0 110.897 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 76.1 p -92.1 164.3 13.64 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.534 1.133 . . . . 0.0 111.053 167.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 100.24 -168.41 20.99 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.156 1.36 . . . . 0.0 113.928 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.58 112.84 11.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 0.0 111.941 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 19.3 m80 -100.66 141.25 33.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.851 1.66 . . . . 0.0 109.129 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.39 125.82 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 109.648 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.7 t -86.85 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 108.099 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -101.64 134.39 44.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.796 1.239 . . . . 0.0 109.915 170.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.2 p -139.75 128.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.278 1.037 . . . . 0.0 112.202 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -115.84 141.71 47.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.599 2.359 . . . . 0.0 111.01 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -137.11 118.71 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.574 2.35 . . . . 0.0 109.357 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.4 t30 56.34 29.02 14.33 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.761 1.224 . . . . 0.0 113.685 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 95.42 3.91 61.14 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.135 1.35 . . . . 0.0 116.169 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -137.62 153.77 49.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.567 1.684 . . . . 0.0 111.482 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -65.27 142.28 58.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.65 -1.281 . . . . 0.0 113.156 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 61.5 t -67.24 147.87 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.624 1.17 . . . . 0.0 109.457 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.05 64.28 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 11.5 m -76.18 -14.18 60.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.581 1.552 . . . . 0.0 114.002 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 10.1 t -85.67 141.57 36.32 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.674 1.19 . . . . 0.0 112.861 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.15 154.2 86.09 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.506 0.859 . . . . 0.0 112.56 -4.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.6 118.88 56.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.58 1.552 . . . . 0.0 108.582 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.16 140.71 12.52 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.071 2.514 . . . . 0.0 111.038 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 16.0 t -137.62 125.34 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.818 1.647 . . . . 0.0 108.118 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.4 t -97.78 122.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.683 0.793 . . . . 0.0 110.192 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.92 131.06 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.17 1.388 . . . . 0.0 110.023 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.9 t -95.24 171.82 8.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.81 1.244 . . . . 0.0 112.331 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -23.36 62.96 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.525 -1.359 . . . . 0.0 112.938 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 4.2 m -74.6 -12.72 60.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -117.71 6.59 12.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.47 1.508 . . . . 0.0 113.744 -173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.45 -39.5 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.024 0.93 . . . . 0.0 112.658 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.0 42.01 0.03 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 123.833 0.73 . . . . 0.0 114.211 -169.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.23 104.97 6.02 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 117.861 0.831 . . . . 0.0 111.981 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.64 93.49 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.523 -0.736 . . . . 0.0 112.797 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 19.4 m -60.09 -27.5 67.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.208 1.003 . . . . 0.0 113.256 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -80.73 -10.4 59.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.398 1.479 . . . . 0.0 114.246 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 93.4 t -81.91 136.09 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.036 1.289 . . . . 0.0 109.455 172.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -131.74 156.8 45.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.24 1.416 . . . . 0.0 110.737 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.6 m -144.7 158.77 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.818 1.247 . . . . 0.0 111.666 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 95.1 p -158.34 172.57 18.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.819 1.247 . . . . 0.0 112.863 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.94 153.09 28.08 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.893 1.235 . . . . 0.0 113.169 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -77.29 -16.46 58.96 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -168.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.06 29.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.704 1.145 . . . . 0.0 114.748 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -87.96 -3.96 58.86 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.683 1.593 . . . . 0.0 112.785 168.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -134.24 -39.57 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.832 1.253 . . . . 0.0 113.936 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.26 148.81 40.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.191 1.396 . . . . 0.0 111.362 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.95 175.86 26.12 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.728 1.156 . . . . 0.0 113.838 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 61.7 m80 -132.13 154.6 49.33 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.284 1.434 . . . . 0.0 111.811 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 9.9 p -67.11 -65.86 0.63 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.394 1.078 . . . . 0.0 112.796 -175.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.77 7.49 44.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.26 1.024 . . . . 0.0 113.507 -166.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.58 143.17 43.89 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.751 2.02 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.48 152.2 48.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.691 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -101.03 162.48 12.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.617 1.567 . . . . 0.0 110.924 168.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.69 149.95 34.46 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 50.2 p90 -159.85 153.73 23.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.695 1.598 . . . . 0.0 111.18 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 142.17 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 109.523 -172.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 39.7 mt -120.24 136.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.519 1.927 . . . . 0.0 109.391 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.0 125.53 41.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.577 1.551 . . . . 0.0 111.892 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 40.3 p -122.35 -13.43 8.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.31 -25.41 68.03 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.632 1.56 . . . . 0.0 114.732 -170.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.15 -16.52 60.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.218 1.007 . . . . 0.0 112.892 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.64 49.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.534 1.534 . . . . 0.0 113.669 172.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 80.52 -119.33 4.88 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.597 1.094 . . . . 0.0 112.063 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -92.49 169.58 10.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.521 1.528 . . . . 0.0 112.822 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.51 -138.49 7.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.009 1.29 . . . . 0.0 112.739 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -178.2 136.15 2.89 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 124.352 0.977 . . . . 0.0 112.017 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.88 122.92 40.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.736 1.614 . . . . 0.0 109.651 -175.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 46.1 m -112.21 132.91 54.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 109.476 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -130.03 135.83 48.71 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.33 1.452 . . . . 0.0 109.633 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 71.0 m -130.6 140.24 50.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.585 0.754 . . . . 0.0 111.01 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.4 mt -118.17 127.11 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.105 1.362 . . . . 0.0 107.764 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.36 140.42 46.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.207 1.403 . . . . 0.0 109.535 -168.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 171.38 -155.82 25.03 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.809 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 -22.69 27.53 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.379 2.719 . . . . 0.0 113.682 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 63.8 m -145.48 160.04 42.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.568 1.147 . . . . 0.0 112.367 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -67.31 146.3 54.25 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.182 0.993 . . . . 0.0 111.228 169.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -130.17 149.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.718 1.607 . . . . 0.0 110.769 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.46 105.46 17.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.768 0.827 . . . . 0.0 110.122 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 41.0 mt -85.51 130.49 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -126.29 157.36 38.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 110.418 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.9 p -144.5 153.45 41.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.795 1.238 . . . . 0.0 112.279 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -158.1 134.99 9.85 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.118 1.367 . . . . 0.0 110.591 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -80.98 131.97 35.35 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.712 0.805 . . . . 0.0 111.905 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.92 168.81 13.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.452 1.501 . . . . 0.0 111.332 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -32.11 69.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.91 -7.52 54.75 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.307 1.443 . . . . 0.0 113.518 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 88.02 6.76 75.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.484 1.516 . . . . 0.0 114.114 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 22.2 p -80.42 154.17 27.82 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.747 1.619 . . . . 0.0 110.617 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -100.35 119.14 37.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.456 0.702 . . . . 0.0 110.597 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -86.54 133.19 33.75 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.698 0.799 . . . . 0.0 109.519 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 19.2 t -113.4 138.05 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.67 1.988 . . . . 0.0 108.645 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 23.9 p -135.85 151.93 50.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.426 1.49 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -163.16 153.16 15.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 111.811 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.4 t -119.31 100.59 49.88 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.405 1.082 . . . . 0.0 110.91 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.75 85.56 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.687 2.925 . . . . 0.0 110.937 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 18.7 m -54.42 -39.41 67.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 0.0 113.936 -170.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -95.32 140.09 22.26 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.259 1.024 . . . . 0.0 111.014 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 165.38 31.98 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.694 2.93 . . . . 0.0 112.358 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 139.54 -160.08 25.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.0 1.286 . . . . 0.0 113.115 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -107.27 119.55 39.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.186 0.994 . . . . 0.0 110.513 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.89 141.31 36.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.463 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.56 131.47 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.237 1.415 . . . . 0.0 108.063 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.7 mt -110.21 119.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.423 1.089 . . . . 0.0 108.901 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -102.14 124.43 47.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 110.697 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.73 115.53 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.394 1.477 . . . . 0.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.7 134.87 48.61 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 0.0 111.604 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -126.99 124.47 39.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.864 1.666 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.78 34.78 19.87 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.022 1.329 . . . . 0.0 113.683 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.4 t70 89.71 -0.65 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.269 3.027 . . . . 0.0 113.929 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -119.39 132.82 55.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.688 1.195 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -69.15 128.42 36.57 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.278 1.431 . . . . 0.0 111.93 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -85.67 160.65 52.83 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 119.133 0.879 . . . . 0.0 112.155 -169.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.92 149.27 43.05 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.071 3.18 . . . . 0.0 114.471 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 80.65 -30.0 2.58 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.222 1.392 . . . . 0.0 113.827 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -72.83 142.58 83.4 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 110.547 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.03 139.59 62.54 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 120.631 1.261 . . . . 0.0 111.896 6.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.14 111.92 24.19 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.066 0.946 . . . . 0.0 110.21 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 67.3 m -85.57 127.41 34.44 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.982 0.913 . . . . 0.0 110.888 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -124.43 112.1 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.66 1.584 . . . . 0.0 109.35 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.56 118.17 21.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.859 0.463 . . . . 0.0 110.722 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.0 t -104.11 124.76 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.874 1.67 . . . . 0.0 109.193 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.1 t -124.87 162.88 23.42 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 112.367 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 122.98 159.22 10.46 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.297 1.903 . . . . 0.0 113.096 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 125.797 1.639 . . . . 0.0 110.223 -173.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 28.3 ttt -118.54 129.35 55.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.669 1.188 . . . . 0.0 111.094 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 4.3 m -123.26 141.77 51.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.947 1.699 . . . . 0.0 108.589 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -156.8 162.02 39.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.4 tt -154.69 145.49 22.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.852 2.061 . . . . 0.0 110.261 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -135.29 143.71 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.609 1.164 . . . . 0.0 112.184 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 42.6 t -132.88 134.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 110.143 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.01 63.71 4.35 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 125.349 1.452 . . . . 0.0 112.057 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 10.1 m -58.51 124.77 20.74 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 114.154 -171.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -156.8 150.02 24.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.114 1.366 . . . . 0.0 111.69 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.71 153.44 21.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.131 0.972 . . . . 0.0 111.382 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -90.73 139.66 30.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.668 1.187 . . . . 0.0 112.116 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 36.1 mm -125.27 123.85 25.21 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 108.935 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.44 149.73 45.11 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.771 2.314 . . . . 0.0 111.526 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.91 148.37 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.089 1.756 . . . . 0.0 108.805 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 53.3 t30 -44.05 116.47 1.0 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.363 1.465 . . . . 0.0 113.772 -170.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 5.1 mp -87.38 130.42 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.008 1.323 . . . . 0.0 109.749 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.7 t -164.16 -175.59 4.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.209 1.403 . . . . 0.0 111.134 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.78 1.0 21.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.631 1.572 . . . . 0.0 113.658 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.1 m -57.33 133.5 55.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.568 1.947 . . . . 0.0 111.338 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.44 122.3 19.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.193 0.997 . . . . 0.0 111.402 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.22 -20.48 60.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.033 0.933 . . . . 0.0 113.076 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 67.5 m -72.97 -18.24 61.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -109.38 5.83 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.665 1.586 . . . . 0.0 113.494 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.3 146.31 29.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.592 1.557 . . . . 0.0 111.455 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 49.9 p -134.59 168.42 19.02 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.222 1.809 . . . . 0.0 109.854 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -145.33 141.76 28.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.821 0.849 . . . . 0.0 112.243 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 64.2 p -135.2 163.35 30.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.693 1.997 . . . . 0.0 109.428 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -115.78 136.55 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.802 1.241 . . . . 0.0 109.55 167.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.0 t -107.03 113.21 62.73 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.59 1.556 . . . . 0.0 108.17 167.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -80.24 173.47 12.49 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.289 3.326 . . . . 0.0 111.272 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.18 -28.01 49.6 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.196 3.264 . . . . 0.0 114.83 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.0 p -79.03 -9.18 59.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.789 1.235 . . . . 0.0 114.143 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.3 0.25 88.71 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.46 1.505 . . . . 0.0 114.695 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.61 84.43 3.28 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.518 1.527 . . . . 0.0 111.491 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.87 133.4 55.4 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.643 1.177 . . . . 0.0 112.009 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.81 149.65 59.98 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.412 1.485 . . . . 0.0 110.986 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.11 154.52 42.05 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.93 3.087 . . . . 0.0 112.669 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 84.9 m -108.24 153.45 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.094 1.358 . . . . 0.0 112.686 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 63.4 tp -88.11 112.57 22.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.455 1.102 . . . . 0.0 109.938 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.75 134.41 33.58 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.967 1.307 . . . . 0.0 111.165 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -142.9 148.86 37.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.008 1.323 . . . . 0.0 112.911 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -80.49 122.38 26.93 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.023 1.329 . . . . 0.0 108.364 160.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.41 177.36 6.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.316 1.446 . . . . 0.0 112.704 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -53.84 -43.03 69.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.504 1.522 . . . . 0.0 114.218 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.17 4.42 53.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.718 1.207 . . . . 0.0 113.688 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.74 -7.02 74.11 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.883 1.23 . . . . 0.0 114.403 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.05 174.24 8.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.894 1.278 . . . . 0.0 112.602 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -127.9 142.47 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.38 1.472 . . . . 0.0 109.548 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.17 34.35 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.72 163.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.12 1.768 . . . . 0.0 112.731 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 4.4 m -137.89 155.4 48.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 110.336 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 16.8 p90 -164.16 -176.07 4.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.185 2.594 . . . . 0.0 108.909 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.2 t -131.35 123.3 19.5 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 119.105 0.866 . . . . 0.0 109.246 169.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.5 148.2 26.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.038 3.158 . . . . 0.0 111.441 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -107.79 -8.34 16.06 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.21 172.74 12.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.027 2.131 . . . . 0.0 109.78 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 168.0 15.17 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.639 1.176 . . . . 0.0 111.529 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.61 -170.39 26.73 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.122 1.344 . . . . 0.0 114.013 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.69 115.09 10.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.221 1.008 . . . . 0.0 111.687 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.0 m80 -98.27 144.05 28.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.757 1.623 . . . . 0.0 109.134 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.59 126.99 54.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.237 1.015 . . . . 0.0 109.544 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.5 t -85.55 118.87 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.41 96.6 7.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.535 1.534 . . . . 0.0 110.089 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 89.0 t -86.08 137.71 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.855 1.662 . . . . 0.0 108.975 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.3 mttm -133.64 131.75 39.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.145 0.978 . . . . 0.0 112.99 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 80.6 tttt -96.25 119.49 34.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.063 1.345 . . . . 0.0 109.281 161.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.46 22.87 5.36 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.845 1.258 . . . . 0.0 114.074 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.14 3.7 88.77 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.401 1.477 . . . . 0.0 115.582 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -106.28 23.28 14.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.397 1.479 . . . . 0.0 113.305 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.7 m-70 65.26 -170.77 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.936 1.694 . . . . 0.0 112.527 -172.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 34.1 m -136.29 171.84 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.943 1.297 . . . . 0.0 110.795 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.7 -29.7 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.5 m -89.46 -10.47 46.27 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.8 p -89.98 153.99 47.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 120.709 -1.244 . . . . 0.0 113.715 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.8 157.16 95.2 Favored 'Cis proline' 0 C--N 1.353 0.78 0 CA-C-N 118.856 0.627 . . . . 0.0 112.41 -4.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.01 122.81 39.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.703 1.201 . . . . 0.0 108.774 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.64 146.36 11.96 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.043 2.495 . . . . 0.0 112.576 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 19.4 t -137.52 125.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.985 1.714 . . . . 0.0 107.921 170.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.2 t -102.09 124.69 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.701 0.8 . . . . 0.0 110.635 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.36 139.53 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.439 1.496 . . . . 0.0 110.232 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 15.2 t -116.7 164.71 14.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.817 1.247 . . . . 0.0 111.449 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.04 -37.65 77.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.401 1.08 . . . . 0.0 112.738 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 48.8 m -60.71 -18.41 54.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.63 -6.63 32.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.166 1.386 . . . . 0.0 113.142 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.61 -32.88 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.086 -1.009 . . . . 0.0 112.701 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 140.42 29.61 0.19 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.754 1.169 . . . . 0.0 113.641 -168.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 28.2 t0 -73.34 114.57 11.69 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.421 1.11 . . . . 0.0 110.685 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.72 74.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.811 0.844 . . . . 0.0 113.015 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 60.4 p -66.85 -21.03 66.03 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.986 -1.071 . . . . 0.0 113.196 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -77.9 -14.85 59.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.775 1.23 . . . . 0.0 113.399 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 48.3 t -79.7 132.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.618 1.099 . . . . 0.0 110.08 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -113.87 154.49 27.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.764 1.625 . . . . 0.0 110.57 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.81 149.75 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.209 1.404 . . . . 0.0 111.008 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 74.6 m -150.78 160.41 43.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.925 1.29 . . . . 0.0 112.325 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 113.76 162.92 14.89 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.418 1.009 . . . . 0.0 115.021 171.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -65.23 -34.42 78.31 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.675 1.59 . . . . 0.0 113.249 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.82 -1.65 33.04 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.934 1.254 . . . . 0.0 115.053 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.1 mt -90.2 -7.27 53.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.401 1.481 . . . . 0.0 112.689 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -128.33 -36.32 1.92 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.834 1.253 . . . . 0.0 113.794 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -158.78 158.09 32.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.683 1.193 . . . . 0.0 112.396 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -154.81 -174.91 25.31 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.441 1.019 . . . . 0.0 114.166 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -141.71 137.97 32.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.324 1.45 . . . . 0.0 111.18 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.2 p -63.48 146.65 53.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.265 0.626 . . . . 0.0 111.307 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 4.4 m-85 73.93 -4.73 2.19 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.069 2.148 . . . . 0.0 113.896 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -120.97 148.4 48.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.795 2.038 . . . . 0.0 110.191 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.47 125.06 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 110.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -86.57 145.51 26.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.273 1.029 . . . . 0.0 109.54 165.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.48 151.45 50.95 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -158.51 152.13 23.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.163 1.785 . . . . 0.0 110.548 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.19 140.46 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.538 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.2 mt -114.57 136.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.281 1.832 . . . . 0.0 109.094 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 57.5 t0 -123.08 100.92 7.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.045 1.738 . . . . 0.0 110.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.9 p -99.2 4.25 46.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.581 1.952 . . . . 0.0 112.831 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.85 -33.15 71.4 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.489 1.041 . . . . 0.0 112.835 -173.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.24 -10.03 55.38 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.376 1.47 . . . . 0.0 113.383 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.84 -9.76 19.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.17 1.788 . . . . 0.0 114.08 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 69.38 -134.89 26.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.954 1.264 . . . . 0.0 114.008 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -74.04 167.36 21.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.079 1.352 . . . . 0.0 112.635 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.97 -116.99 0.97 Allowed Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.558 1.075 . . . . 0.0 112.022 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . 176.2 116.32 0.45 Allowed Glycine 0 N--CA 1.465 0.612 0 C-N-CA 123.87 0.748 . . . . 0.0 112.812 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.03 124.97 29.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.496 1.118 . . . . 0.0 109.517 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 69.0 m -124.52 144.59 50.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.773 1.629 . . . . 0.0 109.616 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -144.35 132.46 21.66 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.344 0.658 . . . . 0.0 110.223 -164.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 49.6 m -132.53 139.03 47.71 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.604 0.762 . . . . 0.0 111.098 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.9 mt -123.93 138.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.723 1.609 . . . . 0.0 108.622 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.94 157.56 44.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 161.85 -146.31 11.93 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.873 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.62 -11.27 24.15 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.582 2.855 . . . . 0.0 113.989 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.8 t -155.97 161.08 40.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.594 1.088 . . . . 0.0 112.411 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 130.39 35.09 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.299 1.44 . . . . 0.0 109.727 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.7 m -114.23 157.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.158 1.383 . . . . 0.0 111.856 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -92.5 126.13 37.45 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.501 0.72 . . . . 0.0 109.813 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.7 mt -106.67 134.64 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 109.427 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -131.87 162.59 30.23 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.014 1.726 . . . . 0.0 111.056 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 23.0 p -137.99 159.95 40.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.391 1.476 . . . . 0.0 112.079 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.83 122.76 6.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.236 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 128.6 34.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.726 1.21 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 69.5 mt -104.41 151.3 23.68 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.507 1.123 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.35 -17.55 64.27 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.734 0.813 . . . . 0.0 113.057 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -70.69 -10.8 60.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.439 1.496 . . . . 0.0 113.453 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.71 -3.2 70.9 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.153 1.835 . . . . 0.0 114.187 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 42.6 p -87.85 168.97 12.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.252 1.821 . . . . 0.0 111.319 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -123.81 127.15 47.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.992 0.917 . . . . 0.0 111.408 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -79.51 135.08 36.54 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.229 165.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 48.0 t -113.14 139.78 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.173 1.789 . . . . 0.0 108.381 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.2 p -133.83 150.47 51.41 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 111.565 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.0 p90 -155.19 146.94 23.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.524 1.13 . . . . 0.0 112.019 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 38.3 t -113.73 106.93 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.275 1.03 . . . . 0.0 111.179 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.67 145.77 16.42 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.571 2.847 . . . . 0.0 111.059 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 91.5 m -104.01 -47.13 4.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -86.61 143.23 35.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.12 162.13 28.98 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.346 2.697 . . . . 0.0 111.3 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.54 -164.69 24.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.24 1.4 . . . . 0.0 113.566 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -90.59 118.99 30.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.499 0.719 . . . . 0.0 111.059 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -100.21 141.1 33.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.719 1.208 . . . . 0.0 110.107 167.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.56 131.05 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.503 1.121 . . . . 0.0 108.359 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.5 mt -113.61 130.58 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.292 1.437 . . . . 0.0 109.372 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -114.19 123.95 50.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.595 1.558 . . . . 0.0 110.115 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.91 119.78 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.065 0.946 . . . . 0.0 109.693 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -122.99 136.48 54.87 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.866 2.066 . . . . 0.0 109.787 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.04 122.13 22.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.661 1.185 . . . . 0.0 110.239 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.67 45.11 27.33 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.901 1.28 . . . . 0.0 111.987 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.6 t0 73.03 -4.47 2.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.848 2.859 . . . . 0.0 114.744 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -101.33 132.52 46.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.571 1.148 . . . . 0.0 110.748 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -69.65 125.61 27.24 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.229 1.012 . . . . 0.0 111.292 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -79.32 153.5 76.67 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.218 -0.926 . . . . 0.0 111.025 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.02 140.97 81.82 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.666 2.244 . . . . 0.0 111.647 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.66 22.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.376 1.465 . . . . 0.0 113.745 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 66.6 m -76.73 153.55 83.28 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 118.594 1.197 . . . . 0.0 111.993 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.56 142.83 73.38 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.311 0.789 . . . . 0.0 111.352 -7.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -96.18 116.52 29.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.415 1.086 . . . . 0.0 110.205 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 58.0 m -83.1 128.67 34.69 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.737 0.815 . . . . 0.0 110.449 169.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -127.07 110.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.541 1.537 . . . . 0.0 109.207 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -78.58 107.73 11.46 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.035 0.534 . . . . 0.0 110.763 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.0 t -94.47 118.06 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.787 1.235 . . . . 0.0 108.806 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -90.3 150.71 21.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.874 0.87 . . . . 0.0 110.847 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -177.2 160.23 27.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.26 0.933 . . . . 0.0 114.552 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 0.0 113.605 -176.094 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 121.199 0.523 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 20.3 ptm -158.76 163.04 37.11 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.618 1.567 . . . . 0.0 112.417 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 19.3 m -136.99 143.9 43.03 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.419 1.888 . . . . 0.0 109.097 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -143.58 165.15 28.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -164.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.65 155.65 32.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.868 2.067 . . . . 0.0 110.5 -175.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 61.1 mttm -136.94 143.83 43.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.444 1.498 . . . . 0.0 111.478 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 57.8 t -141.04 135.66 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.832 1.653 . . . . 0.0 109.534 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.29 133.32 11.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.898 0.761 . . . . 0.0 112.045 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 62.5 m -120.3 146.58 45.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.89 1.276 . . . . 0.0 112.602 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -157.03 150.65 24.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.493 1.117 . . . . 0.0 112.589 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.58 148.86 25.3 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.401 1.081 . . . . 0.0 111.229 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -86.56 126.98 34.85 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.806 1.243 . . . . 0.0 111.203 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.6 mm -113.22 113.29 48.98 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 124.926 1.29 . . . . 0.0 109.01 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.11 138.57 20.58 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.989 2.459 . . . . 0.0 110.948 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 55.2 mt -143.35 136.5 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.82 1.248 . . . . 0.0 109.713 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 11.5 t30 59.22 69.82 0.69 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.305 1.842 . . . . 0.0 113.058 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.68 104.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.73 0.812 . . . . 0.0 109.657 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.6 t -173.69 -168.56 0.44 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.971 2.108 . . . . 0.0 109.928 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.16 51.93 1.05 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.1 1.76 . . . . 0.0 111.893 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 91.9 m -83.72 124.04 30.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.545 1.538 . . . . 0.0 109.773 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -90.46 126.53 35.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.702 1.201 . . . . 0.0 110.258 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -31.06 55.91 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.941 1.296 . . . . 0.0 112.132 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 57.3 m -73.02 -22.92 60.57 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -160.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -111.72 2.47 17.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.402 1.481 . . . . 0.0 114.079 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.79 152.25 20.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.066 1.347 . . . . 0.0 112.084 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.0 p -140.77 172.42 12.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.62 2.368 . . . . 0.0 108.641 165.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -156.56 160.29 39.33 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 78.3 p -133.07 161.5 34.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.461 1.905 . . . . 0.0 109.824 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -111.75 135.13 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.953 1.301 . . . . 0.0 109.243 166.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.8 t -103.52 110.66 64.23 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.74 1.216 . . . . 0.0 107.89 163.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.09 169.43 17.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.766 2.977 . . . . 0.0 110.897 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.51 -19.75 65.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.902 2.401 . . . . 0.0 112.025 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 1.9 m -68.66 -10.57 57.02 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.642 1.577 . . . . 0.0 113.668 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 77.62 -13.3 12.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.131 1.824 . . . . 0.0 115.411 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -80.51 94.92 6.34 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.833 1.253 . . . . 0.0 111.181 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.64 133.97 55.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.161 0.984 . . . . 0.0 111.473 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.28 150.75 62.41 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.356 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.82 156.23 34.95 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.942 3.095 . . . . 0.0 112.882 -176.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 88.7 m -104.93 153.04 21.92 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.35 1.46 . . . . 0.0 112.244 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -96.79 116.72 29.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.468 1.507 . . . . 0.0 107.956 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.88 137.54 32.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.199 1.0 . . . . 0.0 110.613 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.31 137.56 47.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.693 1.197 . . . . 0.0 112.766 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -89.23 120.05 30.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.768 1.227 . . . . 0.0 107.796 160.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.65 164.65 12.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.021 1.328 . . . . 0.0 111.804 -169.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -69.88 -24.3 63.39 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -159.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -90.57 0.1 57.48 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.146 0.979 . . . . 0.0 113.549 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.96 -6.48 54.2 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 125.394 1.473 . . . . 0.0 114.146 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -74.35 174.04 9.41 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.359 1.464 . . . . 0.0 113.197 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 30.3 m -134.46 152.15 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.239 1.416 . . . . 0.0 110.931 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -162.0 -170.84 27.31 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.972 0.796 . . . . 0.0 115.064 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.39 158.89 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.403 1.481 . . . . 0.0 112.686 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 53.4 m -132.24 153.82 50.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.595 1.558 . . . . 0.0 111.047 165.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.2 p90 -165.63 -169.88 1.67 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.769 2.428 . . . . 0.0 108.913 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 92.0 t -133.99 120.75 15.38 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 119.924 1.238 . . . . 0.0 110.29 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.86 147.69 17.09 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.341 3.36 . . . . 0.0 111.279 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.7 -12.29 17.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.79 172.93 12.33 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.856 2.062 . . . . 0.0 109.969 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.9 p -86.1 171.15 11.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.06 1.344 . . . . 0.0 111.89 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.54 -170.03 26.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.075 1.321 . . . . 0.0 113.874 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.46 117.61 12.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.097 0.959 . . . . 0.0 111.78 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.2 m80 -104.24 143.57 32.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.042 1.737 . . . . 0.0 109.269 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.1 122.24 44.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.257 1.023 . . . . 0.0 109.352 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 50.9 t -91.55 125.35 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.157 1.383 . . . . 0.0 108.558 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -110.22 113.53 26.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.217 1.407 . . . . 0.0 110.189 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 42.3 t -102.66 139.49 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.332 1.453 . . . . 0.0 109.36 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -144.81 142.32 29.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -172.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.87 121.41 44.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.052 2.541 . . . . 0.0 109.58 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.1 t30 53.35 30.13 9.78 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.374 1.069 . . . . 0.0 113.545 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.05 66.08 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.64 1.59 . . . . 0.0 115.587 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -101.11 133.3 45.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.28 1.432 . . . . 0.0 110.903 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.06 139.6 57.37 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 91.2 t -76.02 142.52 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.254 1.422 . . . . 0.0 108.874 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.79 62.76 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 20.0 m -76.93 -12.63 59.98 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.832 1.253 . . . . 0.0 114.022 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 47.9 m -84.43 153.79 62.22 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.582 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.98 152.11 88.51 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-O 121.357 0.482 . . . . 0.0 112.306 -4.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.06 124.6 37.92 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.959 1.304 . . . . 0.0 108.742 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.74 137.14 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.887 2.391 . . . . 0.0 111.145 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 48.9 t -133.07 124.34 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.411 1.484 . . . . 0.0 107.815 172.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.7 t -96.87 125.35 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.822 0.849 . . . . 0.0 110.372 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.84 125.74 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.128 1.371 . . . . 0.0 109.198 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.3 t -93.39 158.75 15.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.022 0.929 . . . . 0.0 111.905 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -58.29 -31.58 67.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.09 0.956 . . . . 0.0 113.02 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 24.5 m -66.06 -18.42 65.33 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.2 1.0 . . . . 0.0 113.644 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -92.07 -13.0 31.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.473 1.109 . . . . 0.0 112.703 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.6 mm -70.12 -26.19 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.356 1.062 . . . . 0.0 112.491 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 149.8 63.4 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.356 0.979 . . . . 0.0 113.586 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -76.57 94.19 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.382 0.673 . . . . 0.0 110.922 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.82 61.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.483 1.113 . . . . 0.0 112.627 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.4 p -55.78 -22.82 26.28 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.97 1.708 . . . . 0.0 114.639 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -94.53 -7.98 39.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.306 1.442 . . . . 0.0 113.688 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.2 t -73.98 138.45 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.637 1.108 . . . . 0.0 110.693 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -114.8 147.48 39.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.584 1.554 . . . . 0.0 111.796 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.6 m -143.82 144.17 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.787 1.635 . . . . 0.0 109.807 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.4 m -149.09 156.08 41.68 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.254 -173.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 118.1 162.56 12.37 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 124.706 1.146 . . . . 0.0 114.186 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -65.47 -30.25 71.01 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.729 1.212 . . . . 0.0 113.377 -170.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.1 -1.6 34.78 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.713 1.149 . . . . 0.0 114.878 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.4 -7.67 56.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.182 1.393 . . . . 0.0 112.554 167.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -130.06 -37.55 1.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.161 1.384 . . . . 0.0 114.056 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.19 158.62 37.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.157 0.983 . . . . 0.0 113.405 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.67 -173.37 20.08 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.435 1.493 . . . . 0.0 113.271 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -136.5 146.35 46.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.398 1.079 . . . . 0.0 112.784 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.9 p -67.27 -21.48 65.7 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -120.56 -0.81 10.2 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -142.8 148.45 46.05 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.176 1.39 . . . . 0.0 110.592 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.81 145.33 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.88 2.387 . . . . 0.0 111.76 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -91.14 153.14 20.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.028 1.331 . . . . 0.0 110.442 169.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.53 148.17 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.882 0.873 . . . . 0.0 113.063 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -159.04 149.28 19.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 110.74 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 141.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.256 1.822 . . . . 0.0 109.332 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.72 138.14 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.288 1.835 . . . . 0.0 109.634 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 22.0 t0 -136.7 117.64 14.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 111.69 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 12.4 p -123.34 -10.36 8.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -165.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -64.58 -23.62 67.33 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.539 1.518 . . . . 0.0 114.526 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -19.9 61.51 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.286 1.034 . . . . 0.0 112.785 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -90.51 -0.65 57.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.823 1.649 . . . . 0.0 113.672 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.46 -120.61 5.31 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.06 1.314 . . . . 0.0 112.196 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -107.25 165.43 11.38 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.016 1.726 . . . . 0.0 112.386 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.59 -178.07 19.14 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 115.229 0.852 . . . . 0.0 115.229 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.2 126.44 8.75 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.699 1.142 . . . . 0.0 112.022 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.26 121.25 36.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.289 1.835 . . . . 0.0 108.313 170.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 70.5 m -113.81 146.44 39.94 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.615 1.566 . . . . 0.0 110.867 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -141.34 133.55 27.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.42 1.088 . . . . 0.0 110.233 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.5 m -140.39 123.79 16.93 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.697 0.799 . . . . 0.0 110.929 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.16 137.97 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.454 1.502 . . . . 0.0 108.819 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -144.11 157.39 44.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.183 1.393 . . . . 0.0 110.675 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.24 -151.85 22.52 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.788 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.11 -10.73 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.832 3.022 . . . . 0.0 114.881 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.7 t -160.18 168.6 25.06 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 120.001 1.273 . . . . 0.0 112.666 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.54 151.14 47.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.404 1.481 . . . . 0.0 111.247 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.8 m -135.65 147.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.106 0.963 . . . . 0.0 112.029 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.21 129.82 34.84 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.899 -0.501 . . . . 0.0 109.939 166.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.9 133.91 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 109.174 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.35 158.99 39.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.249 1.82 . . . . 0.0 109.923 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 53.0 p -138.25 159.43 42.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.709 1.204 . . . . 0.0 111.705 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -154.58 116.01 4.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.587 1.155 . . . . 0.0 110.02 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.18 136.19 37.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.979 0.912 . . . . 0.0 111.389 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.79 161.14 15.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.126 1.37 . . . . 0.0 111.819 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.28 -15.89 62.95 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.83 -4.76 53.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.31 0.72 84.62 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.727 1.632 . . . . 0.0 114.203 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 20.8 p -83.51 170.46 14.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.552 1.941 . . . . 0.0 111.212 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 22.3 t -127.09 126.36 42.87 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.875 0.87 . . . . 0.0 111.056 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 28.1 ttm105 -78.11 140.28 39.04 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.201 1.0 . . . . 0.0 109.345 164.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -121.22 137.46 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.049 1.74 . . . . 0.0 108.24 167.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.3 p -135.34 148.93 49.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.323 1.449 . . . . 0.0 111.422 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.04 149.38 21.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.396 1.079 . . . . 0.0 112.218 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 20.4 t -113.78 104.25 55.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.96 0.904 . . . . 0.0 111.385 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.48 135.41 11.77 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.417 2.745 . . . . 0.0 110.554 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.3 m -89.88 -40.14 12.6 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.785 0.834 . . . . 0.0 112.133 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -92.58 149.5 38.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.494 1.118 . . . . 0.0 111.386 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.77 164.88 31.21 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 111.127 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 115.77 -165.01 12.15 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.11 1.338 . . . . 0.0 113.634 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.83 119.18 30.83 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.456 0.702 . . . . 0.0 112.009 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -97.43 141.71 30.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.719 1.207 . . . . 0.0 110.438 163.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.1 134.04 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.651 1.181 . . . . 0.0 108.778 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.18 125.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.452 1.101 . . . . 0.0 109.173 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -99.21 124.73 44.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.546 1.538 . . . . 0.0 109.293 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.32 122.53 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.222 1.009 . . . . 0.0 108.911 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -128.66 136.75 51.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.517 1.927 . . . . 0.0 110.27 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 31.1 t80 -133.8 126.03 29.72 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.713 1.205 . . . . 0.0 110.463 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 33.07 14.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.888 1.275 . . . . 0.0 112.988 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t0 79.75 2.54 2.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 114.44 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.23 133.22 49.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.458 1.103 . . . . 0.0 111.29 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -66.05 122.36 17.22 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.076 1.351 . . . . 0.0 110.668 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -78.91 160.69 71.0 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.146 -0.971 . . . . 0.0 111.651 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.89 138.23 69.12 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.582 2.854 . . . . 0.0 113.141 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.91 -23.15 21.83 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.816 1.198 . . . . 0.0 113.899 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 51.5 m -69.86 144.66 93.58 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.052 1.426 . . . . 0.0 111.327 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.2 137.2 48.81 Favored 'Cis proline' 0 C--N 1.351 0.666 0 CA-C-N 119.618 0.899 . . . . 0.0 111.021 -6.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.35 117.25 28.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.98 0.912 . . . . 0.0 110.268 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 18.3 m -83.08 128.75 34.76 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.501 0.721 . . . . 0.0 111.086 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.7 t -124.04 109.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.184 1.793 . . . . 0.0 108.957 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -79.05 106.04 10.8 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.344 0.658 . . . . 0.0 111.143 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 73.9 t -87.7 121.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -110.39 165.0 12.14 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.859 1.264 . . . . 0.0 111.576 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 136.09 -137.18 8.92 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.178 1.37 . . . . 0.0 112.692 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 CA--C 1.546 0.798 0 C-N-CA 124.505 1.122 . . . . 0.0 111.381 -169.697 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.874 0.368 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.1 ptm -156.94 155.63 31.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.104 0.961 . . . . 0.0 113.296 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.5 m -138.92 152.07 47.43 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.549 . . . . 0.0 110.207 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -143.92 157.63 44.22 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.3 tt -158.78 150.94 21.34 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.017 1.727 . . . . 0.0 110.542 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 94.2 mttt -132.99 148.27 52.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.323 1.049 . . . . 0.0 112.339 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 58.3 t -136.05 131.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.944 1.698 . . . . 0.0 109.57 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -82.43 107.17 2.79 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 15.3 m -83.45 -45.19 13.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -166.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 56.98 -161.16 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.528 1.531 . . . . 0.0 112.865 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -160.68 149.29 16.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.231 1.812 . . . . 0.0 110.398 169.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.2 124.7 35.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 111.106 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.49 116.56 33.41 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.465 1.106 . . . . 0.0 109.359 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.51 144.4 44.94 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.569 2.179 . . . . 0.0 111.167 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.85 146.19 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.685 1.594 . . . . 0.0 108.417 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -46.92 120.14 2.88 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.861 1.264 . . . . 0.0 113.887 -169.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.49 71.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.959 1.303 . . . . 0.0 109.694 -169.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 62.2 p -94.36 -20.38 19.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -163.59 149.08 11.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.062 1.345 . . . . 0.0 111.255 -171.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.3 p -76.25 -11.39 59.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.113 1.365 . . . . 0.0 114.666 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -26.83 28.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.454 1.502 . . . . 0.0 113.25 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -14.36 9.45 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.687 1.195 . . . . 0.0 113.498 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 16.5 m -73.74 -16.28 61.19 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.94 -1.1 . . . . 0.0 113.922 172.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.51 -7.52 2.52 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.9 mp -71.04 166.52 21.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.603 1.561 . . . . 0.0 112.106 168.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 38.5 p -135.61 157.82 45.92 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.024 1.73 . . . . 0.0 110.743 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -146.26 161.77 39.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.217 1.007 . . . . 0.0 113.414 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 37.0 p -132.71 142.01 48.85 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.587 1.955 . . . . 0.0 109.973 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 55.3 t -90.72 127.53 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.352 1.061 . . . . 0.0 108.647 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.7 t -101.68 109.34 59.09 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 108.027 167.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.35 168.04 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.74 2.96 . . . . 0.0 110.634 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.23 -14.01 41.55 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.103 2.535 . . . . 0.0 113.563 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 63.4 p -78.1 -10.33 59.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.519 1.127 . . . . 0.0 113.752 168.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.57 -1.5 87.68 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.778 1.656 . . . . 0.0 114.952 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -79.15 82.76 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.109 1.364 . . . . 0.0 111.508 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.75 132.62 54.51 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.172 1.389 . . . . 0.0 112.051 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -141.65 150.03 55.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.504 1.522 . . . . 0.0 110.701 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.38 152.47 66.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.366 2.71 . . . . 0.0 112.242 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 29.1 p -127.96 148.97 50.53 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.586 1.154 . . . . 0.0 111.301 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 60.0 tp -90.13 126.94 35.97 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.335 1.054 . . . . 0.0 110.257 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.93 140.72 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.235 0.614 . . . . 0.0 110.108 170.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -137.41 137.34 38.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.258 1.423 . . . . 0.0 111.801 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -71.91 126.49 29.88 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.3 mt -105.39 163.77 12.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.948 1.299 . . . . 0.0 111.444 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -66.35 -21.62 66.25 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 -160.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 59.3 t30 -88.73 2.59 53.13 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 119.433 1.015 . . . . 0.0 113.221 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.56 -5.36 70.19 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 125.99 1.757 . . . . 0.0 113.787 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -76.8 -178.77 5.01 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.829 1.652 . . . . 0.0 113.199 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 46.9 t -136.07 141.3 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.128 1.371 . . . . 0.0 109.885 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -150.01 179.75 26.5 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.22 161.96 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.11 1.764 . . . . 0.0 111.614 173.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 47.1 t -147.78 135.63 21.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.272 1.429 . . . . 0.0 110.742 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.97 -176.73 2.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.387 1.875 . . . . 0.0 111.266 -171.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 84.1 t -131.01 125.09 21.01 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.88 1.272 . . . . 0.0 108.999 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.08 145.65 24.85 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.066 3.177 . . . . 0.0 111.209 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.04 1.83 22.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.503 1.121 . . . . 0.0 113.147 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -139.3 172.55 12.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.179 2.191 . . . . 0.0 109.989 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.6 p -99.42 165.98 11.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.166 1.386 . . . . 0.0 110.921 168.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 90.23 -163.96 30.58 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.815 1.198 . . . . 0.0 113.523 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.7 120.07 15.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.892 0.877 . . . . 0.0 111.833 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.6 m80 -107.95 145.82 33.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.207 1.803 . . . . 0.0 109.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.08 126.53 52.47 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.437 1.095 . . . . 0.0 109.87 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 76.8 t -91.48 108.05 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.265 1.426 . . . . 0.0 108.291 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.42 124.41 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 110.2 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -124.71 133.21 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.398 1.079 . . . . 0.0 110.651 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.61 145.96 51.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.845 1.258 . . . . 0.0 113.609 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.6 tttt -118.82 125.99 50.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.546 1.938 . . . . 0.0 109.514 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 9.9 t-20 55.83 25.93 9.03 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.914 1.286 . . . . 0.0 113.969 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.74 -0.85 77.49 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.38 1.467 . . . . 0.0 115.762 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.51 149.22 38.48 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.399 1.6 . . . . 0.0 111.114 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.8 p80 -70.97 147.87 48.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.7 t -73.03 151.28 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.684 1.194 . . . . 0.0 109.544 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.42 -26.24 60.83 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 52.8 p -86.93 -8.01 57.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.432 1.493 . . . . 0.0 114.062 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.0 t -86.76 146.8 42.0 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.075 1.35 . . . . 0.0 112.696 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.36 157.48 82.56 Favored 'Cis proline' 0 C--N 1.351 0.69 0 CA-C-N 119.281 0.779 . . . . 0.0 112.23 -7.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.31 126.38 32.38 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.063 1.345 . . . . 0.0 109.126 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.18 140.95 14.27 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.925 2.416 . . . . 0.0 111.677 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.5 t -134.33 124.59 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.713 1.605 . . . . 0.0 107.648 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.1 t -99.31 124.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.804 0.842 . . . . 0.0 110.438 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.96 123.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.224 1.41 . . . . 0.0 109.356 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.8 t -89.88 152.82 21.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.61 0.764 . . . . 0.0 111.172 170.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -58.56 -27.98 65.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 21.2 m -71.84 -18.57 62.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.043 0.937 . . . . 0.0 112.968 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -89.92 -6.84 55.33 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.101 -0.999 . . . . 0.0 112.769 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.47 -29.84 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.321 1.048 . . . . 0.0 112.194 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.33 61.0 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.029 0.823 . . . . 0.0 114.213 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -74.41 97.89 3.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 117.769 0.784 . . . . 0.0 110.958 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.86 71.42 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.93 0.892 . . . . 0.0 112.179 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 38.6 p -54.65 -28.62 48.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.816 1.647 . . . . 0.0 114.257 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -90.59 -6.3 54.82 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.236 1.414 . . . . 0.0 113.969 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 73.6 t -73.36 136.5 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.874 1.216 . . . . 0.0 109.719 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -115.47 156.36 25.79 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.463 1.505 . . . . 0.0 110.659 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -145.02 156.37 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.227 1.411 . . . . 0.0 110.782 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.91 167.62 28.92 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.164 0.986 . . . . 0.0 112.451 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.74 156.38 22.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.413 1.482 . . . . 0.0 113.555 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -71.18 -25.86 62.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.513 1.125 . . . . 0.0 113.24 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.68 -3.34 33.66 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.808 1.194 . . . . 0.0 115.38 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.8 mt -89.89 -5.15 57.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.778 1.631 . . . . 0.0 112.843 169.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -133.8 -40.71 0.85 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.784 1.234 . . . . 0.0 113.798 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.15 149.77 41.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.268 1.427 . . . . 0.0 111.009 -176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.12 175.47 27.41 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.269 0.938 . . . . 0.0 114.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.2 m80 -134.85 151.74 51.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.401 1.48 . . . . 0.0 111.678 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.6 p -69.08 -45.49 70.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -98.6 -5.73 31.32 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -167.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -123.4 147.82 53.64 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.054 1.742 . . . . 0.0 110.196 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.12 136.41 29.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.588 2.192 . . . . 0.0 110.645 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.11 152.91 23.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.352 1.061 . . . . 0.0 109.996 166.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.86 151.54 47.07 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.4 p90 -158.85 150.91 21.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.675 1.59 . . . . 0.0 110.81 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.98 139.94 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.846 1.658 . . . . 0.0 109.243 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.77 136.41 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.38 1.472 . . . . 0.0 108.771 167.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.6 t0 -120.57 98.23 5.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.201 1.8 . . . . 0.0 110.272 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 20.7 p -91.9 -4.76 54.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.567 1.947 . . . . 0.0 113.144 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -59.32 -35.73 74.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.308 1.043 . . . . 0.0 112.588 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.38 -11.6 59.24 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.035 1.334 . . . . 0.0 113.493 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.45 -3.57 56.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.472 1.509 . . . . 0.0 114.557 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.67 -147.0 23.74 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -78.11 172.09 14.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.442 1.097 . . . . 0.0 112.611 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 135.31 -162.09 24.77 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 124.901 1.238 . . . . 0.0 113.937 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -141.12 143.88 13.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.604 1.573 . . . . 0.0 112.719 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.45 123.83 46.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.485 1.914 . . . . 0.0 109.643 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.1 m -111.95 144.29 41.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.857 1.663 . . . . 0.0 110.314 170.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -146.8 146.36 30.22 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.5 0.72 . . . . 0.0 110.988 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 90.2 p -148.53 152.9 37.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.366 0.603 . . . . 0.0 112.338 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.87 129.83 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.134 1.374 . . . . 0.0 107.856 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.57 147.21 47.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.355 1.862 . . . . 0.0 109.713 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 176.97 -166.8 37.74 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.59 -11.51 24.3 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.337 3.358 . . . . 0.0 113.726 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 21.3 m -152.98 161.26 42.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.084 1.754 . . . . 0.0 111.218 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -68.51 146.98 52.64 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.979 0.912 . . . . 0.0 111.589 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.6 m -129.55 148.39 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.986 1.314 . . . . 0.0 110.911 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.44 110.66 21.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.52 0.728 . . . . 0.0 110.075 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 33.1 mt -87.12 129.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.189 0.995 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -123.93 161.62 25.03 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.579 1.952 . . . . 0.0 110.428 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 7.1 p -142.27 158.03 44.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.964 1.306 . . . . 0.0 112.509 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -151.38 117.07 5.43 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.291 1.436 . . . . 0.0 109.835 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.21 128.65 34.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 110.328 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 74.8 mt -102.57 153.68 19.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.485 1.114 . . . . 0.0 111.981 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -60.2 -28.42 67.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.619 1.167 . . . . 0.0 113.323 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.79 -9.38 58.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.806 1.242 . . . . 0.0 113.589 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.27 66.48 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.963 1.744 . . . . 0.0 114.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.1 p -88.12 170.45 11.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.554 1.942 . . . . 0.0 111.179 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.5 t -129.59 124.5 33.94 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.721 0.808 . . . . 0.0 111.663 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -82.28 137.56 34.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.238 1.415 . . . . 0.0 110.016 169.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 94.4 t -116.18 140.12 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.28 1.832 . . . . 0.0 108.465 166.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.78 149.91 50.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.688 1.595 . . . . 0.0 111.179 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.53 147.73 12.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 111.606 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 t -112.1 101.69 52.36 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 110.521 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -82.14 86.54 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.6 2.867 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.5 m -56.57 -39.11 72.93 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.184 1.394 . . . . 0.0 113.825 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -96.57 141.66 23.42 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.343 1.057 . . . . 0.0 110.699 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.23 166.12 29.58 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.518 2.812 . . . . 0.0 112.214 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.02 -162.37 24.48 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.205 1.384 . . . . 0.0 113.574 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -95.68 125.31 40.18 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.751 0.82 . . . . 0.0 111.126 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.3 142.59 41.71 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.23 1.412 . . . . 0.0 110.485 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 131.57 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.961 1.305 . . . . 0.0 108.389 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.6 mt -114.87 127.76 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.654 1.181 . . . . 0.0 109.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -103.84 127.17 51.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.191 1.396 . . . . 0.0 110.477 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -118.65 119.03 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.976 1.31 . . . . 0.0 109.41 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.3 tttt -135.67 123.96 23.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.325 1.45 . . . . 0.0 110.256 -168.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.5 t80 -121.89 127.52 50.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.702 1.201 . . . . 0.0 110.742 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.82 34.15 12.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.113 1.365 . . . . 0.0 113.409 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 16.2 t70 88.2 -1.84 0.47 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.428 3.091 . . . . 0.0 114.138 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -110.75 134.28 52.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 112.111 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2124 ' ' HIS . . . . . 0.444 ' CE1' ' HG ' ' A' 2128 ' ' SER . 1.0 OUTLIER -65.4 126.81 29.42 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.941 1.297 . . . . 0.0 111.094 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.9 m -76.51 153.91 83.74 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.962 . . . . 0.0 111.193 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.55 138.91 67.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.538 2.159 . . . . 0.0 111.178 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.63 -27.32 14.45 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.306 1.431 . . . . 0.0 113.216 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2128 ' ' SER . . . . . 0.444 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 11.4 t -76.7 144.23 72.87 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.09 0.945 . . . . 0.0 110.663 171.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.03 149.09 86.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.092 1.069 . . . . 0.0 112.035 0.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.95 119.52 38.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.766 1.226 . . . . 0.0 110.744 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 72.2 m -88.95 129.99 35.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.001 0.92 . . . . 0.0 110.776 172.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 12.9 t -124.48 115.52 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.47 1.508 . . . . 0.0 109.782 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 61.7 tttp -80.09 112.29 17.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.065 0.546 . . . . 0.0 110.709 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.5 t -98.05 121.11 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.017 1.327 . . . . 0.0 109.025 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.6 t -108.69 157.6 18.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.698 1.199 . . . . 0.0 111.479 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 165.17 172.34 32.5 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.27 0.938 . . . . 0.0 114.606 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 124.504 1.121 . . . . 0.0 112.92 -178.628 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 120.196 0.046 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 94.8 mtp -96.33 142.12 28.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.883 1.273 . . . . 0.0 111.727 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 7.4 m -122.26 137.43 54.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.637 1.975 . . . . 0.0 108.414 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.23 145.59 32.9 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.375 0.989 . . . . 0.0 113.547 -165.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.38 155.47 30.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.982 1.713 . . . . 0.0 111.183 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -132.67 150.46 52.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.598 1.159 . . . . 0.0 112.597 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.0 t -139.87 137.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.392 1.877 . . . . 0.0 109.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.33 120.13 5.67 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.0 m -106.59 143.45 34.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.57 152.17 23.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.872 0.869 . . . . 0.0 113.025 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.47 148.45 26.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.167 0.987 . . . . 0.0 111.028 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.37 146.5 28.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 112.494 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.33 120.05 20.9 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.824 1.25 . . . . 0.0 108.791 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.69 137.64 14.49 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.366 2.711 . . . . 0.0 110.956 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.15 138.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.206 1.402 . . . . 0.0 109.985 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 51.7 t30 55.1 64.52 1.77 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.918 1.687 . . . . 0.0 112.359 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 11.2 mm -71.67 105.06 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.39 1.076 . . . . 0.0 110.95 -168.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 11.8 t -171.94 177.82 3.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.751 2.02 . . . . 0.0 110.221 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.72 57.18 3.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.528 1.531 . . . . 0.0 111.049 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 39.6 p -75.77 153.27 37.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.244 1.418 . . . . 0.0 112.28 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -98.44 111.63 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.799 1.24 . . . . 0.0 110.485 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.68 -12.3 61.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.124 0.97 . . . . 0.0 113.053 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 66.6 m -77.12 -16.96 58.98 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.746 1.157 . . . . 0.0 113.948 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -116.65 3.8 13.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.254 1.422 . . . . 0.0 114.057 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.02 146.02 37.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 0.0 110.972 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 56.0 p -140.12 168.01 20.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.532 1.933 . . . . 0.0 109.666 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 152.6 31.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.785 0.834 . . . . 0.0 112.596 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 67.3 p -138.85 157.52 45.91 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.523 1.929 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -109.93 133.45 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.646 1.178 . . . . 0.0 109.495 169.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 89.9 t -102.43 110.5 63.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.776 1.23 . . . . 0.0 107.748 164.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.87 169.65 21.29 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.686 2.924 . . . . 0.0 110.838 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -15.17 46.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.971 2.448 . . . . 0.0 113.28 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 62.3 p -80.33 -9.61 59.74 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.828 1.251 . . . . 0.0 113.916 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.03 -1.72 83.66 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.736 1.636 . . . . 0.0 115.118 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -78.98 83.1 5.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.181 1.392 . . . . 0.0 111.643 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -58.77 135.42 57.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.755 1.222 . . . . 0.0 112.383 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -139.48 151.05 65.85 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.47 1.508 . . . . 0.0 111.128 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 155.04 35.98 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.738 2.959 . . . . 0.0 112.704 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 74.6 m -105.66 154.94 19.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.145 1.378 . . . . 0.0 111.794 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.8 119.16 35.91 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.191 1.396 . . . . 0.0 108.586 175.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.73 136.64 34.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.506 1.122 . . . . 0.0 110.886 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 66.9 mttm -136.94 141.22 42.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.725 1.21 . . . . 0.0 113.098 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -87.02 120.34 28.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.598 1.159 . . . . 0.0 107.981 157.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.4 mt -98.86 171.44 8.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.842 1.257 . . . . 0.0 112.969 -166.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -60.96 -20.41 62.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.749 2.02 . . . . 0.0 116.381 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.08 5.76 46.85 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.272 1.029 . . . . 0.0 112.971 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.75 85.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.58 1.562 . . . . 0.0 114.25 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 164.03 21.71 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.038 1.735 . . . . 0.0 113.426 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 82.6 t -102.56 141.43 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.212 1.405 . . . . 0.0 110.15 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.33 -168.17 20.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.264 0.935 . . . . 0.0 114.807 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.66 167.08 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.441 1.496 . . . . 0.0 112.264 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 98.9 p -139.08 159.85 41.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.923 1.289 . . . . 0.0 111.432 162.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.2 p90 -164.07 -178.46 5.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.026 2.13 . . . . 0.0 109.778 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -129.47 122.9 21.09 Favored Pre-proline 0 N--CA 1.482 1.135 0 CA-C-N 119.44 1.018 . . . . 0.0 110.171 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.86 141.58 15.23 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.322 3.348 . . . . 0.0 111.223 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -94.82 -32.9 13.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.7 0.8 . . . . 0.0 112.842 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -111.2 172.1 7.08 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.173 1.789 . . . . 0.0 111.096 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.6 p -90.86 164.21 14.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.838 1.255 . . . . 0.0 111.015 165.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 101.31 -166.68 18.78 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.123 1.344 . . . . 0.0 113.856 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.94 116.86 16.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.928 . . . . 0.0 111.866 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 16.2 m80 -103.77 142.83 33.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.48 1.912 . . . . 0.0 109.44 170.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.84 123.14 47.73 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.571 1.148 . . . . 0.0 109.206 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 35.2 t -90.55 112.57 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.872 1.269 . . . . 0.0 108.583 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -92.98 138.23 31.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.875 1.27 . . . . 0.0 110.531 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 66.6 t -130.46 128.43 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.672 0.789 . . . . 0.0 109.511 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.23 134.76 51.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.114 1.366 . . . . 0.0 112.569 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 84.9 tttt -128.45 129.05 45.57 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 110.162 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 53.08 30.53 9.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.627 1.171 . . . . 0.0 114.056 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.89 5.26 71.26 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.033 1.302 . . . . 0.0 116.019 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -134.62 149.26 50.55 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.665 1.733 . . . . 0.0 111.855 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -70.03 140.65 52.88 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.945 -1.097 . . . . 0.0 112.877 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 21.2 m -76.33 153.07 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.834 0.854 . . . . 0.0 111.527 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -62.77 -23.66 67.33 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 62.1 p -84.78 -3.42 58.61 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.843 1.257 . . . . 0.0 114.034 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 1.7 p -118.48 160.18 40.88 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.685 1.194 . . . . 0.0 112.757 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.0 156.17 98.7 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.48 0.85 . . . . 0.0 113.078 0.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.39 124.6 33.45 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.816 1.647 . . . . 0.0 108.954 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.84 139.34 12.2 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.193 2.595 . . . . 0.0 111.381 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.3 t -135.55 124.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.585 1.554 . . . . 0.0 108.157 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -97.23 122.47 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.757 0.823 . . . . 0.0 110.118 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.51 126.58 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.152 1.381 . . . . 0.0 109.871 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -90.28 168.54 11.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.793 1.237 . . . . 0.0 112.121 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.58 -32.12 73.25 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.332 -1.48 . . . . 0.0 112.978 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.9 m -72.28 -5.31 35.18 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.81 5.73 14.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.069 1.347 . . . . 0.0 113.207 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.43 -31.21 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.143 0.977 . . . . 0.0 112.24 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 164.27 51.05 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.762 0.665 . . . . 0.0 114.762 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.95 92.54 4.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.151 0.976 . . . . 0.0 111.393 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.69 76.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.697 0.799 . . . . 0.0 112.054 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -56.71 -24.98 53.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.343 1.457 . . . . 0.0 113.994 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -90.61 -7.05 53.79 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.15 1.38 . . . . 0.0 113.802 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 58.0 t -77.8 129.85 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.975 1.261 . . . . 0.0 109.741 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -105.69 156.34 18.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 110.687 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.0 m -143.45 151.63 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.056 1.343 . . . . 0.0 110.731 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 57.2 m -149.13 166.49 28.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.309 1.443 . . . . 0.0 112.014 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.04 157.56 26.27 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.479 1.038 . . . . 0.0 113.929 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -78.88 -18.95 53.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.54 -4.64 46.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.69 1.138 . . . . 0.0 114.788 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.45 -4.88 58.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 112.686 168.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -126.88 -36.57 2.19 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.077 1.351 . . . . 0.0 113.668 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -155.67 156.7 35.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.225 1.01 . . . . 0.0 113.093 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.07 -171.88 15.92 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.71 1.624 . . . . 0.0 113.207 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -147.22 145.17 29.37 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.968 0.907 . . . . 0.0 113.399 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 41.3 p -66.09 -23.69 66.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -114.96 1.57 14.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 139.96 31.0 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.29 1.436 . . . . 0.0 110.095 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.84 144.59 54.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.335 2.023 . . . . 0.0 110.547 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -104.11 158.67 16.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.102 1.361 . . . . 0.0 110.711 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 158.71 44.16 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.45 153.73 30.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.449 1.9 . . . . 0.0 110.114 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.63 138.8 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.687 1.595 . . . . 0.0 108.943 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 44.3 mt -110.2 135.06 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.097 1.759 . . . . 0.0 108.756 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.01 97.5 5.46 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.961 1.704 . . . . 0.0 110.46 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.7 p -94.02 0.73 56.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 113.177 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -59.48 -38.79 81.76 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.524 1.056 . . . . 0.0 113.069 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.59 -23.52 45.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.103 0.961 . . . . 0.0 113.032 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -81.36 -11.81 59.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 113.737 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.2 -121.6 5.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.007 1.289 . . . . 0.0 112.335 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.49 163.93 12.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.542 1.537 . . . . 0.0 112.203 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.45 174.24 17.48 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -89.64 122.86 6.67 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.339 0.971 . . . . 0.0 111.424 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.1 tm? -98.08 112.16 24.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.849 1.66 . . . . 0.0 107.718 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.6 m -104.9 145.55 30.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.724 0.81 . . . . 0.0 109.966 168.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.78 137.19 29.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.741 0.817 . . . . 0.0 109.762 -166.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.2 p -140.87 150.5 43.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.85 0.833 . . . . 0.0 112.497 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.42 133.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.49 1.516 . . . . 0.0 107.235 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -142.27 139.14 31.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.645 0.778 . . . . 0.0 110.827 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 179.46 -161.31 27.23 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.033 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.06 -5.61 15.13 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.291 3.327 . . . . 0.0 114.753 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.6 t -157.71 168.18 27.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.754 1.222 . . . . 0.0 111.456 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -69.33 149.14 48.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.364 1.066 . . . . 0.0 111.093 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.5 m -127.58 150.19 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.036 1.334 . . . . 0.0 110.647 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -91.04 109.17 20.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.49 0.716 . . . . 0.0 109.692 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 26.8 mt -85.4 131.74 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.195 0.998 . . . . 0.0 109.432 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -128.08 164.03 23.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.664 1.986 . . . . 0.0 110.471 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -142.59 155.53 44.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.996 1.318 . . . . 0.0 112.073 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.37 114.88 4.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.0 110.067 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.37 130.68 37.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.666 1.186 . . . . 0.0 110.967 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 75.6 mt -103.3 151.34 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.6 1.16 . . . . 0.0 111.705 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.95 -19.6 65.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.304 1.042 . . . . 0.0 113.659 -175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.63 -5.95 54.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 113.109 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 97.24 1.38 59.41 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.87 1.7 . . . . 0.0 114.738 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 168.92 10.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.366 1.866 . . . . 0.0 111.399 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -125.33 124.61 41.96 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.972 0.909 . . . . 0.0 111.543 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -84.07 134.96 34.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.136 1.375 . . . . 0.0 109.54 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 46.3 t -115.91 137.24 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.743 1.617 . . . . 0.0 108.363 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.472 1.909 . . . . 0.0 110.769 -177.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -160.4 155.91 25.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.396 1.078 . . . . 0.0 112.668 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.2 p -124.61 97.01 39.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.17 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.91 143.31 20.61 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.184 2.589 . . . . 0.0 110.345 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 88.7 m -112.11 -44.11 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 0.0 112.135 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -83.42 141.37 42.3 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.471 0.708 . . . . 0.0 110.419 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.98 162.54 34.48 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.28 2.653 . . . . 0.0 111.092 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.47 -144.04 15.89 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.811 1.196 . . . . 0.0 112.144 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -123.53 131.65 53.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.633 0.773 . . . . 0.0 111.779 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -110.21 139.0 45.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.766 1.626 . . . . 0.0 109.977 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.61 134.28 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.85 1.26 . . . . 0.0 108.447 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.67 127.84 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.214 1.406 . . . . 0.0 108.86 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -109.96 119.96 40.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.028 1.331 . . . . 0.0 109.871 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.5 mm -107.68 114.43 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.749 0.785 . . . . 0.0 108.955 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.57 118.0 23.1 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.21 1.004 . . . . 0.0 111.695 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 16.8 t80 -112.7 131.62 55.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.68 1.192 . . . . 0.0 110.259 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.99 35.35 21.78 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.466 1.506 . . . . 0.0 114.283 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.05 10.14 3.8 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.386 2.275 . . . . 0.0 114.24 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -95.57 -128.8 0.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.127 1.371 . . . . 0.0 110.465 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -168.13 125.19 1.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.558 2.343 . . . . 0.0 108.69 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -76.91 151.57 82.16 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-N 120.044 1.293 . . . . 0.0 110.843 -170.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.34 135.24 52.78 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.568 2.178 . . . . 0.0 110.996 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 100.83 -27.02 22.49 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.39 1.471 . . . . 0.0 113.744 -173.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 50.9 m -74.57 150.37 86.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 118.972 1.386 . . . . 0.0 111.67 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.02 141.17 69.75 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 119.205 0.752 . . . . 0.0 111.208 -3.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.57 115.3 27.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.046 0.938 . . . . 0.0 110.378 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 66.4 m -87.63 121.13 29.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.988 0.915 . . . . 0.0 110.359 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -120.32 115.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.662 1.585 . . . . 0.0 109.922 -168.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.92 122.22 26.41 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.963 0.505 . . . . 0.0 111.304 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 76.1 t -106.64 117.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.444 1.498 . . . . 0.0 108.93 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.1 t -105.26 174.6 5.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.176 1.39 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 133.89 -134.09 7.26 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.138 1.352 . . . . 0.0 112.694 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 124.583 1.153 . . . . 0.0 111.159 -169.133 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 121.453 0.644 . . . . 0.0 110.595 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.3 ptt? -148.4 162.66 39.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.888 1.675 . . . . 0.0 110.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 68.7 m -113.78 150.01 34.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.274 1.03 . . . . 0.0 109.845 167.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -144.88 160.26 41.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.3 155.41 33.7 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.277 1.831 . . . . 0.0 110.402 -169.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 68.4 mttm -137.92 150.62 47.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.117 1.367 . . . . 0.0 111.639 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.6 p -155.76 139.39 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.703 1.201 . . . . 0.0 110.818 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -83.08 129.06 8.84 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.813 0.72 . . . . 0.0 111.405 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 44.0 m -113.41 137.41 51.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.137 . . . . 0.0 111.403 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.47 141.58 12.07 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.267 1.027 . . . . 0.0 111.957 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.26 148.25 43.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.872 0.869 . . . . 0.0 111.215 168.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.68 139.53 30.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.144 0.977 . . . . 0.0 112.63 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 72.9 mt -121.55 123.4 27.57 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.521 1.528 . . . . 0.0 108.796 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.55 152.6 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.109 2.54 . . . . 0.0 111.889 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.09 147.23 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.382 1.473 . . . . 0.0 111.037 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 35.4 t30 56.96 77.37 0.27 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.22 1.808 . . . . 0.0 112.159 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 20.3 mm -77.99 73.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.382 1.073 . . . . 0.0 109.349 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 6.6 m -172.69 -177.54 1.71 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.818 2.847 . . . . 0.0 109.383 -169.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -59.09 121.96 12.57 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.133 -0.979 . . . . 0.0 111.256 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.3 m -139.8 142.51 36.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.265 1.826 . . . . 0.0 109.153 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 64.5 t0 -126.94 120.53 29.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.932 1.293 . . . . 0.0 110.242 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.18 -10.25 59.75 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.586 1.154 . . . . 0.0 113.922 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 11.8 t -64.91 -31.26 72.4 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.631 1.105 . . . . 0.0 113.627 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.23 9.41 11.06 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.524 1.53 . . . . 0.0 113.961 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.46 145.18 25.89 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.087 1.355 . . . . 0.0 112.178 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -141.25 163.43 32.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.783 2.033 . . . . 0.0 109.371 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.28 146.78 23.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.7 p -139.25 161.77 36.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.841 2.056 . . . . 0.0 109.993 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.7 t -117.32 138.5 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.368 1.467 . . . . 0.0 110.253 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 93.5 t -105.76 112.94 64.4 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 108.246 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.82 171.94 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.916 3.077 . . . . 0.0 111.605 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.89 -28.5 31.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.706 3.604 . . . . 0.0 115.199 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 60.4 p -81.27 -9.61 59.74 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.25 -2.0 73.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.451 1.5 . . . . 0.0 114.766 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -75.43 89.19 2.65 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.309 1.444 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.3 133.53 56.19 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.078 0.951 . . . . 0.0 111.944 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -129.16 145.83 58.3 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 110.317 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.7 151.17 31.86 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.393 2.729 . . . . 0.0 111.712 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.1 m -95.61 149.63 21.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.215 1.006 . . . . 0.0 111.736 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.25 128.66 34.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 159.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.7 mt -95.89 141.58 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 110.551 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 88.8 mttt -136.78 144.66 43.87 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.502 1.521 . . . . 0.0 111.891 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -98.1 117.68 33.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.646 1.178 . . . . 0.0 107.851 159.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.61 175.15 6.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.853 1.661 . . . . 0.0 112.597 -166.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -56.97 -35.32 69.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.471 1.509 . . . . 0.0 114.692 -166.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.51 3.88 53.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 0.0 113.211 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.81 71.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.394 1.473 . . . . 0.0 114.209 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -73.17 163.57 27.94 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.681 1.592 . . . . 0.0 113.282 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 59.8 t -108.77 144.05 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.249 1.42 . . . . 0.0 110.47 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -146.14 171.49 27.03 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.607 1.098 . . . . 0.0 115.367 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.94 152.96 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.072 1.749 . . . . 0.0 111.898 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 13.6 m -132.65 148.56 52.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.7 1.6 . . . . 0.0 110.235 168.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.8 p90 -164.58 162.01 21.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.224 1.41 . . . . 0.0 111.296 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 93.1 t -102.3 119.5 56.18 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 0.0 109.32 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 145.18 24.3 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.236 3.29 . . . . 0.0 110.586 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -108.72 0.41 20.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 113.411 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -143.15 179.59 6.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.395 2.278 . . . . 0.0 109.698 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -105.09 158.44 16.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.068 1.347 . . . . 0.0 110.452 163.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.36 -164.61 16.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.303 1.43 . . . . 0.0 113.341 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.2 111.5 8.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.354 1.062 . . . . 0.0 111.944 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.7 m80 -95.32 140.55 30.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.466 1.507 . . . . 0.0 109.428 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.58 121.56 42.63 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.99 0.916 . . . . 0.0 109.116 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 44.6 t -86.86 131.76 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.013 1.325 . . . . 0.0 108.349 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -116.4 119.24 35.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.363 1.465 . . . . 0.0 109.818 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 64.5 t -107.89 134.95 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.854 1.262 . . . . 0.0 109.196 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 80.6 mttt -119.77 149.68 41.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 113.091 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -126.41 118.21 24.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.44 2.296 . . . . 0.0 109.042 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 58.01 21.19 7.53 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.862 1.265 . . . . 0.0 114.22 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 101.52 -12.26 58.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.916 1.722 . . . . 0.0 115.79 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -99.66 160.72 14.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.508 1.654 . . . . 0.0 111.222 171.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.0 p80 -65.04 153.2 41.43 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.106 -0.996 . . . . 0.0 112.954 170.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -88.71 154.47 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.721 0.809 . . . . 0.0 110.62 168.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -61.74 -21.73 64.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 67.1 m -82.33 -15.52 52.55 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 19.9 m -84.28 153.21 62.35 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 120.813 -1.18 . . . . 0.0 113.902 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.87 153.73 86.8 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 118.387 0.459 . . . . 0.0 111.812 -5.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 123.01 39.1 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.898 1.279 . . . . 0.0 109.273 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 139.18 11.89 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.082 2.522 . . . . 0.0 111.591 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 34.5 t -135.72 120.42 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.454 1.502 . . . . 0.0 108.352 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 62.0 t -92.78 122.46 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.712 0.805 . . . . 0.0 110.271 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.89 133.29 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.014 1.326 . . . . 0.0 109.656 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 27.4 t -104.65 158.69 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.4 1.08 . . . . 0.0 111.198 169.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -59.36 -29.84 67.97 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.344 -0.847 . . . . 0.0 112.72 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -65.41 -13.73 59.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.479 1.112 . . . . 0.0 113.653 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -93.75 -8.12 41.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.631 1.172 . . . . 0.0 112.471 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.2 116.77 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.516 1.053 . . . . 0.0 110.624 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 70.9 13.35 72.23 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 157.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.52 94.12 2.57 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.642 1.721 . . . . 0.0 110.748 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.45 -36.36 71.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.753 1.221 . . . . 0.0 112.735 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.5 m -54.67 -24.72 23.07 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.515 1.526 . . . . 0.0 114.184 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -86.36 -13.76 45.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.036 1.335 . . . . 0.0 113.469 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.4 t -77.55 134.73 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.43 1.014 . . . . 0.0 110.003 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -122.16 159.74 26.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.446 1.499 . . . . 0.0 110.741 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 32.8 m -147.35 159.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.107 1.363 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.09 169.93 23.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.342 1.057 . . . . 0.0 112.437 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.38 159.25 24.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.296 1.427 . . . . 0.0 113.79 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.52 -27.84 64.49 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.502 1.121 . . . . 0.0 113.362 -169.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.09 -2.73 33.26 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.854 1.216 . . . . 0.0 115.294 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 88.6 mt -88.82 -7.08 56.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.942 1.697 . . . . 0.0 112.66 168.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -133.72 -39.81 0.88 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.996 1.318 . . . . 0.0 113.915 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -140.09 148.48 41.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.189 1.395 . . . . 0.0 111.482 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.7 178.3 28.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.619 1.104 . . . . 0.0 114.203 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.9 m80 -136.83 149.64 47.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.735 1.614 . . . . 0.0 111.655 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.1 p -71.9 -32.6 67.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.54 6.73 14.72 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -138.36 144.39 42.63 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.832 1.653 . . . . 0.0 109.462 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 140.93 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.677 2.252 . . . . 0.0 111.19 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -87.67 151.56 22.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.733 1.213 . . . . 0.0 109.976 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.14 150.01 48.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.112 0.965 . . . . 0.0 113.147 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 152.42 27.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.054 1.341 . . . . 0.0 111.333 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.6 mp -110.88 142.22 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.494 1.918 . . . . 0.0 109.823 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 47.6 mt -114.46 133.59 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.975 1.71 . . . . 0.0 109.595 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 8.6 t0 -117.42 112.03 20.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.781 2.032 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 10.1 p -120.79 -3.71 9.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.537 1.535 . . . . 0.0 113.967 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -29.11 69.76 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.144 1.338 . . . . 0.0 113.47 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.09 -18.15 53.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.669 1.187 . . . . 0.0 112.867 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.99 -5.15 56.96 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.372 1.469 . . . . 0.0 113.818 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.09 -106.15 2.75 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.93 1.252 . . . . 0.0 111.816 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -129.73 145.64 51.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.442 1.497 . . . . 0.0 112.807 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 158.22 175.63 29.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.92 0.772 . . . . 0.0 114.76 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -87.5 121.7 5.95 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.143 0.878 . . . . 0.0 111.056 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 123.29 35.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.184 1.393 . . . . 0.0 108.022 171.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 8.4 t -119.73 145.24 46.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.494 1.918 . . . . 0.0 109.791 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.0 tt -145.32 144.24 30.62 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.716 0.807 . . . . 0.0 110.846 -165.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.4 p -148.13 153.92 39.49 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.78 131.42 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.724 1.61 . . . . 0.0 108.539 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.64 153.14 49.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.723 1.609 . . . . 0.0 110.513 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 166.93 -153.45 23.12 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.096 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.5 -10.51 28.13 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.913 3.076 . . . . 0.0 114.31 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -157.39 168.0 28.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.594 1.088 . . . . 0.0 112.238 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -71.52 150.0 45.23 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.609 1.163 . . . . 0.0 111.087 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.2 m -130.59 152.11 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.565 1.146 . . . . 0.0 111.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -81.47 126.32 31.52 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.58 -0.7 . . . . 0.0 109.832 165.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.2 mt -106.78 132.67 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.191 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -129.73 155.23 46.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.367 1.867 . . . . 0.0 109.533 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.33 158.57 43.81 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.61 1.164 . . . . 0.0 111.553 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.53 128.64 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 0.0 110.94 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.63 118.64 22.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.439 1.096 . . . . 0.0 109.95 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.77 160.35 18.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.14 0.976 . . . . 0.0 111.805 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.15 -20.97 66.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.97 0.908 . . . . 0.0 113.138 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.48 -12.53 59.88 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.863 1.265 . . . . 0.0 113.361 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.45 -1.56 62.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.557 1.551 . . . . 0.0 114.836 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 15.1 p -81.6 162.27 23.17 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 111.259 170.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.2 t -108.51 123.81 49.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.925 0.89 . . . . 0.0 110.751 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 29.9 ttm105 -82.91 137.68 34.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.17 0.988 . . . . 0.0 109.342 165.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 24.3 t -120.64 137.36 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.781 1.632 . . . . 0.0 108.468 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.4 p -137.61 146.07 43.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.365 1.466 . . . . 0.0 111.56 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -160.43 150.21 17.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.534 1.134 . . . . 0.0 112.563 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.4 t -111.93 104.69 56.24 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.107 0.963 . . . . 0.0 110.886 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.67 98.82 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.496 2.798 . . . . 0.0 110.978 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -60.62 -43.96 96.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.441 1.096 . . . . 0.0 113.653 -169.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -94.15 146.15 31.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.215 1.006 . . . . 0.0 111.098 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.64 164.22 32.56 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.33 2.687 . . . . 0.0 111.254 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.17 -140.25 11.65 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.823 1.202 . . . . 0.0 112.184 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -130.15 130.95 45.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.955 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -110.97 144.27 40.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.633 1.573 . . . . 0.0 110.781 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.72 134.31 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.483 1.113 . . . . 0.0 108.868 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.5 mt -111.69 129.12 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.828 1.251 . . . . 0.0 109.08 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -107.18 125.04 50.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.352 1.461 . . . . 0.0 109.935 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.98 124.28 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.998 0.919 . . . . 0.0 109.074 173.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -131.13 135.14 47.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.429 1.492 . . . . 0.0 110.578 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.1 t80 -128.64 121.24 28.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.14 1.376 . . . . 0.0 109.845 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.43 55.84 7.76 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.417 1.487 . . . . 0.0 112.672 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 21.1 t70 79.09 -7.56 1.75 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 128.052 2.541 . . . . 0.0 114.128 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -113.64 128.71 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.8 1.24 . . . . 0.0 111.521 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -67.25 126.17 28.38 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.822 1.249 . . . . 0.0 111.045 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -77.7 154.2 81.0 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.225 -0.922 . . . . 0.0 111.295 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.88 139.49 74.43 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.612 2.208 . . . . 0.0 111.228 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 97.86 -26.84 21.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.25 1.405 . . . . 0.0 113.499 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 73.1 m -74.98 149.71 85.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.716 1.258 . . . . 0.0 111.366 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.85 139.53 62.24 Favored 'Cis proline' 0 C--N 1.351 0.705 0 CA-C-N 119.444 0.837 . . . . 0.0 111.315 -2.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -93.07 112.76 24.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.925 0.89 . . . . 0.0 110.218 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 59.3 m -87.48 118.31 26.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.316 1.047 . . . . 0.0 110.821 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 8.5 t -112.95 116.44 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.967 1.707 . . . . 0.0 109.578 -171.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.78 121.97 27.09 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.908 -0.495 . . . . 0.0 111.03 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 98.6 t -110.41 119.6 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.218 1.407 . . . . 0.0 109.534 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.9 t -97.58 154.38 17.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.631 1.173 . . . . 0.0 111.047 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -173.43 -163.34 26.89 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 126.153 1.781 . . . . 0.0 109.884 -177.484 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 21.3 tpt85 . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 27.9 ptm -78.05 151.81 33.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.776 0.831 . . . . 0.0 111.748 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 12.8 m -127.0 140.03 52.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.471 1.909 . . . . 0.0 108.146 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -143.15 160.32 40.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -166.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.93 151.04 21.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.618 1.967 . . . . 0.0 110.024 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -134.55 146.26 49.49 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.937 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 47.3 t -139.83 133.93 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.644 1.577 . . . . 0.0 109.623 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -86.01 118.05 4.75 Favored Glycine 0 N--CA 1.47 0.93 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 169.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.4 m -121.36 146.84 46.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.924 0.89 . . . . 0.0 112.458 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.85 144.04 11.5 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.173 0.989 . . . . 0.0 112.572 -170.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -70.37 157.81 37.09 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.595 1.158 . . . . 0.0 112.364 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.92 143.47 26.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.919 1.687 . . . . 0.0 112.893 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.13 118.57 18.42 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.969 1.308 . . . . 0.0 109.429 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.55 133.01 11.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.475 2.783 . . . . 0.0 111.639 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 51.2 mt -148.62 142.4 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.493 1.517 . . . . 0.0 110.624 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 57.81 57.4 4.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.072 1.749 . . . . 0.0 112.431 172.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 12.1 mm -71.99 -26.71 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.877 1.271 . . . . 0.0 112.633 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -76.92 54.63 1.03 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.13 1.772 . . . . 0.0 113.717 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -146.93 144.61 29.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.799 1.64 . . . . 0.0 110.726 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -104.09 -40.77 6.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.056 1.742 . . . . 0.0 111.133 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -90.93 108.44 19.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.765 0.826 . . . . 0.0 110.438 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.4 mt -90.37 -8.72 49.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.119 0.968 . . . . 0.0 113.101 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 9.2 t -77.03 -31.48 56.35 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.207 -0.933 . . . . 0.0 112.553 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.84 -2.43 47.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.137 1.375 . . . . 0.0 114.421 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.9 tp -101.3 135.25 43.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.463 1.105 . . . . 0.0 111.406 -170.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -138.97 168.22 20.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.013 1.725 . . . . 0.0 110.46 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -154.09 150.9 28.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.9 p -137.85 165.19 27.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.082 2.153 . . . . 0.0 110.079 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -123.73 139.85 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.852 1.661 . . . . 0.0 110.015 172.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.8 t -111.42 114.16 53.14 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.476 1.51 . . . . 0.0 108.249 166.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.67 170.33 19.33 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.948 3.098 . . . . 0.0 110.771 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.35 -16.61 55.17 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.986 2.458 . . . . 0.0 113.266 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 69.4 m -83.66 -4.18 58.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.328 1.051 . . . . 0.0 113.828 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.37 82.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.597 1.57 . . . . 0.0 115.914 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.35 86.73 3.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.4 1.48 . . . . 0.0 111.588 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.87 135.93 57.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.554 1.142 . . . . 0.0 112.302 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -142.6 151.59 57.67 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.752 1.621 . . . . 0.0 111.352 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.46 155.09 36.2 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.823 3.015 . . . . 0.0 112.23 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 94.8 m -98.1 155.32 17.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.584 1.154 . . . . 0.0 112.815 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.64 135.45 34.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 108.234 162.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.2 mt -108.02 139.06 43.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.218 1.407 . . . . 0.0 111.06 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 64.2 mttm -135.54 128.19 30.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.676 1.19 . . . . 0.0 113.113 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.6 tpt85 -75.83 125.98 30.13 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 148.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 54.8 mt -102.65 159.85 15.09 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.678 1.191 . . . . 0.0 110.76 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -57.89 -32.97 68.23 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -82.17 -1.3 48.53 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 106.39 -27.81 15.68 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.596 1.57 . . . . 0.0 113.785 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.96 169.79 12.58 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.78 1.232 . . . . 0.0 114.179 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 67.9 t -133.15 139.33 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.841 1.656 . . . . 0.0 109.342 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.43 23.32 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 116.179 1.231 . . . . 0.0 116.179 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.93 160.97 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.974 1.709 . . . . 0.0 112.288 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 68.4 m -139.98 149.75 43.63 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.575 1.95 . . . . 0.0 110.184 170.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 21.8 p90 -166.73 167.17 15.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.133 1.773 . . . . 0.0 110.647 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.9 t -116.06 113.57 41.64 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 124.041 0.936 . . . . 0.0 109.803 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.17 151.41 23.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.137 3.225 . . . . 0.0 111.324 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -98.49 -11.61 22.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.062 0.945 . . . . 0.0 113.459 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -139.09 166.72 23.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.01 1.724 . . . . 0.0 110.949 -174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.6 p -87.73 172.58 9.57 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.01 1.324 . . . . 0.0 111.333 169.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.5 -173.3 35.36 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.003 1.287 . . . . 0.0 113.773 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.31 113.48 7.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.149 0.98 . . . . 0.0 111.827 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.5 m80 -99.66 146.47 26.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.828 1.651 . . . . 0.0 109.065 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.79 125.17 50.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 109.412 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 30.1 t -88.37 136.87 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.497 1.119 . . . . 0.0 108.378 167.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -121.02 117.7 27.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.377 1.471 . . . . 0.0 109.865 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 93.9 t -106.14 138.59 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.185 1.394 . . . . 0.0 109.304 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 63.7 mttm -123.47 144.7 49.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.538 1.535 . . . . 0.0 112.646 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 69.2 tttt -118.87 116.38 26.37 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.389 2.276 . . . . 0.0 108.957 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.22 30.16 14.09 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.831 1.252 . . . . 0.0 113.572 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.77 -16.6 60.9 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.879 1.704 . . . . 0.0 115.956 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -97.78 149.99 21.73 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.482 1.641 . . . . 0.0 110.833 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 26.6 p80 -65.8 147.28 53.64 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 121.056 -1.028 . . . . 0.0 113.385 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -84.63 157.51 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.007 0.923 . . . . 0.0 111.132 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.67 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 7.0 m -70.53 -23.24 62.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.427 1.091 . . . . 0.0 113.65 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 150.34 55.22 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.41 148.56 89.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 118.681 0.565 . . . . 0.0 111.843 -4.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.72 118.81 55.47 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.423 1.089 . . . . 0.0 108.68 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.25 138.87 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.834 2.356 . . . . 0.0 111.293 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 51.6 t -134.16 121.9 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.573 1.549 . . . . 0.0 107.905 172.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.4 t -95.13 122.28 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.679 0.792 . . . . 0.0 109.944 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -95.52 129.22 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.751 1.22 . . . . 0.0 109.107 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.1 t -100.74 160.27 14.5 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.956 . . . . 0.0 111.572 172.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -59.17 -30.09 67.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.843 0.857 . . . . 0.0 112.855 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 19.5 m -67.23 -12.61 60.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.763 1.225 . . . . 0.0 113.725 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -97.16 -10.84 25.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.684 1.194 . . . . 0.0 112.779 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.281 1.032 . . . . 0.0 113.167 -170.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 161.92 45.64 0.02 OUTLIER Glycine 0 N--CA 1.469 0.897 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 27.4 t0 -78.52 95.1 5.09 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.063 0.931 . . . . 0.0 111.378 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.17 -39.58 86.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.48 -0.763 . . . . 0.0 112.487 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 29.4 m -60.47 -17.45 45.02 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.953 1.301 . . . . 0.0 113.974 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -93.39 -7.42 44.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.794 1.638 . . . . 0.0 114.487 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.2 t -75.3 137.41 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 120.302 1.41 . . . . 0.0 110.18 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -123.23 161.08 25.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 111.081 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.3 m -147.61 159.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.109 1.364 . . . . 0.0 111.86 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.89 176.05 12.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.097 1.359 . . . . 0.0 112.257 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.03 -165.1 14.3 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 125.553 1.549 . . . . 0.0 114.202 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -97.9 -38.24 9.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.349 1.06 . . . . 0.0 112.615 -172.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -74.08 3.02 40.38 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.489 1.042 . . . . 0.0 115.428 -167.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 98.4 mt -96.1 0.51 51.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.218 1.407 . . . . 0.0 112.412 166.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.73 -42.53 1.13 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.521 1.528 . . . . 0.0 113.471 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -158.77 154.91 27.0 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.49 -171.07 19.68 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.569 1.557 . . . . 0.0 114.017 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.5 m80 -141.27 146.4 36.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.148 1.379 . . . . 0.0 112.219 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 40.1 p -70.55 -21.46 62.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -115.86 -0.56 12.82 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -142.93 142.06 21.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.28 1.432 . . . . 0.0 110.177 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.62 149.4 55.14 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.937 2.424 . . . . 0.0 111.695 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.68 146.34 27.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.852 1.261 . . . . 0.0 110.562 172.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.73 146.47 48.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 112.628 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.5 p90 -152.48 148.58 27.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.403 1.481 . . . . 0.0 110.864 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.59 141.53 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.676 1.59 . . . . 0.0 109.207 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.6 mt -114.95 136.16 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.149 1.779 . . . . 0.0 108.744 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 60.2 t0 -124.52 108.18 11.83 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.152 1.781 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 58.0 p -101.62 0.66 36.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.848 1.659 . . . . 0.0 113.058 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.84 -37.13 80.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.51 1.05 . . . . 0.0 112.521 -172.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.68 -14.14 59.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 113.114 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -94.71 -4.61 47.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.169 1.788 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.71 -99.73 2.22 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.014 1.292 . . . . 0.0 111.947 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -142.21 152.38 43.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.127 1.371 . . . . 0.0 112.286 -165.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.83 179.26 26.44 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -88.19 122.33 6.27 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.39 0.995 . . . . 0.0 111.81 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.4 121.49 35.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.301 1.84 . . . . 0.0 108.334 171.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 15.0 m -113.34 143.25 44.78 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.827 1.251 . . . . 0.0 110.782 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -139.29 133.26 30.98 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 110.343 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.4 m -136.85 127.61 27.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.537 0.735 . . . . 0.0 111.452 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 25.9 mt -104.6 136.8 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.7 1.6 . . . . 0.0 108.948 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -132.79 151.49 51.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.21 1.804 . . . . 0.0 109.293 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.18 -160.31 33.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.194 -0.941 . . . . 0.0 114.59 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.0 -12.04 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 124.125 3.217 . . . . 0.0 114.474 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.5 t -159.48 168.35 26.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.666 1.187 . . . . 0.0 111.687 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -66.35 151.84 46.26 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -131.4 154.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.856 1.262 . . . . 0.0 111.18 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.88 138.22 32.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.694 0.398 . . . . 0.0 110.272 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 44.3 mt -121.4 135.83 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 109.163 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -132.37 154.61 49.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.208 1.803 . . . . 0.0 109.803 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 31.4 p -139.8 152.44 46.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.692 1.197 . . . . 0.0 111.664 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -152.72 106.98 3.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.35 134.43 35.26 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.919 1.288 . . . . 0.0 111.137 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 79.2 mt -110.22 162.28 14.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.481 1.112 . . . . 0.0 113.451 -163.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -70.65 -13.28 62.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.024 1.33 . . . . 0.0 113.159 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.72 -8.09 59.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.433 1.093 . . . . 0.0 112.795 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.09 1.2 73.0 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.349 1.452 . . . . 0.0 114.696 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 49.0 p -93.81 172.42 8.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.364 1.866 . . . . 0.0 111.191 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 47.0 t -129.02 126.63 39.92 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.096 0.958 . . . . 0.0 111.47 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.23 136.29 36.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.366 1.067 . . . . 0.0 109.613 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.4 t -115.25 138.43 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 108.083 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.6 p -134.19 147.0 50.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.177 1.391 . . . . 0.0 110.871 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 6.9 p90 -151.58 152.49 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.006 0.922 . . . . 0.0 112.096 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 8.2 t -123.78 113.23 28.69 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.892 0.877 . . . . 0.0 111.195 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.95 175.54 9.15 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.029 3.153 . . . . 0.0 111.284 174.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 99.5 m -129.25 -46.22 1.22 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.39 1.076 . . . . 0.0 111.91 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -85.92 144.65 39.57 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.919 0.888 . . . . 0.0 110.637 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.16 160.41 33.02 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.092 2.528 . . . . 0.0 110.989 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 132.22 -162.9 24.0 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 125.196 1.379 . . . . 0.0 113.703 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -90.85 121.49 32.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.639 0.776 . . . . 0.0 111.426 176.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -98.98 143.41 29.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.872 1.269 . . . . 0.0 110.854 165.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.34 132.84 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.799 1.639 . . . . 0.0 108.031 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.61 124.58 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.3 1.04 . . . . 0.0 109.82 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -101.35 128.34 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.181 1.792 . . . . 0.0 109.91 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.1 mm -120.67 115.5 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.919 1.287 . . . . 0.0 109.814 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.08 135.37 54.37 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.642 1.577 . . . . 0.0 110.989 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 63.1 t80 -129.69 125.83 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.287 1.435 . . . . 0.0 110.127 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 34.57 18.04 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.165 1.386 . . . . 0.0 113.53 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.252 63.4 m-20 74.05 21.23 2.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.035 2.534 . . . . 0.0 114.176 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -125.38 137.38 54.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.899 1.28 . . . . 0.0 110.972 169.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2124 ' ' HIS . . . . . 0.58 ' CE1' ' HG ' ' A' 2128 ' ' SER . 0.2 OUTLIER -68.45 129.75 40.85 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.487 1.115 . . . . 0.0 110.882 177.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.8 m -77.46 155.23 81.6 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 111.2 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 141.05 75.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.61 2.207 . . . . 0.0 111.432 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 90.37 -24.01 18.89 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.177 1.37 . . . . 0.0 113.608 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2128 ' ' SER . . . . . 0.58 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 22.5 t -76.99 144.62 72.45 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.276 1.038 . . . . 0.0 111.133 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.48 149.57 89.16 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.876 0.992 . . . . 0.0 112.139 -2.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -102.0 127.72 48.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.076 1.351 . . . . 0.0 110.996 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 37.6 m -89.75 135.12 33.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.03 171.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.0 t -132.88 112.52 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.54 1.536 . . . . 0.0 109.556 -168.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.55 108.99 13.51 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.784 -0.572 . . . . 0.0 111.29 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.8 t -95.28 118.18 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 0.0 108.772 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -97.31 152.52 18.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.179 0.992 . . . . 0.0 111.106 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 162.84 -158.28 30.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 126.674 1.989 . . . . 0.0 110.983 -174.266 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.142 0.496 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.9 ptm -146.48 156.04 42.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.0 m -136.72 144.5 43.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.943 2.097 . . . . 0.0 108.581 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -147.83 157.92 43.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -159.77 141.02 12.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.223 1.809 . . . . 0.0 110.107 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 65.8 mttp -125.86 148.05 49.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.509 1.124 . . . . 0.0 112.215 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 23.7 t -133.88 134.46 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.611 1.564 . . . . 0.0 109.895 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.76 54.78 4.85 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.264 1.411 . . . . 0.0 112.882 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 18.9 m -61.98 147.94 45.41 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.57 1.548 . . . . 0.0 114.276 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -168.36 156.62 8.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.846 1.658 . . . . 0.0 111.816 -175.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -81.11 148.61 29.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.149 0.98 . . . . 0.0 111.61 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -93.3 148.76 21.76 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.907 1.283 . . . . 0.0 113.038 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 61.1 mt -133.72 126.74 19.11 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.339 1.456 . . . . 0.0 109.221 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.36 140.14 26.99 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.107 2.538 . . . . 0.0 111.104 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -139.71 135.56 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.96 1.304 . . . . 0.0 110.361 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.8 t30 39.63 69.54 0.29 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.085 2.154 . . . . 0.0 114.016 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.35 120.19 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.092 0.957 . . . . 0.0 111.261 -167.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 4.9 m -172.2 156.76 4.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.124 2.169 . . . . 0.0 110.058 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -86.47 72.11 10.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.162 0.985 . . . . 0.0 110.489 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 35.0 p -97.98 156.63 16.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.989 1.716 . . . . 0.0 111.777 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -91.84 117.79 30.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.466 1.106 . . . . 0.0 110.611 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.52 -9.07 46.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.537 1.135 . . . . 0.0 113.173 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 15.6 m -74.99 -19.33 60.14 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.672 1.189 . . . . 0.0 113.739 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.2 pp -130.25 5.37 4.84 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.514 1.525 . . . . 0.0 113.899 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.33 126.36 54.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.211 2.204 . . . . 0.0 107.768 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -130.85 148.6 52.64 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.244 1.418 . . . . 0.0 110.184 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -138.71 150.16 45.86 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 112.715 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.0 p -140.47 159.84 41.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.606 1.963 . . . . 0.0 109.951 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 3.9 t -114.62 135.54 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.546 1.138 . . . . 0.0 109.598 169.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.7 t -108.39 114.37 59.33 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.066 1.347 . . . . 0.0 108.498 167.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.77 173.11 13.3 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 124.151 3.234 . . . . 0.0 111.269 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.28 -29.11 45.71 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.016 3.144 . . . . 0.0 114.895 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 30.3 p -83.92 -5.57 59.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.219 1.408 . . . . 0.0 114.464 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 80.95 3.02 90.67 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.969 1.271 . . . . 0.0 114.52 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -74.04 77.51 1.71 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.533 1.933 . . . . 0.0 111.706 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.78 133.08 55.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.203 1.001 . . . . 0.0 112.127 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.72 150.03 61.57 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.249 1.42 . . . . 0.0 110.957 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.51 152.63 34.1 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.698 2.932 . . . . 0.0 112.412 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.9 m -91.61 155.12 18.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.484 1.114 . . . . 0.0 111.794 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 65.5 tp -77.82 140.46 39.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 152.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.3 mt -108.3 142.35 38.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.768 1.227 . . . . 0.0 110.347 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -136.89 138.84 41.13 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.919 1.287 . . . . 0.0 112.379 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -80.39 123.73 28.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 151.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.2 mt -96.27 164.25 12.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.234 1.413 . . . . 0.0 111.399 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -63.9 -18.23 63.99 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.15 2.8 56.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.994 0.917 . . . . 0.0 113.198 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.97 -9.03 73.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.028 1.775 . . . . 0.0 114.594 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -80.79 170.37 16.38 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.899 1.68 . . . . 0.0 113.416 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.2 t -115.19 141.73 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.314 1.446 . . . . 0.0 110.483 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -149.35 174.1 29.01 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.44 157.64 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.174 1.79 . . . . 0.0 111.318 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.8 m -137.79 146.59 43.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.565 1.546 . . . . 0.0 109.795 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 4.2 p90 -166.21 171.17 12.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 111.103 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 88.3 t -119.08 121.36 30.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.089 0.955 . . . . 0.0 109.607 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.27 143.22 17.37 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.019 3.146 . . . . 0.0 110.969 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -84.64 -21.67 30.19 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.89 0.876 . . . . 0.0 112.227 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -142.27 172.2 13.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.522 1.929 . . . . 0.0 110.704 -168.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.7 p -91.99 169.94 10.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.911 1.285 . . . . 0.0 111.454 171.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.42 -173.41 23.0 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.374 1.464 . . . . 0.0 113.915 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.82 109.5 6.45 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.32 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 14.5 m80 -95.62 140.55 30.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.231 1.412 . . . . 0.0 109.387 170.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.21 122.91 45.11 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.37 1.068 . . . . 0.0 109.075 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 96.4 t -86.66 118.42 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -101.18 149.42 24.0 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 125.228 1.411 . . . . 0.0 110.567 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.7 p -160.37 126.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 122.167 0.984 . . . . 0.0 111.398 -170.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -128.22 129.43 46.41 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.399 1.879 . . . . 0.0 111.599 -164.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 60.7 tttm -109.93 132.83 53.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.335 1.454 . . . . 0.0 110.223 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.51 -96.69 0.07 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.012 1.325 . . . . 0.0 111.474 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -122.47 10.78 9.15 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.497 1.523 . . . . 0.0 115.533 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -145.93 149.79 34.86 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.091 1.945 . . . . 0.0 113.78 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.29 157.43 37.73 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.653 0.781 . . . . 0.0 112.421 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.6 m -84.86 163.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.84 0.856 . . . . 0.0 111.539 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.2 69.12 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 29.9 m -86.29 -14.63 43.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.966 1.307 . . . . 0.0 114.367 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.3 p -93.03 153.61 41.78 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.869 -1.145 . . . . 0.0 113.478 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.32 150.75 96.04 Favored 'Cis proline' 0 C--N 1.354 0.826 0 CA-C-N 119.125 0.723 . . . . 0.0 112.597 -1.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.86 121.64 50.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.825 1.25 . . . . 0.0 108.469 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.1 138.07 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.854 2.369 . . . . 0.0 111.139 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.3 t -133.99 122.56 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.59 1.556 . . . . 0.0 107.884 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -94.11 122.2 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.489 0.716 . . . . 0.0 110.067 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.91 137.43 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.128 1.371 . . . . 0.0 109.239 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 14.4 t -122.86 161.58 23.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.114 . . . . 0.0 110.896 170.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -61.17 -26.81 67.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.143 0.977 . . . . 0.0 113.602 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 23.8 p -67.53 -15.29 63.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.542 1.137 . . . . 0.0 113.923 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.42 -9.33 47.92 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.627 1.171 . . . . 0.0 112.596 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.77 110.13 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.328 0.967 . . . . 0.0 110.91 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 72.56 11.83 77.14 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 117.274 1.669 . . . . 0.0 117.274 156.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -75.04 91.72 2.56 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.454 1.627 . . . . 0.0 111.212 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.09 67.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.495 1.118 . . . . 0.0 112.38 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.2 m -54.03 -25.49 21.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.952 1.701 . . . . 0.0 114.148 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -88.31 -12.12 44.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.014 1.326 . . . . 0.0 113.619 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 68.4 t -74.33 134.75 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.592 1.087 . . . . 0.0 110.105 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -116.63 158.65 23.39 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.452 1.501 . . . . 0.0 110.876 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 34.8 m -146.61 159.07 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.428 1.491 . . . . 0.0 110.667 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -158.99 168.57 26.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.416 1.086 . . . . 0.0 112.336 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.43 159.32 23.03 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.189 1.376 . . . . 0.0 114.205 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -70.63 -26.71 63.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.112 1.365 . . . . 0.0 113.614 -168.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.97 -4.46 48.52 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.593 1.092 . . . . 0.0 115.063 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.4 -2.77 57.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.162 1.385 . . . . 0.0 112.715 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -128.84 -38.05 1.69 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.951 1.3 . . . . 0.0 113.794 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.75 161.61 39.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.094 0.958 . . . . 0.0 113.177 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.33 -174.24 24.98 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.905 1.241 . . . . 0.0 114.11 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -138.94 144.83 39.19 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.154 1.382 . . . . 0.0 112.105 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 38.6 p -70.51 -18.63 62.96 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.42 -2.14 12.12 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -143.94 144.69 27.52 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.363 1.465 . . . . 0.0 110.178 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.62 150.09 50.3 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.218 . . . . 0.0 111.656 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -98.25 154.09 18.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.42 1.488 . . . . 0.0 110.73 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -134.39 150.94 50.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.808 0.843 . . . . 0.0 112.691 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -157.06 149.84 23.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 110.837 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 140.69 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.842 1.657 . . . . 0.0 109.288 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 43.4 mt -111.68 135.8 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.761 . . . . 0.0 109.032 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 66.5 t0 -125.04 98.37 5.65 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.989 1.715 . . . . 0.0 110.536 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.3 p -94.24 1.0 56.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.316 1.847 . . . . 0.0 113.023 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -61.16 -34.81 75.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.343 0.974 . . . . 0.0 112.851 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.77 -18.24 51.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.522 1.129 . . . . 0.0 113.133 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -88.31 -14.84 37.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.147 1.379 . . . . 0.0 114.014 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.02 -113.17 3.58 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.509 1.052 . . . . 0.0 111.727 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -107.49 144.01 35.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.157 1.383 . . . . 0.0 113.067 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 143.38 144.01 4.2 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.819 1.199 . . . . 0.0 112.982 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -73.65 142.13 30.63 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.632 0.634 . . . . 0.0 112.772 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 127.09 42.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.578 1.551 . . . . 0.0 108.736 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 43.7 t -120.3 135.96 54.84 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.667 1.587 . . . . 0.0 109.506 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -139.58 136.11 34.08 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.288 1.035 . . . . 0.0 110.873 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.7 m -139.83 130.55 25.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 111.398 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 26.5 mt -109.86 136.79 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.463 1.505 . . . . 0.0 108.442 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.5 155.81 42.8 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.162 0.985 . . . . 0.0 111.605 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.39 -146.44 12.56 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.024 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.95 -15.24 36.31 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.897 3.065 . . . . 0.0 114.588 -172.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.9 t -160.44 170.81 20.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.527 1.131 . . . . 0.0 111.669 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -71.99 155.27 40.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.195 0.998 . . . . 0.0 111.589 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.99 162.68 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.3 1.44 . . . . 0.0 110.946 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.49 131.61 36.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.697 0.799 . . . . 0.0 110.146 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.5 mt -111.1 132.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.188 0.995 . . . . 0.0 109.369 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -130.4 155.55 46.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.32 1.848 . . . . 0.0 109.624 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 29.6 p -142.05 160.19 40.72 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.396 1.078 . . . . 0.0 112.315 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -152.55 107.59 3.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.586 1.554 . . . . 0.0 109.347 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.19 129.94 34.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.768 1.227 . . . . 0.0 110.644 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.7 155.99 19.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.711 1.204 . . . . 0.0 112.436 -167.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.12 -18.27 64.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.487 1.115 . . . . 0.0 112.949 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.39 -11.07 60.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.77 -2.88 73.56 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.096 1.808 . . . . 0.0 114.395 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 61.7 p -90.41 174.63 7.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.546 1.938 . . . . 0.0 111.002 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -136.14 128.83 30.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.538 0.735 . . . . 0.0 111.702 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.5 138.03 36.51 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.765 1.226 . . . . 0.0 109.924 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 22.1 t -116.84 138.83 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.656 1.982 . . . . 0.0 108.223 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -137.46 144.02 42.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.345 1.458 . . . . 0.0 111.258 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 8.1 p90 -157.34 151.96 25.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.304 1.042 . . . . 0.0 112.384 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 10.6 t -117.82 108.61 42.49 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.791 0.836 . . . . 0.0 111.213 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.25 152.42 35.04 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.202 2.601 . . . . 0.0 110.527 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 85.2 m -112.69 -37.97 4.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.923 0.889 . . . . 0.0 112.582 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -96.08 148.12 34.03 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 110.733 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 161.23 36.1 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.027 2.485 . . . . 0.0 111.05 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.71 -159.86 18.3 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.109 1.337 . . . . 0.0 113.563 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.7 t30 -95.74 120.01 35.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.052 0.941 . . . . 0.0 111.765 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -98.79 144.9 27.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.775 1.23 . . . . 0.0 110.873 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.22 136.69 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.273 1.429 . . . . 0.0 108.701 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.6 126.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.129 1.372 . . . . 0.0 109.295 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -102.14 131.29 48.74 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.17 1.788 . . . . 0.0 110.297 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.5 mm -123.54 114.2 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.869 1.267 . . . . 0.0 109.592 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -119.71 134.06 55.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.966 1.706 . . . . 0.0 110.908 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -126.36 124.42 40.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.162 1.385 . . . . 0.0 109.737 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.71 36.21 23.2 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.1 1.36 . . . . 0.0 114.035 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 20.9 t70 95.71 -11.2 0.09 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 130.242 3.417 . . . . 0.0 113.611 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -112.72 134.91 54.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.039 . . . . 0.0 112.591 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2124 ' ' HIS . . . . . 0.582 ' CE1' ' HG ' ' A' 2128 ' ' SER . 0.3 OUTLIER -63.4 128.77 37.35 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.884 1.274 . . . . 0.0 110.822 173.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 10.3 m -72.94 156.2 89.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-N 119.551 1.068 . . . . 0.0 111.549 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.07 -35.39 90.27 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.792 2.995 . . . . 0.0 116.393 -170.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.55 75.96 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.567 0.622 . . . . 0.0 114.561 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2128 ' ' SER . . . . . 0.582 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 36.1 t -82.82 146.42 52.48 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.056 1.342 . . . . 0.0 111.442 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.66 152.68 93.29 Favored 'Cis proline' 0 C--N 1.351 0.697 0 CA-C-N 119.815 0.97 . . . . 0.0 112.453 -1.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.38 126.34 51.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 13.9 p -90.01 137.14 32.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.523 1.129 . . . . 0.0 111.35 171.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 21.2 t -133.46 112.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 -168.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -80.72 107.99 13.99 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.529 0.731 . . . . 0.0 111.253 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 92.3 t -94.32 120.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.59 1.156 . . . . 0.0 109.261 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.3 t -97.96 154.14 17.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -171.14 -171.12 36.06 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 29.4 tt0 . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 129.804 3.242 . . . . 0.0 110.867 -178.49 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 120.415 0.15 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 95.7 mtp -122.75 139.23 54.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.632 1.573 . . . . 0.0 111.401 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.1 m -130.11 141.56 50.68 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.29 1.836 . . . . 0.0 108.871 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.1 t60 -140.78 150.69 43.67 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -166.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.47 140.56 20.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.07 1.748 . . . . 0.0 109.641 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.42 144.39 49.49 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.635 1.174 . . . . 0.0 111.282 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.2 p -155.25 141.65 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.093 0.957 . . . . 0.0 111.399 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -75.89 150.81 39.96 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.007 0.813 . . . . 0.0 112.331 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 33.0 m -131.94 127.64 36.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.794 0.837 . . . . 0.0 111.603 -171.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.68 147.24 18.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.633 0.773 . . . . 0.0 112.677 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -82.17 138.25 34.76 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.727 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.49 143.51 33.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.226 1.01 . . . . 0.0 112.178 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.75 125.67 23.08 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.543 1.137 . . . . 0.0 108.97 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.58 140.77 24.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.046 2.498 . . . . 0.0 111.158 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 35.3 mm -137.74 139.17 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.291 1.836 . . . . 0.0 109.065 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.84 46.69 19.32 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 0.0 112.707 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.93 -29.33 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.28 1.832 . . . . 0.0 113.974 -165.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -64.62 -18.41 64.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.28 161.69 37.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.277 1.431 . . . . 0.0 111.952 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.0 m -122.11 121.85 37.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.858 1.263 . . . . 0.0 109.759 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -158.74 128.8 5.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.492 1.517 . . . . 0.0 110.0 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.6 mt -116.06 -3.55 12.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.616 1.566 . . . . 0.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 51.6 m -94.96 -29.17 14.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.051 . . . . 0.0 113.313 -168.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 1.74 12.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.118 1.367 . . . . 0.0 114.442 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.2 tp -91.01 137.21 32.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.924 0.784 . . . . 0.0 111.735 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 33.9 p -141.42 140.03 33.56 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.099 1.759 . . . . 0.0 109.392 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.16 149.93 45.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.866 0.866 . . . . 0.0 113.185 -173.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 77.4 p -138.21 162.63 33.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.075 2.15 . . . . 0.0 109.87 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -118.27 136.44 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.966 1.306 . . . . 0.0 109.791 168.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.8 t -105.28 113.83 64.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.137 1.375 . . . . 0.0 108.27 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.53 172.3 11.5 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.97 3.113 . . . . 0.0 111.737 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.51 -29.14 38.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.85 3.7 . . . . 0.0 114.848 170.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 57.3 p -81.32 -8.29 59.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.796 1.238 . . . . 0.0 114.164 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.5 -0.2 81.78 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.421 1.486 . . . . 0.0 114.815 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -76.58 83.05 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.38 1.472 . . . . 0.0 111.532 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.44 135.77 57.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.727 1.211 . . . . 0.0 112.148 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.79 151.69 66.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.477 1.511 . . . . 0.0 111.323 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.57 152.38 43.01 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.844 3.03 . . . . 0.0 112.392 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 77.9 m -98.3 154.78 17.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.92 1.288 . . . . 0.0 112.179 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.17 116.43 26.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.534 1.134 . . . . 0.0 108.17 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.21 135.78 33.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.604 1.161 . . . . 0.0 111.469 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.37 147.64 52.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.602 1.561 . . . . 0.0 112.413 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -92.6 115.68 28.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.0 mt -90.22 171.5 9.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.612 0.765 . . . . 0.0 112.729 -170.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -59.83 -34.2 72.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 113.814 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 53.7 t30 -80.41 -11.91 59.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.463 1.105 . . . . 0.0 113.814 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 103.81 -14.88 52.86 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.653 1.597 . . . . 0.0 114.525 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 159.87 32.63 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 118.266 1.033 . . . . 0.0 113.183 172.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.7 t -85.06 150.55 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.831 1.252 . . . . 0.0 109.056 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.56 174.53 30.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.109 0.862 . . . . 0.0 114.987 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.43 162.46 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.213 1.805 . . . . 0.0 112.072 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 74.1 m -144.4 150.25 37.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.423 1.889 . . . . 0.0 110.41 166.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.21 178.44 8.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.485 1.914 . . . . 0.0 110.763 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 67.9 t -130.58 123.35 20.27 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.155 0.982 . . . . 0.0 109.93 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.71 148.89 23.1 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.787 3.658 . . . . 0.0 112.075 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 mptt -106.84 -9.76 16.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.516 1.126 . . . . 0.0 113.48 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.76 172.03 13.37 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.664 1.986 . . . . 0.0 110.329 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 32.9 p -96.02 154.38 17.27 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.619 1.168 . . . . 0.0 110.903 167.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 104.31 -165.76 15.08 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.168 1.366 . . . . 0.0 113.931 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.84 114.3 10.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.36 1.064 . . . . 0.0 112.213 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 18.9 m80 -95.77 143.26 27.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.644 1.578 . . . . 0.0 109.07 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -107.37 123.3 48.17 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.053 0.941 . . . . 0.0 108.908 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 93.4 t -83.65 121.23 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 166.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.81 138.56 40.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.153 . . . . 0.0 110.095 170.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -146.42 133.68 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.086 0.946 . . . . 0.0 112.503 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.88 139.69 50.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.893 2.077 . . . . 0.0 111.602 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.87 109.37 20.45 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.422 2.689 . . . . 0.0 108.413 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 54.18 -103.74 0.19 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.925 1.29 . . . . 0.0 111.457 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.03 6.38 34.79 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.871 1.701 . . . . 0.0 115.514 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -129.22 148.72 51.18 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.287 1.543 . . . . 0.0 111.638 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 29.8 p80 -66.01 147.14 53.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.62 -1.3 . . . . 0.0 112.101 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.0 t -72.72 144.85 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.32 -24.73 60.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 54.5 p -84.27 -12.45 54.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.113 1.365 . . . . 0.0 114.075 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 9.6 t -80.01 140.05 53.62 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 120.871 -1.143 . . . . 0.0 112.62 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.27 152.49 83.99 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 119.536 0.87 . . . . 0.0 112.498 -5.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.77 122.58 45.42 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.336 1.454 . . . . 0.0 108.739 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.29 143.09 12.35 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.08 2.52 . . . . 0.0 111.777 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.4 t -139.32 117.45 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.422 1.489 . . . . 0.0 108.486 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 51.3 t -94.85 122.86 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.61 0.764 . . . . 0.0 110.174 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.73 129.43 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.11 1.364 . . . . 0.0 110.364 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 73.3 m -94.77 159.72 14.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.234 1.414 . . . . 0.0 112.102 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -59.25 -26.95 65.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.182 -0.948 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.9 p -65.43 -18.92 65.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.528 1.531 . . . . 0.0 114.18 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.39 -4.87 28.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.241 1.416 . . . . 0.0 112.95 -175.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.1 mm -73.64 -34.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.289 1.036 . . . . 0.0 112.602 -173.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 154.34 45.61 0.02 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.853 0.74 . . . . 0.0 114.388 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.52 100.74 10.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.459 1.129 . . . . 0.0 110.858 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.82 -35.96 69.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.988 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 13.1 t -54.19 -29.08 44.59 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.899 1.279 . . . . 0.0 113.31 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -85.79 -9.85 56.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.728 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 63.3 t -76.94 129.96 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.546 1.066 . . . . 0.0 109.594 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -109.08 155.42 20.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.467 1.507 . . . . 0.0 110.867 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.2 m -145.24 148.62 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.992 1.317 . . . . 0.0 110.938 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.6 m -151.62 157.09 41.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.853 1.261 . . . . 0.0 112.14 -175.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 119.03 161.34 11.66 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.496 1.046 . . . . 0.0 114.953 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -64.74 -33.06 75.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.782 1.633 . . . . 0.0 113.225 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.24 -3.58 46.6 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.783 1.182 . . . . 0.0 115.013 -176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.86 -7.6 57.0 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.242 1.417 . . . . 0.0 112.745 168.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -128.1 -36.9 1.92 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 113.942 -173.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -156.75 157.23 34.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.351 1.06 . . . . 0.0 112.911 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.26 -175.04 25.85 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.564 1.078 . . . . 0.0 114.346 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 62.6 m80 -139.58 142.07 37.14 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.143 1.377 . . . . 0.0 112.128 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 55.8 p -73.2 -14.81 61.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -115.29 -2.89 12.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -145.0 145.35 26.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.562 1.545 . . . . 0.0 110.195 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.49 143.0 50.7 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.543 2.162 . . . . 0.0 111.26 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -96.5 163.03 13.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.253 1.421 . . . . 0.0 110.452 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.46 159.41 44.5 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.82 153.52 24.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.379 1.872 . . . . 0.0 110.222 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.73 140.03 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 109.282 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.31 134.3 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.012 1.725 . . . . 0.0 108.421 168.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.3 t0 -120.0 101.19 7.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.183 1.793 . . . . 0.0 110.102 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.4 p -94.89 0.57 54.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.327 1.851 . . . . 0.0 113.129 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -60.4 -36.12 77.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.443 1.019 . . . . 0.0 113.203 -170.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.99 -17.51 52.7 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.266 1.026 . . . . 0.0 113.214 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.77 -6.67 55.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.552 1.541 . . . . 0.0 113.731 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 78.79 -111.97 3.36 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.166 1.365 . . . . 0.0 112.641 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -115.75 164.81 13.83 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.195 1.798 . . . . 0.0 112.388 -172.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.74 -134.81 5.3 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.523 1.059 . . . . 0.0 113.041 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -155.88 140.56 7.36 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.479 1.038 . . . . 0.0 112.435 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.48 121.45 41.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.357 1.863 . . . . 0.0 109.591 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.7 m -107.81 140.11 41.39 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.241 1.817 . . . . 0.0 109.872 167.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -142.28 137.96 31.01 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.072 0.949 . . . . 0.0 110.045 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 86.5 p -135.17 148.62 49.76 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.557 0.694 . . . . 0.0 111.873 169.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.2 mt -122.91 125.74 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -119.46 145.61 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.314 1.446 . . . . 0.0 109.274 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 174.92 -163.79 34.21 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.92 -2.41 11.46 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.714 3.609 . . . . 0.0 114.225 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -160.53 165.61 30.55 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.949 1.3 . . . . 0.0 111.351 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -71.3 143.0 50.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.277 1.031 . . . . 0.0 110.905 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 7.6 m -121.32 150.23 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.315 1.446 . . . . 0.0 110.693 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.91 110.94 22.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.692 0.797 . . . . 0.0 109.985 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.56 134.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 109.913 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.7 164.3 27.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.551 1.94 . . . . 0.0 110.897 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 14.6 p -138.16 155.26 48.89 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.609 1.564 . . . . 0.0 112.039 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.29 130.61 12.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.719 1.208 . . . . 0.0 110.728 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.6 t70 -85.64 125.37 33.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.793 1.237 . . . . 0.0 110.602 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.05 152.46 18.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.217 1.007 . . . . 0.0 111.835 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.09 -12.57 61.8 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.517 1.127 . . . . 0.0 113.678 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.38 -6.26 59.41 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.83 1.252 . . . . 0.0 113.009 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.2 5.22 59.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.639 1.59 . . . . 0.0 114.856 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 37.2 p -98.46 166.41 11.37 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.456 1.902 . . . . 0.0 111.661 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.3 t -116.35 124.79 50.97 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.274 1.029 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -88.3 133.55 34.04 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.107 1.363 . . . . 0.0 109.623 170.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 60.6 t -111.89 137.29 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.259 1.424 . . . . 0.0 108.741 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.5 p -126.71 146.05 50.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.555 1.942 . . . . 0.0 110.15 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.1 p90 -160.9 149.58 16.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.264 1.026 . . . . 0.0 112.043 175.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.1 t -118.08 113.25 37.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.789 0.836 . . . . 0.0 110.995 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.47 166.75 25.46 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.67 2.914 . . . . 0.0 110.787 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.1 m -129.99 -43.44 1.21 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 0.0 112.551 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -87.89 144.46 34.89 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 123.684 0.793 . . . . 0.0 109.812 168.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.97 164.02 27.81 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.27 2.647 . . . . 0.0 111.319 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 129.53 -160.79 22.76 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.223 1.392 . . . . 0.0 113.679 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -88.73 124.53 34.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.323 0.649 . . . . 0.0 111.305 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -106.05 140.81 38.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.732 1.213 . . . . 0.0 109.884 166.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.9 mp -107.21 127.41 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.955 1.302 . . . . 0.0 108.264 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 14.4 mt -110.86 128.48 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.239 1.016 . . . . 0.0 109.786 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -108.94 125.79 52.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.855 1.262 . . . . 0.0 110.106 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -111.31 121.76 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 173.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 3.6 tmmt? -133.21 127.33 33.54 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.874 1.269 . . . . 0.0 110.982 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -125.6 127.75 46.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.064 1.346 . . . . 0.0 110.651 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 48.95 48.38 20.67 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.705 1.202 . . . . 0.0 112.92 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t70 79.99 -2.2 2.03 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.45 2.7 . . . . 0.0 114.145 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -121.51 127.58 51.16 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.812 -168.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -66.34 125.97 27.31 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.832 1.253 . . . . 0.0 111.297 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.6 m -82.5 159.05 65.06 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.227 -0.92 . . . . 0.0 111.72 -169.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.88 143.08 73.37 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.756 2.971 . . . . 0.0 113.526 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.96 -23.08 19.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.852 1.215 . . . . 0.0 114.232 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 70.7 m -73.44 151.73 89.69 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 118.65 1.225 . . . . 0.0 111.696 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.06 141.67 72.46 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.192 0.747 . . . . 0.0 111.408 -6.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -94.57 117.47 30.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.079 0.951 . . . . 0.0 110.339 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 16.7 m -82.98 129.06 34.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.32 0.648 . . . . 0.0 110.859 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.9 t -123.24 114.58 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.147 1.779 . . . . 0.0 109.172 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.54 105.5 10.89 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.002 0.521 . . . . 0.0 110.969 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 82.9 t -93.13 118.47 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.384 1.074 . . . . 0.0 109.042 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 156.53 16.3 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.388 1.075 . . . . 0.0 110.406 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 174.04 -157.92 26.28 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 N--CA 1.477 0.904 0 C-N-CA 129.195 2.998 . . . . 0.0 112.942 174.142 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 26.9 ptm -61.77 154.56 25.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.694 1.197 . . . . 0.0 113.137 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.8 m -121.52 145.79 47.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.598 1.559 . . . . 0.0 109.069 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -155.76 160.22 40.12 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.1 tt -163.05 155.13 18.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.766 2.026 . . . . 0.0 110.836 -172.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 68.4 mttm -130.25 151.85 50.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 112.766 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.8 t -138.46 131.14 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.651 1.58 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.2 77.35 1.86 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.687 1.136 . . . . 0.0 111.41 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 60.4 m -75.76 152.64 37.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.44 150.19 14.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.907 1.283 . . . . 0.0 112.849 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.39 160.96 25.21 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.755 1.222 . . . . 0.0 111.842 167.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.87 141.33 28.76 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.404 1.482 . . . . 0.0 112.66 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 37.4 mm -123.13 115.69 28.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.257 1.423 . . . . 0.0 108.887 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.7 132.39 11.99 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.35 2.7 . . . . 0.0 111.358 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 33.9 mt -148.39 143.13 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.841 1.656 . . . . 0.0 110.411 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 57.58 51.25 9.82 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.929 1.692 . . . . 0.0 112.478 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.39 -30.25 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.695 1.598 . . . . 0.0 112.614 -170.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 19.5 m -72.25 -15.31 61.92 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -81.77 141.0 33.9 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.208 0.913 . . . . 0.0 112.033 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -115.35 -34.32 4.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.106 1.762 . . . . 0.0 111.448 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.87 60.42 6.23 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.698 1.199 . . . . 0.0 111.815 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.43 -26.08 67.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.89 1.676 . . . . 0.0 112.42 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 20.5 m -59.49 -23.59 62.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.74 2.61 25.83 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.4 mp -84.47 145.98 27.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.483 1.113 . . . . 0.0 111.579 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.3 p -139.94 154.72 47.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.46 1.904 . . . . 0.0 109.171 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -147.97 152.16 37.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.8 p -140.99 159.48 42.12 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.594 1.958 . . . . 0.0 110.414 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.8 t -112.98 134.8 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.055 1.342 . . . . 0.0 109.525 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 99.6 t -103.01 111.68 65.23 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.038 1.335 . . . . 0.0 108.104 163.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.37 168.25 21.8 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.747 2.965 . . . . 0.0 110.743 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.71 -15.85 48.63 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.061 2.507 . . . . 0.0 113.267 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.6 p -79.75 -9.63 59.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 113.923 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.78 -2.01 84.51 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.665 1.602 . . . . 0.0 115.065 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -77.1 77.78 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.442 1.497 . . . . 0.0 111.712 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.77 134.93 56.69 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.864 1.265 . . . . 0.0 112.04 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -140.51 151.04 62.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.216 1.406 . . . . 0.0 111.32 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.38 153.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.87 3.046 . . . . 0.0 112.385 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 86.8 m -98.6 155.7 17.17 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.998 1.319 . . . . 0.0 112.381 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.8 tp -87.88 117.97 27.1 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 160.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 32.2 mt -81.16 140.99 34.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.96 0.904 . . . . 0.0 110.256 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -136.12 141.56 44.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.828 1.251 . . . . 0.0 113.139 -174.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -82.72 117.54 22.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.282 1.433 . . . . 0.0 107.93 157.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.06 171.02 7.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.776 1.23 . . . . 0.0 112.421 -172.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -56.73 -36.71 70.05 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.646 1.578 . . . . 0.0 115.049 -166.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.15 2.22 44.53 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 91.8 1.99 70.04 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.672 1.606 . . . . 0.0 113.994 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.35 166.77 15.34 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.738 1.615 . . . . 0.0 113.837 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 79.8 t -96.9 144.43 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.898 1.679 . . . . 0.0 110.05 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.55 -179.95 32.84 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 123.941 0.781 . . . . 0.0 114.802 171.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.79 157.15 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.394 1.478 . . . . 0.0 112.476 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.1 m -130.32 151.88 50.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.571 1.548 . . . . 0.0 110.777 160.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.4 p90 -167.15 -179.63 4.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.669 2.388 . . . . 0.0 109.495 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.5 t -127.63 120.4 21.85 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 119.273 0.942 . . . . 0.0 110.022 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.93 145.03 17.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.161 3.241 . . . . 0.0 111.206 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 48.0 tttm -94.57 -50.12 5.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.911 0.884 . . . . 0.0 112.074 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.83 171.88 8.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.864 1.666 . . . . 0.0 111.2 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.1 p -91.23 173.69 7.79 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.421 1.488 . . . . 0.0 111.462 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 89.23 -164.98 32.45 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.978 1.275 . . . . 0.0 113.601 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.9 116.23 8.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.073 0.949 . . . . 0.0 111.702 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.4 m80 -103.49 144.56 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.962 1.705 . . . . 0.0 109.003 165.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.75 119.25 38.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.555 1.142 . . . . 0.0 109.681 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 92.3 t -88.11 131.83 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.305 1.042 . . . . 0.0 108.652 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -112.74 140.25 47.67 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.86 1.264 . . . . 0.0 110.054 168.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 2.9 p -138.81 133.36 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.931 0.892 . . . . 0.0 111.164 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -115.11 141.79 47.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.612 1.965 . . . . 0.0 112.649 -163.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -139.45 130.63 26.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.92 2.088 . . . . 0.0 110.055 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.93 31.89 14.24 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.542 1.137 . . . . 0.0 113.636 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.17 -2.62 81.61 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.44 1.495 . . . . 0.0 116.09 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -129.67 150.17 51.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.622 1.711 . . . . 0.0 111.723 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -66.11 139.49 58.16 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.846 -1.159 . . . . 0.0 112.044 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 20.0 m -69.23 161.26 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 111.499 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.93 63.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 17.3 m -76.77 -17.83 58.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.686 1.195 . . . . 0.0 114.127 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 45.0 m -79.05 144.58 63.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.738 -1.226 . . . . 0.0 112.922 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.5 147.19 81.4 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 118.827 0.617 . . . . 0.0 112.044 -5.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -97.31 121.67 58.01 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.924 1.29 . . . . 0.0 108.449 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.42 139.26 12.84 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.839 2.359 . . . . 0.0 111.288 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -131.05 124.14 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.629 1.572 . . . . 0.0 107.402 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.3 t -99.01 121.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.683 0.793 . . . . 0.0 110.084 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.02 122.36 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.902 1.281 . . . . 0.0 109.644 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 154.69 22.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.611 0.764 . . . . 0.0 111.372 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -55.37 -29.26 58.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.221 1.009 . . . . 0.0 112.698 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 34.1 m -68.7 -15.72 63.6 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -92.97 -14.88 26.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.365 1.066 . . . . 0.0 113.004 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.48 -28.42 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.714 1.206 . . . . 0.0 112.52 -173.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 146.77 94.57 0.15 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.132 1.349 . . . . 0.0 112.396 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.67 113.84 21.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.103 1.361 . . . . 0.0 109.477 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 112.282 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.4 m -53.3 -23.02 8.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.051 1.74 . . . . 0.0 114.115 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -87.33 -17.74 31.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.758 1.223 . . . . 0.0 114.151 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.0 t -78.75 136.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.625 1.102 . . . . 0.0 110.162 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -119.73 159.37 24.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.137 1.375 . . . . 0.0 110.516 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 26.9 m -145.92 157.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.58 . . . . 0.0 110.605 -178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -158.44 175.27 13.91 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.373 1.069 . . . . 0.0 112.565 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 101.15 166.67 27.87 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.436 1.493 . . . . 0.0 114.204 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.87 -35.2 79.48 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.611 1.164 . . . . 0.0 112.937 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.34 10.99 5.58 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.588 1.566 . . . . 0.0 115.152 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 80.1 mt -100.11 -7.49 24.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.831 1.652 . . . . 0.0 112.063 165.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -131.7 -41.6 1.05 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.485 1.514 . . . . 0.0 113.846 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.77 154.82 26.84 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.58 -170.58 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.552 1.548 . . . . 0.0 113.865 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 72.6 m80 -140.19 146.91 39.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.054 1.342 . . . . 0.0 112.407 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.8 p -73.26 -17.67 61.3 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.19 -3.61 12.52 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -144.4 145.09 27.68 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 110.268 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.75 145.95 52.81 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.977 2.452 . . . . 0.0 111.801 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -89.66 157.06 18.17 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.661 1.184 . . . . 0.0 110.672 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.95 145.34 44.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.819 0.848 . . . . 0.0 112.346 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -150.37 145.94 26.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.042 1.337 . . . . 0.0 111.023 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.02 144.68 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.21 1.804 . . . . 0.0 109.457 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 22.0 mt -118.96 135.67 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.266 1.826 . . . . 0.0 109.835 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -109.06 43.44 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.338 1.855 . . . . 0.0 112.669 -171.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 1.2 p -57.83 -21.36 41.97 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -29.63 59.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.48 -4.48 59.0 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.696 1.198 . . . . 0.0 113.03 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.77 1.59 34.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.832 1.653 . . . . 0.0 114.422 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.94 -116.81 4.53 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -128.87 161.48 29.74 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.912 1.285 . . . . 0.0 112.628 -174.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.28 166.38 10.88 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.448 1.023 . . . . 0.0 114.563 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -79.52 132.49 11.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.04 0.828 . . . . 0.0 112.462 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 124.33 47.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.548 1.939 . . . . 0.0 107.801 171.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -118.54 139.08 52.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.205 1.002 . . . . 0.0 110.647 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 5.1 tp -122.88 134.06 54.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.91 1.684 . . . . 0.0 109.874 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.6 m -135.82 130.29 33.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.289 0.635 . . . . 0.0 110.501 170.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 44.9 mt -112.86 135.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.537 1.535 . . . . 0.0 109.323 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.92 155.3 50.17 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.908 1.683 . . . . 0.0 109.958 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.41 -159.11 31.67 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.381 -0.825 . . . . 0.0 115.013 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.5 -2.88 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.407 3.404 . . . . 0.0 114.18 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -156.24 161.46 40.25 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.849 1.26 . . . . 0.0 111.338 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -66.29 149.87 49.7 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.324 -0.86 . . . . 0.0 110.074 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 20.3 m -124.05 159.76 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.394 1.078 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.37 122.67 45.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.951 0.9 . . . . 0.0 109.188 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 16.0 mt -105.78 134.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.564 1.145 . . . . 0.0 110.131 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -130.14 165.17 22.86 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 110.598 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -143.07 162.77 34.64 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.071 1.348 . . . . 0.0 112.181 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.83 116.35 5.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.665 1.586 . . . . 0.0 109.706 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.55 132.6 39.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 110.854 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.7 mt -111.1 153.24 25.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.647 1.179 . . . . 0.0 111.702 -173.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.45 -19.07 64.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -83.44 3.37 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.876 1.271 . . . . 0.0 113.077 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.89 -0.2 84.13 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.473 1.511 . . . . 0.0 114.17 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.1 p -81.73 166.4 20.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.095 1.758 . . . . 0.0 111.194 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -129.18 126.1 38.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.048 0.939 . . . . 0.0 110.748 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -81.92 135.03 35.43 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.412 1.085 . . . . 0.0 109.271 166.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.7 t -113.43 140.37 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.714 2.006 . . . . 0.0 108.237 167.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 10.8 p -136.09 150.21 49.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.187 1.395 . . . . 0.0 111.311 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.8 p90 -159.18 149.59 19.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.505 1.122 . . . . 0.0 111.854 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 9.0 t -114.92 108.97 47.76 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.845 0.858 . . . . 0.0 111.013 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.05 154.27 25.47 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.436 2.758 . . . . 0.0 110.56 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 27.1 m -114.28 -42.23 3.36 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.135 0.974 . . . . 0.0 112.408 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -87.9 142.83 32.57 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.769 0.828 . . . . 0.0 110.441 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.32 163.83 31.86 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.312 2.674 . . . . 0.0 111.083 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.27 -143.36 15.02 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.822 1.201 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -124.28 129.7 51.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.458 0.703 . . . . 0.0 111.866 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -108.02 144.98 34.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 110.773 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.14 132.28 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.334 1.454 . . . . 0.0 108.878 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.57 127.9 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.339 1.455 . . . . 0.0 109.199 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -107.46 126.93 53.13 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.095 1.358 . . . . 0.0 110.216 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 12.6 mm -116.65 94.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.582 1.153 . . . . 0.0 110.231 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -86.62 130.39 34.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.907 1.283 . . . . 0.0 110.09 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.22 130.5 46.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.089 0.955 . . . . 0.0 109.825 168.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 56.95 26.0 11.27 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.108 1.363 . . . . 0.0 113.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.6 t70 72.28 12.33 5.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.991 2.516 . . . . 0.0 114.472 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -98.37 -158.82 0.7 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.775 1.63 . . . . 0.0 109.595 165.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2124 ' ' HIS . . . . . 0.577 ' CE1' ' HG ' ' A' 2128 ' ' SER . 0.5 OUTLIER -142.57 127.46 18.3 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.474 -1.392 . . . . 0.0 110.249 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.0 m -73.44 155.16 89.76 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 0.0 112.172 -167.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.14 131.31 38.82 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.654 2.903 . . . . 0.0 112.807 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.88 50.57 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.039 1.304 . . . . 0.0 114.676 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2128 ' ' SER . . . . . 0.577 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 28.9 t -77.42 144.39 70.22 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 118.926 1.363 . . . . 0.0 111.518 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.89 152.68 97.1 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.727 0.938 . . . . 0.0 112.589 -3.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -104.88 132.33 51.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.366 1.466 . . . . 0.0 111.298 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 69.2 m -100.36 126.21 46.69 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.643 1.177 . . . . 0.0 111.272 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.36 111.82 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.749 1.62 . . . . 0.0 109.789 -167.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -77.93 112.7 15.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.793 -0.567 . . . . 0.0 111.169 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 71.3 t -101.39 113.37 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 109.05 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -90.8 154.83 19.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.333 1.053 . . . . 0.0 110.85 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -178.6 -161.9 27.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.871 2.068 . . . . 0.0 109.081 -177.2 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 98.8 mtp -84.0 129.88 34.9 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.969 0.908 . . . . 0.0 111.432 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 21.0 m -113.68 132.68 55.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.193 1.797 . . . . 0.0 108.592 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 7.0 t60 -129.51 152.89 48.55 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -163.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.73 153.89 35.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.196 1.798 . . . . 0.0 110.864 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.8 146.54 43.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.06 1.344 . . . . 0.0 111.949 173.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 60.2 t -143.0 133.94 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.044 1.738 . . . . 0.0 109.617 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.16 132.43 11.08 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.932 0.777 . . . . 0.0 111.54 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 27.2 m -120.65 141.63 50.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.256 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -152.26 156.72 40.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.137 0.975 . . . . 0.0 113.276 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -113.07 151.62 30.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 111.574 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.72 147.38 25.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 0.0 113.128 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.54 126.38 23.42 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 125.309 1.444 . . . . 0.0 108.73 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.81 130.5 9.65 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.198 2.599 . . . . 0.0 111.237 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 40.4 mt -149.63 141.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.392 1.877 . . . . 0.0 108.746 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.3 t30 59.13 53.76 5.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.368 1.467 . . . . 0.0 111.906 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 30.1 mm -56.79 -39.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.747 1.619 . . . . 0.0 113.509 -163.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 17.2 m -77.12 -2.31 33.65 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.43 145.05 51.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 113.481 -171.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 41.2 p -133.13 -20.56 2.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.519 1.927 . . . . 0.0 112.984 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.14 50.8 2.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.303 1.441 . . . . 0.0 111.85 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -1.18 6.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 35.5 p -77.16 -25.9 52.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.705 1.602 . . . . 0.0 114.271 174.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.81 8.4 4.49 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.22 136.14 33.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.503 1.921 . . . . 0.0 109.046 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 11.2 t -148.25 161.47 41.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.811 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.57 154.26 38.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 113.045 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 70.1 p -140.95 163.01 34.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.906 2.082 . . . . 0.0 109.599 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 17.8 t -116.65 136.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.827 1.251 . . . . 0.0 110.182 171.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.3 t -106.62 113.29 63.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.907 1.283 . . . . 0.0 108.497 166.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.03 174.18 9.54 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.402 3.401 . . . . 0.0 111.801 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.81 -29.22 51.6 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.538 3.492 . . . . 0.0 114.619 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 70.9 p -80.91 -3.57 51.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.855 1.262 . . . . 0.0 113.989 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 75.2 -3.11 48.7 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.474 1.511 . . . . 0.0 114.911 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -76.26 91.6 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.953 1.301 . . . . 0.0 110.928 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 131.69 50.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.055 0.942 . . . . 0.0 111.601 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -132.45 144.42 52.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.725 1.61 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.07 153.02 28.35 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.435 2.757 . . . . 0.0 112.287 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.3 m -89.1 151.52 22.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.076 0.951 . . . . 0.0 112.402 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 59.8 tp -86.5 131.76 34.1 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.602 1.161 . . . . 0.0 108.271 157.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mp -99.72 142.1 31.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.603 1.161 . . . . 0.0 110.133 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.6 139.16 36.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.678 1.191 . . . . 0.0 113.049 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -92.34 114.51 27.07 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 156.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.85 169.39 11.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.997 -169.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -62.76 -27.47 69.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -166.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -88.43 3.6 49.43 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 119.155 0.889 . . . . 0.0 113.256 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.06 -4.41 71.15 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 126.122 1.82 . . . . 0.0 114.312 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -80.14 156.14 27.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.391 1.476 . . . . 0.0 113.782 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 68.6 t -89.08 140.94 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.13 1.372 . . . . 0.0 110.126 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.06 177.96 29.57 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.275 0.941 . . . . 0.0 114.488 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.35 161.08 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.142 1.377 . . . . 0.0 111.808 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 49.6 m -134.99 156.72 48.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.147 1.779 . . . . 0.0 110.179 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.8 p90 -164.3 -170.39 2.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.503 1.921 . . . . 0.0 109.381 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 70.3 t -131.85 114.35 15.3 Favored Pre-proline 0 N--CA 1.48 1.029 0 CA-C-N 119.51 1.05 . . . . 0.0 109.825 168.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.97 145.25 31.33 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.738 2.959 . . . . 0.0 110.499 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -115.04 1.15 13.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.44 1.096 . . . . 0.0 113.033 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -141.74 171.34 14.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.377 2.271 . . . . 0.0 109.73 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.9 p -94.97 163.37 13.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.358 1.063 . . . . 0.0 110.742 164.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.22 -167.29 26.24 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.893 1.235 . . . . 0.0 113.738 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.3 114.63 8.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.258 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.3 m80 -99.91 147.56 25.41 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.904 1.682 . . . . 0.0 109.163 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 84.9 mt -105.62 124.21 49.18 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 109.864 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.9 t -89.74 113.69 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.669 1.188 . . . . 0.0 107.956 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -94.09 140.88 29.18 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.53 1.132 . . . . 0.0 110.436 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.3 p -143.89 133.99 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.818 0.818 . . . . 0.0 112.104 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -136.04 137.32 41.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.668 1.987 . . . . 0.0 111.528 -164.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.6 tttt -134.89 132.56 38.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.474 1.509 . . . . 0.0 110.895 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 58.01 25.55 12.42 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.33 5.08 73.06 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.146 1.355 . . . . 0.0 115.605 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -128.9 151.4 49.68 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.426 1.613 . . . . 0.0 111.625 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -64.74 146.66 54.47 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.028 -1.045 . . . . 0.0 112.541 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 58.0 t -72.19 145.34 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.678 0.791 . . . . 0.0 108.895 171.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.63 -29.5 64.6 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 22.1 m -84.79 -4.25 58.98 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.15 1.38 . . . . 0.0 113.972 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 14.9 t -82.32 141.65 46.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.699 -1.25 . . . . 0.0 112.191 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.98 157.06 84.27 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.657 0.913 . . . . 0.0 112.655 -5.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.97 124.38 41.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.541 1.536 . . . . 0.0 108.686 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.39 141.27 14.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.032 2.488 . . . . 0.0 111.314 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.2 t -137.83 123.77 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.481 1.512 . . . . 0.0 108.303 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.8 t -96.53 124.18 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.742 0.817 . . . . 0.0 110.222 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.23 129.07 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.974 1.31 . . . . 0.0 110.145 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -94.91 168.41 10.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.695 1.198 . . . . 0.0 112.717 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.52 -34.89 78.03 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.412 -1.43 . . . . 0.0 111.653 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.8 m -64.63 -12.14 42.64 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.335 1.454 . . . . 0.0 114.892 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -116.01 1.47 13.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.526 1.53 . . . . 0.0 113.105 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.48 -23.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.333 1.053 . . . . 0.0 113.288 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.12 37.57 0.04 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.97 101.23 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.461 1.13 . . . . 0.0 111.377 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.77 82.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.422 0.689 . . . . 0.0 112.819 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 75.7 m -62.1 -25.32 67.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.855 0.862 . . . . 0.0 113.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -79.82 -13.43 59.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.209 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.6 t -77.28 133.17 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 120.141 1.337 . . . . 0.0 109.838 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -112.55 160.83 17.44 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.883 1.673 . . . . 0.0 110.871 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.2 m -146.9 159.29 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.363 1.465 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.49 177.48 10.9 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.608 1.163 . . . . 0.0 112.495 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 93.85 163.07 36.13 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.371 1.462 . . . . 0.0 113.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -75.68 -28.16 58.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.85 0.86 . . . . 0.0 113.205 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.14 0.91 13.09 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.216 1.389 . . . . 0.0 115.326 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.8 mt -92.37 -5.38 52.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.94 1.696 . . . . 0.0 112.643 168.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -133.8 -43.04 0.82 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.964 1.305 . . . . 0.0 113.516 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.23 150.2 40.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.832 1.253 . . . . 0.0 111.613 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.49 -176.23 22.51 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.579 1.085 . . . . 0.0 113.836 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.45 151.44 48.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 111.729 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 37.8 p -76.71 -40.19 49.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.863 0.865 . . . . 0.0 112.489 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -98.1 1.35 47.51 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -140.44 146.78 46.78 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.35 151.76 54.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.183 2.589 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -106.65 130.18 54.44 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.9 1.28 . . . . 0.0 111.038 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -111.93 147.09 36.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.461 1.505 . . . . 0.0 113.323 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 55.9 p90 -156.12 155.05 31.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.868 1.267 . . . . 0.0 112.145 173.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.91 143.66 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.532 1.933 . . . . 0.0 109.705 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 53.2 mt -122.77 133.98 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.521 1.928 . . . . 0.0 108.839 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.1 t0 -128.93 101.1 5.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.802 1.641 . . . . 0.0 110.948 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 39.3 p -96.18 1.46 52.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.187 1.795 . . . . 0.0 113.275 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -60.73 -34.03 73.8 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.367 0.985 . . . . 0.0 113.221 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.07 -12.04 55.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.56 1.144 . . . . 0.0 113.353 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.08 -12.46 35.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.502 1.521 . . . . 0.0 114.073 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.31 -119.28 5.1 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.376 0.988 . . . . 0.0 111.823 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -103.52 162.29 13.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.276 1.831 . . . . 0.0 112.329 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.83 -177.77 29.51 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.929 0.776 . . . . 0.0 114.979 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -104.43 121.78 7.1 Favored Glycine 0 N--CA 1.468 0.793 0 C-N-CA 124.731 1.158 . . . . 0.0 111.113 174.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.49 123.63 36.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.374 1.47 . . . . 0.0 108.37 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 33.6 t -121.75 145.23 48.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.984 1.714 . . . . 0.0 109.73 175.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.11 133.17 22.83 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.521 0.729 . . . . 0.0 110.762 -164.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 7.6 m -129.14 136.54 50.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.805 0.842 . . . . 0.0 110.622 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.5 mt -119.92 138.69 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.863 1.265 . . . . 0.0 108.323 168.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.56 146.55 28.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.798 0.839 . . . . 0.0 111.7 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -176.64 -163.24 28.64 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.903 -173.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.39 -10.18 25.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.017 3.145 . . . . 0.0 114.482 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.1 t -152.38 169.42 22.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.483 1.038 . . . . 0.0 112.067 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.36 143.97 54.82 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.152 1.381 . . . . 0.0 111.137 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -121.08 149.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.754 0.706 . . . . 0.0 111.517 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.32 118.38 34.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.616 0.766 . . . . 0.0 109.469 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 50.0 mt -104.2 135.94 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.146 1.379 . . . . 0.0 109.795 -173.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.27 156.82 43.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.794 1.637 . . . . 0.0 110.384 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 34.0 p -134.46 154.99 51.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.229 1.412 . . . . 0.0 111.438 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -150.51 131.76 14.53 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.647 1.179 . . . . 0.0 110.736 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.91 122.88 29.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.594 1.157 . . . . 0.0 110.561 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.0 mt -92.05 151.9 20.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.927 0.891 . . . . 0.0 111.396 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -63.01 -26.34 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.406 1.082 . . . . 0.0 112.884 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.45 -4.98 42.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.953 1.301 . . . . 0.0 113.469 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.39 4.19 59.66 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.632 1.587 . . . . 0.0 114.745 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -95.31 163.1 13.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.176 1.79 . . . . 0.0 111.453 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 128.47 54.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.24 1.016 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -91.48 136.08 33.38 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.665 167.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 137.73 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.916 1.686 . . . . 0.0 108.414 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 14.3 p -134.94 146.54 49.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.107 1.363 . . . . 0.0 110.561 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.8 p90 -149.82 152.08 34.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.519 0.728 . . . . 0.0 112.86 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 p -115.95 108.41 46.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.963 1.305 . . . . 0.0 111.24 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.75 169.76 17.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.676 2.918 . . . . 0.0 110.795 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 87.4 m -121.19 -51.75 2.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.949 0.899 . . . . 0.0 111.673 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -81.82 143.23 49.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.749 0.82 . . . . 0.0 110.374 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.24 162.15 34.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.124 2.549 . . . . 0.0 111.038 170.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.17 -161.34 24.61 Favored Glycine 0 N--CA 1.472 1.098 0 C-N-CA 125.11 1.338 . . . . 0.0 113.703 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -90.55 122.3 33.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.443 0.697 . . . . 0.0 111.273 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -104.7 136.72 43.69 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 109.865 167.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.39 133.66 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.231 1.412 . . . . 0.0 108.559 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.4 mt -119.44 127.92 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.831 1.252 . . . . 0.0 109.595 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -109.02 125.81 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 110.306 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 24.4 mm -109.37 113.96 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.538 1.135 . . . . 0.0 108.802 172.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -119.15 135.21 54.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.451 1.5 . . . . 0.0 111.026 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 30.4 t80 -130.35 126.89 38.25 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.746 0.818 . . . . 0.0 110.895 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.23 39.39 26.88 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.688 1.595 . . . . 0.0 114.074 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 15.3 t70 79.9 2.26 2.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.023 2.529 . . . . 0.0 114.025 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -96.92 -127.79 0.15 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.157 1.383 . . . . 0.0 110.774 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -171.11 128.57 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.816 2.046 . . . . 0.0 109.884 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -86.65 157.92 54.65 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-N 120.098 1.317 . . . . 0.0 111.706 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.44 141.63 72.25 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.905 3.07 . . . . 0.0 113.567 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 87.84 -21.54 22.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.958 1.266 . . . . 0.0 114.597 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 58.1 m -74.63 148.4 85.34 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.979 1.39 . . . . 0.0 111.874 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.4 140.1 65.38 Favored 'Cis proline' 0 C--N 1.351 0.708 0 CA-C-N 119.369 0.81 . . . . 0.0 111.288 -5.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.48 121.59 35.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.669 1.187 . . . . 0.0 110.514 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.6 m -85.63 124.32 32.04 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.397 0.679 . . . . 0.0 110.443 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.8 t -116.48 114.79 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.926 1.69 . . . . 0.0 109.085 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 58.7 tttp -78.94 103.2 8.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.818 0.447 . . . . 0.0 110.683 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 74.9 t -89.58 114.67 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.609 1.163 . . . . 0.0 108.599 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.3 t -94.27 161.3 14.31 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.112 0.965 . . . . 0.0 111.165 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 152.75 -139.47 7.0 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.092 0.853 . . . . 0.0 113.67 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 125.664 1.586 . . . . 0.0 109.965 -175.477 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.782 0.325 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.0 ptm -126.72 137.45 53.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.753 1.621 . . . . 0.0 110.716 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 14.1 m -108.71 112.69 25.12 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.446 1.498 . . . . 0.0 108.944 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 8.1 t60 -106.47 158.36 16.96 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -162.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -152.91 139.02 18.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.612 2.365 . . . . 0.0 110.012 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.29 144.94 50.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.756 1.222 . . . . 0.0 111.17 167.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.8 p -155.45 141.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.157 0.983 . . . . 0.0 111.338 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.31 150.69 33.81 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.206 0.908 . . . . 0.0 113.268 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 47.0 m -131.92 37.53 3.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.932 1.293 . . . . 0.0 111.668 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -67.84 111.96 4.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.938 1.295 . . . . 0.0 111.257 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -72.13 148.06 46.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.242 1.017 . . . . 0.0 112.33 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.93 150.46 20.15 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 73.0 mt -136.93 126.11 15.35 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.336 1.854 . . . . 0.0 108.961 171.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.78 149.35 12.56 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.855 3.037 . . . . 0.0 112.261 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.12 134.99 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.111 1.365 . . . . 0.0 110.368 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 58.8 t30 42.28 73.05 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.247 2.219 . . . . 0.0 114.866 166.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 21.4 mm -67.54 124.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.863 . . . . 0.0 111.223 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 21.4 t -170.33 166.34 8.68 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.499 1.92 . . . . 0.0 110.432 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -85.55 62.96 7.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.989 1.316 . . . . 0.0 110.868 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.6 p -86.45 158.34 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.62 1.568 . . . . 0.0 112.219 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.43 119.36 27.63 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.482 1.113 . . . . 0.0 110.259 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.2 mp -75.91 -11.11 59.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.113 0.965 . . . . 0.0 113.132 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 17.2 t -67.53 -37.5 82.85 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.611 1.096 . . . . 0.0 113.363 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.47 2.5 24.27 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.11 133.57 35.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.134 1.374 . . . . 0.0 110.526 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 52.9 p -138.82 163.02 33.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.891 1.676 . . . . 0.0 110.381 173.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.9 148.91 29.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.937 0.895 . . . . 0.0 113.148 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -135.78 164.53 27.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.874 2.07 . . . . 0.0 109.767 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -116.24 134.08 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.597 1.159 . . . . 0.0 109.346 166.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.4 t -104.29 111.94 65.31 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.302 1.441 . . . . 0.0 108.11 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.83 169.39 20.75 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.806 3.004 . . . . 0.0 110.872 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.21 -15.83 47.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.058 2.506 . . . . 0.0 113.184 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.6 p -79.85 -4.99 54.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.005 1.322 . . . . 0.0 113.847 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.04 59.11 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.385 1.469 . . . . 0.0 114.965 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -77.67 76.76 4.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.567 1.547 . . . . 0.0 111.637 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -58.29 136.59 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.69 1.196 . . . . 0.0 112.398 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.01 151.34 67.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.441 1.497 . . . . 0.0 111.081 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.39 152.94 44.63 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.741 2.96 . . . . 0.0 112.489 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 90.3 m -95.6 152.68 18.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.17 122.73 33.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.668 1.187 . . . . 0.0 109.113 167.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 66.4 mt -84.07 139.01 32.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.325 1.05 . . . . 0.0 110.635 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 92.2 mttt -141.36 140.6 33.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.948 1.299 . . . . 0.0 112.367 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -87.5 125.9 34.59 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 160.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.8 mt -105.71 176.38 5.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.828 1.651 . . . . 0.0 113.031 -163.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -55.57 -34.89 65.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.635 1.974 . . . . 0.0 115.254 -164.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 20.6 m120 -96.61 5.51 50.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.622 1.169 . . . . 0.0 113.398 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.45 71.9 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.46 1.505 . . . . 0.0 113.965 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -73.8 173.73 9.44 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.961 1.704 . . . . 0.0 113.273 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 98.1 t -127.85 142.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.346 1.459 . . . . 0.0 109.961 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -155.85 -174.75 26.05 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.6 160.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.475 1.91 . . . . 0.0 110.99 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 78.9 p -146.93 155.15 42.06 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.904 1.282 . . . . 0.0 111.125 165.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.46 -175.69 4.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.95 1.7 . . . . 0.0 110.728 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 56.5 t -134.15 124.87 17.66 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.313 1.045 . . . . 0.0 109.244 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.64 150.18 27.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.09 3.194 . . . . 0.0 111.767 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.49 -8.04 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.228 1.011 . . . . 0.0 113.479 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -142.84 171.39 14.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.888 2.075 . . . . 0.0 110.341 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 31.1 p -93.23 164.35 13.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.743 1.217 . . . . 0.0 111.096 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.04 -168.68 24.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.206 1.384 . . . . 0.0 113.544 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.8 117.67 11.68 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.899 0.857 . . . . 0.0 111.719 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 6.7 m80 -103.31 148.29 26.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.067 1.747 . . . . 0.0 109.11 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.86 126.89 53.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.136 0.974 . . . . 0.0 109.696 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 28.4 t -84.82 125.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 163.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -105.46 128.75 53.71 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.462 1.105 . . . . 0.0 110.071 172.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 34.6 t -129.34 129.84 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.986 1.314 . . . . 0.0 109.341 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -139.72 141.51 36.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.53 125.12 53.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.393 2.277 . . . . 0.0 109.477 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.64 26.61 11.41 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.688 1.195 . . . . 0.0 113.425 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 97.05 -13.03 65.34 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.83 1.681 . . . . 0.0 115.937 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.28 144.73 42.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.684 1.742 . . . . 0.0 112.142 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -62.65 142.8 57.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 85.6 t -70.83 149.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.449 1.499 . . . . 0.0 109.462 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.17 64.13 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 70.9 m -86.42 -8.91 57.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.549 1.14 . . . . 0.0 113.785 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 24.7 t -88.9 145.22 34.23 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.069 1.347 . . . . 0.0 112.383 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.52 154.09 95.04 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.608 0.896 . . . . 0.0 112.565 -3.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.8 120.21 50.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.4 1.48 . . . . 0.0 108.515 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.3 142.5 13.38 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.914 2.409 . . . . 0.0 111.38 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.25 125.57 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.27 1.428 . . . . 0.0 108.081 174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 57.4 t -97.01 121.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.499 0.72 . . . . 0.0 109.807 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.87 123.93 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.88 1.272 . . . . 0.0 109.253 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 159.81 15.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.617 0.767 . . . . 0.0 111.402 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -57.48 -30.68 65.27 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.985 0.914 . . . . 0.0 112.782 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 30.9 m -67.29 -18.4 65.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.426 1.09 . . . . 0.0 113.813 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -93.15 -11.12 33.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.517 1.127 . . . . 0.0 112.847 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.19 -35.31 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.438 1.095 . . . . 0.0 112.306 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.98 61.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.911 0.767 . . . . 0.0 113.523 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.12 95.63 8.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.459 0.703 . . . . 0.0 110.853 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.9 69.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.651 0.78 . . . . 0.0 112.388 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.9 m -53.99 -21.16 7.49 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.078 1.751 . . . . 0.0 114.432 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -97.24 -7.5 32.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.562 1.545 . . . . 0.0 113.891 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 94.3 t -75.64 137.28 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.722 1.146 . . . . 0.0 109.94 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -123.2 157.62 32.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.277 1.431 . . . . 0.0 111.072 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 28.0 m -146.34 156.93 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.319 1.448 . . . . 0.0 110.972 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.18 174.24 15.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.625 1.17 . . . . 0.0 112.156 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 110.54 -157.51 14.96 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.395 1.474 . . . . 0.0 113.644 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -109.89 -36.29 5.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.642 1.177 . . . . 0.0 112.549 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.63 -0.18 53.15 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 125.113 1.34 . . . . 0.0 115.606 -171.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.92 -5.47 50.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.33 1.452 . . . . 0.0 112.451 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -125.09 -38.16 2.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.223 1.409 . . . . 0.0 113.346 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.8 154.59 30.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.306 1.042 . . . . 0.0 113.238 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.67 -176.17 24.16 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.399 1.476 . . . . 0.0 113.761 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.0 m80 -140.3 145.45 37.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.768 1.227 . . . . 0.0 112.496 -173.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 46.2 p -68.94 -16.25 63.7 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -117.54 -5.02 11.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -144.88 146.48 31.51 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 110.853 -176.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.24 145.71 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.884 2.39 . . . . 0.0 111.604 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -99.4 148.44 24.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.11 1.364 . . . . 0.0 110.374 171.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.96 146.21 51.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.861 . . . . 0.0 113.093 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.7 148.15 26.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.287 1.435 . . . . 0.0 110.958 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.38 140.29 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 109.165 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 37.9 mt -112.13 134.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.872 1.669 . . . . 0.0 109.272 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 65.3 t0 -125.53 103.73 8.03 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.033 1.733 . . . . 0.0 110.644 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 22.8 p -99.21 0.48 43.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.403 1.881 . . . . 0.0 113.127 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.88 -32.7 72.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 0.0 113.326 -171.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.78 -14.46 58.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.667 1.187 . . . . 0.0 113.451 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.11 -0.56 57.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.344 1.457 . . . . 0.0 114.307 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.3 -136.24 15.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.643 1.116 . . . . 0.0 111.937 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -88.42 169.26 11.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.004 1.322 . . . . 0.0 112.329 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 142.24 -151.55 23.01 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.333 0.968 . . . . 0.0 114.255 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -148.62 148.72 20.42 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.426 1.489 . . . . 0.0 112.691 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 128.51 54.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.838 2.055 . . . . 0.0 109.501 -177.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 11.7 t -121.75 139.44 53.58 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.681 1.592 . . . . 0.0 109.749 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.16 142.14 30.37 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.57 1.148 . . . . 0.0 110.139 -162.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 87.0 p -147.61 149.83 33.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 14.6 mt -117.39 127.8 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.813 1.245 . . . . 0.0 109.289 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -114.58 154.91 27.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.916 2.086 . . . . 0.0 109.229 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 164.01 -162.55 35.28 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.156 -0.965 . . . . 0.0 114.832 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 -6.41 19.14 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.127 3.218 . . . . 0.0 114.294 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.3 t -154.57 157.59 38.5 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.631 1.105 . . . . 0.0 112.248 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 128.25 35.0 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.08 1.352 . . . . 0.0 109.506 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 30.4 m -115.96 169.33 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.984 1.313 . . . . 0.0 111.87 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -110.69 121.28 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.396 1.078 . . . . 0.0 110.193 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.19 132.04 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.859 0.864 . . . . 0.0 108.98 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -120.01 157.89 27.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.184 1.794 . . . . 0.0 109.706 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 36.3 p -136.16 160.42 38.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.657 1.183 . . . . 0.0 111.807 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -152.94 119.54 5.64 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.859 1.264 . . . . 0.0 110.002 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.96 124.15 26.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.354 1.062 . . . . 0.0 110.302 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 61.6 mt -94.95 151.72 18.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.288 1.035 . . . . 0.0 111.441 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -16.1 63.86 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -81.95 -7.03 59.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.875 1.27 . . . . 0.0 113.267 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 98.62 1.63 57.61 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.667 1.603 . . . . 0.0 115.05 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 36.0 p -93.62 171.69 8.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.202 1.801 . . . . 0.0 111.503 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -121.32 124.36 44.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.995 0.918 . . . . 0.0 111.504 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -80.51 134.04 35.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.292 1.037 . . . . 0.0 109.395 165.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.7 t -117.86 137.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 108.186 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.1 p -138.85 148.59 43.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.346 1.458 . . . . 0.0 111.401 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.6 p90 -157.13 150.29 23.84 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.602 1.161 . . . . 0.0 111.914 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.0 t -114.79 105.59 53.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.16 0.984 . . . . 0.0 110.712 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.98 150.0 26.26 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.334 2.689 . . . . 0.0 110.618 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 45.9 m -111.11 -45.83 3.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.073 0.949 . . . . 0.0 112.19 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -85.49 142.3 37.41 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.459 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.97 163.0 33.91 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.268 2.645 . . . . 0.0 111.078 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.45 -144.69 16.7 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 124.871 1.224 . . . . 0.0 112.2 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -123.23 129.97 52.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.645 0.778 . . . . 0.0 111.894 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -107.2 142.98 36.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.673 1.589 . . . . 0.0 110.453 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.16 130.11 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.979 1.311 . . . . 0.0 108.378 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.2 mt -113.58 122.08 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.237 1.015 . . . . 0.0 109.437 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -95.62 128.35 42.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.312 1.445 . . . . 0.0 110.16 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.87 112.97 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.902 1.281 . . . . 0.0 108.993 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -126.37 132.95 51.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.106 1.363 . . . . 0.0 111.451 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -129.68 128.31 42.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.102 1.761 . . . . 0.0 109.729 -177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.19 43.51 26.13 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.22 1.008 . . . . 0.0 113.049 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.0 t0 74.47 7.85 4.5 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.977 2.511 . . . . 0.0 114.806 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -121.96 132.44 54.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.17 1.388 . . . . 0.0 111.234 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2124 ' ' HIS . . . . . 0.558 ' CE1' ' HG ' ' A' 2128 ' ' SER . 0.1 OUTLIER -66.07 126.64 29.27 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 120.907 -1.12 . . . . 0.0 110.97 176.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.5 m -80.67 160.88 65.87 Favored Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 119.335 0.971 . . . . 0.0 112.097 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -53.23 137.68 63.67 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.689 2.926 . . . . 0.0 113.419 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.93 13.59 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.99 1.281 . . . . 0.0 114.213 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2128 ' ' SER . . . . . 0.558 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 14.2 t -76.86 142.94 70.21 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 118.42 1.11 . . . . 0.0 111.041 174.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 144.7 81.8 Favored 'Cis proline' 0 C--N 1.353 0.778 0 CA-C-N 120.002 1.036 . . . . 0.0 111.971 -2.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.79 120.02 36.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.537 1.135 . . . . 0.0 110.42 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 68.3 m -91.05 123.58 34.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.08 0.952 . . . . 0.0 110.449 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 115.38 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.504 1.521 . . . . 0.0 109.996 -166.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.9 tttt -77.81 120.52 22.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.02 0.528 . . . . 0.0 111.239 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.5 t -107.38 119.26 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.073 1.349 . . . . 0.0 109.014 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.8 t -106.42 162.83 13.35 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.768 1.227 . . . . 0.0 111.87 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 127.23 168.3 12.49 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.773 1.654 . . . . 0.0 113.565 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 124.419 1.088 . . . . 0.0 113.85 -168.645 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 1.9 mmm -127.15 128.83 46.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.894 1.278 . . . . 0.0 111.29 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 15.4 m -130.85 146.35 52.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.868 1.667 . . . . 0.0 109.443 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -155.83 159.32 39.29 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.65 154.19 24.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.573 1.949 . . . . 0.0 110.317 -170.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.5 mttt -135.7 144.27 45.84 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.906 1.282 . . . . 0.0 111.714 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 32.5 m -143.0 151.35 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.89 1.276 . . . . 0.0 111.465 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.32 147.36 20.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.409 1.004 . . . . 0.0 112.133 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 26.3 m -136.12 147.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.158 1.383 . . . . 0.0 112.088 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.27 154.69 23.66 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -85.49 161.09 19.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.893 1.277 . . . . 0.0 111.583 167.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.9 135.43 36.43 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.1 mt -125.25 124.0 25.23 Favored Pre-proline 0 N--CA 1.482 1.125 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.69 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.45 133.17 11.64 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.893 2.396 . . . . 0.0 111.464 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 32.4 mt -149.5 143.78 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.046 2.138 . . . . 0.0 107.798 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.1 t30 60.89 45.0 10.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.645 1.178 . . . . 0.0 110.789 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 25.7 mm -43.79 -56.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.826 2.45 . . . . 0.0 115.04 -147.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 49.6 m -105.32 0.88 27.46 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.881 0.872 . . . . 0.0 113.335 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -95.09 74.6 3.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.496 1.518 . . . . 0.0 109.617 -171.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 44.3 p -71.87 22.24 0.05 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.767 2.427 . . . . 0.0 115.59 -168.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.9 t0 -91.19 60.47 4.25 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.893 1.677 . . . . 0.0 111.298 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -21.7 66.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.71 1.204 . . . . 0.0 113.17 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 18.4 m -61.76 -17.71 57.04 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.404 1.482 . . . . 0.0 114.777 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.4 pp -122.63 14.63 10.2 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.33 1.452 . . . . 0.0 113.745 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.19 145.77 26.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 111.588 173.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 29.3 p -146.21 146.77 30.92 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.372 1.869 . . . . 0.0 109.674 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -143.75 149.89 37.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 36.5 p -141.16 140.97 34.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.912 2.085 . . . . 0.0 109.532 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -95.41 133.78 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.718 0.807 . . . . 0.0 109.834 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.7 t -102.17 110.28 62.15 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 107.967 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.74 170.88 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.943 3.096 . . . . 0.0 110.972 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -15.58 49.67 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.002 2.468 . . . . 0.0 113.478 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 79.5 p -80.74 -11.21 59.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.224 . . . . 0.0 113.947 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.21 -1.76 86.26 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.606 1.574 . . . . 0.0 114.973 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -76.83 83.22 3.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.462 1.505 . . . . 0.0 111.626 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.66 134.44 57.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.75 1.22 . . . . 0.0 112.291 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -140.69 149.47 56.88 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.329 1.452 . . . . 0.0 111.615 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.81 153.53 42.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.876 3.051 . . . . 0.0 112.878 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 73.0 m -97.14 156.3 16.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.913 1.285 . . . . 0.0 112.041 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 61.6 tp -87.06 131.46 34.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 0.0 108.744 162.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -97.2 143.48 27.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.55 1.14 . . . . 0.0 110.297 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.8 146.42 34.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.791 1.236 . . . . 0.0 113.476 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -93.49 120.06 33.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.682 1.193 . . . . 0.0 107.903 156.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.71 170.92 9.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.977 -170.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -64.71 -29.27 70.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.026 1.73 . . . . 0.0 114.276 -164.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.2 t30 -86.04 -1.88 57.78 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.653 1.181 . . . . 0.0 113.21 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.95 -2.0 63.66 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.806 1.67 . . . . 0.0 114.531 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 165.81 15.89 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.497 1.519 . . . . 0.0 113.665 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 43.8 t -89.29 145.1 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.045 1.738 . . . . 0.0 110.596 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.0 -173.67 28.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.44 168.22 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.634 . . . . 0.0 112.61 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.4 m -139.06 158.07 44.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.527 1.931 . . . . 0.0 111.107 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -161.71 -174.05 4.03 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.837 2.055 . . . . 0.0 109.704 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 60.1 t -132.19 120.22 17.03 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 119.504 1.047 . . . . 0.0 110.119 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.11 134.57 13.11 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.189 3.259 . . . . 0.0 110.408 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -95.25 -10.18 31.07 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -143.52 174.09 11.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.941 2.097 . . . . 0.0 109.847 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.4 p -85.21 167.75 15.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.683 1.193 . . . . 0.0 111.593 171.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.67 -168.59 21.69 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.163 1.363 . . . . 0.0 114.047 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -73.52 119.04 17.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.082 0.953 . . . . 0.0 111.967 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.0 m80 -109.22 143.24 38.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.583 1.953 . . . . 0.0 109.172 169.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.58 126.07 52.1 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.28 1.032 . . . . 0.0 109.869 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 33.2 t -90.27 111.71 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.644 1.178 . . . . 0.0 108.268 168.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -90.08 136.73 32.87 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.216 1.006 . . . . 0.0 109.76 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 6.8 p -143.99 127.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 121.958 0.885 . . . . 0.0 112.208 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -110.44 135.43 51.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.802 2.041 . . . . 0.0 111.464 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.7 119.77 39.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.097 2.159 . . . . 0.0 109.166 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 56.02 -102.62 0.16 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.011 1.325 . . . . 0.0 111.089 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -112.22 8.59 26.9 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.657 1.599 . . . . 0.0 115.603 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -144.02 151.82 40.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.748 1.774 . . . . 0.0 112.608 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -66.42 144.49 56.49 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.872 -1.143 . . . . 0.0 112.869 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 147.49 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.46 1.104 . . . . 0.0 109.368 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -56.68 -31.05 64.06 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 15.2 m -84.37 -8.2 59.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.003 1.321 . . . . 0.0 113.982 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 23.2 t -82.49 141.42 45.39 Favored Pre-proline 0 CA--C 1.547 0.844 0 O-C-N 120.784 -1.198 . . . . 0.0 112.543 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.92 147.23 83.11 Favored 'Cis proline' 0 C--N 1.353 0.767 0 CA-C-N 119.317 0.792 . . . . 0.0 112.315 -4.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -94.85 118.78 66.68 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.038 1.335 . . . . 0.0 108.619 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.58 140.55 13.35 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.971 2.447 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.6 t -135.79 127.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.952 1.701 . . . . 0.0 107.962 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.0 t -100.29 122.02 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.796 0.838 . . . . 0.0 110.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.81 128.75 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.116 1.366 . . . . 0.0 109.993 -174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.8 t -94.53 172.89 7.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.651 1.18 . . . . 0.0 111.703 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -68.78 -33.55 74.06 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.358 -1.464 . . . . 0.0 112.015 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 14.7 m -67.03 -3.43 7.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.77 4.57 10.55 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.619 1.568 . . . . 0.0 113.19 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 41.1 mm -73.96 -26.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.175 0.99 . . . . 0.0 112.309 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 163.05 53.79 0.02 OUTLIER Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.91 91.05 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.012 0.906 . . . . 0.0 111.235 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.62 69.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.822 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -55.4 -23.95 27.45 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.422 1.489 . . . . 0.0 114.242 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -91.08 -9.14 46.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.088 1.355 . . . . 0.0 113.73 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 134.46 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.136 . . . . 0.0 110.033 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.98 157.78 22.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.651 1.58 . . . . 0.0 110.796 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.9 m -146.3 159.09 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.285 1.434 . . . . 0.0 111.022 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.69 174.52 14.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.794 1.238 . . . . 0.0 112.258 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.66 166.51 30.78 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.316 1.436 . . . . 0.0 114.277 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -75.92 -29.4 58.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.508 1.123 . . . . 0.0 113.454 -167.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -72.27 3.96 20.88 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.115 1.341 . . . . 0.0 115.165 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.88 -8.09 41.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 112.339 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.4 -42.45 1.82 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.148 1.379 . . . . 0.0 113.688 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.01 159.9 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -153.47 -177.56 27.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.223 1.392 . . . . 0.0 114.038 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -131.67 151.17 51.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.707 1.603 . . . . 0.0 112.081 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 32.5 p -71.71 -14.63 62.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -112.56 -9.77 13.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.01 157.12 77.91 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 126.238 1.815 . . . . 0.0 110.844 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.52 141.44 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.805 2.337 . . . . 0.0 110.533 169.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 149.37 22.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.587 1.155 . . . . 0.0 109.854 165.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -134.62 147.69 50.25 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.588 0.755 . . . . 0.0 112.545 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.7 p90 -151.64 150.64 30.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.391 1.476 . . . . 0.0 110.636 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.28 140.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.849 1.659 . . . . 0.0 109.287 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.88 134.55 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.226 1.811 . . . . 0.0 109.049 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.5 t0 -123.99 96.69 5.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.701 . . . . 0.0 110.611 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 7.9 p -95.15 -0.11 53.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.32 2.248 . . . . 0.0 113.172 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -60.15 -38.47 83.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.263 1.025 . . . . 0.0 112.805 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.71 -16.02 57.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.829 1.252 . . . . 0.0 113.319 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -87.38 -2.74 58.84 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.796 1.239 . . . . 0.0 113.865 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 87.16 -122.03 6.03 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.805 1.193 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -113.69 164.67 13.4 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.546 1.538 . . . . 0.0 112.233 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.9 -176.74 26.59 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 169.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -99.0 129.18 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.866 1.222 . . . . 0.0 111.36 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.25 119.43 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 107.863 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.9 t -113.87 141.3 47.52 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.734 1.214 . . . . 0.0 110.108 173.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.1 tt -140.26 132.99 28.99 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.48 1.112 . . . . 0.0 110.331 -163.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.2 m -133.67 133.35 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.642 0.777 . . . . 0.0 111.039 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 55.4 mt -116.63 133.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.282 1.433 . . . . 0.0 108.463 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.39 148.68 44.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.821 0.848 . . . . 0.0 111.381 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 172.84 -163.74 35.64 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.939 0.781 . . . . 0.0 113.87 -172.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.91 -6.4 19.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.045 3.163 . . . . 0.0 114.723 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -155.01 160.9 41.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.084 1.311 . . . . 0.0 113.103 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -59.92 140.93 56.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.988 1.715 . . . . 0.0 111.08 171.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.5 m -132.43 139.54 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.454 0.702 . . . . 0.0 111.389 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.81 102.04 12.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 109.702 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 19.9 mt -80.03 124.2 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -116.43 157.34 25.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.347 1.859 . . . . 0.0 109.929 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 76.6 p -141.28 157.29 45.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.862 1.265 . . . . 0.0 111.165 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -155.05 111.44 3.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.622 1.169 . . . . 0.0 110.178 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.6 126.84 31.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.406 1.083 . . . . 0.0 110.564 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.77 159.85 14.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 111.883 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.34 -22.07 66.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.164 0.986 . . . . 0.0 113.368 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 28.1 t0 -83.44 -0.5 50.34 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.903 1.281 . . . . 0.0 113.323 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.13 -1.52 77.42 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.587 1.565 . . . . 0.0 115.068 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.9 p -85.5 158.69 20.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.762 1.625 . . . . 0.0 111.187 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 26.9 t -114.83 121.82 44.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.732 0.813 . . . . 0.0 111.151 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -75.97 140.48 42.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.606 0.763 . . . . 0.0 109.347 163.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -123.26 138.92 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.36 1.864 . . . . 0.0 108.082 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -136.03 149.14 48.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.573 1.549 . . . . 0.0 111.346 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -159.43 147.91 17.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.651 1.18 . . . . 0.0 111.505 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 33.2 t -117.43 107.12 45.53 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.828 0.851 . . . . 0.0 111.019 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.71 150.67 24.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.694 2.929 . . . . 0.0 110.49 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 90.5 m -112.86 -41.75 3.72 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.995 0.918 . . . . 0.0 112.238 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -83.72 140.79 41.01 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.569 0.748 . . . . 0.0 110.151 171.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.15 23.32 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.379 2.72 . . . . 0.0 111.236 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 122.23 -154.03 16.84 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.12 1.343 . . . . 0.0 113.197 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -93.35 131.85 38.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.092 0.957 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -119.87 150.32 40.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.646 1.578 . . . . 0.0 109.763 168.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.43 131.76 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 109.188 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.29 130.28 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.049 1.34 . . . . 0.0 109.427 171.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -110.37 119.98 40.97 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.115 1.366 . . . . 0.0 109.657 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.2 mm -113.29 117.9 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.335 1.054 . . . . 0.0 109.369 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -134.48 131.8 38.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.5 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.71 123.17 39.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 110.054 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.84 32.91 13.17 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.353 1.461 . . . . 0.0 113.986 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.9 t0 84.16 7.45 0.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.746 2.818 . . . . 0.0 114.654 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -113.73 129.42 56.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.531 1.132 . . . . 0.0 111.278 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -65.23 123.16 18.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.384 1.474 . . . . 0.0 110.376 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -75.01 154.53 86.68 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.197 -0.939 . . . . 0.0 110.983 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.18 137.85 68.72 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.424 2.083 . . . . 0.0 111.274 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.34 -26.74 22.5 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.325 1.44 . . . . 0.0 113.304 -171.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 67.8 m -70.25 150.17 95.95 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 118.895 1.347 . . . . 0.0 112.103 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.98 147.66 83.81 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 119.08 0.707 . . . . 0.0 110.836 -7.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.08 118.78 36.6 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.836 0.854 . . . . 0.0 110.853 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 46.4 m -87.09 125.31 34.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.121 0.968 . . . . 0.0 111.202 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -117.9 122.37 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.927 1.691 . . . . 0.0 109.542 -173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 59.8 tttp -86.86 111.58 20.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.201 0.601 . . . . 0.0 110.781 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 95.8 t -97.31 117.04 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.51 1.124 . . . . 0.0 108.814 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.3 t -94.12 151.92 19.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.964 0.906 . . . . 0.0 111.222 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 173.65 150.85 7.79 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.978 0.799 . . . . 0.0 114.549 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 125.219 1.407 . . . . 0.0 113.678 176.53 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 120.51 0.195 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 17.8 ptm -145.34 142.85 29.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.722 1.209 . . . . 0.0 112.627 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 66.8 m -109.34 154.87 21.92 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 110.273 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -149.63 160.56 43.4 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 152.23 27.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.282 1.833 . . . . 0.0 109.952 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -134.51 143.62 47.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.566 1.146 . . . . 0.0 111.992 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 67.5 t -140.93 132.03 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.909 1.684 . . . . 0.0 109.666 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.24 117.93 4.52 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 40.8 m -80.48 -42.79 21.94 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 59.26 -170.17 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.639 1.576 . . . . 0.0 113.278 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -148.0 147.94 30.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.331 1.453 . . . . 0.0 110.132 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -88.55 133.01 34.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.072 0.949 . . . . 0.0 112.2 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.5 mt -127.62 119.01 21.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 125.093 1.357 . . . . 0.0 109.049 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.07 135.65 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.926 2.417 . . . . 0.0 110.627 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.9 mt -146.08 139.35 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.865 1.666 . . . . 0.0 108.468 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 45.2 t30 63.69 76.57 0.35 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.758 1.623 . . . . 0.0 110.915 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.1 mm -84.75 63.44 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.266 1.426 . . . . 0.0 110.073 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 t -162.76 -178.58 6.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 111.19 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -73.7 125.8 28.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.253 1.021 . . . . 0.0 110.695 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 2.4 m -165.09 137.9 4.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.357 2.263 . . . . 0.0 108.683 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.18 131.49 38.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.716 1.206 . . . . 0.0 111.173 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 1.7 mt -85.23 -13.81 48.73 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -173.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 47.7 m -82.19 -26.78 33.05 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.772 1.169 . . . . 0.0 112.781 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.93 6.26 49.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.268 1.427 . . . . 0.0 113.321 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.91 143.29 31.98 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 0.0 110.666 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 37.6 p -144.03 160.65 40.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.358 1.863 . . . . 0.0 110.365 172.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -157.33 152.6 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.183 0.993 . . . . 0.0 113.214 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -138.0 164.6 28.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.976 2.11 . . . . 0.0 109.747 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -119.56 136.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.353 1.461 . . . . 0.0 110.056 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 96.1 t -104.9 115.6 62.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.33 1.452 . . . . 0.0 108.567 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.91 173.04 10.5 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.987 3.124 . . . . 0.0 111.521 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.43 -33.21 55.82 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 124.343 3.362 . . . . 0.0 113.971 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 17.9 m -73.38 -10.35 59.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.665 1.186 . . . . 0.0 114.038 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.47 -3.48 67.67 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.635 1.588 . . . . 0.0 115.148 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.3 mmm-85 -79.86 90.08 5.29 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.256 1.422 . . . . 0.0 110.772 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.08 136.93 57.7 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.477 1.111 . . . . 0.0 112.117 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -137.05 151.82 72.71 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.576 1.55 . . . . 0.0 111.249 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.88 155.66 38.98 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.672 2.915 . . . . 0.0 112.871 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 87.5 m -100.91 158.89 15.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.889 1.276 . . . . 0.0 112.238 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.9 tt -93.11 121.79 34.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.75 1.22 . . . . 0.0 108.083 167.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.48 141.67 28.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.662 1.185 . . . . 0.0 111.082 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 94.5 mttt -143.3 149.63 38.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.597 1.159 . . . . 0.0 112.978 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -93.77 116.17 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 157.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 88.3 mt -89.24 165.93 14.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.816 0.846 . . . . 0.0 111.519 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -59.69 -25.47 64.79 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 30.1 m120 -77.32 -9.32 58.76 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 96.78 -12.88 65.76 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.099 1.809 . . . . 0.0 114.301 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.05 161.89 26.26 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.565 1.182 . . . . 0.0 113.416 174.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -80.69 148.66 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 109.337 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.85 176.82 30.84 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.274 0.94 . . . . 0.0 114.054 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.53 164.74 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.425 1.49 . . . . 0.0 111.704 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 86.0 p -143.54 152.97 42.09 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 111.964 165.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 13.3 p90 -161.63 173.03 15.31 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.739 2.016 . . . . 0.0 110.656 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 96.9 t -122.69 119.84 28.0 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.446 1.098 . . . . 0.0 109.816 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.4 151.59 22.94 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.754 3.636 . . . . 0.0 111.519 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 13.6 mptt -107.36 -6.22 17.28 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.214 1.006 . . . . 0.0 113.023 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -138.57 167.67 21.44 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.51 1.924 . . . . 0.0 110.639 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.2 p -90.14 165.13 14.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.825 1.25 . . . . 0.0 111.063 168.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.17 -170.79 29.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.077 1.322 . . . . 0.0 113.727 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -71.22 115.94 10.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.185 0.994 . . . . 0.0 112.119 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.9 m80 -100.48 146.58 26.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.007 1.723 . . . . 0.0 109.065 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.53 127.71 54.18 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.119 0.968 . . . . 0.0 109.81 174.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 25.0 t -90.68 123.21 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.664 1.186 . . . . 0.0 108.203 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -105.26 131.52 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.336 . . . . 0.0 110.196 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 21.5 t -130.64 133.36 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.853 0.861 . . . . 0.0 111.101 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -127.6 135.94 50.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.468 1.907 . . . . 0.0 111.591 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -128.75 123.2 32.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.164 2.186 . . . . 0.0 110.192 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.5 t30 55.94 29.28 13.96 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.154 1.381 . . . . 0.0 113.89 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.49 4.75 65.71 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.966 1.27 . . . . 0.0 115.855 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.45 155.88 49.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.406 1.603 . . . . 0.0 111.618 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 67.4 m80 -65.22 143.26 57.94 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.794 -1.191 . . . . 0.0 113.166 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 74.0 t -71.42 142.65 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.438 1.095 . . . . 0.0 109.459 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.01 67.52 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.7 m -81.57 -7.7 59.62 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.968 1.307 . . . . 0.0 113.938 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.1 t -82.92 141.96 44.41 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 120.804 -1.185 . . . . 0.0 112.581 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.07 154.26 86.47 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.646 0.909 . . . . 0.0 112.579 -3.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.39 122.12 46.19 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.483 1.513 . . . . 0.0 108.656 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.16 142.93 12.44 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.11 2.54 . . . . 0.0 111.634 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.9 123.71 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.441 1.497 . . . . 0.0 108.269 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.6 t -99.29 124.52 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.754 0.822 . . . . 0.0 110.172 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.75 128.1 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.997 1.319 . . . . 0.0 109.553 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 60.8 m -100.51 156.34 17.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.108 0.963 . . . . 0.0 111.975 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -56.25 -35.4 67.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.789 1.236 . . . . 0.0 114.168 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 37.0 m -73.72 -12.6 60.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.751 0.82 . . . . 0.0 113.021 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.64 -6.3 52.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.816 1.246 . . . . 0.0 112.628 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 43.0 mm -73.42 -31.93 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.218 0.917 . . . . 0.0 112.494 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 160.93 55.08 0.02 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.48 100.85 10.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.855 0.827 . . . . 0.0 110.315 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.39 -32.61 71.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.74 1.216 . . . . 0.0 113.667 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.55 -21.56 27.26 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.486 1.515 . . . . 0.0 114.027 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.58 -9.94 50.48 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.466 1.506 . . . . 0.0 113.934 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.9 t -79.78 125.96 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 119.949 1.249 . . . . 0.0 111.327 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -105.17 156.04 18.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.644 1.577 . . . . 0.0 110.991 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -147.88 159.17 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.624 1.569 . . . . 0.0 110.861 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.6 t -161.4 177.54 10.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.687 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 100.07 160.63 28.45 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.444 1.497 . . . . 0.0 114.26 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -67.07 -33.14 74.85 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.187 1.395 . . . . 0.0 113.116 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.04 -3.49 36.96 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.05 1.31 . . . . 0.0 115.344 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.69 -7.39 56.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.032 1.333 . . . . 0.0 112.855 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -128.38 -36.01 1.93 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.778 1.231 . . . . 0.0 113.845 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -159.73 157.39 29.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.599 1.16 . . . . 0.0 112.477 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.09 -176.58 24.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.715 1.15 . . . . 0.0 114.106 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -135.43 147.12 48.86 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.887 1.275 . . . . 0.0 112.473 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 20.9 p -67.99 -29.07 68.0 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -112.02 5.81 18.95 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -141.28 154.64 67.65 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.42 1.488 . . . . 0.0 111.068 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.42 136.89 27.12 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.71 2.274 . . . . 0.0 110.738 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -95.82 118.54 32.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.727 1.211 . . . . 0.0 110.146 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -98.29 147.57 24.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.136 0.975 . . . . 0.0 113.369 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.33 153.78 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.253 1.421 . . . . 0.0 111.241 173.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.72 140.08 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.679 1.591 . . . . 0.0 109.456 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.3 mt -114.77 130.66 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.56 1.944 . . . . 0.0 108.901 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.4 t0 -119.55 84.17 2.16 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.603 1.561 . . . . 0.0 110.569 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 3.3 p -84.97 -5.84 59.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.774 2.03 . . . . 0.0 113.288 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -56.03 -40.58 73.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.479 1.036 . . . . 0.0 111.676 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.06 -9.95 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.404 1.482 . . . . 0.0 113.329 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -98.2 0.12 45.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.132 1.773 . . . . 0.0 114.333 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 82.99 -134.04 12.48 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.252 0.93 . . . . 0.0 111.016 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.59 171.49 9.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.758 1.223 . . . . 0.0 112.292 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.87 177.81 19.99 Favored Glycine 0 N--CA 1.472 1.074 0 C-N-CA 124.414 1.006 . . . . 0.0 114.951 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -106.63 131.71 10.78 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.551 1.548 . . . . 0.0 111.815 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.92 121.56 41.95 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.721 2.008 . . . . 0.0 108.913 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 74.8 m -112.56 143.9 42.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.979 1.712 . . . . 0.0 110.266 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.8 tt -143.86 137.4 27.9 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.767 0.827 . . . . 0.0 110.502 -166.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 62.7 m -138.7 135.08 34.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.73 0.812 . . . . 0.0 111.371 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 23.9 mt -122.29 134.56 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.264 1.426 . . . . 0.0 109.13 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.28 154.64 44.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 111.258 -174.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.59 21.29 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.785 -1.008 . . . . 0.0 114.052 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.69 -14.73 36.74 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.029 3.153 . . . . 0.0 114.976 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.3 t -159.16 165.74 33.03 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.955 1.252 . . . . 0.0 112.419 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.01 148.34 51.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.961 1.304 . . . . 0.0 111.775 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 35.9 m -135.12 147.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.562 1.145 . . . . 0.0 112.293 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -88.51 104.38 16.76 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.759 0.824 . . . . 0.0 110.19 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 39.6 mt -84.98 130.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.871 0.868 . . . . 0.0 109.742 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -128.14 155.46 44.4 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.305 1.842 . . . . 0.0 110.333 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.59 156.5 46.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.964 1.306 . . . . 0.0 111.625 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.27 125.83 5.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.983 1.313 . . . . 0.0 110.275 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.64 133.5 36.4 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.335 -0.853 . . . . 0.0 111.199 171.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 50.5 mt -96.19 160.77 14.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.67 1.188 . . . . 0.0 111.732 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.45 -20.68 66.47 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 0.0 113.291 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.62 -3.69 56.55 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.094 1.358 . . . . 0.0 113.274 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.29 -2.94 75.43 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.611 1.577 . . . . 0.0 114.848 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 46.5 p -82.47 167.96 17.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.554 1.542 . . . . 0.0 111.14 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -116.24 127.56 54.86 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.845 0.858 . . . . 0.0 111.196 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -90.86 137.66 32.19 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.703 1.201 . . . . 0.0 109.937 170.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 25.3 t -122.59 138.27 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.4 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.3 p -136.16 151.85 50.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.415 1.486 . . . . 0.0 110.948 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 11.7 p90 -161.27 145.5 13.3 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.427 1.491 . . . . 0.0 110.515 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 25.0 t -107.01 103.41 47.63 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.58 0.752 . . . . 0.0 110.722 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -78.26 110.78 2.93 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.358 2.705 . . . . 0.0 110.128 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.9 m -69.22 -37.98 78.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.647 0.779 . . . . 0.0 112.341 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.29 146.39 34.59 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.035 1.334 . . . . 0.0 111.447 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.37 168.06 25.37 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.275 2.65 . . . . 0.0 111.1 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 114.76 -163.98 12.13 Favored Glycine 0 N--CA 1.472 1.036 0 C-N-CA 125.172 1.368 . . . . 0.0 113.402 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 54.0 t30 -89.89 120.17 30.89 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.9 -0.764 . . . . 0.0 112.174 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.33 143.43 30.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.117 1.367 . . . . 0.0 110.904 164.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.28 134.63 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.926 1.29 . . . . 0.0 108.82 174.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 29.0 mt -116.32 132.95 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.288 1.435 . . . . 0.0 109.521 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -114.17 125.51 54.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.018 1.727 . . . . 0.0 109.904 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.54 124.83 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.974 0.91 . . . . 0.0 109.638 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 31.1 tttt -132.39 127.12 34.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.142 1.377 . . . . 0.0 110.482 -171.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 37.3 t80 -123.8 124.76 43.39 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.12 0.968 . . . . 0.0 110.064 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.99 49.2 17.4 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.469 1.107 . . . . 0.0 111.773 -173.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.84 13.83 9.57 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.373 2.269 . . . . 0.0 114.624 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -119.48 126.8 52.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.104 1.362 . . . . 0.0 110.258 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -65.29 121.58 15.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.616 1.167 . . . . 0.0 111.055 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -79.14 158.69 74.27 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 121.288 -0.883 . . . . 0.0 111.784 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.18 138.07 71.2 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.517 2.811 . . . . 0.0 112.909 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 92.63 -23.24 29.21 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.964 1.268 . . . . 0.0 114.343 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 72.4 m -74.56 149.96 86.52 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 118.916 1.358 . . . . 0.0 111.64 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.52 145.86 80.91 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 119.326 0.795 . . . . 0.0 111.442 -3.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -98.85 120.43 39.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.54 1.136 . . . . 0.0 110.772 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 45.9 m -86.86 133.02 33.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.131 0.972 . . . . 0.0 110.988 171.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 17.2 t -129.93 111.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.63 1.572 . . . . 0.0 109.471 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -81.57 109.58 16.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.015 0.526 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 60.4 t -91.26 127.1 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.131 1.372 . . . . 0.0 109.328 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -117.9 161.94 18.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.739 1.216 . . . . 0.0 112.186 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 129.22 163.29 11.17 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.965 1.745 . . . . 0.0 113.45 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 126.06 1.744 . . . . 0.0 110.291 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 96.9 mtp -89.18 133.03 34.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.428 1.491 . . . . 0.0 112.407 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 18.4 m -118.27 140.59 49.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 108.465 160.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -156.51 158.42 37.16 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.0 tt -161.04 154.64 22.04 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.43 1.892 . . . . 0.0 111.131 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.51 151.34 47.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.002 1.321 . . . . 0.0 112.559 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 52.6 t -139.69 133.98 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.022 1.729 . . . . 0.0 109.458 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -92.5 128.41 9.39 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.885 0.755 . . . . 0.0 111.25 172.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 66.1 m -118.92 144.91 46.17 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.412 1.085 . . . . 0.0 112.53 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.01 151.98 24.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.0 112.357 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.5 149.66 24.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.064 0.946 . . . . 0.0 110.75 166.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.33 134.05 34.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.539 0.735 . . . . 0.0 111.572 169.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.8 mm -112.89 127.48 26.78 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.495 1.518 . . . . 0.0 108.74 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.7 134.31 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.908 2.405 . . . . 0.0 110.478 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 29.9 mm -144.87 140.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.387 1.475 . . . . 0.0 110.293 -168.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.59 55.54 7.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.786 1.634 . . . . 0.0 112.905 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.4 mm -65.76 112.55 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.478 1.111 . . . . 0.0 110.516 -172.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 99.8 p -173.9 172.6 3.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.276 1.43 . . . . 0.0 111.849 -170.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.08 4.82 9.35 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.932 1.693 . . . . 0.0 113.623 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 56.8 m -61.95 134.85 57.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 111.472 -174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.67 132.98 46.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.439 1.496 . . . . 0.0 111.633 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.3 mp -73.76 -21.16 60.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.027 0.931 . . . . 0.0 112.425 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 24.0 m -67.58 -23.46 65.4 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -167.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -114.21 8.95 17.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.35 1.46 . . . . 0.0 113.609 175.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.66 148.09 25.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.026 1.33 . . . . 0.0 111.997 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 47.3 p -141.39 169.65 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.261 2.224 . . . . 0.0 108.974 168.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.42 155.24 37.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 54.6 p -132.25 160.82 35.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.082 2.153 . . . . 0.0 109.153 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -112.8 135.27 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.073 0.949 . . . . 0.0 109.449 166.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.0 t -104.68 113.13 65.25 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.968 1.307 . . . . 0.0 108.196 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.32 173.44 11.65 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.999 3.133 . . . . 0.0 111.128 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.72 -32.69 56.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.127 3.218 . . . . 0.0 113.961 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.5 m -75.65 -4.53 40.69 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 0.0 114.12 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 74.86 -1.76 52.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.286 1.422 . . . . 0.0 115.15 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -77.21 85.56 3.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.516 1.526 . . . . 0.0 111.243 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.09 133.01 54.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.854 1.262 . . . . 0.0 111.929 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -140.58 150.64 61.16 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.174 1.39 . . . . 0.0 111.277 176.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.64 155.55 40.01 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.271 3.314 . . . . 0.0 112.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.2 m -111.28 155.35 23.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.547 1.539 . . . . 0.0 112.207 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 6.2 tt -95.29 116.72 29.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.419 1.488 . . . . 0.0 108.671 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 11.2 mp -84.6 138.11 32.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.476 1.11 . . . . 0.0 111.352 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -133.44 136.17 45.02 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.041 1.336 . . . . 0.0 112.803 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.7 121.73 26.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 152.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.5 162.23 13.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.479 1.112 . . . . 0.0 112.013 -171.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -60.36 -31.65 70.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -86.27 -1.82 57.83 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.971 0.909 . . . . 0.0 113.439 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.62 0.35 57.87 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.504 1.526 . . . . 0.0 114.095 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -80.87 177.31 9.13 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.119 1.368 . . . . 0.0 112.863 170.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 88.6 t -130.15 140.51 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 109.617 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.04 -174.54 25.97 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.61 154.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.613 1.565 . . . . 0.0 111.946 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 16.4 m -121.38 149.59 42.74 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.15 1.38 . . . . 0.0 111.198 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.2 p90 -165.64 -178.87 5.07 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.101 2.16 . . . . 0.0 109.752 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.9 t -128.88 122.44 21.42 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-N 119.258 0.935 . . . . 0.0 109.95 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.81 149.56 23.27 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.115 3.21 . . . . 0.0 111.369 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -106.27 -9.57 16.77 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -143.25 173.63 11.42 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.858 2.063 . . . . 0.0 110.11 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.5 p -88.77 167.35 13.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.656 1.182 . . . . 0.0 111.117 167.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.65 -168.08 30.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.801 1.191 . . . . 0.0 113.57 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.05 116.98 11.98 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.05 0.94 . . . . 0.0 112.005 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.8 m80 -102.58 141.0 36.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.974 1.71 . . . . 0.0 109.042 167.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.86 123.26 44.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.055 0.942 . . . . 0.0 109.229 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.1 t -87.76 113.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.987 1.315 . . . . 0.0 107.811 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -95.21 126.21 40.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.525 1.13 . . . . 0.0 110.225 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 81.3 t -117.71 120.14 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.996 1.319 . . . . 0.0 109.769 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -108.82 130.48 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.97 1.708 . . . . 0.0 111.72 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -108.74 122.94 48.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.545 1.938 . . . . 0.0 109.356 171.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 57.25 -94.27 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.064 1.346 . . . . 0.0 111.72 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -123.37 9.5 8.8 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.863 1.697 . . . . 0.0 115.777 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.6 157.02 43.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.743 1.771 . . . . 0.0 112.393 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -67.34 138.61 56.91 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.888 -1.133 . . . . 0.0 112.783 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 5.9 p -71.44 156.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.389 1.076 . . . . 0.0 110.675 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.06 -28.44 62.58 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.0 m -80.47 -9.65 59.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.942 1.297 . . . . 0.0 114.162 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 31.9 t -90.78 147.56 36.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.9 1.28 . . . . 0.0 113.198 -172.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.26 162.28 76.76 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.26 0.771 . . . . 0.0 112.677 -5.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.01 126.38 28.32 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.685 1.594 . . . . 0.0 109.04 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.66 142.27 12.75 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.117 2.544 . . . . 0.0 112.031 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.9 t -135.87 127.75 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.593 1.557 . . . . 0.0 107.869 170.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 53.9 t -100.39 126.53 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.853 0.861 . . . . 0.0 110.49 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.29 130.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.138 1.375 . . . . 0.0 110.169 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 65.9 m -98.15 156.92 16.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.52 1.128 . . . . 0.0 112.087 174.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -58.52 -30.01 66.75 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 8.7 m -65.34 -19.29 65.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.6 1.16 . . . . 0.0 113.739 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -93.46 -12.17 30.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.713 1.205 . . . . 0.0 112.955 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.7 -24.81 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.659 1.184 . . . . 0.0 112.576 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 134.73 68.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.291 1.424 . . . . 0.0 112.84 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.96 105.79 10.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.262 0.531 . . . . 0.0 110.007 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.49 66.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.841 0.856 . . . . 0.0 112.307 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.1 m -54.18 -23.33 14.04 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.181 1.793 . . . . 0.0 114.468 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -90.9 -12.73 35.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.856 1.262 . . . . 0.0 113.466 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 67.8 t -74.19 133.99 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.625 1.102 . . . . 0.0 109.867 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.55 154.45 24.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 111.171 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.5 m -144.51 150.5 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.471 1.508 . . . . 0.0 110.172 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.7 m -148.12 165.74 29.93 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.91 1.284 . . . . 0.0 112.487 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.48 159.73 24.01 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.517 1.056 . . . . 0.0 114.416 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -71.59 -25.43 62.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.66 1.184 . . . . 0.0 113.373 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.89 -5.76 41.03 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.264 0.935 . . . . 0.0 114.986 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.25 -2.64 58.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.417 1.487 . . . . 0.0 112.893 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -135.84 -38.72 0.71 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -141.56 151.18 42.99 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.772 1.229 . . . . 0.0 111.831 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.43 -176.7 22.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.144 1.354 . . . . 0.0 113.269 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -147.97 145.72 28.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.173 0.989 . . . . 0.0 113.015 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 24.3 p -60.13 -26.13 66.02 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.711 1.605 . . . . 0.0 115.028 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.77 23.22 9.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.245 1.418 . . . . 0.0 112.93 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -145.49 137.34 13.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.642 1.177 . . . . 0.0 110.315 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -71.27 133.68 23.3 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.536 2.157 . . . . 0.0 110.286 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -102.33 131.35 48.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.436 1.494 . . . . 0.0 110.393 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.42 154.21 35.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.862 1.265 . . . . 0.0 113.325 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.71 153.15 27.98 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.005 1.722 . . . . 0.0 111.024 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.61 142.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.496 1.919 . . . . 0.0 109.9 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.1 132.17 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.815 1.646 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 31.4 t0 -125.39 86.75 2.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.46 1.504 . . . . 0.0 111.732 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 16.4 p -83.43 -8.92 59.3 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.422 1.889 . . . . 0.0 113.657 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.89 -30.32 70.09 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.7 1.137 . . . . 0.0 113.616 -175.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.94 -15.58 60.68 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.94 0.896 . . . . 0.0 113.231 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -97.5 -1.63 43.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.95 1.7 . . . . 0.0 114.208 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.78 -128.39 8.55 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.651 1.119 . . . . 0.0 112.296 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -94.22 160.28 14.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.413 1.485 . . . . 0.0 112.234 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.8 174.09 19.38 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.34 126.36 8.72 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.868 1.223 . . . . 0.0 111.852 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.9 123.14 41.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.705 2.002 . . . . 0.0 108.576 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.9 t -116.39 140.51 49.27 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.04 1.336 . . . . 0.0 110.402 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.86 131.0 30.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.663 1.185 . . . . 0.0 110.284 -167.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 56.9 m -135.16 131.14 36.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.796 0.838 . . . . 0.0 110.72 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 22.5 mt -109.27 125.46 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.549 1.54 . . . . 0.0 108.114 173.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.21 139.0 46.96 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.154 1.382 . . . . 0.0 109.742 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -168.82 -175.92 38.6 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -8.58 23.93 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.471 3.447 . . . . 0.0 113.825 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.1 t -154.83 164.84 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.754 1.222 . . . . 0.0 111.875 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.75 146.51 52.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.664 1.186 . . . . 0.0 111.53 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -132.27 141.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.112 0.965 . . . . 0.0 110.822 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.34 125.43 29.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.219 0.608 . . . . 0.0 110.013 169.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 38.4 mt -106.52 127.76 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.94 0.896 . . . . 0.0 108.851 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -124.31 143.68 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 109.854 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 24.9 p -113.74 154.03 28.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.911 1.284 . . . . 0.0 111.248 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.94 120.0 5.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.635 1.174 . . . . 0.0 110.15 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -79.02 123.53 27.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.307 1.043 . . . . 0.0 110.645 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.37 160.12 15.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.104 0.962 . . . . 0.0 111.975 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.6 -25.82 68.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.109 0.963 . . . . 0.0 112.333 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.13 -8.52 50.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.998 1.719 . . . . 0.0 113.777 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.59 -5.48 84.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.768 1.651 . . . . 0.0 114.304 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 25.0 p -82.93 161.41 21.84 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.943 1.697 . . . . 0.0 111.471 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 33.8 t -102.88 123.33 46.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.677 0.791 . . . . 0.0 110.255 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.05 138.2 33.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.867 0.867 . . . . 0.0 109.296 163.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 56.7 t -119.95 133.84 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.059 1.744 . . . . 0.0 108.169 168.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 67.6 m -136.92 138.3 40.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.853 1.261 . . . . 0.0 110.517 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.1 p90 -147.99 148.55 30.85 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.277 1.031 . . . . 0.0 112.465 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 23.2 t -109.15 106.84 59.34 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.538 0.735 . . . . 0.0 111.088 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.37 119.17 4.85 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.992 2.461 . . . . 0.0 109.694 171.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -78.86 -43.54 24.83 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.734 0.814 . . . . 0.0 111.614 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -91.31 147.68 36.01 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.551 1.14 . . . . 0.0 110.933 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.99 167.61 26.66 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.558 2.838 . . . . 0.0 111.734 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.78 -161.28 18.19 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.066 1.317 . . . . 0.0 113.768 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -93.79 126.71 39.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.007 0.923 . . . . 0.0 111.541 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -111.29 142.92 42.89 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.567 1.547 . . . . 0.0 109.808 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.45 123.89 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.595 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.29 124.6 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.896 1.278 . . . . 0.0 109.73 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -104.26 128.9 52.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.893 1.677 . . . . 0.0 109.755 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.3 mm -121.88 111.98 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.858 1.263 . . . . 0.0 109.524 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -121.02 130.92 53.99 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.634 1.574 . . . . 0.0 111.098 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -123.53 126.01 45.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.447 1.499 . . . . 0.0 110.328 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.16 28.77 9.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.342 1.457 . . . . 0.0 113.963 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 87.82 6.89 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 129.147 2.979 . . . . 0.0 114.894 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -114.69 138.27 50.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.726 1.21 . . . . 0.0 111.113 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2124 ' ' HIS . . . . . 0.529 ' CE1' ' HG ' ' A' 2128 ' ' SER . 0.0 OUTLIER -62.77 132.23 51.53 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.165 -0.959 . . . . 0.0 111.143 172.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.1 m -80.4 159.99 68.63 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.529 -0.732 . . . . 0.0 111.516 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.27 136.59 62.81 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.749 2.966 . . . . 0.0 113.354 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 86.04 -19.8 24.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.048 1.309 . . . . 0.0 114.394 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2128 ' ' SER . . . . . 0.529 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 23.1 t -76.4 144.27 74.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 118.613 1.207 . . . . 0.0 111.451 176.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.48 150.7 93.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 119.727 0.938 . . . . 0.0 112.283 -3.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.68 122.29 44.74 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.399 1.479 . . . . 0.0 110.733 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.3 p -86.96 135.28 33.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.419 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.3 t -130.93 113.98 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.186 1.395 . . . . 0.0 109.496 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.13 115.68 22.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.113 0.565 . . . . 0.0 111.154 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 91.4 t -98.22 115.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.232 1.413 . . . . 0.0 109.056 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 4.9 t -102.4 173.81 6.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.947 1.299 . . . . 0.0 111.455 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 116.52 -137.29 13.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.094 1.33 . . . . 0.0 112.615 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 124.768 1.227 . . . . 0.0 112.454 -167.143 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.9 ptt? -70.62 154.24 42.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.438 1.095 . . . . 0.0 112.73 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.0 m -107.59 144.79 34.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.69 1.196 . . . . 0.0 110.117 166.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.31 149.54 51.91 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.561 1.144 . . . . 0.0 113.266 -165.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -157.35 146.24 19.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.066 1.747 . . . . 0.0 110.11 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 48.2 mttp -128.51 149.9 50.4 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.518 1.127 . . . . 0.0 113.0 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.82 139.11 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.32 1.848 . . . . 0.0 109.513 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.96 120.76 5.39 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 4.0 m -111.96 142.74 44.0 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.694 1.197 . . . . 0.0 112.697 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.48 146.0 11.54 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.74 169.35 17.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.977 1.311 . . . . 0.0 111.555 163.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -105.3 137.59 42.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.737 1.215 . . . . 0.0 111.853 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.7 mm -105.27 118.04 56.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.303 1.041 . . . . 0.0 109.02 164.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.13 128.46 10.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.402 2.735 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 57.0 mt -147.44 139.53 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.658 1.583 . . . . 0.0 109.843 -172.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.07 60.26 3.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.803 1.641 . . . . 0.0 112.456 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.4 111.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.44 1.096 . . . . 0.0 111.34 -166.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 m -172.83 146.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.816 2.446 . . . . 0.0 109.33 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.42 -10.16 50.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.77 1.228 . . . . 0.0 113.501 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 24.9 p -91.43 160.3 15.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.338 1.855 . . . . 0.0 112.063 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 60.3 m-20 70.41 3.25 4.39 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.406 2.282 . . . . 0.0 114.679 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.53 -20.86 65.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 113.783 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 28.0 p -77.14 -12.55 59.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 9.74 3.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.179 1.391 . . . . 0.0 114.389 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.95 143.22 34.37 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.207 1.003 . . . . 0.0 110.974 164.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 39.8 p -140.86 160.75 39.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 109.779 173.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.87 150.67 26.24 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.57 0.748 . . . . 0.0 113.013 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 63.6 p -138.8 163.12 33.06 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.977 2.111 . . . . 0.0 109.491 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 137.36 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.911 1.284 . . . . 0.0 109.864 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.1 t -105.6 110.91 64.74 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.111 1.364 . . . . 0.0 108.083 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.57 169.14 20.27 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.893 3.062 . . . . 0.0 110.846 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.16 -15.88 47.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.065 2.51 . . . . 0.0 113.12 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 67.0 p -79.39 -9.3 59.57 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.88 1.272 . . . . 0.0 113.826 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.5 85.21 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.668 1.604 . . . . 0.0 115.185 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -77.61 82.58 4.03 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.374 1.469 . . . . 0.0 111.698 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.83 132.64 54.5 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 111.875 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.06 151.73 59.79 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.405 1.482 . . . . 0.0 111.354 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.9 158.04 34.75 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.951 3.1 . . . . 0.0 112.852 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.9 m -110.18 155.7 21.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.066 1.346 . . . . 0.0 112.457 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.5 tt -99.48 115.23 28.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.82 1.648 . . . . 0.0 108.157 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 4.3 mp -87.08 134.37 33.51 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.578 0.751 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.91 137.23 53.11 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.179 1.392 . . . . 0.0 112.805 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -99.14 124.19 43.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.524 1.529 . . . . 0.0 107.979 161.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.76 171.7 7.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.211 1.404 . . . . 0.0 112.763 -165.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -59.63 -32.19 70.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.33 -2.62 58.51 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.251 1.02 . . . . 0.0 113.446 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.46 -8.4 62.2 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.727 1.632 . . . . 0.0 114.857 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -73.96 168.83 18.69 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.594 1.197 . . . . 0.0 112.975 172.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.3 t -131.26 142.37 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.977 1.311 . . . . 0.0 110.948 -168.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.87 -168.79 20.72 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.846 1.212 . . . . 0.0 113.992 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.72 151.35 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.775 1.23 . . . . 0.0 112.233 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 43.2 m -123.59 155.1 38.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.766 1.626 . . . . 0.0 111.467 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.6 p90 -166.93 -174.68 2.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.497 2.319 . . . . 0.0 109.221 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -128.93 116.23 19.09 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 119.302 0.956 . . . . 0.0 109.706 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.99 139.52 24.41 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.939 3.093 . . . . 0.0 110.574 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -99.96 -6.9 25.85 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.271 1.029 . . . . 0.0 113.08 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -140.16 169.25 18.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.759 2.024 . . . . 0.0 110.363 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 167.11 13.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.277 1.031 . . . . 0.0 110.995 165.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 94.96 -169.3 28.1 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.048 1.309 . . . . 0.0 113.749 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -72.15 118.27 14.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.49 144.16 32.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.351 1.86 . . . . 0.0 109.104 168.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.58 125.95 51.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 0.0 109.642 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 26.3 t -89.35 121.39 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.705 1.202 . . . . 0.0 108.001 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -99.93 128.48 46.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.718 1.207 . . . . 0.0 110.061 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 48.0 t -126.71 131.4 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.595 1.158 . . . . 0.0 110.421 -172.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.9 mttp -123.38 147.58 46.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.734 1.613 . . . . 0.0 112.547 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -118.58 119.83 35.67 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 108.941 169.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.27 30.91 19.22 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.996 1.318 . . . . 0.0 113.247 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.48 2.5 73.11 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.027 1.299 . . . . 0.0 116.052 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -123.59 151.19 43.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.442 1.621 . . . . 0.0 110.999 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.34 144.58 57.06 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 98.2 t -77.63 146.08 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.678 1.191 . . . . 0.0 109.096 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.91 63.57 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -174.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 58.1 p -85.95 -8.05 58.25 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.162 1.385 . . . . 0.0 114.079 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 21.2 t -82.87 144.45 48.09 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.936 1.294 . . . . 0.0 112.358 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.03 155.49 87.41 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.562 0.879 . . . . 0.0 112.613 -3.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.49 120.85 48.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.731 1.612 . . . . 0.0 108.768 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.26 141.61 12.91 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.965 2.443 . . . . 0.0 111.247 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 22.3 t -137.57 126.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.799 1.639 . . . . 0.0 108.093 175.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.8 t -97.31 124.29 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.72 0.808 . . . . 0.0 110.202 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.57 128.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.037 1.335 . . . . 0.0 109.883 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 66.9 m -93.31 170.75 9.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.706 1.202 . . . . 0.0 112.234 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -34.5 77.46 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.323 -1.486 . . . . 0.0 111.604 174.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.0 m -66.17 -2.29 4.1 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.708 1.603 . . . . 0.0 115.27 -173.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.63 5.49 8.21 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.997 1.719 . . . . 0.0 112.96 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 3.5 mm -86.23 -21.83 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.546 1.138 . . . . 0.0 113.557 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.1 38.35 0.04 OUTLIER Glycine 0 N--CA 1.471 0.968 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.36 84.4 4.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.474 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -54.95 -37.01 65.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.609 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.22 -24.95 45.38 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.497 1.519 . . . . 0.0 114.381 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -90.94 -8.52 49.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.698 1.599 . . . . 0.0 114.215 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 90.4 t -73.8 137.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.007 1.276 . . . . 0.0 110.419 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -121.03 155.21 34.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.311 1.444 . . . . 0.0 111.365 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 30.6 m -145.23 153.33 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 109.971 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -154.86 170.88 20.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.025 0.93 . . . . 0.0 112.669 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.05 156.17 30.59 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.224 1.393 . . . . 0.0 113.184 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.04 -21.61 62.24 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.98 -2.16 22.74 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.078 1.323 . . . . 0.0 115.093 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 65.3 mt -90.93 -7.22 52.71 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.165 1.786 . . . . 0.0 112.707 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.06 -32.23 1.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.074 1.349 . . . . 0.0 113.887 -172.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.48 156.86 42.25 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.486 1.514 . . . . 0.0 112.253 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.87 32.5 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.371 0.986 . . . . 0.0 113.797 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.0 m80 -134.22 148.97 50.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 112.699 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 17.1 p -68.78 -29.78 68.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -118.19 0.15 11.69 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.52 146.49 61.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.106 1.763 . . . . 0.0 109.644 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.21 141.32 43.12 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.783 2.322 . . . . 0.0 111.049 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.72 154.29 21.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.41 1.084 . . . . 0.0 110.295 168.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.66 150.26 47.22 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 112.608 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 42.2 p90 -157.13 149.98 23.54 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 110.637 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.53 140.95 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.934 1.694 . . . . 0.0 109.566 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 71.5 mt -112.74 134.62 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.967 1.707 . . . . 0.0 108.86 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 23.2 t70 -137.07 123.22 20.43 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.565 1.546 . . . . 0.0 112.013 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 11.7 p -134.48 -11.75 2.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -157.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.13 -21.94 66.36 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 121.064 1.756 . . . . 0.0 114.542 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.46 -20.47 61.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.76 0.824 . . . . 0.0 112.554 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -92.34 -3.82 54.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.988 1.715 . . . . 0.0 113.423 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.7 -110.28 3.5 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.992 1.282 . . . . 0.0 112.462 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -131.79 151.74 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.534 1.533 . . . . 0.0 112.808 -168.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.87 -179.13 28.71 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -84.76 127.59 8.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.22 0.914 . . . . 0.0 111.239 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.8 124.58 49.8 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.243 1.817 . . . . 0.0 108.363 175.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.8 t -112.06 140.44 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.844 1.257 . . . . 0.0 111.35 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.17 133.73 47.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.248 2.219 . . . . 0.0 108.363 -174.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 83.0 p -143.36 151.76 40.81 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.26 -0.9 . . . . 0.0 112.661 167.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.27 137.52 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.97 1.308 . . . . 0.0 109.296 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.67 155.41 41.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.273 1.429 . . . . 0.0 111.033 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 167.3 -155.5 26.57 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 118.808 -0.996 . . . . 0.0 114.202 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.43 -8.69 23.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.429 3.42 . . . . 0.0 115.368 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.4 t -160.26 162.0 33.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.741 1.217 . . . . 0.0 111.528 173.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.29 146.98 53.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.301 1.041 . . . . 0.0 111.782 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 34.6 m -135.46 147.89 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.035 1.334 . . . . 0.0 111.65 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -88.94 122.55 32.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.862 0.865 . . . . 0.0 110.346 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.21 131.41 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.371 1.068 . . . . 0.0 109.604 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -130.05 161.08 31.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.224 1.81 . . . . 0.0 110.287 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 39.9 p -143.03 163.48 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.489 1.116 . . . . 0.0 112.829 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.13 121.35 6.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.773 1.629 . . . . 0.0 109.969 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.54 131.29 35.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.89 1.276 . . . . 0.0 111.132 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -108.53 153.63 23.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.023 1.329 . . . . 0.0 111.292 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -15.6 63.43 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -76.83 -6.06 50.84 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.753 1.221 . . . . 0.0 112.857 170.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 89.43 2.13 77.1 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.996 1.76 . . . . 0.0 114.082 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 4.1 p -81.64 156.73 24.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.413 1.885 . . . . 0.0 111.31 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -115.43 120.88 41.01 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.994 0.917 . . . . 0.0 110.347 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.8 ttm105 -78.93 133.77 36.9 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.976 0.91 . . . . 0.0 108.846 164.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 27.4 t -115.48 140.54 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.874 1.67 . . . . 0.0 108.518 169.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.7 p -136.21 150.3 48.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.589 1.556 . . . . 0.0 111.334 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.7 p90 -163.12 150.07 12.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 111.415 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 15.0 t -111.59 101.55 51.26 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.907 0.883 . . . . 0.0 110.766 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.64 116.87 4.38 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.104 2.536 . . . . 0.0 110.342 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.6 m -74.06 -39.69 63.3 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.923 0.889 . . . . 0.0 112.396 -173.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -95.07 148.69 35.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.05 1.34 . . . . 0.0 111.478 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.77 164.49 31.86 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.374 2.716 . . . . 0.0 110.98 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 121.01 -163.94 14.36 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.168 1.366 . . . . 0.0 113.284 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.6 t30 -91.55 117.27 29.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.457 0.703 . . . . 0.0 111.99 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -94.96 141.13 29.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.505 1.122 . . . . 0.0 111.145 164.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.77 134.96 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.404 1.482 . . . . 0.0 108.753 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 26.5 mt -118.32 128.36 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.927 1.291 . . . . 0.0 109.111 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -105.72 130.08 53.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 110.884 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 16.0 mm -119.83 120.82 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.002 1.321 . . . . 0.0 110.022 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -131.93 135.99 47.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.22 1.408 . . . . 0.0 111.469 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 69.8 t80 -131.48 129.69 41.46 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.88 1.672 . . . . 0.0 110.652 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.86 29.26 11.68 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.048 1.339 . . . . 0.0 113.424 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.8 t0 83.4 4.53 0.86 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 129.198 2.999 . . . . 0.0 114.668 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -109.05 128.22 54.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.824 1.249 . . . . 0.0 111.186 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2124 ' ' HIS . . . . . 0.469 ' CE1' ' HG ' ' A' 2128 ' ' SER . 3.6 t-80 -63.24 125.98 25.9 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.053 1.341 . . . . 0.0 110.618 172.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.3 m -80.38 156.46 73.65 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-N 119.039 0.836 . . . . 0.0 111.318 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.19 144.45 81.31 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.409 2.072 . . . . 0.0 111.63 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.37 -24.33 14.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.967 1.27 . . . . 0.0 113.423 -172.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2128 ' ' SER . . . . . 0.469 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 10.1 t -77.89 143.04 65.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.167 0.987 . . . . 0.0 110.565 170.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 146.37 84.19 Favored 'Cis proline' 0 C--N 1.353 0.768 0 CA-C-N 120.224 1.116 . . . . 0.0 112.075 0.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -97.63 122.21 40.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.709 1.203 . . . . 0.0 110.546 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.9 m -89.34 129.81 35.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.259 1.024 . . . . 0.0 111.37 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -122.94 112.08 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.2 1.8 . . . . 0.0 109.495 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -81.24 103.07 10.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.189 0.595 . . . . 0.0 111.455 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 61.7 t -87.85 128.9 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 109.45 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -125.25 167.32 15.04 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 114.11 161.1 13.82 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.086 1.803 . . . . 0.0 113.091 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.98 1.712 . . . . 0.0 110.316 -171.024 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 21.4 ptm -146.52 159.17 43.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 113.264 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.5 m -136.86 151.34 48.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.238 2.215 . . . . 0.0 109.084 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -150.67 160.33 43.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -170.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.39 153.68 25.71 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.512 1.925 . . . . 0.0 110.309 -172.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 61.1 mttm -133.91 143.15 48.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.181 1.392 . . . . 0.0 111.525 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 63.9 t -138.86 137.53 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.91 1.684 . . . . 0.0 109.592 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.81 130.08 9.97 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.924 0.773 . . . . 0.0 111.52 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 69.0 m -119.72 150.98 39.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.952 1.301 . . . . 0.0 112.223 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -153.69 152.14 30.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.126 0.971 . . . . 0.0 112.929 -174.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.46 149.79 29.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.443 0.697 . . . . 0.0 110.527 163.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -98.35 125.92 43.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 110.26 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.6 122.49 35.04 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.764 -1.113 . . . . 0.0 109.529 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.76 135.25 21.32 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.942 2.428 . . . . 0.0 110.601 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -148.49 143.53 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.549 1.54 . . . . 0.0 110.03 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.22 59.35 4.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.461 1.504 . . . . 0.0 112.383 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.1 mm -73.82 102.99 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.7 t -167.52 179.01 5.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.87 1.668 . . . . 0.0 111.078 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -85.58 6.03 29.05 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.614 1.566 . . . . 0.0 112.921 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -63.86 139.73 58.8 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.647 1.579 . . . . 0.0 112.076 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.25 158.61 28.87 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.682 1.193 . . . . 0.0 111.959 175.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.2 -23.53 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.34 1.056 . . . . 0.0 113.625 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 91.4 p -71.4 -27.45 63.32 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.12 4.25 51.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.871 1.668 . . . . 0.0 113.503 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.37 140.85 34.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.9 p -138.25 160.88 38.31 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.158 1.783 . . . . 0.0 110.104 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -148.65 148.7 30.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.828 0.851 . . . . 0.0 113.035 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.6 p -142.09 166.81 23.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.744 2.018 . . . . 0.0 109.92 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -122.07 138.44 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 109.595 168.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.1 t -107.07 112.71 63.02 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.297 1.439 . . . . 0.0 108.11 166.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -77.91 171.3 17.49 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.12 3.213 . . . . 0.0 110.773 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.46 -17.51 59.87 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.88 2.387 . . . . 0.0 113.587 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 7.3 t -77.81 -12.14 59.95 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.114 0.966 . . . . 0.0 113.273 170.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 83.8 -0.64 89.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.768 1.651 . . . . 0.0 115.09 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -78.03 86.64 4.2 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.131 1.772 . . . . 0.0 111.105 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -61.01 132.33 53.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.0 0.92 . . . . 0.0 111.837 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -137.41 148.65 62.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 110.663 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.56 155.04 40.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.732 2.955 . . . . 0.0 112.428 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 89.5 m -115.77 151.28 35.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.042 1.337 . . . . 0.0 111.679 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 115.35 26.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.964 0.906 . . . . 0.0 109.346 171.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.91 142.12 42.14 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.467 1.107 . . . . 0.0 110.779 171.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -145.4 149.25 34.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 113.017 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.95 115.81 23.01 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 153.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.77 170.43 11.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.208 1.003 . . . . 0.0 112.503 -173.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 63.3 ttt-85 -60.69 -30.14 69.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.597 1.559 . . . . 0.0 114.315 -169.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -82.55 -10.58 58.93 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.593 1.157 . . . . 0.0 113.684 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.29 55.12 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.87 1.7 . . . . 0.0 114.584 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 166.22 19.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 118.783 1.291 . . . . 0.0 113.403 173.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 90.8 t -93.02 142.94 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.955 1.302 . . . . 0.0 110.197 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.63 -171.87 27.15 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.05 162.96 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.779 1.631 . . . . 0.0 112.675 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 84.7 p -136.99 159.25 42.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.286 1.034 . . . . 0.0 111.916 159.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -165.63 -171.73 2.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.989 2.516 . . . . 0.0 109.309 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 82.0 t -134.65 120.82 14.67 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 110.241 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.34 143.4 15.55 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.384 3.39 . . . . 0.0 110.792 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.41 23.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.73 169.3 18.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.325 1.85 . . . . 0.0 110.582 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -82.07 169.74 16.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 112.076 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.99 -175.83 23.35 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.59 1.567 . . . . 0.0 113.875 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.98 118.39 15.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.897 0.879 . . . . 0.0 111.13 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.3 m80 -103.64 143.85 32.22 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.946 1.699 . . . . 0.0 109.275 170.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 123.26 46.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.089 0.956 . . . . 0.0 108.959 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 58.0 t -85.0 129.69 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.846 1.259 . . . . 0.0 107.881 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -112.33 132.37 55.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.848 1.259 . . . . 0.0 110.339 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 95.1 t -129.6 127.97 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.475 1.11 . . . . 0.0 110.636 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -119.9 135.27 54.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.791 1.636 . . . . 0.0 112.057 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -106.64 114.94 29.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.465 1.906 . . . . 0.0 109.027 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.3 t30 52.62 -101.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.164 1.386 . . . . 0.0 111.763 -172.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.26 5.24 33.65 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.595 1.569 . . . . 0.0 115.876 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -140.6 149.46 42.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.799 1.8 . . . . 0.0 112.809 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -68.7 144.8 54.3 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.102 -0.999 . . . . 0.0 113.028 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.8 m -72.08 160.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 111.481 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.3 67.97 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.2 m -79.88 -15.68 56.87 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 34.1 t -89.19 145.05 33.42 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.536 1.134 . . . . 0.0 113.114 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.96 159.12 84.07 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 119.297 0.785 . . . . 0.0 112.6 -3.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.37 125.54 28.73 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.758 1.623 . . . . 0.0 109.577 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.18 139.26 13.23 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.072 2.515 . . . . 0.0 111.552 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 40.9 t -134.83 125.1 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.837 1.655 . . . . 0.0 107.957 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.3 t -98.17 124.8 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.87 0.868 . . . . 0.0 110.427 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.29 120.73 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.168 1.387 . . . . 0.0 108.747 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 83.2 p -96.3 167.99 10.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.943 0.897 . . . . 0.0 112.119 172.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.64 -22.84 66.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 12.1 t -70.78 -36.03 72.87 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.304 -0.873 . . . . 0.0 111.796 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -74.69 -15.98 60.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.452 1.101 . . . . 0.0 112.728 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 50.2 mm -64.91 -19.91 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.34 1.056 . . . . 0.0 112.037 173.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 132.11 64.6 0.09 OUTLIER Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.609 1.576 . . . . 0.0 113.755 168.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 23.9 t0 -65.85 114.47 5.11 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 117.766 0.783 . . . . 0.0 111.56 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.97 80.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.146 0.978 . . . . 0.0 112.755 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 49.0 m -61.32 -20.46 62.97 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -85.71 -12.0 52.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.137 1.375 . . . . 0.0 114.069 174.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.6 t -76.29 133.41 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.921 1.237 . . . . 0.0 110.117 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -115.52 157.9 23.39 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.655 1.582 . . . . 0.0 110.703 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.3 m -146.5 158.55 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.22 1.408 . . . . 0.0 111.036 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -160.06 169.15 23.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 112.288 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 107.69 160.38 20.93 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.213 1.387 . . . . 0.0 114.444 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -68.88 -32.11 71.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.465 1.506 . . . . 0.0 113.31 -169.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.48 -3.28 47.15 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.039 1.304 . . . . 0.0 115.17 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.56 -8.37 56.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.319 1.447 . . . . 0.0 112.631 168.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.66 -36.19 2.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -158.16 155.71 29.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.478 1.111 . . . . 0.0 112.752 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.03 -175.23 23.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.796 1.189 . . . . 0.0 114.288 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -137.69 148.55 45.78 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.118 1.367 . . . . 0.0 112.657 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 23.3 p -68.98 -35.07 76.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.08 10.2 22.02 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.42 154.85 72.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.608 1.563 . . . . 0.0 110.59 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 144.27 34.41 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.716 2.277 . . . . 0.0 111.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.45 138.36 37.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.404 1.482 . . . . 0.0 110.009 169.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.61 146.03 48.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.021 1.328 . . . . 0.0 113.307 -169.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -158.17 157.38 32.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.089 1.356 . . . . 0.0 112.159 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.43 141.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.476 1.911 . . . . 0.0 109.347 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 50.9 mt -117.1 132.68 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 108.769 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -120.81 100.71 7.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.724 1.61 . . . . 0.0 110.722 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 18.6 p -98.01 0.21 45.88 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.97 2.108 . . . . 0.0 113.034 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -59.88 -37.65 79.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.352 0.978 . . . . 0.0 112.713 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.28 -11.62 59.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.694 1.197 . . . . 0.0 113.247 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.38 49.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.867 1.667 . . . . 0.0 113.804 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.23 -129.54 9.33 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.663 1.125 . . . . 0.0 112.671 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -102.27 170.14 8.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.863 1.665 . . . . 0.0 112.388 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 134.17 -176.67 19.68 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.303 0.954 . . . . 0.0 115.114 168.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -94.56 124.16 7.81 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.685 1.136 . . . . 0.0 112.09 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -95.07 117.83 30.84 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.057 1.743 . . . . 0.0 108.198 170.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 68.3 m -108.76 143.81 37.41 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.492 1.517 . . . . 0.0 110.347 172.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.2 tt -142.12 140.29 32.43 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.869 0.867 . . . . 0.0 110.185 -169.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 92.0 p -143.84 152.6 41.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 112.616 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.3 mt -129.35 133.71 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 107.655 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -141.78 152.22 43.56 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.263 1.025 . . . . 0.0 111.566 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.28 -146.7 12.97 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.664 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.69 -8.85 22.02 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.702 2.934 . . . . 0.0 114.485 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.4 t -159.4 162.88 35.84 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.848 1.204 . . . . 0.0 112.633 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -70.63 146.74 49.82 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.785 1.234 . . . . 0.0 110.892 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.89 145.69 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.992 1.317 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.54 99.39 12.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 110.07 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 42.3 mt -81.04 131.38 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.208 1.003 . . . . 0.0 109.973 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -126.36 152.8 45.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.407 1.883 . . . . 0.0 110.207 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 33.7 p -138.93 154.16 48.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.991 1.316 . . . . 0.0 111.697 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -152.43 126.85 9.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.751 1.22 . . . . 0.0 111.156 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.81 128.08 32.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.506 1.122 . . . . 0.0 110.897 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.4 mt -97.43 155.05 17.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.647 1.179 . . . . 0.0 111.786 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.77 -16.63 64.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.255 1.022 . . . . 0.0 113.429 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -74.15 -11.79 60.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.998 1.319 . . . . 0.0 113.313 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.48 -0.49 65.68 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.936 1.731 . . . . 0.0 114.293 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 41.3 p -89.29 167.69 12.85 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.47 1.908 . . . . 0.0 111.253 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.5 t -117.33 130.34 56.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.083 0.953 . . . . 0.0 111.088 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -94.32 139.72 30.72 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.007 1.323 . . . . 0.0 110.146 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 21.7 t -125.3 139.54 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.009 1.724 . . . . 0.0 108.954 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.8 p -138.02 152.76 49.19 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.402 1.481 . . . . 0.0 111.386 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.9 p90 -162.88 148.42 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.589 1.556 . . . . 0.0 110.806 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 30.2 t -109.2 106.78 59.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.599 0.76 . . . . 0.0 110.658 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.33 106.05 1.98 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.376 2.717 . . . . 0.0 110.238 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.9 m -66.38 -44.0 84.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.03 0.932 . . . . 0.0 112.74 -171.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -92.4 148.21 35.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.431 1.092 . . . . 0.0 110.842 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.88 165.64 29.62 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.321 2.681 . . . . 0.0 111.602 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 125.82 -162.12 20.11 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 125.179 1.371 . . . . 0.0 113.561 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.9 t30 -93.8 125.2 38.29 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.698 0.799 . . . . 0.0 111.524 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -108.89 143.49 38.05 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.107 1.363 . . . . 0.0 110.241 168.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.33 133.72 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 108.533 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 23.7 mt -111.64 129.72 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 109.308 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -108.58 125.29 51.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.423 1.489 . . . . 0.0 110.153 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.8 mm -112.16 121.59 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.011 0.924 . . . . 0.0 109.238 172.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -127.13 133.02 50.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.174 1.789 . . . . 0.0 110.527 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.6 126.55 36.97 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.556 1.142 . . . . 0.0 110.549 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.51 40.01 25.93 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.865 1.266 . . . . 0.0 112.578 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.2 t0 72.87 5.42 5.19 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.576 2.75 . . . . 0.0 114.651 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -109.69 128.71 55.45 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.994 1.318 . . . . 0.0 110.589 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -67.13 123.15 19.47 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.755 1.222 . . . . 0.0 111.104 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.8 m -81.91 160.61 63.15 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.279 -0.888 . . . . 0.0 111.915 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.0 141.76 67.01 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.766 2.977 . . . . 0.0 113.659 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.31 -22.87 17.48 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.022 1.296 . . . . 0.0 114.287 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 74.7 m -73.52 150.57 89.17 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 118.861 1.33 . . . . 0.0 111.525 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -73.52 139.65 62.71 Favored 'Cis proline' 0 C--N 1.352 0.759 0 CA-C-N 119.365 0.809 . . . . 0.0 111.111 -5.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -93.22 114.69 27.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.945 0.898 . . . . 0.0 110.337 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 62.0 m -82.75 128.28 34.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.6 t -123.92 114.9 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.766 1.626 . . . . 0.0 109.636 -171.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -81.57 108.79 15.43 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.629 . . . . 0.0 111.213 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 84.4 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.835 1.254 . . . . 0.0 109.226 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -109.01 164.56 12.3 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.908 1.283 . . . . 0.0 111.882 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 115.15 177.06 18.74 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.703 1.62 . . . . 0.0 113.575 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 12.7 mp0 . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 124.941 1.297 . . . . 0.0 112.473 -172.995 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 120.755 0.312 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.8 ptm -120.41 153.97 35.79 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.233 1.413 . . . . 0.0 112.69 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.8 m -134.78 145.49 48.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.847 2.059 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -146.29 157.03 43.76 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.2 141.36 16.31 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.218 1.807 . . . . 0.0 109.982 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -132.21 143.72 50.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.736 1.214 . . . . 0.0 112.512 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 29.9 m -143.46 151.8 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.331 1.452 . . . . 0.0 111.278 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.16 153.1 27.54 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 124.344 0.973 . . . . 0.0 112.132 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.2 m -140.3 137.03 33.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.508 0.723 . . . . 0.0 112.692 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.0 154.23 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.701 1.2 . . . . 0.0 112.19 -176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.38 133.16 34.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 111.076 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.35 135.03 34.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.219 1.008 . . . . 0.0 110.608 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.76 113.16 30.38 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.886 0.874 . . . . 0.0 109.9 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.43 150.55 36.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.047 2.498 . . . . 0.0 110.587 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 67.9 mt -129.92 141.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.411 1.084 . . . . 0.0 110.039 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 48.7 t-20 11.32 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.41 3.084 . . . . 0.0 115.377 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.05 116.64 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.651 1.18 . . . . 0.0 112.004 -161.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 77.3 p -172.81 166.41 5.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.627 1.971 . . . . 0.0 110.583 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.28 141.9 27.91 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.951 0.9 . . . . 0.0 111.593 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 1.2 m -176.89 139.77 0.3 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.338 2.655 . . . . 0.0 109.106 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.5 133.04 49.56 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.292 1.037 . . . . 0.0 112.317 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 22.1 tp -76.24 -25.57 55.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.277 1.031 . . . . 0.0 113.711 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 49.1 m -84.37 -26.28 28.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -169.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.9 pp -92.47 9.4 34.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.798 1.239 . . . . 0.0 113.577 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.63 148.68 23.05 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.473 1.509 . . . . 0.0 111.811 170.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -136.97 157.43 46.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.107 1.763 . . . . 0.0 109.367 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 148.28 26.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.939 0.896 . . . . 0.0 112.355 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 74.9 p -140.37 160.16 40.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.337 1.855 . . . . 0.0 109.999 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.0 t -114.93 135.42 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.425 1.49 . . . . 0.0 109.471 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.3 t -106.81 110.74 63.84 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.942 1.297 . . . . 0.0 107.889 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 167.73 24.51 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.622 2.881 . . . . 0.0 110.622 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 -14.66 42.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.949 2.432 . . . . 0.0 113.061 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.1 p -79.66 -9.74 59.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.361 1.464 . . . . 0.0 113.936 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.96 -1.68 85.92 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.691 1.615 . . . . 0.0 115.168 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -77.29 81.66 3.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.553 1.541 . . . . 0.0 111.496 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.99 135.72 57.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.636 1.174 . . . . 0.0 112.212 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.79 148.93 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.764 1.626 . . . . 0.0 111.023 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.76 152.54 37.42 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.523 2.815 . . . . 0.0 111.808 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 80.6 m -102.7 151.45 22.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.563 1.145 . . . . 0.0 111.74 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 56.9 tp -83.03 126.59 32.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 108.774 163.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.4 mt -94.87 140.52 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.053 1.341 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.94 145.58 34.69 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.276 1.03 . . . . 0.0 113.021 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -85.78 108.44 18.09 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 153.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.37 166.25 21.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.166 0.986 . . . . 0.0 111.453 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -64.68 -21.61 66.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -81.4 -9.11 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.596 1.158 . . . . 0.0 113.599 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.45 -6.74 61.31 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.866 1.698 . . . . 0.0 114.566 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.06 162.73 19.2 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.697 1.199 . . . . 0.0 113.406 173.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 12.5 p -94.84 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.081 1.352 . . . . 0.0 111.057 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.65 177.8 33.42 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.23 162.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.987 1.715 . . . . 0.0 112.271 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 32.5 t -146.87 148.8 32.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.752 1.621 . . . . 0.0 110.57 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.5 p90 -169.41 175.49 5.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.334 2.254 . . . . 0.0 110.043 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 71.3 t -124.86 116.08 26.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 124.117 0.967 . . . . 0.0 109.805 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.24 143.21 28.07 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.944 3.096 . . . . 0.0 110.858 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.44 -19.26 15.0 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.77 171.0 8.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.264 1.826 . . . . 0.0 110.726 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.9 p -97.91 169.02 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.48 1.512 . . . . 0.0 111.107 169.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.69 -170.65 23.23 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.362 1.458 . . . . 0.0 113.815 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.83 112.02 7.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.025 0.93 . . . . 0.0 111.472 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.47 143.36 28.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.649 1.58 . . . . 0.0 109.269 168.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.83 125.11 50.57 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.336 1.054 . . . . 0.0 109.222 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.3 t -88.69 127.79 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.287 1.035 . . . . 0.0 108.237 168.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -106.41 137.21 44.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.263 1.425 . . . . 0.0 109.96 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 84.7 t -136.33 134.77 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.425 1.09 . . . . 0.0 109.566 -170.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -133.8 132.31 40.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.23 1.412 . . . . 0.0 111.137 -169.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -124.95 128.13 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.791 2.036 . . . . 0.0 109.627 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 46.3 t30 59.94 22.19 11.24 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.048 0.939 . . . . 0.0 113.289 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.94 7.37 83.95 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.941 1.258 . . . . 0.0 114.91 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -119.26 133.74 55.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.033 1.733 . . . . 0.0 109.465 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.18 138.31 58.18 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.494 -1.379 . . . . 0.0 112.135 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 22.9 m -78.83 159.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.214 0.606 . . . . 0.0 112.283 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -64.22 -20.75 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 49.8 m -86.4 -19.34 29.84 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 67.5 p -92.96 154.0 41.86 Favored Pre-proline 0 CA--C 1.55 0.979 0 O-C-N 120.887 -1.133 . . . . 0.0 113.846 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.65 147.58 89.94 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.138 0.728 . . . . 0.0 112.485 -0.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.12 120.22 51.69 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.013 1.325 . . . . 0.0 108.503 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.21 140.53 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.858 2.372 . . . . 0.0 111.288 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 23.4 t -135.44 123.51 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.391 1.476 . . . . 0.0 107.768 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.5 t -96.46 120.99 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.593 0.757 . . . . 0.0 109.795 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 123.01 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.779 1.231 . . . . 0.0 109.035 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 32.5 t -92.36 158.46 16.07 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.729 0.812 . . . . 0.0 111.408 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -59.74 -29.68 68.32 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.252 -0.905 . . . . 0.0 111.428 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.1 m -63.18 -13.26 35.2 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.666 1.186 . . . . 0.0 113.928 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -94.71 -11.17 29.63 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.942 1.297 . . . . 0.0 112.371 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.75 95.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.756 1.222 . . . . 0.0 109.917 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 65.02 24.63 70.35 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 115.0 0.76 . . . . 0.0 115.0 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 34.0 t0 -76.22 89.52 3.11 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.358 1.079 . . . . 0.0 111.9 -171.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.99 75.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.748 1.219 . . . . 0.0 112.789 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.8 m -60.7 -22.12 63.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.302 1.041 . . . . 0.0 113.574 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -88.66 -8.98 53.65 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.077 1.351 . . . . 0.0 113.903 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.5 t -77.52 131.31 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.866 1.212 . . . . 0.0 109.655 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -116.22 161.01 19.61 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.94 1.296 . . . . 0.0 111.373 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -146.11 153.88 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.385 1.474 . . . . 0.0 110.643 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 73.4 m -149.09 165.85 30.51 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.069 1.348 . . . . 0.0 112.103 -173.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.66 162.08 26.0 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 124.345 0.974 . . . . 0.0 114.577 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -73.9 -27.67 61.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 113.644 -167.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.86 -5.58 47.09 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.733 1.159 . . . . 0.0 115.042 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.82 -7.02 58.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.676 1.591 . . . . 0.0 112.787 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -128.29 -36.01 1.95 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.955 1.302 . . . . 0.0 113.8 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.7 155.51 30.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 112.474 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.6 -176.19 21.79 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.881 1.229 . . . . 0.0 114.358 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -139.41 152.67 47.27 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.345 1.458 . . . . 0.0 112.145 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 25.5 p -71.5 -41.84 68.77 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -100.18 -11.16 20.67 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -114.66 145.75 34.54 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.073 1.349 . . . . 0.0 110.258 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.78 137.83 36.31 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.545 2.163 . . . . 0.0 110.422 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -84.03 150.37 25.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.109 0.964 . . . . 0.0 109.997 168.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.25 151.19 46.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -159.26 155.59 27.23 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.613 1.565 . . . . 0.0 111.001 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.52 143.14 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.41 1.884 . . . . 0.0 109.961 -175.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.25 133.89 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.238 1.815 . . . . 0.0 109.026 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.7 t0 -122.81 99.82 6.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.018 1.727 . . . . 0.0 110.875 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 32.6 p -99.73 4.83 45.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.499 1.92 . . . . 0.0 112.735 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.9 -37.32 81.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.255 1.022 . . . . 0.0 112.577 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.27 -28.96 38.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 0.0 112.716 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -72.49 -11.49 60.69 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.86 -108.23 3.22 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.426 1.012 . . . . 0.0 112.068 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.32 147.15 50.25 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.925 1.29 . . . . 0.0 112.97 -168.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 156.73 -137.68 5.56 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.543 1.068 . . . . 0.0 113.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -157.68 141.46 7.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.497 1.046 . . . . 0.0 112.047 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.48 124.99 45.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.916 1.686 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 23.2 t -115.69 138.91 50.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.33 1.452 . . . . 0.0 109.902 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 8.4 tt -136.75 132.95 35.49 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.62 1.168 . . . . 0.0 109.902 -168.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.7 m -133.66 130.23 37.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.386 0.675 . . . . 0.0 111.197 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.9 mt -109.24 130.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.083 1.353 . . . . 0.0 108.244 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.78 142.5 51.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.337 1.455 . . . . 0.0 109.758 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 177.27 -165.24 35.01 Favored Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.1 -9.89 26.41 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.175 3.25 . . . . 0.0 114.05 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.0 t -155.88 162.51 40.41 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.386 1.074 . . . . 0.0 112.078 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -67.31 147.12 53.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.664 1.186 . . . . 0.0 111.327 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 32.2 m -130.84 146.14 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.143 1.377 . . . . 0.0 110.903 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.37 105.82 17.83 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.679 0.792 . . . . 0.0 109.957 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 52.3 mt -84.41 129.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.247 1.019 . . . . 0.0 109.599 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -125.69 161.16 27.91 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 0.0 110.795 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 35.6 p -141.8 155.52 45.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.252 1.421 . . . . 0.0 111.951 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.45 138.05 15.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 111.515 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.0 t70 -86.97 129.03 35.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.117 1.367 . . . . 0.0 111.31 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 43.2 mt -99.31 160.62 14.14 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.308 1.043 . . . . 0.0 112.525 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.37 -17.04 64.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.522 1.129 . . . . 0.0 113.35 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.43 -9.15 59.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.144 1.378 . . . . 0.0 113.291 172.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.81 1.91 82.13 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.412 1.482 . . . . 0.0 114.018 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -89.18 165.49 14.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.332 1.853 . . . . 0.0 111.432 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.6 t -109.94 124.87 52.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.042 . . . . 0.0 110.993 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -83.62 135.4 34.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 165.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 45.7 t -117.36 139.31 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.953 1.701 . . . . 0.0 108.773 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.97 151.61 50.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.782 1.633 . . . . 0.0 111.83 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.39 150.74 14.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.521 1.528 . . . . 0.0 111.787 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.5 t -115.81 99.39 52.5 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.277 1.031 . . . . 0.0 111.039 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.44 94.12 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.706 2.937 . . . . 0.0 110.669 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 51.8 m -63.09 -41.76 99.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.868 . . . . 0.0 112.78 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -87.3 140.78 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.711 0.805 . . . . 0.0 110.668 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.97 168.64 24.38 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.506 2.804 . . . . 0.0 111.554 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 127.0 -147.31 16.84 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.816 1.198 . . . . 0.0 112.695 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -109.75 133.56 53.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.074 0.95 . . . . 0.0 111.836 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -118.29 151.37 37.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.784 1.633 . . . . 0.0 110.707 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.06 133.26 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.518 1.527 . . . . 0.0 108.699 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.54 128.97 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.592 1.157 . . . . 0.0 109.789 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.54 125.25 53.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.895 1.678 . . . . 0.0 110.015 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.6 mm -115.63 116.42 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.11 0.964 . . . . 0.0 109.246 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -125.71 132.8 52.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.16 1.384 . . . . 0.0 111.201 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 72.4 t80 -123.82 124.22 42.2 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.678 1.591 . . . . 0.0 110.312 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.73 30.97 11.99 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.331 1.452 . . . . 0.0 114.177 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.257 7.0 t70 85.68 11.91 0.22 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 128.784 2.834 . . . . 0.0 114.728 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.6 132.18 55.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.556 1.143 . . . . 0.0 111.48 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.86 124.48 23.45 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.338 1.455 . . . . 0.0 110.676 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -80.72 158.76 70.4 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.189 -0.944 . . . . 0.0 111.825 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.51 134.93 64.24 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.649 2.899 . . . . 0.0 113.253 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.85 -22.31 38.73 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.247 1.403 . . . . 0.0 114.073 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 62.9 m -75.22 150.59 85.39 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 118.922 1.361 . . . . 0.0 112.024 172.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.35 142.87 73.16 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.053 0.697 . . . . 0.0 111.113 -4.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.62 127.76 39.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.432 1.093 . . . . 0.0 110.834 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 30.5 t -95.97 129.29 43.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.345 1.058 . . . . 0.0 110.988 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 11.9 t -128.46 117.14 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.001 1.32 . . . . 0.0 110.007 -170.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -85.84 120.35 27.16 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.76 -0.587 . . . . 0.0 110.521 173.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.08 118.99 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.587 1.555 . . . . 0.0 108.862 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 1.3 t -99.61 162.85 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.583 1.153 . . . . 0.0 111.333 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 171.47 -168.35 41.46 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 126.611 1.964 . . . . 0.0 110.215 178.256 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -64.67 -21.94 66.86 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -14.44 61.3 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.239 1.416 . . . . 0.0 114.17 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 84.45 162.88 35.33 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.275 1.417 . . . . 0.0 113.45 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -164.75 154.32 13.39 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.907 1.683 . . . . 0.0 111.478 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.44 -15.49 59.91 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.706 1.202 . . . . 0.0 113.908 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 57.6 m 70.02 -107.24 0.06 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.057 2.143 . . . . 0.0 110.987 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 14.1 ptm -142.48 148.1 37.15 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.769 1.228 . . . . 0.0 111.651 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 161.58 28.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.865 1.266 . . . . 0.0 110.372 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 23.6 ptm -149.39 159.29 44.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 13.3 m -148.53 151.66 35.5 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.377 1.871 . . . . 0.0 109.774 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -147.32 159.77 43.29 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.9 150.85 24.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.539 1.936 . . . . 0.0 109.796 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -134.07 144.08 48.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.546 1.138 . . . . 0.0 111.972 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 46.8 t -140.37 134.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.64 1.576 . . . . 0.0 109.658 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.89 139.51 21.43 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 124.013 0.816 . . . . 0.0 111.661 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 29.6 m -131.22 132.14 44.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.809 0.804 . . . . 0.0 112.764 -166.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.63 148.64 16.19 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -74.47 150.33 39.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.439 1.095 . . . . 0.0 111.323 170.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -93.28 122.81 36.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.422 1.089 . . . . 0.0 110.667 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.9 mm -112.46 108.73 54.2 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.588 1.155 . . . . 0.0 109.266 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.91 137.62 17.78 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.178 2.585 . . . . 0.0 111.17 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 65.1 mt -145.69 141.14 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.377 1.471 . . . . 0.0 110.21 -170.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.26 61.47 2.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.625 1.57 . . . . 0.0 112.0 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.26 104.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.666 1.186 . . . . 0.0 110.616 -169.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.8 t -172.61 178.74 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.274 1.83 . . . . 0.0 110.543 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.99 45.42 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.018 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.8 p -71.47 138.06 48.69 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.001 1.321 . . . . 0.0 111.364 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 15.0 t70 -85.09 141.13 30.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.436 1.094 . . . . 0.0 111.323 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 -16.95 46.53 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 60.4 m -82.16 -31.93 30.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.038 1.29 . . . . 0.0 114.055 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -99.39 -0.49 40.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.5 1.12 . . . . 0.0 113.845 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.83 146.81 24.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.601 1.161 . . . . 0.0 111.492 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 41.0 p -138.87 162.67 34.23 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.732 2.013 . . . . 0.0 109.448 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.1 145.25 24.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.689 0.795 . . . . 0.0 112.08 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.7 p -138.4 162.57 34.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.148 1.779 . . . . 0.0 109.9 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -120.12 137.59 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.21 1.404 . . . . 0.0 109.462 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.1 t -102.82 111.05 64.6 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.14 1.376 . . . . 0.0 107.832 165.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.28 168.65 22.68 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.042 3.161 . . . . 0.0 110.696 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.55 -18.1 61.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.923 2.415 . . . . 0.0 112.645 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 12.8 m -67.63 -17.18 64.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.84 1.256 . . . . 0.0 113.925 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.87 31.24 54.17 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.61 1.1 . . . . 0.0 114.239 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -125.84 97.57 5.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.318 1.447 . . . . 0.0 110.488 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.93 135.74 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.417 1.087 . . . . 0.0 112.155 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -137.49 151.06 70.39 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.515 1.526 . . . . 0.0 111.097 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.19 156.23 42.11 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.793 2.996 . . . . 0.0 112.664 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.0 m -112.48 154.49 25.8 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.354 1.462 . . . . 0.0 111.751 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 58.2 tp -85.85 120.34 27.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.287 1.035 . . . . 0.0 109.397 170.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 21.9 mt -84.03 141.7 30.99 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.597 1.159 . . . . 0.0 110.95 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.23 139.1 31.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.459 1.503 . . . . 0.0 111.75 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -92.82 109.45 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 160.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.57 164.3 23.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.862 1.265 . . . . 0.0 111.735 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.27 -34.52 68.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -167.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.12 -9.24 58.61 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.19 37.99 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 126.003 1.764 . . . . 0.0 114.435 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.07 156.57 33.78 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 113.351 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.6 t -104.08 143.01 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.137 1.375 . . . . 0.0 110.042 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.2 178.61 28.48 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.557 1.075 . . . . 0.0 115.039 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -116.59 165.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.948 1.699 . . . . 0.0 111.615 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 71.1 p -151.59 150.73 30.64 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 110.678 166.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.7 p90 -167.17 167.59 14.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.945 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 59.5 t -110.67 117.68 50.22 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.816 0.846 . . . . 0.0 109.676 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.45 147.65 28.96 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.944 3.096 . . . . 0.0 110.917 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -105.34 -7.67 18.7 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -145.72 174.93 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.403 2.281 . . . . 0.0 109.687 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 36.3 p -88.56 167.07 13.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.614 1.165 . . . . 0.0 111.21 166.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.05 -170.22 25.97 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.268 1.413 . . . . 0.0 113.79 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.84 117.88 12.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.186 0.994 . . . . 0.0 111.742 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.8 m80 -104.11 143.58 32.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.036 1.734 . . . . 0.0 108.968 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.44 125.31 50.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.993 0.917 . . . . 0.0 110.083 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.1 t -85.62 137.46 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -119.96 114.76 22.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.347 1.459 . . . . 0.0 109.693 169.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 94.1 t -106.48 136.52 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.054 1.341 . . . . 0.0 108.995 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -131.09 142.28 50.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.989 1.315 . . . . 0.0 112.435 -172.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -112.81 121.21 44.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.544 1.938 . . . . 0.0 109.169 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.19 26.27 10.12 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.668 1.187 . . . . 0.0 113.259 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.65 84.85 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.649 1.595 . . . . 0.0 115.452 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.43 134.87 46.07 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.167 1.484 . . . . 0.0 109.64 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 19.3 p80 -63.36 140.15 58.84 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.953 -1.092 . . . . 0.0 113.337 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 16.6 m -78.54 159.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.666 0.786 . . . . 0.0 110.983 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.42 62.76 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.4 m -75.35 -20.76 58.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 56.4 m -82.25 149.89 63.01 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.64 150.24 92.49 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 118.649 0.553 . . . . 0.0 111.949 -5.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -107.41 119.24 51.37 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.86 139.89 12.49 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.806 2.338 . . . . 0.0 111.385 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -134.1 124.35 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.384 1.474 . . . . 0.0 107.643 171.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.4 t -99.75 122.58 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.879 0.872 . . . . 0.0 109.97 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.45 128.14 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.886 1.274 . . . . 0.0 109.655 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.2 t -99.66 161.24 13.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.026 0.931 . . . . 0.0 111.457 170.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -59.54 -31.38 69.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.768 0.827 . . . . 0.0 112.87 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -68.0 -14.93 63.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 113.516 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -92.12 -9.5 42.29 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.564 1.146 . . . . 0.0 112.763 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 44.1 mm -76.49 -31.94 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 0.0 112.948 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.44 47.74 0.04 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -85.43 98.9 10.84 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.261 1.031 . . . . 0.0 110.78 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.44 73.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.482 1.113 . . . . 0.0 113.495 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.9 p -56.78 -23.4 42.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 113.91 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -84.84 -14.45 47.92 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.213 1.405 . . . . 0.0 113.913 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.5 t -75.12 135.42 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.641 1.11 . . . . 0.0 110.524 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -113.53 156.88 22.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.381 1.472 . . . . 0.0 111.329 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.55 159.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.697 1.599 . . . . 0.0 110.706 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -159.95 175.69 12.74 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.577 1.151 . . . . 0.0 112.419 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.84 161.73 30.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.239 1.399 . . . . 0.0 114.189 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -72.16 -28.24 63.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.582 1.153 . . . . 0.0 113.398 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.45 -4.29 37.21 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.703 1.144 . . . . 0.0 115.24 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.28 -4.39 58.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.323 1.449 . . . . 0.0 112.76 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -134.53 -40.12 0.8 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.812 1.245 . . . . 0.0 113.876 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.22 152.51 44.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 111.267 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.38 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 122.256 0.92 . . . . 0.0 114.748 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 66.0 m80 -135.43 160.06 39.63 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.543 1.937 . . . . 0.0 110.29 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 16.9 p -71.21 -68.55 0.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.37 0.668 . . . . 0.0 111.498 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -82.44 -14.59 54.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -166.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -104.89 136.71 19.13 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 0.0 109.349 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.49 152.34 54.3 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -105.2 136.77 44.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.018 1.327 . . . . 0.0 110.708 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.4 148.49 42.48 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.282 1.433 . . . . 0.0 113.123 -175.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.5 p90 -155.76 153.61 30.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.369 1.468 . . . . 0.0 111.456 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.87 142.36 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.013 1.725 . . . . 0.0 109.655 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.74 134.69 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.251 1.82 . . . . 0.0 108.621 171.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.84 101.87 7.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.662 1.585 . . . . 0.0 110.833 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.7 p -100.33 -1.64 35.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.515 1.926 . . . . 0.0 112.946 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -57.95 -40.49 80.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.282 1.033 . . . . 0.0 111.627 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.02 -5.62 56.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.477 1.511 . . . . 0.0 113.27 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -101.68 -3.96 27.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.871 1.668 . . . . 0.0 114.734 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.57 -118.86 4.83 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.03 0.824 . . . . 0.0 111.163 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -121.49 165.06 16.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.236 1.415 . . . . 0.0 112.752 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.35 -140.05 7.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.635 1.112 . . . . 0.0 113.188 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -158.87 137.99 5.47 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 124.169 0.89 . . . . 0.0 112.501 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.19 122.52 40.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.488 1.915 . . . . 0.0 109.477 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 12.3 m -110.5 139.86 45.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 110.014 165.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -136.51 134.49 37.63 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.348 1.059 . . . . 0.0 110.174 -168.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.8 m -135.48 125.3 25.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.573 0.749 . . . . 0.0 110.667 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.8 mt -104.07 130.72 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.614 1.166 . . . . 0.0 108.224 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -127.94 147.92 50.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.555 1.542 . . . . 0.0 109.781 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 169.72 -157.81 29.65 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.349 -0.845 . . . . 0.0 114.83 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.5 -20.18 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 113.885 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -151.47 169.84 21.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.567 1.076 . . . . 0.0 112.527 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.19 149.27 50.57 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 9.3 m -132.71 146.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.427 1.091 . . . . 0.0 111.442 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -85.48 111.67 20.2 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.216 0.606 . . . . 0.0 109.821 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.06 132.84 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.392 1.077 . . . . 0.0 109.555 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -128.85 158.58 38.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.158 1.783 . . . . 0.0 110.626 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 32.8 p -139.75 153.63 47.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.132 1.373 . . . . 0.0 111.658 -174.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.41 115.6 4.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.06 1.344 . . . . 0.0 110.461 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.58 129.22 34.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.548 1.139 . . . . 0.0 110.858 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 62.7 mt -101.47 153.84 19.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.546 1.138 . . . . 0.0 112.007 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.81 -18.61 64.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.312 1.045 . . . . 0.0 113.253 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.89 -9.05 58.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.984 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.23 -1.37 62.58 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.084 1.802 . . . . 0.0 114.783 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.0 p -88.87 166.3 14.06 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.117 1.767 . . . . 0.0 111.678 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.0 t -114.85 126.3 54.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 0.0 110.777 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -87.98 134.59 33.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.506 1.122 . . . . 0.0 109.466 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.1 t -117.01 141.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.234 1.814 . . . . 0.0 108.275 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.1 p -134.58 151.24 50.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 110.926 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.95 149.86 29.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.578 0.751 . . . . 0.0 112.955 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.2 t -120.84 99.47 47.06 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.932 1.293 . . . . 0.0 110.192 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.25 135.85 12.36 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.265 2.643 . . . . 0.0 111.829 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 98.2 m -78.3 -46.46 20.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.068 0.547 . . . . 0.0 111.734 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -99.84 148.17 34.43 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.795 1.238 . . . . 0.0 111.06 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 165.26 29.31 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.435 2.757 . . . . 0.0 111.26 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 138.2 -152.59 21.96 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 113.184 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.2 t30 -107.03 121.99 45.57 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.242 1.017 . . . . 0.0 110.663 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -104.45 144.5 31.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.898 1.279 . . . . 0.0 111.104 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.1 130.37 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.716 1.607 . . . . 0.0 107.943 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.1 mt -112.34 121.83 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.638 1.175 . . . . 0.0 109.265 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -100.51 124.85 46.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.582 1.553 . . . . 0.0 109.907 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 34.4 mm -116.56 111.17 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 108.882 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 132.56 53.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.919 1.288 . . . . 0.0 111.276 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 75.3 t80 -125.24 124.14 41.05 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 109.723 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.59 44.67 27.3 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.359 1.064 . . . . 0.0 112.982 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 70.7 m-20 66.39 19.91 10.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.345 2.258 . . . . 0.0 114.634 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -125.53 130.6 52.07 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.593 1.557 . . . . 0.0 110.113 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -71.54 125.65 27.62 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 120.892 -1.13 . . . . 0.0 111.237 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.2 m -78.8 157.44 76.66 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.159 -0.963 . . . . 0.0 111.905 -168.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.87 142.27 64.0 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.83 3.02 . . . . 0.0 113.69 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.34 5.72 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.018 1.294 . . . . 0.0 113.999 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -76.29 144.61 75.0 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-N 118.282 1.041 . . . . 0.0 110.585 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.58 144.52 79.28 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 120.567 1.238 . . . . 0.0 112.273 4.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.76 117.81 35.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.391 1.077 . . . . 0.0 110.427 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.8 p -86.41 136.78 32.99 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.078 0.951 . . . . 0.0 111.395 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.2 t -133.96 113.1 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.203 1.401 . . . . 0.0 109.446 -168.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -77.93 118.29 20.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.99 0.516 . . . . 0.0 110.722 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 81.7 t -110.88 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.879 1.672 . . . . 0.0 109.036 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 9.3 t -104.3 154.36 19.9 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.464 1.106 . . . . 0.0 111.301 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -176.76 173.82 46.58 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.716 1.151 . . . . 0.0 114.484 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -117.01 -176.46 2.99 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.188 1.795 . . . . 0.0 111.027 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -78.03 13.76 13.2 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.182 1.373 . . . . 0.0 115.003 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 95.77 132.85 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 130.929 3.692 . . . . 0.0 110.948 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 22.9 m -141.58 158.67 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.796 2.039 . . . . 0.0 110.591 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 23.0 ptmt . . . . . 0 C--O 1.253 1.274 0 C-N-CA 124.734 1.214 . . . . 0.0 113.896 178.006 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.482 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.8 159.58 34.07 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.464 1.105 . . . . 0.0 112.977 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 15.6 tpt -159.21 144.65 16.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.91 1.684 . . . . 0.0 110.844 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.89 153.43 28.23 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.782 1.182 . . . . 0.0 113.059 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.6 -29.62 61.38 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.03 0.932 . . . . 0.0 112.653 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.04 164.6 11.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.443 1.897 . . . . 0.0 112.596 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 69.1 p -163.6 154.62 16.31 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.209 1.403 . . . . 0.0 111.838 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 36.7 mmt -63.16 130.75 45.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.713 0.805 . . . . 0.0 111.635 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -83.04 149.6 26.84 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.079 0.951 . . . . 0.0 109.611 171.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.8 ptm -144.69 156.93 44.34 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.175 0.99 . . . . 0.0 113.445 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 65.4 m -138.96 148.5 43.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -138.52 156.47 47.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.333 1.053 . . . . 0.0 113.705 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.9 tt -159.82 150.61 19.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.932 1.693 . . . . 0.0 110.431 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.33 148.23 52.13 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 0.0 112.724 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 53.0 t -139.11 134.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.073 1.749 . . . . 0.0 109.375 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.42 123.94 6.99 Favored Glycine 0 N--CA 1.471 0.987 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 70.9 m -97.19 123.3 40.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.272 1.029 . . . . 0.0 111.526 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -125.33 115.28 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.37 1.468 . . . . 0.0 110.013 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.04 142.72 47.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.145 0.578 . . . . 0.0 111.805 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.51 130.58 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.711 1.204 . . . . 0.0 111.586 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.6 mm -122.43 120.86 27.86 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.367 1.467 . . . . 0.0 108.461 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 145.05 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.451 2.101 . . . . 0.0 110.922 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.47 145.13 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.852 1.661 . . . . 0.0 108.51 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.2 t30 -42.46 114.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.093 1.357 . . . . 0.0 113.596 -166.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.35 135.97 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.869 0.868 . . . . 0.0 110.757 -160.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.4 t -159.84 175.7 12.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.729 1.611 . . . . 0.0 110.527 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.11 33.93 0.5 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 112.664 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -71.97 139.03 48.45 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.578 1.551 . . . . 0.0 111.412 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.19 131.06 36.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.098 0.959 . . . . 0.0 111.469 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.75 -14.98 59.43 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 50.8 m -85.7 -24.05 27.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.659 1.118 . . . . 0.0 113.383 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pp -107.26 3.98 26.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.171 1.388 . . . . 0.0 113.98 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.66 146.98 23.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.252 1.421 . . . . 0.0 111.166 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 58.1 p -140.51 152.99 46.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.435 1.494 . . . . 0.0 110.121 167.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.19 148.39 43.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.422 1.089 . . . . 0.0 112.582 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 2.5 p -147.01 132.37 18.54 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.966 2.106 . . . . 0.0 109.552 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -91.7 136.72 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.22 1.008 . . . . 0.0 109.937 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 90.1 t -109.98 113.76 56.8 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.078 1.351 . . . . 0.0 108.372 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.03 172.77 11.61 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.074 3.183 . . . . 0.0 111.232 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.48 -32.53 53.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.977 3.118 . . . . 0.0 113.875 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 16.4 m -74.14 -10.56 59.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.726 1.21 . . . . 0.0 114.238 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.28 74.87 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.523 1.535 . . . . 0.0 115.173 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -75.62 87.62 2.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.811 1.644 . . . . 0.0 111.297 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.65 135.31 57.31 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.261 1.025 . . . . 0.0 111.892 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -140.24 147.18 49.06 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.136 1.375 . . . . 0.0 111.474 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.2 152.49 45.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.934 3.089 . . . . 0.0 112.066 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.6 m -114.11 150.15 34.53 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.05 1.34 . . . . 0.0 112.052 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.86 115.5 28.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.476 1.11 . . . . 0.0 109.033 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.4 mt -78.78 131.15 36.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.106 1.362 . . . . 0.0 111.131 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 95.8 mttt -132.2 142.03 49.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.191 1.397 . . . . 0.0 112.545 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -93.17 122.04 35.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.57 1.148 . . . . 0.0 108.058 161.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.3 mt -100.8 172.71 6.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.841 1.656 . . . . 0.0 112.577 -165.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -57.55 -35.75 70.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.6 1.56 . . . . 0.0 115.038 -165.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 4.46 44.22 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.245 1.018 . . . . 0.0 113.13 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 90.67 -6.36 82.11 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.485 1.517 . . . . 0.0 113.896 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -71.95 162.71 29.06 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.603 1.561 . . . . 0.0 113.153 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 93.1 t -112.07 141.97 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.462 1.505 . . . . 0.0 109.634 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.0 -176.17 24.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.168 0.89 . . . . 0.0 115.164 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.19 165.91 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.475 1.91 . . . . 0.0 111.063 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 66.3 p -149.07 152.57 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.315 1.046 . . . . 0.0 111.278 167.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.4 p90 -169.32 -172.06 1.41 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.585 2.354 . . . . 0.0 109.522 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.8 t -133.77 118.71 14.56 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 0.0 110.085 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.76 147.82 22.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.615 3.544 . . . . 0.0 111.264 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.1 mptt -100.66 -13.25 18.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.045 0.938 . . . . 0.0 113.194 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -139.97 167.8 21.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.187 2.195 . . . . 0.0 110.104 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.0 p -85.24 167.8 15.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.685 1.194 . . . . 0.0 111.435 168.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.29 -174.04 22.69 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.523 1.535 . . . . 0.0 114.059 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.95 113.08 9.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.2 1.0 . . . . 0.0 111.467 -175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -96.97 144.18 27.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 109.169 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.8 mt -103.08 126.41 50.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.764 0.825 . . . . 0.0 110.043 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.5 t -89.71 112.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.903 1.281 . . . . 0.0 107.744 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -92.83 138.51 31.43 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.115 . . . . 0.0 109.665 169.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.3 p -151.55 135.93 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.4 -0.813 . . . . 0.0 111.363 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -137.78 145.71 42.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.451 1.1 . . . . 0.0 113.935 -162.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -114.2 127.08 55.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.737 2.415 . . . . 0.0 109.121 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.58 24.0 8.29 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.265 1.026 . . . . 0.0 113.636 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.83 4.41 65.29 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.442 1.496 . . . . 0.0 115.979 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -127.91 141.56 51.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.832 1.816 . . . . 0.0 111.706 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -61.29 138.27 58.24 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.255 -0.903 . . . . 0.0 113.182 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 19.1 m -74.09 163.02 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.388 0.675 . . . . 0.0 111.334 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.15 -24.85 65.05 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 64.4 m -86.67 -12.26 48.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 28.6 t -86.9 143.14 34.81 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 120.771 -1.205 . . . . 0.0 112.757 -172.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.99 156.85 88.04 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.495 0.855 . . . . 0.0 112.836 -3.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.02 126.99 28.09 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.781 1.632 . . . . 0.0 109.127 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.33 141.22 14.19 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.989 2.459 . . . . 0.0 111.594 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 24.7 t -134.25 122.08 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.863 1.665 . . . . 0.0 107.68 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.8 t -97.53 122.42 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.669 0.788 . . . . 0.0 110.179 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.29 117.76 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.804 1.242 . . . . 0.0 108.942 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 59.3 m -92.69 161.54 14.51 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.091 0.956 . . . . 0.0 111.479 172.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.73 -31.86 70.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.991 -1.068 . . . . 0.0 112.197 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.0 m -59.68 -14.31 13.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.323 1.449 . . . . 0.0 114.202 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -100.11 -9.8 22.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.75 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 38.0 mm -80.89 -27.77 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.747 -1.22 . . . . 0.0 112.856 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 169.1 38.7 0.03 OUTLIER Glycine 0 N--CA 1.469 0.844 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.46 96.93 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.197 0.998 . . . . 0.0 111.259 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.59 93.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.9 0.88 . . . . 0.0 112.356 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.3 m -61.44 -18.89 61.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.705 1.202 . . . . 0.0 113.87 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -89.06 -10.22 48.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.445 1.498 . . . . 0.0 114.36 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.8 t -74.66 137.56 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.18 1.355 . . . . 0.0 110.111 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.3 mmt-85 -121.14 161.19 22.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 110.675 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.4 m -147.94 160.97 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.292 1.437 . . . . 0.0 110.999 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -158.41 175.58 13.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.733 1.213 . . . . 0.0 112.285 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 94.99 161.49 34.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.263 1.411 . . . . 0.0 114.08 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -73.81 -26.77 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 113.611 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.19 -2.25 39.23 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.918 1.247 . . . . 0.0 115.364 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.93 -6.83 50.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.542 1.537 . . . . 0.0 112.674 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.36 -39.95 2.29 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.334 1.453 . . . . 0.0 113.163 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.24 155.68 32.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 0.0 113.233 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.08 -174.41 19.86 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.715 1.626 . . . . 0.0 113.382 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 60.5 m80 -138.57 147.48 43.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.467 1.107 . . . . 0.0 112.7 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.4 p -71.82 -19.79 61.93 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -116.23 -1.9 12.27 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -143.67 147.57 39.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.368 1.467 . . . . 0.0 110.492 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.35 142.43 45.32 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.865 2.377 . . . . 0.0 111.204 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 152.39 20.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.631 1.172 . . . . 0.0 110.246 168.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.58 148.07 51.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.887 0.875 . . . . 0.0 112.362 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.14 151.2 27.97 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.61 140.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.953 1.701 . . . . 0.0 109.508 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.92 136.45 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.638 1.575 . . . . 0.0 108.758 169.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.2 t0 -125.93 99.06 5.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.223 1.809 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.2 p -96.48 1.3 51.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.231 1.812 . . . . 0.0 113.085 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -58.65 -39.34 80.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.539 1.063 . . . . 0.0 112.697 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.65 -13.84 59.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.457 1.103 . . . . 0.0 113.249 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -93.52 -5.35 49.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.878 1.671 . . . . 0.0 113.618 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.14 -119.31 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.733 1.158 . . . . 0.0 112.172 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.55 161.54 16.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.377 1.871 . . . . 0.0 112.498 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 138.29 -176.8 20.53 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.065 0.84 . . . . 0.0 115.117 169.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -92.92 123.21 7.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.459 1.028 . . . . 0.0 111.985 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.33 123.0 42.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.119 1.768 . . . . 0.0 108.394 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -114.72 140.79 48.59 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.288 1.435 . . . . 0.0 110.829 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 2.9 tp -125.61 137.39 53.89 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.362 1.865 . . . . 0.0 109.656 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 68.2 m -138.59 126.66 22.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.254 0.622 . . . . 0.0 110.277 167.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 30.0 mt -111.3 135.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.541 1.136 . . . . 0.0 108.466 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -145.4 154.87 42.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.284 1.034 . . . . 0.0 112.246 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.48 -155.67 26.49 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.879 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.92 -10.21 27.19 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.124 3.216 . . . . 0.0 114.286 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.2 t -152.94 164.3 38.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.662 1.185 . . . . 0.0 111.1 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -69.98 144.23 52.38 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.135 -0.978 . . . . 0.0 111.171 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 17.8 m -125.02 151.93 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 0.0 110.962 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -97.26 131.25 44.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.776 0.83 . . . . 0.0 110.064 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.1 135.37 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.132 1.373 . . . . 0.0 109.737 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.57 164.89 24.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 111.069 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.0 p -136.36 160.22 39.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.482 1.513 . . . . 0.0 112.227 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -154.33 122.53 6.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.362 1.465 . . . . 0.0 110.041 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.25 128.56 33.68 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.419 1.088 . . . . 0.0 110.58 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -101.16 152.43 20.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 111.84 -173.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -66.42 -20.33 66.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.283 1.033 . . . . 0.0 113.423 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.2 t0 -80.25 -3.93 51.18 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.112 1.365 . . . . 0.0 113.256 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.37 0.65 67.27 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.606 1.574 . . . . 0.0 114.571 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 18.5 p -88.76 167.7 13.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.604 1.962 . . . . 0.0 111.558 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 45.6 t -121.42 124.88 45.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.096 0.958 . . . . 0.0 111.207 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -84.18 135.49 34.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.775 1.23 . . . . 0.0 109.642 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.71 141.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.901 1.681 . . . . 0.0 108.587 164.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 3.2 p -130.54 148.74 52.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 110.761 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -157.45 148.65 21.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.428 1.091 . . . . 0.0 111.818 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.9 t -118.33 102.65 50.2 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.862 0.865 . . . . 0.0 111.145 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.58 145.88 23.7 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.245 2.63 . . . . 0.0 110.221 173.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 96.6 m -104.87 -38.62 6.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.984 0.914 . . . . 0.0 112.74 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -103.08 147.53 34.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.929 1.292 . . . . 0.0 110.627 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.89 168.31 23.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.498 2.799 . . . . 0.0 111.902 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 131.98 -145.63 17.35 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 125.126 1.346 . . . . 0.0 112.129 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -123.85 129.72 51.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.565 0.746 . . . . 0.0 111.664 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -108.39 143.65 37.03 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.552 1.541 . . . . 0.0 110.373 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 135.99 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.959 1.304 . . . . 0.0 109.0 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 25.7 mt -117.76 122.97 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.095 1.358 . . . . 0.0 109.385 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -102.06 127.62 48.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.965 1.706 . . . . 0.0 110.269 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 18.9 mm -120.02 112.22 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.877 1.271 . . . . 0.0 109.345 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -122.83 134.42 54.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.316 1.446 . . . . 0.0 111.215 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.9 t80 -127.22 123.93 37.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.486 1.514 . . . . 0.0 110.249 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.02 31.09 12.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.423 1.489 . . . . 0.0 114.069 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.59 12.51 0.68 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.337 2.655 . . . . 0.0 114.679 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -116.76 133.88 55.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.673 1.189 . . . . 0.0 110.71 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -72.06 126.74 30.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 110.946 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.7 m -79.44 153.84 76.44 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.318 -0.864 . . . . 0.0 110.954 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.94 146.86 91.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.816 2.344 . . . . 0.0 112.113 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.49 -29.25 6.3 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.263 1.411 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 3.7 t -78.47 145.48 67.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.076 0.95 . . . . 0.0 110.682 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.54 140.5 67.64 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.507 1.217 . . . . 0.0 111.875 2.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.71 116.0 28.24 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.987 0.915 . . . . 0.0 109.936 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 10.3 p -87.53 124.22 33.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.662 1.185 . . . . 0.0 110.651 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.1 t -121.21 114.98 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 109.733 -167.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -76.99 119.64 21.01 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.368 0.667 . . . . 0.0 111.168 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.7 t -109.24 125.84 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.076 1.35 . . . . 0.0 109.342 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.9 t -125.16 168.83 12.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.032 1.333 . . . . 0.0 112.279 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 118.28 148.36 8.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.293 1.901 . . . . 0.0 112.701 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -164.87 155.17 13.95 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.419 1.888 . . . . 0.0 109.729 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 92.06 40.6 5.15 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.165 0.888 . . . . 0.0 113.131 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -58.6 118.44 5.64 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.49 1.516 . . . . 0.0 111.97 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 8.7 p -167.42 150.66 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 126.479 1.911 . . . . 0.0 110.532 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 C--O 1.253 1.277 0 C-N-CA 124.788 1.235 . . . . 0.0 112.225 177.008 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -80.19 -17.05 53.45 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 42.6 tpp -67.7 147.04 53.18 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.746 1.218 . . . . 0.0 112.166 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.73 52.51 4.18 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.711 1.625 . . . . 0.0 113.051 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 22.4 t0 -151.55 138.7 19.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.973 1.709 . . . . 0.0 111.232 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 36.5 t70 -94.19 -20.67 19.64 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.382 1.473 . . . . 0.0 112.653 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 23.3 m -84.84 24.03 1.11 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.546 1.539 . . . . 0.0 113.914 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 98.8 mmm -51.92 -39.5 59.23 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.949 1.699 . . . . 0.0 114.156 -172.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -130.74 133.51 46.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.194 1.398 . . . . 0.0 109.487 165.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.0 ptm -161.77 151.25 16.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.495 1.518 . . . . 0.0 111.969 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.2 m -130.54 147.53 52.24 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.445 1.898 . . . . 0.0 108.509 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -149.81 160.58 43.45 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -170.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.04 134.2 15.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.004 2.122 . . . . 0.0 108.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -128.04 139.59 52.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.202 1.001 . . . . 0.0 110.896 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.4 p -156.84 139.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.952 0.901 . . . . 0.0 111.764 -175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -73.62 152.91 46.82 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.079 0.847 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 52.1 m -139.83 133.06 29.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.449 1.1 . . . . 0.0 111.174 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -164.54 150.77 10.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.767 0.827 . . . . 0.0 112.864 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -76.99 151.24 35.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 111.197 168.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 141.85 28.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.852 1.261 . . . . 0.0 112.358 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.3 mt -125.45 111.5 25.84 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.034 1.334 . . . . 0.0 108.38 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.82 139.79 17.9 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.988 2.459 . . . . 0.0 110.376 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 66.7 mt -139.34 136.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.306 1.042 . . . . 0.0 110.451 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 52.47 82.18 0.07 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.007 2.123 . . . . 0.0 112.56 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.7 mm -83.14 43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.705 1.202 . . . . 0.0 110.495 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 60.4 m -132.24 -57.42 0.96 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.277 1.431 . . . . 0.0 111.963 -173.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -162.9 107.29 1.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.873 0.869 . . . . 0.0 111.628 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.7 p -141.78 160.83 39.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.585 1.954 . . . . 0.0 110.139 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -151.56 126.77 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.608 1.163 . . . . 0.0 110.81 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.86 -15.25 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 56.5 m -80.65 -9.88 59.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.693 1.133 . . . . 0.0 113.415 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.93 7.42 2.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.53 145.9 24.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.613 1.165 . . . . 0.0 111.84 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 22.8 p -141.94 152.01 43.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.939 2.096 . . . . 0.0 108.829 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.63 149.2 27.33 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 73.1 p -141.68 162.45 35.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.126 2.17 . . . . 0.0 110.056 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -118.07 137.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.275 1.43 . . . . 0.0 109.976 169.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.2 t -105.77 114.12 63.2 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.172 1.389 . . . . 0.0 108.396 167.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.67 173.55 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.166 3.244 . . . . 0.0 111.272 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.22 -33.4 54.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.063 3.175 . . . . 0.0 114.097 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.6 m -75.78 -8.24 56.37 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.29 -1.62 75.12 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.459 1.505 . . . . 0.0 115.196 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -76.9 88.82 3.48 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.445 1.498 . . . . 0.0 111.299 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.47 129.6 41.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.278 1.031 . . . . 0.0 111.796 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -130.63 149.28 73.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.084 1.754 . . . . 0.0 110.6 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.39 153.76 35.59 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.795 2.996 . . . . 0.0 112.547 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 79.8 m -99.16 155.94 17.21 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 112.24 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.7 tt -93.91 113.03 24.96 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.305 1.442 . . . . 0.0 108.101 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mt -83.05 136.37 34.51 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.886 1.275 . . . . 0.0 111.246 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -137.95 143.8 40.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.74 1.216 . . . . 0.0 113.533 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -94.17 122.31 36.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 155.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.49 167.6 11.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.379 1.472 . . . . 0.0 112.303 -166.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.04 -29.9 67.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.34 1.25 53.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.21 1.004 . . . . 0.0 113.341 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.64 67.54 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.804 1.669 . . . . 0.0 114.772 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -77.12 168.97 19.18 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.383 1.473 . . . . 0.0 113.443 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 77.8 t -112.05 140.3 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.452 1.501 . . . . 0.0 110.486 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.12 -171.81 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.355 0.978 . . . . 0.0 115.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.1 162.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.502 1.521 . . . . 0.0 112.458 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 37.0 m -132.33 159.83 38.05 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.946 1.699 . . . . 0.0 110.438 161.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.29 -177.05 5.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.425 1.89 . . . . 0.0 109.998 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.8 t -130.27 121.05 19.33 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.795 0.838 . . . . 0.0 109.738 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.71 139.01 15.51 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.95 3.1 . . . . 0.0 110.799 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 55.6 tptt -88.95 -20.03 25.01 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -135.55 176.01 9.06 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.494 1.918 . . . . 0.0 110.897 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 76.1 p -92.1 164.3 13.64 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.534 1.133 . . . . 0.0 111.053 167.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 100.24 -168.41 20.99 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.156 1.36 . . . . 0.0 113.928 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.58 112.84 11.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 0.0 111.941 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 19.3 m80 -100.66 141.25 33.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.851 1.66 . . . . 0.0 109.129 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.39 125.82 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 109.648 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.7 t -86.85 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 108.099 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -101.64 134.39 44.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.796 1.239 . . . . 0.0 109.915 170.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.2 p -139.75 128.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.278 1.037 . . . . 0.0 112.202 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -115.84 141.71 47.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.599 2.359 . . . . 0.0 111.01 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -137.11 118.71 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.574 2.35 . . . . 0.0 109.357 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.4 t30 56.34 29.02 14.33 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.761 1.224 . . . . 0.0 113.685 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 95.42 3.91 61.14 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.135 1.35 . . . . 0.0 116.169 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -137.62 153.77 49.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.567 1.684 . . . . 0.0 111.482 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -65.27 142.28 58.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.65 -1.281 . . . . 0.0 113.156 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 61.5 t -67.24 147.87 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.624 1.17 . . . . 0.0 109.457 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.05 64.28 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 11.5 m -76.18 -14.18 60.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.581 1.552 . . . . 0.0 114.002 175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 10.1 t -85.67 141.57 36.32 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.674 1.19 . . . . 0.0 112.861 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.15 154.2 86.09 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.506 0.859 . . . . 0.0 112.56 -4.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.6 118.88 56.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.58 1.552 . . . . 0.0 108.582 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.16 140.71 12.52 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.071 2.514 . . . . 0.0 111.038 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 16.0 t -137.62 125.34 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.818 1.647 . . . . 0.0 108.118 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.4 t -97.78 122.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.683 0.793 . . . . 0.0 110.192 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.92 131.06 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.17 1.388 . . . . 0.0 110.023 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.9 t -95.24 171.82 8.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.81 1.244 . . . . 0.0 112.331 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -23.36 62.96 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.525 -1.359 . . . . 0.0 112.938 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 4.2 m -74.6 -12.72 60.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -117.71 6.59 12.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.47 1.508 . . . . 0.0 113.744 -173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.45 -39.5 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.024 0.93 . . . . 0.0 112.658 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.0 42.01 0.03 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 123.833 0.73 . . . . 0.0 114.211 -169.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.23 104.97 6.02 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 117.861 0.831 . . . . 0.0 111.981 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.64 93.49 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.523 -0.736 . . . . 0.0 112.797 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 19.4 m -60.09 -27.5 67.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.208 1.003 . . . . 0.0 113.256 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -80.73 -10.4 59.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.398 1.479 . . . . 0.0 114.246 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 93.4 t -81.91 136.09 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.036 1.289 . . . . 0.0 109.455 172.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -131.74 156.8 45.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.24 1.416 . . . . 0.0 110.737 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.6 m -144.7 158.77 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.818 1.247 . . . . 0.0 111.666 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 95.1 p -158.34 172.57 18.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.819 1.247 . . . . 0.0 112.863 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.94 153.09 28.08 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.893 1.235 . . . . 0.0 113.169 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -77.29 -16.46 58.96 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -168.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.06 29.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.704 1.145 . . . . 0.0 114.748 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -87.96 -3.96 58.86 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.683 1.593 . . . . 0.0 112.785 168.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -134.24 -39.57 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.832 1.253 . . . . 0.0 113.936 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.26 148.81 40.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.191 1.396 . . . . 0.0 111.362 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.95 175.86 26.12 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.728 1.156 . . . . 0.0 113.838 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 61.7 m80 -132.13 154.6 49.33 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.284 1.434 . . . . 0.0 111.811 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 9.9 p -67.11 -65.86 0.63 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.394 1.078 . . . . 0.0 112.796 -175.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.77 7.49 44.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.26 1.024 . . . . 0.0 113.507 -166.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.58 143.17 43.89 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.751 2.02 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.48 152.2 48.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.691 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -101.03 162.48 12.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.617 1.567 . . . . 0.0 110.924 168.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.69 149.95 34.46 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 50.2 p90 -159.85 153.73 23.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.695 1.598 . . . . 0.0 111.18 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 142.17 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 109.523 -172.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 39.7 mt -120.24 136.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.519 1.927 . . . . 0.0 109.391 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.0 125.53 41.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.577 1.551 . . . . 0.0 111.892 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 40.3 p -122.35 -13.43 8.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.31 -25.41 68.03 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.632 1.56 . . . . 0.0 114.732 -170.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.15 -16.52 60.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.218 1.007 . . . . 0.0 112.892 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.64 49.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.534 1.534 . . . . 0.0 113.669 172.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 80.52 -119.33 4.88 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.597 1.094 . . . . 0.0 112.063 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -92.49 169.58 10.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.521 1.528 . . . . 0.0 112.822 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.51 -138.49 7.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.009 1.29 . . . . 0.0 112.739 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -178.2 136.15 2.89 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 124.352 0.977 . . . . 0.0 112.017 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.88 122.92 40.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.736 1.614 . . . . 0.0 109.651 -175.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 46.1 m -112.21 132.91 54.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 109.476 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -130.03 135.83 48.71 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.33 1.452 . . . . 0.0 109.633 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 71.0 m -130.6 140.24 50.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.585 0.754 . . . . 0.0 111.01 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.4 mt -118.17 127.11 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.105 1.362 . . . . 0.0 107.764 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.36 140.42 46.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.207 1.403 . . . . 0.0 109.535 -168.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 171.38 -155.82 25.03 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.809 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 -22.69 27.53 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.379 2.719 . . . . 0.0 113.682 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 63.8 m -145.48 160.04 42.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.568 1.147 . . . . 0.0 112.367 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -67.31 146.3 54.25 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.182 0.993 . . . . 0.0 111.228 169.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -130.17 149.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.718 1.607 . . . . 0.0 110.769 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.46 105.46 17.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.768 0.827 . . . . 0.0 110.122 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 41.0 mt -85.51 130.49 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -126.29 157.36 38.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 110.418 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.9 p -144.5 153.45 41.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.795 1.238 . . . . 0.0 112.279 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -158.1 134.99 9.85 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.118 1.367 . . . . 0.0 110.591 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -80.98 131.97 35.35 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.712 0.805 . . . . 0.0 111.905 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.92 168.81 13.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.452 1.501 . . . . 0.0 111.332 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -32.11 69.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.91 -7.52 54.75 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.307 1.443 . . . . 0.0 113.518 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 88.02 6.76 75.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.484 1.516 . . . . 0.0 114.114 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 22.2 p -80.42 154.17 27.82 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.747 1.619 . . . . 0.0 110.617 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -100.35 119.14 37.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.456 0.702 . . . . 0.0 110.597 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -86.54 133.19 33.75 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.698 0.799 . . . . 0.0 109.519 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 19.2 t -113.4 138.05 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.67 1.988 . . . . 0.0 108.645 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 23.9 p -135.85 151.93 50.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.426 1.49 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -163.16 153.16 15.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 111.811 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.4 t -119.31 100.59 49.88 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.405 1.082 . . . . 0.0 110.91 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.75 85.56 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.687 2.925 . . . . 0.0 110.937 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 18.7 m -54.42 -39.41 67.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 0.0 113.936 -170.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -95.32 140.09 22.26 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.259 1.024 . . . . 0.0 111.014 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 165.38 31.98 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.694 2.93 . . . . 0.0 112.358 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 139.54 -160.08 25.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.0 1.286 . . . . 0.0 113.115 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -107.27 119.55 39.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.186 0.994 . . . . 0.0 110.513 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.89 141.31 36.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.463 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.56 131.47 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.237 1.415 . . . . 0.0 108.063 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.7 mt -110.21 119.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.423 1.089 . . . . 0.0 108.901 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -102.14 124.43 47.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 110.697 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.73 115.53 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.394 1.477 . . . . 0.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.7 134.87 48.61 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 0.0 111.604 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -126.99 124.47 39.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.864 1.666 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.78 34.78 19.87 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.022 1.329 . . . . 0.0 113.683 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.4 t70 89.71 -0.65 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.269 3.027 . . . . 0.0 113.929 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -119.39 132.82 55.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.688 1.195 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -69.15 128.42 36.57 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.278 1.431 . . . . 0.0 111.93 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -85.67 160.65 52.83 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 119.133 0.879 . . . . 0.0 112.155 -169.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.92 149.27 43.05 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.071 3.18 . . . . 0.0 114.471 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 80.65 -30.0 2.58 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.222 1.392 . . . . 0.0 113.827 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -72.83 142.58 83.4 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 110.547 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.03 139.59 62.54 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 120.631 1.261 . . . . 0.0 111.896 6.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.14 111.92 24.19 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.066 0.946 . . . . 0.0 110.21 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 67.3 m -85.57 127.41 34.44 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.982 0.913 . . . . 0.0 110.888 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -124.43 112.1 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.66 1.584 . . . . 0.0 109.35 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.56 118.17 21.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.859 0.463 . . . . 0.0 110.722 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.0 t -104.11 124.76 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.874 1.67 . . . . 0.0 109.193 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.1 t -124.87 162.88 23.42 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 112.367 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 122.98 159.22 10.46 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.297 1.903 . . . . 0.0 113.096 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -163.46 144.27 9.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.797 1.639 . . . . 0.0 110.223 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 87.57 84.91 1.17 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.885 1.231 . . . . 0.0 111.346 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -61.66 128.6 37.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.736 1.214 . . . . 0.0 112.218 -173.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 25.7 t 76.97 117.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 128.857 2.863 . . . . 0.0 109.911 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.161 1.385 . . . . 0.0 111.984 179.443 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.72 153.67 41.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.316 1.047 . . . . 0.0 112.694 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 67.4 mtt -86.39 98.62 11.1 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.533 1.133 . . . . 0.0 110.871 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -67.66 -35.48 86.01 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.54 0.591 . . . . 0.0 113.275 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -71.66 -25.97 62.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.64 1.176 . . . . 0.0 112.995 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.27 -35.35 31.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.336 1.054 . . . . 0.0 111.421 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 16.9 t -64.32 -39.71 94.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.302 1.041 . . . . 0.0 112.655 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 22.2 ptp -162.64 152.18 15.68 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.655 1.182 . . . . 0.0 113.659 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.08 115.58 30.86 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 162.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 28.3 ttt -118.54 129.35 55.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.669 1.188 . . . . 0.0 111.094 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 4.3 m -123.26 141.77 51.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.947 1.699 . . . . 0.0 108.589 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -156.8 162.02 39.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.4 tt -154.69 145.49 22.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.852 2.061 . . . . 0.0 110.261 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -135.29 143.71 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.609 1.164 . . . . 0.0 112.184 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 42.6 t -132.88 134.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 110.143 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.01 63.71 4.35 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 125.349 1.452 . . . . 0.0 112.057 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 10.1 m -58.51 124.77 20.74 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 114.154 -171.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -156.8 150.02 24.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.114 1.366 . . . . 0.0 111.69 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.71 153.44 21.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.131 0.972 . . . . 0.0 111.382 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -90.73 139.66 30.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.668 1.187 . . . . 0.0 112.116 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 36.1 mm -125.27 123.85 25.21 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 108.935 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.44 149.73 45.11 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.771 2.314 . . . . 0.0 111.526 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.91 148.37 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.089 1.756 . . . . 0.0 108.805 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 53.3 t30 -44.05 116.47 1.0 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.363 1.465 . . . . 0.0 113.772 -170.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 5.1 mp -87.38 130.42 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.008 1.323 . . . . 0.0 109.749 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.7 t -164.16 -175.59 4.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.209 1.403 . . . . 0.0 111.134 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.78 1.0 21.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.631 1.572 . . . . 0.0 113.658 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.1 m -57.33 133.5 55.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.568 1.947 . . . . 0.0 111.338 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.44 122.3 19.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.193 0.997 . . . . 0.0 111.402 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.22 -20.48 60.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.033 0.933 . . . . 0.0 113.076 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 67.5 m -72.97 -18.24 61.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -109.38 5.83 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.665 1.586 . . . . 0.0 113.494 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.3 146.31 29.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.592 1.557 . . . . 0.0 111.455 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 49.9 p -134.59 168.42 19.02 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.222 1.809 . . . . 0.0 109.854 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -145.33 141.76 28.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.821 0.849 . . . . 0.0 112.243 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 64.2 p -135.2 163.35 30.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.693 1.997 . . . . 0.0 109.428 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -115.78 136.55 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.802 1.241 . . . . 0.0 109.55 167.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.0 t -107.03 113.21 62.73 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.59 1.556 . . . . 0.0 108.17 167.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -80.24 173.47 12.49 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.289 3.326 . . . . 0.0 111.272 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.18 -28.01 49.6 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.196 3.264 . . . . 0.0 114.83 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.0 p -79.03 -9.18 59.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.789 1.235 . . . . 0.0 114.143 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.3 0.25 88.71 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.46 1.505 . . . . 0.0 114.695 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.61 84.43 3.28 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.518 1.527 . . . . 0.0 111.491 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.87 133.4 55.4 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.643 1.177 . . . . 0.0 112.009 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.81 149.65 59.98 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.412 1.485 . . . . 0.0 110.986 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.11 154.52 42.05 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.93 3.087 . . . . 0.0 112.669 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 84.9 m -108.24 153.45 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.094 1.358 . . . . 0.0 112.686 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 63.4 tp -88.11 112.57 22.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.455 1.102 . . . . 0.0 109.938 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.75 134.41 33.58 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.967 1.307 . . . . 0.0 111.165 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -142.9 148.86 37.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.008 1.323 . . . . 0.0 112.911 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -80.49 122.38 26.93 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.023 1.329 . . . . 0.0 108.364 160.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.41 177.36 6.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.316 1.446 . . . . 0.0 112.704 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -53.84 -43.03 69.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.504 1.522 . . . . 0.0 114.218 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.17 4.42 53.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.718 1.207 . . . . 0.0 113.688 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.74 -7.02 74.11 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.883 1.23 . . . . 0.0 114.403 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.05 174.24 8.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.894 1.278 . . . . 0.0 112.602 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -127.9 142.47 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.38 1.472 . . . . 0.0 109.548 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.17 34.35 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.72 163.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.12 1.768 . . . . 0.0 112.731 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 4.4 m -137.89 155.4 48.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 110.336 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 16.8 p90 -164.16 -176.07 4.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.185 2.594 . . . . 0.0 108.909 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.2 t -131.35 123.3 19.5 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 119.105 0.866 . . . . 0.0 109.246 169.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.5 148.2 26.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.038 3.158 . . . . 0.0 111.441 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -107.79 -8.34 16.06 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.21 172.74 12.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.027 2.131 . . . . 0.0 109.78 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 168.0 15.17 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.639 1.176 . . . . 0.0 111.529 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.61 -170.39 26.73 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.122 1.344 . . . . 0.0 114.013 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.69 115.09 10.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.221 1.008 . . . . 0.0 111.687 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.0 m80 -98.27 144.05 28.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.757 1.623 . . . . 0.0 109.134 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.59 126.99 54.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.237 1.015 . . . . 0.0 109.544 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.5 t -85.55 118.87 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.41 96.6 7.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.535 1.534 . . . . 0.0 110.089 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 89.0 t -86.08 137.71 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.855 1.662 . . . . 0.0 108.975 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.3 mttm -133.64 131.75 39.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.145 0.978 . . . . 0.0 112.99 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 80.6 tttt -96.25 119.49 34.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.063 1.345 . . . . 0.0 109.281 161.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.46 22.87 5.36 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.845 1.258 . . . . 0.0 114.074 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.14 3.7 88.77 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.401 1.477 . . . . 0.0 115.582 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -106.28 23.28 14.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.397 1.479 . . . . 0.0 113.305 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.7 m-70 65.26 -170.77 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.936 1.694 . . . . 0.0 112.527 -172.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 34.1 m -136.29 171.84 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.943 1.297 . . . . 0.0 110.795 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.7 -29.7 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.5 m -89.46 -10.47 46.27 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.8 p -89.98 153.99 47.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 120.709 -1.244 . . . . 0.0 113.715 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.8 157.16 95.2 Favored 'Cis proline' 0 C--N 1.353 0.78 0 CA-C-N 118.856 0.627 . . . . 0.0 112.41 -4.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.01 122.81 39.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.703 1.201 . . . . 0.0 108.774 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.64 146.36 11.96 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.043 2.495 . . . . 0.0 112.576 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 19.4 t -137.52 125.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.985 1.714 . . . . 0.0 107.921 170.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.2 t -102.09 124.69 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.701 0.8 . . . . 0.0 110.635 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.36 139.53 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.439 1.496 . . . . 0.0 110.232 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 15.2 t -116.7 164.71 14.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.817 1.247 . . . . 0.0 111.449 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.04 -37.65 77.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.401 1.08 . . . . 0.0 112.738 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 48.8 m -60.71 -18.41 54.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.63 -6.63 32.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.166 1.386 . . . . 0.0 113.142 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.61 -32.88 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.086 -1.009 . . . . 0.0 112.701 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 140.42 29.61 0.19 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.754 1.169 . . . . 0.0 113.641 -168.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 28.2 t0 -73.34 114.57 11.69 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.421 1.11 . . . . 0.0 110.685 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.72 74.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.811 0.844 . . . . 0.0 113.015 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 60.4 p -66.85 -21.03 66.03 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.986 -1.071 . . . . 0.0 113.196 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -77.9 -14.85 59.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.775 1.23 . . . . 0.0 113.399 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 48.3 t -79.7 132.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.618 1.099 . . . . 0.0 110.08 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -113.87 154.49 27.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.764 1.625 . . . . 0.0 110.57 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.81 149.75 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.209 1.404 . . . . 0.0 111.008 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 74.6 m -150.78 160.41 43.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.925 1.29 . . . . 0.0 112.325 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 113.76 162.92 14.89 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.418 1.009 . . . . 0.0 115.021 171.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -65.23 -34.42 78.31 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.675 1.59 . . . . 0.0 113.249 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.82 -1.65 33.04 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.934 1.254 . . . . 0.0 115.053 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.1 mt -90.2 -7.27 53.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.401 1.481 . . . . 0.0 112.689 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -128.33 -36.32 1.92 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.834 1.253 . . . . 0.0 113.794 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -158.78 158.09 32.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.683 1.193 . . . . 0.0 112.396 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -154.81 -174.91 25.31 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.441 1.019 . . . . 0.0 114.166 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -141.71 137.97 32.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.324 1.45 . . . . 0.0 111.18 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.2 p -63.48 146.65 53.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.265 0.626 . . . . 0.0 111.307 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 4.4 m-85 73.93 -4.73 2.19 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.069 2.148 . . . . 0.0 113.896 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -120.97 148.4 48.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.795 2.038 . . . . 0.0 110.191 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.47 125.06 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 110.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -86.57 145.51 26.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.273 1.029 . . . . 0.0 109.54 165.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.48 151.45 50.95 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -158.51 152.13 23.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.163 1.785 . . . . 0.0 110.548 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.19 140.46 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.538 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.2 mt -114.57 136.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.281 1.832 . . . . 0.0 109.094 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 57.5 t0 -123.08 100.92 7.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.045 1.738 . . . . 0.0 110.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.9 p -99.2 4.25 46.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.581 1.952 . . . . 0.0 112.831 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.85 -33.15 71.4 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.489 1.041 . . . . 0.0 112.835 -173.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.24 -10.03 55.38 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.376 1.47 . . . . 0.0 113.383 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.84 -9.76 19.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.17 1.788 . . . . 0.0 114.08 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 69.38 -134.89 26.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.954 1.264 . . . . 0.0 114.008 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -74.04 167.36 21.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.079 1.352 . . . . 0.0 112.635 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.97 -116.99 0.97 Allowed Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.558 1.075 . . . . 0.0 112.022 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . 176.2 116.32 0.45 Allowed Glycine 0 N--CA 1.465 0.612 0 C-N-CA 123.87 0.748 . . . . 0.0 112.812 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.03 124.97 29.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.496 1.118 . . . . 0.0 109.517 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 69.0 m -124.52 144.59 50.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.773 1.629 . . . . 0.0 109.616 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -144.35 132.46 21.66 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.344 0.658 . . . . 0.0 110.223 -164.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 49.6 m -132.53 139.03 47.71 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.604 0.762 . . . . 0.0 111.098 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.9 mt -123.93 138.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.723 1.609 . . . . 0.0 108.622 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.94 157.56 44.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 161.85 -146.31 11.93 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.873 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.62 -11.27 24.15 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.582 2.855 . . . . 0.0 113.989 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.8 t -155.97 161.08 40.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.594 1.088 . . . . 0.0 112.411 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 130.39 35.09 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.299 1.44 . . . . 0.0 109.727 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.7 m -114.23 157.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.158 1.383 . . . . 0.0 111.856 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -92.5 126.13 37.45 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.501 0.72 . . . . 0.0 109.813 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.7 mt -106.67 134.64 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 109.427 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -131.87 162.59 30.23 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.014 1.726 . . . . 0.0 111.056 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 23.0 p -137.99 159.95 40.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.391 1.476 . . . . 0.0 112.079 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.83 122.76 6.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.236 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 128.6 34.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.726 1.21 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 69.5 mt -104.41 151.3 23.68 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.507 1.123 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.35 -17.55 64.27 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.734 0.813 . . . . 0.0 113.057 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -70.69 -10.8 60.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.439 1.496 . . . . 0.0 113.453 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.71 -3.2 70.9 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.153 1.835 . . . . 0.0 114.187 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 42.6 p -87.85 168.97 12.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.252 1.821 . . . . 0.0 111.319 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -123.81 127.15 47.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.992 0.917 . . . . 0.0 111.408 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -79.51 135.08 36.54 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.229 165.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 48.0 t -113.14 139.78 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.173 1.789 . . . . 0.0 108.381 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.2 p -133.83 150.47 51.41 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 111.565 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.0 p90 -155.19 146.94 23.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.524 1.13 . . . . 0.0 112.019 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 38.3 t -113.73 106.93 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.275 1.03 . . . . 0.0 111.179 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.67 145.77 16.42 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.571 2.847 . . . . 0.0 111.059 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 91.5 m -104.01 -47.13 4.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -86.61 143.23 35.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.12 162.13 28.98 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.346 2.697 . . . . 0.0 111.3 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.54 -164.69 24.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.24 1.4 . . . . 0.0 113.566 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -90.59 118.99 30.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.499 0.719 . . . . 0.0 111.059 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -100.21 141.1 33.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.719 1.208 . . . . 0.0 110.107 167.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.56 131.05 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.503 1.121 . . . . 0.0 108.359 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.5 mt -113.61 130.58 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.292 1.437 . . . . 0.0 109.372 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -114.19 123.95 50.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.595 1.558 . . . . 0.0 110.115 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.91 119.78 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.065 0.946 . . . . 0.0 109.693 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -122.99 136.48 54.87 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.866 2.066 . . . . 0.0 109.787 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.04 122.13 22.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.661 1.185 . . . . 0.0 110.239 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.67 45.11 27.33 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.901 1.28 . . . . 0.0 111.987 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.6 t0 73.03 -4.47 2.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.848 2.859 . . . . 0.0 114.744 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -101.33 132.52 46.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.571 1.148 . . . . 0.0 110.748 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -69.65 125.61 27.24 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.229 1.012 . . . . 0.0 111.292 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -79.32 153.5 76.67 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.218 -0.926 . . . . 0.0 111.025 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.02 140.97 81.82 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.666 2.244 . . . . 0.0 111.647 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.66 22.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.376 1.465 . . . . 0.0 113.745 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 66.6 m -76.73 153.55 83.28 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 118.594 1.197 . . . . 0.0 111.993 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.56 142.83 73.38 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.311 0.789 . . . . 0.0 111.352 -7.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -96.18 116.52 29.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.415 1.086 . . . . 0.0 110.205 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 58.0 m -83.1 128.67 34.69 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.737 0.815 . . . . 0.0 110.449 169.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -127.07 110.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.541 1.537 . . . . 0.0 109.207 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -78.58 107.73 11.46 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.035 0.534 . . . . 0.0 110.763 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.0 t -94.47 118.06 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.787 1.235 . . . . 0.0 108.806 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -90.3 150.71 21.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.874 0.87 . . . . 0.0 110.847 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -177.2 160.23 27.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.26 0.933 . . . . 0.0 114.552 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -113.31 -2.68 13.96 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 0.0 113.605 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 80.89 4.8 90.4 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.461 1.029 . . . . 0.0 114.803 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 58.1 ttp85 84.45 138.49 0.06 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 129.439 3.095 . . . . 0.0 111.612 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 57.7 t -133.3 133.99 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.995 1.718 . . . . 0.0 109.046 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.146 1.378 . . . . 0.0 112.173 179.531 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -81.05 -19.09 44.54 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -75.28 144.19 42.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.416 1.087 . . . . 0.0 112.41 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -88.6 148.2 20.36 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.812 1.196 . . . . 0.0 111.924 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.35 -18.87 64.59 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.82 -10.46 53.44 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.815 1.646 . . . . 0.0 113.73 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 44.3 m -81.0 -15.22 56.8 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 5.2 ppp? -71.59 159.49 34.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.259 1.023 . . . . 0.0 112.11 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -128.23 149.17 50.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.641 1.176 . . . . 0.0 110.798 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 20.3 ptm -158.76 163.04 37.11 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.618 1.567 . . . . 0.0 112.417 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 19.3 m -136.99 143.9 43.03 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.419 1.888 . . . . 0.0 109.097 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -143.58 165.15 28.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -164.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.65 155.65 32.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.868 2.067 . . . . 0.0 110.5 -175.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 61.1 mttm -136.94 143.83 43.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.444 1.498 . . . . 0.0 111.478 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 57.8 t -141.04 135.66 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.832 1.653 . . . . 0.0 109.534 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.29 133.32 11.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.898 0.761 . . . . 0.0 112.045 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 62.5 m -120.3 146.58 45.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.89 1.276 . . . . 0.0 112.602 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -157.03 150.65 24.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.493 1.117 . . . . 0.0 112.589 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.58 148.86 25.3 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.401 1.081 . . . . 0.0 111.229 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -86.56 126.98 34.85 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.806 1.243 . . . . 0.0 111.203 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.6 mm -113.22 113.29 48.98 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 124.926 1.29 . . . . 0.0 109.01 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.11 138.57 20.58 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.989 2.459 . . . . 0.0 110.948 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 55.2 mt -143.35 136.5 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.82 1.248 . . . . 0.0 109.713 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 11.5 t30 59.22 69.82 0.69 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.305 1.842 . . . . 0.0 113.058 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.68 104.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.73 0.812 . . . . 0.0 109.657 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.6 t -173.69 -168.56 0.44 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.971 2.108 . . . . 0.0 109.928 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.16 51.93 1.05 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.1 1.76 . . . . 0.0 111.893 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 91.9 m -83.72 124.04 30.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.545 1.538 . . . . 0.0 109.773 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -90.46 126.53 35.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.702 1.201 . . . . 0.0 110.258 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -31.06 55.91 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.941 1.296 . . . . 0.0 112.132 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 57.3 m -73.02 -22.92 60.57 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -160.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.9 pt? -111.72 2.47 17.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.402 1.481 . . . . 0.0 114.079 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.79 152.25 20.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.066 1.347 . . . . 0.0 112.084 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.0 p -140.77 172.42 12.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.62 2.368 . . . . 0.0 108.641 165.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -156.56 160.29 39.33 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 78.3 p -133.07 161.5 34.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.461 1.905 . . . . 0.0 109.824 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -111.75 135.13 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.953 1.301 . . . . 0.0 109.243 166.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.8 t -103.52 110.66 64.23 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.74 1.216 . . . . 0.0 107.89 163.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.09 169.43 17.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.766 2.977 . . . . 0.0 110.897 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.51 -19.75 65.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.902 2.401 . . . . 0.0 112.025 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 1.9 m -68.66 -10.57 57.02 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.642 1.577 . . . . 0.0 113.668 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 77.62 -13.3 12.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.131 1.824 . . . . 0.0 115.411 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -80.51 94.92 6.34 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.833 1.253 . . . . 0.0 111.181 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.64 133.97 55.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.161 0.984 . . . . 0.0 111.473 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.28 150.75 62.41 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.356 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.82 156.23 34.95 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.942 3.095 . . . . 0.0 112.882 -176.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 88.7 m -104.93 153.04 21.92 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.35 1.46 . . . . 0.0 112.244 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -96.79 116.72 29.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.468 1.507 . . . . 0.0 107.956 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.88 137.54 32.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.199 1.0 . . . . 0.0 110.613 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.31 137.56 47.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.693 1.197 . . . . 0.0 112.766 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -89.23 120.05 30.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.768 1.227 . . . . 0.0 107.796 160.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.65 164.65 12.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.021 1.328 . . . . 0.0 111.804 -169.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -69.88 -24.3 63.39 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -159.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -90.57 0.1 57.48 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.146 0.979 . . . . 0.0 113.549 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.96 -6.48 54.2 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 125.394 1.473 . . . . 0.0 114.146 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -74.35 174.04 9.41 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.359 1.464 . . . . 0.0 113.197 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 30.3 m -134.46 152.15 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.239 1.416 . . . . 0.0 110.931 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -162.0 -170.84 27.31 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.972 0.796 . . . . 0.0 115.064 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.39 158.89 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.403 1.481 . . . . 0.0 112.686 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 53.4 m -132.24 153.82 50.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.595 1.558 . . . . 0.0 111.047 165.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.2 p90 -165.63 -169.88 1.67 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.769 2.428 . . . . 0.0 108.913 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 92.0 t -133.99 120.75 15.38 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 119.924 1.238 . . . . 0.0 110.29 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.86 147.69 17.09 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.341 3.36 . . . . 0.0 111.279 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.7 -12.29 17.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.79 172.93 12.33 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.856 2.062 . . . . 0.0 109.969 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.9 p -86.1 171.15 11.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.06 1.344 . . . . 0.0 111.89 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.54 -170.03 26.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.075 1.321 . . . . 0.0 113.874 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.46 117.61 12.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.097 0.959 . . . . 0.0 111.78 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.2 m80 -104.24 143.57 32.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.042 1.737 . . . . 0.0 109.269 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.1 122.24 44.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.257 1.023 . . . . 0.0 109.352 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 50.9 t -91.55 125.35 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.157 1.383 . . . . 0.0 108.558 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -110.22 113.53 26.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.217 1.407 . . . . 0.0 110.189 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 42.3 t -102.66 139.49 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.332 1.453 . . . . 0.0 109.36 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -144.81 142.32 29.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -172.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.87 121.41 44.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.052 2.541 . . . . 0.0 109.58 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.1 t30 53.35 30.13 9.78 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.374 1.069 . . . . 0.0 113.545 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.05 66.08 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.64 1.59 . . . . 0.0 115.587 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -101.11 133.3 45.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.28 1.432 . . . . 0.0 110.903 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.06 139.6 57.37 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 91.2 t -76.02 142.52 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.254 1.422 . . . . 0.0 108.874 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.79 62.76 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 20.0 m -76.93 -12.63 59.98 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.832 1.253 . . . . 0.0 114.022 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 47.9 m -84.43 153.79 62.22 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.582 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.98 152.11 88.51 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-O 121.357 0.482 . . . . 0.0 112.306 -4.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.06 124.6 37.92 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.959 1.304 . . . . 0.0 108.742 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.74 137.14 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.887 2.391 . . . . 0.0 111.145 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 48.9 t -133.07 124.34 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.411 1.484 . . . . 0.0 107.815 172.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.7 t -96.87 125.35 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.822 0.849 . . . . 0.0 110.372 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.84 125.74 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.128 1.371 . . . . 0.0 109.198 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.3 t -93.39 158.75 15.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.022 0.929 . . . . 0.0 111.905 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -58.29 -31.58 67.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.09 0.956 . . . . 0.0 113.02 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 24.5 m -66.06 -18.42 65.33 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.2 1.0 . . . . 0.0 113.644 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -92.07 -13.0 31.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.473 1.109 . . . . 0.0 112.703 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.6 mm -70.12 -26.19 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.356 1.062 . . . . 0.0 112.491 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 149.8 63.4 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.356 0.979 . . . . 0.0 113.586 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -76.57 94.19 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.382 0.673 . . . . 0.0 110.922 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.82 61.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.483 1.113 . . . . 0.0 112.627 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.4 p -55.78 -22.82 26.28 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.97 1.708 . . . . 0.0 114.639 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -94.53 -7.98 39.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.306 1.442 . . . . 0.0 113.688 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.2 t -73.98 138.45 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.637 1.108 . . . . 0.0 110.693 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -114.8 147.48 39.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.584 1.554 . . . . 0.0 111.796 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.6 m -143.82 144.17 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.787 1.635 . . . . 0.0 109.807 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.4 m -149.09 156.08 41.68 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.254 -173.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 118.1 162.56 12.37 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 124.706 1.146 . . . . 0.0 114.186 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -65.47 -30.25 71.01 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.729 1.212 . . . . 0.0 113.377 -170.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.1 -1.6 34.78 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.713 1.149 . . . . 0.0 114.878 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.4 -7.67 56.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.182 1.393 . . . . 0.0 112.554 167.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -130.06 -37.55 1.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.161 1.384 . . . . 0.0 114.056 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.19 158.62 37.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.157 0.983 . . . . 0.0 113.405 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.67 -173.37 20.08 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.435 1.493 . . . . 0.0 113.271 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -136.5 146.35 46.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.398 1.079 . . . . 0.0 112.784 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.9 p -67.27 -21.48 65.7 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -120.56 -0.81 10.2 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -142.8 148.45 46.05 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.176 1.39 . . . . 0.0 110.592 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.81 145.33 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.88 2.387 . . . . 0.0 111.76 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -91.14 153.14 20.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.028 1.331 . . . . 0.0 110.442 169.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.53 148.17 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.882 0.873 . . . . 0.0 113.063 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -159.04 149.28 19.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 110.74 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 141.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.256 1.822 . . . . 0.0 109.332 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.72 138.14 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.288 1.835 . . . . 0.0 109.634 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 22.0 t0 -136.7 117.64 14.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 111.69 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 12.4 p -123.34 -10.36 8.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -165.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -64.58 -23.62 67.33 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.539 1.518 . . . . 0.0 114.526 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -19.9 61.51 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.286 1.034 . . . . 0.0 112.785 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -90.51 -0.65 57.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.823 1.649 . . . . 0.0 113.672 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.46 -120.61 5.31 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.06 1.314 . . . . 0.0 112.196 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -107.25 165.43 11.38 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.016 1.726 . . . . 0.0 112.386 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.59 -178.07 19.14 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 115.229 0.852 . . . . 0.0 115.229 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.2 126.44 8.75 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.699 1.142 . . . . 0.0 112.022 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.26 121.25 36.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.289 1.835 . . . . 0.0 108.313 170.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 70.5 m -113.81 146.44 39.94 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.615 1.566 . . . . 0.0 110.867 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -141.34 133.55 27.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.42 1.088 . . . . 0.0 110.233 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.5 m -140.39 123.79 16.93 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.697 0.799 . . . . 0.0 110.929 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.16 137.97 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.454 1.502 . . . . 0.0 108.819 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -144.11 157.39 44.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.183 1.393 . . . . 0.0 110.675 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.24 -151.85 22.52 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.788 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.11 -10.73 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.832 3.022 . . . . 0.0 114.881 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.7 t -160.18 168.6 25.06 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 120.001 1.273 . . . . 0.0 112.666 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.54 151.14 47.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.404 1.481 . . . . 0.0 111.247 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.8 m -135.65 147.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.106 0.963 . . . . 0.0 112.029 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.21 129.82 34.84 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.899 -0.501 . . . . 0.0 109.939 166.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.9 133.91 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 109.174 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.35 158.99 39.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.249 1.82 . . . . 0.0 109.923 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 53.0 p -138.25 159.43 42.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.709 1.204 . . . . 0.0 111.705 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -154.58 116.01 4.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.587 1.155 . . . . 0.0 110.02 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.18 136.19 37.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.979 0.912 . . . . 0.0 111.389 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.79 161.14 15.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.126 1.37 . . . . 0.0 111.819 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.28 -15.89 62.95 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.83 -4.76 53.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.31 0.72 84.62 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.727 1.632 . . . . 0.0 114.203 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 20.8 p -83.51 170.46 14.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.552 1.941 . . . . 0.0 111.212 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 22.3 t -127.09 126.36 42.87 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.875 0.87 . . . . 0.0 111.056 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 28.1 ttm105 -78.11 140.28 39.04 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.201 1.0 . . . . 0.0 109.345 164.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -121.22 137.46 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.049 1.74 . . . . 0.0 108.24 167.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.3 p -135.34 148.93 49.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.323 1.449 . . . . 0.0 111.422 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.04 149.38 21.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.396 1.079 . . . . 0.0 112.218 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 20.4 t -113.78 104.25 55.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.96 0.904 . . . . 0.0 111.385 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.48 135.41 11.77 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.417 2.745 . . . . 0.0 110.554 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.3 m -89.88 -40.14 12.6 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.785 0.834 . . . . 0.0 112.133 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -92.58 149.5 38.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.494 1.118 . . . . 0.0 111.386 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.77 164.88 31.21 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 111.127 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 115.77 -165.01 12.15 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.11 1.338 . . . . 0.0 113.634 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.83 119.18 30.83 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.456 0.702 . . . . 0.0 112.009 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -97.43 141.71 30.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.719 1.207 . . . . 0.0 110.438 163.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.1 134.04 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.651 1.181 . . . . 0.0 108.778 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.18 125.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.452 1.101 . . . . 0.0 109.173 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -99.21 124.73 44.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.546 1.538 . . . . 0.0 109.293 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.32 122.53 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.222 1.009 . . . . 0.0 108.911 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -128.66 136.75 51.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.517 1.927 . . . . 0.0 110.27 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 31.1 t80 -133.8 126.03 29.72 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.713 1.205 . . . . 0.0 110.463 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 33.07 14.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.888 1.275 . . . . 0.0 112.988 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t0 79.75 2.54 2.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 114.44 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.23 133.22 49.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.458 1.103 . . . . 0.0 111.29 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -66.05 122.36 17.22 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.076 1.351 . . . . 0.0 110.668 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -78.91 160.69 71.0 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.146 -0.971 . . . . 0.0 111.651 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.89 138.23 69.12 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.582 2.854 . . . . 0.0 113.141 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.91 -23.15 21.83 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.816 1.198 . . . . 0.0 113.899 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 51.5 m -69.86 144.66 93.58 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.052 1.426 . . . . 0.0 111.327 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.2 137.2 48.81 Favored 'Cis proline' 0 C--N 1.351 0.666 0 CA-C-N 119.618 0.899 . . . . 0.0 111.021 -6.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.35 117.25 28.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.98 0.912 . . . . 0.0 110.268 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 18.3 m -83.08 128.75 34.76 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.501 0.721 . . . . 0.0 111.086 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.7 t -124.04 109.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.184 1.793 . . . . 0.0 108.957 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -79.05 106.04 10.8 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.344 0.658 . . . . 0.0 111.143 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 73.9 t -87.7 121.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -110.39 165.0 12.14 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.859 1.264 . . . . 0.0 111.576 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 136.09 -137.18 8.92 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.178 1.37 . . . . 0.0 112.692 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -161.81 -178.29 6.4 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.505 1.122 . . . . 0.0 111.381 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -69.43 145.87 43.08 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.044 0.831 . . . . 0.0 111.903 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -66.22 132.04 47.52 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.117 0.967 . . . . 0.0 112.654 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 89.9 t -78.21 136.55 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.321 1.449 . . . . 0.0 110.073 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.004 1.722 . . . . 0.0 111.658 178.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.25 159.95 33.7 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.332 1.053 . . . . 0.0 112.843 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 53.0 mtt 69.89 8.7 6.83 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.96 2.104 . . . . 0.0 114.468 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.58 146.01 35.02 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.714 1.15 . . . . 0.0 112.559 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 41.2 t0 -164.33 172.97 12.79 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.257 1.823 . . . . 0.0 110.767 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.32 18.54 0.11 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.851 2.06 . . . . 0.0 114.222 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 38.1 m -75.62 53.69 0.73 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.227 2.211 . . . . 0.0 113.353 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 95.0 mmm -62.69 129.0 38.59 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.855 -1.153 . . . . 0.0 111.14 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 152.08 28.23 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.215 1.006 . . . . 0.0 110.16 172.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.1 ptm -156.94 155.63 31.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.104 0.961 . . . . 0.0 113.296 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.5 m -138.92 152.07 47.43 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.549 . . . . 0.0 110.207 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -143.92 157.63 44.22 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.3 tt -158.78 150.94 21.34 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.017 1.727 . . . . 0.0 110.542 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 94.2 mttt -132.99 148.27 52.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.323 1.049 . . . . 0.0 112.339 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 58.3 t -136.05 131.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.944 1.698 . . . . 0.0 109.57 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -82.43 107.17 2.79 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 15.3 m -83.45 -45.19 13.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -166.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 56.98 -161.16 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.528 1.531 . . . . 0.0 112.865 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -160.68 149.29 16.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.231 1.812 . . . . 0.0 110.398 169.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.2 124.7 35.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 111.106 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.49 116.56 33.41 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.465 1.106 . . . . 0.0 109.359 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.51 144.4 44.94 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.569 2.179 . . . . 0.0 111.167 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.85 146.19 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.685 1.594 . . . . 0.0 108.417 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -46.92 120.14 2.88 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.861 1.264 . . . . 0.0 113.887 -169.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.49 71.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.959 1.303 . . . . 0.0 109.694 -169.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 62.2 p -94.36 -20.38 19.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -163.59 149.08 11.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.062 1.345 . . . . 0.0 111.255 -171.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.3 p -76.25 -11.39 59.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.113 1.365 . . . . 0.0 114.666 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -26.83 28.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.454 1.502 . . . . 0.0 113.25 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -14.36 9.45 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.687 1.195 . . . . 0.0 113.498 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 16.5 m -73.74 -16.28 61.19 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.94 -1.1 . . . . 0.0 113.922 172.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.51 -7.52 2.52 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.9 mp -71.04 166.52 21.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.603 1.561 . . . . 0.0 112.106 168.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 38.5 p -135.61 157.82 45.92 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.024 1.73 . . . . 0.0 110.743 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -146.26 161.77 39.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.217 1.007 . . . . 0.0 113.414 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 37.0 p -132.71 142.01 48.85 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.587 1.955 . . . . 0.0 109.973 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 55.3 t -90.72 127.53 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.352 1.061 . . . . 0.0 108.647 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.7 t -101.68 109.34 59.09 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 108.027 167.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.35 168.04 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.74 2.96 . . . . 0.0 110.634 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.23 -14.01 41.55 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.103 2.535 . . . . 0.0 113.563 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 63.4 p -78.1 -10.33 59.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.519 1.127 . . . . 0.0 113.752 168.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.57 -1.5 87.68 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.778 1.656 . . . . 0.0 114.952 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -79.15 82.76 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.109 1.364 . . . . 0.0 111.508 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.75 132.62 54.51 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.172 1.389 . . . . 0.0 112.051 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -141.65 150.03 55.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.504 1.522 . . . . 0.0 110.701 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.38 152.47 66.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.366 2.71 . . . . 0.0 112.242 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 29.1 p -127.96 148.97 50.53 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.586 1.154 . . . . 0.0 111.301 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 60.0 tp -90.13 126.94 35.97 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.335 1.054 . . . . 0.0 110.257 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.93 140.72 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.235 0.614 . . . . 0.0 110.108 170.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -137.41 137.34 38.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.258 1.423 . . . . 0.0 111.801 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -71.91 126.49 29.88 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.3 mt -105.39 163.77 12.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.948 1.299 . . . . 0.0 111.444 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -66.35 -21.62 66.25 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 -160.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 59.3 t30 -88.73 2.59 53.13 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 119.433 1.015 . . . . 0.0 113.221 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.56 -5.36 70.19 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 125.99 1.757 . . . . 0.0 113.787 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -76.8 -178.77 5.01 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.829 1.652 . . . . 0.0 113.199 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 46.9 t -136.07 141.3 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.128 1.371 . . . . 0.0 109.885 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -150.01 179.75 26.5 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.22 161.96 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.11 1.764 . . . . 0.0 111.614 173.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 47.1 t -147.78 135.63 21.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.272 1.429 . . . . 0.0 110.742 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.97 -176.73 2.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.387 1.875 . . . . 0.0 111.266 -171.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 84.1 t -131.01 125.09 21.01 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.88 1.272 . . . . 0.0 108.999 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.08 145.65 24.85 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.066 3.177 . . . . 0.0 111.209 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.04 1.83 22.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.503 1.121 . . . . 0.0 113.147 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -139.3 172.55 12.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.179 2.191 . . . . 0.0 109.989 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.6 p -99.42 165.98 11.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.166 1.386 . . . . 0.0 110.921 168.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 90.23 -163.96 30.58 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.815 1.198 . . . . 0.0 113.523 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.7 120.07 15.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.892 0.877 . . . . 0.0 111.833 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.6 m80 -107.95 145.82 33.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.207 1.803 . . . . 0.0 109.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.08 126.53 52.47 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.437 1.095 . . . . 0.0 109.87 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 76.8 t -91.48 108.05 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.265 1.426 . . . . 0.0 108.291 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.42 124.41 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 110.2 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -124.71 133.21 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.398 1.079 . . . . 0.0 110.651 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.61 145.96 51.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.845 1.258 . . . . 0.0 113.609 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.6 tttt -118.82 125.99 50.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.546 1.938 . . . . 0.0 109.514 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 9.9 t-20 55.83 25.93 9.03 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.914 1.286 . . . . 0.0 113.969 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.74 -0.85 77.49 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.38 1.467 . . . . 0.0 115.762 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.51 149.22 38.48 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.399 1.6 . . . . 0.0 111.114 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.8 p80 -70.97 147.87 48.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.7 t -73.03 151.28 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.684 1.194 . . . . 0.0 109.544 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.42 -26.24 60.83 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 52.8 p -86.93 -8.01 57.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.432 1.493 . . . . 0.0 114.062 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.0 t -86.76 146.8 42.0 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.075 1.35 . . . . 0.0 112.696 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.36 157.48 82.56 Favored 'Cis proline' 0 C--N 1.351 0.69 0 CA-C-N 119.281 0.779 . . . . 0.0 112.23 -7.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.31 126.38 32.38 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.063 1.345 . . . . 0.0 109.126 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.18 140.95 14.27 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.925 2.416 . . . . 0.0 111.677 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.5 t -134.33 124.59 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.713 1.605 . . . . 0.0 107.648 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.1 t -99.31 124.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.804 0.842 . . . . 0.0 110.438 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.96 123.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.224 1.41 . . . . 0.0 109.356 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.8 t -89.88 152.82 21.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.61 0.764 . . . . 0.0 111.172 170.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -58.56 -27.98 65.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 21.2 m -71.84 -18.57 62.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.043 0.937 . . . . 0.0 112.968 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -89.92 -6.84 55.33 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.101 -0.999 . . . . 0.0 112.769 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.47 -29.84 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.321 1.048 . . . . 0.0 112.194 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.33 61.0 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.029 0.823 . . . . 0.0 114.213 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -74.41 97.89 3.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 117.769 0.784 . . . . 0.0 110.958 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.86 71.42 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.93 0.892 . . . . 0.0 112.179 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 38.6 p -54.65 -28.62 48.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.816 1.647 . . . . 0.0 114.257 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -90.59 -6.3 54.82 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.236 1.414 . . . . 0.0 113.969 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 73.6 t -73.36 136.5 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.874 1.216 . . . . 0.0 109.719 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -115.47 156.36 25.79 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.463 1.505 . . . . 0.0 110.659 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -145.02 156.37 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.227 1.411 . . . . 0.0 110.782 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.91 167.62 28.92 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.164 0.986 . . . . 0.0 112.451 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.74 156.38 22.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.413 1.482 . . . . 0.0 113.555 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -71.18 -25.86 62.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.513 1.125 . . . . 0.0 113.24 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.68 -3.34 33.66 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.808 1.194 . . . . 0.0 115.38 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.8 mt -89.89 -5.15 57.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.778 1.631 . . . . 0.0 112.843 169.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -133.8 -40.71 0.85 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.784 1.234 . . . . 0.0 113.798 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.15 149.77 41.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.268 1.427 . . . . 0.0 111.009 -176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.12 175.47 27.41 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.269 0.938 . . . . 0.0 114.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.2 m80 -134.85 151.74 51.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.401 1.48 . . . . 0.0 111.678 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.6 p -69.08 -45.49 70.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -98.6 -5.73 31.32 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -167.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -123.4 147.82 53.64 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.054 1.742 . . . . 0.0 110.196 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.12 136.41 29.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.588 2.192 . . . . 0.0 110.645 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.11 152.91 23.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.352 1.061 . . . . 0.0 109.996 166.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.86 151.54 47.07 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.4 p90 -158.85 150.91 21.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.675 1.59 . . . . 0.0 110.81 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.98 139.94 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.846 1.658 . . . . 0.0 109.243 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.77 136.41 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.38 1.472 . . . . 0.0 108.771 167.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.6 t0 -120.57 98.23 5.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.201 1.8 . . . . 0.0 110.272 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 20.7 p -91.9 -4.76 54.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.567 1.947 . . . . 0.0 113.144 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -59.32 -35.73 74.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.308 1.043 . . . . 0.0 112.588 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.38 -11.6 59.24 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.035 1.334 . . . . 0.0 113.493 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.45 -3.57 56.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.472 1.509 . . . . 0.0 114.557 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.67 -147.0 23.74 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -78.11 172.09 14.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.442 1.097 . . . . 0.0 112.611 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 135.31 -162.09 24.77 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 124.901 1.238 . . . . 0.0 113.937 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -141.12 143.88 13.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.604 1.573 . . . . 0.0 112.719 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.45 123.83 46.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.485 1.914 . . . . 0.0 109.643 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.1 m -111.95 144.29 41.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.857 1.663 . . . . 0.0 110.314 170.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -146.8 146.36 30.22 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.5 0.72 . . . . 0.0 110.988 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 90.2 p -148.53 152.9 37.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.366 0.603 . . . . 0.0 112.338 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.87 129.83 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.134 1.374 . . . . 0.0 107.856 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.57 147.21 47.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.355 1.862 . . . . 0.0 109.713 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 176.97 -166.8 37.74 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.59 -11.51 24.3 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.337 3.358 . . . . 0.0 113.726 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 21.3 m -152.98 161.26 42.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.084 1.754 . . . . 0.0 111.218 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -68.51 146.98 52.64 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.979 0.912 . . . . 0.0 111.589 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.6 m -129.55 148.39 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.986 1.314 . . . . 0.0 110.911 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.44 110.66 21.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.52 0.728 . . . . 0.0 110.075 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 33.1 mt -87.12 129.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.189 0.995 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -123.93 161.62 25.03 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.579 1.952 . . . . 0.0 110.428 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 7.1 p -142.27 158.03 44.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.964 1.306 . . . . 0.0 112.509 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -151.38 117.07 5.43 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.291 1.436 . . . . 0.0 109.835 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.21 128.65 34.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 110.328 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 74.8 mt -102.57 153.68 19.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.485 1.114 . . . . 0.0 111.981 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -60.2 -28.42 67.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.619 1.167 . . . . 0.0 113.323 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.79 -9.38 58.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.806 1.242 . . . . 0.0 113.589 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.27 66.48 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.963 1.744 . . . . 0.0 114.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.1 p -88.12 170.45 11.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.554 1.942 . . . . 0.0 111.179 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.5 t -129.59 124.5 33.94 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.721 0.808 . . . . 0.0 111.663 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -82.28 137.56 34.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.238 1.415 . . . . 0.0 110.016 169.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 94.4 t -116.18 140.12 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.28 1.832 . . . . 0.0 108.465 166.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.78 149.91 50.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.688 1.595 . . . . 0.0 111.179 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.53 147.73 12.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 111.606 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 t -112.1 101.69 52.36 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 110.521 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -82.14 86.54 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.6 2.867 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.5 m -56.57 -39.11 72.93 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.184 1.394 . . . . 0.0 113.825 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -96.57 141.66 23.42 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.343 1.057 . . . . 0.0 110.699 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.23 166.12 29.58 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.518 2.812 . . . . 0.0 112.214 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.02 -162.37 24.48 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.205 1.384 . . . . 0.0 113.574 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -95.68 125.31 40.18 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.751 0.82 . . . . 0.0 111.126 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.3 142.59 41.71 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.23 1.412 . . . . 0.0 110.485 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 131.57 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.961 1.305 . . . . 0.0 108.389 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.6 mt -114.87 127.76 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.654 1.181 . . . . 0.0 109.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -103.84 127.17 51.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.191 1.396 . . . . 0.0 110.477 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -118.65 119.03 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.976 1.31 . . . . 0.0 109.41 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.3 tttt -135.67 123.96 23.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.325 1.45 . . . . 0.0 110.256 -168.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.5 t80 -121.89 127.52 50.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.702 1.201 . . . . 0.0 110.742 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.82 34.15 12.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.113 1.365 . . . . 0.0 113.409 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 16.2 t70 88.2 -1.84 0.47 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.428 3.091 . . . . 0.0 114.138 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -110.75 134.28 52.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 112.111 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2124 ' ' HIS . . . . . 0.444 ' CE1' ' HG ' ' A' 2128 ' ' SER . 1.0 OUTLIER -65.4 126.81 29.42 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.941 1.297 . . . . 0.0 111.094 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.9 m -76.51 153.91 83.74 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.962 . . . . 0.0 111.193 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.55 138.91 67.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.538 2.159 . . . . 0.0 111.178 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.63 -27.32 14.45 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.306 1.431 . . . . 0.0 113.216 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2128 ' ' SER . . . . . 0.444 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 11.4 t -76.7 144.23 72.87 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.09 0.945 . . . . 0.0 110.663 171.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.03 149.09 86.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.092 1.069 . . . . 0.0 112.035 0.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.95 119.52 38.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.766 1.226 . . . . 0.0 110.744 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 72.2 m -88.95 129.99 35.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.001 0.92 . . . . 0.0 110.776 172.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 12.9 t -124.48 115.52 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.47 1.508 . . . . 0.0 109.782 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 61.7 tttp -80.09 112.29 17.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.065 0.546 . . . . 0.0 110.709 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.5 t -98.05 121.11 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.017 1.327 . . . . 0.0 109.025 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.6 t -108.69 157.6 18.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.698 1.199 . . . . 0.0 111.479 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 165.17 172.34 32.5 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.27 0.938 . . . . 0.0 114.606 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -78.46 -21.5 48.97 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.504 1.121 . . . . 0.0 112.92 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 86.38 -1.2 87.39 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.887 1.232 . . . . 0.0 114.958 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 80.36 161.4 0.17 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.104 2.562 . . . . 0.0 112.257 173.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 8.3 p -53.12 143.72 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.524 1.53 . . . . 0.0 112.286 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.092 1.757 . . . . 0.0 112.847 -170.648 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 112.146 -0.381 . . . . 0.0 112.146 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.1 164.86 26.07 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.558 1.143 . . . . 0.0 112.855 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.4 mmt -69.57 141.8 53.72 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.151 0.98 . . . . 0.0 111.932 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -89.3 176.91 43.86 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.878 1.228 . . . . 0.0 113.55 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.92 -9.68 58.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.986 1.314 . . . . 0.0 113.708 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 16.2 t0 -145.62 134.16 22.06 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.51 1.924 . . . . 0.0 110.279 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 55.6 p -97.84 -11.72 22.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.271 1.428 . . . . 0.0 114.229 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 89.5 mtp -66.29 150.58 48.62 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 -149.96 149.21 30.07 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.314 1.446 . . . . 0.0 111.078 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 94.8 mtp -96.33 142.12 28.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.883 1.273 . . . . 0.0 111.727 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 7.4 m -122.26 137.43 54.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.637 1.975 . . . . 0.0 108.414 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.23 145.59 32.9 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.375 0.989 . . . . 0.0 113.547 -165.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.38 155.47 30.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.982 1.713 . . . . 0.0 111.183 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -132.67 150.46 52.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.598 1.159 . . . . 0.0 112.597 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.0 t -139.87 137.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.392 1.877 . . . . 0.0 109.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.33 120.13 5.67 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.0 m -106.59 143.45 34.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.57 152.17 23.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.872 0.869 . . . . 0.0 113.025 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.47 148.45 26.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.167 0.987 . . . . 0.0 111.028 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.37 146.5 28.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 112.494 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.33 120.05 20.9 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.824 1.25 . . . . 0.0 108.791 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.69 137.64 14.49 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.366 2.711 . . . . 0.0 110.956 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.15 138.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.206 1.402 . . . . 0.0 109.985 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 51.7 t30 55.1 64.52 1.77 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.918 1.687 . . . . 0.0 112.359 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 11.2 mm -71.67 105.06 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.39 1.076 . . . . 0.0 110.95 -168.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 11.8 t -171.94 177.82 3.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.751 2.02 . . . . 0.0 110.221 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.72 57.18 3.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.528 1.531 . . . . 0.0 111.049 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 39.6 p -75.77 153.27 37.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.244 1.418 . . . . 0.0 112.28 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -98.44 111.63 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.799 1.24 . . . . 0.0 110.485 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.68 -12.3 61.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.124 0.97 . . . . 0.0 113.053 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 66.6 m -77.12 -16.96 58.98 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.746 1.157 . . . . 0.0 113.948 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -116.65 3.8 13.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.254 1.422 . . . . 0.0 114.057 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.02 146.02 37.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 0.0 110.972 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 56.0 p -140.12 168.01 20.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.532 1.933 . . . . 0.0 109.666 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 152.6 31.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.785 0.834 . . . . 0.0 112.596 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 67.3 p -138.85 157.52 45.91 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.523 1.929 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -109.93 133.45 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.646 1.178 . . . . 0.0 109.495 169.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 89.9 t -102.43 110.5 63.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.776 1.23 . . . . 0.0 107.748 164.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.87 169.65 21.29 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.686 2.924 . . . . 0.0 110.838 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -15.17 46.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.971 2.448 . . . . 0.0 113.28 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 62.3 p -80.33 -9.61 59.74 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.828 1.251 . . . . 0.0 113.916 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.03 -1.72 83.66 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.736 1.636 . . . . 0.0 115.118 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -78.98 83.1 5.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.181 1.392 . . . . 0.0 111.643 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -58.77 135.42 57.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.755 1.222 . . . . 0.0 112.383 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -139.48 151.05 65.85 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.47 1.508 . . . . 0.0 111.128 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 155.04 35.98 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.738 2.959 . . . . 0.0 112.704 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 74.6 m -105.66 154.94 19.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.145 1.378 . . . . 0.0 111.794 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.8 119.16 35.91 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.191 1.396 . . . . 0.0 108.586 175.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.73 136.64 34.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.506 1.122 . . . . 0.0 110.886 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 66.9 mttm -136.94 141.22 42.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.725 1.21 . . . . 0.0 113.098 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -87.02 120.34 28.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.598 1.159 . . . . 0.0 107.981 157.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.4 mt -98.86 171.44 8.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.842 1.257 . . . . 0.0 112.969 -166.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -60.96 -20.41 62.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.749 2.02 . . . . 0.0 116.381 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.08 5.76 46.85 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.272 1.029 . . . . 0.0 112.971 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.75 85.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.58 1.562 . . . . 0.0 114.25 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 164.03 21.71 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.038 1.735 . . . . 0.0 113.426 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 82.6 t -102.56 141.43 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.212 1.405 . . . . 0.0 110.15 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.33 -168.17 20.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.264 0.935 . . . . 0.0 114.807 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.66 167.08 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.441 1.496 . . . . 0.0 112.264 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 98.9 p -139.08 159.85 41.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.923 1.289 . . . . 0.0 111.432 162.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.2 p90 -164.07 -178.46 5.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.026 2.13 . . . . 0.0 109.778 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -129.47 122.9 21.09 Favored Pre-proline 0 N--CA 1.482 1.135 0 CA-C-N 119.44 1.018 . . . . 0.0 110.171 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.86 141.58 15.23 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.322 3.348 . . . . 0.0 111.223 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -94.82 -32.9 13.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.7 0.8 . . . . 0.0 112.842 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -111.2 172.1 7.08 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.173 1.789 . . . . 0.0 111.096 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.6 p -90.86 164.21 14.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.838 1.255 . . . . 0.0 111.015 165.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 101.31 -166.68 18.78 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.123 1.344 . . . . 0.0 113.856 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.94 116.86 16.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.928 . . . . 0.0 111.866 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 16.2 m80 -103.77 142.83 33.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.48 1.912 . . . . 0.0 109.44 170.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.84 123.14 47.73 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.571 1.148 . . . . 0.0 109.206 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 35.2 t -90.55 112.57 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.872 1.269 . . . . 0.0 108.583 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -92.98 138.23 31.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.875 1.27 . . . . 0.0 110.531 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 66.6 t -130.46 128.43 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.672 0.789 . . . . 0.0 109.511 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.23 134.76 51.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.114 1.366 . . . . 0.0 112.569 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 84.9 tttt -128.45 129.05 45.57 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 110.162 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 53.08 30.53 9.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.627 1.171 . . . . 0.0 114.056 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.89 5.26 71.26 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.033 1.302 . . . . 0.0 116.019 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -134.62 149.26 50.55 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.665 1.733 . . . . 0.0 111.855 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -70.03 140.65 52.88 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.945 -1.097 . . . . 0.0 112.877 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 21.2 m -76.33 153.07 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.834 0.854 . . . . 0.0 111.527 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -62.77 -23.66 67.33 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 62.1 p -84.78 -3.42 58.61 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.843 1.257 . . . . 0.0 114.034 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 1.7 p -118.48 160.18 40.88 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.685 1.194 . . . . 0.0 112.757 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.0 156.17 98.7 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.48 0.85 . . . . 0.0 113.078 0.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.39 124.6 33.45 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.816 1.647 . . . . 0.0 108.954 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.84 139.34 12.2 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.193 2.595 . . . . 0.0 111.381 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.3 t -135.55 124.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.585 1.554 . . . . 0.0 108.157 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -97.23 122.47 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.757 0.823 . . . . 0.0 110.118 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.51 126.58 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.152 1.381 . . . . 0.0 109.871 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -90.28 168.54 11.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.793 1.237 . . . . 0.0 112.121 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.58 -32.12 73.25 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.332 -1.48 . . . . 0.0 112.978 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.9 m -72.28 -5.31 35.18 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.81 5.73 14.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.069 1.347 . . . . 0.0 113.207 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.43 -31.21 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.143 0.977 . . . . 0.0 112.24 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 164.27 51.05 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.762 0.665 . . . . 0.0 114.762 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.95 92.54 4.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.151 0.976 . . . . 0.0 111.393 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.69 76.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.697 0.799 . . . . 0.0 112.054 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -56.71 -24.98 53.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.343 1.457 . . . . 0.0 113.994 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -90.61 -7.05 53.79 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.15 1.38 . . . . 0.0 113.802 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 58.0 t -77.8 129.85 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.975 1.261 . . . . 0.0 109.741 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -105.69 156.34 18.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 110.687 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.0 m -143.45 151.63 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.056 1.343 . . . . 0.0 110.731 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 57.2 m -149.13 166.49 28.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.309 1.443 . . . . 0.0 112.014 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.04 157.56 26.27 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.479 1.038 . . . . 0.0 113.929 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -78.88 -18.95 53.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.54 -4.64 46.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.69 1.138 . . . . 0.0 114.788 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.45 -4.88 58.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 112.686 168.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -126.88 -36.57 2.19 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.077 1.351 . . . . 0.0 113.668 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -155.67 156.7 35.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.225 1.01 . . . . 0.0 113.093 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.07 -171.88 15.92 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.71 1.624 . . . . 0.0 113.207 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -147.22 145.17 29.37 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.968 0.907 . . . . 0.0 113.399 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 41.3 p -66.09 -23.69 66.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -114.96 1.57 14.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 139.96 31.0 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.29 1.436 . . . . 0.0 110.095 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.84 144.59 54.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.335 2.023 . . . . 0.0 110.547 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -104.11 158.67 16.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.102 1.361 . . . . 0.0 110.711 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 158.71 44.16 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.45 153.73 30.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.449 1.9 . . . . 0.0 110.114 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.63 138.8 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.687 1.595 . . . . 0.0 108.943 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 44.3 mt -110.2 135.06 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.097 1.759 . . . . 0.0 108.756 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.01 97.5 5.46 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.961 1.704 . . . . 0.0 110.46 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.7 p -94.02 0.73 56.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 113.177 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -59.48 -38.79 81.76 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.524 1.056 . . . . 0.0 113.069 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.59 -23.52 45.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.103 0.961 . . . . 0.0 113.032 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -81.36 -11.81 59.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 113.737 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.2 -121.6 5.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.007 1.289 . . . . 0.0 112.335 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.49 163.93 12.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.542 1.537 . . . . 0.0 112.203 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.45 174.24 17.48 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -89.64 122.86 6.67 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.339 0.971 . . . . 0.0 111.424 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.1 tm? -98.08 112.16 24.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.849 1.66 . . . . 0.0 107.718 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.6 m -104.9 145.55 30.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.724 0.81 . . . . 0.0 109.966 168.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.78 137.19 29.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.741 0.817 . . . . 0.0 109.762 -166.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.2 p -140.87 150.5 43.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.85 0.833 . . . . 0.0 112.497 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.42 133.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.49 1.516 . . . . 0.0 107.235 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -142.27 139.14 31.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.645 0.778 . . . . 0.0 110.827 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 179.46 -161.31 27.23 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.033 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.06 -5.61 15.13 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.291 3.327 . . . . 0.0 114.753 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.6 t -157.71 168.18 27.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.754 1.222 . . . . 0.0 111.456 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -69.33 149.14 48.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.364 1.066 . . . . 0.0 111.093 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.5 m -127.58 150.19 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.036 1.334 . . . . 0.0 110.647 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -91.04 109.17 20.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.49 0.716 . . . . 0.0 109.692 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 26.8 mt -85.4 131.74 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.195 0.998 . . . . 0.0 109.432 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -128.08 164.03 23.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.664 1.986 . . . . 0.0 110.471 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -142.59 155.53 44.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.996 1.318 . . . . 0.0 112.073 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.37 114.88 4.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.0 110.067 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.37 130.68 37.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.666 1.186 . . . . 0.0 110.967 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 75.6 mt -103.3 151.34 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.6 1.16 . . . . 0.0 111.705 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.95 -19.6 65.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.304 1.042 . . . . 0.0 113.659 -175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.63 -5.95 54.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 113.109 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 97.24 1.38 59.41 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.87 1.7 . . . . 0.0 114.738 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 168.92 10.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.366 1.866 . . . . 0.0 111.399 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -125.33 124.61 41.96 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.972 0.909 . . . . 0.0 111.543 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -84.07 134.96 34.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.136 1.375 . . . . 0.0 109.54 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 46.3 t -115.91 137.24 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.743 1.617 . . . . 0.0 108.363 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.472 1.909 . . . . 0.0 110.769 -177.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -160.4 155.91 25.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.396 1.078 . . . . 0.0 112.668 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.2 p -124.61 97.01 39.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.17 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.91 143.31 20.61 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.184 2.589 . . . . 0.0 110.345 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 88.7 m -112.11 -44.11 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 0.0 112.135 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -83.42 141.37 42.3 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.471 0.708 . . . . 0.0 110.419 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.98 162.54 34.48 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.28 2.653 . . . . 0.0 111.092 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.47 -144.04 15.89 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.811 1.196 . . . . 0.0 112.144 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -123.53 131.65 53.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.633 0.773 . . . . 0.0 111.779 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -110.21 139.0 45.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.766 1.626 . . . . 0.0 109.977 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.61 134.28 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.85 1.26 . . . . 0.0 108.447 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.67 127.84 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.214 1.406 . . . . 0.0 108.86 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -109.96 119.96 40.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.028 1.331 . . . . 0.0 109.871 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.5 mm -107.68 114.43 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.749 0.785 . . . . 0.0 108.955 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.57 118.0 23.1 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.21 1.004 . . . . 0.0 111.695 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 16.8 t80 -112.7 131.62 55.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.68 1.192 . . . . 0.0 110.259 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.99 35.35 21.78 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.466 1.506 . . . . 0.0 114.283 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.05 10.14 3.8 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.386 2.275 . . . . 0.0 114.24 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -95.57 -128.8 0.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.127 1.371 . . . . 0.0 110.465 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -168.13 125.19 1.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.558 2.343 . . . . 0.0 108.69 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -76.91 151.57 82.16 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-N 120.044 1.293 . . . . 0.0 110.843 -170.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.34 135.24 52.78 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.568 2.178 . . . . 0.0 110.996 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 100.83 -27.02 22.49 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.39 1.471 . . . . 0.0 113.744 -173.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 50.9 m -74.57 150.37 86.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 118.972 1.386 . . . . 0.0 111.67 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.02 141.17 69.75 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 119.205 0.752 . . . . 0.0 111.208 -3.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.57 115.3 27.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.046 0.938 . . . . 0.0 110.378 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 66.4 m -87.63 121.13 29.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.988 0.915 . . . . 0.0 110.359 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -120.32 115.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.662 1.585 . . . . 0.0 109.922 -168.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.92 122.22 26.41 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.963 0.505 . . . . 0.0 111.304 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 76.1 t -106.64 117.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.444 1.498 . . . . 0.0 108.93 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.1 t -105.26 174.6 5.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.176 1.39 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 133.89 -134.09 7.26 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.138 1.352 . . . . 0.0 112.694 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -160.09 176.15 12.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.583 1.153 . . . . 0.0 111.159 -169.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -67.87 138.06 32.82 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.266 -0.896 . . . . 0.0 111.589 171.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -67.83 143.88 55.59 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.381 1.073 . . . . 0.0 112.79 -172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 31.5 m -127.82 163.96 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.656 1.982 . . . . 0.0 110.914 175.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 124.787 1.235 . . . . 0.0 112.051 178.935 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.2 -22.58 61.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 95.8 mtp -130.37 145.74 51.84 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.835 1.654 . . . . 0.0 110.976 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -106.18 -158.2 22.05 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.421 1.486 . . . . 0.0 113.562 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 31.3 t0 -158.97 165.74 33.38 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.833 2.053 . . . . 0.0 110.414 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -65.11 157.91 27.3 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.372 1.069 . . . . 0.0 112.825 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 86.8 p -157.74 161.51 38.49 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.731 1.212 . . . . 0.0 112.324 -170.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 4.6 ppp? -76.36 148.36 37.47 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.605 -0.685 . . . . 0.0 110.568 164.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.23 153.11 39.27 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.935 1.294 . . . . 0.0 110.595 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.3 ptt? -148.4 162.66 39.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.888 1.675 . . . . 0.0 110.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 68.7 m -113.78 150.01 34.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.274 1.03 . . . . 0.0 109.845 167.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -144.88 160.26 41.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.3 155.41 33.7 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.277 1.831 . . . . 0.0 110.402 -169.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 68.4 mttm -137.92 150.62 47.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.117 1.367 . . . . 0.0 111.639 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.6 p -155.76 139.39 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.703 1.201 . . . . 0.0 110.818 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -83.08 129.06 8.84 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.813 0.72 . . . . 0.0 111.405 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 44.0 m -113.41 137.41 51.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.137 . . . . 0.0 111.403 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.47 141.58 12.07 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.267 1.027 . . . . 0.0 111.957 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.26 148.25 43.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.872 0.869 . . . . 0.0 111.215 168.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.68 139.53 30.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.144 0.977 . . . . 0.0 112.63 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 72.9 mt -121.55 123.4 27.57 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.521 1.528 . . . . 0.0 108.796 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.55 152.6 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.109 2.54 . . . . 0.0 111.889 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.09 147.23 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.382 1.473 . . . . 0.0 111.037 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 35.4 t30 56.96 77.37 0.27 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.22 1.808 . . . . 0.0 112.159 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 20.3 mm -77.99 73.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.382 1.073 . . . . 0.0 109.349 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 6.6 m -172.69 -177.54 1.71 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.818 2.847 . . . . 0.0 109.383 -169.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -59.09 121.96 12.57 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.133 -0.979 . . . . 0.0 111.256 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.3 m -139.8 142.51 36.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.265 1.826 . . . . 0.0 109.153 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 64.5 t0 -126.94 120.53 29.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.932 1.293 . . . . 0.0 110.242 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.18 -10.25 59.75 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.586 1.154 . . . . 0.0 113.922 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 11.8 t -64.91 -31.26 72.4 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.631 1.105 . . . . 0.0 113.627 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.23 9.41 11.06 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.524 1.53 . . . . 0.0 113.961 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.46 145.18 25.89 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.087 1.355 . . . . 0.0 112.178 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -141.25 163.43 32.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.783 2.033 . . . . 0.0 109.371 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.28 146.78 23.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.7 p -139.25 161.77 36.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.841 2.056 . . . . 0.0 109.993 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.7 t -117.32 138.5 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.368 1.467 . . . . 0.0 110.253 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 93.5 t -105.76 112.94 64.4 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 108.246 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.82 171.94 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.916 3.077 . . . . 0.0 111.605 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.89 -28.5 31.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.706 3.604 . . . . 0.0 115.199 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 60.4 p -81.27 -9.61 59.74 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.25 -2.0 73.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.451 1.5 . . . . 0.0 114.766 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -75.43 89.19 2.65 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.309 1.444 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.3 133.53 56.19 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.078 0.951 . . . . 0.0 111.944 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -129.16 145.83 58.3 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 110.317 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.7 151.17 31.86 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.393 2.729 . . . . 0.0 111.712 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.1 m -95.61 149.63 21.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.215 1.006 . . . . 0.0 111.736 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.25 128.66 34.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 159.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.7 mt -95.89 141.58 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 110.551 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 88.8 mttt -136.78 144.66 43.87 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.502 1.521 . . . . 0.0 111.891 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -98.1 117.68 33.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.646 1.178 . . . . 0.0 107.851 159.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.61 175.15 6.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.853 1.661 . . . . 0.0 112.597 -166.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -56.97 -35.32 69.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.471 1.509 . . . . 0.0 114.692 -166.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.51 3.88 53.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 0.0 113.211 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.81 71.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.394 1.473 . . . . 0.0 114.209 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -73.17 163.57 27.94 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.681 1.592 . . . . 0.0 113.282 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 59.8 t -108.77 144.05 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.249 1.42 . . . . 0.0 110.47 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -146.14 171.49 27.03 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.607 1.098 . . . . 0.0 115.367 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.94 152.96 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.072 1.749 . . . . 0.0 111.898 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 13.6 m -132.65 148.56 52.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.7 1.6 . . . . 0.0 110.235 168.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.8 p90 -164.58 162.01 21.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.224 1.41 . . . . 0.0 111.296 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 93.1 t -102.3 119.5 56.18 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 0.0 109.32 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 145.18 24.3 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.236 3.29 . . . . 0.0 110.586 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -108.72 0.41 20.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 113.411 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -143.15 179.59 6.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.395 2.278 . . . . 0.0 109.698 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -105.09 158.44 16.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.068 1.347 . . . . 0.0 110.452 163.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.36 -164.61 16.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.303 1.43 . . . . 0.0 113.341 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.2 111.5 8.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.354 1.062 . . . . 0.0 111.944 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.7 m80 -95.32 140.55 30.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.466 1.507 . . . . 0.0 109.428 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.58 121.56 42.63 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.99 0.916 . . . . 0.0 109.116 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 44.6 t -86.86 131.76 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.013 1.325 . . . . 0.0 108.349 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -116.4 119.24 35.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.363 1.465 . . . . 0.0 109.818 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 64.5 t -107.89 134.95 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.854 1.262 . . . . 0.0 109.196 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 80.6 mttt -119.77 149.68 41.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 113.091 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -126.41 118.21 24.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.44 2.296 . . . . 0.0 109.042 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 58.01 21.19 7.53 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.862 1.265 . . . . 0.0 114.22 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 101.52 -12.26 58.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.916 1.722 . . . . 0.0 115.79 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -99.66 160.72 14.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.508 1.654 . . . . 0.0 111.222 171.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.0 p80 -65.04 153.2 41.43 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.106 -0.996 . . . . 0.0 112.954 170.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -88.71 154.47 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.721 0.809 . . . . 0.0 110.62 168.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -61.74 -21.73 64.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 67.1 m -82.33 -15.52 52.55 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 19.9 m -84.28 153.21 62.35 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 120.813 -1.18 . . . . 0.0 113.902 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.87 153.73 86.8 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 118.387 0.459 . . . . 0.0 111.812 -5.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 123.01 39.1 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.898 1.279 . . . . 0.0 109.273 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 139.18 11.89 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.082 2.522 . . . . 0.0 111.591 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 34.5 t -135.72 120.42 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.454 1.502 . . . . 0.0 108.352 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 62.0 t -92.78 122.46 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.712 0.805 . . . . 0.0 110.271 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.89 133.29 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.014 1.326 . . . . 0.0 109.656 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 27.4 t -104.65 158.69 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.4 1.08 . . . . 0.0 111.198 169.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -59.36 -29.84 67.97 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.344 -0.847 . . . . 0.0 112.72 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -65.41 -13.73 59.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.479 1.112 . . . . 0.0 113.653 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -93.75 -8.12 41.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.631 1.172 . . . . 0.0 112.471 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.2 116.77 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.516 1.053 . . . . 0.0 110.624 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 70.9 13.35 72.23 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 157.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.52 94.12 2.57 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.642 1.721 . . . . 0.0 110.748 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.45 -36.36 71.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.753 1.221 . . . . 0.0 112.735 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.5 m -54.67 -24.72 23.07 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.515 1.526 . . . . 0.0 114.184 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -86.36 -13.76 45.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.036 1.335 . . . . 0.0 113.469 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.4 t -77.55 134.73 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.43 1.014 . . . . 0.0 110.003 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -122.16 159.74 26.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.446 1.499 . . . . 0.0 110.741 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 32.8 m -147.35 159.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.107 1.363 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.09 169.93 23.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.342 1.057 . . . . 0.0 112.437 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.38 159.25 24.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.296 1.427 . . . . 0.0 113.79 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.52 -27.84 64.49 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.502 1.121 . . . . 0.0 113.362 -169.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.09 -2.73 33.26 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.854 1.216 . . . . 0.0 115.294 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 88.6 mt -88.82 -7.08 56.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.942 1.697 . . . . 0.0 112.66 168.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -133.72 -39.81 0.88 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.996 1.318 . . . . 0.0 113.915 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -140.09 148.48 41.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.189 1.395 . . . . 0.0 111.482 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.7 178.3 28.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.619 1.104 . . . . 0.0 114.203 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.9 m80 -136.83 149.64 47.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.735 1.614 . . . . 0.0 111.655 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.1 p -71.9 -32.6 67.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.54 6.73 14.72 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -138.36 144.39 42.63 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.832 1.653 . . . . 0.0 109.462 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 140.93 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.677 2.252 . . . . 0.0 111.19 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -87.67 151.56 22.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.733 1.213 . . . . 0.0 109.976 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.14 150.01 48.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.112 0.965 . . . . 0.0 113.147 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 152.42 27.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.054 1.341 . . . . 0.0 111.333 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.6 mp -110.88 142.22 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.494 1.918 . . . . 0.0 109.823 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 47.6 mt -114.46 133.59 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.975 1.71 . . . . 0.0 109.595 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 8.6 t0 -117.42 112.03 20.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.781 2.032 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 10.1 p -120.79 -3.71 9.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.537 1.535 . . . . 0.0 113.967 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -29.11 69.76 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.144 1.338 . . . . 0.0 113.47 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.09 -18.15 53.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.669 1.187 . . . . 0.0 112.867 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.99 -5.15 56.96 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.372 1.469 . . . . 0.0 113.818 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.09 -106.15 2.75 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.93 1.252 . . . . 0.0 111.816 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -129.73 145.64 51.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.442 1.497 . . . . 0.0 112.807 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 158.22 175.63 29.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.92 0.772 . . . . 0.0 114.76 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -87.5 121.7 5.95 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.143 0.878 . . . . 0.0 111.056 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 123.29 35.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.184 1.393 . . . . 0.0 108.022 171.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 8.4 t -119.73 145.24 46.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.494 1.918 . . . . 0.0 109.791 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.0 tt -145.32 144.24 30.62 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.716 0.807 . . . . 0.0 110.846 -165.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.4 p -148.13 153.92 39.49 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.78 131.42 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.724 1.61 . . . . 0.0 108.539 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.64 153.14 49.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.723 1.609 . . . . 0.0 110.513 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 166.93 -153.45 23.12 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.096 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.5 -10.51 28.13 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.913 3.076 . . . . 0.0 114.31 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -157.39 168.0 28.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.594 1.088 . . . . 0.0 112.238 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -71.52 150.0 45.23 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.609 1.163 . . . . 0.0 111.087 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.2 m -130.59 152.11 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.565 1.146 . . . . 0.0 111.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -81.47 126.32 31.52 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.58 -0.7 . . . . 0.0 109.832 165.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.2 mt -106.78 132.67 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.191 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -129.73 155.23 46.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.367 1.867 . . . . 0.0 109.533 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.33 158.57 43.81 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.61 1.164 . . . . 0.0 111.553 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.53 128.64 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 0.0 110.94 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.63 118.64 22.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.439 1.096 . . . . 0.0 109.95 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.77 160.35 18.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.14 0.976 . . . . 0.0 111.805 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.15 -20.97 66.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.97 0.908 . . . . 0.0 113.138 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.48 -12.53 59.88 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.863 1.265 . . . . 0.0 113.361 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.45 -1.56 62.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.557 1.551 . . . . 0.0 114.836 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 15.1 p -81.6 162.27 23.17 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 111.259 170.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.2 t -108.51 123.81 49.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.925 0.89 . . . . 0.0 110.751 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 29.9 ttm105 -82.91 137.68 34.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.17 0.988 . . . . 0.0 109.342 165.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 24.3 t -120.64 137.36 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.781 1.632 . . . . 0.0 108.468 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.4 p -137.61 146.07 43.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.365 1.466 . . . . 0.0 111.56 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -160.43 150.21 17.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.534 1.134 . . . . 0.0 112.563 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.4 t -111.93 104.69 56.24 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.107 0.963 . . . . 0.0 110.886 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.67 98.82 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.496 2.798 . . . . 0.0 110.978 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -60.62 -43.96 96.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.441 1.096 . . . . 0.0 113.653 -169.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -94.15 146.15 31.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.215 1.006 . . . . 0.0 111.098 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.64 164.22 32.56 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.33 2.687 . . . . 0.0 111.254 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.17 -140.25 11.65 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.823 1.202 . . . . 0.0 112.184 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -130.15 130.95 45.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.955 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -110.97 144.27 40.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.633 1.573 . . . . 0.0 110.781 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.72 134.31 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.483 1.113 . . . . 0.0 108.868 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.5 mt -111.69 129.12 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.828 1.251 . . . . 0.0 109.08 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -107.18 125.04 50.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.352 1.461 . . . . 0.0 109.935 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.98 124.28 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.998 0.919 . . . . 0.0 109.074 173.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -131.13 135.14 47.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.429 1.492 . . . . 0.0 110.578 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.1 t80 -128.64 121.24 28.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.14 1.376 . . . . 0.0 109.845 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.43 55.84 7.76 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.417 1.487 . . . . 0.0 112.672 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 21.1 t70 79.09 -7.56 1.75 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 128.052 2.541 . . . . 0.0 114.128 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -113.64 128.71 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.8 1.24 . . . . 0.0 111.521 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -67.25 126.17 28.38 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.822 1.249 . . . . 0.0 111.045 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -77.7 154.2 81.0 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.225 -0.922 . . . . 0.0 111.295 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.88 139.49 74.43 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.612 2.208 . . . . 0.0 111.228 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 97.86 -26.84 21.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.25 1.405 . . . . 0.0 113.499 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 73.1 m -74.98 149.71 85.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.716 1.258 . . . . 0.0 111.366 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.85 139.53 62.24 Favored 'Cis proline' 0 C--N 1.351 0.705 0 CA-C-N 119.444 0.837 . . . . 0.0 111.315 -2.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -93.07 112.76 24.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.925 0.89 . . . . 0.0 110.218 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 59.3 m -87.48 118.31 26.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.316 1.047 . . . . 0.0 110.821 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 8.5 t -112.95 116.44 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.967 1.707 . . . . 0.0 109.578 -171.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.78 121.97 27.09 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.908 -0.495 . . . . 0.0 111.03 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 98.6 t -110.41 119.6 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.218 1.407 . . . . 0.0 109.534 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.9 t -97.58 154.38 17.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.631 1.173 . . . . 0.0 111.047 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -173.43 -163.34 26.89 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2137 ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' 2138 ' ' GLY . 9.9 tt0 -158.6 -158.27 0.69 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.153 1.781 . . . . 0.0 109.884 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2138 ' ' GLY . . . . . 0.403 ' H ' ' HG2' ' A' 2137 ' ' GLU . . . -72.73 138.43 25.89 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.805 -1.185 . . . . 0.0 111.905 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -66.41 142.15 57.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.207 1.003 . . . . 0.0 112.628 -173.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 10.7 p -58.9 142.64 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.078 1.351 . . . . 0.0 111.524 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 C--O 1.254 1.32 0 C-N-CA 126.072 1.749 . . . . 0.0 111.442 -175.623 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.468 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.66 169.38 17.43 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.5 1.12 . . . . 0.0 112.952 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.78 153.47 43.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.703 1.201 . . . . 0.0 112.936 174.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.57 -18.81 47.12 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.693 1.14 . . . . 0.0 114.116 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -162.09 148.85 13.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.724 2.009 . . . . 0.0 110.172 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 2.3 p30 -77.66 171.5 14.84 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 53.4 p -84.25 -7.88 59.21 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 98.1 mmm -72.38 150.09 43.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.738 1.154 . . . . 0.0 112.479 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 21.3 tpt85 -136.02 116.78 14.03 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.225 1.41 . . . . 0.0 109.802 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 27.9 ptm -78.05 151.81 33.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.776 0.831 . . . . 0.0 111.748 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 12.8 m -127.0 140.03 52.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.471 1.909 . . . . 0.0 108.146 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -143.15 160.32 40.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -166.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.93 151.04 21.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.618 1.967 . . . . 0.0 110.024 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -134.55 146.26 49.49 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.937 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 47.3 t -139.83 133.93 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.644 1.577 . . . . 0.0 109.623 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -86.01 118.05 4.75 Favored Glycine 0 N--CA 1.47 0.93 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 169.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.4 m -121.36 146.84 46.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.924 0.89 . . . . 0.0 112.458 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.85 144.04 11.5 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.173 0.989 . . . . 0.0 112.572 -170.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -70.37 157.81 37.09 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.595 1.158 . . . . 0.0 112.364 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.92 143.47 26.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.919 1.687 . . . . 0.0 112.893 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.13 118.57 18.42 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.969 1.308 . . . . 0.0 109.429 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.55 133.01 11.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.475 2.783 . . . . 0.0 111.639 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 51.2 mt -148.62 142.4 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.493 1.517 . . . . 0.0 110.624 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 57.81 57.4 4.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.072 1.749 . . . . 0.0 112.431 172.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 12.1 mm -71.99 -26.71 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.877 1.271 . . . . 0.0 112.633 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -76.92 54.63 1.03 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.13 1.772 . . . . 0.0 113.717 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -146.93 144.61 29.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.799 1.64 . . . . 0.0 110.726 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -104.09 -40.77 6.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.056 1.742 . . . . 0.0 111.133 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -90.93 108.44 19.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.765 0.826 . . . . 0.0 110.438 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.4 mt -90.37 -8.72 49.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.119 0.968 . . . . 0.0 113.101 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 9.2 t -77.03 -31.48 56.35 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.207 -0.933 . . . . 0.0 112.553 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.84 -2.43 47.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.137 1.375 . . . . 0.0 114.421 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.9 tp -101.3 135.25 43.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.463 1.105 . . . . 0.0 111.406 -170.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -138.97 168.22 20.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.013 1.725 . . . . 0.0 110.46 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -154.09 150.9 28.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.9 p -137.85 165.19 27.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.082 2.153 . . . . 0.0 110.079 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -123.73 139.85 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.852 1.661 . . . . 0.0 110.015 172.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.8 t -111.42 114.16 53.14 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.476 1.51 . . . . 0.0 108.249 166.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.67 170.33 19.33 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.948 3.098 . . . . 0.0 110.771 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.35 -16.61 55.17 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.986 2.458 . . . . 0.0 113.266 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 69.4 m -83.66 -4.18 58.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.328 1.051 . . . . 0.0 113.828 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.37 82.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.597 1.57 . . . . 0.0 115.914 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.35 86.73 3.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.4 1.48 . . . . 0.0 111.588 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.87 135.93 57.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.554 1.142 . . . . 0.0 112.302 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -142.6 151.59 57.67 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.752 1.621 . . . . 0.0 111.352 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.46 155.09 36.2 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.823 3.015 . . . . 0.0 112.23 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 94.8 m -98.1 155.32 17.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.584 1.154 . . . . 0.0 112.815 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.64 135.45 34.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 108.234 162.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.2 mt -108.02 139.06 43.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.218 1.407 . . . . 0.0 111.06 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 64.2 mttm -135.54 128.19 30.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.676 1.19 . . . . 0.0 113.113 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.6 tpt85 -75.83 125.98 30.13 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 148.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 54.8 mt -102.65 159.85 15.09 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.678 1.191 . . . . 0.0 110.76 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -57.89 -32.97 68.23 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -82.17 -1.3 48.53 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 106.39 -27.81 15.68 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.596 1.57 . . . . 0.0 113.785 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.96 169.79 12.58 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.78 1.232 . . . . 0.0 114.179 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 67.9 t -133.15 139.33 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.841 1.656 . . . . 0.0 109.342 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.43 23.32 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 116.179 1.231 . . . . 0.0 116.179 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.93 160.97 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.974 1.709 . . . . 0.0 112.288 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 68.4 m -139.98 149.75 43.63 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.575 1.95 . . . . 0.0 110.184 170.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 21.8 p90 -166.73 167.17 15.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.133 1.773 . . . . 0.0 110.647 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.9 t -116.06 113.57 41.64 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 124.041 0.936 . . . . 0.0 109.803 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.17 151.41 23.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.137 3.225 . . . . 0.0 111.324 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -98.49 -11.61 22.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.062 0.945 . . . . 0.0 113.459 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -139.09 166.72 23.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.01 1.724 . . . . 0.0 110.949 -174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.6 p -87.73 172.58 9.57 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.01 1.324 . . . . 0.0 111.333 169.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.5 -173.3 35.36 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.003 1.287 . . . . 0.0 113.773 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.31 113.48 7.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.149 0.98 . . . . 0.0 111.827 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.5 m80 -99.66 146.47 26.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.828 1.651 . . . . 0.0 109.065 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.79 125.17 50.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 109.412 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 30.1 t -88.37 136.87 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.497 1.119 . . . . 0.0 108.378 167.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -121.02 117.7 27.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.377 1.471 . . . . 0.0 109.865 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 93.9 t -106.14 138.59 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.185 1.394 . . . . 0.0 109.304 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 63.7 mttm -123.47 144.7 49.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.538 1.535 . . . . 0.0 112.646 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 69.2 tttt -118.87 116.38 26.37 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.389 2.276 . . . . 0.0 108.957 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.22 30.16 14.09 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.831 1.252 . . . . 0.0 113.572 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.77 -16.6 60.9 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.879 1.704 . . . . 0.0 115.956 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -97.78 149.99 21.73 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.482 1.641 . . . . 0.0 110.833 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 26.6 p80 -65.8 147.28 53.64 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 121.056 -1.028 . . . . 0.0 113.385 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -84.63 157.51 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.007 0.923 . . . . 0.0 111.132 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.67 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 7.0 m -70.53 -23.24 62.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.427 1.091 . . . . 0.0 113.65 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 150.34 55.22 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.41 148.56 89.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 118.681 0.565 . . . . 0.0 111.843 -4.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.72 118.81 55.47 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.423 1.089 . . . . 0.0 108.68 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.25 138.87 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.834 2.356 . . . . 0.0 111.293 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 51.6 t -134.16 121.9 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.573 1.549 . . . . 0.0 107.905 172.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.4 t -95.13 122.28 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.679 0.792 . . . . 0.0 109.944 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -95.52 129.22 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.751 1.22 . . . . 0.0 109.107 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.1 t -100.74 160.27 14.5 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.956 . . . . 0.0 111.572 172.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -59.17 -30.09 67.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.843 0.857 . . . . 0.0 112.855 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 19.5 m -67.23 -12.61 60.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.763 1.225 . . . . 0.0 113.725 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -97.16 -10.84 25.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.684 1.194 . . . . 0.0 112.779 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.281 1.032 . . . . 0.0 113.167 -170.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 161.92 45.64 0.02 OUTLIER Glycine 0 N--CA 1.469 0.897 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 27.4 t0 -78.52 95.1 5.09 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.063 0.931 . . . . 0.0 111.378 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.17 -39.58 86.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.48 -0.763 . . . . 0.0 112.487 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 29.4 m -60.47 -17.45 45.02 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.953 1.301 . . . . 0.0 113.974 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -93.39 -7.42 44.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.794 1.638 . . . . 0.0 114.487 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.2 t -75.3 137.41 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 120.302 1.41 . . . . 0.0 110.18 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -123.23 161.08 25.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 111.081 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.3 m -147.61 159.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.109 1.364 . . . . 0.0 111.86 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.89 176.05 12.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.097 1.359 . . . . 0.0 112.257 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.03 -165.1 14.3 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 125.553 1.549 . . . . 0.0 114.202 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -97.9 -38.24 9.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.349 1.06 . . . . 0.0 112.615 -172.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -74.08 3.02 40.38 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.489 1.042 . . . . 0.0 115.428 -167.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 98.4 mt -96.1 0.51 51.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.218 1.407 . . . . 0.0 112.412 166.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.73 -42.53 1.13 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.521 1.528 . . . . 0.0 113.471 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -158.77 154.91 27.0 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.49 -171.07 19.68 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.569 1.557 . . . . 0.0 114.017 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.5 m80 -141.27 146.4 36.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.148 1.379 . . . . 0.0 112.219 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 40.1 p -70.55 -21.46 62.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -115.86 -0.56 12.82 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -142.93 142.06 21.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.28 1.432 . . . . 0.0 110.177 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.62 149.4 55.14 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.937 2.424 . . . . 0.0 111.695 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.68 146.34 27.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.852 1.261 . . . . 0.0 110.562 172.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.73 146.47 48.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 112.628 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.5 p90 -152.48 148.58 27.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.403 1.481 . . . . 0.0 110.864 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.59 141.53 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.676 1.59 . . . . 0.0 109.207 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.6 mt -114.95 136.16 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.149 1.779 . . . . 0.0 108.744 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 60.2 t0 -124.52 108.18 11.83 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.152 1.781 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 58.0 p -101.62 0.66 36.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.848 1.659 . . . . 0.0 113.058 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.84 -37.13 80.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.51 1.05 . . . . 0.0 112.521 -172.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.68 -14.14 59.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 113.114 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -94.71 -4.61 47.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.169 1.788 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.71 -99.73 2.22 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.014 1.292 . . . . 0.0 111.947 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -142.21 152.38 43.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.127 1.371 . . . . 0.0 112.286 -165.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.83 179.26 26.44 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -88.19 122.33 6.27 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.39 0.995 . . . . 0.0 111.81 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.4 121.49 35.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.301 1.84 . . . . 0.0 108.334 171.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 15.0 m -113.34 143.25 44.78 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.827 1.251 . . . . 0.0 110.782 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -139.29 133.26 30.98 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 110.343 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.4 m -136.85 127.61 27.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.537 0.735 . . . . 0.0 111.452 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 25.9 mt -104.6 136.8 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.7 1.6 . . . . 0.0 108.948 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -132.79 151.49 51.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.21 1.804 . . . . 0.0 109.293 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.18 -160.31 33.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.194 -0.941 . . . . 0.0 114.59 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.0 -12.04 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 124.125 3.217 . . . . 0.0 114.474 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.5 t -159.48 168.35 26.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.666 1.187 . . . . 0.0 111.687 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -66.35 151.84 46.26 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -131.4 154.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.856 1.262 . . . . 0.0 111.18 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.88 138.22 32.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.694 0.398 . . . . 0.0 110.272 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 44.3 mt -121.4 135.83 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 109.163 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -132.37 154.61 49.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.208 1.803 . . . . 0.0 109.803 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 31.4 p -139.8 152.44 46.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.692 1.197 . . . . 0.0 111.664 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -152.72 106.98 3.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.35 134.43 35.26 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.919 1.288 . . . . 0.0 111.137 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 79.2 mt -110.22 162.28 14.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.481 1.112 . . . . 0.0 113.451 -163.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -70.65 -13.28 62.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.024 1.33 . . . . 0.0 113.159 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.72 -8.09 59.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.433 1.093 . . . . 0.0 112.795 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.09 1.2 73.0 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.349 1.452 . . . . 0.0 114.696 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 49.0 p -93.81 172.42 8.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.364 1.866 . . . . 0.0 111.191 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 47.0 t -129.02 126.63 39.92 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.096 0.958 . . . . 0.0 111.47 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.23 136.29 36.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.366 1.067 . . . . 0.0 109.613 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.4 t -115.25 138.43 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 108.083 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.6 p -134.19 147.0 50.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.177 1.391 . . . . 0.0 110.871 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 6.9 p90 -151.58 152.49 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.006 0.922 . . . . 0.0 112.096 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 8.2 t -123.78 113.23 28.69 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.892 0.877 . . . . 0.0 111.195 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.95 175.54 9.15 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.029 3.153 . . . . 0.0 111.284 174.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 99.5 m -129.25 -46.22 1.22 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.39 1.076 . . . . 0.0 111.91 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -85.92 144.65 39.57 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.919 0.888 . . . . 0.0 110.637 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.16 160.41 33.02 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.092 2.528 . . . . 0.0 110.989 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 132.22 -162.9 24.0 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 125.196 1.379 . . . . 0.0 113.703 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -90.85 121.49 32.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.639 0.776 . . . . 0.0 111.426 176.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -98.98 143.41 29.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.872 1.269 . . . . 0.0 110.854 165.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.34 132.84 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.799 1.639 . . . . 0.0 108.031 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.61 124.58 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.3 1.04 . . . . 0.0 109.82 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -101.35 128.34 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.181 1.792 . . . . 0.0 109.91 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.1 mm -120.67 115.5 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.919 1.287 . . . . 0.0 109.814 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.08 135.37 54.37 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.642 1.577 . . . . 0.0 110.989 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 63.1 t80 -129.69 125.83 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.287 1.435 . . . . 0.0 110.127 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 34.57 18.04 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.165 1.386 . . . . 0.0 113.53 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.252 63.4 m-20 74.05 21.23 2.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.035 2.534 . . . . 0.0 114.176 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -125.38 137.38 54.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.899 1.28 . . . . 0.0 110.972 169.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2124 ' ' HIS . . . . . 0.58 ' CE1' ' HG ' ' A' 2128 ' ' SER . 0.2 OUTLIER -68.45 129.75 40.85 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.487 1.115 . . . . 0.0 110.882 177.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.8 m -77.46 155.23 81.6 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 111.2 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 141.05 75.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.61 2.207 . . . . 0.0 111.432 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 90.37 -24.01 18.89 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.177 1.37 . . . . 0.0 113.608 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2128 ' ' SER . . . . . 0.58 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 22.5 t -76.99 144.62 72.45 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.276 1.038 . . . . 0.0 111.133 173.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.48 149.57 89.16 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.876 0.992 . . . . 0.0 112.139 -2.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -102.0 127.72 48.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.076 1.351 . . . . 0.0 110.996 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 37.6 m -89.75 135.12 33.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.03 171.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.0 t -132.88 112.52 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.54 1.536 . . . . 0.0 109.556 -168.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.55 108.99 13.51 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.784 -0.572 . . . . 0.0 111.29 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.8 t -95.28 118.18 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 0.0 108.772 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -97.31 152.52 18.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.179 0.992 . . . . 0.0 111.106 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 162.84 -158.28 30.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -165.26 179.61 6.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.674 1.989 . . . . 0.0 110.983 -174.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -70.79 133.16 22.73 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.431 -0.793 . . . . 0.0 112.449 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -77.52 145.88 36.69 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.666 1.186 . . . . 0.0 111.86 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 71.1 t -132.51 142.41 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.028 1.731 . . . . 0.0 109.601 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.048 1.739 . . . . 0.0 111.058 177.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.82 -9.38 58.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -67.41 -21.3 65.59 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.56 1.544 . . . . 0.0 114.294 -173.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -175.41 158.65 26.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.23 1.395 . . . . 0.0 113.293 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 17.8 t70 -160.18 153.28 21.73 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.15 1.38 . . . . 0.0 111.827 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.93 4.44 8.22 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.428 1.491 . . . . 0.0 114.922 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 79.6 p -62.37 -21.2 65.15 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.876 1.271 . . . . 0.0 114.221 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 37.4 mmt -73.88 116.42 14.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.125 0.97 . . . . 0.0 110.319 172.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 143.85 55.51 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.145 0.978 . . . . 0.0 111.97 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.9 ptm -146.48 156.04 42.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.0 m -136.72 144.5 43.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.943 2.097 . . . . 0.0 108.581 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -147.83 157.92 43.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -159.77 141.02 12.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.223 1.809 . . . . 0.0 110.107 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 65.8 mttp -125.86 148.05 49.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.509 1.124 . . . . 0.0 112.215 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 23.7 t -133.88 134.46 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.611 1.564 . . . . 0.0 109.895 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.76 54.78 4.85 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.264 1.411 . . . . 0.0 112.882 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 18.9 m -61.98 147.94 45.41 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.57 1.548 . . . . 0.0 114.276 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -168.36 156.62 8.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.846 1.658 . . . . 0.0 111.816 -175.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -81.11 148.61 29.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.149 0.98 . . . . 0.0 111.61 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -93.3 148.76 21.76 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.907 1.283 . . . . 0.0 113.038 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 61.1 mt -133.72 126.74 19.11 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.339 1.456 . . . . 0.0 109.221 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.36 140.14 26.99 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.107 2.538 . . . . 0.0 111.104 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -139.71 135.56 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.96 1.304 . . . . 0.0 110.361 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.8 t30 39.63 69.54 0.29 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.085 2.154 . . . . 0.0 114.016 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.35 120.19 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.092 0.957 . . . . 0.0 111.261 -167.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 4.9 m -172.2 156.76 4.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.124 2.169 . . . . 0.0 110.058 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -86.47 72.11 10.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.162 0.985 . . . . 0.0 110.489 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 35.0 p -97.98 156.63 16.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.989 1.716 . . . . 0.0 111.777 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -91.84 117.79 30.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.466 1.106 . . . . 0.0 110.611 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.52 -9.07 46.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.537 1.135 . . . . 0.0 113.173 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 15.6 m -74.99 -19.33 60.14 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.672 1.189 . . . . 0.0 113.739 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.2 pp -130.25 5.37 4.84 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.514 1.525 . . . . 0.0 113.899 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.33 126.36 54.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.211 2.204 . . . . 0.0 107.768 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -130.85 148.6 52.64 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.244 1.418 . . . . 0.0 110.184 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -138.71 150.16 45.86 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 112.715 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.0 p -140.47 159.84 41.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.606 1.963 . . . . 0.0 109.951 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 3.9 t -114.62 135.54 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.546 1.138 . . . . 0.0 109.598 169.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.7 t -108.39 114.37 59.33 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.066 1.347 . . . . 0.0 108.498 167.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.77 173.11 13.3 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 124.151 3.234 . . . . 0.0 111.269 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.28 -29.11 45.71 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.016 3.144 . . . . 0.0 114.895 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 30.3 p -83.92 -5.57 59.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.219 1.408 . . . . 0.0 114.464 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 80.95 3.02 90.67 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.969 1.271 . . . . 0.0 114.52 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -74.04 77.51 1.71 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.533 1.933 . . . . 0.0 111.706 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.78 133.08 55.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.203 1.001 . . . . 0.0 112.127 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.72 150.03 61.57 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.249 1.42 . . . . 0.0 110.957 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.51 152.63 34.1 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.698 2.932 . . . . 0.0 112.412 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.9 m -91.61 155.12 18.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.484 1.114 . . . . 0.0 111.794 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 65.5 tp -77.82 140.46 39.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 152.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.3 mt -108.3 142.35 38.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.768 1.227 . . . . 0.0 110.347 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -136.89 138.84 41.13 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.919 1.287 . . . . 0.0 112.379 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -80.39 123.73 28.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 151.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.2 mt -96.27 164.25 12.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.234 1.413 . . . . 0.0 111.399 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -63.9 -18.23 63.99 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.15 2.8 56.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.994 0.917 . . . . 0.0 113.198 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.97 -9.03 73.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.028 1.775 . . . . 0.0 114.594 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -80.79 170.37 16.38 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.899 1.68 . . . . 0.0 113.416 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.2 t -115.19 141.73 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.314 1.446 . . . . 0.0 110.483 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -149.35 174.1 29.01 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.44 157.64 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.174 1.79 . . . . 0.0 111.318 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.8 m -137.79 146.59 43.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.565 1.546 . . . . 0.0 109.795 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 4.2 p90 -166.21 171.17 12.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 111.103 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 88.3 t -119.08 121.36 30.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.089 0.955 . . . . 0.0 109.607 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.27 143.22 17.37 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.019 3.146 . . . . 0.0 110.969 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -84.64 -21.67 30.19 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.89 0.876 . . . . 0.0 112.227 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -142.27 172.2 13.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.522 1.929 . . . . 0.0 110.704 -168.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.7 p -91.99 169.94 10.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.911 1.285 . . . . 0.0 111.454 171.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.42 -173.41 23.0 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.374 1.464 . . . . 0.0 113.915 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.82 109.5 6.45 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.32 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 14.5 m80 -95.62 140.55 30.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.231 1.412 . . . . 0.0 109.387 170.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.21 122.91 45.11 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.37 1.068 . . . . 0.0 109.075 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 96.4 t -86.66 118.42 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -101.18 149.42 24.0 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 125.228 1.411 . . . . 0.0 110.567 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.7 p -160.37 126.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 122.167 0.984 . . . . 0.0 111.398 -170.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -128.22 129.43 46.41 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.399 1.879 . . . . 0.0 111.599 -164.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 60.7 tttm -109.93 132.83 53.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.335 1.454 . . . . 0.0 110.223 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.51 -96.69 0.07 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.012 1.325 . . . . 0.0 111.474 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -122.47 10.78 9.15 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.497 1.523 . . . . 0.0 115.533 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -145.93 149.79 34.86 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.091 1.945 . . . . 0.0 113.78 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.29 157.43 37.73 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.653 0.781 . . . . 0.0 112.421 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.6 m -84.86 163.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.84 0.856 . . . . 0.0 111.539 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.2 69.12 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 29.9 m -86.29 -14.63 43.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.966 1.307 . . . . 0.0 114.367 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.3 p -93.03 153.61 41.78 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.869 -1.145 . . . . 0.0 113.478 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.32 150.75 96.04 Favored 'Cis proline' 0 C--N 1.354 0.826 0 CA-C-N 119.125 0.723 . . . . 0.0 112.597 -1.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.86 121.64 50.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.825 1.25 . . . . 0.0 108.469 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.1 138.07 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.854 2.369 . . . . 0.0 111.139 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.3 t -133.99 122.56 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.59 1.556 . . . . 0.0 107.884 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -94.11 122.2 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.489 0.716 . . . . 0.0 110.067 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.91 137.43 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.128 1.371 . . . . 0.0 109.239 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 14.4 t -122.86 161.58 23.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.114 . . . . 0.0 110.896 170.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -61.17 -26.81 67.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.143 0.977 . . . . 0.0 113.602 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 23.8 p -67.53 -15.29 63.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.542 1.137 . . . . 0.0 113.923 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.42 -9.33 47.92 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.627 1.171 . . . . 0.0 112.596 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.77 110.13 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.328 0.967 . . . . 0.0 110.91 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 72.56 11.83 77.14 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 117.274 1.669 . . . . 0.0 117.274 156.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -75.04 91.72 2.56 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.454 1.627 . . . . 0.0 111.212 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.09 67.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.495 1.118 . . . . 0.0 112.38 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.2 m -54.03 -25.49 21.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.952 1.701 . . . . 0.0 114.148 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -88.31 -12.12 44.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.014 1.326 . . . . 0.0 113.619 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 68.4 t -74.33 134.75 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.592 1.087 . . . . 0.0 110.105 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -116.63 158.65 23.39 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.452 1.501 . . . . 0.0 110.876 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 34.8 m -146.61 159.07 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.428 1.491 . . . . 0.0 110.667 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -158.99 168.57 26.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.416 1.086 . . . . 0.0 112.336 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.43 159.32 23.03 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.189 1.376 . . . . 0.0 114.205 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -70.63 -26.71 63.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.112 1.365 . . . . 0.0 113.614 -168.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.97 -4.46 48.52 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.593 1.092 . . . . 0.0 115.063 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.4 -2.77 57.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.162 1.385 . . . . 0.0 112.715 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -128.84 -38.05 1.69 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.951 1.3 . . . . 0.0 113.794 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.75 161.61 39.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.094 0.958 . . . . 0.0 113.177 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.33 -174.24 24.98 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.905 1.241 . . . . 0.0 114.11 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -138.94 144.83 39.19 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.154 1.382 . . . . 0.0 112.105 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 38.6 p -70.51 -18.63 62.96 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.42 -2.14 12.12 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -143.94 144.69 27.52 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.363 1.465 . . . . 0.0 110.178 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.62 150.09 50.3 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.218 . . . . 0.0 111.656 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -98.25 154.09 18.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.42 1.488 . . . . 0.0 110.73 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -134.39 150.94 50.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.808 0.843 . . . . 0.0 112.691 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -157.06 149.84 23.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 110.837 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 140.69 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.842 1.657 . . . . 0.0 109.288 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 43.4 mt -111.68 135.8 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.761 . . . . 0.0 109.032 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 66.5 t0 -125.04 98.37 5.65 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.989 1.715 . . . . 0.0 110.536 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.3 p -94.24 1.0 56.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.316 1.847 . . . . 0.0 113.023 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -61.16 -34.81 75.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.343 0.974 . . . . 0.0 112.851 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.77 -18.24 51.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.522 1.129 . . . . 0.0 113.133 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -88.31 -14.84 37.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.147 1.379 . . . . 0.0 114.014 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.02 -113.17 3.58 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.509 1.052 . . . . 0.0 111.727 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -107.49 144.01 35.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.157 1.383 . . . . 0.0 113.067 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 143.38 144.01 4.2 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.819 1.199 . . . . 0.0 112.982 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -73.65 142.13 30.63 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.632 0.634 . . . . 0.0 112.772 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 127.09 42.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.578 1.551 . . . . 0.0 108.736 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 43.7 t -120.3 135.96 54.84 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.667 1.587 . . . . 0.0 109.506 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -139.58 136.11 34.08 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.288 1.035 . . . . 0.0 110.873 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.7 m -139.83 130.55 25.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 111.398 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 26.5 mt -109.86 136.79 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.463 1.505 . . . . 0.0 108.442 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.5 155.81 42.8 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.162 0.985 . . . . 0.0 111.605 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.39 -146.44 12.56 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.024 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.95 -15.24 36.31 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.897 3.065 . . . . 0.0 114.588 -172.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.9 t -160.44 170.81 20.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.527 1.131 . . . . 0.0 111.669 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -71.99 155.27 40.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.195 0.998 . . . . 0.0 111.589 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.99 162.68 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.3 1.44 . . . . 0.0 110.946 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.49 131.61 36.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.697 0.799 . . . . 0.0 110.146 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.5 mt -111.1 132.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.188 0.995 . . . . 0.0 109.369 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -130.4 155.55 46.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.32 1.848 . . . . 0.0 109.624 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 29.6 p -142.05 160.19 40.72 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.396 1.078 . . . . 0.0 112.315 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -152.55 107.59 3.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.586 1.554 . . . . 0.0 109.347 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.19 129.94 34.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.768 1.227 . . . . 0.0 110.644 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.7 155.99 19.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.711 1.204 . . . . 0.0 112.436 -167.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.12 -18.27 64.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.487 1.115 . . . . 0.0 112.949 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.39 -11.07 60.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.77 -2.88 73.56 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.096 1.808 . . . . 0.0 114.395 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 61.7 p -90.41 174.63 7.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.546 1.938 . . . . 0.0 111.002 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -136.14 128.83 30.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.538 0.735 . . . . 0.0 111.702 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.5 138.03 36.51 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.765 1.226 . . . . 0.0 109.924 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 22.1 t -116.84 138.83 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.656 1.982 . . . . 0.0 108.223 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -137.46 144.02 42.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.345 1.458 . . . . 0.0 111.258 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 8.1 p90 -157.34 151.96 25.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.304 1.042 . . . . 0.0 112.384 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 10.6 t -117.82 108.61 42.49 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.791 0.836 . . . . 0.0 111.213 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.25 152.42 35.04 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.202 2.601 . . . . 0.0 110.527 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 85.2 m -112.69 -37.97 4.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.923 0.889 . . . . 0.0 112.582 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -96.08 148.12 34.03 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 110.733 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 161.23 36.1 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.027 2.485 . . . . 0.0 111.05 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.71 -159.86 18.3 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.109 1.337 . . . . 0.0 113.563 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.7 t30 -95.74 120.01 35.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.052 0.941 . . . . 0.0 111.765 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -98.79 144.9 27.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.775 1.23 . . . . 0.0 110.873 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.22 136.69 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.273 1.429 . . . . 0.0 108.701 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.6 126.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.129 1.372 . . . . 0.0 109.295 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -102.14 131.29 48.74 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.17 1.788 . . . . 0.0 110.297 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.5 mm -123.54 114.2 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.869 1.267 . . . . 0.0 109.592 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -119.71 134.06 55.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.966 1.706 . . . . 0.0 110.908 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -126.36 124.42 40.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.162 1.385 . . . . 0.0 109.737 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.71 36.21 23.2 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.1 1.36 . . . . 0.0 114.035 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 20.9 t70 95.71 -11.2 0.09 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 130.242 3.417 . . . . 0.0 113.611 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -112.72 134.91 54.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.039 . . . . 0.0 112.591 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2124 ' ' HIS . . . . . 0.582 ' CE1' ' HG ' ' A' 2128 ' ' SER . 0.3 OUTLIER -63.4 128.77 37.35 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.884 1.274 . . . . 0.0 110.822 173.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 10.3 m -72.94 156.2 89.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-N 119.551 1.068 . . . . 0.0 111.549 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.07 -35.39 90.27 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.792 2.995 . . . . 0.0 116.393 -170.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.55 75.96 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.567 0.622 . . . . 0.0 114.561 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2128 ' ' SER . . . . . 0.582 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 36.1 t -82.82 146.42 52.48 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.056 1.342 . . . . 0.0 111.442 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.66 152.68 93.29 Favored 'Cis proline' 0 C--N 1.351 0.697 0 CA-C-N 119.815 0.97 . . . . 0.0 112.453 -1.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.38 126.34 51.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 13.9 p -90.01 137.14 32.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.523 1.129 . . . . 0.0 111.35 171.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 21.2 t -133.46 112.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 -168.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -80.72 107.99 13.99 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.529 0.731 . . . . 0.0 111.253 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 92.3 t -94.32 120.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.59 1.156 . . . . 0.0 109.261 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.3 t -97.96 154.14 17.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -171.14 -171.12 36.06 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 29.4 tt0 92.64 137.36 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 129.804 3.242 . . . . 0.0 110.867 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 87.76 64.37 1.37 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.435 1.016 . . . . 0.0 112.099 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -62.95 156.96 22.97 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.817 1.247 . . . . 0.0 113.655 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 28.5 m -67.63 150.92 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.336 1.054 . . . . 0.0 111.338 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.637 1.175 . . . . 0.0 112.45 179.433 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.56 166.33 23.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.439 1.096 . . . . 0.0 113.04 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -72.27 -15.3 61.91 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.164 1.386 . . . . 0.0 114.09 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.42 -105.72 0.68 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.934 1.731 . . . . 0.0 111.48 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 19.8 t70 79.51 -9.8 1.41 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 128.25 2.62 . . . . 0.0 114.177 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 44.1 m-20 78.6 146.26 0.09 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 129.62 3.168 . . . . 0.0 113.704 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 26.9 m -78.17 -10.42 59.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.286 1.034 . . . . 0.0 113.627 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 57.9 tpp -71.29 121.56 18.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.815 1.246 . . . . 0.0 111.338 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.08 152.86 21.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.56 1.144 . . . . 0.0 110.677 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 95.7 mtp -122.75 139.23 54.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.632 1.573 . . . . 0.0 111.401 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.1 m -130.11 141.56 50.68 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.29 1.836 . . . . 0.0 108.871 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.1 t60 -140.78 150.69 43.67 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -166.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.47 140.56 20.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.07 1.748 . . . . 0.0 109.641 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.42 144.39 49.49 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.635 1.174 . . . . 0.0 111.282 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.2 p -155.25 141.65 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.093 0.957 . . . . 0.0 111.399 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -75.89 150.81 39.96 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.007 0.813 . . . . 0.0 112.331 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 33.0 m -131.94 127.64 36.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.794 0.837 . . . . 0.0 111.603 -171.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.68 147.24 18.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.633 0.773 . . . . 0.0 112.677 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -82.17 138.25 34.76 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.727 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.49 143.51 33.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.226 1.01 . . . . 0.0 112.178 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.75 125.67 23.08 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.543 1.137 . . . . 0.0 108.97 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.58 140.77 24.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.046 2.498 . . . . 0.0 111.158 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 35.3 mm -137.74 139.17 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.291 1.836 . . . . 0.0 109.065 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.84 46.69 19.32 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 0.0 112.707 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.93 -29.33 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.28 1.832 . . . . 0.0 113.974 -165.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -64.62 -18.41 64.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.28 161.69 37.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.277 1.431 . . . . 0.0 111.952 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.0 m -122.11 121.85 37.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.858 1.263 . . . . 0.0 109.759 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -158.74 128.8 5.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.492 1.517 . . . . 0.0 110.0 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.6 mt -116.06 -3.55 12.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.616 1.566 . . . . 0.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 51.6 m -94.96 -29.17 14.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.051 . . . . 0.0 113.313 -168.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 1.74 12.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.118 1.367 . . . . 0.0 114.442 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.2 tp -91.01 137.21 32.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.924 0.784 . . . . 0.0 111.735 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 33.9 p -141.42 140.03 33.56 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.099 1.759 . . . . 0.0 109.392 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.16 149.93 45.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.866 0.866 . . . . 0.0 113.185 -173.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 77.4 p -138.21 162.63 33.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.075 2.15 . . . . 0.0 109.87 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -118.27 136.44 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.966 1.306 . . . . 0.0 109.791 168.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.8 t -105.28 113.83 64.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.137 1.375 . . . . 0.0 108.27 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.53 172.3 11.5 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.97 3.113 . . . . 0.0 111.737 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.51 -29.14 38.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.85 3.7 . . . . 0.0 114.848 170.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 57.3 p -81.32 -8.29 59.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.796 1.238 . . . . 0.0 114.164 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.5 -0.2 81.78 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.421 1.486 . . . . 0.0 114.815 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -76.58 83.05 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.38 1.472 . . . . 0.0 111.532 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.44 135.77 57.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.727 1.211 . . . . 0.0 112.148 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.79 151.69 66.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.477 1.511 . . . . 0.0 111.323 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.57 152.38 43.01 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.844 3.03 . . . . 0.0 112.392 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 77.9 m -98.3 154.78 17.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.92 1.288 . . . . 0.0 112.179 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.17 116.43 26.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.534 1.134 . . . . 0.0 108.17 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.21 135.78 33.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.604 1.161 . . . . 0.0 111.469 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.37 147.64 52.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.602 1.561 . . . . 0.0 112.413 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -92.6 115.68 28.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.0 mt -90.22 171.5 9.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.612 0.765 . . . . 0.0 112.729 -170.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -59.83 -34.2 72.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 113.814 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 53.7 t30 -80.41 -11.91 59.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.463 1.105 . . . . 0.0 113.814 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 103.81 -14.88 52.86 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.653 1.597 . . . . 0.0 114.525 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 159.87 32.63 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 118.266 1.033 . . . . 0.0 113.183 172.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.7 t -85.06 150.55 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.831 1.252 . . . . 0.0 109.056 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.56 174.53 30.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.109 0.862 . . . . 0.0 114.987 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.43 162.46 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.213 1.805 . . . . 0.0 112.072 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 74.1 m -144.4 150.25 37.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.423 1.889 . . . . 0.0 110.41 166.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.21 178.44 8.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.485 1.914 . . . . 0.0 110.763 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 67.9 t -130.58 123.35 20.27 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.155 0.982 . . . . 0.0 109.93 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.71 148.89 23.1 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.787 3.658 . . . . 0.0 112.075 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 mptt -106.84 -9.76 16.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.516 1.126 . . . . 0.0 113.48 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.76 172.03 13.37 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.664 1.986 . . . . 0.0 110.329 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 32.9 p -96.02 154.38 17.27 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.619 1.168 . . . . 0.0 110.903 167.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 104.31 -165.76 15.08 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.168 1.366 . . . . 0.0 113.931 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.84 114.3 10.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.36 1.064 . . . . 0.0 112.213 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 18.9 m80 -95.77 143.26 27.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.644 1.578 . . . . 0.0 109.07 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -107.37 123.3 48.17 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.053 0.941 . . . . 0.0 108.908 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 93.4 t -83.65 121.23 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 166.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.81 138.56 40.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.153 . . . . 0.0 110.095 170.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -146.42 133.68 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.086 0.946 . . . . 0.0 112.503 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.88 139.69 50.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.893 2.077 . . . . 0.0 111.602 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.87 109.37 20.45 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.422 2.689 . . . . 0.0 108.413 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 54.18 -103.74 0.19 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.925 1.29 . . . . 0.0 111.457 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.03 6.38 34.79 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.871 1.701 . . . . 0.0 115.514 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -129.22 148.72 51.18 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.287 1.543 . . . . 0.0 111.638 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 29.8 p80 -66.01 147.14 53.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.62 -1.3 . . . . 0.0 112.101 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.0 t -72.72 144.85 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.32 -24.73 60.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 54.5 p -84.27 -12.45 54.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.113 1.365 . . . . 0.0 114.075 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 9.6 t -80.01 140.05 53.62 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 120.871 -1.143 . . . . 0.0 112.62 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.27 152.49 83.99 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 119.536 0.87 . . . . 0.0 112.498 -5.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.77 122.58 45.42 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.336 1.454 . . . . 0.0 108.739 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.29 143.09 12.35 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.08 2.52 . . . . 0.0 111.777 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.4 t -139.32 117.45 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.422 1.489 . . . . 0.0 108.486 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 51.3 t -94.85 122.86 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.61 0.764 . . . . 0.0 110.174 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.73 129.43 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.11 1.364 . . . . 0.0 110.364 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 73.3 m -94.77 159.72 14.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.234 1.414 . . . . 0.0 112.102 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -59.25 -26.95 65.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.182 -0.948 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.9 p -65.43 -18.92 65.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.528 1.531 . . . . 0.0 114.18 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.39 -4.87 28.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.241 1.416 . . . . 0.0 112.95 -175.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.1 mm -73.64 -34.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.289 1.036 . . . . 0.0 112.602 -173.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 154.34 45.61 0.02 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.853 0.74 . . . . 0.0 114.388 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.52 100.74 10.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.459 1.129 . . . . 0.0 110.858 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.82 -35.96 69.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.988 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 13.1 t -54.19 -29.08 44.59 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.899 1.279 . . . . 0.0 113.31 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -85.79 -9.85 56.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.728 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 63.3 t -76.94 129.96 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.546 1.066 . . . . 0.0 109.594 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -109.08 155.42 20.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.467 1.507 . . . . 0.0 110.867 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.2 m -145.24 148.62 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.992 1.317 . . . . 0.0 110.938 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.6 m -151.62 157.09 41.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.853 1.261 . . . . 0.0 112.14 -175.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 119.03 161.34 11.66 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.496 1.046 . . . . 0.0 114.953 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -64.74 -33.06 75.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.782 1.633 . . . . 0.0 113.225 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.24 -3.58 46.6 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.783 1.182 . . . . 0.0 115.013 -176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.86 -7.6 57.0 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.242 1.417 . . . . 0.0 112.745 168.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -128.1 -36.9 1.92 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 113.942 -173.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -156.75 157.23 34.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.351 1.06 . . . . 0.0 112.911 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.26 -175.04 25.85 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.564 1.078 . . . . 0.0 114.346 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 62.6 m80 -139.58 142.07 37.14 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.143 1.377 . . . . 0.0 112.128 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 55.8 p -73.2 -14.81 61.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -115.29 -2.89 12.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -145.0 145.35 26.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.562 1.545 . . . . 0.0 110.195 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.49 143.0 50.7 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.543 2.162 . . . . 0.0 111.26 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -96.5 163.03 13.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.253 1.421 . . . . 0.0 110.452 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.46 159.41 44.5 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.82 153.52 24.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.379 1.872 . . . . 0.0 110.222 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.73 140.03 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 109.282 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.31 134.3 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.012 1.725 . . . . 0.0 108.421 168.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.3 t0 -120.0 101.19 7.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.183 1.793 . . . . 0.0 110.102 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.4 p -94.89 0.57 54.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.327 1.851 . . . . 0.0 113.129 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -60.4 -36.12 77.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.443 1.019 . . . . 0.0 113.203 -170.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.99 -17.51 52.7 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.266 1.026 . . . . 0.0 113.214 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.77 -6.67 55.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.552 1.541 . . . . 0.0 113.731 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 78.79 -111.97 3.36 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.166 1.365 . . . . 0.0 112.641 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -115.75 164.81 13.83 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.195 1.798 . . . . 0.0 112.388 -172.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.74 -134.81 5.3 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.523 1.059 . . . . 0.0 113.041 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -155.88 140.56 7.36 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.479 1.038 . . . . 0.0 112.435 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.48 121.45 41.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.357 1.863 . . . . 0.0 109.591 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.7 m -107.81 140.11 41.39 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.241 1.817 . . . . 0.0 109.872 167.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -142.28 137.96 31.01 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.072 0.949 . . . . 0.0 110.045 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 86.5 p -135.17 148.62 49.76 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.557 0.694 . . . . 0.0 111.873 169.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.2 mt -122.91 125.74 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -119.46 145.61 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.314 1.446 . . . . 0.0 109.274 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 174.92 -163.79 34.21 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.92 -2.41 11.46 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.714 3.609 . . . . 0.0 114.225 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -160.53 165.61 30.55 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.949 1.3 . . . . 0.0 111.351 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -71.3 143.0 50.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.277 1.031 . . . . 0.0 110.905 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 7.6 m -121.32 150.23 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.315 1.446 . . . . 0.0 110.693 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.91 110.94 22.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.692 0.797 . . . . 0.0 109.985 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.56 134.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 109.913 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.7 164.3 27.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.551 1.94 . . . . 0.0 110.897 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 14.6 p -138.16 155.26 48.89 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.609 1.564 . . . . 0.0 112.039 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.29 130.61 12.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.719 1.208 . . . . 0.0 110.728 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.6 t70 -85.64 125.37 33.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.793 1.237 . . . . 0.0 110.602 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.05 152.46 18.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.217 1.007 . . . . 0.0 111.835 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.09 -12.57 61.8 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.517 1.127 . . . . 0.0 113.678 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.38 -6.26 59.41 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.83 1.252 . . . . 0.0 113.009 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.2 5.22 59.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.639 1.59 . . . . 0.0 114.856 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 37.2 p -98.46 166.41 11.37 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.456 1.902 . . . . 0.0 111.661 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.3 t -116.35 124.79 50.97 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.274 1.029 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -88.3 133.55 34.04 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.107 1.363 . . . . 0.0 109.623 170.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 60.6 t -111.89 137.29 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.259 1.424 . . . . 0.0 108.741 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.5 p -126.71 146.05 50.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.555 1.942 . . . . 0.0 110.15 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.1 p90 -160.9 149.58 16.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.264 1.026 . . . . 0.0 112.043 175.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.1 t -118.08 113.25 37.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.789 0.836 . . . . 0.0 110.995 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.47 166.75 25.46 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.67 2.914 . . . . 0.0 110.787 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.1 m -129.99 -43.44 1.21 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 0.0 112.551 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -87.89 144.46 34.89 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 123.684 0.793 . . . . 0.0 109.812 168.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.97 164.02 27.81 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.27 2.647 . . . . 0.0 111.319 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 129.53 -160.79 22.76 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.223 1.392 . . . . 0.0 113.679 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -88.73 124.53 34.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.323 0.649 . . . . 0.0 111.305 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -106.05 140.81 38.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.732 1.213 . . . . 0.0 109.884 166.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.9 mp -107.21 127.41 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.955 1.302 . . . . 0.0 108.264 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 14.4 mt -110.86 128.48 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.239 1.016 . . . . 0.0 109.786 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -108.94 125.79 52.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.855 1.262 . . . . 0.0 110.106 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -111.31 121.76 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 173.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 3.6 tmmt? -133.21 127.33 33.54 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.874 1.269 . . . . 0.0 110.982 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -125.6 127.75 46.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.064 1.346 . . . . 0.0 110.651 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 48.95 48.38 20.67 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.705 1.202 . . . . 0.0 112.92 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t70 79.99 -2.2 2.03 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.45 2.7 . . . . 0.0 114.145 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -121.51 127.58 51.16 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.812 -168.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -66.34 125.97 27.31 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.832 1.253 . . . . 0.0 111.297 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.6 m -82.5 159.05 65.06 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.227 -0.92 . . . . 0.0 111.72 -169.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.88 143.08 73.37 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.756 2.971 . . . . 0.0 113.526 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.96 -23.08 19.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.852 1.215 . . . . 0.0 114.232 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 70.7 m -73.44 151.73 89.69 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 118.65 1.225 . . . . 0.0 111.696 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.06 141.67 72.46 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.192 0.747 . . . . 0.0 111.408 -6.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -94.57 117.47 30.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.079 0.951 . . . . 0.0 110.339 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 16.7 m -82.98 129.06 34.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.32 0.648 . . . . 0.0 110.859 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.9 t -123.24 114.58 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.147 1.779 . . . . 0.0 109.172 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.54 105.5 10.89 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.002 0.521 . . . . 0.0 110.969 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 82.9 t -93.13 118.47 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.384 1.074 . . . . 0.0 109.042 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 156.53 16.3 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.388 1.075 . . . . 0.0 110.406 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 174.04 -157.92 26.28 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 26.9 tt0 85.82 -34.52 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 129.195 2.998 . . . . 0.0 112.942 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -83.65 86.48 1.51 Allowed Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.393 0.997 . . . . 0.0 111.452 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -59.46 142.49 52.32 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.956 1.302 . . . . 0.0 112.287 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 75.7 t -98.71 140.04 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.617 1.567 . . . . 0.0 109.505 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.751 1.62 . . . . 0.0 111.332 179.69 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.307 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.48 -22.78 54.07 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.033 1.333 . . . . 0.0 113.745 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -143.03 -19.53 0.65 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.065 1.346 . . . . 0.0 114.501 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 178.84 -126.18 1.04 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.109 1.338 . . . . 0.0 112.164 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -80.24 12.91 2.6 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.618 1.567 . . . . 0.0 113.42 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.03 -20.54 65.42 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.274 1.83 . . . . 0.0 114.528 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 64.5 p -173.46 159.47 3.69 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.891 2.077 . . . . 0.0 111.12 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 19.0 mmt -138.35 165.92 25.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.267 1.427 . . . . 0.0 111.959 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -57.82 135.16 56.79 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.261 1.425 . . . . 0.0 112.48 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 26.9 ptm -61.77 154.56 25.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.694 1.197 . . . . 0.0 113.137 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.8 m -121.52 145.79 47.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.598 1.559 . . . . 0.0 109.069 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -155.76 160.22 40.12 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.1 tt -163.05 155.13 18.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.766 2.026 . . . . 0.0 110.836 -172.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 68.4 mttm -130.25 151.85 50.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 112.766 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.8 t -138.46 131.14 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.651 1.58 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.2 77.35 1.86 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.687 1.136 . . . . 0.0 111.41 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 60.4 m -75.76 152.64 37.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.44 150.19 14.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.907 1.283 . . . . 0.0 112.849 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.39 160.96 25.21 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.755 1.222 . . . . 0.0 111.842 167.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.87 141.33 28.76 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.404 1.482 . . . . 0.0 112.66 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 37.4 mm -123.13 115.69 28.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.257 1.423 . . . . 0.0 108.887 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.7 132.39 11.99 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.35 2.7 . . . . 0.0 111.358 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 33.9 mt -148.39 143.13 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.841 1.656 . . . . 0.0 110.411 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 57.58 51.25 9.82 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.929 1.692 . . . . 0.0 112.478 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.39 -30.25 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.695 1.598 . . . . 0.0 112.614 -170.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 19.5 m -72.25 -15.31 61.92 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -81.77 141.0 33.9 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.208 0.913 . . . . 0.0 112.033 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -115.35 -34.32 4.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.106 1.762 . . . . 0.0 111.448 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.87 60.42 6.23 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.698 1.199 . . . . 0.0 111.815 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.43 -26.08 67.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.89 1.676 . . . . 0.0 112.42 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 20.5 m -59.49 -23.59 62.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.74 2.61 25.83 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.4 mp -84.47 145.98 27.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.483 1.113 . . . . 0.0 111.579 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.3 p -139.94 154.72 47.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.46 1.904 . . . . 0.0 109.171 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -147.97 152.16 37.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.8 p -140.99 159.48 42.12 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.594 1.958 . . . . 0.0 110.414 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.8 t -112.98 134.8 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.055 1.342 . . . . 0.0 109.525 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 99.6 t -103.01 111.68 65.23 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.038 1.335 . . . . 0.0 108.104 163.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.37 168.25 21.8 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.747 2.965 . . . . 0.0 110.743 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.71 -15.85 48.63 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.061 2.507 . . . . 0.0 113.267 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.6 p -79.75 -9.63 59.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 113.923 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.78 -2.01 84.51 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.665 1.602 . . . . 0.0 115.065 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -77.1 77.78 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.442 1.497 . . . . 0.0 111.712 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.77 134.93 56.69 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.864 1.265 . . . . 0.0 112.04 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -140.51 151.04 62.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.216 1.406 . . . . 0.0 111.32 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.38 153.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.87 3.046 . . . . 0.0 112.385 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 86.8 m -98.6 155.7 17.17 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.998 1.319 . . . . 0.0 112.381 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.8 tp -87.88 117.97 27.1 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 160.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 32.2 mt -81.16 140.99 34.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.96 0.904 . . . . 0.0 110.256 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -136.12 141.56 44.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.828 1.251 . . . . 0.0 113.139 -174.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -82.72 117.54 22.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.282 1.433 . . . . 0.0 107.93 157.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.06 171.02 7.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.776 1.23 . . . . 0.0 112.421 -172.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -56.73 -36.71 70.05 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.646 1.578 . . . . 0.0 115.049 -166.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.15 2.22 44.53 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 91.8 1.99 70.04 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.672 1.606 . . . . 0.0 113.994 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.35 166.77 15.34 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.738 1.615 . . . . 0.0 113.837 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 79.8 t -96.9 144.43 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.898 1.679 . . . . 0.0 110.05 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.55 -179.95 32.84 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 123.941 0.781 . . . . 0.0 114.802 171.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.79 157.15 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.394 1.478 . . . . 0.0 112.476 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.1 m -130.32 151.88 50.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.571 1.548 . . . . 0.0 110.777 160.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.4 p90 -167.15 -179.63 4.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.669 2.388 . . . . 0.0 109.495 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.5 t -127.63 120.4 21.85 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 119.273 0.942 . . . . 0.0 110.022 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.93 145.03 17.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.161 3.241 . . . . 0.0 111.206 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 48.0 tttm -94.57 -50.12 5.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.911 0.884 . . . . 0.0 112.074 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.83 171.88 8.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.864 1.666 . . . . 0.0 111.2 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.1 p -91.23 173.69 7.79 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.421 1.488 . . . . 0.0 111.462 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 89.23 -164.98 32.45 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.978 1.275 . . . . 0.0 113.601 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.9 116.23 8.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.073 0.949 . . . . 0.0 111.702 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.4 m80 -103.49 144.56 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.962 1.705 . . . . 0.0 109.003 165.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.75 119.25 38.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.555 1.142 . . . . 0.0 109.681 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 92.3 t -88.11 131.83 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.305 1.042 . . . . 0.0 108.652 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -112.74 140.25 47.67 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.86 1.264 . . . . 0.0 110.054 168.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 2.9 p -138.81 133.36 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.931 0.892 . . . . 0.0 111.164 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -115.11 141.79 47.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.612 1.965 . . . . 0.0 112.649 -163.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -139.45 130.63 26.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.92 2.088 . . . . 0.0 110.055 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.93 31.89 14.24 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.542 1.137 . . . . 0.0 113.636 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.17 -2.62 81.61 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.44 1.495 . . . . 0.0 116.09 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -129.67 150.17 51.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.622 1.711 . . . . 0.0 111.723 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -66.11 139.49 58.16 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.846 -1.159 . . . . 0.0 112.044 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 20.0 m -69.23 161.26 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 111.499 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.93 63.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 17.3 m -76.77 -17.83 58.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.686 1.195 . . . . 0.0 114.127 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 45.0 m -79.05 144.58 63.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.738 -1.226 . . . . 0.0 112.922 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.5 147.19 81.4 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 118.827 0.617 . . . . 0.0 112.044 -5.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -97.31 121.67 58.01 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.924 1.29 . . . . 0.0 108.449 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.42 139.26 12.84 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.839 2.359 . . . . 0.0 111.288 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -131.05 124.14 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.629 1.572 . . . . 0.0 107.402 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.3 t -99.01 121.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.683 0.793 . . . . 0.0 110.084 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.02 122.36 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.902 1.281 . . . . 0.0 109.644 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 154.69 22.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.611 0.764 . . . . 0.0 111.372 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -55.37 -29.26 58.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.221 1.009 . . . . 0.0 112.698 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 34.1 m -68.7 -15.72 63.6 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -92.97 -14.88 26.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.365 1.066 . . . . 0.0 113.004 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.48 -28.42 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.714 1.206 . . . . 0.0 112.52 -173.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 146.77 94.57 0.15 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.132 1.349 . . . . 0.0 112.396 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.67 113.84 21.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.103 1.361 . . . . 0.0 109.477 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 112.282 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.4 m -53.3 -23.02 8.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.051 1.74 . . . . 0.0 114.115 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -87.33 -17.74 31.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.758 1.223 . . . . 0.0 114.151 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.0 t -78.75 136.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.625 1.102 . . . . 0.0 110.162 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -119.73 159.37 24.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.137 1.375 . . . . 0.0 110.516 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 26.9 m -145.92 157.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.58 . . . . 0.0 110.605 -178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -158.44 175.27 13.91 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.373 1.069 . . . . 0.0 112.565 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 101.15 166.67 27.87 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.436 1.493 . . . . 0.0 114.204 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.87 -35.2 79.48 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.611 1.164 . . . . 0.0 112.937 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.34 10.99 5.58 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.588 1.566 . . . . 0.0 115.152 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 80.1 mt -100.11 -7.49 24.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.831 1.652 . . . . 0.0 112.063 165.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -131.7 -41.6 1.05 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.485 1.514 . . . . 0.0 113.846 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.77 154.82 26.84 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.58 -170.58 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.552 1.548 . . . . 0.0 113.865 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 72.6 m80 -140.19 146.91 39.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.054 1.342 . . . . 0.0 112.407 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.8 p -73.26 -17.67 61.3 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.19 -3.61 12.52 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -144.4 145.09 27.68 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 110.268 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.75 145.95 52.81 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.977 2.452 . . . . 0.0 111.801 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -89.66 157.06 18.17 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.661 1.184 . . . . 0.0 110.672 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.95 145.34 44.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.819 0.848 . . . . 0.0 112.346 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -150.37 145.94 26.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.042 1.337 . . . . 0.0 111.023 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.02 144.68 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.21 1.804 . . . . 0.0 109.457 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 22.0 mt -118.96 135.67 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.266 1.826 . . . . 0.0 109.835 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -109.06 43.44 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.338 1.855 . . . . 0.0 112.669 -171.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 1.2 p -57.83 -21.36 41.97 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -29.63 59.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.48 -4.48 59.0 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.696 1.198 . . . . 0.0 113.03 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.77 1.59 34.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.832 1.653 . . . . 0.0 114.422 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.94 -116.81 4.53 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -128.87 161.48 29.74 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.912 1.285 . . . . 0.0 112.628 -174.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.28 166.38 10.88 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.448 1.023 . . . . 0.0 114.563 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -79.52 132.49 11.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.04 0.828 . . . . 0.0 112.462 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 124.33 47.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.548 1.939 . . . . 0.0 107.801 171.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -118.54 139.08 52.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.205 1.002 . . . . 0.0 110.647 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 5.1 tp -122.88 134.06 54.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.91 1.684 . . . . 0.0 109.874 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.6 m -135.82 130.29 33.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.289 0.635 . . . . 0.0 110.501 170.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 44.9 mt -112.86 135.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.537 1.535 . . . . 0.0 109.323 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.92 155.3 50.17 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.908 1.683 . . . . 0.0 109.958 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.41 -159.11 31.67 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.381 -0.825 . . . . 0.0 115.013 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.5 -2.88 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.407 3.404 . . . . 0.0 114.18 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -156.24 161.46 40.25 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.849 1.26 . . . . 0.0 111.338 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -66.29 149.87 49.7 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.324 -0.86 . . . . 0.0 110.074 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 20.3 m -124.05 159.76 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.394 1.078 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.37 122.67 45.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.951 0.9 . . . . 0.0 109.188 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 16.0 mt -105.78 134.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.564 1.145 . . . . 0.0 110.131 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -130.14 165.17 22.86 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 110.598 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -143.07 162.77 34.64 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.071 1.348 . . . . 0.0 112.181 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.83 116.35 5.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.665 1.586 . . . . 0.0 109.706 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.55 132.6 39.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 110.854 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.7 mt -111.1 153.24 25.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.647 1.179 . . . . 0.0 111.702 -173.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.45 -19.07 64.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -83.44 3.37 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.876 1.271 . . . . 0.0 113.077 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.89 -0.2 84.13 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.473 1.511 . . . . 0.0 114.17 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.1 p -81.73 166.4 20.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.095 1.758 . . . . 0.0 111.194 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -129.18 126.1 38.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.048 0.939 . . . . 0.0 110.748 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -81.92 135.03 35.43 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.412 1.085 . . . . 0.0 109.271 166.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.7 t -113.43 140.37 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.714 2.006 . . . . 0.0 108.237 167.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 10.8 p -136.09 150.21 49.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.187 1.395 . . . . 0.0 111.311 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.8 p90 -159.18 149.59 19.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.505 1.122 . . . . 0.0 111.854 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 9.0 t -114.92 108.97 47.76 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.845 0.858 . . . . 0.0 111.013 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.05 154.27 25.47 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.436 2.758 . . . . 0.0 110.56 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 27.1 m -114.28 -42.23 3.36 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.135 0.974 . . . . 0.0 112.408 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -87.9 142.83 32.57 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.769 0.828 . . . . 0.0 110.441 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.32 163.83 31.86 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.312 2.674 . . . . 0.0 111.083 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.27 -143.36 15.02 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.822 1.201 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -124.28 129.7 51.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.458 0.703 . . . . 0.0 111.866 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -108.02 144.98 34.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 110.773 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.14 132.28 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.334 1.454 . . . . 0.0 108.878 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.57 127.9 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.339 1.455 . . . . 0.0 109.199 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -107.46 126.93 53.13 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.095 1.358 . . . . 0.0 110.216 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 12.6 mm -116.65 94.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.582 1.153 . . . . 0.0 110.231 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -86.62 130.39 34.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.907 1.283 . . . . 0.0 110.09 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.22 130.5 46.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.089 0.955 . . . . 0.0 109.825 168.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 56.95 26.0 11.27 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.108 1.363 . . . . 0.0 113.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.6 t70 72.28 12.33 5.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.991 2.516 . . . . 0.0 114.472 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -98.37 -158.82 0.7 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.775 1.63 . . . . 0.0 109.595 165.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2124 ' ' HIS . . . . . 0.577 ' CE1' ' HG ' ' A' 2128 ' ' SER . 0.5 OUTLIER -142.57 127.46 18.3 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.474 -1.392 . . . . 0.0 110.249 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.0 m -73.44 155.16 89.76 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 0.0 112.172 -167.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.14 131.31 38.82 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.654 2.903 . . . . 0.0 112.807 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.88 50.57 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.039 1.304 . . . . 0.0 114.676 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2128 ' ' SER . . . . . 0.577 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 28.9 t -77.42 144.39 70.22 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 118.926 1.363 . . . . 0.0 111.518 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.89 152.68 97.1 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.727 0.938 . . . . 0.0 112.589 -3.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -104.88 132.33 51.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.366 1.466 . . . . 0.0 111.298 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 69.2 m -100.36 126.21 46.69 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.643 1.177 . . . . 0.0 111.272 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.36 111.82 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.749 1.62 . . . . 0.0 109.789 -167.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -77.93 112.7 15.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.793 -0.567 . . . . 0.0 111.169 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 71.3 t -101.39 113.37 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 109.05 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -90.8 154.83 19.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.333 1.053 . . . . 0.0 110.85 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -178.6 -161.9 27.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -157.64 163.7 37.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.871 2.068 . . . . 0.0 109.081 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -62.81 120.17 20.4 Favored Glycine 0 CA--C 1.533 1.158 0 O-C-N 121.337 -0.852 . . . . 0.0 111.714 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -74.45 118.51 17.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.538 1.135 . . . . 0.0 111.064 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 95.7 t -143.35 142.27 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.495 1.918 . . . . 0.0 109.199 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 3.5 tppp? . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.681 1.593 . . . . 0.0 111.308 178.362 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.512 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.29 158.47 36.31 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.402 1.081 . . . . 0.0 112.811 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -166.03 161.75 17.53 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.962 1.705 . . . . 0.0 111.766 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -68.1 142.61 39.85 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.582 0.61 . . . . 0.0 111.832 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -155.56 36.18 0.37 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.95 1.3 . . . . 0.0 111.537 -171.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 44.2 m-20 71.63 -31.38 0.22 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 129.28 3.032 . . . . 0.0 113.889 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 8.6 t -76.74 164.38 25.92 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.102 1.361 . . . . 0.0 112.416 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 93.4 mmm -77.09 77.58 3.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.341 1.457 . . . . 0.0 111.205 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 -60.08 126.38 27.28 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.099 0.959 . . . . 0.0 110.744 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 98.8 mtp -84.0 129.88 34.9 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.969 0.908 . . . . 0.0 111.432 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 21.0 m -113.68 132.68 55.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.193 1.797 . . . . 0.0 108.592 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 7.0 t60 -129.51 152.89 48.55 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -163.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.73 153.89 35.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.196 1.798 . . . . 0.0 110.864 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.8 146.54 43.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.06 1.344 . . . . 0.0 111.949 173.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 60.2 t -143.0 133.94 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.044 1.738 . . . . 0.0 109.617 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.16 132.43 11.08 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.932 0.777 . . . . 0.0 111.54 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 27.2 m -120.65 141.63 50.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.256 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -152.26 156.72 40.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.137 0.975 . . . . 0.0 113.276 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -113.07 151.62 30.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 111.574 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.72 147.38 25.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 0.0 113.128 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.54 126.38 23.42 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 125.309 1.444 . . . . 0.0 108.73 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.81 130.5 9.65 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.198 2.599 . . . . 0.0 111.237 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 40.4 mt -149.63 141.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.392 1.877 . . . . 0.0 108.746 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.3 t30 59.13 53.76 5.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.368 1.467 . . . . 0.0 111.906 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 30.1 mm -56.79 -39.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.747 1.619 . . . . 0.0 113.509 -163.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 17.2 m -77.12 -2.31 33.65 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.43 145.05 51.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 113.481 -171.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 41.2 p -133.13 -20.56 2.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.519 1.927 . . . . 0.0 112.984 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.14 50.8 2.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.303 1.441 . . . . 0.0 111.85 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -1.18 6.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 35.5 p -77.16 -25.9 52.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.705 1.602 . . . . 0.0 114.271 174.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.81 8.4 4.49 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.22 136.14 33.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.503 1.921 . . . . 0.0 109.046 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 11.2 t -148.25 161.47 41.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.811 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.57 154.26 38.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 113.045 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 70.1 p -140.95 163.01 34.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.906 2.082 . . . . 0.0 109.599 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 17.8 t -116.65 136.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.827 1.251 . . . . 0.0 110.182 171.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.3 t -106.62 113.29 63.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.907 1.283 . . . . 0.0 108.497 166.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.03 174.18 9.54 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.402 3.401 . . . . 0.0 111.801 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.81 -29.22 51.6 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.538 3.492 . . . . 0.0 114.619 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 70.9 p -80.91 -3.57 51.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.855 1.262 . . . . 0.0 113.989 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 75.2 -3.11 48.7 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.474 1.511 . . . . 0.0 114.911 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -76.26 91.6 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.953 1.301 . . . . 0.0 110.928 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 131.69 50.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.055 0.942 . . . . 0.0 111.601 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -132.45 144.42 52.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.725 1.61 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.07 153.02 28.35 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.435 2.757 . . . . 0.0 112.287 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.3 m -89.1 151.52 22.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.076 0.951 . . . . 0.0 112.402 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 59.8 tp -86.5 131.76 34.1 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.602 1.161 . . . . 0.0 108.271 157.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mp -99.72 142.1 31.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.603 1.161 . . . . 0.0 110.133 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.6 139.16 36.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.678 1.191 . . . . 0.0 113.049 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -92.34 114.51 27.07 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 156.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.85 169.39 11.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.997 -169.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -62.76 -27.47 69.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -166.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -88.43 3.6 49.43 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 119.155 0.889 . . . . 0.0 113.256 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.06 -4.41 71.15 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 126.122 1.82 . . . . 0.0 114.312 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -80.14 156.14 27.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.391 1.476 . . . . 0.0 113.782 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 68.6 t -89.08 140.94 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.13 1.372 . . . . 0.0 110.126 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.06 177.96 29.57 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.275 0.941 . . . . 0.0 114.488 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.35 161.08 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.142 1.377 . . . . 0.0 111.808 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 49.6 m -134.99 156.72 48.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.147 1.779 . . . . 0.0 110.179 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.8 p90 -164.3 -170.39 2.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.503 1.921 . . . . 0.0 109.381 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 70.3 t -131.85 114.35 15.3 Favored Pre-proline 0 N--CA 1.48 1.029 0 CA-C-N 119.51 1.05 . . . . 0.0 109.825 168.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.97 145.25 31.33 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.738 2.959 . . . . 0.0 110.499 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -115.04 1.15 13.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.44 1.096 . . . . 0.0 113.033 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -141.74 171.34 14.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.377 2.271 . . . . 0.0 109.73 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.9 p -94.97 163.37 13.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.358 1.063 . . . . 0.0 110.742 164.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.22 -167.29 26.24 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.893 1.235 . . . . 0.0 113.738 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.3 114.63 8.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.258 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.3 m80 -99.91 147.56 25.41 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.904 1.682 . . . . 0.0 109.163 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 84.9 mt -105.62 124.21 49.18 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 109.864 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.9 t -89.74 113.69 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.669 1.188 . . . . 0.0 107.956 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -94.09 140.88 29.18 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.53 1.132 . . . . 0.0 110.436 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.3 p -143.89 133.99 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.818 0.818 . . . . 0.0 112.104 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -136.04 137.32 41.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.668 1.987 . . . . 0.0 111.528 -164.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.6 tttt -134.89 132.56 38.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.474 1.509 . . . . 0.0 110.895 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 58.01 25.55 12.42 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.33 5.08 73.06 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.146 1.355 . . . . 0.0 115.605 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -128.9 151.4 49.68 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.426 1.613 . . . . 0.0 111.625 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -64.74 146.66 54.47 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.028 -1.045 . . . . 0.0 112.541 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 58.0 t -72.19 145.34 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.678 0.791 . . . . 0.0 108.895 171.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.63 -29.5 64.6 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 22.1 m -84.79 -4.25 58.98 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.15 1.38 . . . . 0.0 113.972 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 14.9 t -82.32 141.65 46.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.699 -1.25 . . . . 0.0 112.191 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.98 157.06 84.27 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.657 0.913 . . . . 0.0 112.655 -5.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.97 124.38 41.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.541 1.536 . . . . 0.0 108.686 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.39 141.27 14.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.032 2.488 . . . . 0.0 111.314 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.2 t -137.83 123.77 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.481 1.512 . . . . 0.0 108.303 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.8 t -96.53 124.18 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.742 0.817 . . . . 0.0 110.222 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.23 129.07 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.974 1.31 . . . . 0.0 110.145 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -94.91 168.41 10.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.695 1.198 . . . . 0.0 112.717 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.52 -34.89 78.03 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.412 -1.43 . . . . 0.0 111.653 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.8 m -64.63 -12.14 42.64 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.335 1.454 . . . . 0.0 114.892 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -116.01 1.47 13.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.526 1.53 . . . . 0.0 113.105 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.48 -23.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.333 1.053 . . . . 0.0 113.288 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.12 37.57 0.04 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.97 101.23 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.461 1.13 . . . . 0.0 111.377 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.77 82.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.422 0.689 . . . . 0.0 112.819 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 75.7 m -62.1 -25.32 67.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.855 0.862 . . . . 0.0 113.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -79.82 -13.43 59.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.209 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.6 t -77.28 133.17 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 120.141 1.337 . . . . 0.0 109.838 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -112.55 160.83 17.44 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.883 1.673 . . . . 0.0 110.871 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.2 m -146.9 159.29 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.363 1.465 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.49 177.48 10.9 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.608 1.163 . . . . 0.0 112.495 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 93.85 163.07 36.13 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.371 1.462 . . . . 0.0 113.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -75.68 -28.16 58.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.85 0.86 . . . . 0.0 113.205 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.14 0.91 13.09 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.216 1.389 . . . . 0.0 115.326 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.8 mt -92.37 -5.38 52.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.94 1.696 . . . . 0.0 112.643 168.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -133.8 -43.04 0.82 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.964 1.305 . . . . 0.0 113.516 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.23 150.2 40.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.832 1.253 . . . . 0.0 111.613 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.49 -176.23 22.51 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.579 1.085 . . . . 0.0 113.836 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.45 151.44 48.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 111.729 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 37.8 p -76.71 -40.19 49.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.863 0.865 . . . . 0.0 112.489 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -98.1 1.35 47.51 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -140.44 146.78 46.78 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.35 151.76 54.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.183 2.589 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -106.65 130.18 54.44 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.9 1.28 . . . . 0.0 111.038 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -111.93 147.09 36.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.461 1.505 . . . . 0.0 113.323 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 55.9 p90 -156.12 155.05 31.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.868 1.267 . . . . 0.0 112.145 173.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.91 143.66 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.532 1.933 . . . . 0.0 109.705 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 53.2 mt -122.77 133.98 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.521 1.928 . . . . 0.0 108.839 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.1 t0 -128.93 101.1 5.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.802 1.641 . . . . 0.0 110.948 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 39.3 p -96.18 1.46 52.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.187 1.795 . . . . 0.0 113.275 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -60.73 -34.03 73.8 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.367 0.985 . . . . 0.0 113.221 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.07 -12.04 55.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.56 1.144 . . . . 0.0 113.353 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.08 -12.46 35.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.502 1.521 . . . . 0.0 114.073 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.31 -119.28 5.1 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.376 0.988 . . . . 0.0 111.823 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -103.52 162.29 13.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.276 1.831 . . . . 0.0 112.329 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.83 -177.77 29.51 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.929 0.776 . . . . 0.0 114.979 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -104.43 121.78 7.1 Favored Glycine 0 N--CA 1.468 0.793 0 C-N-CA 124.731 1.158 . . . . 0.0 111.113 174.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.49 123.63 36.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.374 1.47 . . . . 0.0 108.37 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 33.6 t -121.75 145.23 48.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.984 1.714 . . . . 0.0 109.73 175.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.11 133.17 22.83 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.521 0.729 . . . . 0.0 110.762 -164.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 7.6 m -129.14 136.54 50.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.805 0.842 . . . . 0.0 110.622 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.5 mt -119.92 138.69 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.863 1.265 . . . . 0.0 108.323 168.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.56 146.55 28.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.798 0.839 . . . . 0.0 111.7 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -176.64 -163.24 28.64 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.903 -173.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.39 -10.18 25.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.017 3.145 . . . . 0.0 114.482 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.1 t -152.38 169.42 22.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.483 1.038 . . . . 0.0 112.067 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.36 143.97 54.82 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.152 1.381 . . . . 0.0 111.137 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -121.08 149.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.754 0.706 . . . . 0.0 111.517 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.32 118.38 34.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.616 0.766 . . . . 0.0 109.469 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 50.0 mt -104.2 135.94 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.146 1.379 . . . . 0.0 109.795 -173.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.27 156.82 43.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.794 1.637 . . . . 0.0 110.384 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 34.0 p -134.46 154.99 51.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.229 1.412 . . . . 0.0 111.438 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -150.51 131.76 14.53 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.647 1.179 . . . . 0.0 110.736 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.91 122.88 29.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.594 1.157 . . . . 0.0 110.561 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.0 mt -92.05 151.9 20.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.927 0.891 . . . . 0.0 111.396 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -63.01 -26.34 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.406 1.082 . . . . 0.0 112.884 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.45 -4.98 42.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.953 1.301 . . . . 0.0 113.469 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.39 4.19 59.66 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.632 1.587 . . . . 0.0 114.745 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -95.31 163.1 13.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.176 1.79 . . . . 0.0 111.453 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 128.47 54.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.24 1.016 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -91.48 136.08 33.38 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.665 167.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 137.73 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.916 1.686 . . . . 0.0 108.414 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 14.3 p -134.94 146.54 49.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.107 1.363 . . . . 0.0 110.561 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.8 p90 -149.82 152.08 34.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.519 0.728 . . . . 0.0 112.86 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 p -115.95 108.41 46.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.963 1.305 . . . . 0.0 111.24 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.75 169.76 17.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.676 2.918 . . . . 0.0 110.795 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 87.4 m -121.19 -51.75 2.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.949 0.899 . . . . 0.0 111.673 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -81.82 143.23 49.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.749 0.82 . . . . 0.0 110.374 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.24 162.15 34.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.124 2.549 . . . . 0.0 111.038 170.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.17 -161.34 24.61 Favored Glycine 0 N--CA 1.472 1.098 0 C-N-CA 125.11 1.338 . . . . 0.0 113.703 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -90.55 122.3 33.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.443 0.697 . . . . 0.0 111.273 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -104.7 136.72 43.69 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 109.865 167.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.39 133.66 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.231 1.412 . . . . 0.0 108.559 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.4 mt -119.44 127.92 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.831 1.252 . . . . 0.0 109.595 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -109.02 125.81 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 110.306 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 24.4 mm -109.37 113.96 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.538 1.135 . . . . 0.0 108.802 172.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -119.15 135.21 54.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.451 1.5 . . . . 0.0 111.026 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 30.4 t80 -130.35 126.89 38.25 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.746 0.818 . . . . 0.0 110.895 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.23 39.39 26.88 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.688 1.595 . . . . 0.0 114.074 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 15.3 t70 79.9 2.26 2.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.023 2.529 . . . . 0.0 114.025 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -96.92 -127.79 0.15 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.157 1.383 . . . . 0.0 110.774 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -171.11 128.57 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.816 2.046 . . . . 0.0 109.884 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -86.65 157.92 54.65 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-N 120.098 1.317 . . . . 0.0 111.706 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.44 141.63 72.25 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.905 3.07 . . . . 0.0 113.567 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 87.84 -21.54 22.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.958 1.266 . . . . 0.0 114.597 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 58.1 m -74.63 148.4 85.34 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.979 1.39 . . . . 0.0 111.874 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.4 140.1 65.38 Favored 'Cis proline' 0 C--N 1.351 0.708 0 CA-C-N 119.369 0.81 . . . . 0.0 111.288 -5.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.48 121.59 35.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.669 1.187 . . . . 0.0 110.514 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.6 m -85.63 124.32 32.04 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.397 0.679 . . . . 0.0 110.443 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.8 t -116.48 114.79 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.926 1.69 . . . . 0.0 109.085 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 58.7 tttp -78.94 103.2 8.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.818 0.447 . . . . 0.0 110.683 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 74.9 t -89.58 114.67 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.609 1.163 . . . . 0.0 108.599 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.3 t -94.27 161.3 14.31 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.112 0.965 . . . . 0.0 111.165 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 152.75 -139.47 7.0 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.092 0.853 . . . . 0.0 113.67 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -152.18 158.33 42.74 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.664 1.586 . . . . 0.0 109.965 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -70.2 -3.13 44.35 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.473 -1.182 . . . . 0.0 115.732 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 80.78 148.69 0.09 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.172 2.589 . . . . 0.0 112.76 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 98.7 t -67.97 134.49 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.828 1.251 . . . . 0.0 110.045 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 60.4 tttp . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.211 1.404 . . . . 0.0 112.596 -179.178 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -160.69 168.63 24.48 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.909 1.684 . . . . 0.0 111.664 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 22.1 mmt 74.35 -19.99 0.34 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.136 2.574 . . . . 0.0 114.993 170.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.7 4.46 85.76 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.664 1.602 . . . . 0.0 114.341 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -157.51 158.66 36.12 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.5 1.92 . . . . 0.0 111.883 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 2.0 t70 -162.26 -170.42 2.46 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.495 1.918 . . . . 0.0 110.227 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 54.1 p -155.58 143.33 19.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.707 1.203 . . . . 0.0 112.091 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 17.9 tmm? -75.29 127.7 33.74 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.943 0.897 . . . . 0.0 111.197 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.8 128.0 49.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.342 1.457 . . . . 0.0 110.346 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.0 ptm -126.72 137.45 53.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.753 1.621 . . . . 0.0 110.716 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 14.1 m -108.71 112.69 25.12 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.446 1.498 . . . . 0.0 108.944 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 8.1 t60 -106.47 158.36 16.96 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -162.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -152.91 139.02 18.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.612 2.365 . . . . 0.0 110.012 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.29 144.94 50.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.756 1.222 . . . . 0.0 111.17 167.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.8 p -155.45 141.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.157 0.983 . . . . 0.0 111.338 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.31 150.69 33.81 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.206 0.908 . . . . 0.0 113.268 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 47.0 m -131.92 37.53 3.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.932 1.293 . . . . 0.0 111.668 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -67.84 111.96 4.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.938 1.295 . . . . 0.0 111.257 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -72.13 148.06 46.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.242 1.017 . . . . 0.0 112.33 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.93 150.46 20.15 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 73.0 mt -136.93 126.11 15.35 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.336 1.854 . . . . 0.0 108.961 171.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.78 149.35 12.56 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.855 3.037 . . . . 0.0 112.261 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.12 134.99 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.111 1.365 . . . . 0.0 110.368 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 58.8 t30 42.28 73.05 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.247 2.219 . . . . 0.0 114.866 166.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 21.4 mm -67.54 124.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.863 . . . . 0.0 111.223 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 21.4 t -170.33 166.34 8.68 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.499 1.92 . . . . 0.0 110.432 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -85.55 62.96 7.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.989 1.316 . . . . 0.0 110.868 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.6 p -86.45 158.34 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.62 1.568 . . . . 0.0 112.219 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.43 119.36 27.63 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.482 1.113 . . . . 0.0 110.259 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.2 mp -75.91 -11.11 59.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.113 0.965 . . . . 0.0 113.132 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 17.2 t -67.53 -37.5 82.85 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.611 1.096 . . . . 0.0 113.363 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.47 2.5 24.27 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.11 133.57 35.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.134 1.374 . . . . 0.0 110.526 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 52.9 p -138.82 163.02 33.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.891 1.676 . . . . 0.0 110.381 173.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.9 148.91 29.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.937 0.895 . . . . 0.0 113.148 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -135.78 164.53 27.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.874 2.07 . . . . 0.0 109.767 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -116.24 134.08 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.597 1.159 . . . . 0.0 109.346 166.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.4 t -104.29 111.94 65.31 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.302 1.441 . . . . 0.0 108.11 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.83 169.39 20.75 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.806 3.004 . . . . 0.0 110.872 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.21 -15.83 47.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.058 2.506 . . . . 0.0 113.184 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.6 p -79.85 -4.99 54.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.005 1.322 . . . . 0.0 113.847 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.04 59.11 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.385 1.469 . . . . 0.0 114.965 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -77.67 76.76 4.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.567 1.547 . . . . 0.0 111.637 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -58.29 136.59 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.69 1.196 . . . . 0.0 112.398 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.01 151.34 67.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.441 1.497 . . . . 0.0 111.081 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.39 152.94 44.63 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.741 2.96 . . . . 0.0 112.489 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 90.3 m -95.6 152.68 18.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.17 122.73 33.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.668 1.187 . . . . 0.0 109.113 167.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 66.4 mt -84.07 139.01 32.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.325 1.05 . . . . 0.0 110.635 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 92.2 mttt -141.36 140.6 33.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.948 1.299 . . . . 0.0 112.367 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -87.5 125.9 34.59 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 160.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.8 mt -105.71 176.38 5.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.828 1.651 . . . . 0.0 113.031 -163.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -55.57 -34.89 65.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.635 1.974 . . . . 0.0 115.254 -164.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 20.6 m120 -96.61 5.51 50.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.622 1.169 . . . . 0.0 113.398 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.45 71.9 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.46 1.505 . . . . 0.0 113.965 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -73.8 173.73 9.44 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.961 1.704 . . . . 0.0 113.273 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 98.1 t -127.85 142.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.346 1.459 . . . . 0.0 109.961 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -155.85 -174.75 26.05 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.6 160.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.475 1.91 . . . . 0.0 110.99 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 78.9 p -146.93 155.15 42.06 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.904 1.282 . . . . 0.0 111.125 165.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.46 -175.69 4.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.95 1.7 . . . . 0.0 110.728 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 56.5 t -134.15 124.87 17.66 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.313 1.045 . . . . 0.0 109.244 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.64 150.18 27.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.09 3.194 . . . . 0.0 111.767 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.49 -8.04 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.228 1.011 . . . . 0.0 113.479 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -142.84 171.39 14.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.888 2.075 . . . . 0.0 110.341 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 31.1 p -93.23 164.35 13.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.743 1.217 . . . . 0.0 111.096 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.04 -168.68 24.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.206 1.384 . . . . 0.0 113.544 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.8 117.67 11.68 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.899 0.857 . . . . 0.0 111.719 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 6.7 m80 -103.31 148.29 26.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.067 1.747 . . . . 0.0 109.11 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.86 126.89 53.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.136 0.974 . . . . 0.0 109.696 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 28.4 t -84.82 125.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 163.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -105.46 128.75 53.71 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.462 1.105 . . . . 0.0 110.071 172.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 34.6 t -129.34 129.84 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.986 1.314 . . . . 0.0 109.341 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -139.72 141.51 36.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.53 125.12 53.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.393 2.277 . . . . 0.0 109.477 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.64 26.61 11.41 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.688 1.195 . . . . 0.0 113.425 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 97.05 -13.03 65.34 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.83 1.681 . . . . 0.0 115.937 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.28 144.73 42.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.684 1.742 . . . . 0.0 112.142 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -62.65 142.8 57.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 85.6 t -70.83 149.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.449 1.499 . . . . 0.0 109.462 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.17 64.13 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 70.9 m -86.42 -8.91 57.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.549 1.14 . . . . 0.0 113.785 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 24.7 t -88.9 145.22 34.23 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.069 1.347 . . . . 0.0 112.383 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.52 154.09 95.04 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.608 0.896 . . . . 0.0 112.565 -3.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.8 120.21 50.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.4 1.48 . . . . 0.0 108.515 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.3 142.5 13.38 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.914 2.409 . . . . 0.0 111.38 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.25 125.57 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.27 1.428 . . . . 0.0 108.081 174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 57.4 t -97.01 121.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.499 0.72 . . . . 0.0 109.807 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.87 123.93 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.88 1.272 . . . . 0.0 109.253 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 159.81 15.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.617 0.767 . . . . 0.0 111.402 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -57.48 -30.68 65.27 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.985 0.914 . . . . 0.0 112.782 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 30.9 m -67.29 -18.4 65.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.426 1.09 . . . . 0.0 113.813 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -93.15 -11.12 33.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.517 1.127 . . . . 0.0 112.847 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.19 -35.31 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.438 1.095 . . . . 0.0 112.306 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.98 61.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.911 0.767 . . . . 0.0 113.523 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.12 95.63 8.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.459 0.703 . . . . 0.0 110.853 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.9 69.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.651 0.78 . . . . 0.0 112.388 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.9 m -53.99 -21.16 7.49 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.078 1.751 . . . . 0.0 114.432 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -97.24 -7.5 32.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.562 1.545 . . . . 0.0 113.891 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 94.3 t -75.64 137.28 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.722 1.146 . . . . 0.0 109.94 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -123.2 157.62 32.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.277 1.431 . . . . 0.0 111.072 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 28.0 m -146.34 156.93 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.319 1.448 . . . . 0.0 110.972 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.18 174.24 15.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.625 1.17 . . . . 0.0 112.156 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 110.54 -157.51 14.96 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.395 1.474 . . . . 0.0 113.644 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -109.89 -36.29 5.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.642 1.177 . . . . 0.0 112.549 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.63 -0.18 53.15 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 125.113 1.34 . . . . 0.0 115.606 -171.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.92 -5.47 50.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.33 1.452 . . . . 0.0 112.451 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -125.09 -38.16 2.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.223 1.409 . . . . 0.0 113.346 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.8 154.59 30.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.306 1.042 . . . . 0.0 113.238 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.67 -176.17 24.16 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.399 1.476 . . . . 0.0 113.761 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.0 m80 -140.3 145.45 37.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.768 1.227 . . . . 0.0 112.496 -173.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 46.2 p -68.94 -16.25 63.7 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -117.54 -5.02 11.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -144.88 146.48 31.51 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 110.853 -176.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.24 145.71 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.884 2.39 . . . . 0.0 111.604 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -99.4 148.44 24.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.11 1.364 . . . . 0.0 110.374 171.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.96 146.21 51.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.861 . . . . 0.0 113.093 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.7 148.15 26.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.287 1.435 . . . . 0.0 110.958 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.38 140.29 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 109.165 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 37.9 mt -112.13 134.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.872 1.669 . . . . 0.0 109.272 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 65.3 t0 -125.53 103.73 8.03 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.033 1.733 . . . . 0.0 110.644 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 22.8 p -99.21 0.48 43.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.403 1.881 . . . . 0.0 113.127 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.88 -32.7 72.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 0.0 113.326 -171.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.78 -14.46 58.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.667 1.187 . . . . 0.0 113.451 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.11 -0.56 57.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.344 1.457 . . . . 0.0 114.307 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.3 -136.24 15.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.643 1.116 . . . . 0.0 111.937 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -88.42 169.26 11.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.004 1.322 . . . . 0.0 112.329 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 142.24 -151.55 23.01 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.333 0.968 . . . . 0.0 114.255 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -148.62 148.72 20.42 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.426 1.489 . . . . 0.0 112.691 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 128.51 54.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.838 2.055 . . . . 0.0 109.501 -177.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 11.7 t -121.75 139.44 53.58 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.681 1.592 . . . . 0.0 109.749 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.16 142.14 30.37 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.57 1.148 . . . . 0.0 110.139 -162.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 87.0 p -147.61 149.83 33.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 14.6 mt -117.39 127.8 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.813 1.245 . . . . 0.0 109.289 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -114.58 154.91 27.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.916 2.086 . . . . 0.0 109.229 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 164.01 -162.55 35.28 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.156 -0.965 . . . . 0.0 114.832 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 -6.41 19.14 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.127 3.218 . . . . 0.0 114.294 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.3 t -154.57 157.59 38.5 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.631 1.105 . . . . 0.0 112.248 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 128.25 35.0 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.08 1.352 . . . . 0.0 109.506 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 30.4 m -115.96 169.33 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.984 1.313 . . . . 0.0 111.87 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -110.69 121.28 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.396 1.078 . . . . 0.0 110.193 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.19 132.04 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.859 0.864 . . . . 0.0 108.98 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -120.01 157.89 27.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.184 1.794 . . . . 0.0 109.706 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 36.3 p -136.16 160.42 38.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.657 1.183 . . . . 0.0 111.807 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -152.94 119.54 5.64 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.859 1.264 . . . . 0.0 110.002 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.96 124.15 26.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.354 1.062 . . . . 0.0 110.302 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 61.6 mt -94.95 151.72 18.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.288 1.035 . . . . 0.0 111.441 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -16.1 63.86 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -81.95 -7.03 59.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.875 1.27 . . . . 0.0 113.267 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 98.62 1.63 57.61 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.667 1.603 . . . . 0.0 115.05 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 36.0 p -93.62 171.69 8.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.202 1.801 . . . . 0.0 111.503 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -121.32 124.36 44.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.995 0.918 . . . . 0.0 111.504 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -80.51 134.04 35.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.292 1.037 . . . . 0.0 109.395 165.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.7 t -117.86 137.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 108.186 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.1 p -138.85 148.59 43.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.346 1.458 . . . . 0.0 111.401 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.6 p90 -157.13 150.29 23.84 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.602 1.161 . . . . 0.0 111.914 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.0 t -114.79 105.59 53.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.16 0.984 . . . . 0.0 110.712 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.98 150.0 26.26 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.334 2.689 . . . . 0.0 110.618 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 45.9 m -111.11 -45.83 3.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.073 0.949 . . . . 0.0 112.19 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -85.49 142.3 37.41 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.459 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.97 163.0 33.91 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.268 2.645 . . . . 0.0 111.078 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.45 -144.69 16.7 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 124.871 1.224 . . . . 0.0 112.2 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -123.23 129.97 52.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.645 0.778 . . . . 0.0 111.894 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -107.2 142.98 36.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.673 1.589 . . . . 0.0 110.453 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.16 130.11 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.979 1.311 . . . . 0.0 108.378 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.2 mt -113.58 122.08 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.237 1.015 . . . . 0.0 109.437 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -95.62 128.35 42.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.312 1.445 . . . . 0.0 110.16 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.87 112.97 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.902 1.281 . . . . 0.0 108.993 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -126.37 132.95 51.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.106 1.363 . . . . 0.0 111.451 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -129.68 128.31 42.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.102 1.761 . . . . 0.0 109.729 -177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.19 43.51 26.13 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.22 1.008 . . . . 0.0 113.049 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.0 t0 74.47 7.85 4.5 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.977 2.511 . . . . 0.0 114.806 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -121.96 132.44 54.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.17 1.388 . . . . 0.0 111.234 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2124 ' ' HIS . . . . . 0.558 ' CE1' ' HG ' ' A' 2128 ' ' SER . 0.1 OUTLIER -66.07 126.64 29.27 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 120.907 -1.12 . . . . 0.0 110.97 176.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.5 m -80.67 160.88 65.87 Favored Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 119.335 0.971 . . . . 0.0 112.097 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -53.23 137.68 63.67 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.689 2.926 . . . . 0.0 113.419 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.93 13.59 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.99 1.281 . . . . 0.0 114.213 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2128 ' ' SER . . . . . 0.558 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 14.2 t -76.86 142.94 70.21 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 118.42 1.11 . . . . 0.0 111.041 174.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 144.7 81.8 Favored 'Cis proline' 0 C--N 1.353 0.778 0 CA-C-N 120.002 1.036 . . . . 0.0 111.971 -2.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.79 120.02 36.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.537 1.135 . . . . 0.0 110.42 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 68.3 m -91.05 123.58 34.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.08 0.952 . . . . 0.0 110.449 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 115.38 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.504 1.521 . . . . 0.0 109.996 -166.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.9 tttt -77.81 120.52 22.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.02 0.528 . . . . 0.0 111.239 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.5 t -107.38 119.26 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.073 1.349 . . . . 0.0 109.014 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.8 t -106.42 162.83 13.35 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.768 1.227 . . . . 0.0 111.87 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 127.23 168.3 12.49 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.773 1.654 . . . . 0.0 113.565 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.34 -14.59 32.8 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.419 1.088 . . . . 0.0 113.85 -168.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 83.61 152.46 13.37 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.519 1.057 . . . . 0.0 112.473 -170.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -71.89 137.86 47.75 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.965 0.906 . . . . 0.0 112.226 -173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 12.7 p -163.52 147.31 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.323 1.849 . . . . 0.0 110.54 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.193 1.797 . . . . 0.0 111.277 177.968 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.455 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.29 152.51 43.19 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.263 1.025 . . . . 0.0 112.713 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 64.3 ttp -164.12 -56.17 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.627 1.571 . . . . 0.0 111.124 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -99.77 169.23 22.0 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.418 1.485 . . . . 0.0 112.962 173.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -161.33 146.39 13.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.001 1.721 . . . . 0.0 111.046 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -102.5 149.52 24.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.18 1.392 . . . . 0.0 112.685 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 16.4 m -72.33 -21.16 61.37 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 19.2 mmt -72.19 120.6 18.02 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.808 0.843 . . . . 0.0 111.095 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.27 149.83 33.49 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.439 1.096 . . . . 0.0 109.025 166.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 1.9 mmm -127.15 128.83 46.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.894 1.278 . . . . 0.0 111.29 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 15.4 m -130.85 146.35 52.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.868 1.667 . . . . 0.0 109.443 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -155.83 159.32 39.29 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.65 154.19 24.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.573 1.949 . . . . 0.0 110.317 -170.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.5 mttt -135.7 144.27 45.84 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.906 1.282 . . . . 0.0 111.714 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 32.5 m -143.0 151.35 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.89 1.276 . . . . 0.0 111.465 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.32 147.36 20.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.409 1.004 . . . . 0.0 112.133 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 26.3 m -136.12 147.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.158 1.383 . . . . 0.0 112.088 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.27 154.69 23.66 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -85.49 161.09 19.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.893 1.277 . . . . 0.0 111.583 167.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.9 135.43 36.43 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.1 mt -125.25 124.0 25.23 Favored Pre-proline 0 N--CA 1.482 1.125 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.69 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.45 133.17 11.64 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.893 2.396 . . . . 0.0 111.464 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 32.4 mt -149.5 143.78 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.046 2.138 . . . . 0.0 107.798 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.1 t30 60.89 45.0 10.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.645 1.178 . . . . 0.0 110.789 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 25.7 mm -43.79 -56.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.826 2.45 . . . . 0.0 115.04 -147.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 49.6 m -105.32 0.88 27.46 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.881 0.872 . . . . 0.0 113.335 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -95.09 74.6 3.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.496 1.518 . . . . 0.0 109.617 -171.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 44.3 p -71.87 22.24 0.05 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.767 2.427 . . . . 0.0 115.59 -168.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.9 t0 -91.19 60.47 4.25 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.893 1.677 . . . . 0.0 111.298 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -21.7 66.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.71 1.204 . . . . 0.0 113.17 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 18.4 m -61.76 -17.71 57.04 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.404 1.482 . . . . 0.0 114.777 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.4 pp -122.63 14.63 10.2 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.33 1.452 . . . . 0.0 113.745 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.19 145.77 26.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 111.588 173.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 29.3 p -146.21 146.77 30.92 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.372 1.869 . . . . 0.0 109.674 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -143.75 149.89 37.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 36.5 p -141.16 140.97 34.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.912 2.085 . . . . 0.0 109.532 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -95.41 133.78 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.718 0.807 . . . . 0.0 109.834 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.7 t -102.17 110.28 62.15 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 107.967 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.74 170.88 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.943 3.096 . . . . 0.0 110.972 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -15.58 49.67 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.002 2.468 . . . . 0.0 113.478 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 79.5 p -80.74 -11.21 59.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.224 . . . . 0.0 113.947 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.21 -1.76 86.26 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.606 1.574 . . . . 0.0 114.973 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -76.83 83.22 3.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.462 1.505 . . . . 0.0 111.626 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.66 134.44 57.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.75 1.22 . . . . 0.0 112.291 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -140.69 149.47 56.88 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.329 1.452 . . . . 0.0 111.615 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.81 153.53 42.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.876 3.051 . . . . 0.0 112.878 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 73.0 m -97.14 156.3 16.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.913 1.285 . . . . 0.0 112.041 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 61.6 tp -87.06 131.46 34.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 0.0 108.744 162.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -97.2 143.48 27.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.55 1.14 . . . . 0.0 110.297 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.8 146.42 34.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.791 1.236 . . . . 0.0 113.476 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -93.49 120.06 33.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.682 1.193 . . . . 0.0 107.903 156.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.71 170.92 9.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.977 -170.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -64.71 -29.27 70.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.026 1.73 . . . . 0.0 114.276 -164.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.2 t30 -86.04 -1.88 57.78 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.653 1.181 . . . . 0.0 113.21 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.95 -2.0 63.66 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.806 1.67 . . . . 0.0 114.531 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 165.81 15.89 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.497 1.519 . . . . 0.0 113.665 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 43.8 t -89.29 145.1 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.045 1.738 . . . . 0.0 110.596 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.0 -173.67 28.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.44 168.22 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.634 . . . . 0.0 112.61 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.4 m -139.06 158.07 44.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.527 1.931 . . . . 0.0 111.107 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -161.71 -174.05 4.03 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.837 2.055 . . . . 0.0 109.704 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 60.1 t -132.19 120.22 17.03 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 119.504 1.047 . . . . 0.0 110.119 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.11 134.57 13.11 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.189 3.259 . . . . 0.0 110.408 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -95.25 -10.18 31.07 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -143.52 174.09 11.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.941 2.097 . . . . 0.0 109.847 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.4 p -85.21 167.75 15.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.683 1.193 . . . . 0.0 111.593 171.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.67 -168.59 21.69 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.163 1.363 . . . . 0.0 114.047 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -73.52 119.04 17.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.082 0.953 . . . . 0.0 111.967 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.0 m80 -109.22 143.24 38.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.583 1.953 . . . . 0.0 109.172 169.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.58 126.07 52.1 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.28 1.032 . . . . 0.0 109.869 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 33.2 t -90.27 111.71 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.644 1.178 . . . . 0.0 108.268 168.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -90.08 136.73 32.87 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.216 1.006 . . . . 0.0 109.76 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 6.8 p -143.99 127.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 121.958 0.885 . . . . 0.0 112.208 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -110.44 135.43 51.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.802 2.041 . . . . 0.0 111.464 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.7 119.77 39.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.097 2.159 . . . . 0.0 109.166 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 56.02 -102.62 0.16 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.011 1.325 . . . . 0.0 111.089 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -112.22 8.59 26.9 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.657 1.599 . . . . 0.0 115.603 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -144.02 151.82 40.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.748 1.774 . . . . 0.0 112.608 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -66.42 144.49 56.49 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.872 -1.143 . . . . 0.0 112.869 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 147.49 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.46 1.104 . . . . 0.0 109.368 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -56.68 -31.05 64.06 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 15.2 m -84.37 -8.2 59.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.003 1.321 . . . . 0.0 113.982 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 23.2 t -82.49 141.42 45.39 Favored Pre-proline 0 CA--C 1.547 0.844 0 O-C-N 120.784 -1.198 . . . . 0.0 112.543 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.92 147.23 83.11 Favored 'Cis proline' 0 C--N 1.353 0.767 0 CA-C-N 119.317 0.792 . . . . 0.0 112.315 -4.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -94.85 118.78 66.68 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.038 1.335 . . . . 0.0 108.619 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.58 140.55 13.35 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.971 2.447 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.6 t -135.79 127.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.952 1.701 . . . . 0.0 107.962 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.0 t -100.29 122.02 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.796 0.838 . . . . 0.0 110.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.81 128.75 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.116 1.366 . . . . 0.0 109.993 -174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.8 t -94.53 172.89 7.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.651 1.18 . . . . 0.0 111.703 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -68.78 -33.55 74.06 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.358 -1.464 . . . . 0.0 112.015 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 14.7 m -67.03 -3.43 7.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.77 4.57 10.55 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.619 1.568 . . . . 0.0 113.19 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 41.1 mm -73.96 -26.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.175 0.99 . . . . 0.0 112.309 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 163.05 53.79 0.02 OUTLIER Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.91 91.05 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.012 0.906 . . . . 0.0 111.235 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.62 69.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.822 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -55.4 -23.95 27.45 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.422 1.489 . . . . 0.0 114.242 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -91.08 -9.14 46.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.088 1.355 . . . . 0.0 113.73 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 134.46 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.136 . . . . 0.0 110.033 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.98 157.78 22.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.651 1.58 . . . . 0.0 110.796 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.9 m -146.3 159.09 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.285 1.434 . . . . 0.0 111.022 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.69 174.52 14.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.794 1.238 . . . . 0.0 112.258 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.66 166.51 30.78 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.316 1.436 . . . . 0.0 114.277 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -75.92 -29.4 58.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.508 1.123 . . . . 0.0 113.454 -167.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -72.27 3.96 20.88 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.115 1.341 . . . . 0.0 115.165 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.88 -8.09 41.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 112.339 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.4 -42.45 1.82 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.148 1.379 . . . . 0.0 113.688 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.01 159.9 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -153.47 -177.56 27.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.223 1.392 . . . . 0.0 114.038 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -131.67 151.17 51.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.707 1.603 . . . . 0.0 112.081 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 32.5 p -71.71 -14.63 62.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -112.56 -9.77 13.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.01 157.12 77.91 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 126.238 1.815 . . . . 0.0 110.844 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.52 141.44 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.805 2.337 . . . . 0.0 110.533 169.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 149.37 22.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.587 1.155 . . . . 0.0 109.854 165.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -134.62 147.69 50.25 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.588 0.755 . . . . 0.0 112.545 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.7 p90 -151.64 150.64 30.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.391 1.476 . . . . 0.0 110.636 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.28 140.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.849 1.659 . . . . 0.0 109.287 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.88 134.55 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.226 1.811 . . . . 0.0 109.049 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.5 t0 -123.99 96.69 5.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.701 . . . . 0.0 110.611 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 7.9 p -95.15 -0.11 53.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.32 2.248 . . . . 0.0 113.172 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -60.15 -38.47 83.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.263 1.025 . . . . 0.0 112.805 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.71 -16.02 57.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.829 1.252 . . . . 0.0 113.319 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -87.38 -2.74 58.84 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.796 1.239 . . . . 0.0 113.865 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 87.16 -122.03 6.03 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.805 1.193 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -113.69 164.67 13.4 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.546 1.538 . . . . 0.0 112.233 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.9 -176.74 26.59 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 169.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -99.0 129.18 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.866 1.222 . . . . 0.0 111.36 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.25 119.43 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 107.863 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.9 t -113.87 141.3 47.52 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.734 1.214 . . . . 0.0 110.108 173.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.1 tt -140.26 132.99 28.99 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.48 1.112 . . . . 0.0 110.331 -163.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.2 m -133.67 133.35 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.642 0.777 . . . . 0.0 111.039 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 55.4 mt -116.63 133.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.282 1.433 . . . . 0.0 108.463 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.39 148.68 44.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.821 0.848 . . . . 0.0 111.381 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 172.84 -163.74 35.64 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.939 0.781 . . . . 0.0 113.87 -172.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.91 -6.4 19.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.045 3.163 . . . . 0.0 114.723 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -155.01 160.9 41.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.084 1.311 . . . . 0.0 113.103 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -59.92 140.93 56.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.988 1.715 . . . . 0.0 111.08 171.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.5 m -132.43 139.54 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.454 0.702 . . . . 0.0 111.389 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.81 102.04 12.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 109.702 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 19.9 mt -80.03 124.2 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -116.43 157.34 25.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.347 1.859 . . . . 0.0 109.929 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 76.6 p -141.28 157.29 45.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.862 1.265 . . . . 0.0 111.165 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -155.05 111.44 3.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.622 1.169 . . . . 0.0 110.178 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.6 126.84 31.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.406 1.083 . . . . 0.0 110.564 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.77 159.85 14.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 111.883 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.34 -22.07 66.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.164 0.986 . . . . 0.0 113.368 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 28.1 t0 -83.44 -0.5 50.34 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.903 1.281 . . . . 0.0 113.323 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.13 -1.52 77.42 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.587 1.565 . . . . 0.0 115.068 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.9 p -85.5 158.69 20.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.762 1.625 . . . . 0.0 111.187 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 26.9 t -114.83 121.82 44.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.732 0.813 . . . . 0.0 111.151 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -75.97 140.48 42.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.606 0.763 . . . . 0.0 109.347 163.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -123.26 138.92 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.36 1.864 . . . . 0.0 108.082 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -136.03 149.14 48.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.573 1.549 . . . . 0.0 111.346 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -159.43 147.91 17.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.651 1.18 . . . . 0.0 111.505 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 33.2 t -117.43 107.12 45.53 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.828 0.851 . . . . 0.0 111.019 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.71 150.67 24.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.694 2.929 . . . . 0.0 110.49 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 90.5 m -112.86 -41.75 3.72 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.995 0.918 . . . . 0.0 112.238 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -83.72 140.79 41.01 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.569 0.748 . . . . 0.0 110.151 171.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.15 23.32 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.379 2.72 . . . . 0.0 111.236 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 122.23 -154.03 16.84 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.12 1.343 . . . . 0.0 113.197 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -93.35 131.85 38.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.092 0.957 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -119.87 150.32 40.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.646 1.578 . . . . 0.0 109.763 168.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.43 131.76 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 109.188 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.29 130.28 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.049 1.34 . . . . 0.0 109.427 171.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -110.37 119.98 40.97 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.115 1.366 . . . . 0.0 109.657 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.2 mm -113.29 117.9 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.335 1.054 . . . . 0.0 109.369 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -134.48 131.8 38.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.5 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.71 123.17 39.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 110.054 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.84 32.91 13.17 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.353 1.461 . . . . 0.0 113.986 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.9 t0 84.16 7.45 0.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.746 2.818 . . . . 0.0 114.654 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -113.73 129.42 56.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.531 1.132 . . . . 0.0 111.278 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -65.23 123.16 18.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.384 1.474 . . . . 0.0 110.376 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -75.01 154.53 86.68 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.197 -0.939 . . . . 0.0 110.983 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.18 137.85 68.72 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.424 2.083 . . . . 0.0 111.274 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.34 -26.74 22.5 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.325 1.44 . . . . 0.0 113.304 -171.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 67.8 m -70.25 150.17 95.95 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 118.895 1.347 . . . . 0.0 112.103 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.98 147.66 83.81 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 119.08 0.707 . . . . 0.0 110.836 -7.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.08 118.78 36.6 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.836 0.854 . . . . 0.0 110.853 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 46.4 m -87.09 125.31 34.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.121 0.968 . . . . 0.0 111.202 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -117.9 122.37 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.927 1.691 . . . . 0.0 109.542 -173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 59.8 tttp -86.86 111.58 20.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.201 0.601 . . . . 0.0 110.781 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 95.8 t -97.31 117.04 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.51 1.124 . . . . 0.0 108.814 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.3 t -94.12 151.92 19.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.964 0.906 . . . . 0.0 111.222 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 173.65 150.85 7.79 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.978 0.799 . . . . 0.0 114.549 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.47 -3.11 21.3 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.219 1.407 . . . . 0.0 113.678 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 88.67 140.11 7.18 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.461 1.505 . . . . 0.0 112.803 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -83.87 152.07 24.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.514 1.125 . . . . 0.0 112.66 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 93.9 t -91.66 134.67 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.294 1.438 . . . . 0.0 109.232 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.013 1.325 . . . . 0.0 112.329 179.494 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.64 160.49 32.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.405 1.082 . . . . 0.0 112.773 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -73.33 -22.81 60.23 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -96.74 166.12 23.65 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.633 1.587 . . . . 0.0 113.089 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -78.0 -11.74 59.93 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.798 1.239 . . . . 0.0 113.44 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.4 t0 -152.7 163.95 38.69 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.205 1.802 . . . . 0.0 111.648 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 41.8 m -70.09 171.53 9.46 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.854 1.662 . . . . 0.0 113.905 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 94.4 mtp -60.41 148.22 38.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.177 0.991 . . . . 0.0 112.957 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -64.74 135.69 56.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.855 1.262 . . . . 0.0 110.822 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 17.8 ptm -145.34 142.85 29.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.722 1.209 . . . . 0.0 112.627 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 66.8 m -109.34 154.87 21.92 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 110.273 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -149.63 160.56 43.4 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 152.23 27.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.282 1.833 . . . . 0.0 109.952 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -134.51 143.62 47.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.566 1.146 . . . . 0.0 111.992 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 67.5 t -140.93 132.03 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.909 1.684 . . . . 0.0 109.666 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.24 117.93 4.52 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 40.8 m -80.48 -42.79 21.94 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 59.26 -170.17 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.639 1.576 . . . . 0.0 113.278 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -148.0 147.94 30.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.331 1.453 . . . . 0.0 110.132 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -88.55 133.01 34.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.072 0.949 . . . . 0.0 112.2 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.5 mt -127.62 119.01 21.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 125.093 1.357 . . . . 0.0 109.049 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.07 135.65 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.926 2.417 . . . . 0.0 110.627 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.9 mt -146.08 139.35 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.865 1.666 . . . . 0.0 108.468 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 45.2 t30 63.69 76.57 0.35 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.758 1.623 . . . . 0.0 110.915 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.1 mm -84.75 63.44 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.266 1.426 . . . . 0.0 110.073 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 t -162.76 -178.58 6.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 111.19 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -73.7 125.8 28.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.253 1.021 . . . . 0.0 110.695 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 2.4 m -165.09 137.9 4.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.357 2.263 . . . . 0.0 108.683 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.18 131.49 38.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.716 1.206 . . . . 0.0 111.173 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 1.7 mt -85.23 -13.81 48.73 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -173.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 47.7 m -82.19 -26.78 33.05 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.772 1.169 . . . . 0.0 112.781 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.93 6.26 49.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.268 1.427 . . . . 0.0 113.321 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.91 143.29 31.98 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 0.0 110.666 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 37.6 p -144.03 160.65 40.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.358 1.863 . . . . 0.0 110.365 172.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -157.33 152.6 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.183 0.993 . . . . 0.0 113.214 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -138.0 164.6 28.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.976 2.11 . . . . 0.0 109.747 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -119.56 136.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.353 1.461 . . . . 0.0 110.056 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 96.1 t -104.9 115.6 62.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.33 1.452 . . . . 0.0 108.567 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.91 173.04 10.5 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.987 3.124 . . . . 0.0 111.521 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.43 -33.21 55.82 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 124.343 3.362 . . . . 0.0 113.971 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 17.9 m -73.38 -10.35 59.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.665 1.186 . . . . 0.0 114.038 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.47 -3.48 67.67 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.635 1.588 . . . . 0.0 115.148 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.3 mmm-85 -79.86 90.08 5.29 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.256 1.422 . . . . 0.0 110.772 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.08 136.93 57.7 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.477 1.111 . . . . 0.0 112.117 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -137.05 151.82 72.71 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.576 1.55 . . . . 0.0 111.249 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.88 155.66 38.98 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.672 2.915 . . . . 0.0 112.871 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 87.5 m -100.91 158.89 15.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.889 1.276 . . . . 0.0 112.238 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.9 tt -93.11 121.79 34.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.75 1.22 . . . . 0.0 108.083 167.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.48 141.67 28.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.662 1.185 . . . . 0.0 111.082 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 94.5 mttt -143.3 149.63 38.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.597 1.159 . . . . 0.0 112.978 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -93.77 116.17 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 157.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 88.3 mt -89.24 165.93 14.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.816 0.846 . . . . 0.0 111.519 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -59.69 -25.47 64.79 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 30.1 m120 -77.32 -9.32 58.76 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 96.78 -12.88 65.76 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.099 1.809 . . . . 0.0 114.301 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.05 161.89 26.26 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.565 1.182 . . . . 0.0 113.416 174.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -80.69 148.66 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 109.337 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.85 176.82 30.84 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.274 0.94 . . . . 0.0 114.054 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.53 164.74 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.425 1.49 . . . . 0.0 111.704 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 86.0 p -143.54 152.97 42.09 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 111.964 165.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 13.3 p90 -161.63 173.03 15.31 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.739 2.016 . . . . 0.0 110.656 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 96.9 t -122.69 119.84 28.0 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.446 1.098 . . . . 0.0 109.816 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.4 151.59 22.94 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.754 3.636 . . . . 0.0 111.519 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 13.6 mptt -107.36 -6.22 17.28 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.214 1.006 . . . . 0.0 113.023 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -138.57 167.67 21.44 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.51 1.924 . . . . 0.0 110.639 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.2 p -90.14 165.13 14.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.825 1.25 . . . . 0.0 111.063 168.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.17 -170.79 29.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.077 1.322 . . . . 0.0 113.727 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -71.22 115.94 10.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.185 0.994 . . . . 0.0 112.119 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.9 m80 -100.48 146.58 26.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.007 1.723 . . . . 0.0 109.065 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.53 127.71 54.18 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.119 0.968 . . . . 0.0 109.81 174.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 25.0 t -90.68 123.21 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.664 1.186 . . . . 0.0 108.203 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -105.26 131.52 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.336 . . . . 0.0 110.196 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 21.5 t -130.64 133.36 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.853 0.861 . . . . 0.0 111.101 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -127.6 135.94 50.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.468 1.907 . . . . 0.0 111.591 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -128.75 123.2 32.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.164 2.186 . . . . 0.0 110.192 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.5 t30 55.94 29.28 13.96 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.154 1.381 . . . . 0.0 113.89 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.49 4.75 65.71 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.966 1.27 . . . . 0.0 115.855 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.45 155.88 49.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.406 1.603 . . . . 0.0 111.618 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 67.4 m80 -65.22 143.26 57.94 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.794 -1.191 . . . . 0.0 113.166 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 74.0 t -71.42 142.65 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.438 1.095 . . . . 0.0 109.459 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.01 67.52 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.7 m -81.57 -7.7 59.62 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.968 1.307 . . . . 0.0 113.938 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.1 t -82.92 141.96 44.41 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 120.804 -1.185 . . . . 0.0 112.581 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.07 154.26 86.47 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.646 0.909 . . . . 0.0 112.579 -3.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.39 122.12 46.19 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.483 1.513 . . . . 0.0 108.656 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.16 142.93 12.44 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.11 2.54 . . . . 0.0 111.634 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.9 123.71 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.441 1.497 . . . . 0.0 108.269 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.6 t -99.29 124.52 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.754 0.822 . . . . 0.0 110.172 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.75 128.1 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.997 1.319 . . . . 0.0 109.553 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 60.8 m -100.51 156.34 17.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.108 0.963 . . . . 0.0 111.975 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -56.25 -35.4 67.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.789 1.236 . . . . 0.0 114.168 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 37.0 m -73.72 -12.6 60.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.751 0.82 . . . . 0.0 113.021 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.64 -6.3 52.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.816 1.246 . . . . 0.0 112.628 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 43.0 mm -73.42 -31.93 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.218 0.917 . . . . 0.0 112.494 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 160.93 55.08 0.02 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.48 100.85 10.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.855 0.827 . . . . 0.0 110.315 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.39 -32.61 71.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.74 1.216 . . . . 0.0 113.667 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.55 -21.56 27.26 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.486 1.515 . . . . 0.0 114.027 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.58 -9.94 50.48 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.466 1.506 . . . . 0.0 113.934 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.9 t -79.78 125.96 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 119.949 1.249 . . . . 0.0 111.327 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -105.17 156.04 18.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.644 1.577 . . . . 0.0 110.991 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -147.88 159.17 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.624 1.569 . . . . 0.0 110.861 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.6 t -161.4 177.54 10.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.687 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 100.07 160.63 28.45 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.444 1.497 . . . . 0.0 114.26 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -67.07 -33.14 74.85 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.187 1.395 . . . . 0.0 113.116 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.04 -3.49 36.96 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.05 1.31 . . . . 0.0 115.344 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.69 -7.39 56.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.032 1.333 . . . . 0.0 112.855 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -128.38 -36.01 1.93 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.778 1.231 . . . . 0.0 113.845 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -159.73 157.39 29.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.599 1.16 . . . . 0.0 112.477 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.09 -176.58 24.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.715 1.15 . . . . 0.0 114.106 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -135.43 147.12 48.86 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.887 1.275 . . . . 0.0 112.473 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 20.9 p -67.99 -29.07 68.0 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -112.02 5.81 18.95 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -141.28 154.64 67.65 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.42 1.488 . . . . 0.0 111.068 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.42 136.89 27.12 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.71 2.274 . . . . 0.0 110.738 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -95.82 118.54 32.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.727 1.211 . . . . 0.0 110.146 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -98.29 147.57 24.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.136 0.975 . . . . 0.0 113.369 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.33 153.78 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.253 1.421 . . . . 0.0 111.241 173.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.72 140.08 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.679 1.591 . . . . 0.0 109.456 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.3 mt -114.77 130.66 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.56 1.944 . . . . 0.0 108.901 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.4 t0 -119.55 84.17 2.16 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.603 1.561 . . . . 0.0 110.569 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 3.3 p -84.97 -5.84 59.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.774 2.03 . . . . 0.0 113.288 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -56.03 -40.58 73.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.479 1.036 . . . . 0.0 111.676 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.06 -9.95 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.404 1.482 . . . . 0.0 113.329 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -98.2 0.12 45.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.132 1.773 . . . . 0.0 114.333 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 82.99 -134.04 12.48 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.252 0.93 . . . . 0.0 111.016 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.59 171.49 9.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.758 1.223 . . . . 0.0 112.292 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.87 177.81 19.99 Favored Glycine 0 N--CA 1.472 1.074 0 C-N-CA 124.414 1.006 . . . . 0.0 114.951 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -106.63 131.71 10.78 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.551 1.548 . . . . 0.0 111.815 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.92 121.56 41.95 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.721 2.008 . . . . 0.0 108.913 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 74.8 m -112.56 143.9 42.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.979 1.712 . . . . 0.0 110.266 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.8 tt -143.86 137.4 27.9 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.767 0.827 . . . . 0.0 110.502 -166.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 62.7 m -138.7 135.08 34.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.73 0.812 . . . . 0.0 111.371 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 23.9 mt -122.29 134.56 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.264 1.426 . . . . 0.0 109.13 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.28 154.64 44.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 111.258 -174.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.59 21.29 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.785 -1.008 . . . . 0.0 114.052 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.69 -14.73 36.74 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.029 3.153 . . . . 0.0 114.976 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.3 t -159.16 165.74 33.03 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.955 1.252 . . . . 0.0 112.419 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.01 148.34 51.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.961 1.304 . . . . 0.0 111.775 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 35.9 m -135.12 147.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.562 1.145 . . . . 0.0 112.293 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -88.51 104.38 16.76 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.759 0.824 . . . . 0.0 110.19 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 39.6 mt -84.98 130.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.871 0.868 . . . . 0.0 109.742 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -128.14 155.46 44.4 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.305 1.842 . . . . 0.0 110.333 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.59 156.5 46.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.964 1.306 . . . . 0.0 111.625 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.27 125.83 5.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.983 1.313 . . . . 0.0 110.275 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.64 133.5 36.4 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.335 -0.853 . . . . 0.0 111.199 171.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 50.5 mt -96.19 160.77 14.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.67 1.188 . . . . 0.0 111.732 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.45 -20.68 66.47 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 0.0 113.291 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.62 -3.69 56.55 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.094 1.358 . . . . 0.0 113.274 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.29 -2.94 75.43 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.611 1.577 . . . . 0.0 114.848 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 46.5 p -82.47 167.96 17.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.554 1.542 . . . . 0.0 111.14 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -116.24 127.56 54.86 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.845 0.858 . . . . 0.0 111.196 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -90.86 137.66 32.19 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.703 1.201 . . . . 0.0 109.937 170.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 25.3 t -122.59 138.27 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.4 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.3 p -136.16 151.85 50.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.415 1.486 . . . . 0.0 110.948 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 11.7 p90 -161.27 145.5 13.3 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.427 1.491 . . . . 0.0 110.515 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 25.0 t -107.01 103.41 47.63 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.58 0.752 . . . . 0.0 110.722 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -78.26 110.78 2.93 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.358 2.705 . . . . 0.0 110.128 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.9 m -69.22 -37.98 78.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.647 0.779 . . . . 0.0 112.341 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.29 146.39 34.59 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.035 1.334 . . . . 0.0 111.447 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.37 168.06 25.37 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.275 2.65 . . . . 0.0 111.1 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 114.76 -163.98 12.13 Favored Glycine 0 N--CA 1.472 1.036 0 C-N-CA 125.172 1.368 . . . . 0.0 113.402 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 54.0 t30 -89.89 120.17 30.89 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.9 -0.764 . . . . 0.0 112.174 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.33 143.43 30.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.117 1.367 . . . . 0.0 110.904 164.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.28 134.63 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.926 1.29 . . . . 0.0 108.82 174.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 29.0 mt -116.32 132.95 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.288 1.435 . . . . 0.0 109.521 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -114.17 125.51 54.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.018 1.727 . . . . 0.0 109.904 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.54 124.83 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.974 0.91 . . . . 0.0 109.638 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 31.1 tttt -132.39 127.12 34.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.142 1.377 . . . . 0.0 110.482 -171.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 37.3 t80 -123.8 124.76 43.39 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.12 0.968 . . . . 0.0 110.064 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.99 49.2 17.4 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.469 1.107 . . . . 0.0 111.773 -173.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.84 13.83 9.57 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.373 2.269 . . . . 0.0 114.624 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -119.48 126.8 52.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.104 1.362 . . . . 0.0 110.258 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -65.29 121.58 15.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.616 1.167 . . . . 0.0 111.055 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -79.14 158.69 74.27 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 121.288 -0.883 . . . . 0.0 111.784 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.18 138.07 71.2 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.517 2.811 . . . . 0.0 112.909 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 92.63 -23.24 29.21 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.964 1.268 . . . . 0.0 114.343 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 72.4 m -74.56 149.96 86.52 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 118.916 1.358 . . . . 0.0 111.64 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.52 145.86 80.91 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 119.326 0.795 . . . . 0.0 111.442 -3.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -98.85 120.43 39.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.54 1.136 . . . . 0.0 110.772 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 45.9 m -86.86 133.02 33.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.131 0.972 . . . . 0.0 110.988 171.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 17.2 t -129.93 111.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.63 1.572 . . . . 0.0 109.471 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -81.57 109.58 16.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.015 0.526 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 60.4 t -91.26 127.1 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.131 1.372 . . . . 0.0 109.328 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -117.9 161.94 18.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.739 1.216 . . . . 0.0 112.186 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 129.22 163.29 11.17 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.965 1.745 . . . . 0.0 113.45 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.66 162.44 9.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.06 1.744 . . . . 0.0 110.291 -171.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 87.45 32.71 12.9 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.296 0.95 . . . . 0.0 113.554 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -65.7 99.18 0.43 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.086 1.355 . . . . 0.0 111.45 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 91.2 t -145.07 142.0 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 126.932 2.093 . . . . 0.0 108.99 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 C--O 1.254 1.324 0 C-N-CA 125.781 1.633 . . . . 0.0 111.276 177.146 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -158.38 163.83 36.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.648 1.579 . . . . 0.0 111.985 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -76.65 -11.94 59.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.149 1.38 . . . . 0.0 113.728 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 90.48 171.23 43.88 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.567 1.556 . . . . 0.0 113.704 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -158.8 151.1 21.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.95 1.7 . . . . 0.0 111.384 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.22 -18.91 48.2 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 8.6 t -79.38 142.2 36.21 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.956 -1.09 . . . . 0.0 113.777 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 81.0 mmm -79.93 119.64 23.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.758 1.223 . . . . 0.0 109.929 172.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.37 139.11 30.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.049 0.94 . . . . 0.0 112.058 -171.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 96.9 mtp -89.18 133.03 34.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.428 1.491 . . . . 0.0 112.407 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 18.4 m -118.27 140.59 49.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 108.465 160.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -156.51 158.42 37.16 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.0 tt -161.04 154.64 22.04 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.43 1.892 . . . . 0.0 111.131 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.51 151.34 47.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.002 1.321 . . . . 0.0 112.559 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 52.6 t -139.69 133.98 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.022 1.729 . . . . 0.0 109.458 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -92.5 128.41 9.39 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.885 0.755 . . . . 0.0 111.25 172.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 66.1 m -118.92 144.91 46.17 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.412 1.085 . . . . 0.0 112.53 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.01 151.98 24.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.0 112.357 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.5 149.66 24.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.064 0.946 . . . . 0.0 110.75 166.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.33 134.05 34.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.539 0.735 . . . . 0.0 111.572 169.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.8 mm -112.89 127.48 26.78 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.495 1.518 . . . . 0.0 108.74 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.7 134.31 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.908 2.405 . . . . 0.0 110.478 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 29.9 mm -144.87 140.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.387 1.475 . . . . 0.0 110.293 -168.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.59 55.54 7.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.786 1.634 . . . . 0.0 112.905 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.4 mm -65.76 112.55 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.478 1.111 . . . . 0.0 110.516 -172.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 99.8 p -173.9 172.6 3.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.276 1.43 . . . . 0.0 111.849 -170.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.08 4.82 9.35 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.932 1.693 . . . . 0.0 113.623 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 56.8 m -61.95 134.85 57.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 111.472 -174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.67 132.98 46.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.439 1.496 . . . . 0.0 111.633 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.3 mp -73.76 -21.16 60.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.027 0.931 . . . . 0.0 112.425 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 24.0 m -67.58 -23.46 65.4 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -167.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -114.21 8.95 17.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.35 1.46 . . . . 0.0 113.609 175.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.66 148.09 25.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.026 1.33 . . . . 0.0 111.997 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 47.3 p -141.39 169.65 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.261 2.224 . . . . 0.0 108.974 168.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.42 155.24 37.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 54.6 p -132.25 160.82 35.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.082 2.153 . . . . 0.0 109.153 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -112.8 135.27 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.073 0.949 . . . . 0.0 109.449 166.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.0 t -104.68 113.13 65.25 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.968 1.307 . . . . 0.0 108.196 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.32 173.44 11.65 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.999 3.133 . . . . 0.0 111.128 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.72 -32.69 56.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.127 3.218 . . . . 0.0 113.961 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.5 m -75.65 -4.53 40.69 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 0.0 114.12 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 74.86 -1.76 52.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.286 1.422 . . . . 0.0 115.15 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -77.21 85.56 3.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.516 1.526 . . . . 0.0 111.243 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.09 133.01 54.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.854 1.262 . . . . 0.0 111.929 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -140.58 150.64 61.16 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.174 1.39 . . . . 0.0 111.277 176.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.64 155.55 40.01 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.271 3.314 . . . . 0.0 112.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.2 m -111.28 155.35 23.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.547 1.539 . . . . 0.0 112.207 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 6.2 tt -95.29 116.72 29.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.419 1.488 . . . . 0.0 108.671 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 11.2 mp -84.6 138.11 32.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.476 1.11 . . . . 0.0 111.352 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -133.44 136.17 45.02 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.041 1.336 . . . . 0.0 112.803 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.7 121.73 26.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 152.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.5 162.23 13.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.479 1.112 . . . . 0.0 112.013 -171.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -60.36 -31.65 70.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -86.27 -1.82 57.83 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.971 0.909 . . . . 0.0 113.439 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.62 0.35 57.87 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.504 1.526 . . . . 0.0 114.095 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -80.87 177.31 9.13 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.119 1.368 . . . . 0.0 112.863 170.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 88.6 t -130.15 140.51 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 109.617 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.04 -174.54 25.97 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.61 154.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.613 1.565 . . . . 0.0 111.946 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 16.4 m -121.38 149.59 42.74 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.15 1.38 . . . . 0.0 111.198 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.2 p90 -165.64 -178.87 5.07 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.101 2.16 . . . . 0.0 109.752 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.9 t -128.88 122.44 21.42 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-N 119.258 0.935 . . . . 0.0 109.95 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.81 149.56 23.27 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.115 3.21 . . . . 0.0 111.369 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -106.27 -9.57 16.77 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -143.25 173.63 11.42 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.858 2.063 . . . . 0.0 110.11 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.5 p -88.77 167.35 13.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.656 1.182 . . . . 0.0 111.117 167.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.65 -168.08 30.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.801 1.191 . . . . 0.0 113.57 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.05 116.98 11.98 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.05 0.94 . . . . 0.0 112.005 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.8 m80 -102.58 141.0 36.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.974 1.71 . . . . 0.0 109.042 167.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.86 123.26 44.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.055 0.942 . . . . 0.0 109.229 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.1 t -87.76 113.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.987 1.315 . . . . 0.0 107.811 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -95.21 126.21 40.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.525 1.13 . . . . 0.0 110.225 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 81.3 t -117.71 120.14 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.996 1.319 . . . . 0.0 109.769 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -108.82 130.48 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.97 1.708 . . . . 0.0 111.72 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -108.74 122.94 48.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.545 1.938 . . . . 0.0 109.356 171.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 57.25 -94.27 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.064 1.346 . . . . 0.0 111.72 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -123.37 9.5 8.8 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.863 1.697 . . . . 0.0 115.777 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.6 157.02 43.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.743 1.771 . . . . 0.0 112.393 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -67.34 138.61 56.91 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.888 -1.133 . . . . 0.0 112.783 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 5.9 p -71.44 156.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.389 1.076 . . . . 0.0 110.675 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.06 -28.44 62.58 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.0 m -80.47 -9.65 59.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.942 1.297 . . . . 0.0 114.162 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 31.9 t -90.78 147.56 36.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.9 1.28 . . . . 0.0 113.198 -172.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.26 162.28 76.76 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.26 0.771 . . . . 0.0 112.677 -5.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.01 126.38 28.32 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.685 1.594 . . . . 0.0 109.04 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.66 142.27 12.75 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.117 2.544 . . . . 0.0 112.031 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.9 t -135.87 127.75 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.593 1.557 . . . . 0.0 107.869 170.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 53.9 t -100.39 126.53 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.853 0.861 . . . . 0.0 110.49 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.29 130.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.138 1.375 . . . . 0.0 110.169 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 65.9 m -98.15 156.92 16.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.52 1.128 . . . . 0.0 112.087 174.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -58.52 -30.01 66.75 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 8.7 m -65.34 -19.29 65.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.6 1.16 . . . . 0.0 113.739 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -93.46 -12.17 30.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.713 1.205 . . . . 0.0 112.955 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.7 -24.81 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.659 1.184 . . . . 0.0 112.576 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 134.73 68.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.291 1.424 . . . . 0.0 112.84 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.96 105.79 10.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.262 0.531 . . . . 0.0 110.007 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.49 66.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.841 0.856 . . . . 0.0 112.307 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.1 m -54.18 -23.33 14.04 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.181 1.793 . . . . 0.0 114.468 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -90.9 -12.73 35.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.856 1.262 . . . . 0.0 113.466 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 67.8 t -74.19 133.99 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.625 1.102 . . . . 0.0 109.867 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.55 154.45 24.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 111.171 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.5 m -144.51 150.5 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.471 1.508 . . . . 0.0 110.172 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.7 m -148.12 165.74 29.93 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.91 1.284 . . . . 0.0 112.487 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.48 159.73 24.01 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.517 1.056 . . . . 0.0 114.416 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -71.59 -25.43 62.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.66 1.184 . . . . 0.0 113.373 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.89 -5.76 41.03 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.264 0.935 . . . . 0.0 114.986 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.25 -2.64 58.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.417 1.487 . . . . 0.0 112.893 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -135.84 -38.72 0.71 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -141.56 151.18 42.99 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.772 1.229 . . . . 0.0 111.831 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.43 -176.7 22.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.144 1.354 . . . . 0.0 113.269 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -147.97 145.72 28.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.173 0.989 . . . . 0.0 113.015 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 24.3 p -60.13 -26.13 66.02 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.711 1.605 . . . . 0.0 115.028 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.77 23.22 9.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.245 1.418 . . . . 0.0 112.93 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -145.49 137.34 13.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.642 1.177 . . . . 0.0 110.315 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -71.27 133.68 23.3 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.536 2.157 . . . . 0.0 110.286 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -102.33 131.35 48.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.436 1.494 . . . . 0.0 110.393 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.42 154.21 35.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.862 1.265 . . . . 0.0 113.325 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.71 153.15 27.98 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.005 1.722 . . . . 0.0 111.024 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.61 142.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.496 1.919 . . . . 0.0 109.9 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.1 132.17 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.815 1.646 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 31.4 t0 -125.39 86.75 2.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.46 1.504 . . . . 0.0 111.732 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 16.4 p -83.43 -8.92 59.3 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.422 1.889 . . . . 0.0 113.657 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.89 -30.32 70.09 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.7 1.137 . . . . 0.0 113.616 -175.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.94 -15.58 60.68 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.94 0.896 . . . . 0.0 113.231 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -97.5 -1.63 43.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.95 1.7 . . . . 0.0 114.208 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.78 -128.39 8.55 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.651 1.119 . . . . 0.0 112.296 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -94.22 160.28 14.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.413 1.485 . . . . 0.0 112.234 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.8 174.09 19.38 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.34 126.36 8.72 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.868 1.223 . . . . 0.0 111.852 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.9 123.14 41.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.705 2.002 . . . . 0.0 108.576 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.9 t -116.39 140.51 49.27 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.04 1.336 . . . . 0.0 110.402 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.86 131.0 30.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.663 1.185 . . . . 0.0 110.284 -167.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 56.9 m -135.16 131.14 36.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.796 0.838 . . . . 0.0 110.72 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 22.5 mt -109.27 125.46 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.549 1.54 . . . . 0.0 108.114 173.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.21 139.0 46.96 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.154 1.382 . . . . 0.0 109.742 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -168.82 -175.92 38.6 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -8.58 23.93 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.471 3.447 . . . . 0.0 113.825 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.1 t -154.83 164.84 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.754 1.222 . . . . 0.0 111.875 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.75 146.51 52.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.664 1.186 . . . . 0.0 111.53 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -132.27 141.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.112 0.965 . . . . 0.0 110.822 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.34 125.43 29.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.219 0.608 . . . . 0.0 110.013 169.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 38.4 mt -106.52 127.76 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.94 0.896 . . . . 0.0 108.851 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -124.31 143.68 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 109.854 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 24.9 p -113.74 154.03 28.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.911 1.284 . . . . 0.0 111.248 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.94 120.0 5.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.635 1.174 . . . . 0.0 110.15 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -79.02 123.53 27.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.307 1.043 . . . . 0.0 110.645 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.37 160.12 15.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.104 0.962 . . . . 0.0 111.975 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.6 -25.82 68.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.109 0.963 . . . . 0.0 112.333 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.13 -8.52 50.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.998 1.719 . . . . 0.0 113.777 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.59 -5.48 84.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.768 1.651 . . . . 0.0 114.304 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 25.0 p -82.93 161.41 21.84 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.943 1.697 . . . . 0.0 111.471 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 33.8 t -102.88 123.33 46.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.677 0.791 . . . . 0.0 110.255 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.05 138.2 33.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.867 0.867 . . . . 0.0 109.296 163.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 56.7 t -119.95 133.84 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.059 1.744 . . . . 0.0 108.169 168.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 67.6 m -136.92 138.3 40.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.853 1.261 . . . . 0.0 110.517 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.1 p90 -147.99 148.55 30.85 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.277 1.031 . . . . 0.0 112.465 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 23.2 t -109.15 106.84 59.34 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.538 0.735 . . . . 0.0 111.088 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.37 119.17 4.85 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.992 2.461 . . . . 0.0 109.694 171.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -78.86 -43.54 24.83 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.734 0.814 . . . . 0.0 111.614 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -91.31 147.68 36.01 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.551 1.14 . . . . 0.0 110.933 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.99 167.61 26.66 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.558 2.838 . . . . 0.0 111.734 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.78 -161.28 18.19 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.066 1.317 . . . . 0.0 113.768 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -93.79 126.71 39.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.007 0.923 . . . . 0.0 111.541 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -111.29 142.92 42.89 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.567 1.547 . . . . 0.0 109.808 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.45 123.89 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.595 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.29 124.6 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.896 1.278 . . . . 0.0 109.73 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -104.26 128.9 52.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.893 1.677 . . . . 0.0 109.755 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.3 mm -121.88 111.98 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.858 1.263 . . . . 0.0 109.524 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -121.02 130.92 53.99 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.634 1.574 . . . . 0.0 111.098 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -123.53 126.01 45.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.447 1.499 . . . . 0.0 110.328 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.16 28.77 9.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.342 1.457 . . . . 0.0 113.963 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 87.82 6.89 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 129.147 2.979 . . . . 0.0 114.894 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -114.69 138.27 50.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.726 1.21 . . . . 0.0 111.113 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2124 ' ' HIS . . . . . 0.529 ' CE1' ' HG ' ' A' 2128 ' ' SER . 0.0 OUTLIER -62.77 132.23 51.53 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.165 -0.959 . . . . 0.0 111.143 172.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.1 m -80.4 159.99 68.63 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.529 -0.732 . . . . 0.0 111.516 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.27 136.59 62.81 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.749 2.966 . . . . 0.0 113.354 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 86.04 -19.8 24.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.048 1.309 . . . . 0.0 114.394 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2128 ' ' SER . . . . . 0.529 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 23.1 t -76.4 144.27 74.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 118.613 1.207 . . . . 0.0 111.451 176.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.48 150.7 93.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 119.727 0.938 . . . . 0.0 112.283 -3.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.68 122.29 44.74 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.399 1.479 . . . . 0.0 110.733 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.3 p -86.96 135.28 33.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.419 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.3 t -130.93 113.98 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.186 1.395 . . . . 0.0 109.496 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.13 115.68 22.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.113 0.565 . . . . 0.0 111.154 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 91.4 t -98.22 115.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.232 1.413 . . . . 0.0 109.056 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 4.9 t -102.4 173.81 6.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.947 1.299 . . . . 0.0 111.455 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 116.52 -137.29 13.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.094 1.33 . . . . 0.0 112.615 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -145.97 162.59 37.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.768 1.227 . . . . 0.0 112.454 -167.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -69.5 140.39 33.48 Favored Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.473 -0.767 . . . . 0.0 111.891 172.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -67.69 139.15 56.74 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.374 1.07 . . . . 0.0 111.979 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 92.5 t -70.28 131.79 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.767 1.227 . . . . 0.0 110.048 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.234 1.413 . . . . 0.0 112.503 -178.476 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.499 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.5 156.56 36.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.32 1.048 . . . . 0.0 112.859 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.6 ttt -74.85 -27.69 60.37 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.497 1.119 . . . . 0.0 113.003 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 141.43 -174.51 22.88 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.932 1.73 . . . . 0.0 113.226 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.1 t0 -158.09 56.12 0.47 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.47 1.508 . . . . 0.0 110.955 -175.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.43 53.89 1.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.575 1.55 . . . . 0.0 111.193 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 23.2 m -66.77 171.5 5.19 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.423 1.489 . . . . 0.0 113.555 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 38.2 mmt -55.86 127.22 29.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.41 1.084 . . . . 0.0 111.784 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -77.48 151.87 34.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.425 1.09 . . . . 0.0 112.352 -173.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.9 ptt? -70.62 154.24 42.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.438 1.095 . . . . 0.0 112.73 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.0 m -107.59 144.79 34.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.69 1.196 . . . . 0.0 110.117 166.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.31 149.54 51.91 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.561 1.144 . . . . 0.0 113.266 -165.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -157.35 146.24 19.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.066 1.747 . . . . 0.0 110.11 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 48.2 mttp -128.51 149.9 50.4 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.518 1.127 . . . . 0.0 113.0 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.82 139.11 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.32 1.848 . . . . 0.0 109.513 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.96 120.76 5.39 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 4.0 m -111.96 142.74 44.0 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.694 1.197 . . . . 0.0 112.697 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.48 146.0 11.54 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.74 169.35 17.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.977 1.311 . . . . 0.0 111.555 163.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -105.3 137.59 42.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.737 1.215 . . . . 0.0 111.853 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.7 mm -105.27 118.04 56.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.303 1.041 . . . . 0.0 109.02 164.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.13 128.46 10.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.402 2.735 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 57.0 mt -147.44 139.53 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.658 1.583 . . . . 0.0 109.843 -172.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.07 60.26 3.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.803 1.641 . . . . 0.0 112.456 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.4 111.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.44 1.096 . . . . 0.0 111.34 -166.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 m -172.83 146.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.816 2.446 . . . . 0.0 109.33 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.42 -10.16 50.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.77 1.228 . . . . 0.0 113.501 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 24.9 p -91.43 160.3 15.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.338 1.855 . . . . 0.0 112.063 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 60.3 m-20 70.41 3.25 4.39 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.406 2.282 . . . . 0.0 114.679 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.53 -20.86 65.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 113.783 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 28.0 p -77.14 -12.55 59.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 9.74 3.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.179 1.391 . . . . 0.0 114.389 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.95 143.22 34.37 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.207 1.003 . . . . 0.0 110.974 164.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 39.8 p -140.86 160.75 39.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 109.779 173.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.87 150.67 26.24 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.57 0.748 . . . . 0.0 113.013 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 63.6 p -138.8 163.12 33.06 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.977 2.111 . . . . 0.0 109.491 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 137.36 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.911 1.284 . . . . 0.0 109.864 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.1 t -105.6 110.91 64.74 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.111 1.364 . . . . 0.0 108.083 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.57 169.14 20.27 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.893 3.062 . . . . 0.0 110.846 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.16 -15.88 47.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.065 2.51 . . . . 0.0 113.12 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 67.0 p -79.39 -9.3 59.57 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.88 1.272 . . . . 0.0 113.826 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.5 85.21 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.668 1.604 . . . . 0.0 115.185 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -77.61 82.58 4.03 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.374 1.469 . . . . 0.0 111.698 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.83 132.64 54.5 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 111.875 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.06 151.73 59.79 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.405 1.482 . . . . 0.0 111.354 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.9 158.04 34.75 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.951 3.1 . . . . 0.0 112.852 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.9 m -110.18 155.7 21.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.066 1.346 . . . . 0.0 112.457 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.5 tt -99.48 115.23 28.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.82 1.648 . . . . 0.0 108.157 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 4.3 mp -87.08 134.37 33.51 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.578 0.751 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.91 137.23 53.11 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.179 1.392 . . . . 0.0 112.805 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -99.14 124.19 43.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.524 1.529 . . . . 0.0 107.979 161.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.76 171.7 7.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.211 1.404 . . . . 0.0 112.763 -165.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -59.63 -32.19 70.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.33 -2.62 58.51 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.251 1.02 . . . . 0.0 113.446 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.46 -8.4 62.2 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.727 1.632 . . . . 0.0 114.857 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -73.96 168.83 18.69 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.594 1.197 . . . . 0.0 112.975 172.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.3 t -131.26 142.37 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.977 1.311 . . . . 0.0 110.948 -168.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.87 -168.79 20.72 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.846 1.212 . . . . 0.0 113.992 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.72 151.35 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.775 1.23 . . . . 0.0 112.233 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 43.2 m -123.59 155.1 38.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.766 1.626 . . . . 0.0 111.467 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.6 p90 -166.93 -174.68 2.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.497 2.319 . . . . 0.0 109.221 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -128.93 116.23 19.09 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 119.302 0.956 . . . . 0.0 109.706 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.99 139.52 24.41 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.939 3.093 . . . . 0.0 110.574 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -99.96 -6.9 25.85 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.271 1.029 . . . . 0.0 113.08 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -140.16 169.25 18.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.759 2.024 . . . . 0.0 110.363 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 167.11 13.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.277 1.031 . . . . 0.0 110.995 165.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 94.96 -169.3 28.1 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.048 1.309 . . . . 0.0 113.749 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -72.15 118.27 14.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.49 144.16 32.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.351 1.86 . . . . 0.0 109.104 168.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.58 125.95 51.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 0.0 109.642 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 26.3 t -89.35 121.39 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.705 1.202 . . . . 0.0 108.001 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -99.93 128.48 46.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.718 1.207 . . . . 0.0 110.061 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 48.0 t -126.71 131.4 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.595 1.158 . . . . 0.0 110.421 -172.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.9 mttp -123.38 147.58 46.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.734 1.613 . . . . 0.0 112.547 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -118.58 119.83 35.67 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 108.941 169.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.27 30.91 19.22 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.996 1.318 . . . . 0.0 113.247 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.48 2.5 73.11 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.027 1.299 . . . . 0.0 116.052 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -123.59 151.19 43.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.442 1.621 . . . . 0.0 110.999 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.34 144.58 57.06 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 98.2 t -77.63 146.08 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.678 1.191 . . . . 0.0 109.096 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.91 63.57 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -174.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 58.1 p -85.95 -8.05 58.25 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.162 1.385 . . . . 0.0 114.079 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 21.2 t -82.87 144.45 48.09 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.936 1.294 . . . . 0.0 112.358 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.03 155.49 87.41 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.562 0.879 . . . . 0.0 112.613 -3.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.49 120.85 48.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.731 1.612 . . . . 0.0 108.768 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.26 141.61 12.91 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.965 2.443 . . . . 0.0 111.247 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 22.3 t -137.57 126.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.799 1.639 . . . . 0.0 108.093 175.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.8 t -97.31 124.29 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.72 0.808 . . . . 0.0 110.202 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.57 128.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.037 1.335 . . . . 0.0 109.883 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 66.9 m -93.31 170.75 9.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.706 1.202 . . . . 0.0 112.234 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -34.5 77.46 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.323 -1.486 . . . . 0.0 111.604 174.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.0 m -66.17 -2.29 4.1 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.708 1.603 . . . . 0.0 115.27 -173.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.63 5.49 8.21 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.997 1.719 . . . . 0.0 112.96 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 3.5 mm -86.23 -21.83 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.546 1.138 . . . . 0.0 113.557 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.1 38.35 0.04 OUTLIER Glycine 0 N--CA 1.471 0.968 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.36 84.4 4.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.474 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -54.95 -37.01 65.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.609 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.22 -24.95 45.38 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.497 1.519 . . . . 0.0 114.381 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -90.94 -8.52 49.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.698 1.599 . . . . 0.0 114.215 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 90.4 t -73.8 137.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.007 1.276 . . . . 0.0 110.419 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -121.03 155.21 34.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.311 1.444 . . . . 0.0 111.365 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 30.6 m -145.23 153.33 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 109.971 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -154.86 170.88 20.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.025 0.93 . . . . 0.0 112.669 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.05 156.17 30.59 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.224 1.393 . . . . 0.0 113.184 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.04 -21.61 62.24 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.98 -2.16 22.74 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.078 1.323 . . . . 0.0 115.093 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 65.3 mt -90.93 -7.22 52.71 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.165 1.786 . . . . 0.0 112.707 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.06 -32.23 1.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.074 1.349 . . . . 0.0 113.887 -172.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.48 156.86 42.25 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.486 1.514 . . . . 0.0 112.253 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.87 32.5 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.371 0.986 . . . . 0.0 113.797 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.0 m80 -134.22 148.97 50.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 112.699 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 17.1 p -68.78 -29.78 68.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -118.19 0.15 11.69 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.52 146.49 61.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.106 1.763 . . . . 0.0 109.644 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.21 141.32 43.12 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.783 2.322 . . . . 0.0 111.049 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.72 154.29 21.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.41 1.084 . . . . 0.0 110.295 168.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.66 150.26 47.22 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 112.608 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 42.2 p90 -157.13 149.98 23.54 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 110.637 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.53 140.95 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.934 1.694 . . . . 0.0 109.566 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 71.5 mt -112.74 134.62 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.967 1.707 . . . . 0.0 108.86 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 23.2 t70 -137.07 123.22 20.43 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.565 1.546 . . . . 0.0 112.013 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 11.7 p -134.48 -11.75 2.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -157.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.13 -21.94 66.36 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 121.064 1.756 . . . . 0.0 114.542 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.46 -20.47 61.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.76 0.824 . . . . 0.0 112.554 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -92.34 -3.82 54.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.988 1.715 . . . . 0.0 113.423 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.7 -110.28 3.5 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.992 1.282 . . . . 0.0 112.462 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -131.79 151.74 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.534 1.533 . . . . 0.0 112.808 -168.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.87 -179.13 28.71 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -84.76 127.59 8.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.22 0.914 . . . . 0.0 111.239 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.8 124.58 49.8 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.243 1.817 . . . . 0.0 108.363 175.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.8 t -112.06 140.44 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.844 1.257 . . . . 0.0 111.35 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.17 133.73 47.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.248 2.219 . . . . 0.0 108.363 -174.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 83.0 p -143.36 151.76 40.81 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.26 -0.9 . . . . 0.0 112.661 167.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.27 137.52 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.97 1.308 . . . . 0.0 109.296 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.67 155.41 41.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.273 1.429 . . . . 0.0 111.033 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 167.3 -155.5 26.57 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 118.808 -0.996 . . . . 0.0 114.202 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.43 -8.69 23.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.429 3.42 . . . . 0.0 115.368 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.4 t -160.26 162.0 33.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.741 1.217 . . . . 0.0 111.528 173.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.29 146.98 53.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.301 1.041 . . . . 0.0 111.782 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 34.6 m -135.46 147.89 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.035 1.334 . . . . 0.0 111.65 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -88.94 122.55 32.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.862 0.865 . . . . 0.0 110.346 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.21 131.41 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.371 1.068 . . . . 0.0 109.604 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -130.05 161.08 31.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.224 1.81 . . . . 0.0 110.287 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 39.9 p -143.03 163.48 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.489 1.116 . . . . 0.0 112.829 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.13 121.35 6.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.773 1.629 . . . . 0.0 109.969 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.54 131.29 35.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.89 1.276 . . . . 0.0 111.132 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -108.53 153.63 23.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.023 1.329 . . . . 0.0 111.292 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -15.6 63.43 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -76.83 -6.06 50.84 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.753 1.221 . . . . 0.0 112.857 170.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 89.43 2.13 77.1 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.996 1.76 . . . . 0.0 114.082 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 4.1 p -81.64 156.73 24.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.413 1.885 . . . . 0.0 111.31 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -115.43 120.88 41.01 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.994 0.917 . . . . 0.0 110.347 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.8 ttm105 -78.93 133.77 36.9 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.976 0.91 . . . . 0.0 108.846 164.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 27.4 t -115.48 140.54 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.874 1.67 . . . . 0.0 108.518 169.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.7 p -136.21 150.3 48.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.589 1.556 . . . . 0.0 111.334 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.7 p90 -163.12 150.07 12.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 111.415 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 15.0 t -111.59 101.55 51.26 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.907 0.883 . . . . 0.0 110.766 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.64 116.87 4.38 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.104 2.536 . . . . 0.0 110.342 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.6 m -74.06 -39.69 63.3 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.923 0.889 . . . . 0.0 112.396 -173.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -95.07 148.69 35.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.05 1.34 . . . . 0.0 111.478 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.77 164.49 31.86 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.374 2.716 . . . . 0.0 110.98 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 121.01 -163.94 14.36 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.168 1.366 . . . . 0.0 113.284 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.6 t30 -91.55 117.27 29.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.457 0.703 . . . . 0.0 111.99 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -94.96 141.13 29.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.505 1.122 . . . . 0.0 111.145 164.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.77 134.96 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.404 1.482 . . . . 0.0 108.753 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 26.5 mt -118.32 128.36 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.927 1.291 . . . . 0.0 109.111 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -105.72 130.08 53.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 110.884 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 16.0 mm -119.83 120.82 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.002 1.321 . . . . 0.0 110.022 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -131.93 135.99 47.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.22 1.408 . . . . 0.0 111.469 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 69.8 t80 -131.48 129.69 41.46 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.88 1.672 . . . . 0.0 110.652 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.86 29.26 11.68 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.048 1.339 . . . . 0.0 113.424 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.8 t0 83.4 4.53 0.86 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 129.198 2.999 . . . . 0.0 114.668 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -109.05 128.22 54.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.824 1.249 . . . . 0.0 111.186 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2124 ' ' HIS . . . . . 0.469 ' CE1' ' HG ' ' A' 2128 ' ' SER . 3.6 t-80 -63.24 125.98 25.9 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.053 1.341 . . . . 0.0 110.618 172.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.3 m -80.38 156.46 73.65 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-N 119.039 0.836 . . . . 0.0 111.318 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.19 144.45 81.31 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.409 2.072 . . . . 0.0 111.63 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.37 -24.33 14.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.967 1.27 . . . . 0.0 113.423 -172.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2128 ' ' SER . . . . . 0.469 ' HG ' ' CE1' ' A' 2124 ' ' HIS . 10.1 t -77.89 143.04 65.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.167 0.987 . . . . 0.0 110.565 170.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 146.37 84.19 Favored 'Cis proline' 0 C--N 1.353 0.768 0 CA-C-N 120.224 1.116 . . . . 0.0 112.075 0.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -97.63 122.21 40.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.709 1.203 . . . . 0.0 110.546 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.9 m -89.34 129.81 35.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.259 1.024 . . . . 0.0 111.37 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -122.94 112.08 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.2 1.8 . . . . 0.0 109.495 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -81.24 103.07 10.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.189 0.595 . . . . 0.0 111.455 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 61.7 t -87.85 128.9 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 109.45 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -125.25 167.32 15.04 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 114.11 161.1 13.82 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.086 1.803 . . . . 0.0 113.091 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -166.79 152.45 8.04 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.98 1.712 . . . . 0.0 110.316 -171.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 99.32 50.58 1.42 Allowed Glycine 0 N--CA 1.473 1.155 0 C-N-CA 124.537 1.065 . . . . 0.0 113.111 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -73.63 95.13 2.27 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.605 1.162 . . . . 0.0 111.156 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 7.4 p -164.41 151.38 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.402 1.881 . . . . 0.0 110.537 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 65.1 mttp . . . . . 0 C--O 1.254 1.334 0 C-N-CA 125.084 1.354 . . . . 0.0 112.875 179.257 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -79.33 -18.64 52.13 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.3 mmt -113.58 166.55 11.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.584 1.954 . . . . 0.0 111.92 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 149.7 -140.06 7.83 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 125.627 1.584 . . . . 0.0 112.023 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.93 -16.02 63.88 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.346 1.058 . . . . 0.0 112.905 172.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t0 -143.96 161.4 38.83 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.225 2.21 . . . . 0.0 110.28 173.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 22.9 t -124.05 144.37 49.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.725 1.21 . . . . 0.0 112.611 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 22.2 mmt -63.24 135.54 57.16 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.362 -0.836 . . . . 0.0 111.928 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -71.34 138.2 49.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.806 0.843 . . . . 0.0 110.227 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 21.4 ptm -146.52 159.17 43.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 113.264 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.5 m -136.86 151.34 48.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.238 2.215 . . . . 0.0 109.084 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -150.67 160.33 43.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -170.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.39 153.68 25.71 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.512 1.925 . . . . 0.0 110.309 -172.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 61.1 mttm -133.91 143.15 48.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.181 1.392 . . . . 0.0 111.525 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 63.9 t -138.86 137.53 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.91 1.684 . . . . 0.0 109.592 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.81 130.08 9.97 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.924 0.773 . . . . 0.0 111.52 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 69.0 m -119.72 150.98 39.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.952 1.301 . . . . 0.0 112.223 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -153.69 152.14 30.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.126 0.971 . . . . 0.0 112.929 -174.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.46 149.79 29.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.443 0.697 . . . . 0.0 110.527 163.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -98.35 125.92 43.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 110.26 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.6 122.49 35.04 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.764 -1.113 . . . . 0.0 109.529 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.76 135.25 21.32 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.942 2.428 . . . . 0.0 110.601 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -148.49 143.53 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.549 1.54 . . . . 0.0 110.03 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.22 59.35 4.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.461 1.504 . . . . 0.0 112.383 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.1 mm -73.82 102.99 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.7 t -167.52 179.01 5.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.87 1.668 . . . . 0.0 111.078 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -85.58 6.03 29.05 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.614 1.566 . . . . 0.0 112.921 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -63.86 139.73 58.8 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.647 1.579 . . . . 0.0 112.076 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.25 158.61 28.87 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.682 1.193 . . . . 0.0 111.959 175.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.2 -23.53 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.34 1.056 . . . . 0.0 113.625 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 91.4 p -71.4 -27.45 63.32 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.12 4.25 51.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.871 1.668 . . . . 0.0 113.503 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.37 140.85 34.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.9 p -138.25 160.88 38.31 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.158 1.783 . . . . 0.0 110.104 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -148.65 148.7 30.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.828 0.851 . . . . 0.0 113.035 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.6 p -142.09 166.81 23.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.744 2.018 . . . . 0.0 109.92 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -122.07 138.44 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 109.595 168.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.1 t -107.07 112.71 63.02 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.297 1.439 . . . . 0.0 108.11 166.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -77.91 171.3 17.49 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.12 3.213 . . . . 0.0 110.773 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.46 -17.51 59.87 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.88 2.387 . . . . 0.0 113.587 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 7.3 t -77.81 -12.14 59.95 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.114 0.966 . . . . 0.0 113.273 170.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 83.8 -0.64 89.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.768 1.651 . . . . 0.0 115.09 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -78.03 86.64 4.2 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.131 1.772 . . . . 0.0 111.105 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -61.01 132.33 53.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.0 0.92 . . . . 0.0 111.837 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -137.41 148.65 62.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 110.663 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.56 155.04 40.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.732 2.955 . . . . 0.0 112.428 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 89.5 m -115.77 151.28 35.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.042 1.337 . . . . 0.0 111.679 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 115.35 26.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.964 0.906 . . . . 0.0 109.346 171.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.91 142.12 42.14 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.467 1.107 . . . . 0.0 110.779 171.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -145.4 149.25 34.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 113.017 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.95 115.81 23.01 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 153.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.77 170.43 11.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.208 1.003 . . . . 0.0 112.503 -173.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 63.3 ttt-85 -60.69 -30.14 69.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.597 1.559 . . . . 0.0 114.315 -169.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -82.55 -10.58 58.93 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.593 1.157 . . . . 0.0 113.684 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.29 55.12 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.87 1.7 . . . . 0.0 114.584 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 166.22 19.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 118.783 1.291 . . . . 0.0 113.403 173.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 90.8 t -93.02 142.94 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.955 1.302 . . . . 0.0 110.197 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.63 -171.87 27.15 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.05 162.96 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.779 1.631 . . . . 0.0 112.675 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 84.7 p -136.99 159.25 42.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.286 1.034 . . . . 0.0 111.916 159.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -165.63 -171.73 2.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.989 2.516 . . . . 0.0 109.309 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 82.0 t -134.65 120.82 14.67 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 110.241 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.34 143.4 15.55 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.384 3.39 . . . . 0.0 110.792 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.41 23.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.73 169.3 18.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.325 1.85 . . . . 0.0 110.582 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -82.07 169.74 16.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 112.076 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.99 -175.83 23.35 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.59 1.567 . . . . 0.0 113.875 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.98 118.39 15.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.897 0.879 . . . . 0.0 111.13 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.3 m80 -103.64 143.85 32.22 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.946 1.699 . . . . 0.0 109.275 170.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 123.26 46.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.089 0.956 . . . . 0.0 108.959 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 58.0 t -85.0 129.69 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.846 1.259 . . . . 0.0 107.881 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -112.33 132.37 55.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.848 1.259 . . . . 0.0 110.339 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 95.1 t -129.6 127.97 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.475 1.11 . . . . 0.0 110.636 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -119.9 135.27 54.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.791 1.636 . . . . 0.0 112.057 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -106.64 114.94 29.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.465 1.906 . . . . 0.0 109.027 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.3 t30 52.62 -101.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.164 1.386 . . . . 0.0 111.763 -172.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.26 5.24 33.65 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.595 1.569 . . . . 0.0 115.876 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -140.6 149.46 42.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.799 1.8 . . . . 0.0 112.809 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -68.7 144.8 54.3 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.102 -0.999 . . . . 0.0 113.028 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.8 m -72.08 160.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 111.481 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.3 67.97 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.2 m -79.88 -15.68 56.87 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 34.1 t -89.19 145.05 33.42 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.536 1.134 . . . . 0.0 113.114 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.96 159.12 84.07 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 119.297 0.785 . . . . 0.0 112.6 -3.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.37 125.54 28.73 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.758 1.623 . . . . 0.0 109.577 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.18 139.26 13.23 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.072 2.515 . . . . 0.0 111.552 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 40.9 t -134.83 125.1 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.837 1.655 . . . . 0.0 107.957 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.3 t -98.17 124.8 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.87 0.868 . . . . 0.0 110.427 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.29 120.73 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.168 1.387 . . . . 0.0 108.747 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 83.2 p -96.3 167.99 10.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.943 0.897 . . . . 0.0 112.119 172.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.64 -22.84 66.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 12.1 t -70.78 -36.03 72.87 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.304 -0.873 . . . . 0.0 111.796 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -74.69 -15.98 60.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.452 1.101 . . . . 0.0 112.728 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 50.2 mm -64.91 -19.91 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.34 1.056 . . . . 0.0 112.037 173.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 132.11 64.6 0.09 OUTLIER Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.609 1.576 . . . . 0.0 113.755 168.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 23.9 t0 -65.85 114.47 5.11 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 117.766 0.783 . . . . 0.0 111.56 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.97 80.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.146 0.978 . . . . 0.0 112.755 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 49.0 m -61.32 -20.46 62.97 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -85.71 -12.0 52.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.137 1.375 . . . . 0.0 114.069 174.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.6 t -76.29 133.41 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.921 1.237 . . . . 0.0 110.117 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -115.52 157.9 23.39 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.655 1.582 . . . . 0.0 110.703 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.3 m -146.5 158.55 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.22 1.408 . . . . 0.0 111.036 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -160.06 169.15 23.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 112.288 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 107.69 160.38 20.93 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.213 1.387 . . . . 0.0 114.444 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -68.88 -32.11 71.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.465 1.506 . . . . 0.0 113.31 -169.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.48 -3.28 47.15 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.039 1.304 . . . . 0.0 115.17 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.56 -8.37 56.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.319 1.447 . . . . 0.0 112.631 168.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.66 -36.19 2.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -158.16 155.71 29.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.478 1.111 . . . . 0.0 112.752 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.03 -175.23 23.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.796 1.189 . . . . 0.0 114.288 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -137.69 148.55 45.78 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.118 1.367 . . . . 0.0 112.657 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 23.3 p -68.98 -35.07 76.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.08 10.2 22.02 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.42 154.85 72.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.608 1.563 . . . . 0.0 110.59 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 144.27 34.41 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.716 2.277 . . . . 0.0 111.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.45 138.36 37.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.404 1.482 . . . . 0.0 110.009 169.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.61 146.03 48.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.021 1.328 . . . . 0.0 113.307 -169.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -158.17 157.38 32.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.089 1.356 . . . . 0.0 112.159 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.43 141.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.476 1.911 . . . . 0.0 109.347 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 50.9 mt -117.1 132.68 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 108.769 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -120.81 100.71 7.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.724 1.61 . . . . 0.0 110.722 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 18.6 p -98.01 0.21 45.88 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.97 2.108 . . . . 0.0 113.034 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -59.88 -37.65 79.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.352 0.978 . . . . 0.0 112.713 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.28 -11.62 59.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.694 1.197 . . . . 0.0 113.247 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.38 49.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.867 1.667 . . . . 0.0 113.804 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.23 -129.54 9.33 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.663 1.125 . . . . 0.0 112.671 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -102.27 170.14 8.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.863 1.665 . . . . 0.0 112.388 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 134.17 -176.67 19.68 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.303 0.954 . . . . 0.0 115.114 168.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -94.56 124.16 7.81 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.685 1.136 . . . . 0.0 112.09 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -95.07 117.83 30.84 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.057 1.743 . . . . 0.0 108.198 170.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 68.3 m -108.76 143.81 37.41 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.492 1.517 . . . . 0.0 110.347 172.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.2 tt -142.12 140.29 32.43 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.869 0.867 . . . . 0.0 110.185 -169.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 92.0 p -143.84 152.6 41.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 112.616 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.3 mt -129.35 133.71 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 107.655 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -141.78 152.22 43.56 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.263 1.025 . . . . 0.0 111.566 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.28 -146.7 12.97 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.664 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.69 -8.85 22.02 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.702 2.934 . . . . 0.0 114.485 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.4 t -159.4 162.88 35.84 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.848 1.204 . . . . 0.0 112.633 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -70.63 146.74 49.82 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.785 1.234 . . . . 0.0 110.892 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.89 145.69 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.992 1.317 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.54 99.39 12.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 110.07 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 42.3 mt -81.04 131.38 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.208 1.003 . . . . 0.0 109.973 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -126.36 152.8 45.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.407 1.883 . . . . 0.0 110.207 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 33.7 p -138.93 154.16 48.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.991 1.316 . . . . 0.0 111.697 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -152.43 126.85 9.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.751 1.22 . . . . 0.0 111.156 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.81 128.08 32.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.506 1.122 . . . . 0.0 110.897 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.4 mt -97.43 155.05 17.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.647 1.179 . . . . 0.0 111.786 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.77 -16.63 64.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.255 1.022 . . . . 0.0 113.429 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -74.15 -11.79 60.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.998 1.319 . . . . 0.0 113.313 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.48 -0.49 65.68 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.936 1.731 . . . . 0.0 114.293 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 41.3 p -89.29 167.69 12.85 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.47 1.908 . . . . 0.0 111.253 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.5 t -117.33 130.34 56.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.083 0.953 . . . . 0.0 111.088 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -94.32 139.72 30.72 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.007 1.323 . . . . 0.0 110.146 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 21.7 t -125.3 139.54 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.009 1.724 . . . . 0.0 108.954 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.8 p -138.02 152.76 49.19 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.402 1.481 . . . . 0.0 111.386 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.9 p90 -162.88 148.42 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.589 1.556 . . . . 0.0 110.806 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 30.2 t -109.2 106.78 59.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.599 0.76 . . . . 0.0 110.658 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.33 106.05 1.98 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.376 2.717 . . . . 0.0 110.238 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.9 m -66.38 -44.0 84.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.03 0.932 . . . . 0.0 112.74 -171.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -92.4 148.21 35.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.431 1.092 . . . . 0.0 110.842 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.88 165.64 29.62 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.321 2.681 . . . . 0.0 111.602 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 125.82 -162.12 20.11 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 125.179 1.371 . . . . 0.0 113.561 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.9 t30 -93.8 125.2 38.29 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.698 0.799 . . . . 0.0 111.524 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -108.89 143.49 38.05 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.107 1.363 . . . . 0.0 110.241 168.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.33 133.72 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 108.533 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 23.7 mt -111.64 129.72 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 109.308 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -108.58 125.29 51.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.423 1.489 . . . . 0.0 110.153 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.8 mm -112.16 121.59 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.011 0.924 . . . . 0.0 109.238 172.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -127.13 133.02 50.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.174 1.789 . . . . 0.0 110.527 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.6 126.55 36.97 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.556 1.142 . . . . 0.0 110.549 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.51 40.01 25.93 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.865 1.266 . . . . 0.0 112.578 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.2 t0 72.87 5.42 5.19 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.576 2.75 . . . . 0.0 114.651 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -109.69 128.71 55.45 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.994 1.318 . . . . 0.0 110.589 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -67.13 123.15 19.47 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.755 1.222 . . . . 0.0 111.104 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.8 m -81.91 160.61 63.15 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.279 -0.888 . . . . 0.0 111.915 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.0 141.76 67.01 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.766 2.977 . . . . 0.0 113.659 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.31 -22.87 17.48 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.022 1.296 . . . . 0.0 114.287 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 74.7 m -73.52 150.57 89.17 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 118.861 1.33 . . . . 0.0 111.525 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -73.52 139.65 62.71 Favored 'Cis proline' 0 C--N 1.352 0.759 0 CA-C-N 119.365 0.809 . . . . 0.0 111.111 -5.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -93.22 114.69 27.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.945 0.898 . . . . 0.0 110.337 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 62.0 m -82.75 128.28 34.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.6 t -123.92 114.9 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.766 1.626 . . . . 0.0 109.636 -171.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -81.57 108.79 15.43 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.629 . . . . 0.0 111.213 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 84.4 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.835 1.254 . . . . 0.0 109.226 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -109.01 164.56 12.3 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.908 1.283 . . . . 0.0 111.882 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 115.15 177.06 18.74 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.703 1.62 . . . . 0.0 113.575 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -86.9 161.98 17.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.941 1.297 . . . . 0.0 112.473 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -81.24 143.51 23.95 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.177 0.894 . . . . 0.0 111.071 165.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -74.57 142.29 44.7 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.704 0.801 . . . . 0.0 112.347 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 96.1 t -112.27 139.02 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.074 1.749 . . . . 0.0 109.108 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.718 1.607 . . . . 0.0 111.728 -179.092 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.54 151.4 46.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.227 1.011 . . . . 0.0 112.611 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 78.2 mtm -142.71 163.35 33.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.94 1.696 . . . . 0.0 111.539 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 107.01 153.68 19.48 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.603 1.573 . . . . 0.0 113.285 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -85.52 -9.12 57.85 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.411 1.484 . . . . 0.0 114.221 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.15 -4.42 55.34 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.849 1.66 . . . . 0.0 114.692 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 49.4 m -63.21 137.03 58.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.649 1.18 . . . . 0.0 114.038 -175.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 82.9 mmm -74.15 162.88 28.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.781 1.232 . . . . 0.0 111.241 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -128.49 149.56 50.53 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.533 1.133 . . . . 0.0 111.73 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.8 ptm -120.41 153.97 35.79 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.233 1.413 . . . . 0.0 112.69 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.8 m -134.78 145.49 48.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.847 2.059 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -146.29 157.03 43.76 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.2 141.36 16.31 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.218 1.807 . . . . 0.0 109.982 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -132.21 143.72 50.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.736 1.214 . . . . 0.0 112.512 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 29.9 m -143.46 151.8 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.331 1.452 . . . . 0.0 111.278 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.16 153.1 27.54 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 124.344 0.973 . . . . 0.0 112.132 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.2 m -140.3 137.03 33.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.508 0.723 . . . . 0.0 112.692 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.0 154.23 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.701 1.2 . . . . 0.0 112.19 -176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.38 133.16 34.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 111.076 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.35 135.03 34.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.219 1.008 . . . . 0.0 110.608 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.76 113.16 30.38 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.886 0.874 . . . . 0.0 109.9 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.43 150.55 36.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.047 2.498 . . . . 0.0 110.587 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 67.9 mt -129.92 141.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.411 1.084 . . . . 0.0 110.039 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 48.7 t-20 11.32 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.41 3.084 . . . . 0.0 115.377 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.05 116.64 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.651 1.18 . . . . 0.0 112.004 -161.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 77.3 p -172.81 166.41 5.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.627 1.971 . . . . 0.0 110.583 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.28 141.9 27.91 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.951 0.9 . . . . 0.0 111.593 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 1.2 m -176.89 139.77 0.3 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.338 2.655 . . . . 0.0 109.106 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.5 133.04 49.56 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.292 1.037 . . . . 0.0 112.317 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 22.1 tp -76.24 -25.57 55.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.277 1.031 . . . . 0.0 113.711 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 49.1 m -84.37 -26.28 28.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -169.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.9 pp -92.47 9.4 34.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.798 1.239 . . . . 0.0 113.577 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.63 148.68 23.05 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.473 1.509 . . . . 0.0 111.811 170.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -136.97 157.43 46.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.107 1.763 . . . . 0.0 109.367 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 148.28 26.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.939 0.896 . . . . 0.0 112.355 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 74.9 p -140.37 160.16 40.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.337 1.855 . . . . 0.0 109.999 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.0 t -114.93 135.42 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.425 1.49 . . . . 0.0 109.471 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.3 t -106.81 110.74 63.84 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.942 1.297 . . . . 0.0 107.889 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 167.73 24.51 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.622 2.881 . . . . 0.0 110.622 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 -14.66 42.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.949 2.432 . . . . 0.0 113.061 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.1 p -79.66 -9.74 59.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.361 1.464 . . . . 0.0 113.936 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.96 -1.68 85.92 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.691 1.615 . . . . 0.0 115.168 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -77.29 81.66 3.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.553 1.541 . . . . 0.0 111.496 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.99 135.72 57.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.636 1.174 . . . . 0.0 112.212 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.79 148.93 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.764 1.626 . . . . 0.0 111.023 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.76 152.54 37.42 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.523 2.815 . . . . 0.0 111.808 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 80.6 m -102.7 151.45 22.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.563 1.145 . . . . 0.0 111.74 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 56.9 tp -83.03 126.59 32.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 108.774 163.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.4 mt -94.87 140.52 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.053 1.341 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.94 145.58 34.69 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.276 1.03 . . . . 0.0 113.021 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -85.78 108.44 18.09 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 153.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.37 166.25 21.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.166 0.986 . . . . 0.0 111.453 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -64.68 -21.61 66.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -81.4 -9.11 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.596 1.158 . . . . 0.0 113.599 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.45 -6.74 61.31 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.866 1.698 . . . . 0.0 114.566 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.06 162.73 19.2 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.697 1.199 . . . . 0.0 113.406 173.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 12.5 p -94.84 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.081 1.352 . . . . 0.0 111.057 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.65 177.8 33.42 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.23 162.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.987 1.715 . . . . 0.0 112.271 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 32.5 t -146.87 148.8 32.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.752 1.621 . . . . 0.0 110.57 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.5 p90 -169.41 175.49 5.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.334 2.254 . . . . 0.0 110.043 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 71.3 t -124.86 116.08 26.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 124.117 0.967 . . . . 0.0 109.805 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.24 143.21 28.07 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.944 3.096 . . . . 0.0 110.858 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.44 -19.26 15.0 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.77 171.0 8.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.264 1.826 . . . . 0.0 110.726 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.9 p -97.91 169.02 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.48 1.512 . . . . 0.0 111.107 169.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.69 -170.65 23.23 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.362 1.458 . . . . 0.0 113.815 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.83 112.02 7.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.025 0.93 . . . . 0.0 111.472 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.47 143.36 28.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.649 1.58 . . . . 0.0 109.269 168.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.83 125.11 50.57 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.336 1.054 . . . . 0.0 109.222 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.3 t -88.69 127.79 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.287 1.035 . . . . 0.0 108.237 168.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -106.41 137.21 44.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.263 1.425 . . . . 0.0 109.96 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 84.7 t -136.33 134.77 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.425 1.09 . . . . 0.0 109.566 -170.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -133.8 132.31 40.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.23 1.412 . . . . 0.0 111.137 -169.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -124.95 128.13 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.791 2.036 . . . . 0.0 109.627 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 46.3 t30 59.94 22.19 11.24 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.048 0.939 . . . . 0.0 113.289 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.94 7.37 83.95 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.941 1.258 . . . . 0.0 114.91 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -119.26 133.74 55.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.033 1.733 . . . . 0.0 109.465 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.18 138.31 58.18 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.494 -1.379 . . . . 0.0 112.135 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 22.9 m -78.83 159.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.214 0.606 . . . . 0.0 112.283 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -64.22 -20.75 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 49.8 m -86.4 -19.34 29.84 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 67.5 p -92.96 154.0 41.86 Favored Pre-proline 0 CA--C 1.55 0.979 0 O-C-N 120.887 -1.133 . . . . 0.0 113.846 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.65 147.58 89.94 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.138 0.728 . . . . 0.0 112.485 -0.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.12 120.22 51.69 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.013 1.325 . . . . 0.0 108.503 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.21 140.53 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.858 2.372 . . . . 0.0 111.288 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 23.4 t -135.44 123.51 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.391 1.476 . . . . 0.0 107.768 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.5 t -96.46 120.99 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.593 0.757 . . . . 0.0 109.795 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 123.01 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.779 1.231 . . . . 0.0 109.035 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 32.5 t -92.36 158.46 16.07 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.729 0.812 . . . . 0.0 111.408 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -59.74 -29.68 68.32 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.252 -0.905 . . . . 0.0 111.428 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.1 m -63.18 -13.26 35.2 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.666 1.186 . . . . 0.0 113.928 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -94.71 -11.17 29.63 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.942 1.297 . . . . 0.0 112.371 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.75 95.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.756 1.222 . . . . 0.0 109.917 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 65.02 24.63 70.35 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 115.0 0.76 . . . . 0.0 115.0 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 34.0 t0 -76.22 89.52 3.11 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.358 1.079 . . . . 0.0 111.9 -171.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.99 75.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.748 1.219 . . . . 0.0 112.789 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.8 m -60.7 -22.12 63.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.302 1.041 . . . . 0.0 113.574 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -88.66 -8.98 53.65 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.077 1.351 . . . . 0.0 113.903 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.5 t -77.52 131.31 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.866 1.212 . . . . 0.0 109.655 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -116.22 161.01 19.61 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.94 1.296 . . . . 0.0 111.373 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -146.11 153.88 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.385 1.474 . . . . 0.0 110.643 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 73.4 m -149.09 165.85 30.51 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.069 1.348 . . . . 0.0 112.103 -173.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.66 162.08 26.0 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 124.345 0.974 . . . . 0.0 114.577 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -73.9 -27.67 61.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 113.644 -167.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.86 -5.58 47.09 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.733 1.159 . . . . 0.0 115.042 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.82 -7.02 58.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.676 1.591 . . . . 0.0 112.787 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -128.29 -36.01 1.95 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.955 1.302 . . . . 0.0 113.8 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.7 155.51 30.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 112.474 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.6 -176.19 21.79 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.881 1.229 . . . . 0.0 114.358 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -139.41 152.67 47.27 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.345 1.458 . . . . 0.0 112.145 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 25.5 p -71.5 -41.84 68.77 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -100.18 -11.16 20.67 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -114.66 145.75 34.54 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.073 1.349 . . . . 0.0 110.258 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.78 137.83 36.31 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.545 2.163 . . . . 0.0 110.422 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -84.03 150.37 25.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.109 0.964 . . . . 0.0 109.997 168.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.25 151.19 46.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -159.26 155.59 27.23 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.613 1.565 . . . . 0.0 111.001 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.52 143.14 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.41 1.884 . . . . 0.0 109.961 -175.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.25 133.89 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.238 1.815 . . . . 0.0 109.026 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.7 t0 -122.81 99.82 6.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.018 1.727 . . . . 0.0 110.875 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 32.6 p -99.73 4.83 45.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.499 1.92 . . . . 0.0 112.735 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.9 -37.32 81.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.255 1.022 . . . . 0.0 112.577 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.27 -28.96 38.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 0.0 112.716 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -72.49 -11.49 60.69 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.86 -108.23 3.22 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.426 1.012 . . . . 0.0 112.068 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.32 147.15 50.25 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.925 1.29 . . . . 0.0 112.97 -168.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 156.73 -137.68 5.56 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.543 1.068 . . . . 0.0 113.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -157.68 141.46 7.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.497 1.046 . . . . 0.0 112.047 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.48 124.99 45.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.916 1.686 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 23.2 t -115.69 138.91 50.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.33 1.452 . . . . 0.0 109.902 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 8.4 tt -136.75 132.95 35.49 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.62 1.168 . . . . 0.0 109.902 -168.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.7 m -133.66 130.23 37.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.386 0.675 . . . . 0.0 111.197 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.9 mt -109.24 130.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.083 1.353 . . . . 0.0 108.244 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.78 142.5 51.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.337 1.455 . . . . 0.0 109.758 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 177.27 -165.24 35.01 Favored Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.1 -9.89 26.41 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.175 3.25 . . . . 0.0 114.05 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.0 t -155.88 162.51 40.41 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.386 1.074 . . . . 0.0 112.078 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -67.31 147.12 53.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.664 1.186 . . . . 0.0 111.327 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 32.2 m -130.84 146.14 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.143 1.377 . . . . 0.0 110.903 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.37 105.82 17.83 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.679 0.792 . . . . 0.0 109.957 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 52.3 mt -84.41 129.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.247 1.019 . . . . 0.0 109.599 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -125.69 161.16 27.91 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 0.0 110.795 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 35.6 p -141.8 155.52 45.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.252 1.421 . . . . 0.0 111.951 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.45 138.05 15.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 111.515 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.0 t70 -86.97 129.03 35.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.117 1.367 . . . . 0.0 111.31 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 43.2 mt -99.31 160.62 14.14 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.308 1.043 . . . . 0.0 112.525 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.37 -17.04 64.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.522 1.129 . . . . 0.0 113.35 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.43 -9.15 59.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.144 1.378 . . . . 0.0 113.291 172.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.81 1.91 82.13 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.412 1.482 . . . . 0.0 114.018 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -89.18 165.49 14.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.332 1.853 . . . . 0.0 111.432 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.6 t -109.94 124.87 52.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.042 . . . . 0.0 110.993 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -83.62 135.4 34.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 165.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 45.7 t -117.36 139.31 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.953 1.701 . . . . 0.0 108.773 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.97 151.61 50.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.782 1.633 . . . . 0.0 111.83 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.39 150.74 14.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.521 1.528 . . . . 0.0 111.787 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.5 t -115.81 99.39 52.5 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.277 1.031 . . . . 0.0 111.039 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.44 94.12 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.706 2.937 . . . . 0.0 110.669 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 51.8 m -63.09 -41.76 99.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.868 . . . . 0.0 112.78 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -87.3 140.78 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.711 0.805 . . . . 0.0 110.668 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.97 168.64 24.38 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.506 2.804 . . . . 0.0 111.554 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 127.0 -147.31 16.84 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.816 1.198 . . . . 0.0 112.695 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -109.75 133.56 53.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.074 0.95 . . . . 0.0 111.836 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -118.29 151.37 37.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.784 1.633 . . . . 0.0 110.707 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.06 133.26 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.518 1.527 . . . . 0.0 108.699 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.54 128.97 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.592 1.157 . . . . 0.0 109.789 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.54 125.25 53.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.895 1.678 . . . . 0.0 110.015 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.6 mm -115.63 116.42 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.11 0.964 . . . . 0.0 109.246 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -125.71 132.8 52.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.16 1.384 . . . . 0.0 111.201 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 72.4 t80 -123.82 124.22 42.2 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.678 1.591 . . . . 0.0 110.312 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.73 30.97 11.99 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.331 1.452 . . . . 0.0 114.177 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.257 7.0 t70 85.68 11.91 0.22 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 128.784 2.834 . . . . 0.0 114.728 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.6 132.18 55.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.556 1.143 . . . . 0.0 111.48 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.86 124.48 23.45 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.338 1.455 . . . . 0.0 110.676 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -80.72 158.76 70.4 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.189 -0.944 . . . . 0.0 111.825 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.51 134.93 64.24 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.649 2.899 . . . . 0.0 113.253 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.85 -22.31 38.73 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.247 1.403 . . . . 0.0 114.073 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 62.9 m -75.22 150.59 85.39 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 118.922 1.361 . . . . 0.0 112.024 172.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.35 142.87 73.16 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.053 0.697 . . . . 0.0 111.113 -4.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.62 127.76 39.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.432 1.093 . . . . 0.0 110.834 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 30.5 t -95.97 129.29 43.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.345 1.058 . . . . 0.0 110.988 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 11.9 t -128.46 117.14 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.001 1.32 . . . . 0.0 110.007 -170.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -85.84 120.35 27.16 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.76 -0.587 . . . . 0.0 110.521 173.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.08 118.99 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.587 1.555 . . . . 0.0 108.862 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 1.3 t -99.61 162.85 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.583 1.153 . . . . 0.0 111.333 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 171.47 -168.35 41.46 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -137.66 174.62 10.39 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.611 1.964 . . . . 0.0 110.215 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -75.85 138.17 22.56 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.432 -0.792 . . . . 0.0 112.017 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -68.9 145.0 54.05 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.431 1.092 . . . . 0.0 111.289 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 95.8 t -61.64 137.04 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.129 1.371 . . . . 0.0 110.833 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 40.6 ttpt . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.05 1.74 . . . . 0.0 111.294 -176.542 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 110.372 -0.232 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 23.6 ptm -149.39 159.29 44.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 13.3 m -148.53 151.66 35.5 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.377 1.871 . . . . 0.0 109.774 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -147.32 159.77 43.29 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.9 150.85 24.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.539 1.936 . . . . 0.0 109.796 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -134.07 144.08 48.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.546 1.138 . . . . 0.0 111.972 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 46.8 t -140.37 134.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.64 1.576 . . . . 0.0 109.658 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.89 139.51 21.43 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 124.013 0.816 . . . . 0.0 111.661 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 29.6 m -131.22 132.14 44.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.809 0.804 . . . . 0.0 112.764 -166.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.63 148.64 16.19 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -74.47 150.33 39.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.439 1.095 . . . . 0.0 111.323 170.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -93.28 122.81 36.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.422 1.089 . . . . 0.0 110.667 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.9 mm -112.46 108.73 54.2 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.588 1.155 . . . . 0.0 109.266 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.91 137.62 17.78 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.178 2.585 . . . . 0.0 111.17 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 65.1 mt -145.69 141.14 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.377 1.471 . . . . 0.0 110.21 -170.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.26 61.47 2.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.625 1.57 . . . . 0.0 112.0 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.26 104.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.666 1.186 . . . . 0.0 110.616 -169.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.8 t -172.61 178.74 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.274 1.83 . . . . 0.0 110.543 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.99 45.42 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.018 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.8 p -71.47 138.06 48.69 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.001 1.321 . . . . 0.0 111.364 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 15.0 t70 -85.09 141.13 30.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.436 1.094 . . . . 0.0 111.323 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 -16.95 46.53 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 60.4 m -82.16 -31.93 30.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.038 1.29 . . . . 0.0 114.055 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -99.39 -0.49 40.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.5 1.12 . . . . 0.0 113.845 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.83 146.81 24.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.601 1.161 . . . . 0.0 111.492 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 41.0 p -138.87 162.67 34.23 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.732 2.013 . . . . 0.0 109.448 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.1 145.25 24.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.689 0.795 . . . . 0.0 112.08 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.7 p -138.4 162.57 34.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.148 1.779 . . . . 0.0 109.9 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -120.12 137.59 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.21 1.404 . . . . 0.0 109.462 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.1 t -102.82 111.05 64.6 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.14 1.376 . . . . 0.0 107.832 165.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.28 168.65 22.68 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.042 3.161 . . . . 0.0 110.696 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.55 -18.1 61.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.923 2.415 . . . . 0.0 112.645 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 12.8 m -67.63 -17.18 64.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.84 1.256 . . . . 0.0 113.925 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.87 31.24 54.17 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.61 1.1 . . . . 0.0 114.239 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -125.84 97.57 5.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.318 1.447 . . . . 0.0 110.488 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.93 135.74 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.417 1.087 . . . . 0.0 112.155 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -137.49 151.06 70.39 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.515 1.526 . . . . 0.0 111.097 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.19 156.23 42.11 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.793 2.996 . . . . 0.0 112.664 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.0 m -112.48 154.49 25.8 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.354 1.462 . . . . 0.0 111.751 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 58.2 tp -85.85 120.34 27.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.287 1.035 . . . . 0.0 109.397 170.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 21.9 mt -84.03 141.7 30.99 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.597 1.159 . . . . 0.0 110.95 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.23 139.1 31.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.459 1.503 . . . . 0.0 111.75 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -92.82 109.45 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 160.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.57 164.3 23.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.862 1.265 . . . . 0.0 111.735 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.27 -34.52 68.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -167.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.12 -9.24 58.61 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.19 37.99 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 126.003 1.764 . . . . 0.0 114.435 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.07 156.57 33.78 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 113.351 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.6 t -104.08 143.01 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.137 1.375 . . . . 0.0 110.042 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.2 178.61 28.48 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.557 1.075 . . . . 0.0 115.039 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -116.59 165.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.948 1.699 . . . . 0.0 111.615 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 71.1 p -151.59 150.73 30.64 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 110.678 166.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.7 p90 -167.17 167.59 14.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.945 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 59.5 t -110.67 117.68 50.22 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.816 0.846 . . . . 0.0 109.676 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.45 147.65 28.96 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.944 3.096 . . . . 0.0 110.917 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -105.34 -7.67 18.7 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -145.72 174.93 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.403 2.281 . . . . 0.0 109.687 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 36.3 p -88.56 167.07 13.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.614 1.165 . . . . 0.0 111.21 166.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.05 -170.22 25.97 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.268 1.413 . . . . 0.0 113.79 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.84 117.88 12.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.186 0.994 . . . . 0.0 111.742 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.8 m80 -104.11 143.58 32.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.036 1.734 . . . . 0.0 108.968 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.44 125.31 50.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.993 0.917 . . . . 0.0 110.083 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.1 t -85.62 137.46 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -119.96 114.76 22.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.347 1.459 . . . . 0.0 109.693 169.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 94.1 t -106.48 136.52 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.054 1.341 . . . . 0.0 108.995 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -131.09 142.28 50.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.989 1.315 . . . . 0.0 112.435 -172.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -112.81 121.21 44.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.544 1.938 . . . . 0.0 109.169 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.19 26.27 10.12 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.668 1.187 . . . . 0.0 113.259 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.65 84.85 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.649 1.595 . . . . 0.0 115.452 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.43 134.87 46.07 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.167 1.484 . . . . 0.0 109.64 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 19.3 p80 -63.36 140.15 58.84 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.953 -1.092 . . . . 0.0 113.337 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 16.6 m -78.54 159.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.666 0.786 . . . . 0.0 110.983 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.42 62.76 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.4 m -75.35 -20.76 58.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 56.4 m -82.25 149.89 63.01 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.64 150.24 92.49 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 118.649 0.553 . . . . 0.0 111.949 -5.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -107.41 119.24 51.37 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.86 139.89 12.49 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.806 2.338 . . . . 0.0 111.385 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -134.1 124.35 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.384 1.474 . . . . 0.0 107.643 171.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.4 t -99.75 122.58 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.879 0.872 . . . . 0.0 109.97 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.45 128.14 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.886 1.274 . . . . 0.0 109.655 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.2 t -99.66 161.24 13.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.026 0.931 . . . . 0.0 111.457 170.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -59.54 -31.38 69.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.768 0.827 . . . . 0.0 112.87 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -68.0 -14.93 63.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 113.516 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -92.12 -9.5 42.29 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.564 1.146 . . . . 0.0 112.763 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 44.1 mm -76.49 -31.94 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 0.0 112.948 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.44 47.74 0.04 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -85.43 98.9 10.84 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.261 1.031 . . . . 0.0 110.78 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.44 73.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.482 1.113 . . . . 0.0 113.495 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.9 p -56.78 -23.4 42.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 113.91 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -84.84 -14.45 47.92 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.213 1.405 . . . . 0.0 113.913 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.5 t -75.12 135.42 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.641 1.11 . . . . 0.0 110.524 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -113.53 156.88 22.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.381 1.472 . . . . 0.0 111.329 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.55 159.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.697 1.599 . . . . 0.0 110.706 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -159.95 175.69 12.74 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.577 1.151 . . . . 0.0 112.419 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.84 161.73 30.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.239 1.399 . . . . 0.0 114.189 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -72.16 -28.24 63.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.582 1.153 . . . . 0.0 113.398 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.45 -4.29 37.21 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.703 1.144 . . . . 0.0 115.24 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.28 -4.39 58.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.323 1.449 . . . . 0.0 112.76 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -134.53 -40.12 0.8 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.812 1.245 . . . . 0.0 113.876 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.22 152.51 44.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 111.267 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.38 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 122.256 0.92 . . . . 0.0 114.748 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 66.0 m80 -135.43 160.06 39.63 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.543 1.937 . . . . 0.0 110.29 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 16.9 p -71.21 -68.55 0.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.37 0.668 . . . . 0.0 111.498 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -82.44 -14.59 54.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -166.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -104.89 136.71 19.13 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 0.0 109.349 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.49 152.34 54.3 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -105.2 136.77 44.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.018 1.327 . . . . 0.0 110.708 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.4 148.49 42.48 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.282 1.433 . . . . 0.0 113.123 -175.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.5 p90 -155.76 153.61 30.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.369 1.468 . . . . 0.0 111.456 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.87 142.36 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.013 1.725 . . . . 0.0 109.655 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.74 134.69 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.251 1.82 . . . . 0.0 108.621 171.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.84 101.87 7.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.662 1.585 . . . . 0.0 110.833 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.7 p -100.33 -1.64 35.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.515 1.926 . . . . 0.0 112.946 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -57.95 -40.49 80.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.282 1.033 . . . . 0.0 111.627 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.02 -5.62 56.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.477 1.511 . . . . 0.0 113.27 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -101.68 -3.96 27.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.871 1.668 . . . . 0.0 114.734 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.57 -118.86 4.83 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.03 0.824 . . . . 0.0 111.163 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -121.49 165.06 16.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.236 1.415 . . . . 0.0 112.752 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.35 -140.05 7.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.635 1.112 . . . . 0.0 113.188 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -158.87 137.99 5.47 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 124.169 0.89 . . . . 0.0 112.501 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.19 122.52 40.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.488 1.915 . . . . 0.0 109.477 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 12.3 m -110.5 139.86 45.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 110.014 165.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -136.51 134.49 37.63 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.348 1.059 . . . . 0.0 110.174 -168.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.8 m -135.48 125.3 25.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.573 0.749 . . . . 0.0 110.667 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.8 mt -104.07 130.72 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.614 1.166 . . . . 0.0 108.224 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -127.94 147.92 50.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.555 1.542 . . . . 0.0 109.781 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 169.72 -157.81 29.65 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.349 -0.845 . . . . 0.0 114.83 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.5 -20.18 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 113.885 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -151.47 169.84 21.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.567 1.076 . . . . 0.0 112.527 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.19 149.27 50.57 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 9.3 m -132.71 146.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.427 1.091 . . . . 0.0 111.442 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -85.48 111.67 20.2 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.216 0.606 . . . . 0.0 109.821 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.06 132.84 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.392 1.077 . . . . 0.0 109.555 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -128.85 158.58 38.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.158 1.783 . . . . 0.0 110.626 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 32.8 p -139.75 153.63 47.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.132 1.373 . . . . 0.0 111.658 -174.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.41 115.6 4.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.06 1.344 . . . . 0.0 110.461 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.58 129.22 34.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.548 1.139 . . . . 0.0 110.858 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 62.7 mt -101.47 153.84 19.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.546 1.138 . . . . 0.0 112.007 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.81 -18.61 64.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.312 1.045 . . . . 0.0 113.253 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.89 -9.05 58.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.984 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.23 -1.37 62.58 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.084 1.802 . . . . 0.0 114.783 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.0 p -88.87 166.3 14.06 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.117 1.767 . . . . 0.0 111.678 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.0 t -114.85 126.3 54.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 0.0 110.777 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -87.98 134.59 33.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.506 1.122 . . . . 0.0 109.466 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.1 t -117.01 141.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.234 1.814 . . . . 0.0 108.275 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.1 p -134.58 151.24 50.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 110.926 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.95 149.86 29.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.578 0.751 . . . . 0.0 112.955 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.2 t -120.84 99.47 47.06 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.932 1.293 . . . . 0.0 110.192 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.25 135.85 12.36 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.265 2.643 . . . . 0.0 111.829 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 98.2 m -78.3 -46.46 20.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.068 0.547 . . . . 0.0 111.734 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -99.84 148.17 34.43 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.795 1.238 . . . . 0.0 111.06 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 165.26 29.31 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.435 2.757 . . . . 0.0 111.26 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 138.2 -152.59 21.96 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 113.184 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.2 t30 -107.03 121.99 45.57 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.242 1.017 . . . . 0.0 110.663 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -104.45 144.5 31.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.898 1.279 . . . . 0.0 111.104 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.1 130.37 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.716 1.607 . . . . 0.0 107.943 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.1 mt -112.34 121.83 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.638 1.175 . . . . 0.0 109.265 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -100.51 124.85 46.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.582 1.553 . . . . 0.0 109.907 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 34.4 mm -116.56 111.17 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 108.882 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 132.56 53.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.919 1.288 . . . . 0.0 111.276 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 75.3 t80 -125.24 124.14 41.05 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 109.723 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.59 44.67 27.3 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.359 1.064 . . . . 0.0 112.982 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 70.7 m-20 66.39 19.91 10.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.345 2.258 . . . . 0.0 114.634 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -125.53 130.6 52.07 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.593 1.557 . . . . 0.0 110.113 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -71.54 125.65 27.62 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 120.892 -1.13 . . . . 0.0 111.237 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.2 m -78.8 157.44 76.66 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.159 -0.963 . . . . 0.0 111.905 -168.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.87 142.27 64.0 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.83 3.02 . . . . 0.0 113.69 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.34 5.72 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.018 1.294 . . . . 0.0 113.999 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -76.29 144.61 75.0 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-N 118.282 1.041 . . . . 0.0 110.585 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.58 144.52 79.28 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 120.567 1.238 . . . . 0.0 112.273 4.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.76 117.81 35.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.391 1.077 . . . . 0.0 110.427 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.8 p -86.41 136.78 32.99 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.078 0.951 . . . . 0.0 111.395 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.2 t -133.96 113.1 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.203 1.401 . . . . 0.0 109.446 -168.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -77.93 118.29 20.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.99 0.516 . . . . 0.0 110.722 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 81.7 t -110.88 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.879 1.672 . . . . 0.0 109.036 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 9.3 t -104.3 154.36 19.9 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.464 1.106 . . . . 0.0 111.301 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -176.76 173.82 46.58 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.716 1.151 . . . . 0.0 114.484 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 126.188 1.795 . . . . 0.0 111.027 178.225 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.8 ptm -144.69 156.93 44.34 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.175 0.99 . . . . 0.0 113.445 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 65.4 m -138.96 148.5 43.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -138.52 156.47 47.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.333 1.053 . . . . 0.0 113.705 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.9 tt -159.82 150.61 19.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.932 1.693 . . . . 0.0 110.431 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.33 148.23 52.13 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 0.0 112.724 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 53.0 t -139.11 134.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.073 1.749 . . . . 0.0 109.375 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.42 123.94 6.99 Favored Glycine 0 N--CA 1.471 0.987 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 70.9 m -97.19 123.3 40.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.272 1.029 . . . . 0.0 111.526 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -125.33 115.28 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.37 1.468 . . . . 0.0 110.013 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.04 142.72 47.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.145 0.578 . . . . 0.0 111.805 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.51 130.58 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.711 1.204 . . . . 0.0 111.586 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.6 mm -122.43 120.86 27.86 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.367 1.467 . . . . 0.0 108.461 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 145.05 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.451 2.101 . . . . 0.0 110.922 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.47 145.13 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.852 1.661 . . . . 0.0 108.51 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.2 t30 -42.46 114.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.093 1.357 . . . . 0.0 113.596 -166.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.35 135.97 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.869 0.868 . . . . 0.0 110.757 -160.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.4 t -159.84 175.7 12.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.729 1.611 . . . . 0.0 110.527 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.11 33.93 0.5 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 112.664 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -71.97 139.03 48.45 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.578 1.551 . . . . 0.0 111.412 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.19 131.06 36.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.098 0.959 . . . . 0.0 111.469 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.75 -14.98 59.43 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 50.8 m -85.7 -24.05 27.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.659 1.118 . . . . 0.0 113.383 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pp -107.26 3.98 26.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.171 1.388 . . . . 0.0 113.98 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.66 146.98 23.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.252 1.421 . . . . 0.0 111.166 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 58.1 p -140.51 152.99 46.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.435 1.494 . . . . 0.0 110.121 167.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.19 148.39 43.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.422 1.089 . . . . 0.0 112.582 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 2.5 p -147.01 132.37 18.54 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.966 2.106 . . . . 0.0 109.552 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -91.7 136.72 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.22 1.008 . . . . 0.0 109.937 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 90.1 t -109.98 113.76 56.8 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.078 1.351 . . . . 0.0 108.372 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.03 172.77 11.61 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.074 3.183 . . . . 0.0 111.232 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.48 -32.53 53.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.977 3.118 . . . . 0.0 113.875 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 16.4 m -74.14 -10.56 59.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.726 1.21 . . . . 0.0 114.238 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.28 74.87 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.523 1.535 . . . . 0.0 115.173 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -75.62 87.62 2.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.811 1.644 . . . . 0.0 111.297 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.65 135.31 57.31 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.261 1.025 . . . . 0.0 111.892 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -140.24 147.18 49.06 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.136 1.375 . . . . 0.0 111.474 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.2 152.49 45.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.934 3.089 . . . . 0.0 112.066 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.6 m -114.11 150.15 34.53 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.05 1.34 . . . . 0.0 112.052 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.86 115.5 28.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.476 1.11 . . . . 0.0 109.033 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.4 mt -78.78 131.15 36.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.106 1.362 . . . . 0.0 111.131 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 95.8 mttt -132.2 142.03 49.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.191 1.397 . . . . 0.0 112.545 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -93.17 122.04 35.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.57 1.148 . . . . 0.0 108.058 161.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.3 mt -100.8 172.71 6.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.841 1.656 . . . . 0.0 112.577 -165.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -57.55 -35.75 70.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.6 1.56 . . . . 0.0 115.038 -165.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 4.46 44.22 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.245 1.018 . . . . 0.0 113.13 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 90.67 -6.36 82.11 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.485 1.517 . . . . 0.0 113.896 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -71.95 162.71 29.06 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.603 1.561 . . . . 0.0 113.153 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 93.1 t -112.07 141.97 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.462 1.505 . . . . 0.0 109.634 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.0 -176.17 24.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.168 0.89 . . . . 0.0 115.164 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.19 165.91 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.475 1.91 . . . . 0.0 111.063 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 66.3 p -149.07 152.57 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.315 1.046 . . . . 0.0 111.278 167.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.4 p90 -169.32 -172.06 1.41 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.585 2.354 . . . . 0.0 109.522 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.8 t -133.77 118.71 14.56 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 0.0 110.085 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.76 147.82 22.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.615 3.544 . . . . 0.0 111.264 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.1 mptt -100.66 -13.25 18.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.045 0.938 . . . . 0.0 113.194 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -139.97 167.8 21.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.187 2.195 . . . . 0.0 110.104 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.0 p -85.24 167.8 15.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.685 1.194 . . . . 0.0 111.435 168.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.29 -174.04 22.69 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.523 1.535 . . . . 0.0 114.059 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.95 113.08 9.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.2 1.0 . . . . 0.0 111.467 -175.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -96.97 144.18 27.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 109.169 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.8 mt -103.08 126.41 50.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.764 0.825 . . . . 0.0 110.043 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.5 t -89.71 112.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.903 1.281 . . . . 0.0 107.744 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -92.83 138.51 31.43 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.115 . . . . 0.0 109.665 169.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.3 p -151.55 135.93 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.4 -0.813 . . . . 0.0 111.363 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -137.78 145.71 42.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.451 1.1 . . . . 0.0 113.935 -162.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -114.2 127.08 55.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.737 2.415 . . . . 0.0 109.121 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.58 24.0 8.29 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.265 1.026 . . . . 0.0 113.636 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.83 4.41 65.29 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.442 1.496 . . . . 0.0 115.979 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -127.91 141.56 51.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.832 1.816 . . . . 0.0 111.706 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -61.29 138.27 58.24 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.255 -0.903 . . . . 0.0 113.182 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 19.1 m -74.09 163.02 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.388 0.675 . . . . 0.0 111.334 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.15 -24.85 65.05 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 64.4 m -86.67 -12.26 48.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 28.6 t -86.9 143.14 34.81 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 120.771 -1.205 . . . . 0.0 112.757 -172.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.99 156.85 88.04 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.495 0.855 . . . . 0.0 112.836 -3.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.02 126.99 28.09 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.781 1.632 . . . . 0.0 109.127 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.33 141.22 14.19 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.989 2.459 . . . . 0.0 111.594 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 24.7 t -134.25 122.08 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.863 1.665 . . . . 0.0 107.68 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.8 t -97.53 122.42 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.669 0.788 . . . . 0.0 110.179 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.29 117.76 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.804 1.242 . . . . 0.0 108.942 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 59.3 m -92.69 161.54 14.51 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.091 0.956 . . . . 0.0 111.479 172.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.73 -31.86 70.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.991 -1.068 . . . . 0.0 112.197 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.0 m -59.68 -14.31 13.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.323 1.449 . . . . 0.0 114.202 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -100.11 -9.8 22.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.75 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 38.0 mm -80.89 -27.77 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.747 -1.22 . . . . 0.0 112.856 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 169.1 38.7 0.03 OUTLIER Glycine 0 N--CA 1.469 0.844 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.46 96.93 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.197 0.998 . . . . 0.0 111.259 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.59 93.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.9 0.88 . . . . 0.0 112.356 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.3 m -61.44 -18.89 61.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.705 1.202 . . . . 0.0 113.87 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -89.06 -10.22 48.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.445 1.498 . . . . 0.0 114.36 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.8 t -74.66 137.56 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.18 1.355 . . . . 0.0 110.111 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.3 mmt-85 -121.14 161.19 22.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 110.675 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.4 m -147.94 160.97 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.292 1.437 . . . . 0.0 110.999 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -158.41 175.58 13.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.733 1.213 . . . . 0.0 112.285 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 94.99 161.49 34.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.263 1.411 . . . . 0.0 114.08 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -73.81 -26.77 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 113.611 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.19 -2.25 39.23 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.918 1.247 . . . . 0.0 115.364 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.93 -6.83 50.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.542 1.537 . . . . 0.0 112.674 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.36 -39.95 2.29 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.334 1.453 . . . . 0.0 113.163 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.24 155.68 32.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 0.0 113.233 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.08 -174.41 19.86 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.715 1.626 . . . . 0.0 113.382 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 60.5 m80 -138.57 147.48 43.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.467 1.107 . . . . 0.0 112.7 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.4 p -71.82 -19.79 61.93 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -116.23 -1.9 12.27 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -143.67 147.57 39.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.368 1.467 . . . . 0.0 110.492 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.35 142.43 45.32 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.865 2.377 . . . . 0.0 111.204 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 152.39 20.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.631 1.172 . . . . 0.0 110.246 168.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.58 148.07 51.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.887 0.875 . . . . 0.0 112.362 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.14 151.2 27.97 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.61 140.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.953 1.701 . . . . 0.0 109.508 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.92 136.45 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.638 1.575 . . . . 0.0 108.758 169.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.2 t0 -125.93 99.06 5.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.223 1.809 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.2 p -96.48 1.3 51.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.231 1.812 . . . . 0.0 113.085 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -58.65 -39.34 80.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.539 1.063 . . . . 0.0 112.697 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.65 -13.84 59.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.457 1.103 . . . . 0.0 113.249 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -93.52 -5.35 49.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.878 1.671 . . . . 0.0 113.618 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.14 -119.31 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.733 1.158 . . . . 0.0 112.172 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.55 161.54 16.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.377 1.871 . . . . 0.0 112.498 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 138.29 -176.8 20.53 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.065 0.84 . . . . 0.0 115.117 169.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -92.92 123.21 7.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.459 1.028 . . . . 0.0 111.985 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.33 123.0 42.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.119 1.768 . . . . 0.0 108.394 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -114.72 140.79 48.59 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.288 1.435 . . . . 0.0 110.829 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 2.9 tp -125.61 137.39 53.89 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.362 1.865 . . . . 0.0 109.656 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 68.2 m -138.59 126.66 22.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.254 0.622 . . . . 0.0 110.277 167.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 30.0 mt -111.3 135.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.541 1.136 . . . . 0.0 108.466 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -145.4 154.87 42.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.284 1.034 . . . . 0.0 112.246 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.48 -155.67 26.49 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.879 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.92 -10.21 27.19 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.124 3.216 . . . . 0.0 114.286 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.2 t -152.94 164.3 38.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.662 1.185 . . . . 0.0 111.1 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -69.98 144.23 52.38 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.135 -0.978 . . . . 0.0 111.171 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 17.8 m -125.02 151.93 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 0.0 110.962 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -97.26 131.25 44.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.776 0.83 . . . . 0.0 110.064 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.1 135.37 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.132 1.373 . . . . 0.0 109.737 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.57 164.89 24.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 111.069 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.0 p -136.36 160.22 39.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.482 1.513 . . . . 0.0 112.227 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -154.33 122.53 6.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.362 1.465 . . . . 0.0 110.041 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.25 128.56 33.68 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.419 1.088 . . . . 0.0 110.58 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -101.16 152.43 20.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 111.84 -173.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -66.42 -20.33 66.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.283 1.033 . . . . 0.0 113.423 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.2 t0 -80.25 -3.93 51.18 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.112 1.365 . . . . 0.0 113.256 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.37 0.65 67.27 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.606 1.574 . . . . 0.0 114.571 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 18.5 p -88.76 167.7 13.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.604 1.962 . . . . 0.0 111.558 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 45.6 t -121.42 124.88 45.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.096 0.958 . . . . 0.0 111.207 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -84.18 135.49 34.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.775 1.23 . . . . 0.0 109.642 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.71 141.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.901 1.681 . . . . 0.0 108.587 164.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 3.2 p -130.54 148.74 52.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 110.761 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -157.45 148.65 21.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.428 1.091 . . . . 0.0 111.818 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.9 t -118.33 102.65 50.2 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.862 0.865 . . . . 0.0 111.145 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.58 145.88 23.7 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.245 2.63 . . . . 0.0 110.221 173.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 96.6 m -104.87 -38.62 6.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.984 0.914 . . . . 0.0 112.74 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -103.08 147.53 34.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.929 1.292 . . . . 0.0 110.627 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.89 168.31 23.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.498 2.799 . . . . 0.0 111.902 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 131.98 -145.63 17.35 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 125.126 1.346 . . . . 0.0 112.129 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -123.85 129.72 51.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.565 0.746 . . . . 0.0 111.664 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -108.39 143.65 37.03 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.552 1.541 . . . . 0.0 110.373 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 135.99 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.959 1.304 . . . . 0.0 109.0 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 25.7 mt -117.76 122.97 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.095 1.358 . . . . 0.0 109.385 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -102.06 127.62 48.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.965 1.706 . . . . 0.0 110.269 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 18.9 mm -120.02 112.22 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.877 1.271 . . . . 0.0 109.345 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -122.83 134.42 54.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.316 1.446 . . . . 0.0 111.215 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.9 t80 -127.22 123.93 37.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.486 1.514 . . . . 0.0 110.249 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.02 31.09 12.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.423 1.489 . . . . 0.0 114.069 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.59 12.51 0.68 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.337 2.655 . . . . 0.0 114.679 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -116.76 133.88 55.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.673 1.189 . . . . 0.0 110.71 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -72.06 126.74 30.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 110.946 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.7 m -79.44 153.84 76.44 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.318 -0.864 . . . . 0.0 110.954 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.94 146.86 91.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.816 2.344 . . . . 0.0 112.113 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.49 -29.25 6.3 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.263 1.411 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 3.7 t -78.47 145.48 67.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.076 0.95 . . . . 0.0 110.682 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.54 140.5 67.64 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.507 1.217 . . . . 0.0 111.875 2.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.71 116.0 28.24 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.987 0.915 . . . . 0.0 109.936 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 10.3 p -87.53 124.22 33.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.662 1.185 . . . . 0.0 110.651 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.1 t -121.21 114.98 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 109.733 -167.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -76.99 119.64 21.01 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.368 0.667 . . . . 0.0 111.168 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.7 t -109.24 125.84 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.076 1.35 . . . . 0.0 109.342 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.9 t -125.16 168.83 12.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.032 1.333 . . . . 0.0 112.279 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 118.28 148.36 8.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.293 1.901 . . . . 0.0 112.701 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 126.419 1.888 . . . . 0.0 109.729 -173.143 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.0 ptm -161.77 151.25 16.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.495 1.518 . . . . 0.0 111.969 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.2 m -130.54 147.53 52.24 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.445 1.898 . . . . 0.0 108.509 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -149.81 160.58 43.45 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -170.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.04 134.2 15.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.004 2.122 . . . . 0.0 108.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -128.04 139.59 52.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.202 1.001 . . . . 0.0 110.896 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.4 p -156.84 139.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.952 0.901 . . . . 0.0 111.764 -175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -73.62 152.91 46.82 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.079 0.847 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 52.1 m -139.83 133.06 29.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.449 1.1 . . . . 0.0 111.174 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -164.54 150.77 10.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.767 0.827 . . . . 0.0 112.864 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -76.99 151.24 35.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 111.197 168.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 141.85 28.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.852 1.261 . . . . 0.0 112.358 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.3 mt -125.45 111.5 25.84 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.034 1.334 . . . . 0.0 108.38 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.82 139.79 17.9 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.988 2.459 . . . . 0.0 110.376 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 66.7 mt -139.34 136.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.306 1.042 . . . . 0.0 110.451 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 52.47 82.18 0.07 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.007 2.123 . . . . 0.0 112.56 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.7 mm -83.14 43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.705 1.202 . . . . 0.0 110.495 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 60.4 m -132.24 -57.42 0.96 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.277 1.431 . . . . 0.0 111.963 -173.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -162.9 107.29 1.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.873 0.869 . . . . 0.0 111.628 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.7 p -141.78 160.83 39.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.585 1.954 . . . . 0.0 110.139 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -151.56 126.77 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.608 1.163 . . . . 0.0 110.81 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.86 -15.25 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 56.5 m -80.65 -9.88 59.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.693 1.133 . . . . 0.0 113.415 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.93 7.42 2.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.53 145.9 24.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.613 1.165 . . . . 0.0 111.84 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 22.8 p -141.94 152.01 43.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.939 2.096 . . . . 0.0 108.829 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.63 149.2 27.33 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 73.1 p -141.68 162.45 35.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.126 2.17 . . . . 0.0 110.056 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -118.07 137.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.275 1.43 . . . . 0.0 109.976 169.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.2 t -105.77 114.12 63.2 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.172 1.389 . . . . 0.0 108.396 167.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.67 173.55 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.166 3.244 . . . . 0.0 111.272 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.22 -33.4 54.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.063 3.175 . . . . 0.0 114.097 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.6 m -75.78 -8.24 56.37 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.29 -1.62 75.12 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.459 1.505 . . . . 0.0 115.196 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -76.9 88.82 3.48 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.445 1.498 . . . . 0.0 111.299 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.47 129.6 41.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.278 1.031 . . . . 0.0 111.796 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -130.63 149.28 73.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.084 1.754 . . . . 0.0 110.6 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.39 153.76 35.59 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.795 2.996 . . . . 0.0 112.547 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 79.8 m -99.16 155.94 17.21 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 112.24 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.7 tt -93.91 113.03 24.96 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.305 1.442 . . . . 0.0 108.101 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mt -83.05 136.37 34.51 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.886 1.275 . . . . 0.0 111.246 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -137.95 143.8 40.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.74 1.216 . . . . 0.0 113.533 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -94.17 122.31 36.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 155.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.49 167.6 11.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.379 1.472 . . . . 0.0 112.303 -166.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.04 -29.9 67.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.34 1.25 53.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.21 1.004 . . . . 0.0 113.341 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.64 67.54 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.804 1.669 . . . . 0.0 114.772 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -77.12 168.97 19.18 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.383 1.473 . . . . 0.0 113.443 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 77.8 t -112.05 140.3 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.452 1.501 . . . . 0.0 110.486 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.12 -171.81 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.355 0.978 . . . . 0.0 115.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.1 162.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.502 1.521 . . . . 0.0 112.458 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 37.0 m -132.33 159.83 38.05 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.946 1.699 . . . . 0.0 110.438 161.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.29 -177.05 5.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.425 1.89 . . . . 0.0 109.998 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.8 t -130.27 121.05 19.33 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.795 0.838 . . . . 0.0 109.738 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.71 139.01 15.51 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.95 3.1 . . . . 0.0 110.799 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 55.6 tptt -88.95 -20.03 25.01 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -135.55 176.01 9.06 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.494 1.918 . . . . 0.0 110.897 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 76.1 p -92.1 164.3 13.64 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.534 1.133 . . . . 0.0 111.053 167.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 100.24 -168.41 20.99 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.156 1.36 . . . . 0.0 113.928 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.58 112.84 11.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 0.0 111.941 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 19.3 m80 -100.66 141.25 33.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.851 1.66 . . . . 0.0 109.129 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.39 125.82 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 109.648 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.7 t -86.85 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 108.099 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -101.64 134.39 44.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.796 1.239 . . . . 0.0 109.915 170.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.2 p -139.75 128.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.278 1.037 . . . . 0.0 112.202 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -115.84 141.71 47.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.599 2.359 . . . . 0.0 111.01 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -137.11 118.71 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.574 2.35 . . . . 0.0 109.357 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.4 t30 56.34 29.02 14.33 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.761 1.224 . . . . 0.0 113.685 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 95.42 3.91 61.14 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.135 1.35 . . . . 0.0 116.169 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -137.62 153.77 49.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.567 1.684 . . . . 0.0 111.482 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -65.27 142.28 58.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.65 -1.281 . . . . 0.0 113.156 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2030 ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' 2032 ' ' SER . 61.5 t -67.24 147.87 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.624 1.17 . . . . 0.0 109.457 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.05 64.28 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2032 ' ' SER . . . . . 0.422 ' H ' HG12 ' A' 2030 ' ' VAL . 11.5 m -76.18 -14.18 60.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.581 1.552 . . . . 0.0 114.002 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 10.1 t -85.67 141.57 36.32 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.674 1.19 . . . . 0.0 112.861 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.15 154.2 86.09 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.506 0.859 . . . . 0.0 112.56 -4.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.6 118.88 56.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.58 1.552 . . . . 0.0 108.582 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.16 140.71 12.52 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.071 2.514 . . . . 0.0 111.038 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 16.0 t -137.62 125.34 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.818 1.647 . . . . 0.0 108.118 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.4 t -97.78 122.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.683 0.793 . . . . 0.0 110.192 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.92 131.06 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.17 1.388 . . . . 0.0 110.023 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.9 t -95.24 171.82 8.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.81 1.244 . . . . 0.0 112.331 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -23.36 62.96 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.525 -1.359 . . . . 0.0 112.938 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 4.2 m -74.6 -12.72 60.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -117.71 6.59 12.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.47 1.508 . . . . 0.0 113.744 -173.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.45 -39.5 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.024 0.93 . . . . 0.0 112.658 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.0 42.01 0.03 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 123.833 0.73 . . . . 0.0 114.211 -169.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.23 104.97 6.02 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 117.861 0.831 . . . . 0.0 111.981 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.64 93.49 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.523 -0.736 . . . . 0.0 112.797 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 19.4 m -60.09 -27.5 67.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.208 1.003 . . . . 0.0 113.256 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -80.73 -10.4 59.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.398 1.479 . . . . 0.0 114.246 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 93.4 t -81.91 136.09 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.036 1.289 . . . . 0.0 109.455 172.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -131.74 156.8 45.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.24 1.416 . . . . 0.0 110.737 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.6 m -144.7 158.77 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.818 1.247 . . . . 0.0 111.666 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 95.1 p -158.34 172.57 18.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.819 1.247 . . . . 0.0 112.863 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.94 153.09 28.08 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.893 1.235 . . . . 0.0 113.169 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -77.29 -16.46 58.96 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -168.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.06 29.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.704 1.145 . . . . 0.0 114.748 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -87.96 -3.96 58.86 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.683 1.593 . . . . 0.0 112.785 168.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -134.24 -39.57 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.832 1.253 . . . . 0.0 113.936 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.26 148.81 40.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.191 1.396 . . . . 0.0 111.362 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.95 175.86 26.12 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.728 1.156 . . . . 0.0 113.838 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 61.7 m80 -132.13 154.6 49.33 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.284 1.434 . . . . 0.0 111.811 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 9.9 p -67.11 -65.86 0.63 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.394 1.078 . . . . 0.0 112.796 -175.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.77 7.49 44.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.26 1.024 . . . . 0.0 113.507 -166.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.58 143.17 43.89 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.751 2.02 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.48 152.2 48.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.691 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -101.03 162.48 12.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.617 1.567 . . . . 0.0 110.924 168.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.69 149.95 34.46 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 50.2 p90 -159.85 153.73 23.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.695 1.598 . . . . 0.0 111.18 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 142.17 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 109.523 -172.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 39.7 mt -120.24 136.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.519 1.927 . . . . 0.0 109.391 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.0 125.53 41.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.577 1.551 . . . . 0.0 111.892 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 40.3 p -122.35 -13.43 8.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.31 -25.41 68.03 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.632 1.56 . . . . 0.0 114.732 -170.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.15 -16.52 60.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.218 1.007 . . . . 0.0 112.892 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.64 49.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.534 1.534 . . . . 0.0 113.669 172.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 80.52 -119.33 4.88 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.597 1.094 . . . . 0.0 112.063 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -92.49 169.58 10.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.521 1.528 . . . . 0.0 112.822 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.51 -138.49 7.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.009 1.29 . . . . 0.0 112.739 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -178.2 136.15 2.89 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 124.352 0.977 . . . . 0.0 112.017 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.88 122.92 40.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.736 1.614 . . . . 0.0 109.651 -175.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 46.1 m -112.21 132.91 54.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 109.476 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -130.03 135.83 48.71 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.33 1.452 . . . . 0.0 109.633 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 71.0 m -130.6 140.24 50.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.585 0.754 . . . . 0.0 111.01 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.4 mt -118.17 127.11 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.105 1.362 . . . . 0.0 107.764 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.36 140.42 46.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.207 1.403 . . . . 0.0 109.535 -168.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 171.38 -155.82 25.03 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.809 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 -22.69 27.53 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.379 2.719 . . . . 0.0 113.682 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 63.8 m -145.48 160.04 42.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.568 1.147 . . . . 0.0 112.367 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -67.31 146.3 54.25 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.182 0.993 . . . . 0.0 111.228 169.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -130.17 149.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.718 1.607 . . . . 0.0 110.769 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.46 105.46 17.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.768 0.827 . . . . 0.0 110.122 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 41.0 mt -85.51 130.49 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -126.29 157.36 38.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 110.418 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.9 p -144.5 153.45 41.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.795 1.238 . . . . 0.0 112.279 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -158.1 134.99 9.85 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.118 1.367 . . . . 0.0 110.591 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -80.98 131.97 35.35 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.712 0.805 . . . . 0.0 111.905 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.92 168.81 13.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.452 1.501 . . . . 0.0 111.332 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -32.11 69.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.91 -7.52 54.75 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.307 1.443 . . . . 0.0 113.518 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 88.02 6.76 75.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.484 1.516 . . . . 0.0 114.114 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 22.2 p -80.42 154.17 27.82 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.747 1.619 . . . . 0.0 110.617 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -100.35 119.14 37.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.456 0.702 . . . . 0.0 110.597 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -86.54 133.19 33.75 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.698 0.799 . . . . 0.0 109.519 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 19.2 t -113.4 138.05 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.67 1.988 . . . . 0.0 108.645 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 23.9 p -135.85 151.93 50.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.426 1.49 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -163.16 153.16 15.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 111.811 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.4 t -119.31 100.59 49.88 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.405 1.082 . . . . 0.0 110.91 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.75 85.56 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.687 2.925 . . . . 0.0 110.937 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 18.7 m -54.42 -39.41 67.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 0.0 113.936 -170.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -95.32 140.09 22.26 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.259 1.024 . . . . 0.0 111.014 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 165.38 31.98 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.694 2.93 . . . . 0.0 112.358 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 139.54 -160.08 25.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.0 1.286 . . . . 0.0 113.115 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -107.27 119.55 39.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.186 0.994 . . . . 0.0 110.513 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.89 141.31 36.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.463 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.56 131.47 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.237 1.415 . . . . 0.0 108.063 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.7 mt -110.21 119.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.423 1.089 . . . . 0.0 108.901 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -102.14 124.43 47.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 110.697 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.73 115.53 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.394 1.477 . . . . 0.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.7 134.87 48.61 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 0.0 111.604 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -126.99 124.47 39.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.864 1.666 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.78 34.78 19.87 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.022 1.329 . . . . 0.0 113.683 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.4 t70 89.71 -0.65 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.269 3.027 . . . . 0.0 113.929 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -119.39 132.82 55.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.688 1.195 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -69.15 128.42 36.57 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.278 1.431 . . . . 0.0 111.93 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -85.67 160.65 52.83 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 119.133 0.879 . . . . 0.0 112.155 -169.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.92 149.27 43.05 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.071 3.18 . . . . 0.0 114.471 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 80.65 -30.0 2.58 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.222 1.392 . . . . 0.0 113.827 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -72.83 142.58 83.4 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 110.547 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.03 139.59 62.54 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 120.631 1.261 . . . . 0.0 111.896 6.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.14 111.92 24.19 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.066 0.946 . . . . 0.0 110.21 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 67.3 m -85.57 127.41 34.44 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.982 0.913 . . . . 0.0 110.888 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -124.43 112.1 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.66 1.584 . . . . 0.0 109.35 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.56 118.17 21.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.859 0.463 . . . . 0.0 110.722 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.0 t -104.11 124.76 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.874 1.67 . . . . 0.0 109.193 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.1 t -124.87 162.88 23.42 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 112.367 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 122.98 159.22 10.46 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.297 1.903 . . . . 0.0 113.096 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 125.797 1.639 . . . . 0.0 110.223 -173.985 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 28.3 ttt -118.54 129.35 55.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.669 1.188 . . . . 0.0 111.094 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 4.3 m -123.26 141.77 51.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.947 1.699 . . . . 0.0 108.589 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -156.8 162.02 39.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.4 tt -154.69 145.49 22.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.852 2.061 . . . . 0.0 110.261 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -135.29 143.71 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.609 1.164 . . . . 0.0 112.184 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 42.6 t -132.88 134.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 110.143 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.01 63.71 4.35 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 125.349 1.452 . . . . 0.0 112.057 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 10.1 m -58.51 124.77 20.74 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 114.154 -171.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -156.8 150.02 24.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.114 1.366 . . . . 0.0 111.69 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.71 153.44 21.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.131 0.972 . . . . 0.0 111.382 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -90.73 139.66 30.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.668 1.187 . . . . 0.0 112.116 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 36.1 mm -125.27 123.85 25.21 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 108.935 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.44 149.73 45.11 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.771 2.314 . . . . 0.0 111.526 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.91 148.37 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.089 1.756 . . . . 0.0 108.805 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 53.3 t30 -44.05 116.47 1.0 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.363 1.465 . . . . 0.0 113.772 -170.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 5.1 mp -87.38 130.42 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.008 1.323 . . . . 0.0 109.749 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.7 t -164.16 -175.59 4.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.209 1.403 . . . . 0.0 111.134 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.78 1.0 21.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.631 1.572 . . . . 0.0 113.658 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.1 m -57.33 133.5 55.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.568 1.947 . . . . 0.0 111.338 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.44 122.3 19.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.193 0.997 . . . . 0.0 111.402 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.22 -20.48 60.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.033 0.933 . . . . 0.0 113.076 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 67.5 m -72.97 -18.24 61.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -109.38 5.83 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.665 1.586 . . . . 0.0 113.494 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.3 146.31 29.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.592 1.557 . . . . 0.0 111.455 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 49.9 p -134.59 168.42 19.02 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.222 1.809 . . . . 0.0 109.854 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -145.33 141.76 28.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.821 0.849 . . . . 0.0 112.243 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 64.2 p -135.2 163.35 30.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.693 1.997 . . . . 0.0 109.428 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -115.78 136.55 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.802 1.241 . . . . 0.0 109.55 167.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.0 t -107.03 113.21 62.73 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.59 1.556 . . . . 0.0 108.17 167.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -80.24 173.47 12.49 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.289 3.326 . . . . 0.0 111.272 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.18 -28.01 49.6 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.196 3.264 . . . . 0.0 114.83 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.0 p -79.03 -9.18 59.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.789 1.235 . . . . 0.0 114.143 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.3 0.25 88.71 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.46 1.505 . . . . 0.0 114.695 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.61 84.43 3.28 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.518 1.527 . . . . 0.0 111.491 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.87 133.4 55.4 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.643 1.177 . . . . 0.0 112.009 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.81 149.65 59.98 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.412 1.485 . . . . 0.0 110.986 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.11 154.52 42.05 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.93 3.087 . . . . 0.0 112.669 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 84.9 m -108.24 153.45 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.094 1.358 . . . . 0.0 112.686 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 63.4 tp -88.11 112.57 22.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.455 1.102 . . . . 0.0 109.938 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.75 134.41 33.58 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.967 1.307 . . . . 0.0 111.165 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -142.9 148.86 37.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.008 1.323 . . . . 0.0 112.911 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -80.49 122.38 26.93 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.023 1.329 . . . . 0.0 108.364 160.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.41 177.36 6.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.316 1.446 . . . . 0.0 112.704 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -53.84 -43.03 69.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.504 1.522 . . . . 0.0 114.218 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.17 4.42 53.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.718 1.207 . . . . 0.0 113.688 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.74 -7.02 74.11 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.883 1.23 . . . . 0.0 114.403 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.05 174.24 8.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.894 1.278 . . . . 0.0 112.602 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -127.9 142.47 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.38 1.472 . . . . 0.0 109.548 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.17 34.35 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.72 163.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.12 1.768 . . . . 0.0 112.731 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 4.4 m -137.89 155.4 48.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 110.336 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 16.8 p90 -164.16 -176.07 4.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.185 2.594 . . . . 0.0 108.909 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.2 t -131.35 123.3 19.5 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 119.105 0.866 . . . . 0.0 109.246 169.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.5 148.2 26.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.038 3.158 . . . . 0.0 111.441 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -107.79 -8.34 16.06 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.21 172.74 12.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.027 2.131 . . . . 0.0 109.78 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 168.0 15.17 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.639 1.176 . . . . 0.0 111.529 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.61 -170.39 26.73 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.122 1.344 . . . . 0.0 114.013 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.69 115.09 10.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.221 1.008 . . . . 0.0 111.687 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.0 m80 -98.27 144.05 28.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.757 1.623 . . . . 0.0 109.134 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.59 126.99 54.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.237 1.015 . . . . 0.0 109.544 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.5 t -85.55 118.87 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.41 96.6 7.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.535 1.534 . . . . 0.0 110.089 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 89.0 t -86.08 137.71 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.855 1.662 . . . . 0.0 108.975 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.3 mttm -133.64 131.75 39.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.145 0.978 . . . . 0.0 112.99 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 80.6 tttt -96.25 119.49 34.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.063 1.345 . . . . 0.0 109.281 161.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.46 22.87 5.36 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.845 1.258 . . . . 0.0 114.074 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.14 3.7 88.77 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.401 1.477 . . . . 0.0 115.582 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -106.28 23.28 14.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.397 1.479 . . . . 0.0 113.305 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.7 m-70 65.26 -170.77 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.936 1.694 . . . . 0.0 112.527 -172.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 34.1 m -136.29 171.84 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.943 1.297 . . . . 0.0 110.795 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.7 -29.7 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.5 m -89.46 -10.47 46.27 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.8 p -89.98 153.99 47.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 120.709 -1.244 . . . . 0.0 113.715 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.8 157.16 95.2 Favored 'Cis proline' 0 C--N 1.353 0.78 0 CA-C-N 118.856 0.627 . . . . 0.0 112.41 -4.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.01 122.81 39.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.703 1.201 . . . . 0.0 108.774 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.64 146.36 11.96 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.043 2.495 . . . . 0.0 112.576 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 19.4 t -137.52 125.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.985 1.714 . . . . 0.0 107.921 170.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.2 t -102.09 124.69 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.701 0.8 . . . . 0.0 110.635 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.36 139.53 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.439 1.496 . . . . 0.0 110.232 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 15.2 t -116.7 164.71 14.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.817 1.247 . . . . 0.0 111.449 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.04 -37.65 77.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.401 1.08 . . . . 0.0 112.738 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 48.8 m -60.71 -18.41 54.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.63 -6.63 32.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.166 1.386 . . . . 0.0 113.142 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.61 -32.88 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.086 -1.009 . . . . 0.0 112.701 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 140.42 29.61 0.19 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.754 1.169 . . . . 0.0 113.641 -168.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 28.2 t0 -73.34 114.57 11.69 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.421 1.11 . . . . 0.0 110.685 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.72 74.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.811 0.844 . . . . 0.0 113.015 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 60.4 p -66.85 -21.03 66.03 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.986 -1.071 . . . . 0.0 113.196 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -77.9 -14.85 59.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.775 1.23 . . . . 0.0 113.399 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 48.3 t -79.7 132.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.618 1.099 . . . . 0.0 110.08 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -113.87 154.49 27.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.764 1.625 . . . . 0.0 110.57 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.81 149.75 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.209 1.404 . . . . 0.0 111.008 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 74.6 m -150.78 160.41 43.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.925 1.29 . . . . 0.0 112.325 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 113.76 162.92 14.89 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.418 1.009 . . . . 0.0 115.021 171.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -65.23 -34.42 78.31 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.675 1.59 . . . . 0.0 113.249 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.82 -1.65 33.04 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.934 1.254 . . . . 0.0 115.053 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.1 mt -90.2 -7.27 53.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.401 1.481 . . . . 0.0 112.689 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -128.33 -36.32 1.92 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.834 1.253 . . . . 0.0 113.794 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -158.78 158.09 32.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.683 1.193 . . . . 0.0 112.396 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -154.81 -174.91 25.31 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.441 1.019 . . . . 0.0 114.166 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -141.71 137.97 32.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.324 1.45 . . . . 0.0 111.18 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.2 p -63.48 146.65 53.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.265 0.626 . . . . 0.0 111.307 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 4.4 m-85 73.93 -4.73 2.19 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.069 2.148 . . . . 0.0 113.896 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -120.97 148.4 48.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.795 2.038 . . . . 0.0 110.191 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.47 125.06 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 110.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -86.57 145.51 26.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.273 1.029 . . . . 0.0 109.54 165.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.48 151.45 50.95 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -158.51 152.13 23.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.163 1.785 . . . . 0.0 110.548 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.19 140.46 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.538 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.2 mt -114.57 136.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.281 1.832 . . . . 0.0 109.094 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 57.5 t0 -123.08 100.92 7.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.045 1.738 . . . . 0.0 110.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.9 p -99.2 4.25 46.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.581 1.952 . . . . 0.0 112.831 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.85 -33.15 71.4 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.489 1.041 . . . . 0.0 112.835 -173.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.24 -10.03 55.38 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.376 1.47 . . . . 0.0 113.383 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.84 -9.76 19.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.17 1.788 . . . . 0.0 114.08 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 69.38 -134.89 26.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.954 1.264 . . . . 0.0 114.008 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -74.04 167.36 21.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.079 1.352 . . . . 0.0 112.635 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.97 -116.99 0.97 Allowed Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.558 1.075 . . . . 0.0 112.022 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . 176.2 116.32 0.45 Allowed Glycine 0 N--CA 1.465 0.612 0 C-N-CA 123.87 0.748 . . . . 0.0 112.812 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.03 124.97 29.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.496 1.118 . . . . 0.0 109.517 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 69.0 m -124.52 144.59 50.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.773 1.629 . . . . 0.0 109.616 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -144.35 132.46 21.66 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.344 0.658 . . . . 0.0 110.223 -164.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 49.6 m -132.53 139.03 47.71 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.604 0.762 . . . . 0.0 111.098 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.9 mt -123.93 138.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.723 1.609 . . . . 0.0 108.622 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.94 157.56 44.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 161.85 -146.31 11.93 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.873 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.62 -11.27 24.15 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.582 2.855 . . . . 0.0 113.989 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.8 t -155.97 161.08 40.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.594 1.088 . . . . 0.0 112.411 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 130.39 35.09 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.299 1.44 . . . . 0.0 109.727 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.7 m -114.23 157.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.158 1.383 . . . . 0.0 111.856 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -92.5 126.13 37.45 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.501 0.72 . . . . 0.0 109.813 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.7 mt -106.67 134.64 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 109.427 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -131.87 162.59 30.23 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.014 1.726 . . . . 0.0 111.056 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 23.0 p -137.99 159.95 40.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.391 1.476 . . . . 0.0 112.079 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.83 122.76 6.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.236 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 128.6 34.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.726 1.21 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 69.5 mt -104.41 151.3 23.68 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.507 1.123 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.35 -17.55 64.27 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.734 0.813 . . . . 0.0 113.057 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -70.69 -10.8 60.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.439 1.496 . . . . 0.0 113.453 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.71 -3.2 70.9 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.153 1.835 . . . . 0.0 114.187 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 42.6 p -87.85 168.97 12.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.252 1.821 . . . . 0.0 111.319 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -123.81 127.15 47.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.992 0.917 . . . . 0.0 111.408 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -79.51 135.08 36.54 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.229 165.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 48.0 t -113.14 139.78 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.173 1.789 . . . . 0.0 108.381 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.2 p -133.83 150.47 51.41 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 111.565 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.0 p90 -155.19 146.94 23.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.524 1.13 . . . . 0.0 112.019 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 38.3 t -113.73 106.93 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.275 1.03 . . . . 0.0 111.179 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.67 145.77 16.42 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.571 2.847 . . . . 0.0 111.059 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 91.5 m -104.01 -47.13 4.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -86.61 143.23 35.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.12 162.13 28.98 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.346 2.697 . . . . 0.0 111.3 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.54 -164.69 24.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.24 1.4 . . . . 0.0 113.566 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -90.59 118.99 30.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.499 0.719 . . . . 0.0 111.059 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -100.21 141.1 33.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.719 1.208 . . . . 0.0 110.107 167.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.56 131.05 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.503 1.121 . . . . 0.0 108.359 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.5 mt -113.61 130.58 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.292 1.437 . . . . 0.0 109.372 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 21.0 m120 -114.19 123.95 50.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.595 1.558 . . . . 0.0 110.115 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.91 119.78 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.065 0.946 . . . . 0.0 109.693 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -122.99 136.48 54.87 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.866 2.066 . . . . 0.0 109.787 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.04 122.13 22.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.661 1.185 . . . . 0.0 110.239 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.67 45.11 27.33 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.901 1.28 . . . . 0.0 111.987 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.6 t0 73.03 -4.47 2.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.848 2.859 . . . . 0.0 114.744 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -101.33 132.52 46.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.571 1.148 . . . . 0.0 110.748 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -69.65 125.61 27.24 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.229 1.012 . . . . 0.0 111.292 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -79.32 153.5 76.67 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.218 -0.926 . . . . 0.0 111.025 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.02 140.97 81.82 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.666 2.244 . . . . 0.0 111.647 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.66 22.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.376 1.465 . . . . 0.0 113.745 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 66.6 m -76.73 153.55 83.28 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 118.594 1.197 . . . . 0.0 111.993 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.56 142.83 73.38 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.311 0.789 . . . . 0.0 111.352 -7.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -96.18 116.52 29.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.415 1.086 . . . . 0.0 110.205 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 58.0 m -83.1 128.67 34.69 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.737 0.815 . . . . 0.0 110.449 169.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -127.07 110.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.541 1.537 . . . . 0.0 109.207 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -78.58 107.73 11.46 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.035 0.534 . . . . 0.0 110.763 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.0 t -94.47 118.06 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.787 1.235 . . . . 0.0 108.806 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -90.3 150.71 21.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.874 0.87 . . . . 0.0 110.847 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -177.2 160.23 27.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.26 0.933 . . . . 0.0 114.552 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 0.0 113.605 -176.094 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 121.199 0.523 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 20.3 ptm -158.76 163.04 37.11 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.618 1.567 . . . . 0.0 112.417 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 19.3 m -136.99 143.9 43.03 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.419 1.888 . . . . 0.0 109.097 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -143.58 165.15 28.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -164.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1963 ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -156.65 155.65 32.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.868 2.067 . . . . 0.0 110.5 -175.216 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1964 ' ' LYS . . . . . 0.421 ' H ' HD13 ' A' 1963 ' ' LEU . 61.1 mttm -136.94 143.83 43.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.444 1.498 . . . . 0.0 111.478 173.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 57.8 t -141.04 135.66 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.832 1.653 . . . . 0.0 109.534 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.29 133.32 11.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.898 0.761 . . . . 0.0 112.045 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 62.5 m -120.3 146.58 45.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.89 1.276 . . . . 0.0 112.602 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -157.03 150.65 24.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.493 1.117 . . . . 0.0 112.589 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.58 148.86 25.3 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.401 1.081 . . . . 0.0 111.229 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -86.56 126.98 34.85 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.806 1.243 . . . . 0.0 111.203 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.6 mm -113.22 113.29 48.98 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 124.926 1.29 . . . . 0.0 109.01 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.11 138.57 20.58 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.989 2.459 . . . . 0.0 110.948 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 55.2 mt -143.35 136.5 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.82 1.248 . . . . 0.0 109.713 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 11.5 t30 59.22 69.82 0.69 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.305 1.842 . . . . 0.0 113.058 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.68 104.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.73 0.812 . . . . 0.0 109.657 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.6 t -173.69 -168.56 0.44 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.971 2.108 . . . . 0.0 109.928 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.16 51.93 1.05 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.1 1.76 . . . . 0.0 111.893 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 91.9 m -83.72 124.04 30.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.545 1.538 . . . . 0.0 109.773 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -90.46 126.53 35.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.702 1.201 . . . . 0.0 110.258 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -31.06 55.91 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.941 1.296 . . . . 0.0 112.132 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 57.3 m -73.02 -22.92 60.57 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -160.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1982 ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' 1982 ' ' LEU . 1.9 pt? -111.72 2.47 17.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.402 1.481 . . . . 0.0 114.079 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.79 152.25 20.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.066 1.347 . . . . 0.0 112.084 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.0 p -140.77 172.42 12.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.62 2.368 . . . . 0.0 108.641 165.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -156.56 160.29 39.33 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 78.3 p -133.07 161.5 34.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.461 1.905 . . . . 0.0 109.824 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -111.75 135.13 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.953 1.301 . . . . 0.0 109.243 166.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.8 t -103.52 110.66 64.23 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.74 1.216 . . . . 0.0 107.89 163.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.09 169.43 17.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.766 2.977 . . . . 0.0 110.897 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.51 -19.75 65.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.902 2.401 . . . . 0.0 112.025 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 1.9 m -68.66 -10.57 57.02 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.642 1.577 . . . . 0.0 113.668 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 77.62 -13.3 12.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.131 1.824 . . . . 0.0 115.411 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -80.51 94.92 6.34 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.833 1.253 . . . . 0.0 111.181 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.64 133.97 55.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.161 0.984 . . . . 0.0 111.473 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.28 150.75 62.41 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.356 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.82 156.23 34.95 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.942 3.095 . . . . 0.0 112.882 -176.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 88.7 m -104.93 153.04 21.92 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.35 1.46 . . . . 0.0 112.244 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -96.79 116.72 29.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.468 1.507 . . . . 0.0 107.956 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.88 137.54 32.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.199 1.0 . . . . 0.0 110.613 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.31 137.56 47.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.693 1.197 . . . . 0.0 112.766 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -89.23 120.05 30.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.768 1.227 . . . . 0.0 107.796 160.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.65 164.65 12.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.021 1.328 . . . . 0.0 111.804 -169.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -69.88 -24.3 63.39 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -159.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -90.57 0.1 57.48 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.146 0.979 . . . . 0.0 113.549 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.96 -6.48 54.2 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 125.394 1.473 . . . . 0.0 114.146 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -74.35 174.04 9.41 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.359 1.464 . . . . 0.0 113.197 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 30.3 m -134.46 152.15 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.239 1.416 . . . . 0.0 110.931 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -162.0 -170.84 27.31 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.972 0.796 . . . . 0.0 115.064 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.39 158.89 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.403 1.481 . . . . 0.0 112.686 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 53.4 m -132.24 153.82 50.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.595 1.558 . . . . 0.0 111.047 165.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.2 p90 -165.63 -169.88 1.67 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.769 2.428 . . . . 0.0 108.913 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 92.0 t -133.99 120.75 15.38 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 119.924 1.238 . . . . 0.0 110.29 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.86 147.69 17.09 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.341 3.36 . . . . 0.0 111.279 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.7 -12.29 17.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.79 172.93 12.33 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.856 2.062 . . . . 0.0 109.969 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.9 p -86.1 171.15 11.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.06 1.344 . . . . 0.0 111.89 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.54 -170.03 26.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.075 1.321 . . . . 0.0 113.874 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.46 117.61 12.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.097 0.959 . . . . 0.0 111.78 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.2 m80 -104.24 143.57 32.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.042 1.737 . . . . 0.0 109.269 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.1 122.24 44.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.257 1.023 . . . . 0.0 109.352 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 50.9 t -91.55 125.35 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.157 1.383 . . . . 0.0 108.558 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -110.22 113.53 26.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.217 1.407 . . . . 0.0 110.189 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 42.3 t -102.66 139.49 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.332 1.453 . . . . 0.0 109.36 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -144.81 142.32 29.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -172.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.87 121.41 44.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.052 2.541 . . . . 0.0 109.58 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.1 t30 53.35 30.13 9.78 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.374 1.069 . . . . 0.0 113.545 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.05 66.08 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.64 1.59 . . . . 0.0 115.587 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -101.11 133.3 45.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.28 1.432 . . . . 0.0 110.903 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.06 139.6 57.37 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 91.2 t -76.02 142.52 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.254 1.422 . . . . 0.0 108.874 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.79 62.76 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 20.0 m -76.93 -12.63 59.98 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.832 1.253 . . . . 0.0 114.022 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 47.9 m -84.43 153.79 62.22 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.582 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.98 152.11 88.51 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-O 121.357 0.482 . . . . 0.0 112.306 -4.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.06 124.6 37.92 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.959 1.304 . . . . 0.0 108.742 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.74 137.14 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.887 2.391 . . . . 0.0 111.145 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 48.9 t -133.07 124.34 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.411 1.484 . . . . 0.0 107.815 172.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.7 t -96.87 125.35 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.822 0.849 . . . . 0.0 110.372 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.84 125.74 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.128 1.371 . . . . 0.0 109.198 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.3 t -93.39 158.75 15.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.022 0.929 . . . . 0.0 111.905 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -58.29 -31.58 67.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.09 0.956 . . . . 0.0 113.02 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 24.5 m -66.06 -18.42 65.33 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.2 1.0 . . . . 0.0 113.644 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -92.07 -13.0 31.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.473 1.109 . . . . 0.0 112.703 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.6 mm -70.12 -26.19 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.356 1.062 . . . . 0.0 112.491 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 149.8 63.4 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.356 0.979 . . . . 0.0 113.586 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -76.57 94.19 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.382 0.673 . . . . 0.0 110.922 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.82 61.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.483 1.113 . . . . 0.0 112.627 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.4 p -55.78 -22.82 26.28 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.97 1.708 . . . . 0.0 114.639 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -94.53 -7.98 39.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.306 1.442 . . . . 0.0 113.688 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.2 t -73.98 138.45 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.637 1.108 . . . . 0.0 110.693 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -114.8 147.48 39.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.584 1.554 . . . . 0.0 111.796 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.6 m -143.82 144.17 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.787 1.635 . . . . 0.0 109.807 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.4 m -149.09 156.08 41.68 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.254 -173.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 118.1 162.56 12.37 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 124.706 1.146 . . . . 0.0 114.186 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -65.47 -30.25 71.01 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.729 1.212 . . . . 0.0 113.377 -170.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.1 -1.6 34.78 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.713 1.149 . . . . 0.0 114.878 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.4 -7.67 56.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.182 1.393 . . . . 0.0 112.554 167.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -130.06 -37.55 1.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.161 1.384 . . . . 0.0 114.056 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.19 158.62 37.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.157 0.983 . . . . 0.0 113.405 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.67 -173.37 20.08 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.435 1.493 . . . . 0.0 113.271 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -136.5 146.35 46.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.398 1.079 . . . . 0.0 112.784 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.9 p -67.27 -21.48 65.7 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -120.56 -0.81 10.2 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -142.8 148.45 46.05 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.176 1.39 . . . . 0.0 110.592 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.81 145.33 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.88 2.387 . . . . 0.0 111.76 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -91.14 153.14 20.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.028 1.331 . . . . 0.0 110.442 169.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.53 148.17 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.882 0.873 . . . . 0.0 113.063 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -159.04 149.28 19.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 110.74 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 141.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.256 1.822 . . . . 0.0 109.332 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.72 138.14 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.288 1.835 . . . . 0.0 109.634 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 22.0 t0 -136.7 117.64 14.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 111.69 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 12.4 p -123.34 -10.36 8.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -165.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -64.58 -23.62 67.33 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.539 1.518 . . . . 0.0 114.526 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -19.9 61.51 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.286 1.034 . . . . 0.0 112.785 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -90.51 -0.65 57.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.823 1.649 . . . . 0.0 113.672 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.46 -120.61 5.31 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.06 1.314 . . . . 0.0 112.196 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -107.25 165.43 11.38 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.016 1.726 . . . . 0.0 112.386 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.59 -178.07 19.14 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 115.229 0.852 . . . . 0.0 115.229 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.2 126.44 8.75 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.699 1.142 . . . . 0.0 112.022 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.26 121.25 36.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.289 1.835 . . . . 0.0 108.313 170.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 70.5 m -113.81 146.44 39.94 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.615 1.566 . . . . 0.0 110.867 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -141.34 133.55 27.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.42 1.088 . . . . 0.0 110.233 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.5 m -140.39 123.79 16.93 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.697 0.799 . . . . 0.0 110.929 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.16 137.97 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.454 1.502 . . . . 0.0 108.819 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -144.11 157.39 44.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.183 1.393 . . . . 0.0 110.675 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.24 -151.85 22.52 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.788 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.11 -10.73 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.832 3.022 . . . . 0.0 114.881 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.7 t -160.18 168.6 25.06 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 120.001 1.273 . . . . 0.0 112.666 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.54 151.14 47.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.404 1.481 . . . . 0.0 111.247 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.8 m -135.65 147.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.106 0.963 . . . . 0.0 112.029 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.21 129.82 34.84 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.899 -0.501 . . . . 0.0 109.939 166.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.9 133.91 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 109.174 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.35 158.99 39.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.249 1.82 . . . . 0.0 109.923 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 53.0 p -138.25 159.43 42.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.709 1.204 . . . . 0.0 111.705 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -154.58 116.01 4.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.587 1.155 . . . . 0.0 110.02 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.18 136.19 37.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.979 0.912 . . . . 0.0 111.389 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.79 161.14 15.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.126 1.37 . . . . 0.0 111.819 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.28 -15.89 62.95 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.83 -4.76 53.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.31 0.72 84.62 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.727 1.632 . . . . 0.0 114.203 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 20.8 p -83.51 170.46 14.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.552 1.941 . . . . 0.0 111.212 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 22.3 t -127.09 126.36 42.87 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.875 0.87 . . . . 0.0 111.056 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 28.1 ttm105 -78.11 140.28 39.04 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.201 1.0 . . . . 0.0 109.345 164.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -121.22 137.46 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.049 1.74 . . . . 0.0 108.24 167.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.3 p -135.34 148.93 49.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.323 1.449 . . . . 0.0 111.422 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.04 149.38 21.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.396 1.079 . . . . 0.0 112.218 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 20.4 t -113.78 104.25 55.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.96 0.904 . . . . 0.0 111.385 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.48 135.41 11.77 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.417 2.745 . . . . 0.0 110.554 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.3 m -89.88 -40.14 12.6 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.785 0.834 . . . . 0.0 112.133 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -92.58 149.5 38.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.494 1.118 . . . . 0.0 111.386 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.77 164.88 31.21 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 111.127 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 115.77 -165.01 12.15 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.11 1.338 . . . . 0.0 113.634 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.83 119.18 30.83 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.456 0.702 . . . . 0.0 112.009 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -97.43 141.71 30.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.719 1.207 . . . . 0.0 110.438 163.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.1 134.04 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.651 1.181 . . . . 0.0 108.778 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.18 125.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.452 1.101 . . . . 0.0 109.173 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -99.21 124.73 44.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.546 1.538 . . . . 0.0 109.293 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.32 122.53 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.222 1.009 . . . . 0.0 108.911 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -128.66 136.75 51.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.517 1.927 . . . . 0.0 110.27 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 31.1 t80 -133.8 126.03 29.72 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.713 1.205 . . . . 0.0 110.463 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 33.07 14.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.888 1.275 . . . . 0.0 112.988 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t0 79.75 2.54 2.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 114.44 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.23 133.22 49.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.458 1.103 . . . . 0.0 111.29 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -66.05 122.36 17.22 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.076 1.351 . . . . 0.0 110.668 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -78.91 160.69 71.0 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.146 -0.971 . . . . 0.0 111.651 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.89 138.23 69.12 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.582 2.854 . . . . 0.0 113.141 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.91 -23.15 21.83 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.816 1.198 . . . . 0.0 113.899 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 51.5 m -69.86 144.66 93.58 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.052 1.426 . . . . 0.0 111.327 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.2 137.2 48.81 Favored 'Cis proline' 0 C--N 1.351 0.666 0 CA-C-N 119.618 0.899 . . . . 0.0 111.021 -6.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.35 117.25 28.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.98 0.912 . . . . 0.0 110.268 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 18.3 m -83.08 128.75 34.76 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.501 0.721 . . . . 0.0 111.086 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.7 t -124.04 109.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.184 1.793 . . . . 0.0 108.957 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -79.05 106.04 10.8 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.344 0.658 . . . . 0.0 111.143 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 73.9 t -87.7 121.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -110.39 165.0 12.14 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.859 1.264 . . . . 0.0 111.576 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 136.09 -137.18 8.92 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.178 1.37 . . . . 0.0 112.692 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 CA--C 1.546 0.798 0 C-N-CA 124.505 1.122 . . . . 0.0 111.381 -169.697 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.874 0.368 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.1 ptm -156.94 155.63 31.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.104 0.961 . . . . 0.0 113.296 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.5 m -138.92 152.07 47.43 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.549 . . . . 0.0 110.207 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -143.92 157.63 44.22 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.3 tt -158.78 150.94 21.34 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.017 1.727 . . . . 0.0 110.542 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 94.2 mttt -132.99 148.27 52.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.323 1.049 . . . . 0.0 112.339 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 58.3 t -136.05 131.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.944 1.698 . . . . 0.0 109.57 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -82.43 107.17 2.79 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 15.3 m -83.45 -45.19 13.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -166.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 56.98 -161.16 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.528 1.531 . . . . 0.0 112.865 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -160.68 149.29 16.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.231 1.812 . . . . 0.0 110.398 169.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.2 124.7 35.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 111.106 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.49 116.56 33.41 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.465 1.106 . . . . 0.0 109.359 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.51 144.4 44.94 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.569 2.179 . . . . 0.0 111.167 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.85 146.19 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.685 1.594 . . . . 0.0 108.417 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -46.92 120.14 2.88 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.861 1.264 . . . . 0.0 113.887 -169.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.49 71.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.959 1.303 . . . . 0.0 109.694 -169.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 62.2 p -94.36 -20.38 19.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -163.59 149.08 11.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.062 1.345 . . . . 0.0 111.255 -171.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.3 p -76.25 -11.39 59.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.113 1.365 . . . . 0.0 114.666 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -26.83 28.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.454 1.502 . . . . 0.0 113.25 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -14.36 9.45 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.687 1.195 . . . . 0.0 113.498 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 16.5 m -73.74 -16.28 61.19 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.94 -1.1 . . . . 0.0 113.922 172.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.51 -7.52 2.52 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.9 mp -71.04 166.52 21.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.603 1.561 . . . . 0.0 112.106 168.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 38.5 p -135.61 157.82 45.92 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.024 1.73 . . . . 0.0 110.743 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -146.26 161.77 39.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.217 1.007 . . . . 0.0 113.414 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 37.0 p -132.71 142.01 48.85 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.587 1.955 . . . . 0.0 109.973 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 55.3 t -90.72 127.53 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.352 1.061 . . . . 0.0 108.647 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.7 t -101.68 109.34 59.09 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 108.027 167.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.35 168.04 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.74 2.96 . . . . 0.0 110.634 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.23 -14.01 41.55 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.103 2.535 . . . . 0.0 113.563 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 63.4 p -78.1 -10.33 59.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.519 1.127 . . . . 0.0 113.752 168.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.57 -1.5 87.68 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.778 1.656 . . . . 0.0 114.952 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -79.15 82.76 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.109 1.364 . . . . 0.0 111.508 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.75 132.62 54.51 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.172 1.389 . . . . 0.0 112.051 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -141.65 150.03 55.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.504 1.522 . . . . 0.0 110.701 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.38 152.47 66.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.366 2.71 . . . . 0.0 112.242 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 29.1 p -127.96 148.97 50.53 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.586 1.154 . . . . 0.0 111.301 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 60.0 tp -90.13 126.94 35.97 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.335 1.054 . . . . 0.0 110.257 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.93 140.72 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.235 0.614 . . . . 0.0 110.108 170.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -137.41 137.34 38.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.258 1.423 . . . . 0.0 111.801 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -71.91 126.49 29.88 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.3 mt -105.39 163.77 12.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.948 1.299 . . . . 0.0 111.444 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -66.35 -21.62 66.25 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 -160.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 59.3 t30 -88.73 2.59 53.13 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 119.433 1.015 . . . . 0.0 113.221 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.56 -5.36 70.19 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 125.99 1.757 . . . . 0.0 113.787 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -76.8 -178.77 5.01 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.829 1.652 . . . . 0.0 113.199 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 46.9 t -136.07 141.3 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.128 1.371 . . . . 0.0 109.885 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -150.01 179.75 26.5 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.22 161.96 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.11 1.764 . . . . 0.0 111.614 173.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 47.1 t -147.78 135.63 21.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.272 1.429 . . . . 0.0 110.742 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.97 -176.73 2.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.387 1.875 . . . . 0.0 111.266 -171.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 84.1 t -131.01 125.09 21.01 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.88 1.272 . . . . 0.0 108.999 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.08 145.65 24.85 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.066 3.177 . . . . 0.0 111.209 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.04 1.83 22.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.503 1.121 . . . . 0.0 113.147 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -139.3 172.55 12.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.179 2.191 . . . . 0.0 109.989 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.6 p -99.42 165.98 11.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.166 1.386 . . . . 0.0 110.921 168.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 90.23 -163.96 30.58 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.815 1.198 . . . . 0.0 113.523 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.7 120.07 15.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.892 0.877 . . . . 0.0 111.833 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.6 m80 -107.95 145.82 33.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.207 1.803 . . . . 0.0 109.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.08 126.53 52.47 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.437 1.095 . . . . 0.0 109.87 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 76.8 t -91.48 108.05 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.265 1.426 . . . . 0.0 108.291 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.42 124.41 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 110.2 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -124.71 133.21 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.398 1.079 . . . . 0.0 110.651 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.61 145.96 51.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.845 1.258 . . . . 0.0 113.609 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.6 tttt -118.82 125.99 50.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.546 1.938 . . . . 0.0 109.514 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 9.9 t-20 55.83 25.93 9.03 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.914 1.286 . . . . 0.0 113.969 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.74 -0.85 77.49 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.38 1.467 . . . . 0.0 115.762 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.51 149.22 38.48 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.399 1.6 . . . . 0.0 111.114 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.8 p80 -70.97 147.87 48.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.7 t -73.03 151.28 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.684 1.194 . . . . 0.0 109.544 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.42 -26.24 60.83 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 52.8 p -86.93 -8.01 57.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.432 1.493 . . . . 0.0 114.062 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.0 t -86.76 146.8 42.0 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.075 1.35 . . . . 0.0 112.696 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.36 157.48 82.56 Favored 'Cis proline' 0 C--N 1.351 0.69 0 CA-C-N 119.281 0.779 . . . . 0.0 112.23 -7.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.31 126.38 32.38 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.063 1.345 . . . . 0.0 109.126 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.18 140.95 14.27 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.925 2.416 . . . . 0.0 111.677 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.5 t -134.33 124.59 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.713 1.605 . . . . 0.0 107.648 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.1 t -99.31 124.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.804 0.842 . . . . 0.0 110.438 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.96 123.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.224 1.41 . . . . 0.0 109.356 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.8 t -89.88 152.82 21.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.61 0.764 . . . . 0.0 111.172 170.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -58.56 -27.98 65.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 21.2 m -71.84 -18.57 62.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.043 0.937 . . . . 0.0 112.968 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -89.92 -6.84 55.33 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.101 -0.999 . . . . 0.0 112.769 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.47 -29.84 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.321 1.048 . . . . 0.0 112.194 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.33 61.0 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.029 0.823 . . . . 0.0 114.213 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -74.41 97.89 3.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 117.769 0.784 . . . . 0.0 110.958 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.86 71.42 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.93 0.892 . . . . 0.0 112.179 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 38.6 p -54.65 -28.62 48.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.816 1.647 . . . . 0.0 114.257 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -90.59 -6.3 54.82 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.236 1.414 . . . . 0.0 113.969 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 73.6 t -73.36 136.5 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.874 1.216 . . . . 0.0 109.719 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -115.47 156.36 25.79 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.463 1.505 . . . . 0.0 110.659 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -145.02 156.37 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.227 1.411 . . . . 0.0 110.782 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.91 167.62 28.92 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.164 0.986 . . . . 0.0 112.451 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.74 156.38 22.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.413 1.482 . . . . 0.0 113.555 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -71.18 -25.86 62.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.513 1.125 . . . . 0.0 113.24 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.68 -3.34 33.66 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.808 1.194 . . . . 0.0 115.38 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.8 mt -89.89 -5.15 57.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.778 1.631 . . . . 0.0 112.843 169.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -133.8 -40.71 0.85 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.784 1.234 . . . . 0.0 113.798 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.15 149.77 41.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.268 1.427 . . . . 0.0 111.009 -176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.12 175.47 27.41 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.269 0.938 . . . . 0.0 114.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.2 m80 -134.85 151.74 51.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.401 1.48 . . . . 0.0 111.678 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.6 p -69.08 -45.49 70.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -98.6 -5.73 31.32 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -167.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -123.4 147.82 53.64 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.054 1.742 . . . . 0.0 110.196 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.12 136.41 29.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.588 2.192 . . . . 0.0 110.645 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.11 152.91 23.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.352 1.061 . . . . 0.0 109.996 166.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.86 151.54 47.07 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.4 p90 -158.85 150.91 21.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.675 1.59 . . . . 0.0 110.81 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.98 139.94 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.846 1.658 . . . . 0.0 109.243 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.77 136.41 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.38 1.472 . . . . 0.0 108.771 167.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.6 t0 -120.57 98.23 5.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.201 1.8 . . . . 0.0 110.272 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 20.7 p -91.9 -4.76 54.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.567 1.947 . . . . 0.0 113.144 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -59.32 -35.73 74.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.308 1.043 . . . . 0.0 112.588 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.38 -11.6 59.24 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.035 1.334 . . . . 0.0 113.493 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.45 -3.57 56.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.472 1.509 . . . . 0.0 114.557 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.67 -147.0 23.74 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -78.11 172.09 14.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.442 1.097 . . . . 0.0 112.611 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 135.31 -162.09 24.77 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 124.901 1.238 . . . . 0.0 113.937 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -141.12 143.88 13.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.604 1.573 . . . . 0.0 112.719 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.45 123.83 46.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.485 1.914 . . . . 0.0 109.643 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.1 m -111.95 144.29 41.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.857 1.663 . . . . 0.0 110.314 170.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -146.8 146.36 30.22 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.5 0.72 . . . . 0.0 110.988 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 90.2 p -148.53 152.9 37.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.366 0.603 . . . . 0.0 112.338 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.87 129.83 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.134 1.374 . . . . 0.0 107.856 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.57 147.21 47.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.355 1.862 . . . . 0.0 109.713 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 176.97 -166.8 37.74 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.59 -11.51 24.3 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.337 3.358 . . . . 0.0 113.726 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 21.3 m -152.98 161.26 42.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.084 1.754 . . . . 0.0 111.218 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -68.51 146.98 52.64 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.979 0.912 . . . . 0.0 111.589 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.6 m -129.55 148.39 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.986 1.314 . . . . 0.0 110.911 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.44 110.66 21.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.52 0.728 . . . . 0.0 110.075 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 33.1 mt -87.12 129.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.189 0.995 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -123.93 161.62 25.03 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.579 1.952 . . . . 0.0 110.428 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 7.1 p -142.27 158.03 44.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.964 1.306 . . . . 0.0 112.509 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -151.38 117.07 5.43 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.291 1.436 . . . . 0.0 109.835 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.21 128.65 34.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 110.328 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 74.8 mt -102.57 153.68 19.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.485 1.114 . . . . 0.0 111.981 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -60.2 -28.42 67.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.619 1.167 . . . . 0.0 113.323 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.79 -9.38 58.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.806 1.242 . . . . 0.0 113.589 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.27 66.48 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.963 1.744 . . . . 0.0 114.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.1 p -88.12 170.45 11.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.554 1.942 . . . . 0.0 111.179 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.5 t -129.59 124.5 33.94 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.721 0.808 . . . . 0.0 111.663 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -82.28 137.56 34.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.238 1.415 . . . . 0.0 110.016 169.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 94.4 t -116.18 140.12 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.28 1.832 . . . . 0.0 108.465 166.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.78 149.91 50.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.688 1.595 . . . . 0.0 111.179 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.53 147.73 12.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 111.606 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 t -112.1 101.69 52.36 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 110.521 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -82.14 86.54 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.6 2.867 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.5 m -56.57 -39.11 72.93 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.184 1.394 . . . . 0.0 113.825 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -96.57 141.66 23.42 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.343 1.057 . . . . 0.0 110.699 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.23 166.12 29.58 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.518 2.812 . . . . 0.0 112.214 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.02 -162.37 24.48 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.205 1.384 . . . . 0.0 113.574 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -95.68 125.31 40.18 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.751 0.82 . . . . 0.0 111.126 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.3 142.59 41.71 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.23 1.412 . . . . 0.0 110.485 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 131.57 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.961 1.305 . . . . 0.0 108.389 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.6 mt -114.87 127.76 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.654 1.181 . . . . 0.0 109.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -103.84 127.17 51.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.191 1.396 . . . . 0.0 110.477 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -118.65 119.03 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.976 1.31 . . . . 0.0 109.41 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.3 tttt -135.67 123.96 23.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.325 1.45 . . . . 0.0 110.256 -168.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.5 t80 -121.89 127.52 50.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.702 1.201 . . . . 0.0 110.742 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.82 34.15 12.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.113 1.365 . . . . 0.0 113.409 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 16.2 t70 88.2 -1.84 0.47 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.428 3.091 . . . . 0.0 114.138 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -110.75 134.28 52.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 112.111 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.4 126.81 29.42 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.941 1.297 . . . . 0.0 111.094 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.9 m -76.51 153.91 83.74 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.962 . . . . 0.0 111.193 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.55 138.91 67.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.538 2.159 . . . . 0.0 111.178 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.63 -27.32 14.45 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.306 1.431 . . . . 0.0 113.216 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 11.4 t -76.7 144.23 72.87 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.09 0.945 . . . . 0.0 110.663 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.03 149.09 86.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.092 1.069 . . . . 0.0 112.035 0.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.95 119.52 38.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.766 1.226 . . . . 0.0 110.744 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 72.2 m -88.95 129.99 35.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.001 0.92 . . . . 0.0 110.776 172.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 12.9 t -124.48 115.52 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.47 1.508 . . . . 0.0 109.782 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 61.7 tttp -80.09 112.29 17.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.065 0.546 . . . . 0.0 110.709 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.5 t -98.05 121.11 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.017 1.327 . . . . 0.0 109.025 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.6 t -108.69 157.6 18.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.698 1.199 . . . . 0.0 111.479 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 165.17 172.34 32.5 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.27 0.938 . . . . 0.0 114.606 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 124.504 1.121 . . . . 0.0 112.92 -178.628 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 120.196 0.046 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 94.8 mtp -96.33 142.12 28.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.883 1.273 . . . . 0.0 111.727 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 7.4 m -122.26 137.43 54.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.637 1.975 . . . . 0.0 108.414 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.23 145.59 32.9 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.375 0.989 . . . . 0.0 113.547 -165.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.38 155.47 30.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.982 1.713 . . . . 0.0 111.183 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -132.67 150.46 52.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.598 1.159 . . . . 0.0 112.597 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.0 t -139.87 137.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.392 1.877 . . . . 0.0 109.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.33 120.13 5.67 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.0 m -106.59 143.45 34.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.57 152.17 23.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.872 0.869 . . . . 0.0 113.025 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.47 148.45 26.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.167 0.987 . . . . 0.0 111.028 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.37 146.5 28.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 112.494 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.33 120.05 20.9 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.824 1.25 . . . . 0.0 108.791 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.69 137.64 14.49 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.366 2.711 . . . . 0.0 110.956 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.15 138.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.206 1.402 . . . . 0.0 109.985 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 51.7 t30 55.1 64.52 1.77 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.918 1.687 . . . . 0.0 112.359 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 11.2 mm -71.67 105.06 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.39 1.076 . . . . 0.0 110.95 -168.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 11.8 t -171.94 177.82 3.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.751 2.02 . . . . 0.0 110.221 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.72 57.18 3.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.528 1.531 . . . . 0.0 111.049 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 39.6 p -75.77 153.27 37.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.244 1.418 . . . . 0.0 112.28 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -98.44 111.63 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.799 1.24 . . . . 0.0 110.485 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.68 -12.3 61.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.124 0.97 . . . . 0.0 113.053 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 66.6 m -77.12 -16.96 58.98 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.746 1.157 . . . . 0.0 113.948 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -116.65 3.8 13.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.254 1.422 . . . . 0.0 114.057 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.02 146.02 37.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 0.0 110.972 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 56.0 p -140.12 168.01 20.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.532 1.933 . . . . 0.0 109.666 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 152.6 31.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.785 0.834 . . . . 0.0 112.596 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 67.3 p -138.85 157.52 45.91 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.523 1.929 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -109.93 133.45 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.646 1.178 . . . . 0.0 109.495 169.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 89.9 t -102.43 110.5 63.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.776 1.23 . . . . 0.0 107.748 164.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.87 169.65 21.29 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.686 2.924 . . . . 0.0 110.838 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -15.17 46.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.971 2.448 . . . . 0.0 113.28 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 62.3 p -80.33 -9.61 59.74 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.828 1.251 . . . . 0.0 113.916 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.03 -1.72 83.66 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.736 1.636 . . . . 0.0 115.118 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -78.98 83.1 5.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.181 1.392 . . . . 0.0 111.643 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -58.77 135.42 57.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.755 1.222 . . . . 0.0 112.383 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -139.48 151.05 65.85 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.47 1.508 . . . . 0.0 111.128 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 155.04 35.98 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.738 2.959 . . . . 0.0 112.704 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 74.6 m -105.66 154.94 19.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.145 1.378 . . . . 0.0 111.794 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.8 119.16 35.91 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.191 1.396 . . . . 0.0 108.586 175.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.73 136.64 34.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.506 1.122 . . . . 0.0 110.886 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 66.9 mttm -136.94 141.22 42.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.725 1.21 . . . . 0.0 113.098 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -87.02 120.34 28.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.598 1.159 . . . . 0.0 107.981 157.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.4 mt -98.86 171.44 8.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.842 1.257 . . . . 0.0 112.969 -166.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -60.96 -20.41 62.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.749 2.02 . . . . 0.0 116.381 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.08 5.76 46.85 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.272 1.029 . . . . 0.0 112.971 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.75 85.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.58 1.562 . . . . 0.0 114.25 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 164.03 21.71 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.038 1.735 . . . . 0.0 113.426 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 82.6 t -102.56 141.43 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.212 1.405 . . . . 0.0 110.15 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.33 -168.17 20.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.264 0.935 . . . . 0.0 114.807 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.66 167.08 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.441 1.496 . . . . 0.0 112.264 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 98.9 p -139.08 159.85 41.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.923 1.289 . . . . 0.0 111.432 162.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.2 p90 -164.07 -178.46 5.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.026 2.13 . . . . 0.0 109.778 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -129.47 122.9 21.09 Favored Pre-proline 0 N--CA 1.482 1.135 0 CA-C-N 119.44 1.018 . . . . 0.0 110.171 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.86 141.58 15.23 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.322 3.348 . . . . 0.0 111.223 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -94.82 -32.9 13.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.7 0.8 . . . . 0.0 112.842 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -111.2 172.1 7.08 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.173 1.789 . . . . 0.0 111.096 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.6 p -90.86 164.21 14.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.838 1.255 . . . . 0.0 111.015 165.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 101.31 -166.68 18.78 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.123 1.344 . . . . 0.0 113.856 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.94 116.86 16.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.928 . . . . 0.0 111.866 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 16.2 m80 -103.77 142.83 33.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.48 1.912 . . . . 0.0 109.44 170.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.84 123.14 47.73 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.571 1.148 . . . . 0.0 109.206 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 35.2 t -90.55 112.57 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.872 1.269 . . . . 0.0 108.583 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -92.98 138.23 31.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.875 1.27 . . . . 0.0 110.531 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 66.6 t -130.46 128.43 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.672 0.789 . . . . 0.0 109.511 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.23 134.76 51.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.114 1.366 . . . . 0.0 112.569 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 84.9 tttt -128.45 129.05 45.57 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 110.162 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 53.08 30.53 9.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.627 1.171 . . . . 0.0 114.056 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.89 5.26 71.26 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.033 1.302 . . . . 0.0 116.019 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -134.62 149.26 50.55 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.665 1.733 . . . . 0.0 111.855 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -70.03 140.65 52.88 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.945 -1.097 . . . . 0.0 112.877 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 21.2 m -76.33 153.07 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.834 0.854 . . . . 0.0 111.527 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -62.77 -23.66 67.33 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 62.1 p -84.78 -3.42 58.61 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.843 1.257 . . . . 0.0 114.034 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 1.7 p -118.48 160.18 40.88 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.685 1.194 . . . . 0.0 112.757 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.0 156.17 98.7 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.48 0.85 . . . . 0.0 113.078 0.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.39 124.6 33.45 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.816 1.647 . . . . 0.0 108.954 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.84 139.34 12.2 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.193 2.595 . . . . 0.0 111.381 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.3 t -135.55 124.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.585 1.554 . . . . 0.0 108.157 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -97.23 122.47 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.757 0.823 . . . . 0.0 110.118 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.51 126.58 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.152 1.381 . . . . 0.0 109.871 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -90.28 168.54 11.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.793 1.237 . . . . 0.0 112.121 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.58 -32.12 73.25 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.332 -1.48 . . . . 0.0 112.978 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.9 m -72.28 -5.31 35.18 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.81 5.73 14.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.069 1.347 . . . . 0.0 113.207 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.43 -31.21 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.143 0.977 . . . . 0.0 112.24 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 164.27 51.05 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.762 0.665 . . . . 0.0 114.762 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.95 92.54 4.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.151 0.976 . . . . 0.0 111.393 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.69 76.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.697 0.799 . . . . 0.0 112.054 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -56.71 -24.98 53.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.343 1.457 . . . . 0.0 113.994 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -90.61 -7.05 53.79 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.15 1.38 . . . . 0.0 113.802 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 58.0 t -77.8 129.85 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.975 1.261 . . . . 0.0 109.741 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -105.69 156.34 18.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 110.687 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.0 m -143.45 151.63 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.056 1.343 . . . . 0.0 110.731 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 57.2 m -149.13 166.49 28.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.309 1.443 . . . . 0.0 112.014 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.04 157.56 26.27 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.479 1.038 . . . . 0.0 113.929 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -78.88 -18.95 53.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.54 -4.64 46.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.69 1.138 . . . . 0.0 114.788 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.45 -4.88 58.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 112.686 168.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -126.88 -36.57 2.19 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.077 1.351 . . . . 0.0 113.668 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -155.67 156.7 35.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.225 1.01 . . . . 0.0 113.093 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.07 -171.88 15.92 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.71 1.624 . . . . 0.0 113.207 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -147.22 145.17 29.37 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.968 0.907 . . . . 0.0 113.399 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 41.3 p -66.09 -23.69 66.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -114.96 1.57 14.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 139.96 31.0 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.29 1.436 . . . . 0.0 110.095 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.84 144.59 54.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.335 2.023 . . . . 0.0 110.547 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -104.11 158.67 16.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.102 1.361 . . . . 0.0 110.711 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 158.71 44.16 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.45 153.73 30.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.449 1.9 . . . . 0.0 110.114 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.63 138.8 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.687 1.595 . . . . 0.0 108.943 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 44.3 mt -110.2 135.06 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.097 1.759 . . . . 0.0 108.756 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.01 97.5 5.46 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.961 1.704 . . . . 0.0 110.46 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.7 p -94.02 0.73 56.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 113.177 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -59.48 -38.79 81.76 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.524 1.056 . . . . 0.0 113.069 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.59 -23.52 45.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.103 0.961 . . . . 0.0 113.032 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -81.36 -11.81 59.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 113.737 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.2 -121.6 5.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.007 1.289 . . . . 0.0 112.335 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.49 163.93 12.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.542 1.537 . . . . 0.0 112.203 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.45 174.24 17.48 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -89.64 122.86 6.67 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.339 0.971 . . . . 0.0 111.424 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.1 tm? -98.08 112.16 24.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.849 1.66 . . . . 0.0 107.718 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.6 m -104.9 145.55 30.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.724 0.81 . . . . 0.0 109.966 168.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.78 137.19 29.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.741 0.817 . . . . 0.0 109.762 -166.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.2 p -140.87 150.5 43.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.85 0.833 . . . . 0.0 112.497 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.42 133.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.49 1.516 . . . . 0.0 107.235 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -142.27 139.14 31.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.645 0.778 . . . . 0.0 110.827 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 179.46 -161.31 27.23 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.033 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.06 -5.61 15.13 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.291 3.327 . . . . 0.0 114.753 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.6 t -157.71 168.18 27.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.754 1.222 . . . . 0.0 111.456 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -69.33 149.14 48.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.364 1.066 . . . . 0.0 111.093 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.5 m -127.58 150.19 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.036 1.334 . . . . 0.0 110.647 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -91.04 109.17 20.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.49 0.716 . . . . 0.0 109.692 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 26.8 mt -85.4 131.74 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.195 0.998 . . . . 0.0 109.432 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -128.08 164.03 23.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.664 1.986 . . . . 0.0 110.471 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -142.59 155.53 44.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.996 1.318 . . . . 0.0 112.073 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.37 114.88 4.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.0 110.067 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.37 130.68 37.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.666 1.186 . . . . 0.0 110.967 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 75.6 mt -103.3 151.34 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.6 1.16 . . . . 0.0 111.705 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.95 -19.6 65.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.304 1.042 . . . . 0.0 113.659 -175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.63 -5.95 54.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 113.109 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 97.24 1.38 59.41 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.87 1.7 . . . . 0.0 114.738 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 168.92 10.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.366 1.866 . . . . 0.0 111.399 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -125.33 124.61 41.96 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.972 0.909 . . . . 0.0 111.543 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -84.07 134.96 34.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.136 1.375 . . . . 0.0 109.54 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 46.3 t -115.91 137.24 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.743 1.617 . . . . 0.0 108.363 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.472 1.909 . . . . 0.0 110.769 -177.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -160.4 155.91 25.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.396 1.078 . . . . 0.0 112.668 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.2 p -124.61 97.01 39.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.17 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.91 143.31 20.61 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.184 2.589 . . . . 0.0 110.345 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 88.7 m -112.11 -44.11 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 0.0 112.135 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -83.42 141.37 42.3 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.471 0.708 . . . . 0.0 110.419 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.98 162.54 34.48 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.28 2.653 . . . . 0.0 111.092 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.47 -144.04 15.89 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.811 1.196 . . . . 0.0 112.144 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -123.53 131.65 53.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.633 0.773 . . . . 0.0 111.779 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -110.21 139.0 45.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.766 1.626 . . . . 0.0 109.977 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.61 134.28 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.85 1.26 . . . . 0.0 108.447 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.67 127.84 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.214 1.406 . . . . 0.0 108.86 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -109.96 119.96 40.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.028 1.331 . . . . 0.0 109.871 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.5 mm -107.68 114.43 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.749 0.785 . . . . 0.0 108.955 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.57 118.0 23.1 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.21 1.004 . . . . 0.0 111.695 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 16.8 t80 -112.7 131.62 55.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.68 1.192 . . . . 0.0 110.259 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.99 35.35 21.78 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.466 1.506 . . . . 0.0 114.283 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.05 10.14 3.8 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.386 2.275 . . . . 0.0 114.24 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -95.57 -128.8 0.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.127 1.371 . . . . 0.0 110.465 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -168.13 125.19 1.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.558 2.343 . . . . 0.0 108.69 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -76.91 151.57 82.16 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-N 120.044 1.293 . . . . 0.0 110.843 -170.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.34 135.24 52.78 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.568 2.178 . . . . 0.0 110.996 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 100.83 -27.02 22.49 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.39 1.471 . . . . 0.0 113.744 -173.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 50.9 m -74.57 150.37 86.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 118.972 1.386 . . . . 0.0 111.67 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.02 141.17 69.75 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 119.205 0.752 . . . . 0.0 111.208 -3.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.57 115.3 27.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.046 0.938 . . . . 0.0 110.378 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 66.4 m -87.63 121.13 29.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.988 0.915 . . . . 0.0 110.359 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -120.32 115.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.662 1.585 . . . . 0.0 109.922 -168.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.92 122.22 26.41 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.963 0.505 . . . . 0.0 111.304 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 76.1 t -106.64 117.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.444 1.498 . . . . 0.0 108.93 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.1 t -105.26 174.6 5.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.176 1.39 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 133.89 -134.09 7.26 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.138 1.352 . . . . 0.0 112.694 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 124.583 1.153 . . . . 0.0 111.159 -169.133 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 121.453 0.644 . . . . 0.0 110.595 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.3 ptt? -148.4 162.66 39.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.888 1.675 . . . . 0.0 110.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 68.7 m -113.78 150.01 34.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.274 1.03 . . . . 0.0 109.845 167.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -144.88 160.26 41.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1963 ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -155.3 155.41 33.7 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.277 1.831 . . . . 0.0 110.402 -169.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1964 ' ' LYS . . . . . 0.419 ' H ' HD13 ' A' 1963 ' ' LEU . 68.4 mttm -137.92 150.62 47.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.117 1.367 . . . . 0.0 111.639 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.6 p -155.76 139.39 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.703 1.201 . . . . 0.0 110.818 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -83.08 129.06 8.84 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.813 0.72 . . . . 0.0 111.405 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 44.0 m -113.41 137.41 51.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.137 . . . . 0.0 111.403 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.47 141.58 12.07 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.267 1.027 . . . . 0.0 111.957 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.26 148.25 43.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.872 0.869 . . . . 0.0 111.215 168.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.68 139.53 30.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.144 0.977 . . . . 0.0 112.63 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 72.9 mt -121.55 123.4 27.57 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.521 1.528 . . . . 0.0 108.796 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.55 152.6 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.109 2.54 . . . . 0.0 111.889 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.09 147.23 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.382 1.473 . . . . 0.0 111.037 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 35.4 t30 56.96 77.37 0.27 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.22 1.808 . . . . 0.0 112.159 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 20.3 mm -77.99 73.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.382 1.073 . . . . 0.0 109.349 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 6.6 m -172.69 -177.54 1.71 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.818 2.847 . . . . 0.0 109.383 -169.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -59.09 121.96 12.57 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.133 -0.979 . . . . 0.0 111.256 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.3 m -139.8 142.51 36.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.265 1.826 . . . . 0.0 109.153 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 64.5 t0 -126.94 120.53 29.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.932 1.293 . . . . 0.0 110.242 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.18 -10.25 59.75 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.586 1.154 . . . . 0.0 113.922 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 11.8 t -64.91 -31.26 72.4 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.631 1.105 . . . . 0.0 113.627 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.23 9.41 11.06 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.524 1.53 . . . . 0.0 113.961 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.46 145.18 25.89 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.087 1.355 . . . . 0.0 112.178 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -141.25 163.43 32.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.783 2.033 . . . . 0.0 109.371 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.28 146.78 23.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.7 p -139.25 161.77 36.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.841 2.056 . . . . 0.0 109.993 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.7 t -117.32 138.5 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.368 1.467 . . . . 0.0 110.253 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 93.5 t -105.76 112.94 64.4 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 108.246 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.82 171.94 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.916 3.077 . . . . 0.0 111.605 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.89 -28.5 31.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.706 3.604 . . . . 0.0 115.199 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 60.4 p -81.27 -9.61 59.74 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.25 -2.0 73.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.451 1.5 . . . . 0.0 114.766 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -75.43 89.19 2.65 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.309 1.444 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.3 133.53 56.19 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.078 0.951 . . . . 0.0 111.944 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -129.16 145.83 58.3 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 110.317 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.7 151.17 31.86 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.393 2.729 . . . . 0.0 111.712 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.1 m -95.61 149.63 21.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.215 1.006 . . . . 0.0 111.736 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.25 128.66 34.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 159.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.7 mt -95.89 141.58 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 110.551 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 88.8 mttt -136.78 144.66 43.87 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.502 1.521 . . . . 0.0 111.891 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -98.1 117.68 33.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.646 1.178 . . . . 0.0 107.851 159.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.61 175.15 6.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.853 1.661 . . . . 0.0 112.597 -166.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -56.97 -35.32 69.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.471 1.509 . . . . 0.0 114.692 -166.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.51 3.88 53.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 0.0 113.211 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.81 71.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.394 1.473 . . . . 0.0 114.209 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -73.17 163.57 27.94 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.681 1.592 . . . . 0.0 113.282 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 59.8 t -108.77 144.05 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.249 1.42 . . . . 0.0 110.47 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -146.14 171.49 27.03 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.607 1.098 . . . . 0.0 115.367 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.94 152.96 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.072 1.749 . . . . 0.0 111.898 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 13.6 m -132.65 148.56 52.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.7 1.6 . . . . 0.0 110.235 168.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.8 p90 -164.58 162.01 21.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.224 1.41 . . . . 0.0 111.296 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 93.1 t -102.3 119.5 56.18 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 0.0 109.32 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 145.18 24.3 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.236 3.29 . . . . 0.0 110.586 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -108.72 0.41 20.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 113.411 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -143.15 179.59 6.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.395 2.278 . . . . 0.0 109.698 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -105.09 158.44 16.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.068 1.347 . . . . 0.0 110.452 163.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.36 -164.61 16.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.303 1.43 . . . . 0.0 113.341 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.2 111.5 8.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.354 1.062 . . . . 0.0 111.944 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.7 m80 -95.32 140.55 30.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.466 1.507 . . . . 0.0 109.428 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.58 121.56 42.63 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.99 0.916 . . . . 0.0 109.116 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 44.6 t -86.86 131.76 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.013 1.325 . . . . 0.0 108.349 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -116.4 119.24 35.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.363 1.465 . . . . 0.0 109.818 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 64.5 t -107.89 134.95 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.854 1.262 . . . . 0.0 109.196 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 80.6 mttt -119.77 149.68 41.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 113.091 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -126.41 118.21 24.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.44 2.296 . . . . 0.0 109.042 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 58.01 21.19 7.53 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.862 1.265 . . . . 0.0 114.22 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 101.52 -12.26 58.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.916 1.722 . . . . 0.0 115.79 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -99.66 160.72 14.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.508 1.654 . . . . 0.0 111.222 171.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.0 p80 -65.04 153.2 41.43 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.106 -0.996 . . . . 0.0 112.954 170.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -88.71 154.47 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.721 0.809 . . . . 0.0 110.62 168.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -61.74 -21.73 64.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 67.1 m -82.33 -15.52 52.55 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 19.9 m -84.28 153.21 62.35 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 120.813 -1.18 . . . . 0.0 113.902 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.87 153.73 86.8 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 118.387 0.459 . . . . 0.0 111.812 -5.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 123.01 39.1 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.898 1.279 . . . . 0.0 109.273 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 139.18 11.89 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.082 2.522 . . . . 0.0 111.591 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 34.5 t -135.72 120.42 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.454 1.502 . . . . 0.0 108.352 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 62.0 t -92.78 122.46 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.712 0.805 . . . . 0.0 110.271 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.89 133.29 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.014 1.326 . . . . 0.0 109.656 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 27.4 t -104.65 158.69 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.4 1.08 . . . . 0.0 111.198 169.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -59.36 -29.84 67.97 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.344 -0.847 . . . . 0.0 112.72 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -65.41 -13.73 59.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.479 1.112 . . . . 0.0 113.653 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -93.75 -8.12 41.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.631 1.172 . . . . 0.0 112.471 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.2 116.77 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.516 1.053 . . . . 0.0 110.624 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 70.9 13.35 72.23 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 157.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.52 94.12 2.57 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.642 1.721 . . . . 0.0 110.748 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.45 -36.36 71.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.753 1.221 . . . . 0.0 112.735 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.5 m -54.67 -24.72 23.07 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.515 1.526 . . . . 0.0 114.184 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -86.36 -13.76 45.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.036 1.335 . . . . 0.0 113.469 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.4 t -77.55 134.73 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.43 1.014 . . . . 0.0 110.003 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -122.16 159.74 26.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.446 1.499 . . . . 0.0 110.741 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 32.8 m -147.35 159.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.107 1.363 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.09 169.93 23.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.342 1.057 . . . . 0.0 112.437 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.38 159.25 24.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.296 1.427 . . . . 0.0 113.79 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.52 -27.84 64.49 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.502 1.121 . . . . 0.0 113.362 -169.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.09 -2.73 33.26 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.854 1.216 . . . . 0.0 115.294 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 88.6 mt -88.82 -7.08 56.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.942 1.697 . . . . 0.0 112.66 168.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -133.72 -39.81 0.88 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.996 1.318 . . . . 0.0 113.915 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -140.09 148.48 41.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.189 1.395 . . . . 0.0 111.482 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.7 178.3 28.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.619 1.104 . . . . 0.0 114.203 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.9 m80 -136.83 149.64 47.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.735 1.614 . . . . 0.0 111.655 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.1 p -71.9 -32.6 67.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.54 6.73 14.72 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -138.36 144.39 42.63 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.832 1.653 . . . . 0.0 109.462 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 140.93 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.677 2.252 . . . . 0.0 111.19 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -87.67 151.56 22.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.733 1.213 . . . . 0.0 109.976 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.14 150.01 48.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.112 0.965 . . . . 0.0 113.147 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 152.42 27.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.054 1.341 . . . . 0.0 111.333 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.6 mp -110.88 142.22 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.494 1.918 . . . . 0.0 109.823 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 47.6 mt -114.46 133.59 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.975 1.71 . . . . 0.0 109.595 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 8.6 t0 -117.42 112.03 20.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.781 2.032 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 10.1 p -120.79 -3.71 9.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.537 1.535 . . . . 0.0 113.967 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -29.11 69.76 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.144 1.338 . . . . 0.0 113.47 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.09 -18.15 53.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.669 1.187 . . . . 0.0 112.867 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.99 -5.15 56.96 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.372 1.469 . . . . 0.0 113.818 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.09 -106.15 2.75 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.93 1.252 . . . . 0.0 111.816 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -129.73 145.64 51.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.442 1.497 . . . . 0.0 112.807 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 158.22 175.63 29.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.92 0.772 . . . . 0.0 114.76 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -87.5 121.7 5.95 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.143 0.878 . . . . 0.0 111.056 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 123.29 35.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.184 1.393 . . . . 0.0 108.022 171.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 8.4 t -119.73 145.24 46.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.494 1.918 . . . . 0.0 109.791 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.0 tt -145.32 144.24 30.62 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.716 0.807 . . . . 0.0 110.846 -165.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.4 p -148.13 153.92 39.49 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.78 131.42 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.724 1.61 . . . . 0.0 108.539 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.64 153.14 49.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.723 1.609 . . . . 0.0 110.513 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 166.93 -153.45 23.12 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.096 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.5 -10.51 28.13 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.913 3.076 . . . . 0.0 114.31 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -157.39 168.0 28.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.594 1.088 . . . . 0.0 112.238 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -71.52 150.0 45.23 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.609 1.163 . . . . 0.0 111.087 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.2 m -130.59 152.11 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.565 1.146 . . . . 0.0 111.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -81.47 126.32 31.52 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.58 -0.7 . . . . 0.0 109.832 165.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.2 mt -106.78 132.67 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.191 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -129.73 155.23 46.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.367 1.867 . . . . 0.0 109.533 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.33 158.57 43.81 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.61 1.164 . . . . 0.0 111.553 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.53 128.64 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 0.0 110.94 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.63 118.64 22.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.439 1.096 . . . . 0.0 109.95 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.77 160.35 18.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.14 0.976 . . . . 0.0 111.805 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.15 -20.97 66.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.97 0.908 . . . . 0.0 113.138 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.48 -12.53 59.88 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.863 1.265 . . . . 0.0 113.361 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.45 -1.56 62.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.557 1.551 . . . . 0.0 114.836 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 15.1 p -81.6 162.27 23.17 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 111.259 170.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.2 t -108.51 123.81 49.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.925 0.89 . . . . 0.0 110.751 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 29.9 ttm105 -82.91 137.68 34.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.17 0.988 . . . . 0.0 109.342 165.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 24.3 t -120.64 137.36 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.781 1.632 . . . . 0.0 108.468 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.4 p -137.61 146.07 43.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.365 1.466 . . . . 0.0 111.56 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -160.43 150.21 17.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.534 1.134 . . . . 0.0 112.563 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.4 t -111.93 104.69 56.24 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.107 0.963 . . . . 0.0 110.886 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.67 98.82 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.496 2.798 . . . . 0.0 110.978 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -60.62 -43.96 96.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.441 1.096 . . . . 0.0 113.653 -169.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -94.15 146.15 31.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.215 1.006 . . . . 0.0 111.098 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.64 164.22 32.56 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.33 2.687 . . . . 0.0 111.254 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.17 -140.25 11.65 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.823 1.202 . . . . 0.0 112.184 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -130.15 130.95 45.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.955 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -110.97 144.27 40.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.633 1.573 . . . . 0.0 110.781 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.72 134.31 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.483 1.113 . . . . 0.0 108.868 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.5 mt -111.69 129.12 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.828 1.251 . . . . 0.0 109.08 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -107.18 125.04 50.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.352 1.461 . . . . 0.0 109.935 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.98 124.28 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.998 0.919 . . . . 0.0 109.074 173.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -131.13 135.14 47.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.429 1.492 . . . . 0.0 110.578 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.1 t80 -128.64 121.24 28.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.14 1.376 . . . . 0.0 109.845 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.43 55.84 7.76 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.417 1.487 . . . . 0.0 112.672 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 21.1 t70 79.09 -7.56 1.75 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 128.052 2.541 . . . . 0.0 114.128 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -113.64 128.71 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.8 1.24 . . . . 0.0 111.521 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -67.25 126.17 28.38 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.822 1.249 . . . . 0.0 111.045 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -77.7 154.2 81.0 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.225 -0.922 . . . . 0.0 111.295 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.88 139.49 74.43 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.612 2.208 . . . . 0.0 111.228 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 97.86 -26.84 21.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.25 1.405 . . . . 0.0 113.499 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 73.1 m -74.98 149.71 85.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.716 1.258 . . . . 0.0 111.366 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.85 139.53 62.24 Favored 'Cis proline' 0 C--N 1.351 0.705 0 CA-C-N 119.444 0.837 . . . . 0.0 111.315 -2.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -93.07 112.76 24.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.925 0.89 . . . . 0.0 110.218 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 59.3 m -87.48 118.31 26.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.316 1.047 . . . . 0.0 110.821 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 8.5 t -112.95 116.44 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.967 1.707 . . . . 0.0 109.578 -171.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.78 121.97 27.09 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.908 -0.495 . . . . 0.0 111.03 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 98.6 t -110.41 119.6 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.218 1.407 . . . . 0.0 109.534 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.9 t -97.58 154.38 17.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.631 1.173 . . . . 0.0 111.047 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -173.43 -163.34 26.89 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 126.153 1.781 . . . . 0.0 109.884 -177.484 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 21.3 tpt85 . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 27.9 ptm -78.05 151.81 33.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.776 0.831 . . . . 0.0 111.748 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 12.8 m -127.0 140.03 52.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.471 1.909 . . . . 0.0 108.146 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -143.15 160.32 40.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -166.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.93 151.04 21.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.618 1.967 . . . . 0.0 110.024 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -134.55 146.26 49.49 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.937 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 47.3 t -139.83 133.93 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.644 1.577 . . . . 0.0 109.623 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -86.01 118.05 4.75 Favored Glycine 0 N--CA 1.47 0.93 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 169.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.4 m -121.36 146.84 46.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.924 0.89 . . . . 0.0 112.458 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.85 144.04 11.5 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.173 0.989 . . . . 0.0 112.572 -170.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -70.37 157.81 37.09 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.595 1.158 . . . . 0.0 112.364 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.92 143.47 26.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.919 1.687 . . . . 0.0 112.893 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.13 118.57 18.42 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.969 1.308 . . . . 0.0 109.429 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.55 133.01 11.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.475 2.783 . . . . 0.0 111.639 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 51.2 mt -148.62 142.4 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.493 1.517 . . . . 0.0 110.624 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 57.81 57.4 4.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.072 1.749 . . . . 0.0 112.431 172.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 12.1 mm -71.99 -26.71 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.877 1.271 . . . . 0.0 112.633 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -76.92 54.63 1.03 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.13 1.772 . . . . 0.0 113.717 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -146.93 144.61 29.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.799 1.64 . . . . 0.0 110.726 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -104.09 -40.77 6.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.056 1.742 . . . . 0.0 111.133 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -90.93 108.44 19.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.765 0.826 . . . . 0.0 110.438 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.4 mt -90.37 -8.72 49.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.119 0.968 . . . . 0.0 113.101 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 9.2 t -77.03 -31.48 56.35 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.207 -0.933 . . . . 0.0 112.553 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.84 -2.43 47.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.137 1.375 . . . . 0.0 114.421 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.9 tp -101.3 135.25 43.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.463 1.105 . . . . 0.0 111.406 -170.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -138.97 168.22 20.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.013 1.725 . . . . 0.0 110.46 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -154.09 150.9 28.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.9 p -137.85 165.19 27.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.082 2.153 . . . . 0.0 110.079 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -123.73 139.85 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.852 1.661 . . . . 0.0 110.015 172.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.8 t -111.42 114.16 53.14 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.476 1.51 . . . . 0.0 108.249 166.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.67 170.33 19.33 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.948 3.098 . . . . 0.0 110.771 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.35 -16.61 55.17 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.986 2.458 . . . . 0.0 113.266 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 69.4 m -83.66 -4.18 58.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.328 1.051 . . . . 0.0 113.828 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.37 82.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.597 1.57 . . . . 0.0 115.914 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.35 86.73 3.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.4 1.48 . . . . 0.0 111.588 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.87 135.93 57.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.554 1.142 . . . . 0.0 112.302 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -142.6 151.59 57.67 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.752 1.621 . . . . 0.0 111.352 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.46 155.09 36.2 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.823 3.015 . . . . 0.0 112.23 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 94.8 m -98.1 155.32 17.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.584 1.154 . . . . 0.0 112.815 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.64 135.45 34.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 108.234 162.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.2 mt -108.02 139.06 43.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.218 1.407 . . . . 0.0 111.06 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 64.2 mttm -135.54 128.19 30.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.676 1.19 . . . . 0.0 113.113 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.6 tpt85 -75.83 125.98 30.13 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 148.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 54.8 mt -102.65 159.85 15.09 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.678 1.191 . . . . 0.0 110.76 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -57.89 -32.97 68.23 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -82.17 -1.3 48.53 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 106.39 -27.81 15.68 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.596 1.57 . . . . 0.0 113.785 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.96 169.79 12.58 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.78 1.232 . . . . 0.0 114.179 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 67.9 t -133.15 139.33 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.841 1.656 . . . . 0.0 109.342 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.43 23.32 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 116.179 1.231 . . . . 0.0 116.179 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.93 160.97 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.974 1.709 . . . . 0.0 112.288 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 68.4 m -139.98 149.75 43.63 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.575 1.95 . . . . 0.0 110.184 170.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 21.8 p90 -166.73 167.17 15.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.133 1.773 . . . . 0.0 110.647 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.9 t -116.06 113.57 41.64 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 124.041 0.936 . . . . 0.0 109.803 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.17 151.41 23.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.137 3.225 . . . . 0.0 111.324 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -98.49 -11.61 22.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.062 0.945 . . . . 0.0 113.459 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -139.09 166.72 23.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.01 1.724 . . . . 0.0 110.949 -174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.6 p -87.73 172.58 9.57 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.01 1.324 . . . . 0.0 111.333 169.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.5 -173.3 35.36 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.003 1.287 . . . . 0.0 113.773 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.31 113.48 7.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.149 0.98 . . . . 0.0 111.827 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.5 m80 -99.66 146.47 26.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.828 1.651 . . . . 0.0 109.065 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.79 125.17 50.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 109.412 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 30.1 t -88.37 136.87 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.497 1.119 . . . . 0.0 108.378 167.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -121.02 117.7 27.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.377 1.471 . . . . 0.0 109.865 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 93.9 t -106.14 138.59 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.185 1.394 . . . . 0.0 109.304 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 63.7 mttm -123.47 144.7 49.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.538 1.535 . . . . 0.0 112.646 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 69.2 tttt -118.87 116.38 26.37 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.389 2.276 . . . . 0.0 108.957 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.22 30.16 14.09 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.831 1.252 . . . . 0.0 113.572 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.77 -16.6 60.9 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.879 1.704 . . . . 0.0 115.956 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -97.78 149.99 21.73 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.482 1.641 . . . . 0.0 110.833 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 26.6 p80 -65.8 147.28 53.64 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 121.056 -1.028 . . . . 0.0 113.385 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -84.63 157.51 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.007 0.923 . . . . 0.0 111.132 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.67 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 7.0 m -70.53 -23.24 62.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.427 1.091 . . . . 0.0 113.65 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 150.34 55.22 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.41 148.56 89.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 118.681 0.565 . . . . 0.0 111.843 -4.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.72 118.81 55.47 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.423 1.089 . . . . 0.0 108.68 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.25 138.87 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.834 2.356 . . . . 0.0 111.293 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 51.6 t -134.16 121.9 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.573 1.549 . . . . 0.0 107.905 172.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.4 t -95.13 122.28 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.679 0.792 . . . . 0.0 109.944 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -95.52 129.22 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.751 1.22 . . . . 0.0 109.107 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.1 t -100.74 160.27 14.5 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.956 . . . . 0.0 111.572 172.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -59.17 -30.09 67.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.843 0.857 . . . . 0.0 112.855 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 19.5 m -67.23 -12.61 60.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.763 1.225 . . . . 0.0 113.725 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -97.16 -10.84 25.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.684 1.194 . . . . 0.0 112.779 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.281 1.032 . . . . 0.0 113.167 -170.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 161.92 45.64 0.02 OUTLIER Glycine 0 N--CA 1.469 0.897 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 27.4 t0 -78.52 95.1 5.09 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.063 0.931 . . . . 0.0 111.378 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.17 -39.58 86.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.48 -0.763 . . . . 0.0 112.487 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 29.4 m -60.47 -17.45 45.02 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.953 1.301 . . . . 0.0 113.974 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -93.39 -7.42 44.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.794 1.638 . . . . 0.0 114.487 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.2 t -75.3 137.41 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 120.302 1.41 . . . . 0.0 110.18 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -123.23 161.08 25.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 111.081 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.3 m -147.61 159.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.109 1.364 . . . . 0.0 111.86 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.89 176.05 12.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.097 1.359 . . . . 0.0 112.257 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.03 -165.1 14.3 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 125.553 1.549 . . . . 0.0 114.202 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -97.9 -38.24 9.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.349 1.06 . . . . 0.0 112.615 -172.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -74.08 3.02 40.38 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.489 1.042 . . . . 0.0 115.428 -167.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 98.4 mt -96.1 0.51 51.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.218 1.407 . . . . 0.0 112.412 166.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.73 -42.53 1.13 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.521 1.528 . . . . 0.0 113.471 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -158.77 154.91 27.0 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.49 -171.07 19.68 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.569 1.557 . . . . 0.0 114.017 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.5 m80 -141.27 146.4 36.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.148 1.379 . . . . 0.0 112.219 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 40.1 p -70.55 -21.46 62.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -115.86 -0.56 12.82 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -142.93 142.06 21.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.28 1.432 . . . . 0.0 110.177 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.62 149.4 55.14 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.937 2.424 . . . . 0.0 111.695 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.68 146.34 27.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.852 1.261 . . . . 0.0 110.562 172.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.73 146.47 48.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 112.628 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.5 p90 -152.48 148.58 27.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.403 1.481 . . . . 0.0 110.864 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.59 141.53 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.676 1.59 . . . . 0.0 109.207 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.6 mt -114.95 136.16 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.149 1.779 . . . . 0.0 108.744 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 60.2 t0 -124.52 108.18 11.83 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.152 1.781 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 58.0 p -101.62 0.66 36.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.848 1.659 . . . . 0.0 113.058 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.84 -37.13 80.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.51 1.05 . . . . 0.0 112.521 -172.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.68 -14.14 59.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 113.114 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -94.71 -4.61 47.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.169 1.788 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.71 -99.73 2.22 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.014 1.292 . . . . 0.0 111.947 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -142.21 152.38 43.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.127 1.371 . . . . 0.0 112.286 -165.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.83 179.26 26.44 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -88.19 122.33 6.27 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.39 0.995 . . . . 0.0 111.81 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.4 121.49 35.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.301 1.84 . . . . 0.0 108.334 171.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 15.0 m -113.34 143.25 44.78 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.827 1.251 . . . . 0.0 110.782 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -139.29 133.26 30.98 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 110.343 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.4 m -136.85 127.61 27.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.537 0.735 . . . . 0.0 111.452 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 25.9 mt -104.6 136.8 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.7 1.6 . . . . 0.0 108.948 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -132.79 151.49 51.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.21 1.804 . . . . 0.0 109.293 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.18 -160.31 33.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.194 -0.941 . . . . 0.0 114.59 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.0 -12.04 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 124.125 3.217 . . . . 0.0 114.474 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.5 t -159.48 168.35 26.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.666 1.187 . . . . 0.0 111.687 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -66.35 151.84 46.26 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -131.4 154.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.856 1.262 . . . . 0.0 111.18 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.88 138.22 32.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.694 0.398 . . . . 0.0 110.272 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 44.3 mt -121.4 135.83 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 109.163 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -132.37 154.61 49.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.208 1.803 . . . . 0.0 109.803 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 31.4 p -139.8 152.44 46.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.692 1.197 . . . . 0.0 111.664 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -152.72 106.98 3.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.35 134.43 35.26 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.919 1.288 . . . . 0.0 111.137 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 79.2 mt -110.22 162.28 14.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.481 1.112 . . . . 0.0 113.451 -163.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -70.65 -13.28 62.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.024 1.33 . . . . 0.0 113.159 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.72 -8.09 59.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.433 1.093 . . . . 0.0 112.795 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.09 1.2 73.0 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.349 1.452 . . . . 0.0 114.696 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 49.0 p -93.81 172.42 8.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.364 1.866 . . . . 0.0 111.191 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 47.0 t -129.02 126.63 39.92 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.096 0.958 . . . . 0.0 111.47 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.23 136.29 36.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.366 1.067 . . . . 0.0 109.613 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.4 t -115.25 138.43 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 108.083 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.6 p -134.19 147.0 50.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.177 1.391 . . . . 0.0 110.871 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 6.9 p90 -151.58 152.49 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.006 0.922 . . . . 0.0 112.096 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 8.2 t -123.78 113.23 28.69 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.892 0.877 . . . . 0.0 111.195 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.95 175.54 9.15 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.029 3.153 . . . . 0.0 111.284 174.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 99.5 m -129.25 -46.22 1.22 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.39 1.076 . . . . 0.0 111.91 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -85.92 144.65 39.57 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.919 0.888 . . . . 0.0 110.637 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.16 160.41 33.02 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.092 2.528 . . . . 0.0 110.989 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 132.22 -162.9 24.0 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 125.196 1.379 . . . . 0.0 113.703 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -90.85 121.49 32.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.639 0.776 . . . . 0.0 111.426 176.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -98.98 143.41 29.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.872 1.269 . . . . 0.0 110.854 165.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.34 132.84 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.799 1.639 . . . . 0.0 108.031 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.61 124.58 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.3 1.04 . . . . 0.0 109.82 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -101.35 128.34 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.181 1.792 . . . . 0.0 109.91 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.1 mm -120.67 115.5 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.919 1.287 . . . . 0.0 109.814 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.08 135.37 54.37 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.642 1.577 . . . . 0.0 110.989 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 63.1 t80 -129.69 125.83 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.287 1.435 . . . . 0.0 110.127 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 34.57 18.04 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.165 1.386 . . . . 0.0 113.53 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.252 63.4 m-20 74.05 21.23 2.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.035 2.534 . . . . 0.0 114.176 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -125.38 137.38 54.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.899 1.28 . . . . 0.0 110.972 169.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.3 t60 -68.45 129.75 40.85 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.487 1.115 . . . . 0.0 110.882 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.8 m -77.46 155.23 81.6 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 111.2 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 141.05 75.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.61 2.207 . . . . 0.0 111.432 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 90.37 -24.01 18.89 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.177 1.37 . . . . 0.0 113.608 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 22.5 t -76.99 144.62 72.45 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.276 1.038 . . . . 0.0 111.133 173.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.48 149.57 89.16 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.876 0.992 . . . . 0.0 112.139 -2.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -102.0 127.72 48.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.076 1.351 . . . . 0.0 110.996 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 37.6 m -89.75 135.12 33.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.03 171.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.0 t -132.88 112.52 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.54 1.536 . . . . 0.0 109.556 -168.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.55 108.99 13.51 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.784 -0.572 . . . . 0.0 111.29 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.8 t -95.28 118.18 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 0.0 108.772 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -97.31 152.52 18.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.179 0.992 . . . . 0.0 111.106 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 162.84 -158.28 30.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 126.674 1.989 . . . . 0.0 110.983 -174.266 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.142 0.496 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.9 ptm -146.48 156.04 42.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.0 m -136.72 144.5 43.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.943 2.097 . . . . 0.0 108.581 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -147.83 157.92 43.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -159.77 141.02 12.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.223 1.809 . . . . 0.0 110.107 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 65.8 mttp -125.86 148.05 49.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.509 1.124 . . . . 0.0 112.215 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 23.7 t -133.88 134.46 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.611 1.564 . . . . 0.0 109.895 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.76 54.78 4.85 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.264 1.411 . . . . 0.0 112.882 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 18.9 m -61.98 147.94 45.41 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.57 1.548 . . . . 0.0 114.276 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -168.36 156.62 8.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.846 1.658 . . . . 0.0 111.816 -175.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -81.11 148.61 29.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.149 0.98 . . . . 0.0 111.61 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -93.3 148.76 21.76 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.907 1.283 . . . . 0.0 113.038 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 61.1 mt -133.72 126.74 19.11 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.339 1.456 . . . . 0.0 109.221 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.36 140.14 26.99 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.107 2.538 . . . . 0.0 111.104 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -139.71 135.56 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.96 1.304 . . . . 0.0 110.361 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.8 t30 39.63 69.54 0.29 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.085 2.154 . . . . 0.0 114.016 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.35 120.19 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.092 0.957 . . . . 0.0 111.261 -167.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 4.9 m -172.2 156.76 4.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.124 2.169 . . . . 0.0 110.058 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -86.47 72.11 10.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.162 0.985 . . . . 0.0 110.489 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 35.0 p -97.98 156.63 16.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.989 1.716 . . . . 0.0 111.777 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -91.84 117.79 30.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.466 1.106 . . . . 0.0 110.611 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.52 -9.07 46.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.537 1.135 . . . . 0.0 113.173 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 15.6 m -74.99 -19.33 60.14 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.672 1.189 . . . . 0.0 113.739 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.2 pp -130.25 5.37 4.84 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.514 1.525 . . . . 0.0 113.899 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.33 126.36 54.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.211 2.204 . . . . 0.0 107.768 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -130.85 148.6 52.64 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.244 1.418 . . . . 0.0 110.184 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -138.71 150.16 45.86 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 112.715 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.0 p -140.47 159.84 41.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.606 1.963 . . . . 0.0 109.951 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 3.9 t -114.62 135.54 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.546 1.138 . . . . 0.0 109.598 169.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.7 t -108.39 114.37 59.33 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.066 1.347 . . . . 0.0 108.498 167.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.77 173.11 13.3 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 124.151 3.234 . . . . 0.0 111.269 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.28 -29.11 45.71 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.016 3.144 . . . . 0.0 114.895 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 30.3 p -83.92 -5.57 59.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.219 1.408 . . . . 0.0 114.464 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 80.95 3.02 90.67 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.969 1.271 . . . . 0.0 114.52 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -74.04 77.51 1.71 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.533 1.933 . . . . 0.0 111.706 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.78 133.08 55.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.203 1.001 . . . . 0.0 112.127 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.72 150.03 61.57 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.249 1.42 . . . . 0.0 110.957 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.51 152.63 34.1 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.698 2.932 . . . . 0.0 112.412 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.9 m -91.61 155.12 18.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.484 1.114 . . . . 0.0 111.794 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 65.5 tp -77.82 140.46 39.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 152.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.3 mt -108.3 142.35 38.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.768 1.227 . . . . 0.0 110.347 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -136.89 138.84 41.13 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.919 1.287 . . . . 0.0 112.379 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -80.39 123.73 28.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 151.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.2 mt -96.27 164.25 12.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.234 1.413 . . . . 0.0 111.399 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -63.9 -18.23 63.99 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.15 2.8 56.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.994 0.917 . . . . 0.0 113.198 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.97 -9.03 73.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.028 1.775 . . . . 0.0 114.594 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -80.79 170.37 16.38 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.899 1.68 . . . . 0.0 113.416 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.2 t -115.19 141.73 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.314 1.446 . . . . 0.0 110.483 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -149.35 174.1 29.01 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.44 157.64 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.174 1.79 . . . . 0.0 111.318 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.8 m -137.79 146.59 43.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.565 1.546 . . . . 0.0 109.795 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 4.2 p90 -166.21 171.17 12.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 111.103 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 88.3 t -119.08 121.36 30.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.089 0.955 . . . . 0.0 109.607 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.27 143.22 17.37 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.019 3.146 . . . . 0.0 110.969 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -84.64 -21.67 30.19 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.89 0.876 . . . . 0.0 112.227 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -142.27 172.2 13.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.522 1.929 . . . . 0.0 110.704 -168.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.7 p -91.99 169.94 10.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.911 1.285 . . . . 0.0 111.454 171.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.42 -173.41 23.0 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.374 1.464 . . . . 0.0 113.915 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.82 109.5 6.45 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.32 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 14.5 m80 -95.62 140.55 30.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.231 1.412 . . . . 0.0 109.387 170.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.21 122.91 45.11 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.37 1.068 . . . . 0.0 109.075 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 96.4 t -86.66 118.42 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -101.18 149.42 24.0 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 125.228 1.411 . . . . 0.0 110.567 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.7 p -160.37 126.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 122.167 0.984 . . . . 0.0 111.398 -170.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -128.22 129.43 46.41 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.399 1.879 . . . . 0.0 111.599 -164.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 60.7 tttm -109.93 132.83 53.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.335 1.454 . . . . 0.0 110.223 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.51 -96.69 0.07 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.012 1.325 . . . . 0.0 111.474 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -122.47 10.78 9.15 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.497 1.523 . . . . 0.0 115.533 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -145.93 149.79 34.86 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.091 1.945 . . . . 0.0 113.78 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.29 157.43 37.73 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.653 0.781 . . . . 0.0 112.421 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.6 m -84.86 163.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.84 0.856 . . . . 0.0 111.539 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.2 69.12 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 29.9 m -86.29 -14.63 43.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.966 1.307 . . . . 0.0 114.367 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.3 p -93.03 153.61 41.78 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.869 -1.145 . . . . 0.0 113.478 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.32 150.75 96.04 Favored 'Cis proline' 0 C--N 1.354 0.826 0 CA-C-N 119.125 0.723 . . . . 0.0 112.597 -1.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.86 121.64 50.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.825 1.25 . . . . 0.0 108.469 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.1 138.07 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.854 2.369 . . . . 0.0 111.139 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.3 t -133.99 122.56 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.59 1.556 . . . . 0.0 107.884 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -94.11 122.2 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.489 0.716 . . . . 0.0 110.067 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.91 137.43 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.128 1.371 . . . . 0.0 109.239 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 14.4 t -122.86 161.58 23.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.114 . . . . 0.0 110.896 170.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -61.17 -26.81 67.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.143 0.977 . . . . 0.0 113.602 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 23.8 p -67.53 -15.29 63.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.542 1.137 . . . . 0.0 113.923 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.42 -9.33 47.92 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.627 1.171 . . . . 0.0 112.596 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.77 110.13 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.328 0.967 . . . . 0.0 110.91 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 72.56 11.83 77.14 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 117.274 1.669 . . . . 0.0 117.274 156.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -75.04 91.72 2.56 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.454 1.627 . . . . 0.0 111.212 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.09 67.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.495 1.118 . . . . 0.0 112.38 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.2 m -54.03 -25.49 21.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.952 1.701 . . . . 0.0 114.148 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -88.31 -12.12 44.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.014 1.326 . . . . 0.0 113.619 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 68.4 t -74.33 134.75 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.592 1.087 . . . . 0.0 110.105 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -116.63 158.65 23.39 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.452 1.501 . . . . 0.0 110.876 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 34.8 m -146.61 159.07 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.428 1.491 . . . . 0.0 110.667 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -158.99 168.57 26.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.416 1.086 . . . . 0.0 112.336 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.43 159.32 23.03 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.189 1.376 . . . . 0.0 114.205 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -70.63 -26.71 63.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.112 1.365 . . . . 0.0 113.614 -168.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.97 -4.46 48.52 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.593 1.092 . . . . 0.0 115.063 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.4 -2.77 57.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.162 1.385 . . . . 0.0 112.715 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -128.84 -38.05 1.69 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.951 1.3 . . . . 0.0 113.794 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.75 161.61 39.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.094 0.958 . . . . 0.0 113.177 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.33 -174.24 24.98 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.905 1.241 . . . . 0.0 114.11 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -138.94 144.83 39.19 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.154 1.382 . . . . 0.0 112.105 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 38.6 p -70.51 -18.63 62.96 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.42 -2.14 12.12 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -143.94 144.69 27.52 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.363 1.465 . . . . 0.0 110.178 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.62 150.09 50.3 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.218 . . . . 0.0 111.656 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -98.25 154.09 18.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.42 1.488 . . . . 0.0 110.73 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -134.39 150.94 50.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.808 0.843 . . . . 0.0 112.691 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -157.06 149.84 23.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 110.837 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 140.69 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.842 1.657 . . . . 0.0 109.288 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 43.4 mt -111.68 135.8 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.761 . . . . 0.0 109.032 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 66.5 t0 -125.04 98.37 5.65 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.989 1.715 . . . . 0.0 110.536 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.3 p -94.24 1.0 56.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.316 1.847 . . . . 0.0 113.023 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -61.16 -34.81 75.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.343 0.974 . . . . 0.0 112.851 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.77 -18.24 51.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.522 1.129 . . . . 0.0 113.133 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -88.31 -14.84 37.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.147 1.379 . . . . 0.0 114.014 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.02 -113.17 3.58 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.509 1.052 . . . . 0.0 111.727 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -107.49 144.01 35.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.157 1.383 . . . . 0.0 113.067 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 143.38 144.01 4.2 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.819 1.199 . . . . 0.0 112.982 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -73.65 142.13 30.63 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.632 0.634 . . . . 0.0 112.772 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 127.09 42.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.578 1.551 . . . . 0.0 108.736 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 43.7 t -120.3 135.96 54.84 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.667 1.587 . . . . 0.0 109.506 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -139.58 136.11 34.08 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.288 1.035 . . . . 0.0 110.873 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.7 m -139.83 130.55 25.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 111.398 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 26.5 mt -109.86 136.79 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.463 1.505 . . . . 0.0 108.442 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.5 155.81 42.8 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.162 0.985 . . . . 0.0 111.605 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.39 -146.44 12.56 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.024 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.95 -15.24 36.31 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.897 3.065 . . . . 0.0 114.588 -172.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.9 t -160.44 170.81 20.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.527 1.131 . . . . 0.0 111.669 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -71.99 155.27 40.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.195 0.998 . . . . 0.0 111.589 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.99 162.68 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.3 1.44 . . . . 0.0 110.946 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.49 131.61 36.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.697 0.799 . . . . 0.0 110.146 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.5 mt -111.1 132.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.188 0.995 . . . . 0.0 109.369 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -130.4 155.55 46.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.32 1.848 . . . . 0.0 109.624 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 29.6 p -142.05 160.19 40.72 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.396 1.078 . . . . 0.0 112.315 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -152.55 107.59 3.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.586 1.554 . . . . 0.0 109.347 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.19 129.94 34.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.768 1.227 . . . . 0.0 110.644 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.7 155.99 19.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.711 1.204 . . . . 0.0 112.436 -167.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.12 -18.27 64.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.487 1.115 . . . . 0.0 112.949 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.39 -11.07 60.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.77 -2.88 73.56 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.096 1.808 . . . . 0.0 114.395 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 61.7 p -90.41 174.63 7.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.546 1.938 . . . . 0.0 111.002 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -136.14 128.83 30.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.538 0.735 . . . . 0.0 111.702 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.5 138.03 36.51 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.765 1.226 . . . . 0.0 109.924 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 22.1 t -116.84 138.83 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.656 1.982 . . . . 0.0 108.223 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -137.46 144.02 42.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.345 1.458 . . . . 0.0 111.258 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 8.1 p90 -157.34 151.96 25.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.304 1.042 . . . . 0.0 112.384 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 10.6 t -117.82 108.61 42.49 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.791 0.836 . . . . 0.0 111.213 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.25 152.42 35.04 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.202 2.601 . . . . 0.0 110.527 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 85.2 m -112.69 -37.97 4.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.923 0.889 . . . . 0.0 112.582 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -96.08 148.12 34.03 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 110.733 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 161.23 36.1 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.027 2.485 . . . . 0.0 111.05 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.71 -159.86 18.3 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.109 1.337 . . . . 0.0 113.563 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.7 t30 -95.74 120.01 35.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.052 0.941 . . . . 0.0 111.765 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -98.79 144.9 27.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.775 1.23 . . . . 0.0 110.873 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.22 136.69 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.273 1.429 . . . . 0.0 108.701 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.6 126.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.129 1.372 . . . . 0.0 109.295 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -102.14 131.29 48.74 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.17 1.788 . . . . 0.0 110.297 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.5 mm -123.54 114.2 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.869 1.267 . . . . 0.0 109.592 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -119.71 134.06 55.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.966 1.706 . . . . 0.0 110.908 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -126.36 124.42 40.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.162 1.385 . . . . 0.0 109.737 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.71 36.21 23.2 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.1 1.36 . . . . 0.0 114.035 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 20.9 t70 95.71 -11.2 0.09 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 130.242 3.417 . . . . 0.0 113.611 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -112.72 134.91 54.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.039 . . . . 0.0 112.591 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.5 t60 -63.4 128.77 37.35 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.884 1.274 . . . . 0.0 110.822 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 10.3 m -72.94 156.2 89.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-N 119.551 1.068 . . . . 0.0 111.549 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.07 -35.39 90.27 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.792 2.995 . . . . 0.0 116.393 -170.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.55 75.96 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.567 0.622 . . . . 0.0 114.561 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 36.1 t -82.82 146.42 52.48 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.056 1.342 . . . . 0.0 111.442 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.66 152.68 93.29 Favored 'Cis proline' 0 C--N 1.351 0.697 0 CA-C-N 119.815 0.97 . . . . 0.0 112.453 -1.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.38 126.34 51.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 13.9 p -90.01 137.14 32.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.523 1.129 . . . . 0.0 111.35 171.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 21.2 t -133.46 112.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 -168.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -80.72 107.99 13.99 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.529 0.731 . . . . 0.0 111.253 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 92.3 t -94.32 120.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.59 1.156 . . . . 0.0 109.261 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.3 t -97.96 154.14 17.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -171.14 -171.12 36.06 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 29.4 tt0 . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 129.804 3.242 . . . . 0.0 110.867 -178.49 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 120.415 0.15 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 95.7 mtp -122.75 139.23 54.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.632 1.573 . . . . 0.0 111.401 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.1 m -130.11 141.56 50.68 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.29 1.836 . . . . 0.0 108.871 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.1 t60 -140.78 150.69 43.67 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -166.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.47 140.56 20.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.07 1.748 . . . . 0.0 109.641 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.42 144.39 49.49 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.635 1.174 . . . . 0.0 111.282 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.2 p -155.25 141.65 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.093 0.957 . . . . 0.0 111.399 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -75.89 150.81 39.96 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.007 0.813 . . . . 0.0 112.331 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 33.0 m -131.94 127.64 36.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.794 0.837 . . . . 0.0 111.603 -171.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.68 147.24 18.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.633 0.773 . . . . 0.0 112.677 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -82.17 138.25 34.76 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.727 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.49 143.51 33.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.226 1.01 . . . . 0.0 112.178 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.75 125.67 23.08 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.543 1.137 . . . . 0.0 108.97 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.58 140.77 24.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.046 2.498 . . . . 0.0 111.158 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 35.3 mm -137.74 139.17 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.291 1.836 . . . . 0.0 109.065 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.84 46.69 19.32 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 0.0 112.707 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.93 -29.33 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.28 1.832 . . . . 0.0 113.974 -165.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -64.62 -18.41 64.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.28 161.69 37.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.277 1.431 . . . . 0.0 111.952 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.0 m -122.11 121.85 37.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.858 1.263 . . . . 0.0 109.759 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -158.74 128.8 5.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.492 1.517 . . . . 0.0 110.0 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.6 mt -116.06 -3.55 12.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.616 1.566 . . . . 0.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 51.6 m -94.96 -29.17 14.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.051 . . . . 0.0 113.313 -168.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 1.74 12.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.118 1.367 . . . . 0.0 114.442 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.2 tp -91.01 137.21 32.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.924 0.784 . . . . 0.0 111.735 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 33.9 p -141.42 140.03 33.56 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.099 1.759 . . . . 0.0 109.392 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.16 149.93 45.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.866 0.866 . . . . 0.0 113.185 -173.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 77.4 p -138.21 162.63 33.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.075 2.15 . . . . 0.0 109.87 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -118.27 136.44 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.966 1.306 . . . . 0.0 109.791 168.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.8 t -105.28 113.83 64.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.137 1.375 . . . . 0.0 108.27 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.53 172.3 11.5 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.97 3.113 . . . . 0.0 111.737 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.51 -29.14 38.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.85 3.7 . . . . 0.0 114.848 170.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 57.3 p -81.32 -8.29 59.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.796 1.238 . . . . 0.0 114.164 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.5 -0.2 81.78 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.421 1.486 . . . . 0.0 114.815 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -76.58 83.05 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.38 1.472 . . . . 0.0 111.532 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.44 135.77 57.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.727 1.211 . . . . 0.0 112.148 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.79 151.69 66.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.477 1.511 . . . . 0.0 111.323 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.57 152.38 43.01 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.844 3.03 . . . . 0.0 112.392 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 77.9 m -98.3 154.78 17.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.92 1.288 . . . . 0.0 112.179 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.17 116.43 26.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.534 1.134 . . . . 0.0 108.17 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.21 135.78 33.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.604 1.161 . . . . 0.0 111.469 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.37 147.64 52.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.602 1.561 . . . . 0.0 112.413 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -92.6 115.68 28.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.0 mt -90.22 171.5 9.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.612 0.765 . . . . 0.0 112.729 -170.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -59.83 -34.2 72.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 113.814 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 53.7 t30 -80.41 -11.91 59.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.463 1.105 . . . . 0.0 113.814 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 103.81 -14.88 52.86 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.653 1.597 . . . . 0.0 114.525 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 159.87 32.63 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 118.266 1.033 . . . . 0.0 113.183 172.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.7 t -85.06 150.55 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.831 1.252 . . . . 0.0 109.056 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.56 174.53 30.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.109 0.862 . . . . 0.0 114.987 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.43 162.46 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.213 1.805 . . . . 0.0 112.072 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 74.1 m -144.4 150.25 37.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.423 1.889 . . . . 0.0 110.41 166.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.21 178.44 8.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.485 1.914 . . . . 0.0 110.763 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 67.9 t -130.58 123.35 20.27 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.155 0.982 . . . . 0.0 109.93 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.71 148.89 23.1 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.787 3.658 . . . . 0.0 112.075 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 mptt -106.84 -9.76 16.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.516 1.126 . . . . 0.0 113.48 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.76 172.03 13.37 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.664 1.986 . . . . 0.0 110.329 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 32.9 p -96.02 154.38 17.27 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.619 1.168 . . . . 0.0 110.903 167.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 104.31 -165.76 15.08 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.168 1.366 . . . . 0.0 113.931 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.84 114.3 10.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.36 1.064 . . . . 0.0 112.213 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 18.9 m80 -95.77 143.26 27.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.644 1.578 . . . . 0.0 109.07 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -107.37 123.3 48.17 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.053 0.941 . . . . 0.0 108.908 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 93.4 t -83.65 121.23 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 166.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.81 138.56 40.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.153 . . . . 0.0 110.095 170.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -146.42 133.68 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.086 0.946 . . . . 0.0 112.503 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.88 139.69 50.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.893 2.077 . . . . 0.0 111.602 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.87 109.37 20.45 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.422 2.689 . . . . 0.0 108.413 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 54.18 -103.74 0.19 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.925 1.29 . . . . 0.0 111.457 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.03 6.38 34.79 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.871 1.701 . . . . 0.0 115.514 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -129.22 148.72 51.18 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.287 1.543 . . . . 0.0 111.638 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 29.8 p80 -66.01 147.14 53.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.62 -1.3 . . . . 0.0 112.101 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.0 t -72.72 144.85 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.32 -24.73 60.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 54.5 p -84.27 -12.45 54.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.113 1.365 . . . . 0.0 114.075 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 9.6 t -80.01 140.05 53.62 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 120.871 -1.143 . . . . 0.0 112.62 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.27 152.49 83.99 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 119.536 0.87 . . . . 0.0 112.498 -5.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.77 122.58 45.42 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.336 1.454 . . . . 0.0 108.739 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.29 143.09 12.35 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.08 2.52 . . . . 0.0 111.777 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.4 t -139.32 117.45 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.422 1.489 . . . . 0.0 108.486 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 51.3 t -94.85 122.86 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.61 0.764 . . . . 0.0 110.174 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.73 129.43 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.11 1.364 . . . . 0.0 110.364 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 73.3 m -94.77 159.72 14.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.234 1.414 . . . . 0.0 112.102 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -59.25 -26.95 65.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.182 -0.948 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.9 p -65.43 -18.92 65.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.528 1.531 . . . . 0.0 114.18 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.39 -4.87 28.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.241 1.416 . . . . 0.0 112.95 -175.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.1 mm -73.64 -34.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.289 1.036 . . . . 0.0 112.602 -173.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 154.34 45.61 0.02 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.853 0.74 . . . . 0.0 114.388 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.52 100.74 10.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.459 1.129 . . . . 0.0 110.858 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.82 -35.96 69.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.988 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 13.1 t -54.19 -29.08 44.59 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.899 1.279 . . . . 0.0 113.31 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -85.79 -9.85 56.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.728 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 63.3 t -76.94 129.96 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.546 1.066 . . . . 0.0 109.594 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -109.08 155.42 20.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.467 1.507 . . . . 0.0 110.867 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.2 m -145.24 148.62 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.992 1.317 . . . . 0.0 110.938 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.6 m -151.62 157.09 41.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.853 1.261 . . . . 0.0 112.14 -175.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 119.03 161.34 11.66 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.496 1.046 . . . . 0.0 114.953 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -64.74 -33.06 75.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.782 1.633 . . . . 0.0 113.225 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.24 -3.58 46.6 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.783 1.182 . . . . 0.0 115.013 -176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.86 -7.6 57.0 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.242 1.417 . . . . 0.0 112.745 168.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -128.1 -36.9 1.92 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 113.942 -173.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -156.75 157.23 34.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.351 1.06 . . . . 0.0 112.911 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.26 -175.04 25.85 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.564 1.078 . . . . 0.0 114.346 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 62.6 m80 -139.58 142.07 37.14 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.143 1.377 . . . . 0.0 112.128 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 55.8 p -73.2 -14.81 61.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -115.29 -2.89 12.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -145.0 145.35 26.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.562 1.545 . . . . 0.0 110.195 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.49 143.0 50.7 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.543 2.162 . . . . 0.0 111.26 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -96.5 163.03 13.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.253 1.421 . . . . 0.0 110.452 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.46 159.41 44.5 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.82 153.52 24.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.379 1.872 . . . . 0.0 110.222 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.73 140.03 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 109.282 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.31 134.3 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.012 1.725 . . . . 0.0 108.421 168.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.3 t0 -120.0 101.19 7.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.183 1.793 . . . . 0.0 110.102 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.4 p -94.89 0.57 54.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.327 1.851 . . . . 0.0 113.129 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -60.4 -36.12 77.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.443 1.019 . . . . 0.0 113.203 -170.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.99 -17.51 52.7 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.266 1.026 . . . . 0.0 113.214 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.77 -6.67 55.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.552 1.541 . . . . 0.0 113.731 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 78.79 -111.97 3.36 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.166 1.365 . . . . 0.0 112.641 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -115.75 164.81 13.83 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.195 1.798 . . . . 0.0 112.388 -172.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.74 -134.81 5.3 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.523 1.059 . . . . 0.0 113.041 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -155.88 140.56 7.36 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.479 1.038 . . . . 0.0 112.435 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.48 121.45 41.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.357 1.863 . . . . 0.0 109.591 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.7 m -107.81 140.11 41.39 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.241 1.817 . . . . 0.0 109.872 167.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -142.28 137.96 31.01 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.072 0.949 . . . . 0.0 110.045 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 86.5 p -135.17 148.62 49.76 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.557 0.694 . . . . 0.0 111.873 169.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.2 mt -122.91 125.74 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -119.46 145.61 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.314 1.446 . . . . 0.0 109.274 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 174.92 -163.79 34.21 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.92 -2.41 11.46 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.714 3.609 . . . . 0.0 114.225 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -160.53 165.61 30.55 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.949 1.3 . . . . 0.0 111.351 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -71.3 143.0 50.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.277 1.031 . . . . 0.0 110.905 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 7.6 m -121.32 150.23 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.315 1.446 . . . . 0.0 110.693 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.91 110.94 22.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.692 0.797 . . . . 0.0 109.985 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.56 134.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 109.913 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.7 164.3 27.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.551 1.94 . . . . 0.0 110.897 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 14.6 p -138.16 155.26 48.89 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.609 1.564 . . . . 0.0 112.039 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.29 130.61 12.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.719 1.208 . . . . 0.0 110.728 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.6 t70 -85.64 125.37 33.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.793 1.237 . . . . 0.0 110.602 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.05 152.46 18.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.217 1.007 . . . . 0.0 111.835 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.09 -12.57 61.8 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.517 1.127 . . . . 0.0 113.678 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.38 -6.26 59.41 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.83 1.252 . . . . 0.0 113.009 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.2 5.22 59.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.639 1.59 . . . . 0.0 114.856 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 37.2 p -98.46 166.41 11.37 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.456 1.902 . . . . 0.0 111.661 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.3 t -116.35 124.79 50.97 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.274 1.029 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -88.3 133.55 34.04 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.107 1.363 . . . . 0.0 109.623 170.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 60.6 t -111.89 137.29 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.259 1.424 . . . . 0.0 108.741 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.5 p -126.71 146.05 50.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.555 1.942 . . . . 0.0 110.15 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.1 p90 -160.9 149.58 16.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.264 1.026 . . . . 0.0 112.043 175.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.1 t -118.08 113.25 37.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.789 0.836 . . . . 0.0 110.995 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.47 166.75 25.46 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.67 2.914 . . . . 0.0 110.787 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.1 m -129.99 -43.44 1.21 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 0.0 112.551 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -87.89 144.46 34.89 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 123.684 0.793 . . . . 0.0 109.812 168.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.97 164.02 27.81 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.27 2.647 . . . . 0.0 111.319 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 129.53 -160.79 22.76 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.223 1.392 . . . . 0.0 113.679 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -88.73 124.53 34.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.323 0.649 . . . . 0.0 111.305 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -106.05 140.81 38.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.732 1.213 . . . . 0.0 109.884 166.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.9 mp -107.21 127.41 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.955 1.302 . . . . 0.0 108.264 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 14.4 mt -110.86 128.48 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.239 1.016 . . . . 0.0 109.786 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -108.94 125.79 52.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.855 1.262 . . . . 0.0 110.106 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -111.31 121.76 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 173.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 3.6 tmmt? -133.21 127.33 33.54 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.874 1.269 . . . . 0.0 110.982 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -125.6 127.75 46.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.064 1.346 . . . . 0.0 110.651 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 48.95 48.38 20.67 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.705 1.202 . . . . 0.0 112.92 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t70 79.99 -2.2 2.03 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.45 2.7 . . . . 0.0 114.145 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -121.51 127.58 51.16 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.812 -168.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -66.34 125.97 27.31 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.832 1.253 . . . . 0.0 111.297 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.6 m -82.5 159.05 65.06 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.227 -0.92 . . . . 0.0 111.72 -169.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.88 143.08 73.37 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.756 2.971 . . . . 0.0 113.526 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.96 -23.08 19.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.852 1.215 . . . . 0.0 114.232 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 70.7 m -73.44 151.73 89.69 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 118.65 1.225 . . . . 0.0 111.696 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.06 141.67 72.46 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.192 0.747 . . . . 0.0 111.408 -6.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -94.57 117.47 30.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.079 0.951 . . . . 0.0 110.339 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 16.7 m -82.98 129.06 34.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.32 0.648 . . . . 0.0 110.859 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.9 t -123.24 114.58 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.147 1.779 . . . . 0.0 109.172 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.54 105.5 10.89 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.002 0.521 . . . . 0.0 110.969 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 82.9 t -93.13 118.47 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.384 1.074 . . . . 0.0 109.042 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 156.53 16.3 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.388 1.075 . . . . 0.0 110.406 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 174.04 -157.92 26.28 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 N--CA 1.477 0.904 0 C-N-CA 129.195 2.998 . . . . 0.0 112.942 174.142 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 26.9 ptm -61.77 154.56 25.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.694 1.197 . . . . 0.0 113.137 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.8 m -121.52 145.79 47.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.598 1.559 . . . . 0.0 109.069 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -155.76 160.22 40.12 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.1 tt -163.05 155.13 18.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.766 2.026 . . . . 0.0 110.836 -172.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 68.4 mttm -130.25 151.85 50.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 112.766 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.8 t -138.46 131.14 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.651 1.58 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.2 77.35 1.86 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.687 1.136 . . . . 0.0 111.41 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 60.4 m -75.76 152.64 37.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.44 150.19 14.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.907 1.283 . . . . 0.0 112.849 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.39 160.96 25.21 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.755 1.222 . . . . 0.0 111.842 167.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.87 141.33 28.76 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.404 1.482 . . . . 0.0 112.66 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 37.4 mm -123.13 115.69 28.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.257 1.423 . . . . 0.0 108.887 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.7 132.39 11.99 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.35 2.7 . . . . 0.0 111.358 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 33.9 mt -148.39 143.13 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.841 1.656 . . . . 0.0 110.411 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 57.58 51.25 9.82 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.929 1.692 . . . . 0.0 112.478 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.39 -30.25 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.695 1.598 . . . . 0.0 112.614 -170.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 19.5 m -72.25 -15.31 61.92 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -81.77 141.0 33.9 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.208 0.913 . . . . 0.0 112.033 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -115.35 -34.32 4.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.106 1.762 . . . . 0.0 111.448 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.87 60.42 6.23 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.698 1.199 . . . . 0.0 111.815 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.43 -26.08 67.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.89 1.676 . . . . 0.0 112.42 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 20.5 m -59.49 -23.59 62.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.74 2.61 25.83 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.4 mp -84.47 145.98 27.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.483 1.113 . . . . 0.0 111.579 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.3 p -139.94 154.72 47.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.46 1.904 . . . . 0.0 109.171 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -147.97 152.16 37.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.8 p -140.99 159.48 42.12 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.594 1.958 . . . . 0.0 110.414 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.8 t -112.98 134.8 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.055 1.342 . . . . 0.0 109.525 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 99.6 t -103.01 111.68 65.23 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.038 1.335 . . . . 0.0 108.104 163.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.37 168.25 21.8 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.747 2.965 . . . . 0.0 110.743 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.71 -15.85 48.63 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.061 2.507 . . . . 0.0 113.267 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.6 p -79.75 -9.63 59.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 113.923 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.78 -2.01 84.51 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.665 1.602 . . . . 0.0 115.065 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -77.1 77.78 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.442 1.497 . . . . 0.0 111.712 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.77 134.93 56.69 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.864 1.265 . . . . 0.0 112.04 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -140.51 151.04 62.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.216 1.406 . . . . 0.0 111.32 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.38 153.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.87 3.046 . . . . 0.0 112.385 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 86.8 m -98.6 155.7 17.17 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.998 1.319 . . . . 0.0 112.381 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.8 tp -87.88 117.97 27.1 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 160.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 32.2 mt -81.16 140.99 34.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.96 0.904 . . . . 0.0 110.256 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -136.12 141.56 44.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.828 1.251 . . . . 0.0 113.139 -174.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -82.72 117.54 22.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.282 1.433 . . . . 0.0 107.93 157.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.06 171.02 7.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.776 1.23 . . . . 0.0 112.421 -172.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -56.73 -36.71 70.05 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.646 1.578 . . . . 0.0 115.049 -166.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.15 2.22 44.53 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 91.8 1.99 70.04 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.672 1.606 . . . . 0.0 113.994 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.35 166.77 15.34 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.738 1.615 . . . . 0.0 113.837 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 79.8 t -96.9 144.43 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.898 1.679 . . . . 0.0 110.05 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.55 -179.95 32.84 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 123.941 0.781 . . . . 0.0 114.802 171.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.79 157.15 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.394 1.478 . . . . 0.0 112.476 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.1 m -130.32 151.88 50.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.571 1.548 . . . . 0.0 110.777 160.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.4 p90 -167.15 -179.63 4.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.669 2.388 . . . . 0.0 109.495 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.5 t -127.63 120.4 21.85 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 119.273 0.942 . . . . 0.0 110.022 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.93 145.03 17.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.161 3.241 . . . . 0.0 111.206 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 48.0 tttm -94.57 -50.12 5.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.911 0.884 . . . . 0.0 112.074 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.83 171.88 8.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.864 1.666 . . . . 0.0 111.2 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.1 p -91.23 173.69 7.79 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.421 1.488 . . . . 0.0 111.462 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 89.23 -164.98 32.45 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.978 1.275 . . . . 0.0 113.601 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.9 116.23 8.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.073 0.949 . . . . 0.0 111.702 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.4 m80 -103.49 144.56 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.962 1.705 . . . . 0.0 109.003 165.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.75 119.25 38.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.555 1.142 . . . . 0.0 109.681 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 92.3 t -88.11 131.83 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.305 1.042 . . . . 0.0 108.652 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -112.74 140.25 47.67 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.86 1.264 . . . . 0.0 110.054 168.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 2.9 p -138.81 133.36 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.931 0.892 . . . . 0.0 111.164 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -115.11 141.79 47.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.612 1.965 . . . . 0.0 112.649 -163.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -139.45 130.63 26.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.92 2.088 . . . . 0.0 110.055 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.93 31.89 14.24 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.542 1.137 . . . . 0.0 113.636 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.17 -2.62 81.61 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.44 1.495 . . . . 0.0 116.09 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -129.67 150.17 51.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.622 1.711 . . . . 0.0 111.723 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -66.11 139.49 58.16 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.846 -1.159 . . . . 0.0 112.044 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 20.0 m -69.23 161.26 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 111.499 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.93 63.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 17.3 m -76.77 -17.83 58.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.686 1.195 . . . . 0.0 114.127 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 45.0 m -79.05 144.58 63.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.738 -1.226 . . . . 0.0 112.922 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.5 147.19 81.4 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 118.827 0.617 . . . . 0.0 112.044 -5.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -97.31 121.67 58.01 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.924 1.29 . . . . 0.0 108.449 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.42 139.26 12.84 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.839 2.359 . . . . 0.0 111.288 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -131.05 124.14 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.629 1.572 . . . . 0.0 107.402 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.3 t -99.01 121.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.683 0.793 . . . . 0.0 110.084 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.02 122.36 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.902 1.281 . . . . 0.0 109.644 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 154.69 22.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.611 0.764 . . . . 0.0 111.372 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -55.37 -29.26 58.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.221 1.009 . . . . 0.0 112.698 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 34.1 m -68.7 -15.72 63.6 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -92.97 -14.88 26.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.365 1.066 . . . . 0.0 113.004 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.48 -28.42 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.714 1.206 . . . . 0.0 112.52 -173.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 146.77 94.57 0.15 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.132 1.349 . . . . 0.0 112.396 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.67 113.84 21.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.103 1.361 . . . . 0.0 109.477 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 112.282 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.4 m -53.3 -23.02 8.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.051 1.74 . . . . 0.0 114.115 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -87.33 -17.74 31.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.758 1.223 . . . . 0.0 114.151 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.0 t -78.75 136.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.625 1.102 . . . . 0.0 110.162 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -119.73 159.37 24.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.137 1.375 . . . . 0.0 110.516 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 26.9 m -145.92 157.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.58 . . . . 0.0 110.605 -178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -158.44 175.27 13.91 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.373 1.069 . . . . 0.0 112.565 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 101.15 166.67 27.87 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.436 1.493 . . . . 0.0 114.204 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.87 -35.2 79.48 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.611 1.164 . . . . 0.0 112.937 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.34 10.99 5.58 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.588 1.566 . . . . 0.0 115.152 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 80.1 mt -100.11 -7.49 24.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.831 1.652 . . . . 0.0 112.063 165.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -131.7 -41.6 1.05 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.485 1.514 . . . . 0.0 113.846 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.77 154.82 26.84 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.58 -170.58 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.552 1.548 . . . . 0.0 113.865 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 72.6 m80 -140.19 146.91 39.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.054 1.342 . . . . 0.0 112.407 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.8 p -73.26 -17.67 61.3 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.19 -3.61 12.52 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -144.4 145.09 27.68 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 110.268 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.75 145.95 52.81 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.977 2.452 . . . . 0.0 111.801 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -89.66 157.06 18.17 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.661 1.184 . . . . 0.0 110.672 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.95 145.34 44.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.819 0.848 . . . . 0.0 112.346 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -150.37 145.94 26.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.042 1.337 . . . . 0.0 111.023 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.02 144.68 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.21 1.804 . . . . 0.0 109.457 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 22.0 mt -118.96 135.67 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.266 1.826 . . . . 0.0 109.835 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -109.06 43.44 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.338 1.855 . . . . 0.0 112.669 -171.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 1.2 p -57.83 -21.36 41.97 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -29.63 59.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.48 -4.48 59.0 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.696 1.198 . . . . 0.0 113.03 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.77 1.59 34.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.832 1.653 . . . . 0.0 114.422 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.94 -116.81 4.53 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -128.87 161.48 29.74 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.912 1.285 . . . . 0.0 112.628 -174.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.28 166.38 10.88 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.448 1.023 . . . . 0.0 114.563 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -79.52 132.49 11.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.04 0.828 . . . . 0.0 112.462 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 124.33 47.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.548 1.939 . . . . 0.0 107.801 171.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -118.54 139.08 52.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.205 1.002 . . . . 0.0 110.647 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 5.1 tp -122.88 134.06 54.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.91 1.684 . . . . 0.0 109.874 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.6 m -135.82 130.29 33.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.289 0.635 . . . . 0.0 110.501 170.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 44.9 mt -112.86 135.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.537 1.535 . . . . 0.0 109.323 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.92 155.3 50.17 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.908 1.683 . . . . 0.0 109.958 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.41 -159.11 31.67 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.381 -0.825 . . . . 0.0 115.013 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.5 -2.88 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.407 3.404 . . . . 0.0 114.18 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -156.24 161.46 40.25 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.849 1.26 . . . . 0.0 111.338 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -66.29 149.87 49.7 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.324 -0.86 . . . . 0.0 110.074 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 20.3 m -124.05 159.76 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.394 1.078 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.37 122.67 45.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.951 0.9 . . . . 0.0 109.188 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 16.0 mt -105.78 134.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.564 1.145 . . . . 0.0 110.131 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -130.14 165.17 22.86 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 110.598 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -143.07 162.77 34.64 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.071 1.348 . . . . 0.0 112.181 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.83 116.35 5.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.665 1.586 . . . . 0.0 109.706 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.55 132.6 39.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 110.854 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.7 mt -111.1 153.24 25.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.647 1.179 . . . . 0.0 111.702 -173.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.45 -19.07 64.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -83.44 3.37 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.876 1.271 . . . . 0.0 113.077 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.89 -0.2 84.13 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.473 1.511 . . . . 0.0 114.17 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.1 p -81.73 166.4 20.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.095 1.758 . . . . 0.0 111.194 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -129.18 126.1 38.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.048 0.939 . . . . 0.0 110.748 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -81.92 135.03 35.43 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.412 1.085 . . . . 0.0 109.271 166.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.7 t -113.43 140.37 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.714 2.006 . . . . 0.0 108.237 167.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 10.8 p -136.09 150.21 49.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.187 1.395 . . . . 0.0 111.311 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.8 p90 -159.18 149.59 19.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.505 1.122 . . . . 0.0 111.854 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 9.0 t -114.92 108.97 47.76 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.845 0.858 . . . . 0.0 111.013 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.05 154.27 25.47 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.436 2.758 . . . . 0.0 110.56 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 27.1 m -114.28 -42.23 3.36 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.135 0.974 . . . . 0.0 112.408 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -87.9 142.83 32.57 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.769 0.828 . . . . 0.0 110.441 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.32 163.83 31.86 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.312 2.674 . . . . 0.0 111.083 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.27 -143.36 15.02 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.822 1.201 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -124.28 129.7 51.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.458 0.703 . . . . 0.0 111.866 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -108.02 144.98 34.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 110.773 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.14 132.28 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.334 1.454 . . . . 0.0 108.878 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.57 127.9 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.339 1.455 . . . . 0.0 109.199 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -107.46 126.93 53.13 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.095 1.358 . . . . 0.0 110.216 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2118 ' ' ILE . . . . . 0.425 ' HB ' HG22 ' A' 2125 ' ' VAL . 12.6 mm -116.65 94.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.582 1.153 . . . . 0.0 110.231 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -86.62 130.39 34.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.907 1.283 . . . . 0.0 110.09 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.22 130.5 46.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.089 0.955 . . . . 0.0 109.825 168.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 56.95 26.0 11.27 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.108 1.363 . . . . 0.0 113.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.6 t70 72.28 12.33 5.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.991 2.516 . . . . 0.0 114.472 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -98.37 -158.82 0.7 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.775 1.63 . . . . 0.0 109.595 165.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.5 t60 -142.57 127.46 18.3 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.474 -1.392 . . . . 0.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2125 ' ' VAL . . . . . 0.425 HG22 ' HB ' ' A' 2118 ' ' ILE . 4.0 m -73.44 155.16 89.76 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 0.0 112.172 -167.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.14 131.31 38.82 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.654 2.903 . . . . 0.0 112.807 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.88 50.57 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.039 1.304 . . . . 0.0 114.676 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 28.9 t -77.42 144.39 70.22 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 118.926 1.363 . . . . 0.0 111.518 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.89 152.68 97.1 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.727 0.938 . . . . 0.0 112.589 -3.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -104.88 132.33 51.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.366 1.466 . . . . 0.0 111.298 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 69.2 m -100.36 126.21 46.69 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.643 1.177 . . . . 0.0 111.272 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.36 111.82 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.749 1.62 . . . . 0.0 109.789 -167.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -77.93 112.7 15.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.793 -0.567 . . . . 0.0 111.169 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 71.3 t -101.39 113.37 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 109.05 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -90.8 154.83 19.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.333 1.053 . . . . 0.0 110.85 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -178.6 -161.9 27.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.871 2.068 . . . . 0.0 109.081 -177.2 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 98.8 mtp -84.0 129.88 34.9 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.969 0.908 . . . . 0.0 111.432 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 21.0 m -113.68 132.68 55.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.193 1.797 . . . . 0.0 108.592 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 7.0 t60 -129.51 152.89 48.55 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -163.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1963 ' ' LEU . . . . . 0.413 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -151.73 153.89 35.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.196 1.798 . . . . 0.0 110.864 179.27 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1964 ' ' LYS . . . . . 0.413 ' H ' HD13 ' A' 1963 ' ' LEU . 99.0 mttt -137.8 146.54 43.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.06 1.344 . . . . 0.0 111.949 173.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 60.2 t -143.0 133.94 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.044 1.738 . . . . 0.0 109.617 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.16 132.43 11.08 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.932 0.777 . . . . 0.0 111.54 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 27.2 m -120.65 141.63 50.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.256 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -152.26 156.72 40.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.137 0.975 . . . . 0.0 113.276 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -113.07 151.62 30.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 111.574 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.72 147.38 25.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 0.0 113.128 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.54 126.38 23.42 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 125.309 1.444 . . . . 0.0 108.73 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.81 130.5 9.65 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.198 2.599 . . . . 0.0 111.237 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 40.4 mt -149.63 141.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.392 1.877 . . . . 0.0 108.746 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.3 t30 59.13 53.76 5.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.368 1.467 . . . . 0.0 111.906 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 30.1 mm -56.79 -39.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.747 1.619 . . . . 0.0 113.509 -163.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 17.2 m -77.12 -2.31 33.65 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.43 145.05 51.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 113.481 -171.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 41.2 p -133.13 -20.56 2.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.519 1.927 . . . . 0.0 112.984 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.14 50.8 2.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.303 1.441 . . . . 0.0 111.85 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -1.18 6.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 35.5 p -77.16 -25.9 52.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.705 1.602 . . . . 0.0 114.271 174.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.81 8.4 4.49 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.22 136.14 33.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.503 1.921 . . . . 0.0 109.046 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 11.2 t -148.25 161.47 41.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.811 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.57 154.26 38.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 113.045 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 70.1 p -140.95 163.01 34.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.906 2.082 . . . . 0.0 109.599 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 17.8 t -116.65 136.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.827 1.251 . . . . 0.0 110.182 171.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.3 t -106.62 113.29 63.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.907 1.283 . . . . 0.0 108.497 166.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.03 174.18 9.54 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.402 3.401 . . . . 0.0 111.801 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.81 -29.22 51.6 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.538 3.492 . . . . 0.0 114.619 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 70.9 p -80.91 -3.57 51.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.855 1.262 . . . . 0.0 113.989 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 75.2 -3.11 48.7 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.474 1.511 . . . . 0.0 114.911 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -76.26 91.6 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.953 1.301 . . . . 0.0 110.928 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 131.69 50.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.055 0.942 . . . . 0.0 111.601 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -132.45 144.42 52.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.725 1.61 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.07 153.02 28.35 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.435 2.757 . . . . 0.0 112.287 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.3 m -89.1 151.52 22.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.076 0.951 . . . . 0.0 112.402 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 59.8 tp -86.5 131.76 34.1 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.602 1.161 . . . . 0.0 108.271 157.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mp -99.72 142.1 31.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.603 1.161 . . . . 0.0 110.133 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.6 139.16 36.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.678 1.191 . . . . 0.0 113.049 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -92.34 114.51 27.07 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 156.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.85 169.39 11.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.997 -169.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -62.76 -27.47 69.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -166.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -88.43 3.6 49.43 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 119.155 0.889 . . . . 0.0 113.256 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.06 -4.41 71.15 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 126.122 1.82 . . . . 0.0 114.312 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -80.14 156.14 27.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.391 1.476 . . . . 0.0 113.782 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 68.6 t -89.08 140.94 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.13 1.372 . . . . 0.0 110.126 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.06 177.96 29.57 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.275 0.941 . . . . 0.0 114.488 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.35 161.08 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.142 1.377 . . . . 0.0 111.808 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 49.6 m -134.99 156.72 48.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.147 1.779 . . . . 0.0 110.179 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.8 p90 -164.3 -170.39 2.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.503 1.921 . . . . 0.0 109.381 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 70.3 t -131.85 114.35 15.3 Favored Pre-proline 0 N--CA 1.48 1.029 0 CA-C-N 119.51 1.05 . . . . 0.0 109.825 168.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.97 145.25 31.33 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.738 2.959 . . . . 0.0 110.499 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -115.04 1.15 13.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.44 1.096 . . . . 0.0 113.033 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -141.74 171.34 14.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.377 2.271 . . . . 0.0 109.73 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.9 p -94.97 163.37 13.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.358 1.063 . . . . 0.0 110.742 164.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.22 -167.29 26.24 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.893 1.235 . . . . 0.0 113.738 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.3 114.63 8.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.258 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.3 m80 -99.91 147.56 25.41 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.904 1.682 . . . . 0.0 109.163 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 84.9 mt -105.62 124.21 49.18 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 109.864 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.9 t -89.74 113.69 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.669 1.188 . . . . 0.0 107.956 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -94.09 140.88 29.18 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.53 1.132 . . . . 0.0 110.436 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.3 p -143.89 133.99 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.818 0.818 . . . . 0.0 112.104 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -136.04 137.32 41.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.668 1.987 . . . . 0.0 111.528 -164.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.6 tttt -134.89 132.56 38.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.474 1.509 . . . . 0.0 110.895 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 50.3 t30 58.01 25.55 12.42 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.33 5.08 73.06 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.146 1.355 . . . . 0.0 115.605 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -128.9 151.4 49.68 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.426 1.613 . . . . 0.0 111.625 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -64.74 146.66 54.47 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.028 -1.045 . . . . 0.0 112.541 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 58.0 t -72.19 145.34 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.678 0.791 . . . . 0.0 108.895 171.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.63 -29.5 64.6 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 22.1 m -84.79 -4.25 58.98 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.15 1.38 . . . . 0.0 113.972 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 14.9 t -82.32 141.65 46.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.699 -1.25 . . . . 0.0 112.191 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.98 157.06 84.27 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.657 0.913 . . . . 0.0 112.655 -5.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.97 124.38 41.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.541 1.536 . . . . 0.0 108.686 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.39 141.27 14.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.032 2.488 . . . . 0.0 111.314 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.2 t -137.83 123.77 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.481 1.512 . . . . 0.0 108.303 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.8 t -96.53 124.18 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.742 0.817 . . . . 0.0 110.222 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.23 129.07 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.974 1.31 . . . . 0.0 110.145 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -94.91 168.41 10.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.695 1.198 . . . . 0.0 112.717 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.52 -34.89 78.03 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.412 -1.43 . . . . 0.0 111.653 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.8 m -64.63 -12.14 42.64 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.335 1.454 . . . . 0.0 114.892 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -116.01 1.47 13.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.526 1.53 . . . . 0.0 113.105 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.48 -23.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.333 1.053 . . . . 0.0 113.288 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.12 37.57 0.04 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.97 101.23 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.461 1.13 . . . . 0.0 111.377 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.77 82.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.422 0.689 . . . . 0.0 112.819 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 75.7 m -62.1 -25.32 67.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.855 0.862 . . . . 0.0 113.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -79.82 -13.43 59.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.209 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.6 t -77.28 133.17 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 120.141 1.337 . . . . 0.0 109.838 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -112.55 160.83 17.44 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.883 1.673 . . . . 0.0 110.871 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.2 m -146.9 159.29 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.363 1.465 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.49 177.48 10.9 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.608 1.163 . . . . 0.0 112.495 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 93.85 163.07 36.13 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.371 1.462 . . . . 0.0 113.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -75.68 -28.16 58.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.85 0.86 . . . . 0.0 113.205 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.14 0.91 13.09 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.216 1.389 . . . . 0.0 115.326 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.8 mt -92.37 -5.38 52.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.94 1.696 . . . . 0.0 112.643 168.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -133.8 -43.04 0.82 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.964 1.305 . . . . 0.0 113.516 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.23 150.2 40.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.832 1.253 . . . . 0.0 111.613 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.49 -176.23 22.51 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.579 1.085 . . . . 0.0 113.836 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.45 151.44 48.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 111.729 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 37.8 p -76.71 -40.19 49.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.863 0.865 . . . . 0.0 112.489 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -98.1 1.35 47.51 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -140.44 146.78 46.78 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.35 151.76 54.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.183 2.589 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -106.65 130.18 54.44 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.9 1.28 . . . . 0.0 111.038 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -111.93 147.09 36.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.461 1.505 . . . . 0.0 113.323 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 55.9 p90 -156.12 155.05 31.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.868 1.267 . . . . 0.0 112.145 173.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.91 143.66 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.532 1.933 . . . . 0.0 109.705 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 53.2 mt -122.77 133.98 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.521 1.928 . . . . 0.0 108.839 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.1 t0 -128.93 101.1 5.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.802 1.641 . . . . 0.0 110.948 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 39.3 p -96.18 1.46 52.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.187 1.795 . . . . 0.0 113.275 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -60.73 -34.03 73.8 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.367 0.985 . . . . 0.0 113.221 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.07 -12.04 55.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.56 1.144 . . . . 0.0 113.353 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.08 -12.46 35.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.502 1.521 . . . . 0.0 114.073 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.31 -119.28 5.1 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.376 0.988 . . . . 0.0 111.823 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -103.52 162.29 13.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.276 1.831 . . . . 0.0 112.329 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.83 -177.77 29.51 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.929 0.776 . . . . 0.0 114.979 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -104.43 121.78 7.1 Favored Glycine 0 N--CA 1.468 0.793 0 C-N-CA 124.731 1.158 . . . . 0.0 111.113 174.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.49 123.63 36.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.374 1.47 . . . . 0.0 108.37 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 33.6 t -121.75 145.23 48.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.984 1.714 . . . . 0.0 109.73 175.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.11 133.17 22.83 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.521 0.729 . . . . 0.0 110.762 -164.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 7.6 m -129.14 136.54 50.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.805 0.842 . . . . 0.0 110.622 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.5 mt -119.92 138.69 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.863 1.265 . . . . 0.0 108.323 168.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.56 146.55 28.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.798 0.839 . . . . 0.0 111.7 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -176.64 -163.24 28.64 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.903 -173.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.39 -10.18 25.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.017 3.145 . . . . 0.0 114.482 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.1 t -152.38 169.42 22.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.483 1.038 . . . . 0.0 112.067 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.36 143.97 54.82 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.152 1.381 . . . . 0.0 111.137 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -121.08 149.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.754 0.706 . . . . 0.0 111.517 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.32 118.38 34.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.616 0.766 . . . . 0.0 109.469 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 50.0 mt -104.2 135.94 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.146 1.379 . . . . 0.0 109.795 -173.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.27 156.82 43.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.794 1.637 . . . . 0.0 110.384 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 34.0 p -134.46 154.99 51.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.229 1.412 . . . . 0.0 111.438 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -150.51 131.76 14.53 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.647 1.179 . . . . 0.0 110.736 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.91 122.88 29.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.594 1.157 . . . . 0.0 110.561 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.0 mt -92.05 151.9 20.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.927 0.891 . . . . 0.0 111.396 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -63.01 -26.34 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.406 1.082 . . . . 0.0 112.884 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.45 -4.98 42.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.953 1.301 . . . . 0.0 113.469 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.39 4.19 59.66 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.632 1.587 . . . . 0.0 114.745 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -95.31 163.1 13.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.176 1.79 . . . . 0.0 111.453 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 128.47 54.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.24 1.016 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -91.48 136.08 33.38 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.665 167.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 137.73 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.916 1.686 . . . . 0.0 108.414 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 14.3 p -134.94 146.54 49.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.107 1.363 . . . . 0.0 110.561 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.8 p90 -149.82 152.08 34.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.519 0.728 . . . . 0.0 112.86 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 p -115.95 108.41 46.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.963 1.305 . . . . 0.0 111.24 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.75 169.76 17.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.676 2.918 . . . . 0.0 110.795 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 87.4 m -121.19 -51.75 2.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.949 0.899 . . . . 0.0 111.673 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -81.82 143.23 49.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.749 0.82 . . . . 0.0 110.374 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.24 162.15 34.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.124 2.549 . . . . 0.0 111.038 170.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.17 -161.34 24.61 Favored Glycine 0 N--CA 1.472 1.098 0 C-N-CA 125.11 1.338 . . . . 0.0 113.703 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -90.55 122.3 33.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.443 0.697 . . . . 0.0 111.273 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -104.7 136.72 43.69 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 109.865 167.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.39 133.66 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.231 1.412 . . . . 0.0 108.559 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.4 mt -119.44 127.92 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.831 1.252 . . . . 0.0 109.595 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 15.7 m120 -109.02 125.81 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 110.306 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 24.4 mm -109.37 113.96 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.538 1.135 . . . . 0.0 108.802 172.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -119.15 135.21 54.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.451 1.5 . . . . 0.0 111.026 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 30.4 t80 -130.35 126.89 38.25 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.746 0.818 . . . . 0.0 110.895 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.23 39.39 26.88 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.688 1.595 . . . . 0.0 114.074 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 15.3 t70 79.9 2.26 2.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.023 2.529 . . . . 0.0 114.025 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -96.92 -127.79 0.15 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.157 1.383 . . . . 0.0 110.774 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -171.11 128.57 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.816 2.046 . . . . 0.0 109.884 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -86.65 157.92 54.65 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-N 120.098 1.317 . . . . 0.0 111.706 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.44 141.63 72.25 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.905 3.07 . . . . 0.0 113.567 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 87.84 -21.54 22.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.958 1.266 . . . . 0.0 114.597 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 58.1 m -74.63 148.4 85.34 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.979 1.39 . . . . 0.0 111.874 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.4 140.1 65.38 Favored 'Cis proline' 0 C--N 1.351 0.708 0 CA-C-N 119.369 0.81 . . . . 0.0 111.288 -5.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.48 121.59 35.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.669 1.187 . . . . 0.0 110.514 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.6 m -85.63 124.32 32.04 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.397 0.679 . . . . 0.0 110.443 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.8 t -116.48 114.79 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.926 1.69 . . . . 0.0 109.085 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 58.7 tttp -78.94 103.2 8.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.818 0.447 . . . . 0.0 110.683 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 74.9 t -89.58 114.67 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.609 1.163 . . . . 0.0 108.599 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.3 t -94.27 161.3 14.31 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.112 0.965 . . . . 0.0 111.165 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 152.75 -139.47 7.0 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.092 0.853 . . . . 0.0 113.67 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 125.664 1.586 . . . . 0.0 109.965 -175.477 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.782 0.325 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.0 ptm -126.72 137.45 53.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.753 1.621 . . . . 0.0 110.716 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 14.1 m -108.71 112.69 25.12 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.446 1.498 . . . . 0.0 108.944 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 8.1 t60 -106.47 158.36 16.96 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -162.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -152.91 139.02 18.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.612 2.365 . . . . 0.0 110.012 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.29 144.94 50.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.756 1.222 . . . . 0.0 111.17 167.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.8 p -155.45 141.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.157 0.983 . . . . 0.0 111.338 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.31 150.69 33.81 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.206 0.908 . . . . 0.0 113.268 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 47.0 m -131.92 37.53 3.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.932 1.293 . . . . 0.0 111.668 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -67.84 111.96 4.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.938 1.295 . . . . 0.0 111.257 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -72.13 148.06 46.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.242 1.017 . . . . 0.0 112.33 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.93 150.46 20.15 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 73.0 mt -136.93 126.11 15.35 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.336 1.854 . . . . 0.0 108.961 171.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.78 149.35 12.56 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.855 3.037 . . . . 0.0 112.261 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.12 134.99 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.111 1.365 . . . . 0.0 110.368 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 58.8 t30 42.28 73.05 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.247 2.219 . . . . 0.0 114.866 166.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 21.4 mm -67.54 124.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.863 . . . . 0.0 111.223 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 21.4 t -170.33 166.34 8.68 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.499 1.92 . . . . 0.0 110.432 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -85.55 62.96 7.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.989 1.316 . . . . 0.0 110.868 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.6 p -86.45 158.34 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.62 1.568 . . . . 0.0 112.219 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.43 119.36 27.63 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.482 1.113 . . . . 0.0 110.259 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.2 mp -75.91 -11.11 59.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.113 0.965 . . . . 0.0 113.132 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 17.2 t -67.53 -37.5 82.85 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.611 1.096 . . . . 0.0 113.363 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.47 2.5 24.27 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.11 133.57 35.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.134 1.374 . . . . 0.0 110.526 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 52.9 p -138.82 163.02 33.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.891 1.676 . . . . 0.0 110.381 173.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.9 148.91 29.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.937 0.895 . . . . 0.0 113.148 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -135.78 164.53 27.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.874 2.07 . . . . 0.0 109.767 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -116.24 134.08 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.597 1.159 . . . . 0.0 109.346 166.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.4 t -104.29 111.94 65.31 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.302 1.441 . . . . 0.0 108.11 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.83 169.39 20.75 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.806 3.004 . . . . 0.0 110.872 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.21 -15.83 47.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.058 2.506 . . . . 0.0 113.184 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.6 p -79.85 -4.99 54.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.005 1.322 . . . . 0.0 113.847 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.04 59.11 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.385 1.469 . . . . 0.0 114.965 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -77.67 76.76 4.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.567 1.547 . . . . 0.0 111.637 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -58.29 136.59 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.69 1.196 . . . . 0.0 112.398 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.01 151.34 67.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.441 1.497 . . . . 0.0 111.081 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.39 152.94 44.63 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.741 2.96 . . . . 0.0 112.489 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 90.3 m -95.6 152.68 18.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.17 122.73 33.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.668 1.187 . . . . 0.0 109.113 167.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 66.4 mt -84.07 139.01 32.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.325 1.05 . . . . 0.0 110.635 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 92.2 mttt -141.36 140.6 33.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.948 1.299 . . . . 0.0 112.367 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -87.5 125.9 34.59 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 160.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.8 mt -105.71 176.38 5.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.828 1.651 . . . . 0.0 113.031 -163.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -55.57 -34.89 65.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.635 1.974 . . . . 0.0 115.254 -164.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 20.6 m120 -96.61 5.51 50.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.622 1.169 . . . . 0.0 113.398 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.45 71.9 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.46 1.505 . . . . 0.0 113.965 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -73.8 173.73 9.44 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.961 1.704 . . . . 0.0 113.273 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 98.1 t -127.85 142.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.346 1.459 . . . . 0.0 109.961 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -155.85 -174.75 26.05 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.6 160.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.475 1.91 . . . . 0.0 110.99 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 78.9 p -146.93 155.15 42.06 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.904 1.282 . . . . 0.0 111.125 165.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.46 -175.69 4.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.95 1.7 . . . . 0.0 110.728 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 56.5 t -134.15 124.87 17.66 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.313 1.045 . . . . 0.0 109.244 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.64 150.18 27.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.09 3.194 . . . . 0.0 111.767 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.49 -8.04 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.228 1.011 . . . . 0.0 113.479 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -142.84 171.39 14.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.888 2.075 . . . . 0.0 110.341 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 31.1 p -93.23 164.35 13.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.743 1.217 . . . . 0.0 111.096 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.04 -168.68 24.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.206 1.384 . . . . 0.0 113.544 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.8 117.67 11.68 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.899 0.857 . . . . 0.0 111.719 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 6.7 m80 -103.31 148.29 26.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.067 1.747 . . . . 0.0 109.11 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.86 126.89 53.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.136 0.974 . . . . 0.0 109.696 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 28.4 t -84.82 125.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 163.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -105.46 128.75 53.71 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.462 1.105 . . . . 0.0 110.071 172.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 34.6 t -129.34 129.84 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.986 1.314 . . . . 0.0 109.341 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -139.72 141.51 36.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.53 125.12 53.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.393 2.277 . . . . 0.0 109.477 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.64 26.61 11.41 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.688 1.195 . . . . 0.0 113.425 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 97.05 -13.03 65.34 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.83 1.681 . . . . 0.0 115.937 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.28 144.73 42.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.684 1.742 . . . . 0.0 112.142 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -62.65 142.8 57.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 85.6 t -70.83 149.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.449 1.499 . . . . 0.0 109.462 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.17 64.13 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 70.9 m -86.42 -8.91 57.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.549 1.14 . . . . 0.0 113.785 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 24.7 t -88.9 145.22 34.23 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.069 1.347 . . . . 0.0 112.383 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.52 154.09 95.04 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.608 0.896 . . . . 0.0 112.565 -3.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.8 120.21 50.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.4 1.48 . . . . 0.0 108.515 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.3 142.5 13.38 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.914 2.409 . . . . 0.0 111.38 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.25 125.57 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.27 1.428 . . . . 0.0 108.081 174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 57.4 t -97.01 121.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.499 0.72 . . . . 0.0 109.807 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.87 123.93 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.88 1.272 . . . . 0.0 109.253 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 159.81 15.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.617 0.767 . . . . 0.0 111.402 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -57.48 -30.68 65.27 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.985 0.914 . . . . 0.0 112.782 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 30.9 m -67.29 -18.4 65.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.426 1.09 . . . . 0.0 113.813 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -93.15 -11.12 33.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.517 1.127 . . . . 0.0 112.847 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.19 -35.31 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.438 1.095 . . . . 0.0 112.306 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.98 61.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.911 0.767 . . . . 0.0 113.523 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.12 95.63 8.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.459 0.703 . . . . 0.0 110.853 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.9 69.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.651 0.78 . . . . 0.0 112.388 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.9 m -53.99 -21.16 7.49 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.078 1.751 . . . . 0.0 114.432 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -97.24 -7.5 32.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.562 1.545 . . . . 0.0 113.891 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 94.3 t -75.64 137.28 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.722 1.146 . . . . 0.0 109.94 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -123.2 157.62 32.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.277 1.431 . . . . 0.0 111.072 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 28.0 m -146.34 156.93 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.319 1.448 . . . . 0.0 110.972 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.18 174.24 15.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.625 1.17 . . . . 0.0 112.156 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 110.54 -157.51 14.96 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.395 1.474 . . . . 0.0 113.644 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -109.89 -36.29 5.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.642 1.177 . . . . 0.0 112.549 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.63 -0.18 53.15 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 125.113 1.34 . . . . 0.0 115.606 -171.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.92 -5.47 50.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.33 1.452 . . . . 0.0 112.451 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -125.09 -38.16 2.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.223 1.409 . . . . 0.0 113.346 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.8 154.59 30.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.306 1.042 . . . . 0.0 113.238 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.67 -176.17 24.16 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.399 1.476 . . . . 0.0 113.761 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.0 m80 -140.3 145.45 37.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.768 1.227 . . . . 0.0 112.496 -173.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 46.2 p -68.94 -16.25 63.7 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -117.54 -5.02 11.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -144.88 146.48 31.51 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 110.853 -176.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.24 145.71 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.884 2.39 . . . . 0.0 111.604 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -99.4 148.44 24.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.11 1.364 . . . . 0.0 110.374 171.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.96 146.21 51.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.861 . . . . 0.0 113.093 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.7 148.15 26.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.287 1.435 . . . . 0.0 110.958 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.38 140.29 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 109.165 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 37.9 mt -112.13 134.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.872 1.669 . . . . 0.0 109.272 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 65.3 t0 -125.53 103.73 8.03 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.033 1.733 . . . . 0.0 110.644 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 22.8 p -99.21 0.48 43.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.403 1.881 . . . . 0.0 113.127 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.88 -32.7 72.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 0.0 113.326 -171.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.78 -14.46 58.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.667 1.187 . . . . 0.0 113.451 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.11 -0.56 57.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.344 1.457 . . . . 0.0 114.307 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.3 -136.24 15.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.643 1.116 . . . . 0.0 111.937 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -88.42 169.26 11.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.004 1.322 . . . . 0.0 112.329 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 142.24 -151.55 23.01 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.333 0.968 . . . . 0.0 114.255 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -148.62 148.72 20.42 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.426 1.489 . . . . 0.0 112.691 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 128.51 54.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.838 2.055 . . . . 0.0 109.501 -177.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 11.7 t -121.75 139.44 53.58 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.681 1.592 . . . . 0.0 109.749 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.16 142.14 30.37 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.57 1.148 . . . . 0.0 110.139 -162.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 87.0 p -147.61 149.83 33.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 14.6 mt -117.39 127.8 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.813 1.245 . . . . 0.0 109.289 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -114.58 154.91 27.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.916 2.086 . . . . 0.0 109.229 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 164.01 -162.55 35.28 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.156 -0.965 . . . . 0.0 114.832 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 -6.41 19.14 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.127 3.218 . . . . 0.0 114.294 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.3 t -154.57 157.59 38.5 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.631 1.105 . . . . 0.0 112.248 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 128.25 35.0 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.08 1.352 . . . . 0.0 109.506 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 30.4 m -115.96 169.33 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.984 1.313 . . . . 0.0 111.87 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -110.69 121.28 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.396 1.078 . . . . 0.0 110.193 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.19 132.04 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.859 0.864 . . . . 0.0 108.98 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -120.01 157.89 27.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.184 1.794 . . . . 0.0 109.706 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 36.3 p -136.16 160.42 38.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.657 1.183 . . . . 0.0 111.807 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -152.94 119.54 5.64 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.859 1.264 . . . . 0.0 110.002 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.96 124.15 26.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.354 1.062 . . . . 0.0 110.302 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 61.6 mt -94.95 151.72 18.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.288 1.035 . . . . 0.0 111.441 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -16.1 63.86 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -81.95 -7.03 59.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.875 1.27 . . . . 0.0 113.267 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 98.62 1.63 57.61 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.667 1.603 . . . . 0.0 115.05 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 36.0 p -93.62 171.69 8.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.202 1.801 . . . . 0.0 111.503 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -121.32 124.36 44.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.995 0.918 . . . . 0.0 111.504 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -80.51 134.04 35.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.292 1.037 . . . . 0.0 109.395 165.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.7 t -117.86 137.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 108.186 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.1 p -138.85 148.59 43.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.346 1.458 . . . . 0.0 111.401 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.6 p90 -157.13 150.29 23.84 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.602 1.161 . . . . 0.0 111.914 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.0 t -114.79 105.59 53.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.16 0.984 . . . . 0.0 110.712 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.98 150.0 26.26 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.334 2.689 . . . . 0.0 110.618 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 45.9 m -111.11 -45.83 3.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.073 0.949 . . . . 0.0 112.19 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -85.49 142.3 37.41 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.459 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.97 163.0 33.91 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.268 2.645 . . . . 0.0 111.078 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.45 -144.69 16.7 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 124.871 1.224 . . . . 0.0 112.2 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -123.23 129.97 52.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.645 0.778 . . . . 0.0 111.894 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -107.2 142.98 36.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.673 1.589 . . . . 0.0 110.453 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.16 130.11 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.979 1.311 . . . . 0.0 108.378 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.2 mt -113.58 122.08 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.237 1.015 . . . . 0.0 109.437 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -95.62 128.35 42.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.312 1.445 . . . . 0.0 110.16 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.87 112.97 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.902 1.281 . . . . 0.0 108.993 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -126.37 132.95 51.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.106 1.363 . . . . 0.0 111.451 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -129.68 128.31 42.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.102 1.761 . . . . 0.0 109.729 -177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.19 43.51 26.13 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.22 1.008 . . . . 0.0 113.049 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.0 t0 74.47 7.85 4.5 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.977 2.511 . . . . 0.0 114.806 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -121.96 132.44 54.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.17 1.388 . . . . 0.0 111.234 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 126.64 29.27 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 120.907 -1.12 . . . . 0.0 110.97 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.5 m -80.67 160.88 65.87 Favored Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 119.335 0.971 . . . . 0.0 112.097 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -53.23 137.68 63.67 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.689 2.926 . . . . 0.0 113.419 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.93 13.59 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.99 1.281 . . . . 0.0 114.213 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 14.2 t -76.86 142.94 70.21 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 118.42 1.11 . . . . 0.0 111.041 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 144.7 81.8 Favored 'Cis proline' 0 C--N 1.353 0.778 0 CA-C-N 120.002 1.036 . . . . 0.0 111.971 -2.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.79 120.02 36.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.537 1.135 . . . . 0.0 110.42 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 68.3 m -91.05 123.58 34.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.08 0.952 . . . . 0.0 110.449 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 115.38 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.504 1.521 . . . . 0.0 109.996 -166.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.9 tttt -77.81 120.52 22.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.02 0.528 . . . . 0.0 111.239 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.5 t -107.38 119.26 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.073 1.349 . . . . 0.0 109.014 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.8 t -106.42 162.83 13.35 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.768 1.227 . . . . 0.0 111.87 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 127.23 168.3 12.49 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.773 1.654 . . . . 0.0 113.565 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 124.419 1.088 . . . . 0.0 113.85 -168.645 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 1.9 mmm -127.15 128.83 46.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.894 1.278 . . . . 0.0 111.29 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 15.4 m -130.85 146.35 52.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.868 1.667 . . . . 0.0 109.443 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -155.83 159.32 39.29 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1963 ' ' LEU . . . . . 0.449 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -159.65 154.19 24.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.573 1.949 . . . . 0.0 110.317 -170.166 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1964 ' ' LYS . . . . . 0.449 ' H ' HD13 ' A' 1963 ' ' LEU . 95.5 mttt -135.7 144.27 45.84 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.906 1.282 . . . . 0.0 111.714 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 32.5 m -143.0 151.35 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.89 1.276 . . . . 0.0 111.465 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.32 147.36 20.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.409 1.004 . . . . 0.0 112.133 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 26.3 m -136.12 147.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.158 1.383 . . . . 0.0 112.088 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.27 154.69 23.66 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -85.49 161.09 19.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.893 1.277 . . . . 0.0 111.583 167.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.9 135.43 36.43 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.1 mt -125.25 124.0 25.23 Favored Pre-proline 0 N--CA 1.482 1.125 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.69 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.45 133.17 11.64 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.893 2.396 . . . . 0.0 111.464 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 32.4 mt -149.5 143.78 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.046 2.138 . . . . 0.0 107.798 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.1 t30 60.89 45.0 10.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.645 1.178 . . . . 0.0 110.789 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 25.7 mm -43.79 -56.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.826 2.45 . . . . 0.0 115.04 -147.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 49.6 m -105.32 0.88 27.46 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.881 0.872 . . . . 0.0 113.335 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -95.09 74.6 3.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.496 1.518 . . . . 0.0 109.617 -171.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 44.3 p -71.87 22.24 0.05 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.767 2.427 . . . . 0.0 115.59 -168.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.9 t0 -91.19 60.47 4.25 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.893 1.677 . . . . 0.0 111.298 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -21.7 66.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.71 1.204 . . . . 0.0 113.17 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 18.4 m -61.76 -17.71 57.04 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.404 1.482 . . . . 0.0 114.777 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.4 pp -122.63 14.63 10.2 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.33 1.452 . . . . 0.0 113.745 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.19 145.77 26.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 111.588 173.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 29.3 p -146.21 146.77 30.92 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.372 1.869 . . . . 0.0 109.674 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -143.75 149.89 37.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 36.5 p -141.16 140.97 34.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.912 2.085 . . . . 0.0 109.532 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -95.41 133.78 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.718 0.807 . . . . 0.0 109.834 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.7 t -102.17 110.28 62.15 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 107.967 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.74 170.88 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.943 3.096 . . . . 0.0 110.972 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -15.58 49.67 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.002 2.468 . . . . 0.0 113.478 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 79.5 p -80.74 -11.21 59.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.224 . . . . 0.0 113.947 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.21 -1.76 86.26 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.606 1.574 . . . . 0.0 114.973 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -76.83 83.22 3.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.462 1.505 . . . . 0.0 111.626 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.66 134.44 57.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.75 1.22 . . . . 0.0 112.291 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -140.69 149.47 56.88 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.329 1.452 . . . . 0.0 111.615 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.81 153.53 42.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.876 3.051 . . . . 0.0 112.878 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 73.0 m -97.14 156.3 16.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.913 1.285 . . . . 0.0 112.041 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 61.6 tp -87.06 131.46 34.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 0.0 108.744 162.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -97.2 143.48 27.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.55 1.14 . . . . 0.0 110.297 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.8 146.42 34.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.791 1.236 . . . . 0.0 113.476 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -93.49 120.06 33.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.682 1.193 . . . . 0.0 107.903 156.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.71 170.92 9.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.977 -170.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -64.71 -29.27 70.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.026 1.73 . . . . 0.0 114.276 -164.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.2 t30 -86.04 -1.88 57.78 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.653 1.181 . . . . 0.0 113.21 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.95 -2.0 63.66 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.806 1.67 . . . . 0.0 114.531 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 165.81 15.89 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.497 1.519 . . . . 0.0 113.665 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 43.8 t -89.29 145.1 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.045 1.738 . . . . 0.0 110.596 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.0 -173.67 28.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.44 168.22 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.634 . . . . 0.0 112.61 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.4 m -139.06 158.07 44.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.527 1.931 . . . . 0.0 111.107 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -161.71 -174.05 4.03 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.837 2.055 . . . . 0.0 109.704 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 60.1 t -132.19 120.22 17.03 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 119.504 1.047 . . . . 0.0 110.119 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.11 134.57 13.11 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.189 3.259 . . . . 0.0 110.408 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -95.25 -10.18 31.07 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -143.52 174.09 11.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.941 2.097 . . . . 0.0 109.847 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.4 p -85.21 167.75 15.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.683 1.193 . . . . 0.0 111.593 171.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.67 -168.59 21.69 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.163 1.363 . . . . 0.0 114.047 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -73.52 119.04 17.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.082 0.953 . . . . 0.0 111.967 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.0 m80 -109.22 143.24 38.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.583 1.953 . . . . 0.0 109.172 169.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.58 126.07 52.1 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.28 1.032 . . . . 0.0 109.869 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 33.2 t -90.27 111.71 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.644 1.178 . . . . 0.0 108.268 168.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -90.08 136.73 32.87 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.216 1.006 . . . . 0.0 109.76 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 6.8 p -143.99 127.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 121.958 0.885 . . . . 0.0 112.208 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -110.44 135.43 51.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.802 2.041 . . . . 0.0 111.464 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.7 119.77 39.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.097 2.159 . . . . 0.0 109.166 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 56.02 -102.62 0.16 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.011 1.325 . . . . 0.0 111.089 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -112.22 8.59 26.9 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.657 1.599 . . . . 0.0 115.603 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -144.02 151.82 40.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.748 1.774 . . . . 0.0 112.608 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -66.42 144.49 56.49 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.872 -1.143 . . . . 0.0 112.869 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 147.49 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.46 1.104 . . . . 0.0 109.368 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -56.68 -31.05 64.06 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 15.2 m -84.37 -8.2 59.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.003 1.321 . . . . 0.0 113.982 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 23.2 t -82.49 141.42 45.39 Favored Pre-proline 0 CA--C 1.547 0.844 0 O-C-N 120.784 -1.198 . . . . 0.0 112.543 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.92 147.23 83.11 Favored 'Cis proline' 0 C--N 1.353 0.767 0 CA-C-N 119.317 0.792 . . . . 0.0 112.315 -4.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -94.85 118.78 66.68 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.038 1.335 . . . . 0.0 108.619 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.58 140.55 13.35 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.971 2.447 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.6 t -135.79 127.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.952 1.701 . . . . 0.0 107.962 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.0 t -100.29 122.02 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.796 0.838 . . . . 0.0 110.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.81 128.75 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.116 1.366 . . . . 0.0 109.993 -174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.8 t -94.53 172.89 7.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.651 1.18 . . . . 0.0 111.703 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -68.78 -33.55 74.06 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.358 -1.464 . . . . 0.0 112.015 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 14.7 m -67.03 -3.43 7.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.77 4.57 10.55 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.619 1.568 . . . . 0.0 113.19 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 41.1 mm -73.96 -26.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.175 0.99 . . . . 0.0 112.309 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 163.05 53.79 0.02 OUTLIER Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.91 91.05 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.012 0.906 . . . . 0.0 111.235 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.62 69.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.822 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -55.4 -23.95 27.45 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.422 1.489 . . . . 0.0 114.242 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -91.08 -9.14 46.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.088 1.355 . . . . 0.0 113.73 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 134.46 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.136 . . . . 0.0 110.033 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.98 157.78 22.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.651 1.58 . . . . 0.0 110.796 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.9 m -146.3 159.09 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.285 1.434 . . . . 0.0 111.022 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.69 174.52 14.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.794 1.238 . . . . 0.0 112.258 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.66 166.51 30.78 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.316 1.436 . . . . 0.0 114.277 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -75.92 -29.4 58.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.508 1.123 . . . . 0.0 113.454 -167.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -72.27 3.96 20.88 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.115 1.341 . . . . 0.0 115.165 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.88 -8.09 41.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 112.339 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.4 -42.45 1.82 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.148 1.379 . . . . 0.0 113.688 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.01 159.9 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -153.47 -177.56 27.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.223 1.392 . . . . 0.0 114.038 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -131.67 151.17 51.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.707 1.603 . . . . 0.0 112.081 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 32.5 p -71.71 -14.63 62.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -112.56 -9.77 13.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.01 157.12 77.91 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 126.238 1.815 . . . . 0.0 110.844 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.52 141.44 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.805 2.337 . . . . 0.0 110.533 169.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 149.37 22.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.587 1.155 . . . . 0.0 109.854 165.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -134.62 147.69 50.25 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.588 0.755 . . . . 0.0 112.545 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.7 p90 -151.64 150.64 30.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.391 1.476 . . . . 0.0 110.636 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.28 140.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.849 1.659 . . . . 0.0 109.287 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.88 134.55 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.226 1.811 . . . . 0.0 109.049 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.5 t0 -123.99 96.69 5.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.701 . . . . 0.0 110.611 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 7.9 p -95.15 -0.11 53.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.32 2.248 . . . . 0.0 113.172 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -60.15 -38.47 83.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.263 1.025 . . . . 0.0 112.805 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.71 -16.02 57.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.829 1.252 . . . . 0.0 113.319 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -87.38 -2.74 58.84 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.796 1.239 . . . . 0.0 113.865 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 87.16 -122.03 6.03 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.805 1.193 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -113.69 164.67 13.4 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.546 1.538 . . . . 0.0 112.233 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.9 -176.74 26.59 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 169.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -99.0 129.18 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.866 1.222 . . . . 0.0 111.36 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.25 119.43 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 107.863 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.9 t -113.87 141.3 47.52 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.734 1.214 . . . . 0.0 110.108 173.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.1 tt -140.26 132.99 28.99 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.48 1.112 . . . . 0.0 110.331 -163.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.2 m -133.67 133.35 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.642 0.777 . . . . 0.0 111.039 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 55.4 mt -116.63 133.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.282 1.433 . . . . 0.0 108.463 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.39 148.68 44.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.821 0.848 . . . . 0.0 111.381 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 172.84 -163.74 35.64 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.939 0.781 . . . . 0.0 113.87 -172.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.91 -6.4 19.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.045 3.163 . . . . 0.0 114.723 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -155.01 160.9 41.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.084 1.311 . . . . 0.0 113.103 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -59.92 140.93 56.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.988 1.715 . . . . 0.0 111.08 171.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.5 m -132.43 139.54 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.454 0.702 . . . . 0.0 111.389 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.81 102.04 12.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 109.702 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 19.9 mt -80.03 124.2 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -116.43 157.34 25.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.347 1.859 . . . . 0.0 109.929 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 76.6 p -141.28 157.29 45.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.862 1.265 . . . . 0.0 111.165 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -155.05 111.44 3.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.622 1.169 . . . . 0.0 110.178 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.6 126.84 31.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.406 1.083 . . . . 0.0 110.564 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.77 159.85 14.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 111.883 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.34 -22.07 66.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.164 0.986 . . . . 0.0 113.368 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 28.1 t0 -83.44 -0.5 50.34 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.903 1.281 . . . . 0.0 113.323 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.13 -1.52 77.42 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.587 1.565 . . . . 0.0 115.068 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.9 p -85.5 158.69 20.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.762 1.625 . . . . 0.0 111.187 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 26.9 t -114.83 121.82 44.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.732 0.813 . . . . 0.0 111.151 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -75.97 140.48 42.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.606 0.763 . . . . 0.0 109.347 163.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -123.26 138.92 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.36 1.864 . . . . 0.0 108.082 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -136.03 149.14 48.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.573 1.549 . . . . 0.0 111.346 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -159.43 147.91 17.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.651 1.18 . . . . 0.0 111.505 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 33.2 t -117.43 107.12 45.53 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.828 0.851 . . . . 0.0 111.019 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.71 150.67 24.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.694 2.929 . . . . 0.0 110.49 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 90.5 m -112.86 -41.75 3.72 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.995 0.918 . . . . 0.0 112.238 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -83.72 140.79 41.01 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.569 0.748 . . . . 0.0 110.151 171.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.15 23.32 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.379 2.72 . . . . 0.0 111.236 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 122.23 -154.03 16.84 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.12 1.343 . . . . 0.0 113.197 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -93.35 131.85 38.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.092 0.957 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -119.87 150.32 40.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.646 1.578 . . . . 0.0 109.763 168.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.43 131.76 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 109.188 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.29 130.28 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.049 1.34 . . . . 0.0 109.427 171.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -110.37 119.98 40.97 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.115 1.366 . . . . 0.0 109.657 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.2 mm -113.29 117.9 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.335 1.054 . . . . 0.0 109.369 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -134.48 131.8 38.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.5 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.71 123.17 39.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 110.054 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.84 32.91 13.17 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.353 1.461 . . . . 0.0 113.986 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.9 t0 84.16 7.45 0.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.746 2.818 . . . . 0.0 114.654 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -113.73 129.42 56.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.531 1.132 . . . . 0.0 111.278 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -65.23 123.16 18.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.384 1.474 . . . . 0.0 110.376 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -75.01 154.53 86.68 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.197 -0.939 . . . . 0.0 110.983 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.18 137.85 68.72 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.424 2.083 . . . . 0.0 111.274 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.34 -26.74 22.5 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.325 1.44 . . . . 0.0 113.304 -171.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 67.8 m -70.25 150.17 95.95 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 118.895 1.347 . . . . 0.0 112.103 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.98 147.66 83.81 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 119.08 0.707 . . . . 0.0 110.836 -7.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.08 118.78 36.6 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.836 0.854 . . . . 0.0 110.853 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 46.4 m -87.09 125.31 34.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.121 0.968 . . . . 0.0 111.202 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -117.9 122.37 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.927 1.691 . . . . 0.0 109.542 -173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 59.8 tttp -86.86 111.58 20.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.201 0.601 . . . . 0.0 110.781 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 95.8 t -97.31 117.04 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.51 1.124 . . . . 0.0 108.814 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.3 t -94.12 151.92 19.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.964 0.906 . . . . 0.0 111.222 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 173.65 150.85 7.79 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.978 0.799 . . . . 0.0 114.549 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 125.219 1.407 . . . . 0.0 113.678 176.53 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 120.51 0.195 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 17.8 ptm -145.34 142.85 29.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.722 1.209 . . . . 0.0 112.627 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 66.8 m -109.34 154.87 21.92 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 110.273 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -149.63 160.56 43.4 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 152.23 27.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.282 1.833 . . . . 0.0 109.952 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -134.51 143.62 47.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.566 1.146 . . . . 0.0 111.992 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 67.5 t -140.93 132.03 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.909 1.684 . . . . 0.0 109.666 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.24 117.93 4.52 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 40.8 m -80.48 -42.79 21.94 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 59.26 -170.17 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.639 1.576 . . . . 0.0 113.278 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -148.0 147.94 30.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.331 1.453 . . . . 0.0 110.132 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -88.55 133.01 34.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.072 0.949 . . . . 0.0 112.2 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.5 mt -127.62 119.01 21.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 125.093 1.357 . . . . 0.0 109.049 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.07 135.65 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.926 2.417 . . . . 0.0 110.627 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.9 mt -146.08 139.35 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.865 1.666 . . . . 0.0 108.468 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 45.2 t30 63.69 76.57 0.35 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.758 1.623 . . . . 0.0 110.915 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.1 mm -84.75 63.44 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.266 1.426 . . . . 0.0 110.073 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 t -162.76 -178.58 6.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 111.19 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -73.7 125.8 28.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.253 1.021 . . . . 0.0 110.695 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 2.4 m -165.09 137.9 4.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.357 2.263 . . . . 0.0 108.683 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.18 131.49 38.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.716 1.206 . . . . 0.0 111.173 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 1.7 mt -85.23 -13.81 48.73 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -173.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 47.7 m -82.19 -26.78 33.05 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.772 1.169 . . . . 0.0 112.781 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.93 6.26 49.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.268 1.427 . . . . 0.0 113.321 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.91 143.29 31.98 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 0.0 110.666 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 37.6 p -144.03 160.65 40.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.358 1.863 . . . . 0.0 110.365 172.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -157.33 152.6 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.183 0.993 . . . . 0.0 113.214 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -138.0 164.6 28.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.976 2.11 . . . . 0.0 109.747 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -119.56 136.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.353 1.461 . . . . 0.0 110.056 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 96.1 t -104.9 115.6 62.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.33 1.452 . . . . 0.0 108.567 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.91 173.04 10.5 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.987 3.124 . . . . 0.0 111.521 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.43 -33.21 55.82 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 124.343 3.362 . . . . 0.0 113.971 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 17.9 m -73.38 -10.35 59.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.665 1.186 . . . . 0.0 114.038 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.47 -3.48 67.67 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.635 1.588 . . . . 0.0 115.148 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.3 mmm-85 -79.86 90.08 5.29 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.256 1.422 . . . . 0.0 110.772 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.08 136.93 57.7 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.477 1.111 . . . . 0.0 112.117 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -137.05 151.82 72.71 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.576 1.55 . . . . 0.0 111.249 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.88 155.66 38.98 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.672 2.915 . . . . 0.0 112.871 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 87.5 m -100.91 158.89 15.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.889 1.276 . . . . 0.0 112.238 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.9 tt -93.11 121.79 34.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.75 1.22 . . . . 0.0 108.083 167.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.48 141.67 28.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.662 1.185 . . . . 0.0 111.082 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 94.5 mttt -143.3 149.63 38.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.597 1.159 . . . . 0.0 112.978 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -93.77 116.17 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 157.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 88.3 mt -89.24 165.93 14.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.816 0.846 . . . . 0.0 111.519 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -59.69 -25.47 64.79 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 30.1 m120 -77.32 -9.32 58.76 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 96.78 -12.88 65.76 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.099 1.809 . . . . 0.0 114.301 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.05 161.89 26.26 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.565 1.182 . . . . 0.0 113.416 174.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -80.69 148.66 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 109.337 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.85 176.82 30.84 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.274 0.94 . . . . 0.0 114.054 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.53 164.74 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.425 1.49 . . . . 0.0 111.704 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 86.0 p -143.54 152.97 42.09 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 111.964 165.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 13.3 p90 -161.63 173.03 15.31 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.739 2.016 . . . . 0.0 110.656 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 96.9 t -122.69 119.84 28.0 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.446 1.098 . . . . 0.0 109.816 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.4 151.59 22.94 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.754 3.636 . . . . 0.0 111.519 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 13.6 mptt -107.36 -6.22 17.28 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.214 1.006 . . . . 0.0 113.023 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -138.57 167.67 21.44 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.51 1.924 . . . . 0.0 110.639 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.2 p -90.14 165.13 14.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.825 1.25 . . . . 0.0 111.063 168.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.17 -170.79 29.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.077 1.322 . . . . 0.0 113.727 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -71.22 115.94 10.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.185 0.994 . . . . 0.0 112.119 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.9 m80 -100.48 146.58 26.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.007 1.723 . . . . 0.0 109.065 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.53 127.71 54.18 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.119 0.968 . . . . 0.0 109.81 174.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 25.0 t -90.68 123.21 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.664 1.186 . . . . 0.0 108.203 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -105.26 131.52 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.336 . . . . 0.0 110.196 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 21.5 t -130.64 133.36 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.853 0.861 . . . . 0.0 111.101 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -127.6 135.94 50.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.468 1.907 . . . . 0.0 111.591 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -128.75 123.2 32.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.164 2.186 . . . . 0.0 110.192 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.5 t30 55.94 29.28 13.96 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.154 1.381 . . . . 0.0 113.89 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.49 4.75 65.71 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.966 1.27 . . . . 0.0 115.855 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.45 155.88 49.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.406 1.603 . . . . 0.0 111.618 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 67.4 m80 -65.22 143.26 57.94 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.794 -1.191 . . . . 0.0 113.166 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 74.0 t -71.42 142.65 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.438 1.095 . . . . 0.0 109.459 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.01 67.52 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.7 m -81.57 -7.7 59.62 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.968 1.307 . . . . 0.0 113.938 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.1 t -82.92 141.96 44.41 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 120.804 -1.185 . . . . 0.0 112.581 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.07 154.26 86.47 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.646 0.909 . . . . 0.0 112.579 -3.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.39 122.12 46.19 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.483 1.513 . . . . 0.0 108.656 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.16 142.93 12.44 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.11 2.54 . . . . 0.0 111.634 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.9 123.71 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.441 1.497 . . . . 0.0 108.269 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.6 t -99.29 124.52 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.754 0.822 . . . . 0.0 110.172 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.75 128.1 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.997 1.319 . . . . 0.0 109.553 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 60.8 m -100.51 156.34 17.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.108 0.963 . . . . 0.0 111.975 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -56.25 -35.4 67.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.789 1.236 . . . . 0.0 114.168 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 37.0 m -73.72 -12.6 60.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.751 0.82 . . . . 0.0 113.021 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.64 -6.3 52.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.816 1.246 . . . . 0.0 112.628 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 43.0 mm -73.42 -31.93 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.218 0.917 . . . . 0.0 112.494 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 160.93 55.08 0.02 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.48 100.85 10.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.855 0.827 . . . . 0.0 110.315 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.39 -32.61 71.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.74 1.216 . . . . 0.0 113.667 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.55 -21.56 27.26 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.486 1.515 . . . . 0.0 114.027 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.58 -9.94 50.48 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.466 1.506 . . . . 0.0 113.934 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.9 t -79.78 125.96 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 119.949 1.249 . . . . 0.0 111.327 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -105.17 156.04 18.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.644 1.577 . . . . 0.0 110.991 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -147.88 159.17 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.624 1.569 . . . . 0.0 110.861 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.6 t -161.4 177.54 10.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.687 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 100.07 160.63 28.45 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.444 1.497 . . . . 0.0 114.26 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -67.07 -33.14 74.85 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.187 1.395 . . . . 0.0 113.116 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.04 -3.49 36.96 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.05 1.31 . . . . 0.0 115.344 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.69 -7.39 56.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.032 1.333 . . . . 0.0 112.855 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -128.38 -36.01 1.93 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.778 1.231 . . . . 0.0 113.845 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -159.73 157.39 29.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.599 1.16 . . . . 0.0 112.477 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.09 -176.58 24.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.715 1.15 . . . . 0.0 114.106 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -135.43 147.12 48.86 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.887 1.275 . . . . 0.0 112.473 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 20.9 p -67.99 -29.07 68.0 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -112.02 5.81 18.95 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -141.28 154.64 67.65 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.42 1.488 . . . . 0.0 111.068 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.42 136.89 27.12 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.71 2.274 . . . . 0.0 110.738 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -95.82 118.54 32.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.727 1.211 . . . . 0.0 110.146 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -98.29 147.57 24.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.136 0.975 . . . . 0.0 113.369 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.33 153.78 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.253 1.421 . . . . 0.0 111.241 173.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.72 140.08 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.679 1.591 . . . . 0.0 109.456 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.3 mt -114.77 130.66 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.56 1.944 . . . . 0.0 108.901 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.4 t0 -119.55 84.17 2.16 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.603 1.561 . . . . 0.0 110.569 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 3.3 p -84.97 -5.84 59.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.774 2.03 . . . . 0.0 113.288 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -56.03 -40.58 73.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.479 1.036 . . . . 0.0 111.676 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.06 -9.95 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.404 1.482 . . . . 0.0 113.329 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -98.2 0.12 45.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.132 1.773 . . . . 0.0 114.333 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 82.99 -134.04 12.48 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.252 0.93 . . . . 0.0 111.016 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.59 171.49 9.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.758 1.223 . . . . 0.0 112.292 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.87 177.81 19.99 Favored Glycine 0 N--CA 1.472 1.074 0 C-N-CA 124.414 1.006 . . . . 0.0 114.951 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -106.63 131.71 10.78 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.551 1.548 . . . . 0.0 111.815 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.92 121.56 41.95 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.721 2.008 . . . . 0.0 108.913 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 74.8 m -112.56 143.9 42.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.979 1.712 . . . . 0.0 110.266 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.8 tt -143.86 137.4 27.9 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.767 0.827 . . . . 0.0 110.502 -166.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 62.7 m -138.7 135.08 34.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.73 0.812 . . . . 0.0 111.371 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 23.9 mt -122.29 134.56 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.264 1.426 . . . . 0.0 109.13 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.28 154.64 44.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 111.258 -174.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.59 21.29 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.785 -1.008 . . . . 0.0 114.052 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.69 -14.73 36.74 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.029 3.153 . . . . 0.0 114.976 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.3 t -159.16 165.74 33.03 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.955 1.252 . . . . 0.0 112.419 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.01 148.34 51.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.961 1.304 . . . . 0.0 111.775 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 35.9 m -135.12 147.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.562 1.145 . . . . 0.0 112.293 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -88.51 104.38 16.76 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.759 0.824 . . . . 0.0 110.19 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 39.6 mt -84.98 130.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.871 0.868 . . . . 0.0 109.742 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -128.14 155.46 44.4 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.305 1.842 . . . . 0.0 110.333 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.59 156.5 46.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.964 1.306 . . . . 0.0 111.625 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.27 125.83 5.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.983 1.313 . . . . 0.0 110.275 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.64 133.5 36.4 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.335 -0.853 . . . . 0.0 111.199 171.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 50.5 mt -96.19 160.77 14.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.67 1.188 . . . . 0.0 111.732 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.45 -20.68 66.47 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 0.0 113.291 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.62 -3.69 56.55 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.094 1.358 . . . . 0.0 113.274 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.29 -2.94 75.43 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.611 1.577 . . . . 0.0 114.848 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 46.5 p -82.47 167.96 17.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.554 1.542 . . . . 0.0 111.14 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -116.24 127.56 54.86 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.845 0.858 . . . . 0.0 111.196 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -90.86 137.66 32.19 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.703 1.201 . . . . 0.0 109.937 170.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 25.3 t -122.59 138.27 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.4 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.3 p -136.16 151.85 50.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.415 1.486 . . . . 0.0 110.948 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 11.7 p90 -161.27 145.5 13.3 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.427 1.491 . . . . 0.0 110.515 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 25.0 t -107.01 103.41 47.63 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.58 0.752 . . . . 0.0 110.722 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -78.26 110.78 2.93 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.358 2.705 . . . . 0.0 110.128 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.9 m -69.22 -37.98 78.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.647 0.779 . . . . 0.0 112.341 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.29 146.39 34.59 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.035 1.334 . . . . 0.0 111.447 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.37 168.06 25.37 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.275 2.65 . . . . 0.0 111.1 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 114.76 -163.98 12.13 Favored Glycine 0 N--CA 1.472 1.036 0 C-N-CA 125.172 1.368 . . . . 0.0 113.402 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 54.0 t30 -89.89 120.17 30.89 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.9 -0.764 . . . . 0.0 112.174 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.33 143.43 30.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.117 1.367 . . . . 0.0 110.904 164.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.28 134.63 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.926 1.29 . . . . 0.0 108.82 174.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 29.0 mt -116.32 132.95 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.288 1.435 . . . . 0.0 109.521 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -114.17 125.51 54.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.018 1.727 . . . . 0.0 109.904 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.54 124.83 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.974 0.91 . . . . 0.0 109.638 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 31.1 tttt -132.39 127.12 34.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.142 1.377 . . . . 0.0 110.482 -171.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 37.3 t80 -123.8 124.76 43.39 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.12 0.968 . . . . 0.0 110.064 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.99 49.2 17.4 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.469 1.107 . . . . 0.0 111.773 -173.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.84 13.83 9.57 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.373 2.269 . . . . 0.0 114.624 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -119.48 126.8 52.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.104 1.362 . . . . 0.0 110.258 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -65.29 121.58 15.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.616 1.167 . . . . 0.0 111.055 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -79.14 158.69 74.27 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 121.288 -0.883 . . . . 0.0 111.784 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.18 138.07 71.2 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.517 2.811 . . . . 0.0 112.909 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 92.63 -23.24 29.21 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.964 1.268 . . . . 0.0 114.343 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 72.4 m -74.56 149.96 86.52 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 118.916 1.358 . . . . 0.0 111.64 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.52 145.86 80.91 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 119.326 0.795 . . . . 0.0 111.442 -3.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -98.85 120.43 39.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.54 1.136 . . . . 0.0 110.772 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 45.9 m -86.86 133.02 33.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.131 0.972 . . . . 0.0 110.988 171.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 17.2 t -129.93 111.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.63 1.572 . . . . 0.0 109.471 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -81.57 109.58 16.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.015 0.526 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 60.4 t -91.26 127.1 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.131 1.372 . . . . 0.0 109.328 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -117.9 161.94 18.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.739 1.216 . . . . 0.0 112.186 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 129.22 163.29 11.17 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.965 1.745 . . . . 0.0 113.45 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 126.06 1.744 . . . . 0.0 110.291 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 96.9 mtp -89.18 133.03 34.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.428 1.491 . . . . 0.0 112.407 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 18.4 m -118.27 140.59 49.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 108.465 160.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -156.51 158.42 37.16 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.0 tt -161.04 154.64 22.04 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.43 1.892 . . . . 0.0 111.131 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.51 151.34 47.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.002 1.321 . . . . 0.0 112.559 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 52.6 t -139.69 133.98 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.022 1.729 . . . . 0.0 109.458 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -92.5 128.41 9.39 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.885 0.755 . . . . 0.0 111.25 172.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 66.1 m -118.92 144.91 46.17 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.412 1.085 . . . . 0.0 112.53 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.01 151.98 24.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.0 112.357 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.5 149.66 24.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.064 0.946 . . . . 0.0 110.75 166.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.33 134.05 34.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.539 0.735 . . . . 0.0 111.572 169.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.8 mm -112.89 127.48 26.78 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.495 1.518 . . . . 0.0 108.74 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.7 134.31 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.908 2.405 . . . . 0.0 110.478 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 29.9 mm -144.87 140.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.387 1.475 . . . . 0.0 110.293 -168.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.59 55.54 7.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.786 1.634 . . . . 0.0 112.905 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.4 mm -65.76 112.55 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.478 1.111 . . . . 0.0 110.516 -172.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 99.8 p -173.9 172.6 3.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.276 1.43 . . . . 0.0 111.849 -170.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.08 4.82 9.35 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.932 1.693 . . . . 0.0 113.623 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 56.8 m -61.95 134.85 57.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 111.472 -174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.67 132.98 46.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.439 1.496 . . . . 0.0 111.633 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.3 mp -73.76 -21.16 60.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.027 0.931 . . . . 0.0 112.425 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 24.0 m -67.58 -23.46 65.4 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -167.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -114.21 8.95 17.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.35 1.46 . . . . 0.0 113.609 175.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.66 148.09 25.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.026 1.33 . . . . 0.0 111.997 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 47.3 p -141.39 169.65 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.261 2.224 . . . . 0.0 108.974 168.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.42 155.24 37.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 54.6 p -132.25 160.82 35.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.082 2.153 . . . . 0.0 109.153 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -112.8 135.27 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.073 0.949 . . . . 0.0 109.449 166.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.0 t -104.68 113.13 65.25 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.968 1.307 . . . . 0.0 108.196 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.32 173.44 11.65 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.999 3.133 . . . . 0.0 111.128 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.72 -32.69 56.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.127 3.218 . . . . 0.0 113.961 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.5 m -75.65 -4.53 40.69 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 0.0 114.12 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 74.86 -1.76 52.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.286 1.422 . . . . 0.0 115.15 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -77.21 85.56 3.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.516 1.526 . . . . 0.0 111.243 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.09 133.01 54.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.854 1.262 . . . . 0.0 111.929 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -140.58 150.64 61.16 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.174 1.39 . . . . 0.0 111.277 176.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.64 155.55 40.01 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.271 3.314 . . . . 0.0 112.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.2 m -111.28 155.35 23.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.547 1.539 . . . . 0.0 112.207 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 6.2 tt -95.29 116.72 29.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.419 1.488 . . . . 0.0 108.671 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 11.2 mp -84.6 138.11 32.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.476 1.11 . . . . 0.0 111.352 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -133.44 136.17 45.02 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.041 1.336 . . . . 0.0 112.803 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.7 121.73 26.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 152.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.5 162.23 13.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.479 1.112 . . . . 0.0 112.013 -171.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -60.36 -31.65 70.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -86.27 -1.82 57.83 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.971 0.909 . . . . 0.0 113.439 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.62 0.35 57.87 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.504 1.526 . . . . 0.0 114.095 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -80.87 177.31 9.13 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.119 1.368 . . . . 0.0 112.863 170.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 88.6 t -130.15 140.51 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 109.617 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.04 -174.54 25.97 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.61 154.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.613 1.565 . . . . 0.0 111.946 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 16.4 m -121.38 149.59 42.74 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.15 1.38 . . . . 0.0 111.198 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.2 p90 -165.64 -178.87 5.07 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.101 2.16 . . . . 0.0 109.752 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.9 t -128.88 122.44 21.42 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-N 119.258 0.935 . . . . 0.0 109.95 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.81 149.56 23.27 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.115 3.21 . . . . 0.0 111.369 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -106.27 -9.57 16.77 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -143.25 173.63 11.42 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.858 2.063 . . . . 0.0 110.11 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.5 p -88.77 167.35 13.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.656 1.182 . . . . 0.0 111.117 167.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.65 -168.08 30.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.801 1.191 . . . . 0.0 113.57 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.05 116.98 11.98 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.05 0.94 . . . . 0.0 112.005 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.8 m80 -102.58 141.0 36.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.974 1.71 . . . . 0.0 109.042 167.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.86 123.26 44.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.055 0.942 . . . . 0.0 109.229 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.1 t -87.76 113.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.987 1.315 . . . . 0.0 107.811 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -95.21 126.21 40.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.525 1.13 . . . . 0.0 110.225 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 81.3 t -117.71 120.14 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.996 1.319 . . . . 0.0 109.769 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -108.82 130.48 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.97 1.708 . . . . 0.0 111.72 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -108.74 122.94 48.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.545 1.938 . . . . 0.0 109.356 171.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 57.25 -94.27 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.064 1.346 . . . . 0.0 111.72 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -123.37 9.5 8.8 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.863 1.697 . . . . 0.0 115.777 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.6 157.02 43.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.743 1.771 . . . . 0.0 112.393 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -67.34 138.61 56.91 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.888 -1.133 . . . . 0.0 112.783 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 5.9 p -71.44 156.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.389 1.076 . . . . 0.0 110.675 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.06 -28.44 62.58 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.0 m -80.47 -9.65 59.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.942 1.297 . . . . 0.0 114.162 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 31.9 t -90.78 147.56 36.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.9 1.28 . . . . 0.0 113.198 -172.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.26 162.28 76.76 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.26 0.771 . . . . 0.0 112.677 -5.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.01 126.38 28.32 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.685 1.594 . . . . 0.0 109.04 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.66 142.27 12.75 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.117 2.544 . . . . 0.0 112.031 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.9 t -135.87 127.75 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.593 1.557 . . . . 0.0 107.869 170.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 53.9 t -100.39 126.53 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.853 0.861 . . . . 0.0 110.49 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.29 130.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.138 1.375 . . . . 0.0 110.169 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 65.9 m -98.15 156.92 16.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.52 1.128 . . . . 0.0 112.087 174.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -58.52 -30.01 66.75 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 8.7 m -65.34 -19.29 65.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.6 1.16 . . . . 0.0 113.739 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -93.46 -12.17 30.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.713 1.205 . . . . 0.0 112.955 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.7 -24.81 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.659 1.184 . . . . 0.0 112.576 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 134.73 68.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.291 1.424 . . . . 0.0 112.84 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.96 105.79 10.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.262 0.531 . . . . 0.0 110.007 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.49 66.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.841 0.856 . . . . 0.0 112.307 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.1 m -54.18 -23.33 14.04 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.181 1.793 . . . . 0.0 114.468 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -90.9 -12.73 35.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.856 1.262 . . . . 0.0 113.466 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 67.8 t -74.19 133.99 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.625 1.102 . . . . 0.0 109.867 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.55 154.45 24.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 111.171 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.5 m -144.51 150.5 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.471 1.508 . . . . 0.0 110.172 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.7 m -148.12 165.74 29.93 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.91 1.284 . . . . 0.0 112.487 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.48 159.73 24.01 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.517 1.056 . . . . 0.0 114.416 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -71.59 -25.43 62.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.66 1.184 . . . . 0.0 113.373 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.89 -5.76 41.03 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.264 0.935 . . . . 0.0 114.986 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.25 -2.64 58.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.417 1.487 . . . . 0.0 112.893 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -135.84 -38.72 0.71 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -141.56 151.18 42.99 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.772 1.229 . . . . 0.0 111.831 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.43 -176.7 22.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.144 1.354 . . . . 0.0 113.269 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -147.97 145.72 28.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.173 0.989 . . . . 0.0 113.015 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 24.3 p -60.13 -26.13 66.02 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.711 1.605 . . . . 0.0 115.028 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.77 23.22 9.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.245 1.418 . . . . 0.0 112.93 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -145.49 137.34 13.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.642 1.177 . . . . 0.0 110.315 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -71.27 133.68 23.3 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.536 2.157 . . . . 0.0 110.286 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -102.33 131.35 48.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.436 1.494 . . . . 0.0 110.393 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.42 154.21 35.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.862 1.265 . . . . 0.0 113.325 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.71 153.15 27.98 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.005 1.722 . . . . 0.0 111.024 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.61 142.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.496 1.919 . . . . 0.0 109.9 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.1 132.17 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.815 1.646 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2071 ' ' ASP . . . . . 0.455 ' HA ' HH21 ' A' 2073 ' ' ARG . 31.4 t0 -125.39 86.75 2.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.46 1.504 . . . . 0.0 111.732 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 16.4 p -83.43 -8.92 59.3 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.422 1.889 . . . . 0.0 113.657 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2073 ' ' ARG . . . . . 0.455 HH21 ' HA ' ' A' 2071 ' ' ASP . 0.5 OUTLIER -60.89 -30.32 70.09 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.7 1.137 . . . . 0.0 113.616 -175.425 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.94 -15.58 60.68 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.94 0.896 . . . . 0.0 113.231 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -97.5 -1.63 43.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.95 1.7 . . . . 0.0 114.208 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.78 -128.39 8.55 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.651 1.119 . . . . 0.0 112.296 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -94.22 160.28 14.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.413 1.485 . . . . 0.0 112.234 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.8 174.09 19.38 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.34 126.36 8.72 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.868 1.223 . . . . 0.0 111.852 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.9 123.14 41.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.705 2.002 . . . . 0.0 108.576 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.9 t -116.39 140.51 49.27 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.04 1.336 . . . . 0.0 110.402 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.86 131.0 30.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.663 1.185 . . . . 0.0 110.284 -167.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 56.9 m -135.16 131.14 36.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.796 0.838 . . . . 0.0 110.72 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 22.5 mt -109.27 125.46 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.549 1.54 . . . . 0.0 108.114 173.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.21 139.0 46.96 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.154 1.382 . . . . 0.0 109.742 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -168.82 -175.92 38.6 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -8.58 23.93 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.471 3.447 . . . . 0.0 113.825 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.1 t -154.83 164.84 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.754 1.222 . . . . 0.0 111.875 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.75 146.51 52.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.664 1.186 . . . . 0.0 111.53 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -132.27 141.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.112 0.965 . . . . 0.0 110.822 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.34 125.43 29.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.219 0.608 . . . . 0.0 110.013 169.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 38.4 mt -106.52 127.76 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.94 0.896 . . . . 0.0 108.851 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -124.31 143.68 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 109.854 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 24.9 p -113.74 154.03 28.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.911 1.284 . . . . 0.0 111.248 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.94 120.0 5.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.635 1.174 . . . . 0.0 110.15 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -79.02 123.53 27.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.307 1.043 . . . . 0.0 110.645 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.37 160.12 15.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.104 0.962 . . . . 0.0 111.975 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.6 -25.82 68.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.109 0.963 . . . . 0.0 112.333 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.13 -8.52 50.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.998 1.719 . . . . 0.0 113.777 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.59 -5.48 84.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.768 1.651 . . . . 0.0 114.304 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 25.0 p -82.93 161.41 21.84 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.943 1.697 . . . . 0.0 111.471 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 33.8 t -102.88 123.33 46.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.677 0.791 . . . . 0.0 110.255 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.05 138.2 33.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.867 0.867 . . . . 0.0 109.296 163.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 56.7 t -119.95 133.84 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.059 1.744 . . . . 0.0 108.169 168.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 67.6 m -136.92 138.3 40.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.853 1.261 . . . . 0.0 110.517 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.1 p90 -147.99 148.55 30.85 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.277 1.031 . . . . 0.0 112.465 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 23.2 t -109.15 106.84 59.34 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.538 0.735 . . . . 0.0 111.088 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.37 119.17 4.85 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.992 2.461 . . . . 0.0 109.694 171.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -78.86 -43.54 24.83 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.734 0.814 . . . . 0.0 111.614 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -91.31 147.68 36.01 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.551 1.14 . . . . 0.0 110.933 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.99 167.61 26.66 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.558 2.838 . . . . 0.0 111.734 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.78 -161.28 18.19 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.066 1.317 . . . . 0.0 113.768 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -93.79 126.71 39.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.007 0.923 . . . . 0.0 111.541 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -111.29 142.92 42.89 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.567 1.547 . . . . 0.0 109.808 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.45 123.89 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.595 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.29 124.6 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.896 1.278 . . . . 0.0 109.73 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -104.26 128.9 52.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.893 1.677 . . . . 0.0 109.755 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.3 mm -121.88 111.98 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.858 1.263 . . . . 0.0 109.524 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -121.02 130.92 53.99 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.634 1.574 . . . . 0.0 111.098 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -123.53 126.01 45.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.447 1.499 . . . . 0.0 110.328 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.16 28.77 9.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.342 1.457 . . . . 0.0 113.963 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 87.82 6.89 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 129.147 2.979 . . . . 0.0 114.894 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -114.69 138.27 50.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.726 1.21 . . . . 0.0 111.113 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 132.23 51.53 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.165 -0.959 . . . . 0.0 111.143 172.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.1 m -80.4 159.99 68.63 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.529 -0.732 . . . . 0.0 111.516 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.27 136.59 62.81 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.749 2.966 . . . . 0.0 113.354 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 86.04 -19.8 24.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.048 1.309 . . . . 0.0 114.394 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 23.1 t -76.4 144.27 74.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 118.613 1.207 . . . . 0.0 111.451 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.48 150.7 93.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 119.727 0.938 . . . . 0.0 112.283 -3.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.68 122.29 44.74 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.399 1.479 . . . . 0.0 110.733 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.3 p -86.96 135.28 33.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.419 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.3 t -130.93 113.98 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.186 1.395 . . . . 0.0 109.496 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.13 115.68 22.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.113 0.565 . . . . 0.0 111.154 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 91.4 t -98.22 115.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.232 1.413 . . . . 0.0 109.056 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 4.9 t -102.4 173.81 6.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.947 1.299 . . . . 0.0 111.455 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 116.52 -137.29 13.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.094 1.33 . . . . 0.0 112.615 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 124.768 1.227 . . . . 0.0 112.454 -167.143 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.9 ptt? -70.62 154.24 42.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.438 1.095 . . . . 0.0 112.73 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.0 m -107.59 144.79 34.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.69 1.196 . . . . 0.0 110.117 166.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.31 149.54 51.91 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.561 1.144 . . . . 0.0 113.266 -165.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -157.35 146.24 19.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.066 1.747 . . . . 0.0 110.11 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 48.2 mttp -128.51 149.9 50.4 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.518 1.127 . . . . 0.0 113.0 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.82 139.11 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.32 1.848 . . . . 0.0 109.513 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.96 120.76 5.39 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 4.0 m -111.96 142.74 44.0 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.694 1.197 . . . . 0.0 112.697 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.48 146.0 11.54 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.74 169.35 17.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.977 1.311 . . . . 0.0 111.555 163.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -105.3 137.59 42.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.737 1.215 . . . . 0.0 111.853 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.7 mm -105.27 118.04 56.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.303 1.041 . . . . 0.0 109.02 164.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.13 128.46 10.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.402 2.735 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 57.0 mt -147.44 139.53 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.658 1.583 . . . . 0.0 109.843 -172.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.07 60.26 3.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.803 1.641 . . . . 0.0 112.456 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.4 111.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.44 1.096 . . . . 0.0 111.34 -166.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 m -172.83 146.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.816 2.446 . . . . 0.0 109.33 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.42 -10.16 50.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.77 1.228 . . . . 0.0 113.501 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 24.9 p -91.43 160.3 15.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.338 1.855 . . . . 0.0 112.063 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 60.3 m-20 70.41 3.25 4.39 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.406 2.282 . . . . 0.0 114.679 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.53 -20.86 65.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 113.783 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 28.0 p -77.14 -12.55 59.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 9.74 3.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.179 1.391 . . . . 0.0 114.389 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.95 143.22 34.37 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.207 1.003 . . . . 0.0 110.974 164.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 39.8 p -140.86 160.75 39.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 109.779 173.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.87 150.67 26.24 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.57 0.748 . . . . 0.0 113.013 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 63.6 p -138.8 163.12 33.06 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.977 2.111 . . . . 0.0 109.491 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 137.36 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.911 1.284 . . . . 0.0 109.864 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.1 t -105.6 110.91 64.74 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.111 1.364 . . . . 0.0 108.083 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.57 169.14 20.27 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.893 3.062 . . . . 0.0 110.846 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.16 -15.88 47.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.065 2.51 . . . . 0.0 113.12 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 67.0 p -79.39 -9.3 59.57 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.88 1.272 . . . . 0.0 113.826 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.5 85.21 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.668 1.604 . . . . 0.0 115.185 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -77.61 82.58 4.03 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.374 1.469 . . . . 0.0 111.698 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.83 132.64 54.5 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 111.875 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.06 151.73 59.79 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.405 1.482 . . . . 0.0 111.354 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.9 158.04 34.75 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.951 3.1 . . . . 0.0 112.852 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.9 m -110.18 155.7 21.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.066 1.346 . . . . 0.0 112.457 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.5 tt -99.48 115.23 28.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.82 1.648 . . . . 0.0 108.157 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 4.3 mp -87.08 134.37 33.51 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.578 0.751 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.91 137.23 53.11 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.179 1.392 . . . . 0.0 112.805 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -99.14 124.19 43.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.524 1.529 . . . . 0.0 107.979 161.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.76 171.7 7.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.211 1.404 . . . . 0.0 112.763 -165.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -59.63 -32.19 70.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.33 -2.62 58.51 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.251 1.02 . . . . 0.0 113.446 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.46 -8.4 62.2 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.727 1.632 . . . . 0.0 114.857 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -73.96 168.83 18.69 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.594 1.197 . . . . 0.0 112.975 172.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.3 t -131.26 142.37 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.977 1.311 . . . . 0.0 110.948 -168.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.87 -168.79 20.72 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.846 1.212 . . . . 0.0 113.992 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.72 151.35 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.775 1.23 . . . . 0.0 112.233 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 43.2 m -123.59 155.1 38.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.766 1.626 . . . . 0.0 111.467 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.6 p90 -166.93 -174.68 2.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.497 2.319 . . . . 0.0 109.221 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -128.93 116.23 19.09 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 119.302 0.956 . . . . 0.0 109.706 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.99 139.52 24.41 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.939 3.093 . . . . 0.0 110.574 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -99.96 -6.9 25.85 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.271 1.029 . . . . 0.0 113.08 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -140.16 169.25 18.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.759 2.024 . . . . 0.0 110.363 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 167.11 13.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.277 1.031 . . . . 0.0 110.995 165.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 94.96 -169.3 28.1 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.048 1.309 . . . . 0.0 113.749 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -72.15 118.27 14.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.49 144.16 32.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.351 1.86 . . . . 0.0 109.104 168.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.58 125.95 51.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 0.0 109.642 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 26.3 t -89.35 121.39 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.705 1.202 . . . . 0.0 108.001 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -99.93 128.48 46.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.718 1.207 . . . . 0.0 110.061 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 48.0 t -126.71 131.4 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.595 1.158 . . . . 0.0 110.421 -172.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.9 mttp -123.38 147.58 46.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.734 1.613 . . . . 0.0 112.547 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -118.58 119.83 35.67 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 108.941 169.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.27 30.91 19.22 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.996 1.318 . . . . 0.0 113.247 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.48 2.5 73.11 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.027 1.299 . . . . 0.0 116.052 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -123.59 151.19 43.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.442 1.621 . . . . 0.0 110.999 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.34 144.58 57.06 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 98.2 t -77.63 146.08 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.678 1.191 . . . . 0.0 109.096 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.91 63.57 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -174.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 58.1 p -85.95 -8.05 58.25 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.162 1.385 . . . . 0.0 114.079 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 21.2 t -82.87 144.45 48.09 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.936 1.294 . . . . 0.0 112.358 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.03 155.49 87.41 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.562 0.879 . . . . 0.0 112.613 -3.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.49 120.85 48.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.731 1.612 . . . . 0.0 108.768 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.26 141.61 12.91 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.965 2.443 . . . . 0.0 111.247 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 22.3 t -137.57 126.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.799 1.639 . . . . 0.0 108.093 175.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.8 t -97.31 124.29 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.72 0.808 . . . . 0.0 110.202 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.57 128.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.037 1.335 . . . . 0.0 109.883 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 66.9 m -93.31 170.75 9.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.706 1.202 . . . . 0.0 112.234 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -34.5 77.46 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.323 -1.486 . . . . 0.0 111.604 174.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.0 m -66.17 -2.29 4.1 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.708 1.603 . . . . 0.0 115.27 -173.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.63 5.49 8.21 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.997 1.719 . . . . 0.0 112.96 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 3.5 mm -86.23 -21.83 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.546 1.138 . . . . 0.0 113.557 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.1 38.35 0.04 OUTLIER Glycine 0 N--CA 1.471 0.968 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.36 84.4 4.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.474 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -54.95 -37.01 65.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.609 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.22 -24.95 45.38 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.497 1.519 . . . . 0.0 114.381 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -90.94 -8.52 49.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.698 1.599 . . . . 0.0 114.215 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 90.4 t -73.8 137.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.007 1.276 . . . . 0.0 110.419 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -121.03 155.21 34.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.311 1.444 . . . . 0.0 111.365 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 30.6 m -145.23 153.33 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 109.971 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -154.86 170.88 20.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.025 0.93 . . . . 0.0 112.669 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.05 156.17 30.59 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.224 1.393 . . . . 0.0 113.184 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.04 -21.61 62.24 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.98 -2.16 22.74 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.078 1.323 . . . . 0.0 115.093 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 65.3 mt -90.93 -7.22 52.71 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.165 1.786 . . . . 0.0 112.707 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.06 -32.23 1.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.074 1.349 . . . . 0.0 113.887 -172.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.48 156.86 42.25 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.486 1.514 . . . . 0.0 112.253 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.87 32.5 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.371 0.986 . . . . 0.0 113.797 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.0 m80 -134.22 148.97 50.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 112.699 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 17.1 p -68.78 -29.78 68.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -118.19 0.15 11.69 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.52 146.49 61.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.106 1.763 . . . . 0.0 109.644 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.21 141.32 43.12 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.783 2.322 . . . . 0.0 111.049 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.72 154.29 21.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.41 1.084 . . . . 0.0 110.295 168.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.66 150.26 47.22 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 112.608 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 42.2 p90 -157.13 149.98 23.54 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 110.637 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.53 140.95 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.934 1.694 . . . . 0.0 109.566 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 71.5 mt -112.74 134.62 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.967 1.707 . . . . 0.0 108.86 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 23.2 t70 -137.07 123.22 20.43 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.565 1.546 . . . . 0.0 112.013 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 11.7 p -134.48 -11.75 2.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -157.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.13 -21.94 66.36 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 121.064 1.756 . . . . 0.0 114.542 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.46 -20.47 61.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.76 0.824 . . . . 0.0 112.554 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -92.34 -3.82 54.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.988 1.715 . . . . 0.0 113.423 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.7 -110.28 3.5 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.992 1.282 . . . . 0.0 112.462 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -131.79 151.74 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.534 1.533 . . . . 0.0 112.808 -168.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.87 -179.13 28.71 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -84.76 127.59 8.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.22 0.914 . . . . 0.0 111.239 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.8 124.58 49.8 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.243 1.817 . . . . 0.0 108.363 175.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.8 t -112.06 140.44 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.844 1.257 . . . . 0.0 111.35 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.17 133.73 47.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.248 2.219 . . . . 0.0 108.363 -174.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 83.0 p -143.36 151.76 40.81 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.26 -0.9 . . . . 0.0 112.661 167.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.27 137.52 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.97 1.308 . . . . 0.0 109.296 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.67 155.41 41.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.273 1.429 . . . . 0.0 111.033 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 167.3 -155.5 26.57 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 118.808 -0.996 . . . . 0.0 114.202 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.43 -8.69 23.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.429 3.42 . . . . 0.0 115.368 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.4 t -160.26 162.0 33.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.741 1.217 . . . . 0.0 111.528 173.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.29 146.98 53.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.301 1.041 . . . . 0.0 111.782 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 34.6 m -135.46 147.89 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.035 1.334 . . . . 0.0 111.65 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -88.94 122.55 32.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.862 0.865 . . . . 0.0 110.346 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.21 131.41 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.371 1.068 . . . . 0.0 109.604 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -130.05 161.08 31.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.224 1.81 . . . . 0.0 110.287 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 39.9 p -143.03 163.48 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.489 1.116 . . . . 0.0 112.829 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.13 121.35 6.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.773 1.629 . . . . 0.0 109.969 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.54 131.29 35.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.89 1.276 . . . . 0.0 111.132 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -108.53 153.63 23.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.023 1.329 . . . . 0.0 111.292 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -15.6 63.43 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -76.83 -6.06 50.84 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.753 1.221 . . . . 0.0 112.857 170.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 89.43 2.13 77.1 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.996 1.76 . . . . 0.0 114.082 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 4.1 p -81.64 156.73 24.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.413 1.885 . . . . 0.0 111.31 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -115.43 120.88 41.01 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.994 0.917 . . . . 0.0 110.347 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.8 ttm105 -78.93 133.77 36.9 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.976 0.91 . . . . 0.0 108.846 164.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 27.4 t -115.48 140.54 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.874 1.67 . . . . 0.0 108.518 169.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.7 p -136.21 150.3 48.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.589 1.556 . . . . 0.0 111.334 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.7 p90 -163.12 150.07 12.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 111.415 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 15.0 t -111.59 101.55 51.26 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.907 0.883 . . . . 0.0 110.766 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.64 116.87 4.38 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.104 2.536 . . . . 0.0 110.342 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.6 m -74.06 -39.69 63.3 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.923 0.889 . . . . 0.0 112.396 -173.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -95.07 148.69 35.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.05 1.34 . . . . 0.0 111.478 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.77 164.49 31.86 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.374 2.716 . . . . 0.0 110.98 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 121.01 -163.94 14.36 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.168 1.366 . . . . 0.0 113.284 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.6 t30 -91.55 117.27 29.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.457 0.703 . . . . 0.0 111.99 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -94.96 141.13 29.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.505 1.122 . . . . 0.0 111.145 164.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.77 134.96 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.404 1.482 . . . . 0.0 108.753 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 26.5 mt -118.32 128.36 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.927 1.291 . . . . 0.0 109.111 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -105.72 130.08 53.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 110.884 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 16.0 mm -119.83 120.82 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.002 1.321 . . . . 0.0 110.022 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -131.93 135.99 47.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.22 1.408 . . . . 0.0 111.469 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 69.8 t80 -131.48 129.69 41.46 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.88 1.672 . . . . 0.0 110.652 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.86 29.26 11.68 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.048 1.339 . . . . 0.0 113.424 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.8 t0 83.4 4.53 0.86 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 129.198 2.999 . . . . 0.0 114.668 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -109.05 128.22 54.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.824 1.249 . . . . 0.0 111.186 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -63.24 125.98 25.9 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.053 1.341 . . . . 0.0 110.618 172.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.3 m -80.38 156.46 73.65 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-N 119.039 0.836 . . . . 0.0 111.318 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.19 144.45 81.31 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.409 2.072 . . . . 0.0 111.63 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.37 -24.33 14.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.967 1.27 . . . . 0.0 113.423 -172.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 10.1 t -77.89 143.04 65.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.167 0.987 . . . . 0.0 110.565 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 146.37 84.19 Favored 'Cis proline' 0 C--N 1.353 0.768 0 CA-C-N 120.224 1.116 . . . . 0.0 112.075 0.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -97.63 122.21 40.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.709 1.203 . . . . 0.0 110.546 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.9 m -89.34 129.81 35.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.259 1.024 . . . . 0.0 111.37 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -122.94 112.08 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.2 1.8 . . . . 0.0 109.495 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -81.24 103.07 10.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.189 0.595 . . . . 0.0 111.455 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 61.7 t -87.85 128.9 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 109.45 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -125.25 167.32 15.04 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 114.11 161.1 13.82 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.086 1.803 . . . . 0.0 113.091 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.98 1.712 . . . . 0.0 110.316 -171.024 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 21.4 ptm -146.52 159.17 43.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 113.264 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.5 m -136.86 151.34 48.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.238 2.215 . . . . 0.0 109.084 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -150.67 160.33 43.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -170.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1963 ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -158.39 153.68 25.71 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.512 1.925 . . . . 0.0 110.309 -172.654 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1964 ' ' LYS . . . . . 0.427 ' H ' HD13 ' A' 1963 ' ' LEU . 61.1 mttm -133.91 143.15 48.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.181 1.392 . . . . 0.0 111.525 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 63.9 t -138.86 137.53 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.91 1.684 . . . . 0.0 109.592 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.81 130.08 9.97 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.924 0.773 . . . . 0.0 111.52 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 69.0 m -119.72 150.98 39.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.952 1.301 . . . . 0.0 112.223 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -153.69 152.14 30.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.126 0.971 . . . . 0.0 112.929 -174.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.46 149.79 29.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.443 0.697 . . . . 0.0 110.527 163.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -98.35 125.92 43.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 110.26 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.6 122.49 35.04 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.764 -1.113 . . . . 0.0 109.529 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.76 135.25 21.32 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.942 2.428 . . . . 0.0 110.601 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -148.49 143.53 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.549 1.54 . . . . 0.0 110.03 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.22 59.35 4.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.461 1.504 . . . . 0.0 112.383 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.1 mm -73.82 102.99 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.7 t -167.52 179.01 5.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.87 1.668 . . . . 0.0 111.078 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -85.58 6.03 29.05 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.614 1.566 . . . . 0.0 112.921 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -63.86 139.73 58.8 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.647 1.579 . . . . 0.0 112.076 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.25 158.61 28.87 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.682 1.193 . . . . 0.0 111.959 175.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.2 -23.53 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.34 1.056 . . . . 0.0 113.625 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 91.4 p -71.4 -27.45 63.32 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.12 4.25 51.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.871 1.668 . . . . 0.0 113.503 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.37 140.85 34.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.9 p -138.25 160.88 38.31 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.158 1.783 . . . . 0.0 110.104 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -148.65 148.7 30.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.828 0.851 . . . . 0.0 113.035 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.6 p -142.09 166.81 23.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.744 2.018 . . . . 0.0 109.92 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -122.07 138.44 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 109.595 168.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.1 t -107.07 112.71 63.02 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.297 1.439 . . . . 0.0 108.11 166.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -77.91 171.3 17.49 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.12 3.213 . . . . 0.0 110.773 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.46 -17.51 59.87 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.88 2.387 . . . . 0.0 113.587 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 7.3 t -77.81 -12.14 59.95 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.114 0.966 . . . . 0.0 113.273 170.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 83.8 -0.64 89.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.768 1.651 . . . . 0.0 115.09 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -78.03 86.64 4.2 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.131 1.772 . . . . 0.0 111.105 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -61.01 132.33 53.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.0 0.92 . . . . 0.0 111.837 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -137.41 148.65 62.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 110.663 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.56 155.04 40.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.732 2.955 . . . . 0.0 112.428 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 89.5 m -115.77 151.28 35.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.042 1.337 . . . . 0.0 111.679 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 115.35 26.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.964 0.906 . . . . 0.0 109.346 171.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.91 142.12 42.14 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.467 1.107 . . . . 0.0 110.779 171.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -145.4 149.25 34.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 113.017 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.95 115.81 23.01 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 153.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.77 170.43 11.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.208 1.003 . . . . 0.0 112.503 -173.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 63.3 ttt-85 -60.69 -30.14 69.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.597 1.559 . . . . 0.0 114.315 -169.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -82.55 -10.58 58.93 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.593 1.157 . . . . 0.0 113.684 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.29 55.12 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.87 1.7 . . . . 0.0 114.584 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 166.22 19.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 118.783 1.291 . . . . 0.0 113.403 173.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 90.8 t -93.02 142.94 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.955 1.302 . . . . 0.0 110.197 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.63 -171.87 27.15 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.05 162.96 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.779 1.631 . . . . 0.0 112.675 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 84.7 p -136.99 159.25 42.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.286 1.034 . . . . 0.0 111.916 159.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -165.63 -171.73 2.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.989 2.516 . . . . 0.0 109.309 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 82.0 t -134.65 120.82 14.67 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 110.241 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.34 143.4 15.55 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.384 3.39 . . . . 0.0 110.792 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.41 23.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.73 169.3 18.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.325 1.85 . . . . 0.0 110.582 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -82.07 169.74 16.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 112.076 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.99 -175.83 23.35 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.59 1.567 . . . . 0.0 113.875 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.98 118.39 15.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.897 0.879 . . . . 0.0 111.13 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.3 m80 -103.64 143.85 32.22 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.946 1.699 . . . . 0.0 109.275 170.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 123.26 46.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.089 0.956 . . . . 0.0 108.959 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 58.0 t -85.0 129.69 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.846 1.259 . . . . 0.0 107.881 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -112.33 132.37 55.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.848 1.259 . . . . 0.0 110.339 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 95.1 t -129.6 127.97 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.475 1.11 . . . . 0.0 110.636 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -119.9 135.27 54.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.791 1.636 . . . . 0.0 112.057 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -106.64 114.94 29.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.465 1.906 . . . . 0.0 109.027 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.3 t30 52.62 -101.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.164 1.386 . . . . 0.0 111.763 -172.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.26 5.24 33.65 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.595 1.569 . . . . 0.0 115.876 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -140.6 149.46 42.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.799 1.8 . . . . 0.0 112.809 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -68.7 144.8 54.3 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.102 -0.999 . . . . 0.0 113.028 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.8 m -72.08 160.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 111.481 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.3 67.97 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.2 m -79.88 -15.68 56.87 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 34.1 t -89.19 145.05 33.42 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.536 1.134 . . . . 0.0 113.114 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.96 159.12 84.07 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 119.297 0.785 . . . . 0.0 112.6 -3.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.37 125.54 28.73 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.758 1.623 . . . . 0.0 109.577 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.18 139.26 13.23 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.072 2.515 . . . . 0.0 111.552 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 40.9 t -134.83 125.1 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.837 1.655 . . . . 0.0 107.957 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.3 t -98.17 124.8 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.87 0.868 . . . . 0.0 110.427 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.29 120.73 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.168 1.387 . . . . 0.0 108.747 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 83.2 p -96.3 167.99 10.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.943 0.897 . . . . 0.0 112.119 172.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.64 -22.84 66.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 12.1 t -70.78 -36.03 72.87 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.304 -0.873 . . . . 0.0 111.796 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -74.69 -15.98 60.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.452 1.101 . . . . 0.0 112.728 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 50.2 mm -64.91 -19.91 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.34 1.056 . . . . 0.0 112.037 173.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 132.11 64.6 0.09 OUTLIER Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.609 1.576 . . . . 0.0 113.755 168.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 23.9 t0 -65.85 114.47 5.11 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 117.766 0.783 . . . . 0.0 111.56 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.97 80.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.146 0.978 . . . . 0.0 112.755 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 49.0 m -61.32 -20.46 62.97 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -85.71 -12.0 52.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.137 1.375 . . . . 0.0 114.069 174.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.6 t -76.29 133.41 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.921 1.237 . . . . 0.0 110.117 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -115.52 157.9 23.39 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.655 1.582 . . . . 0.0 110.703 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.3 m -146.5 158.55 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.22 1.408 . . . . 0.0 111.036 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -160.06 169.15 23.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 112.288 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 107.69 160.38 20.93 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.213 1.387 . . . . 0.0 114.444 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -68.88 -32.11 71.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.465 1.506 . . . . 0.0 113.31 -169.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.48 -3.28 47.15 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.039 1.304 . . . . 0.0 115.17 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.56 -8.37 56.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.319 1.447 . . . . 0.0 112.631 168.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.66 -36.19 2.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -158.16 155.71 29.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.478 1.111 . . . . 0.0 112.752 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.03 -175.23 23.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.796 1.189 . . . . 0.0 114.288 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -137.69 148.55 45.78 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.118 1.367 . . . . 0.0 112.657 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 23.3 p -68.98 -35.07 76.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.08 10.2 22.02 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.42 154.85 72.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.608 1.563 . . . . 0.0 110.59 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 144.27 34.41 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.716 2.277 . . . . 0.0 111.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.45 138.36 37.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.404 1.482 . . . . 0.0 110.009 169.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.61 146.03 48.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.021 1.328 . . . . 0.0 113.307 -169.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -158.17 157.38 32.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.089 1.356 . . . . 0.0 112.159 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.43 141.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.476 1.911 . . . . 0.0 109.347 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 50.9 mt -117.1 132.68 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 108.769 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -120.81 100.71 7.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.724 1.61 . . . . 0.0 110.722 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 18.6 p -98.01 0.21 45.88 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.97 2.108 . . . . 0.0 113.034 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -59.88 -37.65 79.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.352 0.978 . . . . 0.0 112.713 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.28 -11.62 59.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.694 1.197 . . . . 0.0 113.247 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.38 49.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.867 1.667 . . . . 0.0 113.804 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.23 -129.54 9.33 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.663 1.125 . . . . 0.0 112.671 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -102.27 170.14 8.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.863 1.665 . . . . 0.0 112.388 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 134.17 -176.67 19.68 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.303 0.954 . . . . 0.0 115.114 168.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -94.56 124.16 7.81 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.685 1.136 . . . . 0.0 112.09 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -95.07 117.83 30.84 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.057 1.743 . . . . 0.0 108.198 170.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 68.3 m -108.76 143.81 37.41 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.492 1.517 . . . . 0.0 110.347 172.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.2 tt -142.12 140.29 32.43 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.869 0.867 . . . . 0.0 110.185 -169.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 92.0 p -143.84 152.6 41.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 112.616 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.3 mt -129.35 133.71 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 107.655 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -141.78 152.22 43.56 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.263 1.025 . . . . 0.0 111.566 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.28 -146.7 12.97 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.664 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.69 -8.85 22.02 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.702 2.934 . . . . 0.0 114.485 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.4 t -159.4 162.88 35.84 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.848 1.204 . . . . 0.0 112.633 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -70.63 146.74 49.82 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.785 1.234 . . . . 0.0 110.892 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.89 145.69 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.992 1.317 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.54 99.39 12.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 110.07 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 42.3 mt -81.04 131.38 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.208 1.003 . . . . 0.0 109.973 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -126.36 152.8 45.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.407 1.883 . . . . 0.0 110.207 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 33.7 p -138.93 154.16 48.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.991 1.316 . . . . 0.0 111.697 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -152.43 126.85 9.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.751 1.22 . . . . 0.0 111.156 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.81 128.08 32.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.506 1.122 . . . . 0.0 110.897 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.4 mt -97.43 155.05 17.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.647 1.179 . . . . 0.0 111.786 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.77 -16.63 64.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.255 1.022 . . . . 0.0 113.429 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -74.15 -11.79 60.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.998 1.319 . . . . 0.0 113.313 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.48 -0.49 65.68 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.936 1.731 . . . . 0.0 114.293 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 41.3 p -89.29 167.69 12.85 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.47 1.908 . . . . 0.0 111.253 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.5 t -117.33 130.34 56.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.083 0.953 . . . . 0.0 111.088 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -94.32 139.72 30.72 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.007 1.323 . . . . 0.0 110.146 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 21.7 t -125.3 139.54 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.009 1.724 . . . . 0.0 108.954 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.8 p -138.02 152.76 49.19 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.402 1.481 . . . . 0.0 111.386 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.9 p90 -162.88 148.42 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.589 1.556 . . . . 0.0 110.806 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 30.2 t -109.2 106.78 59.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.599 0.76 . . . . 0.0 110.658 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.33 106.05 1.98 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.376 2.717 . . . . 0.0 110.238 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.9 m -66.38 -44.0 84.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.03 0.932 . . . . 0.0 112.74 -171.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -92.4 148.21 35.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.431 1.092 . . . . 0.0 110.842 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.88 165.64 29.62 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.321 2.681 . . . . 0.0 111.602 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 125.82 -162.12 20.11 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 125.179 1.371 . . . . 0.0 113.561 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.9 t30 -93.8 125.2 38.29 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.698 0.799 . . . . 0.0 111.524 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -108.89 143.49 38.05 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.107 1.363 . . . . 0.0 110.241 168.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.33 133.72 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 108.533 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 23.7 mt -111.64 129.72 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 109.308 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -108.58 125.29 51.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.423 1.489 . . . . 0.0 110.153 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.8 mm -112.16 121.59 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.011 0.924 . . . . 0.0 109.238 172.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -127.13 133.02 50.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.174 1.789 . . . . 0.0 110.527 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.6 126.55 36.97 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.556 1.142 . . . . 0.0 110.549 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.51 40.01 25.93 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.865 1.266 . . . . 0.0 112.578 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.2 t0 72.87 5.42 5.19 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.576 2.75 . . . . 0.0 114.651 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -109.69 128.71 55.45 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.994 1.318 . . . . 0.0 110.589 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -67.13 123.15 19.47 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.755 1.222 . . . . 0.0 111.104 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.8 m -81.91 160.61 63.15 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.279 -0.888 . . . . 0.0 111.915 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.0 141.76 67.01 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.766 2.977 . . . . 0.0 113.659 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.31 -22.87 17.48 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.022 1.296 . . . . 0.0 114.287 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 74.7 m -73.52 150.57 89.17 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 118.861 1.33 . . . . 0.0 111.525 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -73.52 139.65 62.71 Favored 'Cis proline' 0 C--N 1.352 0.759 0 CA-C-N 119.365 0.809 . . . . 0.0 111.111 -5.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -93.22 114.69 27.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.945 0.898 . . . . 0.0 110.337 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 62.0 m -82.75 128.28 34.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.6 t -123.92 114.9 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.766 1.626 . . . . 0.0 109.636 -171.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -81.57 108.79 15.43 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.629 . . . . 0.0 111.213 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 84.4 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.835 1.254 . . . . 0.0 109.226 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -109.01 164.56 12.3 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.908 1.283 . . . . 0.0 111.882 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 115.15 177.06 18.74 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.703 1.62 . . . . 0.0 113.575 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 12.7 mp0 . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 124.941 1.297 . . . . 0.0 112.473 -172.995 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 120.755 0.312 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.8 ptm -120.41 153.97 35.79 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.233 1.413 . . . . 0.0 112.69 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.8 m -134.78 145.49 48.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.847 2.059 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -146.29 157.03 43.76 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.2 141.36 16.31 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.218 1.807 . . . . 0.0 109.982 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -132.21 143.72 50.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.736 1.214 . . . . 0.0 112.512 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 29.9 m -143.46 151.8 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.331 1.452 . . . . 0.0 111.278 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.16 153.1 27.54 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 124.344 0.973 . . . . 0.0 112.132 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.2 m -140.3 137.03 33.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.508 0.723 . . . . 0.0 112.692 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.0 154.23 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.701 1.2 . . . . 0.0 112.19 -176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.38 133.16 34.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 111.076 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.35 135.03 34.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.219 1.008 . . . . 0.0 110.608 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.76 113.16 30.38 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.886 0.874 . . . . 0.0 109.9 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.43 150.55 36.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.047 2.498 . . . . 0.0 110.587 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 67.9 mt -129.92 141.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.411 1.084 . . . . 0.0 110.039 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 48.7 t-20 11.32 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.41 3.084 . . . . 0.0 115.377 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.05 116.64 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.651 1.18 . . . . 0.0 112.004 -161.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 77.3 p -172.81 166.41 5.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.627 1.971 . . . . 0.0 110.583 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.28 141.9 27.91 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.951 0.9 . . . . 0.0 111.593 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 1.2 m -176.89 139.77 0.3 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.338 2.655 . . . . 0.0 109.106 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.5 133.04 49.56 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.292 1.037 . . . . 0.0 112.317 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 22.1 tp -76.24 -25.57 55.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.277 1.031 . . . . 0.0 113.711 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 49.1 m -84.37 -26.28 28.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -169.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.9 pp -92.47 9.4 34.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.798 1.239 . . . . 0.0 113.577 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.63 148.68 23.05 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.473 1.509 . . . . 0.0 111.811 170.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -136.97 157.43 46.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.107 1.763 . . . . 0.0 109.367 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 148.28 26.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.939 0.896 . . . . 0.0 112.355 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 74.9 p -140.37 160.16 40.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.337 1.855 . . . . 0.0 109.999 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.0 t -114.93 135.42 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.425 1.49 . . . . 0.0 109.471 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.3 t -106.81 110.74 63.84 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.942 1.297 . . . . 0.0 107.889 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 167.73 24.51 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.622 2.881 . . . . 0.0 110.622 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 -14.66 42.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.949 2.432 . . . . 0.0 113.061 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.1 p -79.66 -9.74 59.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.361 1.464 . . . . 0.0 113.936 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.96 -1.68 85.92 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.691 1.615 . . . . 0.0 115.168 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -77.29 81.66 3.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.553 1.541 . . . . 0.0 111.496 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.99 135.72 57.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.636 1.174 . . . . 0.0 112.212 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.79 148.93 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.764 1.626 . . . . 0.0 111.023 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.76 152.54 37.42 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.523 2.815 . . . . 0.0 111.808 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 80.6 m -102.7 151.45 22.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.563 1.145 . . . . 0.0 111.74 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 56.9 tp -83.03 126.59 32.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 108.774 163.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.4 mt -94.87 140.52 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.053 1.341 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.94 145.58 34.69 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.276 1.03 . . . . 0.0 113.021 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -85.78 108.44 18.09 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 153.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.37 166.25 21.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.166 0.986 . . . . 0.0 111.453 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -64.68 -21.61 66.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -81.4 -9.11 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.596 1.158 . . . . 0.0 113.599 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.45 -6.74 61.31 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.866 1.698 . . . . 0.0 114.566 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.06 162.73 19.2 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.697 1.199 . . . . 0.0 113.406 173.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 12.5 p -94.84 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.081 1.352 . . . . 0.0 111.057 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.65 177.8 33.42 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.23 162.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.987 1.715 . . . . 0.0 112.271 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 32.5 t -146.87 148.8 32.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.752 1.621 . . . . 0.0 110.57 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.5 p90 -169.41 175.49 5.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.334 2.254 . . . . 0.0 110.043 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 71.3 t -124.86 116.08 26.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 124.117 0.967 . . . . 0.0 109.805 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.24 143.21 28.07 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.944 3.096 . . . . 0.0 110.858 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.44 -19.26 15.0 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.77 171.0 8.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.264 1.826 . . . . 0.0 110.726 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.9 p -97.91 169.02 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.48 1.512 . . . . 0.0 111.107 169.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.69 -170.65 23.23 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.362 1.458 . . . . 0.0 113.815 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.83 112.02 7.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.025 0.93 . . . . 0.0 111.472 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.47 143.36 28.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.649 1.58 . . . . 0.0 109.269 168.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.83 125.11 50.57 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.336 1.054 . . . . 0.0 109.222 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.3 t -88.69 127.79 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.287 1.035 . . . . 0.0 108.237 168.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -106.41 137.21 44.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.263 1.425 . . . . 0.0 109.96 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 84.7 t -136.33 134.77 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.425 1.09 . . . . 0.0 109.566 -170.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -133.8 132.31 40.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.23 1.412 . . . . 0.0 111.137 -169.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -124.95 128.13 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.791 2.036 . . . . 0.0 109.627 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 46.3 t30 59.94 22.19 11.24 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.048 0.939 . . . . 0.0 113.289 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.94 7.37 83.95 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.941 1.258 . . . . 0.0 114.91 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -119.26 133.74 55.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.033 1.733 . . . . 0.0 109.465 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.18 138.31 58.18 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.494 -1.379 . . . . 0.0 112.135 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 22.9 m -78.83 159.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.214 0.606 . . . . 0.0 112.283 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -64.22 -20.75 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 49.8 m -86.4 -19.34 29.84 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 67.5 p -92.96 154.0 41.86 Favored Pre-proline 0 CA--C 1.55 0.979 0 O-C-N 120.887 -1.133 . . . . 0.0 113.846 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.65 147.58 89.94 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.138 0.728 . . . . 0.0 112.485 -0.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.12 120.22 51.69 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.013 1.325 . . . . 0.0 108.503 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.21 140.53 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.858 2.372 . . . . 0.0 111.288 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 23.4 t -135.44 123.51 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.391 1.476 . . . . 0.0 107.768 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.5 t -96.46 120.99 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.593 0.757 . . . . 0.0 109.795 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 123.01 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.779 1.231 . . . . 0.0 109.035 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 32.5 t -92.36 158.46 16.07 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.729 0.812 . . . . 0.0 111.408 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -59.74 -29.68 68.32 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.252 -0.905 . . . . 0.0 111.428 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.1 m -63.18 -13.26 35.2 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.666 1.186 . . . . 0.0 113.928 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -94.71 -11.17 29.63 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.942 1.297 . . . . 0.0 112.371 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.75 95.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.756 1.222 . . . . 0.0 109.917 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 65.02 24.63 70.35 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 115.0 0.76 . . . . 0.0 115.0 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 34.0 t0 -76.22 89.52 3.11 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.358 1.079 . . . . 0.0 111.9 -171.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.99 75.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.748 1.219 . . . . 0.0 112.789 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.8 m -60.7 -22.12 63.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.302 1.041 . . . . 0.0 113.574 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -88.66 -8.98 53.65 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.077 1.351 . . . . 0.0 113.903 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.5 t -77.52 131.31 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.866 1.212 . . . . 0.0 109.655 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -116.22 161.01 19.61 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.94 1.296 . . . . 0.0 111.373 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -146.11 153.88 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.385 1.474 . . . . 0.0 110.643 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 73.4 m -149.09 165.85 30.51 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.069 1.348 . . . . 0.0 112.103 -173.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.66 162.08 26.0 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 124.345 0.974 . . . . 0.0 114.577 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -73.9 -27.67 61.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 113.644 -167.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.86 -5.58 47.09 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.733 1.159 . . . . 0.0 115.042 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.82 -7.02 58.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.676 1.591 . . . . 0.0 112.787 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -128.29 -36.01 1.95 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.955 1.302 . . . . 0.0 113.8 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.7 155.51 30.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 112.474 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.6 -176.19 21.79 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.881 1.229 . . . . 0.0 114.358 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -139.41 152.67 47.27 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.345 1.458 . . . . 0.0 112.145 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 25.5 p -71.5 -41.84 68.77 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -100.18 -11.16 20.67 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -114.66 145.75 34.54 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.073 1.349 . . . . 0.0 110.258 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.78 137.83 36.31 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.545 2.163 . . . . 0.0 110.422 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -84.03 150.37 25.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.109 0.964 . . . . 0.0 109.997 168.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.25 151.19 46.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -159.26 155.59 27.23 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.613 1.565 . . . . 0.0 111.001 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.52 143.14 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.41 1.884 . . . . 0.0 109.961 -175.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.25 133.89 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.238 1.815 . . . . 0.0 109.026 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.7 t0 -122.81 99.82 6.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.018 1.727 . . . . 0.0 110.875 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 32.6 p -99.73 4.83 45.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.499 1.92 . . . . 0.0 112.735 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.9 -37.32 81.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.255 1.022 . . . . 0.0 112.577 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.27 -28.96 38.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 0.0 112.716 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -72.49 -11.49 60.69 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.86 -108.23 3.22 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.426 1.012 . . . . 0.0 112.068 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.32 147.15 50.25 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.925 1.29 . . . . 0.0 112.97 -168.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 156.73 -137.68 5.56 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.543 1.068 . . . . 0.0 113.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -157.68 141.46 7.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.497 1.046 . . . . 0.0 112.047 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.48 124.99 45.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.916 1.686 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 23.2 t -115.69 138.91 50.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.33 1.452 . . . . 0.0 109.902 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 8.4 tt -136.75 132.95 35.49 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.62 1.168 . . . . 0.0 109.902 -168.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.7 m -133.66 130.23 37.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.386 0.675 . . . . 0.0 111.197 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.9 mt -109.24 130.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.083 1.353 . . . . 0.0 108.244 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.78 142.5 51.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.337 1.455 . . . . 0.0 109.758 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 177.27 -165.24 35.01 Favored Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.1 -9.89 26.41 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.175 3.25 . . . . 0.0 114.05 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.0 t -155.88 162.51 40.41 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.386 1.074 . . . . 0.0 112.078 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -67.31 147.12 53.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.664 1.186 . . . . 0.0 111.327 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 32.2 m -130.84 146.14 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.143 1.377 . . . . 0.0 110.903 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.37 105.82 17.83 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.679 0.792 . . . . 0.0 109.957 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 52.3 mt -84.41 129.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.247 1.019 . . . . 0.0 109.599 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -125.69 161.16 27.91 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 0.0 110.795 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 35.6 p -141.8 155.52 45.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.252 1.421 . . . . 0.0 111.951 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.45 138.05 15.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 111.515 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.0 t70 -86.97 129.03 35.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.117 1.367 . . . . 0.0 111.31 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 43.2 mt -99.31 160.62 14.14 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.308 1.043 . . . . 0.0 112.525 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.37 -17.04 64.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.522 1.129 . . . . 0.0 113.35 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.43 -9.15 59.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.144 1.378 . . . . 0.0 113.291 172.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.81 1.91 82.13 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.412 1.482 . . . . 0.0 114.018 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -89.18 165.49 14.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.332 1.853 . . . . 0.0 111.432 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.6 t -109.94 124.87 52.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.042 . . . . 0.0 110.993 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -83.62 135.4 34.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 165.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 45.7 t -117.36 139.31 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.953 1.701 . . . . 0.0 108.773 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.97 151.61 50.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.782 1.633 . . . . 0.0 111.83 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.39 150.74 14.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.521 1.528 . . . . 0.0 111.787 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.5 t -115.81 99.39 52.5 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.277 1.031 . . . . 0.0 111.039 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.44 94.12 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.706 2.937 . . . . 0.0 110.669 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 51.8 m -63.09 -41.76 99.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.868 . . . . 0.0 112.78 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -87.3 140.78 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.711 0.805 . . . . 0.0 110.668 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.97 168.64 24.38 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.506 2.804 . . . . 0.0 111.554 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 127.0 -147.31 16.84 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.816 1.198 . . . . 0.0 112.695 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -109.75 133.56 53.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.074 0.95 . . . . 0.0 111.836 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -118.29 151.37 37.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.784 1.633 . . . . 0.0 110.707 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.06 133.26 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.518 1.527 . . . . 0.0 108.699 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.54 128.97 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.592 1.157 . . . . 0.0 109.789 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.54 125.25 53.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.895 1.678 . . . . 0.0 110.015 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.6 mm -115.63 116.42 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.11 0.964 . . . . 0.0 109.246 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -125.71 132.8 52.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.16 1.384 . . . . 0.0 111.201 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 72.4 t80 -123.82 124.22 42.2 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.678 1.591 . . . . 0.0 110.312 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.73 30.97 11.99 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.331 1.452 . . . . 0.0 114.177 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.257 7.0 t70 85.68 11.91 0.22 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 128.784 2.834 . . . . 0.0 114.728 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.6 132.18 55.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.556 1.143 . . . . 0.0 111.48 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.86 124.48 23.45 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.338 1.455 . . . . 0.0 110.676 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -80.72 158.76 70.4 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.189 -0.944 . . . . 0.0 111.825 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.51 134.93 64.24 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.649 2.899 . . . . 0.0 113.253 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.85 -22.31 38.73 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.247 1.403 . . . . 0.0 114.073 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 62.9 m -75.22 150.59 85.39 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 118.922 1.361 . . . . 0.0 112.024 172.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.35 142.87 73.16 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.053 0.697 . . . . 0.0 111.113 -4.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.62 127.76 39.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.432 1.093 . . . . 0.0 110.834 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 30.5 t -95.97 129.29 43.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.345 1.058 . . . . 0.0 110.988 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 11.9 t -128.46 117.14 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.001 1.32 . . . . 0.0 110.007 -170.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -85.84 120.35 27.16 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.76 -0.587 . . . . 0.0 110.521 173.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.08 118.99 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.587 1.555 . . . . 0.0 108.862 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 1.3 t -99.61 162.85 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.583 1.153 . . . . 0.0 111.333 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 171.47 -168.35 41.46 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 126.611 1.964 . . . . 0.0 110.215 178.256 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -64.67 -21.94 66.86 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -14.44 61.3 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.239 1.416 . . . . 0.0 114.17 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 84.45 162.88 35.33 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.275 1.417 . . . . 0.0 113.45 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -164.75 154.32 13.39 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.907 1.683 . . . . 0.0 111.478 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.44 -15.49 59.91 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.706 1.202 . . . . 0.0 113.908 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 57.6 m 70.02 -107.24 0.06 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.057 2.143 . . . . 0.0 110.987 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 14.1 ptm -142.48 148.1 37.15 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.769 1.228 . . . . 0.0 111.651 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 161.58 28.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.865 1.266 . . . . 0.0 110.372 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 23.6 ptm -149.39 159.29 44.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 13.3 m -148.53 151.66 35.5 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.377 1.871 . . . . 0.0 109.774 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -147.32 159.77 43.29 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.9 150.85 24.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.539 1.936 . . . . 0.0 109.796 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -134.07 144.08 48.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.546 1.138 . . . . 0.0 111.972 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 46.8 t -140.37 134.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.64 1.576 . . . . 0.0 109.658 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.89 139.51 21.43 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 124.013 0.816 . . . . 0.0 111.661 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 29.6 m -131.22 132.14 44.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.809 0.804 . . . . 0.0 112.764 -166.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.63 148.64 16.19 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -74.47 150.33 39.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.439 1.095 . . . . 0.0 111.323 170.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -93.28 122.81 36.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.422 1.089 . . . . 0.0 110.667 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.9 mm -112.46 108.73 54.2 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.588 1.155 . . . . 0.0 109.266 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.91 137.62 17.78 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.178 2.585 . . . . 0.0 111.17 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 65.1 mt -145.69 141.14 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.377 1.471 . . . . 0.0 110.21 -170.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.26 61.47 2.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.625 1.57 . . . . 0.0 112.0 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.26 104.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.666 1.186 . . . . 0.0 110.616 -169.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.8 t -172.61 178.74 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.274 1.83 . . . . 0.0 110.543 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.99 45.42 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.018 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.8 p -71.47 138.06 48.69 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.001 1.321 . . . . 0.0 111.364 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 15.0 t70 -85.09 141.13 30.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.436 1.094 . . . . 0.0 111.323 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 -16.95 46.53 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 60.4 m -82.16 -31.93 30.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.038 1.29 . . . . 0.0 114.055 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -99.39 -0.49 40.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.5 1.12 . . . . 0.0 113.845 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.83 146.81 24.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.601 1.161 . . . . 0.0 111.492 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 41.0 p -138.87 162.67 34.23 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.732 2.013 . . . . 0.0 109.448 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.1 145.25 24.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.689 0.795 . . . . 0.0 112.08 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.7 p -138.4 162.57 34.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.148 1.779 . . . . 0.0 109.9 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -120.12 137.59 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.21 1.404 . . . . 0.0 109.462 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.1 t -102.82 111.05 64.6 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.14 1.376 . . . . 0.0 107.832 165.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.28 168.65 22.68 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.042 3.161 . . . . 0.0 110.696 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.55 -18.1 61.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.923 2.415 . . . . 0.0 112.645 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 12.8 m -67.63 -17.18 64.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.84 1.256 . . . . 0.0 113.925 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.87 31.24 54.17 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.61 1.1 . . . . 0.0 114.239 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -125.84 97.57 5.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.318 1.447 . . . . 0.0 110.488 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.93 135.74 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.417 1.087 . . . . 0.0 112.155 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -137.49 151.06 70.39 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.515 1.526 . . . . 0.0 111.097 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.19 156.23 42.11 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.793 2.996 . . . . 0.0 112.664 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.0 m -112.48 154.49 25.8 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.354 1.462 . . . . 0.0 111.751 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 58.2 tp -85.85 120.34 27.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.287 1.035 . . . . 0.0 109.397 170.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 21.9 mt -84.03 141.7 30.99 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.597 1.159 . . . . 0.0 110.95 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.23 139.1 31.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.459 1.503 . . . . 0.0 111.75 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -92.82 109.45 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 160.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.57 164.3 23.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.862 1.265 . . . . 0.0 111.735 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.27 -34.52 68.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -167.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.12 -9.24 58.61 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.19 37.99 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 126.003 1.764 . . . . 0.0 114.435 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.07 156.57 33.78 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 113.351 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.6 t -104.08 143.01 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.137 1.375 . . . . 0.0 110.042 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.2 178.61 28.48 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.557 1.075 . . . . 0.0 115.039 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -116.59 165.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.948 1.699 . . . . 0.0 111.615 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 71.1 p -151.59 150.73 30.64 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 110.678 166.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.7 p90 -167.17 167.59 14.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.945 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 59.5 t -110.67 117.68 50.22 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.816 0.846 . . . . 0.0 109.676 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.45 147.65 28.96 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.944 3.096 . . . . 0.0 110.917 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -105.34 -7.67 18.7 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -145.72 174.93 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.403 2.281 . . . . 0.0 109.687 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 36.3 p -88.56 167.07 13.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.614 1.165 . . . . 0.0 111.21 166.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.05 -170.22 25.97 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.268 1.413 . . . . 0.0 113.79 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.84 117.88 12.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.186 0.994 . . . . 0.0 111.742 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.8 m80 -104.11 143.58 32.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.036 1.734 . . . . 0.0 108.968 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.44 125.31 50.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.993 0.917 . . . . 0.0 110.083 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.1 t -85.62 137.46 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -119.96 114.76 22.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.347 1.459 . . . . 0.0 109.693 169.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 94.1 t -106.48 136.52 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.054 1.341 . . . . 0.0 108.995 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -131.09 142.28 50.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.989 1.315 . . . . 0.0 112.435 -172.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -112.81 121.21 44.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.544 1.938 . . . . 0.0 109.169 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.19 26.27 10.12 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.668 1.187 . . . . 0.0 113.259 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.65 84.85 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.649 1.595 . . . . 0.0 115.452 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.43 134.87 46.07 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.167 1.484 . . . . 0.0 109.64 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 19.3 p80 -63.36 140.15 58.84 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.953 -1.092 . . . . 0.0 113.337 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 16.6 m -78.54 159.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.666 0.786 . . . . 0.0 110.983 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.42 62.76 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.4 m -75.35 -20.76 58.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 56.4 m -82.25 149.89 63.01 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.64 150.24 92.49 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 118.649 0.553 . . . . 0.0 111.949 -5.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -107.41 119.24 51.37 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.86 139.89 12.49 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.806 2.338 . . . . 0.0 111.385 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -134.1 124.35 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.384 1.474 . . . . 0.0 107.643 171.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.4 t -99.75 122.58 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.879 0.872 . . . . 0.0 109.97 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.45 128.14 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.886 1.274 . . . . 0.0 109.655 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.2 t -99.66 161.24 13.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.026 0.931 . . . . 0.0 111.457 170.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -59.54 -31.38 69.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.768 0.827 . . . . 0.0 112.87 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -68.0 -14.93 63.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 113.516 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -92.12 -9.5 42.29 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.564 1.146 . . . . 0.0 112.763 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 44.1 mm -76.49 -31.94 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 0.0 112.948 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.44 47.74 0.04 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -85.43 98.9 10.84 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.261 1.031 . . . . 0.0 110.78 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.44 73.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.482 1.113 . . . . 0.0 113.495 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.9 p -56.78 -23.4 42.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 113.91 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -84.84 -14.45 47.92 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.213 1.405 . . . . 0.0 113.913 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.5 t -75.12 135.42 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.641 1.11 . . . . 0.0 110.524 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -113.53 156.88 22.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.381 1.472 . . . . 0.0 111.329 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.55 159.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.697 1.599 . . . . 0.0 110.706 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -159.95 175.69 12.74 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.577 1.151 . . . . 0.0 112.419 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.84 161.73 30.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.239 1.399 . . . . 0.0 114.189 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -72.16 -28.24 63.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.582 1.153 . . . . 0.0 113.398 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.45 -4.29 37.21 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.703 1.144 . . . . 0.0 115.24 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.28 -4.39 58.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.323 1.449 . . . . 0.0 112.76 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -134.53 -40.12 0.8 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.812 1.245 . . . . 0.0 113.876 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.22 152.51 44.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 111.267 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.38 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 122.256 0.92 . . . . 0.0 114.748 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 66.0 m80 -135.43 160.06 39.63 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.543 1.937 . . . . 0.0 110.29 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 16.9 p -71.21 -68.55 0.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.37 0.668 . . . . 0.0 111.498 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -82.44 -14.59 54.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -166.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -104.89 136.71 19.13 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 0.0 109.349 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.49 152.34 54.3 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -105.2 136.77 44.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.018 1.327 . . . . 0.0 110.708 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.4 148.49 42.48 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.282 1.433 . . . . 0.0 113.123 -175.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.5 p90 -155.76 153.61 30.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.369 1.468 . . . . 0.0 111.456 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.87 142.36 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.013 1.725 . . . . 0.0 109.655 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.74 134.69 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.251 1.82 . . . . 0.0 108.621 171.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.84 101.87 7.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.662 1.585 . . . . 0.0 110.833 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.7 p -100.33 -1.64 35.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.515 1.926 . . . . 0.0 112.946 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -57.95 -40.49 80.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.282 1.033 . . . . 0.0 111.627 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.02 -5.62 56.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.477 1.511 . . . . 0.0 113.27 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -101.68 -3.96 27.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.871 1.668 . . . . 0.0 114.734 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.57 -118.86 4.83 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.03 0.824 . . . . 0.0 111.163 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -121.49 165.06 16.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.236 1.415 . . . . 0.0 112.752 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.35 -140.05 7.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.635 1.112 . . . . 0.0 113.188 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -158.87 137.99 5.47 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 124.169 0.89 . . . . 0.0 112.501 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.19 122.52 40.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.488 1.915 . . . . 0.0 109.477 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 12.3 m -110.5 139.86 45.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 110.014 165.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -136.51 134.49 37.63 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.348 1.059 . . . . 0.0 110.174 -168.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.8 m -135.48 125.3 25.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.573 0.749 . . . . 0.0 110.667 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.8 mt -104.07 130.72 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.614 1.166 . . . . 0.0 108.224 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -127.94 147.92 50.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.555 1.542 . . . . 0.0 109.781 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 169.72 -157.81 29.65 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.349 -0.845 . . . . 0.0 114.83 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.5 -20.18 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 113.885 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -151.47 169.84 21.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.567 1.076 . . . . 0.0 112.527 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.19 149.27 50.57 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 9.3 m -132.71 146.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.427 1.091 . . . . 0.0 111.442 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -85.48 111.67 20.2 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.216 0.606 . . . . 0.0 109.821 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.06 132.84 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.392 1.077 . . . . 0.0 109.555 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -128.85 158.58 38.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.158 1.783 . . . . 0.0 110.626 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 32.8 p -139.75 153.63 47.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.132 1.373 . . . . 0.0 111.658 -174.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.41 115.6 4.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.06 1.344 . . . . 0.0 110.461 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.58 129.22 34.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.548 1.139 . . . . 0.0 110.858 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 62.7 mt -101.47 153.84 19.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.546 1.138 . . . . 0.0 112.007 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.81 -18.61 64.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.312 1.045 . . . . 0.0 113.253 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.89 -9.05 58.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.984 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.23 -1.37 62.58 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.084 1.802 . . . . 0.0 114.783 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.0 p -88.87 166.3 14.06 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.117 1.767 . . . . 0.0 111.678 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.0 t -114.85 126.3 54.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 0.0 110.777 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -87.98 134.59 33.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.506 1.122 . . . . 0.0 109.466 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.1 t -117.01 141.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.234 1.814 . . . . 0.0 108.275 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.1 p -134.58 151.24 50.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 110.926 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.95 149.86 29.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.578 0.751 . . . . 0.0 112.955 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.2 t -120.84 99.47 47.06 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.932 1.293 . . . . 0.0 110.192 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.25 135.85 12.36 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.265 2.643 . . . . 0.0 111.829 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 98.2 m -78.3 -46.46 20.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.068 0.547 . . . . 0.0 111.734 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -99.84 148.17 34.43 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.795 1.238 . . . . 0.0 111.06 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 165.26 29.31 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.435 2.757 . . . . 0.0 111.26 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 138.2 -152.59 21.96 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 113.184 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.2 t30 -107.03 121.99 45.57 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.242 1.017 . . . . 0.0 110.663 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -104.45 144.5 31.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.898 1.279 . . . . 0.0 111.104 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.1 130.37 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.716 1.607 . . . . 0.0 107.943 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.1 mt -112.34 121.83 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.638 1.175 . . . . 0.0 109.265 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -100.51 124.85 46.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.582 1.553 . . . . 0.0 109.907 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 34.4 mm -116.56 111.17 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 108.882 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 132.56 53.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.919 1.288 . . . . 0.0 111.276 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 75.3 t80 -125.24 124.14 41.05 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 109.723 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.59 44.67 27.3 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.359 1.064 . . . . 0.0 112.982 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 70.7 m-20 66.39 19.91 10.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.345 2.258 . . . . 0.0 114.634 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -125.53 130.6 52.07 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.593 1.557 . . . . 0.0 110.113 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -71.54 125.65 27.62 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 120.892 -1.13 . . . . 0.0 111.237 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.2 m -78.8 157.44 76.66 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.159 -0.963 . . . . 0.0 111.905 -168.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.87 142.27 64.0 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.83 3.02 . . . . 0.0 113.69 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.34 5.72 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.018 1.294 . . . . 0.0 113.999 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -76.29 144.61 75.0 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-N 118.282 1.041 . . . . 0.0 110.585 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.58 144.52 79.28 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 120.567 1.238 . . . . 0.0 112.273 4.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.76 117.81 35.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.391 1.077 . . . . 0.0 110.427 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.8 p -86.41 136.78 32.99 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.078 0.951 . . . . 0.0 111.395 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.2 t -133.96 113.1 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.203 1.401 . . . . 0.0 109.446 -168.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -77.93 118.29 20.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.99 0.516 . . . . 0.0 110.722 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 81.7 t -110.88 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.879 1.672 . . . . 0.0 109.036 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 9.3 t -104.3 154.36 19.9 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.464 1.106 . . . . 0.0 111.301 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -176.76 173.82 46.58 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.716 1.151 . . . . 0.0 114.484 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -117.01 -176.46 2.99 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.188 1.795 . . . . 0.0 111.027 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -78.03 13.76 13.2 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.182 1.373 . . . . 0.0 115.003 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 95.77 132.85 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 130.929 3.692 . . . . 0.0 110.948 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 22.9 m -141.58 158.67 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.796 2.039 . . . . 0.0 110.591 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 23.0 ptmt . . . . . 0 C--O 1.253 1.274 0 C-N-CA 124.734 1.214 . . . . 0.0 113.896 178.006 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.482 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.8 159.58 34.07 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.464 1.105 . . . . 0.0 112.977 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 15.6 tpt -159.21 144.65 16.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.91 1.684 . . . . 0.0 110.844 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.89 153.43 28.23 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.782 1.182 . . . . 0.0 113.059 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.6 -29.62 61.38 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.03 0.932 . . . . 0.0 112.653 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.04 164.6 11.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.443 1.897 . . . . 0.0 112.596 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 69.1 p -163.6 154.62 16.31 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.209 1.403 . . . . 0.0 111.838 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 36.7 mmt -63.16 130.75 45.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.713 0.805 . . . . 0.0 111.635 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -83.04 149.6 26.84 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.079 0.951 . . . . 0.0 109.611 171.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.8 ptm -144.69 156.93 44.34 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.175 0.99 . . . . 0.0 113.445 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 65.4 m -138.96 148.5 43.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -138.52 156.47 47.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.333 1.053 . . . . 0.0 113.705 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.9 tt -159.82 150.61 19.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.932 1.693 . . . . 0.0 110.431 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.33 148.23 52.13 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 0.0 112.724 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 53.0 t -139.11 134.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.073 1.749 . . . . 0.0 109.375 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.42 123.94 6.99 Favored Glycine 0 N--CA 1.471 0.987 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 70.9 m -97.19 123.3 40.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.272 1.029 . . . . 0.0 111.526 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -125.33 115.28 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.37 1.468 . . . . 0.0 110.013 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.04 142.72 47.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.145 0.578 . . . . 0.0 111.805 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.51 130.58 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.711 1.204 . . . . 0.0 111.586 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.6 mm -122.43 120.86 27.86 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.367 1.467 . . . . 0.0 108.461 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 145.05 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.451 2.101 . . . . 0.0 110.922 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.47 145.13 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.852 1.661 . . . . 0.0 108.51 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.2 t30 -42.46 114.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.093 1.357 . . . . 0.0 113.596 -166.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.35 135.97 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.869 0.868 . . . . 0.0 110.757 -160.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.4 t -159.84 175.7 12.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.729 1.611 . . . . 0.0 110.527 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.11 33.93 0.5 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 112.664 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -71.97 139.03 48.45 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.578 1.551 . . . . 0.0 111.412 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.19 131.06 36.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.098 0.959 . . . . 0.0 111.469 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.75 -14.98 59.43 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 50.8 m -85.7 -24.05 27.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.659 1.118 . . . . 0.0 113.383 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pp -107.26 3.98 26.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.171 1.388 . . . . 0.0 113.98 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.66 146.98 23.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.252 1.421 . . . . 0.0 111.166 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 58.1 p -140.51 152.99 46.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.435 1.494 . . . . 0.0 110.121 167.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.19 148.39 43.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.422 1.089 . . . . 0.0 112.582 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 2.5 p -147.01 132.37 18.54 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.966 2.106 . . . . 0.0 109.552 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -91.7 136.72 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.22 1.008 . . . . 0.0 109.937 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 90.1 t -109.98 113.76 56.8 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.078 1.351 . . . . 0.0 108.372 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.03 172.77 11.61 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.074 3.183 . . . . 0.0 111.232 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.48 -32.53 53.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.977 3.118 . . . . 0.0 113.875 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 16.4 m -74.14 -10.56 59.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.726 1.21 . . . . 0.0 114.238 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.28 74.87 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.523 1.535 . . . . 0.0 115.173 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -75.62 87.62 2.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.811 1.644 . . . . 0.0 111.297 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.65 135.31 57.31 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.261 1.025 . . . . 0.0 111.892 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -140.24 147.18 49.06 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.136 1.375 . . . . 0.0 111.474 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.2 152.49 45.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.934 3.089 . . . . 0.0 112.066 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.6 m -114.11 150.15 34.53 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.05 1.34 . . . . 0.0 112.052 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.86 115.5 28.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.476 1.11 . . . . 0.0 109.033 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.4 mt -78.78 131.15 36.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.106 1.362 . . . . 0.0 111.131 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 95.8 mttt -132.2 142.03 49.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.191 1.397 . . . . 0.0 112.545 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -93.17 122.04 35.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.57 1.148 . . . . 0.0 108.058 161.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.3 mt -100.8 172.71 6.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.841 1.656 . . . . 0.0 112.577 -165.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -57.55 -35.75 70.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.6 1.56 . . . . 0.0 115.038 -165.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 4.46 44.22 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.245 1.018 . . . . 0.0 113.13 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 90.67 -6.36 82.11 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.485 1.517 . . . . 0.0 113.896 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -71.95 162.71 29.06 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.603 1.561 . . . . 0.0 113.153 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 93.1 t -112.07 141.97 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.462 1.505 . . . . 0.0 109.634 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.0 -176.17 24.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.168 0.89 . . . . 0.0 115.164 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.19 165.91 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.475 1.91 . . . . 0.0 111.063 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 66.3 p -149.07 152.57 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.315 1.046 . . . . 0.0 111.278 167.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.4 p90 -169.32 -172.06 1.41 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.585 2.354 . . . . 0.0 109.522 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.8 t -133.77 118.71 14.56 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 0.0 110.085 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.76 147.82 22.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.615 3.544 . . . . 0.0 111.264 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.1 mptt -100.66 -13.25 18.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.045 0.938 . . . . 0.0 113.194 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -139.97 167.8 21.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.187 2.195 . . . . 0.0 110.104 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.0 p -85.24 167.8 15.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.685 1.194 . . . . 0.0 111.435 168.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.29 -174.04 22.69 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.523 1.535 . . . . 0.0 114.059 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.95 113.08 9.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.2 1.0 . . . . 0.0 111.467 -175.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -96.97 144.18 27.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 109.169 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.8 mt -103.08 126.41 50.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.764 0.825 . . . . 0.0 110.043 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.5 t -89.71 112.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.903 1.281 . . . . 0.0 107.744 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -92.83 138.51 31.43 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.115 . . . . 0.0 109.665 169.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.3 p -151.55 135.93 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.4 -0.813 . . . . 0.0 111.363 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -137.78 145.71 42.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.451 1.1 . . . . 0.0 113.935 -162.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -114.2 127.08 55.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.737 2.415 . . . . 0.0 109.121 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.58 24.0 8.29 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.265 1.026 . . . . 0.0 113.636 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.83 4.41 65.29 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.442 1.496 . . . . 0.0 115.979 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -127.91 141.56 51.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.832 1.816 . . . . 0.0 111.706 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -61.29 138.27 58.24 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.255 -0.903 . . . . 0.0 113.182 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 19.1 m -74.09 163.02 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.388 0.675 . . . . 0.0 111.334 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.15 -24.85 65.05 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 64.4 m -86.67 -12.26 48.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 28.6 t -86.9 143.14 34.81 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 120.771 -1.205 . . . . 0.0 112.757 -172.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.99 156.85 88.04 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.495 0.855 . . . . 0.0 112.836 -3.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.02 126.99 28.09 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.781 1.632 . . . . 0.0 109.127 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.33 141.22 14.19 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.989 2.459 . . . . 0.0 111.594 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 24.7 t -134.25 122.08 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.863 1.665 . . . . 0.0 107.68 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.8 t -97.53 122.42 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.669 0.788 . . . . 0.0 110.179 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.29 117.76 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.804 1.242 . . . . 0.0 108.942 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 59.3 m -92.69 161.54 14.51 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.091 0.956 . . . . 0.0 111.479 172.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.73 -31.86 70.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.991 -1.068 . . . . 0.0 112.197 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.0 m -59.68 -14.31 13.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.323 1.449 . . . . 0.0 114.202 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -100.11 -9.8 22.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.75 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 38.0 mm -80.89 -27.77 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.747 -1.22 . . . . 0.0 112.856 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 169.1 38.7 0.03 OUTLIER Glycine 0 N--CA 1.469 0.844 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.46 96.93 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.197 0.998 . . . . 0.0 111.259 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.59 93.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.9 0.88 . . . . 0.0 112.356 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.3 m -61.44 -18.89 61.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.705 1.202 . . . . 0.0 113.87 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -89.06 -10.22 48.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.445 1.498 . . . . 0.0 114.36 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.8 t -74.66 137.56 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.18 1.355 . . . . 0.0 110.111 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.3 mmt-85 -121.14 161.19 22.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 110.675 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.4 m -147.94 160.97 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.292 1.437 . . . . 0.0 110.999 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -158.41 175.58 13.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.733 1.213 . . . . 0.0 112.285 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 94.99 161.49 34.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.263 1.411 . . . . 0.0 114.08 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -73.81 -26.77 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 113.611 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.19 -2.25 39.23 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.918 1.247 . . . . 0.0 115.364 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.93 -6.83 50.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.542 1.537 . . . . 0.0 112.674 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.36 -39.95 2.29 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.334 1.453 . . . . 0.0 113.163 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.24 155.68 32.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 0.0 113.233 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.08 -174.41 19.86 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.715 1.626 . . . . 0.0 113.382 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 60.5 m80 -138.57 147.48 43.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.467 1.107 . . . . 0.0 112.7 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.4 p -71.82 -19.79 61.93 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -116.23 -1.9 12.27 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -143.67 147.57 39.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.368 1.467 . . . . 0.0 110.492 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.35 142.43 45.32 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.865 2.377 . . . . 0.0 111.204 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 152.39 20.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.631 1.172 . . . . 0.0 110.246 168.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.58 148.07 51.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.887 0.875 . . . . 0.0 112.362 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.14 151.2 27.97 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.61 140.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.953 1.701 . . . . 0.0 109.508 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.92 136.45 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.638 1.575 . . . . 0.0 108.758 169.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.2 t0 -125.93 99.06 5.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.223 1.809 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.2 p -96.48 1.3 51.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.231 1.812 . . . . 0.0 113.085 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -58.65 -39.34 80.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.539 1.063 . . . . 0.0 112.697 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.65 -13.84 59.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.457 1.103 . . . . 0.0 113.249 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -93.52 -5.35 49.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.878 1.671 . . . . 0.0 113.618 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.14 -119.31 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.733 1.158 . . . . 0.0 112.172 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.55 161.54 16.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.377 1.871 . . . . 0.0 112.498 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 138.29 -176.8 20.53 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.065 0.84 . . . . 0.0 115.117 169.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -92.92 123.21 7.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.459 1.028 . . . . 0.0 111.985 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.33 123.0 42.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.119 1.768 . . . . 0.0 108.394 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -114.72 140.79 48.59 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.288 1.435 . . . . 0.0 110.829 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 2.9 tp -125.61 137.39 53.89 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.362 1.865 . . . . 0.0 109.656 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 68.2 m -138.59 126.66 22.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.254 0.622 . . . . 0.0 110.277 167.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 30.0 mt -111.3 135.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.541 1.136 . . . . 0.0 108.466 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -145.4 154.87 42.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.284 1.034 . . . . 0.0 112.246 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.48 -155.67 26.49 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.879 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.92 -10.21 27.19 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.124 3.216 . . . . 0.0 114.286 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.2 t -152.94 164.3 38.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.662 1.185 . . . . 0.0 111.1 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -69.98 144.23 52.38 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.135 -0.978 . . . . 0.0 111.171 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 17.8 m -125.02 151.93 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 0.0 110.962 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -97.26 131.25 44.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.776 0.83 . . . . 0.0 110.064 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.1 135.37 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.132 1.373 . . . . 0.0 109.737 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.57 164.89 24.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 111.069 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.0 p -136.36 160.22 39.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.482 1.513 . . . . 0.0 112.227 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -154.33 122.53 6.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.362 1.465 . . . . 0.0 110.041 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.25 128.56 33.68 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.419 1.088 . . . . 0.0 110.58 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -101.16 152.43 20.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 111.84 -173.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -66.42 -20.33 66.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.283 1.033 . . . . 0.0 113.423 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.2 t0 -80.25 -3.93 51.18 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.112 1.365 . . . . 0.0 113.256 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.37 0.65 67.27 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.606 1.574 . . . . 0.0 114.571 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 18.5 p -88.76 167.7 13.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.604 1.962 . . . . 0.0 111.558 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 45.6 t -121.42 124.88 45.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.096 0.958 . . . . 0.0 111.207 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -84.18 135.49 34.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.775 1.23 . . . . 0.0 109.642 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.71 141.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.901 1.681 . . . . 0.0 108.587 164.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 3.2 p -130.54 148.74 52.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 110.761 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -157.45 148.65 21.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.428 1.091 . . . . 0.0 111.818 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.9 t -118.33 102.65 50.2 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.862 0.865 . . . . 0.0 111.145 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.58 145.88 23.7 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.245 2.63 . . . . 0.0 110.221 173.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 96.6 m -104.87 -38.62 6.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.984 0.914 . . . . 0.0 112.74 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -103.08 147.53 34.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.929 1.292 . . . . 0.0 110.627 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.89 168.31 23.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.498 2.799 . . . . 0.0 111.902 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 131.98 -145.63 17.35 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 125.126 1.346 . . . . 0.0 112.129 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -123.85 129.72 51.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.565 0.746 . . . . 0.0 111.664 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -108.39 143.65 37.03 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.552 1.541 . . . . 0.0 110.373 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 135.99 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.959 1.304 . . . . 0.0 109.0 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 25.7 mt -117.76 122.97 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.095 1.358 . . . . 0.0 109.385 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -102.06 127.62 48.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.965 1.706 . . . . 0.0 110.269 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 18.9 mm -120.02 112.22 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.877 1.271 . . . . 0.0 109.345 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -122.83 134.42 54.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.316 1.446 . . . . 0.0 111.215 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.9 t80 -127.22 123.93 37.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.486 1.514 . . . . 0.0 110.249 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.02 31.09 12.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.423 1.489 . . . . 0.0 114.069 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.59 12.51 0.68 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.337 2.655 . . . . 0.0 114.679 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -116.76 133.88 55.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.673 1.189 . . . . 0.0 110.71 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -72.06 126.74 30.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 110.946 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.7 m -79.44 153.84 76.44 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.318 -0.864 . . . . 0.0 110.954 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.94 146.86 91.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.816 2.344 . . . . 0.0 112.113 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.49 -29.25 6.3 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.263 1.411 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 3.7 t -78.47 145.48 67.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.076 0.95 . . . . 0.0 110.682 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.54 140.5 67.64 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.507 1.217 . . . . 0.0 111.875 2.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.71 116.0 28.24 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.987 0.915 . . . . 0.0 109.936 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 10.3 p -87.53 124.22 33.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.662 1.185 . . . . 0.0 110.651 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.1 t -121.21 114.98 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 109.733 -167.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -76.99 119.64 21.01 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.368 0.667 . . . . 0.0 111.168 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.7 t -109.24 125.84 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.076 1.35 . . . . 0.0 109.342 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.9 t -125.16 168.83 12.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.032 1.333 . . . . 0.0 112.279 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 118.28 148.36 8.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.293 1.901 . . . . 0.0 112.701 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -164.87 155.17 13.95 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.419 1.888 . . . . 0.0 109.729 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 92.06 40.6 5.15 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.165 0.888 . . . . 0.0 113.131 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -58.6 118.44 5.64 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.49 1.516 . . . . 0.0 111.97 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 8.7 p -167.42 150.66 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 126.479 1.911 . . . . 0.0 110.532 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 C--O 1.253 1.277 0 C-N-CA 124.788 1.235 . . . . 0.0 112.225 177.008 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -80.19 -17.05 53.45 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 42.6 tpp -67.7 147.04 53.18 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.746 1.218 . . . . 0.0 112.166 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.73 52.51 4.18 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.711 1.625 . . . . 0.0 113.051 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 22.4 t0 -151.55 138.7 19.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.973 1.709 . . . . 0.0 111.232 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 36.5 t70 -94.19 -20.67 19.64 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.382 1.473 . . . . 0.0 112.653 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 23.3 m -84.84 24.03 1.11 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.546 1.539 . . . . 0.0 113.914 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 98.8 mmm -51.92 -39.5 59.23 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.949 1.699 . . . . 0.0 114.156 -172.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -130.74 133.51 46.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.194 1.398 . . . . 0.0 109.487 165.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.0 ptm -161.77 151.25 16.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.495 1.518 . . . . 0.0 111.969 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.2 m -130.54 147.53 52.24 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.445 1.898 . . . . 0.0 108.509 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -149.81 160.58 43.45 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -170.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.04 134.2 15.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.004 2.122 . . . . 0.0 108.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -128.04 139.59 52.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.202 1.001 . . . . 0.0 110.896 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.4 p -156.84 139.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.952 0.901 . . . . 0.0 111.764 -175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -73.62 152.91 46.82 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.079 0.847 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 52.1 m -139.83 133.06 29.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.449 1.1 . . . . 0.0 111.174 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -164.54 150.77 10.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.767 0.827 . . . . 0.0 112.864 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -76.99 151.24 35.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 111.197 168.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 141.85 28.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.852 1.261 . . . . 0.0 112.358 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.3 mt -125.45 111.5 25.84 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.034 1.334 . . . . 0.0 108.38 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.82 139.79 17.9 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.988 2.459 . . . . 0.0 110.376 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 66.7 mt -139.34 136.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.306 1.042 . . . . 0.0 110.451 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 52.47 82.18 0.07 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.007 2.123 . . . . 0.0 112.56 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.7 mm -83.14 43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.705 1.202 . . . . 0.0 110.495 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 60.4 m -132.24 -57.42 0.96 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.277 1.431 . . . . 0.0 111.963 -173.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -162.9 107.29 1.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.873 0.869 . . . . 0.0 111.628 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.7 p -141.78 160.83 39.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.585 1.954 . . . . 0.0 110.139 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -151.56 126.77 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.608 1.163 . . . . 0.0 110.81 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.86 -15.25 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 56.5 m -80.65 -9.88 59.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.693 1.133 . . . . 0.0 113.415 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.93 7.42 2.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.53 145.9 24.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.613 1.165 . . . . 0.0 111.84 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 22.8 p -141.94 152.01 43.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.939 2.096 . . . . 0.0 108.829 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.63 149.2 27.33 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 73.1 p -141.68 162.45 35.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.126 2.17 . . . . 0.0 110.056 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -118.07 137.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.275 1.43 . . . . 0.0 109.976 169.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.2 t -105.77 114.12 63.2 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.172 1.389 . . . . 0.0 108.396 167.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.67 173.55 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.166 3.244 . . . . 0.0 111.272 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.22 -33.4 54.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.063 3.175 . . . . 0.0 114.097 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.6 m -75.78 -8.24 56.37 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.29 -1.62 75.12 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.459 1.505 . . . . 0.0 115.196 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -76.9 88.82 3.48 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.445 1.498 . . . . 0.0 111.299 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.47 129.6 41.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.278 1.031 . . . . 0.0 111.796 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -130.63 149.28 73.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.084 1.754 . . . . 0.0 110.6 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.39 153.76 35.59 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.795 2.996 . . . . 0.0 112.547 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 79.8 m -99.16 155.94 17.21 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 112.24 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.7 tt -93.91 113.03 24.96 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.305 1.442 . . . . 0.0 108.101 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mt -83.05 136.37 34.51 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.886 1.275 . . . . 0.0 111.246 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -137.95 143.8 40.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.74 1.216 . . . . 0.0 113.533 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -94.17 122.31 36.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 155.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.49 167.6 11.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.379 1.472 . . . . 0.0 112.303 -166.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.04 -29.9 67.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.34 1.25 53.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.21 1.004 . . . . 0.0 113.341 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.64 67.54 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.804 1.669 . . . . 0.0 114.772 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -77.12 168.97 19.18 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.383 1.473 . . . . 0.0 113.443 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 77.8 t -112.05 140.3 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.452 1.501 . . . . 0.0 110.486 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.12 -171.81 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.355 0.978 . . . . 0.0 115.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.1 162.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.502 1.521 . . . . 0.0 112.458 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 37.0 m -132.33 159.83 38.05 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.946 1.699 . . . . 0.0 110.438 161.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.29 -177.05 5.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.425 1.89 . . . . 0.0 109.998 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.8 t -130.27 121.05 19.33 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.795 0.838 . . . . 0.0 109.738 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.71 139.01 15.51 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.95 3.1 . . . . 0.0 110.799 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 55.6 tptt -88.95 -20.03 25.01 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -135.55 176.01 9.06 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.494 1.918 . . . . 0.0 110.897 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 76.1 p -92.1 164.3 13.64 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.534 1.133 . . . . 0.0 111.053 167.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 100.24 -168.41 20.99 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.156 1.36 . . . . 0.0 113.928 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.58 112.84 11.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 0.0 111.941 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 19.3 m80 -100.66 141.25 33.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.851 1.66 . . . . 0.0 109.129 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.39 125.82 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 109.648 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.7 t -86.85 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 108.099 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -101.64 134.39 44.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.796 1.239 . . . . 0.0 109.915 170.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.2 p -139.75 128.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.278 1.037 . . . . 0.0 112.202 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -115.84 141.71 47.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.599 2.359 . . . . 0.0 111.01 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -137.11 118.71 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.574 2.35 . . . . 0.0 109.357 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.4 t30 56.34 29.02 14.33 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.761 1.224 . . . . 0.0 113.685 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 95.42 3.91 61.14 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.135 1.35 . . . . 0.0 116.169 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -137.62 153.77 49.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.567 1.684 . . . . 0.0 111.482 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -65.27 142.28 58.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.65 -1.281 . . . . 0.0 113.156 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2030 ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' 2032 ' ' SER . 61.5 t -67.24 147.87 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.624 1.17 . . . . 0.0 109.457 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.05 64.28 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2032 ' ' SER . . . . . 0.422 ' H ' HG12 ' A' 2030 ' ' VAL . 11.5 m -76.18 -14.18 60.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.581 1.552 . . . . 0.0 114.002 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 10.1 t -85.67 141.57 36.32 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.674 1.19 . . . . 0.0 112.861 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.15 154.2 86.09 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.506 0.859 . . . . 0.0 112.56 -4.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.6 118.88 56.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.58 1.552 . . . . 0.0 108.582 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.16 140.71 12.52 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.071 2.514 . . . . 0.0 111.038 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 16.0 t -137.62 125.34 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.818 1.647 . . . . 0.0 108.118 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.4 t -97.78 122.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.683 0.793 . . . . 0.0 110.192 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.92 131.06 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.17 1.388 . . . . 0.0 110.023 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.9 t -95.24 171.82 8.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.81 1.244 . . . . 0.0 112.331 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -23.36 62.96 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.525 -1.359 . . . . 0.0 112.938 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 4.2 m -74.6 -12.72 60.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -117.71 6.59 12.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.47 1.508 . . . . 0.0 113.744 -173.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.45 -39.5 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.024 0.93 . . . . 0.0 112.658 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.0 42.01 0.03 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 123.833 0.73 . . . . 0.0 114.211 -169.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.23 104.97 6.02 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 117.861 0.831 . . . . 0.0 111.981 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.64 93.49 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.523 -0.736 . . . . 0.0 112.797 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 19.4 m -60.09 -27.5 67.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.208 1.003 . . . . 0.0 113.256 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -80.73 -10.4 59.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.398 1.479 . . . . 0.0 114.246 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 93.4 t -81.91 136.09 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.036 1.289 . . . . 0.0 109.455 172.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -131.74 156.8 45.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.24 1.416 . . . . 0.0 110.737 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.6 m -144.7 158.77 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.818 1.247 . . . . 0.0 111.666 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 95.1 p -158.34 172.57 18.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.819 1.247 . . . . 0.0 112.863 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.94 153.09 28.08 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.893 1.235 . . . . 0.0 113.169 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -77.29 -16.46 58.96 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -168.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.06 29.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.704 1.145 . . . . 0.0 114.748 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -87.96 -3.96 58.86 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.683 1.593 . . . . 0.0 112.785 168.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -134.24 -39.57 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.832 1.253 . . . . 0.0 113.936 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.26 148.81 40.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.191 1.396 . . . . 0.0 111.362 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.95 175.86 26.12 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.728 1.156 . . . . 0.0 113.838 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 61.7 m80 -132.13 154.6 49.33 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.284 1.434 . . . . 0.0 111.811 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 9.9 p -67.11 -65.86 0.63 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.394 1.078 . . . . 0.0 112.796 -175.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.77 7.49 44.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.26 1.024 . . . . 0.0 113.507 -166.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.58 143.17 43.89 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.751 2.02 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.48 152.2 48.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.691 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -101.03 162.48 12.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.617 1.567 . . . . 0.0 110.924 168.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.69 149.95 34.46 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 50.2 p90 -159.85 153.73 23.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.695 1.598 . . . . 0.0 111.18 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 142.17 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 109.523 -172.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 39.7 mt -120.24 136.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.519 1.927 . . . . 0.0 109.391 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.0 125.53 41.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.577 1.551 . . . . 0.0 111.892 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 40.3 p -122.35 -13.43 8.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.31 -25.41 68.03 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.632 1.56 . . . . 0.0 114.732 -170.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.15 -16.52 60.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.218 1.007 . . . . 0.0 112.892 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.64 49.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.534 1.534 . . . . 0.0 113.669 172.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 80.52 -119.33 4.88 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.597 1.094 . . . . 0.0 112.063 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -92.49 169.58 10.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.521 1.528 . . . . 0.0 112.822 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.51 -138.49 7.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.009 1.29 . . . . 0.0 112.739 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -178.2 136.15 2.89 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 124.352 0.977 . . . . 0.0 112.017 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.88 122.92 40.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.736 1.614 . . . . 0.0 109.651 -175.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 46.1 m -112.21 132.91 54.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 109.476 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -130.03 135.83 48.71 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.33 1.452 . . . . 0.0 109.633 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 71.0 m -130.6 140.24 50.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.585 0.754 . . . . 0.0 111.01 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.4 mt -118.17 127.11 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.105 1.362 . . . . 0.0 107.764 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.36 140.42 46.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.207 1.403 . . . . 0.0 109.535 -168.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 171.38 -155.82 25.03 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.809 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 -22.69 27.53 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.379 2.719 . . . . 0.0 113.682 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 63.8 m -145.48 160.04 42.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.568 1.147 . . . . 0.0 112.367 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -67.31 146.3 54.25 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.182 0.993 . . . . 0.0 111.228 169.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -130.17 149.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.718 1.607 . . . . 0.0 110.769 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.46 105.46 17.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.768 0.827 . . . . 0.0 110.122 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 41.0 mt -85.51 130.49 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -126.29 157.36 38.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 110.418 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.9 p -144.5 153.45 41.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.795 1.238 . . . . 0.0 112.279 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -158.1 134.99 9.85 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.118 1.367 . . . . 0.0 110.591 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -80.98 131.97 35.35 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.712 0.805 . . . . 0.0 111.905 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.92 168.81 13.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.452 1.501 . . . . 0.0 111.332 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -32.11 69.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.91 -7.52 54.75 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.307 1.443 . . . . 0.0 113.518 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 88.02 6.76 75.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.484 1.516 . . . . 0.0 114.114 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 22.2 p -80.42 154.17 27.82 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.747 1.619 . . . . 0.0 110.617 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -100.35 119.14 37.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.456 0.702 . . . . 0.0 110.597 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -86.54 133.19 33.75 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.698 0.799 . . . . 0.0 109.519 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 19.2 t -113.4 138.05 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.67 1.988 . . . . 0.0 108.645 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 23.9 p -135.85 151.93 50.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.426 1.49 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -163.16 153.16 15.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 111.811 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.4 t -119.31 100.59 49.88 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.405 1.082 . . . . 0.0 110.91 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.75 85.56 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.687 2.925 . . . . 0.0 110.937 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 18.7 m -54.42 -39.41 67.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 0.0 113.936 -170.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -95.32 140.09 22.26 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.259 1.024 . . . . 0.0 111.014 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 165.38 31.98 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.694 2.93 . . . . 0.0 112.358 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 139.54 -160.08 25.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.0 1.286 . . . . 0.0 113.115 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -107.27 119.55 39.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.186 0.994 . . . . 0.0 110.513 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.89 141.31 36.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.463 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.56 131.47 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.237 1.415 . . . . 0.0 108.063 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.7 mt -110.21 119.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.423 1.089 . . . . 0.0 108.901 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -102.14 124.43 47.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 110.697 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.73 115.53 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.394 1.477 . . . . 0.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.7 134.87 48.61 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 0.0 111.604 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -126.99 124.47 39.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.864 1.666 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.78 34.78 19.87 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.022 1.329 . . . . 0.0 113.683 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.4 t70 89.71 -0.65 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.269 3.027 . . . . 0.0 113.929 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -119.39 132.82 55.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.688 1.195 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -69.15 128.42 36.57 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.278 1.431 . . . . 0.0 111.93 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -85.67 160.65 52.83 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 119.133 0.879 . . . . 0.0 112.155 -169.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.92 149.27 43.05 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.071 3.18 . . . . 0.0 114.471 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 80.65 -30.0 2.58 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.222 1.392 . . . . 0.0 113.827 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -72.83 142.58 83.4 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 110.547 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.03 139.59 62.54 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 120.631 1.261 . . . . 0.0 111.896 6.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.14 111.92 24.19 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.066 0.946 . . . . 0.0 110.21 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 67.3 m -85.57 127.41 34.44 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.982 0.913 . . . . 0.0 110.888 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -124.43 112.1 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.66 1.584 . . . . 0.0 109.35 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.56 118.17 21.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.859 0.463 . . . . 0.0 110.722 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.0 t -104.11 124.76 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.874 1.67 . . . . 0.0 109.193 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.1 t -124.87 162.88 23.42 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 112.367 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 122.98 159.22 10.46 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.297 1.903 . . . . 0.0 113.096 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -163.46 144.27 9.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.797 1.639 . . . . 0.0 110.223 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 87.57 84.91 1.17 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.885 1.231 . . . . 0.0 111.346 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -61.66 128.6 37.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.736 1.214 . . . . 0.0 112.218 -173.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 25.7 t 76.97 117.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 128.857 2.863 . . . . 0.0 109.911 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.161 1.385 . . . . 0.0 111.984 179.443 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.72 153.67 41.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.316 1.047 . . . . 0.0 112.694 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 67.4 mtt -86.39 98.62 11.1 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.533 1.133 . . . . 0.0 110.871 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -67.66 -35.48 86.01 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.54 0.591 . . . . 0.0 113.275 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -71.66 -25.97 62.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.64 1.176 . . . . 0.0 112.995 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.27 -35.35 31.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.336 1.054 . . . . 0.0 111.421 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 16.9 t -64.32 -39.71 94.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.302 1.041 . . . . 0.0 112.655 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 22.2 ptp -162.64 152.18 15.68 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.655 1.182 . . . . 0.0 113.659 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.08 115.58 30.86 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 162.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 28.3 ttt -118.54 129.35 55.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.669 1.188 . . . . 0.0 111.094 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 4.3 m -123.26 141.77 51.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.947 1.699 . . . . 0.0 108.589 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -156.8 162.02 39.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.4 tt -154.69 145.49 22.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.852 2.061 . . . . 0.0 110.261 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -135.29 143.71 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.609 1.164 . . . . 0.0 112.184 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 42.6 t -132.88 134.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 110.143 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.01 63.71 4.35 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 125.349 1.452 . . . . 0.0 112.057 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 10.1 m -58.51 124.77 20.74 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 114.154 -171.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -156.8 150.02 24.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.114 1.366 . . . . 0.0 111.69 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.71 153.44 21.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.131 0.972 . . . . 0.0 111.382 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -90.73 139.66 30.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.668 1.187 . . . . 0.0 112.116 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 36.1 mm -125.27 123.85 25.21 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 108.935 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.44 149.73 45.11 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.771 2.314 . . . . 0.0 111.526 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.91 148.37 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.089 1.756 . . . . 0.0 108.805 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 53.3 t30 -44.05 116.47 1.0 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.363 1.465 . . . . 0.0 113.772 -170.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 5.1 mp -87.38 130.42 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.008 1.323 . . . . 0.0 109.749 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.7 t -164.16 -175.59 4.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.209 1.403 . . . . 0.0 111.134 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.78 1.0 21.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.631 1.572 . . . . 0.0 113.658 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.1 m -57.33 133.5 55.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.568 1.947 . . . . 0.0 111.338 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.44 122.3 19.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.193 0.997 . . . . 0.0 111.402 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.22 -20.48 60.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.033 0.933 . . . . 0.0 113.076 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 67.5 m -72.97 -18.24 61.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -109.38 5.83 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.665 1.586 . . . . 0.0 113.494 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.3 146.31 29.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.592 1.557 . . . . 0.0 111.455 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 49.9 p -134.59 168.42 19.02 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.222 1.809 . . . . 0.0 109.854 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -145.33 141.76 28.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.821 0.849 . . . . 0.0 112.243 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 64.2 p -135.2 163.35 30.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.693 1.997 . . . . 0.0 109.428 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -115.78 136.55 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.802 1.241 . . . . 0.0 109.55 167.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.0 t -107.03 113.21 62.73 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.59 1.556 . . . . 0.0 108.17 167.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -80.24 173.47 12.49 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.289 3.326 . . . . 0.0 111.272 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.18 -28.01 49.6 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.196 3.264 . . . . 0.0 114.83 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.0 p -79.03 -9.18 59.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.789 1.235 . . . . 0.0 114.143 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.3 0.25 88.71 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.46 1.505 . . . . 0.0 114.695 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.61 84.43 3.28 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.518 1.527 . . . . 0.0 111.491 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.87 133.4 55.4 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.643 1.177 . . . . 0.0 112.009 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.81 149.65 59.98 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.412 1.485 . . . . 0.0 110.986 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.11 154.52 42.05 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.93 3.087 . . . . 0.0 112.669 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 84.9 m -108.24 153.45 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.094 1.358 . . . . 0.0 112.686 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 63.4 tp -88.11 112.57 22.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.455 1.102 . . . . 0.0 109.938 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.75 134.41 33.58 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.967 1.307 . . . . 0.0 111.165 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -142.9 148.86 37.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.008 1.323 . . . . 0.0 112.911 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -80.49 122.38 26.93 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.023 1.329 . . . . 0.0 108.364 160.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.41 177.36 6.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.316 1.446 . . . . 0.0 112.704 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -53.84 -43.03 69.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.504 1.522 . . . . 0.0 114.218 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.17 4.42 53.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.718 1.207 . . . . 0.0 113.688 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.74 -7.02 74.11 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.883 1.23 . . . . 0.0 114.403 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.05 174.24 8.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.894 1.278 . . . . 0.0 112.602 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -127.9 142.47 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.38 1.472 . . . . 0.0 109.548 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.17 34.35 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.72 163.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.12 1.768 . . . . 0.0 112.731 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 4.4 m -137.89 155.4 48.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 110.336 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 16.8 p90 -164.16 -176.07 4.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.185 2.594 . . . . 0.0 108.909 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.2 t -131.35 123.3 19.5 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 119.105 0.866 . . . . 0.0 109.246 169.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.5 148.2 26.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.038 3.158 . . . . 0.0 111.441 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -107.79 -8.34 16.06 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.21 172.74 12.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.027 2.131 . . . . 0.0 109.78 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 168.0 15.17 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.639 1.176 . . . . 0.0 111.529 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.61 -170.39 26.73 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.122 1.344 . . . . 0.0 114.013 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.69 115.09 10.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.221 1.008 . . . . 0.0 111.687 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.0 m80 -98.27 144.05 28.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.757 1.623 . . . . 0.0 109.134 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.59 126.99 54.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.237 1.015 . . . . 0.0 109.544 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.5 t -85.55 118.87 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.41 96.6 7.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.535 1.534 . . . . 0.0 110.089 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 89.0 t -86.08 137.71 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.855 1.662 . . . . 0.0 108.975 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.3 mttm -133.64 131.75 39.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.145 0.978 . . . . 0.0 112.99 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 80.6 tttt -96.25 119.49 34.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.063 1.345 . . . . 0.0 109.281 161.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.46 22.87 5.36 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.845 1.258 . . . . 0.0 114.074 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.14 3.7 88.77 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.401 1.477 . . . . 0.0 115.582 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -106.28 23.28 14.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.397 1.479 . . . . 0.0 113.305 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.7 m-70 65.26 -170.77 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.936 1.694 . . . . 0.0 112.527 -172.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 34.1 m -136.29 171.84 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.943 1.297 . . . . 0.0 110.795 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.7 -29.7 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.5 m -89.46 -10.47 46.27 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.8 p -89.98 153.99 47.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 120.709 -1.244 . . . . 0.0 113.715 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.8 157.16 95.2 Favored 'Cis proline' 0 C--N 1.353 0.78 0 CA-C-N 118.856 0.627 . . . . 0.0 112.41 -4.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.01 122.81 39.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.703 1.201 . . . . 0.0 108.774 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.64 146.36 11.96 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.043 2.495 . . . . 0.0 112.576 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 19.4 t -137.52 125.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.985 1.714 . . . . 0.0 107.921 170.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.2 t -102.09 124.69 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.701 0.8 . . . . 0.0 110.635 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.36 139.53 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.439 1.496 . . . . 0.0 110.232 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 15.2 t -116.7 164.71 14.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.817 1.247 . . . . 0.0 111.449 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.04 -37.65 77.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.401 1.08 . . . . 0.0 112.738 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 48.8 m -60.71 -18.41 54.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.63 -6.63 32.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.166 1.386 . . . . 0.0 113.142 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.61 -32.88 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.086 -1.009 . . . . 0.0 112.701 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 140.42 29.61 0.19 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.754 1.169 . . . . 0.0 113.641 -168.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 28.2 t0 -73.34 114.57 11.69 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.421 1.11 . . . . 0.0 110.685 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.72 74.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.811 0.844 . . . . 0.0 113.015 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 60.4 p -66.85 -21.03 66.03 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.986 -1.071 . . . . 0.0 113.196 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -77.9 -14.85 59.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.775 1.23 . . . . 0.0 113.399 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 48.3 t -79.7 132.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.618 1.099 . . . . 0.0 110.08 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -113.87 154.49 27.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.764 1.625 . . . . 0.0 110.57 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.81 149.75 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.209 1.404 . . . . 0.0 111.008 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 74.6 m -150.78 160.41 43.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.925 1.29 . . . . 0.0 112.325 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 113.76 162.92 14.89 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.418 1.009 . . . . 0.0 115.021 171.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -65.23 -34.42 78.31 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.675 1.59 . . . . 0.0 113.249 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.82 -1.65 33.04 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.934 1.254 . . . . 0.0 115.053 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.1 mt -90.2 -7.27 53.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.401 1.481 . . . . 0.0 112.689 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -128.33 -36.32 1.92 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.834 1.253 . . . . 0.0 113.794 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -158.78 158.09 32.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.683 1.193 . . . . 0.0 112.396 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -154.81 -174.91 25.31 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.441 1.019 . . . . 0.0 114.166 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -141.71 137.97 32.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.324 1.45 . . . . 0.0 111.18 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.2 p -63.48 146.65 53.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.265 0.626 . . . . 0.0 111.307 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 4.4 m-85 73.93 -4.73 2.19 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.069 2.148 . . . . 0.0 113.896 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -120.97 148.4 48.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.795 2.038 . . . . 0.0 110.191 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.47 125.06 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 110.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -86.57 145.51 26.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.273 1.029 . . . . 0.0 109.54 165.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.48 151.45 50.95 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -158.51 152.13 23.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.163 1.785 . . . . 0.0 110.548 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.19 140.46 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.538 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.2 mt -114.57 136.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.281 1.832 . . . . 0.0 109.094 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 57.5 t0 -123.08 100.92 7.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.045 1.738 . . . . 0.0 110.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.9 p -99.2 4.25 46.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.581 1.952 . . . . 0.0 112.831 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.85 -33.15 71.4 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.489 1.041 . . . . 0.0 112.835 -173.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.24 -10.03 55.38 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.376 1.47 . . . . 0.0 113.383 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.84 -9.76 19.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.17 1.788 . . . . 0.0 114.08 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 69.38 -134.89 26.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.954 1.264 . . . . 0.0 114.008 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -74.04 167.36 21.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.079 1.352 . . . . 0.0 112.635 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.97 -116.99 0.97 Allowed Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.558 1.075 . . . . 0.0 112.022 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . 176.2 116.32 0.45 Allowed Glycine 0 N--CA 1.465 0.612 0 C-N-CA 123.87 0.748 . . . . 0.0 112.812 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.03 124.97 29.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.496 1.118 . . . . 0.0 109.517 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 69.0 m -124.52 144.59 50.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.773 1.629 . . . . 0.0 109.616 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -144.35 132.46 21.66 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.344 0.658 . . . . 0.0 110.223 -164.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 49.6 m -132.53 139.03 47.71 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.604 0.762 . . . . 0.0 111.098 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.9 mt -123.93 138.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.723 1.609 . . . . 0.0 108.622 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.94 157.56 44.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 161.85 -146.31 11.93 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.873 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.62 -11.27 24.15 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.582 2.855 . . . . 0.0 113.989 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.8 t -155.97 161.08 40.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.594 1.088 . . . . 0.0 112.411 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 130.39 35.09 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.299 1.44 . . . . 0.0 109.727 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.7 m -114.23 157.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.158 1.383 . . . . 0.0 111.856 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -92.5 126.13 37.45 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.501 0.72 . . . . 0.0 109.813 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.7 mt -106.67 134.64 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 109.427 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -131.87 162.59 30.23 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.014 1.726 . . . . 0.0 111.056 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 23.0 p -137.99 159.95 40.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.391 1.476 . . . . 0.0 112.079 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.83 122.76 6.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.236 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 128.6 34.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.726 1.21 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 69.5 mt -104.41 151.3 23.68 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.507 1.123 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.35 -17.55 64.27 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.734 0.813 . . . . 0.0 113.057 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -70.69 -10.8 60.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.439 1.496 . . . . 0.0 113.453 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.71 -3.2 70.9 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.153 1.835 . . . . 0.0 114.187 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 42.6 p -87.85 168.97 12.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.252 1.821 . . . . 0.0 111.319 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -123.81 127.15 47.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.992 0.917 . . . . 0.0 111.408 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -79.51 135.08 36.54 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.229 165.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 48.0 t -113.14 139.78 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.173 1.789 . . . . 0.0 108.381 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.2 p -133.83 150.47 51.41 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 111.565 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.0 p90 -155.19 146.94 23.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.524 1.13 . . . . 0.0 112.019 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 38.3 t -113.73 106.93 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.275 1.03 . . . . 0.0 111.179 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.67 145.77 16.42 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.571 2.847 . . . . 0.0 111.059 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 91.5 m -104.01 -47.13 4.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -86.61 143.23 35.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.12 162.13 28.98 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.346 2.697 . . . . 0.0 111.3 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.54 -164.69 24.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.24 1.4 . . . . 0.0 113.566 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -90.59 118.99 30.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.499 0.719 . . . . 0.0 111.059 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -100.21 141.1 33.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.719 1.208 . . . . 0.0 110.107 167.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.56 131.05 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.503 1.121 . . . . 0.0 108.359 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.5 mt -113.61 130.58 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.292 1.437 . . . . 0.0 109.372 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 21.0 m120 -114.19 123.95 50.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.595 1.558 . . . . 0.0 110.115 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.91 119.78 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.065 0.946 . . . . 0.0 109.693 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -122.99 136.48 54.87 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.866 2.066 . . . . 0.0 109.787 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.04 122.13 22.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.661 1.185 . . . . 0.0 110.239 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.67 45.11 27.33 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.901 1.28 . . . . 0.0 111.987 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.6 t0 73.03 -4.47 2.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.848 2.859 . . . . 0.0 114.744 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -101.33 132.52 46.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.571 1.148 . . . . 0.0 110.748 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -69.65 125.61 27.24 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.229 1.012 . . . . 0.0 111.292 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -79.32 153.5 76.67 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.218 -0.926 . . . . 0.0 111.025 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.02 140.97 81.82 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.666 2.244 . . . . 0.0 111.647 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.66 22.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.376 1.465 . . . . 0.0 113.745 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 66.6 m -76.73 153.55 83.28 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 118.594 1.197 . . . . 0.0 111.993 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.56 142.83 73.38 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.311 0.789 . . . . 0.0 111.352 -7.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -96.18 116.52 29.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.415 1.086 . . . . 0.0 110.205 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 58.0 m -83.1 128.67 34.69 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.737 0.815 . . . . 0.0 110.449 169.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -127.07 110.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.541 1.537 . . . . 0.0 109.207 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -78.58 107.73 11.46 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.035 0.534 . . . . 0.0 110.763 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.0 t -94.47 118.06 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.787 1.235 . . . . 0.0 108.806 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -90.3 150.71 21.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.874 0.87 . . . . 0.0 110.847 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -177.2 160.23 27.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.26 0.933 . . . . 0.0 114.552 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -113.31 -2.68 13.96 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 0.0 113.605 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 80.89 4.8 90.4 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.461 1.029 . . . . 0.0 114.803 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 58.1 ttp85 84.45 138.49 0.06 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 129.439 3.095 . . . . 0.0 111.612 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 57.7 t -133.3 133.99 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.995 1.718 . . . . 0.0 109.046 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.146 1.378 . . . . 0.0 112.173 179.531 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -81.05 -19.09 44.54 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -75.28 144.19 42.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.416 1.087 . . . . 0.0 112.41 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -88.6 148.2 20.36 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.812 1.196 . . . . 0.0 111.924 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.35 -18.87 64.59 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.82 -10.46 53.44 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.815 1.646 . . . . 0.0 113.73 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 44.3 m -81.0 -15.22 56.8 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 5.2 ppp? -71.59 159.49 34.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.259 1.023 . . . . 0.0 112.11 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -128.23 149.17 50.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.641 1.176 . . . . 0.0 110.798 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 20.3 ptm -158.76 163.04 37.11 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.618 1.567 . . . . 0.0 112.417 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 19.3 m -136.99 143.9 43.03 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.419 1.888 . . . . 0.0 109.097 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -143.58 165.15 28.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -164.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1963 ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -156.65 155.65 32.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.868 2.067 . . . . 0.0 110.5 -175.216 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1964 ' ' LYS . . . . . 0.421 ' H ' HD13 ' A' 1963 ' ' LEU . 61.1 mttm -136.94 143.83 43.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.444 1.498 . . . . 0.0 111.478 173.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 57.8 t -141.04 135.66 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.832 1.653 . . . . 0.0 109.534 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.29 133.32 11.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.898 0.761 . . . . 0.0 112.045 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 62.5 m -120.3 146.58 45.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.89 1.276 . . . . 0.0 112.602 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -157.03 150.65 24.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.493 1.117 . . . . 0.0 112.589 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.58 148.86 25.3 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.401 1.081 . . . . 0.0 111.229 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -86.56 126.98 34.85 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.806 1.243 . . . . 0.0 111.203 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.6 mm -113.22 113.29 48.98 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 124.926 1.29 . . . . 0.0 109.01 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.11 138.57 20.58 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.989 2.459 . . . . 0.0 110.948 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 55.2 mt -143.35 136.5 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.82 1.248 . . . . 0.0 109.713 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 11.5 t30 59.22 69.82 0.69 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.305 1.842 . . . . 0.0 113.058 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.68 104.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.73 0.812 . . . . 0.0 109.657 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.6 t -173.69 -168.56 0.44 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.971 2.108 . . . . 0.0 109.928 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.16 51.93 1.05 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.1 1.76 . . . . 0.0 111.893 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 91.9 m -83.72 124.04 30.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.545 1.538 . . . . 0.0 109.773 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -90.46 126.53 35.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.702 1.201 . . . . 0.0 110.258 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -31.06 55.91 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.941 1.296 . . . . 0.0 112.132 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 57.3 m -73.02 -22.92 60.57 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -160.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1982 ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' 1982 ' ' LEU . 1.9 pt? -111.72 2.47 17.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.402 1.481 . . . . 0.0 114.079 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.79 152.25 20.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.066 1.347 . . . . 0.0 112.084 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.0 p -140.77 172.42 12.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.62 2.368 . . . . 0.0 108.641 165.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -156.56 160.29 39.33 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 78.3 p -133.07 161.5 34.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.461 1.905 . . . . 0.0 109.824 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -111.75 135.13 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.953 1.301 . . . . 0.0 109.243 166.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.8 t -103.52 110.66 64.23 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.74 1.216 . . . . 0.0 107.89 163.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.09 169.43 17.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.766 2.977 . . . . 0.0 110.897 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.51 -19.75 65.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.902 2.401 . . . . 0.0 112.025 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 1.9 m -68.66 -10.57 57.02 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.642 1.577 . . . . 0.0 113.668 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 77.62 -13.3 12.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.131 1.824 . . . . 0.0 115.411 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -80.51 94.92 6.34 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.833 1.253 . . . . 0.0 111.181 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.64 133.97 55.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.161 0.984 . . . . 0.0 111.473 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.28 150.75 62.41 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.356 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.82 156.23 34.95 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.942 3.095 . . . . 0.0 112.882 -176.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 88.7 m -104.93 153.04 21.92 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.35 1.46 . . . . 0.0 112.244 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -96.79 116.72 29.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.468 1.507 . . . . 0.0 107.956 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.88 137.54 32.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.199 1.0 . . . . 0.0 110.613 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.31 137.56 47.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.693 1.197 . . . . 0.0 112.766 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -89.23 120.05 30.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.768 1.227 . . . . 0.0 107.796 160.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.65 164.65 12.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.021 1.328 . . . . 0.0 111.804 -169.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -69.88 -24.3 63.39 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -159.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -90.57 0.1 57.48 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.146 0.979 . . . . 0.0 113.549 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.96 -6.48 54.2 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 125.394 1.473 . . . . 0.0 114.146 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -74.35 174.04 9.41 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.359 1.464 . . . . 0.0 113.197 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 30.3 m -134.46 152.15 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.239 1.416 . . . . 0.0 110.931 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -162.0 -170.84 27.31 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.972 0.796 . . . . 0.0 115.064 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.39 158.89 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.403 1.481 . . . . 0.0 112.686 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 53.4 m -132.24 153.82 50.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.595 1.558 . . . . 0.0 111.047 165.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.2 p90 -165.63 -169.88 1.67 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.769 2.428 . . . . 0.0 108.913 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 92.0 t -133.99 120.75 15.38 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 119.924 1.238 . . . . 0.0 110.29 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.86 147.69 17.09 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.341 3.36 . . . . 0.0 111.279 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.7 -12.29 17.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.79 172.93 12.33 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.856 2.062 . . . . 0.0 109.969 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.9 p -86.1 171.15 11.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.06 1.344 . . . . 0.0 111.89 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.54 -170.03 26.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.075 1.321 . . . . 0.0 113.874 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.46 117.61 12.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.097 0.959 . . . . 0.0 111.78 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.2 m80 -104.24 143.57 32.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.042 1.737 . . . . 0.0 109.269 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.1 122.24 44.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.257 1.023 . . . . 0.0 109.352 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 50.9 t -91.55 125.35 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.157 1.383 . . . . 0.0 108.558 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -110.22 113.53 26.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.217 1.407 . . . . 0.0 110.189 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 42.3 t -102.66 139.49 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.332 1.453 . . . . 0.0 109.36 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -144.81 142.32 29.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -172.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.87 121.41 44.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.052 2.541 . . . . 0.0 109.58 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.1 t30 53.35 30.13 9.78 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.374 1.069 . . . . 0.0 113.545 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.05 66.08 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.64 1.59 . . . . 0.0 115.587 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -101.11 133.3 45.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.28 1.432 . . . . 0.0 110.903 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.06 139.6 57.37 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 91.2 t -76.02 142.52 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.254 1.422 . . . . 0.0 108.874 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.79 62.76 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 20.0 m -76.93 -12.63 59.98 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.832 1.253 . . . . 0.0 114.022 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 47.9 m -84.43 153.79 62.22 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.582 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.98 152.11 88.51 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-O 121.357 0.482 . . . . 0.0 112.306 -4.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.06 124.6 37.92 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.959 1.304 . . . . 0.0 108.742 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.74 137.14 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.887 2.391 . . . . 0.0 111.145 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 48.9 t -133.07 124.34 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.411 1.484 . . . . 0.0 107.815 172.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.7 t -96.87 125.35 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.822 0.849 . . . . 0.0 110.372 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.84 125.74 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.128 1.371 . . . . 0.0 109.198 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.3 t -93.39 158.75 15.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.022 0.929 . . . . 0.0 111.905 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -58.29 -31.58 67.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.09 0.956 . . . . 0.0 113.02 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 24.5 m -66.06 -18.42 65.33 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.2 1.0 . . . . 0.0 113.644 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -92.07 -13.0 31.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.473 1.109 . . . . 0.0 112.703 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.6 mm -70.12 -26.19 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.356 1.062 . . . . 0.0 112.491 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 149.8 63.4 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.356 0.979 . . . . 0.0 113.586 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -76.57 94.19 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.382 0.673 . . . . 0.0 110.922 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.82 61.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.483 1.113 . . . . 0.0 112.627 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.4 p -55.78 -22.82 26.28 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.97 1.708 . . . . 0.0 114.639 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -94.53 -7.98 39.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.306 1.442 . . . . 0.0 113.688 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.2 t -73.98 138.45 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.637 1.108 . . . . 0.0 110.693 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -114.8 147.48 39.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.584 1.554 . . . . 0.0 111.796 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.6 m -143.82 144.17 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.787 1.635 . . . . 0.0 109.807 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.4 m -149.09 156.08 41.68 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.254 -173.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 118.1 162.56 12.37 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 124.706 1.146 . . . . 0.0 114.186 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -65.47 -30.25 71.01 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.729 1.212 . . . . 0.0 113.377 -170.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.1 -1.6 34.78 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.713 1.149 . . . . 0.0 114.878 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.4 -7.67 56.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.182 1.393 . . . . 0.0 112.554 167.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -130.06 -37.55 1.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.161 1.384 . . . . 0.0 114.056 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.19 158.62 37.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.157 0.983 . . . . 0.0 113.405 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.67 -173.37 20.08 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.435 1.493 . . . . 0.0 113.271 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -136.5 146.35 46.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.398 1.079 . . . . 0.0 112.784 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.9 p -67.27 -21.48 65.7 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -120.56 -0.81 10.2 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -142.8 148.45 46.05 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.176 1.39 . . . . 0.0 110.592 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.81 145.33 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.88 2.387 . . . . 0.0 111.76 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -91.14 153.14 20.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.028 1.331 . . . . 0.0 110.442 169.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.53 148.17 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.882 0.873 . . . . 0.0 113.063 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -159.04 149.28 19.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 110.74 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 141.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.256 1.822 . . . . 0.0 109.332 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.72 138.14 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.288 1.835 . . . . 0.0 109.634 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 22.0 t0 -136.7 117.64 14.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 111.69 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 12.4 p -123.34 -10.36 8.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -165.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -64.58 -23.62 67.33 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.539 1.518 . . . . 0.0 114.526 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -19.9 61.51 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.286 1.034 . . . . 0.0 112.785 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -90.51 -0.65 57.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.823 1.649 . . . . 0.0 113.672 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.46 -120.61 5.31 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.06 1.314 . . . . 0.0 112.196 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -107.25 165.43 11.38 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.016 1.726 . . . . 0.0 112.386 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.59 -178.07 19.14 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 115.229 0.852 . . . . 0.0 115.229 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.2 126.44 8.75 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.699 1.142 . . . . 0.0 112.022 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.26 121.25 36.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.289 1.835 . . . . 0.0 108.313 170.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 70.5 m -113.81 146.44 39.94 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.615 1.566 . . . . 0.0 110.867 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -141.34 133.55 27.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.42 1.088 . . . . 0.0 110.233 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.5 m -140.39 123.79 16.93 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.697 0.799 . . . . 0.0 110.929 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.16 137.97 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.454 1.502 . . . . 0.0 108.819 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -144.11 157.39 44.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.183 1.393 . . . . 0.0 110.675 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.24 -151.85 22.52 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.788 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.11 -10.73 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.832 3.022 . . . . 0.0 114.881 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.7 t -160.18 168.6 25.06 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 120.001 1.273 . . . . 0.0 112.666 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.54 151.14 47.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.404 1.481 . . . . 0.0 111.247 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.8 m -135.65 147.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.106 0.963 . . . . 0.0 112.029 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.21 129.82 34.84 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.899 -0.501 . . . . 0.0 109.939 166.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.9 133.91 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 109.174 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.35 158.99 39.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.249 1.82 . . . . 0.0 109.923 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 53.0 p -138.25 159.43 42.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.709 1.204 . . . . 0.0 111.705 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -154.58 116.01 4.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.587 1.155 . . . . 0.0 110.02 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.18 136.19 37.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.979 0.912 . . . . 0.0 111.389 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.79 161.14 15.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.126 1.37 . . . . 0.0 111.819 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.28 -15.89 62.95 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.83 -4.76 53.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.31 0.72 84.62 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.727 1.632 . . . . 0.0 114.203 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 20.8 p -83.51 170.46 14.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.552 1.941 . . . . 0.0 111.212 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 22.3 t -127.09 126.36 42.87 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.875 0.87 . . . . 0.0 111.056 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 28.1 ttm105 -78.11 140.28 39.04 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.201 1.0 . . . . 0.0 109.345 164.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -121.22 137.46 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.049 1.74 . . . . 0.0 108.24 167.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.3 p -135.34 148.93 49.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.323 1.449 . . . . 0.0 111.422 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.04 149.38 21.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.396 1.079 . . . . 0.0 112.218 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 20.4 t -113.78 104.25 55.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.96 0.904 . . . . 0.0 111.385 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.48 135.41 11.77 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.417 2.745 . . . . 0.0 110.554 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.3 m -89.88 -40.14 12.6 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.785 0.834 . . . . 0.0 112.133 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -92.58 149.5 38.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.494 1.118 . . . . 0.0 111.386 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.77 164.88 31.21 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 111.127 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 115.77 -165.01 12.15 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.11 1.338 . . . . 0.0 113.634 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.83 119.18 30.83 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.456 0.702 . . . . 0.0 112.009 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -97.43 141.71 30.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.719 1.207 . . . . 0.0 110.438 163.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.1 134.04 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.651 1.181 . . . . 0.0 108.778 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.18 125.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.452 1.101 . . . . 0.0 109.173 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -99.21 124.73 44.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.546 1.538 . . . . 0.0 109.293 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.32 122.53 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.222 1.009 . . . . 0.0 108.911 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -128.66 136.75 51.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.517 1.927 . . . . 0.0 110.27 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 31.1 t80 -133.8 126.03 29.72 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.713 1.205 . . . . 0.0 110.463 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 33.07 14.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.888 1.275 . . . . 0.0 112.988 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t0 79.75 2.54 2.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 114.44 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.23 133.22 49.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.458 1.103 . . . . 0.0 111.29 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -66.05 122.36 17.22 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.076 1.351 . . . . 0.0 110.668 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -78.91 160.69 71.0 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.146 -0.971 . . . . 0.0 111.651 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.89 138.23 69.12 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.582 2.854 . . . . 0.0 113.141 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.91 -23.15 21.83 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.816 1.198 . . . . 0.0 113.899 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 51.5 m -69.86 144.66 93.58 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.052 1.426 . . . . 0.0 111.327 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.2 137.2 48.81 Favored 'Cis proline' 0 C--N 1.351 0.666 0 CA-C-N 119.618 0.899 . . . . 0.0 111.021 -6.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.35 117.25 28.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.98 0.912 . . . . 0.0 110.268 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 18.3 m -83.08 128.75 34.76 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.501 0.721 . . . . 0.0 111.086 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.7 t -124.04 109.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.184 1.793 . . . . 0.0 108.957 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -79.05 106.04 10.8 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.344 0.658 . . . . 0.0 111.143 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 73.9 t -87.7 121.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -110.39 165.0 12.14 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.859 1.264 . . . . 0.0 111.576 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 136.09 -137.18 8.92 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.178 1.37 . . . . 0.0 112.692 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -161.81 -178.29 6.4 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.505 1.122 . . . . 0.0 111.381 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -69.43 145.87 43.08 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.044 0.831 . . . . 0.0 111.903 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -66.22 132.04 47.52 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.117 0.967 . . . . 0.0 112.654 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 89.9 t -78.21 136.55 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.321 1.449 . . . . 0.0 110.073 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.004 1.722 . . . . 0.0 111.658 178.912 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.25 159.95 33.7 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.332 1.053 . . . . 0.0 112.843 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 53.0 mtt 69.89 8.7 6.83 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.96 2.104 . . . . 0.0 114.468 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.58 146.01 35.02 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.714 1.15 . . . . 0.0 112.559 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 41.2 t0 -164.33 172.97 12.79 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.257 1.823 . . . . 0.0 110.767 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.32 18.54 0.11 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.851 2.06 . . . . 0.0 114.222 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 38.1 m -75.62 53.69 0.73 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.227 2.211 . . . . 0.0 113.353 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 95.0 mmm -62.69 129.0 38.59 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.855 -1.153 . . . . 0.0 111.14 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 152.08 28.23 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.215 1.006 . . . . 0.0 110.16 172.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.1 ptm -156.94 155.63 31.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.104 0.961 . . . . 0.0 113.296 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.5 m -138.92 152.07 47.43 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.549 . . . . 0.0 110.207 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -143.92 157.63 44.22 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.3 tt -158.78 150.94 21.34 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.017 1.727 . . . . 0.0 110.542 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 94.2 mttt -132.99 148.27 52.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.323 1.049 . . . . 0.0 112.339 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 58.3 t -136.05 131.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.944 1.698 . . . . 0.0 109.57 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -82.43 107.17 2.79 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 15.3 m -83.45 -45.19 13.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -166.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 56.98 -161.16 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.528 1.531 . . . . 0.0 112.865 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -160.68 149.29 16.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.231 1.812 . . . . 0.0 110.398 169.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.2 124.7 35.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 111.106 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.49 116.56 33.41 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.465 1.106 . . . . 0.0 109.359 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.51 144.4 44.94 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.569 2.179 . . . . 0.0 111.167 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.85 146.19 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.685 1.594 . . . . 0.0 108.417 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -46.92 120.14 2.88 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.861 1.264 . . . . 0.0 113.887 -169.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.49 71.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.959 1.303 . . . . 0.0 109.694 -169.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 62.2 p -94.36 -20.38 19.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -163.59 149.08 11.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.062 1.345 . . . . 0.0 111.255 -171.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.3 p -76.25 -11.39 59.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.113 1.365 . . . . 0.0 114.666 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -26.83 28.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.454 1.502 . . . . 0.0 113.25 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -14.36 9.45 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.687 1.195 . . . . 0.0 113.498 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 16.5 m -73.74 -16.28 61.19 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.94 -1.1 . . . . 0.0 113.922 172.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.51 -7.52 2.52 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.9 mp -71.04 166.52 21.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.603 1.561 . . . . 0.0 112.106 168.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 38.5 p -135.61 157.82 45.92 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.024 1.73 . . . . 0.0 110.743 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -146.26 161.77 39.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.217 1.007 . . . . 0.0 113.414 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 37.0 p -132.71 142.01 48.85 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.587 1.955 . . . . 0.0 109.973 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 55.3 t -90.72 127.53 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.352 1.061 . . . . 0.0 108.647 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.7 t -101.68 109.34 59.09 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 108.027 167.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.35 168.04 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.74 2.96 . . . . 0.0 110.634 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.23 -14.01 41.55 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.103 2.535 . . . . 0.0 113.563 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 63.4 p -78.1 -10.33 59.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.519 1.127 . . . . 0.0 113.752 168.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.57 -1.5 87.68 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.778 1.656 . . . . 0.0 114.952 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -79.15 82.76 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.109 1.364 . . . . 0.0 111.508 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.75 132.62 54.51 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.172 1.389 . . . . 0.0 112.051 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -141.65 150.03 55.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.504 1.522 . . . . 0.0 110.701 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.38 152.47 66.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.366 2.71 . . . . 0.0 112.242 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 29.1 p -127.96 148.97 50.53 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.586 1.154 . . . . 0.0 111.301 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 60.0 tp -90.13 126.94 35.97 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.335 1.054 . . . . 0.0 110.257 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.93 140.72 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.235 0.614 . . . . 0.0 110.108 170.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -137.41 137.34 38.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.258 1.423 . . . . 0.0 111.801 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -71.91 126.49 29.88 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.3 mt -105.39 163.77 12.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.948 1.299 . . . . 0.0 111.444 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -66.35 -21.62 66.25 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 -160.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 59.3 t30 -88.73 2.59 53.13 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 119.433 1.015 . . . . 0.0 113.221 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.56 -5.36 70.19 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 125.99 1.757 . . . . 0.0 113.787 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -76.8 -178.77 5.01 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.829 1.652 . . . . 0.0 113.199 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 46.9 t -136.07 141.3 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.128 1.371 . . . . 0.0 109.885 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -150.01 179.75 26.5 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.22 161.96 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.11 1.764 . . . . 0.0 111.614 173.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 47.1 t -147.78 135.63 21.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.272 1.429 . . . . 0.0 110.742 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.97 -176.73 2.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.387 1.875 . . . . 0.0 111.266 -171.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 84.1 t -131.01 125.09 21.01 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.88 1.272 . . . . 0.0 108.999 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.08 145.65 24.85 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.066 3.177 . . . . 0.0 111.209 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.04 1.83 22.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.503 1.121 . . . . 0.0 113.147 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -139.3 172.55 12.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.179 2.191 . . . . 0.0 109.989 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.6 p -99.42 165.98 11.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.166 1.386 . . . . 0.0 110.921 168.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 90.23 -163.96 30.58 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.815 1.198 . . . . 0.0 113.523 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.7 120.07 15.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.892 0.877 . . . . 0.0 111.833 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.6 m80 -107.95 145.82 33.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.207 1.803 . . . . 0.0 109.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.08 126.53 52.47 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.437 1.095 . . . . 0.0 109.87 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 76.8 t -91.48 108.05 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.265 1.426 . . . . 0.0 108.291 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.42 124.41 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 110.2 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -124.71 133.21 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.398 1.079 . . . . 0.0 110.651 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.61 145.96 51.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.845 1.258 . . . . 0.0 113.609 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.6 tttt -118.82 125.99 50.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.546 1.938 . . . . 0.0 109.514 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 9.9 t-20 55.83 25.93 9.03 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.914 1.286 . . . . 0.0 113.969 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.74 -0.85 77.49 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.38 1.467 . . . . 0.0 115.762 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.51 149.22 38.48 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.399 1.6 . . . . 0.0 111.114 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.8 p80 -70.97 147.87 48.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.7 t -73.03 151.28 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.684 1.194 . . . . 0.0 109.544 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.42 -26.24 60.83 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 52.8 p -86.93 -8.01 57.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.432 1.493 . . . . 0.0 114.062 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.0 t -86.76 146.8 42.0 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.075 1.35 . . . . 0.0 112.696 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.36 157.48 82.56 Favored 'Cis proline' 0 C--N 1.351 0.69 0 CA-C-N 119.281 0.779 . . . . 0.0 112.23 -7.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.31 126.38 32.38 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.063 1.345 . . . . 0.0 109.126 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.18 140.95 14.27 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.925 2.416 . . . . 0.0 111.677 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.5 t -134.33 124.59 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.713 1.605 . . . . 0.0 107.648 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.1 t -99.31 124.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.804 0.842 . . . . 0.0 110.438 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.96 123.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.224 1.41 . . . . 0.0 109.356 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.8 t -89.88 152.82 21.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.61 0.764 . . . . 0.0 111.172 170.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -58.56 -27.98 65.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 21.2 m -71.84 -18.57 62.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.043 0.937 . . . . 0.0 112.968 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -89.92 -6.84 55.33 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.101 -0.999 . . . . 0.0 112.769 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.47 -29.84 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.321 1.048 . . . . 0.0 112.194 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.33 61.0 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.029 0.823 . . . . 0.0 114.213 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -74.41 97.89 3.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 117.769 0.784 . . . . 0.0 110.958 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.86 71.42 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.93 0.892 . . . . 0.0 112.179 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 38.6 p -54.65 -28.62 48.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.816 1.647 . . . . 0.0 114.257 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -90.59 -6.3 54.82 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.236 1.414 . . . . 0.0 113.969 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 73.6 t -73.36 136.5 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.874 1.216 . . . . 0.0 109.719 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -115.47 156.36 25.79 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.463 1.505 . . . . 0.0 110.659 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -145.02 156.37 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.227 1.411 . . . . 0.0 110.782 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.91 167.62 28.92 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.164 0.986 . . . . 0.0 112.451 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.74 156.38 22.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.413 1.482 . . . . 0.0 113.555 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -71.18 -25.86 62.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.513 1.125 . . . . 0.0 113.24 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.68 -3.34 33.66 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.808 1.194 . . . . 0.0 115.38 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.8 mt -89.89 -5.15 57.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.778 1.631 . . . . 0.0 112.843 169.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -133.8 -40.71 0.85 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.784 1.234 . . . . 0.0 113.798 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.15 149.77 41.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.268 1.427 . . . . 0.0 111.009 -176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.12 175.47 27.41 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.269 0.938 . . . . 0.0 114.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.2 m80 -134.85 151.74 51.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.401 1.48 . . . . 0.0 111.678 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.6 p -69.08 -45.49 70.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -98.6 -5.73 31.32 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -167.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -123.4 147.82 53.64 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.054 1.742 . . . . 0.0 110.196 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.12 136.41 29.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.588 2.192 . . . . 0.0 110.645 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.11 152.91 23.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.352 1.061 . . . . 0.0 109.996 166.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.86 151.54 47.07 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.4 p90 -158.85 150.91 21.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.675 1.59 . . . . 0.0 110.81 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.98 139.94 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.846 1.658 . . . . 0.0 109.243 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.77 136.41 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.38 1.472 . . . . 0.0 108.771 167.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.6 t0 -120.57 98.23 5.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.201 1.8 . . . . 0.0 110.272 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 20.7 p -91.9 -4.76 54.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.567 1.947 . . . . 0.0 113.144 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -59.32 -35.73 74.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.308 1.043 . . . . 0.0 112.588 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.38 -11.6 59.24 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.035 1.334 . . . . 0.0 113.493 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.45 -3.57 56.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.472 1.509 . . . . 0.0 114.557 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.67 -147.0 23.74 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -78.11 172.09 14.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.442 1.097 . . . . 0.0 112.611 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 135.31 -162.09 24.77 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 124.901 1.238 . . . . 0.0 113.937 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -141.12 143.88 13.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.604 1.573 . . . . 0.0 112.719 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.45 123.83 46.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.485 1.914 . . . . 0.0 109.643 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.1 m -111.95 144.29 41.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.857 1.663 . . . . 0.0 110.314 170.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -146.8 146.36 30.22 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.5 0.72 . . . . 0.0 110.988 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 90.2 p -148.53 152.9 37.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.366 0.603 . . . . 0.0 112.338 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.87 129.83 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.134 1.374 . . . . 0.0 107.856 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.57 147.21 47.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.355 1.862 . . . . 0.0 109.713 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 176.97 -166.8 37.74 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.59 -11.51 24.3 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.337 3.358 . . . . 0.0 113.726 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 21.3 m -152.98 161.26 42.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.084 1.754 . . . . 0.0 111.218 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -68.51 146.98 52.64 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.979 0.912 . . . . 0.0 111.589 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.6 m -129.55 148.39 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.986 1.314 . . . . 0.0 110.911 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.44 110.66 21.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.52 0.728 . . . . 0.0 110.075 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 33.1 mt -87.12 129.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.189 0.995 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -123.93 161.62 25.03 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.579 1.952 . . . . 0.0 110.428 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 7.1 p -142.27 158.03 44.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.964 1.306 . . . . 0.0 112.509 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -151.38 117.07 5.43 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.291 1.436 . . . . 0.0 109.835 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.21 128.65 34.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 110.328 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 74.8 mt -102.57 153.68 19.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.485 1.114 . . . . 0.0 111.981 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -60.2 -28.42 67.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.619 1.167 . . . . 0.0 113.323 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.79 -9.38 58.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.806 1.242 . . . . 0.0 113.589 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.27 66.48 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.963 1.744 . . . . 0.0 114.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.1 p -88.12 170.45 11.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.554 1.942 . . . . 0.0 111.179 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.5 t -129.59 124.5 33.94 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.721 0.808 . . . . 0.0 111.663 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -82.28 137.56 34.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.238 1.415 . . . . 0.0 110.016 169.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 94.4 t -116.18 140.12 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.28 1.832 . . . . 0.0 108.465 166.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.78 149.91 50.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.688 1.595 . . . . 0.0 111.179 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.53 147.73 12.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 111.606 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 t -112.1 101.69 52.36 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 110.521 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -82.14 86.54 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.6 2.867 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.5 m -56.57 -39.11 72.93 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.184 1.394 . . . . 0.0 113.825 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -96.57 141.66 23.42 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.343 1.057 . . . . 0.0 110.699 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.23 166.12 29.58 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.518 2.812 . . . . 0.0 112.214 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.02 -162.37 24.48 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.205 1.384 . . . . 0.0 113.574 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -95.68 125.31 40.18 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.751 0.82 . . . . 0.0 111.126 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.3 142.59 41.71 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.23 1.412 . . . . 0.0 110.485 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 131.57 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.961 1.305 . . . . 0.0 108.389 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.6 mt -114.87 127.76 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.654 1.181 . . . . 0.0 109.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -103.84 127.17 51.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.191 1.396 . . . . 0.0 110.477 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -118.65 119.03 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.976 1.31 . . . . 0.0 109.41 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.3 tttt -135.67 123.96 23.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.325 1.45 . . . . 0.0 110.256 -168.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.5 t80 -121.89 127.52 50.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.702 1.201 . . . . 0.0 110.742 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.82 34.15 12.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.113 1.365 . . . . 0.0 113.409 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 16.2 t70 88.2 -1.84 0.47 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.428 3.091 . . . . 0.0 114.138 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -110.75 134.28 52.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 112.111 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.4 126.81 29.42 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.941 1.297 . . . . 0.0 111.094 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.9 m -76.51 153.91 83.74 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.962 . . . . 0.0 111.193 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.55 138.91 67.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.538 2.159 . . . . 0.0 111.178 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.63 -27.32 14.45 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.306 1.431 . . . . 0.0 113.216 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 11.4 t -76.7 144.23 72.87 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.09 0.945 . . . . 0.0 110.663 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.03 149.09 86.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.092 1.069 . . . . 0.0 112.035 0.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.95 119.52 38.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.766 1.226 . . . . 0.0 110.744 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 72.2 m -88.95 129.99 35.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.001 0.92 . . . . 0.0 110.776 172.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 12.9 t -124.48 115.52 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.47 1.508 . . . . 0.0 109.782 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 61.7 tttp -80.09 112.29 17.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.065 0.546 . . . . 0.0 110.709 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.5 t -98.05 121.11 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.017 1.327 . . . . 0.0 109.025 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.6 t -108.69 157.6 18.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.698 1.199 . . . . 0.0 111.479 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 165.17 172.34 32.5 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.27 0.938 . . . . 0.0 114.606 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -78.46 -21.5 48.97 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.504 1.121 . . . . 0.0 112.92 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 86.38 -1.2 87.39 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.887 1.232 . . . . 0.0 114.958 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 80.36 161.4 0.17 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.104 2.562 . . . . 0.0 112.257 173.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 8.3 p -53.12 143.72 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.524 1.53 . . . . 0.0 112.286 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.092 1.757 . . . . 0.0 112.847 -170.648 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 112.146 -0.381 . . . . 0.0 112.146 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.1 164.86 26.07 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.558 1.143 . . . . 0.0 112.855 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.4 mmt -69.57 141.8 53.72 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.151 0.98 . . . . 0.0 111.932 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -89.3 176.91 43.86 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.878 1.228 . . . . 0.0 113.55 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.92 -9.68 58.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.986 1.314 . . . . 0.0 113.708 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 16.2 t0 -145.62 134.16 22.06 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.51 1.924 . . . . 0.0 110.279 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 55.6 p -97.84 -11.72 22.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.271 1.428 . . . . 0.0 114.229 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 89.5 mtp -66.29 150.58 48.62 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 -149.96 149.21 30.07 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.314 1.446 . . . . 0.0 111.078 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 94.8 mtp -96.33 142.12 28.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.883 1.273 . . . . 0.0 111.727 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 7.4 m -122.26 137.43 54.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.637 1.975 . . . . 0.0 108.414 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.23 145.59 32.9 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.375 0.989 . . . . 0.0 113.547 -165.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.38 155.47 30.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.982 1.713 . . . . 0.0 111.183 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -132.67 150.46 52.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.598 1.159 . . . . 0.0 112.597 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.0 t -139.87 137.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.392 1.877 . . . . 0.0 109.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.33 120.13 5.67 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.0 m -106.59 143.45 34.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.57 152.17 23.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.872 0.869 . . . . 0.0 113.025 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.47 148.45 26.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.167 0.987 . . . . 0.0 111.028 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.37 146.5 28.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 112.494 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.33 120.05 20.9 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.824 1.25 . . . . 0.0 108.791 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.69 137.64 14.49 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.366 2.711 . . . . 0.0 110.956 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.15 138.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.206 1.402 . . . . 0.0 109.985 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 51.7 t30 55.1 64.52 1.77 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.918 1.687 . . . . 0.0 112.359 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 11.2 mm -71.67 105.06 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.39 1.076 . . . . 0.0 110.95 -168.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 11.8 t -171.94 177.82 3.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.751 2.02 . . . . 0.0 110.221 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.72 57.18 3.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.528 1.531 . . . . 0.0 111.049 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 39.6 p -75.77 153.27 37.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.244 1.418 . . . . 0.0 112.28 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -98.44 111.63 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.799 1.24 . . . . 0.0 110.485 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.68 -12.3 61.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.124 0.97 . . . . 0.0 113.053 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 66.6 m -77.12 -16.96 58.98 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.746 1.157 . . . . 0.0 113.948 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -116.65 3.8 13.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.254 1.422 . . . . 0.0 114.057 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.02 146.02 37.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 0.0 110.972 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 56.0 p -140.12 168.01 20.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.532 1.933 . . . . 0.0 109.666 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 152.6 31.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.785 0.834 . . . . 0.0 112.596 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 67.3 p -138.85 157.52 45.91 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.523 1.929 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -109.93 133.45 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.646 1.178 . . . . 0.0 109.495 169.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 89.9 t -102.43 110.5 63.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.776 1.23 . . . . 0.0 107.748 164.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.87 169.65 21.29 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.686 2.924 . . . . 0.0 110.838 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -15.17 46.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.971 2.448 . . . . 0.0 113.28 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 62.3 p -80.33 -9.61 59.74 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.828 1.251 . . . . 0.0 113.916 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.03 -1.72 83.66 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.736 1.636 . . . . 0.0 115.118 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -78.98 83.1 5.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.181 1.392 . . . . 0.0 111.643 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -58.77 135.42 57.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.755 1.222 . . . . 0.0 112.383 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -139.48 151.05 65.85 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.47 1.508 . . . . 0.0 111.128 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 155.04 35.98 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.738 2.959 . . . . 0.0 112.704 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 74.6 m -105.66 154.94 19.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.145 1.378 . . . . 0.0 111.794 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.8 119.16 35.91 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.191 1.396 . . . . 0.0 108.586 175.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.73 136.64 34.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.506 1.122 . . . . 0.0 110.886 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 66.9 mttm -136.94 141.22 42.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.725 1.21 . . . . 0.0 113.098 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -87.02 120.34 28.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.598 1.159 . . . . 0.0 107.981 157.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.4 mt -98.86 171.44 8.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.842 1.257 . . . . 0.0 112.969 -166.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -60.96 -20.41 62.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.749 2.02 . . . . 0.0 116.381 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.08 5.76 46.85 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.272 1.029 . . . . 0.0 112.971 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.75 85.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.58 1.562 . . . . 0.0 114.25 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 164.03 21.71 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.038 1.735 . . . . 0.0 113.426 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 82.6 t -102.56 141.43 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.212 1.405 . . . . 0.0 110.15 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.33 -168.17 20.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.264 0.935 . . . . 0.0 114.807 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.66 167.08 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.441 1.496 . . . . 0.0 112.264 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 98.9 p -139.08 159.85 41.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.923 1.289 . . . . 0.0 111.432 162.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.2 p90 -164.07 -178.46 5.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.026 2.13 . . . . 0.0 109.778 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -129.47 122.9 21.09 Favored Pre-proline 0 N--CA 1.482 1.135 0 CA-C-N 119.44 1.018 . . . . 0.0 110.171 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.86 141.58 15.23 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.322 3.348 . . . . 0.0 111.223 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -94.82 -32.9 13.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.7 0.8 . . . . 0.0 112.842 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -111.2 172.1 7.08 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.173 1.789 . . . . 0.0 111.096 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.6 p -90.86 164.21 14.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.838 1.255 . . . . 0.0 111.015 165.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 101.31 -166.68 18.78 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.123 1.344 . . . . 0.0 113.856 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.94 116.86 16.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.928 . . . . 0.0 111.866 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 16.2 m80 -103.77 142.83 33.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.48 1.912 . . . . 0.0 109.44 170.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.84 123.14 47.73 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.571 1.148 . . . . 0.0 109.206 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 35.2 t -90.55 112.57 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.872 1.269 . . . . 0.0 108.583 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -92.98 138.23 31.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.875 1.27 . . . . 0.0 110.531 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 66.6 t -130.46 128.43 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.672 0.789 . . . . 0.0 109.511 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.23 134.76 51.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.114 1.366 . . . . 0.0 112.569 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 84.9 tttt -128.45 129.05 45.57 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 110.162 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 53.08 30.53 9.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.627 1.171 . . . . 0.0 114.056 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.89 5.26 71.26 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.033 1.302 . . . . 0.0 116.019 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -134.62 149.26 50.55 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.665 1.733 . . . . 0.0 111.855 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -70.03 140.65 52.88 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.945 -1.097 . . . . 0.0 112.877 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 21.2 m -76.33 153.07 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.834 0.854 . . . . 0.0 111.527 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -62.77 -23.66 67.33 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 62.1 p -84.78 -3.42 58.61 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.843 1.257 . . . . 0.0 114.034 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 1.7 p -118.48 160.18 40.88 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.685 1.194 . . . . 0.0 112.757 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.0 156.17 98.7 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.48 0.85 . . . . 0.0 113.078 0.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.39 124.6 33.45 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.816 1.647 . . . . 0.0 108.954 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.84 139.34 12.2 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.193 2.595 . . . . 0.0 111.381 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.3 t -135.55 124.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.585 1.554 . . . . 0.0 108.157 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -97.23 122.47 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.757 0.823 . . . . 0.0 110.118 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.51 126.58 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.152 1.381 . . . . 0.0 109.871 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -90.28 168.54 11.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.793 1.237 . . . . 0.0 112.121 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.58 -32.12 73.25 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.332 -1.48 . . . . 0.0 112.978 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.9 m -72.28 -5.31 35.18 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.81 5.73 14.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.069 1.347 . . . . 0.0 113.207 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.43 -31.21 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.143 0.977 . . . . 0.0 112.24 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 164.27 51.05 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.762 0.665 . . . . 0.0 114.762 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.95 92.54 4.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.151 0.976 . . . . 0.0 111.393 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.69 76.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.697 0.799 . . . . 0.0 112.054 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -56.71 -24.98 53.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.343 1.457 . . . . 0.0 113.994 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -90.61 -7.05 53.79 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.15 1.38 . . . . 0.0 113.802 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 58.0 t -77.8 129.85 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.975 1.261 . . . . 0.0 109.741 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -105.69 156.34 18.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 110.687 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.0 m -143.45 151.63 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.056 1.343 . . . . 0.0 110.731 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 57.2 m -149.13 166.49 28.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.309 1.443 . . . . 0.0 112.014 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.04 157.56 26.27 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.479 1.038 . . . . 0.0 113.929 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -78.88 -18.95 53.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.54 -4.64 46.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.69 1.138 . . . . 0.0 114.788 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.45 -4.88 58.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 112.686 168.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -126.88 -36.57 2.19 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.077 1.351 . . . . 0.0 113.668 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -155.67 156.7 35.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.225 1.01 . . . . 0.0 113.093 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.07 -171.88 15.92 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.71 1.624 . . . . 0.0 113.207 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -147.22 145.17 29.37 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.968 0.907 . . . . 0.0 113.399 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 41.3 p -66.09 -23.69 66.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -114.96 1.57 14.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 139.96 31.0 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.29 1.436 . . . . 0.0 110.095 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.84 144.59 54.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.335 2.023 . . . . 0.0 110.547 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -104.11 158.67 16.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.102 1.361 . . . . 0.0 110.711 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 158.71 44.16 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.45 153.73 30.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.449 1.9 . . . . 0.0 110.114 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.63 138.8 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.687 1.595 . . . . 0.0 108.943 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 44.3 mt -110.2 135.06 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.097 1.759 . . . . 0.0 108.756 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.01 97.5 5.46 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.961 1.704 . . . . 0.0 110.46 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.7 p -94.02 0.73 56.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 113.177 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -59.48 -38.79 81.76 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.524 1.056 . . . . 0.0 113.069 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.59 -23.52 45.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.103 0.961 . . . . 0.0 113.032 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -81.36 -11.81 59.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 113.737 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.2 -121.6 5.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.007 1.289 . . . . 0.0 112.335 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.49 163.93 12.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.542 1.537 . . . . 0.0 112.203 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.45 174.24 17.48 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -89.64 122.86 6.67 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.339 0.971 . . . . 0.0 111.424 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.1 tm? -98.08 112.16 24.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.849 1.66 . . . . 0.0 107.718 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.6 m -104.9 145.55 30.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.724 0.81 . . . . 0.0 109.966 168.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.78 137.19 29.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.741 0.817 . . . . 0.0 109.762 -166.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.2 p -140.87 150.5 43.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.85 0.833 . . . . 0.0 112.497 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.42 133.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.49 1.516 . . . . 0.0 107.235 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -142.27 139.14 31.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.645 0.778 . . . . 0.0 110.827 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 179.46 -161.31 27.23 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.033 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.06 -5.61 15.13 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.291 3.327 . . . . 0.0 114.753 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.6 t -157.71 168.18 27.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.754 1.222 . . . . 0.0 111.456 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -69.33 149.14 48.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.364 1.066 . . . . 0.0 111.093 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.5 m -127.58 150.19 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.036 1.334 . . . . 0.0 110.647 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -91.04 109.17 20.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.49 0.716 . . . . 0.0 109.692 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 26.8 mt -85.4 131.74 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.195 0.998 . . . . 0.0 109.432 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -128.08 164.03 23.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.664 1.986 . . . . 0.0 110.471 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -142.59 155.53 44.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.996 1.318 . . . . 0.0 112.073 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.37 114.88 4.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.0 110.067 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.37 130.68 37.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.666 1.186 . . . . 0.0 110.967 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 75.6 mt -103.3 151.34 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.6 1.16 . . . . 0.0 111.705 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.95 -19.6 65.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.304 1.042 . . . . 0.0 113.659 -175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.63 -5.95 54.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 113.109 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 97.24 1.38 59.41 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.87 1.7 . . . . 0.0 114.738 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 168.92 10.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.366 1.866 . . . . 0.0 111.399 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -125.33 124.61 41.96 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.972 0.909 . . . . 0.0 111.543 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -84.07 134.96 34.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.136 1.375 . . . . 0.0 109.54 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 46.3 t -115.91 137.24 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.743 1.617 . . . . 0.0 108.363 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.472 1.909 . . . . 0.0 110.769 -177.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -160.4 155.91 25.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.396 1.078 . . . . 0.0 112.668 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.2 p -124.61 97.01 39.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.17 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.91 143.31 20.61 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.184 2.589 . . . . 0.0 110.345 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 88.7 m -112.11 -44.11 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 0.0 112.135 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -83.42 141.37 42.3 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.471 0.708 . . . . 0.0 110.419 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.98 162.54 34.48 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.28 2.653 . . . . 0.0 111.092 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.47 -144.04 15.89 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.811 1.196 . . . . 0.0 112.144 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -123.53 131.65 53.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.633 0.773 . . . . 0.0 111.779 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -110.21 139.0 45.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.766 1.626 . . . . 0.0 109.977 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.61 134.28 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.85 1.26 . . . . 0.0 108.447 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.67 127.84 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.214 1.406 . . . . 0.0 108.86 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -109.96 119.96 40.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.028 1.331 . . . . 0.0 109.871 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.5 mm -107.68 114.43 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.749 0.785 . . . . 0.0 108.955 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.57 118.0 23.1 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.21 1.004 . . . . 0.0 111.695 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 16.8 t80 -112.7 131.62 55.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.68 1.192 . . . . 0.0 110.259 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.99 35.35 21.78 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.466 1.506 . . . . 0.0 114.283 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.05 10.14 3.8 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.386 2.275 . . . . 0.0 114.24 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -95.57 -128.8 0.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.127 1.371 . . . . 0.0 110.465 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -168.13 125.19 1.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.558 2.343 . . . . 0.0 108.69 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -76.91 151.57 82.16 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-N 120.044 1.293 . . . . 0.0 110.843 -170.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.34 135.24 52.78 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.568 2.178 . . . . 0.0 110.996 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 100.83 -27.02 22.49 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.39 1.471 . . . . 0.0 113.744 -173.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 50.9 m -74.57 150.37 86.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 118.972 1.386 . . . . 0.0 111.67 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.02 141.17 69.75 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 119.205 0.752 . . . . 0.0 111.208 -3.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.57 115.3 27.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.046 0.938 . . . . 0.0 110.378 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 66.4 m -87.63 121.13 29.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.988 0.915 . . . . 0.0 110.359 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -120.32 115.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.662 1.585 . . . . 0.0 109.922 -168.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.92 122.22 26.41 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.963 0.505 . . . . 0.0 111.304 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 76.1 t -106.64 117.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.444 1.498 . . . . 0.0 108.93 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.1 t -105.26 174.6 5.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.176 1.39 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 133.89 -134.09 7.26 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.138 1.352 . . . . 0.0 112.694 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -160.09 176.15 12.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.583 1.153 . . . . 0.0 111.159 -169.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -67.87 138.06 32.82 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.266 -0.896 . . . . 0.0 111.589 171.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -67.83 143.88 55.59 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.381 1.073 . . . . 0.0 112.79 -172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 31.5 m -127.82 163.96 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.656 1.982 . . . . 0.0 110.914 175.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 124.787 1.235 . . . . 0.0 112.051 178.935 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.2 -22.58 61.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 95.8 mtp -130.37 145.74 51.84 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.835 1.654 . . . . 0.0 110.976 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -106.18 -158.2 22.05 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.421 1.486 . . . . 0.0 113.562 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 31.3 t0 -158.97 165.74 33.38 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.833 2.053 . . . . 0.0 110.414 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -65.11 157.91 27.3 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.372 1.069 . . . . 0.0 112.825 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 86.8 p -157.74 161.51 38.49 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.731 1.212 . . . . 0.0 112.324 -170.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 4.6 ppp? -76.36 148.36 37.47 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.605 -0.685 . . . . 0.0 110.568 164.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.23 153.11 39.27 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.935 1.294 . . . . 0.0 110.595 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.3 ptt? -148.4 162.66 39.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.888 1.675 . . . . 0.0 110.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 68.7 m -113.78 150.01 34.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.274 1.03 . . . . 0.0 109.845 167.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -144.88 160.26 41.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1963 ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -155.3 155.41 33.7 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.277 1.831 . . . . 0.0 110.402 -169.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1964 ' ' LYS . . . . . 0.419 ' H ' HD13 ' A' 1963 ' ' LEU . 68.4 mttm -137.92 150.62 47.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.117 1.367 . . . . 0.0 111.639 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.6 p -155.76 139.39 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.703 1.201 . . . . 0.0 110.818 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -83.08 129.06 8.84 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.813 0.72 . . . . 0.0 111.405 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 44.0 m -113.41 137.41 51.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.137 . . . . 0.0 111.403 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.47 141.58 12.07 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.267 1.027 . . . . 0.0 111.957 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.26 148.25 43.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.872 0.869 . . . . 0.0 111.215 168.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.68 139.53 30.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.144 0.977 . . . . 0.0 112.63 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 72.9 mt -121.55 123.4 27.57 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.521 1.528 . . . . 0.0 108.796 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.55 152.6 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.109 2.54 . . . . 0.0 111.889 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.09 147.23 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.382 1.473 . . . . 0.0 111.037 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 35.4 t30 56.96 77.37 0.27 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.22 1.808 . . . . 0.0 112.159 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 20.3 mm -77.99 73.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.382 1.073 . . . . 0.0 109.349 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 6.6 m -172.69 -177.54 1.71 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.818 2.847 . . . . 0.0 109.383 -169.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -59.09 121.96 12.57 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.133 -0.979 . . . . 0.0 111.256 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.3 m -139.8 142.51 36.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.265 1.826 . . . . 0.0 109.153 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 64.5 t0 -126.94 120.53 29.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.932 1.293 . . . . 0.0 110.242 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.18 -10.25 59.75 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.586 1.154 . . . . 0.0 113.922 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 11.8 t -64.91 -31.26 72.4 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.631 1.105 . . . . 0.0 113.627 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.23 9.41 11.06 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.524 1.53 . . . . 0.0 113.961 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.46 145.18 25.89 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.087 1.355 . . . . 0.0 112.178 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -141.25 163.43 32.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.783 2.033 . . . . 0.0 109.371 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.28 146.78 23.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.7 p -139.25 161.77 36.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.841 2.056 . . . . 0.0 109.993 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.7 t -117.32 138.5 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.368 1.467 . . . . 0.0 110.253 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 93.5 t -105.76 112.94 64.4 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 108.246 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.82 171.94 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.916 3.077 . . . . 0.0 111.605 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.89 -28.5 31.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.706 3.604 . . . . 0.0 115.199 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 60.4 p -81.27 -9.61 59.74 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.25 -2.0 73.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.451 1.5 . . . . 0.0 114.766 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -75.43 89.19 2.65 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.309 1.444 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.3 133.53 56.19 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.078 0.951 . . . . 0.0 111.944 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -129.16 145.83 58.3 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 110.317 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.7 151.17 31.86 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.393 2.729 . . . . 0.0 111.712 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.1 m -95.61 149.63 21.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.215 1.006 . . . . 0.0 111.736 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.25 128.66 34.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 159.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.7 mt -95.89 141.58 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 110.551 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 88.8 mttt -136.78 144.66 43.87 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.502 1.521 . . . . 0.0 111.891 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -98.1 117.68 33.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.646 1.178 . . . . 0.0 107.851 159.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.61 175.15 6.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.853 1.661 . . . . 0.0 112.597 -166.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -56.97 -35.32 69.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.471 1.509 . . . . 0.0 114.692 -166.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.51 3.88 53.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 0.0 113.211 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.81 71.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.394 1.473 . . . . 0.0 114.209 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -73.17 163.57 27.94 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.681 1.592 . . . . 0.0 113.282 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 59.8 t -108.77 144.05 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.249 1.42 . . . . 0.0 110.47 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -146.14 171.49 27.03 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.607 1.098 . . . . 0.0 115.367 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.94 152.96 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.072 1.749 . . . . 0.0 111.898 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 13.6 m -132.65 148.56 52.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.7 1.6 . . . . 0.0 110.235 168.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.8 p90 -164.58 162.01 21.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.224 1.41 . . . . 0.0 111.296 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 93.1 t -102.3 119.5 56.18 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 0.0 109.32 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 145.18 24.3 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.236 3.29 . . . . 0.0 110.586 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -108.72 0.41 20.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 113.411 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -143.15 179.59 6.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.395 2.278 . . . . 0.0 109.698 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -105.09 158.44 16.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.068 1.347 . . . . 0.0 110.452 163.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.36 -164.61 16.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.303 1.43 . . . . 0.0 113.341 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.2 111.5 8.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.354 1.062 . . . . 0.0 111.944 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.7 m80 -95.32 140.55 30.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.466 1.507 . . . . 0.0 109.428 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.58 121.56 42.63 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.99 0.916 . . . . 0.0 109.116 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 44.6 t -86.86 131.76 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.013 1.325 . . . . 0.0 108.349 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -116.4 119.24 35.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.363 1.465 . . . . 0.0 109.818 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 64.5 t -107.89 134.95 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.854 1.262 . . . . 0.0 109.196 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 80.6 mttt -119.77 149.68 41.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 113.091 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -126.41 118.21 24.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.44 2.296 . . . . 0.0 109.042 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 58.01 21.19 7.53 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.862 1.265 . . . . 0.0 114.22 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 101.52 -12.26 58.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.916 1.722 . . . . 0.0 115.79 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -99.66 160.72 14.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.508 1.654 . . . . 0.0 111.222 171.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.0 p80 -65.04 153.2 41.43 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.106 -0.996 . . . . 0.0 112.954 170.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -88.71 154.47 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.721 0.809 . . . . 0.0 110.62 168.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -61.74 -21.73 64.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 67.1 m -82.33 -15.52 52.55 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 19.9 m -84.28 153.21 62.35 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 120.813 -1.18 . . . . 0.0 113.902 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.87 153.73 86.8 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 118.387 0.459 . . . . 0.0 111.812 -5.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 123.01 39.1 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.898 1.279 . . . . 0.0 109.273 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 139.18 11.89 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.082 2.522 . . . . 0.0 111.591 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 34.5 t -135.72 120.42 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.454 1.502 . . . . 0.0 108.352 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 62.0 t -92.78 122.46 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.712 0.805 . . . . 0.0 110.271 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.89 133.29 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.014 1.326 . . . . 0.0 109.656 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 27.4 t -104.65 158.69 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.4 1.08 . . . . 0.0 111.198 169.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -59.36 -29.84 67.97 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.344 -0.847 . . . . 0.0 112.72 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -65.41 -13.73 59.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.479 1.112 . . . . 0.0 113.653 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -93.75 -8.12 41.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.631 1.172 . . . . 0.0 112.471 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.2 116.77 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.516 1.053 . . . . 0.0 110.624 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 70.9 13.35 72.23 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 157.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.52 94.12 2.57 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.642 1.721 . . . . 0.0 110.748 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.45 -36.36 71.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.753 1.221 . . . . 0.0 112.735 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.5 m -54.67 -24.72 23.07 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.515 1.526 . . . . 0.0 114.184 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -86.36 -13.76 45.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.036 1.335 . . . . 0.0 113.469 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.4 t -77.55 134.73 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.43 1.014 . . . . 0.0 110.003 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -122.16 159.74 26.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.446 1.499 . . . . 0.0 110.741 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 32.8 m -147.35 159.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.107 1.363 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.09 169.93 23.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.342 1.057 . . . . 0.0 112.437 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.38 159.25 24.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.296 1.427 . . . . 0.0 113.79 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.52 -27.84 64.49 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.502 1.121 . . . . 0.0 113.362 -169.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.09 -2.73 33.26 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.854 1.216 . . . . 0.0 115.294 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 88.6 mt -88.82 -7.08 56.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.942 1.697 . . . . 0.0 112.66 168.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -133.72 -39.81 0.88 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.996 1.318 . . . . 0.0 113.915 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -140.09 148.48 41.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.189 1.395 . . . . 0.0 111.482 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.7 178.3 28.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.619 1.104 . . . . 0.0 114.203 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.9 m80 -136.83 149.64 47.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.735 1.614 . . . . 0.0 111.655 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.1 p -71.9 -32.6 67.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.54 6.73 14.72 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -138.36 144.39 42.63 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.832 1.653 . . . . 0.0 109.462 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 140.93 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.677 2.252 . . . . 0.0 111.19 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -87.67 151.56 22.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.733 1.213 . . . . 0.0 109.976 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.14 150.01 48.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.112 0.965 . . . . 0.0 113.147 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 152.42 27.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.054 1.341 . . . . 0.0 111.333 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.6 mp -110.88 142.22 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.494 1.918 . . . . 0.0 109.823 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 47.6 mt -114.46 133.59 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.975 1.71 . . . . 0.0 109.595 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 8.6 t0 -117.42 112.03 20.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.781 2.032 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 10.1 p -120.79 -3.71 9.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.537 1.535 . . . . 0.0 113.967 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -29.11 69.76 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.144 1.338 . . . . 0.0 113.47 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.09 -18.15 53.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.669 1.187 . . . . 0.0 112.867 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.99 -5.15 56.96 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.372 1.469 . . . . 0.0 113.818 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.09 -106.15 2.75 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.93 1.252 . . . . 0.0 111.816 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -129.73 145.64 51.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.442 1.497 . . . . 0.0 112.807 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 158.22 175.63 29.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.92 0.772 . . . . 0.0 114.76 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -87.5 121.7 5.95 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.143 0.878 . . . . 0.0 111.056 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 123.29 35.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.184 1.393 . . . . 0.0 108.022 171.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 8.4 t -119.73 145.24 46.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.494 1.918 . . . . 0.0 109.791 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.0 tt -145.32 144.24 30.62 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.716 0.807 . . . . 0.0 110.846 -165.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.4 p -148.13 153.92 39.49 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.78 131.42 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.724 1.61 . . . . 0.0 108.539 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.64 153.14 49.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.723 1.609 . . . . 0.0 110.513 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 166.93 -153.45 23.12 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.096 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.5 -10.51 28.13 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.913 3.076 . . . . 0.0 114.31 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -157.39 168.0 28.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.594 1.088 . . . . 0.0 112.238 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -71.52 150.0 45.23 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.609 1.163 . . . . 0.0 111.087 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.2 m -130.59 152.11 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.565 1.146 . . . . 0.0 111.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -81.47 126.32 31.52 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.58 -0.7 . . . . 0.0 109.832 165.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.2 mt -106.78 132.67 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.191 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -129.73 155.23 46.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.367 1.867 . . . . 0.0 109.533 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.33 158.57 43.81 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.61 1.164 . . . . 0.0 111.553 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.53 128.64 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 0.0 110.94 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.63 118.64 22.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.439 1.096 . . . . 0.0 109.95 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.77 160.35 18.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.14 0.976 . . . . 0.0 111.805 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.15 -20.97 66.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.97 0.908 . . . . 0.0 113.138 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.48 -12.53 59.88 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.863 1.265 . . . . 0.0 113.361 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.45 -1.56 62.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.557 1.551 . . . . 0.0 114.836 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 15.1 p -81.6 162.27 23.17 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 111.259 170.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.2 t -108.51 123.81 49.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.925 0.89 . . . . 0.0 110.751 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 29.9 ttm105 -82.91 137.68 34.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.17 0.988 . . . . 0.0 109.342 165.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 24.3 t -120.64 137.36 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.781 1.632 . . . . 0.0 108.468 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.4 p -137.61 146.07 43.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.365 1.466 . . . . 0.0 111.56 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -160.43 150.21 17.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.534 1.134 . . . . 0.0 112.563 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.4 t -111.93 104.69 56.24 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.107 0.963 . . . . 0.0 110.886 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.67 98.82 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.496 2.798 . . . . 0.0 110.978 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -60.62 -43.96 96.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.441 1.096 . . . . 0.0 113.653 -169.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -94.15 146.15 31.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.215 1.006 . . . . 0.0 111.098 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.64 164.22 32.56 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.33 2.687 . . . . 0.0 111.254 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.17 -140.25 11.65 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.823 1.202 . . . . 0.0 112.184 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -130.15 130.95 45.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.955 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -110.97 144.27 40.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.633 1.573 . . . . 0.0 110.781 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.72 134.31 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.483 1.113 . . . . 0.0 108.868 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.5 mt -111.69 129.12 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.828 1.251 . . . . 0.0 109.08 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -107.18 125.04 50.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.352 1.461 . . . . 0.0 109.935 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.98 124.28 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.998 0.919 . . . . 0.0 109.074 173.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -131.13 135.14 47.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.429 1.492 . . . . 0.0 110.578 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.1 t80 -128.64 121.24 28.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.14 1.376 . . . . 0.0 109.845 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.43 55.84 7.76 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.417 1.487 . . . . 0.0 112.672 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 21.1 t70 79.09 -7.56 1.75 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 128.052 2.541 . . . . 0.0 114.128 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -113.64 128.71 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.8 1.24 . . . . 0.0 111.521 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -67.25 126.17 28.38 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.822 1.249 . . . . 0.0 111.045 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -77.7 154.2 81.0 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.225 -0.922 . . . . 0.0 111.295 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.88 139.49 74.43 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.612 2.208 . . . . 0.0 111.228 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 97.86 -26.84 21.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.25 1.405 . . . . 0.0 113.499 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 73.1 m -74.98 149.71 85.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.716 1.258 . . . . 0.0 111.366 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.85 139.53 62.24 Favored 'Cis proline' 0 C--N 1.351 0.705 0 CA-C-N 119.444 0.837 . . . . 0.0 111.315 -2.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -93.07 112.76 24.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.925 0.89 . . . . 0.0 110.218 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 59.3 m -87.48 118.31 26.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.316 1.047 . . . . 0.0 110.821 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 8.5 t -112.95 116.44 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.967 1.707 . . . . 0.0 109.578 -171.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.78 121.97 27.09 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.908 -0.495 . . . . 0.0 111.03 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 98.6 t -110.41 119.6 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.218 1.407 . . . . 0.0 109.534 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.9 t -97.58 154.38 17.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.631 1.173 . . . . 0.0 111.047 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -173.43 -163.34 26.89 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -158.6 -158.27 0.69 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.153 1.781 . . . . 0.0 109.884 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -72.73 138.43 25.89 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.805 -1.185 . . . . 0.0 111.905 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -66.41 142.15 57.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.207 1.003 . . . . 0.0 112.628 -173.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 10.7 p -58.9 142.64 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.078 1.351 . . . . 0.0 111.524 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 C--O 1.254 1.32 0 C-N-CA 126.072 1.749 . . . . 0.0 111.442 -175.623 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.468 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.66 169.38 17.43 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.5 1.12 . . . . 0.0 112.952 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.78 153.47 43.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.703 1.201 . . . . 0.0 112.936 174.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.57 -18.81 47.12 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.693 1.14 . . . . 0.0 114.116 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -162.09 148.85 13.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.724 2.009 . . . . 0.0 110.172 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 2.3 p30 -77.66 171.5 14.84 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 53.4 p -84.25 -7.88 59.21 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 98.1 mmm -72.38 150.09 43.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.738 1.154 . . . . 0.0 112.479 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 21.3 tpt85 -136.02 116.78 14.03 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.225 1.41 . . . . 0.0 109.802 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 27.9 ptm -78.05 151.81 33.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.776 0.831 . . . . 0.0 111.748 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 12.8 m -127.0 140.03 52.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.471 1.909 . . . . 0.0 108.146 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -143.15 160.32 40.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -166.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.93 151.04 21.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.618 1.967 . . . . 0.0 110.024 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -134.55 146.26 49.49 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.937 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 47.3 t -139.83 133.93 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.644 1.577 . . . . 0.0 109.623 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -86.01 118.05 4.75 Favored Glycine 0 N--CA 1.47 0.93 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 169.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.4 m -121.36 146.84 46.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.924 0.89 . . . . 0.0 112.458 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.85 144.04 11.5 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.173 0.989 . . . . 0.0 112.572 -170.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -70.37 157.81 37.09 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.595 1.158 . . . . 0.0 112.364 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.92 143.47 26.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.919 1.687 . . . . 0.0 112.893 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.13 118.57 18.42 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.969 1.308 . . . . 0.0 109.429 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.55 133.01 11.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.475 2.783 . . . . 0.0 111.639 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 51.2 mt -148.62 142.4 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.493 1.517 . . . . 0.0 110.624 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 57.81 57.4 4.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.072 1.749 . . . . 0.0 112.431 172.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 12.1 mm -71.99 -26.71 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.877 1.271 . . . . 0.0 112.633 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -76.92 54.63 1.03 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.13 1.772 . . . . 0.0 113.717 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -146.93 144.61 29.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.799 1.64 . . . . 0.0 110.726 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -104.09 -40.77 6.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.056 1.742 . . . . 0.0 111.133 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -90.93 108.44 19.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.765 0.826 . . . . 0.0 110.438 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.4 mt -90.37 -8.72 49.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.119 0.968 . . . . 0.0 113.101 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 9.2 t -77.03 -31.48 56.35 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.207 -0.933 . . . . 0.0 112.553 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.84 -2.43 47.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.137 1.375 . . . . 0.0 114.421 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.9 tp -101.3 135.25 43.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.463 1.105 . . . . 0.0 111.406 -170.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -138.97 168.22 20.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.013 1.725 . . . . 0.0 110.46 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -154.09 150.9 28.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.9 p -137.85 165.19 27.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.082 2.153 . . . . 0.0 110.079 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -123.73 139.85 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.852 1.661 . . . . 0.0 110.015 172.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.8 t -111.42 114.16 53.14 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.476 1.51 . . . . 0.0 108.249 166.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.67 170.33 19.33 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.948 3.098 . . . . 0.0 110.771 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.35 -16.61 55.17 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.986 2.458 . . . . 0.0 113.266 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 69.4 m -83.66 -4.18 58.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.328 1.051 . . . . 0.0 113.828 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.37 82.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.597 1.57 . . . . 0.0 115.914 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.35 86.73 3.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.4 1.48 . . . . 0.0 111.588 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.87 135.93 57.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.554 1.142 . . . . 0.0 112.302 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -142.6 151.59 57.67 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.752 1.621 . . . . 0.0 111.352 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.46 155.09 36.2 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.823 3.015 . . . . 0.0 112.23 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 94.8 m -98.1 155.32 17.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.584 1.154 . . . . 0.0 112.815 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.64 135.45 34.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 108.234 162.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.2 mt -108.02 139.06 43.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.218 1.407 . . . . 0.0 111.06 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 64.2 mttm -135.54 128.19 30.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.676 1.19 . . . . 0.0 113.113 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.6 tpt85 -75.83 125.98 30.13 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 148.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 54.8 mt -102.65 159.85 15.09 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.678 1.191 . . . . 0.0 110.76 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -57.89 -32.97 68.23 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -82.17 -1.3 48.53 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 106.39 -27.81 15.68 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.596 1.57 . . . . 0.0 113.785 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.96 169.79 12.58 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.78 1.232 . . . . 0.0 114.179 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 67.9 t -133.15 139.33 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.841 1.656 . . . . 0.0 109.342 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.43 23.32 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 116.179 1.231 . . . . 0.0 116.179 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.93 160.97 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.974 1.709 . . . . 0.0 112.288 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 68.4 m -139.98 149.75 43.63 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.575 1.95 . . . . 0.0 110.184 170.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 21.8 p90 -166.73 167.17 15.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.133 1.773 . . . . 0.0 110.647 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.9 t -116.06 113.57 41.64 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 124.041 0.936 . . . . 0.0 109.803 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.17 151.41 23.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.137 3.225 . . . . 0.0 111.324 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -98.49 -11.61 22.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.062 0.945 . . . . 0.0 113.459 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -139.09 166.72 23.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.01 1.724 . . . . 0.0 110.949 -174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.6 p -87.73 172.58 9.57 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.01 1.324 . . . . 0.0 111.333 169.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.5 -173.3 35.36 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.003 1.287 . . . . 0.0 113.773 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.31 113.48 7.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.149 0.98 . . . . 0.0 111.827 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.5 m80 -99.66 146.47 26.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.828 1.651 . . . . 0.0 109.065 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.79 125.17 50.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 109.412 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 30.1 t -88.37 136.87 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.497 1.119 . . . . 0.0 108.378 167.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -121.02 117.7 27.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.377 1.471 . . . . 0.0 109.865 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 93.9 t -106.14 138.59 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.185 1.394 . . . . 0.0 109.304 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 63.7 mttm -123.47 144.7 49.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.538 1.535 . . . . 0.0 112.646 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 69.2 tttt -118.87 116.38 26.37 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.389 2.276 . . . . 0.0 108.957 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.22 30.16 14.09 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.831 1.252 . . . . 0.0 113.572 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.77 -16.6 60.9 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.879 1.704 . . . . 0.0 115.956 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -97.78 149.99 21.73 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.482 1.641 . . . . 0.0 110.833 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 26.6 p80 -65.8 147.28 53.64 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 121.056 -1.028 . . . . 0.0 113.385 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -84.63 157.51 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.007 0.923 . . . . 0.0 111.132 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.67 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 7.0 m -70.53 -23.24 62.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.427 1.091 . . . . 0.0 113.65 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 150.34 55.22 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.41 148.56 89.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 118.681 0.565 . . . . 0.0 111.843 -4.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.72 118.81 55.47 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.423 1.089 . . . . 0.0 108.68 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.25 138.87 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.834 2.356 . . . . 0.0 111.293 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 51.6 t -134.16 121.9 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.573 1.549 . . . . 0.0 107.905 172.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.4 t -95.13 122.28 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.679 0.792 . . . . 0.0 109.944 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -95.52 129.22 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.751 1.22 . . . . 0.0 109.107 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.1 t -100.74 160.27 14.5 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.956 . . . . 0.0 111.572 172.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -59.17 -30.09 67.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.843 0.857 . . . . 0.0 112.855 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 19.5 m -67.23 -12.61 60.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.763 1.225 . . . . 0.0 113.725 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -97.16 -10.84 25.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.684 1.194 . . . . 0.0 112.779 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.281 1.032 . . . . 0.0 113.167 -170.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 161.92 45.64 0.02 OUTLIER Glycine 0 N--CA 1.469 0.897 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 27.4 t0 -78.52 95.1 5.09 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.063 0.931 . . . . 0.0 111.378 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.17 -39.58 86.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.48 -0.763 . . . . 0.0 112.487 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 29.4 m -60.47 -17.45 45.02 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.953 1.301 . . . . 0.0 113.974 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -93.39 -7.42 44.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.794 1.638 . . . . 0.0 114.487 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.2 t -75.3 137.41 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 120.302 1.41 . . . . 0.0 110.18 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -123.23 161.08 25.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 111.081 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.3 m -147.61 159.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.109 1.364 . . . . 0.0 111.86 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.89 176.05 12.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.097 1.359 . . . . 0.0 112.257 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.03 -165.1 14.3 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 125.553 1.549 . . . . 0.0 114.202 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -97.9 -38.24 9.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.349 1.06 . . . . 0.0 112.615 -172.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -74.08 3.02 40.38 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.489 1.042 . . . . 0.0 115.428 -167.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 98.4 mt -96.1 0.51 51.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.218 1.407 . . . . 0.0 112.412 166.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.73 -42.53 1.13 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.521 1.528 . . . . 0.0 113.471 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -158.77 154.91 27.0 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.49 -171.07 19.68 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.569 1.557 . . . . 0.0 114.017 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.5 m80 -141.27 146.4 36.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.148 1.379 . . . . 0.0 112.219 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 40.1 p -70.55 -21.46 62.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -115.86 -0.56 12.82 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -142.93 142.06 21.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.28 1.432 . . . . 0.0 110.177 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.62 149.4 55.14 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.937 2.424 . . . . 0.0 111.695 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.68 146.34 27.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.852 1.261 . . . . 0.0 110.562 172.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.73 146.47 48.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 112.628 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.5 p90 -152.48 148.58 27.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.403 1.481 . . . . 0.0 110.864 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.59 141.53 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.676 1.59 . . . . 0.0 109.207 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.6 mt -114.95 136.16 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.149 1.779 . . . . 0.0 108.744 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 60.2 t0 -124.52 108.18 11.83 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.152 1.781 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 58.0 p -101.62 0.66 36.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.848 1.659 . . . . 0.0 113.058 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.84 -37.13 80.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.51 1.05 . . . . 0.0 112.521 -172.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.68 -14.14 59.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 113.114 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -94.71 -4.61 47.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.169 1.788 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.71 -99.73 2.22 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.014 1.292 . . . . 0.0 111.947 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -142.21 152.38 43.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.127 1.371 . . . . 0.0 112.286 -165.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.83 179.26 26.44 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -88.19 122.33 6.27 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.39 0.995 . . . . 0.0 111.81 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.4 121.49 35.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.301 1.84 . . . . 0.0 108.334 171.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 15.0 m -113.34 143.25 44.78 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.827 1.251 . . . . 0.0 110.782 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -139.29 133.26 30.98 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 110.343 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.4 m -136.85 127.61 27.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.537 0.735 . . . . 0.0 111.452 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 25.9 mt -104.6 136.8 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.7 1.6 . . . . 0.0 108.948 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -132.79 151.49 51.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.21 1.804 . . . . 0.0 109.293 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.18 -160.31 33.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.194 -0.941 . . . . 0.0 114.59 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.0 -12.04 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 124.125 3.217 . . . . 0.0 114.474 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.5 t -159.48 168.35 26.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.666 1.187 . . . . 0.0 111.687 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -66.35 151.84 46.26 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -131.4 154.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.856 1.262 . . . . 0.0 111.18 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.88 138.22 32.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.694 0.398 . . . . 0.0 110.272 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 44.3 mt -121.4 135.83 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 109.163 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -132.37 154.61 49.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.208 1.803 . . . . 0.0 109.803 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 31.4 p -139.8 152.44 46.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.692 1.197 . . . . 0.0 111.664 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -152.72 106.98 3.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.35 134.43 35.26 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.919 1.288 . . . . 0.0 111.137 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 79.2 mt -110.22 162.28 14.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.481 1.112 . . . . 0.0 113.451 -163.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -70.65 -13.28 62.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.024 1.33 . . . . 0.0 113.159 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.72 -8.09 59.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.433 1.093 . . . . 0.0 112.795 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.09 1.2 73.0 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.349 1.452 . . . . 0.0 114.696 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 49.0 p -93.81 172.42 8.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.364 1.866 . . . . 0.0 111.191 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 47.0 t -129.02 126.63 39.92 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.096 0.958 . . . . 0.0 111.47 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.23 136.29 36.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.366 1.067 . . . . 0.0 109.613 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.4 t -115.25 138.43 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 108.083 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.6 p -134.19 147.0 50.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.177 1.391 . . . . 0.0 110.871 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 6.9 p90 -151.58 152.49 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.006 0.922 . . . . 0.0 112.096 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 8.2 t -123.78 113.23 28.69 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.892 0.877 . . . . 0.0 111.195 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.95 175.54 9.15 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.029 3.153 . . . . 0.0 111.284 174.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 99.5 m -129.25 -46.22 1.22 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.39 1.076 . . . . 0.0 111.91 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -85.92 144.65 39.57 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.919 0.888 . . . . 0.0 110.637 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.16 160.41 33.02 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.092 2.528 . . . . 0.0 110.989 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 132.22 -162.9 24.0 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 125.196 1.379 . . . . 0.0 113.703 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -90.85 121.49 32.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.639 0.776 . . . . 0.0 111.426 176.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -98.98 143.41 29.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.872 1.269 . . . . 0.0 110.854 165.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.34 132.84 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.799 1.639 . . . . 0.0 108.031 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.61 124.58 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.3 1.04 . . . . 0.0 109.82 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -101.35 128.34 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.181 1.792 . . . . 0.0 109.91 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.1 mm -120.67 115.5 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.919 1.287 . . . . 0.0 109.814 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.08 135.37 54.37 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.642 1.577 . . . . 0.0 110.989 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 63.1 t80 -129.69 125.83 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.287 1.435 . . . . 0.0 110.127 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 34.57 18.04 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.165 1.386 . . . . 0.0 113.53 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.252 63.4 m-20 74.05 21.23 2.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.035 2.534 . . . . 0.0 114.176 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -125.38 137.38 54.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.899 1.28 . . . . 0.0 110.972 169.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.3 t60 -68.45 129.75 40.85 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.487 1.115 . . . . 0.0 110.882 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.8 m -77.46 155.23 81.6 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 111.2 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 141.05 75.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.61 2.207 . . . . 0.0 111.432 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 90.37 -24.01 18.89 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.177 1.37 . . . . 0.0 113.608 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 22.5 t -76.99 144.62 72.45 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.276 1.038 . . . . 0.0 111.133 173.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.48 149.57 89.16 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.876 0.992 . . . . 0.0 112.139 -2.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -102.0 127.72 48.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.076 1.351 . . . . 0.0 110.996 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 37.6 m -89.75 135.12 33.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.03 171.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.0 t -132.88 112.52 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.54 1.536 . . . . 0.0 109.556 -168.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.55 108.99 13.51 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.784 -0.572 . . . . 0.0 111.29 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.8 t -95.28 118.18 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 0.0 108.772 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -97.31 152.52 18.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.179 0.992 . . . . 0.0 111.106 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 162.84 -158.28 30.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -165.26 179.61 6.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.674 1.989 . . . . 0.0 110.983 -174.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -70.79 133.16 22.73 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.431 -0.793 . . . . 0.0 112.449 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -77.52 145.88 36.69 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.666 1.186 . . . . 0.0 111.86 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 71.1 t -132.51 142.41 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.028 1.731 . . . . 0.0 109.601 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.048 1.739 . . . . 0.0 111.058 177.952 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.82 -9.38 58.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -67.41 -21.3 65.59 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.56 1.544 . . . . 0.0 114.294 -173.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -175.41 158.65 26.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.23 1.395 . . . . 0.0 113.293 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 17.8 t70 -160.18 153.28 21.73 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.15 1.38 . . . . 0.0 111.827 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.93 4.44 8.22 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.428 1.491 . . . . 0.0 114.922 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 79.6 p -62.37 -21.2 65.15 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.876 1.271 . . . . 0.0 114.221 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 37.4 mmt -73.88 116.42 14.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.125 0.97 . . . . 0.0 110.319 172.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 143.85 55.51 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.145 0.978 . . . . 0.0 111.97 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.9 ptm -146.48 156.04 42.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.0 m -136.72 144.5 43.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.943 2.097 . . . . 0.0 108.581 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -147.83 157.92 43.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -159.77 141.02 12.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.223 1.809 . . . . 0.0 110.107 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 65.8 mttp -125.86 148.05 49.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.509 1.124 . . . . 0.0 112.215 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 23.7 t -133.88 134.46 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.611 1.564 . . . . 0.0 109.895 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.76 54.78 4.85 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.264 1.411 . . . . 0.0 112.882 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 18.9 m -61.98 147.94 45.41 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.57 1.548 . . . . 0.0 114.276 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -168.36 156.62 8.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.846 1.658 . . . . 0.0 111.816 -175.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -81.11 148.61 29.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.149 0.98 . . . . 0.0 111.61 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -93.3 148.76 21.76 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.907 1.283 . . . . 0.0 113.038 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 61.1 mt -133.72 126.74 19.11 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.339 1.456 . . . . 0.0 109.221 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.36 140.14 26.99 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.107 2.538 . . . . 0.0 111.104 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -139.71 135.56 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.96 1.304 . . . . 0.0 110.361 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.8 t30 39.63 69.54 0.29 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.085 2.154 . . . . 0.0 114.016 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.35 120.19 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.092 0.957 . . . . 0.0 111.261 -167.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 4.9 m -172.2 156.76 4.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.124 2.169 . . . . 0.0 110.058 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -86.47 72.11 10.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.162 0.985 . . . . 0.0 110.489 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 35.0 p -97.98 156.63 16.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.989 1.716 . . . . 0.0 111.777 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -91.84 117.79 30.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.466 1.106 . . . . 0.0 110.611 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.52 -9.07 46.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.537 1.135 . . . . 0.0 113.173 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 15.6 m -74.99 -19.33 60.14 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.672 1.189 . . . . 0.0 113.739 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.2 pp -130.25 5.37 4.84 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.514 1.525 . . . . 0.0 113.899 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.33 126.36 54.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.211 2.204 . . . . 0.0 107.768 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -130.85 148.6 52.64 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.244 1.418 . . . . 0.0 110.184 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -138.71 150.16 45.86 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 112.715 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.0 p -140.47 159.84 41.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.606 1.963 . . . . 0.0 109.951 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 3.9 t -114.62 135.54 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.546 1.138 . . . . 0.0 109.598 169.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.7 t -108.39 114.37 59.33 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.066 1.347 . . . . 0.0 108.498 167.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.77 173.11 13.3 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 124.151 3.234 . . . . 0.0 111.269 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.28 -29.11 45.71 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.016 3.144 . . . . 0.0 114.895 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 30.3 p -83.92 -5.57 59.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.219 1.408 . . . . 0.0 114.464 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 80.95 3.02 90.67 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.969 1.271 . . . . 0.0 114.52 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -74.04 77.51 1.71 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.533 1.933 . . . . 0.0 111.706 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.78 133.08 55.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.203 1.001 . . . . 0.0 112.127 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.72 150.03 61.57 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.249 1.42 . . . . 0.0 110.957 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.51 152.63 34.1 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.698 2.932 . . . . 0.0 112.412 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.9 m -91.61 155.12 18.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.484 1.114 . . . . 0.0 111.794 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 65.5 tp -77.82 140.46 39.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 152.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.3 mt -108.3 142.35 38.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.768 1.227 . . . . 0.0 110.347 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -136.89 138.84 41.13 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.919 1.287 . . . . 0.0 112.379 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -80.39 123.73 28.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 151.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.2 mt -96.27 164.25 12.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.234 1.413 . . . . 0.0 111.399 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -63.9 -18.23 63.99 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.15 2.8 56.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.994 0.917 . . . . 0.0 113.198 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.97 -9.03 73.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.028 1.775 . . . . 0.0 114.594 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -80.79 170.37 16.38 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.899 1.68 . . . . 0.0 113.416 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.2 t -115.19 141.73 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.314 1.446 . . . . 0.0 110.483 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -149.35 174.1 29.01 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.44 157.64 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.174 1.79 . . . . 0.0 111.318 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.8 m -137.79 146.59 43.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.565 1.546 . . . . 0.0 109.795 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 4.2 p90 -166.21 171.17 12.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 111.103 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 88.3 t -119.08 121.36 30.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.089 0.955 . . . . 0.0 109.607 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.27 143.22 17.37 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.019 3.146 . . . . 0.0 110.969 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -84.64 -21.67 30.19 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.89 0.876 . . . . 0.0 112.227 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -142.27 172.2 13.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.522 1.929 . . . . 0.0 110.704 -168.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.7 p -91.99 169.94 10.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.911 1.285 . . . . 0.0 111.454 171.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.42 -173.41 23.0 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.374 1.464 . . . . 0.0 113.915 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.82 109.5 6.45 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.32 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 14.5 m80 -95.62 140.55 30.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.231 1.412 . . . . 0.0 109.387 170.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.21 122.91 45.11 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.37 1.068 . . . . 0.0 109.075 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 96.4 t -86.66 118.42 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -101.18 149.42 24.0 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 125.228 1.411 . . . . 0.0 110.567 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.7 p -160.37 126.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 122.167 0.984 . . . . 0.0 111.398 -170.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -128.22 129.43 46.41 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.399 1.879 . . . . 0.0 111.599 -164.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 60.7 tttm -109.93 132.83 53.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.335 1.454 . . . . 0.0 110.223 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.51 -96.69 0.07 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.012 1.325 . . . . 0.0 111.474 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -122.47 10.78 9.15 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.497 1.523 . . . . 0.0 115.533 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -145.93 149.79 34.86 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.091 1.945 . . . . 0.0 113.78 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.29 157.43 37.73 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.653 0.781 . . . . 0.0 112.421 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.6 m -84.86 163.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.84 0.856 . . . . 0.0 111.539 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.2 69.12 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 29.9 m -86.29 -14.63 43.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.966 1.307 . . . . 0.0 114.367 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.3 p -93.03 153.61 41.78 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.869 -1.145 . . . . 0.0 113.478 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.32 150.75 96.04 Favored 'Cis proline' 0 C--N 1.354 0.826 0 CA-C-N 119.125 0.723 . . . . 0.0 112.597 -1.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.86 121.64 50.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.825 1.25 . . . . 0.0 108.469 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.1 138.07 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.854 2.369 . . . . 0.0 111.139 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.3 t -133.99 122.56 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.59 1.556 . . . . 0.0 107.884 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -94.11 122.2 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.489 0.716 . . . . 0.0 110.067 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.91 137.43 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.128 1.371 . . . . 0.0 109.239 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 14.4 t -122.86 161.58 23.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.114 . . . . 0.0 110.896 170.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -61.17 -26.81 67.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.143 0.977 . . . . 0.0 113.602 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 23.8 p -67.53 -15.29 63.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.542 1.137 . . . . 0.0 113.923 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.42 -9.33 47.92 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.627 1.171 . . . . 0.0 112.596 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.77 110.13 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.328 0.967 . . . . 0.0 110.91 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 72.56 11.83 77.14 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 117.274 1.669 . . . . 0.0 117.274 156.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -75.04 91.72 2.56 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.454 1.627 . . . . 0.0 111.212 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.09 67.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.495 1.118 . . . . 0.0 112.38 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.2 m -54.03 -25.49 21.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.952 1.701 . . . . 0.0 114.148 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -88.31 -12.12 44.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.014 1.326 . . . . 0.0 113.619 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 68.4 t -74.33 134.75 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.592 1.087 . . . . 0.0 110.105 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -116.63 158.65 23.39 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.452 1.501 . . . . 0.0 110.876 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 34.8 m -146.61 159.07 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.428 1.491 . . . . 0.0 110.667 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -158.99 168.57 26.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.416 1.086 . . . . 0.0 112.336 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.43 159.32 23.03 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.189 1.376 . . . . 0.0 114.205 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -70.63 -26.71 63.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.112 1.365 . . . . 0.0 113.614 -168.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.97 -4.46 48.52 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.593 1.092 . . . . 0.0 115.063 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.4 -2.77 57.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.162 1.385 . . . . 0.0 112.715 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -128.84 -38.05 1.69 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.951 1.3 . . . . 0.0 113.794 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.75 161.61 39.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.094 0.958 . . . . 0.0 113.177 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.33 -174.24 24.98 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.905 1.241 . . . . 0.0 114.11 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -138.94 144.83 39.19 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.154 1.382 . . . . 0.0 112.105 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 38.6 p -70.51 -18.63 62.96 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.42 -2.14 12.12 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -143.94 144.69 27.52 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.363 1.465 . . . . 0.0 110.178 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.62 150.09 50.3 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.218 . . . . 0.0 111.656 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -98.25 154.09 18.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.42 1.488 . . . . 0.0 110.73 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -134.39 150.94 50.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.808 0.843 . . . . 0.0 112.691 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -157.06 149.84 23.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 110.837 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 140.69 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.842 1.657 . . . . 0.0 109.288 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 43.4 mt -111.68 135.8 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.761 . . . . 0.0 109.032 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 66.5 t0 -125.04 98.37 5.65 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.989 1.715 . . . . 0.0 110.536 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.3 p -94.24 1.0 56.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.316 1.847 . . . . 0.0 113.023 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -61.16 -34.81 75.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.343 0.974 . . . . 0.0 112.851 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.77 -18.24 51.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.522 1.129 . . . . 0.0 113.133 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -88.31 -14.84 37.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.147 1.379 . . . . 0.0 114.014 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.02 -113.17 3.58 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.509 1.052 . . . . 0.0 111.727 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -107.49 144.01 35.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.157 1.383 . . . . 0.0 113.067 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 143.38 144.01 4.2 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.819 1.199 . . . . 0.0 112.982 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -73.65 142.13 30.63 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.632 0.634 . . . . 0.0 112.772 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 127.09 42.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.578 1.551 . . . . 0.0 108.736 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 43.7 t -120.3 135.96 54.84 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.667 1.587 . . . . 0.0 109.506 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -139.58 136.11 34.08 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.288 1.035 . . . . 0.0 110.873 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.7 m -139.83 130.55 25.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 111.398 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 26.5 mt -109.86 136.79 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.463 1.505 . . . . 0.0 108.442 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.5 155.81 42.8 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.162 0.985 . . . . 0.0 111.605 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.39 -146.44 12.56 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.024 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.95 -15.24 36.31 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.897 3.065 . . . . 0.0 114.588 -172.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.9 t -160.44 170.81 20.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.527 1.131 . . . . 0.0 111.669 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -71.99 155.27 40.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.195 0.998 . . . . 0.0 111.589 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.99 162.68 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.3 1.44 . . . . 0.0 110.946 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.49 131.61 36.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.697 0.799 . . . . 0.0 110.146 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.5 mt -111.1 132.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.188 0.995 . . . . 0.0 109.369 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -130.4 155.55 46.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.32 1.848 . . . . 0.0 109.624 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 29.6 p -142.05 160.19 40.72 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.396 1.078 . . . . 0.0 112.315 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -152.55 107.59 3.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.586 1.554 . . . . 0.0 109.347 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.19 129.94 34.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.768 1.227 . . . . 0.0 110.644 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.7 155.99 19.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.711 1.204 . . . . 0.0 112.436 -167.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.12 -18.27 64.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.487 1.115 . . . . 0.0 112.949 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.39 -11.07 60.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.77 -2.88 73.56 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.096 1.808 . . . . 0.0 114.395 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 61.7 p -90.41 174.63 7.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.546 1.938 . . . . 0.0 111.002 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -136.14 128.83 30.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.538 0.735 . . . . 0.0 111.702 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.5 138.03 36.51 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.765 1.226 . . . . 0.0 109.924 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 22.1 t -116.84 138.83 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.656 1.982 . . . . 0.0 108.223 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -137.46 144.02 42.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.345 1.458 . . . . 0.0 111.258 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 8.1 p90 -157.34 151.96 25.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.304 1.042 . . . . 0.0 112.384 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 10.6 t -117.82 108.61 42.49 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.791 0.836 . . . . 0.0 111.213 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.25 152.42 35.04 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.202 2.601 . . . . 0.0 110.527 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 85.2 m -112.69 -37.97 4.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.923 0.889 . . . . 0.0 112.582 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -96.08 148.12 34.03 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 110.733 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 161.23 36.1 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.027 2.485 . . . . 0.0 111.05 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.71 -159.86 18.3 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.109 1.337 . . . . 0.0 113.563 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.7 t30 -95.74 120.01 35.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.052 0.941 . . . . 0.0 111.765 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -98.79 144.9 27.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.775 1.23 . . . . 0.0 110.873 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.22 136.69 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.273 1.429 . . . . 0.0 108.701 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.6 126.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.129 1.372 . . . . 0.0 109.295 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -102.14 131.29 48.74 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.17 1.788 . . . . 0.0 110.297 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.5 mm -123.54 114.2 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.869 1.267 . . . . 0.0 109.592 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -119.71 134.06 55.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.966 1.706 . . . . 0.0 110.908 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -126.36 124.42 40.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.162 1.385 . . . . 0.0 109.737 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.71 36.21 23.2 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.1 1.36 . . . . 0.0 114.035 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 20.9 t70 95.71 -11.2 0.09 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 130.242 3.417 . . . . 0.0 113.611 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -112.72 134.91 54.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.039 . . . . 0.0 112.591 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.5 t60 -63.4 128.77 37.35 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.884 1.274 . . . . 0.0 110.822 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 10.3 m -72.94 156.2 89.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-N 119.551 1.068 . . . . 0.0 111.549 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.07 -35.39 90.27 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.792 2.995 . . . . 0.0 116.393 -170.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.55 75.96 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.567 0.622 . . . . 0.0 114.561 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 36.1 t -82.82 146.42 52.48 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.056 1.342 . . . . 0.0 111.442 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.66 152.68 93.29 Favored 'Cis proline' 0 C--N 1.351 0.697 0 CA-C-N 119.815 0.97 . . . . 0.0 112.453 -1.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.38 126.34 51.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 13.9 p -90.01 137.14 32.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.523 1.129 . . . . 0.0 111.35 171.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 21.2 t -133.46 112.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 -168.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -80.72 107.99 13.99 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.529 0.731 . . . . 0.0 111.253 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 92.3 t -94.32 120.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.59 1.156 . . . . 0.0 109.261 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.3 t -97.96 154.14 17.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -171.14 -171.12 36.06 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 29.4 tt0 92.64 137.36 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 129.804 3.242 . . . . 0.0 110.867 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 87.76 64.37 1.37 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.435 1.016 . . . . 0.0 112.099 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -62.95 156.96 22.97 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.817 1.247 . . . . 0.0 113.655 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 28.5 m -67.63 150.92 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.336 1.054 . . . . 0.0 111.338 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.637 1.175 . . . . 0.0 112.45 179.433 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.56 166.33 23.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.439 1.096 . . . . 0.0 113.04 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -72.27 -15.3 61.91 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.164 1.386 . . . . 0.0 114.09 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.42 -105.72 0.68 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.934 1.731 . . . . 0.0 111.48 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 19.8 t70 79.51 -9.8 1.41 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 128.25 2.62 . . . . 0.0 114.177 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 44.1 m-20 78.6 146.26 0.09 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 129.62 3.168 . . . . 0.0 113.704 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 26.9 m -78.17 -10.42 59.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.286 1.034 . . . . 0.0 113.627 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 57.9 tpp -71.29 121.56 18.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.815 1.246 . . . . 0.0 111.338 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.08 152.86 21.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.56 1.144 . . . . 0.0 110.677 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 95.7 mtp -122.75 139.23 54.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.632 1.573 . . . . 0.0 111.401 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.1 m -130.11 141.56 50.68 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.29 1.836 . . . . 0.0 108.871 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.1 t60 -140.78 150.69 43.67 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -166.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.47 140.56 20.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.07 1.748 . . . . 0.0 109.641 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.42 144.39 49.49 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.635 1.174 . . . . 0.0 111.282 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.2 p -155.25 141.65 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.093 0.957 . . . . 0.0 111.399 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -75.89 150.81 39.96 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.007 0.813 . . . . 0.0 112.331 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 33.0 m -131.94 127.64 36.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.794 0.837 . . . . 0.0 111.603 -171.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.68 147.24 18.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.633 0.773 . . . . 0.0 112.677 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -82.17 138.25 34.76 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.727 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.49 143.51 33.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.226 1.01 . . . . 0.0 112.178 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.75 125.67 23.08 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.543 1.137 . . . . 0.0 108.97 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.58 140.77 24.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.046 2.498 . . . . 0.0 111.158 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 35.3 mm -137.74 139.17 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.291 1.836 . . . . 0.0 109.065 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.84 46.69 19.32 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 0.0 112.707 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.93 -29.33 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.28 1.832 . . . . 0.0 113.974 -165.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -64.62 -18.41 64.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.28 161.69 37.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.277 1.431 . . . . 0.0 111.952 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.0 m -122.11 121.85 37.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.858 1.263 . . . . 0.0 109.759 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -158.74 128.8 5.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.492 1.517 . . . . 0.0 110.0 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.6 mt -116.06 -3.55 12.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.616 1.566 . . . . 0.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 51.6 m -94.96 -29.17 14.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.051 . . . . 0.0 113.313 -168.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 1.74 12.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.118 1.367 . . . . 0.0 114.442 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.2 tp -91.01 137.21 32.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.924 0.784 . . . . 0.0 111.735 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 33.9 p -141.42 140.03 33.56 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.099 1.759 . . . . 0.0 109.392 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.16 149.93 45.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.866 0.866 . . . . 0.0 113.185 -173.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 77.4 p -138.21 162.63 33.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.075 2.15 . . . . 0.0 109.87 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -118.27 136.44 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.966 1.306 . . . . 0.0 109.791 168.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.8 t -105.28 113.83 64.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.137 1.375 . . . . 0.0 108.27 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.53 172.3 11.5 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.97 3.113 . . . . 0.0 111.737 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.51 -29.14 38.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.85 3.7 . . . . 0.0 114.848 170.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 57.3 p -81.32 -8.29 59.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.796 1.238 . . . . 0.0 114.164 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.5 -0.2 81.78 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.421 1.486 . . . . 0.0 114.815 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -76.58 83.05 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.38 1.472 . . . . 0.0 111.532 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.44 135.77 57.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.727 1.211 . . . . 0.0 112.148 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.79 151.69 66.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.477 1.511 . . . . 0.0 111.323 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.57 152.38 43.01 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.844 3.03 . . . . 0.0 112.392 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 77.9 m -98.3 154.78 17.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.92 1.288 . . . . 0.0 112.179 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.17 116.43 26.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.534 1.134 . . . . 0.0 108.17 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.21 135.78 33.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.604 1.161 . . . . 0.0 111.469 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.37 147.64 52.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.602 1.561 . . . . 0.0 112.413 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -92.6 115.68 28.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.0 mt -90.22 171.5 9.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.612 0.765 . . . . 0.0 112.729 -170.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -59.83 -34.2 72.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 113.814 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 53.7 t30 -80.41 -11.91 59.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.463 1.105 . . . . 0.0 113.814 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 103.81 -14.88 52.86 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.653 1.597 . . . . 0.0 114.525 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 159.87 32.63 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 118.266 1.033 . . . . 0.0 113.183 172.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.7 t -85.06 150.55 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.831 1.252 . . . . 0.0 109.056 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.56 174.53 30.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.109 0.862 . . . . 0.0 114.987 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.43 162.46 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.213 1.805 . . . . 0.0 112.072 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 74.1 m -144.4 150.25 37.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.423 1.889 . . . . 0.0 110.41 166.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.21 178.44 8.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.485 1.914 . . . . 0.0 110.763 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 67.9 t -130.58 123.35 20.27 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.155 0.982 . . . . 0.0 109.93 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.71 148.89 23.1 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.787 3.658 . . . . 0.0 112.075 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 mptt -106.84 -9.76 16.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.516 1.126 . . . . 0.0 113.48 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.76 172.03 13.37 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.664 1.986 . . . . 0.0 110.329 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 32.9 p -96.02 154.38 17.27 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.619 1.168 . . . . 0.0 110.903 167.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 104.31 -165.76 15.08 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.168 1.366 . . . . 0.0 113.931 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.84 114.3 10.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.36 1.064 . . . . 0.0 112.213 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 18.9 m80 -95.77 143.26 27.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.644 1.578 . . . . 0.0 109.07 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -107.37 123.3 48.17 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.053 0.941 . . . . 0.0 108.908 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 93.4 t -83.65 121.23 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 166.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.81 138.56 40.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.153 . . . . 0.0 110.095 170.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -146.42 133.68 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.086 0.946 . . . . 0.0 112.503 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.88 139.69 50.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.893 2.077 . . . . 0.0 111.602 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.87 109.37 20.45 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.422 2.689 . . . . 0.0 108.413 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 54.18 -103.74 0.19 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.925 1.29 . . . . 0.0 111.457 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.03 6.38 34.79 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.871 1.701 . . . . 0.0 115.514 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -129.22 148.72 51.18 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.287 1.543 . . . . 0.0 111.638 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 29.8 p80 -66.01 147.14 53.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.62 -1.3 . . . . 0.0 112.101 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.0 t -72.72 144.85 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.32 -24.73 60.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 54.5 p -84.27 -12.45 54.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.113 1.365 . . . . 0.0 114.075 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 9.6 t -80.01 140.05 53.62 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 120.871 -1.143 . . . . 0.0 112.62 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.27 152.49 83.99 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 119.536 0.87 . . . . 0.0 112.498 -5.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.77 122.58 45.42 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.336 1.454 . . . . 0.0 108.739 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.29 143.09 12.35 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.08 2.52 . . . . 0.0 111.777 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.4 t -139.32 117.45 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.422 1.489 . . . . 0.0 108.486 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 51.3 t -94.85 122.86 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.61 0.764 . . . . 0.0 110.174 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.73 129.43 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.11 1.364 . . . . 0.0 110.364 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 73.3 m -94.77 159.72 14.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.234 1.414 . . . . 0.0 112.102 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -59.25 -26.95 65.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.182 -0.948 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.9 p -65.43 -18.92 65.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.528 1.531 . . . . 0.0 114.18 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.39 -4.87 28.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.241 1.416 . . . . 0.0 112.95 -175.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.1 mm -73.64 -34.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.289 1.036 . . . . 0.0 112.602 -173.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 154.34 45.61 0.02 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.853 0.74 . . . . 0.0 114.388 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.52 100.74 10.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.459 1.129 . . . . 0.0 110.858 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.82 -35.96 69.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.988 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 13.1 t -54.19 -29.08 44.59 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.899 1.279 . . . . 0.0 113.31 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -85.79 -9.85 56.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.728 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 63.3 t -76.94 129.96 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.546 1.066 . . . . 0.0 109.594 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -109.08 155.42 20.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.467 1.507 . . . . 0.0 110.867 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.2 m -145.24 148.62 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.992 1.317 . . . . 0.0 110.938 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.6 m -151.62 157.09 41.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.853 1.261 . . . . 0.0 112.14 -175.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 119.03 161.34 11.66 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.496 1.046 . . . . 0.0 114.953 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -64.74 -33.06 75.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.782 1.633 . . . . 0.0 113.225 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.24 -3.58 46.6 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.783 1.182 . . . . 0.0 115.013 -176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.86 -7.6 57.0 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.242 1.417 . . . . 0.0 112.745 168.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -128.1 -36.9 1.92 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 113.942 -173.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -156.75 157.23 34.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.351 1.06 . . . . 0.0 112.911 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.26 -175.04 25.85 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.564 1.078 . . . . 0.0 114.346 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 62.6 m80 -139.58 142.07 37.14 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.143 1.377 . . . . 0.0 112.128 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 55.8 p -73.2 -14.81 61.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -115.29 -2.89 12.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -145.0 145.35 26.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.562 1.545 . . . . 0.0 110.195 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.49 143.0 50.7 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.543 2.162 . . . . 0.0 111.26 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -96.5 163.03 13.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.253 1.421 . . . . 0.0 110.452 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.46 159.41 44.5 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.82 153.52 24.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.379 1.872 . . . . 0.0 110.222 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.73 140.03 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 109.282 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.31 134.3 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.012 1.725 . . . . 0.0 108.421 168.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.3 t0 -120.0 101.19 7.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.183 1.793 . . . . 0.0 110.102 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.4 p -94.89 0.57 54.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.327 1.851 . . . . 0.0 113.129 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -60.4 -36.12 77.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.443 1.019 . . . . 0.0 113.203 -170.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.99 -17.51 52.7 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.266 1.026 . . . . 0.0 113.214 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.77 -6.67 55.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.552 1.541 . . . . 0.0 113.731 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 78.79 -111.97 3.36 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.166 1.365 . . . . 0.0 112.641 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -115.75 164.81 13.83 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.195 1.798 . . . . 0.0 112.388 -172.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.74 -134.81 5.3 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.523 1.059 . . . . 0.0 113.041 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -155.88 140.56 7.36 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.479 1.038 . . . . 0.0 112.435 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.48 121.45 41.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.357 1.863 . . . . 0.0 109.591 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.7 m -107.81 140.11 41.39 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.241 1.817 . . . . 0.0 109.872 167.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -142.28 137.96 31.01 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.072 0.949 . . . . 0.0 110.045 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 86.5 p -135.17 148.62 49.76 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.557 0.694 . . . . 0.0 111.873 169.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.2 mt -122.91 125.74 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -119.46 145.61 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.314 1.446 . . . . 0.0 109.274 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 174.92 -163.79 34.21 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.92 -2.41 11.46 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.714 3.609 . . . . 0.0 114.225 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -160.53 165.61 30.55 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.949 1.3 . . . . 0.0 111.351 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -71.3 143.0 50.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.277 1.031 . . . . 0.0 110.905 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 7.6 m -121.32 150.23 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.315 1.446 . . . . 0.0 110.693 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.91 110.94 22.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.692 0.797 . . . . 0.0 109.985 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.56 134.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 109.913 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.7 164.3 27.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.551 1.94 . . . . 0.0 110.897 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 14.6 p -138.16 155.26 48.89 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.609 1.564 . . . . 0.0 112.039 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.29 130.61 12.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.719 1.208 . . . . 0.0 110.728 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.6 t70 -85.64 125.37 33.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.793 1.237 . . . . 0.0 110.602 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.05 152.46 18.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.217 1.007 . . . . 0.0 111.835 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.09 -12.57 61.8 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.517 1.127 . . . . 0.0 113.678 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.38 -6.26 59.41 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.83 1.252 . . . . 0.0 113.009 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.2 5.22 59.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.639 1.59 . . . . 0.0 114.856 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 37.2 p -98.46 166.41 11.37 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.456 1.902 . . . . 0.0 111.661 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.3 t -116.35 124.79 50.97 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.274 1.029 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -88.3 133.55 34.04 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.107 1.363 . . . . 0.0 109.623 170.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 60.6 t -111.89 137.29 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.259 1.424 . . . . 0.0 108.741 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.5 p -126.71 146.05 50.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.555 1.942 . . . . 0.0 110.15 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.1 p90 -160.9 149.58 16.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.264 1.026 . . . . 0.0 112.043 175.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.1 t -118.08 113.25 37.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.789 0.836 . . . . 0.0 110.995 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.47 166.75 25.46 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.67 2.914 . . . . 0.0 110.787 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.1 m -129.99 -43.44 1.21 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 0.0 112.551 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -87.89 144.46 34.89 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 123.684 0.793 . . . . 0.0 109.812 168.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.97 164.02 27.81 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.27 2.647 . . . . 0.0 111.319 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 129.53 -160.79 22.76 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.223 1.392 . . . . 0.0 113.679 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -88.73 124.53 34.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.323 0.649 . . . . 0.0 111.305 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -106.05 140.81 38.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.732 1.213 . . . . 0.0 109.884 166.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.9 mp -107.21 127.41 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.955 1.302 . . . . 0.0 108.264 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 14.4 mt -110.86 128.48 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.239 1.016 . . . . 0.0 109.786 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -108.94 125.79 52.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.855 1.262 . . . . 0.0 110.106 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -111.31 121.76 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 173.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 3.6 tmmt? -133.21 127.33 33.54 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.874 1.269 . . . . 0.0 110.982 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -125.6 127.75 46.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.064 1.346 . . . . 0.0 110.651 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 48.95 48.38 20.67 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.705 1.202 . . . . 0.0 112.92 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t70 79.99 -2.2 2.03 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.45 2.7 . . . . 0.0 114.145 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -121.51 127.58 51.16 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.812 -168.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -66.34 125.97 27.31 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.832 1.253 . . . . 0.0 111.297 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.6 m -82.5 159.05 65.06 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.227 -0.92 . . . . 0.0 111.72 -169.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.88 143.08 73.37 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.756 2.971 . . . . 0.0 113.526 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.96 -23.08 19.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.852 1.215 . . . . 0.0 114.232 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 70.7 m -73.44 151.73 89.69 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 118.65 1.225 . . . . 0.0 111.696 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.06 141.67 72.46 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.192 0.747 . . . . 0.0 111.408 -6.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -94.57 117.47 30.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.079 0.951 . . . . 0.0 110.339 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 16.7 m -82.98 129.06 34.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.32 0.648 . . . . 0.0 110.859 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.9 t -123.24 114.58 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.147 1.779 . . . . 0.0 109.172 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.54 105.5 10.89 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.002 0.521 . . . . 0.0 110.969 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 82.9 t -93.13 118.47 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.384 1.074 . . . . 0.0 109.042 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 156.53 16.3 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.388 1.075 . . . . 0.0 110.406 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 174.04 -157.92 26.28 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 26.9 tt0 85.82 -34.52 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 129.195 2.998 . . . . 0.0 112.942 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -83.65 86.48 1.51 Allowed Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.393 0.997 . . . . 0.0 111.452 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -59.46 142.49 52.32 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.956 1.302 . . . . 0.0 112.287 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 75.7 t -98.71 140.04 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.617 1.567 . . . . 0.0 109.505 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.751 1.62 . . . . 0.0 111.332 179.69 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.307 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.48 -22.78 54.07 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.033 1.333 . . . . 0.0 113.745 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -143.03 -19.53 0.65 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.065 1.346 . . . . 0.0 114.501 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 178.84 -126.18 1.04 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.109 1.338 . . . . 0.0 112.164 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -80.24 12.91 2.6 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.618 1.567 . . . . 0.0 113.42 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.03 -20.54 65.42 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.274 1.83 . . . . 0.0 114.528 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 64.5 p -173.46 159.47 3.69 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.891 2.077 . . . . 0.0 111.12 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 19.0 mmt -138.35 165.92 25.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.267 1.427 . . . . 0.0 111.959 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -57.82 135.16 56.79 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.261 1.425 . . . . 0.0 112.48 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 26.9 ptm -61.77 154.56 25.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.694 1.197 . . . . 0.0 113.137 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.8 m -121.52 145.79 47.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.598 1.559 . . . . 0.0 109.069 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -155.76 160.22 40.12 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.1 tt -163.05 155.13 18.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.766 2.026 . . . . 0.0 110.836 -172.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 68.4 mttm -130.25 151.85 50.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 112.766 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.8 t -138.46 131.14 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.651 1.58 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.2 77.35 1.86 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.687 1.136 . . . . 0.0 111.41 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 60.4 m -75.76 152.64 37.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.44 150.19 14.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.907 1.283 . . . . 0.0 112.849 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.39 160.96 25.21 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.755 1.222 . . . . 0.0 111.842 167.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.87 141.33 28.76 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.404 1.482 . . . . 0.0 112.66 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 37.4 mm -123.13 115.69 28.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.257 1.423 . . . . 0.0 108.887 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.7 132.39 11.99 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.35 2.7 . . . . 0.0 111.358 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 33.9 mt -148.39 143.13 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.841 1.656 . . . . 0.0 110.411 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 57.58 51.25 9.82 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.929 1.692 . . . . 0.0 112.478 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.39 -30.25 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.695 1.598 . . . . 0.0 112.614 -170.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 19.5 m -72.25 -15.31 61.92 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -81.77 141.0 33.9 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.208 0.913 . . . . 0.0 112.033 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -115.35 -34.32 4.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.106 1.762 . . . . 0.0 111.448 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.87 60.42 6.23 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.698 1.199 . . . . 0.0 111.815 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.43 -26.08 67.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.89 1.676 . . . . 0.0 112.42 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 20.5 m -59.49 -23.59 62.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.74 2.61 25.83 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.4 mp -84.47 145.98 27.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.483 1.113 . . . . 0.0 111.579 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.3 p -139.94 154.72 47.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.46 1.904 . . . . 0.0 109.171 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -147.97 152.16 37.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.8 p -140.99 159.48 42.12 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.594 1.958 . . . . 0.0 110.414 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.8 t -112.98 134.8 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.055 1.342 . . . . 0.0 109.525 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 99.6 t -103.01 111.68 65.23 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.038 1.335 . . . . 0.0 108.104 163.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.37 168.25 21.8 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.747 2.965 . . . . 0.0 110.743 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.71 -15.85 48.63 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.061 2.507 . . . . 0.0 113.267 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.6 p -79.75 -9.63 59.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 113.923 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.78 -2.01 84.51 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.665 1.602 . . . . 0.0 115.065 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -77.1 77.78 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.442 1.497 . . . . 0.0 111.712 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.77 134.93 56.69 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.864 1.265 . . . . 0.0 112.04 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -140.51 151.04 62.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.216 1.406 . . . . 0.0 111.32 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.38 153.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.87 3.046 . . . . 0.0 112.385 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 86.8 m -98.6 155.7 17.17 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.998 1.319 . . . . 0.0 112.381 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.8 tp -87.88 117.97 27.1 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 160.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 32.2 mt -81.16 140.99 34.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.96 0.904 . . . . 0.0 110.256 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -136.12 141.56 44.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.828 1.251 . . . . 0.0 113.139 -174.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -82.72 117.54 22.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.282 1.433 . . . . 0.0 107.93 157.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.06 171.02 7.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.776 1.23 . . . . 0.0 112.421 -172.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -56.73 -36.71 70.05 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.646 1.578 . . . . 0.0 115.049 -166.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.15 2.22 44.53 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 91.8 1.99 70.04 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.672 1.606 . . . . 0.0 113.994 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.35 166.77 15.34 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.738 1.615 . . . . 0.0 113.837 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 79.8 t -96.9 144.43 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.898 1.679 . . . . 0.0 110.05 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.55 -179.95 32.84 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 123.941 0.781 . . . . 0.0 114.802 171.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.79 157.15 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.394 1.478 . . . . 0.0 112.476 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.1 m -130.32 151.88 50.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.571 1.548 . . . . 0.0 110.777 160.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.4 p90 -167.15 -179.63 4.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.669 2.388 . . . . 0.0 109.495 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.5 t -127.63 120.4 21.85 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 119.273 0.942 . . . . 0.0 110.022 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.93 145.03 17.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.161 3.241 . . . . 0.0 111.206 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 48.0 tttm -94.57 -50.12 5.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.911 0.884 . . . . 0.0 112.074 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.83 171.88 8.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.864 1.666 . . . . 0.0 111.2 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.1 p -91.23 173.69 7.79 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.421 1.488 . . . . 0.0 111.462 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 89.23 -164.98 32.45 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.978 1.275 . . . . 0.0 113.601 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.9 116.23 8.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.073 0.949 . . . . 0.0 111.702 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.4 m80 -103.49 144.56 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.962 1.705 . . . . 0.0 109.003 165.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.75 119.25 38.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.555 1.142 . . . . 0.0 109.681 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 92.3 t -88.11 131.83 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.305 1.042 . . . . 0.0 108.652 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -112.74 140.25 47.67 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.86 1.264 . . . . 0.0 110.054 168.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 2.9 p -138.81 133.36 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.931 0.892 . . . . 0.0 111.164 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -115.11 141.79 47.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.612 1.965 . . . . 0.0 112.649 -163.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -139.45 130.63 26.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.92 2.088 . . . . 0.0 110.055 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.93 31.89 14.24 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.542 1.137 . . . . 0.0 113.636 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.17 -2.62 81.61 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.44 1.495 . . . . 0.0 116.09 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -129.67 150.17 51.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.622 1.711 . . . . 0.0 111.723 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -66.11 139.49 58.16 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.846 -1.159 . . . . 0.0 112.044 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 20.0 m -69.23 161.26 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 111.499 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.93 63.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 17.3 m -76.77 -17.83 58.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.686 1.195 . . . . 0.0 114.127 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 45.0 m -79.05 144.58 63.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.738 -1.226 . . . . 0.0 112.922 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.5 147.19 81.4 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 118.827 0.617 . . . . 0.0 112.044 -5.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -97.31 121.67 58.01 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.924 1.29 . . . . 0.0 108.449 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.42 139.26 12.84 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.839 2.359 . . . . 0.0 111.288 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -131.05 124.14 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.629 1.572 . . . . 0.0 107.402 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.3 t -99.01 121.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.683 0.793 . . . . 0.0 110.084 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.02 122.36 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.902 1.281 . . . . 0.0 109.644 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 154.69 22.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.611 0.764 . . . . 0.0 111.372 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -55.37 -29.26 58.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.221 1.009 . . . . 0.0 112.698 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 34.1 m -68.7 -15.72 63.6 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -92.97 -14.88 26.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.365 1.066 . . . . 0.0 113.004 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.48 -28.42 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.714 1.206 . . . . 0.0 112.52 -173.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 146.77 94.57 0.15 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.132 1.349 . . . . 0.0 112.396 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.67 113.84 21.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.103 1.361 . . . . 0.0 109.477 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 112.282 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.4 m -53.3 -23.02 8.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.051 1.74 . . . . 0.0 114.115 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -87.33 -17.74 31.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.758 1.223 . . . . 0.0 114.151 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.0 t -78.75 136.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.625 1.102 . . . . 0.0 110.162 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -119.73 159.37 24.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.137 1.375 . . . . 0.0 110.516 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 26.9 m -145.92 157.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.58 . . . . 0.0 110.605 -178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -158.44 175.27 13.91 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.373 1.069 . . . . 0.0 112.565 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 101.15 166.67 27.87 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.436 1.493 . . . . 0.0 114.204 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.87 -35.2 79.48 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.611 1.164 . . . . 0.0 112.937 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.34 10.99 5.58 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.588 1.566 . . . . 0.0 115.152 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 80.1 mt -100.11 -7.49 24.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.831 1.652 . . . . 0.0 112.063 165.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -131.7 -41.6 1.05 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.485 1.514 . . . . 0.0 113.846 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.77 154.82 26.84 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.58 -170.58 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.552 1.548 . . . . 0.0 113.865 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 72.6 m80 -140.19 146.91 39.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.054 1.342 . . . . 0.0 112.407 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.8 p -73.26 -17.67 61.3 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.19 -3.61 12.52 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -144.4 145.09 27.68 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 110.268 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.75 145.95 52.81 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.977 2.452 . . . . 0.0 111.801 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -89.66 157.06 18.17 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.661 1.184 . . . . 0.0 110.672 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.95 145.34 44.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.819 0.848 . . . . 0.0 112.346 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -150.37 145.94 26.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.042 1.337 . . . . 0.0 111.023 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.02 144.68 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.21 1.804 . . . . 0.0 109.457 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 22.0 mt -118.96 135.67 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.266 1.826 . . . . 0.0 109.835 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -109.06 43.44 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.338 1.855 . . . . 0.0 112.669 -171.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 1.2 p -57.83 -21.36 41.97 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -29.63 59.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.48 -4.48 59.0 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.696 1.198 . . . . 0.0 113.03 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.77 1.59 34.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.832 1.653 . . . . 0.0 114.422 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.94 -116.81 4.53 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -128.87 161.48 29.74 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.912 1.285 . . . . 0.0 112.628 -174.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.28 166.38 10.88 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.448 1.023 . . . . 0.0 114.563 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -79.52 132.49 11.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.04 0.828 . . . . 0.0 112.462 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 124.33 47.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.548 1.939 . . . . 0.0 107.801 171.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -118.54 139.08 52.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.205 1.002 . . . . 0.0 110.647 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 5.1 tp -122.88 134.06 54.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.91 1.684 . . . . 0.0 109.874 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.6 m -135.82 130.29 33.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.289 0.635 . . . . 0.0 110.501 170.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 44.9 mt -112.86 135.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.537 1.535 . . . . 0.0 109.323 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.92 155.3 50.17 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.908 1.683 . . . . 0.0 109.958 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.41 -159.11 31.67 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.381 -0.825 . . . . 0.0 115.013 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.5 -2.88 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.407 3.404 . . . . 0.0 114.18 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -156.24 161.46 40.25 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.849 1.26 . . . . 0.0 111.338 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -66.29 149.87 49.7 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.324 -0.86 . . . . 0.0 110.074 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 20.3 m -124.05 159.76 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.394 1.078 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.37 122.67 45.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.951 0.9 . . . . 0.0 109.188 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 16.0 mt -105.78 134.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.564 1.145 . . . . 0.0 110.131 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -130.14 165.17 22.86 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 110.598 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -143.07 162.77 34.64 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.071 1.348 . . . . 0.0 112.181 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.83 116.35 5.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.665 1.586 . . . . 0.0 109.706 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.55 132.6 39.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 110.854 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.7 mt -111.1 153.24 25.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.647 1.179 . . . . 0.0 111.702 -173.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.45 -19.07 64.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -83.44 3.37 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.876 1.271 . . . . 0.0 113.077 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.89 -0.2 84.13 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.473 1.511 . . . . 0.0 114.17 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.1 p -81.73 166.4 20.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.095 1.758 . . . . 0.0 111.194 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -129.18 126.1 38.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.048 0.939 . . . . 0.0 110.748 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -81.92 135.03 35.43 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.412 1.085 . . . . 0.0 109.271 166.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.7 t -113.43 140.37 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.714 2.006 . . . . 0.0 108.237 167.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 10.8 p -136.09 150.21 49.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.187 1.395 . . . . 0.0 111.311 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.8 p90 -159.18 149.59 19.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.505 1.122 . . . . 0.0 111.854 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 9.0 t -114.92 108.97 47.76 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.845 0.858 . . . . 0.0 111.013 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.05 154.27 25.47 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.436 2.758 . . . . 0.0 110.56 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 27.1 m -114.28 -42.23 3.36 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.135 0.974 . . . . 0.0 112.408 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -87.9 142.83 32.57 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.769 0.828 . . . . 0.0 110.441 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.32 163.83 31.86 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.312 2.674 . . . . 0.0 111.083 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.27 -143.36 15.02 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.822 1.201 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -124.28 129.7 51.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.458 0.703 . . . . 0.0 111.866 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -108.02 144.98 34.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 110.773 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.14 132.28 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.334 1.454 . . . . 0.0 108.878 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.57 127.9 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.339 1.455 . . . . 0.0 109.199 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -107.46 126.93 53.13 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.095 1.358 . . . . 0.0 110.216 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2118 ' ' ILE . . . . . 0.425 ' HB ' HG22 ' A' 2125 ' ' VAL . 12.6 mm -116.65 94.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.582 1.153 . . . . 0.0 110.231 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -86.62 130.39 34.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.907 1.283 . . . . 0.0 110.09 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.22 130.5 46.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.089 0.955 . . . . 0.0 109.825 168.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 56.95 26.0 11.27 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.108 1.363 . . . . 0.0 113.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.6 t70 72.28 12.33 5.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.991 2.516 . . . . 0.0 114.472 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -98.37 -158.82 0.7 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.775 1.63 . . . . 0.0 109.595 165.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.5 t60 -142.57 127.46 18.3 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.474 -1.392 . . . . 0.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2125 ' ' VAL . . . . . 0.425 HG22 ' HB ' ' A' 2118 ' ' ILE . 4.0 m -73.44 155.16 89.76 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 0.0 112.172 -167.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.14 131.31 38.82 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.654 2.903 . . . . 0.0 112.807 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.88 50.57 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.039 1.304 . . . . 0.0 114.676 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 28.9 t -77.42 144.39 70.22 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 118.926 1.363 . . . . 0.0 111.518 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.89 152.68 97.1 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.727 0.938 . . . . 0.0 112.589 -3.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -104.88 132.33 51.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.366 1.466 . . . . 0.0 111.298 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 69.2 m -100.36 126.21 46.69 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.643 1.177 . . . . 0.0 111.272 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.36 111.82 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.749 1.62 . . . . 0.0 109.789 -167.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -77.93 112.7 15.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.793 -0.567 . . . . 0.0 111.169 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 71.3 t -101.39 113.37 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 109.05 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -90.8 154.83 19.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.333 1.053 . . . . 0.0 110.85 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -178.6 -161.9 27.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -157.64 163.7 37.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.871 2.068 . . . . 0.0 109.081 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -62.81 120.17 20.4 Favored Glycine 0 CA--C 1.533 1.158 0 O-C-N 121.337 -0.852 . . . . 0.0 111.714 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -74.45 118.51 17.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.538 1.135 . . . . 0.0 111.064 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 95.7 t -143.35 142.27 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.495 1.918 . . . . 0.0 109.199 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 3.5 tppp? . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.681 1.593 . . . . 0.0 111.308 178.362 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.512 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.29 158.47 36.31 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.402 1.081 . . . . 0.0 112.811 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -166.03 161.75 17.53 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.962 1.705 . . . . 0.0 111.766 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -68.1 142.61 39.85 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.582 0.61 . . . . 0.0 111.832 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -155.56 36.18 0.37 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.95 1.3 . . . . 0.0 111.537 -171.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 44.2 m-20 71.63 -31.38 0.22 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 129.28 3.032 . . . . 0.0 113.889 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 8.6 t -76.74 164.38 25.92 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.102 1.361 . . . . 0.0 112.416 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 93.4 mmm -77.09 77.58 3.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.341 1.457 . . . . 0.0 111.205 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 -60.08 126.38 27.28 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.099 0.959 . . . . 0.0 110.744 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 98.8 mtp -84.0 129.88 34.9 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.969 0.908 . . . . 0.0 111.432 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 21.0 m -113.68 132.68 55.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.193 1.797 . . . . 0.0 108.592 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 7.0 t60 -129.51 152.89 48.55 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -163.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1963 ' ' LEU . . . . . 0.413 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -151.73 153.89 35.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.196 1.798 . . . . 0.0 110.864 179.27 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1964 ' ' LYS . . . . . 0.413 ' H ' HD13 ' A' 1963 ' ' LEU . 99.0 mttt -137.8 146.54 43.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.06 1.344 . . . . 0.0 111.949 173.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 60.2 t -143.0 133.94 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.044 1.738 . . . . 0.0 109.617 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.16 132.43 11.08 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.932 0.777 . . . . 0.0 111.54 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 27.2 m -120.65 141.63 50.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.256 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -152.26 156.72 40.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.137 0.975 . . . . 0.0 113.276 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -113.07 151.62 30.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 111.574 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.72 147.38 25.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 0.0 113.128 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.54 126.38 23.42 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 125.309 1.444 . . . . 0.0 108.73 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.81 130.5 9.65 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.198 2.599 . . . . 0.0 111.237 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 40.4 mt -149.63 141.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.392 1.877 . . . . 0.0 108.746 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.3 t30 59.13 53.76 5.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.368 1.467 . . . . 0.0 111.906 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 30.1 mm -56.79 -39.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.747 1.619 . . . . 0.0 113.509 -163.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 17.2 m -77.12 -2.31 33.65 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.43 145.05 51.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 113.481 -171.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 41.2 p -133.13 -20.56 2.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.519 1.927 . . . . 0.0 112.984 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.14 50.8 2.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.303 1.441 . . . . 0.0 111.85 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -1.18 6.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 35.5 p -77.16 -25.9 52.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.705 1.602 . . . . 0.0 114.271 174.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.81 8.4 4.49 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.22 136.14 33.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.503 1.921 . . . . 0.0 109.046 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 11.2 t -148.25 161.47 41.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.811 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.57 154.26 38.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 113.045 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 70.1 p -140.95 163.01 34.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.906 2.082 . . . . 0.0 109.599 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 17.8 t -116.65 136.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.827 1.251 . . . . 0.0 110.182 171.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.3 t -106.62 113.29 63.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.907 1.283 . . . . 0.0 108.497 166.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.03 174.18 9.54 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.402 3.401 . . . . 0.0 111.801 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.81 -29.22 51.6 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.538 3.492 . . . . 0.0 114.619 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 70.9 p -80.91 -3.57 51.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.855 1.262 . . . . 0.0 113.989 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 75.2 -3.11 48.7 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.474 1.511 . . . . 0.0 114.911 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -76.26 91.6 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.953 1.301 . . . . 0.0 110.928 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 131.69 50.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.055 0.942 . . . . 0.0 111.601 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -132.45 144.42 52.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.725 1.61 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.07 153.02 28.35 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.435 2.757 . . . . 0.0 112.287 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.3 m -89.1 151.52 22.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.076 0.951 . . . . 0.0 112.402 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 59.8 tp -86.5 131.76 34.1 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.602 1.161 . . . . 0.0 108.271 157.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mp -99.72 142.1 31.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.603 1.161 . . . . 0.0 110.133 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.6 139.16 36.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.678 1.191 . . . . 0.0 113.049 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -92.34 114.51 27.07 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 156.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.85 169.39 11.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.997 -169.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -62.76 -27.47 69.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -166.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -88.43 3.6 49.43 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 119.155 0.889 . . . . 0.0 113.256 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.06 -4.41 71.15 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 126.122 1.82 . . . . 0.0 114.312 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -80.14 156.14 27.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.391 1.476 . . . . 0.0 113.782 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 68.6 t -89.08 140.94 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.13 1.372 . . . . 0.0 110.126 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.06 177.96 29.57 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.275 0.941 . . . . 0.0 114.488 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.35 161.08 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.142 1.377 . . . . 0.0 111.808 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 49.6 m -134.99 156.72 48.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.147 1.779 . . . . 0.0 110.179 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.8 p90 -164.3 -170.39 2.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.503 1.921 . . . . 0.0 109.381 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 70.3 t -131.85 114.35 15.3 Favored Pre-proline 0 N--CA 1.48 1.029 0 CA-C-N 119.51 1.05 . . . . 0.0 109.825 168.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.97 145.25 31.33 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.738 2.959 . . . . 0.0 110.499 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -115.04 1.15 13.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.44 1.096 . . . . 0.0 113.033 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -141.74 171.34 14.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.377 2.271 . . . . 0.0 109.73 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.9 p -94.97 163.37 13.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.358 1.063 . . . . 0.0 110.742 164.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.22 -167.29 26.24 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.893 1.235 . . . . 0.0 113.738 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.3 114.63 8.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.258 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.3 m80 -99.91 147.56 25.41 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.904 1.682 . . . . 0.0 109.163 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 84.9 mt -105.62 124.21 49.18 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 109.864 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.9 t -89.74 113.69 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.669 1.188 . . . . 0.0 107.956 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -94.09 140.88 29.18 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.53 1.132 . . . . 0.0 110.436 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.3 p -143.89 133.99 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.818 0.818 . . . . 0.0 112.104 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -136.04 137.32 41.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.668 1.987 . . . . 0.0 111.528 -164.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.6 tttt -134.89 132.56 38.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.474 1.509 . . . . 0.0 110.895 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 50.3 t30 58.01 25.55 12.42 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.33 5.08 73.06 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.146 1.355 . . . . 0.0 115.605 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -128.9 151.4 49.68 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.426 1.613 . . . . 0.0 111.625 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -64.74 146.66 54.47 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.028 -1.045 . . . . 0.0 112.541 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 58.0 t -72.19 145.34 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.678 0.791 . . . . 0.0 108.895 171.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.63 -29.5 64.6 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 22.1 m -84.79 -4.25 58.98 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.15 1.38 . . . . 0.0 113.972 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 14.9 t -82.32 141.65 46.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.699 -1.25 . . . . 0.0 112.191 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.98 157.06 84.27 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.657 0.913 . . . . 0.0 112.655 -5.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.97 124.38 41.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.541 1.536 . . . . 0.0 108.686 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.39 141.27 14.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.032 2.488 . . . . 0.0 111.314 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.2 t -137.83 123.77 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.481 1.512 . . . . 0.0 108.303 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.8 t -96.53 124.18 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.742 0.817 . . . . 0.0 110.222 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.23 129.07 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.974 1.31 . . . . 0.0 110.145 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -94.91 168.41 10.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.695 1.198 . . . . 0.0 112.717 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.52 -34.89 78.03 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.412 -1.43 . . . . 0.0 111.653 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.8 m -64.63 -12.14 42.64 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.335 1.454 . . . . 0.0 114.892 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -116.01 1.47 13.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.526 1.53 . . . . 0.0 113.105 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.48 -23.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.333 1.053 . . . . 0.0 113.288 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.12 37.57 0.04 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.97 101.23 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.461 1.13 . . . . 0.0 111.377 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.77 82.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.422 0.689 . . . . 0.0 112.819 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 75.7 m -62.1 -25.32 67.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.855 0.862 . . . . 0.0 113.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -79.82 -13.43 59.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.209 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.6 t -77.28 133.17 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 120.141 1.337 . . . . 0.0 109.838 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -112.55 160.83 17.44 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.883 1.673 . . . . 0.0 110.871 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.2 m -146.9 159.29 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.363 1.465 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.49 177.48 10.9 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.608 1.163 . . . . 0.0 112.495 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 93.85 163.07 36.13 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.371 1.462 . . . . 0.0 113.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -75.68 -28.16 58.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.85 0.86 . . . . 0.0 113.205 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.14 0.91 13.09 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.216 1.389 . . . . 0.0 115.326 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.8 mt -92.37 -5.38 52.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.94 1.696 . . . . 0.0 112.643 168.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -133.8 -43.04 0.82 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.964 1.305 . . . . 0.0 113.516 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.23 150.2 40.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.832 1.253 . . . . 0.0 111.613 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.49 -176.23 22.51 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.579 1.085 . . . . 0.0 113.836 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.45 151.44 48.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 111.729 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 37.8 p -76.71 -40.19 49.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.863 0.865 . . . . 0.0 112.489 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -98.1 1.35 47.51 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -140.44 146.78 46.78 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.35 151.76 54.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.183 2.589 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -106.65 130.18 54.44 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.9 1.28 . . . . 0.0 111.038 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -111.93 147.09 36.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.461 1.505 . . . . 0.0 113.323 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 55.9 p90 -156.12 155.05 31.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.868 1.267 . . . . 0.0 112.145 173.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.91 143.66 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.532 1.933 . . . . 0.0 109.705 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 53.2 mt -122.77 133.98 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.521 1.928 . . . . 0.0 108.839 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.1 t0 -128.93 101.1 5.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.802 1.641 . . . . 0.0 110.948 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 39.3 p -96.18 1.46 52.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.187 1.795 . . . . 0.0 113.275 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -60.73 -34.03 73.8 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.367 0.985 . . . . 0.0 113.221 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.07 -12.04 55.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.56 1.144 . . . . 0.0 113.353 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.08 -12.46 35.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.502 1.521 . . . . 0.0 114.073 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.31 -119.28 5.1 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.376 0.988 . . . . 0.0 111.823 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -103.52 162.29 13.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.276 1.831 . . . . 0.0 112.329 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.83 -177.77 29.51 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.929 0.776 . . . . 0.0 114.979 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -104.43 121.78 7.1 Favored Glycine 0 N--CA 1.468 0.793 0 C-N-CA 124.731 1.158 . . . . 0.0 111.113 174.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.49 123.63 36.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.374 1.47 . . . . 0.0 108.37 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 33.6 t -121.75 145.23 48.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.984 1.714 . . . . 0.0 109.73 175.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.11 133.17 22.83 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.521 0.729 . . . . 0.0 110.762 -164.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 7.6 m -129.14 136.54 50.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.805 0.842 . . . . 0.0 110.622 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.5 mt -119.92 138.69 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.863 1.265 . . . . 0.0 108.323 168.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.56 146.55 28.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.798 0.839 . . . . 0.0 111.7 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -176.64 -163.24 28.64 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.903 -173.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.39 -10.18 25.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.017 3.145 . . . . 0.0 114.482 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.1 t -152.38 169.42 22.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.483 1.038 . . . . 0.0 112.067 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.36 143.97 54.82 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.152 1.381 . . . . 0.0 111.137 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -121.08 149.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.754 0.706 . . . . 0.0 111.517 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.32 118.38 34.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.616 0.766 . . . . 0.0 109.469 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 50.0 mt -104.2 135.94 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.146 1.379 . . . . 0.0 109.795 -173.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.27 156.82 43.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.794 1.637 . . . . 0.0 110.384 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 34.0 p -134.46 154.99 51.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.229 1.412 . . . . 0.0 111.438 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -150.51 131.76 14.53 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.647 1.179 . . . . 0.0 110.736 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.91 122.88 29.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.594 1.157 . . . . 0.0 110.561 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.0 mt -92.05 151.9 20.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.927 0.891 . . . . 0.0 111.396 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -63.01 -26.34 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.406 1.082 . . . . 0.0 112.884 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.45 -4.98 42.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.953 1.301 . . . . 0.0 113.469 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.39 4.19 59.66 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.632 1.587 . . . . 0.0 114.745 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -95.31 163.1 13.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.176 1.79 . . . . 0.0 111.453 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 128.47 54.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.24 1.016 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -91.48 136.08 33.38 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.665 167.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 137.73 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.916 1.686 . . . . 0.0 108.414 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 14.3 p -134.94 146.54 49.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.107 1.363 . . . . 0.0 110.561 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.8 p90 -149.82 152.08 34.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.519 0.728 . . . . 0.0 112.86 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 p -115.95 108.41 46.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.963 1.305 . . . . 0.0 111.24 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.75 169.76 17.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.676 2.918 . . . . 0.0 110.795 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 87.4 m -121.19 -51.75 2.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.949 0.899 . . . . 0.0 111.673 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -81.82 143.23 49.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.749 0.82 . . . . 0.0 110.374 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.24 162.15 34.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.124 2.549 . . . . 0.0 111.038 170.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.17 -161.34 24.61 Favored Glycine 0 N--CA 1.472 1.098 0 C-N-CA 125.11 1.338 . . . . 0.0 113.703 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -90.55 122.3 33.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.443 0.697 . . . . 0.0 111.273 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -104.7 136.72 43.69 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 109.865 167.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.39 133.66 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.231 1.412 . . . . 0.0 108.559 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.4 mt -119.44 127.92 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.831 1.252 . . . . 0.0 109.595 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 15.7 m120 -109.02 125.81 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 110.306 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 24.4 mm -109.37 113.96 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.538 1.135 . . . . 0.0 108.802 172.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -119.15 135.21 54.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.451 1.5 . . . . 0.0 111.026 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 30.4 t80 -130.35 126.89 38.25 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.746 0.818 . . . . 0.0 110.895 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.23 39.39 26.88 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.688 1.595 . . . . 0.0 114.074 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 15.3 t70 79.9 2.26 2.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.023 2.529 . . . . 0.0 114.025 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -96.92 -127.79 0.15 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.157 1.383 . . . . 0.0 110.774 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -171.11 128.57 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.816 2.046 . . . . 0.0 109.884 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -86.65 157.92 54.65 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-N 120.098 1.317 . . . . 0.0 111.706 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.44 141.63 72.25 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.905 3.07 . . . . 0.0 113.567 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 87.84 -21.54 22.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.958 1.266 . . . . 0.0 114.597 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 58.1 m -74.63 148.4 85.34 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.979 1.39 . . . . 0.0 111.874 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.4 140.1 65.38 Favored 'Cis proline' 0 C--N 1.351 0.708 0 CA-C-N 119.369 0.81 . . . . 0.0 111.288 -5.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.48 121.59 35.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.669 1.187 . . . . 0.0 110.514 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.6 m -85.63 124.32 32.04 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.397 0.679 . . . . 0.0 110.443 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.8 t -116.48 114.79 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.926 1.69 . . . . 0.0 109.085 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 58.7 tttp -78.94 103.2 8.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.818 0.447 . . . . 0.0 110.683 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 74.9 t -89.58 114.67 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.609 1.163 . . . . 0.0 108.599 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.3 t -94.27 161.3 14.31 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.112 0.965 . . . . 0.0 111.165 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 152.75 -139.47 7.0 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.092 0.853 . . . . 0.0 113.67 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -152.18 158.33 42.74 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.664 1.586 . . . . 0.0 109.965 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -70.2 -3.13 44.35 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.473 -1.182 . . . . 0.0 115.732 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 80.78 148.69 0.09 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.172 2.589 . . . . 0.0 112.76 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 98.7 t -67.97 134.49 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.828 1.251 . . . . 0.0 110.045 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 60.4 tttp . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.211 1.404 . . . . 0.0 112.596 -179.178 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -160.69 168.63 24.48 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.909 1.684 . . . . 0.0 111.664 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 22.1 mmt 74.35 -19.99 0.34 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.136 2.574 . . . . 0.0 114.993 170.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.7 4.46 85.76 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.664 1.602 . . . . 0.0 114.341 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -157.51 158.66 36.12 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.5 1.92 . . . . 0.0 111.883 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 2.0 t70 -162.26 -170.42 2.46 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.495 1.918 . . . . 0.0 110.227 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 54.1 p -155.58 143.33 19.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.707 1.203 . . . . 0.0 112.091 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 17.9 tmm? -75.29 127.7 33.74 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.943 0.897 . . . . 0.0 111.197 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.8 128.0 49.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.342 1.457 . . . . 0.0 110.346 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.0 ptm -126.72 137.45 53.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.753 1.621 . . . . 0.0 110.716 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 14.1 m -108.71 112.69 25.12 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.446 1.498 . . . . 0.0 108.944 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 8.1 t60 -106.47 158.36 16.96 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -162.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -152.91 139.02 18.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.612 2.365 . . . . 0.0 110.012 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.29 144.94 50.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.756 1.222 . . . . 0.0 111.17 167.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.8 p -155.45 141.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.157 0.983 . . . . 0.0 111.338 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.31 150.69 33.81 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.206 0.908 . . . . 0.0 113.268 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 47.0 m -131.92 37.53 3.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.932 1.293 . . . . 0.0 111.668 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -67.84 111.96 4.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.938 1.295 . . . . 0.0 111.257 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -72.13 148.06 46.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.242 1.017 . . . . 0.0 112.33 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.93 150.46 20.15 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 73.0 mt -136.93 126.11 15.35 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.336 1.854 . . . . 0.0 108.961 171.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.78 149.35 12.56 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.855 3.037 . . . . 0.0 112.261 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.12 134.99 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.111 1.365 . . . . 0.0 110.368 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 58.8 t30 42.28 73.05 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.247 2.219 . . . . 0.0 114.866 166.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 21.4 mm -67.54 124.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.863 . . . . 0.0 111.223 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 21.4 t -170.33 166.34 8.68 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.499 1.92 . . . . 0.0 110.432 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -85.55 62.96 7.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.989 1.316 . . . . 0.0 110.868 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.6 p -86.45 158.34 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.62 1.568 . . . . 0.0 112.219 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.43 119.36 27.63 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.482 1.113 . . . . 0.0 110.259 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.2 mp -75.91 -11.11 59.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.113 0.965 . . . . 0.0 113.132 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 17.2 t -67.53 -37.5 82.85 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.611 1.096 . . . . 0.0 113.363 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.47 2.5 24.27 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.11 133.57 35.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.134 1.374 . . . . 0.0 110.526 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 52.9 p -138.82 163.02 33.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.891 1.676 . . . . 0.0 110.381 173.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.9 148.91 29.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.937 0.895 . . . . 0.0 113.148 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -135.78 164.53 27.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.874 2.07 . . . . 0.0 109.767 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -116.24 134.08 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.597 1.159 . . . . 0.0 109.346 166.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.4 t -104.29 111.94 65.31 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.302 1.441 . . . . 0.0 108.11 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.83 169.39 20.75 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.806 3.004 . . . . 0.0 110.872 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.21 -15.83 47.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.058 2.506 . . . . 0.0 113.184 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.6 p -79.85 -4.99 54.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.005 1.322 . . . . 0.0 113.847 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.04 59.11 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.385 1.469 . . . . 0.0 114.965 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -77.67 76.76 4.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.567 1.547 . . . . 0.0 111.637 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -58.29 136.59 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.69 1.196 . . . . 0.0 112.398 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.01 151.34 67.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.441 1.497 . . . . 0.0 111.081 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.39 152.94 44.63 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.741 2.96 . . . . 0.0 112.489 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 90.3 m -95.6 152.68 18.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.17 122.73 33.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.668 1.187 . . . . 0.0 109.113 167.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 66.4 mt -84.07 139.01 32.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.325 1.05 . . . . 0.0 110.635 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 92.2 mttt -141.36 140.6 33.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.948 1.299 . . . . 0.0 112.367 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -87.5 125.9 34.59 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 160.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.8 mt -105.71 176.38 5.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.828 1.651 . . . . 0.0 113.031 -163.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -55.57 -34.89 65.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.635 1.974 . . . . 0.0 115.254 -164.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 20.6 m120 -96.61 5.51 50.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.622 1.169 . . . . 0.0 113.398 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.45 71.9 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.46 1.505 . . . . 0.0 113.965 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -73.8 173.73 9.44 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.961 1.704 . . . . 0.0 113.273 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 98.1 t -127.85 142.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.346 1.459 . . . . 0.0 109.961 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -155.85 -174.75 26.05 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.6 160.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.475 1.91 . . . . 0.0 110.99 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 78.9 p -146.93 155.15 42.06 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.904 1.282 . . . . 0.0 111.125 165.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.46 -175.69 4.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.95 1.7 . . . . 0.0 110.728 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 56.5 t -134.15 124.87 17.66 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.313 1.045 . . . . 0.0 109.244 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.64 150.18 27.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.09 3.194 . . . . 0.0 111.767 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.49 -8.04 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.228 1.011 . . . . 0.0 113.479 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -142.84 171.39 14.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.888 2.075 . . . . 0.0 110.341 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 31.1 p -93.23 164.35 13.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.743 1.217 . . . . 0.0 111.096 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.04 -168.68 24.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.206 1.384 . . . . 0.0 113.544 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.8 117.67 11.68 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.899 0.857 . . . . 0.0 111.719 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 6.7 m80 -103.31 148.29 26.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.067 1.747 . . . . 0.0 109.11 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.86 126.89 53.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.136 0.974 . . . . 0.0 109.696 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 28.4 t -84.82 125.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 163.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -105.46 128.75 53.71 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.462 1.105 . . . . 0.0 110.071 172.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 34.6 t -129.34 129.84 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.986 1.314 . . . . 0.0 109.341 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -139.72 141.51 36.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.53 125.12 53.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.393 2.277 . . . . 0.0 109.477 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.64 26.61 11.41 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.688 1.195 . . . . 0.0 113.425 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 97.05 -13.03 65.34 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.83 1.681 . . . . 0.0 115.937 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.28 144.73 42.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.684 1.742 . . . . 0.0 112.142 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -62.65 142.8 57.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 85.6 t -70.83 149.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.449 1.499 . . . . 0.0 109.462 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.17 64.13 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 70.9 m -86.42 -8.91 57.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.549 1.14 . . . . 0.0 113.785 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 24.7 t -88.9 145.22 34.23 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.069 1.347 . . . . 0.0 112.383 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.52 154.09 95.04 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.608 0.896 . . . . 0.0 112.565 -3.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.8 120.21 50.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.4 1.48 . . . . 0.0 108.515 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.3 142.5 13.38 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.914 2.409 . . . . 0.0 111.38 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.25 125.57 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.27 1.428 . . . . 0.0 108.081 174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 57.4 t -97.01 121.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.499 0.72 . . . . 0.0 109.807 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.87 123.93 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.88 1.272 . . . . 0.0 109.253 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 159.81 15.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.617 0.767 . . . . 0.0 111.402 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -57.48 -30.68 65.27 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.985 0.914 . . . . 0.0 112.782 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 30.9 m -67.29 -18.4 65.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.426 1.09 . . . . 0.0 113.813 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -93.15 -11.12 33.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.517 1.127 . . . . 0.0 112.847 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.19 -35.31 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.438 1.095 . . . . 0.0 112.306 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.98 61.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.911 0.767 . . . . 0.0 113.523 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.12 95.63 8.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.459 0.703 . . . . 0.0 110.853 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.9 69.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.651 0.78 . . . . 0.0 112.388 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.9 m -53.99 -21.16 7.49 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.078 1.751 . . . . 0.0 114.432 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -97.24 -7.5 32.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.562 1.545 . . . . 0.0 113.891 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 94.3 t -75.64 137.28 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.722 1.146 . . . . 0.0 109.94 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -123.2 157.62 32.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.277 1.431 . . . . 0.0 111.072 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 28.0 m -146.34 156.93 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.319 1.448 . . . . 0.0 110.972 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.18 174.24 15.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.625 1.17 . . . . 0.0 112.156 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 110.54 -157.51 14.96 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.395 1.474 . . . . 0.0 113.644 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -109.89 -36.29 5.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.642 1.177 . . . . 0.0 112.549 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.63 -0.18 53.15 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 125.113 1.34 . . . . 0.0 115.606 -171.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.92 -5.47 50.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.33 1.452 . . . . 0.0 112.451 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -125.09 -38.16 2.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.223 1.409 . . . . 0.0 113.346 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.8 154.59 30.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.306 1.042 . . . . 0.0 113.238 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.67 -176.17 24.16 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.399 1.476 . . . . 0.0 113.761 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.0 m80 -140.3 145.45 37.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.768 1.227 . . . . 0.0 112.496 -173.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 46.2 p -68.94 -16.25 63.7 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -117.54 -5.02 11.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -144.88 146.48 31.51 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 110.853 -176.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.24 145.71 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.884 2.39 . . . . 0.0 111.604 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -99.4 148.44 24.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.11 1.364 . . . . 0.0 110.374 171.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.96 146.21 51.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.861 . . . . 0.0 113.093 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.7 148.15 26.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.287 1.435 . . . . 0.0 110.958 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.38 140.29 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 109.165 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 37.9 mt -112.13 134.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.872 1.669 . . . . 0.0 109.272 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 65.3 t0 -125.53 103.73 8.03 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.033 1.733 . . . . 0.0 110.644 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 22.8 p -99.21 0.48 43.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.403 1.881 . . . . 0.0 113.127 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.88 -32.7 72.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 0.0 113.326 -171.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.78 -14.46 58.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.667 1.187 . . . . 0.0 113.451 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.11 -0.56 57.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.344 1.457 . . . . 0.0 114.307 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.3 -136.24 15.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.643 1.116 . . . . 0.0 111.937 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -88.42 169.26 11.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.004 1.322 . . . . 0.0 112.329 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 142.24 -151.55 23.01 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.333 0.968 . . . . 0.0 114.255 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -148.62 148.72 20.42 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.426 1.489 . . . . 0.0 112.691 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 128.51 54.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.838 2.055 . . . . 0.0 109.501 -177.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 11.7 t -121.75 139.44 53.58 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.681 1.592 . . . . 0.0 109.749 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.16 142.14 30.37 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.57 1.148 . . . . 0.0 110.139 -162.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 87.0 p -147.61 149.83 33.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 14.6 mt -117.39 127.8 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.813 1.245 . . . . 0.0 109.289 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -114.58 154.91 27.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.916 2.086 . . . . 0.0 109.229 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 164.01 -162.55 35.28 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.156 -0.965 . . . . 0.0 114.832 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 -6.41 19.14 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.127 3.218 . . . . 0.0 114.294 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.3 t -154.57 157.59 38.5 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.631 1.105 . . . . 0.0 112.248 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 128.25 35.0 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.08 1.352 . . . . 0.0 109.506 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 30.4 m -115.96 169.33 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.984 1.313 . . . . 0.0 111.87 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -110.69 121.28 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.396 1.078 . . . . 0.0 110.193 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.19 132.04 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.859 0.864 . . . . 0.0 108.98 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -120.01 157.89 27.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.184 1.794 . . . . 0.0 109.706 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 36.3 p -136.16 160.42 38.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.657 1.183 . . . . 0.0 111.807 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -152.94 119.54 5.64 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.859 1.264 . . . . 0.0 110.002 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.96 124.15 26.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.354 1.062 . . . . 0.0 110.302 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 61.6 mt -94.95 151.72 18.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.288 1.035 . . . . 0.0 111.441 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -16.1 63.86 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -81.95 -7.03 59.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.875 1.27 . . . . 0.0 113.267 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 98.62 1.63 57.61 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.667 1.603 . . . . 0.0 115.05 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 36.0 p -93.62 171.69 8.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.202 1.801 . . . . 0.0 111.503 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -121.32 124.36 44.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.995 0.918 . . . . 0.0 111.504 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -80.51 134.04 35.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.292 1.037 . . . . 0.0 109.395 165.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.7 t -117.86 137.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 108.186 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.1 p -138.85 148.59 43.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.346 1.458 . . . . 0.0 111.401 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.6 p90 -157.13 150.29 23.84 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.602 1.161 . . . . 0.0 111.914 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.0 t -114.79 105.59 53.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.16 0.984 . . . . 0.0 110.712 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.98 150.0 26.26 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.334 2.689 . . . . 0.0 110.618 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 45.9 m -111.11 -45.83 3.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.073 0.949 . . . . 0.0 112.19 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -85.49 142.3 37.41 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.459 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.97 163.0 33.91 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.268 2.645 . . . . 0.0 111.078 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.45 -144.69 16.7 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 124.871 1.224 . . . . 0.0 112.2 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -123.23 129.97 52.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.645 0.778 . . . . 0.0 111.894 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -107.2 142.98 36.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.673 1.589 . . . . 0.0 110.453 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.16 130.11 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.979 1.311 . . . . 0.0 108.378 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.2 mt -113.58 122.08 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.237 1.015 . . . . 0.0 109.437 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -95.62 128.35 42.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.312 1.445 . . . . 0.0 110.16 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.87 112.97 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.902 1.281 . . . . 0.0 108.993 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -126.37 132.95 51.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.106 1.363 . . . . 0.0 111.451 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -129.68 128.31 42.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.102 1.761 . . . . 0.0 109.729 -177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.19 43.51 26.13 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.22 1.008 . . . . 0.0 113.049 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.0 t0 74.47 7.85 4.5 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.977 2.511 . . . . 0.0 114.806 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -121.96 132.44 54.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.17 1.388 . . . . 0.0 111.234 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 126.64 29.27 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 120.907 -1.12 . . . . 0.0 110.97 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.5 m -80.67 160.88 65.87 Favored Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 119.335 0.971 . . . . 0.0 112.097 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -53.23 137.68 63.67 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.689 2.926 . . . . 0.0 113.419 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.93 13.59 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.99 1.281 . . . . 0.0 114.213 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 14.2 t -76.86 142.94 70.21 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 118.42 1.11 . . . . 0.0 111.041 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 144.7 81.8 Favored 'Cis proline' 0 C--N 1.353 0.778 0 CA-C-N 120.002 1.036 . . . . 0.0 111.971 -2.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.79 120.02 36.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.537 1.135 . . . . 0.0 110.42 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 68.3 m -91.05 123.58 34.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.08 0.952 . . . . 0.0 110.449 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 115.38 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.504 1.521 . . . . 0.0 109.996 -166.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.9 tttt -77.81 120.52 22.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.02 0.528 . . . . 0.0 111.239 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.5 t -107.38 119.26 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.073 1.349 . . . . 0.0 109.014 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.8 t -106.42 162.83 13.35 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.768 1.227 . . . . 0.0 111.87 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 127.23 168.3 12.49 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.773 1.654 . . . . 0.0 113.565 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.34 -14.59 32.8 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.419 1.088 . . . . 0.0 113.85 -168.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 83.61 152.46 13.37 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.519 1.057 . . . . 0.0 112.473 -170.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -71.89 137.86 47.75 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.965 0.906 . . . . 0.0 112.226 -173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 12.7 p -163.52 147.31 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.323 1.849 . . . . 0.0 110.54 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.193 1.797 . . . . 0.0 111.277 177.968 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.455 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.29 152.51 43.19 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.263 1.025 . . . . 0.0 112.713 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 64.3 ttp -164.12 -56.17 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.627 1.571 . . . . 0.0 111.124 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -99.77 169.23 22.0 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.418 1.485 . . . . 0.0 112.962 173.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -161.33 146.39 13.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.001 1.721 . . . . 0.0 111.046 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -102.5 149.52 24.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.18 1.392 . . . . 0.0 112.685 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 16.4 m -72.33 -21.16 61.37 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 19.2 mmt -72.19 120.6 18.02 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.808 0.843 . . . . 0.0 111.095 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.27 149.83 33.49 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.439 1.096 . . . . 0.0 109.025 166.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 1.9 mmm -127.15 128.83 46.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.894 1.278 . . . . 0.0 111.29 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 15.4 m -130.85 146.35 52.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.868 1.667 . . . . 0.0 109.443 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -155.83 159.32 39.29 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1963 ' ' LEU . . . . . 0.449 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -159.65 154.19 24.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.573 1.949 . . . . 0.0 110.317 -170.166 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1964 ' ' LYS . . . . . 0.449 ' H ' HD13 ' A' 1963 ' ' LEU . 95.5 mttt -135.7 144.27 45.84 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.906 1.282 . . . . 0.0 111.714 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 32.5 m -143.0 151.35 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.89 1.276 . . . . 0.0 111.465 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.32 147.36 20.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.409 1.004 . . . . 0.0 112.133 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 26.3 m -136.12 147.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.158 1.383 . . . . 0.0 112.088 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.27 154.69 23.66 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -85.49 161.09 19.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.893 1.277 . . . . 0.0 111.583 167.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.9 135.43 36.43 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.1 mt -125.25 124.0 25.23 Favored Pre-proline 0 N--CA 1.482 1.125 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.69 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.45 133.17 11.64 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.893 2.396 . . . . 0.0 111.464 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 32.4 mt -149.5 143.78 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.046 2.138 . . . . 0.0 107.798 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.1 t30 60.89 45.0 10.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.645 1.178 . . . . 0.0 110.789 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 25.7 mm -43.79 -56.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.826 2.45 . . . . 0.0 115.04 -147.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 49.6 m -105.32 0.88 27.46 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.881 0.872 . . . . 0.0 113.335 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -95.09 74.6 3.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.496 1.518 . . . . 0.0 109.617 -171.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 44.3 p -71.87 22.24 0.05 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.767 2.427 . . . . 0.0 115.59 -168.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.9 t0 -91.19 60.47 4.25 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.893 1.677 . . . . 0.0 111.298 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -21.7 66.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.71 1.204 . . . . 0.0 113.17 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 18.4 m -61.76 -17.71 57.04 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.404 1.482 . . . . 0.0 114.777 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.4 pp -122.63 14.63 10.2 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.33 1.452 . . . . 0.0 113.745 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.19 145.77 26.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 111.588 173.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 29.3 p -146.21 146.77 30.92 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.372 1.869 . . . . 0.0 109.674 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -143.75 149.89 37.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 36.5 p -141.16 140.97 34.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.912 2.085 . . . . 0.0 109.532 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -95.41 133.78 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.718 0.807 . . . . 0.0 109.834 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.7 t -102.17 110.28 62.15 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 107.967 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.74 170.88 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.943 3.096 . . . . 0.0 110.972 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -15.58 49.67 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.002 2.468 . . . . 0.0 113.478 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 79.5 p -80.74 -11.21 59.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.224 . . . . 0.0 113.947 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.21 -1.76 86.26 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.606 1.574 . . . . 0.0 114.973 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -76.83 83.22 3.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.462 1.505 . . . . 0.0 111.626 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.66 134.44 57.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.75 1.22 . . . . 0.0 112.291 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -140.69 149.47 56.88 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.329 1.452 . . . . 0.0 111.615 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.81 153.53 42.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.876 3.051 . . . . 0.0 112.878 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 73.0 m -97.14 156.3 16.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.913 1.285 . . . . 0.0 112.041 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 61.6 tp -87.06 131.46 34.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 0.0 108.744 162.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -97.2 143.48 27.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.55 1.14 . . . . 0.0 110.297 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.8 146.42 34.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.791 1.236 . . . . 0.0 113.476 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -93.49 120.06 33.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.682 1.193 . . . . 0.0 107.903 156.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.71 170.92 9.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.977 -170.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -64.71 -29.27 70.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.026 1.73 . . . . 0.0 114.276 -164.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.2 t30 -86.04 -1.88 57.78 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.653 1.181 . . . . 0.0 113.21 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.95 -2.0 63.66 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.806 1.67 . . . . 0.0 114.531 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 165.81 15.89 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.497 1.519 . . . . 0.0 113.665 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 43.8 t -89.29 145.1 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.045 1.738 . . . . 0.0 110.596 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.0 -173.67 28.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.44 168.22 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.634 . . . . 0.0 112.61 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.4 m -139.06 158.07 44.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.527 1.931 . . . . 0.0 111.107 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -161.71 -174.05 4.03 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.837 2.055 . . . . 0.0 109.704 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 60.1 t -132.19 120.22 17.03 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 119.504 1.047 . . . . 0.0 110.119 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.11 134.57 13.11 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.189 3.259 . . . . 0.0 110.408 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -95.25 -10.18 31.07 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -143.52 174.09 11.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.941 2.097 . . . . 0.0 109.847 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.4 p -85.21 167.75 15.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.683 1.193 . . . . 0.0 111.593 171.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.67 -168.59 21.69 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.163 1.363 . . . . 0.0 114.047 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -73.52 119.04 17.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.082 0.953 . . . . 0.0 111.967 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.0 m80 -109.22 143.24 38.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.583 1.953 . . . . 0.0 109.172 169.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.58 126.07 52.1 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.28 1.032 . . . . 0.0 109.869 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 33.2 t -90.27 111.71 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.644 1.178 . . . . 0.0 108.268 168.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -90.08 136.73 32.87 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.216 1.006 . . . . 0.0 109.76 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 6.8 p -143.99 127.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 121.958 0.885 . . . . 0.0 112.208 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -110.44 135.43 51.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.802 2.041 . . . . 0.0 111.464 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.7 119.77 39.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.097 2.159 . . . . 0.0 109.166 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 56.02 -102.62 0.16 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.011 1.325 . . . . 0.0 111.089 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -112.22 8.59 26.9 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.657 1.599 . . . . 0.0 115.603 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -144.02 151.82 40.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.748 1.774 . . . . 0.0 112.608 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -66.42 144.49 56.49 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.872 -1.143 . . . . 0.0 112.869 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 147.49 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.46 1.104 . . . . 0.0 109.368 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -56.68 -31.05 64.06 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 15.2 m -84.37 -8.2 59.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.003 1.321 . . . . 0.0 113.982 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 23.2 t -82.49 141.42 45.39 Favored Pre-proline 0 CA--C 1.547 0.844 0 O-C-N 120.784 -1.198 . . . . 0.0 112.543 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.92 147.23 83.11 Favored 'Cis proline' 0 C--N 1.353 0.767 0 CA-C-N 119.317 0.792 . . . . 0.0 112.315 -4.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -94.85 118.78 66.68 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.038 1.335 . . . . 0.0 108.619 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.58 140.55 13.35 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.971 2.447 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.6 t -135.79 127.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.952 1.701 . . . . 0.0 107.962 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.0 t -100.29 122.02 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.796 0.838 . . . . 0.0 110.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.81 128.75 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.116 1.366 . . . . 0.0 109.993 -174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.8 t -94.53 172.89 7.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.651 1.18 . . . . 0.0 111.703 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -68.78 -33.55 74.06 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.358 -1.464 . . . . 0.0 112.015 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 14.7 m -67.03 -3.43 7.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.77 4.57 10.55 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.619 1.568 . . . . 0.0 113.19 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 41.1 mm -73.96 -26.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.175 0.99 . . . . 0.0 112.309 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 163.05 53.79 0.02 OUTLIER Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.91 91.05 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.012 0.906 . . . . 0.0 111.235 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.62 69.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.822 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -55.4 -23.95 27.45 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.422 1.489 . . . . 0.0 114.242 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -91.08 -9.14 46.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.088 1.355 . . . . 0.0 113.73 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 134.46 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.136 . . . . 0.0 110.033 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.98 157.78 22.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.651 1.58 . . . . 0.0 110.796 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.9 m -146.3 159.09 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.285 1.434 . . . . 0.0 111.022 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.69 174.52 14.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.794 1.238 . . . . 0.0 112.258 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.66 166.51 30.78 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.316 1.436 . . . . 0.0 114.277 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -75.92 -29.4 58.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.508 1.123 . . . . 0.0 113.454 -167.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -72.27 3.96 20.88 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.115 1.341 . . . . 0.0 115.165 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.88 -8.09 41.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 112.339 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.4 -42.45 1.82 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.148 1.379 . . . . 0.0 113.688 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.01 159.9 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -153.47 -177.56 27.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.223 1.392 . . . . 0.0 114.038 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -131.67 151.17 51.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.707 1.603 . . . . 0.0 112.081 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 32.5 p -71.71 -14.63 62.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -112.56 -9.77 13.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.01 157.12 77.91 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 126.238 1.815 . . . . 0.0 110.844 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.52 141.44 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.805 2.337 . . . . 0.0 110.533 169.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 149.37 22.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.587 1.155 . . . . 0.0 109.854 165.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -134.62 147.69 50.25 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.588 0.755 . . . . 0.0 112.545 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.7 p90 -151.64 150.64 30.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.391 1.476 . . . . 0.0 110.636 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.28 140.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.849 1.659 . . . . 0.0 109.287 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.88 134.55 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.226 1.811 . . . . 0.0 109.049 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.5 t0 -123.99 96.69 5.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.701 . . . . 0.0 110.611 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 7.9 p -95.15 -0.11 53.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.32 2.248 . . . . 0.0 113.172 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -60.15 -38.47 83.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.263 1.025 . . . . 0.0 112.805 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.71 -16.02 57.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.829 1.252 . . . . 0.0 113.319 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -87.38 -2.74 58.84 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.796 1.239 . . . . 0.0 113.865 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 87.16 -122.03 6.03 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.805 1.193 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -113.69 164.67 13.4 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.546 1.538 . . . . 0.0 112.233 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.9 -176.74 26.59 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 169.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -99.0 129.18 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.866 1.222 . . . . 0.0 111.36 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.25 119.43 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 107.863 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.9 t -113.87 141.3 47.52 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.734 1.214 . . . . 0.0 110.108 173.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.1 tt -140.26 132.99 28.99 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.48 1.112 . . . . 0.0 110.331 -163.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.2 m -133.67 133.35 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.642 0.777 . . . . 0.0 111.039 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 55.4 mt -116.63 133.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.282 1.433 . . . . 0.0 108.463 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.39 148.68 44.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.821 0.848 . . . . 0.0 111.381 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 172.84 -163.74 35.64 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.939 0.781 . . . . 0.0 113.87 -172.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.91 -6.4 19.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.045 3.163 . . . . 0.0 114.723 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -155.01 160.9 41.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.084 1.311 . . . . 0.0 113.103 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -59.92 140.93 56.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.988 1.715 . . . . 0.0 111.08 171.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.5 m -132.43 139.54 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.454 0.702 . . . . 0.0 111.389 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.81 102.04 12.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 109.702 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 19.9 mt -80.03 124.2 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -116.43 157.34 25.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.347 1.859 . . . . 0.0 109.929 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 76.6 p -141.28 157.29 45.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.862 1.265 . . . . 0.0 111.165 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -155.05 111.44 3.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.622 1.169 . . . . 0.0 110.178 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.6 126.84 31.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.406 1.083 . . . . 0.0 110.564 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.77 159.85 14.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 111.883 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.34 -22.07 66.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.164 0.986 . . . . 0.0 113.368 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 28.1 t0 -83.44 -0.5 50.34 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.903 1.281 . . . . 0.0 113.323 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.13 -1.52 77.42 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.587 1.565 . . . . 0.0 115.068 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.9 p -85.5 158.69 20.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.762 1.625 . . . . 0.0 111.187 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 26.9 t -114.83 121.82 44.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.732 0.813 . . . . 0.0 111.151 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -75.97 140.48 42.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.606 0.763 . . . . 0.0 109.347 163.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -123.26 138.92 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.36 1.864 . . . . 0.0 108.082 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -136.03 149.14 48.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.573 1.549 . . . . 0.0 111.346 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -159.43 147.91 17.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.651 1.18 . . . . 0.0 111.505 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 33.2 t -117.43 107.12 45.53 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.828 0.851 . . . . 0.0 111.019 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.71 150.67 24.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.694 2.929 . . . . 0.0 110.49 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 90.5 m -112.86 -41.75 3.72 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.995 0.918 . . . . 0.0 112.238 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -83.72 140.79 41.01 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.569 0.748 . . . . 0.0 110.151 171.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.15 23.32 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.379 2.72 . . . . 0.0 111.236 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 122.23 -154.03 16.84 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.12 1.343 . . . . 0.0 113.197 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -93.35 131.85 38.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.092 0.957 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -119.87 150.32 40.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.646 1.578 . . . . 0.0 109.763 168.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.43 131.76 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 109.188 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.29 130.28 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.049 1.34 . . . . 0.0 109.427 171.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -110.37 119.98 40.97 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.115 1.366 . . . . 0.0 109.657 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.2 mm -113.29 117.9 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.335 1.054 . . . . 0.0 109.369 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -134.48 131.8 38.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.5 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.71 123.17 39.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 110.054 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.84 32.91 13.17 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.353 1.461 . . . . 0.0 113.986 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.9 t0 84.16 7.45 0.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.746 2.818 . . . . 0.0 114.654 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -113.73 129.42 56.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.531 1.132 . . . . 0.0 111.278 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -65.23 123.16 18.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.384 1.474 . . . . 0.0 110.376 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -75.01 154.53 86.68 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.197 -0.939 . . . . 0.0 110.983 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.18 137.85 68.72 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.424 2.083 . . . . 0.0 111.274 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.34 -26.74 22.5 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.325 1.44 . . . . 0.0 113.304 -171.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 67.8 m -70.25 150.17 95.95 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 118.895 1.347 . . . . 0.0 112.103 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.98 147.66 83.81 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 119.08 0.707 . . . . 0.0 110.836 -7.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.08 118.78 36.6 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.836 0.854 . . . . 0.0 110.853 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 46.4 m -87.09 125.31 34.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.121 0.968 . . . . 0.0 111.202 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -117.9 122.37 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.927 1.691 . . . . 0.0 109.542 -173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 59.8 tttp -86.86 111.58 20.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.201 0.601 . . . . 0.0 110.781 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 95.8 t -97.31 117.04 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.51 1.124 . . . . 0.0 108.814 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.3 t -94.12 151.92 19.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.964 0.906 . . . . 0.0 111.222 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 173.65 150.85 7.79 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.978 0.799 . . . . 0.0 114.549 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.47 -3.11 21.3 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.219 1.407 . . . . 0.0 113.678 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 88.67 140.11 7.18 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.461 1.505 . . . . 0.0 112.803 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -83.87 152.07 24.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.514 1.125 . . . . 0.0 112.66 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 93.9 t -91.66 134.67 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.294 1.438 . . . . 0.0 109.232 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.013 1.325 . . . . 0.0 112.329 179.494 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.64 160.49 32.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.405 1.082 . . . . 0.0 112.773 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -73.33 -22.81 60.23 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -96.74 166.12 23.65 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.633 1.587 . . . . 0.0 113.089 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -78.0 -11.74 59.93 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.798 1.239 . . . . 0.0 113.44 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.4 t0 -152.7 163.95 38.69 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.205 1.802 . . . . 0.0 111.648 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 41.8 m -70.09 171.53 9.46 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.854 1.662 . . . . 0.0 113.905 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 94.4 mtp -60.41 148.22 38.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.177 0.991 . . . . 0.0 112.957 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -64.74 135.69 56.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.855 1.262 . . . . 0.0 110.822 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 17.8 ptm -145.34 142.85 29.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.722 1.209 . . . . 0.0 112.627 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 66.8 m -109.34 154.87 21.92 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 110.273 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -149.63 160.56 43.4 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 152.23 27.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.282 1.833 . . . . 0.0 109.952 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -134.51 143.62 47.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.566 1.146 . . . . 0.0 111.992 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 67.5 t -140.93 132.03 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.909 1.684 . . . . 0.0 109.666 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.24 117.93 4.52 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 40.8 m -80.48 -42.79 21.94 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 59.26 -170.17 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.639 1.576 . . . . 0.0 113.278 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -148.0 147.94 30.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.331 1.453 . . . . 0.0 110.132 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -88.55 133.01 34.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.072 0.949 . . . . 0.0 112.2 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.5 mt -127.62 119.01 21.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 125.093 1.357 . . . . 0.0 109.049 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.07 135.65 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.926 2.417 . . . . 0.0 110.627 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.9 mt -146.08 139.35 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.865 1.666 . . . . 0.0 108.468 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 45.2 t30 63.69 76.57 0.35 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.758 1.623 . . . . 0.0 110.915 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.1 mm -84.75 63.44 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.266 1.426 . . . . 0.0 110.073 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 t -162.76 -178.58 6.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 111.19 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -73.7 125.8 28.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.253 1.021 . . . . 0.0 110.695 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 2.4 m -165.09 137.9 4.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.357 2.263 . . . . 0.0 108.683 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.18 131.49 38.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.716 1.206 . . . . 0.0 111.173 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 1.7 mt -85.23 -13.81 48.73 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -173.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 47.7 m -82.19 -26.78 33.05 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.772 1.169 . . . . 0.0 112.781 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.93 6.26 49.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.268 1.427 . . . . 0.0 113.321 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.91 143.29 31.98 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 0.0 110.666 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 37.6 p -144.03 160.65 40.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.358 1.863 . . . . 0.0 110.365 172.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -157.33 152.6 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.183 0.993 . . . . 0.0 113.214 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -138.0 164.6 28.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.976 2.11 . . . . 0.0 109.747 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -119.56 136.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.353 1.461 . . . . 0.0 110.056 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 96.1 t -104.9 115.6 62.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.33 1.452 . . . . 0.0 108.567 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.91 173.04 10.5 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.987 3.124 . . . . 0.0 111.521 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.43 -33.21 55.82 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 124.343 3.362 . . . . 0.0 113.971 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 17.9 m -73.38 -10.35 59.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.665 1.186 . . . . 0.0 114.038 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.47 -3.48 67.67 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.635 1.588 . . . . 0.0 115.148 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.3 mmm-85 -79.86 90.08 5.29 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.256 1.422 . . . . 0.0 110.772 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.08 136.93 57.7 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.477 1.111 . . . . 0.0 112.117 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -137.05 151.82 72.71 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.576 1.55 . . . . 0.0 111.249 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.88 155.66 38.98 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.672 2.915 . . . . 0.0 112.871 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 87.5 m -100.91 158.89 15.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.889 1.276 . . . . 0.0 112.238 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.9 tt -93.11 121.79 34.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.75 1.22 . . . . 0.0 108.083 167.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.48 141.67 28.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.662 1.185 . . . . 0.0 111.082 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 94.5 mttt -143.3 149.63 38.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.597 1.159 . . . . 0.0 112.978 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -93.77 116.17 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 157.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 88.3 mt -89.24 165.93 14.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.816 0.846 . . . . 0.0 111.519 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -59.69 -25.47 64.79 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 30.1 m120 -77.32 -9.32 58.76 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 96.78 -12.88 65.76 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.099 1.809 . . . . 0.0 114.301 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.05 161.89 26.26 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.565 1.182 . . . . 0.0 113.416 174.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -80.69 148.66 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 109.337 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.85 176.82 30.84 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.274 0.94 . . . . 0.0 114.054 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.53 164.74 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.425 1.49 . . . . 0.0 111.704 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 86.0 p -143.54 152.97 42.09 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 111.964 165.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 13.3 p90 -161.63 173.03 15.31 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.739 2.016 . . . . 0.0 110.656 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 96.9 t -122.69 119.84 28.0 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.446 1.098 . . . . 0.0 109.816 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.4 151.59 22.94 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.754 3.636 . . . . 0.0 111.519 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 13.6 mptt -107.36 -6.22 17.28 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.214 1.006 . . . . 0.0 113.023 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -138.57 167.67 21.44 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.51 1.924 . . . . 0.0 110.639 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.2 p -90.14 165.13 14.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.825 1.25 . . . . 0.0 111.063 168.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.17 -170.79 29.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.077 1.322 . . . . 0.0 113.727 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -71.22 115.94 10.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.185 0.994 . . . . 0.0 112.119 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.9 m80 -100.48 146.58 26.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.007 1.723 . . . . 0.0 109.065 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.53 127.71 54.18 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.119 0.968 . . . . 0.0 109.81 174.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 25.0 t -90.68 123.21 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.664 1.186 . . . . 0.0 108.203 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -105.26 131.52 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.336 . . . . 0.0 110.196 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 21.5 t -130.64 133.36 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.853 0.861 . . . . 0.0 111.101 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -127.6 135.94 50.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.468 1.907 . . . . 0.0 111.591 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -128.75 123.2 32.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.164 2.186 . . . . 0.0 110.192 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.5 t30 55.94 29.28 13.96 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.154 1.381 . . . . 0.0 113.89 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.49 4.75 65.71 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.966 1.27 . . . . 0.0 115.855 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.45 155.88 49.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.406 1.603 . . . . 0.0 111.618 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 67.4 m80 -65.22 143.26 57.94 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.794 -1.191 . . . . 0.0 113.166 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 74.0 t -71.42 142.65 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.438 1.095 . . . . 0.0 109.459 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.01 67.52 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.7 m -81.57 -7.7 59.62 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.968 1.307 . . . . 0.0 113.938 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.1 t -82.92 141.96 44.41 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 120.804 -1.185 . . . . 0.0 112.581 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.07 154.26 86.47 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.646 0.909 . . . . 0.0 112.579 -3.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.39 122.12 46.19 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.483 1.513 . . . . 0.0 108.656 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.16 142.93 12.44 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.11 2.54 . . . . 0.0 111.634 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.9 123.71 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.441 1.497 . . . . 0.0 108.269 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.6 t -99.29 124.52 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.754 0.822 . . . . 0.0 110.172 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.75 128.1 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.997 1.319 . . . . 0.0 109.553 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 60.8 m -100.51 156.34 17.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.108 0.963 . . . . 0.0 111.975 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -56.25 -35.4 67.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.789 1.236 . . . . 0.0 114.168 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 37.0 m -73.72 -12.6 60.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.751 0.82 . . . . 0.0 113.021 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.64 -6.3 52.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.816 1.246 . . . . 0.0 112.628 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 43.0 mm -73.42 -31.93 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.218 0.917 . . . . 0.0 112.494 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 160.93 55.08 0.02 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.48 100.85 10.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.855 0.827 . . . . 0.0 110.315 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.39 -32.61 71.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.74 1.216 . . . . 0.0 113.667 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.55 -21.56 27.26 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.486 1.515 . . . . 0.0 114.027 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.58 -9.94 50.48 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.466 1.506 . . . . 0.0 113.934 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.9 t -79.78 125.96 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 119.949 1.249 . . . . 0.0 111.327 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -105.17 156.04 18.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.644 1.577 . . . . 0.0 110.991 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -147.88 159.17 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.624 1.569 . . . . 0.0 110.861 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.6 t -161.4 177.54 10.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.687 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 100.07 160.63 28.45 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.444 1.497 . . . . 0.0 114.26 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -67.07 -33.14 74.85 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.187 1.395 . . . . 0.0 113.116 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.04 -3.49 36.96 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.05 1.31 . . . . 0.0 115.344 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.69 -7.39 56.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.032 1.333 . . . . 0.0 112.855 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -128.38 -36.01 1.93 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.778 1.231 . . . . 0.0 113.845 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -159.73 157.39 29.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.599 1.16 . . . . 0.0 112.477 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.09 -176.58 24.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.715 1.15 . . . . 0.0 114.106 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -135.43 147.12 48.86 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.887 1.275 . . . . 0.0 112.473 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 20.9 p -67.99 -29.07 68.0 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -112.02 5.81 18.95 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -141.28 154.64 67.65 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.42 1.488 . . . . 0.0 111.068 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.42 136.89 27.12 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.71 2.274 . . . . 0.0 110.738 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -95.82 118.54 32.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.727 1.211 . . . . 0.0 110.146 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -98.29 147.57 24.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.136 0.975 . . . . 0.0 113.369 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.33 153.78 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.253 1.421 . . . . 0.0 111.241 173.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.72 140.08 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.679 1.591 . . . . 0.0 109.456 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.3 mt -114.77 130.66 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.56 1.944 . . . . 0.0 108.901 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.4 t0 -119.55 84.17 2.16 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.603 1.561 . . . . 0.0 110.569 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 3.3 p -84.97 -5.84 59.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.774 2.03 . . . . 0.0 113.288 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -56.03 -40.58 73.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.479 1.036 . . . . 0.0 111.676 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.06 -9.95 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.404 1.482 . . . . 0.0 113.329 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -98.2 0.12 45.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.132 1.773 . . . . 0.0 114.333 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 82.99 -134.04 12.48 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.252 0.93 . . . . 0.0 111.016 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.59 171.49 9.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.758 1.223 . . . . 0.0 112.292 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.87 177.81 19.99 Favored Glycine 0 N--CA 1.472 1.074 0 C-N-CA 124.414 1.006 . . . . 0.0 114.951 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -106.63 131.71 10.78 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.551 1.548 . . . . 0.0 111.815 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.92 121.56 41.95 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.721 2.008 . . . . 0.0 108.913 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 74.8 m -112.56 143.9 42.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.979 1.712 . . . . 0.0 110.266 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.8 tt -143.86 137.4 27.9 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.767 0.827 . . . . 0.0 110.502 -166.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 62.7 m -138.7 135.08 34.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.73 0.812 . . . . 0.0 111.371 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 23.9 mt -122.29 134.56 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.264 1.426 . . . . 0.0 109.13 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.28 154.64 44.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 111.258 -174.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.59 21.29 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.785 -1.008 . . . . 0.0 114.052 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.69 -14.73 36.74 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.029 3.153 . . . . 0.0 114.976 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.3 t -159.16 165.74 33.03 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.955 1.252 . . . . 0.0 112.419 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.01 148.34 51.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.961 1.304 . . . . 0.0 111.775 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 35.9 m -135.12 147.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.562 1.145 . . . . 0.0 112.293 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -88.51 104.38 16.76 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.759 0.824 . . . . 0.0 110.19 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 39.6 mt -84.98 130.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.871 0.868 . . . . 0.0 109.742 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -128.14 155.46 44.4 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.305 1.842 . . . . 0.0 110.333 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.59 156.5 46.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.964 1.306 . . . . 0.0 111.625 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.27 125.83 5.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.983 1.313 . . . . 0.0 110.275 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.64 133.5 36.4 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.335 -0.853 . . . . 0.0 111.199 171.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 50.5 mt -96.19 160.77 14.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.67 1.188 . . . . 0.0 111.732 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.45 -20.68 66.47 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 0.0 113.291 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.62 -3.69 56.55 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.094 1.358 . . . . 0.0 113.274 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.29 -2.94 75.43 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.611 1.577 . . . . 0.0 114.848 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 46.5 p -82.47 167.96 17.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.554 1.542 . . . . 0.0 111.14 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -116.24 127.56 54.86 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.845 0.858 . . . . 0.0 111.196 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -90.86 137.66 32.19 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.703 1.201 . . . . 0.0 109.937 170.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 25.3 t -122.59 138.27 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.4 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.3 p -136.16 151.85 50.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.415 1.486 . . . . 0.0 110.948 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 11.7 p90 -161.27 145.5 13.3 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.427 1.491 . . . . 0.0 110.515 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 25.0 t -107.01 103.41 47.63 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.58 0.752 . . . . 0.0 110.722 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -78.26 110.78 2.93 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.358 2.705 . . . . 0.0 110.128 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.9 m -69.22 -37.98 78.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.647 0.779 . . . . 0.0 112.341 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.29 146.39 34.59 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.035 1.334 . . . . 0.0 111.447 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.37 168.06 25.37 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.275 2.65 . . . . 0.0 111.1 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 114.76 -163.98 12.13 Favored Glycine 0 N--CA 1.472 1.036 0 C-N-CA 125.172 1.368 . . . . 0.0 113.402 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 54.0 t30 -89.89 120.17 30.89 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.9 -0.764 . . . . 0.0 112.174 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.33 143.43 30.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.117 1.367 . . . . 0.0 110.904 164.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.28 134.63 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.926 1.29 . . . . 0.0 108.82 174.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 29.0 mt -116.32 132.95 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.288 1.435 . . . . 0.0 109.521 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -114.17 125.51 54.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.018 1.727 . . . . 0.0 109.904 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.54 124.83 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.974 0.91 . . . . 0.0 109.638 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 31.1 tttt -132.39 127.12 34.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.142 1.377 . . . . 0.0 110.482 -171.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 37.3 t80 -123.8 124.76 43.39 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.12 0.968 . . . . 0.0 110.064 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.99 49.2 17.4 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.469 1.107 . . . . 0.0 111.773 -173.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.84 13.83 9.57 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.373 2.269 . . . . 0.0 114.624 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -119.48 126.8 52.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.104 1.362 . . . . 0.0 110.258 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -65.29 121.58 15.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.616 1.167 . . . . 0.0 111.055 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -79.14 158.69 74.27 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 121.288 -0.883 . . . . 0.0 111.784 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.18 138.07 71.2 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.517 2.811 . . . . 0.0 112.909 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 92.63 -23.24 29.21 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.964 1.268 . . . . 0.0 114.343 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 72.4 m -74.56 149.96 86.52 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 118.916 1.358 . . . . 0.0 111.64 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.52 145.86 80.91 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 119.326 0.795 . . . . 0.0 111.442 -3.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -98.85 120.43 39.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.54 1.136 . . . . 0.0 110.772 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 45.9 m -86.86 133.02 33.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.131 0.972 . . . . 0.0 110.988 171.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 17.2 t -129.93 111.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.63 1.572 . . . . 0.0 109.471 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -81.57 109.58 16.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.015 0.526 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 60.4 t -91.26 127.1 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.131 1.372 . . . . 0.0 109.328 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -117.9 161.94 18.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.739 1.216 . . . . 0.0 112.186 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 129.22 163.29 11.17 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.965 1.745 . . . . 0.0 113.45 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.66 162.44 9.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.06 1.744 . . . . 0.0 110.291 -171.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 87.45 32.71 12.9 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.296 0.95 . . . . 0.0 113.554 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -65.7 99.18 0.43 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.086 1.355 . . . . 0.0 111.45 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 91.2 t -145.07 142.0 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 126.932 2.093 . . . . 0.0 108.99 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 C--O 1.254 1.324 0 C-N-CA 125.781 1.633 . . . . 0.0 111.276 177.146 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -158.38 163.83 36.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.648 1.579 . . . . 0.0 111.985 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -76.65 -11.94 59.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.149 1.38 . . . . 0.0 113.728 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 90.48 171.23 43.88 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.567 1.556 . . . . 0.0 113.704 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -158.8 151.1 21.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.95 1.7 . . . . 0.0 111.384 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.22 -18.91 48.2 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -175.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 8.6 t -79.38 142.2 36.21 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.956 -1.09 . . . . 0.0 113.777 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 81.0 mmm -79.93 119.64 23.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.758 1.223 . . . . 0.0 109.929 172.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.37 139.11 30.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.049 0.94 . . . . 0.0 112.058 -171.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 96.9 mtp -89.18 133.03 34.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.428 1.491 . . . . 0.0 112.407 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 18.4 m -118.27 140.59 49.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 108.465 160.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -156.51 158.42 37.16 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.0 tt -161.04 154.64 22.04 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.43 1.892 . . . . 0.0 111.131 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.51 151.34 47.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.002 1.321 . . . . 0.0 112.559 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 52.6 t -139.69 133.98 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.022 1.729 . . . . 0.0 109.458 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -92.5 128.41 9.39 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.885 0.755 . . . . 0.0 111.25 172.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 66.1 m -118.92 144.91 46.17 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.412 1.085 . . . . 0.0 112.53 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.01 151.98 24.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.0 112.357 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.5 149.66 24.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.064 0.946 . . . . 0.0 110.75 166.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.33 134.05 34.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.539 0.735 . . . . 0.0 111.572 169.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.8 mm -112.89 127.48 26.78 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.495 1.518 . . . . 0.0 108.74 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.7 134.31 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.908 2.405 . . . . 0.0 110.478 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 29.9 mm -144.87 140.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.387 1.475 . . . . 0.0 110.293 -168.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.59 55.54 7.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.786 1.634 . . . . 0.0 112.905 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.4 mm -65.76 112.55 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.478 1.111 . . . . 0.0 110.516 -172.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 99.8 p -173.9 172.6 3.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.276 1.43 . . . . 0.0 111.849 -170.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.08 4.82 9.35 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.932 1.693 . . . . 0.0 113.623 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 56.8 m -61.95 134.85 57.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 111.472 -174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.67 132.98 46.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.439 1.496 . . . . 0.0 111.633 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.3 mp -73.76 -21.16 60.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.027 0.931 . . . . 0.0 112.425 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 24.0 m -67.58 -23.46 65.4 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -167.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -114.21 8.95 17.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.35 1.46 . . . . 0.0 113.609 175.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.66 148.09 25.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.026 1.33 . . . . 0.0 111.997 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 47.3 p -141.39 169.65 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.261 2.224 . . . . 0.0 108.974 168.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.42 155.24 37.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 54.6 p -132.25 160.82 35.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.082 2.153 . . . . 0.0 109.153 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -112.8 135.27 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.073 0.949 . . . . 0.0 109.449 166.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.0 t -104.68 113.13 65.25 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.968 1.307 . . . . 0.0 108.196 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.32 173.44 11.65 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.999 3.133 . . . . 0.0 111.128 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.72 -32.69 56.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.127 3.218 . . . . 0.0 113.961 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.5 m -75.65 -4.53 40.69 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 0.0 114.12 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 74.86 -1.76 52.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.286 1.422 . . . . 0.0 115.15 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -77.21 85.56 3.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.516 1.526 . . . . 0.0 111.243 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.09 133.01 54.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.854 1.262 . . . . 0.0 111.929 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -140.58 150.64 61.16 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.174 1.39 . . . . 0.0 111.277 176.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.64 155.55 40.01 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.271 3.314 . . . . 0.0 112.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.2 m -111.28 155.35 23.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.547 1.539 . . . . 0.0 112.207 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 6.2 tt -95.29 116.72 29.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.419 1.488 . . . . 0.0 108.671 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 11.2 mp -84.6 138.11 32.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.476 1.11 . . . . 0.0 111.352 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -133.44 136.17 45.02 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.041 1.336 . . . . 0.0 112.803 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.7 121.73 26.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 152.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.5 162.23 13.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.479 1.112 . . . . 0.0 112.013 -171.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -60.36 -31.65 70.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -86.27 -1.82 57.83 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.971 0.909 . . . . 0.0 113.439 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.62 0.35 57.87 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.504 1.526 . . . . 0.0 114.095 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -80.87 177.31 9.13 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.119 1.368 . . . . 0.0 112.863 170.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 88.6 t -130.15 140.51 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 109.617 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.04 -174.54 25.97 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.61 154.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.613 1.565 . . . . 0.0 111.946 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 16.4 m -121.38 149.59 42.74 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.15 1.38 . . . . 0.0 111.198 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.2 p90 -165.64 -178.87 5.07 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.101 2.16 . . . . 0.0 109.752 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.9 t -128.88 122.44 21.42 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-N 119.258 0.935 . . . . 0.0 109.95 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.81 149.56 23.27 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.115 3.21 . . . . 0.0 111.369 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -106.27 -9.57 16.77 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -143.25 173.63 11.42 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.858 2.063 . . . . 0.0 110.11 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.5 p -88.77 167.35 13.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.656 1.182 . . . . 0.0 111.117 167.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.65 -168.08 30.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.801 1.191 . . . . 0.0 113.57 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.05 116.98 11.98 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.05 0.94 . . . . 0.0 112.005 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.8 m80 -102.58 141.0 36.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.974 1.71 . . . . 0.0 109.042 167.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.86 123.26 44.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.055 0.942 . . . . 0.0 109.229 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.1 t -87.76 113.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.987 1.315 . . . . 0.0 107.811 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -95.21 126.21 40.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.525 1.13 . . . . 0.0 110.225 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 81.3 t -117.71 120.14 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.996 1.319 . . . . 0.0 109.769 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -108.82 130.48 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.97 1.708 . . . . 0.0 111.72 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -108.74 122.94 48.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.545 1.938 . . . . 0.0 109.356 171.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 57.25 -94.27 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.064 1.346 . . . . 0.0 111.72 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -123.37 9.5 8.8 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.863 1.697 . . . . 0.0 115.777 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.6 157.02 43.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.743 1.771 . . . . 0.0 112.393 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -67.34 138.61 56.91 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.888 -1.133 . . . . 0.0 112.783 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 5.9 p -71.44 156.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.389 1.076 . . . . 0.0 110.675 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.06 -28.44 62.58 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.0 m -80.47 -9.65 59.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.942 1.297 . . . . 0.0 114.162 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 31.9 t -90.78 147.56 36.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.9 1.28 . . . . 0.0 113.198 -172.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.26 162.28 76.76 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.26 0.771 . . . . 0.0 112.677 -5.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.01 126.38 28.32 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.685 1.594 . . . . 0.0 109.04 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.66 142.27 12.75 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.117 2.544 . . . . 0.0 112.031 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.9 t -135.87 127.75 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.593 1.557 . . . . 0.0 107.869 170.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 53.9 t -100.39 126.53 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.853 0.861 . . . . 0.0 110.49 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.29 130.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.138 1.375 . . . . 0.0 110.169 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 65.9 m -98.15 156.92 16.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.52 1.128 . . . . 0.0 112.087 174.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -58.52 -30.01 66.75 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 8.7 m -65.34 -19.29 65.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.6 1.16 . . . . 0.0 113.739 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -93.46 -12.17 30.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.713 1.205 . . . . 0.0 112.955 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.7 -24.81 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.659 1.184 . . . . 0.0 112.576 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 134.73 68.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.291 1.424 . . . . 0.0 112.84 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.96 105.79 10.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.262 0.531 . . . . 0.0 110.007 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.49 66.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.841 0.856 . . . . 0.0 112.307 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.1 m -54.18 -23.33 14.04 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.181 1.793 . . . . 0.0 114.468 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -90.9 -12.73 35.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.856 1.262 . . . . 0.0 113.466 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 67.8 t -74.19 133.99 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.625 1.102 . . . . 0.0 109.867 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.55 154.45 24.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 111.171 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.5 m -144.51 150.5 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.471 1.508 . . . . 0.0 110.172 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.7 m -148.12 165.74 29.93 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.91 1.284 . . . . 0.0 112.487 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.48 159.73 24.01 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.517 1.056 . . . . 0.0 114.416 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -71.59 -25.43 62.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.66 1.184 . . . . 0.0 113.373 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.89 -5.76 41.03 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.264 0.935 . . . . 0.0 114.986 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.25 -2.64 58.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.417 1.487 . . . . 0.0 112.893 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -135.84 -38.72 0.71 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -141.56 151.18 42.99 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.772 1.229 . . . . 0.0 111.831 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.43 -176.7 22.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.144 1.354 . . . . 0.0 113.269 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -147.97 145.72 28.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.173 0.989 . . . . 0.0 113.015 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 24.3 p -60.13 -26.13 66.02 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.711 1.605 . . . . 0.0 115.028 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.77 23.22 9.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.245 1.418 . . . . 0.0 112.93 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -145.49 137.34 13.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.642 1.177 . . . . 0.0 110.315 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -71.27 133.68 23.3 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.536 2.157 . . . . 0.0 110.286 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -102.33 131.35 48.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.436 1.494 . . . . 0.0 110.393 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.42 154.21 35.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.862 1.265 . . . . 0.0 113.325 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.71 153.15 27.98 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.005 1.722 . . . . 0.0 111.024 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.61 142.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.496 1.919 . . . . 0.0 109.9 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.1 132.17 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.815 1.646 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2071 ' ' ASP . . . . . 0.455 ' HA ' HH21 ' A' 2073 ' ' ARG . 31.4 t0 -125.39 86.75 2.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.46 1.504 . . . . 0.0 111.732 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 16.4 p -83.43 -8.92 59.3 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.422 1.889 . . . . 0.0 113.657 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2073 ' ' ARG . . . . . 0.455 HH21 ' HA ' ' A' 2071 ' ' ASP . 0.5 OUTLIER -60.89 -30.32 70.09 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.7 1.137 . . . . 0.0 113.616 -175.425 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.94 -15.58 60.68 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.94 0.896 . . . . 0.0 113.231 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -97.5 -1.63 43.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.95 1.7 . . . . 0.0 114.208 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.78 -128.39 8.55 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.651 1.119 . . . . 0.0 112.296 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -94.22 160.28 14.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.413 1.485 . . . . 0.0 112.234 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.8 174.09 19.38 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.34 126.36 8.72 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.868 1.223 . . . . 0.0 111.852 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.9 123.14 41.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.705 2.002 . . . . 0.0 108.576 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.9 t -116.39 140.51 49.27 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.04 1.336 . . . . 0.0 110.402 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.86 131.0 30.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.663 1.185 . . . . 0.0 110.284 -167.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 56.9 m -135.16 131.14 36.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.796 0.838 . . . . 0.0 110.72 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 22.5 mt -109.27 125.46 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.549 1.54 . . . . 0.0 108.114 173.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.21 139.0 46.96 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.154 1.382 . . . . 0.0 109.742 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -168.82 -175.92 38.6 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -8.58 23.93 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.471 3.447 . . . . 0.0 113.825 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.1 t -154.83 164.84 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.754 1.222 . . . . 0.0 111.875 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.75 146.51 52.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.664 1.186 . . . . 0.0 111.53 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -132.27 141.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.112 0.965 . . . . 0.0 110.822 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.34 125.43 29.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.219 0.608 . . . . 0.0 110.013 169.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 38.4 mt -106.52 127.76 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.94 0.896 . . . . 0.0 108.851 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -124.31 143.68 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 109.854 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 24.9 p -113.74 154.03 28.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.911 1.284 . . . . 0.0 111.248 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.94 120.0 5.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.635 1.174 . . . . 0.0 110.15 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -79.02 123.53 27.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.307 1.043 . . . . 0.0 110.645 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.37 160.12 15.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.104 0.962 . . . . 0.0 111.975 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.6 -25.82 68.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.109 0.963 . . . . 0.0 112.333 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.13 -8.52 50.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.998 1.719 . . . . 0.0 113.777 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.59 -5.48 84.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.768 1.651 . . . . 0.0 114.304 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 25.0 p -82.93 161.41 21.84 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.943 1.697 . . . . 0.0 111.471 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 33.8 t -102.88 123.33 46.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.677 0.791 . . . . 0.0 110.255 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.05 138.2 33.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.867 0.867 . . . . 0.0 109.296 163.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 56.7 t -119.95 133.84 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.059 1.744 . . . . 0.0 108.169 168.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 67.6 m -136.92 138.3 40.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.853 1.261 . . . . 0.0 110.517 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.1 p90 -147.99 148.55 30.85 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.277 1.031 . . . . 0.0 112.465 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 23.2 t -109.15 106.84 59.34 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.538 0.735 . . . . 0.0 111.088 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.37 119.17 4.85 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.992 2.461 . . . . 0.0 109.694 171.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -78.86 -43.54 24.83 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.734 0.814 . . . . 0.0 111.614 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -91.31 147.68 36.01 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.551 1.14 . . . . 0.0 110.933 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.99 167.61 26.66 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.558 2.838 . . . . 0.0 111.734 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.78 -161.28 18.19 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.066 1.317 . . . . 0.0 113.768 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -93.79 126.71 39.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.007 0.923 . . . . 0.0 111.541 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -111.29 142.92 42.89 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.567 1.547 . . . . 0.0 109.808 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.45 123.89 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.595 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.29 124.6 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.896 1.278 . . . . 0.0 109.73 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -104.26 128.9 52.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.893 1.677 . . . . 0.0 109.755 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.3 mm -121.88 111.98 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.858 1.263 . . . . 0.0 109.524 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -121.02 130.92 53.99 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.634 1.574 . . . . 0.0 111.098 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -123.53 126.01 45.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.447 1.499 . . . . 0.0 110.328 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.16 28.77 9.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.342 1.457 . . . . 0.0 113.963 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 87.82 6.89 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 129.147 2.979 . . . . 0.0 114.894 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -114.69 138.27 50.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.726 1.21 . . . . 0.0 111.113 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 132.23 51.53 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.165 -0.959 . . . . 0.0 111.143 172.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.1 m -80.4 159.99 68.63 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.529 -0.732 . . . . 0.0 111.516 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.27 136.59 62.81 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.749 2.966 . . . . 0.0 113.354 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 86.04 -19.8 24.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.048 1.309 . . . . 0.0 114.394 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 23.1 t -76.4 144.27 74.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 118.613 1.207 . . . . 0.0 111.451 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.48 150.7 93.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 119.727 0.938 . . . . 0.0 112.283 -3.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.68 122.29 44.74 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.399 1.479 . . . . 0.0 110.733 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.3 p -86.96 135.28 33.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.419 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.3 t -130.93 113.98 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.186 1.395 . . . . 0.0 109.496 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.13 115.68 22.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.113 0.565 . . . . 0.0 111.154 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 91.4 t -98.22 115.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.232 1.413 . . . . 0.0 109.056 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 4.9 t -102.4 173.81 6.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.947 1.299 . . . . 0.0 111.455 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 116.52 -137.29 13.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.094 1.33 . . . . 0.0 112.615 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -145.97 162.59 37.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.768 1.227 . . . . 0.0 112.454 -167.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -69.5 140.39 33.48 Favored Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.473 -0.767 . . . . 0.0 111.891 172.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -67.69 139.15 56.74 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.374 1.07 . . . . 0.0 111.979 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 92.5 t -70.28 131.79 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.767 1.227 . . . . 0.0 110.048 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.234 1.413 . . . . 0.0 112.503 -178.476 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.499 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.5 156.56 36.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.32 1.048 . . . . 0.0 112.859 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.6 ttt -74.85 -27.69 60.37 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.497 1.119 . . . . 0.0 113.003 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 141.43 -174.51 22.88 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.932 1.73 . . . . 0.0 113.226 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.1 t0 -158.09 56.12 0.47 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.47 1.508 . . . . 0.0 110.955 -175.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.43 53.89 1.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.575 1.55 . . . . 0.0 111.193 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 23.2 m -66.77 171.5 5.19 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.423 1.489 . . . . 0.0 113.555 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 38.2 mmt -55.86 127.22 29.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.41 1.084 . . . . 0.0 111.784 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -77.48 151.87 34.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.425 1.09 . . . . 0.0 112.352 -173.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.9 ptt? -70.62 154.24 42.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.438 1.095 . . . . 0.0 112.73 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.0 m -107.59 144.79 34.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.69 1.196 . . . . 0.0 110.117 166.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.31 149.54 51.91 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.561 1.144 . . . . 0.0 113.266 -165.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -157.35 146.24 19.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.066 1.747 . . . . 0.0 110.11 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 48.2 mttp -128.51 149.9 50.4 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.518 1.127 . . . . 0.0 113.0 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.82 139.11 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.32 1.848 . . . . 0.0 109.513 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.96 120.76 5.39 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 4.0 m -111.96 142.74 44.0 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.694 1.197 . . . . 0.0 112.697 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.48 146.0 11.54 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.74 169.35 17.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.977 1.311 . . . . 0.0 111.555 163.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -105.3 137.59 42.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.737 1.215 . . . . 0.0 111.853 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.7 mm -105.27 118.04 56.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.303 1.041 . . . . 0.0 109.02 164.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.13 128.46 10.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.402 2.735 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 57.0 mt -147.44 139.53 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.658 1.583 . . . . 0.0 109.843 -172.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.07 60.26 3.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.803 1.641 . . . . 0.0 112.456 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.4 111.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.44 1.096 . . . . 0.0 111.34 -166.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 m -172.83 146.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.816 2.446 . . . . 0.0 109.33 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.42 -10.16 50.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.77 1.228 . . . . 0.0 113.501 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 24.9 p -91.43 160.3 15.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.338 1.855 . . . . 0.0 112.063 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 60.3 m-20 70.41 3.25 4.39 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.406 2.282 . . . . 0.0 114.679 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.53 -20.86 65.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 113.783 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 28.0 p -77.14 -12.55 59.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 9.74 3.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.179 1.391 . . . . 0.0 114.389 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.95 143.22 34.37 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.207 1.003 . . . . 0.0 110.974 164.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 39.8 p -140.86 160.75 39.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 109.779 173.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.87 150.67 26.24 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.57 0.748 . . . . 0.0 113.013 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 63.6 p -138.8 163.12 33.06 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.977 2.111 . . . . 0.0 109.491 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 137.36 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.911 1.284 . . . . 0.0 109.864 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.1 t -105.6 110.91 64.74 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.111 1.364 . . . . 0.0 108.083 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.57 169.14 20.27 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.893 3.062 . . . . 0.0 110.846 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.16 -15.88 47.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.065 2.51 . . . . 0.0 113.12 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 67.0 p -79.39 -9.3 59.57 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.88 1.272 . . . . 0.0 113.826 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.5 85.21 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.668 1.604 . . . . 0.0 115.185 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -77.61 82.58 4.03 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.374 1.469 . . . . 0.0 111.698 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.83 132.64 54.5 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 111.875 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.06 151.73 59.79 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.405 1.482 . . . . 0.0 111.354 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.9 158.04 34.75 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.951 3.1 . . . . 0.0 112.852 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.9 m -110.18 155.7 21.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.066 1.346 . . . . 0.0 112.457 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.5 tt -99.48 115.23 28.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.82 1.648 . . . . 0.0 108.157 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 4.3 mp -87.08 134.37 33.51 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.578 0.751 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.91 137.23 53.11 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.179 1.392 . . . . 0.0 112.805 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -99.14 124.19 43.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.524 1.529 . . . . 0.0 107.979 161.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.76 171.7 7.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.211 1.404 . . . . 0.0 112.763 -165.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -59.63 -32.19 70.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.33 -2.62 58.51 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.251 1.02 . . . . 0.0 113.446 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.46 -8.4 62.2 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.727 1.632 . . . . 0.0 114.857 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -73.96 168.83 18.69 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.594 1.197 . . . . 0.0 112.975 172.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.3 t -131.26 142.37 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.977 1.311 . . . . 0.0 110.948 -168.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.87 -168.79 20.72 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.846 1.212 . . . . 0.0 113.992 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.72 151.35 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.775 1.23 . . . . 0.0 112.233 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 43.2 m -123.59 155.1 38.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.766 1.626 . . . . 0.0 111.467 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.6 p90 -166.93 -174.68 2.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.497 2.319 . . . . 0.0 109.221 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -128.93 116.23 19.09 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 119.302 0.956 . . . . 0.0 109.706 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.99 139.52 24.41 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.939 3.093 . . . . 0.0 110.574 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -99.96 -6.9 25.85 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.271 1.029 . . . . 0.0 113.08 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -140.16 169.25 18.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.759 2.024 . . . . 0.0 110.363 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 167.11 13.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.277 1.031 . . . . 0.0 110.995 165.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 94.96 -169.3 28.1 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.048 1.309 . . . . 0.0 113.749 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -72.15 118.27 14.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.49 144.16 32.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.351 1.86 . . . . 0.0 109.104 168.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.58 125.95 51.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 0.0 109.642 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 26.3 t -89.35 121.39 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.705 1.202 . . . . 0.0 108.001 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -99.93 128.48 46.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.718 1.207 . . . . 0.0 110.061 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 48.0 t -126.71 131.4 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.595 1.158 . . . . 0.0 110.421 -172.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.9 mttp -123.38 147.58 46.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.734 1.613 . . . . 0.0 112.547 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -118.58 119.83 35.67 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 108.941 169.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.27 30.91 19.22 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.996 1.318 . . . . 0.0 113.247 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.48 2.5 73.11 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.027 1.299 . . . . 0.0 116.052 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -123.59 151.19 43.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.442 1.621 . . . . 0.0 110.999 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.34 144.58 57.06 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 98.2 t -77.63 146.08 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.678 1.191 . . . . 0.0 109.096 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.91 63.57 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -174.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 58.1 p -85.95 -8.05 58.25 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.162 1.385 . . . . 0.0 114.079 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 21.2 t -82.87 144.45 48.09 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.936 1.294 . . . . 0.0 112.358 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.03 155.49 87.41 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.562 0.879 . . . . 0.0 112.613 -3.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.49 120.85 48.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.731 1.612 . . . . 0.0 108.768 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.26 141.61 12.91 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.965 2.443 . . . . 0.0 111.247 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 22.3 t -137.57 126.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.799 1.639 . . . . 0.0 108.093 175.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.8 t -97.31 124.29 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.72 0.808 . . . . 0.0 110.202 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.57 128.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.037 1.335 . . . . 0.0 109.883 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 66.9 m -93.31 170.75 9.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.706 1.202 . . . . 0.0 112.234 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -34.5 77.46 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.323 -1.486 . . . . 0.0 111.604 174.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.0 m -66.17 -2.29 4.1 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.708 1.603 . . . . 0.0 115.27 -173.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.63 5.49 8.21 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.997 1.719 . . . . 0.0 112.96 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 3.5 mm -86.23 -21.83 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.546 1.138 . . . . 0.0 113.557 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.1 38.35 0.04 OUTLIER Glycine 0 N--CA 1.471 0.968 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.36 84.4 4.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.474 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -54.95 -37.01 65.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.609 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.22 -24.95 45.38 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.497 1.519 . . . . 0.0 114.381 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -90.94 -8.52 49.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.698 1.599 . . . . 0.0 114.215 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 90.4 t -73.8 137.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.007 1.276 . . . . 0.0 110.419 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -121.03 155.21 34.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.311 1.444 . . . . 0.0 111.365 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 30.6 m -145.23 153.33 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 109.971 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -154.86 170.88 20.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.025 0.93 . . . . 0.0 112.669 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.05 156.17 30.59 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.224 1.393 . . . . 0.0 113.184 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.04 -21.61 62.24 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.98 -2.16 22.74 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.078 1.323 . . . . 0.0 115.093 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 65.3 mt -90.93 -7.22 52.71 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.165 1.786 . . . . 0.0 112.707 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.06 -32.23 1.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.074 1.349 . . . . 0.0 113.887 -172.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.48 156.86 42.25 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.486 1.514 . . . . 0.0 112.253 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.87 32.5 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.371 0.986 . . . . 0.0 113.797 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.0 m80 -134.22 148.97 50.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 112.699 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 17.1 p -68.78 -29.78 68.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -118.19 0.15 11.69 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.52 146.49 61.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.106 1.763 . . . . 0.0 109.644 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.21 141.32 43.12 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.783 2.322 . . . . 0.0 111.049 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.72 154.29 21.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.41 1.084 . . . . 0.0 110.295 168.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.66 150.26 47.22 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 112.608 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 42.2 p90 -157.13 149.98 23.54 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 110.637 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.53 140.95 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.934 1.694 . . . . 0.0 109.566 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 71.5 mt -112.74 134.62 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.967 1.707 . . . . 0.0 108.86 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 23.2 t70 -137.07 123.22 20.43 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.565 1.546 . . . . 0.0 112.013 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 11.7 p -134.48 -11.75 2.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -157.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.13 -21.94 66.36 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 121.064 1.756 . . . . 0.0 114.542 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.46 -20.47 61.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.76 0.824 . . . . 0.0 112.554 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -92.34 -3.82 54.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.988 1.715 . . . . 0.0 113.423 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.7 -110.28 3.5 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.992 1.282 . . . . 0.0 112.462 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -131.79 151.74 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.534 1.533 . . . . 0.0 112.808 -168.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.87 -179.13 28.71 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -84.76 127.59 8.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.22 0.914 . . . . 0.0 111.239 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.8 124.58 49.8 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.243 1.817 . . . . 0.0 108.363 175.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.8 t -112.06 140.44 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.844 1.257 . . . . 0.0 111.35 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.17 133.73 47.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.248 2.219 . . . . 0.0 108.363 -174.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 83.0 p -143.36 151.76 40.81 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.26 -0.9 . . . . 0.0 112.661 167.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.27 137.52 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.97 1.308 . . . . 0.0 109.296 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.67 155.41 41.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.273 1.429 . . . . 0.0 111.033 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 167.3 -155.5 26.57 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 118.808 -0.996 . . . . 0.0 114.202 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.43 -8.69 23.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.429 3.42 . . . . 0.0 115.368 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.4 t -160.26 162.0 33.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.741 1.217 . . . . 0.0 111.528 173.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.29 146.98 53.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.301 1.041 . . . . 0.0 111.782 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 34.6 m -135.46 147.89 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.035 1.334 . . . . 0.0 111.65 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -88.94 122.55 32.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.862 0.865 . . . . 0.0 110.346 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.21 131.41 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.371 1.068 . . . . 0.0 109.604 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -130.05 161.08 31.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.224 1.81 . . . . 0.0 110.287 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 39.9 p -143.03 163.48 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.489 1.116 . . . . 0.0 112.829 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.13 121.35 6.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.773 1.629 . . . . 0.0 109.969 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.54 131.29 35.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.89 1.276 . . . . 0.0 111.132 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -108.53 153.63 23.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.023 1.329 . . . . 0.0 111.292 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -15.6 63.43 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -76.83 -6.06 50.84 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.753 1.221 . . . . 0.0 112.857 170.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 89.43 2.13 77.1 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.996 1.76 . . . . 0.0 114.082 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 4.1 p -81.64 156.73 24.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.413 1.885 . . . . 0.0 111.31 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -115.43 120.88 41.01 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.994 0.917 . . . . 0.0 110.347 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.8 ttm105 -78.93 133.77 36.9 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.976 0.91 . . . . 0.0 108.846 164.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 27.4 t -115.48 140.54 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.874 1.67 . . . . 0.0 108.518 169.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.7 p -136.21 150.3 48.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.589 1.556 . . . . 0.0 111.334 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.7 p90 -163.12 150.07 12.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 111.415 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 15.0 t -111.59 101.55 51.26 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.907 0.883 . . . . 0.0 110.766 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.64 116.87 4.38 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.104 2.536 . . . . 0.0 110.342 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.6 m -74.06 -39.69 63.3 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.923 0.889 . . . . 0.0 112.396 -173.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -95.07 148.69 35.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.05 1.34 . . . . 0.0 111.478 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.77 164.49 31.86 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.374 2.716 . . . . 0.0 110.98 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 121.01 -163.94 14.36 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.168 1.366 . . . . 0.0 113.284 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.6 t30 -91.55 117.27 29.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.457 0.703 . . . . 0.0 111.99 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -94.96 141.13 29.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.505 1.122 . . . . 0.0 111.145 164.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.77 134.96 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.404 1.482 . . . . 0.0 108.753 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 26.5 mt -118.32 128.36 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.927 1.291 . . . . 0.0 109.111 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -105.72 130.08 53.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 110.884 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 16.0 mm -119.83 120.82 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.002 1.321 . . . . 0.0 110.022 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -131.93 135.99 47.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.22 1.408 . . . . 0.0 111.469 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 69.8 t80 -131.48 129.69 41.46 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.88 1.672 . . . . 0.0 110.652 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.86 29.26 11.68 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.048 1.339 . . . . 0.0 113.424 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.8 t0 83.4 4.53 0.86 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 129.198 2.999 . . . . 0.0 114.668 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -109.05 128.22 54.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.824 1.249 . . . . 0.0 111.186 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -63.24 125.98 25.9 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.053 1.341 . . . . 0.0 110.618 172.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.3 m -80.38 156.46 73.65 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-N 119.039 0.836 . . . . 0.0 111.318 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.19 144.45 81.31 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.409 2.072 . . . . 0.0 111.63 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.37 -24.33 14.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.967 1.27 . . . . 0.0 113.423 -172.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 10.1 t -77.89 143.04 65.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.167 0.987 . . . . 0.0 110.565 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 146.37 84.19 Favored 'Cis proline' 0 C--N 1.353 0.768 0 CA-C-N 120.224 1.116 . . . . 0.0 112.075 0.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -97.63 122.21 40.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.709 1.203 . . . . 0.0 110.546 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.9 m -89.34 129.81 35.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.259 1.024 . . . . 0.0 111.37 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -122.94 112.08 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.2 1.8 . . . . 0.0 109.495 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -81.24 103.07 10.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.189 0.595 . . . . 0.0 111.455 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 61.7 t -87.85 128.9 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 109.45 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -125.25 167.32 15.04 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 114.11 161.1 13.82 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.086 1.803 . . . . 0.0 113.091 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -166.79 152.45 8.04 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.98 1.712 . . . . 0.0 110.316 -171.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 99.32 50.58 1.42 Allowed Glycine 0 N--CA 1.473 1.155 0 C-N-CA 124.537 1.065 . . . . 0.0 113.111 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -73.63 95.13 2.27 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.605 1.162 . . . . 0.0 111.156 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 7.4 p -164.41 151.38 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.402 1.881 . . . . 0.0 110.537 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 65.1 mttp . . . . . 0 C--O 1.254 1.334 0 C-N-CA 125.084 1.354 . . . . 0.0 112.875 179.257 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -79.33 -18.64 52.13 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.3 mmt -113.58 166.55 11.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.584 1.954 . . . . 0.0 111.92 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 149.7 -140.06 7.83 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 125.627 1.584 . . . . 0.0 112.023 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.93 -16.02 63.88 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.346 1.058 . . . . 0.0 112.905 172.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t0 -143.96 161.4 38.83 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.225 2.21 . . . . 0.0 110.28 173.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 22.9 t -124.05 144.37 49.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.725 1.21 . . . . 0.0 112.611 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 22.2 mmt -63.24 135.54 57.16 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.362 -0.836 . . . . 0.0 111.928 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -71.34 138.2 49.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.806 0.843 . . . . 0.0 110.227 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 21.4 ptm -146.52 159.17 43.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 113.264 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.5 m -136.86 151.34 48.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.238 2.215 . . . . 0.0 109.084 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -150.67 160.33 43.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -170.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1963 ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -158.39 153.68 25.71 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.512 1.925 . . . . 0.0 110.309 -172.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1964 ' ' LYS . . . . . 0.427 ' H ' HD13 ' A' 1963 ' ' LEU . 61.1 mttm -133.91 143.15 48.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.181 1.392 . . . . 0.0 111.525 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 63.9 t -138.86 137.53 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.91 1.684 . . . . 0.0 109.592 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.81 130.08 9.97 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.924 0.773 . . . . 0.0 111.52 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 69.0 m -119.72 150.98 39.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.952 1.301 . . . . 0.0 112.223 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -153.69 152.14 30.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.126 0.971 . . . . 0.0 112.929 -174.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.46 149.79 29.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.443 0.697 . . . . 0.0 110.527 163.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -98.35 125.92 43.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 110.26 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.6 122.49 35.04 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.764 -1.113 . . . . 0.0 109.529 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.76 135.25 21.32 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.942 2.428 . . . . 0.0 110.601 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -148.49 143.53 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.549 1.54 . . . . 0.0 110.03 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.22 59.35 4.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.461 1.504 . . . . 0.0 112.383 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.1 mm -73.82 102.99 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.7 t -167.52 179.01 5.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.87 1.668 . . . . 0.0 111.078 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -85.58 6.03 29.05 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.614 1.566 . . . . 0.0 112.921 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -63.86 139.73 58.8 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.647 1.579 . . . . 0.0 112.076 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.25 158.61 28.87 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.682 1.193 . . . . 0.0 111.959 175.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.2 -23.53 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.34 1.056 . . . . 0.0 113.625 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 91.4 p -71.4 -27.45 63.32 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.12 4.25 51.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.871 1.668 . . . . 0.0 113.503 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.37 140.85 34.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.9 p -138.25 160.88 38.31 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.158 1.783 . . . . 0.0 110.104 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -148.65 148.7 30.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.828 0.851 . . . . 0.0 113.035 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.6 p -142.09 166.81 23.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.744 2.018 . . . . 0.0 109.92 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -122.07 138.44 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 109.595 168.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.1 t -107.07 112.71 63.02 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.297 1.439 . . . . 0.0 108.11 166.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -77.91 171.3 17.49 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.12 3.213 . . . . 0.0 110.773 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.46 -17.51 59.87 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.88 2.387 . . . . 0.0 113.587 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 7.3 t -77.81 -12.14 59.95 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.114 0.966 . . . . 0.0 113.273 170.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 83.8 -0.64 89.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.768 1.651 . . . . 0.0 115.09 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -78.03 86.64 4.2 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.131 1.772 . . . . 0.0 111.105 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -61.01 132.33 53.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.0 0.92 . . . . 0.0 111.837 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -137.41 148.65 62.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 110.663 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.56 155.04 40.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.732 2.955 . . . . 0.0 112.428 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 89.5 m -115.77 151.28 35.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.042 1.337 . . . . 0.0 111.679 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 115.35 26.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.964 0.906 . . . . 0.0 109.346 171.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.91 142.12 42.14 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.467 1.107 . . . . 0.0 110.779 171.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -145.4 149.25 34.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 113.017 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.95 115.81 23.01 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 153.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.77 170.43 11.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.208 1.003 . . . . 0.0 112.503 -173.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 63.3 ttt-85 -60.69 -30.14 69.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.597 1.559 . . . . 0.0 114.315 -169.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -82.55 -10.58 58.93 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.593 1.157 . . . . 0.0 113.684 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.29 55.12 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.87 1.7 . . . . 0.0 114.584 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 166.22 19.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 118.783 1.291 . . . . 0.0 113.403 173.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 90.8 t -93.02 142.94 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.955 1.302 . . . . 0.0 110.197 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.63 -171.87 27.15 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.05 162.96 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.779 1.631 . . . . 0.0 112.675 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 84.7 p -136.99 159.25 42.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.286 1.034 . . . . 0.0 111.916 159.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -165.63 -171.73 2.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.989 2.516 . . . . 0.0 109.309 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 82.0 t -134.65 120.82 14.67 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 110.241 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.34 143.4 15.55 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.384 3.39 . . . . 0.0 110.792 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.41 23.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.73 169.3 18.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.325 1.85 . . . . 0.0 110.582 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -82.07 169.74 16.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 112.076 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.99 -175.83 23.35 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.59 1.567 . . . . 0.0 113.875 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.98 118.39 15.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.897 0.879 . . . . 0.0 111.13 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.3 m80 -103.64 143.85 32.22 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.946 1.699 . . . . 0.0 109.275 170.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 123.26 46.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.089 0.956 . . . . 0.0 108.959 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 58.0 t -85.0 129.69 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.846 1.259 . . . . 0.0 107.881 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -112.33 132.37 55.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.848 1.259 . . . . 0.0 110.339 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 95.1 t -129.6 127.97 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.475 1.11 . . . . 0.0 110.636 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -119.9 135.27 54.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.791 1.636 . . . . 0.0 112.057 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -106.64 114.94 29.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.465 1.906 . . . . 0.0 109.027 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.3 t30 52.62 -101.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.164 1.386 . . . . 0.0 111.763 -172.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.26 5.24 33.65 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.595 1.569 . . . . 0.0 115.876 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -140.6 149.46 42.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.799 1.8 . . . . 0.0 112.809 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -68.7 144.8 54.3 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.102 -0.999 . . . . 0.0 113.028 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.8 m -72.08 160.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 111.481 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.3 67.97 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.2 m -79.88 -15.68 56.87 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 34.1 t -89.19 145.05 33.42 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.536 1.134 . . . . 0.0 113.114 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.96 159.12 84.07 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 119.297 0.785 . . . . 0.0 112.6 -3.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.37 125.54 28.73 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.758 1.623 . . . . 0.0 109.577 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.18 139.26 13.23 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.072 2.515 . . . . 0.0 111.552 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 40.9 t -134.83 125.1 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.837 1.655 . . . . 0.0 107.957 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.3 t -98.17 124.8 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.87 0.868 . . . . 0.0 110.427 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.29 120.73 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.168 1.387 . . . . 0.0 108.747 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 83.2 p -96.3 167.99 10.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.943 0.897 . . . . 0.0 112.119 172.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.64 -22.84 66.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 12.1 t -70.78 -36.03 72.87 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.304 -0.873 . . . . 0.0 111.796 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -74.69 -15.98 60.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.452 1.101 . . . . 0.0 112.728 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 50.2 mm -64.91 -19.91 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.34 1.056 . . . . 0.0 112.037 173.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 132.11 64.6 0.09 OUTLIER Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.609 1.576 . . . . 0.0 113.755 168.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 23.9 t0 -65.85 114.47 5.11 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 117.766 0.783 . . . . 0.0 111.56 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.97 80.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.146 0.978 . . . . 0.0 112.755 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 49.0 m -61.32 -20.46 62.97 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -85.71 -12.0 52.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.137 1.375 . . . . 0.0 114.069 174.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.6 t -76.29 133.41 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.921 1.237 . . . . 0.0 110.117 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -115.52 157.9 23.39 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.655 1.582 . . . . 0.0 110.703 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.3 m -146.5 158.55 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.22 1.408 . . . . 0.0 111.036 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -160.06 169.15 23.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 112.288 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 107.69 160.38 20.93 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.213 1.387 . . . . 0.0 114.444 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -68.88 -32.11 71.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.465 1.506 . . . . 0.0 113.31 -169.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.48 -3.28 47.15 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.039 1.304 . . . . 0.0 115.17 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.56 -8.37 56.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.319 1.447 . . . . 0.0 112.631 168.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.66 -36.19 2.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -158.16 155.71 29.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.478 1.111 . . . . 0.0 112.752 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.03 -175.23 23.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.796 1.189 . . . . 0.0 114.288 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -137.69 148.55 45.78 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.118 1.367 . . . . 0.0 112.657 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 23.3 p -68.98 -35.07 76.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.08 10.2 22.02 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.42 154.85 72.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.608 1.563 . . . . 0.0 110.59 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 144.27 34.41 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.716 2.277 . . . . 0.0 111.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.45 138.36 37.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.404 1.482 . . . . 0.0 110.009 169.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.61 146.03 48.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.021 1.328 . . . . 0.0 113.307 -169.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -158.17 157.38 32.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.089 1.356 . . . . 0.0 112.159 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.43 141.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.476 1.911 . . . . 0.0 109.347 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 50.9 mt -117.1 132.68 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 108.769 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -120.81 100.71 7.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.724 1.61 . . . . 0.0 110.722 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 18.6 p -98.01 0.21 45.88 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.97 2.108 . . . . 0.0 113.034 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -59.88 -37.65 79.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.352 0.978 . . . . 0.0 112.713 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.28 -11.62 59.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.694 1.197 . . . . 0.0 113.247 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.38 49.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.867 1.667 . . . . 0.0 113.804 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.23 -129.54 9.33 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.663 1.125 . . . . 0.0 112.671 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -102.27 170.14 8.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.863 1.665 . . . . 0.0 112.388 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 134.17 -176.67 19.68 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.303 0.954 . . . . 0.0 115.114 168.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -94.56 124.16 7.81 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.685 1.136 . . . . 0.0 112.09 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -95.07 117.83 30.84 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.057 1.743 . . . . 0.0 108.198 170.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 68.3 m -108.76 143.81 37.41 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.492 1.517 . . . . 0.0 110.347 172.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.2 tt -142.12 140.29 32.43 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.869 0.867 . . . . 0.0 110.185 -169.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 92.0 p -143.84 152.6 41.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 112.616 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.3 mt -129.35 133.71 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 107.655 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -141.78 152.22 43.56 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.263 1.025 . . . . 0.0 111.566 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.28 -146.7 12.97 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.664 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.69 -8.85 22.02 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.702 2.934 . . . . 0.0 114.485 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.4 t -159.4 162.88 35.84 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.848 1.204 . . . . 0.0 112.633 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -70.63 146.74 49.82 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.785 1.234 . . . . 0.0 110.892 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.89 145.69 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.992 1.317 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.54 99.39 12.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 110.07 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 42.3 mt -81.04 131.38 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.208 1.003 . . . . 0.0 109.973 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -126.36 152.8 45.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.407 1.883 . . . . 0.0 110.207 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 33.7 p -138.93 154.16 48.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.991 1.316 . . . . 0.0 111.697 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -152.43 126.85 9.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.751 1.22 . . . . 0.0 111.156 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.81 128.08 32.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.506 1.122 . . . . 0.0 110.897 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.4 mt -97.43 155.05 17.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.647 1.179 . . . . 0.0 111.786 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.77 -16.63 64.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.255 1.022 . . . . 0.0 113.429 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -74.15 -11.79 60.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.998 1.319 . . . . 0.0 113.313 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.48 -0.49 65.68 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.936 1.731 . . . . 0.0 114.293 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 41.3 p -89.29 167.69 12.85 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.47 1.908 . . . . 0.0 111.253 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.5 t -117.33 130.34 56.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.083 0.953 . . . . 0.0 111.088 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -94.32 139.72 30.72 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.007 1.323 . . . . 0.0 110.146 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 21.7 t -125.3 139.54 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.009 1.724 . . . . 0.0 108.954 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.8 p -138.02 152.76 49.19 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.402 1.481 . . . . 0.0 111.386 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.9 p90 -162.88 148.42 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.589 1.556 . . . . 0.0 110.806 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 30.2 t -109.2 106.78 59.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.599 0.76 . . . . 0.0 110.658 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.33 106.05 1.98 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.376 2.717 . . . . 0.0 110.238 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.9 m -66.38 -44.0 84.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.03 0.932 . . . . 0.0 112.74 -171.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -92.4 148.21 35.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.431 1.092 . . . . 0.0 110.842 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.88 165.64 29.62 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.321 2.681 . . . . 0.0 111.602 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 125.82 -162.12 20.11 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 125.179 1.371 . . . . 0.0 113.561 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.9 t30 -93.8 125.2 38.29 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.698 0.799 . . . . 0.0 111.524 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -108.89 143.49 38.05 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.107 1.363 . . . . 0.0 110.241 168.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.33 133.72 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 108.533 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 23.7 mt -111.64 129.72 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 109.308 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -108.58 125.29 51.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.423 1.489 . . . . 0.0 110.153 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.8 mm -112.16 121.59 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.011 0.924 . . . . 0.0 109.238 172.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -127.13 133.02 50.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.174 1.789 . . . . 0.0 110.527 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.6 126.55 36.97 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.556 1.142 . . . . 0.0 110.549 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.51 40.01 25.93 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.865 1.266 . . . . 0.0 112.578 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.2 t0 72.87 5.42 5.19 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.576 2.75 . . . . 0.0 114.651 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -109.69 128.71 55.45 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.994 1.318 . . . . 0.0 110.589 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -67.13 123.15 19.47 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.755 1.222 . . . . 0.0 111.104 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.8 m -81.91 160.61 63.15 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.279 -0.888 . . . . 0.0 111.915 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.0 141.76 67.01 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.766 2.977 . . . . 0.0 113.659 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.31 -22.87 17.48 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.022 1.296 . . . . 0.0 114.287 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 74.7 m -73.52 150.57 89.17 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 118.861 1.33 . . . . 0.0 111.525 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -73.52 139.65 62.71 Favored 'Cis proline' 0 C--N 1.352 0.759 0 CA-C-N 119.365 0.809 . . . . 0.0 111.111 -5.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -93.22 114.69 27.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.945 0.898 . . . . 0.0 110.337 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 62.0 m -82.75 128.28 34.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.6 t -123.92 114.9 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.766 1.626 . . . . 0.0 109.636 -171.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -81.57 108.79 15.43 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.629 . . . . 0.0 111.213 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 84.4 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.835 1.254 . . . . 0.0 109.226 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -109.01 164.56 12.3 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.908 1.283 . . . . 0.0 111.882 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 115.15 177.06 18.74 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.703 1.62 . . . . 0.0 113.575 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -86.9 161.98 17.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.941 1.297 . . . . 0.0 112.473 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -81.24 143.51 23.95 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.177 0.894 . . . . 0.0 111.071 165.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -74.57 142.29 44.7 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.704 0.801 . . . . 0.0 112.347 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 96.1 t -112.27 139.02 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.074 1.749 . . . . 0.0 109.108 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.718 1.607 . . . . 0.0 111.728 -179.092 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.54 151.4 46.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.227 1.011 . . . . 0.0 112.611 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 78.2 mtm -142.71 163.35 33.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.94 1.696 . . . . 0.0 111.539 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 107.01 153.68 19.48 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.603 1.573 . . . . 0.0 113.285 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -85.52 -9.12 57.85 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.411 1.484 . . . . 0.0 114.221 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.15 -4.42 55.34 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.849 1.66 . . . . 0.0 114.692 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 49.4 m -63.21 137.03 58.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.649 1.18 . . . . 0.0 114.038 -175.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 82.9 mmm -74.15 162.88 28.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.781 1.232 . . . . 0.0 111.241 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -128.49 149.56 50.53 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.533 1.133 . . . . 0.0 111.73 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.8 ptm -120.41 153.97 35.79 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.233 1.413 . . . . 0.0 112.69 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.8 m -134.78 145.49 48.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.847 2.059 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -146.29 157.03 43.76 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.2 141.36 16.31 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.218 1.807 . . . . 0.0 109.982 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -132.21 143.72 50.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.736 1.214 . . . . 0.0 112.512 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 29.9 m -143.46 151.8 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.331 1.452 . . . . 0.0 111.278 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.16 153.1 27.54 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 124.344 0.973 . . . . 0.0 112.132 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.2 m -140.3 137.03 33.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.508 0.723 . . . . 0.0 112.692 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.0 154.23 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.701 1.2 . . . . 0.0 112.19 -176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.38 133.16 34.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 111.076 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.35 135.03 34.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.219 1.008 . . . . 0.0 110.608 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.76 113.16 30.38 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.886 0.874 . . . . 0.0 109.9 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.43 150.55 36.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.047 2.498 . . . . 0.0 110.587 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 67.9 mt -129.92 141.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.411 1.084 . . . . 0.0 110.039 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 48.7 t-20 11.32 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.41 3.084 . . . . 0.0 115.377 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.05 116.64 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.651 1.18 . . . . 0.0 112.004 -161.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 77.3 p -172.81 166.41 5.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.627 1.971 . . . . 0.0 110.583 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.28 141.9 27.91 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.951 0.9 . . . . 0.0 111.593 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 1.2 m -176.89 139.77 0.3 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.338 2.655 . . . . 0.0 109.106 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.5 133.04 49.56 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.292 1.037 . . . . 0.0 112.317 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 22.1 tp -76.24 -25.57 55.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.277 1.031 . . . . 0.0 113.711 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 49.1 m -84.37 -26.28 28.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -169.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.9 pp -92.47 9.4 34.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.798 1.239 . . . . 0.0 113.577 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.63 148.68 23.05 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.473 1.509 . . . . 0.0 111.811 170.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -136.97 157.43 46.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.107 1.763 . . . . 0.0 109.367 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 148.28 26.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.939 0.896 . . . . 0.0 112.355 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 74.9 p -140.37 160.16 40.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.337 1.855 . . . . 0.0 109.999 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.0 t -114.93 135.42 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.425 1.49 . . . . 0.0 109.471 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.3 t -106.81 110.74 63.84 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.942 1.297 . . . . 0.0 107.889 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 167.73 24.51 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.622 2.881 . . . . 0.0 110.622 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 -14.66 42.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.949 2.432 . . . . 0.0 113.061 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.1 p -79.66 -9.74 59.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.361 1.464 . . . . 0.0 113.936 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.96 -1.68 85.92 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.691 1.615 . . . . 0.0 115.168 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -77.29 81.66 3.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.553 1.541 . . . . 0.0 111.496 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.99 135.72 57.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.636 1.174 . . . . 0.0 112.212 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.79 148.93 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.764 1.626 . . . . 0.0 111.023 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.76 152.54 37.42 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.523 2.815 . . . . 0.0 111.808 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 80.6 m -102.7 151.45 22.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.563 1.145 . . . . 0.0 111.74 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 56.9 tp -83.03 126.59 32.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 108.774 163.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.4 mt -94.87 140.52 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.053 1.341 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.94 145.58 34.69 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.276 1.03 . . . . 0.0 113.021 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -85.78 108.44 18.09 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 153.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.37 166.25 21.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.166 0.986 . . . . 0.0 111.453 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -64.68 -21.61 66.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -81.4 -9.11 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.596 1.158 . . . . 0.0 113.599 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.45 -6.74 61.31 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.866 1.698 . . . . 0.0 114.566 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.06 162.73 19.2 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.697 1.199 . . . . 0.0 113.406 173.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 12.5 p -94.84 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.081 1.352 . . . . 0.0 111.057 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.65 177.8 33.42 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.23 162.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.987 1.715 . . . . 0.0 112.271 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 32.5 t -146.87 148.8 32.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.752 1.621 . . . . 0.0 110.57 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.5 p90 -169.41 175.49 5.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.334 2.254 . . . . 0.0 110.043 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 71.3 t -124.86 116.08 26.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 124.117 0.967 . . . . 0.0 109.805 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.24 143.21 28.07 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.944 3.096 . . . . 0.0 110.858 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.44 -19.26 15.0 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.77 171.0 8.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.264 1.826 . . . . 0.0 110.726 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.9 p -97.91 169.02 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.48 1.512 . . . . 0.0 111.107 169.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.69 -170.65 23.23 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.362 1.458 . . . . 0.0 113.815 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.83 112.02 7.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.025 0.93 . . . . 0.0 111.472 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.47 143.36 28.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.649 1.58 . . . . 0.0 109.269 168.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.83 125.11 50.57 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.336 1.054 . . . . 0.0 109.222 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.3 t -88.69 127.79 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.287 1.035 . . . . 0.0 108.237 168.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -106.41 137.21 44.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.263 1.425 . . . . 0.0 109.96 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 84.7 t -136.33 134.77 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.425 1.09 . . . . 0.0 109.566 -170.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -133.8 132.31 40.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.23 1.412 . . . . 0.0 111.137 -169.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -124.95 128.13 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.791 2.036 . . . . 0.0 109.627 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 46.3 t30 59.94 22.19 11.24 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.048 0.939 . . . . 0.0 113.289 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.94 7.37 83.95 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.941 1.258 . . . . 0.0 114.91 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -119.26 133.74 55.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.033 1.733 . . . . 0.0 109.465 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.18 138.31 58.18 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.494 -1.379 . . . . 0.0 112.135 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 22.9 m -78.83 159.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.214 0.606 . . . . 0.0 112.283 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -64.22 -20.75 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 49.8 m -86.4 -19.34 29.84 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 67.5 p -92.96 154.0 41.86 Favored Pre-proline 0 CA--C 1.55 0.979 0 O-C-N 120.887 -1.133 . . . . 0.0 113.846 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.65 147.58 89.94 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.138 0.728 . . . . 0.0 112.485 -0.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.12 120.22 51.69 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.013 1.325 . . . . 0.0 108.503 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.21 140.53 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.858 2.372 . . . . 0.0 111.288 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 23.4 t -135.44 123.51 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.391 1.476 . . . . 0.0 107.768 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.5 t -96.46 120.99 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.593 0.757 . . . . 0.0 109.795 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 123.01 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.779 1.231 . . . . 0.0 109.035 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 32.5 t -92.36 158.46 16.07 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.729 0.812 . . . . 0.0 111.408 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -59.74 -29.68 68.32 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.252 -0.905 . . . . 0.0 111.428 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.1 m -63.18 -13.26 35.2 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.666 1.186 . . . . 0.0 113.928 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -94.71 -11.17 29.63 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.942 1.297 . . . . 0.0 112.371 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.75 95.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.756 1.222 . . . . 0.0 109.917 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 65.02 24.63 70.35 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 115.0 0.76 . . . . 0.0 115.0 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 34.0 t0 -76.22 89.52 3.11 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.358 1.079 . . . . 0.0 111.9 -171.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.99 75.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.748 1.219 . . . . 0.0 112.789 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.8 m -60.7 -22.12 63.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.302 1.041 . . . . 0.0 113.574 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -88.66 -8.98 53.65 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.077 1.351 . . . . 0.0 113.903 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.5 t -77.52 131.31 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.866 1.212 . . . . 0.0 109.655 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -116.22 161.01 19.61 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.94 1.296 . . . . 0.0 111.373 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -146.11 153.88 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.385 1.474 . . . . 0.0 110.643 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 73.4 m -149.09 165.85 30.51 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.069 1.348 . . . . 0.0 112.103 -173.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.66 162.08 26.0 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 124.345 0.974 . . . . 0.0 114.577 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -73.9 -27.67 61.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 113.644 -167.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.86 -5.58 47.09 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.733 1.159 . . . . 0.0 115.042 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.82 -7.02 58.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.676 1.591 . . . . 0.0 112.787 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -128.29 -36.01 1.95 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.955 1.302 . . . . 0.0 113.8 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.7 155.51 30.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 112.474 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.6 -176.19 21.79 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.881 1.229 . . . . 0.0 114.358 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -139.41 152.67 47.27 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.345 1.458 . . . . 0.0 112.145 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 25.5 p -71.5 -41.84 68.77 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -100.18 -11.16 20.67 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -114.66 145.75 34.54 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.073 1.349 . . . . 0.0 110.258 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.78 137.83 36.31 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.545 2.163 . . . . 0.0 110.422 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -84.03 150.37 25.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.109 0.964 . . . . 0.0 109.997 168.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.25 151.19 46.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -159.26 155.59 27.23 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.613 1.565 . . . . 0.0 111.001 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.52 143.14 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.41 1.884 . . . . 0.0 109.961 -175.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.25 133.89 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.238 1.815 . . . . 0.0 109.026 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.7 t0 -122.81 99.82 6.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.018 1.727 . . . . 0.0 110.875 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 32.6 p -99.73 4.83 45.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.499 1.92 . . . . 0.0 112.735 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.9 -37.32 81.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.255 1.022 . . . . 0.0 112.577 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.27 -28.96 38.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 0.0 112.716 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -72.49 -11.49 60.69 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.86 -108.23 3.22 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.426 1.012 . . . . 0.0 112.068 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.32 147.15 50.25 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.925 1.29 . . . . 0.0 112.97 -168.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 156.73 -137.68 5.56 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.543 1.068 . . . . 0.0 113.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -157.68 141.46 7.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.497 1.046 . . . . 0.0 112.047 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.48 124.99 45.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.916 1.686 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 23.2 t -115.69 138.91 50.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.33 1.452 . . . . 0.0 109.902 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 8.4 tt -136.75 132.95 35.49 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.62 1.168 . . . . 0.0 109.902 -168.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.7 m -133.66 130.23 37.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.386 0.675 . . . . 0.0 111.197 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.9 mt -109.24 130.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.083 1.353 . . . . 0.0 108.244 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.78 142.5 51.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.337 1.455 . . . . 0.0 109.758 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 177.27 -165.24 35.01 Favored Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.1 -9.89 26.41 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.175 3.25 . . . . 0.0 114.05 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.0 t -155.88 162.51 40.41 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.386 1.074 . . . . 0.0 112.078 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -67.31 147.12 53.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.664 1.186 . . . . 0.0 111.327 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 32.2 m -130.84 146.14 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.143 1.377 . . . . 0.0 110.903 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.37 105.82 17.83 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.679 0.792 . . . . 0.0 109.957 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 52.3 mt -84.41 129.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.247 1.019 . . . . 0.0 109.599 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -125.69 161.16 27.91 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 0.0 110.795 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 35.6 p -141.8 155.52 45.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.252 1.421 . . . . 0.0 111.951 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.45 138.05 15.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 111.515 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.0 t70 -86.97 129.03 35.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.117 1.367 . . . . 0.0 111.31 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 43.2 mt -99.31 160.62 14.14 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.308 1.043 . . . . 0.0 112.525 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.37 -17.04 64.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.522 1.129 . . . . 0.0 113.35 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.43 -9.15 59.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.144 1.378 . . . . 0.0 113.291 172.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.81 1.91 82.13 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.412 1.482 . . . . 0.0 114.018 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -89.18 165.49 14.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.332 1.853 . . . . 0.0 111.432 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.6 t -109.94 124.87 52.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.042 . . . . 0.0 110.993 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -83.62 135.4 34.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 165.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 45.7 t -117.36 139.31 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.953 1.701 . . . . 0.0 108.773 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.97 151.61 50.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.782 1.633 . . . . 0.0 111.83 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.39 150.74 14.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.521 1.528 . . . . 0.0 111.787 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.5 t -115.81 99.39 52.5 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.277 1.031 . . . . 0.0 111.039 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.44 94.12 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.706 2.937 . . . . 0.0 110.669 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 51.8 m -63.09 -41.76 99.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.868 . . . . 0.0 112.78 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -87.3 140.78 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.711 0.805 . . . . 0.0 110.668 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.97 168.64 24.38 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.506 2.804 . . . . 0.0 111.554 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 127.0 -147.31 16.84 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.816 1.198 . . . . 0.0 112.695 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -109.75 133.56 53.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.074 0.95 . . . . 0.0 111.836 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -118.29 151.37 37.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.784 1.633 . . . . 0.0 110.707 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.06 133.26 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.518 1.527 . . . . 0.0 108.699 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.54 128.97 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.592 1.157 . . . . 0.0 109.789 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.54 125.25 53.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.895 1.678 . . . . 0.0 110.015 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.6 mm -115.63 116.42 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.11 0.964 . . . . 0.0 109.246 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -125.71 132.8 52.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.16 1.384 . . . . 0.0 111.201 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 72.4 t80 -123.82 124.22 42.2 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.678 1.591 . . . . 0.0 110.312 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.73 30.97 11.99 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.331 1.452 . . . . 0.0 114.177 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.257 7.0 t70 85.68 11.91 0.22 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 128.784 2.834 . . . . 0.0 114.728 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.6 132.18 55.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.556 1.143 . . . . 0.0 111.48 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.86 124.48 23.45 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.338 1.455 . . . . 0.0 110.676 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -80.72 158.76 70.4 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.189 -0.944 . . . . 0.0 111.825 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.51 134.93 64.24 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.649 2.899 . . . . 0.0 113.253 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.85 -22.31 38.73 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.247 1.403 . . . . 0.0 114.073 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 62.9 m -75.22 150.59 85.39 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 118.922 1.361 . . . . 0.0 112.024 172.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.35 142.87 73.16 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.053 0.697 . . . . 0.0 111.113 -4.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.62 127.76 39.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.432 1.093 . . . . 0.0 110.834 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 30.5 t -95.97 129.29 43.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.345 1.058 . . . . 0.0 110.988 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 11.9 t -128.46 117.14 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.001 1.32 . . . . 0.0 110.007 -170.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -85.84 120.35 27.16 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.76 -0.587 . . . . 0.0 110.521 173.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.08 118.99 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.587 1.555 . . . . 0.0 108.862 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 1.3 t -99.61 162.85 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.583 1.153 . . . . 0.0 111.333 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 171.47 -168.35 41.46 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -137.66 174.62 10.39 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.611 1.964 . . . . 0.0 110.215 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -75.85 138.17 22.56 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.432 -0.792 . . . . 0.0 112.017 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -68.9 145.0 54.05 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.431 1.092 . . . . 0.0 111.289 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 95.8 t -61.64 137.04 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.129 1.371 . . . . 0.0 110.833 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 40.6 ttpt . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.05 1.74 . . . . 0.0 111.294 -176.542 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 110.372 -0.232 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 23.6 ptm -149.39 159.29 44.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 13.3 m -148.53 151.66 35.5 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.377 1.871 . . . . 0.0 109.774 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -147.32 159.77 43.29 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.9 150.85 24.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.539 1.936 . . . . 0.0 109.796 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -134.07 144.08 48.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.546 1.138 . . . . 0.0 111.972 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 46.8 t -140.37 134.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.64 1.576 . . . . 0.0 109.658 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.89 139.51 21.43 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 124.013 0.816 . . . . 0.0 111.661 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 29.6 m -131.22 132.14 44.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.809 0.804 . . . . 0.0 112.764 -166.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.63 148.64 16.19 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -74.47 150.33 39.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.439 1.095 . . . . 0.0 111.323 170.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -93.28 122.81 36.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.422 1.089 . . . . 0.0 110.667 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.9 mm -112.46 108.73 54.2 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.588 1.155 . . . . 0.0 109.266 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.91 137.62 17.78 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.178 2.585 . . . . 0.0 111.17 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 65.1 mt -145.69 141.14 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.377 1.471 . . . . 0.0 110.21 -170.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.26 61.47 2.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.625 1.57 . . . . 0.0 112.0 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.26 104.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.666 1.186 . . . . 0.0 110.616 -169.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.8 t -172.61 178.74 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.274 1.83 . . . . 0.0 110.543 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.99 45.42 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.018 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.8 p -71.47 138.06 48.69 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.001 1.321 . . . . 0.0 111.364 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 15.0 t70 -85.09 141.13 30.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.436 1.094 . . . . 0.0 111.323 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 -16.95 46.53 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 60.4 m -82.16 -31.93 30.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.038 1.29 . . . . 0.0 114.055 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -99.39 -0.49 40.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.5 1.12 . . . . 0.0 113.845 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.83 146.81 24.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.601 1.161 . . . . 0.0 111.492 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 41.0 p -138.87 162.67 34.23 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.732 2.013 . . . . 0.0 109.448 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.1 145.25 24.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.689 0.795 . . . . 0.0 112.08 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.7 p -138.4 162.57 34.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.148 1.779 . . . . 0.0 109.9 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -120.12 137.59 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.21 1.404 . . . . 0.0 109.462 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.1 t -102.82 111.05 64.6 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.14 1.376 . . . . 0.0 107.832 165.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.28 168.65 22.68 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.042 3.161 . . . . 0.0 110.696 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.55 -18.1 61.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.923 2.415 . . . . 0.0 112.645 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 12.8 m -67.63 -17.18 64.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.84 1.256 . . . . 0.0 113.925 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.87 31.24 54.17 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.61 1.1 . . . . 0.0 114.239 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -125.84 97.57 5.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.318 1.447 . . . . 0.0 110.488 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.93 135.74 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.417 1.087 . . . . 0.0 112.155 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -137.49 151.06 70.39 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.515 1.526 . . . . 0.0 111.097 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.19 156.23 42.11 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.793 2.996 . . . . 0.0 112.664 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.0 m -112.48 154.49 25.8 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.354 1.462 . . . . 0.0 111.751 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 58.2 tp -85.85 120.34 27.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.287 1.035 . . . . 0.0 109.397 170.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 21.9 mt -84.03 141.7 30.99 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.597 1.159 . . . . 0.0 110.95 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.23 139.1 31.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.459 1.503 . . . . 0.0 111.75 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -92.82 109.45 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 160.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.57 164.3 23.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.862 1.265 . . . . 0.0 111.735 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.27 -34.52 68.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -167.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.12 -9.24 58.61 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.19 37.99 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 126.003 1.764 . . . . 0.0 114.435 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.07 156.57 33.78 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 113.351 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.6 t -104.08 143.01 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.137 1.375 . . . . 0.0 110.042 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.2 178.61 28.48 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.557 1.075 . . . . 0.0 115.039 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -116.59 165.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.948 1.699 . . . . 0.0 111.615 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 71.1 p -151.59 150.73 30.64 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 110.678 166.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.7 p90 -167.17 167.59 14.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.945 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 59.5 t -110.67 117.68 50.22 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.816 0.846 . . . . 0.0 109.676 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.45 147.65 28.96 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.944 3.096 . . . . 0.0 110.917 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -105.34 -7.67 18.7 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -145.72 174.93 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.403 2.281 . . . . 0.0 109.687 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 36.3 p -88.56 167.07 13.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.614 1.165 . . . . 0.0 111.21 166.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.05 -170.22 25.97 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.268 1.413 . . . . 0.0 113.79 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.84 117.88 12.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.186 0.994 . . . . 0.0 111.742 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.8 m80 -104.11 143.58 32.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.036 1.734 . . . . 0.0 108.968 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.44 125.31 50.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.993 0.917 . . . . 0.0 110.083 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.1 t -85.62 137.46 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -119.96 114.76 22.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.347 1.459 . . . . 0.0 109.693 169.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 94.1 t -106.48 136.52 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.054 1.341 . . . . 0.0 108.995 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -131.09 142.28 50.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.989 1.315 . . . . 0.0 112.435 -172.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -112.81 121.21 44.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.544 1.938 . . . . 0.0 109.169 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.19 26.27 10.12 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.668 1.187 . . . . 0.0 113.259 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.65 84.85 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.649 1.595 . . . . 0.0 115.452 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.43 134.87 46.07 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.167 1.484 . . . . 0.0 109.64 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 19.3 p80 -63.36 140.15 58.84 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.953 -1.092 . . . . 0.0 113.337 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 16.6 m -78.54 159.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.666 0.786 . . . . 0.0 110.983 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.42 62.76 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.4 m -75.35 -20.76 58.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 56.4 m -82.25 149.89 63.01 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.64 150.24 92.49 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 118.649 0.553 . . . . 0.0 111.949 -5.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -107.41 119.24 51.37 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.86 139.89 12.49 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.806 2.338 . . . . 0.0 111.385 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -134.1 124.35 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.384 1.474 . . . . 0.0 107.643 171.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.4 t -99.75 122.58 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.879 0.872 . . . . 0.0 109.97 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.45 128.14 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.886 1.274 . . . . 0.0 109.655 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.2 t -99.66 161.24 13.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.026 0.931 . . . . 0.0 111.457 170.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -59.54 -31.38 69.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.768 0.827 . . . . 0.0 112.87 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -68.0 -14.93 63.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 113.516 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -92.12 -9.5 42.29 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.564 1.146 . . . . 0.0 112.763 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 44.1 mm -76.49 -31.94 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 0.0 112.948 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.44 47.74 0.04 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -85.43 98.9 10.84 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.261 1.031 . . . . 0.0 110.78 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.44 73.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.482 1.113 . . . . 0.0 113.495 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.9 p -56.78 -23.4 42.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 113.91 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -84.84 -14.45 47.92 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.213 1.405 . . . . 0.0 113.913 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.5 t -75.12 135.42 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.641 1.11 . . . . 0.0 110.524 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -113.53 156.88 22.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.381 1.472 . . . . 0.0 111.329 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.55 159.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.697 1.599 . . . . 0.0 110.706 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -159.95 175.69 12.74 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.577 1.151 . . . . 0.0 112.419 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.84 161.73 30.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.239 1.399 . . . . 0.0 114.189 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -72.16 -28.24 63.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.582 1.153 . . . . 0.0 113.398 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.45 -4.29 37.21 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.703 1.144 . . . . 0.0 115.24 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.28 -4.39 58.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.323 1.449 . . . . 0.0 112.76 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -134.53 -40.12 0.8 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.812 1.245 . . . . 0.0 113.876 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.22 152.51 44.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 111.267 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.38 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 122.256 0.92 . . . . 0.0 114.748 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 66.0 m80 -135.43 160.06 39.63 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.543 1.937 . . . . 0.0 110.29 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 16.9 p -71.21 -68.55 0.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.37 0.668 . . . . 0.0 111.498 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -82.44 -14.59 54.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -166.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -104.89 136.71 19.13 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 0.0 109.349 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.49 152.34 54.3 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -105.2 136.77 44.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.018 1.327 . . . . 0.0 110.708 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.4 148.49 42.48 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.282 1.433 . . . . 0.0 113.123 -175.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.5 p90 -155.76 153.61 30.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.369 1.468 . . . . 0.0 111.456 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.87 142.36 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.013 1.725 . . . . 0.0 109.655 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.74 134.69 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.251 1.82 . . . . 0.0 108.621 171.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.84 101.87 7.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.662 1.585 . . . . 0.0 110.833 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.7 p -100.33 -1.64 35.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.515 1.926 . . . . 0.0 112.946 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -57.95 -40.49 80.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.282 1.033 . . . . 0.0 111.627 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.02 -5.62 56.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.477 1.511 . . . . 0.0 113.27 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -101.68 -3.96 27.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.871 1.668 . . . . 0.0 114.734 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.57 -118.86 4.83 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.03 0.824 . . . . 0.0 111.163 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -121.49 165.06 16.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.236 1.415 . . . . 0.0 112.752 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.35 -140.05 7.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.635 1.112 . . . . 0.0 113.188 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -158.87 137.99 5.47 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 124.169 0.89 . . . . 0.0 112.501 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.19 122.52 40.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.488 1.915 . . . . 0.0 109.477 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 12.3 m -110.5 139.86 45.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 110.014 165.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -136.51 134.49 37.63 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.348 1.059 . . . . 0.0 110.174 -168.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.8 m -135.48 125.3 25.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.573 0.749 . . . . 0.0 110.667 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.8 mt -104.07 130.72 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.614 1.166 . . . . 0.0 108.224 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -127.94 147.92 50.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.555 1.542 . . . . 0.0 109.781 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 169.72 -157.81 29.65 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.349 -0.845 . . . . 0.0 114.83 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.5 -20.18 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 113.885 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -151.47 169.84 21.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.567 1.076 . . . . 0.0 112.527 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.19 149.27 50.57 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 9.3 m -132.71 146.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.427 1.091 . . . . 0.0 111.442 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -85.48 111.67 20.2 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.216 0.606 . . . . 0.0 109.821 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.06 132.84 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.392 1.077 . . . . 0.0 109.555 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -128.85 158.58 38.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.158 1.783 . . . . 0.0 110.626 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 32.8 p -139.75 153.63 47.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.132 1.373 . . . . 0.0 111.658 -174.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.41 115.6 4.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.06 1.344 . . . . 0.0 110.461 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.58 129.22 34.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.548 1.139 . . . . 0.0 110.858 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 62.7 mt -101.47 153.84 19.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.546 1.138 . . . . 0.0 112.007 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.81 -18.61 64.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.312 1.045 . . . . 0.0 113.253 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.89 -9.05 58.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.984 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.23 -1.37 62.58 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.084 1.802 . . . . 0.0 114.783 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.0 p -88.87 166.3 14.06 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.117 1.767 . . . . 0.0 111.678 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.0 t -114.85 126.3 54.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 0.0 110.777 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -87.98 134.59 33.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.506 1.122 . . . . 0.0 109.466 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.1 t -117.01 141.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.234 1.814 . . . . 0.0 108.275 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.1 p -134.58 151.24 50.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 110.926 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.95 149.86 29.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.578 0.751 . . . . 0.0 112.955 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.2 t -120.84 99.47 47.06 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.932 1.293 . . . . 0.0 110.192 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.25 135.85 12.36 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.265 2.643 . . . . 0.0 111.829 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 98.2 m -78.3 -46.46 20.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.068 0.547 . . . . 0.0 111.734 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -99.84 148.17 34.43 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.795 1.238 . . . . 0.0 111.06 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 165.26 29.31 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.435 2.757 . . . . 0.0 111.26 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 138.2 -152.59 21.96 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 113.184 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.2 t30 -107.03 121.99 45.57 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.242 1.017 . . . . 0.0 110.663 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -104.45 144.5 31.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.898 1.279 . . . . 0.0 111.104 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.1 130.37 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.716 1.607 . . . . 0.0 107.943 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.1 mt -112.34 121.83 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.638 1.175 . . . . 0.0 109.265 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -100.51 124.85 46.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.582 1.553 . . . . 0.0 109.907 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 34.4 mm -116.56 111.17 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 108.882 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 132.56 53.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.919 1.288 . . . . 0.0 111.276 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 75.3 t80 -125.24 124.14 41.05 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 109.723 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.59 44.67 27.3 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.359 1.064 . . . . 0.0 112.982 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 70.7 m-20 66.39 19.91 10.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.345 2.258 . . . . 0.0 114.634 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -125.53 130.6 52.07 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.593 1.557 . . . . 0.0 110.113 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -71.54 125.65 27.62 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 120.892 -1.13 . . . . 0.0 111.237 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.2 m -78.8 157.44 76.66 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.159 -0.963 . . . . 0.0 111.905 -168.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.87 142.27 64.0 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.83 3.02 . . . . 0.0 113.69 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.34 5.72 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.018 1.294 . . . . 0.0 113.999 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -76.29 144.61 75.0 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-N 118.282 1.041 . . . . 0.0 110.585 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.58 144.52 79.28 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 120.567 1.238 . . . . 0.0 112.273 4.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.76 117.81 35.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.391 1.077 . . . . 0.0 110.427 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.8 p -86.41 136.78 32.99 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.078 0.951 . . . . 0.0 111.395 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.2 t -133.96 113.1 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.203 1.401 . . . . 0.0 109.446 -168.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -77.93 118.29 20.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.99 0.516 . . . . 0.0 110.722 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 81.7 t -110.88 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.879 1.672 . . . . 0.0 109.036 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 9.3 t -104.3 154.36 19.9 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.464 1.106 . . . . 0.0 111.301 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -176.76 173.82 46.58 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.716 1.151 . . . . 0.0 114.484 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 126.188 1.795 . . . . 0.0 111.027 178.225 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.8 ptm -144.69 156.93 44.34 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.175 0.99 . . . . 0.0 113.445 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 65.4 m -138.96 148.5 43.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -138.52 156.47 47.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.333 1.053 . . . . 0.0 113.705 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.9 tt -159.82 150.61 19.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.932 1.693 . . . . 0.0 110.431 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.33 148.23 52.13 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 0.0 112.724 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 53.0 t -139.11 134.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.073 1.749 . . . . 0.0 109.375 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.42 123.94 6.99 Favored Glycine 0 N--CA 1.471 0.987 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 70.9 m -97.19 123.3 40.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.272 1.029 . . . . 0.0 111.526 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -125.33 115.28 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.37 1.468 . . . . 0.0 110.013 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.04 142.72 47.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.145 0.578 . . . . 0.0 111.805 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.51 130.58 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.711 1.204 . . . . 0.0 111.586 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.6 mm -122.43 120.86 27.86 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.367 1.467 . . . . 0.0 108.461 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 145.05 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.451 2.101 . . . . 0.0 110.922 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.47 145.13 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.852 1.661 . . . . 0.0 108.51 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.2 t30 -42.46 114.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.093 1.357 . . . . 0.0 113.596 -166.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.35 135.97 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.869 0.868 . . . . 0.0 110.757 -160.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.4 t -159.84 175.7 12.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.729 1.611 . . . . 0.0 110.527 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.11 33.93 0.5 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 112.664 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -71.97 139.03 48.45 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.578 1.551 . . . . 0.0 111.412 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.19 131.06 36.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.098 0.959 . . . . 0.0 111.469 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.75 -14.98 59.43 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 50.8 m -85.7 -24.05 27.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.659 1.118 . . . . 0.0 113.383 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pp -107.26 3.98 26.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.171 1.388 . . . . 0.0 113.98 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.66 146.98 23.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.252 1.421 . . . . 0.0 111.166 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 58.1 p -140.51 152.99 46.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.435 1.494 . . . . 0.0 110.121 167.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.19 148.39 43.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.422 1.089 . . . . 0.0 112.582 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 2.5 p -147.01 132.37 18.54 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.966 2.106 . . . . 0.0 109.552 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -91.7 136.72 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.22 1.008 . . . . 0.0 109.937 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 90.1 t -109.98 113.76 56.8 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.078 1.351 . . . . 0.0 108.372 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.03 172.77 11.61 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.074 3.183 . . . . 0.0 111.232 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.48 -32.53 53.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.977 3.118 . . . . 0.0 113.875 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 16.4 m -74.14 -10.56 59.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.726 1.21 . . . . 0.0 114.238 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.28 74.87 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.523 1.535 . . . . 0.0 115.173 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -75.62 87.62 2.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.811 1.644 . . . . 0.0 111.297 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.65 135.31 57.31 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.261 1.025 . . . . 0.0 111.892 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -140.24 147.18 49.06 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.136 1.375 . . . . 0.0 111.474 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.2 152.49 45.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.934 3.089 . . . . 0.0 112.066 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.6 m -114.11 150.15 34.53 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.05 1.34 . . . . 0.0 112.052 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.86 115.5 28.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.476 1.11 . . . . 0.0 109.033 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.4 mt -78.78 131.15 36.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.106 1.362 . . . . 0.0 111.131 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 95.8 mttt -132.2 142.03 49.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.191 1.397 . . . . 0.0 112.545 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -93.17 122.04 35.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.57 1.148 . . . . 0.0 108.058 161.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.3 mt -100.8 172.71 6.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.841 1.656 . . . . 0.0 112.577 -165.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -57.55 -35.75 70.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.6 1.56 . . . . 0.0 115.038 -165.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 4.46 44.22 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.245 1.018 . . . . 0.0 113.13 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 90.67 -6.36 82.11 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.485 1.517 . . . . 0.0 113.896 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -71.95 162.71 29.06 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.603 1.561 . . . . 0.0 113.153 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 93.1 t -112.07 141.97 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.462 1.505 . . . . 0.0 109.634 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.0 -176.17 24.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.168 0.89 . . . . 0.0 115.164 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.19 165.91 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.475 1.91 . . . . 0.0 111.063 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 66.3 p -149.07 152.57 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.315 1.046 . . . . 0.0 111.278 167.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.4 p90 -169.32 -172.06 1.41 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.585 2.354 . . . . 0.0 109.522 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.8 t -133.77 118.71 14.56 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 0.0 110.085 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.76 147.82 22.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.615 3.544 . . . . 0.0 111.264 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.1 mptt -100.66 -13.25 18.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.045 0.938 . . . . 0.0 113.194 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -139.97 167.8 21.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.187 2.195 . . . . 0.0 110.104 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.0 p -85.24 167.8 15.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.685 1.194 . . . . 0.0 111.435 168.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.29 -174.04 22.69 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.523 1.535 . . . . 0.0 114.059 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.95 113.08 9.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.2 1.0 . . . . 0.0 111.467 -175.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -96.97 144.18 27.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 109.169 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.8 mt -103.08 126.41 50.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.764 0.825 . . . . 0.0 110.043 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.5 t -89.71 112.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.903 1.281 . . . . 0.0 107.744 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -92.83 138.51 31.43 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.115 . . . . 0.0 109.665 169.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.3 p -151.55 135.93 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.4 -0.813 . . . . 0.0 111.363 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -137.78 145.71 42.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.451 1.1 . . . . 0.0 113.935 -162.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -114.2 127.08 55.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.737 2.415 . . . . 0.0 109.121 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.58 24.0 8.29 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.265 1.026 . . . . 0.0 113.636 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.83 4.41 65.29 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.442 1.496 . . . . 0.0 115.979 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -127.91 141.56 51.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.832 1.816 . . . . 0.0 111.706 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -61.29 138.27 58.24 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.255 -0.903 . . . . 0.0 113.182 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 19.1 m -74.09 163.02 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.388 0.675 . . . . 0.0 111.334 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.15 -24.85 65.05 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 64.4 m -86.67 -12.26 48.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 28.6 t -86.9 143.14 34.81 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 120.771 -1.205 . . . . 0.0 112.757 -172.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.99 156.85 88.04 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.495 0.855 . . . . 0.0 112.836 -3.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.02 126.99 28.09 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.781 1.632 . . . . 0.0 109.127 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.33 141.22 14.19 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.989 2.459 . . . . 0.0 111.594 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 24.7 t -134.25 122.08 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.863 1.665 . . . . 0.0 107.68 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.8 t -97.53 122.42 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.669 0.788 . . . . 0.0 110.179 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.29 117.76 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.804 1.242 . . . . 0.0 108.942 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 59.3 m -92.69 161.54 14.51 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.091 0.956 . . . . 0.0 111.479 172.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.73 -31.86 70.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.991 -1.068 . . . . 0.0 112.197 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.0 m -59.68 -14.31 13.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.323 1.449 . . . . 0.0 114.202 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -100.11 -9.8 22.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.75 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 38.0 mm -80.89 -27.77 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.747 -1.22 . . . . 0.0 112.856 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 169.1 38.7 0.03 OUTLIER Glycine 0 N--CA 1.469 0.844 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.46 96.93 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.197 0.998 . . . . 0.0 111.259 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.59 93.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.9 0.88 . . . . 0.0 112.356 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.3 m -61.44 -18.89 61.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.705 1.202 . . . . 0.0 113.87 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -89.06 -10.22 48.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.445 1.498 . . . . 0.0 114.36 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.8 t -74.66 137.56 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.18 1.355 . . . . 0.0 110.111 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.3 mmt-85 -121.14 161.19 22.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 110.675 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.4 m -147.94 160.97 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.292 1.437 . . . . 0.0 110.999 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -158.41 175.58 13.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.733 1.213 . . . . 0.0 112.285 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 94.99 161.49 34.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.263 1.411 . . . . 0.0 114.08 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -73.81 -26.77 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 113.611 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.19 -2.25 39.23 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.918 1.247 . . . . 0.0 115.364 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.93 -6.83 50.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.542 1.537 . . . . 0.0 112.674 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.36 -39.95 2.29 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.334 1.453 . . . . 0.0 113.163 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.24 155.68 32.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 0.0 113.233 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.08 -174.41 19.86 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.715 1.626 . . . . 0.0 113.382 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 60.5 m80 -138.57 147.48 43.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.467 1.107 . . . . 0.0 112.7 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.4 p -71.82 -19.79 61.93 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -116.23 -1.9 12.27 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -143.67 147.57 39.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.368 1.467 . . . . 0.0 110.492 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.35 142.43 45.32 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.865 2.377 . . . . 0.0 111.204 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 152.39 20.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.631 1.172 . . . . 0.0 110.246 168.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.58 148.07 51.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.887 0.875 . . . . 0.0 112.362 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.14 151.2 27.97 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.61 140.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.953 1.701 . . . . 0.0 109.508 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.92 136.45 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.638 1.575 . . . . 0.0 108.758 169.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.2 t0 -125.93 99.06 5.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.223 1.809 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.2 p -96.48 1.3 51.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.231 1.812 . . . . 0.0 113.085 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -58.65 -39.34 80.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.539 1.063 . . . . 0.0 112.697 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.65 -13.84 59.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.457 1.103 . . . . 0.0 113.249 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -93.52 -5.35 49.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.878 1.671 . . . . 0.0 113.618 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.14 -119.31 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.733 1.158 . . . . 0.0 112.172 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.55 161.54 16.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.377 1.871 . . . . 0.0 112.498 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 138.29 -176.8 20.53 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.065 0.84 . . . . 0.0 115.117 169.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -92.92 123.21 7.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.459 1.028 . . . . 0.0 111.985 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.33 123.0 42.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.119 1.768 . . . . 0.0 108.394 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -114.72 140.79 48.59 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.288 1.435 . . . . 0.0 110.829 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 2.9 tp -125.61 137.39 53.89 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.362 1.865 . . . . 0.0 109.656 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 68.2 m -138.59 126.66 22.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.254 0.622 . . . . 0.0 110.277 167.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 30.0 mt -111.3 135.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.541 1.136 . . . . 0.0 108.466 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -145.4 154.87 42.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.284 1.034 . . . . 0.0 112.246 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.48 -155.67 26.49 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.879 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.92 -10.21 27.19 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.124 3.216 . . . . 0.0 114.286 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.2 t -152.94 164.3 38.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.662 1.185 . . . . 0.0 111.1 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -69.98 144.23 52.38 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.135 -0.978 . . . . 0.0 111.171 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 17.8 m -125.02 151.93 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 0.0 110.962 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -97.26 131.25 44.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.776 0.83 . . . . 0.0 110.064 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.1 135.37 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.132 1.373 . . . . 0.0 109.737 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.57 164.89 24.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 111.069 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.0 p -136.36 160.22 39.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.482 1.513 . . . . 0.0 112.227 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -154.33 122.53 6.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.362 1.465 . . . . 0.0 110.041 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.25 128.56 33.68 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.419 1.088 . . . . 0.0 110.58 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -101.16 152.43 20.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 111.84 -173.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -66.42 -20.33 66.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.283 1.033 . . . . 0.0 113.423 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.2 t0 -80.25 -3.93 51.18 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.112 1.365 . . . . 0.0 113.256 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.37 0.65 67.27 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.606 1.574 . . . . 0.0 114.571 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 18.5 p -88.76 167.7 13.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.604 1.962 . . . . 0.0 111.558 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 45.6 t -121.42 124.88 45.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.096 0.958 . . . . 0.0 111.207 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -84.18 135.49 34.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.775 1.23 . . . . 0.0 109.642 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.71 141.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.901 1.681 . . . . 0.0 108.587 164.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 3.2 p -130.54 148.74 52.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 110.761 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -157.45 148.65 21.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.428 1.091 . . . . 0.0 111.818 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.9 t -118.33 102.65 50.2 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.862 0.865 . . . . 0.0 111.145 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.58 145.88 23.7 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.245 2.63 . . . . 0.0 110.221 173.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 96.6 m -104.87 -38.62 6.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.984 0.914 . . . . 0.0 112.74 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -103.08 147.53 34.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.929 1.292 . . . . 0.0 110.627 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.89 168.31 23.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.498 2.799 . . . . 0.0 111.902 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 131.98 -145.63 17.35 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 125.126 1.346 . . . . 0.0 112.129 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -123.85 129.72 51.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.565 0.746 . . . . 0.0 111.664 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -108.39 143.65 37.03 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.552 1.541 . . . . 0.0 110.373 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 135.99 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.959 1.304 . . . . 0.0 109.0 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 25.7 mt -117.76 122.97 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.095 1.358 . . . . 0.0 109.385 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -102.06 127.62 48.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.965 1.706 . . . . 0.0 110.269 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 18.9 mm -120.02 112.22 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.877 1.271 . . . . 0.0 109.345 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -122.83 134.42 54.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.316 1.446 . . . . 0.0 111.215 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.9 t80 -127.22 123.93 37.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.486 1.514 . . . . 0.0 110.249 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.02 31.09 12.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.423 1.489 . . . . 0.0 114.069 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.59 12.51 0.68 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.337 2.655 . . . . 0.0 114.679 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -116.76 133.88 55.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.673 1.189 . . . . 0.0 110.71 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -72.06 126.74 30.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 110.946 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.7 m -79.44 153.84 76.44 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.318 -0.864 . . . . 0.0 110.954 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.94 146.86 91.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.816 2.344 . . . . 0.0 112.113 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.49 -29.25 6.3 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.263 1.411 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 3.7 t -78.47 145.48 67.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.076 0.95 . . . . 0.0 110.682 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.54 140.5 67.64 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.507 1.217 . . . . 0.0 111.875 2.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.71 116.0 28.24 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.987 0.915 . . . . 0.0 109.936 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 10.3 p -87.53 124.22 33.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.662 1.185 . . . . 0.0 110.651 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.1 t -121.21 114.98 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 109.733 -167.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -76.99 119.64 21.01 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.368 0.667 . . . . 0.0 111.168 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.7 t -109.24 125.84 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.076 1.35 . . . . 0.0 109.342 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.9 t -125.16 168.83 12.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.032 1.333 . . . . 0.0 112.279 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 118.28 148.36 8.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.293 1.901 . . . . 0.0 112.701 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 126.419 1.888 . . . . 0.0 109.729 -173.143 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.0 ptm -161.77 151.25 16.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.495 1.518 . . . . 0.0 111.969 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.2 m -130.54 147.53 52.24 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.445 1.898 . . . . 0.0 108.509 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -149.81 160.58 43.45 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -170.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.04 134.2 15.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.004 2.122 . . . . 0.0 108.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -128.04 139.59 52.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.202 1.001 . . . . 0.0 110.896 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.4 p -156.84 139.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.952 0.901 . . . . 0.0 111.764 -175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -73.62 152.91 46.82 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.079 0.847 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 52.1 m -139.83 133.06 29.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.449 1.1 . . . . 0.0 111.174 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -164.54 150.77 10.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.767 0.827 . . . . 0.0 112.864 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -76.99 151.24 35.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 111.197 168.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 141.85 28.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.852 1.261 . . . . 0.0 112.358 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.3 mt -125.45 111.5 25.84 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.034 1.334 . . . . 0.0 108.38 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.82 139.79 17.9 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.988 2.459 . . . . 0.0 110.376 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 66.7 mt -139.34 136.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.306 1.042 . . . . 0.0 110.451 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 52.47 82.18 0.07 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.007 2.123 . . . . 0.0 112.56 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.7 mm -83.14 43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.705 1.202 . . . . 0.0 110.495 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 60.4 m -132.24 -57.42 0.96 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.277 1.431 . . . . 0.0 111.963 -173.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -162.9 107.29 1.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.873 0.869 . . . . 0.0 111.628 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.7 p -141.78 160.83 39.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.585 1.954 . . . . 0.0 110.139 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -151.56 126.77 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.608 1.163 . . . . 0.0 110.81 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.86 -15.25 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 56.5 m -80.65 -9.88 59.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.693 1.133 . . . . 0.0 113.415 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.93 7.42 2.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.53 145.9 24.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.613 1.165 . . . . 0.0 111.84 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 22.8 p -141.94 152.01 43.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.939 2.096 . . . . 0.0 108.829 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.63 149.2 27.33 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 73.1 p -141.68 162.45 35.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.126 2.17 . . . . 0.0 110.056 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -118.07 137.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.275 1.43 . . . . 0.0 109.976 169.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.2 t -105.77 114.12 63.2 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.172 1.389 . . . . 0.0 108.396 167.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.67 173.55 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.166 3.244 . . . . 0.0 111.272 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.22 -33.4 54.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.063 3.175 . . . . 0.0 114.097 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.6 m -75.78 -8.24 56.37 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.29 -1.62 75.12 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.459 1.505 . . . . 0.0 115.196 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -76.9 88.82 3.48 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.445 1.498 . . . . 0.0 111.299 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.47 129.6 41.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.278 1.031 . . . . 0.0 111.796 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -130.63 149.28 73.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.084 1.754 . . . . 0.0 110.6 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.39 153.76 35.59 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.795 2.996 . . . . 0.0 112.547 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 79.8 m -99.16 155.94 17.21 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 112.24 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.7 tt -93.91 113.03 24.96 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.305 1.442 . . . . 0.0 108.101 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mt -83.05 136.37 34.51 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.886 1.275 . . . . 0.0 111.246 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -137.95 143.8 40.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.74 1.216 . . . . 0.0 113.533 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -94.17 122.31 36.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 155.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.49 167.6 11.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.379 1.472 . . . . 0.0 112.303 -166.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.04 -29.9 67.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.34 1.25 53.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.21 1.004 . . . . 0.0 113.341 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.64 67.54 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.804 1.669 . . . . 0.0 114.772 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -77.12 168.97 19.18 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.383 1.473 . . . . 0.0 113.443 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 77.8 t -112.05 140.3 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.452 1.501 . . . . 0.0 110.486 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.12 -171.81 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.355 0.978 . . . . 0.0 115.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.1 162.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.502 1.521 . . . . 0.0 112.458 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 37.0 m -132.33 159.83 38.05 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.946 1.699 . . . . 0.0 110.438 161.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.29 -177.05 5.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.425 1.89 . . . . 0.0 109.998 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.8 t -130.27 121.05 19.33 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.795 0.838 . . . . 0.0 109.738 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.71 139.01 15.51 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.95 3.1 . . . . 0.0 110.799 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 55.6 tptt -88.95 -20.03 25.01 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -135.55 176.01 9.06 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.494 1.918 . . . . 0.0 110.897 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 76.1 p -92.1 164.3 13.64 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.534 1.133 . . . . 0.0 111.053 167.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 100.24 -168.41 20.99 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.156 1.36 . . . . 0.0 113.928 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.58 112.84 11.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 0.0 111.941 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 19.3 m80 -100.66 141.25 33.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.851 1.66 . . . . 0.0 109.129 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.39 125.82 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 109.648 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.7 t -86.85 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 108.099 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -101.64 134.39 44.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.796 1.239 . . . . 0.0 109.915 170.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.2 p -139.75 128.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.278 1.037 . . . . 0.0 112.202 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -115.84 141.71 47.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.599 2.359 . . . . 0.0 111.01 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -137.11 118.71 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.574 2.35 . . . . 0.0 109.357 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.4 t30 56.34 29.02 14.33 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.761 1.224 . . . . 0.0 113.685 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 95.42 3.91 61.14 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.135 1.35 . . . . 0.0 116.169 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -137.62 153.77 49.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.567 1.684 . . . . 0.0 111.482 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -65.27 142.28 58.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.65 -1.281 . . . . 0.0 113.156 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' 2032 ' ' SER . 61.5 t -67.24 147.87 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.624 1.17 . . . . 0.0 109.457 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.05 64.28 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . 0.422 ' H ' HG12 ' A' 2030 ' ' VAL . 11.5 m -76.18 -14.18 60.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.581 1.552 . . . . 0.0 114.002 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 10.1 t -85.67 141.57 36.32 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.674 1.19 . . . . 0.0 112.861 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.15 154.2 86.09 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.506 0.859 . . . . 0.0 112.56 -4.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.6 118.88 56.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.58 1.552 . . . . 0.0 108.582 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.16 140.71 12.52 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.071 2.514 . . . . 0.0 111.038 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 16.0 t -137.62 125.34 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.818 1.647 . . . . 0.0 108.118 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.4 t -97.78 122.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.683 0.793 . . . . 0.0 110.192 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.92 131.06 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.17 1.388 . . . . 0.0 110.023 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.9 t -95.24 171.82 8.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.81 1.244 . . . . 0.0 112.331 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -23.36 62.96 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.525 -1.359 . . . . 0.0 112.938 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 4.2 m -74.6 -12.72 60.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -117.71 6.59 12.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.47 1.508 . . . . 0.0 113.744 -173.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.45 -39.5 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.024 0.93 . . . . 0.0 112.658 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.0 42.01 0.03 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 123.833 0.73 . . . . 0.0 114.211 -169.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.23 104.97 6.02 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 117.861 0.831 . . . . 0.0 111.981 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.64 93.49 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.523 -0.736 . . . . 0.0 112.797 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 19.4 m -60.09 -27.5 67.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.208 1.003 . . . . 0.0 113.256 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -80.73 -10.4 59.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.398 1.479 . . . . 0.0 114.246 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 93.4 t -81.91 136.09 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.036 1.289 . . . . 0.0 109.455 172.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -131.74 156.8 45.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.24 1.416 . . . . 0.0 110.737 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.6 m -144.7 158.77 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.818 1.247 . . . . 0.0 111.666 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 95.1 p -158.34 172.57 18.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.819 1.247 . . . . 0.0 112.863 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.94 153.09 28.08 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.893 1.235 . . . . 0.0 113.169 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -77.29 -16.46 58.96 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -168.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.06 29.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.704 1.145 . . . . 0.0 114.748 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -87.96 -3.96 58.86 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.683 1.593 . . . . 0.0 112.785 168.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -134.24 -39.57 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.832 1.253 . . . . 0.0 113.936 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.26 148.81 40.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.191 1.396 . . . . 0.0 111.362 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.95 175.86 26.12 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.728 1.156 . . . . 0.0 113.838 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 61.7 m80 -132.13 154.6 49.33 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.284 1.434 . . . . 0.0 111.811 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 9.9 p -67.11 -65.86 0.63 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.394 1.078 . . . . 0.0 112.796 -175.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.77 7.49 44.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.26 1.024 . . . . 0.0 113.507 -166.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.58 143.17 43.89 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.751 2.02 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.48 152.2 48.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.691 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -101.03 162.48 12.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.617 1.567 . . . . 0.0 110.924 168.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.69 149.95 34.46 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 50.2 p90 -159.85 153.73 23.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.695 1.598 . . . . 0.0 111.18 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 142.17 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 109.523 -172.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 39.7 mt -120.24 136.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.519 1.927 . . . . 0.0 109.391 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.0 125.53 41.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.577 1.551 . . . . 0.0 111.892 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 40.3 p -122.35 -13.43 8.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.31 -25.41 68.03 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.632 1.56 . . . . 0.0 114.732 -170.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.15 -16.52 60.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.218 1.007 . . . . 0.0 112.892 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.64 49.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.534 1.534 . . . . 0.0 113.669 172.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 80.52 -119.33 4.88 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.597 1.094 . . . . 0.0 112.063 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -92.49 169.58 10.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.521 1.528 . . . . 0.0 112.822 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.51 -138.49 7.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.009 1.29 . . . . 0.0 112.739 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -178.2 136.15 2.89 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 124.352 0.977 . . . . 0.0 112.017 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.88 122.92 40.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.736 1.614 . . . . 0.0 109.651 -175.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 46.1 m -112.21 132.91 54.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 109.476 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -130.03 135.83 48.71 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.33 1.452 . . . . 0.0 109.633 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 71.0 m -130.6 140.24 50.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.585 0.754 . . . . 0.0 111.01 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.4 mt -118.17 127.11 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.105 1.362 . . . . 0.0 107.764 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.36 140.42 46.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.207 1.403 . . . . 0.0 109.535 -168.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 171.38 -155.82 25.03 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.809 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 -22.69 27.53 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.379 2.719 . . . . 0.0 113.682 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 63.8 m -145.48 160.04 42.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.568 1.147 . . . . 0.0 112.367 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -67.31 146.3 54.25 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.182 0.993 . . . . 0.0 111.228 169.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -130.17 149.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.718 1.607 . . . . 0.0 110.769 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.46 105.46 17.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.768 0.827 . . . . 0.0 110.122 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 41.0 mt -85.51 130.49 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -126.29 157.36 38.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 110.418 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.9 p -144.5 153.45 41.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.795 1.238 . . . . 0.0 112.279 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -158.1 134.99 9.85 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.118 1.367 . . . . 0.0 110.591 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -80.98 131.97 35.35 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.712 0.805 . . . . 0.0 111.905 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.92 168.81 13.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.452 1.501 . . . . 0.0 111.332 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -32.11 69.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.91 -7.52 54.75 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.307 1.443 . . . . 0.0 113.518 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 88.02 6.76 75.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.484 1.516 . . . . 0.0 114.114 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 22.2 p -80.42 154.17 27.82 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.747 1.619 . . . . 0.0 110.617 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -100.35 119.14 37.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.456 0.702 . . . . 0.0 110.597 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -86.54 133.19 33.75 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.698 0.799 . . . . 0.0 109.519 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 19.2 t -113.4 138.05 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.67 1.988 . . . . 0.0 108.645 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 23.9 p -135.85 151.93 50.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.426 1.49 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -163.16 153.16 15.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 111.811 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.4 t -119.31 100.59 49.88 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.405 1.082 . . . . 0.0 110.91 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.75 85.56 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.687 2.925 . . . . 0.0 110.937 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 18.7 m -54.42 -39.41 67.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 0.0 113.936 -170.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -95.32 140.09 22.26 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.259 1.024 . . . . 0.0 111.014 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 165.38 31.98 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.694 2.93 . . . . 0.0 112.358 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 139.54 -160.08 25.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.0 1.286 . . . . 0.0 113.115 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -107.27 119.55 39.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.186 0.994 . . . . 0.0 110.513 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.89 141.31 36.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.463 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.56 131.47 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.237 1.415 . . . . 0.0 108.063 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.7 mt -110.21 119.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.423 1.089 . . . . 0.0 108.901 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -102.14 124.43 47.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 110.697 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.73 115.53 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.394 1.477 . . . . 0.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.7 134.87 48.61 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 0.0 111.604 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -126.99 124.47 39.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.864 1.666 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.78 34.78 19.87 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.022 1.329 . . . . 0.0 113.683 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.4 t70 89.71 -0.65 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.269 3.027 . . . . 0.0 113.929 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -119.39 132.82 55.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.688 1.195 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -69.15 128.42 36.57 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.278 1.431 . . . . 0.0 111.93 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -85.67 160.65 52.83 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 119.133 0.879 . . . . 0.0 112.155 -169.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.92 149.27 43.05 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.071 3.18 . . . . 0.0 114.471 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 80.65 -30.0 2.58 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.222 1.392 . . . . 0.0 113.827 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -72.83 142.58 83.4 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 110.547 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.03 139.59 62.54 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 120.631 1.261 . . . . 0.0 111.896 6.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.14 111.92 24.19 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.066 0.946 . . . . 0.0 110.21 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 67.3 m -85.57 127.41 34.44 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.982 0.913 . . . . 0.0 110.888 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -124.43 112.1 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.66 1.584 . . . . 0.0 109.35 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.56 118.17 21.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.859 0.463 . . . . 0.0 110.722 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.0 t -104.11 124.76 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.874 1.67 . . . . 0.0 109.193 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.1 t -124.87 162.88 23.42 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 112.367 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 122.98 159.22 10.46 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.297 1.903 . . . . 0.0 113.096 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 125.797 1.639 . . . . 0.0 110.223 -173.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 28.3 ttt -118.54 129.35 55.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.669 1.188 . . . . 0.0 111.094 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 4.3 m -123.26 141.77 51.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.947 1.699 . . . . 0.0 108.589 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -156.8 162.02 39.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.4 tt -154.69 145.49 22.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.852 2.061 . . . . 0.0 110.261 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -135.29 143.71 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.609 1.164 . . . . 0.0 112.184 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 42.6 t -132.88 134.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 110.143 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.01 63.71 4.35 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 125.349 1.452 . . . . 0.0 112.057 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 10.1 m -58.51 124.77 20.74 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 114.154 -171.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -156.8 150.02 24.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.114 1.366 . . . . 0.0 111.69 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.71 153.44 21.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.131 0.972 . . . . 0.0 111.382 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -90.73 139.66 30.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.668 1.187 . . . . 0.0 112.116 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 36.1 mm -125.27 123.85 25.21 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 108.935 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.44 149.73 45.11 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.771 2.314 . . . . 0.0 111.526 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.91 148.37 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.089 1.756 . . . . 0.0 108.805 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 53.3 t30 -44.05 116.47 1.0 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.363 1.465 . . . . 0.0 113.772 -170.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 5.1 mp -87.38 130.42 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.008 1.323 . . . . 0.0 109.749 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.7 t -164.16 -175.59 4.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.209 1.403 . . . . 0.0 111.134 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.78 1.0 21.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.631 1.572 . . . . 0.0 113.658 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.1 m -57.33 133.5 55.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.568 1.947 . . . . 0.0 111.338 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.44 122.3 19.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.193 0.997 . . . . 0.0 111.402 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.22 -20.48 60.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.033 0.933 . . . . 0.0 113.076 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 67.5 m -72.97 -18.24 61.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -109.38 5.83 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.665 1.586 . . . . 0.0 113.494 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.3 146.31 29.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.592 1.557 . . . . 0.0 111.455 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 49.9 p -134.59 168.42 19.02 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.222 1.809 . . . . 0.0 109.854 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -145.33 141.76 28.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.821 0.849 . . . . 0.0 112.243 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 64.2 p -135.2 163.35 30.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.693 1.997 . . . . 0.0 109.428 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -115.78 136.55 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.802 1.241 . . . . 0.0 109.55 167.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.0 t -107.03 113.21 62.73 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.59 1.556 . . . . 0.0 108.17 167.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -80.24 173.47 12.49 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.289 3.326 . . . . 0.0 111.272 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.18 -28.01 49.6 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.196 3.264 . . . . 0.0 114.83 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.0 p -79.03 -9.18 59.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.789 1.235 . . . . 0.0 114.143 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.3 0.25 88.71 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.46 1.505 . . . . 0.0 114.695 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.61 84.43 3.28 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.518 1.527 . . . . 0.0 111.491 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.87 133.4 55.4 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.643 1.177 . . . . 0.0 112.009 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.81 149.65 59.98 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.412 1.485 . . . . 0.0 110.986 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.11 154.52 42.05 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.93 3.087 . . . . 0.0 112.669 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 84.9 m -108.24 153.45 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.094 1.358 . . . . 0.0 112.686 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 63.4 tp -88.11 112.57 22.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.455 1.102 . . . . 0.0 109.938 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.75 134.41 33.58 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.967 1.307 . . . . 0.0 111.165 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -142.9 148.86 37.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.008 1.323 . . . . 0.0 112.911 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -80.49 122.38 26.93 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.023 1.329 . . . . 0.0 108.364 160.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.41 177.36 6.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.316 1.446 . . . . 0.0 112.704 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -53.84 -43.03 69.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.504 1.522 . . . . 0.0 114.218 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.17 4.42 53.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.718 1.207 . . . . 0.0 113.688 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.74 -7.02 74.11 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.883 1.23 . . . . 0.0 114.403 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.05 174.24 8.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.894 1.278 . . . . 0.0 112.602 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -127.9 142.47 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.38 1.472 . . . . 0.0 109.548 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.17 34.35 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.72 163.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.12 1.768 . . . . 0.0 112.731 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 4.4 m -137.89 155.4 48.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 110.336 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 16.8 p90 -164.16 -176.07 4.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.185 2.594 . . . . 0.0 108.909 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.2 t -131.35 123.3 19.5 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 119.105 0.866 . . . . 0.0 109.246 169.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.5 148.2 26.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.038 3.158 . . . . 0.0 111.441 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -107.79 -8.34 16.06 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.21 172.74 12.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.027 2.131 . . . . 0.0 109.78 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 168.0 15.17 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.639 1.176 . . . . 0.0 111.529 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.61 -170.39 26.73 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.122 1.344 . . . . 0.0 114.013 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.69 115.09 10.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.221 1.008 . . . . 0.0 111.687 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.0 m80 -98.27 144.05 28.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.757 1.623 . . . . 0.0 109.134 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.59 126.99 54.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.237 1.015 . . . . 0.0 109.544 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.5 t -85.55 118.87 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.41 96.6 7.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.535 1.534 . . . . 0.0 110.089 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 89.0 t -86.08 137.71 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.855 1.662 . . . . 0.0 108.975 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.3 mttm -133.64 131.75 39.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.145 0.978 . . . . 0.0 112.99 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 80.6 tttt -96.25 119.49 34.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.063 1.345 . . . . 0.0 109.281 161.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.46 22.87 5.36 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.845 1.258 . . . . 0.0 114.074 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.14 3.7 88.77 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.401 1.477 . . . . 0.0 115.582 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -106.28 23.28 14.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.397 1.479 . . . . 0.0 113.305 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.7 m-70 65.26 -170.77 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.936 1.694 . . . . 0.0 112.527 -172.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 34.1 m -136.29 171.84 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.943 1.297 . . . . 0.0 110.795 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.7 -29.7 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.5 m -89.46 -10.47 46.27 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.8 p -89.98 153.99 47.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 120.709 -1.244 . . . . 0.0 113.715 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.8 157.16 95.2 Favored 'Cis proline' 0 C--N 1.353 0.78 0 CA-C-N 118.856 0.627 . . . . 0.0 112.41 -4.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.01 122.81 39.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.703 1.201 . . . . 0.0 108.774 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.64 146.36 11.96 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.043 2.495 . . . . 0.0 112.576 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 19.4 t -137.52 125.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.985 1.714 . . . . 0.0 107.921 170.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.2 t -102.09 124.69 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.701 0.8 . . . . 0.0 110.635 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.36 139.53 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.439 1.496 . . . . 0.0 110.232 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 15.2 t -116.7 164.71 14.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.817 1.247 . . . . 0.0 111.449 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.04 -37.65 77.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.401 1.08 . . . . 0.0 112.738 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 48.8 m -60.71 -18.41 54.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.63 -6.63 32.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.166 1.386 . . . . 0.0 113.142 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.61 -32.88 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.086 -1.009 . . . . 0.0 112.701 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 140.42 29.61 0.19 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.754 1.169 . . . . 0.0 113.641 -168.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 28.2 t0 -73.34 114.57 11.69 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.421 1.11 . . . . 0.0 110.685 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.72 74.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.811 0.844 . . . . 0.0 113.015 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 60.4 p -66.85 -21.03 66.03 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.986 -1.071 . . . . 0.0 113.196 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -77.9 -14.85 59.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.775 1.23 . . . . 0.0 113.399 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 48.3 t -79.7 132.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.618 1.099 . . . . 0.0 110.08 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -113.87 154.49 27.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.764 1.625 . . . . 0.0 110.57 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.81 149.75 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.209 1.404 . . . . 0.0 111.008 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 74.6 m -150.78 160.41 43.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.925 1.29 . . . . 0.0 112.325 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 113.76 162.92 14.89 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.418 1.009 . . . . 0.0 115.021 171.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -65.23 -34.42 78.31 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.675 1.59 . . . . 0.0 113.249 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.82 -1.65 33.04 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.934 1.254 . . . . 0.0 115.053 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.1 mt -90.2 -7.27 53.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.401 1.481 . . . . 0.0 112.689 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -128.33 -36.32 1.92 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.834 1.253 . . . . 0.0 113.794 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -158.78 158.09 32.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.683 1.193 . . . . 0.0 112.396 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -154.81 -174.91 25.31 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.441 1.019 . . . . 0.0 114.166 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -141.71 137.97 32.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.324 1.45 . . . . 0.0 111.18 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.2 p -63.48 146.65 53.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.265 0.626 . . . . 0.0 111.307 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 4.4 m-85 73.93 -4.73 2.19 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.069 2.148 . . . . 0.0 113.896 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -120.97 148.4 48.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.795 2.038 . . . . 0.0 110.191 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.47 125.06 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 110.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -86.57 145.51 26.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.273 1.029 . . . . 0.0 109.54 165.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.48 151.45 50.95 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -158.51 152.13 23.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.163 1.785 . . . . 0.0 110.548 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.19 140.46 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.538 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.2 mt -114.57 136.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.281 1.832 . . . . 0.0 109.094 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 57.5 t0 -123.08 100.92 7.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.045 1.738 . . . . 0.0 110.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.9 p -99.2 4.25 46.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.581 1.952 . . . . 0.0 112.831 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.85 -33.15 71.4 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.489 1.041 . . . . 0.0 112.835 -173.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.24 -10.03 55.38 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.376 1.47 . . . . 0.0 113.383 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.84 -9.76 19.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.17 1.788 . . . . 0.0 114.08 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 69.38 -134.89 26.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.954 1.264 . . . . 0.0 114.008 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -74.04 167.36 21.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.079 1.352 . . . . 0.0 112.635 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.97 -116.99 0.97 Allowed Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.558 1.075 . . . . 0.0 112.022 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . 176.2 116.32 0.45 Allowed Glycine 0 N--CA 1.465 0.612 0 C-N-CA 123.87 0.748 . . . . 0.0 112.812 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.03 124.97 29.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.496 1.118 . . . . 0.0 109.517 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 69.0 m -124.52 144.59 50.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.773 1.629 . . . . 0.0 109.616 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -144.35 132.46 21.66 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.344 0.658 . . . . 0.0 110.223 -164.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 49.6 m -132.53 139.03 47.71 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.604 0.762 . . . . 0.0 111.098 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.9 mt -123.93 138.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.723 1.609 . . . . 0.0 108.622 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.94 157.56 44.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 161.85 -146.31 11.93 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.873 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.62 -11.27 24.15 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.582 2.855 . . . . 0.0 113.989 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.8 t -155.97 161.08 40.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.594 1.088 . . . . 0.0 112.411 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 130.39 35.09 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.299 1.44 . . . . 0.0 109.727 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.7 m -114.23 157.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.158 1.383 . . . . 0.0 111.856 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -92.5 126.13 37.45 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.501 0.72 . . . . 0.0 109.813 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.7 mt -106.67 134.64 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 109.427 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -131.87 162.59 30.23 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.014 1.726 . . . . 0.0 111.056 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 23.0 p -137.99 159.95 40.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.391 1.476 . . . . 0.0 112.079 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.83 122.76 6.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.236 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 128.6 34.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.726 1.21 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 69.5 mt -104.41 151.3 23.68 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.507 1.123 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.35 -17.55 64.27 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.734 0.813 . . . . 0.0 113.057 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -70.69 -10.8 60.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.439 1.496 . . . . 0.0 113.453 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.71 -3.2 70.9 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.153 1.835 . . . . 0.0 114.187 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 42.6 p -87.85 168.97 12.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.252 1.821 . . . . 0.0 111.319 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -123.81 127.15 47.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.992 0.917 . . . . 0.0 111.408 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -79.51 135.08 36.54 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.229 165.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 48.0 t -113.14 139.78 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.173 1.789 . . . . 0.0 108.381 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.2 p -133.83 150.47 51.41 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 111.565 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.0 p90 -155.19 146.94 23.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.524 1.13 . . . . 0.0 112.019 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 38.3 t -113.73 106.93 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.275 1.03 . . . . 0.0 111.179 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.67 145.77 16.42 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.571 2.847 . . . . 0.0 111.059 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 91.5 m -104.01 -47.13 4.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -86.61 143.23 35.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.12 162.13 28.98 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.346 2.697 . . . . 0.0 111.3 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.54 -164.69 24.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.24 1.4 . . . . 0.0 113.566 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -90.59 118.99 30.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.499 0.719 . . . . 0.0 111.059 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -100.21 141.1 33.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.719 1.208 . . . . 0.0 110.107 167.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.56 131.05 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.503 1.121 . . . . 0.0 108.359 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.5 mt -113.61 130.58 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.292 1.437 . . . . 0.0 109.372 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -114.19 123.95 50.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.595 1.558 . . . . 0.0 110.115 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.91 119.78 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.065 0.946 . . . . 0.0 109.693 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -122.99 136.48 54.87 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.866 2.066 . . . . 0.0 109.787 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.04 122.13 22.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.661 1.185 . . . . 0.0 110.239 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.67 45.11 27.33 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.901 1.28 . . . . 0.0 111.987 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.6 t0 73.03 -4.47 2.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.848 2.859 . . . . 0.0 114.744 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -101.33 132.52 46.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.571 1.148 . . . . 0.0 110.748 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -69.65 125.61 27.24 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.229 1.012 . . . . 0.0 111.292 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -79.32 153.5 76.67 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.218 -0.926 . . . . 0.0 111.025 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.02 140.97 81.82 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.666 2.244 . . . . 0.0 111.647 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.66 22.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.376 1.465 . . . . 0.0 113.745 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 66.6 m -76.73 153.55 83.28 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 118.594 1.197 . . . . 0.0 111.993 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.56 142.83 73.38 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.311 0.789 . . . . 0.0 111.352 -7.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -96.18 116.52 29.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.415 1.086 . . . . 0.0 110.205 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 58.0 m -83.1 128.67 34.69 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.737 0.815 . . . . 0.0 110.449 169.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -127.07 110.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.541 1.537 . . . . 0.0 109.207 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -78.58 107.73 11.46 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.035 0.534 . . . . 0.0 110.763 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.0 t -94.47 118.06 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.787 1.235 . . . . 0.0 108.806 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -90.3 150.71 21.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.874 0.87 . . . . 0.0 110.847 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -177.2 160.23 27.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.26 0.933 . . . . 0.0 114.552 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 0.0 113.605 -176.094 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 121.199 0.523 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 20.3 ptm -158.76 163.04 37.11 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.618 1.567 . . . . 0.0 112.417 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 19.3 m -136.99 143.9 43.03 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.419 1.888 . . . . 0.0 109.097 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -143.58 165.15 28.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -164.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -156.65 155.65 32.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.868 2.067 . . . . 0.0 110.5 -175.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . 0.421 ' H ' HD13 ' A' 1963 ' ' LEU . 61.1 mttm -136.94 143.83 43.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.444 1.498 . . . . 0.0 111.478 173.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 57.8 t -141.04 135.66 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.832 1.653 . . . . 0.0 109.534 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.29 133.32 11.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.898 0.761 . . . . 0.0 112.045 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 62.5 m -120.3 146.58 45.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.89 1.276 . . . . 0.0 112.602 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -157.03 150.65 24.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.493 1.117 . . . . 0.0 112.589 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.58 148.86 25.3 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.401 1.081 . . . . 0.0 111.229 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -86.56 126.98 34.85 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.806 1.243 . . . . 0.0 111.203 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.6 mm -113.22 113.29 48.98 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 124.926 1.29 . . . . 0.0 109.01 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.11 138.57 20.58 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.989 2.459 . . . . 0.0 110.948 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 55.2 mt -143.35 136.5 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.82 1.248 . . . . 0.0 109.713 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 11.5 t30 59.22 69.82 0.69 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.305 1.842 . . . . 0.0 113.058 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.68 104.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.73 0.812 . . . . 0.0 109.657 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.6 t -173.69 -168.56 0.44 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.971 2.108 . . . . 0.0 109.928 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.16 51.93 1.05 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.1 1.76 . . . . 0.0 111.893 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 91.9 m -83.72 124.04 30.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.545 1.538 . . . . 0.0 109.773 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -90.46 126.53 35.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.702 1.201 . . . . 0.0 110.258 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -31.06 55.91 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.941 1.296 . . . . 0.0 112.132 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 57.3 m -73.02 -22.92 60.57 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -160.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' 1982 ' ' LEU . 1.9 pt? -111.72 2.47 17.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.402 1.481 . . . . 0.0 114.079 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.79 152.25 20.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.066 1.347 . . . . 0.0 112.084 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.0 p -140.77 172.42 12.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.62 2.368 . . . . 0.0 108.641 165.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -156.56 160.29 39.33 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 78.3 p -133.07 161.5 34.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.461 1.905 . . . . 0.0 109.824 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -111.75 135.13 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.953 1.301 . . . . 0.0 109.243 166.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.8 t -103.52 110.66 64.23 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.74 1.216 . . . . 0.0 107.89 163.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.09 169.43 17.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.766 2.977 . . . . 0.0 110.897 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.51 -19.75 65.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.902 2.401 . . . . 0.0 112.025 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 1.9 m -68.66 -10.57 57.02 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.642 1.577 . . . . 0.0 113.668 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 77.62 -13.3 12.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.131 1.824 . . . . 0.0 115.411 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -80.51 94.92 6.34 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.833 1.253 . . . . 0.0 111.181 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.64 133.97 55.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.161 0.984 . . . . 0.0 111.473 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.28 150.75 62.41 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.356 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.82 156.23 34.95 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.942 3.095 . . . . 0.0 112.882 -176.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 88.7 m -104.93 153.04 21.92 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.35 1.46 . . . . 0.0 112.244 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -96.79 116.72 29.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.468 1.507 . . . . 0.0 107.956 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.88 137.54 32.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.199 1.0 . . . . 0.0 110.613 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.31 137.56 47.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.693 1.197 . . . . 0.0 112.766 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -89.23 120.05 30.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.768 1.227 . . . . 0.0 107.796 160.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.65 164.65 12.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.021 1.328 . . . . 0.0 111.804 -169.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -69.88 -24.3 63.39 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -159.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -90.57 0.1 57.48 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.146 0.979 . . . . 0.0 113.549 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.96 -6.48 54.2 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 125.394 1.473 . . . . 0.0 114.146 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -74.35 174.04 9.41 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.359 1.464 . . . . 0.0 113.197 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 30.3 m -134.46 152.15 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.239 1.416 . . . . 0.0 110.931 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -162.0 -170.84 27.31 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.972 0.796 . . . . 0.0 115.064 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.39 158.89 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.403 1.481 . . . . 0.0 112.686 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 53.4 m -132.24 153.82 50.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.595 1.558 . . . . 0.0 111.047 165.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.2 p90 -165.63 -169.88 1.67 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.769 2.428 . . . . 0.0 108.913 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 92.0 t -133.99 120.75 15.38 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 119.924 1.238 . . . . 0.0 110.29 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.86 147.69 17.09 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.341 3.36 . . . . 0.0 111.279 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.7 -12.29 17.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.79 172.93 12.33 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.856 2.062 . . . . 0.0 109.969 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.9 p -86.1 171.15 11.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.06 1.344 . . . . 0.0 111.89 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.54 -170.03 26.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.075 1.321 . . . . 0.0 113.874 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.46 117.61 12.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.097 0.959 . . . . 0.0 111.78 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.2 m80 -104.24 143.57 32.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.042 1.737 . . . . 0.0 109.269 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.1 122.24 44.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.257 1.023 . . . . 0.0 109.352 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 50.9 t -91.55 125.35 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.157 1.383 . . . . 0.0 108.558 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -110.22 113.53 26.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.217 1.407 . . . . 0.0 110.189 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 42.3 t -102.66 139.49 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.332 1.453 . . . . 0.0 109.36 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -144.81 142.32 29.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -172.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.87 121.41 44.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.052 2.541 . . . . 0.0 109.58 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.1 t30 53.35 30.13 9.78 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.374 1.069 . . . . 0.0 113.545 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.05 66.08 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.64 1.59 . . . . 0.0 115.587 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -101.11 133.3 45.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.28 1.432 . . . . 0.0 110.903 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.06 139.6 57.37 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 91.2 t -76.02 142.52 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.254 1.422 . . . . 0.0 108.874 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.79 62.76 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 20.0 m -76.93 -12.63 59.98 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.832 1.253 . . . . 0.0 114.022 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 47.9 m -84.43 153.79 62.22 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.582 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.98 152.11 88.51 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-O 121.357 0.482 . . . . 0.0 112.306 -4.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.06 124.6 37.92 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.959 1.304 . . . . 0.0 108.742 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.74 137.14 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.887 2.391 . . . . 0.0 111.145 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 48.9 t -133.07 124.34 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.411 1.484 . . . . 0.0 107.815 172.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.7 t -96.87 125.35 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.822 0.849 . . . . 0.0 110.372 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.84 125.74 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.128 1.371 . . . . 0.0 109.198 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.3 t -93.39 158.75 15.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.022 0.929 . . . . 0.0 111.905 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -58.29 -31.58 67.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.09 0.956 . . . . 0.0 113.02 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 24.5 m -66.06 -18.42 65.33 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.2 1.0 . . . . 0.0 113.644 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -92.07 -13.0 31.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.473 1.109 . . . . 0.0 112.703 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.6 mm -70.12 -26.19 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.356 1.062 . . . . 0.0 112.491 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 149.8 63.4 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.356 0.979 . . . . 0.0 113.586 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -76.57 94.19 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.382 0.673 . . . . 0.0 110.922 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.82 61.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.483 1.113 . . . . 0.0 112.627 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.4 p -55.78 -22.82 26.28 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.97 1.708 . . . . 0.0 114.639 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -94.53 -7.98 39.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.306 1.442 . . . . 0.0 113.688 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.2 t -73.98 138.45 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.637 1.108 . . . . 0.0 110.693 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -114.8 147.48 39.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.584 1.554 . . . . 0.0 111.796 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.6 m -143.82 144.17 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.787 1.635 . . . . 0.0 109.807 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.4 m -149.09 156.08 41.68 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.254 -173.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 118.1 162.56 12.37 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 124.706 1.146 . . . . 0.0 114.186 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -65.47 -30.25 71.01 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.729 1.212 . . . . 0.0 113.377 -170.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.1 -1.6 34.78 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.713 1.149 . . . . 0.0 114.878 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.4 -7.67 56.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.182 1.393 . . . . 0.0 112.554 167.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -130.06 -37.55 1.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.161 1.384 . . . . 0.0 114.056 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.19 158.62 37.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.157 0.983 . . . . 0.0 113.405 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.67 -173.37 20.08 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.435 1.493 . . . . 0.0 113.271 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -136.5 146.35 46.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.398 1.079 . . . . 0.0 112.784 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.9 p -67.27 -21.48 65.7 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -120.56 -0.81 10.2 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -142.8 148.45 46.05 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.176 1.39 . . . . 0.0 110.592 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.81 145.33 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.88 2.387 . . . . 0.0 111.76 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -91.14 153.14 20.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.028 1.331 . . . . 0.0 110.442 169.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.53 148.17 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.882 0.873 . . . . 0.0 113.063 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -159.04 149.28 19.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 110.74 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 141.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.256 1.822 . . . . 0.0 109.332 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.72 138.14 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.288 1.835 . . . . 0.0 109.634 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 22.0 t0 -136.7 117.64 14.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 111.69 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 12.4 p -123.34 -10.36 8.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -165.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -64.58 -23.62 67.33 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.539 1.518 . . . . 0.0 114.526 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -19.9 61.51 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.286 1.034 . . . . 0.0 112.785 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -90.51 -0.65 57.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.823 1.649 . . . . 0.0 113.672 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.46 -120.61 5.31 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.06 1.314 . . . . 0.0 112.196 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -107.25 165.43 11.38 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.016 1.726 . . . . 0.0 112.386 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.59 -178.07 19.14 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 115.229 0.852 . . . . 0.0 115.229 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.2 126.44 8.75 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.699 1.142 . . . . 0.0 112.022 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.26 121.25 36.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.289 1.835 . . . . 0.0 108.313 170.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 70.5 m -113.81 146.44 39.94 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.615 1.566 . . . . 0.0 110.867 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -141.34 133.55 27.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.42 1.088 . . . . 0.0 110.233 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.5 m -140.39 123.79 16.93 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.697 0.799 . . . . 0.0 110.929 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.16 137.97 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.454 1.502 . . . . 0.0 108.819 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -144.11 157.39 44.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.183 1.393 . . . . 0.0 110.675 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.24 -151.85 22.52 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.788 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.11 -10.73 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.832 3.022 . . . . 0.0 114.881 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.7 t -160.18 168.6 25.06 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 120.001 1.273 . . . . 0.0 112.666 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.54 151.14 47.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.404 1.481 . . . . 0.0 111.247 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.8 m -135.65 147.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.106 0.963 . . . . 0.0 112.029 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.21 129.82 34.84 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.899 -0.501 . . . . 0.0 109.939 166.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.9 133.91 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 109.174 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.35 158.99 39.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.249 1.82 . . . . 0.0 109.923 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 53.0 p -138.25 159.43 42.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.709 1.204 . . . . 0.0 111.705 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -154.58 116.01 4.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.587 1.155 . . . . 0.0 110.02 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.18 136.19 37.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.979 0.912 . . . . 0.0 111.389 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.79 161.14 15.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.126 1.37 . . . . 0.0 111.819 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.28 -15.89 62.95 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.83 -4.76 53.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.31 0.72 84.62 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.727 1.632 . . . . 0.0 114.203 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 20.8 p -83.51 170.46 14.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.552 1.941 . . . . 0.0 111.212 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 22.3 t -127.09 126.36 42.87 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.875 0.87 . . . . 0.0 111.056 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 28.1 ttm105 -78.11 140.28 39.04 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.201 1.0 . . . . 0.0 109.345 164.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -121.22 137.46 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.049 1.74 . . . . 0.0 108.24 167.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.3 p -135.34 148.93 49.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.323 1.449 . . . . 0.0 111.422 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.04 149.38 21.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.396 1.079 . . . . 0.0 112.218 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 20.4 t -113.78 104.25 55.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.96 0.904 . . . . 0.0 111.385 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.48 135.41 11.77 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.417 2.745 . . . . 0.0 110.554 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.3 m -89.88 -40.14 12.6 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.785 0.834 . . . . 0.0 112.133 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -92.58 149.5 38.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.494 1.118 . . . . 0.0 111.386 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.77 164.88 31.21 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 111.127 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 115.77 -165.01 12.15 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.11 1.338 . . . . 0.0 113.634 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.83 119.18 30.83 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.456 0.702 . . . . 0.0 112.009 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -97.43 141.71 30.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.719 1.207 . . . . 0.0 110.438 163.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.1 134.04 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.651 1.181 . . . . 0.0 108.778 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.18 125.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.452 1.101 . . . . 0.0 109.173 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -99.21 124.73 44.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.546 1.538 . . . . 0.0 109.293 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.32 122.53 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.222 1.009 . . . . 0.0 108.911 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -128.66 136.75 51.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.517 1.927 . . . . 0.0 110.27 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 31.1 t80 -133.8 126.03 29.72 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.713 1.205 . . . . 0.0 110.463 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 33.07 14.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.888 1.275 . . . . 0.0 112.988 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t0 79.75 2.54 2.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 114.44 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.23 133.22 49.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.458 1.103 . . . . 0.0 111.29 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -66.05 122.36 17.22 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.076 1.351 . . . . 0.0 110.668 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -78.91 160.69 71.0 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.146 -0.971 . . . . 0.0 111.651 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.89 138.23 69.12 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.582 2.854 . . . . 0.0 113.141 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.91 -23.15 21.83 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.816 1.198 . . . . 0.0 113.899 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 51.5 m -69.86 144.66 93.58 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.052 1.426 . . . . 0.0 111.327 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.2 137.2 48.81 Favored 'Cis proline' 0 C--N 1.351 0.666 0 CA-C-N 119.618 0.899 . . . . 0.0 111.021 -6.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.35 117.25 28.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.98 0.912 . . . . 0.0 110.268 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 18.3 m -83.08 128.75 34.76 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.501 0.721 . . . . 0.0 111.086 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.7 t -124.04 109.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.184 1.793 . . . . 0.0 108.957 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -79.05 106.04 10.8 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.344 0.658 . . . . 0.0 111.143 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 73.9 t -87.7 121.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -110.39 165.0 12.14 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.859 1.264 . . . . 0.0 111.576 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 136.09 -137.18 8.92 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.178 1.37 . . . . 0.0 112.692 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 CA--C 1.546 0.798 0 C-N-CA 124.505 1.122 . . . . 0.0 111.381 -169.697 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 120.874 0.368 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.1 ptm -156.94 155.63 31.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.104 0.961 . . . . 0.0 113.296 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.5 m -138.92 152.07 47.43 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.549 . . . . 0.0 110.207 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -143.92 157.63 44.22 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.3 tt -158.78 150.94 21.34 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.017 1.727 . . . . 0.0 110.542 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 94.2 mttt -132.99 148.27 52.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.323 1.049 . . . . 0.0 112.339 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 58.3 t -136.05 131.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.944 1.698 . . . . 0.0 109.57 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -82.43 107.17 2.79 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 15.3 m -83.45 -45.19 13.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -166.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 56.98 -161.16 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.528 1.531 . . . . 0.0 112.865 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -160.68 149.29 16.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.231 1.812 . . . . 0.0 110.398 169.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.2 124.7 35.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 111.106 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.49 116.56 33.41 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.465 1.106 . . . . 0.0 109.359 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.51 144.4 44.94 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.569 2.179 . . . . 0.0 111.167 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.85 146.19 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.685 1.594 . . . . 0.0 108.417 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -46.92 120.14 2.88 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.861 1.264 . . . . 0.0 113.887 -169.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.49 71.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.959 1.303 . . . . 0.0 109.694 -169.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 62.2 p -94.36 -20.38 19.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -163.59 149.08 11.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.062 1.345 . . . . 0.0 111.255 -171.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.3 p -76.25 -11.39 59.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.113 1.365 . . . . 0.0 114.666 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -26.83 28.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.454 1.502 . . . . 0.0 113.25 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -14.36 9.45 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.687 1.195 . . . . 0.0 113.498 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 16.5 m -73.74 -16.28 61.19 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.94 -1.1 . . . . 0.0 113.922 172.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.51 -7.52 2.52 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.9 mp -71.04 166.52 21.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.603 1.561 . . . . 0.0 112.106 168.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 38.5 p -135.61 157.82 45.92 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.024 1.73 . . . . 0.0 110.743 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -146.26 161.77 39.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.217 1.007 . . . . 0.0 113.414 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 37.0 p -132.71 142.01 48.85 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.587 1.955 . . . . 0.0 109.973 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 55.3 t -90.72 127.53 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.352 1.061 . . . . 0.0 108.647 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.7 t -101.68 109.34 59.09 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 108.027 167.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.35 168.04 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.74 2.96 . . . . 0.0 110.634 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.23 -14.01 41.55 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.103 2.535 . . . . 0.0 113.563 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 63.4 p -78.1 -10.33 59.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.519 1.127 . . . . 0.0 113.752 168.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.57 -1.5 87.68 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.778 1.656 . . . . 0.0 114.952 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -79.15 82.76 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.109 1.364 . . . . 0.0 111.508 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.75 132.62 54.51 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.172 1.389 . . . . 0.0 112.051 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -141.65 150.03 55.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.504 1.522 . . . . 0.0 110.701 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.38 152.47 66.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.366 2.71 . . . . 0.0 112.242 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 29.1 p -127.96 148.97 50.53 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.586 1.154 . . . . 0.0 111.301 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 60.0 tp -90.13 126.94 35.97 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.335 1.054 . . . . 0.0 110.257 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.93 140.72 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.235 0.614 . . . . 0.0 110.108 170.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -137.41 137.34 38.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.258 1.423 . . . . 0.0 111.801 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -71.91 126.49 29.88 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.3 mt -105.39 163.77 12.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.948 1.299 . . . . 0.0 111.444 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -66.35 -21.62 66.25 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 -160.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 59.3 t30 -88.73 2.59 53.13 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 119.433 1.015 . . . . 0.0 113.221 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.56 -5.36 70.19 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 125.99 1.757 . . . . 0.0 113.787 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -76.8 -178.77 5.01 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.829 1.652 . . . . 0.0 113.199 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 46.9 t -136.07 141.3 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.128 1.371 . . . . 0.0 109.885 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -150.01 179.75 26.5 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.22 161.96 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.11 1.764 . . . . 0.0 111.614 173.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 47.1 t -147.78 135.63 21.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.272 1.429 . . . . 0.0 110.742 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.97 -176.73 2.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.387 1.875 . . . . 0.0 111.266 -171.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 84.1 t -131.01 125.09 21.01 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.88 1.272 . . . . 0.0 108.999 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.08 145.65 24.85 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.066 3.177 . . . . 0.0 111.209 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.04 1.83 22.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.503 1.121 . . . . 0.0 113.147 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -139.3 172.55 12.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.179 2.191 . . . . 0.0 109.989 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.6 p -99.42 165.98 11.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.166 1.386 . . . . 0.0 110.921 168.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 90.23 -163.96 30.58 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.815 1.198 . . . . 0.0 113.523 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.7 120.07 15.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.892 0.877 . . . . 0.0 111.833 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.6 m80 -107.95 145.82 33.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.207 1.803 . . . . 0.0 109.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.08 126.53 52.47 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.437 1.095 . . . . 0.0 109.87 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 76.8 t -91.48 108.05 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.265 1.426 . . . . 0.0 108.291 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.42 124.41 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 110.2 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -124.71 133.21 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.398 1.079 . . . . 0.0 110.651 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.61 145.96 51.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.845 1.258 . . . . 0.0 113.609 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.6 tttt -118.82 125.99 50.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.546 1.938 . . . . 0.0 109.514 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 9.9 t-20 55.83 25.93 9.03 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.914 1.286 . . . . 0.0 113.969 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.74 -0.85 77.49 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.38 1.467 . . . . 0.0 115.762 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.51 149.22 38.48 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.399 1.6 . . . . 0.0 111.114 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.8 p80 -70.97 147.87 48.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.7 t -73.03 151.28 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.684 1.194 . . . . 0.0 109.544 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.42 -26.24 60.83 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 52.8 p -86.93 -8.01 57.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.432 1.493 . . . . 0.0 114.062 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.0 t -86.76 146.8 42.0 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.075 1.35 . . . . 0.0 112.696 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.36 157.48 82.56 Favored 'Cis proline' 0 C--N 1.351 0.69 0 CA-C-N 119.281 0.779 . . . . 0.0 112.23 -7.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.31 126.38 32.38 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.063 1.345 . . . . 0.0 109.126 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.18 140.95 14.27 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.925 2.416 . . . . 0.0 111.677 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.5 t -134.33 124.59 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.713 1.605 . . . . 0.0 107.648 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.1 t -99.31 124.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.804 0.842 . . . . 0.0 110.438 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.96 123.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.224 1.41 . . . . 0.0 109.356 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.8 t -89.88 152.82 21.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.61 0.764 . . . . 0.0 111.172 170.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -58.56 -27.98 65.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 21.2 m -71.84 -18.57 62.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.043 0.937 . . . . 0.0 112.968 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -89.92 -6.84 55.33 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.101 -0.999 . . . . 0.0 112.769 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.47 -29.84 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.321 1.048 . . . . 0.0 112.194 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.33 61.0 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.029 0.823 . . . . 0.0 114.213 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -74.41 97.89 3.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 117.769 0.784 . . . . 0.0 110.958 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.86 71.42 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.93 0.892 . . . . 0.0 112.179 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 38.6 p -54.65 -28.62 48.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.816 1.647 . . . . 0.0 114.257 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -90.59 -6.3 54.82 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.236 1.414 . . . . 0.0 113.969 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 73.6 t -73.36 136.5 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.874 1.216 . . . . 0.0 109.719 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -115.47 156.36 25.79 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.463 1.505 . . . . 0.0 110.659 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -145.02 156.37 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.227 1.411 . . . . 0.0 110.782 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.91 167.62 28.92 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.164 0.986 . . . . 0.0 112.451 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.74 156.38 22.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.413 1.482 . . . . 0.0 113.555 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -71.18 -25.86 62.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.513 1.125 . . . . 0.0 113.24 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.68 -3.34 33.66 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.808 1.194 . . . . 0.0 115.38 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.8 mt -89.89 -5.15 57.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.778 1.631 . . . . 0.0 112.843 169.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -133.8 -40.71 0.85 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.784 1.234 . . . . 0.0 113.798 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.15 149.77 41.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.268 1.427 . . . . 0.0 111.009 -176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.12 175.47 27.41 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.269 0.938 . . . . 0.0 114.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.2 m80 -134.85 151.74 51.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.401 1.48 . . . . 0.0 111.678 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.6 p -69.08 -45.49 70.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -98.6 -5.73 31.32 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -167.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -123.4 147.82 53.64 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.054 1.742 . . . . 0.0 110.196 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.12 136.41 29.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.588 2.192 . . . . 0.0 110.645 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.11 152.91 23.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.352 1.061 . . . . 0.0 109.996 166.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.86 151.54 47.07 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.4 p90 -158.85 150.91 21.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.675 1.59 . . . . 0.0 110.81 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.98 139.94 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.846 1.658 . . . . 0.0 109.243 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.77 136.41 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.38 1.472 . . . . 0.0 108.771 167.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.6 t0 -120.57 98.23 5.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.201 1.8 . . . . 0.0 110.272 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 20.7 p -91.9 -4.76 54.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.567 1.947 . . . . 0.0 113.144 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -59.32 -35.73 74.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.308 1.043 . . . . 0.0 112.588 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.38 -11.6 59.24 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.035 1.334 . . . . 0.0 113.493 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.45 -3.57 56.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.472 1.509 . . . . 0.0 114.557 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.67 -147.0 23.74 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -78.11 172.09 14.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.442 1.097 . . . . 0.0 112.611 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 135.31 -162.09 24.77 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 124.901 1.238 . . . . 0.0 113.937 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -141.12 143.88 13.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.604 1.573 . . . . 0.0 112.719 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.45 123.83 46.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.485 1.914 . . . . 0.0 109.643 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.1 m -111.95 144.29 41.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.857 1.663 . . . . 0.0 110.314 170.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -146.8 146.36 30.22 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.5 0.72 . . . . 0.0 110.988 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 90.2 p -148.53 152.9 37.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.366 0.603 . . . . 0.0 112.338 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.87 129.83 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.134 1.374 . . . . 0.0 107.856 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.57 147.21 47.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.355 1.862 . . . . 0.0 109.713 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 176.97 -166.8 37.74 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.59 -11.51 24.3 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.337 3.358 . . . . 0.0 113.726 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 21.3 m -152.98 161.26 42.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.084 1.754 . . . . 0.0 111.218 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -68.51 146.98 52.64 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.979 0.912 . . . . 0.0 111.589 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.6 m -129.55 148.39 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.986 1.314 . . . . 0.0 110.911 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.44 110.66 21.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.52 0.728 . . . . 0.0 110.075 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 33.1 mt -87.12 129.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.189 0.995 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -123.93 161.62 25.03 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.579 1.952 . . . . 0.0 110.428 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 7.1 p -142.27 158.03 44.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.964 1.306 . . . . 0.0 112.509 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -151.38 117.07 5.43 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.291 1.436 . . . . 0.0 109.835 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.21 128.65 34.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 110.328 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 74.8 mt -102.57 153.68 19.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.485 1.114 . . . . 0.0 111.981 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -60.2 -28.42 67.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.619 1.167 . . . . 0.0 113.323 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.79 -9.38 58.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.806 1.242 . . . . 0.0 113.589 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.27 66.48 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.963 1.744 . . . . 0.0 114.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.1 p -88.12 170.45 11.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.554 1.942 . . . . 0.0 111.179 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.5 t -129.59 124.5 33.94 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.721 0.808 . . . . 0.0 111.663 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -82.28 137.56 34.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.238 1.415 . . . . 0.0 110.016 169.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 94.4 t -116.18 140.12 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.28 1.832 . . . . 0.0 108.465 166.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.78 149.91 50.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.688 1.595 . . . . 0.0 111.179 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.53 147.73 12.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 111.606 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 t -112.1 101.69 52.36 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 110.521 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -82.14 86.54 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.6 2.867 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.5 m -56.57 -39.11 72.93 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.184 1.394 . . . . 0.0 113.825 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -96.57 141.66 23.42 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.343 1.057 . . . . 0.0 110.699 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.23 166.12 29.58 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.518 2.812 . . . . 0.0 112.214 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.02 -162.37 24.48 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.205 1.384 . . . . 0.0 113.574 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -95.68 125.31 40.18 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.751 0.82 . . . . 0.0 111.126 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.3 142.59 41.71 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.23 1.412 . . . . 0.0 110.485 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 131.57 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.961 1.305 . . . . 0.0 108.389 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.6 mt -114.87 127.76 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.654 1.181 . . . . 0.0 109.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -103.84 127.17 51.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.191 1.396 . . . . 0.0 110.477 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -118.65 119.03 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.976 1.31 . . . . 0.0 109.41 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.3 tttt -135.67 123.96 23.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.325 1.45 . . . . 0.0 110.256 -168.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.5 t80 -121.89 127.52 50.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.702 1.201 . . . . 0.0 110.742 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.82 34.15 12.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.113 1.365 . . . . 0.0 113.409 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 16.2 t70 88.2 -1.84 0.47 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.428 3.091 . . . . 0.0 114.138 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -110.75 134.28 52.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 112.111 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.4 126.81 29.42 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.941 1.297 . . . . 0.0 111.094 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.9 m -76.51 153.91 83.74 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.962 . . . . 0.0 111.193 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.55 138.91 67.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.538 2.159 . . . . 0.0 111.178 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.63 -27.32 14.45 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.306 1.431 . . . . 0.0 113.216 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 11.4 t -76.7 144.23 72.87 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.09 0.945 . . . . 0.0 110.663 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.03 149.09 86.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.092 1.069 . . . . 0.0 112.035 0.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.95 119.52 38.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.766 1.226 . . . . 0.0 110.744 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 72.2 m -88.95 129.99 35.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.001 0.92 . . . . 0.0 110.776 172.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 12.9 t -124.48 115.52 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.47 1.508 . . . . 0.0 109.782 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 61.7 tttp -80.09 112.29 17.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.065 0.546 . . . . 0.0 110.709 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.5 t -98.05 121.11 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.017 1.327 . . . . 0.0 109.025 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.6 t -108.69 157.6 18.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.698 1.199 . . . . 0.0 111.479 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 165.17 172.34 32.5 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.27 0.938 . . . . 0.0 114.606 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 124.504 1.121 . . . . 0.0 112.92 -178.628 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 120.196 0.046 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 94.8 mtp -96.33 142.12 28.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.883 1.273 . . . . 0.0 111.727 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 7.4 m -122.26 137.43 54.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.637 1.975 . . . . 0.0 108.414 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.23 145.59 32.9 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.375 0.989 . . . . 0.0 113.547 -165.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.38 155.47 30.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.982 1.713 . . . . 0.0 111.183 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -132.67 150.46 52.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.598 1.159 . . . . 0.0 112.597 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.0 t -139.87 137.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.392 1.877 . . . . 0.0 109.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.33 120.13 5.67 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.0 m -106.59 143.45 34.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.57 152.17 23.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.872 0.869 . . . . 0.0 113.025 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.47 148.45 26.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.167 0.987 . . . . 0.0 111.028 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.37 146.5 28.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 112.494 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.33 120.05 20.9 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.824 1.25 . . . . 0.0 108.791 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.69 137.64 14.49 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.366 2.711 . . . . 0.0 110.956 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.15 138.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.206 1.402 . . . . 0.0 109.985 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 51.7 t30 55.1 64.52 1.77 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.918 1.687 . . . . 0.0 112.359 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 11.2 mm -71.67 105.06 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.39 1.076 . . . . 0.0 110.95 -168.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 11.8 t -171.94 177.82 3.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.751 2.02 . . . . 0.0 110.221 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.72 57.18 3.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.528 1.531 . . . . 0.0 111.049 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 39.6 p -75.77 153.27 37.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.244 1.418 . . . . 0.0 112.28 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -98.44 111.63 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.799 1.24 . . . . 0.0 110.485 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.68 -12.3 61.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.124 0.97 . . . . 0.0 113.053 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 66.6 m -77.12 -16.96 58.98 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.746 1.157 . . . . 0.0 113.948 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -116.65 3.8 13.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.254 1.422 . . . . 0.0 114.057 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.02 146.02 37.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 0.0 110.972 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 56.0 p -140.12 168.01 20.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.532 1.933 . . . . 0.0 109.666 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 152.6 31.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.785 0.834 . . . . 0.0 112.596 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 67.3 p -138.85 157.52 45.91 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.523 1.929 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -109.93 133.45 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.646 1.178 . . . . 0.0 109.495 169.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 89.9 t -102.43 110.5 63.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.776 1.23 . . . . 0.0 107.748 164.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.87 169.65 21.29 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.686 2.924 . . . . 0.0 110.838 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -15.17 46.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.971 2.448 . . . . 0.0 113.28 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 62.3 p -80.33 -9.61 59.74 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.828 1.251 . . . . 0.0 113.916 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.03 -1.72 83.66 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.736 1.636 . . . . 0.0 115.118 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -78.98 83.1 5.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.181 1.392 . . . . 0.0 111.643 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -58.77 135.42 57.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.755 1.222 . . . . 0.0 112.383 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -139.48 151.05 65.85 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.47 1.508 . . . . 0.0 111.128 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 155.04 35.98 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.738 2.959 . . . . 0.0 112.704 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 74.6 m -105.66 154.94 19.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.145 1.378 . . . . 0.0 111.794 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.8 119.16 35.91 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.191 1.396 . . . . 0.0 108.586 175.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.73 136.64 34.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.506 1.122 . . . . 0.0 110.886 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 66.9 mttm -136.94 141.22 42.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.725 1.21 . . . . 0.0 113.098 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -87.02 120.34 28.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.598 1.159 . . . . 0.0 107.981 157.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.4 mt -98.86 171.44 8.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.842 1.257 . . . . 0.0 112.969 -166.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -60.96 -20.41 62.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.749 2.02 . . . . 0.0 116.381 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.08 5.76 46.85 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.272 1.029 . . . . 0.0 112.971 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.75 85.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.58 1.562 . . . . 0.0 114.25 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 164.03 21.71 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.038 1.735 . . . . 0.0 113.426 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 82.6 t -102.56 141.43 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.212 1.405 . . . . 0.0 110.15 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.33 -168.17 20.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.264 0.935 . . . . 0.0 114.807 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.66 167.08 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.441 1.496 . . . . 0.0 112.264 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 98.9 p -139.08 159.85 41.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.923 1.289 . . . . 0.0 111.432 162.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.2 p90 -164.07 -178.46 5.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.026 2.13 . . . . 0.0 109.778 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -129.47 122.9 21.09 Favored Pre-proline 0 N--CA 1.482 1.135 0 CA-C-N 119.44 1.018 . . . . 0.0 110.171 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.86 141.58 15.23 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.322 3.348 . . . . 0.0 111.223 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -94.82 -32.9 13.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.7 0.8 . . . . 0.0 112.842 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -111.2 172.1 7.08 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.173 1.789 . . . . 0.0 111.096 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.6 p -90.86 164.21 14.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.838 1.255 . . . . 0.0 111.015 165.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 101.31 -166.68 18.78 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.123 1.344 . . . . 0.0 113.856 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.94 116.86 16.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.928 . . . . 0.0 111.866 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 16.2 m80 -103.77 142.83 33.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.48 1.912 . . . . 0.0 109.44 170.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.84 123.14 47.73 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.571 1.148 . . . . 0.0 109.206 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 35.2 t -90.55 112.57 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.872 1.269 . . . . 0.0 108.583 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -92.98 138.23 31.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.875 1.27 . . . . 0.0 110.531 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 66.6 t -130.46 128.43 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.672 0.789 . . . . 0.0 109.511 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.23 134.76 51.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.114 1.366 . . . . 0.0 112.569 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 84.9 tttt -128.45 129.05 45.57 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 110.162 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 53.08 30.53 9.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.627 1.171 . . . . 0.0 114.056 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.89 5.26 71.26 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.033 1.302 . . . . 0.0 116.019 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -134.62 149.26 50.55 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.665 1.733 . . . . 0.0 111.855 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -70.03 140.65 52.88 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.945 -1.097 . . . . 0.0 112.877 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 21.2 m -76.33 153.07 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.834 0.854 . . . . 0.0 111.527 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -62.77 -23.66 67.33 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 62.1 p -84.78 -3.42 58.61 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.843 1.257 . . . . 0.0 114.034 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 1.7 p -118.48 160.18 40.88 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.685 1.194 . . . . 0.0 112.757 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.0 156.17 98.7 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.48 0.85 . . . . 0.0 113.078 0.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.39 124.6 33.45 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.816 1.647 . . . . 0.0 108.954 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.84 139.34 12.2 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.193 2.595 . . . . 0.0 111.381 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.3 t -135.55 124.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.585 1.554 . . . . 0.0 108.157 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -97.23 122.47 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.757 0.823 . . . . 0.0 110.118 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.51 126.58 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.152 1.381 . . . . 0.0 109.871 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -90.28 168.54 11.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.793 1.237 . . . . 0.0 112.121 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.58 -32.12 73.25 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.332 -1.48 . . . . 0.0 112.978 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.9 m -72.28 -5.31 35.18 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.81 5.73 14.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.069 1.347 . . . . 0.0 113.207 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.43 -31.21 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.143 0.977 . . . . 0.0 112.24 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 164.27 51.05 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.762 0.665 . . . . 0.0 114.762 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.95 92.54 4.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.151 0.976 . . . . 0.0 111.393 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.69 76.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.697 0.799 . . . . 0.0 112.054 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -56.71 -24.98 53.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.343 1.457 . . . . 0.0 113.994 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -90.61 -7.05 53.79 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.15 1.38 . . . . 0.0 113.802 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 58.0 t -77.8 129.85 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.975 1.261 . . . . 0.0 109.741 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -105.69 156.34 18.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 110.687 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.0 m -143.45 151.63 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.056 1.343 . . . . 0.0 110.731 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 57.2 m -149.13 166.49 28.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.309 1.443 . . . . 0.0 112.014 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.04 157.56 26.27 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.479 1.038 . . . . 0.0 113.929 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -78.88 -18.95 53.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.54 -4.64 46.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.69 1.138 . . . . 0.0 114.788 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.45 -4.88 58.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 112.686 168.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -126.88 -36.57 2.19 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.077 1.351 . . . . 0.0 113.668 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -155.67 156.7 35.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.225 1.01 . . . . 0.0 113.093 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.07 -171.88 15.92 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.71 1.624 . . . . 0.0 113.207 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -147.22 145.17 29.37 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.968 0.907 . . . . 0.0 113.399 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 41.3 p -66.09 -23.69 66.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -114.96 1.57 14.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 139.96 31.0 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.29 1.436 . . . . 0.0 110.095 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.84 144.59 54.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.335 2.023 . . . . 0.0 110.547 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -104.11 158.67 16.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.102 1.361 . . . . 0.0 110.711 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 158.71 44.16 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.45 153.73 30.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.449 1.9 . . . . 0.0 110.114 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.63 138.8 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.687 1.595 . . . . 0.0 108.943 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 44.3 mt -110.2 135.06 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.097 1.759 . . . . 0.0 108.756 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.01 97.5 5.46 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.961 1.704 . . . . 0.0 110.46 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.7 p -94.02 0.73 56.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 113.177 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -59.48 -38.79 81.76 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.524 1.056 . . . . 0.0 113.069 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.59 -23.52 45.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.103 0.961 . . . . 0.0 113.032 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -81.36 -11.81 59.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 113.737 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.2 -121.6 5.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.007 1.289 . . . . 0.0 112.335 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.49 163.93 12.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.542 1.537 . . . . 0.0 112.203 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.45 174.24 17.48 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -89.64 122.86 6.67 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.339 0.971 . . . . 0.0 111.424 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.1 tm? -98.08 112.16 24.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.849 1.66 . . . . 0.0 107.718 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.6 m -104.9 145.55 30.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.724 0.81 . . . . 0.0 109.966 168.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.78 137.19 29.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.741 0.817 . . . . 0.0 109.762 -166.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.2 p -140.87 150.5 43.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.85 0.833 . . . . 0.0 112.497 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.42 133.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.49 1.516 . . . . 0.0 107.235 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -142.27 139.14 31.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.645 0.778 . . . . 0.0 110.827 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 179.46 -161.31 27.23 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.033 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.06 -5.61 15.13 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.291 3.327 . . . . 0.0 114.753 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.6 t -157.71 168.18 27.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.754 1.222 . . . . 0.0 111.456 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -69.33 149.14 48.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.364 1.066 . . . . 0.0 111.093 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.5 m -127.58 150.19 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.036 1.334 . . . . 0.0 110.647 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -91.04 109.17 20.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.49 0.716 . . . . 0.0 109.692 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 26.8 mt -85.4 131.74 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.195 0.998 . . . . 0.0 109.432 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -128.08 164.03 23.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.664 1.986 . . . . 0.0 110.471 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -142.59 155.53 44.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.996 1.318 . . . . 0.0 112.073 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.37 114.88 4.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.0 110.067 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.37 130.68 37.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.666 1.186 . . . . 0.0 110.967 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 75.6 mt -103.3 151.34 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.6 1.16 . . . . 0.0 111.705 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.95 -19.6 65.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.304 1.042 . . . . 0.0 113.659 -175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.63 -5.95 54.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 113.109 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 97.24 1.38 59.41 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.87 1.7 . . . . 0.0 114.738 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 168.92 10.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.366 1.866 . . . . 0.0 111.399 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -125.33 124.61 41.96 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.972 0.909 . . . . 0.0 111.543 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -84.07 134.96 34.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.136 1.375 . . . . 0.0 109.54 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 46.3 t -115.91 137.24 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.743 1.617 . . . . 0.0 108.363 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.472 1.909 . . . . 0.0 110.769 -177.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -160.4 155.91 25.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.396 1.078 . . . . 0.0 112.668 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.2 p -124.61 97.01 39.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.17 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.91 143.31 20.61 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.184 2.589 . . . . 0.0 110.345 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 88.7 m -112.11 -44.11 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 0.0 112.135 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -83.42 141.37 42.3 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.471 0.708 . . . . 0.0 110.419 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.98 162.54 34.48 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.28 2.653 . . . . 0.0 111.092 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.47 -144.04 15.89 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.811 1.196 . . . . 0.0 112.144 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -123.53 131.65 53.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.633 0.773 . . . . 0.0 111.779 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -110.21 139.0 45.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.766 1.626 . . . . 0.0 109.977 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.61 134.28 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.85 1.26 . . . . 0.0 108.447 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.67 127.84 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.214 1.406 . . . . 0.0 108.86 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -109.96 119.96 40.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.028 1.331 . . . . 0.0 109.871 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.5 mm -107.68 114.43 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.749 0.785 . . . . 0.0 108.955 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.57 118.0 23.1 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.21 1.004 . . . . 0.0 111.695 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 16.8 t80 -112.7 131.62 55.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.68 1.192 . . . . 0.0 110.259 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.99 35.35 21.78 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.466 1.506 . . . . 0.0 114.283 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.05 10.14 3.8 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.386 2.275 . . . . 0.0 114.24 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -95.57 -128.8 0.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.127 1.371 . . . . 0.0 110.465 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -168.13 125.19 1.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.558 2.343 . . . . 0.0 108.69 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -76.91 151.57 82.16 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-N 120.044 1.293 . . . . 0.0 110.843 -170.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.34 135.24 52.78 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.568 2.178 . . . . 0.0 110.996 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 100.83 -27.02 22.49 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.39 1.471 . . . . 0.0 113.744 -173.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 50.9 m -74.57 150.37 86.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 118.972 1.386 . . . . 0.0 111.67 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.02 141.17 69.75 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 119.205 0.752 . . . . 0.0 111.208 -3.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.57 115.3 27.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.046 0.938 . . . . 0.0 110.378 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 66.4 m -87.63 121.13 29.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.988 0.915 . . . . 0.0 110.359 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -120.32 115.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.662 1.585 . . . . 0.0 109.922 -168.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.92 122.22 26.41 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.963 0.505 . . . . 0.0 111.304 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 76.1 t -106.64 117.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.444 1.498 . . . . 0.0 108.93 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.1 t -105.26 174.6 5.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.176 1.39 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 133.89 -134.09 7.26 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.138 1.352 . . . . 0.0 112.694 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 124.583 1.153 . . . . 0.0 111.159 -169.133 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 121.453 0.644 . . . . 0.0 110.595 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.3 ptt? -148.4 162.66 39.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.888 1.675 . . . . 0.0 110.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 68.7 m -113.78 150.01 34.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.274 1.03 . . . . 0.0 109.845 167.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -144.88 160.26 41.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -155.3 155.41 33.7 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.277 1.831 . . . . 0.0 110.402 -169.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . 0.419 ' H ' HD13 ' A' 1963 ' ' LEU . 68.4 mttm -137.92 150.62 47.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.117 1.367 . . . . 0.0 111.639 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.6 p -155.76 139.39 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.703 1.201 . . . . 0.0 110.818 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -83.08 129.06 8.84 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.813 0.72 . . . . 0.0 111.405 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 44.0 m -113.41 137.41 51.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.137 . . . . 0.0 111.403 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.47 141.58 12.07 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.267 1.027 . . . . 0.0 111.957 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.26 148.25 43.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.872 0.869 . . . . 0.0 111.215 168.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.68 139.53 30.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.144 0.977 . . . . 0.0 112.63 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 72.9 mt -121.55 123.4 27.57 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.521 1.528 . . . . 0.0 108.796 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.55 152.6 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.109 2.54 . . . . 0.0 111.889 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.09 147.23 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.382 1.473 . . . . 0.0 111.037 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 35.4 t30 56.96 77.37 0.27 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.22 1.808 . . . . 0.0 112.159 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 20.3 mm -77.99 73.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.382 1.073 . . . . 0.0 109.349 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 6.6 m -172.69 -177.54 1.71 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.818 2.847 . . . . 0.0 109.383 -169.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -59.09 121.96 12.57 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.133 -0.979 . . . . 0.0 111.256 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.3 m -139.8 142.51 36.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.265 1.826 . . . . 0.0 109.153 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 64.5 t0 -126.94 120.53 29.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.932 1.293 . . . . 0.0 110.242 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.18 -10.25 59.75 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.586 1.154 . . . . 0.0 113.922 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 11.8 t -64.91 -31.26 72.4 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.631 1.105 . . . . 0.0 113.627 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.23 9.41 11.06 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.524 1.53 . . . . 0.0 113.961 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.46 145.18 25.89 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.087 1.355 . . . . 0.0 112.178 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -141.25 163.43 32.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.783 2.033 . . . . 0.0 109.371 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.28 146.78 23.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.7 p -139.25 161.77 36.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.841 2.056 . . . . 0.0 109.993 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.7 t -117.32 138.5 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.368 1.467 . . . . 0.0 110.253 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 93.5 t -105.76 112.94 64.4 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 108.246 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.82 171.94 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.916 3.077 . . . . 0.0 111.605 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.89 -28.5 31.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.706 3.604 . . . . 0.0 115.199 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 60.4 p -81.27 -9.61 59.74 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.25 -2.0 73.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.451 1.5 . . . . 0.0 114.766 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -75.43 89.19 2.65 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.309 1.444 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.3 133.53 56.19 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.078 0.951 . . . . 0.0 111.944 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -129.16 145.83 58.3 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 110.317 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.7 151.17 31.86 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.393 2.729 . . . . 0.0 111.712 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.1 m -95.61 149.63 21.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.215 1.006 . . . . 0.0 111.736 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.25 128.66 34.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 159.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.7 mt -95.89 141.58 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 110.551 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 88.8 mttt -136.78 144.66 43.87 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.502 1.521 . . . . 0.0 111.891 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -98.1 117.68 33.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.646 1.178 . . . . 0.0 107.851 159.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.61 175.15 6.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.853 1.661 . . . . 0.0 112.597 -166.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -56.97 -35.32 69.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.471 1.509 . . . . 0.0 114.692 -166.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.51 3.88 53.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 0.0 113.211 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.81 71.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.394 1.473 . . . . 0.0 114.209 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -73.17 163.57 27.94 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.681 1.592 . . . . 0.0 113.282 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 59.8 t -108.77 144.05 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.249 1.42 . . . . 0.0 110.47 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -146.14 171.49 27.03 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.607 1.098 . . . . 0.0 115.367 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.94 152.96 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.072 1.749 . . . . 0.0 111.898 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 13.6 m -132.65 148.56 52.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.7 1.6 . . . . 0.0 110.235 168.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.8 p90 -164.58 162.01 21.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.224 1.41 . . . . 0.0 111.296 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 93.1 t -102.3 119.5 56.18 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 0.0 109.32 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 145.18 24.3 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.236 3.29 . . . . 0.0 110.586 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -108.72 0.41 20.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 113.411 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -143.15 179.59 6.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.395 2.278 . . . . 0.0 109.698 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -105.09 158.44 16.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.068 1.347 . . . . 0.0 110.452 163.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.36 -164.61 16.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.303 1.43 . . . . 0.0 113.341 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.2 111.5 8.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.354 1.062 . . . . 0.0 111.944 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.7 m80 -95.32 140.55 30.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.466 1.507 . . . . 0.0 109.428 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.58 121.56 42.63 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.99 0.916 . . . . 0.0 109.116 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 44.6 t -86.86 131.76 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.013 1.325 . . . . 0.0 108.349 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -116.4 119.24 35.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.363 1.465 . . . . 0.0 109.818 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 64.5 t -107.89 134.95 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.854 1.262 . . . . 0.0 109.196 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 80.6 mttt -119.77 149.68 41.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 113.091 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -126.41 118.21 24.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.44 2.296 . . . . 0.0 109.042 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 58.01 21.19 7.53 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.862 1.265 . . . . 0.0 114.22 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 101.52 -12.26 58.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.916 1.722 . . . . 0.0 115.79 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -99.66 160.72 14.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.508 1.654 . . . . 0.0 111.222 171.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.0 p80 -65.04 153.2 41.43 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.106 -0.996 . . . . 0.0 112.954 170.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -88.71 154.47 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.721 0.809 . . . . 0.0 110.62 168.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -61.74 -21.73 64.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 67.1 m -82.33 -15.52 52.55 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 19.9 m -84.28 153.21 62.35 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 120.813 -1.18 . . . . 0.0 113.902 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.87 153.73 86.8 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 118.387 0.459 . . . . 0.0 111.812 -5.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 123.01 39.1 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.898 1.279 . . . . 0.0 109.273 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 139.18 11.89 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.082 2.522 . . . . 0.0 111.591 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 34.5 t -135.72 120.42 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.454 1.502 . . . . 0.0 108.352 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 62.0 t -92.78 122.46 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.712 0.805 . . . . 0.0 110.271 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.89 133.29 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.014 1.326 . . . . 0.0 109.656 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 27.4 t -104.65 158.69 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.4 1.08 . . . . 0.0 111.198 169.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -59.36 -29.84 67.97 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.344 -0.847 . . . . 0.0 112.72 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -65.41 -13.73 59.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.479 1.112 . . . . 0.0 113.653 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -93.75 -8.12 41.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.631 1.172 . . . . 0.0 112.471 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.2 116.77 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.516 1.053 . . . . 0.0 110.624 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 70.9 13.35 72.23 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 157.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.52 94.12 2.57 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.642 1.721 . . . . 0.0 110.748 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.45 -36.36 71.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.753 1.221 . . . . 0.0 112.735 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.5 m -54.67 -24.72 23.07 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.515 1.526 . . . . 0.0 114.184 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -86.36 -13.76 45.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.036 1.335 . . . . 0.0 113.469 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.4 t -77.55 134.73 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.43 1.014 . . . . 0.0 110.003 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -122.16 159.74 26.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.446 1.499 . . . . 0.0 110.741 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 32.8 m -147.35 159.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.107 1.363 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.09 169.93 23.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.342 1.057 . . . . 0.0 112.437 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.38 159.25 24.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.296 1.427 . . . . 0.0 113.79 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.52 -27.84 64.49 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.502 1.121 . . . . 0.0 113.362 -169.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.09 -2.73 33.26 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.854 1.216 . . . . 0.0 115.294 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 88.6 mt -88.82 -7.08 56.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.942 1.697 . . . . 0.0 112.66 168.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -133.72 -39.81 0.88 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.996 1.318 . . . . 0.0 113.915 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -140.09 148.48 41.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.189 1.395 . . . . 0.0 111.482 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.7 178.3 28.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.619 1.104 . . . . 0.0 114.203 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.9 m80 -136.83 149.64 47.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.735 1.614 . . . . 0.0 111.655 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.1 p -71.9 -32.6 67.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.54 6.73 14.72 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -138.36 144.39 42.63 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.832 1.653 . . . . 0.0 109.462 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 140.93 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.677 2.252 . . . . 0.0 111.19 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -87.67 151.56 22.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.733 1.213 . . . . 0.0 109.976 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.14 150.01 48.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.112 0.965 . . . . 0.0 113.147 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 152.42 27.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.054 1.341 . . . . 0.0 111.333 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.6 mp -110.88 142.22 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.494 1.918 . . . . 0.0 109.823 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 47.6 mt -114.46 133.59 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.975 1.71 . . . . 0.0 109.595 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 8.6 t0 -117.42 112.03 20.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.781 2.032 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 10.1 p -120.79 -3.71 9.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.537 1.535 . . . . 0.0 113.967 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -29.11 69.76 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.144 1.338 . . . . 0.0 113.47 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.09 -18.15 53.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.669 1.187 . . . . 0.0 112.867 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.99 -5.15 56.96 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.372 1.469 . . . . 0.0 113.818 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.09 -106.15 2.75 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.93 1.252 . . . . 0.0 111.816 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -129.73 145.64 51.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.442 1.497 . . . . 0.0 112.807 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 158.22 175.63 29.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.92 0.772 . . . . 0.0 114.76 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -87.5 121.7 5.95 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.143 0.878 . . . . 0.0 111.056 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 123.29 35.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.184 1.393 . . . . 0.0 108.022 171.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 8.4 t -119.73 145.24 46.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.494 1.918 . . . . 0.0 109.791 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.0 tt -145.32 144.24 30.62 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.716 0.807 . . . . 0.0 110.846 -165.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.4 p -148.13 153.92 39.49 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.78 131.42 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.724 1.61 . . . . 0.0 108.539 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.64 153.14 49.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.723 1.609 . . . . 0.0 110.513 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 166.93 -153.45 23.12 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.096 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.5 -10.51 28.13 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.913 3.076 . . . . 0.0 114.31 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -157.39 168.0 28.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.594 1.088 . . . . 0.0 112.238 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -71.52 150.0 45.23 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.609 1.163 . . . . 0.0 111.087 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.2 m -130.59 152.11 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.565 1.146 . . . . 0.0 111.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -81.47 126.32 31.52 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.58 -0.7 . . . . 0.0 109.832 165.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.2 mt -106.78 132.67 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.191 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -129.73 155.23 46.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.367 1.867 . . . . 0.0 109.533 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.33 158.57 43.81 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.61 1.164 . . . . 0.0 111.553 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.53 128.64 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 0.0 110.94 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.63 118.64 22.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.439 1.096 . . . . 0.0 109.95 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.77 160.35 18.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.14 0.976 . . . . 0.0 111.805 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.15 -20.97 66.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.97 0.908 . . . . 0.0 113.138 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.48 -12.53 59.88 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.863 1.265 . . . . 0.0 113.361 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.45 -1.56 62.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.557 1.551 . . . . 0.0 114.836 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 15.1 p -81.6 162.27 23.17 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 111.259 170.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.2 t -108.51 123.81 49.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.925 0.89 . . . . 0.0 110.751 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 29.9 ttm105 -82.91 137.68 34.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.17 0.988 . . . . 0.0 109.342 165.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 24.3 t -120.64 137.36 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.781 1.632 . . . . 0.0 108.468 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.4 p -137.61 146.07 43.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.365 1.466 . . . . 0.0 111.56 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -160.43 150.21 17.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.534 1.134 . . . . 0.0 112.563 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.4 t -111.93 104.69 56.24 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.107 0.963 . . . . 0.0 110.886 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.67 98.82 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.496 2.798 . . . . 0.0 110.978 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -60.62 -43.96 96.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.441 1.096 . . . . 0.0 113.653 -169.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -94.15 146.15 31.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.215 1.006 . . . . 0.0 111.098 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.64 164.22 32.56 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.33 2.687 . . . . 0.0 111.254 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.17 -140.25 11.65 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.823 1.202 . . . . 0.0 112.184 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -130.15 130.95 45.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.955 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -110.97 144.27 40.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.633 1.573 . . . . 0.0 110.781 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.72 134.31 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.483 1.113 . . . . 0.0 108.868 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.5 mt -111.69 129.12 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.828 1.251 . . . . 0.0 109.08 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -107.18 125.04 50.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.352 1.461 . . . . 0.0 109.935 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.98 124.28 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.998 0.919 . . . . 0.0 109.074 173.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -131.13 135.14 47.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.429 1.492 . . . . 0.0 110.578 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.1 t80 -128.64 121.24 28.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.14 1.376 . . . . 0.0 109.845 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.43 55.84 7.76 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.417 1.487 . . . . 0.0 112.672 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 21.1 t70 79.09 -7.56 1.75 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 128.052 2.541 . . . . 0.0 114.128 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -113.64 128.71 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.8 1.24 . . . . 0.0 111.521 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -67.25 126.17 28.38 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.822 1.249 . . . . 0.0 111.045 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -77.7 154.2 81.0 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.225 -0.922 . . . . 0.0 111.295 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.88 139.49 74.43 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.612 2.208 . . . . 0.0 111.228 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 97.86 -26.84 21.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.25 1.405 . . . . 0.0 113.499 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 73.1 m -74.98 149.71 85.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.716 1.258 . . . . 0.0 111.366 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.85 139.53 62.24 Favored 'Cis proline' 0 C--N 1.351 0.705 0 CA-C-N 119.444 0.837 . . . . 0.0 111.315 -2.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -93.07 112.76 24.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.925 0.89 . . . . 0.0 110.218 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 59.3 m -87.48 118.31 26.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.316 1.047 . . . . 0.0 110.821 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 8.5 t -112.95 116.44 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.967 1.707 . . . . 0.0 109.578 -171.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.78 121.97 27.09 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.908 -0.495 . . . . 0.0 111.03 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 98.6 t -110.41 119.6 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.218 1.407 . . . . 0.0 109.534 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.9 t -97.58 154.38 17.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.631 1.173 . . . . 0.0 111.047 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -173.43 -163.34 26.89 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 126.153 1.781 . . . . 0.0 109.884 -177.484 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 21.3 tpt85 . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 27.9 ptm -78.05 151.81 33.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.776 0.831 . . . . 0.0 111.748 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 12.8 m -127.0 140.03 52.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.471 1.909 . . . . 0.0 108.146 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -143.15 160.32 40.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -166.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.93 151.04 21.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.618 1.967 . . . . 0.0 110.024 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -134.55 146.26 49.49 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.937 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 47.3 t -139.83 133.93 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.644 1.577 . . . . 0.0 109.623 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -86.01 118.05 4.75 Favored Glycine 0 N--CA 1.47 0.93 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 169.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.4 m -121.36 146.84 46.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.924 0.89 . . . . 0.0 112.458 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.85 144.04 11.5 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.173 0.989 . . . . 0.0 112.572 -170.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -70.37 157.81 37.09 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.595 1.158 . . . . 0.0 112.364 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.92 143.47 26.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.919 1.687 . . . . 0.0 112.893 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.13 118.57 18.42 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.969 1.308 . . . . 0.0 109.429 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.55 133.01 11.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.475 2.783 . . . . 0.0 111.639 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 51.2 mt -148.62 142.4 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.493 1.517 . . . . 0.0 110.624 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 57.81 57.4 4.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.072 1.749 . . . . 0.0 112.431 172.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 12.1 mm -71.99 -26.71 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.877 1.271 . . . . 0.0 112.633 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -76.92 54.63 1.03 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.13 1.772 . . . . 0.0 113.717 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -146.93 144.61 29.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.799 1.64 . . . . 0.0 110.726 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -104.09 -40.77 6.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.056 1.742 . . . . 0.0 111.133 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -90.93 108.44 19.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.765 0.826 . . . . 0.0 110.438 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.4 mt -90.37 -8.72 49.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.119 0.968 . . . . 0.0 113.101 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 9.2 t -77.03 -31.48 56.35 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.207 -0.933 . . . . 0.0 112.553 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.84 -2.43 47.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.137 1.375 . . . . 0.0 114.421 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.9 tp -101.3 135.25 43.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.463 1.105 . . . . 0.0 111.406 -170.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -138.97 168.22 20.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.013 1.725 . . . . 0.0 110.46 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -154.09 150.9 28.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.9 p -137.85 165.19 27.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.082 2.153 . . . . 0.0 110.079 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -123.73 139.85 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.852 1.661 . . . . 0.0 110.015 172.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.8 t -111.42 114.16 53.14 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.476 1.51 . . . . 0.0 108.249 166.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.67 170.33 19.33 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.948 3.098 . . . . 0.0 110.771 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.35 -16.61 55.17 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.986 2.458 . . . . 0.0 113.266 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 69.4 m -83.66 -4.18 58.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.328 1.051 . . . . 0.0 113.828 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.37 82.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.597 1.57 . . . . 0.0 115.914 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.35 86.73 3.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.4 1.48 . . . . 0.0 111.588 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.87 135.93 57.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.554 1.142 . . . . 0.0 112.302 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -142.6 151.59 57.67 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.752 1.621 . . . . 0.0 111.352 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.46 155.09 36.2 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.823 3.015 . . . . 0.0 112.23 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 94.8 m -98.1 155.32 17.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.584 1.154 . . . . 0.0 112.815 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.64 135.45 34.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 108.234 162.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.2 mt -108.02 139.06 43.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.218 1.407 . . . . 0.0 111.06 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 64.2 mttm -135.54 128.19 30.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.676 1.19 . . . . 0.0 113.113 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.6 tpt85 -75.83 125.98 30.13 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 148.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 54.8 mt -102.65 159.85 15.09 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.678 1.191 . . . . 0.0 110.76 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -57.89 -32.97 68.23 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -82.17 -1.3 48.53 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 106.39 -27.81 15.68 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.596 1.57 . . . . 0.0 113.785 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.96 169.79 12.58 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.78 1.232 . . . . 0.0 114.179 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 67.9 t -133.15 139.33 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.841 1.656 . . . . 0.0 109.342 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.43 23.32 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 116.179 1.231 . . . . 0.0 116.179 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.93 160.97 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.974 1.709 . . . . 0.0 112.288 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 68.4 m -139.98 149.75 43.63 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.575 1.95 . . . . 0.0 110.184 170.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 21.8 p90 -166.73 167.17 15.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.133 1.773 . . . . 0.0 110.647 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.9 t -116.06 113.57 41.64 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 124.041 0.936 . . . . 0.0 109.803 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.17 151.41 23.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.137 3.225 . . . . 0.0 111.324 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -98.49 -11.61 22.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.062 0.945 . . . . 0.0 113.459 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -139.09 166.72 23.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.01 1.724 . . . . 0.0 110.949 -174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.6 p -87.73 172.58 9.57 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.01 1.324 . . . . 0.0 111.333 169.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.5 -173.3 35.36 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.003 1.287 . . . . 0.0 113.773 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.31 113.48 7.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.149 0.98 . . . . 0.0 111.827 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.5 m80 -99.66 146.47 26.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.828 1.651 . . . . 0.0 109.065 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.79 125.17 50.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 109.412 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 30.1 t -88.37 136.87 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.497 1.119 . . . . 0.0 108.378 167.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -121.02 117.7 27.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.377 1.471 . . . . 0.0 109.865 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 93.9 t -106.14 138.59 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.185 1.394 . . . . 0.0 109.304 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 63.7 mttm -123.47 144.7 49.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.538 1.535 . . . . 0.0 112.646 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 69.2 tttt -118.87 116.38 26.37 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.389 2.276 . . . . 0.0 108.957 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.22 30.16 14.09 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.831 1.252 . . . . 0.0 113.572 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.77 -16.6 60.9 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.879 1.704 . . . . 0.0 115.956 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -97.78 149.99 21.73 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.482 1.641 . . . . 0.0 110.833 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 26.6 p80 -65.8 147.28 53.64 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 121.056 -1.028 . . . . 0.0 113.385 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -84.63 157.51 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.007 0.923 . . . . 0.0 111.132 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.67 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 7.0 m -70.53 -23.24 62.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.427 1.091 . . . . 0.0 113.65 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 150.34 55.22 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.41 148.56 89.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 118.681 0.565 . . . . 0.0 111.843 -4.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.72 118.81 55.47 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.423 1.089 . . . . 0.0 108.68 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.25 138.87 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.834 2.356 . . . . 0.0 111.293 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 51.6 t -134.16 121.9 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.573 1.549 . . . . 0.0 107.905 172.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.4 t -95.13 122.28 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.679 0.792 . . . . 0.0 109.944 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -95.52 129.22 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.751 1.22 . . . . 0.0 109.107 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.1 t -100.74 160.27 14.5 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.956 . . . . 0.0 111.572 172.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -59.17 -30.09 67.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.843 0.857 . . . . 0.0 112.855 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 19.5 m -67.23 -12.61 60.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.763 1.225 . . . . 0.0 113.725 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -97.16 -10.84 25.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.684 1.194 . . . . 0.0 112.779 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.281 1.032 . . . . 0.0 113.167 -170.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 161.92 45.64 0.02 OUTLIER Glycine 0 N--CA 1.469 0.897 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 27.4 t0 -78.52 95.1 5.09 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.063 0.931 . . . . 0.0 111.378 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.17 -39.58 86.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.48 -0.763 . . . . 0.0 112.487 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 29.4 m -60.47 -17.45 45.02 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.953 1.301 . . . . 0.0 113.974 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -93.39 -7.42 44.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.794 1.638 . . . . 0.0 114.487 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.2 t -75.3 137.41 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 120.302 1.41 . . . . 0.0 110.18 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -123.23 161.08 25.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 111.081 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.3 m -147.61 159.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.109 1.364 . . . . 0.0 111.86 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.89 176.05 12.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.097 1.359 . . . . 0.0 112.257 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.03 -165.1 14.3 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 125.553 1.549 . . . . 0.0 114.202 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -97.9 -38.24 9.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.349 1.06 . . . . 0.0 112.615 -172.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -74.08 3.02 40.38 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.489 1.042 . . . . 0.0 115.428 -167.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 98.4 mt -96.1 0.51 51.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.218 1.407 . . . . 0.0 112.412 166.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.73 -42.53 1.13 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.521 1.528 . . . . 0.0 113.471 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -158.77 154.91 27.0 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.49 -171.07 19.68 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.569 1.557 . . . . 0.0 114.017 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.5 m80 -141.27 146.4 36.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.148 1.379 . . . . 0.0 112.219 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 40.1 p -70.55 -21.46 62.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -115.86 -0.56 12.82 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -142.93 142.06 21.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.28 1.432 . . . . 0.0 110.177 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.62 149.4 55.14 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.937 2.424 . . . . 0.0 111.695 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.68 146.34 27.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.852 1.261 . . . . 0.0 110.562 172.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.73 146.47 48.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 112.628 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.5 p90 -152.48 148.58 27.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.403 1.481 . . . . 0.0 110.864 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.59 141.53 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.676 1.59 . . . . 0.0 109.207 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.6 mt -114.95 136.16 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.149 1.779 . . . . 0.0 108.744 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 60.2 t0 -124.52 108.18 11.83 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.152 1.781 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 58.0 p -101.62 0.66 36.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.848 1.659 . . . . 0.0 113.058 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.84 -37.13 80.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.51 1.05 . . . . 0.0 112.521 -172.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.68 -14.14 59.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 113.114 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -94.71 -4.61 47.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.169 1.788 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.71 -99.73 2.22 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.014 1.292 . . . . 0.0 111.947 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -142.21 152.38 43.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.127 1.371 . . . . 0.0 112.286 -165.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.83 179.26 26.44 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -88.19 122.33 6.27 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.39 0.995 . . . . 0.0 111.81 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.4 121.49 35.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.301 1.84 . . . . 0.0 108.334 171.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 15.0 m -113.34 143.25 44.78 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.827 1.251 . . . . 0.0 110.782 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -139.29 133.26 30.98 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 110.343 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.4 m -136.85 127.61 27.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.537 0.735 . . . . 0.0 111.452 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 25.9 mt -104.6 136.8 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.7 1.6 . . . . 0.0 108.948 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -132.79 151.49 51.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.21 1.804 . . . . 0.0 109.293 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.18 -160.31 33.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.194 -0.941 . . . . 0.0 114.59 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.0 -12.04 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 124.125 3.217 . . . . 0.0 114.474 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.5 t -159.48 168.35 26.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.666 1.187 . . . . 0.0 111.687 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -66.35 151.84 46.26 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -131.4 154.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.856 1.262 . . . . 0.0 111.18 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.88 138.22 32.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.694 0.398 . . . . 0.0 110.272 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 44.3 mt -121.4 135.83 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 109.163 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -132.37 154.61 49.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.208 1.803 . . . . 0.0 109.803 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 31.4 p -139.8 152.44 46.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.692 1.197 . . . . 0.0 111.664 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -152.72 106.98 3.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.35 134.43 35.26 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.919 1.288 . . . . 0.0 111.137 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 79.2 mt -110.22 162.28 14.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.481 1.112 . . . . 0.0 113.451 -163.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -70.65 -13.28 62.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.024 1.33 . . . . 0.0 113.159 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.72 -8.09 59.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.433 1.093 . . . . 0.0 112.795 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.09 1.2 73.0 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.349 1.452 . . . . 0.0 114.696 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 49.0 p -93.81 172.42 8.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.364 1.866 . . . . 0.0 111.191 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 47.0 t -129.02 126.63 39.92 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.096 0.958 . . . . 0.0 111.47 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.23 136.29 36.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.366 1.067 . . . . 0.0 109.613 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.4 t -115.25 138.43 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 108.083 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.6 p -134.19 147.0 50.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.177 1.391 . . . . 0.0 110.871 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 6.9 p90 -151.58 152.49 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.006 0.922 . . . . 0.0 112.096 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 8.2 t -123.78 113.23 28.69 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.892 0.877 . . . . 0.0 111.195 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.95 175.54 9.15 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.029 3.153 . . . . 0.0 111.284 174.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 99.5 m -129.25 -46.22 1.22 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.39 1.076 . . . . 0.0 111.91 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -85.92 144.65 39.57 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.919 0.888 . . . . 0.0 110.637 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.16 160.41 33.02 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.092 2.528 . . . . 0.0 110.989 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 132.22 -162.9 24.0 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 125.196 1.379 . . . . 0.0 113.703 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -90.85 121.49 32.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.639 0.776 . . . . 0.0 111.426 176.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -98.98 143.41 29.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.872 1.269 . . . . 0.0 110.854 165.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.34 132.84 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.799 1.639 . . . . 0.0 108.031 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.61 124.58 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.3 1.04 . . . . 0.0 109.82 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -101.35 128.34 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.181 1.792 . . . . 0.0 109.91 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.1 mm -120.67 115.5 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.919 1.287 . . . . 0.0 109.814 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.08 135.37 54.37 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.642 1.577 . . . . 0.0 110.989 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 63.1 t80 -129.69 125.83 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.287 1.435 . . . . 0.0 110.127 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 34.57 18.04 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.165 1.386 . . . . 0.0 113.53 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.252 63.4 m-20 74.05 21.23 2.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.035 2.534 . . . . 0.0 114.176 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -125.38 137.38 54.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.899 1.28 . . . . 0.0 110.972 169.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 129.75 40.85 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.487 1.115 . . . . 0.0 110.882 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.8 m -77.46 155.23 81.6 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 111.2 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 141.05 75.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.61 2.207 . . . . 0.0 111.432 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 90.37 -24.01 18.89 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.177 1.37 . . . . 0.0 113.608 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 22.5 t -76.99 144.62 72.45 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.276 1.038 . . . . 0.0 111.133 173.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.48 149.57 89.16 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.876 0.992 . . . . 0.0 112.139 -2.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -102.0 127.72 48.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.076 1.351 . . . . 0.0 110.996 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 37.6 m -89.75 135.12 33.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.03 171.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.0 t -132.88 112.52 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.54 1.536 . . . . 0.0 109.556 -168.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.55 108.99 13.51 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.784 -0.572 . . . . 0.0 111.29 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.8 t -95.28 118.18 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 0.0 108.772 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -97.31 152.52 18.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.179 0.992 . . . . 0.0 111.106 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 162.84 -158.28 30.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.544 0.745 0 C-N-CA 126.674 1.989 . . . . 0.0 110.983 -174.266 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.142 0.496 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.9 ptm -146.48 156.04 42.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.0 m -136.72 144.5 43.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.943 2.097 . . . . 0.0 108.581 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -147.83 157.92 43.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -159.77 141.02 12.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.223 1.809 . . . . 0.0 110.107 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 65.8 mttp -125.86 148.05 49.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.509 1.124 . . . . 0.0 112.215 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 23.7 t -133.88 134.46 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.611 1.564 . . . . 0.0 109.895 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.76 54.78 4.85 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.264 1.411 . . . . 0.0 112.882 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 18.9 m -61.98 147.94 45.41 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.57 1.548 . . . . 0.0 114.276 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -168.36 156.62 8.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.846 1.658 . . . . 0.0 111.816 -175.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -81.11 148.61 29.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.149 0.98 . . . . 0.0 111.61 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -93.3 148.76 21.76 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.907 1.283 . . . . 0.0 113.038 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 61.1 mt -133.72 126.74 19.11 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.339 1.456 . . . . 0.0 109.221 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.36 140.14 26.99 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.107 2.538 . . . . 0.0 111.104 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -139.71 135.56 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.96 1.304 . . . . 0.0 110.361 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.8 t30 39.63 69.54 0.29 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.085 2.154 . . . . 0.0 114.016 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.35 120.19 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.092 0.957 . . . . 0.0 111.261 -167.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 4.9 m -172.2 156.76 4.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.124 2.169 . . . . 0.0 110.058 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -86.47 72.11 10.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.162 0.985 . . . . 0.0 110.489 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 35.0 p -97.98 156.63 16.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.989 1.716 . . . . 0.0 111.777 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -91.84 117.79 30.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.466 1.106 . . . . 0.0 110.611 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.52 -9.07 46.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.537 1.135 . . . . 0.0 113.173 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 15.6 m -74.99 -19.33 60.14 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.672 1.189 . . . . 0.0 113.739 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.2 pp -130.25 5.37 4.84 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.514 1.525 . . . . 0.0 113.899 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.33 126.36 54.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.211 2.204 . . . . 0.0 107.768 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -130.85 148.6 52.64 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.244 1.418 . . . . 0.0 110.184 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -138.71 150.16 45.86 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 112.715 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.0 p -140.47 159.84 41.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.606 1.963 . . . . 0.0 109.951 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 3.9 t -114.62 135.54 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.546 1.138 . . . . 0.0 109.598 169.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.7 t -108.39 114.37 59.33 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.066 1.347 . . . . 0.0 108.498 167.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.77 173.11 13.3 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 124.151 3.234 . . . . 0.0 111.269 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.28 -29.11 45.71 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.016 3.144 . . . . 0.0 114.895 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 30.3 p -83.92 -5.57 59.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.219 1.408 . . . . 0.0 114.464 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 80.95 3.02 90.67 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.969 1.271 . . . . 0.0 114.52 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -74.04 77.51 1.71 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.533 1.933 . . . . 0.0 111.706 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.78 133.08 55.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.203 1.001 . . . . 0.0 112.127 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.72 150.03 61.57 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.249 1.42 . . . . 0.0 110.957 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.51 152.63 34.1 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.698 2.932 . . . . 0.0 112.412 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.9 m -91.61 155.12 18.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.484 1.114 . . . . 0.0 111.794 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 65.5 tp -77.82 140.46 39.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 152.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.3 mt -108.3 142.35 38.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.768 1.227 . . . . 0.0 110.347 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -136.89 138.84 41.13 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.919 1.287 . . . . 0.0 112.379 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -80.39 123.73 28.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 151.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.2 mt -96.27 164.25 12.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.234 1.413 . . . . 0.0 111.399 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -63.9 -18.23 63.99 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.15 2.8 56.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.994 0.917 . . . . 0.0 113.198 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.97 -9.03 73.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.028 1.775 . . . . 0.0 114.594 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -80.79 170.37 16.38 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.899 1.68 . . . . 0.0 113.416 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.2 t -115.19 141.73 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.314 1.446 . . . . 0.0 110.483 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -149.35 174.1 29.01 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.44 157.64 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.174 1.79 . . . . 0.0 111.318 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.8 m -137.79 146.59 43.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.565 1.546 . . . . 0.0 109.795 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 4.2 p90 -166.21 171.17 12.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 111.103 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 88.3 t -119.08 121.36 30.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.089 0.955 . . . . 0.0 109.607 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.27 143.22 17.37 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.019 3.146 . . . . 0.0 110.969 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -84.64 -21.67 30.19 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.89 0.876 . . . . 0.0 112.227 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -142.27 172.2 13.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.522 1.929 . . . . 0.0 110.704 -168.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.7 p -91.99 169.94 10.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.911 1.285 . . . . 0.0 111.454 171.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.42 -173.41 23.0 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.374 1.464 . . . . 0.0 113.915 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.82 109.5 6.45 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.32 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 14.5 m80 -95.62 140.55 30.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.231 1.412 . . . . 0.0 109.387 170.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.21 122.91 45.11 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.37 1.068 . . . . 0.0 109.075 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 96.4 t -86.66 118.42 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -101.18 149.42 24.0 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 125.228 1.411 . . . . 0.0 110.567 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.7 p -160.37 126.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 122.167 0.984 . . . . 0.0 111.398 -170.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -128.22 129.43 46.41 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.399 1.879 . . . . 0.0 111.599 -164.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 60.7 tttm -109.93 132.83 53.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.335 1.454 . . . . 0.0 110.223 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.51 -96.69 0.07 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.012 1.325 . . . . 0.0 111.474 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -122.47 10.78 9.15 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.497 1.523 . . . . 0.0 115.533 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -145.93 149.79 34.86 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.091 1.945 . . . . 0.0 113.78 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.29 157.43 37.73 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.653 0.781 . . . . 0.0 112.421 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.6 m -84.86 163.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.84 0.856 . . . . 0.0 111.539 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.2 69.12 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 29.9 m -86.29 -14.63 43.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.966 1.307 . . . . 0.0 114.367 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.3 p -93.03 153.61 41.78 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.869 -1.145 . . . . 0.0 113.478 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.32 150.75 96.04 Favored 'Cis proline' 0 C--N 1.354 0.826 0 CA-C-N 119.125 0.723 . . . . 0.0 112.597 -1.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.86 121.64 50.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.825 1.25 . . . . 0.0 108.469 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.1 138.07 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.854 2.369 . . . . 0.0 111.139 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.3 t -133.99 122.56 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.59 1.556 . . . . 0.0 107.884 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -94.11 122.2 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.489 0.716 . . . . 0.0 110.067 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.91 137.43 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.128 1.371 . . . . 0.0 109.239 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 14.4 t -122.86 161.58 23.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.114 . . . . 0.0 110.896 170.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -61.17 -26.81 67.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.143 0.977 . . . . 0.0 113.602 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 23.8 p -67.53 -15.29 63.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.542 1.137 . . . . 0.0 113.923 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.42 -9.33 47.92 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.627 1.171 . . . . 0.0 112.596 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.77 110.13 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.328 0.967 . . . . 0.0 110.91 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 72.56 11.83 77.14 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 117.274 1.669 . . . . 0.0 117.274 156.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -75.04 91.72 2.56 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.454 1.627 . . . . 0.0 111.212 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.09 67.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.495 1.118 . . . . 0.0 112.38 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.2 m -54.03 -25.49 21.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.952 1.701 . . . . 0.0 114.148 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -88.31 -12.12 44.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.014 1.326 . . . . 0.0 113.619 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 68.4 t -74.33 134.75 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.592 1.087 . . . . 0.0 110.105 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -116.63 158.65 23.39 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.452 1.501 . . . . 0.0 110.876 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 34.8 m -146.61 159.07 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.428 1.491 . . . . 0.0 110.667 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -158.99 168.57 26.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.416 1.086 . . . . 0.0 112.336 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.43 159.32 23.03 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.189 1.376 . . . . 0.0 114.205 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -70.63 -26.71 63.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.112 1.365 . . . . 0.0 113.614 -168.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.97 -4.46 48.52 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.593 1.092 . . . . 0.0 115.063 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.4 -2.77 57.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.162 1.385 . . . . 0.0 112.715 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -128.84 -38.05 1.69 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.951 1.3 . . . . 0.0 113.794 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.75 161.61 39.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.094 0.958 . . . . 0.0 113.177 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.33 -174.24 24.98 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.905 1.241 . . . . 0.0 114.11 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -138.94 144.83 39.19 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.154 1.382 . . . . 0.0 112.105 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 38.6 p -70.51 -18.63 62.96 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.42 -2.14 12.12 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -143.94 144.69 27.52 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.363 1.465 . . . . 0.0 110.178 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.62 150.09 50.3 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.218 . . . . 0.0 111.656 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -98.25 154.09 18.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.42 1.488 . . . . 0.0 110.73 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -134.39 150.94 50.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.808 0.843 . . . . 0.0 112.691 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -157.06 149.84 23.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 110.837 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 140.69 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.842 1.657 . . . . 0.0 109.288 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 43.4 mt -111.68 135.8 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.761 . . . . 0.0 109.032 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 66.5 t0 -125.04 98.37 5.65 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.989 1.715 . . . . 0.0 110.536 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.3 p -94.24 1.0 56.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.316 1.847 . . . . 0.0 113.023 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -61.16 -34.81 75.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.343 0.974 . . . . 0.0 112.851 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.77 -18.24 51.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.522 1.129 . . . . 0.0 113.133 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -88.31 -14.84 37.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.147 1.379 . . . . 0.0 114.014 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.02 -113.17 3.58 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.509 1.052 . . . . 0.0 111.727 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -107.49 144.01 35.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.157 1.383 . . . . 0.0 113.067 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 143.38 144.01 4.2 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.819 1.199 . . . . 0.0 112.982 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -73.65 142.13 30.63 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.632 0.634 . . . . 0.0 112.772 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 127.09 42.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.578 1.551 . . . . 0.0 108.736 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 43.7 t -120.3 135.96 54.84 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.667 1.587 . . . . 0.0 109.506 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -139.58 136.11 34.08 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.288 1.035 . . . . 0.0 110.873 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.7 m -139.83 130.55 25.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 111.398 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 26.5 mt -109.86 136.79 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.463 1.505 . . . . 0.0 108.442 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.5 155.81 42.8 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.162 0.985 . . . . 0.0 111.605 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.39 -146.44 12.56 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.024 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.95 -15.24 36.31 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.897 3.065 . . . . 0.0 114.588 -172.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.9 t -160.44 170.81 20.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.527 1.131 . . . . 0.0 111.669 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -71.99 155.27 40.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.195 0.998 . . . . 0.0 111.589 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.99 162.68 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.3 1.44 . . . . 0.0 110.946 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.49 131.61 36.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.697 0.799 . . . . 0.0 110.146 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.5 mt -111.1 132.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.188 0.995 . . . . 0.0 109.369 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -130.4 155.55 46.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.32 1.848 . . . . 0.0 109.624 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 29.6 p -142.05 160.19 40.72 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.396 1.078 . . . . 0.0 112.315 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -152.55 107.59 3.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.586 1.554 . . . . 0.0 109.347 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.19 129.94 34.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.768 1.227 . . . . 0.0 110.644 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.7 155.99 19.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.711 1.204 . . . . 0.0 112.436 -167.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.12 -18.27 64.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.487 1.115 . . . . 0.0 112.949 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.39 -11.07 60.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.77 -2.88 73.56 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.096 1.808 . . . . 0.0 114.395 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 61.7 p -90.41 174.63 7.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.546 1.938 . . . . 0.0 111.002 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -136.14 128.83 30.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.538 0.735 . . . . 0.0 111.702 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.5 138.03 36.51 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.765 1.226 . . . . 0.0 109.924 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 22.1 t -116.84 138.83 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.656 1.982 . . . . 0.0 108.223 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -137.46 144.02 42.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.345 1.458 . . . . 0.0 111.258 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 8.1 p90 -157.34 151.96 25.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.304 1.042 . . . . 0.0 112.384 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 10.6 t -117.82 108.61 42.49 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.791 0.836 . . . . 0.0 111.213 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.25 152.42 35.04 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.202 2.601 . . . . 0.0 110.527 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 85.2 m -112.69 -37.97 4.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.923 0.889 . . . . 0.0 112.582 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -96.08 148.12 34.03 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 110.733 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 161.23 36.1 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.027 2.485 . . . . 0.0 111.05 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.71 -159.86 18.3 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.109 1.337 . . . . 0.0 113.563 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.7 t30 -95.74 120.01 35.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.052 0.941 . . . . 0.0 111.765 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -98.79 144.9 27.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.775 1.23 . . . . 0.0 110.873 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.22 136.69 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.273 1.429 . . . . 0.0 108.701 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.6 126.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.129 1.372 . . . . 0.0 109.295 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -102.14 131.29 48.74 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.17 1.788 . . . . 0.0 110.297 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.5 mm -123.54 114.2 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.869 1.267 . . . . 0.0 109.592 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -119.71 134.06 55.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.966 1.706 . . . . 0.0 110.908 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -126.36 124.42 40.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.162 1.385 . . . . 0.0 109.737 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.71 36.21 23.2 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.1 1.36 . . . . 0.0 114.035 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 20.9 t70 95.71 -11.2 0.09 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 130.242 3.417 . . . . 0.0 113.611 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -112.72 134.91 54.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.039 . . . . 0.0 112.591 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.4 128.77 37.35 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.884 1.274 . . . . 0.0 110.822 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 10.3 m -72.94 156.2 89.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-N 119.551 1.068 . . . . 0.0 111.549 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.07 -35.39 90.27 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.792 2.995 . . . . 0.0 116.393 -170.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.55 75.96 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.567 0.622 . . . . 0.0 114.561 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 36.1 t -82.82 146.42 52.48 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.056 1.342 . . . . 0.0 111.442 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.66 152.68 93.29 Favored 'Cis proline' 0 C--N 1.351 0.697 0 CA-C-N 119.815 0.97 . . . . 0.0 112.453 -1.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.38 126.34 51.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 13.9 p -90.01 137.14 32.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.523 1.129 . . . . 0.0 111.35 171.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 21.2 t -133.46 112.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 -168.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -80.72 107.99 13.99 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.529 0.731 . . . . 0.0 111.253 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 92.3 t -94.32 120.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.59 1.156 . . . . 0.0 109.261 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.3 t -97.96 154.14 17.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -171.14 -171.12 36.06 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 29.4 tt0 . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 129.804 3.242 . . . . 0.0 110.867 -178.49 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 120.415 0.15 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 95.7 mtp -122.75 139.23 54.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.632 1.573 . . . . 0.0 111.401 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.1 m -130.11 141.56 50.68 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.29 1.836 . . . . 0.0 108.871 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.1 t60 -140.78 150.69 43.67 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -166.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.47 140.56 20.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.07 1.748 . . . . 0.0 109.641 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.42 144.39 49.49 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.635 1.174 . . . . 0.0 111.282 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.2 p -155.25 141.65 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.093 0.957 . . . . 0.0 111.399 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -75.89 150.81 39.96 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.007 0.813 . . . . 0.0 112.331 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 33.0 m -131.94 127.64 36.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.794 0.837 . . . . 0.0 111.603 -171.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.68 147.24 18.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.633 0.773 . . . . 0.0 112.677 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -82.17 138.25 34.76 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.727 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.49 143.51 33.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.226 1.01 . . . . 0.0 112.178 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.75 125.67 23.08 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.543 1.137 . . . . 0.0 108.97 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.58 140.77 24.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.046 2.498 . . . . 0.0 111.158 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 35.3 mm -137.74 139.17 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.291 1.836 . . . . 0.0 109.065 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.84 46.69 19.32 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 0.0 112.707 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.93 -29.33 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.28 1.832 . . . . 0.0 113.974 -165.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -64.62 -18.41 64.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.28 161.69 37.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.277 1.431 . . . . 0.0 111.952 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.0 m -122.11 121.85 37.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.858 1.263 . . . . 0.0 109.759 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -158.74 128.8 5.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.492 1.517 . . . . 0.0 110.0 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.6 mt -116.06 -3.55 12.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.616 1.566 . . . . 0.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 51.6 m -94.96 -29.17 14.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.051 . . . . 0.0 113.313 -168.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 1.74 12.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.118 1.367 . . . . 0.0 114.442 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.2 tp -91.01 137.21 32.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.924 0.784 . . . . 0.0 111.735 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 33.9 p -141.42 140.03 33.56 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.099 1.759 . . . . 0.0 109.392 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.16 149.93 45.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.866 0.866 . . . . 0.0 113.185 -173.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 77.4 p -138.21 162.63 33.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.075 2.15 . . . . 0.0 109.87 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -118.27 136.44 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.966 1.306 . . . . 0.0 109.791 168.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.8 t -105.28 113.83 64.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.137 1.375 . . . . 0.0 108.27 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.53 172.3 11.5 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.97 3.113 . . . . 0.0 111.737 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.51 -29.14 38.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.85 3.7 . . . . 0.0 114.848 170.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 57.3 p -81.32 -8.29 59.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.796 1.238 . . . . 0.0 114.164 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.5 -0.2 81.78 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.421 1.486 . . . . 0.0 114.815 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -76.58 83.05 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.38 1.472 . . . . 0.0 111.532 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.44 135.77 57.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.727 1.211 . . . . 0.0 112.148 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.79 151.69 66.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.477 1.511 . . . . 0.0 111.323 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.57 152.38 43.01 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.844 3.03 . . . . 0.0 112.392 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 77.9 m -98.3 154.78 17.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.92 1.288 . . . . 0.0 112.179 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.17 116.43 26.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.534 1.134 . . . . 0.0 108.17 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.21 135.78 33.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.604 1.161 . . . . 0.0 111.469 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.37 147.64 52.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.602 1.561 . . . . 0.0 112.413 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -92.6 115.68 28.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.0 mt -90.22 171.5 9.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.612 0.765 . . . . 0.0 112.729 -170.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -59.83 -34.2 72.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 113.814 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 53.7 t30 -80.41 -11.91 59.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.463 1.105 . . . . 0.0 113.814 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 103.81 -14.88 52.86 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.653 1.597 . . . . 0.0 114.525 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 159.87 32.63 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 118.266 1.033 . . . . 0.0 113.183 172.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.7 t -85.06 150.55 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.831 1.252 . . . . 0.0 109.056 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.56 174.53 30.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.109 0.862 . . . . 0.0 114.987 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.43 162.46 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.213 1.805 . . . . 0.0 112.072 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 74.1 m -144.4 150.25 37.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.423 1.889 . . . . 0.0 110.41 166.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.21 178.44 8.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.485 1.914 . . . . 0.0 110.763 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 67.9 t -130.58 123.35 20.27 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.155 0.982 . . . . 0.0 109.93 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.71 148.89 23.1 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.787 3.658 . . . . 0.0 112.075 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 mptt -106.84 -9.76 16.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.516 1.126 . . . . 0.0 113.48 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.76 172.03 13.37 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.664 1.986 . . . . 0.0 110.329 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 32.9 p -96.02 154.38 17.27 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.619 1.168 . . . . 0.0 110.903 167.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 104.31 -165.76 15.08 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.168 1.366 . . . . 0.0 113.931 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.84 114.3 10.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.36 1.064 . . . . 0.0 112.213 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 18.9 m80 -95.77 143.26 27.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.644 1.578 . . . . 0.0 109.07 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -107.37 123.3 48.17 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.053 0.941 . . . . 0.0 108.908 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 93.4 t -83.65 121.23 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 166.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.81 138.56 40.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.153 . . . . 0.0 110.095 170.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -146.42 133.68 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.086 0.946 . . . . 0.0 112.503 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.88 139.69 50.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.893 2.077 . . . . 0.0 111.602 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.87 109.37 20.45 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.422 2.689 . . . . 0.0 108.413 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 54.18 -103.74 0.19 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.925 1.29 . . . . 0.0 111.457 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.03 6.38 34.79 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.871 1.701 . . . . 0.0 115.514 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -129.22 148.72 51.18 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.287 1.543 . . . . 0.0 111.638 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 29.8 p80 -66.01 147.14 53.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.62 -1.3 . . . . 0.0 112.101 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.0 t -72.72 144.85 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.32 -24.73 60.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 54.5 p -84.27 -12.45 54.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.113 1.365 . . . . 0.0 114.075 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 9.6 t -80.01 140.05 53.62 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 120.871 -1.143 . . . . 0.0 112.62 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.27 152.49 83.99 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 119.536 0.87 . . . . 0.0 112.498 -5.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.77 122.58 45.42 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.336 1.454 . . . . 0.0 108.739 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.29 143.09 12.35 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.08 2.52 . . . . 0.0 111.777 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.4 t -139.32 117.45 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.422 1.489 . . . . 0.0 108.486 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 51.3 t -94.85 122.86 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.61 0.764 . . . . 0.0 110.174 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.73 129.43 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.11 1.364 . . . . 0.0 110.364 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 73.3 m -94.77 159.72 14.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.234 1.414 . . . . 0.0 112.102 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -59.25 -26.95 65.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.182 -0.948 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.9 p -65.43 -18.92 65.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.528 1.531 . . . . 0.0 114.18 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.39 -4.87 28.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.241 1.416 . . . . 0.0 112.95 -175.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.1 mm -73.64 -34.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.289 1.036 . . . . 0.0 112.602 -173.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 154.34 45.61 0.02 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.853 0.74 . . . . 0.0 114.388 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.52 100.74 10.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.459 1.129 . . . . 0.0 110.858 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.82 -35.96 69.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.988 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 13.1 t -54.19 -29.08 44.59 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.899 1.279 . . . . 0.0 113.31 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -85.79 -9.85 56.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.728 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 63.3 t -76.94 129.96 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.546 1.066 . . . . 0.0 109.594 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -109.08 155.42 20.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.467 1.507 . . . . 0.0 110.867 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.2 m -145.24 148.62 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.992 1.317 . . . . 0.0 110.938 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.6 m -151.62 157.09 41.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.853 1.261 . . . . 0.0 112.14 -175.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 119.03 161.34 11.66 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.496 1.046 . . . . 0.0 114.953 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -64.74 -33.06 75.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.782 1.633 . . . . 0.0 113.225 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.24 -3.58 46.6 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.783 1.182 . . . . 0.0 115.013 -176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.86 -7.6 57.0 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.242 1.417 . . . . 0.0 112.745 168.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -128.1 -36.9 1.92 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 113.942 -173.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -156.75 157.23 34.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.351 1.06 . . . . 0.0 112.911 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.26 -175.04 25.85 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.564 1.078 . . . . 0.0 114.346 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 62.6 m80 -139.58 142.07 37.14 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.143 1.377 . . . . 0.0 112.128 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 55.8 p -73.2 -14.81 61.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -115.29 -2.89 12.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -145.0 145.35 26.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.562 1.545 . . . . 0.0 110.195 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.49 143.0 50.7 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.543 2.162 . . . . 0.0 111.26 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -96.5 163.03 13.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.253 1.421 . . . . 0.0 110.452 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.46 159.41 44.5 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.82 153.52 24.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.379 1.872 . . . . 0.0 110.222 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.73 140.03 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 109.282 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.31 134.3 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.012 1.725 . . . . 0.0 108.421 168.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.3 t0 -120.0 101.19 7.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.183 1.793 . . . . 0.0 110.102 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.4 p -94.89 0.57 54.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.327 1.851 . . . . 0.0 113.129 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -60.4 -36.12 77.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.443 1.019 . . . . 0.0 113.203 -170.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.99 -17.51 52.7 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.266 1.026 . . . . 0.0 113.214 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.77 -6.67 55.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.552 1.541 . . . . 0.0 113.731 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 78.79 -111.97 3.36 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.166 1.365 . . . . 0.0 112.641 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -115.75 164.81 13.83 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.195 1.798 . . . . 0.0 112.388 -172.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.74 -134.81 5.3 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.523 1.059 . . . . 0.0 113.041 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -155.88 140.56 7.36 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.479 1.038 . . . . 0.0 112.435 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.48 121.45 41.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.357 1.863 . . . . 0.0 109.591 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.7 m -107.81 140.11 41.39 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.241 1.817 . . . . 0.0 109.872 167.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -142.28 137.96 31.01 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.072 0.949 . . . . 0.0 110.045 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 86.5 p -135.17 148.62 49.76 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.557 0.694 . . . . 0.0 111.873 169.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.2 mt -122.91 125.74 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -119.46 145.61 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.314 1.446 . . . . 0.0 109.274 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 174.92 -163.79 34.21 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.92 -2.41 11.46 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.714 3.609 . . . . 0.0 114.225 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -160.53 165.61 30.55 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.949 1.3 . . . . 0.0 111.351 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -71.3 143.0 50.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.277 1.031 . . . . 0.0 110.905 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 7.6 m -121.32 150.23 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.315 1.446 . . . . 0.0 110.693 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.91 110.94 22.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.692 0.797 . . . . 0.0 109.985 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.56 134.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 109.913 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.7 164.3 27.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.551 1.94 . . . . 0.0 110.897 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 14.6 p -138.16 155.26 48.89 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.609 1.564 . . . . 0.0 112.039 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.29 130.61 12.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.719 1.208 . . . . 0.0 110.728 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.6 t70 -85.64 125.37 33.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.793 1.237 . . . . 0.0 110.602 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.05 152.46 18.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.217 1.007 . . . . 0.0 111.835 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.09 -12.57 61.8 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.517 1.127 . . . . 0.0 113.678 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.38 -6.26 59.41 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.83 1.252 . . . . 0.0 113.009 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.2 5.22 59.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.639 1.59 . . . . 0.0 114.856 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 37.2 p -98.46 166.41 11.37 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.456 1.902 . . . . 0.0 111.661 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.3 t -116.35 124.79 50.97 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.274 1.029 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -88.3 133.55 34.04 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.107 1.363 . . . . 0.0 109.623 170.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 60.6 t -111.89 137.29 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.259 1.424 . . . . 0.0 108.741 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.5 p -126.71 146.05 50.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.555 1.942 . . . . 0.0 110.15 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.1 p90 -160.9 149.58 16.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.264 1.026 . . . . 0.0 112.043 175.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.1 t -118.08 113.25 37.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.789 0.836 . . . . 0.0 110.995 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.47 166.75 25.46 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.67 2.914 . . . . 0.0 110.787 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.1 m -129.99 -43.44 1.21 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 0.0 112.551 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -87.89 144.46 34.89 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 123.684 0.793 . . . . 0.0 109.812 168.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.97 164.02 27.81 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.27 2.647 . . . . 0.0 111.319 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 129.53 -160.79 22.76 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.223 1.392 . . . . 0.0 113.679 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -88.73 124.53 34.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.323 0.649 . . . . 0.0 111.305 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -106.05 140.81 38.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.732 1.213 . . . . 0.0 109.884 166.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.9 mp -107.21 127.41 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.955 1.302 . . . . 0.0 108.264 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 14.4 mt -110.86 128.48 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.239 1.016 . . . . 0.0 109.786 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -108.94 125.79 52.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.855 1.262 . . . . 0.0 110.106 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -111.31 121.76 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 173.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 3.6 tmmt? -133.21 127.33 33.54 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.874 1.269 . . . . 0.0 110.982 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -125.6 127.75 46.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.064 1.346 . . . . 0.0 110.651 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 48.95 48.38 20.67 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.705 1.202 . . . . 0.0 112.92 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t70 79.99 -2.2 2.03 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.45 2.7 . . . . 0.0 114.145 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -121.51 127.58 51.16 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.812 -168.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -66.34 125.97 27.31 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.832 1.253 . . . . 0.0 111.297 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.6 m -82.5 159.05 65.06 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.227 -0.92 . . . . 0.0 111.72 -169.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.88 143.08 73.37 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.756 2.971 . . . . 0.0 113.526 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.96 -23.08 19.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.852 1.215 . . . . 0.0 114.232 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 70.7 m -73.44 151.73 89.69 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 118.65 1.225 . . . . 0.0 111.696 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.06 141.67 72.46 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.192 0.747 . . . . 0.0 111.408 -6.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -94.57 117.47 30.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.079 0.951 . . . . 0.0 110.339 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 16.7 m -82.98 129.06 34.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.32 0.648 . . . . 0.0 110.859 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.9 t -123.24 114.58 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.147 1.779 . . . . 0.0 109.172 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.54 105.5 10.89 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.002 0.521 . . . . 0.0 110.969 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 82.9 t -93.13 118.47 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.384 1.074 . . . . 0.0 109.042 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 156.53 16.3 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.388 1.075 . . . . 0.0 110.406 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 174.04 -157.92 26.28 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 N--CA 1.477 0.904 0 C-N-CA 129.195 2.998 . . . . 0.0 112.942 174.142 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 26.9 ptm -61.77 154.56 25.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.694 1.197 . . . . 0.0 113.137 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.8 m -121.52 145.79 47.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.598 1.559 . . . . 0.0 109.069 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -155.76 160.22 40.12 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.1 tt -163.05 155.13 18.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.766 2.026 . . . . 0.0 110.836 -172.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 68.4 mttm -130.25 151.85 50.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 112.766 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.8 t -138.46 131.14 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.651 1.58 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.2 77.35 1.86 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.687 1.136 . . . . 0.0 111.41 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 60.4 m -75.76 152.64 37.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.44 150.19 14.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.907 1.283 . . . . 0.0 112.849 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.39 160.96 25.21 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.755 1.222 . . . . 0.0 111.842 167.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.87 141.33 28.76 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.404 1.482 . . . . 0.0 112.66 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 37.4 mm -123.13 115.69 28.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.257 1.423 . . . . 0.0 108.887 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.7 132.39 11.99 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.35 2.7 . . . . 0.0 111.358 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 33.9 mt -148.39 143.13 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.841 1.656 . . . . 0.0 110.411 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 57.58 51.25 9.82 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.929 1.692 . . . . 0.0 112.478 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.39 -30.25 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.695 1.598 . . . . 0.0 112.614 -170.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 19.5 m -72.25 -15.31 61.92 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -81.77 141.0 33.9 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.208 0.913 . . . . 0.0 112.033 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -115.35 -34.32 4.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.106 1.762 . . . . 0.0 111.448 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.87 60.42 6.23 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.698 1.199 . . . . 0.0 111.815 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.43 -26.08 67.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.89 1.676 . . . . 0.0 112.42 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 20.5 m -59.49 -23.59 62.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.74 2.61 25.83 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.4 mp -84.47 145.98 27.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.483 1.113 . . . . 0.0 111.579 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.3 p -139.94 154.72 47.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.46 1.904 . . . . 0.0 109.171 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -147.97 152.16 37.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.8 p -140.99 159.48 42.12 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.594 1.958 . . . . 0.0 110.414 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.8 t -112.98 134.8 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.055 1.342 . . . . 0.0 109.525 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 99.6 t -103.01 111.68 65.23 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.038 1.335 . . . . 0.0 108.104 163.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.37 168.25 21.8 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.747 2.965 . . . . 0.0 110.743 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.71 -15.85 48.63 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.061 2.507 . . . . 0.0 113.267 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.6 p -79.75 -9.63 59.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 113.923 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.78 -2.01 84.51 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.665 1.602 . . . . 0.0 115.065 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -77.1 77.78 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.442 1.497 . . . . 0.0 111.712 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.77 134.93 56.69 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.864 1.265 . . . . 0.0 112.04 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -140.51 151.04 62.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.216 1.406 . . . . 0.0 111.32 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.38 153.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.87 3.046 . . . . 0.0 112.385 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 86.8 m -98.6 155.7 17.17 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.998 1.319 . . . . 0.0 112.381 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.8 tp -87.88 117.97 27.1 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 160.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 32.2 mt -81.16 140.99 34.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.96 0.904 . . . . 0.0 110.256 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -136.12 141.56 44.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.828 1.251 . . . . 0.0 113.139 -174.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -82.72 117.54 22.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.282 1.433 . . . . 0.0 107.93 157.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.06 171.02 7.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.776 1.23 . . . . 0.0 112.421 -172.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -56.73 -36.71 70.05 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.646 1.578 . . . . 0.0 115.049 -166.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.15 2.22 44.53 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 91.8 1.99 70.04 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.672 1.606 . . . . 0.0 113.994 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.35 166.77 15.34 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.738 1.615 . . . . 0.0 113.837 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 79.8 t -96.9 144.43 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.898 1.679 . . . . 0.0 110.05 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.55 -179.95 32.84 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 123.941 0.781 . . . . 0.0 114.802 171.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.79 157.15 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.394 1.478 . . . . 0.0 112.476 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.1 m -130.32 151.88 50.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.571 1.548 . . . . 0.0 110.777 160.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.4 p90 -167.15 -179.63 4.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.669 2.388 . . . . 0.0 109.495 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.5 t -127.63 120.4 21.85 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 119.273 0.942 . . . . 0.0 110.022 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.93 145.03 17.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.161 3.241 . . . . 0.0 111.206 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 48.0 tttm -94.57 -50.12 5.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.911 0.884 . . . . 0.0 112.074 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.83 171.88 8.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.864 1.666 . . . . 0.0 111.2 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.1 p -91.23 173.69 7.79 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.421 1.488 . . . . 0.0 111.462 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 89.23 -164.98 32.45 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.978 1.275 . . . . 0.0 113.601 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.9 116.23 8.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.073 0.949 . . . . 0.0 111.702 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.4 m80 -103.49 144.56 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.962 1.705 . . . . 0.0 109.003 165.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.75 119.25 38.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.555 1.142 . . . . 0.0 109.681 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 92.3 t -88.11 131.83 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.305 1.042 . . . . 0.0 108.652 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -112.74 140.25 47.67 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.86 1.264 . . . . 0.0 110.054 168.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 2.9 p -138.81 133.36 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.931 0.892 . . . . 0.0 111.164 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -115.11 141.79 47.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.612 1.965 . . . . 0.0 112.649 -163.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -139.45 130.63 26.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.92 2.088 . . . . 0.0 110.055 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.93 31.89 14.24 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.542 1.137 . . . . 0.0 113.636 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.17 -2.62 81.61 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.44 1.495 . . . . 0.0 116.09 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -129.67 150.17 51.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.622 1.711 . . . . 0.0 111.723 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -66.11 139.49 58.16 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.846 -1.159 . . . . 0.0 112.044 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 20.0 m -69.23 161.26 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 111.499 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.93 63.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 17.3 m -76.77 -17.83 58.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.686 1.195 . . . . 0.0 114.127 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 45.0 m -79.05 144.58 63.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.738 -1.226 . . . . 0.0 112.922 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.5 147.19 81.4 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 118.827 0.617 . . . . 0.0 112.044 -5.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -97.31 121.67 58.01 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.924 1.29 . . . . 0.0 108.449 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.42 139.26 12.84 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.839 2.359 . . . . 0.0 111.288 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -131.05 124.14 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.629 1.572 . . . . 0.0 107.402 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.3 t -99.01 121.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.683 0.793 . . . . 0.0 110.084 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.02 122.36 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.902 1.281 . . . . 0.0 109.644 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 154.69 22.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.611 0.764 . . . . 0.0 111.372 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -55.37 -29.26 58.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.221 1.009 . . . . 0.0 112.698 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 34.1 m -68.7 -15.72 63.6 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -92.97 -14.88 26.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.365 1.066 . . . . 0.0 113.004 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.48 -28.42 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.714 1.206 . . . . 0.0 112.52 -173.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 146.77 94.57 0.15 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.132 1.349 . . . . 0.0 112.396 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.67 113.84 21.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.103 1.361 . . . . 0.0 109.477 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 112.282 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.4 m -53.3 -23.02 8.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.051 1.74 . . . . 0.0 114.115 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -87.33 -17.74 31.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.758 1.223 . . . . 0.0 114.151 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.0 t -78.75 136.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.625 1.102 . . . . 0.0 110.162 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -119.73 159.37 24.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.137 1.375 . . . . 0.0 110.516 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 26.9 m -145.92 157.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.58 . . . . 0.0 110.605 -178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -158.44 175.27 13.91 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.373 1.069 . . . . 0.0 112.565 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 101.15 166.67 27.87 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.436 1.493 . . . . 0.0 114.204 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.87 -35.2 79.48 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.611 1.164 . . . . 0.0 112.937 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.34 10.99 5.58 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.588 1.566 . . . . 0.0 115.152 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 80.1 mt -100.11 -7.49 24.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.831 1.652 . . . . 0.0 112.063 165.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -131.7 -41.6 1.05 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.485 1.514 . . . . 0.0 113.846 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.77 154.82 26.84 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.58 -170.58 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.552 1.548 . . . . 0.0 113.865 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 72.6 m80 -140.19 146.91 39.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.054 1.342 . . . . 0.0 112.407 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.8 p -73.26 -17.67 61.3 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.19 -3.61 12.52 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -144.4 145.09 27.68 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 110.268 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.75 145.95 52.81 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.977 2.452 . . . . 0.0 111.801 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -89.66 157.06 18.17 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.661 1.184 . . . . 0.0 110.672 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.95 145.34 44.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.819 0.848 . . . . 0.0 112.346 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -150.37 145.94 26.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.042 1.337 . . . . 0.0 111.023 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.02 144.68 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.21 1.804 . . . . 0.0 109.457 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 22.0 mt -118.96 135.67 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.266 1.826 . . . . 0.0 109.835 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -109.06 43.44 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.338 1.855 . . . . 0.0 112.669 -171.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 1.2 p -57.83 -21.36 41.97 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -29.63 59.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.48 -4.48 59.0 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.696 1.198 . . . . 0.0 113.03 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.77 1.59 34.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.832 1.653 . . . . 0.0 114.422 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.94 -116.81 4.53 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -128.87 161.48 29.74 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.912 1.285 . . . . 0.0 112.628 -174.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.28 166.38 10.88 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.448 1.023 . . . . 0.0 114.563 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -79.52 132.49 11.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.04 0.828 . . . . 0.0 112.462 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 124.33 47.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.548 1.939 . . . . 0.0 107.801 171.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -118.54 139.08 52.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.205 1.002 . . . . 0.0 110.647 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 5.1 tp -122.88 134.06 54.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.91 1.684 . . . . 0.0 109.874 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.6 m -135.82 130.29 33.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.289 0.635 . . . . 0.0 110.501 170.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 44.9 mt -112.86 135.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.537 1.535 . . . . 0.0 109.323 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.92 155.3 50.17 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.908 1.683 . . . . 0.0 109.958 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.41 -159.11 31.67 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.381 -0.825 . . . . 0.0 115.013 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.5 -2.88 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.407 3.404 . . . . 0.0 114.18 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -156.24 161.46 40.25 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.849 1.26 . . . . 0.0 111.338 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -66.29 149.87 49.7 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.324 -0.86 . . . . 0.0 110.074 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 20.3 m -124.05 159.76 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.394 1.078 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.37 122.67 45.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.951 0.9 . . . . 0.0 109.188 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 16.0 mt -105.78 134.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.564 1.145 . . . . 0.0 110.131 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -130.14 165.17 22.86 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 110.598 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -143.07 162.77 34.64 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.071 1.348 . . . . 0.0 112.181 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.83 116.35 5.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.665 1.586 . . . . 0.0 109.706 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.55 132.6 39.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 110.854 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.7 mt -111.1 153.24 25.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.647 1.179 . . . . 0.0 111.702 -173.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.45 -19.07 64.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -83.44 3.37 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.876 1.271 . . . . 0.0 113.077 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.89 -0.2 84.13 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.473 1.511 . . . . 0.0 114.17 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.1 p -81.73 166.4 20.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.095 1.758 . . . . 0.0 111.194 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -129.18 126.1 38.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.048 0.939 . . . . 0.0 110.748 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -81.92 135.03 35.43 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.412 1.085 . . . . 0.0 109.271 166.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.7 t -113.43 140.37 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.714 2.006 . . . . 0.0 108.237 167.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 10.8 p -136.09 150.21 49.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.187 1.395 . . . . 0.0 111.311 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.8 p90 -159.18 149.59 19.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.505 1.122 . . . . 0.0 111.854 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 9.0 t -114.92 108.97 47.76 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.845 0.858 . . . . 0.0 111.013 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.05 154.27 25.47 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.436 2.758 . . . . 0.0 110.56 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 27.1 m -114.28 -42.23 3.36 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.135 0.974 . . . . 0.0 112.408 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -87.9 142.83 32.57 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.769 0.828 . . . . 0.0 110.441 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.32 163.83 31.86 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.312 2.674 . . . . 0.0 111.083 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.27 -143.36 15.02 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.822 1.201 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -124.28 129.7 51.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.458 0.703 . . . . 0.0 111.866 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -108.02 144.98 34.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 110.773 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.14 132.28 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.334 1.454 . . . . 0.0 108.878 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.57 127.9 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.339 1.455 . . . . 0.0 109.199 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -107.46 126.93 53.13 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.095 1.358 . . . . 0.0 110.216 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . 0.425 ' HB ' HG22 ' A' 2125 ' ' VAL . 12.6 mm -116.65 94.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.582 1.153 . . . . 0.0 110.231 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -86.62 130.39 34.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.907 1.283 . . . . 0.0 110.09 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.22 130.5 46.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.089 0.955 . . . . 0.0 109.825 168.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 56.95 26.0 11.27 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.108 1.363 . . . . 0.0 113.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.6 t70 72.28 12.33 5.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.991 2.516 . . . . 0.0 114.472 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -98.37 -158.82 0.7 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.775 1.63 . . . . 0.0 109.595 165.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -142.57 127.46 18.3 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.474 -1.392 . . . . 0.0 110.249 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . 0.425 HG22 ' HB ' ' A' 2118 ' ' ILE . 4.0 m -73.44 155.16 89.76 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 0.0 112.172 -167.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.14 131.31 38.82 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.654 2.903 . . . . 0.0 112.807 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.88 50.57 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.039 1.304 . . . . 0.0 114.676 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 28.9 t -77.42 144.39 70.22 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 118.926 1.363 . . . . 0.0 111.518 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.89 152.68 97.1 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.727 0.938 . . . . 0.0 112.589 -3.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -104.88 132.33 51.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.366 1.466 . . . . 0.0 111.298 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 69.2 m -100.36 126.21 46.69 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.643 1.177 . . . . 0.0 111.272 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.36 111.82 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.749 1.62 . . . . 0.0 109.789 -167.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -77.93 112.7 15.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.793 -0.567 . . . . 0.0 111.169 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 71.3 t -101.39 113.37 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 109.05 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -90.8 154.83 19.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.333 1.053 . . . . 0.0 110.85 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -178.6 -161.9 27.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.871 2.068 . . . . 0.0 109.081 -177.2 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 98.8 mtp -84.0 129.88 34.9 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.969 0.908 . . . . 0.0 111.432 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 21.0 m -113.68 132.68 55.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.193 1.797 . . . . 0.0 108.592 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 7.0 t60 -129.51 152.89 48.55 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -163.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . 0.413 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -151.73 153.89 35.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.196 1.798 . . . . 0.0 110.864 179.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . 0.413 ' H ' HD13 ' A' 1963 ' ' LEU . 99.0 mttt -137.8 146.54 43.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.06 1.344 . . . . 0.0 111.949 173.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 60.2 t -143.0 133.94 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.044 1.738 . . . . 0.0 109.617 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.16 132.43 11.08 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.932 0.777 . . . . 0.0 111.54 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 27.2 m -120.65 141.63 50.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.256 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -152.26 156.72 40.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.137 0.975 . . . . 0.0 113.276 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -113.07 151.62 30.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 111.574 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.72 147.38 25.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 0.0 113.128 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.54 126.38 23.42 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 125.309 1.444 . . . . 0.0 108.73 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.81 130.5 9.65 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.198 2.599 . . . . 0.0 111.237 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 40.4 mt -149.63 141.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.392 1.877 . . . . 0.0 108.746 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.3 t30 59.13 53.76 5.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.368 1.467 . . . . 0.0 111.906 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 30.1 mm -56.79 -39.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.747 1.619 . . . . 0.0 113.509 -163.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 17.2 m -77.12 -2.31 33.65 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.43 145.05 51.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 113.481 -171.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 41.2 p -133.13 -20.56 2.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.519 1.927 . . . . 0.0 112.984 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.14 50.8 2.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.303 1.441 . . . . 0.0 111.85 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -1.18 6.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 35.5 p -77.16 -25.9 52.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.705 1.602 . . . . 0.0 114.271 174.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.81 8.4 4.49 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.22 136.14 33.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.503 1.921 . . . . 0.0 109.046 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 11.2 t -148.25 161.47 41.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.811 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.57 154.26 38.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 113.045 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 70.1 p -140.95 163.01 34.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.906 2.082 . . . . 0.0 109.599 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 17.8 t -116.65 136.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.827 1.251 . . . . 0.0 110.182 171.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.3 t -106.62 113.29 63.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.907 1.283 . . . . 0.0 108.497 166.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.03 174.18 9.54 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.402 3.401 . . . . 0.0 111.801 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.81 -29.22 51.6 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.538 3.492 . . . . 0.0 114.619 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 70.9 p -80.91 -3.57 51.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.855 1.262 . . . . 0.0 113.989 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 75.2 -3.11 48.7 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.474 1.511 . . . . 0.0 114.911 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -76.26 91.6 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.953 1.301 . . . . 0.0 110.928 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 131.69 50.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.055 0.942 . . . . 0.0 111.601 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -132.45 144.42 52.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.725 1.61 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.07 153.02 28.35 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.435 2.757 . . . . 0.0 112.287 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.3 m -89.1 151.52 22.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.076 0.951 . . . . 0.0 112.402 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 59.8 tp -86.5 131.76 34.1 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.602 1.161 . . . . 0.0 108.271 157.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mp -99.72 142.1 31.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.603 1.161 . . . . 0.0 110.133 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.6 139.16 36.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.678 1.191 . . . . 0.0 113.049 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -92.34 114.51 27.07 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 156.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.85 169.39 11.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.997 -169.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -62.76 -27.47 69.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -166.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -88.43 3.6 49.43 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 119.155 0.889 . . . . 0.0 113.256 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.06 -4.41 71.15 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 126.122 1.82 . . . . 0.0 114.312 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -80.14 156.14 27.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.391 1.476 . . . . 0.0 113.782 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 68.6 t -89.08 140.94 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.13 1.372 . . . . 0.0 110.126 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.06 177.96 29.57 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.275 0.941 . . . . 0.0 114.488 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.35 161.08 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.142 1.377 . . . . 0.0 111.808 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 49.6 m -134.99 156.72 48.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.147 1.779 . . . . 0.0 110.179 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.8 p90 -164.3 -170.39 2.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.503 1.921 . . . . 0.0 109.381 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 70.3 t -131.85 114.35 15.3 Favored Pre-proline 0 N--CA 1.48 1.029 0 CA-C-N 119.51 1.05 . . . . 0.0 109.825 168.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.97 145.25 31.33 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.738 2.959 . . . . 0.0 110.499 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -115.04 1.15 13.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.44 1.096 . . . . 0.0 113.033 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -141.74 171.34 14.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.377 2.271 . . . . 0.0 109.73 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.9 p -94.97 163.37 13.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.358 1.063 . . . . 0.0 110.742 164.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.22 -167.29 26.24 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.893 1.235 . . . . 0.0 113.738 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.3 114.63 8.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.258 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.3 m80 -99.91 147.56 25.41 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.904 1.682 . . . . 0.0 109.163 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 84.9 mt -105.62 124.21 49.18 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 109.864 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.9 t -89.74 113.69 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.669 1.188 . . . . 0.0 107.956 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -94.09 140.88 29.18 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.53 1.132 . . . . 0.0 110.436 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.3 p -143.89 133.99 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.818 0.818 . . . . 0.0 112.104 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -136.04 137.32 41.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.668 1.987 . . . . 0.0 111.528 -164.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.6 tttt -134.89 132.56 38.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.474 1.509 . . . . 0.0 110.895 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 58.01 25.55 12.42 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.33 5.08 73.06 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.146 1.355 . . . . 0.0 115.605 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -128.9 151.4 49.68 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.426 1.613 . . . . 0.0 111.625 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -64.74 146.66 54.47 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.028 -1.045 . . . . 0.0 112.541 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 58.0 t -72.19 145.34 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.678 0.791 . . . . 0.0 108.895 171.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.63 -29.5 64.6 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 22.1 m -84.79 -4.25 58.98 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.15 1.38 . . . . 0.0 113.972 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 14.9 t -82.32 141.65 46.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.699 -1.25 . . . . 0.0 112.191 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.98 157.06 84.27 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.657 0.913 . . . . 0.0 112.655 -5.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.97 124.38 41.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.541 1.536 . . . . 0.0 108.686 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.39 141.27 14.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.032 2.488 . . . . 0.0 111.314 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.2 t -137.83 123.77 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.481 1.512 . . . . 0.0 108.303 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.8 t -96.53 124.18 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.742 0.817 . . . . 0.0 110.222 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.23 129.07 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.974 1.31 . . . . 0.0 110.145 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -94.91 168.41 10.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.695 1.198 . . . . 0.0 112.717 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.52 -34.89 78.03 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.412 -1.43 . . . . 0.0 111.653 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.8 m -64.63 -12.14 42.64 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.335 1.454 . . . . 0.0 114.892 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -116.01 1.47 13.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.526 1.53 . . . . 0.0 113.105 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.48 -23.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.333 1.053 . . . . 0.0 113.288 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.12 37.57 0.04 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.97 101.23 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.461 1.13 . . . . 0.0 111.377 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.77 82.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.422 0.689 . . . . 0.0 112.819 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 75.7 m -62.1 -25.32 67.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.855 0.862 . . . . 0.0 113.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -79.82 -13.43 59.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.209 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.6 t -77.28 133.17 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 120.141 1.337 . . . . 0.0 109.838 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -112.55 160.83 17.44 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.883 1.673 . . . . 0.0 110.871 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.2 m -146.9 159.29 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.363 1.465 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.49 177.48 10.9 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.608 1.163 . . . . 0.0 112.495 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 93.85 163.07 36.13 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.371 1.462 . . . . 0.0 113.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -75.68 -28.16 58.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.85 0.86 . . . . 0.0 113.205 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.14 0.91 13.09 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.216 1.389 . . . . 0.0 115.326 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.8 mt -92.37 -5.38 52.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.94 1.696 . . . . 0.0 112.643 168.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -133.8 -43.04 0.82 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.964 1.305 . . . . 0.0 113.516 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.23 150.2 40.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.832 1.253 . . . . 0.0 111.613 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.49 -176.23 22.51 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.579 1.085 . . . . 0.0 113.836 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.45 151.44 48.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 111.729 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 37.8 p -76.71 -40.19 49.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.863 0.865 . . . . 0.0 112.489 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -98.1 1.35 47.51 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -140.44 146.78 46.78 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.35 151.76 54.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.183 2.589 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -106.65 130.18 54.44 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.9 1.28 . . . . 0.0 111.038 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -111.93 147.09 36.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.461 1.505 . . . . 0.0 113.323 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 55.9 p90 -156.12 155.05 31.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.868 1.267 . . . . 0.0 112.145 173.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.91 143.66 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.532 1.933 . . . . 0.0 109.705 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 53.2 mt -122.77 133.98 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.521 1.928 . . . . 0.0 108.839 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.1 t0 -128.93 101.1 5.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.802 1.641 . . . . 0.0 110.948 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 39.3 p -96.18 1.46 52.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.187 1.795 . . . . 0.0 113.275 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -60.73 -34.03 73.8 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.367 0.985 . . . . 0.0 113.221 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.07 -12.04 55.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.56 1.144 . . . . 0.0 113.353 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.08 -12.46 35.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.502 1.521 . . . . 0.0 114.073 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.31 -119.28 5.1 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.376 0.988 . . . . 0.0 111.823 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -103.52 162.29 13.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.276 1.831 . . . . 0.0 112.329 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.83 -177.77 29.51 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.929 0.776 . . . . 0.0 114.979 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -104.43 121.78 7.1 Favored Glycine 0 N--CA 1.468 0.793 0 C-N-CA 124.731 1.158 . . . . 0.0 111.113 174.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.49 123.63 36.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.374 1.47 . . . . 0.0 108.37 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 33.6 t -121.75 145.23 48.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.984 1.714 . . . . 0.0 109.73 175.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.11 133.17 22.83 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.521 0.729 . . . . 0.0 110.762 -164.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 7.6 m -129.14 136.54 50.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.805 0.842 . . . . 0.0 110.622 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.5 mt -119.92 138.69 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.863 1.265 . . . . 0.0 108.323 168.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.56 146.55 28.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.798 0.839 . . . . 0.0 111.7 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -176.64 -163.24 28.64 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.903 -173.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.39 -10.18 25.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.017 3.145 . . . . 0.0 114.482 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.1 t -152.38 169.42 22.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.483 1.038 . . . . 0.0 112.067 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.36 143.97 54.82 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.152 1.381 . . . . 0.0 111.137 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -121.08 149.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.754 0.706 . . . . 0.0 111.517 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.32 118.38 34.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.616 0.766 . . . . 0.0 109.469 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 50.0 mt -104.2 135.94 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.146 1.379 . . . . 0.0 109.795 -173.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.27 156.82 43.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.794 1.637 . . . . 0.0 110.384 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 34.0 p -134.46 154.99 51.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.229 1.412 . . . . 0.0 111.438 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -150.51 131.76 14.53 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.647 1.179 . . . . 0.0 110.736 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.91 122.88 29.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.594 1.157 . . . . 0.0 110.561 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.0 mt -92.05 151.9 20.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.927 0.891 . . . . 0.0 111.396 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -63.01 -26.34 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.406 1.082 . . . . 0.0 112.884 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.45 -4.98 42.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.953 1.301 . . . . 0.0 113.469 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.39 4.19 59.66 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.632 1.587 . . . . 0.0 114.745 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -95.31 163.1 13.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.176 1.79 . . . . 0.0 111.453 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 128.47 54.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.24 1.016 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -91.48 136.08 33.38 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.665 167.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 137.73 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.916 1.686 . . . . 0.0 108.414 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 14.3 p -134.94 146.54 49.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.107 1.363 . . . . 0.0 110.561 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.8 p90 -149.82 152.08 34.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.519 0.728 . . . . 0.0 112.86 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 p -115.95 108.41 46.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.963 1.305 . . . . 0.0 111.24 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.75 169.76 17.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.676 2.918 . . . . 0.0 110.795 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 87.4 m -121.19 -51.75 2.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.949 0.899 . . . . 0.0 111.673 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -81.82 143.23 49.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.749 0.82 . . . . 0.0 110.374 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.24 162.15 34.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.124 2.549 . . . . 0.0 111.038 170.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.17 -161.34 24.61 Favored Glycine 0 N--CA 1.472 1.098 0 C-N-CA 125.11 1.338 . . . . 0.0 113.703 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -90.55 122.3 33.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.443 0.697 . . . . 0.0 111.273 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -104.7 136.72 43.69 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 109.865 167.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.39 133.66 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.231 1.412 . . . . 0.0 108.559 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.4 mt -119.44 127.92 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.831 1.252 . . . . 0.0 109.595 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -109.02 125.81 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 110.306 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 24.4 mm -109.37 113.96 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.538 1.135 . . . . 0.0 108.802 172.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -119.15 135.21 54.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.451 1.5 . . . . 0.0 111.026 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 30.4 t80 -130.35 126.89 38.25 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.746 0.818 . . . . 0.0 110.895 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.23 39.39 26.88 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.688 1.595 . . . . 0.0 114.074 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 15.3 t70 79.9 2.26 2.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.023 2.529 . . . . 0.0 114.025 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -96.92 -127.79 0.15 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.157 1.383 . . . . 0.0 110.774 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -171.11 128.57 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.816 2.046 . . . . 0.0 109.884 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -86.65 157.92 54.65 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-N 120.098 1.317 . . . . 0.0 111.706 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.44 141.63 72.25 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.905 3.07 . . . . 0.0 113.567 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 87.84 -21.54 22.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.958 1.266 . . . . 0.0 114.597 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 58.1 m -74.63 148.4 85.34 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.979 1.39 . . . . 0.0 111.874 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.4 140.1 65.38 Favored 'Cis proline' 0 C--N 1.351 0.708 0 CA-C-N 119.369 0.81 . . . . 0.0 111.288 -5.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.48 121.59 35.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.669 1.187 . . . . 0.0 110.514 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.6 m -85.63 124.32 32.04 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.397 0.679 . . . . 0.0 110.443 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.8 t -116.48 114.79 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.926 1.69 . . . . 0.0 109.085 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 58.7 tttp -78.94 103.2 8.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.818 0.447 . . . . 0.0 110.683 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 74.9 t -89.58 114.67 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.609 1.163 . . . . 0.0 108.599 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.3 t -94.27 161.3 14.31 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.112 0.965 . . . . 0.0 111.165 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 152.75 -139.47 7.0 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.092 0.853 . . . . 0.0 113.67 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 125.664 1.586 . . . . 0.0 109.965 -175.477 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.782 0.325 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.0 ptm -126.72 137.45 53.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.753 1.621 . . . . 0.0 110.716 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 14.1 m -108.71 112.69 25.12 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.446 1.498 . . . . 0.0 108.944 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 8.1 t60 -106.47 158.36 16.96 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -162.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -152.91 139.02 18.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.612 2.365 . . . . 0.0 110.012 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.29 144.94 50.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.756 1.222 . . . . 0.0 111.17 167.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.8 p -155.45 141.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.157 0.983 . . . . 0.0 111.338 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.31 150.69 33.81 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.206 0.908 . . . . 0.0 113.268 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 47.0 m -131.92 37.53 3.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.932 1.293 . . . . 0.0 111.668 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -67.84 111.96 4.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.938 1.295 . . . . 0.0 111.257 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -72.13 148.06 46.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.242 1.017 . . . . 0.0 112.33 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.93 150.46 20.15 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 73.0 mt -136.93 126.11 15.35 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.336 1.854 . . . . 0.0 108.961 171.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.78 149.35 12.56 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.855 3.037 . . . . 0.0 112.261 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.12 134.99 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.111 1.365 . . . . 0.0 110.368 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 58.8 t30 42.28 73.05 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.247 2.219 . . . . 0.0 114.866 166.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 21.4 mm -67.54 124.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.863 . . . . 0.0 111.223 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 21.4 t -170.33 166.34 8.68 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.499 1.92 . . . . 0.0 110.432 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -85.55 62.96 7.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.989 1.316 . . . . 0.0 110.868 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.6 p -86.45 158.34 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.62 1.568 . . . . 0.0 112.219 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.43 119.36 27.63 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.482 1.113 . . . . 0.0 110.259 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.2 mp -75.91 -11.11 59.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.113 0.965 . . . . 0.0 113.132 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 17.2 t -67.53 -37.5 82.85 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.611 1.096 . . . . 0.0 113.363 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.47 2.5 24.27 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.11 133.57 35.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.134 1.374 . . . . 0.0 110.526 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 52.9 p -138.82 163.02 33.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.891 1.676 . . . . 0.0 110.381 173.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.9 148.91 29.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.937 0.895 . . . . 0.0 113.148 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -135.78 164.53 27.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.874 2.07 . . . . 0.0 109.767 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -116.24 134.08 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.597 1.159 . . . . 0.0 109.346 166.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.4 t -104.29 111.94 65.31 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.302 1.441 . . . . 0.0 108.11 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.83 169.39 20.75 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.806 3.004 . . . . 0.0 110.872 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.21 -15.83 47.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.058 2.506 . . . . 0.0 113.184 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.6 p -79.85 -4.99 54.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.005 1.322 . . . . 0.0 113.847 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.04 59.11 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.385 1.469 . . . . 0.0 114.965 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -77.67 76.76 4.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.567 1.547 . . . . 0.0 111.637 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -58.29 136.59 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.69 1.196 . . . . 0.0 112.398 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.01 151.34 67.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.441 1.497 . . . . 0.0 111.081 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.39 152.94 44.63 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.741 2.96 . . . . 0.0 112.489 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 90.3 m -95.6 152.68 18.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.17 122.73 33.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.668 1.187 . . . . 0.0 109.113 167.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 66.4 mt -84.07 139.01 32.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.325 1.05 . . . . 0.0 110.635 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 92.2 mttt -141.36 140.6 33.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.948 1.299 . . . . 0.0 112.367 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -87.5 125.9 34.59 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 160.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.8 mt -105.71 176.38 5.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.828 1.651 . . . . 0.0 113.031 -163.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -55.57 -34.89 65.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.635 1.974 . . . . 0.0 115.254 -164.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 20.6 m120 -96.61 5.51 50.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.622 1.169 . . . . 0.0 113.398 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.45 71.9 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.46 1.505 . . . . 0.0 113.965 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -73.8 173.73 9.44 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.961 1.704 . . . . 0.0 113.273 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 98.1 t -127.85 142.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.346 1.459 . . . . 0.0 109.961 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -155.85 -174.75 26.05 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.6 160.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.475 1.91 . . . . 0.0 110.99 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 78.9 p -146.93 155.15 42.06 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.904 1.282 . . . . 0.0 111.125 165.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.46 -175.69 4.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.95 1.7 . . . . 0.0 110.728 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 56.5 t -134.15 124.87 17.66 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.313 1.045 . . . . 0.0 109.244 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.64 150.18 27.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.09 3.194 . . . . 0.0 111.767 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.49 -8.04 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.228 1.011 . . . . 0.0 113.479 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -142.84 171.39 14.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.888 2.075 . . . . 0.0 110.341 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 31.1 p -93.23 164.35 13.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.743 1.217 . . . . 0.0 111.096 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.04 -168.68 24.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.206 1.384 . . . . 0.0 113.544 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.8 117.67 11.68 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.899 0.857 . . . . 0.0 111.719 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 6.7 m80 -103.31 148.29 26.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.067 1.747 . . . . 0.0 109.11 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.86 126.89 53.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.136 0.974 . . . . 0.0 109.696 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 28.4 t -84.82 125.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 163.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -105.46 128.75 53.71 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.462 1.105 . . . . 0.0 110.071 172.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 34.6 t -129.34 129.84 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.986 1.314 . . . . 0.0 109.341 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -139.72 141.51 36.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.53 125.12 53.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.393 2.277 . . . . 0.0 109.477 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.64 26.61 11.41 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.688 1.195 . . . . 0.0 113.425 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 97.05 -13.03 65.34 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.83 1.681 . . . . 0.0 115.937 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.28 144.73 42.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.684 1.742 . . . . 0.0 112.142 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -62.65 142.8 57.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 85.6 t -70.83 149.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.449 1.499 . . . . 0.0 109.462 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.17 64.13 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 70.9 m -86.42 -8.91 57.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.549 1.14 . . . . 0.0 113.785 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 24.7 t -88.9 145.22 34.23 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.069 1.347 . . . . 0.0 112.383 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.52 154.09 95.04 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.608 0.896 . . . . 0.0 112.565 -3.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.8 120.21 50.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.4 1.48 . . . . 0.0 108.515 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.3 142.5 13.38 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.914 2.409 . . . . 0.0 111.38 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.25 125.57 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.27 1.428 . . . . 0.0 108.081 174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 57.4 t -97.01 121.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.499 0.72 . . . . 0.0 109.807 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.87 123.93 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.88 1.272 . . . . 0.0 109.253 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 159.81 15.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.617 0.767 . . . . 0.0 111.402 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -57.48 -30.68 65.27 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.985 0.914 . . . . 0.0 112.782 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 30.9 m -67.29 -18.4 65.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.426 1.09 . . . . 0.0 113.813 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -93.15 -11.12 33.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.517 1.127 . . . . 0.0 112.847 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.19 -35.31 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.438 1.095 . . . . 0.0 112.306 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.98 61.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.911 0.767 . . . . 0.0 113.523 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.12 95.63 8.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.459 0.703 . . . . 0.0 110.853 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.9 69.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.651 0.78 . . . . 0.0 112.388 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.9 m -53.99 -21.16 7.49 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.078 1.751 . . . . 0.0 114.432 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -97.24 -7.5 32.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.562 1.545 . . . . 0.0 113.891 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 94.3 t -75.64 137.28 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.722 1.146 . . . . 0.0 109.94 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -123.2 157.62 32.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.277 1.431 . . . . 0.0 111.072 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 28.0 m -146.34 156.93 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.319 1.448 . . . . 0.0 110.972 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.18 174.24 15.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.625 1.17 . . . . 0.0 112.156 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 110.54 -157.51 14.96 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.395 1.474 . . . . 0.0 113.644 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -109.89 -36.29 5.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.642 1.177 . . . . 0.0 112.549 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.63 -0.18 53.15 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 125.113 1.34 . . . . 0.0 115.606 -171.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.92 -5.47 50.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.33 1.452 . . . . 0.0 112.451 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -125.09 -38.16 2.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.223 1.409 . . . . 0.0 113.346 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.8 154.59 30.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.306 1.042 . . . . 0.0 113.238 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.67 -176.17 24.16 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.399 1.476 . . . . 0.0 113.761 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.0 m80 -140.3 145.45 37.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.768 1.227 . . . . 0.0 112.496 -173.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 46.2 p -68.94 -16.25 63.7 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -117.54 -5.02 11.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -144.88 146.48 31.51 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 110.853 -176.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.24 145.71 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.884 2.39 . . . . 0.0 111.604 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -99.4 148.44 24.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.11 1.364 . . . . 0.0 110.374 171.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.96 146.21 51.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.861 . . . . 0.0 113.093 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.7 148.15 26.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.287 1.435 . . . . 0.0 110.958 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.38 140.29 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 109.165 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 37.9 mt -112.13 134.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.872 1.669 . . . . 0.0 109.272 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 65.3 t0 -125.53 103.73 8.03 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.033 1.733 . . . . 0.0 110.644 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 22.8 p -99.21 0.48 43.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.403 1.881 . . . . 0.0 113.127 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.88 -32.7 72.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 0.0 113.326 -171.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.78 -14.46 58.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.667 1.187 . . . . 0.0 113.451 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.11 -0.56 57.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.344 1.457 . . . . 0.0 114.307 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.3 -136.24 15.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.643 1.116 . . . . 0.0 111.937 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -88.42 169.26 11.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.004 1.322 . . . . 0.0 112.329 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 142.24 -151.55 23.01 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.333 0.968 . . . . 0.0 114.255 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -148.62 148.72 20.42 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.426 1.489 . . . . 0.0 112.691 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 128.51 54.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.838 2.055 . . . . 0.0 109.501 -177.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 11.7 t -121.75 139.44 53.58 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.681 1.592 . . . . 0.0 109.749 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.16 142.14 30.37 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.57 1.148 . . . . 0.0 110.139 -162.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 87.0 p -147.61 149.83 33.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 14.6 mt -117.39 127.8 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.813 1.245 . . . . 0.0 109.289 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -114.58 154.91 27.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.916 2.086 . . . . 0.0 109.229 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 164.01 -162.55 35.28 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.156 -0.965 . . . . 0.0 114.832 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 -6.41 19.14 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.127 3.218 . . . . 0.0 114.294 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.3 t -154.57 157.59 38.5 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.631 1.105 . . . . 0.0 112.248 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 128.25 35.0 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.08 1.352 . . . . 0.0 109.506 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 30.4 m -115.96 169.33 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.984 1.313 . . . . 0.0 111.87 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -110.69 121.28 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.396 1.078 . . . . 0.0 110.193 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.19 132.04 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.859 0.864 . . . . 0.0 108.98 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -120.01 157.89 27.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.184 1.794 . . . . 0.0 109.706 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 36.3 p -136.16 160.42 38.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.657 1.183 . . . . 0.0 111.807 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -152.94 119.54 5.64 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.859 1.264 . . . . 0.0 110.002 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.96 124.15 26.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.354 1.062 . . . . 0.0 110.302 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 61.6 mt -94.95 151.72 18.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.288 1.035 . . . . 0.0 111.441 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -16.1 63.86 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -81.95 -7.03 59.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.875 1.27 . . . . 0.0 113.267 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 98.62 1.63 57.61 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.667 1.603 . . . . 0.0 115.05 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 36.0 p -93.62 171.69 8.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.202 1.801 . . . . 0.0 111.503 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -121.32 124.36 44.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.995 0.918 . . . . 0.0 111.504 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -80.51 134.04 35.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.292 1.037 . . . . 0.0 109.395 165.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.7 t -117.86 137.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 108.186 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.1 p -138.85 148.59 43.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.346 1.458 . . . . 0.0 111.401 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.6 p90 -157.13 150.29 23.84 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.602 1.161 . . . . 0.0 111.914 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.0 t -114.79 105.59 53.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.16 0.984 . . . . 0.0 110.712 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.98 150.0 26.26 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.334 2.689 . . . . 0.0 110.618 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 45.9 m -111.11 -45.83 3.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.073 0.949 . . . . 0.0 112.19 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -85.49 142.3 37.41 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.459 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.97 163.0 33.91 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.268 2.645 . . . . 0.0 111.078 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.45 -144.69 16.7 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 124.871 1.224 . . . . 0.0 112.2 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -123.23 129.97 52.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.645 0.778 . . . . 0.0 111.894 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -107.2 142.98 36.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.673 1.589 . . . . 0.0 110.453 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.16 130.11 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.979 1.311 . . . . 0.0 108.378 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.2 mt -113.58 122.08 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.237 1.015 . . . . 0.0 109.437 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -95.62 128.35 42.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.312 1.445 . . . . 0.0 110.16 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.87 112.97 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.902 1.281 . . . . 0.0 108.993 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -126.37 132.95 51.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.106 1.363 . . . . 0.0 111.451 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -129.68 128.31 42.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.102 1.761 . . . . 0.0 109.729 -177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.19 43.51 26.13 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.22 1.008 . . . . 0.0 113.049 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.0 t0 74.47 7.85 4.5 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.977 2.511 . . . . 0.0 114.806 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -121.96 132.44 54.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.17 1.388 . . . . 0.0 111.234 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 126.64 29.27 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 120.907 -1.12 . . . . 0.0 110.97 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.5 m -80.67 160.88 65.87 Favored Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 119.335 0.971 . . . . 0.0 112.097 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -53.23 137.68 63.67 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.689 2.926 . . . . 0.0 113.419 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.93 13.59 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.99 1.281 . . . . 0.0 114.213 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 14.2 t -76.86 142.94 70.21 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 118.42 1.11 . . . . 0.0 111.041 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 144.7 81.8 Favored 'Cis proline' 0 C--N 1.353 0.778 0 CA-C-N 120.002 1.036 . . . . 0.0 111.971 -2.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.79 120.02 36.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.537 1.135 . . . . 0.0 110.42 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 68.3 m -91.05 123.58 34.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.08 0.952 . . . . 0.0 110.449 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 115.38 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.504 1.521 . . . . 0.0 109.996 -166.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.9 tttt -77.81 120.52 22.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.02 0.528 . . . . 0.0 111.239 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.5 t -107.38 119.26 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.073 1.349 . . . . 0.0 109.014 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.8 t -106.42 162.83 13.35 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.768 1.227 . . . . 0.0 111.87 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 127.23 168.3 12.49 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.773 1.654 . . . . 0.0 113.565 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 124.419 1.088 . . . . 0.0 113.85 -168.645 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 1.9 mmm -127.15 128.83 46.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.894 1.278 . . . . 0.0 111.29 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 15.4 m -130.85 146.35 52.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.868 1.667 . . . . 0.0 109.443 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -155.83 159.32 39.29 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . 0.449 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -159.65 154.19 24.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.573 1.949 . . . . 0.0 110.317 -170.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . 0.449 ' H ' HD13 ' A' 1963 ' ' LEU . 95.5 mttt -135.7 144.27 45.84 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.906 1.282 . . . . 0.0 111.714 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 32.5 m -143.0 151.35 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.89 1.276 . . . . 0.0 111.465 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.32 147.36 20.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.409 1.004 . . . . 0.0 112.133 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 26.3 m -136.12 147.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.158 1.383 . . . . 0.0 112.088 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.27 154.69 23.66 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -85.49 161.09 19.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.893 1.277 . . . . 0.0 111.583 167.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.9 135.43 36.43 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.1 mt -125.25 124.0 25.23 Favored Pre-proline 0 N--CA 1.482 1.125 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.69 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.45 133.17 11.64 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.893 2.396 . . . . 0.0 111.464 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 32.4 mt -149.5 143.78 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.046 2.138 . . . . 0.0 107.798 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.1 t30 60.89 45.0 10.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.645 1.178 . . . . 0.0 110.789 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 25.7 mm -43.79 -56.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.826 2.45 . . . . 0.0 115.04 -147.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 49.6 m -105.32 0.88 27.46 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.881 0.872 . . . . 0.0 113.335 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -95.09 74.6 3.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.496 1.518 . . . . 0.0 109.617 -171.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 44.3 p -71.87 22.24 0.05 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.767 2.427 . . . . 0.0 115.59 -168.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.9 t0 -91.19 60.47 4.25 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.893 1.677 . . . . 0.0 111.298 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -21.7 66.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.71 1.204 . . . . 0.0 113.17 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 18.4 m -61.76 -17.71 57.04 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.404 1.482 . . . . 0.0 114.777 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.4 pp -122.63 14.63 10.2 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.33 1.452 . . . . 0.0 113.745 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.19 145.77 26.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 111.588 173.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 29.3 p -146.21 146.77 30.92 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.372 1.869 . . . . 0.0 109.674 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -143.75 149.89 37.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 36.5 p -141.16 140.97 34.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.912 2.085 . . . . 0.0 109.532 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -95.41 133.78 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.718 0.807 . . . . 0.0 109.834 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.7 t -102.17 110.28 62.15 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 107.967 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.74 170.88 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.943 3.096 . . . . 0.0 110.972 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -15.58 49.67 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.002 2.468 . . . . 0.0 113.478 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 79.5 p -80.74 -11.21 59.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.224 . . . . 0.0 113.947 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.21 -1.76 86.26 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.606 1.574 . . . . 0.0 114.973 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -76.83 83.22 3.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.462 1.505 . . . . 0.0 111.626 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.66 134.44 57.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.75 1.22 . . . . 0.0 112.291 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -140.69 149.47 56.88 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.329 1.452 . . . . 0.0 111.615 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.81 153.53 42.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.876 3.051 . . . . 0.0 112.878 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 73.0 m -97.14 156.3 16.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.913 1.285 . . . . 0.0 112.041 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 61.6 tp -87.06 131.46 34.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 0.0 108.744 162.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -97.2 143.48 27.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.55 1.14 . . . . 0.0 110.297 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.8 146.42 34.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.791 1.236 . . . . 0.0 113.476 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -93.49 120.06 33.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.682 1.193 . . . . 0.0 107.903 156.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.71 170.92 9.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.977 -170.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -64.71 -29.27 70.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.026 1.73 . . . . 0.0 114.276 -164.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.2 t30 -86.04 -1.88 57.78 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.653 1.181 . . . . 0.0 113.21 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.95 -2.0 63.66 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.806 1.67 . . . . 0.0 114.531 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 165.81 15.89 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.497 1.519 . . . . 0.0 113.665 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 43.8 t -89.29 145.1 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.045 1.738 . . . . 0.0 110.596 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.0 -173.67 28.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.44 168.22 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.634 . . . . 0.0 112.61 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.4 m -139.06 158.07 44.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.527 1.931 . . . . 0.0 111.107 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -161.71 -174.05 4.03 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.837 2.055 . . . . 0.0 109.704 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 60.1 t -132.19 120.22 17.03 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 119.504 1.047 . . . . 0.0 110.119 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.11 134.57 13.11 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.189 3.259 . . . . 0.0 110.408 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -95.25 -10.18 31.07 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -143.52 174.09 11.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.941 2.097 . . . . 0.0 109.847 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.4 p -85.21 167.75 15.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.683 1.193 . . . . 0.0 111.593 171.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.67 -168.59 21.69 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.163 1.363 . . . . 0.0 114.047 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -73.52 119.04 17.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.082 0.953 . . . . 0.0 111.967 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.0 m80 -109.22 143.24 38.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.583 1.953 . . . . 0.0 109.172 169.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.58 126.07 52.1 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.28 1.032 . . . . 0.0 109.869 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 33.2 t -90.27 111.71 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.644 1.178 . . . . 0.0 108.268 168.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -90.08 136.73 32.87 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.216 1.006 . . . . 0.0 109.76 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 6.8 p -143.99 127.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 121.958 0.885 . . . . 0.0 112.208 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -110.44 135.43 51.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.802 2.041 . . . . 0.0 111.464 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.7 119.77 39.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.097 2.159 . . . . 0.0 109.166 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 56.02 -102.62 0.16 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.011 1.325 . . . . 0.0 111.089 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -112.22 8.59 26.9 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.657 1.599 . . . . 0.0 115.603 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -144.02 151.82 40.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.748 1.774 . . . . 0.0 112.608 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -66.42 144.49 56.49 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.872 -1.143 . . . . 0.0 112.869 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 147.49 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.46 1.104 . . . . 0.0 109.368 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -56.68 -31.05 64.06 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 15.2 m -84.37 -8.2 59.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.003 1.321 . . . . 0.0 113.982 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 23.2 t -82.49 141.42 45.39 Favored Pre-proline 0 CA--C 1.547 0.844 0 O-C-N 120.784 -1.198 . . . . 0.0 112.543 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.92 147.23 83.11 Favored 'Cis proline' 0 C--N 1.353 0.767 0 CA-C-N 119.317 0.792 . . . . 0.0 112.315 -4.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -94.85 118.78 66.68 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.038 1.335 . . . . 0.0 108.619 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.58 140.55 13.35 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.971 2.447 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.6 t -135.79 127.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.952 1.701 . . . . 0.0 107.962 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.0 t -100.29 122.02 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.796 0.838 . . . . 0.0 110.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.81 128.75 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.116 1.366 . . . . 0.0 109.993 -174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.8 t -94.53 172.89 7.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.651 1.18 . . . . 0.0 111.703 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -68.78 -33.55 74.06 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.358 -1.464 . . . . 0.0 112.015 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 14.7 m -67.03 -3.43 7.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.77 4.57 10.55 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.619 1.568 . . . . 0.0 113.19 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 41.1 mm -73.96 -26.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.175 0.99 . . . . 0.0 112.309 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 163.05 53.79 0.02 OUTLIER Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.91 91.05 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.012 0.906 . . . . 0.0 111.235 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.62 69.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.822 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -55.4 -23.95 27.45 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.422 1.489 . . . . 0.0 114.242 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -91.08 -9.14 46.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.088 1.355 . . . . 0.0 113.73 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 134.46 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.136 . . . . 0.0 110.033 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.98 157.78 22.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.651 1.58 . . . . 0.0 110.796 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.9 m -146.3 159.09 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.285 1.434 . . . . 0.0 111.022 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.69 174.52 14.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.794 1.238 . . . . 0.0 112.258 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.66 166.51 30.78 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.316 1.436 . . . . 0.0 114.277 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -75.92 -29.4 58.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.508 1.123 . . . . 0.0 113.454 -167.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -72.27 3.96 20.88 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.115 1.341 . . . . 0.0 115.165 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.88 -8.09 41.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 112.339 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.4 -42.45 1.82 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.148 1.379 . . . . 0.0 113.688 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.01 159.9 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -153.47 -177.56 27.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.223 1.392 . . . . 0.0 114.038 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -131.67 151.17 51.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.707 1.603 . . . . 0.0 112.081 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 32.5 p -71.71 -14.63 62.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -112.56 -9.77 13.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.01 157.12 77.91 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 126.238 1.815 . . . . 0.0 110.844 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.52 141.44 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.805 2.337 . . . . 0.0 110.533 169.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 149.37 22.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.587 1.155 . . . . 0.0 109.854 165.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -134.62 147.69 50.25 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.588 0.755 . . . . 0.0 112.545 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.7 p90 -151.64 150.64 30.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.391 1.476 . . . . 0.0 110.636 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.28 140.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.849 1.659 . . . . 0.0 109.287 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.88 134.55 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.226 1.811 . . . . 0.0 109.049 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.5 t0 -123.99 96.69 5.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.701 . . . . 0.0 110.611 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 7.9 p -95.15 -0.11 53.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.32 2.248 . . . . 0.0 113.172 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -60.15 -38.47 83.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.263 1.025 . . . . 0.0 112.805 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.71 -16.02 57.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.829 1.252 . . . . 0.0 113.319 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -87.38 -2.74 58.84 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.796 1.239 . . . . 0.0 113.865 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 87.16 -122.03 6.03 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.805 1.193 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -113.69 164.67 13.4 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.546 1.538 . . . . 0.0 112.233 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.9 -176.74 26.59 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 169.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -99.0 129.18 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.866 1.222 . . . . 0.0 111.36 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.25 119.43 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 107.863 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.9 t -113.87 141.3 47.52 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.734 1.214 . . . . 0.0 110.108 173.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.1 tt -140.26 132.99 28.99 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.48 1.112 . . . . 0.0 110.331 -163.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.2 m -133.67 133.35 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.642 0.777 . . . . 0.0 111.039 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 55.4 mt -116.63 133.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.282 1.433 . . . . 0.0 108.463 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.39 148.68 44.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.821 0.848 . . . . 0.0 111.381 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 172.84 -163.74 35.64 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.939 0.781 . . . . 0.0 113.87 -172.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.91 -6.4 19.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.045 3.163 . . . . 0.0 114.723 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -155.01 160.9 41.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.084 1.311 . . . . 0.0 113.103 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -59.92 140.93 56.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.988 1.715 . . . . 0.0 111.08 171.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.5 m -132.43 139.54 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.454 0.702 . . . . 0.0 111.389 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.81 102.04 12.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 109.702 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 19.9 mt -80.03 124.2 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -116.43 157.34 25.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.347 1.859 . . . . 0.0 109.929 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 76.6 p -141.28 157.29 45.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.862 1.265 . . . . 0.0 111.165 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -155.05 111.44 3.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.622 1.169 . . . . 0.0 110.178 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.6 126.84 31.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.406 1.083 . . . . 0.0 110.564 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.77 159.85 14.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 111.883 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.34 -22.07 66.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.164 0.986 . . . . 0.0 113.368 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 28.1 t0 -83.44 -0.5 50.34 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.903 1.281 . . . . 0.0 113.323 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.13 -1.52 77.42 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.587 1.565 . . . . 0.0 115.068 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.9 p -85.5 158.69 20.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.762 1.625 . . . . 0.0 111.187 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 26.9 t -114.83 121.82 44.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.732 0.813 . . . . 0.0 111.151 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -75.97 140.48 42.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.606 0.763 . . . . 0.0 109.347 163.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -123.26 138.92 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.36 1.864 . . . . 0.0 108.082 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -136.03 149.14 48.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.573 1.549 . . . . 0.0 111.346 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -159.43 147.91 17.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.651 1.18 . . . . 0.0 111.505 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 33.2 t -117.43 107.12 45.53 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.828 0.851 . . . . 0.0 111.019 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.71 150.67 24.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.694 2.929 . . . . 0.0 110.49 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 90.5 m -112.86 -41.75 3.72 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.995 0.918 . . . . 0.0 112.238 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -83.72 140.79 41.01 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.569 0.748 . . . . 0.0 110.151 171.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.15 23.32 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.379 2.72 . . . . 0.0 111.236 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 122.23 -154.03 16.84 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.12 1.343 . . . . 0.0 113.197 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -93.35 131.85 38.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.092 0.957 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -119.87 150.32 40.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.646 1.578 . . . . 0.0 109.763 168.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.43 131.76 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 109.188 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.29 130.28 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.049 1.34 . . . . 0.0 109.427 171.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -110.37 119.98 40.97 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.115 1.366 . . . . 0.0 109.657 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.2 mm -113.29 117.9 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.335 1.054 . . . . 0.0 109.369 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -134.48 131.8 38.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.5 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.71 123.17 39.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 110.054 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.84 32.91 13.17 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.353 1.461 . . . . 0.0 113.986 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.9 t0 84.16 7.45 0.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.746 2.818 . . . . 0.0 114.654 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -113.73 129.42 56.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.531 1.132 . . . . 0.0 111.278 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -65.23 123.16 18.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.384 1.474 . . . . 0.0 110.376 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -75.01 154.53 86.68 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.197 -0.939 . . . . 0.0 110.983 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.18 137.85 68.72 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.424 2.083 . . . . 0.0 111.274 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.34 -26.74 22.5 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.325 1.44 . . . . 0.0 113.304 -171.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 67.8 m -70.25 150.17 95.95 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 118.895 1.347 . . . . 0.0 112.103 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.98 147.66 83.81 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 119.08 0.707 . . . . 0.0 110.836 -7.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.08 118.78 36.6 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.836 0.854 . . . . 0.0 110.853 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 46.4 m -87.09 125.31 34.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.121 0.968 . . . . 0.0 111.202 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -117.9 122.37 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.927 1.691 . . . . 0.0 109.542 -173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 59.8 tttp -86.86 111.58 20.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.201 0.601 . . . . 0.0 110.781 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 95.8 t -97.31 117.04 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.51 1.124 . . . . 0.0 108.814 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.3 t -94.12 151.92 19.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.964 0.906 . . . . 0.0 111.222 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 173.65 150.85 7.79 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.978 0.799 . . . . 0.0 114.549 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 125.219 1.407 . . . . 0.0 113.678 176.53 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 120.51 0.195 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 17.8 ptm -145.34 142.85 29.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.722 1.209 . . . . 0.0 112.627 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 66.8 m -109.34 154.87 21.92 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 110.273 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -149.63 160.56 43.4 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 152.23 27.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.282 1.833 . . . . 0.0 109.952 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -134.51 143.62 47.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.566 1.146 . . . . 0.0 111.992 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 67.5 t -140.93 132.03 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.909 1.684 . . . . 0.0 109.666 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.24 117.93 4.52 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 40.8 m -80.48 -42.79 21.94 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 59.26 -170.17 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.639 1.576 . . . . 0.0 113.278 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -148.0 147.94 30.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.331 1.453 . . . . 0.0 110.132 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -88.55 133.01 34.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.072 0.949 . . . . 0.0 112.2 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.5 mt -127.62 119.01 21.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 125.093 1.357 . . . . 0.0 109.049 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.07 135.65 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.926 2.417 . . . . 0.0 110.627 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.9 mt -146.08 139.35 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.865 1.666 . . . . 0.0 108.468 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 45.2 t30 63.69 76.57 0.35 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.758 1.623 . . . . 0.0 110.915 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.1 mm -84.75 63.44 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.266 1.426 . . . . 0.0 110.073 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 t -162.76 -178.58 6.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 111.19 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -73.7 125.8 28.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.253 1.021 . . . . 0.0 110.695 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 2.4 m -165.09 137.9 4.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.357 2.263 . . . . 0.0 108.683 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.18 131.49 38.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.716 1.206 . . . . 0.0 111.173 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 1.7 mt -85.23 -13.81 48.73 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -173.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 47.7 m -82.19 -26.78 33.05 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.772 1.169 . . . . 0.0 112.781 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.93 6.26 49.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.268 1.427 . . . . 0.0 113.321 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.91 143.29 31.98 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 0.0 110.666 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 37.6 p -144.03 160.65 40.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.358 1.863 . . . . 0.0 110.365 172.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -157.33 152.6 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.183 0.993 . . . . 0.0 113.214 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -138.0 164.6 28.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.976 2.11 . . . . 0.0 109.747 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -119.56 136.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.353 1.461 . . . . 0.0 110.056 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 96.1 t -104.9 115.6 62.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.33 1.452 . . . . 0.0 108.567 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.91 173.04 10.5 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.987 3.124 . . . . 0.0 111.521 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.43 -33.21 55.82 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 124.343 3.362 . . . . 0.0 113.971 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 17.9 m -73.38 -10.35 59.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.665 1.186 . . . . 0.0 114.038 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.47 -3.48 67.67 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.635 1.588 . . . . 0.0 115.148 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.3 mmm-85 -79.86 90.08 5.29 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.256 1.422 . . . . 0.0 110.772 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.08 136.93 57.7 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.477 1.111 . . . . 0.0 112.117 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -137.05 151.82 72.71 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.576 1.55 . . . . 0.0 111.249 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.88 155.66 38.98 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.672 2.915 . . . . 0.0 112.871 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 87.5 m -100.91 158.89 15.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.889 1.276 . . . . 0.0 112.238 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.9 tt -93.11 121.79 34.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.75 1.22 . . . . 0.0 108.083 167.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.48 141.67 28.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.662 1.185 . . . . 0.0 111.082 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 94.5 mttt -143.3 149.63 38.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.597 1.159 . . . . 0.0 112.978 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -93.77 116.17 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 157.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 88.3 mt -89.24 165.93 14.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.816 0.846 . . . . 0.0 111.519 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -59.69 -25.47 64.79 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 30.1 m120 -77.32 -9.32 58.76 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 96.78 -12.88 65.76 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.099 1.809 . . . . 0.0 114.301 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.05 161.89 26.26 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.565 1.182 . . . . 0.0 113.416 174.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -80.69 148.66 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 109.337 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.85 176.82 30.84 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.274 0.94 . . . . 0.0 114.054 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.53 164.74 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.425 1.49 . . . . 0.0 111.704 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 86.0 p -143.54 152.97 42.09 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 111.964 165.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 13.3 p90 -161.63 173.03 15.31 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.739 2.016 . . . . 0.0 110.656 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 96.9 t -122.69 119.84 28.0 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.446 1.098 . . . . 0.0 109.816 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.4 151.59 22.94 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.754 3.636 . . . . 0.0 111.519 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 13.6 mptt -107.36 -6.22 17.28 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.214 1.006 . . . . 0.0 113.023 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -138.57 167.67 21.44 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.51 1.924 . . . . 0.0 110.639 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.2 p -90.14 165.13 14.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.825 1.25 . . . . 0.0 111.063 168.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.17 -170.79 29.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.077 1.322 . . . . 0.0 113.727 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -71.22 115.94 10.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.185 0.994 . . . . 0.0 112.119 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.9 m80 -100.48 146.58 26.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.007 1.723 . . . . 0.0 109.065 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.53 127.71 54.18 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.119 0.968 . . . . 0.0 109.81 174.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 25.0 t -90.68 123.21 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.664 1.186 . . . . 0.0 108.203 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -105.26 131.52 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.336 . . . . 0.0 110.196 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 21.5 t -130.64 133.36 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.853 0.861 . . . . 0.0 111.101 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -127.6 135.94 50.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.468 1.907 . . . . 0.0 111.591 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -128.75 123.2 32.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.164 2.186 . . . . 0.0 110.192 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.5 t30 55.94 29.28 13.96 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.154 1.381 . . . . 0.0 113.89 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.49 4.75 65.71 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.966 1.27 . . . . 0.0 115.855 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.45 155.88 49.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.406 1.603 . . . . 0.0 111.618 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 67.4 m80 -65.22 143.26 57.94 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.794 -1.191 . . . . 0.0 113.166 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 74.0 t -71.42 142.65 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.438 1.095 . . . . 0.0 109.459 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.01 67.52 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.7 m -81.57 -7.7 59.62 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.968 1.307 . . . . 0.0 113.938 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.1 t -82.92 141.96 44.41 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 120.804 -1.185 . . . . 0.0 112.581 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.07 154.26 86.47 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.646 0.909 . . . . 0.0 112.579 -3.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.39 122.12 46.19 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.483 1.513 . . . . 0.0 108.656 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.16 142.93 12.44 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.11 2.54 . . . . 0.0 111.634 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.9 123.71 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.441 1.497 . . . . 0.0 108.269 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.6 t -99.29 124.52 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.754 0.822 . . . . 0.0 110.172 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.75 128.1 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.997 1.319 . . . . 0.0 109.553 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 60.8 m -100.51 156.34 17.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.108 0.963 . . . . 0.0 111.975 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -56.25 -35.4 67.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.789 1.236 . . . . 0.0 114.168 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 37.0 m -73.72 -12.6 60.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.751 0.82 . . . . 0.0 113.021 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.64 -6.3 52.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.816 1.246 . . . . 0.0 112.628 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 43.0 mm -73.42 -31.93 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.218 0.917 . . . . 0.0 112.494 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 160.93 55.08 0.02 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.48 100.85 10.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.855 0.827 . . . . 0.0 110.315 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.39 -32.61 71.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.74 1.216 . . . . 0.0 113.667 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.55 -21.56 27.26 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.486 1.515 . . . . 0.0 114.027 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.58 -9.94 50.48 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.466 1.506 . . . . 0.0 113.934 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.9 t -79.78 125.96 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 119.949 1.249 . . . . 0.0 111.327 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -105.17 156.04 18.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.644 1.577 . . . . 0.0 110.991 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -147.88 159.17 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.624 1.569 . . . . 0.0 110.861 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.6 t -161.4 177.54 10.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.687 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 100.07 160.63 28.45 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.444 1.497 . . . . 0.0 114.26 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -67.07 -33.14 74.85 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.187 1.395 . . . . 0.0 113.116 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.04 -3.49 36.96 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.05 1.31 . . . . 0.0 115.344 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.69 -7.39 56.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.032 1.333 . . . . 0.0 112.855 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -128.38 -36.01 1.93 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.778 1.231 . . . . 0.0 113.845 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -159.73 157.39 29.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.599 1.16 . . . . 0.0 112.477 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.09 -176.58 24.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.715 1.15 . . . . 0.0 114.106 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -135.43 147.12 48.86 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.887 1.275 . . . . 0.0 112.473 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 20.9 p -67.99 -29.07 68.0 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -112.02 5.81 18.95 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -141.28 154.64 67.65 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.42 1.488 . . . . 0.0 111.068 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.42 136.89 27.12 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.71 2.274 . . . . 0.0 110.738 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -95.82 118.54 32.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.727 1.211 . . . . 0.0 110.146 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -98.29 147.57 24.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.136 0.975 . . . . 0.0 113.369 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.33 153.78 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.253 1.421 . . . . 0.0 111.241 173.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.72 140.08 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.679 1.591 . . . . 0.0 109.456 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.3 mt -114.77 130.66 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.56 1.944 . . . . 0.0 108.901 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.4 t0 -119.55 84.17 2.16 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.603 1.561 . . . . 0.0 110.569 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 3.3 p -84.97 -5.84 59.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.774 2.03 . . . . 0.0 113.288 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -56.03 -40.58 73.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.479 1.036 . . . . 0.0 111.676 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.06 -9.95 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.404 1.482 . . . . 0.0 113.329 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -98.2 0.12 45.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.132 1.773 . . . . 0.0 114.333 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 82.99 -134.04 12.48 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.252 0.93 . . . . 0.0 111.016 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.59 171.49 9.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.758 1.223 . . . . 0.0 112.292 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.87 177.81 19.99 Favored Glycine 0 N--CA 1.472 1.074 0 C-N-CA 124.414 1.006 . . . . 0.0 114.951 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -106.63 131.71 10.78 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.551 1.548 . . . . 0.0 111.815 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.92 121.56 41.95 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.721 2.008 . . . . 0.0 108.913 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 74.8 m -112.56 143.9 42.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.979 1.712 . . . . 0.0 110.266 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.8 tt -143.86 137.4 27.9 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.767 0.827 . . . . 0.0 110.502 -166.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 62.7 m -138.7 135.08 34.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.73 0.812 . . . . 0.0 111.371 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 23.9 mt -122.29 134.56 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.264 1.426 . . . . 0.0 109.13 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.28 154.64 44.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 111.258 -174.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.59 21.29 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.785 -1.008 . . . . 0.0 114.052 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.69 -14.73 36.74 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.029 3.153 . . . . 0.0 114.976 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.3 t -159.16 165.74 33.03 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.955 1.252 . . . . 0.0 112.419 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.01 148.34 51.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.961 1.304 . . . . 0.0 111.775 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 35.9 m -135.12 147.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.562 1.145 . . . . 0.0 112.293 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -88.51 104.38 16.76 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.759 0.824 . . . . 0.0 110.19 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 39.6 mt -84.98 130.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.871 0.868 . . . . 0.0 109.742 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -128.14 155.46 44.4 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.305 1.842 . . . . 0.0 110.333 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.59 156.5 46.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.964 1.306 . . . . 0.0 111.625 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.27 125.83 5.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.983 1.313 . . . . 0.0 110.275 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.64 133.5 36.4 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.335 -0.853 . . . . 0.0 111.199 171.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 50.5 mt -96.19 160.77 14.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.67 1.188 . . . . 0.0 111.732 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.45 -20.68 66.47 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 0.0 113.291 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.62 -3.69 56.55 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.094 1.358 . . . . 0.0 113.274 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.29 -2.94 75.43 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.611 1.577 . . . . 0.0 114.848 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 46.5 p -82.47 167.96 17.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.554 1.542 . . . . 0.0 111.14 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -116.24 127.56 54.86 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.845 0.858 . . . . 0.0 111.196 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -90.86 137.66 32.19 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.703 1.201 . . . . 0.0 109.937 170.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 25.3 t -122.59 138.27 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.4 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.3 p -136.16 151.85 50.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.415 1.486 . . . . 0.0 110.948 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 11.7 p90 -161.27 145.5 13.3 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.427 1.491 . . . . 0.0 110.515 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 25.0 t -107.01 103.41 47.63 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.58 0.752 . . . . 0.0 110.722 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -78.26 110.78 2.93 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.358 2.705 . . . . 0.0 110.128 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.9 m -69.22 -37.98 78.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.647 0.779 . . . . 0.0 112.341 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.29 146.39 34.59 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.035 1.334 . . . . 0.0 111.447 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.37 168.06 25.37 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.275 2.65 . . . . 0.0 111.1 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 114.76 -163.98 12.13 Favored Glycine 0 N--CA 1.472 1.036 0 C-N-CA 125.172 1.368 . . . . 0.0 113.402 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 54.0 t30 -89.89 120.17 30.89 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.9 -0.764 . . . . 0.0 112.174 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.33 143.43 30.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.117 1.367 . . . . 0.0 110.904 164.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.28 134.63 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.926 1.29 . . . . 0.0 108.82 174.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 29.0 mt -116.32 132.95 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.288 1.435 . . . . 0.0 109.521 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -114.17 125.51 54.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.018 1.727 . . . . 0.0 109.904 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.54 124.83 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.974 0.91 . . . . 0.0 109.638 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 31.1 tttt -132.39 127.12 34.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.142 1.377 . . . . 0.0 110.482 -171.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 37.3 t80 -123.8 124.76 43.39 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.12 0.968 . . . . 0.0 110.064 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.99 49.2 17.4 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.469 1.107 . . . . 0.0 111.773 -173.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.84 13.83 9.57 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.373 2.269 . . . . 0.0 114.624 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -119.48 126.8 52.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.104 1.362 . . . . 0.0 110.258 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -65.29 121.58 15.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.616 1.167 . . . . 0.0 111.055 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -79.14 158.69 74.27 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 121.288 -0.883 . . . . 0.0 111.784 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.18 138.07 71.2 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.517 2.811 . . . . 0.0 112.909 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 92.63 -23.24 29.21 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.964 1.268 . . . . 0.0 114.343 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 72.4 m -74.56 149.96 86.52 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 118.916 1.358 . . . . 0.0 111.64 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.52 145.86 80.91 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 119.326 0.795 . . . . 0.0 111.442 -3.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -98.85 120.43 39.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.54 1.136 . . . . 0.0 110.772 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 45.9 m -86.86 133.02 33.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.131 0.972 . . . . 0.0 110.988 171.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 17.2 t -129.93 111.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.63 1.572 . . . . 0.0 109.471 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -81.57 109.58 16.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.015 0.526 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 60.4 t -91.26 127.1 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.131 1.372 . . . . 0.0 109.328 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -117.9 161.94 18.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.739 1.216 . . . . 0.0 112.186 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 129.22 163.29 11.17 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.965 1.745 . . . . 0.0 113.45 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 126.06 1.744 . . . . 0.0 110.291 -171.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 96.9 mtp -89.18 133.03 34.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.428 1.491 . . . . 0.0 112.407 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 18.4 m -118.27 140.59 49.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 108.465 160.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -156.51 158.42 37.16 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.0 tt -161.04 154.64 22.04 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.43 1.892 . . . . 0.0 111.131 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.51 151.34 47.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.002 1.321 . . . . 0.0 112.559 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 52.6 t -139.69 133.98 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.022 1.729 . . . . 0.0 109.458 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -92.5 128.41 9.39 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.885 0.755 . . . . 0.0 111.25 172.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 66.1 m -118.92 144.91 46.17 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.412 1.085 . . . . 0.0 112.53 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.01 151.98 24.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.0 112.357 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.5 149.66 24.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.064 0.946 . . . . 0.0 110.75 166.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.33 134.05 34.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.539 0.735 . . . . 0.0 111.572 169.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.8 mm -112.89 127.48 26.78 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.495 1.518 . . . . 0.0 108.74 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.7 134.31 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.908 2.405 . . . . 0.0 110.478 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 29.9 mm -144.87 140.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.387 1.475 . . . . 0.0 110.293 -168.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.59 55.54 7.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.786 1.634 . . . . 0.0 112.905 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.4 mm -65.76 112.55 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.478 1.111 . . . . 0.0 110.516 -172.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 99.8 p -173.9 172.6 3.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.276 1.43 . . . . 0.0 111.849 -170.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.08 4.82 9.35 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.932 1.693 . . . . 0.0 113.623 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 56.8 m -61.95 134.85 57.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 111.472 -174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.67 132.98 46.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.439 1.496 . . . . 0.0 111.633 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.3 mp -73.76 -21.16 60.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.027 0.931 . . . . 0.0 112.425 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 24.0 m -67.58 -23.46 65.4 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -167.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -114.21 8.95 17.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.35 1.46 . . . . 0.0 113.609 175.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.66 148.09 25.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.026 1.33 . . . . 0.0 111.997 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 47.3 p -141.39 169.65 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.261 2.224 . . . . 0.0 108.974 168.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.42 155.24 37.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 54.6 p -132.25 160.82 35.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.082 2.153 . . . . 0.0 109.153 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -112.8 135.27 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.073 0.949 . . . . 0.0 109.449 166.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.0 t -104.68 113.13 65.25 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.968 1.307 . . . . 0.0 108.196 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.32 173.44 11.65 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.999 3.133 . . . . 0.0 111.128 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.72 -32.69 56.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.127 3.218 . . . . 0.0 113.961 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.5 m -75.65 -4.53 40.69 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 0.0 114.12 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 74.86 -1.76 52.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.286 1.422 . . . . 0.0 115.15 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -77.21 85.56 3.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.516 1.526 . . . . 0.0 111.243 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.09 133.01 54.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.854 1.262 . . . . 0.0 111.929 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -140.58 150.64 61.16 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.174 1.39 . . . . 0.0 111.277 176.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.64 155.55 40.01 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.271 3.314 . . . . 0.0 112.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.2 m -111.28 155.35 23.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.547 1.539 . . . . 0.0 112.207 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 6.2 tt -95.29 116.72 29.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.419 1.488 . . . . 0.0 108.671 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 11.2 mp -84.6 138.11 32.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.476 1.11 . . . . 0.0 111.352 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -133.44 136.17 45.02 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.041 1.336 . . . . 0.0 112.803 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.7 121.73 26.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 152.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.5 162.23 13.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.479 1.112 . . . . 0.0 112.013 -171.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -60.36 -31.65 70.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -86.27 -1.82 57.83 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.971 0.909 . . . . 0.0 113.439 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.62 0.35 57.87 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.504 1.526 . . . . 0.0 114.095 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -80.87 177.31 9.13 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.119 1.368 . . . . 0.0 112.863 170.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 88.6 t -130.15 140.51 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 109.617 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.04 -174.54 25.97 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.61 154.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.613 1.565 . . . . 0.0 111.946 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 16.4 m -121.38 149.59 42.74 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.15 1.38 . . . . 0.0 111.198 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.2 p90 -165.64 -178.87 5.07 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.101 2.16 . . . . 0.0 109.752 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.9 t -128.88 122.44 21.42 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-N 119.258 0.935 . . . . 0.0 109.95 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.81 149.56 23.27 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.115 3.21 . . . . 0.0 111.369 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -106.27 -9.57 16.77 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -143.25 173.63 11.42 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.858 2.063 . . . . 0.0 110.11 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.5 p -88.77 167.35 13.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.656 1.182 . . . . 0.0 111.117 167.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.65 -168.08 30.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.801 1.191 . . . . 0.0 113.57 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.05 116.98 11.98 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.05 0.94 . . . . 0.0 112.005 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.8 m80 -102.58 141.0 36.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.974 1.71 . . . . 0.0 109.042 167.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.86 123.26 44.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.055 0.942 . . . . 0.0 109.229 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.1 t -87.76 113.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.987 1.315 . . . . 0.0 107.811 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -95.21 126.21 40.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.525 1.13 . . . . 0.0 110.225 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 81.3 t -117.71 120.14 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.996 1.319 . . . . 0.0 109.769 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -108.82 130.48 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.97 1.708 . . . . 0.0 111.72 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -108.74 122.94 48.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.545 1.938 . . . . 0.0 109.356 171.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 57.25 -94.27 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.064 1.346 . . . . 0.0 111.72 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -123.37 9.5 8.8 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.863 1.697 . . . . 0.0 115.777 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.6 157.02 43.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.743 1.771 . . . . 0.0 112.393 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -67.34 138.61 56.91 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.888 -1.133 . . . . 0.0 112.783 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 5.9 p -71.44 156.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.389 1.076 . . . . 0.0 110.675 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.06 -28.44 62.58 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.0 m -80.47 -9.65 59.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.942 1.297 . . . . 0.0 114.162 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 31.9 t -90.78 147.56 36.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.9 1.28 . . . . 0.0 113.198 -172.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.26 162.28 76.76 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.26 0.771 . . . . 0.0 112.677 -5.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.01 126.38 28.32 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.685 1.594 . . . . 0.0 109.04 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.66 142.27 12.75 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.117 2.544 . . . . 0.0 112.031 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.9 t -135.87 127.75 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.593 1.557 . . . . 0.0 107.869 170.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 53.9 t -100.39 126.53 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.853 0.861 . . . . 0.0 110.49 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.29 130.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.138 1.375 . . . . 0.0 110.169 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 65.9 m -98.15 156.92 16.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.52 1.128 . . . . 0.0 112.087 174.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -58.52 -30.01 66.75 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 8.7 m -65.34 -19.29 65.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.6 1.16 . . . . 0.0 113.739 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -93.46 -12.17 30.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.713 1.205 . . . . 0.0 112.955 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.7 -24.81 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.659 1.184 . . . . 0.0 112.576 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 134.73 68.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.291 1.424 . . . . 0.0 112.84 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.96 105.79 10.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.262 0.531 . . . . 0.0 110.007 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.49 66.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.841 0.856 . . . . 0.0 112.307 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.1 m -54.18 -23.33 14.04 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.181 1.793 . . . . 0.0 114.468 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -90.9 -12.73 35.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.856 1.262 . . . . 0.0 113.466 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 67.8 t -74.19 133.99 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.625 1.102 . . . . 0.0 109.867 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.55 154.45 24.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 111.171 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.5 m -144.51 150.5 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.471 1.508 . . . . 0.0 110.172 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.7 m -148.12 165.74 29.93 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.91 1.284 . . . . 0.0 112.487 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.48 159.73 24.01 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.517 1.056 . . . . 0.0 114.416 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -71.59 -25.43 62.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.66 1.184 . . . . 0.0 113.373 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.89 -5.76 41.03 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.264 0.935 . . . . 0.0 114.986 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.25 -2.64 58.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.417 1.487 . . . . 0.0 112.893 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -135.84 -38.72 0.71 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -141.56 151.18 42.99 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.772 1.229 . . . . 0.0 111.831 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.43 -176.7 22.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.144 1.354 . . . . 0.0 113.269 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -147.97 145.72 28.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.173 0.989 . . . . 0.0 113.015 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 24.3 p -60.13 -26.13 66.02 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.711 1.605 . . . . 0.0 115.028 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.77 23.22 9.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.245 1.418 . . . . 0.0 112.93 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -145.49 137.34 13.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.642 1.177 . . . . 0.0 110.315 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -71.27 133.68 23.3 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.536 2.157 . . . . 0.0 110.286 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -102.33 131.35 48.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.436 1.494 . . . . 0.0 110.393 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.42 154.21 35.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.862 1.265 . . . . 0.0 113.325 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.71 153.15 27.98 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.005 1.722 . . . . 0.0 111.024 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.61 142.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.496 1.919 . . . . 0.0 109.9 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.1 132.17 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.815 1.646 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . 0.455 ' HA ' HH21 ' A' 2073 ' ' ARG . 31.4 t0 -125.39 86.75 2.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.46 1.504 . . . . 0.0 111.732 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 16.4 p -83.43 -8.92 59.3 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.422 1.889 . . . . 0.0 113.657 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . 0.455 HH21 ' HA ' ' A' 2071 ' ' ASP . 0.5 OUTLIER -60.89 -30.32 70.09 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.7 1.137 . . . . 0.0 113.616 -175.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.94 -15.58 60.68 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.94 0.896 . . . . 0.0 113.231 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -97.5 -1.63 43.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.95 1.7 . . . . 0.0 114.208 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.78 -128.39 8.55 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.651 1.119 . . . . 0.0 112.296 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -94.22 160.28 14.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.413 1.485 . . . . 0.0 112.234 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.8 174.09 19.38 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.34 126.36 8.72 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.868 1.223 . . . . 0.0 111.852 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.9 123.14 41.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.705 2.002 . . . . 0.0 108.576 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.9 t -116.39 140.51 49.27 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.04 1.336 . . . . 0.0 110.402 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.86 131.0 30.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.663 1.185 . . . . 0.0 110.284 -167.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 56.9 m -135.16 131.14 36.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.796 0.838 . . . . 0.0 110.72 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 22.5 mt -109.27 125.46 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.549 1.54 . . . . 0.0 108.114 173.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.21 139.0 46.96 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.154 1.382 . . . . 0.0 109.742 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -168.82 -175.92 38.6 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -8.58 23.93 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.471 3.447 . . . . 0.0 113.825 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.1 t -154.83 164.84 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.754 1.222 . . . . 0.0 111.875 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.75 146.51 52.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.664 1.186 . . . . 0.0 111.53 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -132.27 141.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.112 0.965 . . . . 0.0 110.822 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.34 125.43 29.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.219 0.608 . . . . 0.0 110.013 169.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 38.4 mt -106.52 127.76 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.94 0.896 . . . . 0.0 108.851 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -124.31 143.68 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 109.854 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 24.9 p -113.74 154.03 28.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.911 1.284 . . . . 0.0 111.248 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.94 120.0 5.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.635 1.174 . . . . 0.0 110.15 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -79.02 123.53 27.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.307 1.043 . . . . 0.0 110.645 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.37 160.12 15.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.104 0.962 . . . . 0.0 111.975 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.6 -25.82 68.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.109 0.963 . . . . 0.0 112.333 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.13 -8.52 50.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.998 1.719 . . . . 0.0 113.777 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.59 -5.48 84.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.768 1.651 . . . . 0.0 114.304 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 25.0 p -82.93 161.41 21.84 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.943 1.697 . . . . 0.0 111.471 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 33.8 t -102.88 123.33 46.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.677 0.791 . . . . 0.0 110.255 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.05 138.2 33.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.867 0.867 . . . . 0.0 109.296 163.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 56.7 t -119.95 133.84 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.059 1.744 . . . . 0.0 108.169 168.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 67.6 m -136.92 138.3 40.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.853 1.261 . . . . 0.0 110.517 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.1 p90 -147.99 148.55 30.85 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.277 1.031 . . . . 0.0 112.465 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 23.2 t -109.15 106.84 59.34 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.538 0.735 . . . . 0.0 111.088 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.37 119.17 4.85 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.992 2.461 . . . . 0.0 109.694 171.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -78.86 -43.54 24.83 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.734 0.814 . . . . 0.0 111.614 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -91.31 147.68 36.01 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.551 1.14 . . . . 0.0 110.933 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.99 167.61 26.66 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.558 2.838 . . . . 0.0 111.734 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.78 -161.28 18.19 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.066 1.317 . . . . 0.0 113.768 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -93.79 126.71 39.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.007 0.923 . . . . 0.0 111.541 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -111.29 142.92 42.89 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.567 1.547 . . . . 0.0 109.808 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.45 123.89 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.595 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.29 124.6 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.896 1.278 . . . . 0.0 109.73 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -104.26 128.9 52.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.893 1.677 . . . . 0.0 109.755 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.3 mm -121.88 111.98 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.858 1.263 . . . . 0.0 109.524 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -121.02 130.92 53.99 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.634 1.574 . . . . 0.0 111.098 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -123.53 126.01 45.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.447 1.499 . . . . 0.0 110.328 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.16 28.77 9.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.342 1.457 . . . . 0.0 113.963 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 87.82 6.89 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 129.147 2.979 . . . . 0.0 114.894 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -114.69 138.27 50.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.726 1.21 . . . . 0.0 111.113 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 132.23 51.53 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.165 -0.959 . . . . 0.0 111.143 172.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.1 m -80.4 159.99 68.63 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.529 -0.732 . . . . 0.0 111.516 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.27 136.59 62.81 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.749 2.966 . . . . 0.0 113.354 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 86.04 -19.8 24.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.048 1.309 . . . . 0.0 114.394 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 23.1 t -76.4 144.27 74.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 118.613 1.207 . . . . 0.0 111.451 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.48 150.7 93.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 119.727 0.938 . . . . 0.0 112.283 -3.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.68 122.29 44.74 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.399 1.479 . . . . 0.0 110.733 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.3 p -86.96 135.28 33.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.419 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.3 t -130.93 113.98 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.186 1.395 . . . . 0.0 109.496 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.13 115.68 22.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.113 0.565 . . . . 0.0 111.154 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 91.4 t -98.22 115.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.232 1.413 . . . . 0.0 109.056 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 4.9 t -102.4 173.81 6.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.947 1.299 . . . . 0.0 111.455 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 116.52 -137.29 13.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.094 1.33 . . . . 0.0 112.615 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.473 0.705 0 C-N-CA 124.768 1.227 . . . . 0.0 112.454 -167.143 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.9 ptt? -70.62 154.24 42.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.438 1.095 . . . . 0.0 112.73 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.0 m -107.59 144.79 34.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.69 1.196 . . . . 0.0 110.117 166.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.31 149.54 51.91 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.561 1.144 . . . . 0.0 113.266 -165.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -157.35 146.24 19.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.066 1.747 . . . . 0.0 110.11 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 48.2 mttp -128.51 149.9 50.4 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.518 1.127 . . . . 0.0 113.0 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.82 139.11 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.32 1.848 . . . . 0.0 109.513 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.96 120.76 5.39 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 4.0 m -111.96 142.74 44.0 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.694 1.197 . . . . 0.0 112.697 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.48 146.0 11.54 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.74 169.35 17.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.977 1.311 . . . . 0.0 111.555 163.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -105.3 137.59 42.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.737 1.215 . . . . 0.0 111.853 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.7 mm -105.27 118.04 56.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.303 1.041 . . . . 0.0 109.02 164.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.13 128.46 10.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.402 2.735 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 57.0 mt -147.44 139.53 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.658 1.583 . . . . 0.0 109.843 -172.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.07 60.26 3.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.803 1.641 . . . . 0.0 112.456 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.4 111.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.44 1.096 . . . . 0.0 111.34 -166.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 m -172.83 146.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.816 2.446 . . . . 0.0 109.33 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.42 -10.16 50.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.77 1.228 . . . . 0.0 113.501 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 24.9 p -91.43 160.3 15.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.338 1.855 . . . . 0.0 112.063 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 60.3 m-20 70.41 3.25 4.39 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.406 2.282 . . . . 0.0 114.679 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.53 -20.86 65.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 113.783 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 28.0 p -77.14 -12.55 59.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 9.74 3.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.179 1.391 . . . . 0.0 114.389 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.95 143.22 34.37 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.207 1.003 . . . . 0.0 110.974 164.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 39.8 p -140.86 160.75 39.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 109.779 173.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.87 150.67 26.24 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.57 0.748 . . . . 0.0 113.013 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 63.6 p -138.8 163.12 33.06 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.977 2.111 . . . . 0.0 109.491 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 137.36 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.911 1.284 . . . . 0.0 109.864 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.1 t -105.6 110.91 64.74 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.111 1.364 . . . . 0.0 108.083 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.57 169.14 20.27 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.893 3.062 . . . . 0.0 110.846 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.16 -15.88 47.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.065 2.51 . . . . 0.0 113.12 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 67.0 p -79.39 -9.3 59.57 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.88 1.272 . . . . 0.0 113.826 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.5 85.21 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.668 1.604 . . . . 0.0 115.185 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -77.61 82.58 4.03 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.374 1.469 . . . . 0.0 111.698 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.83 132.64 54.5 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 111.875 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.06 151.73 59.79 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.405 1.482 . . . . 0.0 111.354 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.9 158.04 34.75 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.951 3.1 . . . . 0.0 112.852 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.9 m -110.18 155.7 21.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.066 1.346 . . . . 0.0 112.457 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.5 tt -99.48 115.23 28.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.82 1.648 . . . . 0.0 108.157 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 4.3 mp -87.08 134.37 33.51 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.578 0.751 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.91 137.23 53.11 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.179 1.392 . . . . 0.0 112.805 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -99.14 124.19 43.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.524 1.529 . . . . 0.0 107.979 161.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.76 171.7 7.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.211 1.404 . . . . 0.0 112.763 -165.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -59.63 -32.19 70.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.33 -2.62 58.51 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.251 1.02 . . . . 0.0 113.446 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.46 -8.4 62.2 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.727 1.632 . . . . 0.0 114.857 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -73.96 168.83 18.69 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.594 1.197 . . . . 0.0 112.975 172.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.3 t -131.26 142.37 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.977 1.311 . . . . 0.0 110.948 -168.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.87 -168.79 20.72 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.846 1.212 . . . . 0.0 113.992 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.72 151.35 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.775 1.23 . . . . 0.0 112.233 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 43.2 m -123.59 155.1 38.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.766 1.626 . . . . 0.0 111.467 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.6 p90 -166.93 -174.68 2.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.497 2.319 . . . . 0.0 109.221 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -128.93 116.23 19.09 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 119.302 0.956 . . . . 0.0 109.706 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.99 139.52 24.41 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.939 3.093 . . . . 0.0 110.574 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -99.96 -6.9 25.85 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.271 1.029 . . . . 0.0 113.08 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -140.16 169.25 18.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.759 2.024 . . . . 0.0 110.363 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 167.11 13.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.277 1.031 . . . . 0.0 110.995 165.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 94.96 -169.3 28.1 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.048 1.309 . . . . 0.0 113.749 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -72.15 118.27 14.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.49 144.16 32.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.351 1.86 . . . . 0.0 109.104 168.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.58 125.95 51.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 0.0 109.642 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 26.3 t -89.35 121.39 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.705 1.202 . . . . 0.0 108.001 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -99.93 128.48 46.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.718 1.207 . . . . 0.0 110.061 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 48.0 t -126.71 131.4 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.595 1.158 . . . . 0.0 110.421 -172.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.9 mttp -123.38 147.58 46.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.734 1.613 . . . . 0.0 112.547 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -118.58 119.83 35.67 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 108.941 169.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.27 30.91 19.22 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.996 1.318 . . . . 0.0 113.247 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.48 2.5 73.11 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.027 1.299 . . . . 0.0 116.052 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -123.59 151.19 43.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.442 1.621 . . . . 0.0 110.999 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.34 144.58 57.06 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 98.2 t -77.63 146.08 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.678 1.191 . . . . 0.0 109.096 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.91 63.57 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -174.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 58.1 p -85.95 -8.05 58.25 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.162 1.385 . . . . 0.0 114.079 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 21.2 t -82.87 144.45 48.09 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.936 1.294 . . . . 0.0 112.358 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.03 155.49 87.41 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.562 0.879 . . . . 0.0 112.613 -3.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.49 120.85 48.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.731 1.612 . . . . 0.0 108.768 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.26 141.61 12.91 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.965 2.443 . . . . 0.0 111.247 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 22.3 t -137.57 126.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.799 1.639 . . . . 0.0 108.093 175.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.8 t -97.31 124.29 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.72 0.808 . . . . 0.0 110.202 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.57 128.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.037 1.335 . . . . 0.0 109.883 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 66.9 m -93.31 170.75 9.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.706 1.202 . . . . 0.0 112.234 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -34.5 77.46 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.323 -1.486 . . . . 0.0 111.604 174.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.0 m -66.17 -2.29 4.1 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.708 1.603 . . . . 0.0 115.27 -173.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.63 5.49 8.21 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.997 1.719 . . . . 0.0 112.96 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 3.5 mm -86.23 -21.83 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.546 1.138 . . . . 0.0 113.557 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.1 38.35 0.04 OUTLIER Glycine 0 N--CA 1.471 0.968 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.36 84.4 4.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.474 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -54.95 -37.01 65.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.609 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.22 -24.95 45.38 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.497 1.519 . . . . 0.0 114.381 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -90.94 -8.52 49.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.698 1.599 . . . . 0.0 114.215 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 90.4 t -73.8 137.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.007 1.276 . . . . 0.0 110.419 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -121.03 155.21 34.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.311 1.444 . . . . 0.0 111.365 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 30.6 m -145.23 153.33 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 109.971 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -154.86 170.88 20.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.025 0.93 . . . . 0.0 112.669 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.05 156.17 30.59 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.224 1.393 . . . . 0.0 113.184 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.04 -21.61 62.24 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.98 -2.16 22.74 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.078 1.323 . . . . 0.0 115.093 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 65.3 mt -90.93 -7.22 52.71 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.165 1.786 . . . . 0.0 112.707 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.06 -32.23 1.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.074 1.349 . . . . 0.0 113.887 -172.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.48 156.86 42.25 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.486 1.514 . . . . 0.0 112.253 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.87 32.5 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.371 0.986 . . . . 0.0 113.797 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.0 m80 -134.22 148.97 50.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 112.699 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 17.1 p -68.78 -29.78 68.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -118.19 0.15 11.69 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.52 146.49 61.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.106 1.763 . . . . 0.0 109.644 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.21 141.32 43.12 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.783 2.322 . . . . 0.0 111.049 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.72 154.29 21.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.41 1.084 . . . . 0.0 110.295 168.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.66 150.26 47.22 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 112.608 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 42.2 p90 -157.13 149.98 23.54 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 110.637 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.53 140.95 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.934 1.694 . . . . 0.0 109.566 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 71.5 mt -112.74 134.62 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.967 1.707 . . . . 0.0 108.86 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 23.2 t70 -137.07 123.22 20.43 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.565 1.546 . . . . 0.0 112.013 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 11.7 p -134.48 -11.75 2.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -157.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.13 -21.94 66.36 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 121.064 1.756 . . . . 0.0 114.542 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.46 -20.47 61.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.76 0.824 . . . . 0.0 112.554 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -92.34 -3.82 54.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.988 1.715 . . . . 0.0 113.423 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.7 -110.28 3.5 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.992 1.282 . . . . 0.0 112.462 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -131.79 151.74 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.534 1.533 . . . . 0.0 112.808 -168.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.87 -179.13 28.71 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -84.76 127.59 8.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.22 0.914 . . . . 0.0 111.239 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.8 124.58 49.8 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.243 1.817 . . . . 0.0 108.363 175.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.8 t -112.06 140.44 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.844 1.257 . . . . 0.0 111.35 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.17 133.73 47.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.248 2.219 . . . . 0.0 108.363 -174.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 83.0 p -143.36 151.76 40.81 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.26 -0.9 . . . . 0.0 112.661 167.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.27 137.52 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.97 1.308 . . . . 0.0 109.296 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.67 155.41 41.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.273 1.429 . . . . 0.0 111.033 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 167.3 -155.5 26.57 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 118.808 -0.996 . . . . 0.0 114.202 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.43 -8.69 23.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.429 3.42 . . . . 0.0 115.368 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.4 t -160.26 162.0 33.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.741 1.217 . . . . 0.0 111.528 173.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.29 146.98 53.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.301 1.041 . . . . 0.0 111.782 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 34.6 m -135.46 147.89 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.035 1.334 . . . . 0.0 111.65 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -88.94 122.55 32.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.862 0.865 . . . . 0.0 110.346 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.21 131.41 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.371 1.068 . . . . 0.0 109.604 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -130.05 161.08 31.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.224 1.81 . . . . 0.0 110.287 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 39.9 p -143.03 163.48 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.489 1.116 . . . . 0.0 112.829 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.13 121.35 6.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.773 1.629 . . . . 0.0 109.969 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.54 131.29 35.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.89 1.276 . . . . 0.0 111.132 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -108.53 153.63 23.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.023 1.329 . . . . 0.0 111.292 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -15.6 63.43 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -76.83 -6.06 50.84 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.753 1.221 . . . . 0.0 112.857 170.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 89.43 2.13 77.1 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.996 1.76 . . . . 0.0 114.082 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 4.1 p -81.64 156.73 24.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.413 1.885 . . . . 0.0 111.31 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -115.43 120.88 41.01 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.994 0.917 . . . . 0.0 110.347 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.8 ttm105 -78.93 133.77 36.9 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.976 0.91 . . . . 0.0 108.846 164.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 27.4 t -115.48 140.54 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.874 1.67 . . . . 0.0 108.518 169.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.7 p -136.21 150.3 48.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.589 1.556 . . . . 0.0 111.334 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.7 p90 -163.12 150.07 12.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 111.415 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 15.0 t -111.59 101.55 51.26 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.907 0.883 . . . . 0.0 110.766 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.64 116.87 4.38 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.104 2.536 . . . . 0.0 110.342 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.6 m -74.06 -39.69 63.3 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.923 0.889 . . . . 0.0 112.396 -173.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -95.07 148.69 35.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.05 1.34 . . . . 0.0 111.478 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.77 164.49 31.86 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.374 2.716 . . . . 0.0 110.98 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 121.01 -163.94 14.36 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.168 1.366 . . . . 0.0 113.284 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.6 t30 -91.55 117.27 29.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.457 0.703 . . . . 0.0 111.99 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -94.96 141.13 29.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.505 1.122 . . . . 0.0 111.145 164.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.77 134.96 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.404 1.482 . . . . 0.0 108.753 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 26.5 mt -118.32 128.36 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.927 1.291 . . . . 0.0 109.111 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -105.72 130.08 53.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 110.884 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 16.0 mm -119.83 120.82 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.002 1.321 . . . . 0.0 110.022 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -131.93 135.99 47.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.22 1.408 . . . . 0.0 111.469 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 69.8 t80 -131.48 129.69 41.46 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.88 1.672 . . . . 0.0 110.652 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.86 29.26 11.68 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.048 1.339 . . . . 0.0 113.424 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.8 t0 83.4 4.53 0.86 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 129.198 2.999 . . . . 0.0 114.668 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -109.05 128.22 54.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.824 1.249 . . . . 0.0 111.186 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -63.24 125.98 25.9 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.053 1.341 . . . . 0.0 110.618 172.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.3 m -80.38 156.46 73.65 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-N 119.039 0.836 . . . . 0.0 111.318 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.19 144.45 81.31 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.409 2.072 . . . . 0.0 111.63 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.37 -24.33 14.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.967 1.27 . . . . 0.0 113.423 -172.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 10.1 t -77.89 143.04 65.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.167 0.987 . . . . 0.0 110.565 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 146.37 84.19 Favored 'Cis proline' 0 C--N 1.353 0.768 0 CA-C-N 120.224 1.116 . . . . 0.0 112.075 0.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -97.63 122.21 40.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.709 1.203 . . . . 0.0 110.546 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.9 m -89.34 129.81 35.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.259 1.024 . . . . 0.0 111.37 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -122.94 112.08 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.2 1.8 . . . . 0.0 109.495 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -81.24 103.07 10.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.189 0.595 . . . . 0.0 111.455 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 61.7 t -87.85 128.9 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 109.45 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -125.25 167.32 15.04 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 114.11 161.1 13.82 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.086 1.803 . . . . 0.0 113.091 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.98 1.712 . . . . 0.0 110.316 -171.024 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.8 0.333 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 21.4 ptm -146.52 159.17 43.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 113.264 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.5 m -136.86 151.34 48.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.238 2.215 . . . . 0.0 109.084 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -150.67 160.33 43.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -170.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -158.39 153.68 25.71 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.512 1.925 . . . . 0.0 110.309 -172.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . 0.427 ' H ' HD13 ' A' 1963 ' ' LEU . 61.1 mttm -133.91 143.15 48.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.181 1.392 . . . . 0.0 111.525 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 63.9 t -138.86 137.53 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.91 1.684 . . . . 0.0 109.592 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.81 130.08 9.97 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.924 0.773 . . . . 0.0 111.52 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 69.0 m -119.72 150.98 39.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.952 1.301 . . . . 0.0 112.223 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -153.69 152.14 30.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.126 0.971 . . . . 0.0 112.929 -174.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.46 149.79 29.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.443 0.697 . . . . 0.0 110.527 163.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -98.35 125.92 43.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 110.26 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.6 122.49 35.04 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.764 -1.113 . . . . 0.0 109.529 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.76 135.25 21.32 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.942 2.428 . . . . 0.0 110.601 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -148.49 143.53 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.549 1.54 . . . . 0.0 110.03 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.22 59.35 4.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.461 1.504 . . . . 0.0 112.383 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.1 mm -73.82 102.99 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.7 t -167.52 179.01 5.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.87 1.668 . . . . 0.0 111.078 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -85.58 6.03 29.05 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.614 1.566 . . . . 0.0 112.921 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -63.86 139.73 58.8 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.647 1.579 . . . . 0.0 112.076 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.25 158.61 28.87 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.682 1.193 . . . . 0.0 111.959 175.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.2 -23.53 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.34 1.056 . . . . 0.0 113.625 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 91.4 p -71.4 -27.45 63.32 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.12 4.25 51.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.871 1.668 . . . . 0.0 113.503 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.37 140.85 34.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.9 p -138.25 160.88 38.31 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.158 1.783 . . . . 0.0 110.104 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -148.65 148.7 30.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.828 0.851 . . . . 0.0 113.035 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.6 p -142.09 166.81 23.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.744 2.018 . . . . 0.0 109.92 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -122.07 138.44 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 109.595 168.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.1 t -107.07 112.71 63.02 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.297 1.439 . . . . 0.0 108.11 166.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -77.91 171.3 17.49 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.12 3.213 . . . . 0.0 110.773 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.46 -17.51 59.87 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.88 2.387 . . . . 0.0 113.587 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 7.3 t -77.81 -12.14 59.95 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.114 0.966 . . . . 0.0 113.273 170.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 83.8 -0.64 89.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.768 1.651 . . . . 0.0 115.09 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -78.03 86.64 4.2 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.131 1.772 . . . . 0.0 111.105 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -61.01 132.33 53.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.0 0.92 . . . . 0.0 111.837 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -137.41 148.65 62.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 110.663 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.56 155.04 40.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.732 2.955 . . . . 0.0 112.428 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 89.5 m -115.77 151.28 35.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.042 1.337 . . . . 0.0 111.679 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 115.35 26.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.964 0.906 . . . . 0.0 109.346 171.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.91 142.12 42.14 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.467 1.107 . . . . 0.0 110.779 171.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -145.4 149.25 34.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 113.017 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.95 115.81 23.01 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 153.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.77 170.43 11.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.208 1.003 . . . . 0.0 112.503 -173.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 63.3 ttt-85 -60.69 -30.14 69.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.597 1.559 . . . . 0.0 114.315 -169.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -82.55 -10.58 58.93 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.593 1.157 . . . . 0.0 113.684 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.29 55.12 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.87 1.7 . . . . 0.0 114.584 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 166.22 19.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 118.783 1.291 . . . . 0.0 113.403 173.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 90.8 t -93.02 142.94 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.955 1.302 . . . . 0.0 110.197 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.63 -171.87 27.15 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.05 162.96 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.779 1.631 . . . . 0.0 112.675 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 84.7 p -136.99 159.25 42.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.286 1.034 . . . . 0.0 111.916 159.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -165.63 -171.73 2.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.989 2.516 . . . . 0.0 109.309 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 82.0 t -134.65 120.82 14.67 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 110.241 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.34 143.4 15.55 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.384 3.39 . . . . 0.0 110.792 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.41 23.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.73 169.3 18.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.325 1.85 . . . . 0.0 110.582 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -82.07 169.74 16.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 112.076 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.99 -175.83 23.35 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.59 1.567 . . . . 0.0 113.875 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.98 118.39 15.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.897 0.879 . . . . 0.0 111.13 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.3 m80 -103.64 143.85 32.22 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.946 1.699 . . . . 0.0 109.275 170.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 123.26 46.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.089 0.956 . . . . 0.0 108.959 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 58.0 t -85.0 129.69 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.846 1.259 . . . . 0.0 107.881 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -112.33 132.37 55.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.848 1.259 . . . . 0.0 110.339 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 95.1 t -129.6 127.97 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.475 1.11 . . . . 0.0 110.636 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -119.9 135.27 54.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.791 1.636 . . . . 0.0 112.057 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -106.64 114.94 29.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.465 1.906 . . . . 0.0 109.027 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.3 t30 52.62 -101.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.164 1.386 . . . . 0.0 111.763 -172.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.26 5.24 33.65 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.595 1.569 . . . . 0.0 115.876 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -140.6 149.46 42.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.799 1.8 . . . . 0.0 112.809 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -68.7 144.8 54.3 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.102 -0.999 . . . . 0.0 113.028 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.8 m -72.08 160.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 111.481 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.3 67.97 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.2 m -79.88 -15.68 56.87 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 34.1 t -89.19 145.05 33.42 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.536 1.134 . . . . 0.0 113.114 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.96 159.12 84.07 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 119.297 0.785 . . . . 0.0 112.6 -3.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.37 125.54 28.73 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.758 1.623 . . . . 0.0 109.577 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.18 139.26 13.23 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.072 2.515 . . . . 0.0 111.552 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 40.9 t -134.83 125.1 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.837 1.655 . . . . 0.0 107.957 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.3 t -98.17 124.8 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.87 0.868 . . . . 0.0 110.427 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.29 120.73 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.168 1.387 . . . . 0.0 108.747 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 83.2 p -96.3 167.99 10.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.943 0.897 . . . . 0.0 112.119 172.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.64 -22.84 66.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 12.1 t -70.78 -36.03 72.87 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.304 -0.873 . . . . 0.0 111.796 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -74.69 -15.98 60.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.452 1.101 . . . . 0.0 112.728 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 50.2 mm -64.91 -19.91 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.34 1.056 . . . . 0.0 112.037 173.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 132.11 64.6 0.09 OUTLIER Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.609 1.576 . . . . 0.0 113.755 168.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 23.9 t0 -65.85 114.47 5.11 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 117.766 0.783 . . . . 0.0 111.56 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.97 80.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.146 0.978 . . . . 0.0 112.755 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 49.0 m -61.32 -20.46 62.97 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -85.71 -12.0 52.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.137 1.375 . . . . 0.0 114.069 174.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.6 t -76.29 133.41 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.921 1.237 . . . . 0.0 110.117 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -115.52 157.9 23.39 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.655 1.582 . . . . 0.0 110.703 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.3 m -146.5 158.55 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.22 1.408 . . . . 0.0 111.036 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -160.06 169.15 23.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 112.288 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 107.69 160.38 20.93 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.213 1.387 . . . . 0.0 114.444 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -68.88 -32.11 71.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.465 1.506 . . . . 0.0 113.31 -169.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.48 -3.28 47.15 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.039 1.304 . . . . 0.0 115.17 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.56 -8.37 56.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.319 1.447 . . . . 0.0 112.631 168.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.66 -36.19 2.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -158.16 155.71 29.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.478 1.111 . . . . 0.0 112.752 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.03 -175.23 23.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.796 1.189 . . . . 0.0 114.288 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -137.69 148.55 45.78 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.118 1.367 . . . . 0.0 112.657 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 23.3 p -68.98 -35.07 76.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.08 10.2 22.02 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.42 154.85 72.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.608 1.563 . . . . 0.0 110.59 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 144.27 34.41 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.716 2.277 . . . . 0.0 111.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.45 138.36 37.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.404 1.482 . . . . 0.0 110.009 169.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.61 146.03 48.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.021 1.328 . . . . 0.0 113.307 -169.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -158.17 157.38 32.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.089 1.356 . . . . 0.0 112.159 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.43 141.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.476 1.911 . . . . 0.0 109.347 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 50.9 mt -117.1 132.68 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 108.769 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -120.81 100.71 7.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.724 1.61 . . . . 0.0 110.722 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 18.6 p -98.01 0.21 45.88 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.97 2.108 . . . . 0.0 113.034 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -59.88 -37.65 79.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.352 0.978 . . . . 0.0 112.713 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.28 -11.62 59.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.694 1.197 . . . . 0.0 113.247 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.38 49.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.867 1.667 . . . . 0.0 113.804 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.23 -129.54 9.33 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.663 1.125 . . . . 0.0 112.671 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -102.27 170.14 8.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.863 1.665 . . . . 0.0 112.388 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 134.17 -176.67 19.68 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.303 0.954 . . . . 0.0 115.114 168.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -94.56 124.16 7.81 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.685 1.136 . . . . 0.0 112.09 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -95.07 117.83 30.84 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.057 1.743 . . . . 0.0 108.198 170.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 68.3 m -108.76 143.81 37.41 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.492 1.517 . . . . 0.0 110.347 172.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.2 tt -142.12 140.29 32.43 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.869 0.867 . . . . 0.0 110.185 -169.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 92.0 p -143.84 152.6 41.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 112.616 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.3 mt -129.35 133.71 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 107.655 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -141.78 152.22 43.56 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.263 1.025 . . . . 0.0 111.566 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.28 -146.7 12.97 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.664 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.69 -8.85 22.02 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.702 2.934 . . . . 0.0 114.485 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.4 t -159.4 162.88 35.84 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.848 1.204 . . . . 0.0 112.633 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -70.63 146.74 49.82 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.785 1.234 . . . . 0.0 110.892 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.89 145.69 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.992 1.317 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.54 99.39 12.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 110.07 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 42.3 mt -81.04 131.38 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.208 1.003 . . . . 0.0 109.973 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -126.36 152.8 45.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.407 1.883 . . . . 0.0 110.207 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 33.7 p -138.93 154.16 48.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.991 1.316 . . . . 0.0 111.697 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -152.43 126.85 9.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.751 1.22 . . . . 0.0 111.156 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.81 128.08 32.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.506 1.122 . . . . 0.0 110.897 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.4 mt -97.43 155.05 17.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.647 1.179 . . . . 0.0 111.786 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.77 -16.63 64.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.255 1.022 . . . . 0.0 113.429 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -74.15 -11.79 60.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.998 1.319 . . . . 0.0 113.313 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.48 -0.49 65.68 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.936 1.731 . . . . 0.0 114.293 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 41.3 p -89.29 167.69 12.85 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.47 1.908 . . . . 0.0 111.253 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.5 t -117.33 130.34 56.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.083 0.953 . . . . 0.0 111.088 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -94.32 139.72 30.72 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.007 1.323 . . . . 0.0 110.146 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 21.7 t -125.3 139.54 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.009 1.724 . . . . 0.0 108.954 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.8 p -138.02 152.76 49.19 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.402 1.481 . . . . 0.0 111.386 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.9 p90 -162.88 148.42 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.589 1.556 . . . . 0.0 110.806 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 30.2 t -109.2 106.78 59.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.599 0.76 . . . . 0.0 110.658 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.33 106.05 1.98 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.376 2.717 . . . . 0.0 110.238 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.9 m -66.38 -44.0 84.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.03 0.932 . . . . 0.0 112.74 -171.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -92.4 148.21 35.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.431 1.092 . . . . 0.0 110.842 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.88 165.64 29.62 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.321 2.681 . . . . 0.0 111.602 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 125.82 -162.12 20.11 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 125.179 1.371 . . . . 0.0 113.561 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.9 t30 -93.8 125.2 38.29 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.698 0.799 . . . . 0.0 111.524 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -108.89 143.49 38.05 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.107 1.363 . . . . 0.0 110.241 168.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.33 133.72 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 108.533 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 23.7 mt -111.64 129.72 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 109.308 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -108.58 125.29 51.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.423 1.489 . . . . 0.0 110.153 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.8 mm -112.16 121.59 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.011 0.924 . . . . 0.0 109.238 172.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -127.13 133.02 50.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.174 1.789 . . . . 0.0 110.527 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.6 126.55 36.97 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.556 1.142 . . . . 0.0 110.549 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.51 40.01 25.93 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.865 1.266 . . . . 0.0 112.578 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.2 t0 72.87 5.42 5.19 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.576 2.75 . . . . 0.0 114.651 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -109.69 128.71 55.45 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.994 1.318 . . . . 0.0 110.589 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -67.13 123.15 19.47 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.755 1.222 . . . . 0.0 111.104 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.8 m -81.91 160.61 63.15 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.279 -0.888 . . . . 0.0 111.915 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.0 141.76 67.01 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.766 2.977 . . . . 0.0 113.659 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.31 -22.87 17.48 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.022 1.296 . . . . 0.0 114.287 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 74.7 m -73.52 150.57 89.17 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 118.861 1.33 . . . . 0.0 111.525 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -73.52 139.65 62.71 Favored 'Cis proline' 0 C--N 1.352 0.759 0 CA-C-N 119.365 0.809 . . . . 0.0 111.111 -5.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -93.22 114.69 27.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.945 0.898 . . . . 0.0 110.337 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 62.0 m -82.75 128.28 34.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.6 t -123.92 114.9 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.766 1.626 . . . . 0.0 109.636 -171.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -81.57 108.79 15.43 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.629 . . . . 0.0 111.213 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 84.4 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.835 1.254 . . . . 0.0 109.226 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -109.01 164.56 12.3 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.908 1.283 . . . . 0.0 111.882 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 115.15 177.06 18.74 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.703 1.62 . . . . 0.0 113.575 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 12.7 mp0 . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 124.941 1.297 . . . . 0.0 112.473 -172.995 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 120.755 0.312 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.8 ptm -120.41 153.97 35.79 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.233 1.413 . . . . 0.0 112.69 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.8 m -134.78 145.49 48.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.847 2.059 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -146.29 157.03 43.76 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.2 141.36 16.31 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.218 1.807 . . . . 0.0 109.982 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -132.21 143.72 50.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.736 1.214 . . . . 0.0 112.512 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 29.9 m -143.46 151.8 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.331 1.452 . . . . 0.0 111.278 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.16 153.1 27.54 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 124.344 0.973 . . . . 0.0 112.132 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.2 m -140.3 137.03 33.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.508 0.723 . . . . 0.0 112.692 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.0 154.23 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.701 1.2 . . . . 0.0 112.19 -176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.38 133.16 34.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 111.076 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.35 135.03 34.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.219 1.008 . . . . 0.0 110.608 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.76 113.16 30.38 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.886 0.874 . . . . 0.0 109.9 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.43 150.55 36.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.047 2.498 . . . . 0.0 110.587 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 67.9 mt -129.92 141.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.411 1.084 . . . . 0.0 110.039 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 48.7 t-20 11.32 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.41 3.084 . . . . 0.0 115.377 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.05 116.64 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.651 1.18 . . . . 0.0 112.004 -161.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1976 ' ' SER . . . . . . . . . . . . . 77.3 p -172.81 166.41 5.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.627 1.971 . . . . 0.0 110.583 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.28 141.9 27.91 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.951 0.9 . . . . 0.0 111.593 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1978 ' ' THR . . . . . . . . . . . . . 1.2 m -176.89 139.77 0.3 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.338 2.655 . . . . 0.0 109.106 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.5 133.04 49.56 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.292 1.037 . . . . 0.0 112.317 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 22.1 tp -76.24 -25.57 55.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.277 1.031 . . . . 0.0 113.711 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1981 ' ' SER . . . . . . . . . . . . . 49.1 m -84.37 -26.28 28.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -169.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.9 pp -92.47 9.4 34.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.798 1.239 . . . . 0.0 113.577 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.63 148.68 23.05 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.473 1.509 . . . . 0.0 111.811 170.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -136.97 157.43 46.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.107 1.763 . . . . 0.0 109.367 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 148.28 26.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.939 0.896 . . . . 0.0 112.355 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1986 ' ' THR . . . . . . . . . . . . . 74.9 p -140.37 160.16 40.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.337 1.855 . . . . 0.0 109.999 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.0 t -114.93 135.42 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.425 1.49 . . . . 0.0 109.471 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.3 t -106.81 110.74 63.84 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.942 1.297 . . . . 0.0 107.889 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 167.73 24.51 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.622 2.881 . . . . 0.0 110.622 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 -14.66 42.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.949 2.432 . . . . 0.0 113.061 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.1 p -79.66 -9.74 59.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.361 1.464 . . . . 0.0 113.936 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.96 -1.68 85.92 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.691 1.615 . . . . 0.0 115.168 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -77.29 81.66 3.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.553 1.541 . . . . 0.0 111.496 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.99 135.72 57.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.636 1.174 . . . . 0.0 112.212 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.79 148.93 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.764 1.626 . . . . 0.0 111.023 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.76 152.54 37.42 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.523 2.815 . . . . 0.0 111.808 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 80.6 m -102.7 151.45 22.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.563 1.145 . . . . 0.0 111.74 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 56.9 tp -83.03 126.59 32.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 108.774 163.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.4 mt -94.87 140.52 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.053 1.341 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.94 145.58 34.69 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.276 1.03 . . . . 0.0 113.021 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -85.78 108.44 18.09 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 153.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.37 166.25 21.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.166 0.986 . . . . 0.0 111.453 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -64.68 -21.61 66.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -81.4 -9.11 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.596 1.158 . . . . 0.0 113.599 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.45 -6.74 61.31 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.866 1.698 . . . . 0.0 114.566 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.06 162.73 19.2 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.697 1.199 . . . . 0.0 113.406 173.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 12.5 p -94.84 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.081 1.352 . . . . 0.0 111.057 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.65 177.8 33.42 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.23 162.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.987 1.715 . . . . 0.0 112.271 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2010 ' ' SER . . . . . . . . . . . . . 32.5 t -146.87 148.8 32.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.752 1.621 . . . . 0.0 110.57 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.5 p90 -169.41 175.49 5.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.334 2.254 . . . . 0.0 110.043 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 71.3 t -124.86 116.08 26.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 124.117 0.967 . . . . 0.0 109.805 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.24 143.21 28.07 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.944 3.096 . . . . 0.0 110.858 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.44 -19.26 15.0 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.77 171.0 8.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.264 1.826 . . . . 0.0 110.726 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.9 p -97.91 169.02 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.48 1.512 . . . . 0.0 111.107 169.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.69 -170.65 23.23 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.362 1.458 . . . . 0.0 113.815 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.83 112.02 7.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.025 0.93 . . . . 0.0 111.472 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.47 143.36 28.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.649 1.58 . . . . 0.0 109.269 168.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.83 125.11 50.57 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.336 1.054 . . . . 0.0 109.222 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.3 t -88.69 127.79 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.287 1.035 . . . . 0.0 108.237 168.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -106.41 137.21 44.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.263 1.425 . . . . 0.0 109.96 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 84.7 t -136.33 134.77 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.425 1.09 . . . . 0.0 109.566 -170.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -133.8 132.31 40.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.23 1.412 . . . . 0.0 111.137 -169.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -124.95 128.13 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.791 2.036 . . . . 0.0 109.627 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 46.3 t30 59.94 22.19 11.24 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.048 0.939 . . . . 0.0 113.289 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.94 7.37 83.95 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.941 1.258 . . . . 0.0 114.91 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -119.26 133.74 55.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.033 1.733 . . . . 0.0 109.465 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.18 138.31 58.18 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.494 -1.379 . . . . 0.0 112.135 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 22.9 m -78.83 159.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.214 0.606 . . . . 0.0 112.283 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -64.22 -20.75 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2032 ' ' SER . . . . . . . . . . . . . 49.8 m -86.4 -19.34 29.84 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2033 ' ' SER . . . . . . . . . . . . . 67.5 p -92.96 154.0 41.86 Favored Pre-proline 0 CA--C 1.55 0.979 0 O-C-N 120.887 -1.133 . . . . 0.0 113.846 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.65 147.58 89.94 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.138 0.728 . . . . 0.0 112.485 -0.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.12 120.22 51.69 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.013 1.325 . . . . 0.0 108.503 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.21 140.53 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.858 2.372 . . . . 0.0 111.288 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 23.4 t -135.44 123.51 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.391 1.476 . . . . 0.0 107.768 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.5 t -96.46 120.99 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.593 0.757 . . . . 0.0 109.795 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 123.01 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.779 1.231 . . . . 0.0 109.035 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2040 ' ' SER . . . . . . . . . . . . . 32.5 t -92.36 158.46 16.07 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.729 0.812 . . . . 0.0 111.408 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -59.74 -29.68 68.32 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.252 -0.905 . . . . 0.0 111.428 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.1 m -63.18 -13.26 35.2 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.666 1.186 . . . . 0.0 113.928 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -94.71 -11.17 29.63 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.942 1.297 . . . . 0.0 112.371 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.75 95.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.756 1.222 . . . . 0.0 109.917 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 65.02 24.63 70.35 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 115.0 0.76 . . . . 0.0 115.0 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 34.0 t0 -76.22 89.52 3.11 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.358 1.079 . . . . 0.0 111.9 -171.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.99 75.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.748 1.219 . . . . 0.0 112.789 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.8 m -60.7 -22.12 63.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.302 1.041 . . . . 0.0 113.574 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -88.66 -8.98 53.65 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.077 1.351 . . . . 0.0 113.903 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.5 t -77.52 131.31 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.866 1.212 . . . . 0.0 109.655 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -116.22 161.01 19.61 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.94 1.296 . . . . 0.0 111.373 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -146.11 153.88 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.385 1.474 . . . . 0.0 110.643 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2053 ' ' SER . . . . . . . . . . . . . 73.4 m -149.09 165.85 30.51 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.069 1.348 . . . . 0.0 112.103 -173.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.66 162.08 26.0 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 124.345 0.974 . . . . 0.0 114.577 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -73.9 -27.67 61.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 113.644 -167.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.86 -5.58 47.09 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.733 1.159 . . . . 0.0 115.042 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.82 -7.02 58.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.676 1.591 . . . . 0.0 112.787 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -128.29 -36.01 1.95 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.955 1.302 . . . . 0.0 113.8 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.7 155.51 30.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 112.474 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.6 -176.19 21.79 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.881 1.229 . . . . 0.0 114.358 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -139.41 152.67 47.27 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.345 1.458 . . . . 0.0 112.145 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2062 ' ' THR . . . . . . . . . . . . . 25.5 p -71.5 -41.84 68.77 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -100.18 -11.16 20.67 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -114.66 145.75 34.54 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.073 1.349 . . . . 0.0 110.258 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.78 137.83 36.31 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.545 2.163 . . . . 0.0 110.422 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -84.03 150.37 25.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.109 0.964 . . . . 0.0 109.997 168.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.25 151.19 46.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -159.26 155.59 27.23 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.613 1.565 . . . . 0.0 111.001 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.52 143.14 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.41 1.884 . . . . 0.0 109.961 -175.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.25 133.89 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.238 1.815 . . . . 0.0 109.026 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.7 t0 -122.81 99.82 6.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.018 1.727 . . . . 0.0 110.875 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2072 ' ' THR . . . . . . . . . . . . . 32.6 p -99.73 4.83 45.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.499 1.92 . . . . 0.0 112.735 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.9 -37.32 81.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.255 1.022 . . . . 0.0 112.577 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.27 -28.96 38.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 0.0 112.716 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -72.49 -11.49 60.69 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.86 -108.23 3.22 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.426 1.012 . . . . 0.0 112.068 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.32 147.15 50.25 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.925 1.29 . . . . 0.0 112.97 -168.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 156.73 -137.68 5.56 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.543 1.068 . . . . 0.0 113.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -157.68 141.46 7.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.497 1.046 . . . . 0.0 112.047 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.48 124.99 45.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.916 1.686 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2081 ' ' SER . . . . . . . . . . . . . 23.2 t -115.69 138.91 50.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.33 1.452 . . . . 0.0 109.902 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 8.4 tt -136.75 132.95 35.49 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.62 1.168 . . . . 0.0 109.902 -168.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.7 m -133.66 130.23 37.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.386 0.675 . . . . 0.0 111.197 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.9 mt -109.24 130.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.083 1.353 . . . . 0.0 108.244 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.78 142.5 51.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.337 1.455 . . . . 0.0 109.758 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 177.27 -165.24 35.01 Favored Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.1 -9.89 26.41 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.175 3.25 . . . . 0.0 114.05 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.0 t -155.88 162.51 40.41 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.386 1.074 . . . . 0.0 112.078 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -67.31 147.12 53.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.664 1.186 . . . . 0.0 111.327 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 32.2 m -130.84 146.14 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.143 1.377 . . . . 0.0 110.903 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.37 105.82 17.83 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.679 0.792 . . . . 0.0 109.957 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 52.3 mt -84.41 129.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.247 1.019 . . . . 0.0 109.599 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -125.69 161.16 27.91 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 0.0 110.795 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2094 ' ' THR . . . . . . . . . . . . . 35.6 p -141.8 155.52 45.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.252 1.421 . . . . 0.0 111.951 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.45 138.05 15.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 111.515 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.0 t70 -86.97 129.03 35.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.117 1.367 . . . . 0.0 111.31 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 43.2 mt -99.31 160.62 14.14 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.308 1.043 . . . . 0.0 112.525 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.37 -17.04 64.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.522 1.129 . . . . 0.0 113.35 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.43 -9.15 59.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.144 1.378 . . . . 0.0 113.291 172.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.81 1.91 82.13 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.412 1.482 . . . . 0.0 114.018 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -89.18 165.49 14.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.332 1.853 . . . . 0.0 111.432 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.6 t -109.94 124.87 52.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.042 . . . . 0.0 110.993 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -83.62 135.4 34.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 165.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 45.7 t -117.36 139.31 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.953 1.701 . . . . 0.0 108.773 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.97 151.61 50.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.782 1.633 . . . . 0.0 111.83 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.39 150.74 14.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.521 1.528 . . . . 0.0 111.787 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.5 t -115.81 99.39 52.5 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.277 1.031 . . . . 0.0 111.039 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.44 94.12 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.706 2.937 . . . . 0.0 110.669 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2109 ' ' THR . . . . . . . . . . . . . 51.8 m -63.09 -41.76 99.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.868 . . . . 0.0 112.78 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -87.3 140.78 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.711 0.805 . . . . 0.0 110.668 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.97 168.64 24.38 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.506 2.804 . . . . 0.0 111.554 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 127.0 -147.31 16.84 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.816 1.198 . . . . 0.0 112.695 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -109.75 133.56 53.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.074 0.95 . . . . 0.0 111.836 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -118.29 151.37 37.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.784 1.633 . . . . 0.0 110.707 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.06 133.26 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.518 1.527 . . . . 0.0 108.699 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.54 128.97 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.592 1.157 . . . . 0.0 109.789 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.54 125.25 53.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.895 1.678 . . . . 0.0 110.015 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.6 mm -115.63 116.42 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.11 0.964 . . . . 0.0 109.246 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -125.71 132.8 52.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.16 1.384 . . . . 0.0 111.201 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 72.4 t80 -123.82 124.22 42.2 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.678 1.591 . . . . 0.0 110.312 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.73 30.97 11.99 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.331 1.452 . . . . 0.0 114.177 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.257 7.0 t70 85.68 11.91 0.22 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 128.784 2.834 . . . . 0.0 114.728 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.6 132.18 55.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.556 1.143 . . . . 0.0 111.48 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.86 124.48 23.45 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.338 1.455 . . . . 0.0 110.676 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -80.72 158.76 70.4 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.189 -0.944 . . . . 0.0 111.825 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.51 134.93 64.24 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.649 2.899 . . . . 0.0 113.253 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.85 -22.31 38.73 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.247 1.403 . . . . 0.0 114.073 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2128 ' ' SER . . . . . . . . . . . . . 62.9 m -75.22 150.59 85.39 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 118.922 1.361 . . . . 0.0 112.024 172.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.35 142.87 73.16 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.053 0.697 . . . . 0.0 111.113 -4.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.62 127.76 39.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.432 1.093 . . . . 0.0 110.834 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2131 ' ' SER . . . . . . . . . . . . . 30.5 t -95.97 129.29 43.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.345 1.058 . . . . 0.0 110.988 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 11.9 t -128.46 117.14 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.001 1.32 . . . . 0.0 110.007 -170.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -85.84 120.35 27.16 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.76 -0.587 . . . . 0.0 110.521 173.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.08 118.99 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.587 1.555 . . . . 0.0 108.862 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2135 ' ' THR . . . . . . . . . . . . . 1.3 t -99.61 162.85 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.583 1.153 . . . . 0.0 111.333 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 171.47 -168.35 41.46 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 . . . . . 0 CA--C 1.544 0.723 0 C-N-CA 126.611 1.964 . . . . 0.0 110.215 178.256 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -64.67 -21.94 66.86 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -14.44 61.3 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.239 1.416 . . . . 0.0 114.17 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 84.45 162.88 35.33 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.275 1.417 . . . . 0.0 113.45 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -164.75 154.32 13.39 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.907 1.683 . . . . 0.0 111.478 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.44 -15.49 59.91 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.706 1.202 . . . . 0.0 113.908 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 57.6 m 70.02 -107.24 0.06 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.057 2.143 . . . . 0.0 110.987 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 14.1 ptm -142.48 148.1 37.15 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.769 1.228 . . . . 0.0 111.651 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 161.58 28.41 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.865 1.266 . . . . 0.0 110.372 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 23.6 ptm -149.39 159.29 44.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 13.3 m -148.53 151.66 35.5 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.377 1.871 . . . . 0.0 109.774 174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -147.32 159.77 43.29 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.9 150.85 24.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.539 1.936 . . . . 0.0 109.796 -171.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.9 mttt -134.07 144.08 48.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.546 1.138 . . . . 0.0 111.972 175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 46.8 t -140.37 134.84 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.64 1.576 . . . . 0.0 109.658 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.89 139.51 21.43 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 124.013 0.816 . . . . 0.0 111.661 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 29.6 m -131.22 132.14 44.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.809 0.804 . . . . 0.0 112.764 -166.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.63 148.64 16.19 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -74.47 150.33 39.94 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.439 1.095 . . . . 0.0 111.323 170.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -93.28 122.81 36.06 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.422 1.089 . . . . 0.0 110.667 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.9 mm -112.46 108.73 54.2 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 124.588 1.155 . . . . 0.0 109.266 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -76.91 137.62 17.78 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.178 2.585 . . . . 0.0 111.17 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 65.1 mt -145.69 141.14 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.377 1.471 . . . . 0.0 110.21 -170.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.26 61.47 2.89 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.625 1.57 . . . . 0.0 112.0 173.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.26 104.5 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.666 1.186 . . . . 0.0 110.616 -169.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.8 t -172.61 178.74 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.274 1.83 . . . . 0.0 110.543 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -83.99 45.42 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.887 1.675 . . . . 0.0 112.018 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.8 p -71.47 138.06 48.69 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.001 1.321 . . . . 0.0 111.364 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 15.0 t70 -85.09 141.13 30.45 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.436 1.094 . . . . 0.0 111.323 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.59 -16.95 46.53 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 60.4 m -82.16 -31.93 30.26 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.038 1.29 . . . . 0.0 114.055 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pt? -99.39 -0.49 40.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.5 1.12 . . . . 0.0 113.845 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.83 146.81 24.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.601 1.161 . . . . 0.0 111.492 173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 41.0 p -138.87 162.67 34.23 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.732 2.013 . . . . 0.0 109.448 170.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.1 145.25 24.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.689 0.795 . . . . 0.0 112.08 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.7 p -138.4 162.57 34.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.148 1.779 . . . . 0.0 109.9 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -120.12 137.59 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.21 1.404 . . . . 0.0 109.462 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.1 t -102.82 111.05 64.6 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.14 1.376 . . . . 0.0 107.832 165.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.28 168.65 22.68 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.042 3.161 . . . . 0.0 110.696 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.55 -18.1 61.74 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.923 2.415 . . . . 0.0 112.645 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 12.8 m -67.63 -17.18 64.52 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.84 1.256 . . . . 0.0 113.925 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.87 31.24 54.17 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.61 1.1 . . . . 0.0 114.239 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -125.84 97.57 5.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.318 1.447 . . . . 0.0 110.488 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.93 135.74 57.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.417 1.087 . . . . 0.0 112.155 -173.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -137.49 151.06 70.39 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.515 1.526 . . . . 0.0 111.097 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.19 156.23 42.11 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.793 2.996 . . . . 0.0 112.664 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.0 m -112.48 154.49 25.8 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.354 1.462 . . . . 0.0 111.751 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 58.2 tp -85.85 120.34 27.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.287 1.035 . . . . 0.0 109.397 170.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 21.9 mt -84.03 141.7 30.99 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.597 1.159 . . . . 0.0 110.95 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 80.1 mttt -142.23 139.1 31.88 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.459 1.503 . . . . 0.0 111.75 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -92.82 109.45 20.88 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 160.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.5 mt -80.57 164.3 23.02 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.862 1.265 . . . . 0.0 111.735 -172.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -57.27 -34.52 68.72 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -167.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -77.12 -9.24 58.61 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 107.93 -13.19 37.99 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 126.003 1.764 . . . . 0.0 114.435 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.07 156.57 33.78 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.931 1.292 . . . . 0.0 113.351 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.6 t -104.08 143.01 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.137 1.375 . . . . 0.0 110.042 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.2 178.61 28.48 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.557 1.075 . . . . 0.0 115.039 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -116.59 165.27 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.948 1.699 . . . . 0.0 111.615 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 71.1 p -151.59 150.73 30.64 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 110.678 166.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.7 p90 -167.17 167.59 14.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.84 1.656 . . . . 0.0 110.945 -170.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 59.5 t -110.67 117.68 50.22 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.816 0.846 . . . . 0.0 109.676 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.45 147.65 28.96 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.944 3.096 . . . . 0.0 110.917 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -105.34 -7.67 18.7 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -145.72 174.93 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.403 2.281 . . . . 0.0 109.687 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 36.3 p -88.56 167.07 13.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.614 1.165 . . . . 0.0 111.21 166.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.05 -170.22 25.97 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.268 1.413 . . . . 0.0 113.79 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.84 117.88 12.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.186 0.994 . . . . 0.0 111.742 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.8 m80 -104.11 143.58 32.71 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.036 1.734 . . . . 0.0 108.968 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.44 125.31 50.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.993 0.917 . . . . 0.0 110.083 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.1 t -85.62 137.46 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 167.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -119.96 114.76 22.53 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.347 1.459 . . . . 0.0 109.693 169.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 94.1 t -106.48 136.52 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.054 1.341 . . . . 0.0 108.995 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -131.09 142.28 50.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.989 1.315 . . . . 0.0 112.435 -172.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -112.81 121.21 44.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.544 1.938 . . . . 0.0 109.169 169.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.19 26.27 10.12 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.668 1.187 . . . . 0.0 113.259 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 88.13 -1.65 84.85 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.649 1.595 . . . . 0.0 115.452 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.43 134.87 46.07 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.167 1.484 . . . . 0.0 109.64 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 19.3 p80 -63.36 140.15 58.84 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 120.953 -1.092 . . . . 0.0 113.337 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 16.6 m -78.54 159.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.666 0.786 . . . . 0.0 110.983 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.42 62.76 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.4 m -75.35 -20.76 58.83 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 56.4 m -82.25 149.89 63.01 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.64 150.24 92.49 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 118.649 0.553 . . . . 0.0 111.949 -5.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -107.41 119.24 51.37 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.86 139.89 12.49 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.806 2.338 . . . . 0.0 111.385 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -134.1 124.35 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.384 1.474 . . . . 0.0 107.643 171.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.4 t -99.75 122.58 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.879 0.872 . . . . 0.0 109.97 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.45 128.14 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.886 1.274 . . . . 0.0 109.655 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.2 t -99.66 161.24 13.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.026 0.931 . . . . 0.0 111.457 170.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -59.54 -31.38 69.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.768 0.827 . . . . 0.0 112.87 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -68.0 -14.93 63.35 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 113.516 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -92.12 -9.5 42.29 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.564 1.146 . . . . 0.0 112.763 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 44.1 mm -76.49 -31.94 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.14 0.976 . . . . 0.0 112.948 -171.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.44 47.74 0.04 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 115.179 0.832 . . . . 0.0 115.179 -173.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -85.43 98.9 10.84 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.261 1.031 . . . . 0.0 110.78 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.85 -32.44 73.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.482 1.113 . . . . 0.0 113.495 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.9 p -56.78 -23.4 42.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.273 1.429 . . . . 0.0 113.91 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -84.84 -14.45 47.92 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.213 1.405 . . . . 0.0 113.913 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.5 t -75.12 135.42 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 119.641 1.11 . . . . 0.0 110.524 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -113.53 156.88 22.81 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.381 1.472 . . . . 0.0 111.329 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.55 159.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.697 1.599 . . . . 0.0 110.706 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -159.95 175.69 12.74 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.577 1.151 . . . . 0.0 112.419 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.84 161.73 30.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.239 1.399 . . . . 0.0 114.189 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -72.16 -28.24 63.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.582 1.153 . . . . 0.0 113.398 -169.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.45 -4.29 37.21 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.703 1.144 . . . . 0.0 115.24 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.28 -4.39 58.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.323 1.449 . . . . 0.0 112.76 169.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -134.53 -40.12 0.8 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.812 1.245 . . . . 0.0 113.876 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.22 152.51 44.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 111.267 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.38 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 122.256 0.92 . . . . 0.0 114.748 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 66.0 m80 -135.43 160.06 39.63 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.543 1.937 . . . . 0.0 110.29 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 16.9 p -71.21 -68.55 0.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.37 0.668 . . . . 0.0 111.498 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -82.44 -14.59 54.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -166.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -104.89 136.71 19.13 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.203 1.401 . . . . 0.0 109.349 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.49 152.34 54.3 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.158 2.572 . . . . 0.0 111.731 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -105.2 136.77 44.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.018 1.327 . . . . 0.0 110.708 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.4 148.49 42.48 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.282 1.433 . . . . 0.0 113.123 -175.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.5 p90 -155.76 153.61 30.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.369 1.468 . . . . 0.0 111.456 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.87 142.36 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.013 1.725 . . . . 0.0 109.655 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.74 134.69 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.251 1.82 . . . . 0.0 108.621 171.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.84 101.87 7.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.662 1.585 . . . . 0.0 110.833 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.7 p -100.33 -1.64 35.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.515 1.926 . . . . 0.0 112.946 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -57.95 -40.49 80.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.282 1.033 . . . . 0.0 111.627 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.02 -5.62 56.1 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.477 1.511 . . . . 0.0 113.27 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -101.68 -3.96 27.34 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.871 1.668 . . . . 0.0 114.734 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.57 -118.86 4.83 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.03 0.824 . . . . 0.0 111.163 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -121.49 165.06 16.19 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.236 1.415 . . . . 0.0 112.752 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.35 -140.05 7.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.635 1.112 . . . . 0.0 113.188 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -158.87 137.99 5.47 Favored Glycine 0 N--CA 1.466 0.66 0 C-N-CA 124.169 0.89 . . . . 0.0 112.501 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.19 122.52 40.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.488 1.915 . . . . 0.0 109.477 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 12.3 m -110.5 139.86 45.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.509 1.124 . . . . 0.0 110.014 165.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -136.51 134.49 37.63 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.348 1.059 . . . . 0.0 110.174 -168.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.8 m -135.48 125.3 25.58 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.573 0.749 . . . . 0.0 110.667 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.8 mt -104.07 130.72 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.614 1.166 . . . . 0.0 108.224 173.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -127.94 147.92 50.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.555 1.542 . . . . 0.0 109.781 -175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 169.72 -157.81 29.65 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 121.349 -0.845 . . . . 0.0 114.83 -178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.5 -20.18 41.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.196 2.597 . . . . 0.0 113.885 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -151.47 169.84 21.07 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.567 1.076 . . . . 0.0 112.527 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -66.19 149.27 50.57 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 9.3 m -132.71 146.72 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.427 1.091 . . . . 0.0 111.442 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -85.48 111.67 20.2 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.216 0.606 . . . . 0.0 109.821 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.06 132.84 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.392 1.077 . . . . 0.0 109.555 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -128.85 158.58 38.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.158 1.783 . . . . 0.0 110.626 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 32.8 p -139.75 153.63 47.22 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.132 1.373 . . . . 0.0 111.658 -174.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -153.41 115.6 4.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.06 1.344 . . . . 0.0 110.461 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.58 129.22 34.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.548 1.139 . . . . 0.0 110.858 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 62.7 mt -101.47 153.84 19.35 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.546 1.138 . . . . 0.0 112.007 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.81 -18.61 64.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.312 1.045 . . . . 0.0 113.253 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.89 -9.05 58.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.356 1.463 . . . . 0.0 112.984 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.23 -1.37 62.58 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.084 1.802 . . . . 0.0 114.783 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.0 p -88.87 166.3 14.06 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.117 1.767 . . . . 0.0 111.678 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.0 t -114.85 126.3 54.66 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.15 0.98 . . . . 0.0 110.777 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -87.98 134.59 33.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.506 1.122 . . . . 0.0 109.466 167.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.1 t -117.01 141.16 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.234 1.814 . . . . 0.0 108.275 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.1 p -134.58 151.24 50.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.475 1.51 . . . . 0.0 110.926 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -151.95 149.86 29.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.578 0.751 . . . . 0.0 112.955 171.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.2 t -120.84 99.47 47.06 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.932 1.293 . . . . 0.0 110.192 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.25 135.85 12.36 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.265 2.643 . . . . 0.0 111.829 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 98.2 m -78.3 -46.46 20.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.068 0.547 . . . . 0.0 111.734 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -99.84 148.17 34.43 Favored Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 124.795 1.238 . . . . 0.0 111.06 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 165.26 29.31 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.435 2.757 . . . . 0.0 111.26 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 138.2 -152.59 21.96 Favored Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.091 1.329 . . . . 0.0 113.184 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.2 t30 -107.03 121.99 45.57 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.242 1.017 . . . . 0.0 110.663 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -104.45 144.5 31.58 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.898 1.279 . . . . 0.0 111.104 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.1 130.37 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.716 1.607 . . . . 0.0 107.943 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.1 mt -112.34 121.83 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.638 1.175 . . . . 0.0 109.265 175.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -100.51 124.85 46.61 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.582 1.553 . . . . 0.0 109.907 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 34.4 mm -116.56 111.17 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.841 1.256 . . . . 0.0 108.882 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.8 132.56 53.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.919 1.288 . . . . 0.0 111.276 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 75.3 t80 -125.24 124.14 41.05 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.818 1.647 . . . . 0.0 109.723 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.59 44.67 27.3 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.359 1.064 . . . . 0.0 112.982 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 70.7 m-20 66.39 19.91 10.96 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.345 2.258 . . . . 0.0 114.634 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -125.53 130.6 52.07 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.593 1.557 . . . . 0.0 110.113 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -71.54 125.65 27.62 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 120.892 -1.13 . . . . 0.0 111.237 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.2 m -78.8 157.44 76.66 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.159 -0.963 . . . . 0.0 111.905 -168.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.87 142.27 64.0 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.83 3.02 . . . . 0.0 113.69 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.32 -26.34 5.72 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.018 1.294 . . . . 0.0 113.999 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -76.29 144.61 75.0 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-N 118.282 1.041 . . . . 0.0 110.585 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.58 144.52 79.28 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 120.567 1.238 . . . . 0.0 112.273 4.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -101.76 117.81 35.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.391 1.077 . . . . 0.0 110.427 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.8 p -86.41 136.78 32.99 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.078 0.951 . . . . 0.0 111.395 171.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.2 t -133.96 113.1 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.203 1.401 . . . . 0.0 109.446 -168.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -77.93 118.29 20.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.99 0.516 . . . . 0.0 110.722 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 81.7 t -110.88 121.96 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.879 1.672 . . . . 0.0 109.036 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 9.3 t -104.3 154.36 19.9 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.464 1.106 . . . . 0.0 111.301 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -176.76 173.82 46.58 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.716 1.151 . . . . 0.0 114.484 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -117.01 -176.46 2.99 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.188 1.795 . . . . 0.0 111.027 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -78.03 13.76 13.2 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.182 1.373 . . . . 0.0 115.003 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 95.77 132.85 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 130.929 3.692 . . . . 0.0 110.948 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 22.9 m -141.58 158.67 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.796 2.039 . . . . 0.0 110.591 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 23.0 ptmt . . . . . 0 C--O 1.253 1.274 0 C-N-CA 124.734 1.214 . . . . 0.0 113.896 178.006 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.482 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.8 159.58 34.07 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.464 1.105 . . . . 0.0 112.977 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 15.6 tpt -159.21 144.65 16.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.91 1.684 . . . . 0.0 110.844 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.89 153.43 28.23 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.782 1.182 . . . . 0.0 113.059 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.6 -29.62 61.38 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.03 0.932 . . . . 0.0 112.653 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.04 164.6 11.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.443 1.897 . . . . 0.0 112.596 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 69.1 p -163.6 154.62 16.31 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.209 1.403 . . . . 0.0 111.838 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 36.7 mmt -63.16 130.75 45.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.713 0.805 . . . . 0.0 111.635 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -83.04 149.6 26.84 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.079 0.951 . . . . 0.0 109.611 171.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.8 ptm -144.69 156.93 44.34 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.175 0.99 . . . . 0.0 113.445 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 65.4 m -138.96 148.5 43.6 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.662 1.585 . . . . 0.0 110.204 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -138.52 156.47 47.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.333 1.053 . . . . 0.0 113.705 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.9 tt -159.82 150.61 19.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.932 1.693 . . . . 0.0 110.431 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.33 148.23 52.13 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.173 0.989 . . . . 0.0 112.724 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 53.0 t -139.11 134.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.073 1.749 . . . . 0.0 109.375 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.42 123.94 6.99 Favored Glycine 0 N--CA 1.471 0.987 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 70.9 m -97.19 123.3 40.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.272 1.029 . . . . 0.0 111.526 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -125.33 115.28 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.37 1.468 . . . . 0.0 110.013 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.04 142.72 47.65 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.145 0.578 . . . . 0.0 111.805 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.51 130.58 36.16 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.711 1.204 . . . . 0.0 111.586 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.6 mm -122.43 120.86 27.86 Favored Pre-proline 0 N--CA 1.47 0.563 0 C-N-CA 125.367 1.467 . . . . 0.0 108.461 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 145.05 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.451 2.101 . . . . 0.0 110.922 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.47 145.13 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.852 1.661 . . . . 0.0 108.51 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.2 t30 -42.46 114.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.093 1.357 . . . . 0.0 113.596 -166.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.35 135.97 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.869 0.868 . . . . 0.0 110.757 -160.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 10.4 t -159.84 175.7 12.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.729 1.611 . . . . 0.0 110.527 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -84.11 33.93 0.5 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 112.664 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -71.97 139.03 48.45 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.578 1.551 . . . . 0.0 111.412 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.19 131.06 36.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.098 0.959 . . . . 0.0 111.469 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.8 mt -77.75 -14.98 59.43 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 50.8 m -85.7 -24.05 27.15 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.659 1.118 . . . . 0.0 113.383 -177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.5 pp -107.26 3.98 26.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.171 1.388 . . . . 0.0 113.98 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -94.66 146.98 23.77 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.252 1.421 . . . . 0.0 111.166 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 58.1 p -140.51 152.99 46.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.435 1.494 . . . . 0.0 110.121 167.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.19 148.39 43.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.422 1.089 . . . . 0.0 112.582 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 2.5 p -147.01 132.37 18.54 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.966 2.106 . . . . 0.0 109.552 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -91.7 136.72 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.22 1.008 . . . . 0.0 109.937 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 90.1 t -109.98 113.76 56.8 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.078 1.351 . . . . 0.0 108.372 165.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.03 172.77 11.61 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.074 3.183 . . . . 0.0 111.232 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.48 -32.53 53.35 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.977 3.118 . . . . 0.0 113.875 169.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 16.4 m -74.14 -10.56 59.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.726 1.21 . . . . 0.0 114.238 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.28 74.87 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.523 1.535 . . . . 0.0 115.173 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -75.62 87.62 2.71 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.811 1.644 . . . . 0.0 111.297 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.65 135.31 57.31 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.261 1.025 . . . . 0.0 111.892 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -140.24 147.18 49.06 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.136 1.375 . . . . 0.0 111.474 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.2 152.49 45.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.934 3.089 . . . . 0.0 112.066 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.6 m -114.11 150.15 34.53 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.05 1.34 . . . . 0.0 112.052 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 5.0 tt -91.86 115.5 28.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.476 1.11 . . . . 0.0 109.033 175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.4 mt -78.78 131.15 36.42 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.106 1.362 . . . . 0.0 111.131 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 95.8 mttt -132.2 142.03 49.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.191 1.397 . . . . 0.0 112.545 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -93.17 122.04 35.15 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.57 1.148 . . . . 0.0 108.058 161.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.3 mt -100.8 172.71 6.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.841 1.656 . . . . 0.0 112.577 -165.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -57.55 -35.75 70.72 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.6 1.56 . . . . 0.0 115.038 -165.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.77 4.46 44.22 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.245 1.018 . . . . 0.0 113.13 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 90.67 -6.36 82.11 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.485 1.517 . . . . 0.0 113.896 -176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -71.95 162.71 29.06 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.603 1.561 . . . . 0.0 113.153 174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 93.1 t -112.07 141.97 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.462 1.505 . . . . 0.0 109.634 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.0 -176.17 24.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.168 0.89 . . . . 0.0 115.164 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -121.19 165.91 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.475 1.91 . . . . 0.0 111.063 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 66.3 p -149.07 152.57 36.43 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.315 1.046 . . . . 0.0 111.278 167.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.4 p90 -169.32 -172.06 1.41 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.585 2.354 . . . . 0.0 109.522 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.8 t -133.77 118.71 14.56 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.077 0.951 . . . . 0.0 110.085 170.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.76 147.82 22.08 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.615 3.544 . . . . 0.0 111.264 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.1 mptt -100.66 -13.25 18.61 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.045 0.938 . . . . 0.0 113.194 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -139.97 167.8 21.29 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.187 2.195 . . . . 0.0 110.104 -177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.0 p -85.24 167.8 15.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.685 1.194 . . . . 0.0 111.435 168.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.29 -174.04 22.69 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.523 1.535 . . . . 0.0 114.059 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.95 113.08 9.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.2 1.0 . . . . 0.0 111.467 -175.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -96.97 144.18 27.12 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.415 1.486 . . . . 0.0 109.169 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 75.8 mt -103.08 126.41 50.24 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.764 0.825 . . . . 0.0 110.043 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.5 t -89.71 112.15 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.903 1.281 . . . . 0.0 107.744 167.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -92.83 138.51 31.43 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.489 1.115 . . . . 0.0 109.665 169.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.3 p -151.55 135.93 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.4 -0.813 . . . . 0.0 111.363 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -137.78 145.71 42.71 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.451 1.1 . . . . 0.0 113.935 -162.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -114.2 127.08 55.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.737 2.415 . . . . 0.0 109.121 176.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 10.5 t-20 56.58 24.0 8.29 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.265 1.026 . . . . 0.0 113.636 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.83 4.41 65.29 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.442 1.496 . . . . 0.0 115.979 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -127.91 141.56 51.51 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.832 1.816 . . . . 0.0 111.706 176.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -61.29 138.27 58.24 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.255 -0.903 . . . . 0.0 113.182 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 19.1 m -74.09 163.02 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.388 0.675 . . . . 0.0 111.334 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.15 -24.85 65.05 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 64.4 m -86.67 -12.26 48.89 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 28.6 t -86.9 143.14 34.81 Favored Pre-proline 0 CA--C 1.547 0.859 0 O-C-N 120.771 -1.205 . . . . 0.0 112.757 -172.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.99 156.85 88.04 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.495 0.855 . . . . 0.0 112.836 -3.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.02 126.99 28.09 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.781 1.632 . . . . 0.0 109.127 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.33 141.22 14.19 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.989 2.459 . . . . 0.0 111.594 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 24.7 t -134.25 122.08 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.863 1.665 . . . . 0.0 107.68 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.8 t -97.53 122.42 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.669 0.788 . . . . 0.0 110.179 -175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -101.29 117.76 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.804 1.242 . . . . 0.0 108.942 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 59.3 m -92.69 161.54 14.51 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.091 0.956 . . . . 0.0 111.479 172.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.73 -31.86 70.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.991 -1.068 . . . . 0.0 112.197 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.0 m -59.68 -14.31 13.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.323 1.449 . . . . 0.0 114.202 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -100.11 -9.8 22.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.148 1.379 . . . . 0.0 112.75 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 38.0 mm -80.89 -27.77 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.747 -1.22 . . . . 0.0 112.856 -172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 169.1 38.7 0.03 OUTLIER Glycine 0 N--CA 1.469 0.844 0 N-CA-C 115.173 0.829 . . . . 0.0 115.173 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.46 96.93 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.197 0.998 . . . . 0.0 111.259 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.59 93.07 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.9 0.88 . . . . 0.0 112.356 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.3 m -61.44 -18.89 61.01 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.705 1.202 . . . . 0.0 113.87 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -89.06 -10.22 48.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.445 1.498 . . . . 0.0 114.36 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.8 t -74.66 137.56 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 120.18 1.355 . . . . 0.0 110.111 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.3 mmt-85 -121.14 161.19 22.24 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 110.675 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.4 m -147.94 160.97 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.292 1.437 . . . . 0.0 110.999 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.9 t -158.41 175.58 13.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.733 1.213 . . . . 0.0 112.285 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 94.99 161.49 34.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.263 1.411 . . . . 0.0 114.08 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -73.81 -26.77 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 113.611 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.19 -2.25 39.23 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.918 1.247 . . . . 0.0 115.364 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.9 mt -91.93 -6.83 50.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.542 1.537 . . . . 0.0 112.674 168.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.36 -39.95 2.29 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.334 1.453 . . . . 0.0 113.163 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.24 155.68 32.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.11 0.964 . . . . 0.0 113.233 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.08 -174.41 19.86 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.715 1.626 . . . . 0.0 113.382 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 60.5 m80 -138.57 147.48 43.08 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.467 1.107 . . . . 0.0 112.7 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.4 p -71.82 -19.79 61.93 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -116.23 -1.9 12.27 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -143.67 147.57 39.65 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.368 1.467 . . . . 0.0 110.492 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.35 142.43 45.32 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.865 2.377 . . . . 0.0 111.204 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 152.39 20.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.631 1.172 . . . . 0.0 110.246 168.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.58 148.07 51.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.887 0.875 . . . . 0.0 112.362 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -155.14 151.2 27.97 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.973 1.309 . . . . 0.0 111.225 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.61 140.83 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.953 1.701 . . . . 0.0 109.508 -175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.92 136.45 48.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.638 1.575 . . . . 0.0 108.758 169.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.2 t0 -125.93 99.06 5.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.223 1.809 . . . . 0.0 110.498 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.2 p -96.48 1.3 51.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.231 1.812 . . . . 0.0 113.085 176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -58.65 -39.34 80.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.539 1.063 . . . . 0.0 112.697 -174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.65 -13.84 59.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.457 1.103 . . . . 0.0 113.249 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -93.52 -5.35 49.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.878 1.671 . . . . 0.0 113.618 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.14 -119.31 4.83 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.733 1.158 . . . . 0.0 112.172 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.55 161.54 16.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.377 1.871 . . . . 0.0 112.498 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 138.29 -176.8 20.53 Favored Glycine 0 N--CA 1.474 1.217 0 C-N-CA 124.065 0.84 . . . . 0.0 115.117 169.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -92.92 123.21 7.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.459 1.028 . . . . 0.0 111.985 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -98.33 123.0 42.2 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.119 1.768 . . . . 0.0 108.394 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -114.72 140.79 48.59 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.288 1.435 . . . . 0.0 110.829 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 2.9 tp -125.61 137.39 53.89 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.362 1.865 . . . . 0.0 109.656 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 68.2 m -138.59 126.66 22.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.254 0.622 . . . . 0.0 110.277 167.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 30.0 mt -111.3 135.16 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.541 1.136 . . . . 0.0 108.466 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -145.4 154.87 42.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.284 1.034 . . . . 0.0 112.246 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.48 -155.67 26.49 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.297 -0.724 . . . . 0.0 114.879 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.92 -10.21 27.19 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.124 3.216 . . . . 0.0 114.286 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.2 t -152.94 164.3 38.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.662 1.185 . . . . 0.0 111.1 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -69.98 144.23 52.38 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.135 -0.978 . . . . 0.0 111.171 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 17.8 m -125.02 151.93 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 124.837 1.255 . . . . 0.0 110.962 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -97.26 131.25 44.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.776 0.83 . . . . 0.0 110.064 170.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.1 135.37 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.132 1.373 . . . . 0.0 109.737 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -131.57 164.89 24.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 111.069 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.0 p -136.36 160.22 39.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.482 1.513 . . . . 0.0 112.227 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -154.33 122.53 6.04 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.362 1.465 . . . . 0.0 110.041 173.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.25 128.56 33.68 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.419 1.088 . . . . 0.0 110.58 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -101.16 152.43 20.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 111.84 -173.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -66.42 -20.33 66.03 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.283 1.033 . . . . 0.0 113.423 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.2 t0 -80.25 -3.93 51.18 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.112 1.365 . . . . 0.0 113.256 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.37 0.65 67.27 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.606 1.574 . . . . 0.0 114.571 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 18.5 p -88.76 167.7 13.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.604 1.962 . . . . 0.0 111.558 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 45.6 t -121.42 124.88 45.56 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.096 0.958 . . . . 0.0 111.207 178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -84.18 135.49 34.35 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.775 1.23 . . . . 0.0 109.642 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 59.2 t -112.71 141.56 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.901 1.681 . . . . 0.0 108.587 164.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 3.2 p -130.54 148.74 52.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.628 1.571 . . . . 0.0 110.761 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -157.45 148.65 21.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.428 1.091 . . . . 0.0 111.818 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.9 t -118.33 102.65 50.2 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.862 0.865 . . . . 0.0 111.145 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.58 145.88 23.7 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.245 2.63 . . . . 0.0 110.221 173.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 96.6 m -104.87 -38.62 6.58 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.984 0.914 . . . . 0.0 112.74 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -103.08 147.53 34.27 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.929 1.292 . . . . 0.0 110.627 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.89 168.31 23.7 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.498 2.799 . . . . 0.0 111.902 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 131.98 -145.63 17.35 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 125.126 1.346 . . . . 0.0 112.129 -177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -123.85 129.72 51.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.565 0.746 . . . . 0.0 111.664 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -108.39 143.65 37.03 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.552 1.541 . . . . 0.0 110.373 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 135.99 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.959 1.304 . . . . 0.0 109.0 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 25.7 mt -117.76 122.97 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.095 1.358 . . . . 0.0 109.385 174.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -102.06 127.62 48.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.965 1.706 . . . . 0.0 110.269 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 18.9 mm -120.02 112.22 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.877 1.271 . . . . 0.0 109.345 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -122.83 134.42 54.4 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.316 1.446 . . . . 0.0 111.215 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.9 t80 -127.22 123.93 37.74 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.486 1.514 . . . . 0.0 110.249 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.02 31.09 12.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.423 1.489 . . . . 0.0 114.069 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.59 12.51 0.68 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.337 2.655 . . . . 0.0 114.679 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -116.76 133.88 55.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.673 1.189 . . . . 0.0 110.71 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -72.06 126.74 30.52 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.278 1.031 . . . . 0.0 110.946 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.7 m -79.44 153.84 76.44 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.318 -0.864 . . . . 0.0 110.954 -170.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.94 146.86 91.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.816 2.344 . . . . 0.0 112.113 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.49 -29.25 6.3 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.263 1.411 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 3.7 t -78.47 145.48 67.88 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.076 0.95 . . . . 0.0 110.682 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.54 140.5 67.64 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.507 1.217 . . . . 0.0 111.875 2.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.71 116.0 28.24 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.987 0.915 . . . . 0.0 109.936 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 10.3 p -87.53 124.22 33.24 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.662 1.185 . . . . 0.0 110.651 172.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.1 t -121.21 114.98 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 109.733 -167.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -76.99 119.64 21.01 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.368 0.667 . . . . 0.0 111.168 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.7 t -109.24 125.84 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.076 1.35 . . . . 0.0 109.342 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.9 t -125.16 168.83 12.88 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.032 1.333 . . . . 0.0 112.279 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 118.28 148.36 8.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.293 1.901 . . . . 0.0 112.701 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -164.87 155.17 13.95 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.419 1.888 . . . . 0.0 109.729 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 92.06 40.6 5.15 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 124.165 0.888 . . . . 0.0 113.131 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -58.6 118.44 5.64 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.49 1.516 . . . . 0.0 111.97 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 8.7 p -167.42 150.66 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 126.479 1.911 . . . . 0.0 110.532 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 64.8 tttm . . . . . 0 C--O 1.253 1.277 0 C-N-CA 124.788 1.235 . . . . 0.0 112.225 177.008 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -80.19 -17.05 53.45 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 42.6 tpp -67.7 147.04 53.18 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.746 1.218 . . . . 0.0 112.166 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.73 52.51 4.18 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.711 1.625 . . . . 0.0 113.051 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 22.4 t0 -151.55 138.7 19.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.973 1.709 . . . . 0.0 111.232 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 36.5 t70 -94.19 -20.67 19.64 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.382 1.473 . . . . 0.0 112.653 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 23.3 m -84.84 24.03 1.11 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.546 1.539 . . . . 0.0 113.914 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 98.8 mmm -51.92 -39.5 59.23 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.949 1.699 . . . . 0.0 114.156 -172.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -130.74 133.51 46.09 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.194 1.398 . . . . 0.0 109.487 165.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.0 ptm -161.77 151.25 16.26 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.495 1.518 . . . . 0.0 111.969 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.2 m -130.54 147.53 52.24 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.445 1.898 . . . . 0.0 108.509 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -149.81 160.58 43.45 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -170.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -152.04 134.2 15.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.004 2.122 . . . . 0.0 108.858 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -128.04 139.59 52.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.202 1.001 . . . . 0.0 110.896 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.4 p -156.84 139.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.952 0.901 . . . . 0.0 111.764 -175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -73.62 152.91 46.82 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.079 0.847 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 52.1 m -139.83 133.06 29.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.449 1.1 . . . . 0.0 111.174 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -164.54 150.77 10.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.767 0.827 . . . . 0.0 112.864 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -76.99 151.24 35.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.986 0.914 . . . . 0.0 111.197 168.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -89.08 141.85 28.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.852 1.261 . . . . 0.0 112.358 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.3 mt -125.45 111.5 25.84 Favored Pre-proline 0 N--CA 1.471 0.623 0 C-N-CA 125.034 1.334 . . . . 0.0 108.38 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.82 139.79 17.9 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.988 2.459 . . . . 0.0 110.376 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 66.7 mt -139.34 136.37 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.306 1.042 . . . . 0.0 110.451 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 52.47 82.18 0.07 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.007 2.123 . . . . 0.0 112.56 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.7 mm -83.14 43.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.705 1.202 . . . . 0.0 110.495 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 60.4 m -132.24 -57.42 0.96 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.277 1.431 . . . . 0.0 111.963 -173.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -162.9 107.29 1.1 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.873 0.869 . . . . 0.0 111.628 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.7 p -141.78 160.83 39.38 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.585 1.954 . . . . 0.0 110.139 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 11.3 t70 -151.56 126.77 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.608 1.163 . . . . 0.0 110.81 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.86 -15.25 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 56.5 m -80.65 -9.88 59.76 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.693 1.133 . . . . 0.0 113.415 175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.0 pp -136.93 7.42 2.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.53 145.9 24.23 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.613 1.165 . . . . 0.0 111.84 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 22.8 p -141.94 152.01 43.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.939 2.096 . . . . 0.0 108.829 165.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.63 149.2 27.33 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 73.1 p -141.68 162.45 35.46 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.126 2.17 . . . . 0.0 110.056 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -118.07 137.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.275 1.43 . . . . 0.0 109.976 169.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 85.2 t -105.77 114.12 63.2 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.172 1.389 . . . . 0.0 108.396 167.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.67 173.55 11.23 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.166 3.244 . . . . 0.0 111.272 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.22 -33.4 54.6 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.063 3.175 . . . . 0.0 114.097 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.6 m -75.78 -8.24 56.37 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.29 -1.62 75.12 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.459 1.505 . . . . 0.0 115.196 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -76.9 88.82 3.48 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.445 1.498 . . . . 0.0 111.299 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.47 129.6 41.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.278 1.031 . . . . 0.0 111.796 -175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -130.63 149.28 73.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 126.084 1.754 . . . . 0.0 110.6 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.39 153.76 35.59 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.795 2.996 . . . . 0.0 112.547 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 79.8 m -99.16 155.94 17.21 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.705 1.202 . . . . 0.0 112.24 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.7 tt -93.91 113.03 24.96 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.305 1.442 . . . . 0.0 108.101 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mt -83.05 136.37 34.51 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.886 1.275 . . . . 0.0 111.246 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -137.95 143.8 40.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.74 1.216 . . . . 0.0 113.533 -170.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -94.17 122.31 36.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 155.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.49 167.6 11.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.379 1.472 . . . . 0.0 112.303 -166.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -59.04 -29.9 67.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.34 1.25 53.85 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.21 1.004 . . . . 0.0 113.341 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.64 67.54 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.804 1.669 . . . . 0.0 114.772 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -77.12 168.97 19.18 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.383 1.473 . . . . 0.0 113.443 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 77.8 t -112.05 140.3 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 125.452 1.501 . . . . 0.0 110.486 -174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.12 -171.81 24.49 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.355 0.978 . . . . 0.0 115.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.1 162.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.502 1.521 . . . . 0.0 112.458 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 37.0 m -132.33 159.83 38.05 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.946 1.699 . . . . 0.0 110.438 161.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.29 -177.05 5.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.425 1.89 . . . . 0.0 109.998 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.8 t -130.27 121.05 19.33 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.795 0.838 . . . . 0.0 109.738 171.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.71 139.01 15.51 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.95 3.1 . . . . 0.0 110.799 175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 55.6 tptt -88.95 -20.03 25.01 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -135.55 176.01 9.06 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.494 1.918 . . . . 0.0 110.897 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 76.1 p -92.1 164.3 13.64 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.534 1.133 . . . . 0.0 111.053 167.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 100.24 -168.41 20.99 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.156 1.36 . . . . 0.0 113.928 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -74.58 112.84 11.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.264 1.026 . . . . 0.0 111.941 -172.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 19.3 m80 -100.66 141.25 33.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.851 1.66 . . . . 0.0 109.129 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.39 125.82 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.972 0.909 . . . . 0.0 109.648 174.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.7 t -86.85 121.84 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.667 1.187 . . . . 0.0 108.099 167.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -101.64 134.39 44.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.796 1.239 . . . . 0.0 109.915 170.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.2 p -139.75 128.86 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-O 122.278 1.037 . . . . 0.0 112.202 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -115.84 141.71 47.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.599 2.359 . . . . 0.0 111.01 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.7 tttt -137.11 118.71 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.574 2.35 . . . . 0.0 109.357 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.4 t30 56.34 29.02 14.33 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.761 1.224 . . . . 0.0 113.685 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 95.42 3.91 61.14 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 125.135 1.35 . . . . 0.0 116.169 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -137.62 153.77 49.83 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.567 1.684 . . . . 0.0 111.482 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -65.27 142.28 58.33 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.65 -1.281 . . . . 0.0 113.156 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . 0.422 HG12 ' H ' ' A' 2032 ' ' SER . 61.5 t -67.24 147.87 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.624 1.17 . . . . 0.0 109.457 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.05 64.28 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . 0.422 ' H ' HG12 ' A' 2030 ' ' VAL . 11.5 m -76.18 -14.18 60.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.581 1.552 . . . . 0.0 114.002 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 10.1 t -85.67 141.57 36.32 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.674 1.19 . . . . 0.0 112.861 -172.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.15 154.2 86.09 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.506 0.859 . . . . 0.0 112.56 -4.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.6 118.88 56.46 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.58 1.552 . . . . 0.0 108.582 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.16 140.71 12.52 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.071 2.514 . . . . 0.0 111.038 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 16.0 t -137.62 125.34 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.818 1.647 . . . . 0.0 108.118 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.4 t -97.78 122.12 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.683 0.793 . . . . 0.0 110.192 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.92 131.06 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.17 1.388 . . . . 0.0 110.023 -174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.9 t -95.24 171.82 8.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.81 1.244 . . . . 0.0 112.331 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -23.36 62.96 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.525 -1.359 . . . . 0.0 112.938 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 4.2 m -74.6 -12.72 60.52 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -117.71 6.59 12.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.47 1.508 . . . . 0.0 113.744 -173.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.45 -39.5 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.024 0.93 . . . . 0.0 112.658 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 170.0 42.01 0.03 OUTLIER Glycine 0 N--CA 1.469 0.889 0 C-N-CA 123.833 0.73 . . . . 0.0 114.211 -169.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.23 104.97 6.02 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 117.861 0.831 . . . . 0.0 111.981 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.64 93.49 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.523 -0.736 . . . . 0.0 112.797 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 19.4 m -60.09 -27.5 67.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.208 1.003 . . . . 0.0 113.256 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -80.73 -10.4 59.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.398 1.479 . . . . 0.0 114.246 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 93.4 t -81.91 136.09 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 120.036 1.289 . . . . 0.0 109.455 172.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 19.9 mmt85 -131.74 156.8 45.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.24 1.416 . . . . 0.0 110.737 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.6 m -144.7 158.77 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.818 1.247 . . . . 0.0 111.666 -173.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 95.1 p -158.34 172.57 18.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.819 1.247 . . . . 0.0 112.863 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.94 153.09 28.08 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.893 1.235 . . . . 0.0 113.169 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -77.29 -16.46 58.96 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -168.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.48 -4.06 29.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.704 1.145 . . . . 0.0 114.748 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -87.96 -3.96 58.86 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.683 1.593 . . . . 0.0 112.785 168.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -134.24 -39.57 0.83 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.832 1.253 . . . . 0.0 113.936 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -141.26 148.81 40.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.191 1.396 . . . . 0.0 111.362 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.95 175.86 26.12 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.728 1.156 . . . . 0.0 113.838 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 61.7 m80 -132.13 154.6 49.33 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.284 1.434 . . . . 0.0 111.811 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 9.9 p -67.11 -65.86 0.63 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.394 1.078 . . . . 0.0 112.796 -175.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -93.77 7.49 44.66 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.26 1.024 . . . . 0.0 113.507 -166.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -135.58 143.17 43.89 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.751 2.02 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.48 152.2 48.61 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.068 2.512 . . . . 0.0 112.691 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -101.03 162.48 12.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.617 1.567 . . . . 0.0 110.924 168.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.69 149.95 34.46 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 50.2 p90 -159.85 153.73 23.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.695 1.598 . . . . 0.0 111.18 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.29 142.17 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.962 1.705 . . . . 0.0 109.523 -172.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 39.7 mt -120.24 136.91 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.519 1.927 . . . . 0.0 109.391 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.0 125.53 41.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.577 1.551 . . . . 0.0 111.892 176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 40.3 p -122.35 -13.43 8.07 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -170.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.31 -25.41 68.03 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.632 1.56 . . . . 0.0 114.732 -170.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.15 -16.52 60.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.218 1.007 . . . . 0.0 112.892 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.51 -9.64 49.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.534 1.534 . . . . 0.0 113.669 172.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 80.52 -119.33 4.88 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.597 1.094 . . . . 0.0 112.063 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -92.49 169.58 10.43 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.521 1.528 . . . . 0.0 112.822 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.51 -138.49 7.67 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.009 1.29 . . . . 0.0 112.739 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -178.2 136.15 2.89 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 124.352 0.977 . . . . 0.0 112.017 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.88 122.92 40.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.736 1.614 . . . . 0.0 109.651 -175.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 46.1 m -112.21 132.91 54.65 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.098 1.359 . . . . 0.0 109.476 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -130.03 135.83 48.71 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.33 1.452 . . . . 0.0 109.633 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 71.0 m -130.6 140.24 50.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.585 0.754 . . . . 0.0 111.01 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.4 mt -118.17 127.11 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.105 1.362 . . . . 0.0 107.764 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.36 140.42 46.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.207 1.403 . . . . 0.0 109.535 -168.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 171.38 -155.82 25.03 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.826 -0.986 . . . . 0.0 113.809 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 -22.69 27.53 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.379 2.719 . . . . 0.0 113.682 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 63.8 m -145.48 160.04 42.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.568 1.147 . . . . 0.0 112.367 -177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.5 ttpt -67.31 146.3 54.25 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.182 0.993 . . . . 0.0 111.228 169.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -130.17 149.09 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.718 1.607 . . . . 0.0 110.769 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -89.46 105.46 17.81 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.768 0.827 . . . . 0.0 110.122 175.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 41.0 mt -85.51 130.49 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.333 1.053 . . . . 0.0 109.711 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -126.29 157.36 38.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 110.418 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 19.9 p -144.5 153.45 41.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.795 1.238 . . . . 0.0 112.279 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -158.1 134.99 9.85 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.118 1.367 . . . . 0.0 110.591 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -80.98 131.97 35.35 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.712 0.805 . . . . 0.0 111.905 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.92 168.81 13.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.452 1.501 . . . . 0.0 111.332 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.78 -32.11 69.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.91 -7.52 54.75 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.307 1.443 . . . . 0.0 113.518 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 88.02 6.76 75.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.484 1.516 . . . . 0.0 114.114 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 22.2 p -80.42 154.17 27.82 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.747 1.619 . . . . 0.0 110.617 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -100.35 119.14 37.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.456 0.702 . . . . 0.0 110.597 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -86.54 133.19 33.75 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.698 0.799 . . . . 0.0 109.519 167.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 19.2 t -113.4 138.05 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.67 1.988 . . . . 0.0 108.645 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 23.9 p -135.85 151.93 50.53 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.426 1.49 . . . . 0.0 111.473 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -163.16 153.16 15.73 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 111.811 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.4 t -119.31 100.59 49.88 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.405 1.082 . . . . 0.0 110.91 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.75 85.56 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.687 2.925 . . . . 0.0 110.937 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 18.7 m -54.42 -39.41 67.31 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.134 1.374 . . . . 0.0 113.936 -170.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -95.32 140.09 22.26 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.259 1.024 . . . . 0.0 111.014 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.29 165.38 31.98 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.694 2.93 . . . . 0.0 112.358 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 139.54 -160.08 25.95 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.0 1.286 . . . . 0.0 113.115 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -107.27 119.55 39.7 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.186 0.994 . . . . 0.0 110.513 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -103.89 141.31 36.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.07 1.348 . . . . 0.0 110.463 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.56 131.47 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.237 1.415 . . . . 0.0 108.063 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.7 mt -110.21 119.22 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.423 1.089 . . . . 0.0 108.901 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -102.14 124.43 47.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.264 1.426 . . . . 0.0 110.697 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.73 115.53 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.394 1.477 . . . . 0.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.7 134.87 48.61 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 0.0 111.604 -175.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -126.99 124.47 39.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.864 1.666 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.78 34.78 19.87 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.022 1.329 . . . . 0.0 113.683 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.4 t70 89.71 -0.65 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 129.269 3.027 . . . . 0.0 113.929 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -119.39 132.82 55.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.688 1.195 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -69.15 128.42 36.57 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.278 1.431 . . . . 0.0 111.93 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -85.67 160.65 52.83 Favored Pre-proline 0 N--CA 1.488 1.46 0 CA-C-N 119.133 0.879 . . . . 0.0 112.155 -169.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -54.92 149.27 43.05 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.071 3.18 . . . . 0.0 114.471 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 80.65 -30.0 2.58 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.222 1.392 . . . . 0.0 113.827 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 2.5 t -72.83 142.58 83.4 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.425 1.09 . . . . 0.0 110.547 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.03 139.59 62.54 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 120.631 1.261 . . . . 0.0 111.896 6.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.14 111.92 24.19 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.066 0.946 . . . . 0.0 110.21 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 67.3 m -85.57 127.41 34.44 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.982 0.913 . . . . 0.0 110.888 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -124.43 112.1 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.66 1.584 . . . . 0.0 109.35 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.56 118.17 21.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.859 0.463 . . . . 0.0 110.722 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.0 t -104.11 124.76 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.874 1.67 . . . . 0.0 109.193 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.1 t -124.87 162.88 23.42 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 112.367 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 122.98 159.22 10.46 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.297 1.903 . . . . 0.0 113.096 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -163.46 144.27 9.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.797 1.639 . . . . 0.0 110.223 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 87.57 84.91 1.17 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.885 1.231 . . . . 0.0 111.346 -177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -61.66 128.6 37.03 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.736 1.214 . . . . 0.0 112.218 -173.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 25.7 t 76.97 117.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 128.857 2.863 . . . . 0.0 109.911 -173.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.253 1.241 0 C-N-CA 125.161 1.385 . . . . 0.0 111.984 179.443 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.72 153.67 41.05 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.316 1.047 . . . . 0.0 112.694 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 67.4 mtt -86.39 98.62 11.1 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.533 1.133 . . . . 0.0 110.871 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -67.66 -35.48 86.01 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.54 0.591 . . . . 0.0 113.275 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -71.66 -25.97 62.34 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.64 1.176 . . . . 0.0 112.995 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.27 -35.35 31.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.336 1.054 . . . . 0.0 111.421 171.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 16.9 t -64.32 -39.71 94.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.302 1.041 . . . . 0.0 112.655 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 22.2 ptp -162.64 152.18 15.68 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.655 1.182 . . . . 0.0 113.659 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.08 115.58 30.86 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 162.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 28.3 ttt -118.54 129.35 55.3 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.669 1.188 . . . . 0.0 111.094 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 4.3 m -123.26 141.77 51.63 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.947 1.699 . . . . 0.0 108.589 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -156.8 162.02 39.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.4 tt -154.69 145.49 22.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.852 2.061 . . . . 0.0 110.261 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -135.29 143.71 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.609 1.164 . . . . 0.0 112.184 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 42.6 t -132.88 134.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 110.143 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.01 63.71 4.35 Favored Glycine 0 N--CA 1.471 1.022 0 C-N-CA 125.349 1.452 . . . . 0.0 112.057 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 10.1 m -58.51 124.77 20.74 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 114.154 -171.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -156.8 150.02 24.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.114 1.366 . . . . 0.0 111.69 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.71 153.44 21.73 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.131 0.972 . . . . 0.0 111.382 171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -90.73 139.66 30.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.668 1.187 . . . . 0.0 112.116 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 36.1 mm -125.27 123.85 25.21 Favored Pre-proline 0 N--CA 1.475 0.778 0 C-N-CA 124.417 1.087 . . . . 0.0 108.935 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -73.44 149.73 45.11 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.771 2.314 . . . . 0.0 111.526 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 45.2 mm -120.91 148.37 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.089 1.756 . . . . 0.0 108.805 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 53.3 t30 -44.05 116.47 1.0 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.363 1.465 . . . . 0.0 113.772 -170.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 5.1 mp -87.38 130.42 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.008 1.323 . . . . 0.0 109.749 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.7 t -164.16 -175.59 4.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.209 1.403 . . . . 0.0 111.134 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -77.78 1.0 21.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.631 1.572 . . . . 0.0 113.658 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.1 m -57.33 133.5 55.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.568 1.947 . . . . 0.0 111.338 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.3 t0 -70.44 122.3 19.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.193 0.997 . . . . 0.0 111.402 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.22 -20.48 60.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.033 0.933 . . . . 0.0 113.076 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 67.5 m -72.97 -18.24 61.39 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -109.38 5.83 23.82 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.665 1.586 . . . . 0.0 113.494 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.3 146.31 29.52 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.592 1.557 . . . . 0.0 111.455 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 49.9 p -134.59 168.42 19.02 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.222 1.809 . . . . 0.0 109.854 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -145.33 141.76 28.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.821 0.849 . . . . 0.0 112.243 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 64.2 p -135.2 163.35 30.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.693 1.997 . . . . 0.0 109.428 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -115.78 136.55 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.802 1.241 . . . . 0.0 109.55 167.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.0 t -107.03 113.21 62.73 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.59 1.556 . . . . 0.0 108.17 167.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -80.24 173.47 12.49 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.289 3.326 . . . . 0.0 111.272 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.18 -28.01 49.6 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.196 3.264 . . . . 0.0 114.83 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.0 p -79.03 -9.18 59.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.789 1.235 . . . . 0.0 114.143 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.3 0.25 88.71 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.46 1.505 . . . . 0.0 114.695 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.61 84.43 3.28 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.518 1.527 . . . . 0.0 111.491 -176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.87 133.4 55.4 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.643 1.177 . . . . 0.0 112.009 -175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.81 149.65 59.98 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.412 1.485 . . . . 0.0 110.986 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.11 154.52 42.05 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.93 3.087 . . . . 0.0 112.669 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 84.9 m -108.24 153.45 23.2 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.094 1.358 . . . . 0.0 112.686 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 63.4 tp -88.11 112.57 22.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.455 1.102 . . . . 0.0 109.938 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.75 134.41 33.58 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.967 1.307 . . . . 0.0 111.165 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -142.9 148.86 37.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.008 1.323 . . . . 0.0 112.911 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -80.49 122.38 26.93 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.023 1.329 . . . . 0.0 108.364 160.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.41 177.36 6.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.316 1.446 . . . . 0.0 112.704 -171.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -53.84 -43.03 69.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.504 1.522 . . . . 0.0 114.218 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.17 4.42 53.91 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.718 1.207 . . . . 0.0 113.688 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.74 -7.02 74.11 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.883 1.23 . . . . 0.0 114.403 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -73.05 174.24 8.18 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.894 1.278 . . . . 0.0 112.602 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -127.9 142.47 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 125.38 1.472 . . . . 0.0 109.548 -173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -159.73 -179.17 34.35 Favored Glycine 0 N--CA 1.467 0.721 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.72 163.02 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.12 1.768 . . . . 0.0 112.731 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 4.4 m -137.89 155.4 48.98 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.044 1.738 . . . . 0.0 110.336 159.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 16.8 p90 -164.16 -176.07 4.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.185 2.594 . . . . 0.0 108.909 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.2 t -131.35 123.3 19.5 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-N 119.105 0.866 . . . . 0.0 109.246 169.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.5 148.2 26.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.038 3.158 . . . . 0.0 111.441 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -107.79 -8.34 16.06 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.21 172.74 12.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.027 2.131 . . . . 0.0 109.78 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.4 p -85.21 168.0 15.17 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.639 1.176 . . . . 0.0 111.529 171.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.61 -170.39 26.73 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.122 1.344 . . . . 0.0 114.013 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -71.69 115.09 10.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.221 1.008 . . . . 0.0 111.687 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.0 m80 -98.27 144.05 28.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.757 1.623 . . . . 0.0 109.134 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.59 126.99 54.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.237 1.015 . . . . 0.0 109.544 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.5 t -85.55 118.87 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.41 96.6 7.27 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.535 1.534 . . . . 0.0 110.089 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 89.0 t -86.08 137.71 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.855 1.662 . . . . 0.0 108.975 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.3 mttm -133.64 131.75 39.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.145 0.978 . . . . 0.0 112.99 -170.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 80.6 tttt -96.25 119.49 34.84 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.063 1.345 . . . . 0.0 109.281 161.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.6 t30 55.46 22.87 5.36 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.845 1.258 . . . . 0.0 114.074 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.14 3.7 88.77 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.401 1.477 . . . . 0.0 115.582 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -106.28 23.28 14.36 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.397 1.479 . . . . 0.0 113.305 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.7 m-70 65.26 -170.77 0.19 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.936 1.694 . . . . 0.0 112.527 -172.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 34.1 m -136.29 171.84 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.943 1.297 . . . . 0.0 110.795 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.7 -29.7 70.89 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 14.5 m -89.46 -10.47 46.27 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.8 p -89.98 153.99 47.31 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 120.709 -1.244 . . . . 0.0 113.715 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.8 157.16 95.2 Favored 'Cis proline' 0 C--N 1.353 0.78 0 CA-C-N 118.856 0.627 . . . . 0.0 112.41 -4.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.01 122.81 39.57 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.703 1.201 . . . . 0.0 108.774 175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.64 146.36 11.96 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.043 2.495 . . . . 0.0 112.576 -177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 19.4 t -137.52 125.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.985 1.714 . . . . 0.0 107.921 170.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.2 t -102.09 124.69 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.701 0.8 . . . . 0.0 110.635 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.36 139.53 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.439 1.496 . . . . 0.0 110.232 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 15.2 t -116.7 164.71 14.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.817 1.247 . . . . 0.0 111.449 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.04 -37.65 77.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.401 1.08 . . . . 0.0 112.738 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 48.8 m -60.71 -18.41 54.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.63 -6.63 32.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.166 1.386 . . . . 0.0 113.142 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 34.3 mm -72.61 -32.88 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.086 -1.009 . . . . 0.0 112.701 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 140.42 29.61 0.19 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.754 1.169 . . . . 0.0 113.641 -168.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 28.2 t0 -73.34 114.57 11.69 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.421 1.11 . . . . 0.0 110.685 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.72 74.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.811 0.844 . . . . 0.0 113.015 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 60.4 p -66.85 -21.03 66.03 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.986 -1.071 . . . . 0.0 113.196 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -77.9 -14.85 59.41 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.775 1.23 . . . . 0.0 113.399 173.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 48.3 t -79.7 132.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 119.618 1.099 . . . . 0.0 110.08 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -113.87 154.49 27.4 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.764 1.625 . . . . 0.0 110.57 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -145.81 149.75 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.209 1.404 . . . . 0.0 111.008 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 74.6 m -150.78 160.41 43.88 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.925 1.29 . . . . 0.0 112.325 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 113.76 162.92 14.89 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.418 1.009 . . . . 0.0 115.021 171.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -65.23 -34.42 78.31 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.675 1.59 . . . . 0.0 113.249 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.82 -1.65 33.04 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.934 1.254 . . . . 0.0 115.053 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.1 mt -90.2 -7.27 53.98 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.401 1.481 . . . . 0.0 112.689 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -128.33 -36.32 1.92 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.834 1.253 . . . . 0.0 113.794 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -158.78 158.09 32.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.683 1.193 . . . . 0.0 112.396 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -154.81 -174.91 25.31 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.441 1.019 . . . . 0.0 114.166 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -141.71 137.97 32.07 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.324 1.45 . . . . 0.0 111.18 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.2 p -63.48 146.65 53.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.265 0.626 . . . . 0.0 111.307 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 4.4 m-85 73.93 -4.73 2.19 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.069 2.148 . . . . 0.0 113.896 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -120.97 148.4 48.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.795 2.038 . . . . 0.0 110.191 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.47 125.06 9.83 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.576 2.184 . . . . 0.0 110.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -86.57 145.51 26.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.273 1.029 . . . . 0.0 109.54 165.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.48 151.45 50.95 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -158.51 152.13 23.31 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.163 1.785 . . . . 0.0 110.548 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.19 140.46 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.538 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.2 mt -114.57 136.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.281 1.832 . . . . 0.0 109.094 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 57.5 t0 -123.08 100.92 7.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.045 1.738 . . . . 0.0 110.582 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 28.9 p -99.2 4.25 46.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.581 1.952 . . . . 0.0 112.831 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -59.85 -33.15 71.4 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.489 1.041 . . . . 0.0 112.835 -173.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.24 -10.03 55.38 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.376 1.47 . . . . 0.0 113.383 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.84 -9.76 19.66 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.17 1.788 . . . . 0.0 114.08 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 69.38 -134.89 26.86 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.954 1.264 . . . . 0.0 114.008 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -74.04 167.36 21.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.079 1.352 . . . . 0.0 112.635 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.97 -116.99 0.97 Allowed Glycine 0 N--CA 1.468 0.799 0 C-N-CA 124.558 1.075 . . . . 0.0 112.022 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . 176.2 116.32 0.45 Allowed Glycine 0 N--CA 1.465 0.612 0 C-N-CA 123.87 0.748 . . . . 0.0 112.812 175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.03 124.97 29.19 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.496 1.118 . . . . 0.0 109.517 175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 69.0 m -124.52 144.59 50.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.773 1.629 . . . . 0.0 109.616 172.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -144.35 132.46 21.66 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 123.344 0.658 . . . . 0.0 110.223 -164.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 49.6 m -132.53 139.03 47.71 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.604 0.762 . . . . 0.0 111.098 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.9 mt -123.93 138.12 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.723 1.609 . . . . 0.0 108.622 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.94 157.56 44.1 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 161.85 -146.31 11.93 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.873 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.62 -11.27 24.15 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.582 2.855 . . . . 0.0 113.989 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.8 t -155.97 161.08 40.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.594 1.088 . . . . 0.0 112.411 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.58 130.39 35.09 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.299 1.44 . . . . 0.0 109.727 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.7 m -114.23 157.51 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.158 1.383 . . . . 0.0 111.856 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -92.5 126.13 37.45 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.501 0.72 . . . . 0.0 109.813 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 28.7 mt -106.67 134.64 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 109.427 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -131.87 162.59 30.23 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.014 1.726 . . . . 0.0 111.056 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 23.0 p -137.99 159.95 40.64 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.391 1.476 . . . . 0.0 112.079 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.83 122.76 6.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.438 1.495 . . . . 0.0 110.236 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.33 128.6 34.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.726 1.21 . . . . 0.0 110.864 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 69.5 mt -104.41 151.3 23.68 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.507 1.123 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.35 -17.55 64.27 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.734 0.813 . . . . 0.0 113.057 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -70.69 -10.8 60.23 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.439 1.496 . . . . 0.0 113.453 171.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 93.71 -3.2 70.9 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.153 1.835 . . . . 0.0 114.187 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 42.6 p -87.85 168.97 12.45 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.252 1.821 . . . . 0.0 111.319 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -123.81 127.15 47.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.992 0.917 . . . . 0.0 111.408 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -79.51 135.08 36.54 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.845 0.858 . . . . 0.0 109.229 165.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 48.0 t -113.14 139.78 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.173 1.789 . . . . 0.0 108.381 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.2 p -133.83 150.47 51.41 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.143 1.377 . . . . 0.0 111.565 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.0 p90 -155.19 146.94 23.27 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.524 1.13 . . . . 0.0 112.019 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 38.3 t -113.73 106.93 53.36 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.275 1.03 . . . . 0.0 111.179 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.67 145.77 16.42 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.571 2.847 . . . . 0.0 111.059 174.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 91.5 m -104.01 -47.13 4.27 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.115 0.966 . . . . 0.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -86.61 143.23 35.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.032 0.933 . . . . 0.0 110.517 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.12 162.13 28.98 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.346 2.697 . . . . 0.0 111.3 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.54 -164.69 24.88 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.24 1.4 . . . . 0.0 113.566 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 46.9 t30 -90.59 118.99 30.47 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.499 0.719 . . . . 0.0 111.059 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -100.21 141.1 33.5 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.719 1.208 . . . . 0.0 110.107 167.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.56 131.05 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.503 1.121 . . . . 0.0 108.359 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.5 mt -113.61 130.58 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.292 1.437 . . . . 0.0 109.372 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -114.19 123.95 50.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.595 1.558 . . . . 0.0 110.115 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.91 119.78 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.065 0.946 . . . . 0.0 109.693 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -122.99 136.48 54.87 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.866 2.066 . . . . 0.0 109.787 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.04 122.13 22.55 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.661 1.185 . . . . 0.0 110.239 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.67 45.11 27.33 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.901 1.28 . . . . 0.0 111.987 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.6 t0 73.03 -4.47 2.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 128.848 2.859 . . . . 0.0 114.744 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -101.33 132.52 46.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.571 1.148 . . . . 0.0 110.748 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -69.65 125.61 27.24 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.229 1.012 . . . . 0.0 111.292 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -79.32 153.5 76.67 Favored Pre-proline 0 N--CA 1.486 1.341 0 O-C-N 121.218 -0.926 . . . . 0.0 111.025 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.02 140.97 81.82 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.666 2.244 . . . . 0.0 111.647 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.66 22.58 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.376 1.465 . . . . 0.0 113.745 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 66.6 m -76.73 153.55 83.28 Favored Pre-proline 0 CA--C 1.55 0.956 0 CA-C-N 118.594 1.197 . . . . 0.0 111.993 171.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.56 142.83 73.38 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 119.311 0.789 . . . . 0.0 111.352 -7.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -96.18 116.52 29.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.415 1.086 . . . . 0.0 110.205 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 58.0 m -83.1 128.67 34.69 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.737 0.815 . . . . 0.0 110.449 169.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -127.07 110.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.541 1.537 . . . . 0.0 109.207 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 56.8 tttp -78.58 107.73 11.46 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.035 0.534 . . . . 0.0 110.763 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.0 t -94.47 118.06 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.787 1.235 . . . . 0.0 108.806 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -90.3 150.71 21.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.874 0.87 . . . . 0.0 110.847 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -177.2 160.23 27.03 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.26 0.933 . . . . 0.0 114.552 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -113.31 -2.68 13.96 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 0.0 113.605 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 80.89 4.8 90.4 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.461 1.029 . . . . 0.0 114.803 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 58.1 ttp85 84.45 138.49 0.06 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 129.439 3.095 . . . . 0.0 111.612 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 57.7 t -133.3 133.99 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.995 1.718 . . . . 0.0 109.046 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 125.146 1.378 . . . . 0.0 112.173 179.531 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -81.05 -19.09 44.54 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -75.28 144.19 42.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.416 1.087 . . . . 0.0 112.41 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -88.6 148.2 20.36 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.812 1.196 . . . . 0.0 111.924 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.35 -18.87 64.59 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.82 -10.46 53.44 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.815 1.646 . . . . 0.0 113.73 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 44.3 m -81.0 -15.22 56.8 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 5.2 ppp? -71.59 159.49 34.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.259 1.023 . . . . 0.0 112.11 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -128.23 149.17 50.58 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.641 1.176 . . . . 0.0 110.798 175.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 20.3 ptm -158.76 163.04 37.11 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.618 1.567 . . . . 0.0 112.417 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 19.3 m -136.99 143.9 43.03 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.419 1.888 . . . . 0.0 109.097 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -143.58 165.15 28.39 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 -164.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -156.65 155.65 32.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.868 2.067 . . . . 0.0 110.5 -175.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . 0.421 ' H ' HD13 ' A' 1963 ' ' LEU . 61.1 mttm -136.94 143.83 43.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.444 1.498 . . . . 0.0 111.478 173.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 57.8 t -141.04 135.66 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.832 1.653 . . . . 0.0 109.534 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.29 133.32 11.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 123.898 0.761 . . . . 0.0 112.045 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 62.5 m -120.3 146.58 45.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.89 1.276 . . . . 0.0 112.602 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -157.03 150.65 24.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.493 1.117 . . . . 0.0 112.589 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.58 148.86 25.3 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.401 1.081 . . . . 0.0 111.229 169.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -86.56 126.98 34.85 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.806 1.243 . . . . 0.0 111.203 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.6 mm -113.22 113.29 48.98 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 124.926 1.29 . . . . 0.0 109.01 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.11 138.57 20.58 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.989 2.459 . . . . 0.0 110.948 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 55.2 mt -143.35 136.5 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.82 1.248 . . . . 0.0 109.713 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 11.5 t30 59.22 69.82 0.69 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.305 1.842 . . . . 0.0 113.058 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.4 mm -71.68 104.48 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.73 0.812 . . . . 0.0 109.657 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.6 t -173.69 -168.56 0.44 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.971 2.108 . . . . 0.0 109.928 -172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.16 51.93 1.05 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.1 1.76 . . . . 0.0 111.893 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 91.9 m -83.72 124.04 30.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.545 1.538 . . . . 0.0 109.773 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -90.46 126.53 35.93 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.702 1.201 . . . . 0.0 110.258 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -31.06 55.91 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.941 1.296 . . . . 0.0 112.132 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 57.3 m -73.02 -22.92 60.57 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -160.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' 1982 ' ' LEU . 1.9 pt? -111.72 2.47 17.21 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.402 1.481 . . . . 0.0 114.079 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.79 152.25 20.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.066 1.347 . . . . 0.0 112.084 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.0 p -140.77 172.42 12.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.62 2.368 . . . . 0.0 108.641 165.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -156.56 160.29 39.33 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 78.3 p -133.07 161.5 34.22 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.461 1.905 . . . . 0.0 109.824 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -111.75 135.13 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.953 1.301 . . . . 0.0 109.243 166.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.8 t -103.52 110.66 64.23 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.74 1.216 . . . . 0.0 107.89 163.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.09 169.43 17.66 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.766 2.977 . . . . 0.0 110.897 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.51 -19.75 65.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.902 2.401 . . . . 0.0 112.025 168.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 1.9 m -68.66 -10.57 57.02 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.642 1.577 . . . . 0.0 113.668 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 77.62 -13.3 12.54 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.131 1.824 . . . . 0.0 115.411 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 44.8 mmt-85 -80.51 94.92 6.34 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.833 1.253 . . . . 0.0 111.181 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.64 133.97 55.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.161 0.984 . . . . 0.0 111.473 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.28 150.75 62.41 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.123 1.369 . . . . 0.0 111.356 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.82 156.23 34.95 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.942 3.095 . . . . 0.0 112.882 -176.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 88.7 m -104.93 153.04 21.92 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.35 1.46 . . . . 0.0 112.244 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -96.79 116.72 29.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.468 1.507 . . . . 0.0 107.956 168.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.88 137.54 32.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.199 1.0 . . . . 0.0 110.613 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.31 137.56 47.49 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.693 1.197 . . . . 0.0 112.766 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -89.23 120.05 30.26 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.768 1.227 . . . . 0.0 107.796 160.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 75.8 mt -97.65 164.65 12.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.021 1.328 . . . . 0.0 111.804 -169.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -69.88 -24.3 63.39 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -159.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 52.1 t30 -90.57 0.1 57.48 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.146 0.979 . . . . 0.0 113.549 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.96 -6.48 54.2 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 125.394 1.473 . . . . 0.0 114.146 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -74.35 174.04 9.41 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.359 1.464 . . . . 0.0 113.197 171.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 30.3 m -134.46 152.15 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.239 1.416 . . . . 0.0 110.931 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -162.0 -170.84 27.31 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.972 0.796 . . . . 0.0 115.064 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.39 158.89 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.403 1.481 . . . . 0.0 112.686 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 53.4 m -132.24 153.82 50.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.595 1.558 . . . . 0.0 111.047 165.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.2 p90 -165.63 -169.88 1.67 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.769 2.428 . . . . 0.0 108.913 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 92.0 t -133.99 120.75 15.38 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 119.924 1.238 . . . . 0.0 110.29 169.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.86 147.69 17.09 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 124.341 3.36 . . . . 0.0 111.279 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.7 -12.29 17.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.79 172.93 12.33 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.856 2.062 . . . . 0.0 109.969 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 39.9 p -86.1 171.15 11.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.06 1.344 . . . . 0.0 111.89 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 96.54 -170.03 26.53 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.075 1.321 . . . . 0.0 113.874 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.46 117.61 12.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.097 0.959 . . . . 0.0 111.78 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.2 m80 -104.24 143.57 32.77 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.042 1.737 . . . . 0.0 109.269 168.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.1 122.24 44.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.257 1.023 . . . . 0.0 109.352 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 50.9 t -91.55 125.35 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.157 1.383 . . . . 0.0 108.558 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -110.22 113.53 26.29 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.217 1.407 . . . . 0.0 110.189 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 42.3 t -102.66 139.49 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.332 1.453 . . . . 0.0 109.36 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -144.81 142.32 29.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -172.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.87 121.41 44.01 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.052 2.541 . . . . 0.0 109.58 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.1 t30 53.35 30.13 9.78 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.374 1.069 . . . . 0.0 113.545 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.05 66.08 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.64 1.59 . . . . 0.0 115.587 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -101.11 133.3 45.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.28 1.432 . . . . 0.0 110.903 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -60.06 139.6 57.37 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 91.2 t -76.02 142.52 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.254 1.422 . . . . 0.0 108.874 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.91 -24.79 62.76 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 20.0 m -76.93 -12.63 59.98 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.832 1.253 . . . . 0.0 114.022 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 47.9 m -84.43 153.79 62.22 Favored Pre-proline 0 CA--C 1.548 0.868 0 O-C-N 120.853 -1.154 . . . . 0.0 113.582 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.98 152.11 88.51 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-O 121.357 0.482 . . . . 0.0 112.306 -4.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.06 124.6 37.92 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.959 1.304 . . . . 0.0 108.742 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.74 137.14 12.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.887 2.391 . . . . 0.0 111.145 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 48.9 t -133.07 124.34 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.411 1.484 . . . . 0.0 107.815 172.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.7 t -96.87 125.35 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.822 0.849 . . . . 0.0 110.372 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.84 125.74 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.128 1.371 . . . . 0.0 109.198 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.3 t -93.39 158.75 15.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.022 0.929 . . . . 0.0 111.905 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -58.29 -31.58 67.62 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.09 0.956 . . . . 0.0 113.02 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 24.5 m -66.06 -18.42 65.33 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.2 1.0 . . . . 0.0 113.644 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -92.07 -13.0 31.54 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.473 1.109 . . . . 0.0 112.703 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.6 mm -70.12 -26.19 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.356 1.062 . . . . 0.0 112.491 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 149.8 63.4 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.356 0.979 . . . . 0.0 113.586 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -76.57 94.19 3.7 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.382 0.673 . . . . 0.0 110.922 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.82 61.9 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.483 1.113 . . . . 0.0 112.627 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 40.4 p -55.78 -22.82 26.28 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.97 1.708 . . . . 0.0 114.639 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -94.53 -7.98 39.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.306 1.442 . . . . 0.0 113.688 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.2 t -73.98 138.45 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.637 1.108 . . . . 0.0 110.693 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -114.8 147.48 39.74 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.584 1.554 . . . . 0.0 111.796 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.6 m -143.82 144.17 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.787 1.635 . . . . 0.0 109.807 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.4 m -149.09 156.08 41.68 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.403 1.081 . . . . 0.0 112.254 -173.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 118.1 162.56 12.37 Favored Glycine 0 N--CA 1.474 1.214 0 C-N-CA 124.706 1.146 . . . . 0.0 114.186 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -65.47 -30.25 71.01 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.729 1.212 . . . . 0.0 113.377 -170.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.1 -1.6 34.78 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.713 1.149 . . . . 0.0 114.878 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.4 -7.67 56.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.182 1.393 . . . . 0.0 112.554 167.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -130.06 -37.55 1.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.161 1.384 . . . . 0.0 114.056 -172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.19 158.62 37.92 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.157 0.983 . . . . 0.0 113.405 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.67 -173.37 20.08 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.435 1.493 . . . . 0.0 113.271 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 65.1 m80 -136.5 146.35 46.16 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.398 1.079 . . . . 0.0 112.784 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 36.9 p -67.27 -21.48 65.7 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -120.56 -0.81 10.2 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -171.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -142.8 148.45 46.05 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 125.176 1.39 . . . . 0.0 110.592 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.81 145.33 40.63 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.88 2.387 . . . . 0.0 111.76 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -91.14 153.14 20.27 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.028 1.331 . . . . 0.0 110.442 169.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.53 148.17 47.46 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.882 0.873 . . . . 0.0 113.063 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 43.9 p90 -159.04 149.28 19.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.711 1.604 . . . . 0.0 110.74 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 141.83 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.256 1.822 . . . . 0.0 109.332 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.72 138.14 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.288 1.835 . . . . 0.0 109.634 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 22.0 t0 -136.7 117.64 14.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 111.69 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 12.4 p -123.34 -10.36 8.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -165.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -64.58 -23.62 67.33 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 120.539 1.518 . . . . 0.0 114.526 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -72.43 -19.9 61.51 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.286 1.034 . . . . 0.0 112.785 173.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -90.51 -0.65 57.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.823 1.649 . . . . 0.0 113.672 172.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.46 -120.61 5.31 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.06 1.314 . . . . 0.0 112.196 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -107.25 165.43 11.38 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.016 1.726 . . . . 0.0 112.386 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.59 -178.07 19.14 Favored Glycine 0 N--CA 1.473 1.162 0 N-CA-C 115.229 0.852 . . . . 0.0 115.229 167.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.2 126.44 8.75 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.699 1.142 . . . . 0.0 112.022 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.26 121.25 36.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.289 1.835 . . . . 0.0 108.313 170.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 70.5 m -113.81 146.44 39.94 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.615 1.566 . . . . 0.0 110.867 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -141.34 133.55 27.96 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.42 1.088 . . . . 0.0 110.233 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.5 m -140.39 123.79 16.93 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.697 0.799 . . . . 0.0 110.929 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.16 137.97 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.454 1.502 . . . . 0.0 108.819 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -144.11 157.39 44.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.183 1.393 . . . . 0.0 110.675 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.24 -151.85 22.52 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.788 -174.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.11 -10.73 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.832 3.022 . . . . 0.0 114.881 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.7 t -160.18 168.6 25.06 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 120.001 1.273 . . . . 0.0 112.666 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -67.54 151.14 47.86 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.404 1.481 . . . . 0.0 111.247 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.8 m -135.65 147.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.106 0.963 . . . . 0.0 112.029 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.21 129.82 34.84 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.899 -0.501 . . . . 0.0 109.939 166.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.9 133.91 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.217 1.007 . . . . 0.0 109.174 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -131.35 158.99 39.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.249 1.82 . . . . 0.0 109.923 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 53.0 p -138.25 159.43 42.06 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.709 1.204 . . . . 0.0 111.705 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -154.58 116.01 4.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.587 1.155 . . . . 0.0 110.02 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -78.18 136.19 37.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.979 0.912 . . . . 0.0 111.389 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.79 161.14 15.73 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.126 1.37 . . . . 0.0 111.819 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.28 -15.89 62.95 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.83 -4.76 53.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.988 1.315 . . . . 0.0 112.999 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.31 0.72 84.62 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.727 1.632 . . . . 0.0 114.203 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 20.8 p -83.51 170.46 14.38 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.552 1.941 . . . . 0.0 111.212 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 22.3 t -127.09 126.36 42.87 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.875 0.87 . . . . 0.0 111.056 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 28.1 ttm105 -78.11 140.28 39.04 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.201 1.0 . . . . 0.0 109.345 164.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -121.22 137.46 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.049 1.74 . . . . 0.0 108.24 167.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 4.3 p -135.34 148.93 49.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.323 1.449 . . . . 0.0 111.422 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.04 149.38 21.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.396 1.079 . . . . 0.0 112.218 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 20.4 t -113.78 104.25 55.18 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 123.96 0.904 . . . . 0.0 111.385 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.48 135.41 11.77 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.417 2.745 . . . . 0.0 110.554 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.3 m -89.88 -40.14 12.6 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.785 0.834 . . . . 0.0 112.133 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -92.58 149.5 38.2 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.494 1.118 . . . . 0.0 111.386 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.77 164.88 31.21 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 111.127 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 115.77 -165.01 12.15 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.11 1.338 . . . . 0.0 113.634 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.83 119.18 30.83 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.456 0.702 . . . . 0.0 112.009 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -97.43 141.71 30.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.719 1.207 . . . . 0.0 110.438 163.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -102.1 134.04 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.651 1.181 . . . . 0.0 108.778 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.18 125.45 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.452 1.101 . . . . 0.0 109.173 169.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -99.21 124.73 44.49 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.546 1.538 . . . . 0.0 109.293 173.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 32.3 mm -114.32 122.53 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.222 1.009 . . . . 0.0 108.911 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -128.66 136.75 51.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.517 1.927 . . . . 0.0 110.27 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 31.1 t80 -133.8 126.03 29.72 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.713 1.205 . . . . 0.0 110.463 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 33.07 14.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.888 1.275 . . . . 0.0 112.988 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t0 79.75 2.54 2.14 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.808 2.843 . . . . 0.0 114.44 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.23 133.22 49.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.458 1.103 . . . . 0.0 111.29 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -66.05 122.36 17.22 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.076 1.351 . . . . 0.0 110.668 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -78.91 160.69 71.0 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.146 -0.971 . . . . 0.0 111.651 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.89 138.23 69.12 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.582 2.854 . . . . 0.0 113.141 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.91 -23.15 21.83 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.816 1.198 . . . . 0.0 113.899 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 51.5 m -69.86 144.66 93.58 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.052 1.426 . . . . 0.0 111.327 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.2 137.2 48.81 Favored 'Cis proline' 0 C--N 1.351 0.666 0 CA-C-N 119.618 0.899 . . . . 0.0 111.021 -6.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.35 117.25 28.16 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.98 0.912 . . . . 0.0 110.268 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 18.3 m -83.08 128.75 34.76 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.501 0.721 . . . . 0.0 111.086 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.7 t -124.04 109.83 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.184 1.793 . . . . 0.0 108.957 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -79.05 106.04 10.8 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.344 0.658 . . . . 0.0 111.143 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 73.9 t -87.7 121.19 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 176.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -110.39 165.0 12.14 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.859 1.264 . . . . 0.0 111.576 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 136.09 -137.18 8.92 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.178 1.37 . . . . 0.0 112.692 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -161.81 -178.29 6.4 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.505 1.122 . . . . 0.0 111.381 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -69.43 145.87 43.08 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.044 0.831 . . . . 0.0 111.903 171.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -66.22 132.04 47.52 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.117 0.967 . . . . 0.0 112.654 -171.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 89.9 t -78.21 136.55 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.321 1.449 . . . . 0.0 110.073 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.004 1.722 . . . . 0.0 111.658 178.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.497 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.25 159.95 33.7 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.332 1.053 . . . . 0.0 112.843 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 53.0 mtt 69.89 8.7 6.83 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.96 2.104 . . . . 0.0 114.468 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.58 146.01 35.02 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.714 1.15 . . . . 0.0 112.559 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 41.2 t0 -164.33 172.97 12.79 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.257 1.823 . . . . 0.0 110.767 -175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.32 18.54 0.11 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.851 2.06 . . . . 0.0 114.222 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 38.1 m -75.62 53.69 0.73 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.227 2.211 . . . . 0.0 113.353 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 95.0 mmm -62.69 129.0 38.59 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.855 -1.153 . . . . 0.0 111.14 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 152.08 28.23 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.215 1.006 . . . . 0.0 110.16 172.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.1 ptm -156.94 155.63 31.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.104 0.961 . . . . 0.0 113.296 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.5 m -138.92 152.07 47.43 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.574 1.549 . . . . 0.0 110.207 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -143.92 157.63 44.22 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 9.3 tt -158.78 150.94 21.34 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.017 1.727 . . . . 0.0 110.542 -169.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 94.2 mttt -132.99 148.27 52.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.323 1.049 . . . . 0.0 112.339 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 58.3 t -136.05 131.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.944 1.698 . . . . 0.0 109.57 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -82.43 107.17 2.79 Favored Glycine 0 N--CA 1.47 0.925 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 15.3 m -83.45 -45.19 13.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -166.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 56.98 -161.16 0.21 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.528 1.531 . . . . 0.0 112.865 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -160.68 149.29 16.55 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.231 1.812 . . . . 0.0 110.398 169.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -91.2 124.7 35.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 111.106 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.49 116.56 33.41 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.465 1.106 . . . . 0.0 109.359 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.51 144.4 44.94 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.569 2.179 . . . . 0.0 111.167 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 46.3 mm -120.85 146.19 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.685 1.594 . . . . 0.0 108.417 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -46.92 120.14 2.88 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.861 1.264 . . . . 0.0 113.887 -169.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.49 71.52 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.959 1.303 . . . . 0.0 109.694 -169.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 62.2 p -94.36 -20.38 19.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -163.59 149.08 11.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.062 1.345 . . . . 0.0 111.255 -171.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 38.3 p -76.25 -11.39 59.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.113 1.365 . . . . 0.0 114.666 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -26.83 28.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.454 1.502 . . . . 0.0 113.25 176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -14.36 9.45 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.687 1.195 . . . . 0.0 113.498 173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 16.5 m -73.74 -16.28 61.19 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.94 -1.1 . . . . 0.0 113.922 172.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.51 -7.52 2.52 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.9 mp -71.04 166.52 21.2 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.603 1.561 . . . . 0.0 112.106 168.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 38.5 p -135.61 157.82 45.92 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.024 1.73 . . . . 0.0 110.743 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -146.26 161.77 39.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.217 1.007 . . . . 0.0 113.414 -171.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 37.0 p -132.71 142.01 48.85 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.587 1.955 . . . . 0.0 109.973 176.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 55.3 t -90.72 127.53 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.352 1.061 . . . . 0.0 108.647 170.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.7 t -101.68 109.34 59.09 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.754 1.222 . . . . 0.0 108.027 167.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.35 168.04 24.61 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.74 2.96 . . . . 0.0 110.634 174.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.23 -14.01 41.55 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.103 2.535 . . . . 0.0 113.563 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 63.4 p -78.1 -10.33 59.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.519 1.127 . . . . 0.0 113.752 168.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.57 -1.5 87.68 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.778 1.656 . . . . 0.0 114.952 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -79.15 82.76 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.109 1.364 . . . . 0.0 111.508 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -59.75 132.62 54.51 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.172 1.389 . . . . 0.0 112.051 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -141.65 150.03 55.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.504 1.522 . . . . 0.0 110.701 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.38 152.47 66.12 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.366 2.71 . . . . 0.0 112.242 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 29.1 p -127.96 148.97 50.53 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.586 1.154 . . . . 0.0 111.301 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 60.0 tp -90.13 126.94 35.97 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.335 1.054 . . . . 0.0 110.257 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.93 140.72 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.235 0.614 . . . . 0.0 110.108 170.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -137.41 137.34 38.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.258 1.423 . . . . 0.0 111.801 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -71.91 126.49 29.88 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.3 mt -105.39 163.77 12.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.948 1.299 . . . . 0.0 111.444 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -66.35 -21.62 66.25 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 -160.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 59.3 t30 -88.73 2.59 53.13 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 119.433 1.015 . . . . 0.0 113.221 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.56 -5.36 70.19 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 125.99 1.757 . . . . 0.0 113.787 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -76.8 -178.77 5.01 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.829 1.652 . . . . 0.0 113.199 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 46.9 t -136.07 141.3 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.128 1.371 . . . . 0.0 109.885 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -150.01 179.75 26.5 Favored Glycine 0 N--CA 1.467 0.712 0 N-CA-C 115.178 0.831 . . . . 0.0 115.178 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.9 pp -110.22 161.96 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.11 1.764 . . . . 0.0 111.614 173.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 47.1 t -147.78 135.63 21.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.272 1.429 . . . . 0.0 110.742 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.9 p90 -170.97 -176.73 2.05 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.387 1.875 . . . . 0.0 111.266 -171.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 84.1 t -131.01 125.09 21.01 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.88 1.272 . . . . 0.0 108.999 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.08 145.65 24.85 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.066 3.177 . . . . 0.0 111.209 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.04 1.83 22.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.503 1.121 . . . . 0.0 113.147 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -139.3 172.55 12.66 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.179 2.191 . . . . 0.0 109.989 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.6 p -99.42 165.98 11.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.166 1.386 . . . . 0.0 110.921 168.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 90.23 -163.96 30.58 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.815 1.198 . . . . 0.0 113.523 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.7 120.07 15.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.892 0.877 . . . . 0.0 111.833 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.6 m80 -107.95 145.82 33.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.207 1.803 . . . . 0.0 109.326 169.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.08 126.53 52.47 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.437 1.095 . . . . 0.0 109.87 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 76.8 t -91.48 108.05 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.265 1.426 . . . . 0.0 108.291 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -92.42 124.41 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 110.2 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -124.71 133.21 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.398 1.079 . . . . 0.0 110.651 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.61 145.96 51.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.845 1.258 . . . . 0.0 113.609 -169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.6 tttt -118.82 125.99 50.81 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.546 1.938 . . . . 0.0 109.514 168.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 9.9 t-20 55.83 25.93 9.03 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.914 1.286 . . . . 0.0 113.969 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.74 -0.85 77.49 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.38 1.467 . . . . 0.0 115.762 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -115.51 149.22 38.48 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.399 1.6 . . . . 0.0 111.114 174.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.8 p80 -70.97 147.87 48.24 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.7 t -73.03 151.28 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.684 1.194 . . . . 0.0 109.544 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.42 -26.24 60.83 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 52.8 p -86.93 -8.01 57.64 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.432 1.493 . . . . 0.0 114.062 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.0 t -86.76 146.8 42.0 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.075 1.35 . . . . 0.0 112.696 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.36 157.48 82.56 Favored 'Cis proline' 0 C--N 1.351 0.69 0 CA-C-N 119.281 0.779 . . . . 0.0 112.23 -7.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.31 126.38 32.38 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.063 1.345 . . . . 0.0 109.126 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.18 140.95 14.27 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.925 2.416 . . . . 0.0 111.677 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.5 t -134.33 124.59 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.713 1.605 . . . . 0.0 107.648 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.1 t -99.31 124.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.804 0.842 . . . . 0.0 110.438 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.96 123.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.224 1.41 . . . . 0.0 109.356 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.8 t -89.88 152.82 21.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.61 0.764 . . . . 0.0 111.172 170.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -58.56 -27.98 65.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 21.2 m -71.84 -18.57 62.06 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.043 0.937 . . . . 0.0 112.968 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -89.92 -6.84 55.33 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.101 -0.999 . . . . 0.0 112.769 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.47 -29.84 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.321 1.048 . . . . 0.0 112.194 -177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.33 61.0 0.01 OUTLIER Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.029 0.823 . . . . 0.0 114.213 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -74.41 97.89 3.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 117.769 0.784 . . . . 0.0 110.958 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.86 71.42 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.93 0.892 . . . . 0.0 112.179 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 38.6 p -54.65 -28.62 48.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.816 1.647 . . . . 0.0 114.257 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -90.59 -6.3 54.82 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.236 1.414 . . . . 0.0 113.969 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 73.6 t -73.36 136.5 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.874 1.216 . . . . 0.0 109.719 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -115.47 156.36 25.79 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.463 1.505 . . . . 0.0 110.659 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -145.02 156.37 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.227 1.411 . . . . 0.0 110.782 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.91 167.62 28.92 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.164 0.986 . . . . 0.0 112.451 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.74 156.38 22.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.413 1.482 . . . . 0.0 113.555 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -71.18 -25.86 62.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.513 1.125 . . . . 0.0 113.24 -170.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.68 -3.34 33.66 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.808 1.194 . . . . 0.0 115.38 -175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.8 mt -89.89 -5.15 57.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.778 1.631 . . . . 0.0 112.843 169.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -133.8 -40.71 0.85 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.784 1.234 . . . . 0.0 113.798 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -141.15 149.77 41.92 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.268 1.427 . . . . 0.0 111.009 -176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.12 175.47 27.41 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.269 0.938 . . . . 0.0 114.139 175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.2 m80 -134.85 151.74 51.17 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.401 1.48 . . . . 0.0 111.678 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.6 p -69.08 -45.49 70.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -98.6 -5.73 31.32 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -167.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -123.4 147.82 53.64 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 126.054 1.742 . . . . 0.0 110.196 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.12 136.41 29.35 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.588 2.192 . . . . 0.0 110.645 175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.11 152.91 23.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.352 1.061 . . . . 0.0 109.996 166.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.86 151.54 47.07 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.4 p90 -158.85 150.91 21.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.675 1.59 . . . . 0.0 110.81 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.98 139.94 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 125.846 1.658 . . . . 0.0 109.243 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.77 136.41 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.38 1.472 . . . . 0.0 108.771 167.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.6 t0 -120.57 98.23 5.93 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.201 1.8 . . . . 0.0 110.272 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 20.7 p -91.9 -4.76 54.31 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.567 1.947 . . . . 0.0 113.144 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -59.32 -35.73 74.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.308 1.043 . . . . 0.0 112.588 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.38 -11.6 59.24 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.035 1.334 . . . . 0.0 113.493 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.45 -3.57 56.48 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.472 1.509 . . . . 0.0 114.557 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.67 -147.0 23.74 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.457 1.027 . . . . 0.0 111.753 -174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -78.11 172.09 14.05 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.442 1.097 . . . . 0.0 112.611 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 135.31 -162.09 24.77 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 124.901 1.238 . . . . 0.0 113.937 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -141.12 143.88 13.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.604 1.573 . . . . 0.0 112.719 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.45 123.83 46.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.485 1.914 . . . . 0.0 109.643 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.1 m -111.95 144.29 41.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.857 1.663 . . . . 0.0 110.314 170.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.9 tt -146.8 146.36 30.22 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.5 0.72 . . . . 0.0 110.988 -165.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 90.2 p -148.53 152.9 37.64 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.366 0.603 . . . . 0.0 112.338 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.5 mt -123.87 129.83 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.134 1.374 . . . . 0.0 107.856 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -123.57 147.21 47.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.355 1.862 . . . . 0.0 109.713 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 176.97 -166.8 37.74 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.59 -11.51 24.3 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.337 3.358 . . . . 0.0 113.726 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 21.3 m -152.98 161.26 42.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.084 1.754 . . . . 0.0 111.218 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -68.51 146.98 52.64 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.979 0.912 . . . . 0.0 111.589 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 29.6 m -129.55 148.39 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.986 1.314 . . . . 0.0 110.911 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.44 110.66 21.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.52 0.728 . . . . 0.0 110.075 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 33.1 mt -87.12 129.9 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.189 0.995 . . . . 0.0 109.444 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -123.93 161.62 25.03 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.579 1.952 . . . . 0.0 110.428 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 7.1 p -142.27 158.03 44.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.964 1.306 . . . . 0.0 112.509 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -151.38 117.07 5.43 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.291 1.436 . . . . 0.0 109.835 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.21 128.65 34.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.479 1.112 . . . . 0.0 110.328 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 74.8 mt -102.57 153.68 19.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.485 1.114 . . . . 0.0 111.981 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -60.2 -28.42 67.96 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.619 1.167 . . . . 0.0 113.323 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -71.79 -9.38 58.22 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.806 1.242 . . . . 0.0 113.589 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.08 -0.27 66.48 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.963 1.744 . . . . 0.0 114.162 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.1 p -88.12 170.45 11.05 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.554 1.942 . . . . 0.0 111.179 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.5 t -129.59 124.5 33.94 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.721 0.808 . . . . 0.0 111.663 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -82.28 137.56 34.8 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.238 1.415 . . . . 0.0 110.016 169.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 94.4 t -116.18 140.12 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.28 1.832 . . . . 0.0 108.465 166.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.78 149.91 50.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.688 1.595 . . . . 0.0 111.179 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 17.6 p90 -162.53 147.73 12.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.909 1.284 . . . . 0.0 111.606 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 t -112.1 101.69 52.36 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.227 1.011 . . . . 0.0 110.521 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -82.14 86.54 1.52 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.6 2.867 . . . . 0.0 110.544 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.5 m -56.57 -39.11 72.93 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.184 1.394 . . . . 0.0 113.825 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -96.57 141.66 23.42 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.343 1.057 . . . . 0.0 110.699 175.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.23 166.12 29.58 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.518 2.812 . . . . 0.0 112.214 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.02 -162.37 24.48 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.205 1.384 . . . . 0.0 113.574 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -95.68 125.31 40.18 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.751 0.82 . . . . 0.0 111.126 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.3 142.59 41.71 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.23 1.412 . . . . 0.0 110.485 171.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.0 mp -108.25 131.57 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.961 1.305 . . . . 0.0 108.389 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 17.6 mt -114.87 127.76 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.654 1.181 . . . . 0.0 109.468 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -103.84 127.17 51.35 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.191 1.396 . . . . 0.0 110.477 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -118.65 119.03 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.976 1.31 . . . . 0.0 109.41 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.3 tttt -135.67 123.96 23.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.325 1.45 . . . . 0.0 110.256 -168.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.5 t80 -121.89 127.52 50.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.702 1.201 . . . . 0.0 110.742 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.82 34.15 12.7 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.113 1.365 . . . . 0.0 113.409 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 16.2 t70 88.2 -1.84 0.47 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.428 3.091 . . . . 0.0 114.138 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -110.75 134.28 52.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 112.111 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.4 126.81 29.42 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.941 1.297 . . . . 0.0 111.094 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.9 m -76.51 153.91 83.74 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.962 . . . . 0.0 111.193 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -63.55 138.91 67.4 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.538 2.159 . . . . 0.0 111.178 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.63 -27.32 14.45 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.306 1.431 . . . . 0.0 113.216 -171.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 11.4 t -76.7 144.23 72.87 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.09 0.945 . . . . 0.0 110.663 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.03 149.09 86.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 120.092 1.069 . . . . 0.0 112.035 0.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -102.95 119.52 38.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.766 1.226 . . . . 0.0 110.744 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 72.2 m -88.95 129.99 35.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.001 0.92 . . . . 0.0 110.776 172.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 12.9 t -124.48 115.52 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.47 1.508 . . . . 0.0 109.782 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 61.7 tttp -80.09 112.29 17.25 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.065 0.546 . . . . 0.0 110.709 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 93.5 t -98.05 121.11 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.017 1.327 . . . . 0.0 109.025 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.6 t -108.69 157.6 18.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.698 1.199 . . . . 0.0 111.479 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 165.17 172.34 32.5 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.27 0.938 . . . . 0.0 114.606 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -78.46 -21.5 48.97 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.504 1.121 . . . . 0.0 112.92 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 86.38 -1.2 87.39 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.887 1.232 . . . . 0.0 114.958 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 80.36 161.4 0.17 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.104 2.562 . . . . 0.0 112.257 173.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 8.3 p -53.12 143.72 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.524 1.53 . . . . 0.0 112.286 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.092 1.757 . . . . 0.0 112.847 -170.648 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 112.146 -0.381 . . . . 0.0 112.146 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.1 164.86 26.07 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.558 1.143 . . . . 0.0 112.855 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.4 mmt -69.57 141.8 53.72 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.151 0.98 . . . . 0.0 111.932 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -89.3 176.91 43.86 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.878 1.228 . . . . 0.0 113.55 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -76.92 -9.68 58.85 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.986 1.314 . . . . 0.0 113.708 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 16.2 t0 -145.62 134.16 22.06 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.51 1.924 . . . . 0.0 110.279 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 55.6 p -97.84 -11.72 22.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.271 1.428 . . . . 0.0 114.229 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 89.5 mtp -66.29 150.58 48.62 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 9.3 tpt85 -149.96 149.21 30.07 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.314 1.446 . . . . 0.0 111.078 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 94.8 mtp -96.33 142.12 28.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.883 1.273 . . . . 0.0 111.727 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 7.4 m -122.26 137.43 54.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.637 1.975 . . . . 0.0 108.414 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.0 t60 -143.23 145.59 32.9 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.375 0.989 . . . . 0.0 113.547 -165.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.38 155.47 30.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.982 1.713 . . . . 0.0 111.183 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 56.7 mttp -132.67 150.46 52.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.598 1.159 . . . . 0.0 112.597 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.0 t -139.87 137.12 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.392 1.877 . . . . 0.0 109.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -89.33 120.13 5.67 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 170.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.0 m -106.59 143.45 34.68 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 112.027 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.57 152.17 23.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.872 0.869 . . . . 0.0 113.025 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.47 148.45 26.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.167 0.987 . . . . 0.0 111.028 166.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.37 146.5 28.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.254 1.022 . . . . 0.0 112.494 173.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.33 120.05 20.9 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 124.824 1.25 . . . . 0.0 108.791 170.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -78.69 137.64 14.49 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.366 2.711 . . . . 0.0 110.956 176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 48.9 mt -146.15 138.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.206 1.402 . . . . 0.0 109.985 -171.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 51.7 t30 55.1 64.52 1.77 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.918 1.687 . . . . 0.0 112.359 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 11.2 mm -71.67 105.06 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.39 1.076 . . . . 0.0 110.95 -168.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 11.8 t -171.94 177.82 3.16 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.751 2.02 . . . . 0.0 110.221 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.72 57.18 3.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.528 1.531 . . . . 0.0 111.049 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 39.6 p -75.77 153.27 37.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.244 1.418 . . . . 0.0 112.28 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -98.44 111.63 23.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.799 1.24 . . . . 0.0 110.485 175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.68 -12.3 61.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.124 0.97 . . . . 0.0 113.053 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 66.6 m -77.12 -16.96 58.98 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.746 1.157 . . . . 0.0 113.948 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.3 pp -116.65 3.8 13.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.254 1.422 . . . . 0.0 114.057 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.02 146.02 37.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 0.0 110.972 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 56.0 p -140.12 168.01 20.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 126.532 1.933 . . . . 0.0 109.666 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 152.6 31.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.785 0.834 . . . . 0.0 112.596 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 67.3 p -138.85 157.52 45.91 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.523 1.929 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -109.93 133.45 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.646 1.178 . . . . 0.0 109.495 169.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 89.9 t -102.43 110.5 63.0 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.776 1.23 . . . . 0.0 107.748 164.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.87 169.65 21.29 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.686 2.924 . . . . 0.0 110.838 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.01 -15.17 46.15 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.971 2.448 . . . . 0.0 113.28 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 62.3 p -80.33 -9.61 59.74 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.828 1.251 . . . . 0.0 113.916 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.03 -1.72 83.66 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.736 1.636 . . . . 0.0 115.118 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -78.98 83.1 5.1 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.181 1.392 . . . . 0.0 111.643 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -58.77 135.42 57.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.755 1.222 . . . . 0.0 112.383 -175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -139.48 151.05 65.85 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.47 1.508 . . . . 0.0 111.128 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.5 155.04 35.98 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.738 2.959 . . . . 0.0 112.704 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 74.6 m -105.66 154.94 19.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.145 1.378 . . . . 0.0 111.794 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.1 tt -97.8 119.16 35.91 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.191 1.396 . . . . 0.0 108.586 175.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.73 136.64 34.1 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.506 1.122 . . . . 0.0 110.886 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 66.9 mttm -136.94 141.22 42.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.725 1.21 . . . . 0.0 113.098 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -87.02 120.34 28.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.598 1.159 . . . . 0.0 107.981 157.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.4 mt -98.86 171.44 8.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.842 1.257 . . . . 0.0 112.969 -166.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -60.96 -20.41 62.28 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.749 2.02 . . . . 0.0 116.381 -169.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.08 5.76 46.85 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.272 1.029 . . . . 0.0 112.971 175.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 88.01 -3.75 85.72 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.58 1.562 . . . . 0.0 114.25 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.02 164.03 21.71 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.038 1.735 . . . . 0.0 113.426 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 82.6 t -102.56 141.43 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.212 1.405 . . . . 0.0 110.15 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -158.33 -168.17 20.2 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.264 0.935 . . . . 0.0 114.807 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.66 167.08 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.441 1.496 . . . . 0.0 112.264 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 98.9 p -139.08 159.85 41.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.923 1.289 . . . . 0.0 111.432 162.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 10.2 p90 -164.07 -178.46 5.6 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.026 2.13 . . . . 0.0 109.778 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -129.47 122.9 21.09 Favored Pre-proline 0 N--CA 1.482 1.135 0 CA-C-N 119.44 1.018 . . . . 0.0 110.171 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.86 141.58 15.23 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.322 3.348 . . . . 0.0 111.223 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -94.82 -32.9 13.07 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.7 0.8 . . . . 0.0 112.842 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -111.2 172.1 7.08 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.173 1.789 . . . . 0.0 111.096 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.6 p -90.86 164.21 14.13 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.838 1.255 . . . . 0.0 111.015 165.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 101.31 -166.68 18.78 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.123 1.344 . . . . 0.0 113.856 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.94 116.86 16.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.021 0.928 . . . . 0.0 111.866 -173.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 16.2 m80 -103.77 142.83 33.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.48 1.912 . . . . 0.0 109.44 170.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.84 123.14 47.73 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.571 1.148 . . . . 0.0 109.206 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 35.2 t -90.55 112.57 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.872 1.269 . . . . 0.0 108.583 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -92.98 138.23 31.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.875 1.27 . . . . 0.0 110.531 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 66.6 t -130.46 128.43 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.672 0.789 . . . . 0.0 109.511 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -126.23 134.76 51.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.114 1.366 . . . . 0.0 112.569 -166.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 84.9 tttt -128.45 129.05 45.57 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 110.162 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 53.08 30.53 9.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.627 1.171 . . . . 0.0 114.056 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.89 5.26 71.26 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.033 1.302 . . . . 0.0 116.019 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -134.62 149.26 50.55 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.665 1.733 . . . . 0.0 111.855 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -70.03 140.65 52.88 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 120.945 -1.097 . . . . 0.0 112.877 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 21.2 m -76.33 153.07 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.834 0.854 . . . . 0.0 111.527 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -62.77 -23.66 67.33 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 62.1 p -84.78 -3.42 58.61 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.843 1.257 . . . . 0.0 114.034 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 1.7 p -118.48 160.18 40.88 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.685 1.194 . . . . 0.0 112.757 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.0 156.17 98.7 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.48 0.85 . . . . 0.0 113.078 0.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.39 124.6 33.45 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.816 1.647 . . . . 0.0 108.954 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -80.84 139.34 12.2 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.193 2.595 . . . . 0.0 111.381 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.3 t -135.55 124.69 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.585 1.554 . . . . 0.0 108.157 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -97.23 122.47 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.757 0.823 . . . . 0.0 110.118 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.51 126.58 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.152 1.381 . . . . 0.0 109.871 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -90.28 168.54 11.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.793 1.237 . . . . 0.0 112.121 172.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -66.58 -32.12 73.25 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.332 -1.48 . . . . 0.0 112.978 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.9 m -72.28 -5.31 35.18 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.81 5.73 14.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.069 1.347 . . . . 0.0 113.207 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.43 -31.21 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.143 0.977 . . . . 0.0 112.24 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 164.27 51.05 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.762 0.665 . . . . 0.0 114.762 -174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.95 92.54 4.31 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.151 0.976 . . . . 0.0 111.393 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.69 76.99 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.697 0.799 . . . . 0.0 112.054 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -56.71 -24.98 53.13 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.343 1.457 . . . . 0.0 113.994 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -90.61 -7.05 53.79 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.15 1.38 . . . . 0.0 113.802 175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 58.0 t -77.8 129.85 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.975 1.261 . . . . 0.0 109.741 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -105.69 156.34 18.38 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.708 1.603 . . . . 0.0 110.687 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.0 m -143.45 151.63 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.056 1.343 . . . . 0.0 110.731 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 57.2 m -149.13 166.49 28.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.309 1.443 . . . . 0.0 112.014 -174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.04 157.56 26.27 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.479 1.038 . . . . 0.0 113.929 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -78.88 -18.95 53.09 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -166.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.54 -4.64 46.59 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.69 1.138 . . . . 0.0 114.788 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.45 -4.88 58.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.714 1.605 . . . . 0.0 112.686 168.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -126.88 -36.57 2.19 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.077 1.351 . . . . 0.0 113.668 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -155.67 156.7 35.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.225 1.01 . . . . 0.0 113.093 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -146.07 -171.88 15.92 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.71 1.624 . . . . 0.0 113.207 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -147.22 145.17 29.37 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.968 0.907 . . . . 0.0 113.399 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 41.3 p -66.09 -23.69 66.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -114.96 1.57 14.03 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.5 139.96 31.0 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.29 1.436 . . . . 0.0 110.095 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.84 144.59 54.08 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.335 2.023 . . . . 0.0 110.547 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -104.11 158.67 16.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.102 1.361 . . . . 0.0 110.711 173.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 158.71 44.16 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -155.45 153.73 30.79 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.449 1.9 . . . . 0.0 110.114 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.63 138.8 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.687 1.595 . . . . 0.0 108.943 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 44.3 mt -110.2 135.06 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.097 1.759 . . . . 0.0 108.756 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 61.6 t0 -123.01 97.5 5.46 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.961 1.704 . . . . 0.0 110.46 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 19.7 p -94.02 0.73 56.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 113.177 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -59.48 -38.79 81.76 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.524 1.056 . . . . 0.0 113.069 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.59 -23.52 45.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.103 0.961 . . . . 0.0 113.032 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -81.36 -11.81 59.18 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.114 1.366 . . . . 0.0 113.737 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 84.2 -121.6 5.59 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.007 1.289 . . . . 0.0 112.335 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.49 163.93 12.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.542 1.537 . . . . 0.0 112.203 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 145.45 174.24 17.48 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 115.219 0.848 . . . . 0.0 115.219 168.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -89.64 122.86 6.67 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.339 0.971 . . . . 0.0 111.424 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.1 tm? -98.08 112.16 24.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.849 1.66 . . . . 0.0 107.718 171.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.6 m -104.9 145.55 30.24 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.724 0.81 . . . . 0.0 109.966 168.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.78 137.19 29.55 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.741 0.817 . . . . 0.0 109.762 -166.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.2 p -140.87 150.5 43.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.85 0.833 . . . . 0.0 112.497 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.42 133.84 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.49 1.516 . . . . 0.0 107.235 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -142.27 139.14 31.82 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.645 0.778 . . . . 0.0 110.827 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 179.46 -161.31 27.23 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.451 -1.194 . . . . 0.0 113.033 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.06 -5.61 15.13 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.291 3.327 . . . . 0.0 114.753 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.6 t -157.71 168.18 27.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.754 1.222 . . . . 0.0 111.456 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -69.33 149.14 48.77 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.364 1.066 . . . . 0.0 111.093 171.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.5 m -127.58 150.19 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.036 1.334 . . . . 0.0 110.647 171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -91.04 109.17 20.41 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.49 0.716 . . . . 0.0 109.692 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 26.8 mt -85.4 131.74 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.195 0.998 . . . . 0.0 109.432 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -128.08 164.03 23.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.664 1.986 . . . . 0.0 110.471 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -142.59 155.53 44.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.996 1.318 . . . . 0.0 112.073 -173.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.37 114.88 4.52 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.378 1.471 . . . . 0.0 110.067 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -77.37 130.68 37.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.666 1.186 . . . . 0.0 110.967 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 75.6 mt -103.3 151.34 22.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.6 1.16 . . . . 0.0 111.705 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.95 -19.6 65.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.304 1.042 . . . . 0.0 113.659 -175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.63 -5.95 54.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 113.109 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 97.24 1.38 59.41 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.87 1.7 . . . . 0.0 114.738 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 168.92 10.95 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.366 1.866 . . . . 0.0 111.399 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 49.1 t -125.33 124.61 41.96 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.972 0.909 . . . . 0.0 111.543 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -84.07 134.96 34.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.136 1.375 . . . . 0.0 109.54 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 46.3 t -115.91 137.24 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.743 1.617 . . . . 0.0 108.363 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.85 149.18 50.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.472 1.909 . . . . 0.0 110.769 -177.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 23.3 p90 -160.4 155.91 25.27 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.396 1.078 . . . . 0.0 112.668 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.2 p -124.61 97.01 39.95 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.17 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.91 143.31 20.61 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.184 2.589 . . . . 0.0 110.345 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 88.7 m -112.11 -44.11 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 0.0 112.135 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -83.42 141.37 42.3 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.471 0.708 . . . . 0.0 110.419 173.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.98 162.54 34.48 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.28 2.653 . . . . 0.0 111.092 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.47 -144.04 15.89 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.811 1.196 . . . . 0.0 112.144 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -123.53 131.65 53.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.633 0.773 . . . . 0.0 111.779 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -110.21 139.0 45.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.766 1.626 . . . . 0.0 109.977 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.61 134.28 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.85 1.26 . . . . 0.0 108.447 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.67 127.84 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.214 1.406 . . . . 0.0 108.86 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -109.96 119.96 40.95 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.028 1.331 . . . . 0.0 109.871 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.5 mm -107.68 114.43 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 121.749 0.785 . . . . 0.0 108.955 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.57 118.0 23.1 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.21 1.004 . . . . 0.0 111.695 -170.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 16.8 t80 -112.7 131.62 55.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.68 1.192 . . . . 0.0 110.259 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.99 35.35 21.78 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.466 1.506 . . . . 0.0 114.283 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 75.05 10.14 3.8 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.386 2.275 . . . . 0.0 114.24 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -95.57 -128.8 0.14 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.127 1.371 . . . . 0.0 110.465 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -168.13 125.19 1.09 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.558 2.343 . . . . 0.0 108.69 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -76.91 151.57 82.16 Favored Pre-proline 0 N--CA 1.488 1.433 0 CA-C-N 120.044 1.293 . . . . 0.0 110.843 -170.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.34 135.24 52.78 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.568 2.178 . . . . 0.0 110.996 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 100.83 -27.02 22.49 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.39 1.471 . . . . 0.0 113.744 -173.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 50.9 m -74.57 150.37 86.74 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 118.972 1.386 . . . . 0.0 111.67 170.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.02 141.17 69.75 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 119.205 0.752 . . . . 0.0 111.208 -3.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -95.57 115.3 27.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.046 0.938 . . . . 0.0 110.378 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 66.4 m -87.63 121.13 29.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.988 0.915 . . . . 0.0 110.359 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -120.32 115.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.662 1.585 . . . . 0.0 109.922 -168.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.92 122.22 26.41 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.963 0.505 . . . . 0.0 111.304 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 76.1 t -106.64 117.72 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.444 1.498 . . . . 0.0 108.93 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.1 t -105.26 174.6 5.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.176 1.39 . . . . 0.0 111.523 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 133.89 -134.09 7.26 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.138 1.352 . . . . 0.0 112.694 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -160.09 176.15 12.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.583 1.153 . . . . 0.0 111.159 -169.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -67.87 138.06 32.82 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.266 -0.896 . . . . 0.0 111.589 171.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -67.83 143.88 55.59 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.381 1.073 . . . . 0.0 112.79 -172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 31.5 m -127.82 163.96 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.656 1.982 . . . . 0.0 110.914 175.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.254 1.34 0 C-N-CA 124.787 1.235 . . . . 0.0 112.051 178.935 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.2 -22.58 61.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 95.8 mtp -130.37 145.74 51.84 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.835 1.654 . . . . 0.0 110.976 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -106.18 -158.2 22.05 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.421 1.486 . . . . 0.0 113.562 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 31.3 t0 -158.97 165.74 33.38 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.833 2.053 . . . . 0.0 110.414 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -65.11 157.91 27.3 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.372 1.069 . . . . 0.0 112.825 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 86.8 p -157.74 161.51 38.49 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.731 1.212 . . . . 0.0 112.324 -170.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 4.6 ppp? -76.36 148.36 37.47 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.605 -0.685 . . . . 0.0 110.568 164.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.23 153.11 39.27 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.935 1.294 . . . . 0.0 110.595 174.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 25.3 ptt? -148.4 162.66 39.13 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.888 1.675 . . . . 0.0 110.975 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 68.7 m -113.78 150.01 34.07 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.274 1.03 . . . . 0.0 109.845 167.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -144.88 160.26 41.58 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . 0.419 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -155.3 155.41 33.7 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.277 1.831 . . . . 0.0 110.402 -169.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . 0.419 ' H ' HD13 ' A' 1963 ' ' LEU . 68.4 mttm -137.92 150.62 47.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.117 1.367 . . . . 0.0 111.639 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 14.6 p -155.76 139.39 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.703 1.201 . . . . 0.0 110.818 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -83.08 129.06 8.84 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.813 0.72 . . . . 0.0 111.405 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 44.0 m -113.41 137.41 51.58 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.544 1.137 . . . . 0.0 111.403 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.47 141.58 12.07 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.267 1.027 . . . . 0.0 111.957 -176.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -73.26 148.25 43.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.872 0.869 . . . . 0.0 111.215 168.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.68 139.53 30.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.144 0.977 . . . . 0.0 112.63 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 72.9 mt -121.55 123.4 27.57 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.521 1.528 . . . . 0.0 108.796 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.55 152.6 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.109 2.54 . . . . 0.0 111.889 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.09 147.23 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.382 1.473 . . . . 0.0 111.037 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 35.4 t30 56.96 77.37 0.27 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.22 1.808 . . . . 0.0 112.159 -174.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 20.3 mm -77.99 73.81 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.382 1.073 . . . . 0.0 109.349 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 6.6 m -172.69 -177.54 1.71 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.818 2.847 . . . . 0.0 109.383 -169.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -59.09 121.96 12.57 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.133 -0.979 . . . . 0.0 111.256 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 22.3 m -139.8 142.51 36.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.265 1.826 . . . . 0.0 109.153 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 64.5 t0 -126.94 120.53 29.34 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.932 1.293 . . . . 0.0 110.242 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.18 -10.25 59.75 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.586 1.154 . . . . 0.0 113.922 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 11.8 t -64.91 -31.26 72.4 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.631 1.105 . . . . 0.0 113.627 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.1 pt? -120.23 9.41 11.06 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.524 1.53 . . . . 0.0 113.961 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.46 145.18 25.89 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.087 1.355 . . . . 0.0 112.178 -178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -141.25 163.43 32.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.783 2.033 . . . . 0.0 109.371 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.28 146.78 23.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.7 p -139.25 161.77 36.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.841 2.056 . . . . 0.0 109.993 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.7 t -117.32 138.5 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.368 1.467 . . . . 0.0 110.253 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 93.5 t -105.76 112.94 64.4 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 108.246 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.82 171.94 12.62 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.916 3.077 . . . . 0.0 111.605 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.89 -28.5 31.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.706 3.604 . . . . 0.0 115.199 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 60.4 p -81.27 -9.61 59.74 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.25 -2.0 73.07 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.451 1.5 . . . . 0.0 114.766 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -75.43 89.19 2.65 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.309 1.444 . . . . 0.0 110.967 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.3 133.53 56.19 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.078 0.951 . . . . 0.0 111.944 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -129.16 145.83 58.3 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.806 1.642 . . . . 0.0 110.317 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.7 151.17 31.86 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.393 2.729 . . . . 0.0 111.712 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.1 m -95.61 149.63 21.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.215 1.006 . . . . 0.0 111.736 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 62.8 tp -82.25 128.66 34.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 159.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 24.7 mt -95.89 141.58 29.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.58 1.152 . . . . 0.0 110.551 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 88.8 mttt -136.78 144.66 43.87 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.502 1.521 . . . . 0.0 111.891 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -98.1 117.68 33.01 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.646 1.178 . . . . 0.0 107.851 159.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.61 175.15 6.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.853 1.661 . . . . 0.0 112.597 -166.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -56.97 -35.32 69.02 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.471 1.509 . . . . 0.0 114.692 -166.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.51 3.88 53.91 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 124.608 1.163 . . . . 0.0 113.211 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.33 -9.81 71.74 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.394 1.473 . . . . 0.0 114.209 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -73.17 163.57 27.94 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.681 1.592 . . . . 0.0 113.282 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 59.8 t -108.77 144.05 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.249 1.42 . . . . 0.0 110.47 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -146.14 171.49 27.03 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.607 1.098 . . . . 0.0 115.367 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -118.94 152.96 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.072 1.749 . . . . 0.0 111.898 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 13.6 m -132.65 148.56 52.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.7 1.6 . . . . 0.0 110.235 168.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.8 p90 -164.58 162.01 21.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.224 1.41 . . . . 0.0 111.296 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 93.1 t -102.3 119.5 56.18 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 123.938 0.895 . . . . 0.0 109.32 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.12 145.18 24.3 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.236 3.29 . . . . 0.0 110.586 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -108.72 0.41 20.51 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.076 0.95 . . . . 0.0 113.411 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -143.15 179.59 6.97 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.395 2.278 . . . . 0.0 109.698 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -105.09 158.44 16.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.068 1.347 . . . . 0.0 110.452 163.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.36 -164.61 16.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.303 1.43 . . . . 0.0 113.341 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.2 111.5 8.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.354 1.062 . . . . 0.0 111.944 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.7 m80 -95.32 140.55 30.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.466 1.507 . . . . 0.0 109.428 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.58 121.56 42.63 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.99 0.916 . . . . 0.0 109.116 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 44.6 t -86.86 131.76 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.013 1.325 . . . . 0.0 108.349 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 47.1 m-70 -116.4 119.24 35.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.363 1.465 . . . . 0.0 109.818 172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 64.5 t -107.89 134.95 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.854 1.262 . . . . 0.0 109.196 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 80.6 mttt -119.77 149.68 41.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.156 1.382 . . . . 0.0 113.091 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -126.41 118.21 24.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.44 2.296 . . . . 0.0 109.042 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 58.01 21.19 7.53 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 124.862 1.265 . . . . 0.0 114.22 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 101.52 -12.26 58.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.916 1.722 . . . . 0.0 115.79 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -99.66 160.72 14.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.508 1.654 . . . . 0.0 111.222 171.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 30.0 p80 -65.04 153.2 41.43 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.106 -0.996 . . . . 0.0 112.954 170.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -88.71 154.47 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.721 0.809 . . . . 0.0 110.62 168.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -61.74 -21.73 64.78 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -175.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 67.1 m -82.33 -15.52 52.55 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 19.9 m -84.28 153.21 62.35 Favored Pre-proline 0 N--CA 1.475 0.815 0 O-C-N 120.813 -1.18 . . . . 0.0 113.902 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.87 153.73 86.8 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 118.387 0.459 . . . . 0.0 111.812 -5.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.82 123.01 39.1 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.898 1.279 . . . . 0.0 109.273 177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.98 139.18 11.89 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.082 2.522 . . . . 0.0 111.591 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 34.5 t -135.72 120.42 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.454 1.502 . . . . 0.0 108.352 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 62.0 t -92.78 122.46 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.712 0.805 . . . . 0.0 110.271 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.89 133.29 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.014 1.326 . . . . 0.0 109.656 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 27.4 t -104.65 158.69 16.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.4 1.08 . . . . 0.0 111.198 169.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -59.36 -29.84 67.97 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.344 -0.847 . . . . 0.0 112.72 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 16.8 m -65.41 -13.73 59.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.479 1.112 . . . . 0.0 113.653 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -93.75 -8.12 41.62 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.631 1.172 . . . . 0.0 112.471 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 21.2 mt -113.2 116.77 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.516 1.053 . . . . 0.0 110.624 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 70.9 13.35 72.23 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 116.955 1.542 . . . . 0.0 116.955 157.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -74.52 94.12 2.57 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.642 1.721 . . . . 0.0 110.748 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.45 -36.36 71.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.753 1.221 . . . . 0.0 112.735 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.5 m -54.67 -24.72 23.07 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.515 1.526 . . . . 0.0 114.184 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -86.36 -13.76 45.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.036 1.335 . . . . 0.0 113.469 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.4 t -77.55 134.73 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 119.43 1.014 . . . . 0.0 110.003 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -122.16 159.74 26.58 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.446 1.499 . . . . 0.0 110.741 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 32.8 m -147.35 159.07 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.107 1.363 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -158.09 169.93 23.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.342 1.057 . . . . 0.0 112.437 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.38 159.25 24.05 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.296 1.427 . . . . 0.0 113.79 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.52 -27.84 64.49 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.502 1.121 . . . . 0.0 113.362 -169.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.09 -2.73 33.26 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.854 1.216 . . . . 0.0 115.294 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 88.6 mt -88.82 -7.08 56.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.942 1.697 . . . . 0.0 112.66 168.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -133.72 -39.81 0.88 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.996 1.318 . . . . 0.0 113.915 -172.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -140.09 148.48 41.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.189 1.395 . . . . 0.0 111.482 -176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.7 178.3 28.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.619 1.104 . . . . 0.0 114.203 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.9 m80 -136.83 149.64 47.85 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.735 1.614 . . . . 0.0 111.655 -177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 18.1 p -71.9 -32.6 67.56 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -177.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -115.54 6.73 14.72 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -138.36 144.39 42.63 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.832 1.653 . . . . 0.0 109.462 174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.57 140.93 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.677 2.252 . . . . 0.0 111.19 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -87.67 151.56 22.84 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.733 1.213 . . . . 0.0 109.976 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.14 150.01 48.89 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.112 0.965 . . . . 0.0 113.147 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 152.42 27.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.054 1.341 . . . . 0.0 111.333 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.6 mp -110.88 142.22 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.494 1.918 . . . . 0.0 109.823 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 47.6 mt -114.46 133.59 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.975 1.71 . . . . 0.0 109.595 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 8.6 t0 -117.42 112.03 20.12 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.781 2.032 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 10.1 p -120.79 -3.71 9.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.537 1.535 . . . . 0.0 113.967 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -29.11 69.76 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.144 1.338 . . . . 0.0 113.47 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.09 -18.15 53.87 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.669 1.187 . . . . 0.0 112.867 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.99 -5.15 56.96 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.372 1.469 . . . . 0.0 113.818 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.09 -106.15 2.75 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.93 1.252 . . . . 0.0 111.816 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -129.73 145.64 51.53 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.442 1.497 . . . . 0.0 112.807 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 158.22 175.63 29.36 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.92 0.772 . . . . 0.0 114.76 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -87.5 121.7 5.95 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.143 0.878 . . . . 0.0 111.056 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.45 123.29 35.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.184 1.393 . . . . 0.0 108.022 171.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 8.4 t -119.73 145.24 46.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.494 1.918 . . . . 0.0 109.791 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.0 tt -145.32 144.24 30.62 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.716 0.807 . . . . 0.0 110.846 -165.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 89.4 p -148.13 153.92 39.49 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.78 131.42 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.724 1.61 . . . . 0.0 108.539 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.64 153.14 49.9 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.723 1.609 . . . . 0.0 110.513 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 166.93 -153.45 23.12 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.096 -175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.5 -10.51 28.13 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.913 3.076 . . . . 0.0 114.31 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -157.39 168.0 28.61 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.594 1.088 . . . . 0.0 112.238 173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -71.52 150.0 45.23 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.609 1.163 . . . . 0.0 111.087 171.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 19.2 m -130.59 152.11 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.565 1.146 . . . . 0.0 111.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -81.47 126.32 31.52 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.58 -0.7 . . . . 0.0 109.832 165.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.2 mt -106.78 132.67 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.901 0.88 . . . . 0.0 109.191 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -129.73 155.23 46.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.367 1.867 . . . . 0.0 109.533 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.33 158.57 43.81 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.61 1.164 . . . . 0.0 111.553 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -154.53 128.64 8.92 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 0.0 110.94 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.63 118.64 22.38 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.439 1.096 . . . . 0.0 109.95 171.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.77 160.35 18.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.14 0.976 . . . . 0.0 111.805 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.15 -20.97 66.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.97 0.908 . . . . 0.0 113.138 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -79.48 -12.53 59.88 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.863 1.265 . . . . 0.0 113.361 174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.45 -1.56 62.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.557 1.551 . . . . 0.0 114.836 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 15.1 p -81.6 162.27 23.17 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.731 1.612 . . . . 0.0 111.259 170.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.2 t -108.51 123.81 49.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.925 0.89 . . . . 0.0 110.751 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 29.9 ttm105 -82.91 137.68 34.13 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.17 0.988 . . . . 0.0 109.342 165.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 24.3 t -120.64 137.36 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.781 1.632 . . . . 0.0 108.468 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.4 p -137.61 146.07 43.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.365 1.466 . . . . 0.0 111.56 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -160.43 150.21 17.76 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.534 1.134 . . . . 0.0 112.563 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.4 t -111.93 104.69 56.24 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 124.107 0.963 . . . . 0.0 110.886 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.67 98.82 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.496 2.798 . . . . 0.0 110.978 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -60.62 -43.96 96.87 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.441 1.096 . . . . 0.0 113.653 -169.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -94.15 146.15 31.07 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.215 1.006 . . . . 0.0 111.098 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.64 164.22 32.56 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.33 2.687 . . . . 0.0 111.254 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.17 -140.25 11.65 Favored Glycine 0 N--CA 1.47 0.94 0 C-N-CA 124.823 1.202 . . . . 0.0 112.184 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -130.15 130.95 45.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.592 0.757 . . . . 0.0 111.955 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -110.97 144.27 40.33 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.633 1.573 . . . . 0.0 110.781 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.72 134.31 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.483 1.113 . . . . 0.0 108.868 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.5 mt -111.69 129.12 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.828 1.251 . . . . 0.0 109.08 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -107.18 125.04 50.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.352 1.461 . . . . 0.0 109.935 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.98 124.28 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.998 0.919 . . . . 0.0 109.074 173.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -131.13 135.14 47.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.429 1.492 . . . . 0.0 110.578 -173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 50.1 t80 -128.64 121.24 28.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.14 1.376 . . . . 0.0 109.845 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.43 55.84 7.76 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.417 1.487 . . . . 0.0 112.672 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 21.1 t70 79.09 -7.56 1.75 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 128.052 2.541 . . . . 0.0 114.128 176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -113.64 128.71 56.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.8 1.24 . . . . 0.0 111.521 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -67.25 126.17 28.38 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.822 1.249 . . . . 0.0 111.045 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.2 m -77.7 154.2 81.0 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.225 -0.922 . . . . 0.0 111.295 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.88 139.49 74.43 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.612 2.208 . . . . 0.0 111.228 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 97.86 -26.84 21.68 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.25 1.405 . . . . 0.0 113.499 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 73.1 m -74.98 149.71 85.45 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 118.716 1.258 . . . . 0.0 111.366 169.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -74.85 139.53 62.24 Favored 'Cis proline' 0 C--N 1.351 0.705 0 CA-C-N 119.444 0.837 . . . . 0.0 111.315 -2.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -93.07 112.76 24.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.925 0.89 . . . . 0.0 110.218 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 59.3 m -87.48 118.31 26.86 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.316 1.047 . . . . 0.0 110.821 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 8.5 t -112.95 116.44 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.967 1.707 . . . . 0.0 109.578 -171.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.78 121.97 27.09 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.908 -0.495 . . . . 0.0 111.03 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 98.6 t -110.41 119.6 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.218 1.407 . . . . 0.0 109.534 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.9 t -97.58 154.38 17.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.631 1.173 . . . . 0.0 111.047 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -173.43 -163.34 26.89 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.408 0.923 . . . . 0.0 115.408 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -158.6 -158.27 0.69 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.153 1.781 . . . . 0.0 109.884 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -72.73 138.43 25.89 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.805 -1.185 . . . . 0.0 111.905 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -66.41 142.15 57.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.207 1.003 . . . . 0.0 112.628 -173.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 10.7 p -58.9 142.64 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.078 1.351 . . . . 0.0 111.524 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 C--O 1.254 1.32 0 C-N-CA 126.072 1.749 . . . . 0.0 111.442 -175.623 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.468 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.66 169.38 17.43 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.5 1.12 . . . . 0.0 112.952 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.78 153.47 43.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.703 1.201 . . . . 0.0 112.936 174.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.57 -18.81 47.12 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.693 1.14 . . . . 0.0 114.116 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -162.09 148.85 13.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.724 2.009 . . . . 0.0 110.172 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 2.3 p30 -77.66 171.5 14.84 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 53.4 p -84.25 -7.88 59.21 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 -169.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 98.1 mmm -72.38 150.09 43.75 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.738 1.154 . . . . 0.0 112.479 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 21.3 tpt85 -136.02 116.78 14.03 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.225 1.41 . . . . 0.0 109.802 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 27.9 ptm -78.05 151.81 33.3 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.776 0.831 . . . . 0.0 111.748 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 12.8 m -127.0 140.03 52.6 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.471 1.909 . . . . 0.0 108.146 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -143.15 160.32 40.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -166.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.93 151.04 21.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.618 1.967 . . . . 0.0 110.024 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.4 mttt -134.55 146.26 49.49 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.937 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 47.3 t -139.83 133.93 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.644 1.577 . . . . 0.0 109.623 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -86.01 118.05 4.75 Favored Glycine 0 N--CA 1.47 0.93 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 169.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.4 m -121.36 146.84 46.45 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.924 0.89 . . . . 0.0 112.458 -168.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.85 144.04 11.5 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.173 0.989 . . . . 0.0 112.572 -170.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -70.37 157.81 37.09 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.595 1.158 . . . . 0.0 112.364 170.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -94.92 143.47 26.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.919 1.687 . . . . 0.0 112.893 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.4 mt -130.13 118.57 18.42 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 124.969 1.308 . . . . 0.0 109.429 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.55 133.01 11.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.475 2.783 . . . . 0.0 111.639 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 51.2 mt -148.62 142.4 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.493 1.517 . . . . 0.0 110.624 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 57.81 57.4 4.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.072 1.749 . . . . 0.0 112.431 172.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 12.1 mm -71.99 -26.71 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.877 1.271 . . . . 0.0 112.633 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -76.92 54.63 1.03 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.13 1.772 . . . . 0.0 113.717 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -146.93 144.61 29.36 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.799 1.64 . . . . 0.0 110.726 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -104.09 -40.77 6.05 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.056 1.742 . . . . 0.0 111.133 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -90.93 108.44 19.86 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.765 0.826 . . . . 0.0 110.438 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 57.4 mt -90.37 -8.72 49.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.119 0.968 . . . . 0.0 113.101 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 9.2 t -77.03 -31.48 56.35 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.207 -0.933 . . . . 0.0 112.553 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.84 -2.43 47.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.137 1.375 . . . . 0.0 114.421 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.9 tp -101.3 135.25 43.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.463 1.105 . . . . 0.0 111.406 -170.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -138.97 168.22 20.32 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.013 1.725 . . . . 0.0 110.46 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -154.09 150.9 28.68 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 69.9 p -137.85 165.19 27.09 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.082 2.153 . . . . 0.0 110.079 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.2 t -123.73 139.85 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.852 1.661 . . . . 0.0 110.015 172.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.8 t -111.42 114.16 53.14 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.476 1.51 . . . . 0.0 108.249 166.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.67 170.33 19.33 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.948 3.098 . . . . 0.0 110.771 176.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.35 -16.61 55.17 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.986 2.458 . . . . 0.0 113.266 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 69.4 m -83.66 -4.18 58.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.328 1.051 . . . . 0.0 113.828 170.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.56 -2.37 82.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.597 1.57 . . . . 0.0 115.914 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.35 86.73 3.75 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.4 1.48 . . . . 0.0 111.588 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.87 135.93 57.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.554 1.142 . . . . 0.0 112.302 -175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -142.6 151.59 57.67 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.752 1.621 . . . . 0.0 111.352 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.46 155.09 36.2 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.823 3.015 . . . . 0.0 112.23 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 94.8 m -98.1 155.32 17.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.584 1.154 . . . . 0.0 112.815 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.64 135.45 34.59 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 108.234 162.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 8.2 mt -108.02 139.06 43.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.218 1.407 . . . . 0.0 111.06 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 64.2 mttm -135.54 128.19 30.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.676 1.19 . . . . 0.0 113.113 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.6 tpt85 -75.83 125.98 30.13 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 148.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 54.8 mt -102.65 159.85 15.09 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.678 1.191 . . . . 0.0 110.76 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -57.89 -32.97 68.23 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -82.17 -1.3 48.53 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 106.39 -27.81 15.68 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.596 1.57 . . . . 0.0 113.785 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.96 169.79 12.58 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.78 1.232 . . . . 0.0 114.179 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 67.9 t -133.15 139.33 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.841 1.656 . . . . 0.0 109.342 -171.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.54 -175.43 23.32 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 116.179 1.231 . . . . 0.0 116.179 -175.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.93 160.97 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.974 1.709 . . . . 0.0 112.288 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 68.4 m -139.98 149.75 43.63 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.575 1.95 . . . . 0.0 110.184 170.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 21.8 p90 -166.73 167.17 15.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.133 1.773 . . . . 0.0 110.647 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 58.9 t -116.06 113.57 41.64 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 124.041 0.936 . . . . 0.0 109.803 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.17 151.41 23.48 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 124.137 3.225 . . . . 0.0 111.324 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -98.49 -11.61 22.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.062 0.945 . . . . 0.0 113.459 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -139.09 166.72 23.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.01 1.724 . . . . 0.0 110.949 -174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.6 p -87.73 172.58 9.57 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.01 1.324 . . . . 0.0 111.333 169.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.5 -173.3 35.36 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.003 1.287 . . . . 0.0 113.773 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.31 113.48 7.5 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.149 0.98 . . . . 0.0 111.827 -174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 7.5 m80 -99.66 146.47 26.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.828 1.651 . . . . 0.0 109.065 165.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.79 125.17 50.66 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.26 1.024 . . . . 0.0 109.412 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 30.1 t -88.37 136.87 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.497 1.119 . . . . 0.0 108.378 167.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -121.02 117.7 27.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.377 1.471 . . . . 0.0 109.865 173.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 93.9 t -106.14 138.59 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.185 1.394 . . . . 0.0 109.304 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 63.7 mttm -123.47 144.7 49.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.538 1.535 . . . . 0.0 112.646 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 69.2 tttt -118.87 116.38 26.37 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.389 2.276 . . . . 0.0 108.957 170.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.6 t30 55.22 30.16 14.09 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.831 1.252 . . . . 0.0 113.572 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 94.77 -16.6 60.9 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.879 1.704 . . . . 0.0 115.956 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -97.78 149.99 21.73 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.482 1.641 . . . . 0.0 110.833 174.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 26.6 p80 -65.8 147.28 53.64 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 121.056 -1.028 . . . . 0.0 113.385 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 18.0 m -84.63 157.51 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.007 0.923 . . . . 0.0 111.132 175.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.67 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 7.0 m -70.53 -23.24 62.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.427 1.091 . . . . 0.0 113.65 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 71.1 m -84.99 150.34 55.22 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.41 148.56 89.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 118.681 0.565 . . . . 0.0 111.843 -4.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.72 118.81 55.47 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.423 1.089 . . . . 0.0 108.68 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.25 138.87 12.86 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.834 2.356 . . . . 0.0 111.293 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 51.6 t -134.16 121.9 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.573 1.549 . . . . 0.0 107.905 172.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.4 t -95.13 122.28 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.679 0.792 . . . . 0.0 109.944 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -95.52 129.22 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.751 1.22 . . . . 0.0 109.107 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 23.1 t -100.74 160.27 14.5 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.089 0.956 . . . . 0.0 111.572 172.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -59.17 -30.09 67.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.843 0.857 . . . . 0.0 112.855 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 19.5 m -67.23 -12.61 60.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.763 1.225 . . . . 0.0 113.725 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -97.16 -10.84 25.14 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.684 1.194 . . . . 0.0 112.779 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.6 mm -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.281 1.032 . . . . 0.0 113.167 -170.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 161.92 45.64 0.02 OUTLIER Glycine 0 N--CA 1.469 0.897 0 N-CA-C 114.766 0.667 . . . . 0.0 114.766 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 27.4 t0 -78.52 95.1 5.09 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.063 0.931 . . . . 0.0 111.378 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.17 -39.58 86.93 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.48 -0.763 . . . . 0.0 112.487 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 29.4 m -60.47 -17.45 45.02 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.953 1.301 . . . . 0.0 113.974 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -93.39 -7.42 44.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.794 1.638 . . . . 0.0 114.487 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 81.2 t -75.3 137.41 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 120.302 1.41 . . . . 0.0 110.18 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 78.6 mmt-85 -123.23 161.08 25.23 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.604 1.562 . . . . 0.0 111.081 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 27.3 m -147.61 159.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.109 1.364 . . . . 0.0 111.86 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.89 176.05 12.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.097 1.359 . . . . 0.0 112.257 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.03 -165.1 14.3 Favored Glycine 0 N--CA 1.476 1.35 0 C-N-CA 125.553 1.549 . . . . 0.0 114.202 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -97.9 -38.24 9.5 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.349 1.06 . . . . 0.0 112.615 -172.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -74.08 3.02 40.38 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.489 1.042 . . . . 0.0 115.428 -167.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 98.4 mt -96.1 0.51 51.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.218 1.407 . . . . 0.0 112.412 166.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.73 -42.53 1.13 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.521 1.528 . . . . 0.0 113.471 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -158.77 154.91 27.0 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.49 -171.07 19.68 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.569 1.557 . . . . 0.0 114.017 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.5 m80 -141.27 146.4 36.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.148 1.379 . . . . 0.0 112.219 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 40.1 p -70.55 -21.46 62.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -115.86 -0.56 12.82 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -142.93 142.06 21.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.28 1.432 . . . . 0.0 110.177 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.62 149.4 55.14 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.937 2.424 . . . . 0.0 111.695 -178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.68 146.34 27.32 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.852 1.261 . . . . 0.0 110.562 172.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.73 146.47 48.26 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.141 0.976 . . . . 0.0 112.628 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.5 p90 -152.48 148.58 27.59 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.403 1.481 . . . . 0.0 110.864 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.59 141.53 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.676 1.59 . . . . 0.0 109.207 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 40.6 mt -114.95 136.16 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 126.149 1.779 . . . . 0.0 108.744 172.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 60.2 t0 -124.52 108.18 11.83 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.152 1.781 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 58.0 p -101.62 0.66 36.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.848 1.659 . . . . 0.0 113.058 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -60.84 -37.13 80.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.51 1.05 . . . . 0.0 112.521 -172.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.4 t70 -78.68 -14.14 59.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.603 1.161 . . . . 0.0 113.114 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -94.71 -4.61 47.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.169 1.788 . . . . 0.0 113.668 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.71 -99.73 2.22 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 125.014 1.292 . . . . 0.0 111.947 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -142.21 152.38 43.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.127 1.371 . . . . 0.0 112.286 -165.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 150.83 179.26 26.44 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -88.19 122.33 6.27 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.39 0.995 . . . . 0.0 111.81 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.4 121.49 35.99 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.301 1.84 . . . . 0.0 108.334 171.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 15.0 m -113.34 143.25 44.78 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.827 1.251 . . . . 0.0 110.782 170.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.1 tt -139.29 133.26 30.98 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 110.343 -169.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 70.4 m -136.85 127.61 27.25 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.537 0.735 . . . . 0.0 111.452 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 25.9 mt -104.6 136.8 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.7 1.6 . . . . 0.0 108.948 174.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -132.79 151.49 51.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.21 1.804 . . . . 0.0 109.293 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 168.18 -160.31 33.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.194 -0.941 . . . . 0.0 114.59 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.0 -12.04 33.96 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 124.125 3.217 . . . . 0.0 114.474 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.5 t -159.48 168.35 26.43 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.666 1.187 . . . . 0.0 111.687 172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -66.35 151.84 46.26 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.732 1.213 . . . . 0.0 111.558 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -131.4 154.04 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.856 1.262 . . . . 0.0 111.18 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -84.88 138.22 32.66 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.694 0.398 . . . . 0.0 110.272 163.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 44.3 mt -121.4 135.83 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 109.163 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -132.37 154.61 49.6 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.208 1.803 . . . . 0.0 109.803 -177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 31.4 p -139.8 152.44 46.55 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.692 1.197 . . . . 0.0 111.664 -174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -152.72 106.98 3.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.962 1.305 . . . . 0.0 110.089 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -82.35 134.43 35.26 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.919 1.288 . . . . 0.0 111.137 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 79.2 mt -110.22 162.28 14.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.481 1.112 . . . . 0.0 113.451 -163.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -70.65 -13.28 62.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.024 1.33 . . . . 0.0 113.159 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.72 -8.09 59.34 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.433 1.093 . . . . 0.0 112.795 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.09 1.2 73.0 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.349 1.452 . . . . 0.0 114.696 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 49.0 p -93.81 172.42 8.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.364 1.866 . . . . 0.0 111.191 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 47.0 t -129.02 126.63 39.92 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.096 0.958 . . . . 0.0 111.47 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.23 136.29 36.43 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.366 1.067 . . . . 0.0 109.613 166.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.4 t -115.25 138.43 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 108.083 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.6 p -134.19 147.0 50.68 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.177 1.391 . . . . 0.0 110.871 177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 6.9 p90 -151.58 152.49 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.006 0.922 . . . . 0.0 112.096 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 8.2 t -123.78 113.23 28.69 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.892 0.877 . . . . 0.0 111.195 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.95 175.54 9.15 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.029 3.153 . . . . 0.0 111.284 174.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 99.5 m -129.25 -46.22 1.22 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.39 1.076 . . . . 0.0 111.91 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -85.92 144.65 39.57 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.919 0.888 . . . . 0.0 110.637 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.16 160.41 33.02 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.092 2.528 . . . . 0.0 110.989 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 132.22 -162.9 24.0 Favored Glycine 0 N--CA 1.472 1.048 0 C-N-CA 125.196 1.379 . . . . 0.0 113.703 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -90.85 121.49 32.75 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.639 0.776 . . . . 0.0 111.426 176.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -98.98 143.41 29.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.872 1.269 . . . . 0.0 110.854 165.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.9 mp -107.34 132.84 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.799 1.639 . . . . 0.0 108.031 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.61 124.58 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.3 1.04 . . . . 0.0 109.82 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -101.35 128.34 47.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.181 1.792 . . . . 0.0 109.91 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 26.1 mm -120.67 115.5 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.919 1.287 . . . . 0.0 109.814 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.08 135.37 54.37 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.642 1.577 . . . . 0.0 110.989 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 63.1 t80 -129.69 125.83 36.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.287 1.435 . . . . 0.0 110.127 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.27 34.57 18.04 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.165 1.386 . . . . 0.0 113.53 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.252 63.4 m-20 74.05 21.23 2.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.035 2.534 . . . . 0.0 114.176 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -125.38 137.38 54.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.899 1.28 . . . . 0.0 110.972 169.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.45 129.75 40.85 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.487 1.115 . . . . 0.0 110.882 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.8 m -77.46 155.23 81.6 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.159 -0.963 . . . . 0.0 111.2 -174.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.01 141.05 75.44 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.61 2.207 . . . . 0.0 111.432 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 90.37 -24.01 18.89 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.177 1.37 . . . . 0.0 113.608 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 22.5 t -76.99 144.62 72.45 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 118.276 1.038 . . . . 0.0 111.133 173.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.48 149.57 89.16 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.876 0.992 . . . . 0.0 112.139 -2.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -102.0 127.72 48.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.076 1.351 . . . . 0.0 110.996 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 37.6 m -89.75 135.12 33.81 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.152 0.981 . . . . 0.0 111.03 171.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.0 t -132.88 112.52 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.54 1.536 . . . . 0.0 109.556 -168.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -79.55 108.99 13.51 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.784 -0.572 . . . . 0.0 111.29 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 70.8 t -95.28 118.18 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 0.0 108.772 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.4 t -97.31 152.52 18.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.179 0.992 . . . . 0.0 111.106 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 162.84 -158.28 30.49 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 -176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -165.26 179.61 6.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.674 1.989 . . . . 0.0 110.983 -174.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -70.79 133.16 22.73 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.431 -0.793 . . . . 0.0 112.449 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -77.52 145.88 36.69 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.666 1.186 . . . . 0.0 111.86 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 71.1 t -132.51 142.41 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 126.028 1.731 . . . . 0.0 109.601 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.048 1.739 . . . . 0.0 111.058 177.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.82 -9.38 58.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -67.41 -21.3 65.59 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.56 1.544 . . . . 0.0 114.294 -173.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -175.41 158.65 26.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.23 1.395 . . . . 0.0 113.293 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 17.8 t70 -160.18 153.28 21.73 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.15 1.38 . . . . 0.0 111.827 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.93 4.44 8.22 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.428 1.491 . . . . 0.0 114.922 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 79.6 p -62.37 -21.2 65.15 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.876 1.271 . . . . 0.0 114.221 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 37.4 mmt -73.88 116.42 14.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.125 0.97 . . . . 0.0 110.319 172.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.9 143.85 55.51 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.145 0.978 . . . . 0.0 111.97 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 22.9 ptm -146.48 156.04 42.98 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.141 1.376 . . . . 0.0 112.465 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.0 m -136.72 144.5 43.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.943 2.097 . . . . 0.0 108.581 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -147.83 157.92 43.77 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -168.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -159.77 141.02 12.64 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.223 1.809 . . . . 0.0 110.107 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 65.8 mttp -125.86 148.05 49.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.509 1.124 . . . . 0.0 112.215 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 23.7 t -133.88 134.46 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.611 1.564 . . . . 0.0 109.895 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.76 54.78 4.85 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.264 1.411 . . . . 0.0 112.882 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 18.9 m -61.98 147.94 45.41 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.57 1.548 . . . . 0.0 114.276 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -168.36 156.62 8.52 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.846 1.658 . . . . 0.0 111.816 -175.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -81.11 148.61 29.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.149 0.98 . . . . 0.0 111.61 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -93.3 148.76 21.76 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.907 1.283 . . . . 0.0 113.038 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 61.1 mt -133.72 126.74 19.11 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.339 1.456 . . . . 0.0 109.221 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.36 140.14 26.99 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.107 2.538 . . . . 0.0 111.104 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -139.71 135.56 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.96 1.304 . . . . 0.0 110.361 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.8 t30 39.63 69.54 0.29 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.085 2.154 . . . . 0.0 114.016 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.35 120.19 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.092 0.957 . . . . 0.0 111.261 -167.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 4.9 m -172.2 156.76 4.01 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.124 2.169 . . . . 0.0 110.058 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -86.47 72.11 10.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.162 0.985 . . . . 0.0 110.489 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 35.0 p -97.98 156.63 16.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.989 1.716 . . . . 0.0 111.777 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -91.84 117.79 30.11 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.466 1.106 . . . . 0.0 110.611 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.52 -9.07 46.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.537 1.135 . . . . 0.0 113.173 -177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 15.6 m -74.99 -19.33 60.14 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.672 1.189 . . . . 0.0 113.739 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 3.2 pp -130.25 5.37 4.84 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.514 1.525 . . . . 0.0 113.899 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -110.33 126.36 54.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.211 2.204 . . . . 0.0 107.768 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 35.6 p -130.85 148.6 52.64 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.244 1.418 . . . . 0.0 110.184 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -138.71 150.16 45.86 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.054 0.942 . . . . 0.0 112.715 -176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 81.0 p -140.47 159.84 41.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.606 1.963 . . . . 0.0 109.951 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 3.9 t -114.62 135.54 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.546 1.138 . . . . 0.0 109.598 169.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.7 t -108.39 114.37 59.33 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.066 1.347 . . . . 0.0 108.498 167.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.77 173.11 13.3 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 124.151 3.234 . . . . 0.0 111.269 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.28 -29.11 45.71 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.016 3.144 . . . . 0.0 114.895 174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 30.3 p -83.92 -5.57 59.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.219 1.408 . . . . 0.0 114.464 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 80.95 3.02 90.67 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 124.969 1.271 . . . . 0.0 114.52 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.9 mtt85 -74.04 77.51 1.71 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.533 1.933 . . . . 0.0 111.706 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.78 133.08 55.76 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.203 1.001 . . . . 0.0 112.127 -175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.72 150.03 61.57 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.249 1.42 . . . . 0.0 110.957 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.51 152.63 34.1 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.698 2.932 . . . . 0.0 112.412 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 72.9 m -91.61 155.12 18.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.484 1.114 . . . . 0.0 111.794 171.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 65.5 tp -77.82 140.46 39.4 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 152.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.3 mt -108.3 142.35 38.73 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.768 1.227 . . . . 0.0 110.347 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 59.2 mttm -136.89 138.84 41.13 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.919 1.287 . . . . 0.0 112.379 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -80.39 123.73 28.28 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 151.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.2 mt -96.27 164.25 12.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.234 1.413 . . . . 0.0 111.399 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -63.9 -18.23 63.99 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -169.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.15 2.8 56.37 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.994 0.917 . . . . 0.0 113.198 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 93.97 -9.03 73.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.028 1.775 . . . . 0.0 114.594 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -80.79 170.37 16.38 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.899 1.68 . . . . 0.0 113.416 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 91.2 t -115.19 141.73 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.314 1.446 . . . . 0.0 110.483 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -149.35 174.1 29.01 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 115.687 1.035 . . . . 0.0 115.687 178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.44 157.64 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.174 1.79 . . . . 0.0 111.318 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.8 m -137.79 146.59 43.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.565 1.546 . . . . 0.0 109.795 165.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 4.2 p90 -166.21 171.17 12.52 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 111.103 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 88.3 t -119.08 121.36 30.43 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.089 0.955 . . . . 0.0 109.607 171.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.27 143.22 17.37 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.019 3.146 . . . . 0.0 110.969 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -84.64 -21.67 30.19 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.89 0.876 . . . . 0.0 112.227 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -142.27 172.2 13.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.522 1.929 . . . . 0.0 110.704 -168.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.7 p -91.99 169.94 10.25 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.911 1.285 . . . . 0.0 111.454 171.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 102.42 -173.41 23.0 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.374 1.464 . . . . 0.0 113.915 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.82 109.5 6.45 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.08 0.952 . . . . 0.0 111.32 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 14.5 m80 -95.62 140.55 30.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.231 1.412 . . . . 0.0 109.387 170.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.21 122.91 45.11 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.37 1.068 . . . . 0.0 109.075 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 96.4 t -86.66 118.42 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -101.18 149.42 24.0 Favored 'General case' 0 C--O 1.246 0.91 0 C-N-CA 125.228 1.411 . . . . 0.0 110.567 169.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 3.7 p -160.37 126.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 122.167 0.984 . . . . 0.0 111.398 -170.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -128.22 129.43 46.41 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 126.399 1.879 . . . . 0.0 111.599 -164.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 60.7 tttm -109.93 132.83 53.8 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.335 1.454 . . . . 0.0 110.223 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 47.7 t30 56.51 -96.69 0.07 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.012 1.325 . . . . 0.0 111.474 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -122.47 10.78 9.15 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.497 1.523 . . . . 0.0 115.533 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -145.93 149.79 34.86 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.091 1.945 . . . . 0.0 113.78 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -70.29 157.43 37.73 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.653 0.781 . . . . 0.0 112.421 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.6 m -84.86 163.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.84 0.856 . . . . 0.0 111.539 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.2 69.12 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 29.9 m -86.29 -14.63 43.11 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.966 1.307 . . . . 0.0 114.367 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 64.3 p -93.03 153.61 41.78 Favored Pre-proline 0 CA--C 1.551 0.993 0 O-C-N 120.869 -1.145 . . . . 0.0 113.478 -174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.32 150.75 96.04 Favored 'Cis proline' 0 C--N 1.354 0.826 0 CA-C-N 119.125 0.723 . . . . 0.0 112.597 -1.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.86 121.64 50.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.825 1.25 . . . . 0.0 108.469 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.1 138.07 12.59 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.854 2.369 . . . . 0.0 111.139 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.3 t -133.99 122.56 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.59 1.556 . . . . 0.0 107.884 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.0 t -94.11 122.2 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.489 0.716 . . . . 0.0 110.067 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.91 137.43 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.128 1.371 . . . . 0.0 109.239 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 14.4 t -122.86 161.58 23.8 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.486 1.114 . . . . 0.0 110.896 170.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -61.17 -26.81 67.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.143 0.977 . . . . 0.0 113.602 -171.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 23.8 p -67.53 -15.29 63.58 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.542 1.137 . . . . 0.0 113.923 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.42 -9.33 47.92 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.627 1.171 . . . . 0.0 112.596 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 28.2 mt -110.77 110.13 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.328 0.967 . . . . 0.0 110.91 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 72.56 11.83 77.14 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 117.274 1.669 . . . . 0.0 117.274 156.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -75.04 91.72 2.56 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.454 1.627 . . . . 0.0 111.212 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.09 67.47 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.495 1.118 . . . . 0.0 112.38 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.2 m -54.03 -25.49 21.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.952 1.701 . . . . 0.0 114.148 175.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -88.31 -12.12 44.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.014 1.326 . . . . 0.0 113.619 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 68.4 t -74.33 134.75 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.592 1.087 . . . . 0.0 110.105 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -116.63 158.65 23.39 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.452 1.501 . . . . 0.0 110.876 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 34.8 m -146.61 159.07 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.428 1.491 . . . . 0.0 110.667 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -158.99 168.57 26.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.416 1.086 . . . . 0.0 112.336 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 105.43 159.32 23.03 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.189 1.376 . . . . 0.0 114.205 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -70.63 -26.71 63.6 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.112 1.365 . . . . 0.0 113.614 -168.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.97 -4.46 48.52 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.593 1.092 . . . . 0.0 115.063 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.4 -2.77 57.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.162 1.385 . . . . 0.0 112.715 168.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -128.84 -38.05 1.69 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.951 1.3 . . . . 0.0 113.794 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -156.75 161.61 39.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.094 0.958 . . . . 0.0 113.177 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.33 -174.24 24.98 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.905 1.241 . . . . 0.0 114.11 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -138.94 144.83 39.19 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.154 1.382 . . . . 0.0 112.105 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 38.6 p -70.51 -18.63 62.96 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -116.42 -2.14 12.12 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -143.94 144.69 27.52 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.363 1.465 . . . . 0.0 110.178 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.62 150.09 50.3 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.218 . . . . 0.0 111.656 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -98.25 154.09 18.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.42 1.488 . . . . 0.0 110.73 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -134.39 150.94 50.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.808 0.843 . . . . 0.0 112.691 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -157.06 149.84 23.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.605 1.562 . . . . 0.0 110.837 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.21 140.69 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.842 1.657 . . . . 0.0 109.288 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 43.4 mt -111.68 135.8 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.761 . . . . 0.0 109.032 173.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 66.5 t0 -125.04 98.37 5.65 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.989 1.715 . . . . 0.0 110.536 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.3 p -94.24 1.0 56.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.316 1.847 . . . . 0.0 113.023 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -61.16 -34.81 75.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.343 0.974 . . . . 0.0 112.851 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -79.77 -18.24 51.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.522 1.129 . . . . 0.0 113.133 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -88.31 -14.84 37.27 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.147 1.379 . . . . 0.0 114.014 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.02 -113.17 3.58 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.509 1.052 . . . . 0.0 111.727 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -107.49 144.01 35.04 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.157 1.383 . . . . 0.0 113.067 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 143.38 144.01 4.2 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.819 1.199 . . . . 0.0 112.982 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -73.65 142.13 30.63 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.632 0.634 . . . . 0.0 112.772 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.32 127.09 42.98 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.578 1.551 . . . . 0.0 108.736 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 43.7 t -120.3 135.96 54.84 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.667 1.587 . . . . 0.0 109.506 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -139.58 136.11 34.08 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.288 1.035 . . . . 0.0 110.873 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.7 m -139.83 130.55 25.88 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.833 0.853 . . . . 0.0 111.398 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 26.5 mt -109.86 136.79 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.463 1.505 . . . . 0.0 108.442 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -146.5 155.81 42.8 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.162 0.985 . . . . 0.0 111.605 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.39 -146.44 12.56 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.737 -1.035 . . . . 0.0 114.024 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.95 -15.24 36.31 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.897 3.065 . . . . 0.0 114.588 -172.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.9 t -160.44 170.81 20.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.527 1.131 . . . . 0.0 111.669 174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -71.99 155.27 40.52 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.195 0.998 . . . . 0.0 111.589 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.99 162.68 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.3 1.44 . . . . 0.0 110.946 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.49 131.61 36.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.697 0.799 . . . . 0.0 110.146 164.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 49.5 mt -111.1 132.87 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.188 0.995 . . . . 0.0 109.369 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -130.4 155.55 46.22 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.32 1.848 . . . . 0.0 109.624 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 29.6 p -142.05 160.19 40.72 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.396 1.078 . . . . 0.0 112.315 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -152.55 107.59 3.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.586 1.554 . . . . 0.0 109.347 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.19 129.94 34.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.768 1.227 . . . . 0.0 110.644 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 78.1 mt -106.7 155.99 19.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.711 1.204 . . . . 0.0 112.436 -167.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.12 -18.27 64.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.487 1.115 . . . . 0.0 112.949 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -72.39 -11.07 60.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.77 -2.88 73.56 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.096 1.808 . . . . 0.0 114.395 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 61.7 p -90.41 174.63 7.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.546 1.938 . . . . 0.0 111.002 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -136.14 128.83 30.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.538 0.735 . . . . 0.0 111.702 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -80.5 138.03 36.51 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.765 1.226 . . . . 0.0 109.924 168.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 22.1 t -116.84 138.83 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.656 1.982 . . . . 0.0 108.223 167.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -137.46 144.02 42.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.345 1.458 . . . . 0.0 111.258 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 8.1 p90 -157.34 151.96 25.35 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.304 1.042 . . . . 0.0 112.384 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 10.6 t -117.82 108.61 42.49 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.791 0.836 . . . . 0.0 111.213 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -76.25 152.42 35.04 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.202 2.601 . . . . 0.0 110.527 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 85.2 m -112.69 -37.97 4.73 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.923 0.889 . . . . 0.0 112.582 -175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -96.08 148.12 34.03 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.393 1.077 . . . . 0.0 110.733 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.99 161.23 36.1 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.027 2.485 . . . . 0.0 111.05 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.71 -159.86 18.3 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.109 1.337 . . . . 0.0 113.563 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 48.7 t30 -95.74 120.01 35.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.052 0.941 . . . . 0.0 111.765 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -98.79 144.9 27.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.775 1.23 . . . . 0.0 110.873 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.22 136.69 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.273 1.429 . . . . 0.0 108.701 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.6 126.12 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.129 1.372 . . . . 0.0 109.295 173.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -102.14 131.29 48.74 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.17 1.788 . . . . 0.0 110.297 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.5 mm -123.54 114.2 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.869 1.267 . . . . 0.0 109.592 176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -119.71 134.06 55.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.966 1.706 . . . . 0.0 110.908 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 79.5 t80 -126.36 124.42 40.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.162 1.385 . . . . 0.0 109.737 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.71 36.21 23.2 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.1 1.36 . . . . 0.0 114.035 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 20.9 t70 95.71 -11.2 0.09 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 130.242 3.417 . . . . 0.0 113.611 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -112.72 134.91 54.01 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.039 . . . . 0.0 112.591 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.4 128.77 37.35 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.884 1.274 . . . . 0.0 110.822 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 10.3 m -72.94 156.2 89.93 Favored Pre-proline 0 N--CA 1.489 1.475 0 CA-C-N 119.551 1.068 . . . . 0.0 111.549 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.07 -35.39 90.27 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.792 2.995 . . . . 0.0 116.393 -170.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.55 75.96 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-N 118.567 0.622 . . . . 0.0 114.561 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 36.1 t -82.82 146.42 52.48 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.056 1.342 . . . . 0.0 111.442 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.66 152.68 93.29 Favored 'Cis proline' 0 C--N 1.351 0.697 0 CA-C-N 119.815 0.97 . . . . 0.0 112.453 -1.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.38 126.34 51.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 13.9 p -90.01 137.14 32.59 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.523 1.129 . . . . 0.0 111.35 171.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 21.2 t -133.46 112.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 -168.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -80.72 107.99 13.99 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.529 0.731 . . . . 0.0 111.253 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 92.3 t -94.32 120.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.59 1.156 . . . . 0.0 109.261 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 7.3 t -97.96 154.14 17.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 174.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -171.14 -171.12 36.06 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 115.847 1.099 . . . . 0.0 115.847 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 29.4 tt0 92.64 137.36 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 129.804 3.242 . . . . 0.0 110.867 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 87.76 64.37 1.37 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.435 1.016 . . . . 0.0 112.099 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -62.95 156.96 22.97 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.817 1.247 . . . . 0.0 113.655 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 28.5 m -67.63 150.92 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.336 1.054 . . . . 0.0 111.338 171.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.637 1.175 . . . . 0.0 112.45 179.433 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.56 166.33 23.45 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.439 1.096 . . . . 0.0 113.04 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -72.27 -15.3 61.91 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.164 1.386 . . . . 0.0 114.09 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.42 -105.72 0.68 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.934 1.731 . . . . 0.0 111.48 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 19.8 t70 79.51 -9.8 1.41 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 128.25 2.62 . . . . 0.0 114.177 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 44.1 m-20 78.6 146.26 0.09 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 129.62 3.168 . . . . 0.0 113.704 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 26.9 m -78.17 -10.42 59.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.286 1.034 . . . . 0.0 113.627 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 57.9 tpp -71.29 121.56 18.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.815 1.246 . . . . 0.0 111.338 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.08 152.86 21.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.56 1.144 . . . . 0.0 110.677 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 95.7 mtp -122.75 139.23 54.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.632 1.573 . . . . 0.0 111.401 177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.1 m -130.11 141.56 50.68 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.29 1.836 . . . . 0.0 108.871 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 2.1 t60 -140.78 150.69 43.67 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -166.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.47 140.56 20.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.07 1.748 . . . . 0.0 109.641 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.42 144.39 49.49 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.635 1.174 . . . . 0.0 111.282 173.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.2 p -155.25 141.65 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.093 0.957 . . . . 0.0 111.399 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -75.89 150.81 39.96 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.007 0.813 . . . . 0.0 112.331 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 33.0 m -131.94 127.64 36.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.794 0.837 . . . . 0.0 111.603 -171.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.68 147.24 18.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.633 0.773 . . . . 0.0 112.677 -177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -82.17 138.25 34.76 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.957 0.903 . . . . 0.0 110.727 168.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.49 143.51 33.28 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.226 1.01 . . . . 0.0 112.178 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 65.0 mt -128.75 125.67 23.08 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.543 1.137 . . . . 0.0 108.97 176.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.58 140.77 24.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.046 2.498 . . . . 0.0 111.158 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 35.3 mm -137.74 139.17 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.291 1.836 . . . . 0.0 109.065 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.84 46.69 19.32 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.829 1.252 . . . . 0.0 112.707 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 94.0 mt -56.93 -29.33 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.28 1.832 . . . . 0.0 113.974 -165.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 16.8 m -64.62 -18.41 64.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.28 161.69 37.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.277 1.431 . . . . 0.0 111.952 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.0 m -122.11 121.85 37.88 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.858 1.263 . . . . 0.0 109.759 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 9.0 t0 -158.74 128.8 5.85 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.492 1.517 . . . . 0.0 110.0 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.6 mt -116.06 -3.55 12.07 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.616 1.566 . . . . 0.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 51.6 m -94.96 -29.17 14.79 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.326 1.051 . . . . 0.0 113.313 -168.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.03 1.74 12.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.118 1.367 . . . . 0.0 114.442 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.2 tp -91.01 137.21 32.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.924 0.784 . . . . 0.0 111.735 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 33.9 p -141.42 140.03 33.56 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.099 1.759 . . . . 0.0 109.392 172.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -139.16 149.93 45.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.866 0.866 . . . . 0.0 113.185 -173.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 77.4 p -138.21 162.63 33.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.075 2.15 . . . . 0.0 109.87 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -118.27 136.44 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.966 1.306 . . . . 0.0 109.791 168.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.8 t -105.28 113.83 64.05 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.137 1.375 . . . . 0.0 108.27 166.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.53 172.3 11.5 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.97 3.113 . . . . 0.0 111.737 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -52.51 -29.14 38.97 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.85 3.7 . . . . 0.0 114.848 170.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 57.3 p -81.32 -8.29 59.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.796 1.238 . . . . 0.0 114.164 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.5 -0.2 81.78 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.421 1.486 . . . . 0.0 114.815 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -76.58 83.05 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.38 1.472 . . . . 0.0 111.532 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.44 135.77 57.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.727 1.211 . . . . 0.0 112.148 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.79 151.69 66.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.477 1.511 . . . . 0.0 111.323 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.57 152.38 43.01 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.844 3.03 . . . . 0.0 112.392 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 77.9 m -98.3 154.78 17.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.92 1.288 . . . . 0.0 112.179 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.17 116.43 26.35 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.534 1.134 . . . . 0.0 108.17 168.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 22.4 mt -87.21 135.78 33.18 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.604 1.161 . . . . 0.0 111.469 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.7 mttt -132.37 147.64 52.39 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.602 1.561 . . . . 0.0 112.413 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -92.6 115.68 28.32 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 81.0 mt -90.22 171.5 9.45 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.612 0.765 . . . . 0.0 112.729 -170.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -59.83 -34.2 72.77 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 113.814 -172.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 53.7 t30 -80.41 -11.91 59.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.463 1.105 . . . . 0.0 113.814 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 103.81 -14.88 52.86 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.653 1.597 . . . . 0.0 114.525 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.41 159.87 32.63 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 118.266 1.033 . . . . 0.0 113.183 172.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.7 t -85.06 150.55 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.831 1.252 . . . . 0.0 109.056 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -151.56 174.53 30.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 124.109 0.862 . . . . 0.0 114.987 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -119.43 162.46 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.213 1.805 . . . . 0.0 112.072 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 74.1 m -144.4 150.25 37.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.423 1.889 . . . . 0.0 110.41 166.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.21 178.44 8.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.485 1.914 . . . . 0.0 110.763 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 67.9 t -130.58 123.35 20.27 Favored Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.155 0.982 . . . . 0.0 109.93 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.71 148.89 23.1 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 124.787 3.658 . . . . 0.0 112.075 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 14.4 mptt -106.84 -9.76 16.25 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.516 1.126 . . . . 0.0 113.48 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.76 172.03 13.37 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.664 1.986 . . . . 0.0 110.329 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 32.9 p -96.02 154.38 17.27 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.619 1.168 . . . . 0.0 110.903 167.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 104.31 -165.76 15.08 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.168 1.366 . . . . 0.0 113.931 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -72.84 114.3 10.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.36 1.064 . . . . 0.0 112.213 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 18.9 m80 -95.77 143.26 27.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.644 1.578 . . . . 0.0 109.07 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.2 mm? -107.37 123.3 48.17 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.053 0.941 . . . . 0.0 108.908 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 93.4 t -83.65 121.23 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 166.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.81 138.56 40.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.584 1.153 . . . . 0.0 110.095 170.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.4 p -146.42 133.68 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 122.086 0.946 . . . . 0.0 112.503 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -117.88 139.69 50.77 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.893 2.077 . . . . 0.0 111.602 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 44.9 tttm -108.87 109.37 20.45 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.422 2.689 . . . . 0.0 108.413 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 54.18 -103.74 0.19 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.925 1.29 . . . . 0.0 111.457 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.03 6.38 34.79 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.871 1.701 . . . . 0.0 115.514 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -129.22 148.72 51.18 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.287 1.543 . . . . 0.0 111.638 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 29.8 p80 -66.01 147.14 53.82 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.62 -1.3 . . . . 0.0 112.101 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 49.0 t -72.72 144.85 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 173.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.32 -24.73 60.56 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 54.5 p -84.27 -12.45 54.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.113 1.365 . . . . 0.0 114.075 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 9.6 t -80.01 140.05 53.62 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 120.871 -1.143 . . . . 0.0 112.62 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.27 152.49 83.99 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 119.536 0.87 . . . . 0.0 112.498 -5.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.77 122.58 45.42 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.336 1.454 . . . . 0.0 108.739 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -82.29 143.09 12.35 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.08 2.52 . . . . 0.0 111.777 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.4 t -139.32 117.45 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.422 1.489 . . . . 0.0 108.486 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 51.3 t -94.85 122.86 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.61 0.764 . . . . 0.0 110.174 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.73 129.43 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.11 1.364 . . . . 0.0 110.364 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 73.3 m -94.77 159.72 14.93 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.234 1.414 . . . . 0.0 112.102 171.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -59.25 -26.95 65.34 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.182 -0.948 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.9 p -65.43 -18.92 65.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.528 1.531 . . . . 0.0 114.18 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.39 -4.87 28.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.241 1.416 . . . . 0.0 112.95 -175.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 42.1 mm -73.64 -34.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.289 1.036 . . . . 0.0 112.602 -173.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 154.34 45.61 0.02 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.853 0.74 . . . . 0.0 114.388 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.52 100.74 10.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.459 1.129 . . . . 0.0 110.858 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.82 -35.96 69.39 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.44 1.096 . . . . 0.0 112.988 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 13.1 t -54.19 -29.08 44.59 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.899 1.279 . . . . 0.0 113.31 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -85.79 -9.85 56.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.992 1.317 . . . . 0.0 113.728 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 63.3 t -76.94 129.96 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.546 1.066 . . . . 0.0 109.594 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -109.08 155.42 20.99 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.467 1.507 . . . . 0.0 110.867 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.2 m -145.24 148.62 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.992 1.317 . . . . 0.0 110.938 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.6 m -151.62 157.09 41.7 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.853 1.261 . . . . 0.0 112.14 -175.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 119.03 161.34 11.66 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.496 1.046 . . . . 0.0 114.953 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -64.74 -33.06 75.09 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.782 1.633 . . . . 0.0 113.225 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.24 -3.58 46.6 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.783 1.182 . . . . 0.0 115.013 -176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.86 -7.6 57.0 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.242 1.417 . . . . 0.0 112.745 168.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -128.1 -36.9 1.92 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.722 1.209 . . . . 0.0 113.942 -173.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -156.75 157.23 34.69 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.351 1.06 . . . . 0.0 112.911 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -155.26 -175.04 25.85 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.564 1.078 . . . . 0.0 114.346 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 62.6 m80 -139.58 142.07 37.14 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.143 1.377 . . . . 0.0 112.128 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 55.8 p -73.2 -14.81 61.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -115.29 -2.89 12.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -145.0 145.35 26.98 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.562 1.545 . . . . 0.0 110.195 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -69.49 143.0 50.7 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.543 2.162 . . . . 0.0 111.26 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -96.5 163.03 13.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.253 1.421 . . . . 0.0 110.452 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.46 159.41 44.5 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 49.3 p90 -158.82 153.52 24.62 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.379 1.872 . . . . 0.0 110.222 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.73 140.03 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 109.282 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.31 134.3 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.012 1.725 . . . . 0.0 108.421 168.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.3 t0 -120.0 101.19 7.68 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.183 1.793 . . . . 0.0 110.102 177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 35.4 p -94.89 0.57 54.88 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.327 1.851 . . . . 0.0 113.129 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -60.4 -36.12 77.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.443 1.019 . . . . 0.0 113.203 -170.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.99 -17.51 52.7 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.266 1.026 . . . . 0.0 113.214 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -89.77 -6.67 55.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.552 1.541 . . . . 0.0 113.731 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 78.79 -111.97 3.36 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.166 1.365 . . . . 0.0 112.641 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -115.75 164.81 13.83 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.195 1.798 . . . . 0.0 112.388 -172.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.74 -134.81 5.3 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.523 1.059 . . . . 0.0 113.041 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -155.88 140.56 7.36 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.479 1.038 . . . . 0.0 112.435 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.48 121.45 41.17 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.357 1.863 . . . . 0.0 109.591 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 66.7 m -107.81 140.11 41.39 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.241 1.817 . . . . 0.0 109.872 167.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -142.28 137.96 31.01 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.072 0.949 . . . . 0.0 110.045 -170.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 86.5 p -135.17 148.62 49.76 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.557 0.694 . . . . 0.0 111.873 169.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 27.2 mt -122.91 125.74 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 172.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -119.46 145.61 46.13 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.314 1.446 . . . . 0.0 109.274 -176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 174.92 -163.79 34.21 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.92 -2.41 11.46 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.714 3.609 . . . . 0.0 114.225 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -160.53 165.61 30.55 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.949 1.3 . . . . 0.0 111.351 169.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -71.3 143.0 50.47 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.277 1.031 . . . . 0.0 110.905 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 7.6 m -121.32 150.23 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.315 1.446 . . . . 0.0 110.693 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -91.91 110.94 22.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.692 0.797 . . . . 0.0 109.985 174.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 36.7 mt -93.56 134.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.75 1.22 . . . . 0.0 109.913 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -132.7 164.3 27.05 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.551 1.94 . . . . 0.0 110.897 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 14.6 p -138.16 155.26 48.89 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.609 1.564 . . . . 0.0 112.039 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.29 130.61 12.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.719 1.208 . . . . 0.0 110.728 170.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.6 t70 -85.64 125.37 33.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.793 1.237 . . . . 0.0 110.602 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 59.3 mt -96.05 152.46 18.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.217 1.007 . . . . 0.0 111.835 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.09 -12.57 61.8 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.517 1.127 . . . . 0.0 113.678 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.38 -6.26 59.41 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.83 1.252 . . . . 0.0 113.009 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.2 5.22 59.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.639 1.59 . . . . 0.0 114.856 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 37.2 p -98.46 166.41 11.37 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.456 1.902 . . . . 0.0 111.661 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.3 t -116.35 124.79 50.97 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.274 1.029 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -88.3 133.55 34.04 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.107 1.363 . . . . 0.0 109.623 170.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 60.6 t -111.89 137.29 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.259 1.424 . . . . 0.0 108.741 168.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.5 p -126.71 146.05 50.36 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.555 1.942 . . . . 0.0 110.15 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.1 p90 -160.9 149.58 16.4 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.264 1.026 . . . . 0.0 112.043 175.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.1 t -118.08 113.25 37.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.789 0.836 . . . . 0.0 110.995 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.47 166.75 25.46 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.67 2.914 . . . . 0.0 110.787 169.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.1 m -129.99 -43.44 1.21 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.913 0.885 . . . . 0.0 112.551 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -87.89 144.46 34.89 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 123.684 0.793 . . . . 0.0 109.812 168.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.97 164.02 27.81 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.27 2.647 . . . . 0.0 111.319 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 129.53 -160.79 22.76 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.223 1.392 . . . . 0.0 113.679 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 51.2 t30 -88.73 124.53 34.21 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.323 0.649 . . . . 0.0 111.305 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -106.05 140.81 38.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.732 1.213 . . . . 0.0 109.884 166.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 2.9 mp -107.21 127.41 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.955 1.302 . . . . 0.0 108.264 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 14.4 mt -110.86 128.48 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.239 1.016 . . . . 0.0 109.786 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -108.94 125.79 52.4 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.855 1.262 . . . . 0.0 110.106 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 27.6 mm -111.31 121.76 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.256 1.022 . . . . 0.0 109.055 173.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 3.6 tmmt? -133.21 127.33 33.54 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.874 1.269 . . . . 0.0 110.982 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -125.6 127.75 46.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.064 1.346 . . . . 0.0 110.651 -174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 48.95 48.38 20.67 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.705 1.202 . . . . 0.0 112.92 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 17.7 t70 79.99 -2.2 2.03 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 128.45 2.7 . . . . 0.0 114.145 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -121.51 127.58 51.16 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.735 1.214 . . . . 0.0 111.812 -168.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -66.34 125.97 27.31 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.832 1.253 . . . . 0.0 111.297 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.6 m -82.5 159.05 65.06 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.227 -0.92 . . . . 0.0 111.72 -169.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.88 143.08 73.37 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.756 2.971 . . . . 0.0 113.526 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.96 -23.08 19.07 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.852 1.215 . . . . 0.0 114.232 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 70.7 m -73.44 151.73 89.69 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 118.65 1.225 . . . . 0.0 111.696 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -73.06 141.67 72.46 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.192 0.747 . . . . 0.0 111.408 -6.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -94.57 117.47 30.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.079 0.951 . . . . 0.0 110.339 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 16.7 m -82.98 129.06 34.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.32 0.648 . . . . 0.0 110.859 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.9 t -123.24 114.58 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.147 1.779 . . . . 0.0 109.172 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.54 105.5 10.89 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.002 0.521 . . . . 0.0 110.969 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 82.9 t -93.13 118.47 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.384 1.074 . . . . 0.0 109.042 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -94.92 156.53 16.3 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.388 1.075 . . . . 0.0 110.406 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 174.04 -157.92 26.28 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 116.002 1.161 . . . . 0.0 116.002 -172.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 26.9 tt0 85.82 -34.52 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 129.195 2.998 . . . . 0.0 112.942 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -83.65 86.48 1.51 Allowed Glycine 0 N--CA 1.469 0.866 0 C-N-CA 124.393 0.997 . . . . 0.0 111.452 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -59.46 142.49 52.32 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.956 1.302 . . . . 0.0 112.287 -177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 75.7 t -98.71 140.04 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.617 1.567 . . . . 0.0 109.505 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.751 1.62 . . . . 0.0 111.332 179.69 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.307 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.48 -22.78 54.07 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.033 1.333 . . . . 0.0 113.745 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -143.03 -19.53 0.65 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.065 1.346 . . . . 0.0 114.501 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 178.84 -126.18 1.04 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.109 1.338 . . . . 0.0 112.164 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -80.24 12.91 2.6 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.618 1.567 . . . . 0.0 113.42 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.03 -20.54 65.42 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.274 1.83 . . . . 0.0 114.528 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 64.5 p -173.46 159.47 3.69 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.891 2.077 . . . . 0.0 111.12 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 19.0 mmt -138.35 165.92 25.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.267 1.427 . . . . 0.0 111.959 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -57.82 135.16 56.79 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.261 1.425 . . . . 0.0 112.48 -174.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 26.9 ptm -61.77 154.56 25.36 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.694 1.197 . . . . 0.0 113.137 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 5.8 m -121.52 145.79 47.59 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.598 1.559 . . . . 0.0 109.069 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -155.76 160.22 40.12 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.1 tt -163.05 155.13 18.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.766 2.026 . . . . 0.0 110.836 -172.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 68.4 mttm -130.25 151.85 50.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.713 1.205 . . . . 0.0 112.766 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 40.8 t -138.46 131.14 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.651 1.58 . . . . 0.0 109.788 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.2 77.35 1.86 Allowed Glycine 0 N--CA 1.471 1.0 0 C-N-CA 124.687 1.136 . . . . 0.0 111.41 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 60.4 m -75.76 152.64 37.36 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.44 150.19 14.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.907 1.283 . . . . 0.0 112.849 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.39 160.96 25.21 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.755 1.222 . . . . 0.0 111.842 167.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -94.87 141.33 28.76 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.404 1.482 . . . . 0.0 112.66 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 37.4 mm -123.13 115.69 28.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.257 1.423 . . . . 0.0 108.887 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.7 132.39 11.99 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.35 2.7 . . . . 0.0 111.358 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 33.9 mt -148.39 143.13 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.841 1.656 . . . . 0.0 110.411 -169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 41.8 t-20 57.58 51.25 9.82 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.929 1.692 . . . . 0.0 112.478 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.2 mm -60.39 -30.25 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 125.695 1.598 . . . . 0.0 112.614 -170.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 19.5 m -72.25 -15.31 61.92 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -81.77 141.0 33.9 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.208 0.913 . . . . 0.0 112.033 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 87.1 m -115.35 -34.32 4.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.106 1.762 . . . . 0.0 111.448 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.87 60.42 6.23 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.698 1.199 . . . . 0.0 111.815 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -61.43 -26.08 67.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.89 1.676 . . . . 0.0 112.42 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 20.5 m -59.49 -23.59 62.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.74 2.61 25.83 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 1.4 mp -84.47 145.98 27.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.483 1.113 . . . . 0.0 111.579 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 40.3 p -139.94 154.72 47.29 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.46 1.904 . . . . 0.0 109.171 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -147.97 152.16 37.03 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.8 p -140.99 159.48 42.12 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.594 1.958 . . . . 0.0 110.414 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.8 t -112.98 134.8 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.055 1.342 . . . . 0.0 109.525 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 99.6 t -103.01 111.68 65.23 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.038 1.335 . . . . 0.0 108.104 163.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.37 168.25 21.8 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.747 2.965 . . . . 0.0 110.743 174.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.71 -15.85 48.63 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.061 2.507 . . . . 0.0 113.267 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 76.6 p -79.75 -9.63 59.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 113.923 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.78 -2.01 84.51 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.665 1.602 . . . . 0.0 115.065 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -77.1 77.78 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.442 1.497 . . . . 0.0 111.712 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.77 134.93 56.69 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.864 1.265 . . . . 0.0 112.04 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -140.51 151.04 62.71 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.216 1.406 . . . . 0.0 111.32 177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.38 153.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.87 3.046 . . . . 0.0 112.385 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 86.8 m -98.6 155.7 17.17 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.998 1.319 . . . . 0.0 112.381 175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.8 tp -87.88 117.97 27.1 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 160.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 32.2 mt -81.16 140.99 34.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.96 0.904 . . . . 0.0 110.256 171.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -136.12 141.56 44.18 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.828 1.251 . . . . 0.0 113.139 -174.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -82.72 117.54 22.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.282 1.433 . . . . 0.0 107.93 157.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.06 171.02 7.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.776 1.23 . . . . 0.0 112.421 -172.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -56.73 -36.71 70.05 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.646 1.578 . . . . 0.0 115.049 -166.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -85.15 2.22 44.53 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 91.8 1.99 70.04 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.672 1.606 . . . . 0.0 113.994 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.35 166.77 15.34 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.738 1.615 . . . . 0.0 113.837 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 79.8 t -96.9 144.43 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.898 1.679 . . . . 0.0 110.05 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.55 -179.95 32.84 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 123.941 0.781 . . . . 0.0 114.802 171.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.79 157.15 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.394 1.478 . . . . 0.0 112.476 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.1 m -130.32 151.88 50.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.571 1.548 . . . . 0.0 110.777 160.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 5.4 p90 -167.15 -179.63 4.67 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.669 2.388 . . . . 0.0 109.495 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 90.5 t -127.63 120.4 21.85 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-N 119.273 0.942 . . . . 0.0 110.022 171.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.93 145.03 17.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.161 3.241 . . . . 0.0 111.206 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 48.0 tttm -94.57 -50.12 5.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.911 0.884 . . . . 0.0 112.074 174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.83 171.88 8.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.864 1.666 . . . . 0.0 111.2 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.1 p -91.23 173.69 7.79 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.421 1.488 . . . . 0.0 111.462 169.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 89.23 -164.98 32.45 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.978 1.275 . . . . 0.0 113.601 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.9 116.23 8.33 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.073 0.949 . . . . 0.0 111.702 -174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 11.4 m80 -103.49 144.56 31.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.962 1.705 . . . . 0.0 109.003 165.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 95.9 mt -108.75 119.25 38.98 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.555 1.142 . . . . 0.0 109.681 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 92.3 t -88.11 131.83 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.305 1.042 . . . . 0.0 108.652 170.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -112.74 140.25 47.67 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.86 1.264 . . . . 0.0 110.054 168.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 2.9 p -138.81 133.36 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.931 0.892 . . . . 0.0 111.164 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -115.11 141.79 47.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.612 1.965 . . . . 0.0 112.649 -163.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 88.6 tttt -139.45 130.63 26.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.92 2.088 . . . . 0.0 110.055 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 65.2 t30 53.93 31.89 14.24 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.542 1.137 . . . . 0.0 113.636 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.17 -2.62 81.61 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.44 1.495 . . . . 0.0 116.09 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -129.67 150.17 51.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.622 1.711 . . . . 0.0 111.723 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -66.11 139.49 58.16 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.846 -1.159 . . . . 0.0 112.044 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 20.0 m -69.23 161.26 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 111.499 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.18 -26.93 63.36 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 17.3 m -76.77 -17.83 58.81 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.686 1.195 . . . . 0.0 114.127 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 45.0 m -79.05 144.58 63.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 120.738 -1.226 . . . . 0.0 112.922 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.5 147.19 81.4 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 118.827 0.617 . . . . 0.0 112.044 -5.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -97.31 121.67 58.01 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.924 1.29 . . . . 0.0 108.449 171.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.42 139.26 12.84 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.839 2.359 . . . . 0.0 111.288 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.7 t -131.05 124.14 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.629 1.572 . . . . 0.0 107.402 171.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 60.3 t -99.01 121.66 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.683 0.793 . . . . 0.0 110.084 -176.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -100.02 122.36 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.902 1.281 . . . . 0.0 109.644 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 42.8 t -84.71 154.69 22.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.611 0.764 . . . . 0.0 111.372 169.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -55.37 -29.26 58.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.221 1.009 . . . . 0.0 112.698 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 34.1 m -68.7 -15.72 63.6 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -92.97 -14.88 26.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.365 1.066 . . . . 0.0 113.004 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.0 mm -67.48 -28.42 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.714 1.206 . . . . 0.0 112.52 -173.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 146.77 94.57 0.15 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.132 1.349 . . . . 0.0 112.396 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -118.67 113.84 21.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.103 1.361 . . . . 0.0 109.477 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.73 71.8 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 112.282 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.4 m -53.3 -23.02 8.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.051 1.74 . . . . 0.0 114.115 174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -87.33 -17.74 31.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.758 1.223 . . . . 0.0 114.151 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.0 t -78.75 136.45 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.625 1.102 . . . . 0.0 110.162 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 80.4 mmt-85 -119.73 159.37 24.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.137 1.375 . . . . 0.0 110.516 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 26.9 m -145.92 157.23 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.58 . . . . 0.0 110.605 -178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -158.44 175.27 13.91 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.373 1.069 . . . . 0.0 112.565 -176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 101.15 166.67 27.87 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.436 1.493 . . . . 0.0 114.204 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.87 -35.2 79.48 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.611 1.164 . . . . 0.0 112.937 -170.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.34 10.99 5.58 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.588 1.566 . . . . 0.0 115.152 -173.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 80.1 mt -100.11 -7.49 24.82 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.831 1.652 . . . . 0.0 112.063 165.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -131.7 -41.6 1.05 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.485 1.514 . . . . 0.0 113.846 -171.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.77 154.82 26.84 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -150.58 -170.58 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.552 1.548 . . . . 0.0 113.865 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 72.6 m80 -140.19 146.91 39.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.054 1.342 . . . . 0.0 112.407 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 39.8 p -73.26 -17.67 61.3 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -115.19 -3.61 12.52 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -144.4 145.09 27.68 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.525 1.53 . . . . 0.0 110.268 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.75 145.95 52.81 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.977 2.452 . . . . 0.0 111.801 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -89.66 157.06 18.17 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.661 1.184 . . . . 0.0 110.672 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.95 145.34 44.1 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.819 0.848 . . . . 0.0 112.346 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -150.37 145.94 26.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.042 1.337 . . . . 0.0 111.023 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.02 144.68 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.21 1.804 . . . . 0.0 109.457 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 22.0 mt -118.96 135.67 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.266 1.826 . . . . 0.0 109.835 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -109.06 43.44 1.27 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.338 1.855 . . . . 0.0 112.669 -171.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 1.2 p -57.83 -21.36 41.97 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -29.63 59.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.48 -4.48 59.0 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.696 1.198 . . . . 0.0 113.03 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -102.77 1.59 34.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.832 1.653 . . . . 0.0 114.422 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.94 -116.81 4.53 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -128.87 161.48 29.74 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.912 1.285 . . . . 0.0 112.628 -174.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 136.28 166.38 10.88 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 124.448 1.023 . . . . 0.0 114.563 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -79.52 132.49 11.47 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.04 0.828 . . . . 0.0 112.462 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 124.33 47.25 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.548 1.939 . . . . 0.0 107.801 171.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 7.0 t -118.54 139.08 52.02 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.205 1.002 . . . . 0.0 110.647 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 5.1 tp -122.88 134.06 54.39 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.91 1.684 . . . . 0.0 109.874 -171.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.6 m -135.82 130.29 33.75 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.289 0.635 . . . . 0.0 110.501 170.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 44.9 mt -112.86 135.53 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.537 1.535 . . . . 0.0 109.323 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -133.92 155.3 50.17 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.908 1.683 . . . . 0.0 109.958 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.41 -159.11 31.67 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.381 -0.825 . . . . 0.0 115.013 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.5 -2.88 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.407 3.404 . . . . 0.0 114.18 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.6 t -156.24 161.46 40.25 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.849 1.26 . . . . 0.0 111.338 173.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 13.5 ttpp -66.29 149.87 49.7 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.324 -0.86 . . . . 0.0 110.074 166.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 20.3 m -124.05 159.76 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.394 1.078 . . . . 0.0 110.735 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -103.37 122.67 45.31 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.951 0.9 . . . . 0.0 109.188 171.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 16.0 mt -105.78 134.85 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.564 1.145 . . . . 0.0 110.131 -171.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -130.14 165.17 22.86 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.246 1.818 . . . . 0.0 110.598 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 27.5 p -143.07 162.77 34.64 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.071 1.348 . . . . 0.0 112.181 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.83 116.35 5.08 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.665 1.586 . . . . 0.0 109.706 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.55 132.6 39.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.703 1.201 . . . . 0.0 110.854 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.7 mt -111.1 153.24 25.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.647 1.179 . . . . 0.0 111.702 -173.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.45 -19.07 64.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -83.44 3.37 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.876 1.271 . . . . 0.0 113.077 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.89 -0.2 84.13 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.473 1.511 . . . . 0.0 114.17 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.1 p -81.73 166.4 20.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.095 1.758 . . . . 0.0 111.194 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.5 t -129.18 126.1 38.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.048 0.939 . . . . 0.0 110.748 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -81.92 135.03 35.43 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.412 1.085 . . . . 0.0 109.271 166.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.7 t -113.43 140.37 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.714 2.006 . . . . 0.0 108.237 167.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 10.8 p -136.09 150.21 49.03 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.187 1.395 . . . . 0.0 111.311 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.8 p90 -159.18 149.59 19.42 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.505 1.122 . . . . 0.0 111.854 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 9.0 t -114.92 108.97 47.76 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.845 0.858 . . . . 0.0 111.013 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.05 154.27 25.47 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.436 2.758 . . . . 0.0 110.56 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 27.1 m -114.28 -42.23 3.36 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.135 0.974 . . . . 0.0 112.408 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -87.9 142.83 32.57 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.769 0.828 . . . . 0.0 110.441 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.32 163.83 31.86 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.312 2.674 . . . . 0.0 111.083 173.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 134.27 -143.36 15.02 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 124.822 1.201 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -124.28 129.7 51.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.458 0.703 . . . . 0.0 111.866 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -108.02 144.98 34.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 110.773 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.14 132.28 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.334 1.454 . . . . 0.0 108.878 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 11.1 mm -108.57 127.9 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.339 1.455 . . . . 0.0 109.199 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -107.46 126.93 53.13 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.095 1.358 . . . . 0.0 110.216 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . 0.425 ' HB ' HG22 ' A' 2125 ' ' VAL . 12.6 mm -116.65 94.2 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.582 1.153 . . . . 0.0 110.231 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -86.62 130.39 34.51 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.907 1.283 . . . . 0.0 110.09 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.22 130.5 46.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.089 0.955 . . . . 0.0 109.825 168.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 56.95 26.0 11.27 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.108 1.363 . . . . 0.0 113.895 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.6 t70 72.28 12.33 5.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.991 2.516 . . . . 0.0 114.472 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -98.37 -158.82 0.7 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.775 1.63 . . . . 0.0 109.595 165.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -142.57 127.46 18.3 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.474 -1.392 . . . . 0.0 110.249 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . 0.425 HG22 ' HB ' ' A' 2118 ' ' ILE . 4.0 m -73.44 155.16 89.76 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 0.0 112.172 -167.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.14 131.31 38.82 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.654 2.903 . . . . 0.0 112.807 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.88 50.57 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.039 1.304 . . . . 0.0 114.676 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 28.9 t -77.42 144.39 70.22 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 118.926 1.363 . . . . 0.0 111.518 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.89 152.68 97.1 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.727 0.938 . . . . 0.0 112.589 -3.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -104.88 132.33 51.26 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.366 1.466 . . . . 0.0 111.298 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 69.2 m -100.36 126.21 46.69 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.643 1.177 . . . . 0.0 111.272 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.36 111.82 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.749 1.62 . . . . 0.0 109.789 -167.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 60.1 tttp -77.93 112.7 15.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.793 -0.567 . . . . 0.0 111.169 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 71.3 t -101.39 113.37 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 109.05 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.7 t -90.8 154.83 19.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.333 1.053 . . . . 0.0 110.85 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . -178.6 -161.9 27.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 115.74 1.056 . . . . 0.0 115.74 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -157.64 163.7 37.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.871 2.068 . . . . 0.0 109.081 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -62.81 120.17 20.4 Favored Glycine 0 CA--C 1.533 1.158 0 O-C-N 121.337 -0.852 . . . . 0.0 111.714 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -74.45 118.51 17.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.538 1.135 . . . . 0.0 111.064 -175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 95.7 t -143.35 142.27 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.495 1.918 . . . . 0.0 109.199 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 3.5 tppp? . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.681 1.593 . . . . 0.0 111.308 178.362 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.512 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.29 158.47 36.31 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.402 1.081 . . . . 0.0 112.811 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.4 ptp -166.03 161.75 17.53 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.962 1.705 . . . . 0.0 111.766 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -68.1 142.61 39.85 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.582 0.61 . . . . 0.0 111.832 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -155.56 36.18 0.37 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.95 1.3 . . . . 0.0 111.537 -171.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 44.2 m-20 71.63 -31.38 0.22 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 129.28 3.032 . . . . 0.0 113.889 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 8.6 t -76.74 164.38 25.92 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.102 1.361 . . . . 0.0 112.416 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 93.4 mmm -77.09 77.58 3.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.341 1.457 . . . . 0.0 111.205 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 24.8 tpp180 -60.08 126.38 27.28 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.099 0.959 . . . . 0.0 110.744 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 98.8 mtp -84.0 129.88 34.9 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.969 0.908 . . . . 0.0 111.432 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 21.0 m -113.68 132.68 55.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.193 1.797 . . . . 0.0 108.592 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 7.0 t60 -129.51 152.89 48.55 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -163.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . 0.413 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -151.73 153.89 35.22 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.196 1.798 . . . . 0.0 110.864 179.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . 0.413 ' H ' HD13 ' A' 1963 ' ' LEU . 99.0 mttt -137.8 146.54 43.68 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.06 1.344 . . . . 0.0 111.949 173.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 60.2 t -143.0 133.94 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.044 1.738 . . . . 0.0 109.617 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.16 132.43 11.08 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 123.932 0.777 . . . . 0.0 111.54 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 27.2 m -120.65 141.63 50.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.473 1.109 . . . . 0.0 112.256 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -152.26 156.72 40.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.137 0.975 . . . . 0.0 113.276 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -113.07 151.62 30.52 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 111.574 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.72 147.38 25.89 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 0.0 113.128 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 54.9 mt -128.54 126.38 23.42 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 125.309 1.444 . . . . 0.0 108.73 169.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.81 130.5 9.65 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.198 2.599 . . . . 0.0 111.237 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 40.4 mt -149.63 141.69 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.392 1.877 . . . . 0.0 108.746 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.3 t30 59.13 53.76 5.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.368 1.467 . . . . 0.0 111.906 175.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 30.1 mm -56.79 -39.52 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.747 1.619 . . . . 0.0 113.509 -163.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 17.2 m -77.12 -2.31 33.65 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -70.43 145.05 51.28 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 113.481 -171.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 41.2 p -133.13 -20.56 2.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.519 1.927 . . . . 0.0 112.984 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -88.14 50.8 2.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.303 1.441 . . . . 0.0 111.85 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -1.18 6.66 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 35.5 p -77.16 -25.9 52.42 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.705 1.602 . . . . 0.0 114.271 174.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.81 8.4 4.49 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.22 136.14 33.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.503 1.921 . . . . 0.0 109.046 166.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 11.2 t -148.25 161.47 41.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.811 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.57 154.26 38.42 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.429 1.092 . . . . 0.0 113.045 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 70.1 p -140.95 163.01 34.12 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.906 2.082 . . . . 0.0 109.599 177.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 17.8 t -116.65 136.06 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.827 1.251 . . . . 0.0 110.182 171.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 92.3 t -106.62 113.29 63.13 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.907 1.283 . . . . 0.0 108.497 166.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -83.03 174.18 9.54 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.402 3.401 . . . . 0.0 111.801 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.81 -29.22 51.6 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.538 3.492 . . . . 0.0 114.619 170.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 70.9 p -80.91 -3.57 51.88 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.855 1.262 . . . . 0.0 113.989 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 75.2 -3.11 48.7 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.474 1.511 . . . . 0.0 114.911 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -76.26 91.6 3.23 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.953 1.301 . . . . 0.0 110.928 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 131.69 50.73 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.055 0.942 . . . . 0.0 111.601 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -132.45 144.42 52.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.725 1.61 . . . . 0.0 110.04 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.07 153.02 28.35 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.435 2.757 . . . . 0.0 112.287 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 82.3 m -89.1 151.52 22.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.076 0.951 . . . . 0.0 112.402 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 59.8 tp -86.5 131.76 34.1 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.602 1.161 . . . . 0.0 108.271 157.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.7 mp -99.72 142.1 31.65 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.603 1.161 . . . . 0.0 110.133 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -139.6 139.16 36.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.678 1.191 . . . . 0.0 113.049 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -92.34 114.51 27.07 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 156.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 76.7 mt -89.85 169.39 11.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.997 -169.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -62.76 -27.47 69.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -166.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -88.43 3.6 49.43 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 119.155 0.889 . . . . 0.0 113.256 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.06 -4.41 71.15 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 126.122 1.82 . . . . 0.0 114.312 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -80.14 156.14 27.13 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.391 1.476 . . . . 0.0 113.782 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 68.6 t -89.08 140.94 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.13 1.372 . . . . 0.0 110.126 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.06 177.96 29.57 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.275 0.941 . . . . 0.0 114.488 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.35 161.08 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.142 1.377 . . . . 0.0 111.808 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 49.6 m -134.99 156.72 48.54 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.147 1.779 . . . . 0.0 110.179 170.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.8 p90 -164.3 -170.39 2.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.503 1.921 . . . . 0.0 109.381 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 70.3 t -131.85 114.35 15.3 Favored Pre-proline 0 N--CA 1.48 1.029 0 CA-C-N 119.51 1.05 . . . . 0.0 109.825 168.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.97 145.25 31.33 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.738 2.959 . . . . 0.0 110.499 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 99.7 mttt -115.04 1.15 13.87 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.44 1.096 . . . . 0.0 113.033 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -141.74 171.34 14.19 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.377 2.271 . . . . 0.0 109.73 178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 37.9 p -94.97 163.37 13.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.358 1.063 . . . . 0.0 110.742 164.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.22 -167.29 26.24 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.893 1.235 . . . . 0.0 113.738 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.3 114.63 8.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.258 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.3 m80 -99.91 147.56 25.41 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.904 1.682 . . . . 0.0 109.163 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 84.9 mt -105.62 124.21 49.18 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.327 1.051 . . . . 0.0 109.864 175.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 91.9 t -89.74 113.69 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.669 1.188 . . . . 0.0 107.956 168.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -94.09 140.88 29.18 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.53 1.132 . . . . 0.0 110.436 172.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 7.3 p -143.89 133.99 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.818 0.818 . . . . 0.0 112.104 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -136.04 137.32 41.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.668 1.987 . . . . 0.0 111.528 -164.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 82.6 tttt -134.89 132.56 38.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.474 1.509 . . . . 0.0 110.895 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 13.2 t-20 58.01 25.55 12.42 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.47 1.108 . . . . 0.0 113.368 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 89.33 5.08 73.06 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.146 1.355 . . . . 0.0 115.605 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -128.9 151.4 49.68 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.426 1.613 . . . . 0.0 111.625 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -64.74 146.66 54.47 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.028 -1.045 . . . . 0.0 112.541 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 58.0 t -72.19 145.34 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.678 0.791 . . . . 0.0 108.895 171.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.63 -29.5 64.6 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 22.1 m -84.79 -4.25 58.98 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.15 1.38 . . . . 0.0 113.972 177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 14.9 t -82.32 141.65 46.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 120.699 -1.25 . . . . 0.0 112.191 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.98 157.06 84.27 Favored 'Cis proline' 0 C--N 1.353 0.781 0 CA-C-N 119.657 0.913 . . . . 0.0 112.655 -5.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.2 mp -100.97 124.38 41.95 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.541 1.536 . . . . 0.0 108.686 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.39 141.27 14.11 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.032 2.488 . . . . 0.0 111.314 176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 38.2 t -137.83 123.77 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.481 1.512 . . . . 0.0 108.303 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.8 t -96.53 124.18 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.742 0.817 . . . . 0.0 110.222 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.23 129.07 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.974 1.31 . . . . 0.0 110.145 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 72.4 m -94.91 168.41 10.81 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.695 1.198 . . . . 0.0 112.717 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -67.52 -34.89 78.03 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.412 -1.43 . . . . 0.0 111.653 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 13.8 m -64.63 -12.14 42.64 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.335 1.454 . . . . 0.0 114.892 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -116.01 1.47 13.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.526 1.53 . . . . 0.0 113.105 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.48 -23.81 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.333 1.053 . . . . 0.0 113.288 -175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.12 37.57 0.04 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 13.2 t0 -73.97 101.23 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 118.461 1.13 . . . . 0.0 111.377 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.77 82.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.422 0.689 . . . . 0.0 112.819 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 75.7 m -62.1 -25.32 67.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.855 0.862 . . . . 0.0 113.007 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -79.82 -13.43 59.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.978 1.311 . . . . 0.0 114.209 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 61.6 t -77.28 133.17 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 120.141 1.337 . . . . 0.0 109.838 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -112.55 160.83 17.44 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.883 1.673 . . . . 0.0 110.871 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 29.2 m -146.9 159.29 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.363 1.465 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.8 t -159.49 177.48 10.9 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.608 1.163 . . . . 0.0 112.495 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 93.85 163.07 36.13 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.371 1.462 . . . . 0.0 113.908 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -75.68 -28.16 58.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.85 0.86 . . . . 0.0 113.205 -169.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.14 0.91 13.09 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.216 1.389 . . . . 0.0 115.326 -175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 89.8 mt -92.37 -5.38 52.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.94 1.696 . . . . 0.0 112.643 168.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -133.8 -43.04 0.82 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.964 1.305 . . . . 0.0 113.516 -173.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -142.23 150.2 40.63 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.832 1.253 . . . . 0.0 111.613 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -149.49 -176.23 22.51 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.579 1.085 . . . . 0.0 113.836 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.45 151.44 48.5 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 111.729 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 37.8 p -76.71 -40.19 49.54 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.863 0.865 . . . . 0.0 112.489 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -98.1 1.35 47.51 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -140.44 146.78 46.78 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.35 151.76 54.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.183 2.589 . . . . 0.0 111.847 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -106.65 130.18 54.44 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.9 1.28 . . . . 0.0 111.038 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -111.93 147.09 36.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.461 1.505 . . . . 0.0 113.323 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 55.9 p90 -156.12 155.05 31.87 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.868 1.267 . . . . 0.0 112.145 173.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.91 143.66 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.532 1.933 . . . . 0.0 109.705 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 53.2 mt -122.77 133.98 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.521 1.928 . . . . 0.0 108.839 174.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 59.1 t0 -128.93 101.1 5.92 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.802 1.641 . . . . 0.0 110.948 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 39.3 p -96.18 1.46 52.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.187 1.795 . . . . 0.0 113.275 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -60.73 -34.03 73.8 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.367 0.985 . . . . 0.0 113.221 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -84.07 -12.04 55.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.56 1.144 . . . . 0.0 113.353 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.08 -12.46 35.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.502 1.521 . . . . 0.0 114.073 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.31 -119.28 5.1 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.376 0.988 . . . . 0.0 111.823 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -103.52 162.29 13.17 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.276 1.831 . . . . 0.0 112.329 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.83 -177.77 29.51 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 123.929 0.776 . . . . 0.0 114.979 170.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -104.43 121.78 7.1 Favored Glycine 0 N--CA 1.468 0.793 0 C-N-CA 124.731 1.158 . . . . 0.0 111.113 174.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.49 123.63 36.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.374 1.47 . . . . 0.0 108.37 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 33.6 t -121.75 145.23 48.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.984 1.714 . . . . 0.0 109.73 175.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.11 133.17 22.83 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.521 0.729 . . . . 0.0 110.762 -164.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 7.6 m -129.14 136.54 50.33 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.805 0.842 . . . . 0.0 110.622 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.5 mt -119.92 138.69 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.863 1.265 . . . . 0.0 108.323 168.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.56 146.55 28.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.798 0.839 . . . . 0.0 111.7 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -176.64 -163.24 28.64 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 119.132 -0.815 . . . . 0.0 113.903 -173.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.39 -10.18 25.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 124.017 3.145 . . . . 0.0 114.482 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.1 t -152.38 169.42 22.58 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.483 1.038 . . . . 0.0 112.067 167.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.36 143.97 54.82 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.152 1.381 . . . . 0.0 111.137 171.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 14.8 m -121.08 149.17 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 118.754 0.706 . . . . 0.0 111.517 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.32 118.38 34.85 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.616 0.766 . . . . 0.0 109.469 173.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 50.0 mt -104.2 135.94 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.146 1.379 . . . . 0.0 109.795 -173.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -129.27 156.82 43.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.794 1.637 . . . . 0.0 110.384 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 34.0 p -134.46 154.99 51.12 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.229 1.412 . . . . 0.0 111.438 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -150.51 131.76 14.53 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.647 1.179 . . . . 0.0 110.736 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.91 122.88 29.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.594 1.157 . . . . 0.0 110.561 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.0 mt -92.05 151.9 20.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.927 0.891 . . . . 0.0 111.396 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -63.01 -26.34 68.81 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.406 1.082 . . . . 0.0 112.884 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -75.45 -4.98 42.7 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.953 1.301 . . . . 0.0 113.469 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 96.39 4.19 59.66 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.632 1.587 . . . . 0.0 114.745 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -95.31 163.1 13.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.176 1.79 . . . . 0.0 111.453 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.5 t -108.05 128.47 54.7 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.24 1.016 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -91.48 136.08 33.38 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.665 167.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 23.9 t -120.02 137.73 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.916 1.686 . . . . 0.0 108.414 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 14.3 p -134.94 146.54 49.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.107 1.363 . . . . 0.0 110.561 178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.8 p90 -149.82 152.08 34.58 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.519 0.728 . . . . 0.0 112.86 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 13.5 p -115.95 108.41 46.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.963 1.305 . . . . 0.0 111.24 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -79.75 169.76 17.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.676 2.918 . . . . 0.0 110.795 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 87.4 m -121.19 -51.75 2.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.949 0.899 . . . . 0.0 111.673 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -81.82 143.23 49.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.749 0.82 . . . . 0.0 110.374 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.24 162.15 34.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.124 2.549 . . . . 0.0 111.038 170.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 135.17 -161.34 24.61 Favored Glycine 0 N--CA 1.472 1.098 0 C-N-CA 125.11 1.338 . . . . 0.0 113.703 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 49.1 t30 -90.55 122.3 33.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.443 0.697 . . . . 0.0 111.273 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -104.7 136.72 43.69 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.858 1.263 . . . . 0.0 109.865 167.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.39 133.66 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.231 1.412 . . . . 0.0 108.559 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.4 mt -119.44 127.92 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.831 1.252 . . . . 0.0 109.595 173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -109.02 125.81 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.968 1.307 . . . . 0.0 110.306 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 24.4 mm -109.37 113.96 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.538 1.135 . . . . 0.0 108.802 172.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -119.15 135.21 54.77 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.451 1.5 . . . . 0.0 111.026 -173.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 30.4 t80 -130.35 126.89 38.25 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.746 0.818 . . . . 0.0 110.895 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.23 39.39 26.88 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.688 1.595 . . . . 0.0 114.074 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 15.3 t70 79.9 2.26 2.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.023 2.529 . . . . 0.0 114.025 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -96.92 -127.79 0.15 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.157 1.383 . . . . 0.0 110.774 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -171.11 128.57 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.816 2.046 . . . . 0.0 109.884 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.5 m -86.65 157.92 54.65 Favored Pre-proline 0 N--CA 1.488 1.432 0 CA-C-N 120.098 1.317 . . . . 0.0 111.706 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.44 141.63 72.25 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.905 3.07 . . . . 0.0 113.567 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 87.84 -21.54 22.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.958 1.266 . . . . 0.0 114.597 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 58.1 m -74.63 148.4 85.34 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 118.979 1.39 . . . . 0.0 111.874 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.4 140.1 65.38 Favored 'Cis proline' 0 C--N 1.351 0.708 0 CA-C-N 119.369 0.81 . . . . 0.0 111.288 -5.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -93.48 121.59 35.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.669 1.187 . . . . 0.0 110.514 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.6 m -85.63 124.32 32.04 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.397 0.679 . . . . 0.0 110.443 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.8 t -116.48 114.79 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.926 1.69 . . . . 0.0 109.085 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 58.7 tttp -78.94 103.2 8.72 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.818 0.447 . . . . 0.0 110.683 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 74.9 t -89.58 114.67 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.609 1.163 . . . . 0.0 108.599 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.3 t -94.27 161.3 14.31 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.112 0.965 . . . . 0.0 111.165 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 152.75 -139.47 7.0 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.092 0.853 . . . . 0.0 113.67 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -152.18 158.33 42.74 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.664 1.586 . . . . 0.0 109.965 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -70.2 -3.13 44.35 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.473 -1.182 . . . . 0.0 115.732 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 80.78 148.69 0.09 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.172 2.589 . . . . 0.0 112.76 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 98.7 t -67.97 134.49 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.828 1.251 . . . . 0.0 110.045 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 60.4 tttp . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.211 1.404 . . . . 0.0 112.596 -179.178 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -160.69 168.63 24.48 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.909 1.684 . . . . 0.0 111.664 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 22.1 mmt 74.35 -19.99 0.34 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 128.136 2.574 . . . . 0.0 114.993 170.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.7 4.46 85.76 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.664 1.602 . . . . 0.0 114.341 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -157.51 158.66 36.12 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.5 1.92 . . . . 0.0 111.883 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 2.0 t70 -162.26 -170.42 2.46 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.495 1.918 . . . . 0.0 110.227 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 54.1 p -155.58 143.33 19.72 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.707 1.203 . . . . 0.0 112.091 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 17.9 tmm? -75.29 127.7 33.74 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.943 0.897 . . . . 0.0 111.197 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.8 128.0 49.74 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.342 1.457 . . . . 0.0 110.346 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.0 ptm -126.72 137.45 53.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.753 1.621 . . . . 0.0 110.716 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 14.1 m -108.71 112.69 25.12 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.446 1.498 . . . . 0.0 108.944 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 8.1 t60 -106.47 158.36 16.96 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -162.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 2.8 tm? -152.91 139.02 18.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.612 2.365 . . . . 0.0 110.012 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.29 144.94 50.24 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.756 1.222 . . . . 0.0 111.17 167.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 13.8 p -155.45 141.51 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.157 0.983 . . . . 0.0 111.338 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -79.31 150.69 33.81 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.206 0.908 . . . . 0.0 113.268 -176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 47.0 m -131.92 37.53 3.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.932 1.293 . . . . 0.0 111.668 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -67.84 111.96 4.62 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.938 1.295 . . . . 0.0 111.257 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -72.13 148.06 46.06 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.242 1.017 . . . . 0.0 112.33 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -94.93 150.46 20.15 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 73.0 mt -136.93 126.11 15.35 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.336 1.854 . . . . 0.0 108.961 171.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.78 149.35 12.56 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.855 3.037 . . . . 0.0 112.261 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 4.7 mp -140.12 134.99 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.111 1.365 . . . . 0.0 110.368 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 58.8 t30 42.28 73.05 0.14 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.247 2.219 . . . . 0.0 114.866 166.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 21.4 mm -67.54 124.35 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.863 . . . . 0.0 111.223 -173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 21.4 t -170.33 166.34 8.68 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.499 1.92 . . . . 0.0 110.432 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -85.55 62.96 7.8 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.989 1.316 . . . . 0.0 110.868 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 27.6 p -86.45 158.34 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.62 1.568 . . . . 0.0 112.219 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.43 119.36 27.63 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.482 1.113 . . . . 0.0 110.259 170.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 11.2 mp -75.91 -11.11 59.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.113 0.965 . . . . 0.0 113.132 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 17.2 t -67.53 -37.5 82.85 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.611 1.096 . . . . 0.0 113.363 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.47 2.5 24.27 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 13.8 mt -91.11 133.57 35.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.134 1.374 . . . . 0.0 110.526 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 52.9 p -138.82 163.02 33.33 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.891 1.676 . . . . 0.0 110.381 173.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -149.9 148.91 29.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.937 0.895 . . . . 0.0 113.148 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -135.78 164.53 27.7 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.874 2.07 . . . . 0.0 109.767 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -116.24 134.08 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.597 1.159 . . . . 0.0 109.346 166.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.4 t -104.29 111.94 65.31 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.302 1.441 . . . . 0.0 108.11 168.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.83 169.39 20.75 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.806 3.004 . . . . 0.0 110.872 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.21 -15.83 47.1 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.058 2.506 . . . . 0.0 113.184 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.6 p -79.85 -4.99 54.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.005 1.322 . . . . 0.0 113.847 168.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.04 59.11 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.385 1.469 . . . . 0.0 114.965 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -77.67 76.76 4.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.567 1.547 . . . . 0.0 111.637 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -58.29 136.59 57.39 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.69 1.196 . . . . 0.0 112.398 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -139.01 151.34 67.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.441 1.497 . . . . 0.0 111.081 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.39 152.94 44.63 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.741 2.96 . . . . 0.0 112.489 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 90.3 m -95.6 152.68 18.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.58 1.152 . . . . 0.0 112.105 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 54.1 tp -90.17 122.73 33.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.668 1.187 . . . . 0.0 109.113 167.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 66.4 mt -84.07 139.01 32.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.325 1.05 . . . . 0.0 110.635 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 92.2 mttt -141.36 140.6 33.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.948 1.299 . . . . 0.0 112.367 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -87.5 125.9 34.59 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 160.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 90.8 mt -105.71 176.38 5.18 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.828 1.651 . . . . 0.0 113.031 -163.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 59.3 mtm-85 -55.57 -34.89 65.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.635 1.974 . . . . 0.0 115.254 -164.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 20.6 m120 -96.61 5.51 50.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.622 1.169 . . . . 0.0 113.398 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.45 71.9 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.46 1.505 . . . . 0.0 113.965 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -73.8 173.73 9.44 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.961 1.704 . . . . 0.0 113.273 173.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 98.1 t -127.85 142.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 125.346 1.459 . . . . 0.0 109.961 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -155.85 -174.75 26.05 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.5 pp -108.6 160.86 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.475 1.91 . . . . 0.0 110.99 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 78.9 p -146.93 155.15 42.06 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.904 1.282 . . . . 0.0 111.125 165.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 12.5 p90 -163.46 -175.69 4.34 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.95 1.7 . . . . 0.0 110.728 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 56.5 t -134.15 124.87 17.66 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.313 1.045 . . . . 0.0 109.244 168.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.64 150.18 27.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.09 3.194 . . . . 0.0 111.767 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -103.49 -8.04 20.42 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.228 1.011 . . . . 0.0 113.479 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -142.84 171.39 14.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.888 2.075 . . . . 0.0 110.341 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 31.1 p -93.23 164.35 13.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.743 1.217 . . . . 0.0 111.096 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 97.04 -168.68 24.74 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.206 1.384 . . . . 0.0 113.544 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.8 117.67 11.68 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.899 0.857 . . . . 0.0 111.719 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 6.7 m80 -103.31 148.29 26.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.067 1.747 . . . . 0.0 109.11 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 85.1 mt -107.86 126.89 53.21 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.136 0.974 . . . . 0.0 109.696 173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 28.4 t -84.82 125.01 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 163.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -105.46 128.75 53.71 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.462 1.105 . . . . 0.0 110.071 172.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 34.6 t -129.34 129.84 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.986 1.314 . . . . 0.0 109.341 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -139.72 141.51 36.91 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -174.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.53 125.12 53.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.393 2.277 . . . . 0.0 109.477 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.64 26.61 11.41 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.688 1.195 . . . . 0.0 113.425 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 97.05 -13.03 65.34 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.83 1.681 . . . . 0.0 115.937 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.28 144.73 42.22 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.684 1.742 . . . . 0.0 112.142 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -62.65 142.8 57.9 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 85.6 t -70.83 149.51 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.449 1.499 . . . . 0.0 109.462 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.44 -25.17 64.13 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 70.9 m -86.42 -8.91 57.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.549 1.14 . . . . 0.0 113.785 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 24.7 t -88.9 145.22 34.23 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.069 1.347 . . . . 0.0 112.383 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -77.52 154.09 95.04 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.608 0.896 . . . . 0.0 112.565 -3.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.8 120.21 50.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.4 1.48 . . . . 0.0 108.515 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.3 142.5 13.38 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.914 2.409 . . . . 0.0 111.38 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.25 125.57 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.27 1.428 . . . . 0.0 108.081 174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 57.4 t -97.01 121.76 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.499 0.72 . . . . 0.0 109.807 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.87 123.93 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.88 1.272 . . . . 0.0 109.253 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 159.81 15.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.617 0.767 . . . . 0.0 111.402 170.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -57.48 -30.68 65.27 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.985 0.914 . . . . 0.0 112.782 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 30.9 m -67.29 -18.4 65.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.426 1.09 . . . . 0.0 113.813 177.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -93.15 -11.12 33.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.517 1.127 . . . . 0.0 112.847 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.19 -35.31 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.438 1.095 . . . . 0.0 112.306 -174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 157.98 61.61 0.01 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 123.911 0.767 . . . . 0.0 113.523 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.12 95.63 8.68 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.459 0.703 . . . . 0.0 110.853 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -56.23 -36.9 69.0 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.651 0.78 . . . . 0.0 112.388 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.9 m -53.99 -21.16 7.49 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.078 1.751 . . . . 0.0 114.432 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -97.24 -7.5 32.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.562 1.545 . . . . 0.0 113.891 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 94.3 t -75.64 137.28 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.722 1.146 . . . . 0.0 109.94 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -123.2 157.62 32.62 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.277 1.431 . . . . 0.0 111.072 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 28.0 m -146.34 156.93 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.319 1.448 . . . . 0.0 110.972 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.18 174.24 15.49 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.625 1.17 . . . . 0.0 112.156 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 110.54 -157.51 14.96 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.395 1.474 . . . . 0.0 113.644 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -109.89 -36.29 5.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.642 1.177 . . . . 0.0 112.549 -169.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -73.63 -0.18 53.15 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 125.113 1.34 . . . . 0.0 115.606 -171.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.92 -5.47 50.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.33 1.452 . . . . 0.0 112.451 167.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -125.09 -38.16 2.35 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.223 1.409 . . . . 0.0 113.346 -176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.8 154.59 30.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.306 1.042 . . . . 0.0 113.238 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.67 -176.17 24.16 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.399 1.476 . . . . 0.0 113.761 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 68.0 m80 -140.3 145.45 37.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.768 1.227 . . . . 0.0 112.496 -173.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 46.2 p -68.94 -16.25 63.7 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -117.54 -5.02 11.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.638 1.348 . . . . 0.0 114.638 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -144.88 146.48 31.51 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 110.853 -176.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.24 145.71 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.884 2.39 . . . . 0.0 111.604 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -99.4 148.44 24.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.11 1.364 . . . . 0.0 110.374 171.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.96 146.21 51.03 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.851 0.861 . . . . 0.0 113.093 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.7 148.15 26.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.287 1.435 . . . . 0.0 110.958 173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.38 140.29 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.64 1.576 . . . . 0.0 109.165 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 37.9 mt -112.13 134.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.872 1.669 . . . . 0.0 109.272 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 65.3 t0 -125.53 103.73 8.03 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.033 1.733 . . . . 0.0 110.644 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 22.8 p -99.21 0.48 43.35 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.403 1.881 . . . . 0.0 113.127 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.88 -32.7 72.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 0.0 113.326 -171.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.78 -14.46 58.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.667 1.187 . . . . 0.0 113.451 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -91.11 -0.56 57.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.344 1.457 . . . . 0.0 114.307 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 81.3 -136.24 15.81 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.643 1.116 . . . . 0.0 111.937 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -88.42 169.26 11.95 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.004 1.322 . . . . 0.0 112.329 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 142.24 -151.55 23.01 Favored Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.333 0.968 . . . . 0.0 114.255 171.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -148.62 148.72 20.42 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.426 1.489 . . . . 0.0 112.691 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.12 128.51 54.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.838 2.055 . . . . 0.0 109.501 -177.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 11.7 t -121.75 139.44 53.58 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.681 1.592 . . . . 0.0 109.749 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.5 tt -144.16 142.14 30.37 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.57 1.148 . . . . 0.0 110.139 -162.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 87.0 p -147.61 149.83 33.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 14.6 mt -117.39 127.8 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.813 1.245 . . . . 0.0 109.289 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -114.58 154.91 27.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.916 2.086 . . . . 0.0 109.229 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 164.01 -162.55 35.28 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.156 -0.965 . . . . 0.0 114.832 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 -6.41 19.14 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.127 3.218 . . . . 0.0 114.294 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.3 t -154.57 157.59 38.5 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.631 1.105 . . . . 0.0 112.248 173.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 128.25 35.0 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.08 1.352 . . . . 0.0 109.506 173.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 30.4 m -115.96 169.33 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.984 1.313 . . . . 0.0 111.87 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -110.69 121.28 44.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.396 1.078 . . . . 0.0 110.193 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.19 132.04 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.859 0.864 . . . . 0.0 108.98 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -120.01 157.89 27.93 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.184 1.794 . . . . 0.0 109.706 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 36.3 p -136.16 160.42 38.73 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.657 1.183 . . . . 0.0 111.807 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -152.94 119.54 5.64 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.859 1.264 . . . . 0.0 110.002 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.3 t70 -74.96 124.15 26.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.354 1.062 . . . . 0.0 110.302 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 61.6 mt -94.95 151.72 18.95 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.288 1.035 . . . . 0.0 111.441 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -16.1 63.86 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -174.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -81.95 -7.03 59.58 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.875 1.27 . . . . 0.0 113.267 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 98.62 1.63 57.61 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.667 1.603 . . . . 0.0 115.05 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 36.0 p -93.62 171.69 8.73 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.202 1.801 . . . . 0.0 111.503 175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -121.32 124.36 44.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.995 0.918 . . . . 0.0 111.504 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -80.51 134.04 35.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.292 1.037 . . . . 0.0 109.395 165.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 39.7 t -117.86 137.5 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.389 1.876 . . . . 0.0 108.186 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.1 p -138.85 148.59 43.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.346 1.458 . . . . 0.0 111.401 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.6 p90 -157.13 150.29 23.84 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.602 1.161 . . . . 0.0 111.914 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 12.0 t -114.79 105.59 53.09 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.16 0.984 . . . . 0.0 110.712 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -77.98 150.0 26.26 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.334 2.689 . . . . 0.0 110.618 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 45.9 m -111.11 -45.83 3.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.073 0.949 . . . . 0.0 112.19 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -85.49 142.3 37.41 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.778 0.831 . . . . 0.0 110.459 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.97 163.0 33.91 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.268 2.645 . . . . 0.0 111.078 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 133.45 -144.69 16.7 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 124.871 1.224 . . . . 0.0 112.2 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -123.23 129.97 52.11 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.645 0.778 . . . . 0.0 111.894 176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -107.2 142.98 36.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.673 1.589 . . . . 0.0 110.453 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.16 130.11 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.979 1.311 . . . . 0.0 108.378 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 18.2 mt -113.58 122.08 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.237 1.015 . . . . 0.0 109.437 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -95.62 128.35 42.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.312 1.445 . . . . 0.0 110.16 174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.87 112.97 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.902 1.281 . . . . 0.0 108.993 174.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -126.37 132.95 51.44 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.106 1.363 . . . . 0.0 111.451 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 87.7 t80 -129.68 128.31 42.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.102 1.761 . . . . 0.0 109.729 -177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 50.19 43.51 26.13 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.22 1.008 . . . . 0.0 113.049 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 12.0 t0 74.47 7.85 4.5 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.977 2.511 . . . . 0.0 114.806 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -121.96 132.44 54.54 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.17 1.388 . . . . 0.0 111.234 -175.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 126.64 29.27 Favored 'General case' 0 CA--C 1.553 1.064 0 O-C-N 120.907 -1.12 . . . . 0.0 110.97 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.5 m -80.67 160.88 65.87 Favored Pre-proline 0 N--CA 1.488 1.47 0 CA-C-N 119.335 0.971 . . . . 0.0 112.097 -172.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -53.23 137.68 63.67 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.689 2.926 . . . . 0.0 113.419 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.93 13.59 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.99 1.281 . . . . 0.0 114.213 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 14.2 t -76.86 142.94 70.21 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 118.42 1.11 . . . . 0.0 111.041 174.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 144.7 81.8 Favored 'Cis proline' 0 C--N 1.353 0.778 0 CA-C-N 120.002 1.036 . . . . 0.0 111.971 -2.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.79 120.02 36.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.537 1.135 . . . . 0.0 110.42 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 68.3 m -91.05 123.58 34.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.08 0.952 . . . . 0.0 110.449 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 13.3 t -122.56 115.38 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.504 1.521 . . . . 0.0 109.996 -166.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.9 tttt -77.81 120.52 22.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.02 0.528 . . . . 0.0 111.239 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 75.5 t -107.38 119.26 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.073 1.349 . . . . 0.0 109.014 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.8 t -106.42 162.83 13.35 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.768 1.227 . . . . 0.0 111.87 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 127.23 168.3 12.49 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.773 1.654 . . . . 0.0 113.565 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.34 -14.59 32.8 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.419 1.088 . . . . 0.0 113.85 -168.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 83.61 152.46 13.37 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.519 1.057 . . . . 0.0 112.473 -170.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -71.89 137.86 47.75 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.965 0.906 . . . . 0.0 112.226 -173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 12.7 p -163.52 147.31 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.323 1.849 . . . . 0.0 110.54 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.193 1.797 . . . . 0.0 111.277 177.968 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.455 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.29 152.51 43.19 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.263 1.025 . . . . 0.0 112.713 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 64.3 ttp -164.12 -56.17 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.627 1.571 . . . . 0.0 111.124 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -99.77 169.23 22.0 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.418 1.485 . . . . 0.0 112.962 173.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -161.33 146.39 13.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.001 1.721 . . . . 0.0 111.046 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -102.5 149.52 24.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.18 1.392 . . . . 0.0 112.685 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 16.4 m -72.33 -21.16 61.37 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 19.2 mmt -72.19 120.6 18.02 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.808 0.843 . . . . 0.0 111.095 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.27 149.83 33.49 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.439 1.096 . . . . 0.0 109.025 166.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 1.9 mmm -127.15 128.83 46.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.894 1.278 . . . . 0.0 111.29 -175.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 15.4 m -130.85 146.35 52.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.868 1.667 . . . . 0.0 109.443 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 33.7 p-80 -155.83 159.32 39.29 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -169.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . 0.449 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -159.65 154.19 24.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.573 1.949 . . . . 0.0 110.317 -170.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . 0.449 ' H ' HD13 ' A' 1963 ' ' LEU . 95.5 mttt -135.7 144.27 45.84 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.906 1.282 . . . . 0.0 111.714 175.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 32.5 m -143.0 151.35 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.89 1.276 . . . . 0.0 111.465 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.32 147.36 20.07 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.409 1.004 . . . . 0.0 112.133 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 26.3 m -136.12 147.07 47.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.158 1.383 . . . . 0.0 112.088 -177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -160.27 154.69 23.66 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -171.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -85.49 161.09 19.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.893 1.277 . . . . 0.0 111.583 167.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -94.9 135.43 36.43 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.918 1.287 . . . . 0.0 111.33 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 56.1 mt -125.25 124.0 25.23 Favored Pre-proline 0 N--CA 1.482 1.125 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.69 170.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.45 133.17 11.64 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.893 2.396 . . . . 0.0 111.464 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 32.4 mt -149.5 143.78 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.046 2.138 . . . . 0.0 107.798 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 52.1 t30 60.89 45.0 10.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.645 1.178 . . . . 0.0 110.789 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 25.7 mm -43.79 -56.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 127.826 2.45 . . . . 0.0 115.04 -147.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 49.6 m -105.32 0.88 27.46 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.881 0.872 . . . . 0.0 113.335 -171.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -95.09 74.6 3.45 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.496 1.518 . . . . 0.0 109.617 -171.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 44.3 p -71.87 22.24 0.05 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 127.767 2.427 . . . . 0.0 115.59 -168.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 47.9 t0 -91.19 60.47 4.25 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.893 1.677 . . . . 0.0 111.298 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.29 -21.7 66.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.71 1.204 . . . . 0.0 113.17 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 18.4 m -61.76 -17.71 57.04 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.404 1.482 . . . . 0.0 114.777 -175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.4 pp -122.63 14.63 10.2 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.33 1.452 . . . . 0.0 113.745 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.19 145.77 26.87 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.467 1.107 . . . . 0.0 111.588 173.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 29.3 p -146.21 146.77 30.92 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.372 1.869 . . . . 0.0 109.674 170.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -143.75 149.89 37.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 36.5 p -141.16 140.97 34.16 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.912 2.085 . . . . 0.0 109.532 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -95.41 133.78 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.718 0.807 . . . . 0.0 109.834 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.7 t -102.17 110.28 62.15 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.021 1.328 . . . . 0.0 107.967 165.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.74 170.88 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.943 3.096 . . . . 0.0 110.972 175.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.79 -15.58 49.67 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.002 2.468 . . . . 0.0 113.478 176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 79.5 p -80.74 -11.21 59.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.759 1.224 . . . . 0.0 113.947 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 82.21 -1.76 86.26 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.606 1.574 . . . . 0.0 114.973 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -76.83 83.22 3.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.462 1.505 . . . . 0.0 111.626 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -59.66 134.44 57.02 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.75 1.22 . . . . 0.0 112.291 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -140.69 149.47 56.88 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.329 1.452 . . . . 0.0 111.615 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.81 153.53 42.82 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.876 3.051 . . . . 0.0 112.878 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 73.0 m -97.14 156.3 16.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.913 1.285 . . . . 0.0 112.041 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 61.6 tp -87.06 131.46 34.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.733 1.213 . . . . 0.0 108.744 162.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.8 mp -97.2 143.48 27.95 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.55 1.14 . . . . 0.0 110.297 177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.8 146.42 34.2 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.791 1.236 . . . . 0.0 113.476 -171.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -93.49 120.06 33.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.682 1.193 . . . . 0.0 107.903 156.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.71 170.92 9.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.517 1.127 . . . . 0.0 112.977 -170.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 62.7 mtt85 -64.71 -29.27 70.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.026 1.73 . . . . 0.0 114.276 -164.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.2 t30 -86.04 -1.88 57.78 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.653 1.181 . . . . 0.0 113.21 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 95.95 -2.0 63.66 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.806 1.67 . . . . 0.0 114.531 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.59 165.81 15.89 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.497 1.519 . . . . 0.0 113.665 176.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 43.8 t -89.29 145.1 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.045 1.738 . . . . 0.0 110.596 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.0 -173.67 28.81 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.44 168.22 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.634 . . . . 0.0 112.61 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 36.4 m -139.06 158.07 44.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.527 1.931 . . . . 0.0 111.107 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -161.71 -174.05 4.03 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.837 2.055 . . . . 0.0 109.704 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 60.1 t -132.19 120.22 17.03 Favored Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 119.504 1.047 . . . . 0.0 110.119 169.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.11 134.57 13.11 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.189 3.259 . . . . 0.0 110.408 171.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -95.25 -10.18 31.07 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -143.52 174.09 11.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.941 2.097 . . . . 0.0 109.847 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 38.4 p -85.21 167.75 15.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.683 1.193 . . . . 0.0 111.593 171.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.67 -168.59 21.69 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.163 1.363 . . . . 0.0 114.047 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -73.52 119.04 17.19 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.082 0.953 . . . . 0.0 111.967 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 17.0 m80 -109.22 143.24 38.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.583 1.953 . . . . 0.0 109.172 169.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.58 126.07 52.1 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.28 1.032 . . . . 0.0 109.869 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 33.2 t -90.27 111.71 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.644 1.178 . . . . 0.0 108.268 168.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -90.08 136.73 32.87 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.216 1.006 . . . . 0.0 109.76 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 6.8 p -143.99 127.57 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 121.958 0.885 . . . . 0.0 112.208 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -110.44 135.43 51.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.802 2.041 . . . . 0.0 111.464 -176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -112.7 119.77 39.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.097 2.159 . . . . 0.0 109.166 172.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.5 t-20 56.02 -102.62 0.16 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.011 1.325 . . . . 0.0 111.089 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -112.22 8.59 26.9 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.657 1.599 . . . . 0.0 115.603 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -144.02 151.82 40.2 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.748 1.774 . . . . 0.0 112.608 -172.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -66.42 144.49 56.49 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.872 -1.143 . . . . 0.0 112.869 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 92.2 t -63.42 147.49 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.46 1.104 . . . . 0.0 109.368 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -56.68 -31.05 64.06 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 15.2 m -84.37 -8.2 59.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.003 1.321 . . . . 0.0 113.982 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 23.2 t -82.49 141.42 45.39 Favored Pre-proline 0 CA--C 1.547 0.844 0 O-C-N 120.784 -1.198 . . . . 0.0 112.543 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.92 147.23 83.11 Favored 'Cis proline' 0 C--N 1.353 0.767 0 CA-C-N 119.317 0.792 . . . . 0.0 112.315 -4.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 5.0 mp -94.85 118.78 66.68 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 125.038 1.335 . . . . 0.0 108.619 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.58 140.55 13.35 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.971 2.447 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 18.6 t -135.79 127.33 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.952 1.701 . . . . 0.0 107.962 175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 58.0 t -100.29 122.02 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.796 0.838 . . . . 0.0 110.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.81 128.75 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.116 1.366 . . . . 0.0 109.993 -174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 12.8 t -94.53 172.89 7.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.651 1.18 . . . . 0.0 111.703 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -68.78 -33.55 74.06 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.358 -1.464 . . . . 0.0 112.015 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 14.7 m -67.03 -3.43 7.22 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -173.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.77 4.57 10.55 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.619 1.568 . . . . 0.0 113.19 176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 41.1 mm -73.96 -26.47 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.175 0.99 . . . . 0.0 112.309 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 163.05 53.79 0.02 OUTLIER Glycine 0 C--N 1.342 0.862 0 N-CA-C 114.989 0.755 . . . . 0.0 114.989 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.91 91.05 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 118.012 0.906 . . . . 0.0 111.235 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.08 -39.62 69.5 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.822 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 18.8 m -55.4 -23.95 27.45 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.422 1.489 . . . . 0.0 114.242 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -91.08 -9.14 46.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.088 1.355 . . . . 0.0 113.73 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 134.46 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.7 1.136 . . . . 0.0 110.033 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.98 157.78 22.95 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.651 1.58 . . . . 0.0 110.796 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 33.9 m -146.3 159.09 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.285 1.434 . . . . 0.0 111.022 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.0 t -158.69 174.52 14.92 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.794 1.238 . . . . 0.0 112.258 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 98.66 166.51 30.78 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.316 1.436 . . . . 0.0 114.277 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -75.92 -29.4 58.37 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.508 1.123 . . . . 0.0 113.454 -167.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -72.27 3.96 20.88 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.115 1.341 . . . . 0.0 115.165 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 87.5 mt -93.88 -8.09 41.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 112.339 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -126.4 -42.45 1.82 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.148 1.379 . . . . 0.0 113.688 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -158.01 159.9 36.89 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -153.47 -177.56 27.11 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.223 1.392 . . . . 0.0 114.038 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -131.67 151.17 51.83 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.707 1.603 . . . . 0.0 112.081 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 32.5 p -71.71 -14.63 62.08 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -112.56 -9.77 13.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -130.01 157.12 77.91 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 126.238 1.815 . . . . 0.0 110.844 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.52 141.44 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.805 2.337 . . . . 0.0 110.533 169.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -90.76 149.37 22.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.587 1.155 . . . . 0.0 109.854 165.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -134.62 147.69 50.25 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.588 0.755 . . . . 0.0 112.545 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.7 p90 -151.64 150.64 30.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.391 1.476 . . . . 0.0 110.636 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.28 140.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.849 1.659 . . . . 0.0 109.287 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.88 134.55 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.226 1.811 . . . . 0.0 109.049 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.5 t0 -123.99 96.69 5.04 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.701 . . . . 0.0 110.611 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 7.9 p -95.15 -0.11 53.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.32 2.248 . . . . 0.0 113.172 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -60.15 -38.47 83.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.263 1.025 . . . . 0.0 112.805 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -78.71 -16.02 57.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.829 1.252 . . . . 0.0 113.319 176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -87.38 -2.74 58.84 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.796 1.239 . . . . 0.0 113.865 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 87.16 -122.03 6.03 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.805 1.193 . . . . 0.0 111.432 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -113.69 164.67 13.4 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.546 1.538 . . . . 0.0 112.233 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.9 -176.74 26.59 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 169.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -99.0 129.18 9.81 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.866 1.222 . . . . 0.0 111.36 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.25 119.43 38.74 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.753 1.621 . . . . 0.0 107.863 172.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 29.9 t -113.87 141.3 47.52 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.734 1.214 . . . . 0.0 110.108 173.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.1 tt -140.26 132.99 28.99 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.48 1.112 . . . . 0.0 110.331 -163.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 67.2 m -133.67 133.35 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.642 0.777 . . . . 0.0 111.039 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 55.4 mt -116.63 133.28 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 125.282 1.433 . . . . 0.0 108.463 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -138.39 148.68 44.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.821 0.848 . . . . 0.0 111.381 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 172.84 -163.74 35.64 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.939 0.781 . . . . 0.0 113.87 -172.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.91 -6.4 19.04 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.045 3.163 . . . . 0.0 114.723 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 6.7 t -155.01 160.9 41.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.084 1.311 . . . . 0.0 113.103 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -59.92 140.93 56.35 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.988 1.715 . . . . 0.0 111.08 171.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.5 m -132.43 139.54 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.454 0.702 . . . . 0.0 111.389 173.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -83.81 102.04 12.05 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 109.702 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 19.9 mt -80.03 124.2 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -116.43 157.34 25.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.347 1.859 . . . . 0.0 109.929 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 76.6 p -141.28 157.29 45.42 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.862 1.265 . . . . 0.0 111.165 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -155.05 111.44 3.21 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.622 1.169 . . . . 0.0 110.178 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.6 126.84 31.52 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.406 1.083 . . . . 0.0 110.564 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.77 159.85 14.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 111.883 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.34 -22.07 66.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.164 0.986 . . . . 0.0 113.368 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 28.1 t0 -83.44 -0.5 50.34 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.903 1.281 . . . . 0.0 113.323 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 91.13 -1.52 77.42 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.587 1.565 . . . . 0.0 115.068 174.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 27.9 p -85.5 158.69 20.1 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.762 1.625 . . . . 0.0 111.187 173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 26.9 t -114.83 121.82 44.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.732 0.813 . . . . 0.0 111.151 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -75.97 140.48 42.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.606 0.763 . . . . 0.0 109.347 163.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 40.9 t -123.26 138.92 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.36 1.864 . . . . 0.0 108.082 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 1.2 p -136.03 149.14 48.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.573 1.549 . . . . 0.0 111.346 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -159.43 147.91 17.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.651 1.18 . . . . 0.0 111.505 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 33.2 t -117.43 107.12 45.53 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.828 0.851 . . . . 0.0 111.019 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.71 150.67 24.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.694 2.929 . . . . 0.0 110.49 173.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 90.5 m -112.86 -41.75 3.72 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.995 0.918 . . . . 0.0 112.238 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -83.72 140.79 41.01 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 123.569 0.748 . . . . 0.0 110.151 171.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.15 23.32 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.379 2.72 . . . . 0.0 111.236 174.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 122.23 -154.03 16.84 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.12 1.343 . . . . 0.0 113.197 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -93.35 131.85 38.13 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.092 0.957 . . . . 0.0 112.514 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -119.87 150.32 40.65 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.646 1.578 . . . . 0.0 109.763 168.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.2 mp -118.43 131.76 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.634 1.174 . . . . 0.0 109.188 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.29 130.28 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.049 1.34 . . . . 0.0 109.427 171.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -110.37 119.98 40.97 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.115 1.366 . . . . 0.0 109.657 173.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 28.2 mm -113.29 117.9 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.335 1.054 . . . . 0.0 109.369 174.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -134.48 131.8 38.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.224 1.41 . . . . 0.0 111.5 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 40.6 t80 -123.71 123.17 39.92 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 110.054 -174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 52.84 32.91 13.17 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.353 1.461 . . . . 0.0 113.986 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.9 t0 84.16 7.45 0.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.746 2.818 . . . . 0.0 114.654 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -113.73 129.42 56.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.531 1.132 . . . . 0.0 111.278 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -65.23 123.16 18.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.384 1.474 . . . . 0.0 110.376 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -75.01 154.53 86.68 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.197 -0.939 . . . . 0.0 110.983 -171.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.18 137.85 68.72 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.424 2.083 . . . . 0.0 111.274 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 98.34 -26.74 22.5 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.325 1.44 . . . . 0.0 113.304 -171.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 67.8 m -70.25 150.17 95.95 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 118.895 1.347 . . . . 0.0 112.103 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.98 147.66 83.81 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 CA-C-N 119.08 0.707 . . . . 0.0 110.836 -7.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -99.08 118.78 36.6 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.836 0.854 . . . . 0.0 110.853 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 46.4 m -87.09 125.31 34.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.121 0.968 . . . . 0.0 111.202 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 16.5 t -117.9 122.37 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.927 1.691 . . . . 0.0 109.542 -173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 59.8 tttp -86.86 111.58 20.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.201 0.601 . . . . 0.0 110.781 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 95.8 t -97.31 117.04 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.51 1.124 . . . . 0.0 108.814 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 6.3 t -94.12 151.92 19.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.964 0.906 . . . . 0.0 111.222 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 173.65 150.85 7.79 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.978 0.799 . . . . 0.0 114.549 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -106.47 -3.11 21.3 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.219 1.407 . . . . 0.0 113.678 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 88.67 140.11 7.18 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.461 1.505 . . . . 0.0 112.803 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -83.87 152.07 24.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.514 1.125 . . . . 0.0 112.66 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 93.9 t -91.66 134.67 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.294 1.438 . . . . 0.0 109.232 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.013 1.325 . . . . 0.0 112.329 179.494 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.64 160.49 32.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.405 1.082 . . . . 0.0 112.773 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -73.33 -22.81 60.23 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -96.74 166.12 23.65 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.633 1.587 . . . . 0.0 113.089 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -78.0 -11.74 59.93 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.798 1.239 . . . . 0.0 113.44 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.4 t0 -152.7 163.95 38.69 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.205 1.802 . . . . 0.0 111.648 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 41.8 m -70.09 171.53 9.46 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.854 1.662 . . . . 0.0 113.905 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 94.4 mtp -60.41 148.22 38.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.177 0.991 . . . . 0.0 112.957 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -64.74 135.69 56.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.855 1.262 . . . . 0.0 110.822 175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 17.8 ptm -145.34 142.85 29.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.722 1.209 . . . . 0.0 112.627 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 66.8 m -109.34 154.87 21.92 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 110.273 173.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -149.63 160.56 43.4 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.16 152.23 27.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.282 1.833 . . . . 0.0 109.952 -171.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -134.51 143.62 47.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.566 1.146 . . . . 0.0 111.992 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 67.5 t -140.93 132.03 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.909 1.684 . . . . 0.0 109.666 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -81.24 117.93 4.52 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 40.8 m -80.48 -42.79 21.94 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -170.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . 59.26 -170.17 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.639 1.576 . . . . 0.0 113.278 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -148.0 147.94 30.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.331 1.453 . . . . 0.0 110.132 167.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -88.55 133.01 34.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.072 0.949 . . . . 0.0 112.2 -171.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 41.5 mt -127.62 119.01 21.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 125.093 1.357 . . . . 0.0 109.049 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.07 135.65 14.02 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.926 2.417 . . . . 0.0 110.627 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 47.9 mt -146.08 139.35 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.865 1.666 . . . . 0.0 108.468 -176.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 45.2 t30 63.69 76.57 0.35 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.758 1.623 . . . . 0.0 110.915 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 10.1 mm -84.75 63.44 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.266 1.426 . . . . 0.0 110.073 -173.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 t -162.76 -178.58 6.25 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.918 1.687 . . . . 0.0 111.19 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -73.7 125.8 28.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.253 1.021 . . . . 0.0 110.695 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 2.4 m -165.09 137.9 4.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.357 2.263 . . . . 0.0 108.683 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 12.6 t70 -77.18 131.49 38.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.716 1.206 . . . . 0.0 111.173 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 1.7 mt -85.23 -13.81 48.73 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -173.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 47.7 m -82.19 -26.78 33.05 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.772 1.169 . . . . 0.0 112.781 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 2.5 pp -93.93 6.26 49.03 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.268 1.427 . . . . 0.0 113.321 173.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.91 143.29 31.98 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 0.0 110.666 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 37.6 p -144.03 160.65 40.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.358 1.863 . . . . 0.0 110.365 172.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -157.33 152.6 26.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.183 0.993 . . . . 0.0 113.214 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 66.9 p -138.0 164.6 28.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.976 2.11 . . . . 0.0 109.747 178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.4 t -119.56 136.46 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.353 1.461 . . . . 0.0 110.056 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 96.1 t -104.9 115.6 62.2 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.33 1.452 . . . . 0.0 108.567 167.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.91 173.04 10.5 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 123.987 3.124 . . . . 0.0 111.521 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.43 -33.21 55.82 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 124.343 3.362 . . . . 0.0 113.971 170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 17.9 m -73.38 -10.35 59.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.665 1.186 . . . . 0.0 114.038 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 79.47 -3.48 67.67 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.635 1.588 . . . . 0.0 115.148 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.3 mmm-85 -79.86 90.08 5.29 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.256 1.422 . . . . 0.0 110.772 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -64.08 136.93 57.7 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.477 1.111 . . . . 0.0 112.117 -173.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -137.05 151.82 72.71 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.576 1.55 . . . . 0.0 111.249 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.88 155.66 38.98 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.672 2.915 . . . . 0.0 112.871 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 87.5 m -100.91 158.89 15.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.889 1.276 . . . . 0.0 112.238 172.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 2.9 tt -93.11 121.79 34.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.75 1.22 . . . . 0.0 108.083 167.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.48 141.67 28.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.662 1.185 . . . . 0.0 111.082 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 94.5 mttt -143.3 149.63 38.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.597 1.159 . . . . 0.0 112.978 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -93.77 116.17 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.597 -1.261 . . . . 0.0 107.597 157.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 88.3 mt -89.24 165.93 14.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.816 0.846 . . . . 0.0 111.519 -174.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -59.69 -25.47 64.79 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 30.1 m120 -77.32 -9.32 58.76 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 96.78 -12.88 65.76 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.099 1.809 . . . . 0.0 114.301 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.05 161.89 26.26 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.565 1.182 . . . . 0.0 113.416 174.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 95.9 t -80.69 148.66 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.666 1.186 . . . . 0.0 109.337 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -152.85 176.82 30.84 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.274 0.94 . . . . 0.0 114.054 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.53 164.74 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.425 1.49 . . . . 0.0 111.704 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 86.0 p -143.54 152.97 42.09 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.028 0.931 . . . . 0.0 111.964 165.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 13.3 p90 -161.63 173.03 15.31 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.739 2.016 . . . . 0.0 110.656 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 96.9 t -122.69 119.84 28.0 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.446 1.098 . . . . 0.0 109.816 172.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.4 151.59 22.94 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.754 3.636 . . . . 0.0 111.519 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 13.6 mptt -107.36 -6.22 17.28 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.214 1.006 . . . . 0.0 113.023 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -138.57 167.67 21.44 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.51 1.924 . . . . 0.0 110.639 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.2 p -90.14 165.13 14.15 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.825 1.25 . . . . 0.0 111.063 168.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 95.17 -170.79 29.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.077 1.322 . . . . 0.0 113.727 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -71.22 115.94 10.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.185 0.994 . . . . 0.0 112.119 -172.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 12.9 m80 -100.48 146.58 26.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.007 1.723 . . . . 0.0 109.065 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.53 127.71 54.18 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.119 0.968 . . . . 0.0 109.81 174.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 25.0 t -90.68 123.21 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.664 1.186 . . . . 0.0 108.203 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -105.26 131.52 52.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.336 . . . . 0.0 110.196 174.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 21.5 t -130.64 133.36 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.853 0.861 . . . . 0.0 111.101 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -127.6 135.94 50.97 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.468 1.907 . . . . 0.0 111.591 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -128.75 123.2 32.37 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.164 2.186 . . . . 0.0 110.192 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 64.5 t30 55.94 29.28 13.96 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.154 1.381 . . . . 0.0 113.89 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 92.49 4.75 65.71 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.966 1.27 . . . . 0.0 115.855 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -134.45 155.88 49.56 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.406 1.603 . . . . 0.0 111.618 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 67.4 m80 -65.22 143.26 57.94 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 120.794 -1.191 . . . . 0.0 113.166 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 74.0 t -71.42 142.65 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.438 1.095 . . . . 0.0 109.459 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.01 67.52 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.7 m -81.57 -7.7 59.62 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.968 1.307 . . . . 0.0 113.938 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 16.1 t -82.92 141.96 44.41 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 120.804 -1.185 . . . . 0.0 112.581 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.07 154.26 86.47 Favored 'Cis proline' 0 C--N 1.354 0.822 0 CA-C-N 119.646 0.909 . . . . 0.0 112.579 -3.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.39 122.12 46.19 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.483 1.513 . . . . 0.0 108.656 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.16 142.93 12.44 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.11 2.54 . . . . 0.0 111.634 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 21.8 t -138.9 123.71 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.441 1.497 . . . . 0.0 108.269 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.6 t -99.29 124.52 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.754 0.822 . . . . 0.0 110.172 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.75 128.1 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.997 1.319 . . . . 0.0 109.553 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 60.8 m -100.51 156.34 17.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.108 0.963 . . . . 0.0 111.975 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -56.25 -35.4 67.37 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.789 1.236 . . . . 0.0 114.168 -174.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 37.0 m -73.72 -12.6 60.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.751 0.82 . . . . 0.0 113.021 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -91.64 -6.3 52.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.816 1.246 . . . . 0.0 112.628 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 43.0 mm -73.42 -31.93 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.218 0.917 . . . . 0.0 112.494 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 160.93 55.08 0.02 OUTLIER Glycine 0 CA--C 1.528 0.87 0 N-CA-C 114.759 0.664 . . . . 0.0 114.759 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.48 100.85 10.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.855 0.827 . . . . 0.0 110.315 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -60.39 -32.61 71.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.74 1.216 . . . . 0.0 113.667 -177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.55 -21.56 27.26 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.486 1.515 . . . . 0.0 114.027 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.58 -9.94 50.48 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.466 1.506 . . . . 0.0 113.934 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 97.9 t -79.78 125.96 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 119.949 1.249 . . . . 0.0 111.327 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 14.9 mmp_? -105.17 156.04 18.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.644 1.577 . . . . 0.0 110.991 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.8 m -147.88 159.17 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.624 1.569 . . . . 0.0 110.861 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 7.6 t -161.4 177.54 10.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.761 1.224 . . . . 0.0 112.687 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 100.07 160.63 28.45 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.444 1.497 . . . . 0.0 114.26 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -67.07 -33.14 74.85 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.187 1.395 . . . . 0.0 113.116 -170.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -69.04 -3.49 36.96 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.05 1.31 . . . . 0.0 115.344 -175.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 95.0 mt -88.69 -7.39 56.41 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.032 1.333 . . . . 0.0 112.855 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -128.38 -36.01 1.93 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.778 1.231 . . . . 0.0 113.845 -173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -159.73 157.39 29.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.599 1.16 . . . . 0.0 112.477 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -151.09 -176.58 24.1 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.715 1.15 . . . . 0.0 114.106 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 70.3 m80 -135.43 147.12 48.86 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.887 1.275 . . . . 0.0 112.473 -177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 20.9 p -67.99 -29.07 68.0 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -112.02 5.81 18.95 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -141.28 154.64 67.65 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 125.42 1.488 . . . . 0.0 111.068 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.42 136.89 27.12 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.71 2.274 . . . . 0.0 110.738 173.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -95.82 118.54 32.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.727 1.211 . . . . 0.0 110.146 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -98.29 147.57 24.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.136 0.975 . . . . 0.0 113.369 -175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.33 153.78 32.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.253 1.421 . . . . 0.0 111.241 173.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.72 140.08 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.679 1.591 . . . . 0.0 109.456 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 54.3 mt -114.77 130.66 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.56 1.944 . . . . 0.0 108.901 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 64.4 t0 -119.55 84.17 2.16 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.603 1.561 . . . . 0.0 110.569 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 3.3 p -84.97 -5.84 59.35 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.774 2.03 . . . . 0.0 113.288 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -56.03 -40.58 73.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.479 1.036 . . . . 0.0 111.676 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.06 -9.95 59.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.404 1.482 . . . . 0.0 113.329 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -98.2 0.12 45.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.132 1.773 . . . . 0.0 114.333 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 82.99 -134.04 12.48 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.252 0.93 . . . . 0.0 111.016 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.59 171.49 9.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.758 1.223 . . . . 0.0 112.292 176.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 144.87 177.81 19.99 Favored Glycine 0 N--CA 1.472 1.074 0 C-N-CA 124.414 1.006 . . . . 0.0 114.951 171.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -106.63 131.71 10.78 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 125.551 1.548 . . . . 0.0 111.815 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.92 121.56 41.95 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.721 2.008 . . . . 0.0 108.913 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 74.8 m -112.56 143.9 42.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.979 1.712 . . . . 0.0 110.266 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.8 tt -143.86 137.4 27.9 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.767 0.827 . . . . 0.0 110.502 -166.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 62.7 m -138.7 135.08 34.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.73 0.812 . . . . 0.0 111.371 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 23.9 mt -122.29 134.56 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.264 1.426 . . . . 0.0 109.13 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.28 154.64 44.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 111.258 -174.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 163.25 -151.59 21.29 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.785 -1.008 . . . . 0.0 114.052 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.69 -14.73 36.74 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.029 3.153 . . . . 0.0 114.976 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 7.3 t -159.16 165.74 33.03 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.955 1.252 . . . . 0.0 112.419 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.01 148.34 51.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.961 1.304 . . . . 0.0 111.775 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 35.9 m -135.12 147.97 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.562 1.145 . . . . 0.0 112.293 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -88.51 104.38 16.76 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.759 0.824 . . . . 0.0 110.19 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 39.6 mt -84.98 130.63 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.871 0.868 . . . . 0.0 109.742 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -128.14 155.46 44.4 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.305 1.842 . . . . 0.0 110.333 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 45.7 p -140.59 156.5 46.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.964 1.306 . . . . 0.0 111.625 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.27 125.83 5.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.983 1.313 . . . . 0.0 110.275 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.64 133.5 36.4 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.335 -0.853 . . . . 0.0 111.199 171.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 50.5 mt -96.19 160.77 14.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.67 1.188 . . . . 0.0 111.732 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -65.45 -20.68 66.47 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.242 1.017 . . . . 0.0 113.291 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.62 -3.69 56.55 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.094 1.358 . . . . 0.0 113.274 174.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 92.29 -2.94 75.43 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.611 1.577 . . . . 0.0 114.848 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 46.5 p -82.47 167.96 17.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.554 1.542 . . . . 0.0 111.14 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 48.6 t -116.24 127.56 54.86 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.845 0.858 . . . . 0.0 111.196 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -90.86 137.66 32.19 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.703 1.201 . . . . 0.0 109.937 170.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 25.3 t -122.59 138.27 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 126.072 1.749 . . . . 0.0 108.4 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.3 p -136.16 151.85 50.19 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.415 1.486 . . . . 0.0 110.948 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 11.7 p90 -161.27 145.5 13.3 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.427 1.491 . . . . 0.0 110.515 175.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 25.0 t -107.01 103.41 47.63 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.58 0.752 . . . . 0.0 110.722 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -78.26 110.78 2.93 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.358 2.705 . . . . 0.0 110.128 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.9 m -69.22 -37.98 78.33 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.647 0.779 . . . . 0.0 112.341 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -90.29 146.39 34.59 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.035 1.334 . . . . 0.0 111.447 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.37 168.06 25.37 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.275 2.65 . . . . 0.0 111.1 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 114.76 -163.98 12.13 Favored Glycine 0 N--CA 1.472 1.036 0 C-N-CA 125.172 1.368 . . . . 0.0 113.402 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 54.0 t30 -89.89 120.17 30.89 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.9 -0.764 . . . . 0.0 112.174 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.33 143.43 30.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.117 1.367 . . . . 0.0 110.904 164.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -106.28 134.63 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.926 1.29 . . . . 0.0 108.82 174.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 29.0 mt -116.32 132.95 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.288 1.435 . . . . 0.0 109.521 173.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -114.17 125.51 54.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.018 1.727 . . . . 0.0 109.904 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.1 mm -114.54 124.83 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.974 0.91 . . . . 0.0 109.638 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 31.1 tttt -132.39 127.12 34.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.142 1.377 . . . . 0.0 110.482 -171.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 37.3 t80 -123.8 124.76 43.39 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.12 0.968 . . . . 0.0 110.064 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 47.99 49.2 17.4 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.469 1.107 . . . . 0.0 111.773 -173.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 18.3 t70 66.84 13.83 9.57 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.373 2.269 . . . . 0.0 114.624 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -119.48 126.8 52.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.104 1.362 . . . . 0.0 110.258 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -65.29 121.58 15.13 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.616 1.167 . . . . 0.0 111.055 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.8 m -79.14 158.69 74.27 Favored Pre-proline 0 N--CA 1.486 1.325 0 O-C-N 121.288 -0.883 . . . . 0.0 111.784 -168.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.18 138.07 71.2 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.517 2.811 . . . . 0.0 112.909 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 92.63 -23.24 29.21 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.964 1.268 . . . . 0.0 114.343 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 72.4 m -74.56 149.96 86.52 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 118.916 1.358 . . . . 0.0 111.64 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.52 145.86 80.91 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 119.326 0.795 . . . . 0.0 111.442 -3.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -98.85 120.43 39.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.54 1.136 . . . . 0.0 110.772 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 45.9 m -86.86 133.02 33.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.131 0.972 . . . . 0.0 110.988 171.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 17.2 t -129.93 111.08 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.63 1.572 . . . . 0.0 109.471 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -81.57 109.58 16.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.015 0.526 . . . . 0.0 111.383 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 60.4 t -91.26 127.1 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.131 1.372 . . . . 0.0 109.328 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.6 t -117.9 161.94 18.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.739 1.216 . . . . 0.0 112.186 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 129.22 163.29 11.17 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.965 1.745 . . . . 0.0 113.45 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.66 162.44 9.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.06 1.744 . . . . 0.0 110.291 -171.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 87.45 32.71 12.9 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.296 0.95 . . . . 0.0 113.554 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -65.7 99.18 0.43 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.086 1.355 . . . . 0.0 111.45 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 91.2 t -145.07 142.0 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 126.932 2.093 . . . . 0.0 108.99 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 C--O 1.254 1.324 0 C-N-CA 125.781 1.633 . . . . 0.0 111.276 177.146 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -158.38 163.83 36.88 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.648 1.579 . . . . 0.0 111.985 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -76.65 -11.94 59.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.149 1.38 . . . . 0.0 113.728 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 90.48 171.23 43.88 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.567 1.556 . . . . 0.0 113.704 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -158.8 151.1 21.47 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.95 1.7 . . . . 0.0 111.384 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.22 -18.91 48.2 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -175.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 8.6 t -79.38 142.2 36.21 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.956 -1.09 . . . . 0.0 113.777 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 81.0 mmm -79.93 119.64 23.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.758 1.223 . . . . 0.0 109.929 172.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.37 139.11 30.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.049 0.94 . . . . 0.0 112.058 -171.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 96.9 mtp -89.18 133.03 34.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.428 1.491 . . . . 0.0 112.407 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 18.4 m -118.27 140.59 49.58 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.036 1.334 . . . . 0.0 108.465 160.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -156.51 158.42 37.16 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 8.0 tt -161.04 154.64 22.04 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.43 1.892 . . . . 0.0 111.131 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.51 151.34 47.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.002 1.321 . . . . 0.0 112.559 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 52.6 t -139.69 133.98 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.022 1.729 . . . . 0.0 109.458 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -92.5 128.41 9.39 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.885 0.755 . . . . 0.0 111.25 172.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 66.1 m -118.92 144.91 46.17 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.412 1.085 . . . . 0.0 112.53 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -158.01 151.98 24.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.553 1.141 . . . . 0.0 112.357 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -86.5 149.66 24.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.064 0.946 . . . . 0.0 110.75 166.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.33 134.05 34.57 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.539 0.735 . . . . 0.0 111.572 169.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 50.8 mm -112.89 127.48 26.78 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.495 1.518 . . . . 0.0 108.74 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.7 134.31 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.908 2.405 . . . . 0.0 110.478 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 29.9 mm -144.87 140.81 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 125.387 1.475 . . . . 0.0 110.293 -168.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 63.4 t30 54.59 55.54 7.85 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.786 1.634 . . . . 0.0 112.905 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 15.4 mm -65.76 112.55 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.478 1.111 . . . . 0.0 110.516 -172.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 99.8 p -173.9 172.6 3.42 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.276 1.43 . . . . 0.0 111.849 -170.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.08 4.82 9.35 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.932 1.693 . . . . 0.0 113.623 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 56.8 m -61.95 134.85 57.19 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.573 1.549 . . . . 0.0 111.472 -174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.67 132.98 46.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.439 1.496 . . . . 0.0 111.633 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 10.3 mp -73.76 -21.16 60.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.027 0.931 . . . . 0.0 112.425 176.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 24.0 m -67.58 -23.46 65.4 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -167.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -114.21 8.95 17.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.35 1.46 . . . . 0.0 113.609 175.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 4.7 mp -101.66 148.09 25.66 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.026 1.33 . . . . 0.0 111.997 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 47.3 p -141.39 169.65 17.2 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.261 2.224 . . . . 0.0 108.974 168.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -152.42 155.24 37.16 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 54.6 p -132.25 160.82 35.06 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.082 2.153 . . . . 0.0 109.153 173.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.5 t -112.8 135.27 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.073 0.949 . . . . 0.0 109.449 166.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 94.0 t -104.68 113.13 65.25 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.968 1.307 . . . . 0.0 108.196 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -81.32 173.44 11.65 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.999 3.133 . . . . 0.0 111.128 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.72 -32.69 56.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 124.127 3.218 . . . . 0.0 113.961 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 19.5 m -75.65 -4.53 40.69 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.708 1.203 . . . . 0.0 114.12 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 74.86 -1.76 52.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.286 1.422 . . . . 0.0 115.15 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -77.21 85.56 3.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.516 1.526 . . . . 0.0 111.243 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -62.09 133.01 54.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.854 1.262 . . . . 0.0 111.929 -176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -140.58 150.64 61.16 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.174 1.39 . . . . 0.0 111.277 176.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.64 155.55 40.01 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.271 3.314 . . . . 0.0 112.984 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.2 m -111.28 155.35 23.15 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.547 1.539 . . . . 0.0 112.207 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 6.2 tt -95.29 116.72 29.14 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.419 1.488 . . . . 0.0 108.671 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 11.2 mp -84.6 138.11 32.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.476 1.11 . . . . 0.0 111.352 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 89.0 mttt -133.44 136.17 45.02 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.041 1.336 . . . . 0.0 112.803 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -80.7 121.73 26.24 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 152.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.5 162.23 13.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.479 1.112 . . . . 0.0 112.013 -171.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -60.36 -31.65 70.54 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -163.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -86.27 -1.82 57.83 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.971 0.909 . . . . 0.0 113.439 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.62 0.35 57.87 Favored Glycine 0 N--CA 1.474 1.196 0 C-N-CA 125.504 1.526 . . . . 0.0 114.095 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -80.87 177.31 9.13 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.119 1.368 . . . . 0.0 112.863 170.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 88.6 t -130.15 140.51 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 109.617 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.04 -174.54 25.97 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 115.331 0.892 . . . . 0.0 115.331 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.61 154.18 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.613 1.565 . . . . 0.0 111.946 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 16.4 m -121.38 149.59 42.74 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.15 1.38 . . . . 0.0 111.198 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.2 p90 -165.64 -178.87 5.07 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.101 2.16 . . . . 0.0 109.752 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 95.9 t -128.88 122.44 21.42 Favored Pre-proline 0 N--CA 1.482 1.13 0 CA-C-N 119.258 0.935 . . . . 0.0 109.95 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.81 149.56 23.27 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 124.115 3.21 . . . . 0.0 111.369 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 95.0 mttt -106.27 -9.57 16.77 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -143.25 173.63 11.42 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.858 2.063 . . . . 0.0 110.11 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 40.5 p -88.77 167.35 13.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.656 1.182 . . . . 0.0 111.117 167.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 92.65 -168.08 30.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.801 1.191 . . . . 0.0 113.57 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -71.05 116.98 11.98 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.05 0.94 . . . . 0.0 112.005 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.8 m80 -102.58 141.0 36.12 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.974 1.71 . . . . 0.0 109.042 167.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.86 123.26 44.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.055 0.942 . . . . 0.0 109.229 177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 47.1 t -87.76 113.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.987 1.315 . . . . 0.0 107.811 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -95.21 126.21 40.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.525 1.13 . . . . 0.0 110.225 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 81.3 t -117.71 120.14 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.996 1.319 . . . . 0.0 109.769 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -108.82 130.48 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.97 1.708 . . . . 0.0 111.72 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -108.74 122.94 48.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.545 1.938 . . . . 0.0 109.356 171.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 23.6 t-20 57.25 -94.27 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.064 1.346 . . . . 0.0 111.72 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -123.37 9.5 8.8 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.863 1.697 . . . . 0.0 115.777 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -146.6 157.02 43.65 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.743 1.771 . . . . 0.0 112.393 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -67.34 138.61 56.91 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.888 -1.133 . . . . 0.0 112.783 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 5.9 p -71.44 156.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.389 1.076 . . . . 0.0 110.675 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -57.06 -28.44 62.58 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -174.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.0 m -80.47 -9.65 59.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.942 1.297 . . . . 0.0 114.162 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 31.9 t -90.78 147.56 36.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.9 1.28 . . . . 0.0 113.198 -172.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.26 162.28 76.76 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.26 0.771 . . . . 0.0 112.677 -5.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.01 126.38 28.32 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.685 1.594 . . . . 0.0 109.04 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.66 142.27 12.75 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.117 2.544 . . . . 0.0 112.031 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 39.9 t -135.87 127.75 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.593 1.557 . . . . 0.0 107.869 170.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 53.9 t -100.39 126.53 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.853 0.861 . . . . 0.0 110.49 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.29 130.46 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.138 1.375 . . . . 0.0 110.169 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 65.9 m -98.15 156.92 16.45 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.52 1.128 . . . . 0.0 112.087 174.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -58.52 -30.01 66.75 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 8.7 m -65.34 -19.29 65.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.6 1.16 . . . . 0.0 113.739 178.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -93.46 -12.17 30.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.713 1.205 . . . . 0.0 112.955 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.7 -24.81 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.659 1.184 . . . . 0.0 112.576 -173.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 134.73 68.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.699 0 C-N-CA 125.291 1.424 . . . . 0.0 112.84 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -78.96 105.79 10.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.262 0.531 . . . . 0.0 110.007 172.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -55.04 -37.49 66.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.841 0.856 . . . . 0.0 112.307 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 17.1 m -54.18 -23.33 14.04 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.181 1.793 . . . . 0.0 114.468 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -90.9 -12.73 35.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.856 1.262 . . . . 0.0 113.466 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 67.8 t -74.19 133.99 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 119.625 1.102 . . . . 0.0 109.867 -177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.55 154.45 24.78 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 111.171 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 31.5 m -144.51 150.5 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.471 1.508 . . . . 0.0 110.172 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 75.7 m -148.12 165.74 29.93 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.91 1.284 . . . . 0.0 112.487 -173.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 104.48 159.73 24.01 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 124.517 1.056 . . . . 0.0 114.416 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -71.59 -25.43 62.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.66 1.184 . . . . 0.0 113.373 -170.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.89 -5.76 41.03 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.264 0.935 . . . . 0.0 114.986 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -88.25 -2.64 58.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.417 1.487 . . . . 0.0 112.893 168.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -135.84 -38.72 0.71 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -141.56 151.18 42.99 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.772 1.229 . . . . 0.0 111.831 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.43 -176.7 22.08 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.144 1.354 . . . . 0.0 113.269 172.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -147.97 145.72 28.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.173 0.989 . . . . 0.0 113.015 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 24.3 p -60.13 -26.13 66.02 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.711 1.605 . . . . 0.0 115.028 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.77 23.22 9.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.245 1.418 . . . . 0.0 112.93 -173.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -145.49 137.34 13.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.642 1.177 . . . . 0.0 110.315 -178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -71.27 133.68 23.3 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.536 2.157 . . . . 0.0 110.286 169.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -102.33 131.35 48.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.436 1.494 . . . . 0.0 110.393 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.42 154.21 35.48 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.862 1.265 . . . . 0.0 113.325 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 51.6 p90 -156.71 153.15 27.98 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.005 1.722 . . . . 0.0 111.024 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.61 142.68 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.496 1.919 . . . . 0.0 109.9 -173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 34.4 mt -120.1 132.17 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.815 1.646 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . 0.455 ' HA ' HH21 ' A' 2073 ' ' ARG . 31.4 t0 -125.39 86.75 2.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.46 1.504 . . . . 0.0 111.732 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 16.4 p -83.43 -8.92 59.3 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.422 1.889 . . . . 0.0 113.657 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . 0.455 HH21 ' HA ' ' A' 2071 ' ' ASP . 0.5 OUTLIER -60.89 -30.32 70.09 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.7 1.137 . . . . 0.0 113.616 -175.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -74.94 -15.58 60.68 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.94 0.896 . . . . 0.0 113.231 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -97.5 -1.63 43.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.95 1.7 . . . . 0.0 114.208 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 83.78 -128.39 8.55 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.651 1.119 . . . . 0.0 112.296 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -94.22 160.28 14.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.413 1.485 . . . . 0.0 112.234 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 147.8 174.09 19.38 Favored Glycine 0 N--CA 1.472 1.07 0 N-CA-C 115.675 1.03 . . . . 0.0 115.675 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -95.34 126.36 8.72 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.868 1.223 . . . . 0.0 111.852 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -97.9 123.14 41.75 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.705 2.002 . . . . 0.0 108.576 172.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.9 t -116.39 140.51 49.27 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.04 1.336 . . . . 0.0 110.402 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 10.4 tt -137.86 131.0 30.4 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.663 1.185 . . . . 0.0 110.284 -167.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 56.9 m -135.16 131.14 36.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.796 0.838 . . . . 0.0 110.72 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 22.5 mt -109.27 125.46 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.549 1.54 . . . . 0.0 108.114 173.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.21 139.0 46.96 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.154 1.382 . . . . 0.0 109.742 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . -168.82 -175.92 38.6 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.74 -8.58 23.93 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.471 3.447 . . . . 0.0 113.825 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.1 t -154.83 164.84 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.754 1.222 . . . . 0.0 111.875 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.75 146.51 52.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.664 1.186 . . . . 0.0 111.53 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 33.6 m -132.27 141.02 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.112 0.965 . . . . 0.0 110.822 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.34 125.43 29.35 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.219 0.608 . . . . 0.0 110.013 169.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 38.4 mt -106.52 127.76 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.94 0.896 . . . . 0.0 108.851 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -124.31 143.68 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 109.854 -174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 24.9 p -113.74 154.03 28.03 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.911 1.284 . . . . 0.0 111.248 176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.94 120.0 5.36 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.635 1.174 . . . . 0.0 110.15 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -79.02 123.53 27.4 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.307 1.043 . . . . 0.0 110.645 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.37 160.12 15.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.104 0.962 . . . . 0.0 111.975 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.6 -25.82 68.41 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.109 0.963 . . . . 0.0 112.333 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.13 -8.52 50.3 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.998 1.719 . . . . 0.0 113.777 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.59 -5.48 84.92 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.768 1.651 . . . . 0.0 114.304 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 25.0 p -82.93 161.41 21.84 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.943 1.697 . . . . 0.0 111.471 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 33.8 t -102.88 123.33 46.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.677 0.791 . . . . 0.0 110.255 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -83.05 138.2 33.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.867 0.867 . . . . 0.0 109.296 163.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 56.7 t -119.95 133.84 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.059 1.744 . . . . 0.0 108.169 168.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 67.6 m -136.92 138.3 40.51 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.853 1.261 . . . . 0.0 110.517 -172.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 12.1 p90 -147.99 148.55 30.85 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.277 1.031 . . . . 0.0 112.465 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 23.2 t -109.15 106.84 59.34 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.538 0.735 . . . . 0.0 111.088 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -77.37 119.17 4.85 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.992 2.461 . . . . 0.0 109.694 171.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 28.7 m -78.86 -43.54 24.83 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.734 0.814 . . . . 0.0 111.614 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -91.31 147.68 36.01 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.551 1.14 . . . . 0.0 110.933 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.99 167.61 26.66 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.558 2.838 . . . . 0.0 111.734 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 123.78 -161.28 18.19 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.066 1.317 . . . . 0.0 113.768 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.7 t30 -93.79 126.71 39.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.007 0.923 . . . . 0.0 111.541 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -111.29 142.92 42.89 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.567 1.547 . . . . 0.0 109.808 169.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.45 123.89 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.595 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.29 124.6 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.896 1.278 . . . . 0.0 109.73 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -104.26 128.9 52.07 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.893 1.677 . . . . 0.0 109.755 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.3 mm -121.88 111.98 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.858 1.263 . . . . 0.0 109.524 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -121.02 130.92 53.99 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.634 1.574 . . . . 0.0 111.098 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 35.2 t80 -123.53 126.01 45.92 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.447 1.499 . . . . 0.0 110.328 177.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.16 28.77 9.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.342 1.457 . . . . 0.0 113.963 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 7.2 t70 87.82 6.89 0.21 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 129.147 2.979 . . . . 0.0 114.894 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -114.69 138.27 50.9 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.726 1.21 . . . . 0.0 111.113 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 132.23 51.53 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.165 -0.959 . . . . 0.0 111.143 172.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 4.1 m -80.4 159.99 68.63 Favored Pre-proline 0 N--CA 1.486 1.366 0 O-C-N 121.529 -0.732 . . . . 0.0 111.516 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.27 136.59 62.81 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.749 2.966 . . . . 0.0 113.354 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 86.04 -19.8 24.16 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.048 1.309 . . . . 0.0 114.394 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 23.1 t -76.4 144.27 74.04 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-N 118.613 1.207 . . . . 0.0 111.451 176.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -76.48 150.7 93.63 Favored 'Cis proline' 0 C--N 1.352 0.75 0 CA-C-N 119.727 0.938 . . . . 0.0 112.283 -3.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -103.68 122.29 44.74 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.399 1.479 . . . . 0.0 110.733 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 14.3 p -86.96 135.28 33.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.124 0.969 . . . . 0.0 111.419 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 18.3 t -130.93 113.98 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.186 1.395 . . . . 0.0 109.496 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.13 115.68 22.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.113 0.565 . . . . 0.0 111.154 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 91.4 t -98.22 115.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.232 1.413 . . . . 0.0 109.056 177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 4.9 t -102.4 173.81 6.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.947 1.299 . . . . 0.0 111.455 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 116.52 -137.29 13.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.094 1.33 . . . . 0.0 112.615 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -145.97 162.59 37.48 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.768 1.227 . . . . 0.0 112.454 -167.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -69.5 140.39 33.48 Favored Glycine 0 CA--C 1.534 1.251 0 O-C-N 121.473 -0.767 . . . . 0.0 111.891 172.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -67.69 139.15 56.74 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.374 1.07 . . . . 0.0 111.979 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 92.5 t -70.28 131.79 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.767 1.227 . . . . 0.0 110.048 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.234 1.413 . . . . 0.0 112.503 -178.476 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.499 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.5 156.56 36.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.32 1.048 . . . . 0.0 112.859 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.6 ttt -74.85 -27.69 60.37 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.497 1.119 . . . . 0.0 113.003 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 141.43 -174.51 22.88 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.932 1.73 . . . . 0.0 113.226 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.1 t0 -158.09 56.12 0.47 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.47 1.508 . . . . 0.0 110.955 -175.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 26.2 t0 -146.43 53.89 1.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.575 1.55 . . . . 0.0 111.193 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 23.2 m -66.77 171.5 5.19 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.423 1.489 . . . . 0.0 113.555 178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 38.2 mmt -55.86 127.22 29.17 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.41 1.084 . . . . 0.0 111.784 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -77.48 151.87 34.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.425 1.09 . . . . 0.0 112.352 -173.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.9 ptt? -70.62 154.24 42.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.438 1.095 . . . . 0.0 112.73 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 73.0 m -107.59 144.79 34.12 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.69 1.196 . . . . 0.0 110.117 166.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.31 149.54 51.91 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.561 1.144 . . . . 0.0 113.266 -165.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -157.35 146.24 19.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.066 1.747 . . . . 0.0 110.11 -173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 48.2 mttp -128.51 149.9 50.4 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.518 1.127 . . . . 0.0 113.0 173.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 39.3 t -139.82 139.11 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.32 1.848 . . . . 0.0 109.513 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -84.96 120.76 5.39 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 171.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 4.0 m -111.96 142.74 44.0 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.694 1.197 . . . . 0.0 112.697 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -162.48 146.0 11.54 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.74 169.35 17.72 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.977 1.311 . . . . 0.0 111.555 163.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -105.3 137.59 42.84 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.737 1.215 . . . . 0.0 111.853 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 44.7 mm -105.27 118.04 56.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.303 1.041 . . . . 0.0 109.02 164.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.13 128.46 10.62 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.402 2.735 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 57.0 mt -147.44 139.53 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.658 1.583 . . . . 0.0 109.843 -172.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.07 60.26 3.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.803 1.641 . . . . 0.0 112.456 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 16.5 mm -67.4 111.13 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.44 1.096 . . . . 0.0 111.34 -166.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 8.0 m -172.83 146.07 1.53 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.816 2.446 . . . . 0.0 109.33 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.42 -10.16 50.15 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.77 1.228 . . . . 0.0 113.501 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 24.9 p -91.43 160.3 15.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.338 1.855 . . . . 0.0 112.063 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 60.3 m-20 70.41 3.25 4.39 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.406 2.282 . . . . 0.0 114.679 172.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.53 -20.86 65.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.525 1.13 . . . . 0.0 113.783 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 28.0 p -77.14 -12.55 59.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.305 1.442 . . . . 0.0 114.356 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.25 9.74 3.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.179 1.391 . . . . 0.0 114.389 178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.95 143.22 34.37 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.207 1.003 . . . . 0.0 110.974 164.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 39.8 p -140.86 160.75 39.39 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.352 1.861 . . . . 0.0 109.779 173.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -155.87 150.67 26.24 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.57 0.748 . . . . 0.0 113.013 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 63.6 p -138.8 163.12 33.06 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.977 2.111 . . . . 0.0 109.491 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 137.36 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.911 1.284 . . . . 0.0 109.864 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 95.1 t -105.6 110.91 64.74 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.111 1.364 . . . . 0.0 108.083 165.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.57 169.14 20.27 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.893 3.062 . . . . 0.0 110.846 175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.16 -15.88 47.43 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.065 2.51 . . . . 0.0 113.12 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 67.0 p -79.39 -9.3 59.57 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.88 1.272 . . . . 0.0 113.826 169.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.38 -1.5 85.21 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 125.668 1.604 . . . . 0.0 115.185 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -77.61 82.58 4.03 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.374 1.469 . . . . 0.0 111.698 -177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -60.83 132.64 54.5 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.418 1.087 . . . . 0.0 111.875 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.06 151.73 59.79 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.405 1.482 . . . . 0.0 111.354 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.9 158.04 34.75 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.951 3.1 . . . . 0.0 112.852 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 85.9 m -110.18 155.7 21.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.066 1.346 . . . . 0.0 112.457 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 4.5 tt -99.48 115.23 28.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.82 1.648 . . . . 0.0 108.157 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 4.3 mp -87.08 134.37 33.51 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.578 0.751 . . . . 0.0 110.617 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.9 mttt -126.91 137.23 53.11 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.179 1.392 . . . . 0.0 112.805 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -99.14 124.19 43.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.524 1.529 . . . . 0.0 107.979 161.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 67.4 mt -99.76 171.7 7.72 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.211 1.404 . . . . 0.0 112.763 -165.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 -59.63 -32.19 70.2 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -171.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.33 -2.62 58.51 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.251 1.02 . . . . 0.0 113.446 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.46 -8.4 62.2 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.727 1.632 . . . . 0.0 114.857 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -73.96 168.83 18.69 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 118.594 1.197 . . . . 0.0 112.975 172.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 61.3 t -131.26 142.37 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.977 1.311 . . . . 0.0 110.948 -168.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -157.87 -168.79 20.72 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.846 1.212 . . . . 0.0 113.992 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.72 151.35 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.775 1.23 . . . . 0.0 112.233 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 43.2 m -123.59 155.1 38.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.766 1.626 . . . . 0.0 111.467 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 9.6 p90 -166.93 -174.68 2.78 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.497 2.319 . . . . 0.0 109.221 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 85.5 t -128.93 116.23 19.09 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 119.302 0.956 . . . . 0.0 109.706 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.99 139.52 24.41 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.939 3.093 . . . . 0.0 110.574 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -99.96 -6.9 25.85 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.271 1.029 . . . . 0.0 113.08 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -140.16 169.25 18.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.759 2.024 . . . . 0.0 110.363 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.2 p -88.48 167.11 13.72 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.277 1.031 . . . . 0.0 110.995 165.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 94.96 -169.3 28.1 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.048 1.309 . . . . 0.0 113.749 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -72.15 118.27 14.82 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 -172.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.2 m80 -105.49 144.16 32.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.351 1.86 . . . . 0.0 109.104 168.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.58 125.95 51.2 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 0.0 109.642 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 26.3 t -89.35 121.39 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.705 1.202 . . . . 0.0 108.001 168.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -99.93 128.48 46.02 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.718 1.207 . . . . 0.0 110.061 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 48.0 t -126.71 131.4 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.595 1.158 . . . . 0.0 110.421 -172.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 64.9 mttp -123.38 147.58 46.94 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.734 1.613 . . . . 0.0 112.547 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 83.5 tttt -118.58 119.83 35.67 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.607 1.963 . . . . 0.0 108.941 169.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.27 30.91 19.22 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.996 1.318 . . . . 0.0 113.247 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 90.48 2.5 73.11 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.027 1.299 . . . . 0.0 116.052 177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -123.59 151.19 43.2 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.442 1.621 . . . . 0.0 110.999 173.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.34 144.58 57.06 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 98.2 t -77.63 146.08 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.678 1.191 . . . . 0.0 109.096 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -59.23 -24.91 63.57 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.003 1.482 . . . . 0.0 115.003 -174.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 58.1 p -85.95 -8.05 58.25 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.162 1.385 . . . . 0.0 114.079 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 21.2 t -82.87 144.45 48.09 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 124.936 1.294 . . . . 0.0 112.358 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.03 155.49 87.41 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.562 0.879 . . . . 0.0 112.613 -3.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.49 120.85 48.07 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.731 1.612 . . . . 0.0 108.768 177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.26 141.61 12.91 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.965 2.443 . . . . 0.0 111.247 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 22.3 t -137.57 126.91 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.799 1.639 . . . . 0.0 108.093 175.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 61.8 t -97.31 124.29 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.72 0.808 . . . . 0.0 110.202 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.57 128.1 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.037 1.335 . . . . 0.0 109.883 -175.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 66.9 m -93.31 170.75 9.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.706 1.202 . . . . 0.0 112.234 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -34.5 77.46 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.323 -1.486 . . . . 0.0 111.604 174.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 11.0 m -66.17 -2.29 4.1 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.708 1.603 . . . . 0.0 115.27 -173.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.63 5.49 8.21 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.997 1.719 . . . . 0.0 112.96 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 3.5 mm -86.23 -21.83 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.546 1.138 . . . . 0.0 113.557 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 173.1 38.35 0.04 OUTLIER Glycine 0 N--CA 1.471 0.968 0 N-CA-C 115.67 1.028 . . . . 0.0 115.67 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.36 84.4 4.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.162 0.985 . . . . 0.0 111.474 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -54.95 -37.01 65.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.272 1.029 . . . . 0.0 112.609 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 41.6 p -56.22 -24.95 45.38 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.497 1.519 . . . . 0.0 114.381 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -90.94 -8.52 49.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.698 1.599 . . . . 0.0 114.215 176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 90.4 t -73.8 137.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 120.007 1.276 . . . . 0.0 110.419 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -121.03 155.21 34.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.311 1.444 . . . . 0.0 111.365 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 30.6 m -145.23 153.33 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.618 1.567 . . . . 0.0 109.971 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.1 t -154.86 170.88 20.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.025 0.93 . . . . 0.0 112.669 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 97.05 156.17 30.59 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.224 1.393 . . . . 0.0 113.184 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.04 -21.61 62.24 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -67.98 -2.16 22.74 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.078 1.323 . . . . 0.0 115.093 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 65.3 mt -90.93 -7.22 52.71 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.165 1.786 . . . . 0.0 112.707 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -134.06 -32.23 1.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.074 1.349 . . . . 0.0 113.887 -172.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.48 156.86 42.25 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.486 1.514 . . . . 0.0 112.253 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -158.06 -178.87 32.5 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.371 0.986 . . . . 0.0 113.797 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 63.0 m80 -134.22 148.97 50.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.64 1.176 . . . . 0.0 112.699 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 17.1 p -68.78 -29.78 68.22 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -118.19 0.15 11.69 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -132.52 146.49 61.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.106 1.763 . . . . 0.0 109.644 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.21 141.32 43.12 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.783 2.322 . . . . 0.0 111.049 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -85.72 154.29 21.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.41 1.084 . . . . 0.0 110.295 168.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.66 150.26 47.22 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.58 0.752 . . . . 0.0 112.608 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 42.2 p90 -157.13 149.98 23.54 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 110.637 176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.53 140.95 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.934 1.694 . . . . 0.0 109.566 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 71.5 mt -112.74 134.62 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.967 1.707 . . . . 0.0 108.86 173.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 23.2 t70 -137.07 123.22 20.43 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.565 1.546 . . . . 0.0 112.013 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 11.7 p -134.48 -11.75 2.41 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -157.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.13 -21.94 66.36 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 121.064 1.756 . . . . 0.0 114.542 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.46 -20.47 61.38 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.76 0.824 . . . . 0.0 112.554 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -92.34 -3.82 54.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.988 1.715 . . . . 0.0 113.423 169.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 86.7 -110.28 3.5 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.992 1.282 . . . . 0.0 112.462 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -131.79 151.74 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.534 1.533 . . . . 0.0 112.808 -168.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 151.87 -179.13 28.71 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 115.223 0.849 . . . . 0.0 115.223 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -84.76 127.59 8.23 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.22 0.914 . . . . 0.0 111.239 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.8 124.58 49.8 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.243 1.817 . . . . 0.0 108.363 175.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 6.8 t -112.06 140.44 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.844 1.257 . . . . 0.0 111.35 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -129.17 133.73 47.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.248 2.219 . . . . 0.0 108.363 -174.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 83.0 p -143.36 151.76 40.81 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.26 -0.9 . . . . 0.0 112.661 167.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 20.9 mt -131.27 137.52 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.97 1.308 . . . . 0.0 109.296 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -148.67 155.41 41.0 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.273 1.429 . . . . 0.0 111.033 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 167.3 -155.5 26.57 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 118.808 -0.996 . . . . 0.0 114.202 -174.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.43 -8.69 23.78 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.429 3.42 . . . . 0.0 115.368 -174.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.4 t -160.26 162.0 33.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.741 1.217 . . . . 0.0 111.528 173.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.29 146.98 53.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.301 1.041 . . . . 0.0 111.782 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 34.6 m -135.46 147.89 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.035 1.334 . . . . 0.0 111.65 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -88.94 122.55 32.41 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.862 0.865 . . . . 0.0 110.346 172.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.21 131.41 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.371 1.068 . . . . 0.0 109.604 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -130.05 161.08 31.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.224 1.81 . . . . 0.0 110.287 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 39.9 p -143.03 163.48 32.68 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.489 1.116 . . . . 0.0 112.829 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -152.13 121.35 6.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.773 1.629 . . . . 0.0 109.969 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.54 131.29 35.0 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.89 1.276 . . . . 0.0 111.132 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 58.2 mt -108.53 153.63 23.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.023 1.329 . . . . 0.0 111.292 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -15.6 63.43 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -76.83 -6.06 50.84 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.753 1.221 . . . . 0.0 112.857 170.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 89.43 2.13 77.1 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.996 1.76 . . . . 0.0 114.082 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 4.1 p -81.64 156.73 24.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.413 1.885 . . . . 0.0 111.31 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 46.6 t -115.43 120.88 41.01 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.994 0.917 . . . . 0.0 110.347 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 31.8 ttm105 -78.93 133.77 36.9 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.976 0.91 . . . . 0.0 108.846 164.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 27.4 t -115.48 140.54 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.874 1.67 . . . . 0.0 108.518 169.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.7 p -136.21 150.3 48.94 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.589 1.556 . . . . 0.0 111.334 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 10.7 p90 -163.12 150.07 12.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.488 1.515 . . . . 0.0 111.415 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 15.0 t -111.59 101.55 51.26 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.907 0.883 . . . . 0.0 110.766 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.64 116.87 4.38 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.104 2.536 . . . . 0.0 110.342 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 32.6 m -74.06 -39.69 63.3 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.923 0.889 . . . . 0.0 112.396 -173.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -95.07 148.69 35.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.05 1.34 . . . . 0.0 111.478 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.77 164.49 31.86 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.374 2.716 . . . . 0.0 110.98 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 121.01 -163.94 14.36 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.168 1.366 . . . . 0.0 113.284 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.6 t30 -91.55 117.27 29.56 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.457 0.703 . . . . 0.0 111.99 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -94.96 141.13 29.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.505 1.122 . . . . 0.0 111.145 164.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.77 134.96 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.404 1.482 . . . . 0.0 108.753 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 26.5 mt -118.32 128.36 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.927 1.291 . . . . 0.0 109.111 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -105.72 130.08 53.8 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 110.884 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 16.0 mm -119.83 120.82 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.002 1.321 . . . . 0.0 110.022 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 1.9 tmmm? -131.93 135.99 47.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.22 1.408 . . . . 0.0 111.469 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 69.8 t80 -131.48 129.69 41.46 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.88 1.672 . . . . 0.0 110.652 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 54.86 29.26 11.68 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.048 1.339 . . . . 0.0 113.424 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 8.8 t0 83.4 4.53 0.86 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 129.198 2.999 . . . . 0.0 114.668 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -109.05 128.22 54.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.824 1.249 . . . . 0.0 111.186 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -63.24 125.98 25.9 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.053 1.341 . . . . 0.0 110.618 172.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.3 m -80.38 156.46 73.65 Favored Pre-proline 0 N--CA 1.487 1.403 0 CA-C-N 119.039 0.836 . . . . 0.0 111.318 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.19 144.45 81.31 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.409 2.072 . . . . 0.0 111.63 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 89.37 -24.33 14.58 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.967 1.27 . . . . 0.0 113.423 -172.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 10.1 t -77.89 143.04 65.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.167 0.987 . . . . 0.0 110.565 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.59 146.37 84.19 Favored 'Cis proline' 0 C--N 1.353 0.768 0 CA-C-N 120.224 1.116 . . . . 0.0 112.075 0.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -97.63 122.21 40.44 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.709 1.203 . . . . 0.0 110.546 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 15.9 m -89.34 129.81 35.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.259 1.024 . . . . 0.0 111.37 173.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 15.4 t -122.94 112.08 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.2 1.8 . . . . 0.0 109.495 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -81.24 103.07 10.77 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.189 0.595 . . . . 0.0 111.455 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 61.7 t -87.85 128.9 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 109.45 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -125.25 167.32 15.04 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 114.11 161.1 13.82 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.086 1.803 . . . . 0.0 113.091 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -166.79 152.45 8.04 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.98 1.712 . . . . 0.0 110.316 -171.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . 99.32 50.58 1.42 Allowed Glycine 0 N--CA 1.473 1.155 0 C-N-CA 124.537 1.065 . . . . 0.0 113.111 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -73.63 95.13 2.27 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.605 1.162 . . . . 0.0 111.156 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 7.4 p -164.41 151.38 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.402 1.881 . . . . 0.0 110.537 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 65.1 mttp . . . . . 0 C--O 1.254 1.334 0 C-N-CA 125.084 1.354 . . . . 0.0 112.875 179.257 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -79.33 -18.64 52.13 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.3 mmt -113.58 166.55 11.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.584 1.954 . . . . 0.0 111.92 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 149.7 -140.06 7.83 Favored Glycine 0 N--CA 1.47 0.966 0 C-N-CA 125.627 1.584 . . . . 0.0 112.023 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.8 t70 -67.93 -16.02 63.88 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.346 1.058 . . . . 0.0 112.905 172.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t0 -143.96 161.4 38.83 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.225 2.21 . . . . 0.0 110.28 173.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 22.9 t -124.05 144.37 49.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.725 1.21 . . . . 0.0 112.611 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 22.2 mmt -63.24 135.54 57.16 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.362 -0.836 . . . . 0.0 111.928 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -71.34 138.2 49.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.806 0.843 . . . . 0.0 110.227 178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 21.4 ptm -146.52 159.17 43.77 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.656 1.182 . . . . 0.0 113.264 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 3.5 m -136.86 151.34 48.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.238 2.215 . . . . 0.0 109.084 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -150.67 160.33 43.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -170.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' 1964 ' ' LYS . 0.2 OUTLIER -158.39 153.68 25.71 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.512 1.925 . . . . 0.0 110.309 -172.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . 0.427 ' H ' HD13 ' A' 1963 ' ' LEU . 61.1 mttm -133.91 143.15 48.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.181 1.392 . . . . 0.0 111.525 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 63.9 t -138.86 137.53 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.91 1.684 . . . . 0.0 109.592 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -88.81 130.08 9.97 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.924 0.773 . . . . 0.0 111.52 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 69.0 m -119.72 150.98 39.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.952 1.301 . . . . 0.0 112.223 -176.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -153.69 152.14 30.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.126 0.971 . . . . 0.0 112.929 -174.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -80.46 149.79 29.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.443 0.697 . . . . 0.0 110.527 163.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -98.35 125.92 43.67 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 110.26 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 42.7 mm -113.6 122.49 35.04 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 117.764 -1.113 . . . . 0.0 109.529 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.76 135.25 21.32 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.942 2.428 . . . . 0.0 110.601 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 31.6 mm -148.49 143.53 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.549 1.54 . . . . 0.0 110.03 -168.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 50.8 t30 55.22 59.35 4.03 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.461 1.504 . . . . 0.0 112.383 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 33.1 mm -73.82 102.99 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 9.7 t -167.52 179.01 5.12 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.87 1.668 . . . . 0.0 111.078 -171.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -85.58 6.03 29.05 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.614 1.566 . . . . 0.0 112.921 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 17.1 p -63.86 139.73 58.8 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.647 1.579 . . . . 0.0 112.076 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.25 158.61 28.87 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.682 1.193 . . . . 0.0 111.959 175.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.2 -23.53 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.34 1.056 . . . . 0.0 113.625 -177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 91.4 p -71.4 -27.45 63.32 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -168.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.12 4.25 51.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.871 1.668 . . . . 0.0 113.503 173.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.0 tp -100.37 140.85 34.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.675 1.19 . . . . 0.0 111.788 -173.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.9 p -138.25 160.88 38.31 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.158 1.783 . . . . 0.0 110.104 172.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -148.65 148.7 30.39 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.828 0.851 . . . . 0.0 113.035 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 71.6 p -142.09 166.81 23.69 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.744 2.018 . . . . 0.0 109.92 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.1 t -122.07 138.44 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 109.595 168.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 84.1 t -107.07 112.71 63.02 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.297 1.439 . . . . 0.0 108.11 166.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -77.91 171.3 17.49 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.12 3.213 . . . . 0.0 110.773 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.46 -17.51 59.87 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.88 2.387 . . . . 0.0 113.587 174.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 7.3 t -77.81 -12.14 59.95 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.114 0.966 . . . . 0.0 113.273 170.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 83.8 -0.64 89.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.768 1.651 . . . . 0.0 115.09 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 62.5 mtt-85 -78.03 86.64 4.2 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.131 1.772 . . . . 0.0 111.105 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -61.01 132.33 53.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.0 0.92 . . . . 0.0 111.837 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -137.41 148.65 62.69 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.596 1.558 . . . . 0.0 110.663 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.56 155.04 40.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.732 2.955 . . . . 0.0 112.428 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 89.5 m -115.77 151.28 35.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.042 1.337 . . . . 0.0 111.679 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 55.1 tp -88.65 115.35 26.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.964 0.906 . . . . 0.0 109.346 171.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.2 mt -75.91 142.12 42.14 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.467 1.107 . . . . 0.0 110.779 171.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 96.8 mttt -145.4 149.25 34.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.795 1.238 . . . . 0.0 113.017 -175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.95 115.81 23.01 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 153.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 69.3 mt -86.77 170.43 11.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.208 1.003 . . . . 0.0 112.503 -173.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 63.3 ttt-85 -60.69 -30.14 69.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.597 1.559 . . . . 0.0 114.315 -169.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -82.55 -10.58 58.93 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.593 1.157 . . . . 0.0 113.684 176.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.29 55.12 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.87 1.7 . . . . 0.0 114.584 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 166.22 19.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 118.783 1.291 . . . . 0.0 113.403 173.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 90.8 t -93.02 142.94 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.955 1.302 . . . . 0.0 110.197 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -160.63 -171.87 27.15 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 115.18 0.832 . . . . 0.0 115.18 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.05 162.96 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.779 1.631 . . . . 0.0 112.675 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 84.7 p -136.99 159.25 42.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.286 1.034 . . . . 0.0 111.916 159.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 11.1 p90 -165.63 -171.73 2.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.989 2.516 . . . . 0.0 109.309 -176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 82.0 t -134.65 120.82 14.67 Favored Pre-proline 0 N--CA 1.482 1.129 0 CA-C-N 119.863 1.21 . . . . 0.0 110.241 169.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.34 143.4 15.55 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.384 3.39 . . . . 0.0 110.792 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 -9.41 23.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.73 169.3 18.28 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.325 1.85 . . . . 0.0 110.582 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 34.9 p -82.07 169.74 16.33 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 112.076 173.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 103.99 -175.83 23.35 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.59 1.567 . . . . 0.0 113.875 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.98 118.39 15.88 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.897 0.879 . . . . 0.0 111.13 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 9.3 m80 -103.64 143.85 32.22 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.946 1.699 . . . . 0.0 109.275 170.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 123.26 46.07 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.089 0.956 . . . . 0.0 108.959 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 58.0 t -85.0 129.69 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.846 1.259 . . . . 0.0 107.881 167.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -112.33 132.37 55.02 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.848 1.259 . . . . 0.0 110.339 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 95.1 t -129.6 127.97 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.475 1.11 . . . . 0.0 110.636 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -119.9 135.27 54.95 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.791 1.636 . . . . 0.0 112.057 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -106.64 114.94 29.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.465 1.906 . . . . 0.0 109.027 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 49.3 t30 52.62 -101.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.164 1.386 . . . . 0.0 111.763 -172.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . -108.26 5.24 33.65 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.595 1.569 . . . . 0.0 115.876 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -140.6 149.46 42.37 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.799 1.8 . . . . 0.0 112.809 -173.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -68.7 144.8 54.3 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 121.102 -0.999 . . . . 0.0 113.028 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 26.8 m -72.08 160.14 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 111.481 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.3 67.97 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 19.2 m -79.88 -15.68 56.87 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 34.1 t -89.19 145.05 33.42 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.536 1.134 . . . . 0.0 113.114 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.96 159.12 84.07 Favored 'Cis proline' 0 C--N 1.353 0.798 0 CA-C-N 119.297 0.785 . . . . 0.0 112.6 -3.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.37 125.54 28.73 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.758 1.623 . . . . 0.0 109.577 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.18 139.26 13.23 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.072 2.515 . . . . 0.0 111.552 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 40.9 t -134.83 125.1 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.837 1.655 . . . . 0.0 107.957 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.3 t -98.17 124.8 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.87 0.868 . . . . 0.0 110.427 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.29 120.73 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.168 1.387 . . . . 0.0 108.747 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 83.2 p -96.3 167.99 10.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.943 0.897 . . . . 0.0 112.119 172.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -62.64 -22.84 66.74 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 12.1 t -70.78 -36.03 72.87 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.304 -0.873 . . . . 0.0 111.796 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -74.69 -15.98 60.77 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.452 1.101 . . . . 0.0 112.728 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 50.2 mm -64.91 -19.91 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.34 1.056 . . . . 0.0 112.037 173.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 132.11 64.6 0.09 OUTLIER Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.609 1.576 . . . . 0.0 113.755 168.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 23.9 t0 -65.85 114.47 5.11 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 117.766 0.783 . . . . 0.0 111.56 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.97 80.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.146 0.978 . . . . 0.0 112.755 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 49.0 m -61.32 -20.46 62.97 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -85.71 -12.0 52.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.137 1.375 . . . . 0.0 114.069 174.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 59.6 t -76.29 133.41 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.921 1.237 . . . . 0.0 110.117 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -115.52 157.9 23.39 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.655 1.582 . . . . 0.0 110.703 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 35.3 m -146.5 158.55 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.22 1.408 . . . . 0.0 111.036 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 8.3 t -160.06 169.15 23.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.62 1.168 . . . . 0.0 112.288 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 107.69 160.38 20.93 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.213 1.387 . . . . 0.0 114.444 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -68.88 -32.11 71.53 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.465 1.506 . . . . 0.0 113.31 -169.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -70.48 -3.28 47.15 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.039 1.304 . . . . 0.0 115.17 -175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 94.3 mt -87.56 -8.37 56.4 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.319 1.447 . . . . 0.0 112.631 168.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -127.66 -36.19 2.07 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -158.16 155.71 29.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.478 1.111 . . . . 0.0 112.752 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -152.03 -175.23 23.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.796 1.189 . . . . 0.0 114.288 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -137.69 148.55 45.78 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.118 1.367 . . . . 0.0 112.657 -175.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 23.3 p -68.98 -35.07 76.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -111.08 10.2 22.02 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.42 154.85 72.06 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.608 1.563 . . . . 0.0 110.59 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 144.27 34.41 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.716 2.277 . . . . 0.0 111.172 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -100.45 138.36 37.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.404 1.482 . . . . 0.0 110.009 169.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.61 146.03 48.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.021 1.328 . . . . 0.0 113.307 -169.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.9 p90 -158.17 157.38 32.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.089 1.356 . . . . 0.0 112.159 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.43 141.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 126.476 1.911 . . . . 0.0 109.347 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 50.9 mt -117.1 132.68 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 108.769 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 63.7 t0 -120.81 100.71 7.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.724 1.61 . . . . 0.0 110.722 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 18.6 p -98.01 0.21 45.88 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.97 2.108 . . . . 0.0 113.034 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -59.88 -37.65 79.98 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.352 0.978 . . . . 0.0 112.713 -172.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.28 -11.62 59.31 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.694 1.197 . . . . 0.0 113.247 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -95.39 -2.38 49.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.867 1.667 . . . . 0.0 113.804 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.23 -129.54 9.33 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.663 1.125 . . . . 0.0 112.671 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -102.27 170.14 8.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.863 1.665 . . . . 0.0 112.388 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 134.17 -176.67 19.68 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 124.303 0.954 . . . . 0.0 115.114 168.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -94.56 124.16 7.81 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.685 1.136 . . . . 0.0 112.09 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 1.2 tm? -95.07 117.83 30.84 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.057 1.743 . . . . 0.0 108.198 170.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 68.3 m -108.76 143.81 37.41 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.492 1.517 . . . . 0.0 110.347 172.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 9.2 tt -142.12 140.29 32.43 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.869 0.867 . . . . 0.0 110.185 -169.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 92.0 p -143.84 152.6 41.39 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.617 0.722 . . . . 0.0 112.616 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 24.3 mt -129.35 133.71 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 107.655 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -141.78 152.22 43.56 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.263 1.025 . . . . 0.0 111.566 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 160.28 -146.7 12.97 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-O 118.815 -0.992 . . . . 0.0 113.664 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.69 -8.85 22.02 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.702 2.934 . . . . 0.0 114.485 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 5.4 t -159.4 162.88 35.84 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.848 1.204 . . . . 0.0 112.633 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -70.63 146.74 49.82 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.785 1.234 . . . . 0.0 110.892 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 23.3 m -131.89 145.69 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.992 1.317 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.54 99.39 12.26 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.862 0.865 . . . . 0.0 110.07 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 42.3 mt -81.04 131.38 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.208 1.003 . . . . 0.0 109.973 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -126.36 152.8 45.79 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.407 1.883 . . . . 0.0 110.207 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 33.7 p -138.93 154.16 48.31 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.991 1.316 . . . . 0.0 111.697 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -152.43 126.85 9.32 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.751 1.22 . . . . 0.0 111.156 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.81 128.08 32.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.506 1.122 . . . . 0.0 110.897 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 72.4 mt -97.43 155.05 17.09 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.647 1.179 . . . . 0.0 111.786 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.77 -16.63 64.21 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.255 1.022 . . . . 0.0 113.429 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -74.15 -11.79 60.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.998 1.319 . . . . 0.0 113.313 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 94.48 -0.49 65.68 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.936 1.731 . . . . 0.0 114.293 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 41.3 p -89.29 167.69 12.85 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.47 1.908 . . . . 0.0 111.253 175.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 43.5 t -117.33 130.34 56.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.083 0.953 . . . . 0.0 111.088 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -94.32 139.72 30.72 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.007 1.323 . . . . 0.0 110.146 172.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 21.7 t -125.3 139.54 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.009 1.724 . . . . 0.0 108.954 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 12.8 p -138.02 152.76 49.19 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.402 1.481 . . . . 0.0 111.386 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 18.9 p90 -162.88 148.42 12.04 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.589 1.556 . . . . 0.0 110.806 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 30.2 t -109.2 106.78 59.21 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 123.599 0.76 . . . . 0.0 110.658 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.33 106.05 1.98 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.376 2.717 . . . . 0.0 110.238 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 24.9 m -66.38 -44.0 84.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.03 0.932 . . . . 0.0 112.74 -171.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -92.4 148.21 35.99 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.431 1.092 . . . . 0.0 110.842 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.88 165.64 29.62 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.321 2.681 . . . . 0.0 111.602 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 125.82 -162.12 20.11 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 125.179 1.371 . . . . 0.0 113.561 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 50.9 t30 -93.8 125.2 38.29 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.698 0.799 . . . . 0.0 111.524 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -108.89 143.49 38.05 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.107 1.363 . . . . 0.0 110.241 168.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.33 133.72 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.748 1.219 . . . . 0.0 108.533 173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 23.7 mt -111.64 129.72 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.987 1.315 . . . . 0.0 109.308 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -108.58 125.29 51.68 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.423 1.489 . . . . 0.0 110.153 175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 25.8 mm -112.16 121.59 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.011 0.924 . . . . 0.0 109.238 172.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -127.13 133.02 50.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.174 1.789 . . . . 0.0 110.527 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 21.1 t80 -130.6 126.55 36.97 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.556 1.142 . . . . 0.0 110.549 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 51.51 40.01 25.93 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.865 1.266 . . . . 0.0 112.578 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . . 19.2 t0 72.87 5.42 5.19 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.576 2.75 . . . . 0.0 114.651 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -109.69 128.71 55.45 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.994 1.318 . . . . 0.0 110.589 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -67.13 123.15 19.47 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.755 1.222 . . . . 0.0 111.104 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 2.8 m -81.91 160.61 63.15 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.279 -0.888 . . . . 0.0 111.915 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.0 141.76 67.01 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.766 2.977 . . . . 0.0 113.659 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 88.31 -22.87 17.48 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.022 1.296 . . . . 0.0 114.287 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 74.7 m -73.52 150.57 89.17 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 118.861 1.33 . . . . 0.0 111.525 171.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -73.52 139.65 62.71 Favored 'Cis proline' 0 C--N 1.352 0.759 0 CA-C-N 119.365 0.809 . . . . 0.0 111.111 -5.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -93.22 114.69 27.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.945 0.898 . . . . 0.0 110.337 176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 62.0 m -82.75 128.28 34.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.877 0.871 . . . . 0.0 110.933 172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 14.6 t -123.92 114.9 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.766 1.626 . . . . 0.0 109.636 -171.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -81.57 108.79 15.43 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.274 0.629 . . . . 0.0 111.213 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 84.4 t -94.68 121.45 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.835 1.254 . . . . 0.0 109.226 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 5.5 t -109.01 164.56 12.3 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.908 1.283 . . . . 0.0 111.882 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 115.15 177.06 18.74 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.703 1.62 . . . . 0.0 113.575 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -86.9 161.98 17.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.941 1.297 . . . . 0.0 112.473 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -81.24 143.51 23.95 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.177 0.894 . . . . 0.0 111.071 165.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -74.57 142.29 44.7 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.704 0.801 . . . . 0.0 112.347 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 96.1 t -112.27 139.02 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.074 1.749 . . . . 0.0 109.108 172.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.718 1.607 . . . . 0.0 111.728 -179.092 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.54 151.4 46.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.227 1.011 . . . . 0.0 112.611 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 78.2 mtm -142.71 163.35 33.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.94 1.696 . . . . 0.0 111.539 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 107.01 153.68 19.48 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.603 1.573 . . . . 0.0 113.285 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -85.52 -9.12 57.85 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.411 1.484 . . . . 0.0 114.221 -177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.15 -4.42 55.34 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.849 1.66 . . . . 0.0 114.692 -175.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1957 ' ' SER . . . . . . . . . . . . . 49.4 m -63.21 137.03 58.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.649 1.18 . . . . 0.0 114.038 -175.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1958 ' ' MET . . . . . . . . . . . . . 82.9 mmm -74.15 162.88 28.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.781 1.232 . . . . 0.0 111.241 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1959 ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -128.49 149.56 50.53 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.533 1.133 . . . . 0.0 111.73 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1960 ' ' MET . . . . . . . . . . . . . 24.8 ptm -120.41 153.97 35.79 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.233 1.413 . . . . 0.0 112.69 176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1961 ' ' SER . . . . . . . . . . . . . 6.8 m -134.78 145.49 48.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.847 2.059 . . . . 0.0 108.994 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1962 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -146.29 157.03 43.76 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1963 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.2 141.36 16.31 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.218 1.807 . . . . 0.0 109.982 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1964 ' ' LYS . . . . . . . . . . . . . 98.6 mttt -132.21 143.72 50.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.736 1.214 . . . . 0.0 112.512 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1965 ' ' VAL . . . . . . . . . . . . . 29.9 m -143.46 151.8 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 125.331 1.452 . . . . 0.0 111.278 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1966 ' ' GLY . . . . . . . . . . . . . . . -85.16 153.1 27.54 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 124.344 0.973 . . . . 0.0 112.132 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1967 ' ' SER . . . . . . . . . . . . . 49.2 m -140.3 137.03 33.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.508 0.723 . . . . 0.0 112.692 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1968 ' ' ALA . . . . . . . . . . . . . . . -161.0 154.23 21.55 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.701 1.2 . . . . 0.0 112.19 -176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1969 ' ' ALA . . . . . . . . . . . . . . . -84.38 133.16 34.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.008 0.923 . . . . 0.0 111.076 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1970 ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -85.35 135.03 34.06 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.219 1.008 . . . . 0.0 110.608 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1971 ' ' ILE . . . . . . . . . . . . . 63.3 mt -122.76 113.16 30.38 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.886 0.874 . . . . 0.0 109.9 -177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1972 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.43 150.55 36.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.047 2.498 . . . . 0.0 110.587 171.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1973 ' ' ILE . . . . . . . . . . . . . 67.9 mt -129.92 141.06 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.411 1.084 . . . . 0.0 110.039 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1974 ' ' ASN . . . . . . . . . . . . . 48.7 t-20 11.32 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.41 3.084 . . . . 0.0 115.377 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1975 ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.05 116.64 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.651 1.18 . . . . 0.0 112.004 -161.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1976 ' ' SER . . . . . . . . . . . . . 77.3 p -172.81 166.41 5.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.627 1.971 . . . . 0.0 110.583 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1977 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.28 141.9 27.91 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.951 0.9 . . . . 0.0 111.593 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1978 ' ' THR . . . . . . . . . . . . . 1.2 m -176.89 139.77 0.3 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.338 2.655 . . . . 0.0 109.106 -174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1979 ' ' ASP . . . . . . . . . . . . . 13.5 t70 -66.5 133.04 49.56 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.292 1.037 . . . . 0.0 112.317 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1980 ' ' LEU . . . . . . . . . . . . . 22.1 tp -76.24 -25.57 55.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.277 1.031 . . . . 0.0 113.711 -172.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1981 ' ' SER . . . . . . . . . . . . . 49.1 m -84.37 -26.28 28.51 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -169.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1982 ' ' LEU . . . . . . . . . . . . . 1.9 pp -92.47 9.4 34.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.798 1.239 . . . . 0.0 113.577 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1983 ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.63 148.68 23.05 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.473 1.509 . . . . 0.0 111.811 170.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1984 ' ' THR . . . . . . . . . . . . . 45.3 p -136.97 157.43 46.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.107 1.763 . . . . 0.0 109.367 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1985 ' ' ALA . . . . . . . . . . . . . . . -153.44 148.28 26.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.939 0.896 . . . . 0.0 112.355 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1986 ' ' THR . . . . . . . . . . . . . 74.9 p -140.37 160.16 40.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.337 1.855 . . . . 0.0 109.999 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1987 ' ' VAL . . . . . . . . . . . . . 2.0 t -114.93 135.42 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.425 1.49 . . . . 0.0 109.471 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1988 ' ' VAL . . . . . . . . . . . . . 98.3 t -106.81 110.74 63.84 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.942 1.297 . . . . 0.0 107.889 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1989 ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.07 167.73 24.51 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.622 2.881 . . . . 0.0 110.622 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1990 ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.76 -14.66 42.38 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.949 2.432 . . . . 0.0 113.061 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1991 ' ' SER . . . . . . . . . . . . . 61.1 p -79.66 -9.74 59.68 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.361 1.464 . . . . 0.0 113.936 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1992 ' ' GLY . . . . . . . . . . . . . . . 81.96 -1.68 85.92 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.691 1.615 . . . . 0.0 115.168 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1993 ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -77.29 81.66 3.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.553 1.541 . . . . 0.0 111.496 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1994 ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -58.99 135.72 57.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.636 1.174 . . . . 0.0 112.212 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1995 ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -138.79 148.93 60.2 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.764 1.626 . . . . 0.0 111.023 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1996 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.76 152.54 37.42 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.523 2.815 . . . . 0.0 111.808 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1997 ' ' CYS . . . . . . . . . . . . . 80.6 m -102.7 151.45 22.37 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.563 1.145 . . . . 0.0 111.74 173.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1998 ' ' LEU . . . . . . . . . . . . . 56.9 tp -83.03 126.59 32.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.878 0.871 . . . . 0.0 108.774 163.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1999 ' ' LEU . . . . . . . . . . . . . 15.4 mt -94.87 140.52 29.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.053 1.341 . . . . 0.0 110.36 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2000 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -141.94 145.58 34.69 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.276 1.03 . . . . 0.0 113.021 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2001 ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -85.78 108.44 18.09 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 153.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2002 ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.37 166.25 21.47 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.166 0.986 . . . . 0.0 111.453 -173.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2003 ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -64.68 -21.61 66.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2004 ' ' ASN . . . . . . . . . . . . . 57.1 t30 -81.4 -9.11 59.8 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.596 1.158 . . . . 0.0 113.599 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2005 ' ' GLY . . . . . . . . . . . . . . . 98.45 -6.74 61.31 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.866 1.698 . . . . 0.0 114.566 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2006 ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.06 162.73 19.2 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.697 1.199 . . . . 0.0 113.406 173.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2007 ' ' VAL . . . . . . . . . . . . . 12.5 p -94.84 142.11 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.081 1.352 . . . . 0.0 111.057 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2008 ' ' GLY . . . . . . . . . . . . . . . -156.65 177.8 33.42 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 115.569 0.987 . . . . 0.0 115.569 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2009 ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.23 162.64 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.987 1.715 . . . . 0.0 112.271 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2010 ' ' SER . . . . . . . . . . . . . 32.5 t -146.87 148.8 32.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.752 1.621 . . . . 0.0 110.57 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2011 ' ' PHE . . . . . . . . . . . . . 8.5 p90 -169.41 175.49 5.49 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.334 2.254 . . . . 0.0 110.043 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2012 ' ' VAL . . . . . . . . . . . . . 71.3 t -124.86 116.08 26.31 Favored Pre-proline 0 N--CA 1.48 1.037 0 C-N-CA 124.117 0.967 . . . . 0.0 109.805 172.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2013 ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.24 143.21 28.07 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.944 3.096 . . . . 0.0 110.858 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2014 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.44 -19.26 15.0 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 173.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2015 ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -116.77 171.0 8.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.264 1.826 . . . . 0.0 110.726 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2016 ' ' THR . . . . . . . . . . . . . 41.9 p -97.91 169.02 9.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.48 1.512 . . . . 0.0 111.107 169.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2017 ' ' GLY . . . . . . . . . . . . . . . 99.69 -170.65 23.23 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.362 1.458 . . . . 0.0 113.815 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2018 ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -71.83 112.02 7.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.025 0.93 . . . . 0.0 111.472 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2019 ' ' HIS . . . . . . . . . . . . . 8.9 m80 -97.47 143.36 28.27 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.649 1.58 . . . . 0.0 109.269 168.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2020 ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.83 125.11 50.57 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.336 1.054 . . . . 0.0 109.222 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2021 ' ' VAL . . . . . . . . . . . . . 21.3 t -88.69 127.79 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.287 1.035 . . . . 0.0 108.237 168.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2022 ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -106.41 137.21 44.81 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.263 1.425 . . . . 0.0 109.96 171.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2023 ' ' VAL . . . . . . . . . . . . . 84.7 t -136.33 134.77 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.425 1.09 . . . . 0.0 109.566 -170.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2024 ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -133.8 132.31 40.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.23 1.412 . . . . 0.0 111.137 -169.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2025 ' ' LYS . . . . . . . . . . . . . 87.3 tttt -124.95 128.13 48.13 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.791 2.036 . . . . 0.0 109.627 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2026 ' ' ASN . . . . . . . . . . . . . 46.3 t30 59.94 22.19 11.24 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.048 0.939 . . . . 0.0 113.289 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2027 ' ' GLY . . . . . . . . . . . . . . . 84.94 7.37 83.95 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 124.941 1.258 . . . . 0.0 114.91 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2028 ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -119.26 133.74 55.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.033 1.733 . . . . 0.0 109.465 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2029 ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.18 138.31 58.18 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.494 -1.379 . . . . 0.0 112.135 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2030 ' ' VAL . . . . . . . . . . . . . 22.9 m -78.83 159.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.214 0.606 . . . . 0.0 112.283 -170.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2031 ' ' ALA . . . . . . . . . . . . . . . -64.22 -20.75 66.25 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2032 ' ' SER . . . . . . . . . . . . . 49.8 m -86.4 -19.34 29.84 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2033 ' ' SER . . . . . . . . . . . . . 67.5 p -92.96 154.0 41.86 Favored Pre-proline 0 CA--C 1.55 0.979 0 O-C-N 120.887 -1.133 . . . . 0.0 113.846 -173.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2034 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.65 147.58 89.94 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.138 0.728 . . . . 0.0 112.485 -0.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2035 ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.12 120.22 51.69 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.013 1.325 . . . . 0.0 108.503 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2036 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.21 140.53 12.36 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.858 2.372 . . . . 0.0 111.288 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2037 ' ' VAL . . . . . . . . . . . . . 23.4 t -135.44 123.51 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.391 1.476 . . . . 0.0 107.768 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2038 ' ' VAL . . . . . . . . . . . . . 59.5 t -96.46 120.99 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.593 0.757 . . . . 0.0 109.795 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2039 ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.3 123.01 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.779 1.231 . . . . 0.0 109.035 -177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2040 ' ' SER . . . . . . . . . . . . . 32.5 t -92.36 158.46 16.07 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.729 0.812 . . . . 0.0 111.408 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2041 ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -59.74 -29.68 68.32 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.252 -0.905 . . . . 0.0 111.428 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2042 ' ' SER . . . . . . . . . . . . . 18.1 m -63.18 -13.26 35.2 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.666 1.186 . . . . 0.0 113.928 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2043 ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -94.71 -11.17 29.63 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.942 1.297 . . . . 0.0 112.371 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2044 ' ' ILE . . . . . . . . . . . . . 48.6 mm -95.75 95.99 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.756 1.222 . . . . 0.0 109.917 -175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2045 ' ' GLY . . . . . . . . . . . . . . . 65.02 24.63 70.35 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 115.0 0.76 . . . . 0.0 115.0 168.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2046 ' ' ASP . . . . . . . . . . . . . 34.0 t0 -76.22 89.52 3.11 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.358 1.079 . . . . 0.0 111.9 -171.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2047 ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.99 75.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.748 1.219 . . . . 0.0 112.789 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2048 ' ' SER . . . . . . . . . . . . . 34.8 m -60.7 -22.12 63.6 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.302 1.041 . . . . 0.0 113.574 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2049 ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -88.66 -8.98 53.65 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.077 1.351 . . . . 0.0 113.903 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2050 ' ' VAL . . . . . . . . . . . . . 60.5 t -77.52 131.31 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.866 1.212 . . . . 0.0 109.655 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2051 ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -116.22 161.01 19.61 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.94 1.296 . . . . 0.0 111.373 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2052 ' ' VAL . . . . . . . . . . . . . 36.0 m -146.11 153.88 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.385 1.474 . . . . 0.0 110.643 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2053 ' ' SER . . . . . . . . . . . . . 73.4 m -149.09 165.85 30.51 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.069 1.348 . . . . 0.0 112.103 -173.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2054 ' ' GLY . . . . . . . . . . . . . . . 102.66 162.08 26.0 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 124.345 0.974 . . . . 0.0 114.577 173.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2055 ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -73.9 -27.67 61.16 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.967 1.307 . . . . 0.0 113.644 -167.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2056 ' ' GLY . . . . . . . . . . . . . . . -68.86 -5.58 47.09 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.733 1.159 . . . . 0.0 115.042 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2057 ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.82 -7.02 58.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.676 1.591 . . . . 0.0 112.787 169.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2058 ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -128.29 -36.01 1.95 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.955 1.302 . . . . 0.0 113.8 -173.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2059 ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.7 155.51 30.09 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 112.474 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2060 ' ' GLY . . . . . . . . . . . . . . . -148.6 -176.19 21.79 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.881 1.229 . . . . 0.0 114.358 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2061 ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -139.41 152.67 47.27 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.345 1.458 . . . . 0.0 112.145 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2062 ' ' THR . . . . . . . . . . . . . 25.5 p -71.5 -41.84 68.77 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2063 ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -100.18 -11.16 20.67 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -170.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2064 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -114.66 145.75 34.54 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.073 1.349 . . . . 0.0 110.258 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2065 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.78 137.83 36.31 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.545 2.163 . . . . 0.0 110.422 175.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2066 ' ' ALA . . . . . . . . . . . . . . . -84.03 150.37 25.65 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.109 0.964 . . . . 0.0 109.997 168.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2067 ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.25 151.19 46.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2068 ' ' PHE . . . . . . . . . . . . . 52.2 p90 -159.26 155.59 27.23 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.613 1.565 . . . . 0.0 111.001 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2069 ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.52 143.14 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.41 1.884 . . . . 0.0 109.961 -175.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2070 ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.25 133.89 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 126.238 1.815 . . . . 0.0 109.026 172.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2071 ' ' ASP . . . . . . . . . . . . . 62.7 t0 -122.81 99.82 6.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.018 1.727 . . . . 0.0 110.875 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2072 ' ' THR . . . . . . . . . . . . . 32.6 p -99.73 4.83 45.64 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.499 1.92 . . . . 0.0 112.735 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2073 ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -60.9 -37.32 81.82 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.255 1.022 . . . . 0.0 112.577 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2074 ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.27 -28.96 38.29 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.071 0.948 . . . . 0.0 112.716 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2075 ' ' ALA . . . . . . . . . . . . . . . -72.49 -11.49 60.69 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2076 ' ' GLY . . . . . . . . . . . . . . . 85.86 -108.23 3.22 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.426 1.012 . . . . 0.0 112.068 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2077 ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -127.32 147.15 50.25 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.925 1.29 . . . . 0.0 112.97 -168.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2078 ' ' GLY . . . . . . . . . . . . . . . 156.73 -137.68 5.56 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.543 1.068 . . . . 0.0 113.283 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2079 ' ' GLY . . . . . . . . . . . . . . . -157.68 141.46 7.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.497 1.046 . . . . 0.0 112.047 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2080 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.48 124.99 45.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.916 1.686 . . . . 0.0 109.38 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2081 ' ' SER . . . . . . . . . . . . . 23.2 t -115.69 138.91 50.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.33 1.452 . . . . 0.0 109.902 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2082 ' ' LEU . . . . . . . . . . . . . 8.4 tt -136.75 132.95 35.49 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.62 1.168 . . . . 0.0 109.902 -168.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2083 ' ' SER . . . . . . . . . . . . . 66.7 m -133.66 130.23 37.95 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.386 0.675 . . . . 0.0 111.197 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2084 ' ' ILE . . . . . . . . . . . . . 21.9 mt -109.24 130.07 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.083 1.353 . . . . 0.0 108.244 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2085 ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.78 142.5 51.37 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.337 1.455 . . . . 0.0 109.758 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2086 ' ' GLY . . . . . . . . . . . . . . . 177.27 -165.24 35.01 Favored Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2087 ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.1 -9.89 26.41 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.175 3.25 . . . . 0.0 114.05 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2088 ' ' SER . . . . . . . . . . . . . 8.0 t -155.88 162.51 40.41 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.386 1.074 . . . . 0.0 112.078 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2089 ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -67.31 147.12 53.38 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.664 1.186 . . . . 0.0 111.327 173.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2090 ' ' VAL . . . . . . . . . . . . . 32.2 m -130.84 146.14 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.143 1.377 . . . . 0.0 110.903 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2091 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.37 105.82 17.83 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.679 0.792 . . . . 0.0 109.957 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2092 ' ' ILE . . . . . . . . . . . . . 52.3 mt -84.41 129.1 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.247 1.019 . . . . 0.0 109.599 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2093 ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -125.69 161.16 27.91 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 0.0 110.795 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2094 ' ' THR . . . . . . . . . . . . . 35.6 p -141.8 155.52 45.59 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.252 1.421 . . . . 0.0 111.951 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2095 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.45 138.05 15.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 111.515 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2096 ' ' ASP . . . . . . . . . . . . . 35.0 t70 -86.97 129.03 35.05 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.117 1.367 . . . . 0.0 111.31 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2097 ' ' LEU . . . . . . . . . . . . . 43.2 mt -99.31 160.62 14.14 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.308 1.043 . . . . 0.0 112.525 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2098 ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -67.37 -17.04 64.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.522 1.129 . . . . 0.0 113.35 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2099 ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -78.43 -9.15 59.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.144 1.378 . . . . 0.0 113.291 172.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2100 ' ' GLY . . . . . . . . . . . . . . . 87.81 1.91 82.13 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.412 1.482 . . . . 0.0 114.018 -175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2101 ' ' THR . . . . . . . . . . . . . 40.4 p -89.18 165.49 14.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.332 1.853 . . . . 0.0 111.432 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2102 ' ' CYS . . . . . . . . . . . . . 42.6 t -109.94 124.87 52.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.304 1.042 . . . . 0.0 110.993 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2103 ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -83.62 135.4 34.62 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 165.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2104 ' ' VAL . . . . . . . . . . . . . 45.7 t -117.36 139.31 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.953 1.701 . . . . 0.0 108.773 171.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2105 ' ' THR . . . . . . . . . . . . . 2.9 p -134.97 151.61 50.99 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.782 1.633 . . . . 0.0 111.83 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2106 ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.39 150.74 14.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.521 1.528 . . . . 0.0 111.787 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2107 ' ' CYS . . . . . . . . . . . . . 11.5 t -115.81 99.39 52.5 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.277 1.031 . . . . 0.0 111.039 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2108 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.44 94.12 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.706 2.937 . . . . 0.0 110.669 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2109 ' ' THR . . . . . . . . . . . . . 51.8 m -63.09 -41.76 99.47 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.868 . . . . 0.0 112.78 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2110 ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -87.3 140.78 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.711 0.805 . . . . 0.0 110.668 174.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2111 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.97 168.64 24.38 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.506 2.804 . . . . 0.0 111.554 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2112 ' ' GLY . . . . . . . . . . . . . . . 127.0 -147.31 16.84 Favored Glycine 0 N--CA 1.47 0.938 0 C-N-CA 124.816 1.198 . . . . 0.0 112.695 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2113 ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -109.75 133.56 53.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.074 0.95 . . . . 0.0 111.836 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2114 ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -118.29 151.37 37.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.784 1.633 . . . . 0.0 110.707 172.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2115 ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.06 133.26 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.518 1.527 . . . . 0.0 108.699 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2116 ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.54 128.97 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.592 1.157 . . . . 0.0 109.789 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2117 ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -110.54 125.25 53.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.895 1.678 . . . . 0.0 110.015 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2118 ' ' ILE . . . . . . . . . . . . . 23.6 mm -115.63 116.42 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.11 0.964 . . . . 0.0 109.246 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2119 ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -125.71 132.8 52.3 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.16 1.384 . . . . 0.0 111.201 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2120 ' ' PHE . . . . . . . . . . . . . 72.4 t80 -123.82 124.22 42.2 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.678 1.591 . . . . 0.0 110.312 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2121 ' ' ALA . . . . . . . . . . . . . . . 53.73 30.97 11.99 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.331 1.452 . . . . 0.0 114.177 177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2122 ' ' ASP . . . . . . . . . . . . 0.257 7.0 t70 85.68 11.91 0.22 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 128.784 2.834 . . . . 0.0 114.728 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2123 ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -120.6 132.18 55.01 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.556 1.143 . . . . 0.0 111.48 173.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2124 ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -67.86 124.48 23.45 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.338 1.455 . . . . 0.0 110.676 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2125 ' ' VAL . . . . . . . . . . . . . 3.0 m -80.72 158.76 70.4 Favored Pre-proline 0 N--CA 1.486 1.33 0 O-C-N 121.189 -0.944 . . . . 0.0 111.825 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2126 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.51 134.93 64.24 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.649 2.899 . . . . 0.0 113.253 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2127 ' ' GLY . . . . . . . . . . . . . . . 94.85 -22.31 38.73 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.247 1.403 . . . . 0.0 114.073 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2128 ' ' SER . . . . . . . . . . . . . 62.9 m -75.22 150.59 85.39 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 118.922 1.361 . . . . 0.0 112.024 172.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2129 ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.35 142.87 73.16 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.053 0.697 . . . . 0.0 111.113 -4.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2130 ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -93.62 127.76 39.46 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.432 1.093 . . . . 0.0 110.834 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2131 ' ' SER . . . . . . . . . . . . . 30.5 t -95.97 129.29 43.27 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.345 1.058 . . . . 0.0 110.988 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2132 ' ' VAL . . . . . . . . . . . . . 11.9 t -128.46 117.14 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.001 1.32 . . . . 0.0 110.007 -170.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2133 ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -85.84 120.35 27.16 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.76 -0.587 . . . . 0.0 110.521 173.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2134 ' ' VAL . . . . . . . . . . . . . 78.9 t -102.08 118.99 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.587 1.555 . . . . 0.0 108.862 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2135 ' ' THR . . . . . . . . . . . . . 1.3 t -99.61 162.85 12.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.583 1.153 . . . . 0.0 111.333 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2136 ' ' GLY . . . . . . . . . . . . . . . 171.47 -168.35 41.46 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 -177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2137 ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -137.66 174.62 10.39 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.611 1.964 . . . . 0.0 110.215 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2138 ' ' GLY . . . . . . . . . . . . . . . -75.85 138.17 22.56 Favored Glycine 0 CA--C 1.533 1.159 0 O-C-N 121.432 -0.792 . . . . 0.0 112.017 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2139 ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -68.9 145.0 54.05 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.431 1.092 . . . . 0.0 111.289 177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2140 ' ' VAL . . . . . . . . . . . . . 95.8 t -61.64 137.04 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.129 1.371 . . . . 0.0 110.833 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2141 ' ' LYS . . . . . . . . . . . . . 40.6 ttpt . . . . . 0 C--O 1.253 1.288 0 C-N-CA 126.05 1.74 . . . . 0.0 111.294 -176.542 . . . . . . . . 0 0 . 1 stop_ save_